PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhang, JB; Martinoia, E; De Angeli, A				Zhang, Jingbo; Martinoia, Enrico; De Angeli, Alexis			Cytosolic Nucleotides Block and Regulate the Arabidopsis Vacuolar Anion Channel AtALMT9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ALUMINUM TOLERANCE; GUARD-CELLS; ROOT-TIPS; FRACTIONATION; MECHANISM; PROVIDE	The aluminum-activated malate transporters (ALMTs) form a membrane protein family exhibiting different physiological roles in plants, varying from conferring tolerance to environmental Al3+ to the regulation of stomatal movement. The regulation of the anion channels of the ALMT family is largely unknown. Identifying intracellular modulators of the activity of anion channels is fundamental to understanding their physiological functions. In this study we investigated the role of cytosolic nucleotides in regulating the activity of the vacuolar anion channel AtALMT9. We found that cytosolic nucleotides modulate the transport activity of AtALMT9. This modulation was based on a direct block of the pore of the channel at negative membrane potentials (open channel block) by the nucleotide and not by a phosphorylation mechanism. The block by nucleotides of AtALMT9-mediated currents was voltage dependent. The blocking efficiency of intracellular nucleotides increased with the number of phosphate groups and ATP was the most effective cellular blocker. Interestingly, the ATP block induced a marked modification of the current-voltage characteristic of AtALMT9. In addition, increased concentrations of vacuolar anions were able to shift the ATP block threshold to a more negative membrane potential. The block of AtALMT9-mediated anion currents by ATP at negative membrane potentials acts as a gate of the channel and vacuolar anion tune this gating mechanism. Our results suggest that anion transport across the vacuolar membrane in plant cells is controlled by cytosolic nucleotides and the energetic status of the cell.	[Zhang, Jingbo; Martinoia, Enrico; De Angeli, Alexis] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [De Angeli, Alexis] CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France	University of Zurich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Martinoia, E (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	enrico.martinoia@botinst.uzh.ch; alexis.de-angeli@isv.cnrs-gif.fr	Zhang, Jing/GWZ-7332-2022; Martinoia, Enrico/AAH-8712-2021		Chinese Scholarship Council; Swiss National Foundation	Chinese Scholarship Council(China Scholarship Council); Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by grants from the Chinese Scholarship Council (to J. Z.) and the Swiss National Foundation (to E. M. and A. D. A).	Colcombet J, 2001, J BIOL CHEM, V276, P36139, DOI 10.1074/jbc.M103126200; De Angeli A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2815; De Angeli A, 2009, J BIOL CHEM, V284, P26526, DOI 10.1074/jbc.M109.005132; Delhaize E, 2004, P NATL ACAD SCI USA, V101, P15249, DOI 10.1073/pnas.0406258101; Duby G, 2009, PFLUG ARCH EUR J PHY, V457, P645, DOI 10.1007/s00424-008-0457-x; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; GERHARDT R, 1984, PLANT PHYSIOL, V75, P542, DOI 10.1104/pp.75.3.542; GOUT E, 1992, J BIOL CHEM, V267, P13903; HEDRICH R, 1990, EMBO J, V9, P3889, DOI 10.1002/j.1460-2075.1990.tb07608.x; HEDRICH R, 1993, EMBO J, V12, P897, DOI 10.1002/j.1460-2075.1993.tb05730.x; Hoekenga OA, 2006, P NATL ACAD SCI USA, V103, P9738, DOI 10.1073/pnas.0602868103; Kovermann P, 2007, PLANT J, V52, P1169, DOI 10.1111/j.1365-313X.2007.03367.x; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; Martinoia E, 2012, ANNU REV PLANT BIOL, V63, P183, DOI 10.1146/annurev-arplant-042811-105608; Meyer S, 2011, PLANT J, V67, P247, DOI 10.1111/j.1365-313X.2011.04587.x; Meyer S, 2010, PLANT J, V63, P1054, DOI 10.1111/j.1365-313X.2010.04302.x; Mumm P, 2013, MOL PLANT, V6, P1550, DOI 10.1093/mp/sst008; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Raschke K, 2003, PLANTA, V217, P651, DOI 10.1007/s00425-003-1034-3; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Sasaki T, 2010, PLANT CELL PHYSIOL, V51, P354, DOI 10.1093/pcp/pcq016; SchulzLessdorf B, 1996, PLANT J, V10, P993, DOI 10.1046/j.1365-313X.1996.10060993.x; Thomine S, 1997, J MEMBRANE BIOL, V159, P71, DOI 10.1007/s002329900270; WINTER H, 1994, PLANTA, V193, P530, DOI 10.1007/BF02411558; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; XIA JH, 1995, PLANT PHYSIOL, V108, P589, DOI 10.1104/pp.108.2.589; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; YAZAKI Y, 1988, PLANT CELL PHYSIOL, V29, P919; Zhang JB, 2013, PLANT PHYSIOL, V163, P830, DOI 10.1104/pp.113.219832	32	16	17	1	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25581	25589		10.1074/jbc.M114.576108	http://dx.doi.org/10.1074/jbc.M114.576108			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25028514	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000342130800019
J	Favrot, L; Lajiness, DH; Ronning, DR				Favrot, Lorenza; Lajiness, Daniel H.; Ronning, Donald R.			Inactivation of the Mycobacterium tuberculosis Antigen 85 Complex by Covalent, Allosteric Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; RESISTANCE; MECHANISM; PROTEINS; BIOSYNTHESIS; ENVELOPE; THERAPY; EBSELEN; TARGETS; TRYPSIN	The rise of multidrug-resistant and totally drug-resistant tuberculosis and the association with an increasing number of HIV-positive patients developing tuberculosis emphasize the necessity to find new antitubercular targets and drugs. The antigen 85 (Ag85) complex from Mycobacterium tuberculosis plays important roles in the biosynthesis of major components of the mycobacterial cell envelope. For this reason, Ag85 has emerged as an attractive drug target. Recently, ebselen was identified as an effective inhibitor of the Ag85 complex through covalent modification of a cysteine residue proximal to the Ag85 active site and is therefore a covalent, allosteric inhibitor. To expand the understanding of this process, we have solved the x-ray crystal structures of Ag85C covalently modified with ebselen and other thiol-reactive compounds, p-chloromercuribenzoic acid and iodoacetamide, as well as the structure of a cysteine to glycine mutant. All four structures confirm that chemical modification or mutation at this particular cysteine residue leads to the disruption of the active site hydrogen-bonded network essential for Ag85 catalysis. We also describe x-ray crystal structures of Ag85C single mutants within the catalytic triad and show that a mutation of any one of these three residues promotes the same conformational change observed in the cysteine-modified forms. These results provide evidence for active site dynamics that may afford new strategies for the development of selective and potent Ag85 inhibitors.	[Favrot, Lorenza; Lajiness, Daniel H.; Ronning, Donald R.] Univ Toledo, Dept Chem & Biochem, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Ronning, DR (corresponding author), Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA.	donald.ronning@utoledo.edu		Ronning, Donald/0000-0003-2583-8849	National Institutes of Health (NIH) [AI089653, AI105084]; DOE [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NCI, NIH [Y1-CO-1020]; NIGMS, NIH [Y1-GM-1104]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105084, R15AI089653] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants AI089653 and AI105084. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the DOE under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). GM/CA has been funded in whole or in part with Federal funds from NCI, NIH, Grant Y1-CO-1020 and NIGMS, NIH, Grant Y1-GM-1104.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Backus KM, 2011, NAT CHEM BIOL, V7, P228, DOI 10.1038/NCHEMBIO.539; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; BARRON ESG, 1945, J BIOL CHEM, V157, P221; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Boucau J, 2009, ANAL BIOCHEM, V385, P120, DOI 10.1016/j.ab.2008.10.018; Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; CRAIK CS, 1987, SCIENCE, V237, P909, DOI 10.1126/science.3303334; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Favrot L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3748; Favrot L, 2012, EXPERT REV ANTI-INFE, V10, P1023, DOI [10.1586/eri.12.91, 10.1586/ERI.12.91]; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Harth G, 1996, INFECT IMMUN, V64, P3038, DOI 10.1128/IAI.64.8.3038-3047.1996; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Jackson M, 2013, FUTURE MICROBIOL, V8, P855, DOI 10.2217/fmb.13.52; JARLIER V, 1994, FEMS MICROBIOL LETT, V123, P11, DOI 10.1111/j.1574-6968.1994.tb07194.x; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Leiros HKS, 2001, ACTA CRYSTALLOGR D, V57, P488, DOI 10.1107/S0907444901000646; Loewenberg S, 2012, LANCET, V379, P205, DOI 10.1016/S0140-6736(12)60085-3; Lu J, 2013, FASEB J, V27, P1394, DOI 10.1096/fj.12-223305; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Nguyen L, 2005, J BACTERIOL, V187, P6603, DOI 10.1128/JB.187.19.6603-6611.2005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parnham M, 2000, EXPERT OPIN INV DRUG, V9, P607, DOI 10.1517/13543784.9.3.607; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Ravelli RBG, 2000, STRUCTURE, V8, P315, DOI 10.1016/S0969-2126(00)00109-X; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Sanki AK, 2009, GLYCOCONJUGATE J, V26, P589, DOI 10.1007/s10719-008-9211-z; Singh N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2320; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; SPRANG S, 1987, SCIENCE, V237, P905, DOI 10.1126/science.3112942; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Weiner M, 2005, CLIN INFECT DIS, V40, P1481, DOI 10.1086/429321; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12	47	31	32	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25031	25040		10.1074/jbc.M114.582445	http://dx.doi.org/10.1074/jbc.M114.582445			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25028518	Green Published, hybrid			2022-12-25	WOS:000341985300027
J	Lennon, FE; Mirzapoiazova, T; Mambetsariev, N; Mambetsariev, B; Salgia, R; Singleton, PA				Lennon, Frances E.; Mirzapoiazova, Tamara; Mambetsariev, Nurbek; Mambetsariev, Bolot; Salgia, Ravi; Singleton, Patrick A.			Transactivation of the Receptor-tyrosine Kinase Ephrin Receptor A2 Is Required for the Low Molecular Weight Hyaluronan-mediated Angiogenesis That Is implicated in Tumor Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; CD44; Endothelial Cell; Hyaluronan; Hyaluronate; Ras Homolog Gene Family; Member A (RhoA); Dbs; EphA2; PATJ; Anginex	NUCLEOTIDE EXCHANGE FACTOR; ENDOTHELIAL-CELLS; GROWTH-FACTOR; SIGNALING PATHWAYS; EPHA RECEPTOR; ADHESION MOLECULES; VASCULAR-DISEASE; UP-REGULATION; CD44; OLIGOSACCHARIDES	Background: Hyaluronan (HA)-mediated angiogenesis has been implicated in tumor progression. Results: LMW-HA-mediated transactivation of EphA2 is required for PATJ and Dbs membrane recruitment and subsequent RhoA activation required for angiogenesis. Conclusion: EphA2 plays a crucial role in HA-mediated angiogenesis. Significance: Targeting downstream effectors of LMW-HA could be a useful therapeutic intervention for angiogenesis-associated diseases including various malignancies. Angiogenesis or the formation of new blood vessels is important in the growth and metastatic potential of various cancers. Therefore, understanding the mechanism(s) by which angiogenesis occurs can have important therapeutic implications in numerous malignancies. We and others have demonstrated that low molecular weight hyaluronan (LMW-HA, approximate to 2500 Da) promotes endothelial cell (EC) barrier disruption and angiogenesis. However, the mechanism(s) by which this occurs is poorly defined. Our data indicate that treatment of human EC with LMW-HA induced CD44v10 association with the receptor-tyrosine kinase, EphA2, transactivation (tyrosine phosphorylation) of EphA2, and recruitment of the PDZ domain scaffolding protein, PATJ, to the cell periphery. Silencing (siRNA) CD44, EphA2, PATJ, or Dbs (RhoGEF) expression blocked LMW-HA-mediated angiogenesis (EC proliferation, migration, and tubule formation). In addition, silencing EphA2, PATJ, Src, or Dbs expression blocked LMW-HA-mediated RhoA activation. To translate our in vitro findings, we utilized a novel anginex/liposomal targeting of murine angiogenic endothelium with either CD44 or EphA2 siRNA and observed inhibition of LMW-HA-induced angiogenesis in implanted Matrigel plugs. Taken together, these results indicate LMW-HA-mediated transactivation of EphA2 is required for PATJ and Dbs membrane recruitment and subsequent RhoA activation required for angiogenesis. These results suggest that targeting downstream effectors of LMW-HA could be a useful therapeutic intervention for angiogenesis-associated diseases including tumor progression.	[Singleton, Patrick A.] Univ Chicago, Dept Med, Chicago, IL 60657 USA; [Lennon, Frances E.; Mirzapoiazova, Tamara; Mambetsariev, Nurbek; Mambetsariev, Bolot; Singleton, Patrick A.] Univ Chicago, Sect Pulm & Crit Care, Chicago, IL 60657 USA; [Salgia, Ravi] Univ Chicago, Sect Hematol & Oncol, Chicago, IL 60657 USA	University of Chicago; University of Chicago; University of Chicago	Singleton, PA (corresponding author), Univ Chicago, Dept Med, MC 6076,I-503C,5841 South Maryland Ave, Chicago, IL 60657 USA.	psinglet@mail.bsd.uchicago.edu			National Institutes of Health (NHLBI) [RO1-HL 095723]; American Heart Association National Scientist Development Grant [0730277N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095723] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association National Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-HL 095723 (NHLBI; to P. A. S.). This work was also supported by the American Heart Association National Scientist Development Grant 0730277N (to P. A. S.).	Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Beauchamp A, 2012, SEMIN CELL DEV BIOL, V23, P109, DOI 10.1016/j.semcdb.2011.10.019; Bin Fang W, 2008, J BIOL CHEM, V283, P16017, DOI 10.1074/jbc.M709934200; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Brandwijk RJMGE, 2007, BIOCONJUGATE CHEM, V18, P785, DOI 10.1021/bc060316h; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Carpenter TC, 2012, AM J RESP CELL MOL, V46, P40, DOI 10.1165/rcmb.2011-0044OC; Chan B, 2009, THROMB RES, V123, P745, DOI 10.1016/j.thromres.2008.07.010; Cheng N, 2002, MOL CANCER RES, V1, P2; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; Dentener MA, 2005, THORAX, V60, P114, DOI 10.1136/thx.2003.020842; Dings RPM, 2010, BIOCONJUGATE CHEM, V21, P20, DOI 10.1021/bc900287y; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Fang BW, 2008, J CELL SCI, V121, P358, DOI 10.1242/jcs.017145; Faoro L, 2010, J BIOL CHEM, V285, P18575, DOI 10.1074/jbc.M109.075085; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; Folkman J, 1974, Symp Soc Dev Biol, V30, P43; FOLKMAN J, 1991, ANN SURG, V214, P414, DOI 10.1097/00000658-199110000-00006; Gao F, 2008, CLIN INVEST MED, V31, pE106, DOI 10.25011/cim.v31i3.3467; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Griffioen AW, 2001, BIOCHEM J, V354, P233, DOI 10.1042/0264-6021:3540233; Gusenbauer S, 2013, ONCOGENE, V32, P3846, DOI 10.1038/onc.2012.396; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hsieh HL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-152; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Itano N, 2008, CANCER SCI, V99, P1720, DOI 10.1111/j.1349-7006.2008.00885.x; Kostenko EV, 2006, MOL CELL BIOL, V26, P8964, DOI 10.1128/MCB.00670-06; Krupinski J, 2007, BIOMARK INSIGHTS, V2, P361; Larson J, 2008, AM J PHYSIOL-LUNG C, V295, pL431, DOI 10.1152/ajplung.90256.2008; Lennon FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091577; Lennon FE, 2011, AM J PHYSIOL-LUNG C, V301, pL137, DOI 10.1152/ajplung.00071.2010; Leong Tai Teck, 2005, Curr Rheumatol Rep, V7, P325, DOI 10.1007/s11926-005-0044-5; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; Olofsson B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090921; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Park D, 2012, MOL CELLS, V33, P563, DOI 10.1007/s10059-012-2294-1; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Sainz-Jaspeado M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071449; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; Semerano L, 2011, JOINT BONE SPINE, V78, P118, DOI 10.1016/j.jbspin.2010.06.004; Shimizu T, 2012, CURR PHARM DESIGN, V18, P303, DOI 10.2174/138161212799040367; Shin K, 2007, EMBO REP, V8, P158, DOI 10.1038/sj.embor.7400890; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Singleton PA, 2010, AM J PHYSIOL-LUNG C, V299, pL639, DOI 10.1152/ajplung.00405.2009; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; STAMENKOVIC I, 1989, CELL, V56, P1057, DOI 10.1016/0092-8674(89)90638-7; STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Termeer C, 2003, TRENDS IMMUNOL, V24, P112, DOI 10.1016/S1471-4906(03)00029-2; Thijssen VL, 2008, AM J PATHOL, V172, P545, DOI 10.2353/ajpath.2008.070938; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P771, DOI 10.1001/archotol.132.7.771; Wang YZ, 2011, EXP BIOL MED, V236, P84, DOI 10.1258/ebm.2010.010206; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; WHITEHEAD I, 1995, ONCOGENE, V10, P713; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Yamauchi J, 2002, BIOCHEM BIOPH RES CO, V296, P85, DOI 10.1016/S0006-291X(02)00839-2; Zhou N, 2011, MICROVASC RES, V82, P113, DOI 10.1016/j.mvr.2011.06.005	75	26	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24043	24058		10.1074/jbc.M114.554766	http://dx.doi.org/10.1074/jbc.M114.554766			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023279	Green Published, hybrid			2022-12-25	WOS:000341505600005
J	Vidilaseris, K; Shimanovskaya, E; Esson, HJ; Morriswood, B; Dong, G				Vidilaseris, Keni; Shimanovskaya, Ekaterina; Esson, Heather J.; Morriswood, Brooke; Dong, Gang			Assembly Mechanism of Trypanosoma brucei BILBO1, a Multidomain Cytoskeletal Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium-binding Protein; Cytoskeleton; Electron Microscopy (EM); Protein Assembly; Trypanosoma brucei; EF-hand; Leucine Zipper; TbBILBO1; Coiled Coil; Flagellar Pocket Collar	VARIANT SURFACE GLYCOPROTEIN; ANTIPARALLEL COILED COILS; TRANSFER-RNA SYNTHETASE; LEUCINE-ZIPPER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BINDING PROTEINS; FLAGELLAR POCKET; OPTIMIZATION; DIMERIZATION	Background: TbBILBO1 is the only known protein component of the flagellar pocket collar, but its assembly remains unknown. Results: Structural dissections of the three different domains of TbBILBO1 revealed their roles in protein assembly. Conclusion: TbBILBO1 forms a linear filament that interacts laterally to form a fibrous bundle. Significance: The data show how two types of coiled coil act together to assemble TbBILBO1 into long filaments. Trypanosoma brucei BILBO1 (TbBILBO1) is an essential component of the flagellar pocket collar of trypanosomes. We recently reported the high resolution structure of the N-terminal domain of TbBILBO1. Here, we provide further structural dissections of its other three constituent domains: EF-hand, coiled coil, and leucine zipper. We found that the EF-hand changes its conformation upon calcium binding, the central coiled coil forms an antiparallel dimer, and the C-terminal leucine zipper appears to contain targeting information. Furthermore, interdimer interactions between adjacent leucine zippers allow TbBILBO1 to form extended filaments in vitro. These filaments were additionally found to condense into fibers through lateral interactions. Based on these experimental data, we propose a mechanism for TbBILBO1 assembly at the flagellar pocket collar.	Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; Med Univ Vienna, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna	Morriswood, B (corresponding author), Univ Vienna, Dr Bohrgasse 9-3, A-1030 Vienna, Austria.	brooke.morriswood@univie.ac.at; gang.dong@meduniwien.ac.at	Vidilaseris, Keni/Q-1243-2019; Morriswood, Brooke/AAY-9714-2020	Vidilaseris, Keni/0000-0002-6453-6600; Morriswood, Brooke/0000-0001-7031-3801; Dong, Gang/0000-0001-9745-8103	Max F. Perutz Laboratories; Austrian Science Fund [P24383-B21]; Osterreichischer Austauschdienst graduate scholarship; Austrian Science Fund (FWF) [P 24383] Funding Source: researchfish	Max F. Perutz Laboratories; Austrian Science Fund(Austrian Science Fund (FWF)); Osterreichischer Austauschdienst graduate scholarship; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by funding from the Max F. Perutz Laboratories and by Grant P24383-B21 from the Austrian Science Fund (to G. D.).; Supported by an Osterreichischer Austauschdienst graduate scholarship from 2009 to 2012.	Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; BARRY JD, 1979, J CELL SCI, V37, P287; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; BRYSON JW, 1995, SCIENCE, V270, P935, DOI 10.1126/science.270.5238.935; Chen CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-366; Diao JS, 2010, PROTEIN SCI, V19, P319, DOI 10.1002/pro.316; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; DUBIN PL, 1989, J CHROMATOGR, V479, P159, DOI 10.1016/S0021-9673(01)83327-6; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; Gerace L, 2012, J STRUCT BIOL, V177, P24, DOI 10.1016/j.jsb.2011.11.007; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Han BG, 2002, FEBS LETT, V521, P24, DOI 10.1016/S0014-5793(02)02780-1; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Junius FK, 1996, J BIOL CHEM, V271, P13663, DOI 10.1074/jbc.271.23.13663; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lavigne P, 1998, J MOL BIOL, V281, P165, DOI 10.1006/jmbi.1998.1914; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lu Q, 2012, P NATL ACAD SCI USA, V109, P17388, DOI 10.1073/pnas.1208642109; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Oakley MG, 1997, BIOCHEMISTRY-US, V36, P2544, DOI 10.1021/bi962391t; Oakley MG, 2001, CURR OPIN STRUC BIOL, V11, P450, DOI 10.1016/S0959-440X(00)00232-3; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pal A, 2003, BIOCHEM J, V374, P443, DOI 10.1042/BJ20030469; Passon DM, 2012, P NATL ACAD SCI USA, V109, P4846, DOI 10.1073/pnas.1120792109; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Song XM, 2012, CELL REPORTS, V1, P665, DOI 10.1016/j.celrep.2012.04.012; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Vidilaseris K, 2014, J BIOL CHEM, V289, P3724, DOI 10.1074/jbc.M113.529032; Welburn SC, 2012, ADV PARASIT, V79, P299, DOI 10.1016/B978-0-12-398457-9.00004-4; Zheng CL, 2010, BLOOD, V115, P1081, DOI 10.1182/blood-2009-09-241877; Zuccola HJ, 1998, STRUCTURE, V6, P821, DOI 10.1016/S0969-2126(98)00084-7	41	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23870	23881		10.1074/jbc.M114.554659	http://dx.doi.org/10.1074/jbc.M114.554659			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25031322	Green Published, hybrid			2022-12-25	WOS:000341505000053
J	Hu, C; Wang, FX; Dong, YH; Dai, JC				Hu, Chao; Wang, Feixiang; Dong, Yehao; Dai, Jican			A Novel Method to Establish a Rat ED Model Using Internal Iliac Artery Ligation Combined with Hyperlipidemia	PLOS ONE			English	Article							INDUCED ERECTILE DYSFUNCTION; ENDOTHELIAL GROWTH-FACTOR; CAVERNOSAL SMOOTH-MUSCLE; EXPERIMENTAL HYPERCHOLESTEROLEMIA; STEM-CELLS; HYPERPLASIA; MECHANISMS; EXPRESSION; ISCHEMIA; TISSUE	Objective: To investigate a novel method, namely using bilateral internal iliac artery ligation combined with a high-fat diet (BCH), for establishing a rat model of erectile dysfunction (ED) that, compared to classical approaches, more closely mimics the chronic pathophysiology of human ED after acute ischemic insult. Materials and Methods: Forty 4-month-old male Sprague Dawley rats were randomly placed into five groups (n = 8 per group): normal control (NC), bilateral internal iliac artery ligation (BIIAL), high-fat diet (HFD), BCH, and mock surgery (MS). All rats were induced for 12 weeks. Copulatory behavior, intracavernosal pressure (ICP), ICP/mean arterial pressure, hematoxylin-eosin staining, Masson's trichrome staining, serum lipid levels, and endothelial and neuronal nitric oxide synthase immunohistochemical staining of the cavernous smooth muscle and endothelium were assessed. Data were analyzed by SAS 8.0 for Windows. Results: Serum total cholesterol and triglyceride levels were significantly higher in the HFD and BCH groups than the NC and MS groups. High density lipoprotein levels were significantly lower in the HFD and BCH groups than the NC and MS groups. The ICP values and mount and intromission numbers were significantly lower in the BIIAL, HFD, and BCH groups than in the NC and MS groups. ICP was significantly lower in the BCH group than in the BIIAL and HFD groups. Cavernous smooth muscle and endothelial damage increased in the HFD and BCH groups. Cavernous smooth muscle to collagen ratio, nNOS and eNOS staining decreased significantly in the BIIAL, HFD, and BCH groups compared to the NC and MS groups. Conclusions: The novel BCH model mimics the chronic pathophysiology of ED in humans and avoids the drawbacks of traditional ED models.	[Hu, Chao; Dong, Yehao; Dai, Jican] Shanghai Jiao Tong Univ, Affiliated Ren Ji Hosp, Dept Urol, Sch Med, Shanghai 200030, Peoples R China; [Wang, Feixiang] Shanghai Key Lab Forens Med, Inst Forens Sci, Natl Minist Justice, Shanghai, Peoples R China	Shanghai Jiao Tong University; Institute of Forensic Science Ministry of Justice PRC	Dai, JC (corresponding author), Shanghai Jiao Tong Univ, Affiliated Ren Ji Hosp, Dept Urol, Sch Med, Shanghai 200030, Peoples R China.	jican_dai@aliyun.com		Hu, Chao/0000-0001-5895-6038	science and technology commission of Shanghai municipality [08411951800]	science and technology commission of Shanghai municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The projects were supported by major scientific and technological issues (science and technology commission of Shanghai municipality, reference No. 08411951800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2012, J PHARMACOL SCI, V120, P250, DOI 10.1254/jphs.12113SC; Alvarenga TA, 2010, J SEX MED, V7, P2435, DOI 10.1111/j.1743-6109.2010.01851.x; Amany S, 2013, EXP CLIN ENDOCR DIAB, V121, P230, DOI 10.1055/s-0033-1341428; AZADZOI KM, 1992, J UROLOGY, V147, P1675, DOI 10.1016/S0022-5347(17)37676-0; Azadzoi KM, 1998, J UROLOGY, V160, P2216, DOI 10.1016/S0022-5347(01)62299-7; Bakircioglu ME, 2000, J UROLOGY, V164, P1798, DOI 10.1016/S0022-5347(05)67109-1; Chitaley K, 2008, J SEX MED, V5, P1149, DOI 10.1111/j.1743-6109.2008.00787.x; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Feng XT, 2012, BIOSCI BIOTECH BIOCH, V76, P257, DOI 10.1271/bbb.110568; Gaudreault N, 2012, ARTERIOSCL THROM VAS, V32, P264, DOI 10.1161/ATVBAHA.111.238964; Gholami SS, 2003, J UROLOGY, V169, P1577, DOI 10.1097/01.ju.0000055120.73261.76; HEATON JPW, 1991, J UROLOGY, V145, P1099, DOI 10.1016/S0022-5347(17)38543-9; Hotta Y, 2011, J SEX MED, V8, P705, DOI 10.1111/j.1743-6109.2010.02153.x; Huang YC, 2010, J SEX MED, V7, P1391, DOI 10.1111/j.1743-6109.2009.01697.x; Hurt KJ, 2012, P NATL ACAD SCI USA, V109, P16624, DOI 10.1073/pnas.1213790109; Iacono F, 2005, J UROLOGY, V173, P1673, DOI 10.1097/01.ju.0000154356.76027.4f; Karaboga R, 2006, UROLOGY, V67, P431, DOI 10.1016/j.urology.2005.08.049; Kendirci M, 2007, EUR UROL, V52, P555, DOI 10.1016/j.eururo.2007.03.022; Kimura M, 2011, J SEX MED, V8, P2215, DOI 10.1111/j.1743-6109.2011.02351.x; Kovanecz I, 2012, J SEX MED, V9, P2814, DOI 10.1111/j.1743-6109.2012.02913.x; Labazi H, 2013, J SEX MED, V10, P2154, DOI 10.1111/jsm.12245; Lee MC, 2002, J UROLOGY, V167, P761, DOI 10.1016/S0022-5347(01)69141-9; Liu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072790; Metze M, 2007, J TRAUMA, V63, P394, DOI 10.1097/01.ta.0000241145.02748.df; Nash M S, 2001, J Spinal Cord Med, V24, P2; Oudot A, 2010, J SEX MED, V7, P406; Prieto Castro Rafael, 2010, Archivos Espanoles de Urologia, V63, P637; Qiu XF, 2011, BJU INT, V108, P1866, DOI 10.1111/j.1464-410X.2011.10162.x; Wang J, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.08.026; White S, 2003, J UROLOGY, V169, P363; Xie DH, 2007, J SEX MED, V4, P898, DOI 10.1111/j.1743-6109.2007.00518.x; Yesilli C, 2001, UROLOGY, V57, P1184, DOI 10.1016/S0090-4295(01)00974-8; Zanoli P, 2009, J ETHNOPHARMACOL, V126, P308, DOI 10.1016/j.jep.2009.08.021	33	3	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102583	10.1371/journal.pone.0102583	http://dx.doi.org/10.1371/journal.pone.0102583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047124	Green Published, Green Submitted, gold			2022-12-25	WOS:000339558100048
J	Lumjuan, N; Wicheer, J; Leelapat, P; Choochote, W; Somboon, P				Lumjuan, Nongkran; Wicheer, Jureeporn; Leelapat, Posri; Choochote, Wej; Somboon, Pradya			Identification and Characterisation of Aedes aegypti Aldehyde Dehydrogenases Involved in Pyrethroid Metabolism	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; INSECTICIDE RESISTANCE; DENGUE VECTOR; DROSOPHILA-MELANOGASTER; MOLECULAR-BASIS; DETOXIFICATION GENES; ANOPHELES-GAMBIAE; DIETARY ETHANOL; SELECTION; PERMETHRIN	Background: Pyrethroid insecticides, especially permethrin and deltamethrin, have been used extensively worldwide for mosquito control. However, insecticide resistance can spread through a population very rapidly under strong selection pressure from insecticide use. The upregulation of aldehyde dehydrogenase (ALDH) has been reported upon pyrethroid treatment. In Aedes aegypti, the increase in ALDH activity against the hydrolytic product of pyrethroid has been observed in DDT/permethrin-resistant strains. The objective of this study was to identify the role of individual ALDHs involved in pyrethroid metabolism. Methodology/Principal Findings: Three ALDHs were identified; two of these, ALDH9948 and ALDH14080, were upregulated in terms of both mRNA and protein levels in a DDT/pyrethroid-resistant strain of Ae. aegypti. Recombinant ALDH9948 and ALDH14080 exhibited oxidase activities to catalyse the oxidation of a permethrin intermediate, phenoxybenzyl aldehyde (PBald), to phenoxybenzoic acid (PBacid). Conclusions/Significance: ALDHs have been identified in association with permethrin resistance in Ae. aegypti. Characterisation of recombinant ALDHs confirmed the role of this protein in pyrethroid metabolism. Understanding the biochemical and molecular mechanisms of pyrethroid resistance provides information for improving vector control strategies.	[Lumjuan, Nongkran; Wicheer, Jureeporn; Leelapat, Posri] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Choochote, Wej; Somboon, Pradya] Chiang Mai Univ, Fac Med, Dept Parasitol, Chiang Mai 50000, Thailand	Chiang Mai University; Chiang Mai University	Lumjuan, N (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand.	nklumjuan@yahoo.com	Somboon, Pradya/AAL-3458-2020	Somboon, Pradya/0000-0002-0760-4363; Lumjuan, Nongkran/0000-0001-9663-3328	National Research Council of Thailand (NRTC); Thailand Research Fund (TRF) [RTA5480006]	National Research Council of Thailand (NRTC); Thailand Research Fund (TRF)(Thailand Research Fund (TRF))	This study was supported by grants from the National Research Council of Thailand (NRTC) to NL and Thailand Research Fund (TRF) to WC and NL (TRF Senior Research Scholar: RTA5480006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Chandor-Proust A, 2013, BIOCHEM J, V455, P75, DOI 10.1042/BJ20130577; Chareonviriyaphap T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-280; Choi J, 2002, PEST BIOCH PHYSL, V22, P249; David JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-174; Ding YC, 2005, BIOCHEM J, V387, P879, DOI 10.1042/BJ20041850; Feyereisen R., 2005, P1; Fry JD, 2008, EVOLUTION, V62, P66, DOI 10.1111/j.1558-5646.2007.00288.x; Fry JD, 2006, GENET RES, V87, P87, DOI 10.1017/S0016672306008032; Fry JD, 2004, INTEGR COMP BIOL, V44, P275, DOI 10.1093/icb/44.4.275; Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hodgson E, 2003, J BIOCHEM MOL TOXIC, V17, P201, DOI 10.1002/jbt.10080; Ismail HM, 2013, P NATL ACAD SCI USA, V110, P19766, DOI 10.1073/pnas.1320185110; Kaneko H, 2011, J AGR FOOD CHEM, V59, P2786, DOI 10.1021/jf102567z; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; MAHARAJ R, 2011, OPEN ACCESS INSECT P, V3, P27, DOI DOI 10.2147/OAIP.S8620; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x; Montella IR, 2012, MEM I OSWALDO CRUZ, V107, P437, DOI 10.1590/S0074-02762012000400001; MORSE D, 1984, SCIENCE, V226, P1434, DOI 10.1126/science.226.4681.1434; Nakamura Y, 2007, TOXICOLOGY, V235, P176, DOI 10.1016/j.tox.2007.03.016; Nishi K, 2006, ARCH BIOCHEM BIOPHYS, V445, P115, DOI 10.1016/j.abb.2005.11.005; Oakeshott JG, 2005, CHEM-BIOL INTERACT, V157, P269, DOI 10.1016/j.cbi.2005.10.041; Rajatileka S, 2008, ACTA TROP, V108, P54, DOI 10.1016/j.actatropica.2008.08.004; Ranson H., 2005, P383; Riveron JM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r27; Ross MK, 2006, BIOCHEM PHARMACOL, V71, P657, DOI 10.1016/j.bcp.2005.11.020; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; Somwang P, 2011, PARASITOL RES, V109, P531, DOI 10.1007/s00436-011-2280-0; Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595; Stevenson BJ, 2011, INSECT BIOCHEM MOLEC, V41, P492, DOI 10.1016/j.ibmb.2011.02.003; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Strode C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044578, 10.1371/journal.pone.0039439]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x; Yoon M, 2006, TOXICOL SCI, V89, P386, DOI 10.1093/toxsci/kfj045	48	16	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102746	10.1371/journal.pone.0102746	http://dx.doi.org/10.1371/journal.pone.0102746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047125	Green Submitted, gold, Green Published			2022-12-25	WOS:000339558100068
J	Czarnecki, O; Yang, J; Wang, XP; Wang, SC; Muchero, W; Tuskan, GA; Chen, JG				Czarnecki, Olaf; Yang, Jun; Wang, Xiaoping; Wang, Shucai; Muchero, Wellington; Tuskan, Gerald A.; Chen, Jin-Gui			Characterization of MORE AXILLARY GROWTH Genes in Populus	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; PHOSPHORUS DEFICIENCY; PHOSPHATE DEFICIENCY; STRIGOLACTONE; ARABIDOPSIS; INHIBITION; SIGNAL; RICE; MAX1; ACTS	Background: Strigolactones are a new class of plant hormones that play a key role in regulating shoot branching. Studies of branching mutants in Arabidopsis, pea, rice and petunia have identified several key genes involved in strigolactone biosynthesis or signaling pathway. In the model plant Arabidopsis, MORE AXILLARY GROWTH1 (MAX1), MAX2, MAX3 and MAX4 are four founding members of strigolactone pathway genes. However, little is known about the strigolactone pathway genes in the woody perennial plants. Methodology/Principal Finding: Here we report the identification of MAX homologues in the woody model plant Populus trichocarpa. We identified the sequence homologues for each MAX protein in P. trichocarpa. Gene expression analysis revealed that Populus MAX paralogous genes are differentially expressed across various tissues and organs. Furthermore, we showed that Populus MAX genes could complement or partially complement the shoot branching phenotypes of the corresponding Arabidopsis max mutants. Conclusion/Significance: This study provides genetic evidence that strigolactone pathway genes are likely conserved in the woody perennial plants and lays a foundation for further characterization of strigolactone pathway and its functions in the woody perennial plants.	[Czarnecki, Olaf; Yang, Jun; Wang, Xiaoping; Muchero, Wellington; Tuskan, Gerald A.; Chen, Jin-Gui] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Yang, Jun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Wang, Xiaoping; Wang, Shucai] NE Normal Univ, Inst Cytol & Genet, Key Lab Mol Epigenet MOE, Changchun, Peoples R China	United States Department of Energy (DOE); Oak Ridge National Laboratory; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Northeast Normal University - China	Chen, JG (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	chenj@ornl.gov	Wang, Xiaoping/P-1077-2017; Czarnecki, Olaf/AAV-1638-2021; Tuskan, Gerald/A-6225-2011; Chen, Jin-Gui/AFV-6337-2022; Chen, Jin-Gui/A-4773-2011	Wang, Xiaoping/0000-0002-5032-3671; Tuskan, Gerald/0000-0003-0106-1289; Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201; Czarnecki, Olaf/0000-0001-5726-9586; muchero, wellington/0000-0002-0200-9856; Wang, Shucai/0000-0001-7619-2385	United States Department of Energy, Office of Science, Biological and Environmental Research; United States Department of Energy [DE-AC05-00OR22725]; Laboratory Directed Research and Development Program (Seed Money Fund) of Oak Ridge National Laboratory; Chinese Academy of Sciences [201019]; China Scholarship Council	United States Department of Energy, Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); Laboratory Directed Research and Development Program (Seed Money Fund) of Oak Ridge National Laboratory; Chinese Academy of Sciences(Chinese Academy of Sciences); China Scholarship Council(China Scholarship Council)	This work was supported by the Plant-Microbe Interfaces Scientific Focus Area (http://pmi.ornl.gov:8080/pmi/index.jsp) in the Genomic Science Program, United States Department of Energy, Office of Science, Biological and Environmental Research (http://science.energy.gov/ber/). Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the United States Department of Energy under contract DE-AC05-00OR22725. The early phase of this work was supported by the Laboratory Directed Research and Development Program (Seed Money Fund) of Oak Ridge National Laboratory (http://www.ornl.gov/). J.Y. was partially supported by a visiting scholarship from the Chinese Academy of Sciences (http://english.cas.cn/) (grant number: 201019). X.W. was partially supported by a visiting scholarship from the China Scholarship Council (http://en.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Brewer PB, 2013, MOL PLANT, V6, P18, DOI 10.1093/mp/sss130; Ha CV, 2014, P NATL ACAD SCI USA, V111, P851, DOI 10.1073/pnas.1322135111; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czarnecki O, 2013, INT J MOL SCI, V14, P7681, DOI 10.3390/ijms14047681; de Saint Germain A, 2013, CURR OPIN PLANT BIOL, V16, P583, DOI 10.1016/j.pbi.2013.06.007; Domagalska MA, 2011, NAT REV MOL CELL BIO, V12, P211, DOI 10.1038/nrm3088; Foo E, 2013, MOL PLANT, V6, P76, DOI 10.1093/mp/sss115; Gaiji Noura, 2012, BMC Res Notes, V5, P307, DOI 10.1186/1756-0500-5-307; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; HOLSTERS M, 1980, PLASMID, V3, P212, DOI 10.1016/0147-619X(80)90110-9; Janssen BJ, 2014, CURR OPIN PLANT BIOL, V17, P28, DOI 10.1016/j.pbi.2013.11.004; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Kohlen W, 2011, PLANT PHYSIOL, V155, P974, DOI 10.1104/pp.110.164640; Koltai H, 2011, NEW PHYTOL, V190, P545, DOI 10.1111/j.1469-8137.2011.03678.x; Kretzschmar T, 2012, NATURE, V483, P341, DOI 10.1038/nature10873; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Li Z, 2014, J PROTEOME RES, V13, P1359, DOI 10.1021/pr400925t; Lin H, 2009, PLANT CELL, V21, P1512, DOI 10.1105/tpc.109.065987; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; Mason MG, 2013, NEW PHYTOL, V198, P975, DOI 10.1111/nph.12268; Mayzlish-Gati E, 2012, PLANT PHYSIOL, V160, P1329, DOI 10.1104/pp.112.202358; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Rasmussen A, 2013, PLANTA, V238, P615, DOI 10.1007/s00425-013-1911-3; Ruyter-Spira C, 2013, TRENDS PLANT SCI, V18, P72, DOI 10.1016/j.tplants.2012.10.003; Salmon J, 2014, PLANT BIOTECHNOL J, V12, P480, DOI 10.1111/pbi.12154; Seto Y, 2012, PLANT CELL PHYSIOL, V53, P1843, DOI 10.1093/pcp/pcs142; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Tsuchiya Y, 2012, MOL BIOSYST, V8, P464, DOI 10.1039/c1mb05195d; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Umehara M, 2010, PLANT CELL PHYSIOL, V51, P1118, DOI 10.1093/pcp/pcq084; Waldie T, 2014, PLANT J, V79, P607, DOI 10.1111/tpj.12488; Wang YH, 2011, CURR OPIN PLANT BIOL, V14, P94, DOI 10.1016/j.pbi.2010.11.002; Wang Y, 2013, DEV CELL, V27, P681, DOI 10.1016/j.devcel.2013.11.010; Ward SP, 2013, PLANT PHYSIOL, V162, P800, DOI 10.1104/pp.113.218461; Waters MT, 2012, PLANT PHYSIOL, V159, P1073, DOI 10.1104/pp.112.196253; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Yoneyama K, 2007, PLANTA, V227, P125, DOI 10.1007/s00425-007-0600-5; Yoneyama K, 2007, PLANTA, V225, P1031, DOI 10.1007/s00425-006-0410-1; Yoneyama K, 2012, PLANTA, V235, P1197, DOI 10.1007/s00425-011-1568-8; Zheng ZY, 2014, MOL PLANT, V7, P934, DOI 10.1093/mp/ssu021; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878	56	21	23	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102757	10.1371/journal.pone.0102757	http://dx.doi.org/10.1371/journal.pone.0102757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036388	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200083
J	Liu, LB; Hansen, CG; Honeyman, BJ; Nichols, BJ; Pilch, PF				Liu, Libin; Hansen, Carsten G.; Honeyman, Brian J.; Nichols, Benjamin J.; Pilch, Paul F.			Cavin-3 Knockout Mice Show that Cavin-3 Is Not Essential for Caveolae Formation, for Maintenance of Body Composition, or for Glucose Tolerance	PLOS ONE			English	Article							TRANSCRIPTION COMPLEXES; ADIPOCYTE CAVEOLAE; LIPID-METABOLISM; POLYMERASE-I; PROTEIN; PTRF; DISSOCIATION; DELETION; MOUSE	The cavins are a family of proteins associated with caveolae, cavin-1, -2 and -3 being widely expressed while cavin-4 is restricted to striated muscle. Deletion of cavin-1 results in phenotypes including metabolic changes consistent with adipocyte dysfunction, and caveolae are completely absent. Deletion of cavin-2 causes tissue-specific loss of caveolae. The consequences of cavin-3 deletion are less clear, as there are divergent data on the abundance of caveolae in cavin-3 null mice. Here we examine the consequences of cavin-3 deficiency in vivo by making cavin-3 knockout mice. We find that loss of cavin-3 has minimal or no effects on the levels of other caveolar proteins, does not appear to play a major role in formation of protein complexes important for caveolar morphogenesis, and has no significant effect on caveolae abundance. Cavin-3 null mice have the same body weight and fat mass as wild type animals at ages 8 through 30 weeks on both normal chow and high fat diets. Likewise, the two mouse strains exhibit identical glucose tolerance tests on both diets. Microarray analysis from adipose tissue shows that the changes in mRNA expression between cavin-3 null and wild type mouse are minimal. We conclude that cavin-3 is not absolutely required for making caveolae, and suggest that the mechanistic link between cavin-3 and metabolic regulation remains uncertain.	[Liu, Libin; Honeyman, Brian J.; Pilch, Paul F.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Hansen, Carsten G.; Nichols, Benjamin J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Pilch, Paul F.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; MRC Laboratory Molecular Biology; Boston University	Pilch, PF (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	ppilch@bu.edu	Liu, Libin/ABH-6019-2020	Hansen, Carsten/0000-0003-0746-7482; Pilch, Paul/0000-0003-1997-0499; Liu, Libin/0000-0001-5056-1517	United States National Institutes of Health [DK097708, DK092942]; National Institutes of Health (NIH) [UL1-TR000157]; NIH [U01HG004085, U01HG004080, U42RR024244]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR024244] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004085, U01HG004080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097708, R01DK092942] Funding Source: NIH RePORTER; MRC [MC_U105178778] Funding Source: UKRI; Medical Research Council [MC_U105178778] Funding Source: researchfish	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the United States National Institutes of Health DK097708 and DK092942 to PFP and National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program UL1-TR000157 to CTSI at the Boston University. The ES cells used for this research project were generated by the trans-NIH Knock-Out Mouse Project (KOMP) and obtained from the KOMP Repository. NIH grants to Velocigene at Regeneron Inc (U01HG004085) and the CSD Consortium (U01HG004080) funded the generation of gene-targeted ES cells for 8500 genes in the KOMP Program and archived and distributed by the KOMP Repository at University of California Davis and CHORI (U42RR024244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Breen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034516; Ding SY, 2014, J BIOL CHEM, V289, P8473, DOI 10.1074/jbc.M113.546242; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; GUSTINCICH S, 1993, CELL GROWTH DIFFER, V4, P753; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2808; Hernandez VJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00905; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Jansa P, 1999, MOL GEN GENET, V262, P508, DOI 10.1007/s004380051112; Kulkarni RN, 2003, DIABETES, V52, P1528, DOI 10.2337/diabetes.52.6.1528; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Liu LB, 2006, MOL BIOL CELL, V17, P4249, DOI 10.1091/mbc.E06-04-0278; Ludwig A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001640; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Mineo C, 1998, J CELL BIOL, V141, P601, DOI 10.1083/jcb.141.3.601; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; PALADE GE, 1953, J APPL PHYS, V24, P1424; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pilch PF, 2011, TRENDS ENDOCRIN MET, V22, P318, DOI 10.1016/j.tem.2011.04.001; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Schneider K, 2012, EMBO REP, V13, P1138, DOI 10.1038/embor.2012.158; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Souto RP, 2003, J BIOL CHEM, V278, P18321, DOI 10.1074/jbc.M211541200; Vinten J, 2001, CELL TISSUE RES, V305, P99, DOI 10.1007/s004410100389; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102935	10.1371/journal.pone.0102935	http://dx.doi.org/10.1371/journal.pone.0102935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036884	gold, Green Submitted, Green Published			2022-12-25	WOS:000339615200100
J	Ning, DF; Song, AL; Fan, FL; Li, ZJ; Liang, YC				Ning, Dongfeng; Song, Alin; Fan, Fenliang; Li, Zhaojun; Liang, Yongchao			Effects of Slag-Based Silicon Fertilizer on Rice Growth and Brown-Spot Resistance	PLOS ONE			English	Article							SHEATH BLIGHT; BIPOLARIS-ORYZAE; STEEL SLAG; BLAST; ACCUMULATION; COMPONENTS; PLANTS; DEFICIENCY; MECHANISMS; MANAGEMENT	It is well documented that slag-based silicon fertilizers have beneficial effects on the growth and disease resistance of rice. However, their effects vary greatly with sources of slag and are closely related to availability of silicon (Si) in these materials. To date, few researches have been done to compare the differences in plant performance and disease resistance between different slag-based silicon fertilizers applied at the same rate of plant-available Si. In the present study both steel and iron slags were chosen to investigate their effects on rice growth and disease resistance under greenhouse conditions. Both scanning electron microscopy (SEM) and transmission electron microscopy (TEM) were used to examine the effects of slags on ultrastructural changes in leaves of rice naturally infected by Bipolaris oryaze, the causal agent of brown spot. The results showed that both slag-based Si fertilizers tested significantly increased rice growth and yield, but decreased brown spot incidence, with steel slag showing a stronger effect than iron slag. The results of SEM analysis showed that application of slags led to more pronounced cell silicification in rice leaves, more silica cells, and more pronounced and larger papilla as well. The results of TEM analysis showed that mesophyll cells of slag-untreated rice leaf were disorganized, with colonization of the fungus (Bipolaris oryzae), including chloroplast degradation and cell wall alterations. The application of slag maintained mesophyll cells relatively intact and increased the thickness of silicon layer. It can be concluded that applying slag-based fertilizer to Si-deficient paddy soil is necessary for improving both rice productivity and brown spot resistance. The immobile silicon deposited in host cell walls and papillae sites is the first physical barrier for fungal penetration, while the soluble Si in the cytoplasm enhances physiological or induced resistance to fungal colonization.	[Ning, Dongfeng; Song, Alin; Fan, Fenliang; Li, Zhaojun; Liang, Yongchao] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Crop Nutr & Fertilizat, Minist Agr, Beijing 100193, Peoples R China; [Liang, Yongchao] Zhejiang Univ, Coll Environm & Resource Sci, Key Lab Environm Remediat & Ecol Hlth, Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Zhejiang University	Liang, YC (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Crop Nutr & Fertilizat, Minist Agr, Beijing 100193, Peoples R China.	ycliang@zju.edu.cn	Ning, dongfeng/P-2697-2014; Fan, Fenliang/G-6090-2012; Li, zhaojun/E-5735-2012; Liang, Yongchao/D-5809-2012; Liang, Yongchao/S-9281-2019	Ning, dongfeng/0000-0001-6899-9453; Liang, Yongchao/0000-0002-0501-2823; Liang, Yongchao/0000-0002-0501-2823	Ministry of Science and Technology, China; National Natural Science Foundation of China [41301310]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was jointly supported by The 12th Five-year Key Programs entitled "Techniques for Agricultural Use of Steel and Iron Slag: Research and Demonstration" and "Study of Key Technologies for Alleviating Obstacle Factors and Improving Productivity of Low-Yield Cropland" supported by Ministry of Science and Technology, China and The National Natural Science Foundation of China entitled "The quantitative study of influence of straw returning on silicon releasing in typical rice soil of Southern China (41301310)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2001, CROP PROT, V20, P43, DOI 10.1016/S0261-2194(00)00051-X; Bocharnikova E. A., 2010, Russian Agricultural Sciences, V36, P446, DOI 10.3103/S1068367410060157; Buck GB, 2010, J PLANT NUTR, V34, P272, DOI 10.1080/01904167.2011.533327; Cai KZ, 2008, PHYSIOL PLANTARUM, V134, P324, DOI 10.1111/j.1399-3054.2008.01140.x; Cha W, 2006, WATER RES, V40, P1034, DOI 10.1016/j.watres.2005.12.039; Dai WeiMin, 2005, Chinese Journal of Rice Science, V19, P460; Dallagnol LJ, 2011, PHYTOPATHOLOGY, V101, P92, DOI 10.1094/PHYTO-04-10-0105; Dallagnol LJ, 2009, PHYTOPATHOLOGY, V99, P116, DOI 10.1094/PHYTO-99-1-0116; Datnoff LE, 1997, CROP PROT, V16, P525, DOI 10.1016/S0261-2194(97)00033-1; DATNOFF LE, 1991, PLANT DIS, V75, P729, DOI 10.1094/PD-75-0729; DEREN CW, 1994, CROP SCI, V34, P733, DOI 10.2135/cropsci1994.0011183X003400030024x; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Foy C.D., 1992, ADV SOIL SCI, P97, DOI DOI 10.1007/978-1-4612-2894-3_5; Guntzer F, 2012, AGRON SUSTAIN DEV, V32, P201, DOI 10.1007/s13593-011-0039-8; Hayasaka T, 2008, PHYTOPATHOLOGY, V98, P1038, DOI 10.1094/PHYTO-98-9-1038; Kato N, 1997, SOIL SCI PLANT NUTR, V43, P329, DOI 10.1080/00380768.1997.10414757; Kim SG, 2002, PHYTOPATHOLOGY, V92, P1095, DOI 10.1094/PHYTO.2002.92.10.1095; Lee T. S., 1981, Journal of Agricultural Research of China, V30, P35; Liang YC, 2005, PLANT PATHOL, V54, P678, DOI 10.1111/j.1365-3059.2005.01246.x; LIANG YC, 1994, COMMUN SOIL SCI PLAN, V25, P2285, DOI 10.1080/00103629409369189; Liang YC, 2007, ENVIRON POLLUT, V147, P422, DOI 10.1016/j.envpol.2006.06.008; Lu RK, 2000, ANAL METHODS SOIL AG, P201; Ma J.F., 2002, SOIL FERTILIZER PLAN, V1st, P1; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; MARCHETTI MA, 1984, PLANT DIS, V68, P288, DOI 10.1094/PD-69-288; Motlagh M. R. S., 2008, International Journal of Agriculture and Biology, V10, P638; Motz H, 2001, WASTE MANAGE, V21, P285, DOI 10.1016/S0956-053X(00)00102-1; Nanayakkara UN, 2008, PLANT DIS, V92, P870, DOI 10.1094/PDIS-92-6-0870; Nguyen NV, 2006, PADDY WATER ENVIRON, V4, P1, DOI 10.1007/s10333-005-0031-5; Ou SH, 1985, RICE DIS; Raven JA, 2003, NEW PHYTOL, V158, P419, DOI 10.1046/j.1469-8137.2003.00778.x; Rodrigues F. A., 2005, Fitopatologia Brasileira, V30, P457, DOI 10.1590/S0100-41582005000500001; Rodrigues FA, 2005, PHYSIOL MOL PLANT P, V66, P144, DOI 10.1016/j.pmpp.2005.06.002; Rodrigues FA, 2004, PHYTOPATHOLOGY, V94, P177, DOI 10.1094/PHYTO.2004.94.2.177; Rodrigues FA, 2003, PHYTOPATHOLOGY, V93, P535, DOI 10.1094/PHYTO.2003.93.5.535; Rodrigues FA, 2003, PHYTOPATHOLOGY, V93, P256, DOI 10.1094/PHYTO.2003.93.3.256; Rodrigues FA, 2003, CROP PROT, V22, P23, DOI 10.1016/S0261-2194(02)00084-4; Savant NK, 1997, ADV AGRON, V58, P151; Seebold KW, 2004, PLANT DIS, V88, P253, DOI 10.1094/PDIS.2004.88.3.253; Seebold KW, 2001, PHYTOPATHOLOGY, V91, P63, DOI 10.1094/PHYTO.2001.91.1.63; Shen HT, 2003, WASTE MANAGE, V23, P933, DOI 10.1016/S0956-053X(02)00164-2; Sun WC, 2010, EUR J PLANT PATHOL, V128, P39, DOI 10.1007/s10658-010-9625-x; TAKAHASHI K, 1981, Bulletin of the Shikoku National Agricultural Experiment Station, P75; Wailes E. J., 1997, ARKANSAS AGR EXP STA, P177; Wang H., 2001, STUD PLANT SCI, V8, P343, DOI [10.1016/S0928-3420(01)80025-2, DOI 10.1016/S0928-3420(01)80025-2]; Winslow MD, 1997, PLANT SOIL, V188, P239, DOI 10.1023/A:1004298817861; Wu SP, 2007, BUILD ENVIRON, V42, P2580, DOI 10.1016/j.buildenv.2006.06.008; YOSHIDA SHOICHI, 1965, BULL NAT INST AGR SCI SER B [JAP], V15, P1; Zhang Guo-Liang, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P600; Zhu GL, 2010, IRON STEEL SCRAP, V1, P12	52	59	64	7	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102681	10.1371/journal.pone.0102681	http://dx.doi.org/10.1371/journal.pone.0102681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036893	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200079
J	Caspani, EM; Crossley, PH; Redondo-Garcia, C; Martinez, S				Caspani, Elisabetta M.; Crossley, Philip H.; Redondo-Garcia, Carolina; Martinez, Salvador			Glioblastoma: A Pathogenic Crosstalk between Tumor Cells and Pericytes	PLOS ONE			English	Article							MICROVASCULAR PERICYTES; SMOOTH-MUSCLE; STEM-CELLS; CO-OPTION; BRAIN; ACTIVATION; GLIOMA; MARKER; CDC42; MACROPHAGES	Cancers likely originate in progenitor zones containing stem cells and perivascular stromal cells. Much evidence suggests stromal cells play a central role in tumor initiation and progression. Brain perivascular cells (pericytes) are contractile and function normally to regulate vessel tone and morphology, have stem cell properties, are interconvertible with macrophages and are involved in new vessel formation during angiogenesis. Nevertheless, how pericytes contribute to brain tumor infiltration is not known. In this study we have investigated the underlying mechanism by which the most lethal brain cancer, Glioblastoma Multiforme (GBM) interacts with pre-existing blood vessels (co-option) to promote tumor initiation and progression. Here, using mouse xenografts and laminin-coated silicone substrates, we show that GBM malignancy proceeds via specific and previously unknown interactions of tumor cells with brain pericytes. Two-photon and confocal live imaging revealed that GBM cells employ novel, Cdc42-dependent and actin-based cytoplasmic extensions, that we call flectopodia, to modify the normal contractile activity of pericytes. This results in the co-option of modified preexisting blood vessels that support the expansion of the tumor margin. Furthermore, our data provide evidence for GBM cell/pericyte fusion-hybrids, some of which are located on abnormally constricted vessels ahead of the tumor and linked to tumor-promoting hypoxia. Remarkably, inhibiting Cdc42 function impairs vessel co-option and converts pericytes to a phagocytic/macrophage-like phenotype, thus favoring an innate immune response against the tumor. Our work, therefore, identifies for the first time a key GBM contact-dependent interaction that switches pericyte function from tumor-suppressor to tumor-promoter, indicating that GBM may harbor the seeds of its own destruction. These data support the development of therapeutic strategies directed against co-option (preventing incorporation and modification of pre-existing blood vessels), possibly in combination with anti-angiogenesis (blocking new vessel formation), which could lead to improved vascular targeting not only in Glioblastoma but also for other cancers.	[Caspani, Elisabetta M.; Crossley, Philip H.; Redondo-Garcia, Carolina; Martinez, Salvador] Univ Miguel Hernandez, Spanish Natl Res Council, Inst Neurosci, Lab Expt Embryol, Alicante, Spain; [Martinez, Salvador] Ctr Invest Biosanitaria Red Salud Mental, Murcia, Spain; [Martinez, Salvador] Inst Murciano Invest Biosanitaria Arrixaca, Murcia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche	Caspani, EM (corresponding author), Univ Miguel Hernandez, Spanish Natl Res Council, Inst Neurosci, Lab Expt Embryol, Alicante, Spain.	elisabetta_caspani@yahoo.it	Caspani, Elisabetta/AHD-8211-2022; Martinez, Salvador/L-4896-2014	Martinez, Salvador/0000-0002-2910-8926; Martinez, Salvador/0000-0002-9320-4103	Spanish Ministry of Science and Innovation: FEDER [BFU-2010-27326]; Consolider [CSD2007-00023]; Health Institute Carlos III: Red TERCEL [RD12/0019/0024]; Marie Curie Intra-European Fellowship	Spanish Ministry of Science and Innovation: FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Health Institute Carlos III: Red TERCEL; Marie Curie Intra-European Fellowship(European Commission)	This work was funded by Spanish Ministry of Science and Innovation: FEDER (BFU-2010-27326) and Consolider (CSD2007-00023); Health Institute Carlos III: Red TERCEL (RD12/0019/0024); P.H.C was also supported by Marie Curie Intra-European Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard B, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/485156; Anfuso CD, 2014, BIOCHIMIE, V99, P77, DOI 10.1016/j.biochi.2013.11.013; Appaix Florence, 2014, World J Stem Cells, V6, P134, DOI 10.4252/wjsc.v6.i2.134; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Atkinson B, 2006, BLOOD CELL MOL DIS, V36, P217, DOI 10.1016/j.bcmd.2005.12.025; Bageritz J, 2014, CELL DEATH DIFFER, V21, P929, DOI 10.1038/cdd.2014.12; Balabanov R, 1996, MICROVASC RES, V52, P127, DOI 10.1006/mvre.1996.0049; Berger M, 2005, BLOOD, V105, P1094, DOI 10.1182/blood-2004-06-2315; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Budde MD, 2012, NMR BIOMED, V25, P726, DOI 10.1002/nbm.1786; Burger PC, 2007, TUMORS CENTRAL NER 4, P65; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Corselli M, 2013, CYTOM PART A, V83A, P714, DOI [10.1002/cyto.22313, 10.1002/cyto.a.22313]; Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902; De Sanctis F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00069; Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70; Ding YP, 2012, CANCER MICROENVIRON, V5, P225, DOI 10.1007/s12307-012-0106-y; Dome B, 2003, J NEUROPATH EXP NEUR, V62, P655; Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105; Dore-Duffy P, 2008, CURR PHARM DESIGN, V14, P1581, DOI 10.2174/138161208784705469; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Fomchenko EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020605; Franco M, 2011, HORM METAB RES, V43, P884, DOI 10.1055/s-0031-1284381; Gadea G, 2002, EMBO J, V21, P2373, DOI 10.1093/emboj/21.10.2373; Gadea G, 2008, CURR BIOL, V18, P1456, DOI 10.1016/j.cub.2008.08.053; Goding JW, 2000, J LEUKOCYTE BIOL, V67, P285, DOI 10.1002/jlb.67.3.285; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Henry EP, 2006, NAT CHEM BIOL, V2, P39, DOI 10.1038/nchembio751; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hirase H, 2004, GLIA, V46, P95, DOI 10.1002/glia.10295; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Hurtado-Alvarado G, 2014, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00080; Li N, 2007, J PROTEOME RES, V6, P3304, DOI 10.1021/pr0702363; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Mravic M, 2014, INT ORTHOP, V38, P1819, DOI 10.1007/s00264-014-2295-0; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Ochs K, 2013, J NEUROIMMUNOL, V265, P106, DOI 10.1016/j.jneuroim.2013.09.011; Oishi K, 2007, MICROVASC RES, V73, P20, DOI 10.1016/j.mvr.2006.08.004; Oser M, 2011, EUR J CELL BIOL, V90, P181, DOI 10.1016/j.ejcb.2010.08.006; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Pellegatti P, 2011, FASEB J, V25, P1264, DOI 10.1096/fj.10-169854; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Pieper C, 2014, BRAIN RES, V1550, P1, DOI 10.1016/j.brainres.2014.01.004; Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian CN, 2013, NAT REV UROL, V10, P300, DOI 10.1038/nrurol.2013.26; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rupp C, 2015, ONCOGENE, V34, P815, DOI 10.1038/onc.2014.18; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Tang XQ, 2013, CANCER LETT, V332, P3, DOI 10.1016/j.canlet.2013.01.024; Thomas WE, 1999, BRAIN RES REV, V31, P42, DOI 10.1016/S0165-0173(99)00024-7; Travaglione S, 2002, TOXICOL IN VITRO, V16, P405, DOI 10.1016/S0887-2333(02)00028-0; Venere M, 2011, GLIA, V59, P1148, DOI 10.1002/glia.21185; Xu B, 2006, ORG BIOMOL CHEM, V4, P4149, DOI 10.1039/b609143a; Xu S, 2013, NEURO-ONCOLOGY, V15, P1160, DOI 10.1093/neuonc/not067; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Yiin JJ, 2009, NEURO-ONCOLOGY, V11, P779, DOI 10.1215/15228517-2008-017; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	69	76	78	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101402	10.1371/journal.pone.0101402	http://dx.doi.org/10.1371/journal.pone.0101402			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032689	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300015
J	Choi, KS; Kim, SH; Kim, ED; Lee, SH; Han, SJ; Yoon, S; Chang, KT; Seo, KY				Choi, Kyoung Sub; Kim, Sang-Hyun; Kim, Eun-Do; Lee, Sang-Ho; Han, Soo Jung; Yoon, Sangchul; Chang, Kyu-Tae; Seo, Kyoung Yul			Protection from Hemolytic Uremic Syndrome by Eyedrop Vaccination with Modified Enterohemorrhagic E-coli Outer Membrane Vesicles	PLOS ONE			English	Article							SHIGA-TOXIN; MUCOSAL VACCINE; B-SUBUNIT; LIPOPOLYSACCHARIDE; IMMUNITY; INFECTION; ANTIGEN; VIRULENCE; RESPONSES; PROTEINS	We investigated whether eyedrop vaccination using modified outer membrane vesicles (mOMVs) is effective for protecting against hemolytic uremic syndrome (HUS) caused by enterohemorrhagic E. coli (EHEC) O157:H7 infection. Modified OMVs and waaJ-mOMVs were prepared from cultures of MsbB- and Shiga toxin A subunit (STxA)-deficient EHEC O157:H7 bacteria with or without an additional waaJ mutation. BALB/c mice were immunized by eyedrop mOMVs, waaJ-mOMVs, and mOMVs plus polymyxin B (PMB). Mice were boosted at 2 weeks, and challenged peritoneally with wild-type OMVs (wtOMVs) at 4 weeks. As parameters for evaluation of the OMV-mediated immune protection, serum and mucosal immunoglobulins, body weight change and blood urea nitrogen (BUN)/Creatinin (Cr) were tested, as well as histopathology of renal tissue. In order to confirm the safety of mOMVs for eyedrop use, body weight and ocular histopathological changes were monitored in mice. Modified OMVs having penta-acylated lipid A moiety did not contain STxA subunit proteins but retained non-toxic Shiga toxin B (STxB) subunit. Removal of the polymeric O-antigen of O157 LPS was confirmed in waaJ-mOMVs. The mice group vaccinated with mOMVs elicited greater humoral and mucosal immune responses than did the waaJ-mOMVs and PBS-treated groups. Eyedrop vaccination of mOMVs plus PMB reduced the level of humoral and mucosal immune responses, suggesting that intact O157 LPS antigen can be a critical component for enhancing the immunogenicity of the mOMVs. After challenge, mice vaccinated with mOMVs were protected from a lethal dose of wtOMVs administered intraperitoneally, conversely mice in the PBS control group were not. Collectively, for the first time, EHEC O157-derived mOMV eyedrop vaccine was experimentally evaluated as an efficient and safe means of vaccine development against EHEC O157:H7 infection-associated HUS.	[Choi, Kyoung Sub; Kim, Eun-Do] Yonsei Univ, Grad Sch, Seoul 120749, South Korea; [Choi, Kyoung Sub] Ilsan Hosp, Natl Hlth Insurance Serv, Dept Ophthalmol, Goyang City, South Korea; [Kim, Sang-Hyun; Lee, Sang-Ho] Korea Res Inst Biosci & Biotechnol, Viral Infect Dis Res Ctr, Taejon, South Korea; [Kim, Eun-Do; Han, Soo Jung; Yoon, Sangchul; Seo, Kyoung Yul] Yonsei Univ, Coll Med, Eye & Ear Hosp, Dept Ophthalmol,Severance Hosp,Inst Vis Res, Seoul, South Korea; [Kim, Eun-Do] Yonsei Univ, Brain Korea Project Med Sci 21, Seoul 120749, South Korea; [Chang, Kyu-Tae] Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Cheongwon, Chungbuk, South Korea	Yonsei University; National Health Insurance Service; NHIS Ilsan Hospital; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Yonsei University; Yonsei University Health System; Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Chang, KT (corresponding author), Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Cheongwon, Chungbuk, South Korea.	changkt@kribb.re.kr; seoky@yuhs.ac	Seo, Kyoung Yul/I-5484-2019	Yoon, Sangchul/0000-0003-0454-9597; Seo, Kyoung Yul/0000-0002-9855-1980	Korea Healthcare technology RD Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea [A121861]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [NRF-2013M3A9D5072551]	Korea Healthcare technology RD Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning	This study was supported by a grant from the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Grant No.: A121861). Additional funding was received from the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013M3A9D5072551). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adotevi O, 2007, J IMMUNOL, V179, P3371, DOI 10.4049/jimmunol.179.5.3371; Amor K, 2000, INFECT IMMUN, V68, P1116, DOI 10.1128/IAI.68.3.1116-1124.2000; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Camacho AI, 2011, VACCINE, V29, P8222, DOI 10.1016/j.vaccine.2011.08.121; Domingues MM, 2012, BIOPOLYMERS, V98, P338, DOI 10.1002/bip.22095; Ellis TN, 2010, INFECT IMMUN, V78, P3822, DOI 10.1128/IAI.00433-10; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hu K, 2011, VACCINE, V29, P1455, DOI 10.1016/j.vaccine.2010.12.031; JAYAWARDANE GWL, 1995, VET MICROBIOL, V46, P69, DOI 10.1016/0378-1135(95)00073-J; Karmali MA, 2004, MOL BIOTECHNOL, V26, P117, DOI 10.1385/MB:26:2:117; Kim SH, 2011, FEMS IMMUNOL MED MIC, V63, P427, DOI 10.1111/j.1574-695X.2011.00869.x; Kim SH, 2010, FEMS IMMUNOL MED MIC, V58, P412, DOI 10.1111/j.1574-695X.2010.00654.x; Kim SH, 2009, BBA-BIOMEMBRANES, V1788, P2150, DOI 10.1016/j.bbamem.2009.08.001; Kim SH, 2004, INFECT IMMUN, V72, P1174, DOI 10.1128/IAI.72.2.1174-1180.2004; Kong QK, 2011, INFECT IMMUN, V79, P4227, DOI 10.1128/IAI.05398-11; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lee DH, 2011, VACCINE, V29, P8293, DOI 10.1016/j.vaccine.2011.08.102; Leipold MD, 2007, J BIOL CHEM, V282, P1257, DOI 10.1074/jbc.M608164200; McConnell MJ, 2011, INFECT IMMUN, V79, P518, DOI 10.1128/IAI.00741-10; Nagatake T, 2009, J EXP MED, V206, P2351, DOI 10.1084/jem.20091436; Nagy G, 2008, BIOL CHEM, V389, P513, DOI 10.1515/BC.2008.056; Nieves W, 2011, VACCINE, V29, P8381, DOI 10.1016/j.vaccine.2011.08.058; Okada K, 2011, ADV OTO-RHINO-LARYNG, V72, P31, DOI 10.1159/000324591; Park KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011334; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Roy K, 2011, CLIN VACCINE IMMUNOL, V18, P1803, DOI 10.1128/CVI.05217-11; Seo KY, 2010, J IMMUNOL, V185, P3610, DOI 10.4049/jimmunol.1000680; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tsuji T, 2008, VACCINE, V26, P2092, DOI 10.1016/j.vaccine.2008.02.034; Tsuji T, 2008, VACCINE, V26, P469, DOI 10.1016/j.vaccine.2007.11.038; van de Waterbeemd B, 2010, VACCINE, V28, P4810, DOI 10.1016/j.vaccine.2010.04.082; van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778; Yoon JW, 2008, J VET SCI, V9, P219, DOI 10.4142/jvs.2008.9.3.219; Zhang XH, 2011, VACCINE, V29, P3923, DOI 10.1016/j.vaccine.2011.02.007; ZUNDEL E, 1992, ANN RECH VET, V23, P177	36	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100229	10.1371/journal.pone.0100229	http://dx.doi.org/10.1371/journal.pone.0100229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032703	Green Submitted, gold, Green Published			2022-12-25	WOS:000339418300007
J	Gianoarli, L; Luiselli, D; Crivello, AM; Lang, M; Ferraretti, AP; De Fanti, S; Magli, MC; Romeo, G				Gianoarli, Luca; Luiselli, Donata; Crivello, Anna Maria; Lang, Martin; Ferraretti, Anna Pia; De Fanti, Sara; Magli, M. Cristina; Romeo, Giovanni			Mitogenomes of Polar Bodies and Corresponding Oocytes	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; HETEROPLASMY; SELECTION; MUTATIONS; DISEASE; MTDNA	The objective of the present study was to develop an approach that could assess the chromosomal status and the mitochondrial DNA (mtDNA) content of oocytes and their corresponding polar bodies (PBs) with the goal of obtaining a comparative picture of the segregation process both for nuclear and mtDNA. After Whole Genome Amplification (WGA), sequencing of the whole mitochondrial genome was attempted to analyze the segregation of mutant and wild-type mtDNA during human meiosis. Three triads, composed of oocyte and corresponding PBs, were analyzed and their chromosome status was successfully assessed. The complete mitochondrial genome (mitogenome) was almost entirely sequenced in the oocytes (95.99% compared to 98.43% in blood), while the percentage of sequences obtained in the corresponding PB1 and PB2 was lower (69.70% and 69.04% respectively). The comparison with the mtDNA sequence in blood revealed no changes in the D-loop region for any of the cells of each triad. In the coding region of blood mtDNA and oocyte mtDNA sequences showed full correspondence, whereas all PBs had at least one change with respect to the blood-oocyte pairs. In all, 9 changes were found, either in PB1 or PB2: 4 in MT-ND5, 2 in MT-RNR2, and 1 each in MT-ATP8, MT-ND4, MT-CYTB. The full concordance between oocyte and blood in the 3 triads, and the relegation of changes to PBs, revealed the unexpected coexistence of different variants, giving a refined estimation of mitochondrial heteroplasmy. Should these findings be confirmed by additional data, an active mechanism could be postulated in the oocyte to preserve a condition of 'normality'.	[Gianoarli, Luca; Crivello, Anna Maria; Ferraretti, Anna Pia; Magli, M. Cristina] SISMER Reprod Med Unit, Bologna, Italy; [Luiselli, Donata; Lang, Martin; De Fanti, Sara; Romeo, Giovanni] Univ Bologna, Bologna, Italy; [Romeo, Giovanni] European Sch Genet Med, Bologna, Italy	University of Bologna	Gianoarli, L (corresponding author), SISMER Reprod Med Unit, Bologna, Italy.	luca.gianaroli@sismer.it	Lang, Martin/AAW-8645-2021	Lang, Martin/0000-0002-0242-6713; Crivello, Anna Maria/0000-0002-2836-5752				Cummins J M, 2002, Reprod Biomed Online, V4, P176; Eichenlaub-Ritter U, 2011, MITOCHONDRION, V11, P783, DOI 10.1016/j.mito.2010.08.011; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Geraedts J, 2011, HUM REPROD, V26, P3173, DOI 10.1093/humrep/der294; Gigarel N, 2011, AM J HUM GENET, V88, P494, DOI 10.1016/j.ajhg.2011.03.010; Hill JH, 2014, NAT GENET, V46, P389, DOI 10.1038/ng.2920; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Maragh S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-7; Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417; Nara Akina, 2009, Leg Med (Tokyo), V11 Suppl 1, pS115, DOI 10.1016/j.legalmed.2009.01.114; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043; Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Wallace DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0267	15	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102182	10.1371/journal.pone.0102182	http://dx.doi.org/10.1371/journal.pone.0102182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032828	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300040
J	Hirai, S; Endo, S; Saito, R; Hirose, M; Ueno, T; Suzuki, H; Yamato, K; Abei, M; Hyodo, I				Hirai, Sachiko; Endo, Shinji; Saito, Rie; Hirose, Mitsuaki; Ueno, Takunori; Suzuki, Hideo; Yamato, Kenji; Abei, Masato; Hyodo, Ichinosuke			Antitumor Effects of a Sirtuin Inhibitor, Tenovin-6, against Gastric Cancer Cells via Death Receptor 5 Up-Regulation	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; TRAIL-INDUCED APOPTOSIS; P53; EXPRESSION; SENESCENCE; CHEMOSENSITIVITY; ADENOCARCINOMA; TRICHOSTATIN; COMBINATION; METABOLISM	Up-regulated sirtuin 1 (SIRT1), an NAD(+)-dependent class III histone deacetylase, deacetylates p53 and inhibits its transcriptional activity, leading to cell survival. SIRT1 overexpression has been reported to predict poor survival in some malignancies, including gastric cancer. However, the antitumor effect of SIRT1 inhibition remains elusive in gastric cancer. Here, we investigated the antitumor mechanisms of a sirtuin inhibitor, tenovin-6, in seven human gastric cancer cell lines (four cell lines with wild-type TP53, two with mutant-type TP53, and one with null TP53). Interestingly, tenovin-6 induced apoptosis in all cell lines, not only those with wild-type TP53, but also mutant-type and null versions, accompanied by up-regulation of death receptor 5 (DR5). In the KatoIII cell line (TP53-null), DR5 silencing markedly attenuated tenovin-6-induced apoptosis, suggesting that the pivotal mechanism behind its antitumor effects is based on activation of the death receptor signal pathway. Although endoplasmic reticulum stress caused by sirtuin inhibitors was reported to induce DR5 up-regulation in other cancer cell lines, we could not find marked activation of its related molecules, such as ATF6, PERK, and CHOP, in gastric cancer cells treated with tenovin-6. Tenovin-6 in combination with docetaxel or SN-38 exerted a slight to moderate synergistic cytotoxicity against gastric cancer cells. In conclusion, tenovin-6 has potent antitumor activity against human gastric cancer cells via DR5 up-regulation. Our results should be helpful for the future clinical development of sirtuin inhibitors.	[Hirai, Sachiko; Endo, Shinji; Saito, Rie; Hirose, Mitsuaki; Ueno, Takunori; Suzuki, Hideo; Yamato, Kenji; Abei, Masato; Hyodo, Ichinosuke] Univ Tsukuba, Inst Clin Med, Dept Gastroenterol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan	University of Tsukuba	Endo, S (corresponding author), Univ Tsukuba, Inst Clin Med, Dept Gastroenterol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan.	shinj.endo@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to IH). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2010, J CLIN ONCOL, V28, P1547, DOI 10.1200/JCO.2009.25.4706; Alcain FJ, 2009, EXPERT OPIN THER PAT, V19, P283, DOI 10.1517/13543770902755111; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Bruzzese F, 2009, MOL CANCER THER, V8, P3075, DOI 10.1158/1535-7163.MCT-09-0254; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chang H, 2010, J CANCER RES CLIN, V136, P1901, DOI 10.1007/s00432-010-0849-0; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Endo S, 2011, CANCER SCI, V102, P605, DOI 10.1111/j.1349-7006.2010.01821.x; Engel D, 2006, J CANCER RES CLIN, V132, P673, DOI 10.1007/s00432-006-0116-6; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Groves MJ, 2013, BRIT J CANCER, V109, P2434, DOI 10.1038/bjc.2013.601; Guo F, 2005, BLOOD, V105, P1246, DOI 10.1182/blood-2004-05-2041; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hwang JJ, 2012, INVEST NEW DRUG, V30, P1434, DOI 10.1007/s10637-011-9718-1; Iida S, 2000, INT J CANCER, V87, P654, DOI 10.1002/1097-0215(20000901)87:5<654::AID-IJC6>3.0.CO;2-P; Jang BG, 2011, PATHOBIOLOGY, V78, P302, DOI 10.1159/000321703; Kim SY, 2009, ANN NY ACAD SCI, V1171, P270, DOI 10.1111/j.1749-6632.2009.04721.x; Kong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037222; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Liu GB, 2012, J CELL MOL MED, V16, P1618, DOI 10.1111/j.1582-4934.2011.01401.x; Malago JJ, 2003, CELL STRESS CHAPERON, V8, P194, DOI 10.1379/1466-1268(2003)008<0194:ELOHSP>2.0.CO;2; Michelangeli F, 2011, BIOCHEM SOC T, V39, P789, DOI 10.1042/BST0390789; Musch MW, 2001, CELL GROWTH DIFFER, V12, P419; Na YS, 2011, CANCER CHEMOTH PHARM, V68, P389, DOI 10.1007/s00280-010-1495-6; Na YS, 2010, ONCOL REP, V24, P1509, DOI 10.3892/or_00001012; Nishiyama M, 2009, GASTRIC CANCER, V12, P132, DOI 10.1007/s10120-009-0521-z; Nosho K, 2009, MODERN PATHOL, V22, P922, DOI 10.1038/modpathol.2009.49; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roth M., 2013, ONCOGENE, DOI 10. 1038/onc. 2013. 120; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Soussi T, 2006, CLIN CANCER RES, V12, P62, DOI 10.1158/1078-0432.CCR-05-0413; Sunami Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057633; Sung B, 2012, FREE RADICAL BIO MED, V53, P1977, DOI 10.1016/j.freeradbiomed.2012.08.012; Tiwary R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011865; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Ueno T, 2013, ONCOL RES, V21, P155, DOI 10.3727/096504013X13854886566598; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang DG, 2013, ONCOL LETT, V6, P1492, DOI 10.3892/ol.2013.1565; Wang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076662; Woo JS, 2013, BIOCHEM BIOPH RES CO, V431, P354, DOI 10.1016/j.bbrc.2012.11.134; Yamato K, 2008, CANCER GENE THER, V15, P140, DOI 10.1038/sj.cgt.7701118; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang QC, 2012, ASIAN PAC J CANCER P, V13, P3471, DOI 10.7314/APJCP.2012.13.7.3471; Zhang XT, 2006, ONCOL REP, V16, P563; Zhao G, 2011, GENE THER, V18, P920, DOI 10.1038/gt.2011.81; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	57	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102831	10.1371/journal.pone.0102831	http://dx.doi.org/10.1371/journal.pone.0102831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033286	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300100
J	Bolton, HM; Burgess, PW; Gilbert, SJ; Serpell, L				Bolton, Heather M.; Burgess, Paul W.; Gilbert, Sam J.; Serpell, Lucy			Increased Set Shifting Costs in Fasted Healthy Volunteers	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; ANTERIOR CINGULATE CORTEX; RESTORED ANOREXIA-NERVOSA; CEREBRAL-BLOOD-FLOW; EATING-DISORDERS; BULIMIA-NERVOSA; EXECUTIVE FUNCTION; FUTURE-DIRECTIONS; CENTRAL COHERENCE; EDE-Q	We investigated the impact of temporary food restriction on a set shifting task requiring participants to judge clusters of pictures against a frequently changing rule. 60 healthy female participants underwent two testing sessions: once after fasting for 16 hours and once in a satiated state. Participants also completed a battery of questionnaires (Hospital Anxiety and Depression Scale [HADS]; Persistence, Perseveration and Perfectionism Questionnaire [PPPQ-22]; and Eating Disorders Examination Questionnaire [EDE-Q6]). Set shifting costs were significantly increased after fasting; this effect was independent of self-reported mood and perseveration. Furthermore, higher levels of weight concern predicted a general performance decrement under conditions of fasting. We conclude that relatively short periods of fasting can lead to set shifting impairments. This finding may have relevance to studies of development, individual differences, and the interpretation of psychometric tests. It also could have implications for understanding the etiology and maintenance of eating disorders, in which impaired set shifting has been implicated.	[Bolton, Heather M.; Burgess, Paul W.; Gilbert, Sam J.; Serpell, Lucy] UCL, Div Psychol & Language Sci, London, England; [Bolton, Heather M.] South London & Maudsley NHS Fdn Trust, Bethlem Royal Hosp, Beckenham, Kent, England; [Serpell, Lucy] North East London NHS Fdn Trust, Porters Ave Hlth Ctr, Dagenham, Essex, England	University of London; University College London	Bolton, HM (corresponding author), UCL, Div Psychol & Language Sci, London, England.	boltonheather@gmail.com	Gilbert, Sam J./C-1909-2008; Gilbert, Sam/V-2503-2019; Burgess, Paul W/A-1811-2010	Gilbert, Sam J./0000-0002-3839-7045; Gilbert, Sam/0000-0002-3839-7045; Serpell, Lucy/0000-0001-8543-8383	Royal Society University Research Fellowship	Royal Society University Research Fellowship(Royal Society of London)	SJG is supported by a Royal Society University Research Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agras WS, 2008, NORD J PSYCHIAT, V62, P19, DOI 10.1080/08039480802315632; Anderluh MB, 2003, AM J PSYCHIAT, V160, P242, DOI 10.1176/appi.ajp.160.2.242; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Benau EM, 2014, APPETITE, V77, P52, DOI 10.1016/j.appet.2014.02.014; Berkman ND, 2007, INT J EAT DISORDER, V40, P293, DOI 10.1002/eat.20369; Bissonette GB, 2013, BEHAV BRAIN RES, V250, P91, DOI 10.1016/j.bbr.2013.04.037; Brooks SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022259; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Danner UN, 2012, INT J EAT DISORDER, V45, P685, DOI 10.1002/eat.22007; Doniger GA, 2006, BEHAV NEUROSCI, V120, P804, DOI 10.1037/0735-7044.120.4.804; Duchesne Monica, 2004, Rev. Bras. Psiquiatr., V26, P107, DOI 10.1590/S1516-44462004000200008; Epling WF, 2006, INT J EAT DISORDER, V3, P27; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Fairburn CG, 2008, COGNITIVE BEHAV THER; Fairburn Christopher G., 1993, P317; Fassino S, 2002, INT J EAT DISORDER, V31, P274, DOI 10.1002/eat.10028; Giel KE, 2012, PSYCHIAT RES, V200, P538, DOI 10.1016/j.psychres.2012.06.004; Gillberg IC, 2010, J CLIN EXP NEUROPSYC, V32, P358, DOI 10.1080/13803390903066857; Gowers S, 2004, J CHILD PSYCHOL PSYC, V45, P63, DOI 10.1046/j.0021-9630.2003.00309.x; Grant MM, 2001, BIOL PSYCHIAT, V50, P35, DOI 10.1016/S0006-3223(00)01072-6; Gu BM, 2008, BRAIN, V131, P155, DOI 10.1093/brain/awm277; Holliday J, 2005, AM J PSYCHIAT, V162, P2269, DOI 10.1176/appi.ajp.162.12.2269; Ilonen T, 2000, NORD J PSYCHIAT, V54, P275, DOI 10.1080/080394800448156; Kanakam N, 2013, WORLD J BIOL PSYCHIA, V14, P464, DOI 10.3109/15622975.2012.665478; Keys A, 1950, BIOL HUMAN FASTING; Kingston K, 1996, PSYCHOL MED, V26, P15, DOI 10.1017/S0033291700033687; Kojima S, 2005, PSYCHIAT RES-NEUROIM, V140, P251, DOI 10.1016/j.pscychresns.2005.08.002; Lang K, 2014, INT J EAT DISORDER, V47, P394, DOI 10.1002/eat.22235; Lindner SE, 2014, EUR EAT DISORD REV, V22, P252, DOI 10.1002/erv.2293; Lopez C, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-40; Luce KH, 1999, INT J EAT DISORDER, V25, P349, DOI 10.1002/(SICI)1098-108X(199904)25:3&lt;349::AID-EAT15&gt;3.0.CO;2-M; McCormick LM, 2008, INT J EAT DISORDER, V41, P602, DOI 10.1002/eat.20549; Merwin Rhonda M, 2011, Eat Disord, V19, P62, DOI 10.1080/10640266.2011.533606; Mond JM, 2006, BEHAV RES THER, V44, P53, DOI 10.1016/j.brat.2004.12.003; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Muhlau M, 2007, AM J PSYCHIAT, V164, P1850, DOI 10.1176/appi.ajp.2007.06111861; Nikendei C, 2011, PSYCHOL MED, V41, P829, DOI 10.1017/S0033291710001121; Oberndorfer TA, 2011, INT J EAT DISORDER, V44, P1, DOI 10.1002/eat.20750; Owen L, 2013, BRIT J NUTR, V110, P1873, DOI 10.1017/S0007114513001141; Owen Lauren, 2012, Psychopharmacology (Berl), V220, P577, DOI 10.1007/s00213-011-2510-2; Papadopoulos FC, 2009, BRIT J PSYCHIAT, V194, P10, DOI 10.1192/bjp.bp.108.054742; Piech RM, 2009, COGNITION EMOTION, V23, P528, DOI 10.1080/02699930802012153; Pollice C, 1997, INT J EAT DISORDER, V21, P367, DOI 10.1002/(SICI)1098-108X(1997)21:4&lt;367::AID-EAT10&gt;3.0.CO;2-W; Rastam M, 2001, DEV MED CHILD NEUROL, V43, P239, DOI 10.1017/S0012162201000457; Reimers S, 2005, DEV PSYCHOL, V41, P661, DOI 10.1037/0012-1649.41.4.661; Roberts ME, 2007, PSYCHOL MED, V37, P1075, DOI 10.1017/S0033291707009877; Roberts ME, 2010, J PSYCHIATR RES, V44, P964, DOI 10.1016/j.jpsychires.2010.03.001; Salbach-Andrae H, 2008, CHILD PSYCHIAT HUM D, V39, P261, DOI 10.1007/s10578-007-0086-1; SANDSON J, 1987, NEUROLOGY, V37, P1736, DOI 10.1212/WNL.37.11.1736; Sato Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061108; Serpell L, 2009, BEHAV THER, V40, P260, DOI 10.1016/j.beth.2008.07.001; Shott ME, 2012, EUR EAT DISORD REV, V20, P343, DOI 10.1002/erv.2172; Sidiropoulos Michael, 2007, Mcgill J Med, V10, P20; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Steinglass J, 2006, INT J EAT DISORDER, V39, P267, DOI 10.1002/eat.20244; Stewart SH, 1997, INT J EAT DISORDER, V21, P129, DOI 10.1002/(SICI)1098-108X(199703)21:2&lt;129::AID-EAT3&gt;3.0.CO;2-N; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; SULLIVAN PF, 1995, AM J PSYCHIAT, V152, P1073; Tchanturia K, 2002, Eat Weight Disord, V7, P312; Tchanturia K., 2010, COGNITIVE REMEDIATIO; Tchanturia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028331; Tchanturia K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020462; Tchanturia K, 2011, CURR TOP BEHAV NEURO, V6, P269, DOI 10.1007/7854_2010_90; Tenconi E, 2010, WORLD J BIOL PSYCHIA, V11, P813, DOI 10.3109/15622975.2010.483250; Treasure J, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-13; Uher R, 2006, BEHAV BRAIN RES, V169, P111, DOI 10.1016/j.bbr.2005.12.008; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; Wagner A, 2006, BIOL PSYCHIAT, V59, P291, DOI 10.1016/j.biopsych.2005.06.014; Wilsdon A, 2006, J PSYCHIATR RES, V40, P746, DOI 10.1016/j.jpsychires.2005.10.006; Zakzanis KK, 2010, J NEUROPSYCHOL, V4, P89, DOI 10.1348/174866409X459674; Zastrow A, 2009, AM J PSYCHIAT, V166, P608, DOI 10.1176/appi.ajp.2008.08050775; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	73	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101946	10.1371/journal.pone.0101946	http://dx.doi.org/10.1371/journal.pone.0101946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025179	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400028
J	Marlin, D; Nicolson, SW; Yusuf, AA; Stevenson, PC; Heyman, HM; Kruger, K				Marlin, Danica; Nicolson, Susan W.; Yusuf, Abdullahi A.; Stevenson, Philip C.; Heyman, Heino M.; Krueger, Kerstin			The Only African Wild Tobacco, Nicotiana africana: Alkaloid Content and the Effect of Herbivory	PLOS ONE			English	Article							INDUCED RESPONSES; INDUCED DEFENSE; LEAF HERBIVORY; EVOLUTION; NECTAR; COSTS; RESISTANCE; TOLERANCE; PLANTS; DAMAGE	Herbivory in some Nicotiana species is known to induce alkaloid production. This study examined herbivore-induced defenses in the nornicotine-rich African tobacco N. africana, the only Nicotiana species indigenous to Africa. We tested the predictions that: 1) N. africana will have high constitutive levels of leaf, flower and nectar alkaloids; 2) leaf herbivory by the African bollworm Helicoverpa armigera will induce increased alkaloid levels in leaves, flowers and nectar; and 3) increased alkaloid concentrations in herbivore-damaged plants will negatively affect larval growth. We grew N. africana in large pots in a greenhouse and exposed flowering plants to densities of one, three and six fourth-instar larvae of H. armigera, for four days. Leaves, flowers and nectar were analyzed for nicotine, nornicotine and anabasine. The principal leaf alkaloid was nornicotine (mean: 28 mu g/g dry mass) followed by anabasine (4.9 mu g/g) and nicotine (0.6 mu g/g). Nornicotine was found in low quantities in the flowers, but no nicotine or anabasine were recorded. The nectar contained none of the alkaloids measured. Larval growth was reduced when leaves of flowering plants were exposed to six larvae. As predicted by the optimal defense theory, herbivory had a localized effect and caused an increase in nornicotine concentrations in both undamaged top leaves of herbivore damaged plants and herbivore damaged leaves exposed to one and three larvae. The nicotine concentration increased in damaged compared to undamaged middle leaves. The nornicotine concentration was lower in damaged leaves of plants exposed to six compared to three larvae, suggesting that N. africana rather invests in new growth as opposed to protecting older leaves under severe attack. The results indicate that the nornicotine-rich N. africana will be unattractive to herbivores and more so when damaged, but that potential pollinators will be unaffected because the nectar remains alkaloid-free even after herbivory.	[Marlin, Danica; Nicolson, Susan W.; Yusuf, Abdullahi A.; Krueger, Kerstin] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Stevenson, Philip C.] Royal Bot Gardens, Richmond, Surrey, England; [Stevenson, Philip C.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England; [Heyman, Heino M.; Krueger, Kerstin] Univ Pretoria, Dept Plant Sci, ZA-0002 Pretoria, South Africa	University of Pretoria; Royal Botanic Gardens, Kew; University of Greenwich; University of Pretoria	Kruger, K (corresponding author), Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	kkruger@zoology.up.ac.za	Krüger, Kerstin/A-6082-2011; Yusuf, Abdullahi Ahmed/E-4701-2011; Marlin, Danica/AAW-3988-2021; stevenson, philip c/E-8741-2013; Marlin, Danica/J-4218-2019; Heyman, Heino Martin/I-1670-2014; Stevenson, Philip C/E-8822-2013	Krüger, Kerstin/0000-0001-6357-1589; Yusuf, Abdullahi Ahmed/0000-0002-8625-6490; Marlin, Danica/0000-0003-3153-5246; stevenson, philip c/0000-0002-0736-3619; Heyman, Heino Martin/0000-0003-0941-2506; Stevenson, Philip C/0000-0002-0736-3619; Nicolson, Susan/0000-0001-6024-9383	National Research Foundation of South Africa [73671]; University of Pretoria; BBSRC [BB/I000445/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000445/1] Funding Source: researchfish	National Research Foundation of South Africa(National Research Foundation - South Africa); University of Pretoria; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was funded by the National Research Foundation of South Africa (73671) and the University of Pretoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2006, ECOL LETT, V9, P960, DOI 10.1111/j.1461-0248.2006.00944.x; Adler LS, 2012, ECOL LETT, V15, P1140, DOI 10.1111/j.1461-0248.2012.01838.x; Baldwin IT, 1999, J CHEM ECOL, V25, P3, DOI 10.1023/A:1020880931488; BALDWIN IT, 1988, J CHEM ECOL, V14, P1113, DOI 10.1007/BF01019339; BALDWIN IT, 1994, OECOLOGIA, V97, P424, DOI 10.1007/BF00317335; BALDWIN IT, 1993, J CHEM ECOL, V19, P1143, DOI 10.1007/BF00987376; BALDWIN IT, 1988, OECOLOGIA, V75, P367, DOI 10.1007/BF00376939; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Cherry Andy, 2003, P329, DOI 10.1079/9780851996394.0329; Clarkson JJ, 2004, MOL PHYLOGENET EVOL, V33, P75, DOI 10.1016/j.ympev.2004.05.002; CORESTA, 2009, SCAL COD GROWTH STAG; Craven P, 2004, NICOTIANA AFRICANA; Dobson A.J., 2013, INTRO STAT MODELLING; Euler M, 1996, OECOLOGIA, V107, P102, DOI 10.1007/BF00582240; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Giess W, 1982, DINTERIA, V16, P11; Goodspeed TH, 1954, CHRONICA BOT; Halpern SL, 2010, OECOLOGIA, V163, P961, DOI 10.1007/s00442-010-1651-z; Heil M, 2001, EUR J PLANT PATHOL, V107, P137, DOI 10.1023/A:1008793009517; Heil M, 2010, EVOL ECOL, V24, P555, DOI 10.1007/s10682-009-9348-7; Hoft M, 1996, OECOLOGIA, V107, P160, DOI 10.1007/BF00327899; JEFFREY RN, 1964, PLANT PHYSIOL, V39, P480, DOI 10.1104/pp.39.3.480; Kaplan I, 2008, J CHEM ECOL, V34, P1349, DOI 10.1007/s10886-008-9541-0; Kessler D, 2008, SCIENCE, V321, P1200, DOI 10.1126/science.1160072; Kessler D, 2012, PLANT J, V71, P529, DOI 10.1111/j.1365-313X.2012.05008.x; Knapp S, 2004, TAXON, V53, P73, DOI 10.2307/4135490; Ladiges PY, 2011, J BIOGEOGR, V38, P2066, DOI 10.1111/j.1365-2699.2011.02554.x; Leete, 1983, ALKALOIDS CHEM BIOL, V1, P85; Lerch-Henning S, 2013, J AVIAN BIOL, V44, P408, DOI 10.1111/j.1600-048X.2013.00079.x; Manson JS, 2013, J ECOL, V101, P1604, DOI 10.1111/1365-2745.12144; McCall AC, 2006, OECOLOGIA, V146, P566, DOI 10.1007/s00442-005-0284-0; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Meier U., 2018, GROWTH STAGES MONOAN, DOI [10.5073/20180906-074619, DOI 10.5073/20180906-074619]; NARAYAN RKJ, 1987, PLANT SYST EVOL, V157, P161, DOI 10.1007/BF00936195; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Ohnmeiss TE, 1997, NEW PHYTOL, V137, P441, DOI 10.1046/j.1469-8137.1997.00845.x; Ohnmeiss TE, 2000, ECOLOGY, V81, P1765, DOI 10.1890/0012-9658(2000)081[1765:ODTPTO]2.0.CO;2; Payne R., 2012, INTRO GENSTAT WINDOW; Preisser EL, 2007, ACTA OECOL, V31, P210, DOI 10.1016/j.actao.2006.09.004; Purrington CB, 2000, CURR OPIN PLANT BIOL, V3, P305, DOI 10.1016/S1369-5266(00)00085-6; Raguso RA, 2006, PHYTOCHEMISTRY, V67, P1931, DOI 10.1016/j.phytochem.2006.05.038; Richardson CH, 1936, J ECON ENTOMOL, V29, P850, DOI 10.1093/jee/29.5.850; SAITOH F, 1985, PHYTOCHEMISTRY, V24, P477, DOI 10.1016/S0031-9422(00)80751-7; SCHOONHOVEN LM, 1998, INSECT PLANT BIOL; SEVERSON RF, 1988, J CHEM ECOL, V14, P1485, DOI 10.1007/BF01012420; SISSON VA, 1990, BEITR TABAKFORSCH, V14, P327, DOI 10.2478/cttr-2013-0610; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Tadmor-Melamed H, 2004, FUNCT ECOL, V18, P844, DOI 10.1111/j.0269-8463.2004.00929.x; Tiedeken EJ, 2014, J EXP BIOL, V217, P1620, DOI 10.1242/jeb.097543; Van Dam NM, 2001, ECOL ENTOMOL, V26, P578, DOI 10.1046/j.1365-2311.2001.00366.x; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; YANG RSH, 1969, ANN ENTOMOL SOC AM, V62, P141, DOI 10.1093/aesa/62.1.141; Zangerl A. R., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P363; Zangerl AR, 2003, BASIC APPL ECOL, V4, P91, DOI 10.1078/1439-1791-00135	56	11	12	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102661	10.1371/journal.pone.0102661	http://dx.doi.org/10.1371/journal.pone.0102661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025217	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000339992400099
J	Walter, S; Glymour, M; Avendano, M				Walter, Stefan; Glymour, Maria; Avendano, Mauricio			The Health Effects of US Unemployment Insurance Policy: Does Income from Unemployment Benefits Prevent Cardiovascular Disease?	PLOS ONE			English	Article							INVOLUNTARY JOB LOSS; CORONARY-HEART-DISEASE; RETIREMENT SURVEY; MYOCARDIAL-INFARCTION; OLDER WORKERS; DEPRESSIVE SYMPTOMS; FINNISH MEN; ILL HEALTH; STROKE; RISK	Objective: Previous studies suggest that unemployment predicts increased cardiovascular disease (CVD) risk, but whether unemployment insurance programs mitigate this risk has not been assessed. Exploiting US state variations in unemployment insurance benefit programs, we tested the hypothesis that more generous benefits reduce CVD risk. Methods: Cohort data came from 16,108 participants in the Health and Retirement Study (HRS) aged 50-65 at baseline interviewed from 1992 to 2010. Data on first and recurrent CVD diagnosis assessed through biennial interviews were linked to the generosity of unemployment benefit programmes in each state and year. Using state fixed-effect models, we assessed whether state changes in the generosity of unemployment benefits predicted CVD risk. Results: States with higher unemployment benefits had lower incidence of CVD, so that a 1% increase in benefits was associated with 18% lower odds of CVD (OR: 0.82, 95%-CI: 0.71-0.94). This association remained after introducing US census regional division fixed effects, but disappeared after introducing state fixed effects (OR: 1.02, 95%-CI: 0.79-1.31). This was consistent with the fact that unemployment was not associated with CVD risk in state-fixed effect models. Conclusion: Although states with more generous unemployment benefits had lower CVD incidence, this appeared to be due to confounding by state-level characteristics. Possible explanations are the lack of short-term effects of unemployment on CVD risk. Future studies should assess whether benefits at earlier stages of the life-course influence long-term risk of CVD.	[Walter, Stefan; Glymour, Maria; Avendano, Mauricio] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Walter, Stefan] Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands; [Walter, Stefan] Erasmus Univ, Dept Epidemiol, Med Ctr, Rotterdam, Netherlands; [Glymour, Maria] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Avendano, Mauricio] Univ London London Sch Econ & Polit Sci, LSE Hlth & Social Care, London WC2A 2AE, England	Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco; University of London; London School Economics & Political Science	Walter, S (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA.	swalter@hsph.harvard.edu	Avendano, Mauricio/C-9658-2018	Avendano, Mauricio/0000-0002-7295-2911; Glymour, M. Maria/0000-0001-9644-3081; Walter, Stefan/0000-0002-6010-7550	Robert Wood Johnsons Foundation	Robert Wood Johnsons Foundation	Stefan Walter and Mauricio Avedano were supported by a Robert Wood Johnsons Foundation seed grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avendano M, 2008, STROKE, V39, P1533, DOI 10.1161/STROKEAHA.107.490383; Bartley M, 2010, J EPIDEMIOL COMMUN H, V64, P5, DOI 10.1136/jech.2009.089797; BARTLEY M, 1994, J EPIDEMIOL COMMUN H, V48, P333, DOI 10.1136/jech.48.4.333; Chan S, 1999, AM ECON REV, V89, P211, DOI 10.1257/aer.89.2.211; Clemens Tom, 2009, Health Stat Q, P7; Deb P, 2011, J HEALTH ECON, V30, P317, DOI 10.1016/j.jhealeco.2010.12.009; Falba T, 2005, ADDICTION, V100, P1330, DOI 10.1111/j.1360-0443.2005.01150.x; Gallo WT, 2006, OCCUP ENVIRON MED, V63, P683, DOI 10.1136/oem.2006.026823; Gallo WT, 2006, INT ARCH OCC ENV HEA, V80, P109, DOI 10.1007/s00420-006-0108-5; Gallo WT, 2006, J GERONTOL B-PSYCHOL, V61, pS221, DOI 10.1093/geronb/61.4.S221; Gallo WT, 2009, RES AGING, V31, P345, DOI 10.1177/0164027508330722; Gallo WT, 2000, J GERONTOL B-PSYCHOL, V55, pS131, DOI 10.1093/geronb/55.3.S131; Gallo WT, 2004, AM J IND MED, V45, P408, DOI 10.1002/ajim.20004; Gallo WT, 2001, J GERONTOL B-PSYCHOL, V56, pS3, DOI 10.1093/geronb/56.1.S3; Glymour MM, 2009, STROKE, V40, P873, DOI 10.1161/STROKEAHA.108.529479; Grimaud O, 2011, AGE AGEING, V40, P116, DOI 10.1093/ageing/afq142; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Herd P, 2008, MILBANK Q, V86, P5, DOI 10.1111/j.1468-0009.2007.00512.x; Hintikka J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-410; JACOBSON LS, 1993, AM ECON REV, V83, P685; Johnson Richard W., 2013, FINANCIAL CONSEQUENC; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; KAWACHI I, 1994, CIRCULATION, V89, P1992, DOI 10.1161/01.CIR.89.5.1992; KUBZANSKY LD, 2000, SOCIAL EPIDEMIOLOGY, P213; Lindahl M, 2005, J HUM RESOUR, V40, P144, DOI 10.3368/jhr.XL.1.144; Lundin A, 2010, J EPIDEMIOL COMMUN H, V64, P22, DOI 10.1136/jech.2008.079269; Mandal B, 2011, SOC SCI MED, V72, P576, DOI 10.1016/j.socscimed.2010.11.014; Martikainen P, 2007, AM J EPIDEMIOL, V165, P1070, DOI 10.1093/aje/kwm057; MARTIKAINEN PT, 1990, BMJ-BRIT MED J, V301, P407, DOI 10.1136/bmj.301.6749.407; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Sjolander P, 2008, SCAND J PUBLIC HEALT, V36, P84, DOI 10.1177/1403494807085305; Smith JP, 2007, J HUM RESOUR, V42, P739; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Toivanen S, 2011, SCAND J PUBLIC HEALT, V39, P797, DOI 10.1177/1403494811418280; Vroman, 2001, LOW BENEFIT RECIPIEN; Vroman W., 2009, MON LABOR REV; Whang W, 2009, J AM COLL CARDIOL, V53, P950, DOI 10.1016/j.jacc.2008.10.060; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101193	10.1371/journal.pone.0101193	http://dx.doi.org/10.1371/journal.pone.0101193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025281	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400010
J	Lee, KH; Park, JW; Sung, HS; Choi, YJ; Kim, WH; Lee, HS; Chung, HJ; Shin, HW; Cho, CH; Kim, TY; Li, SH; Youn, HD; Kim, SJ; Chun, YS				Lee, K-H; Park, J-W; Sung, H-S; Choi, Y-J; Kim, W. H.; Lee, H. S.; Chung, H-J; Shin, H-W; Cho, C-H; Kim, T-Y; Li, S-H; Youn, H-D; Kim, S. J.; Chun, Y-S			PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer	ONCOGENE			English	Article							PLANT HOMEODOMAIN; COLON-CANCER; TRANSCRIPTION; ACETYLATION; ACTIVATION; EXPRESSION; BINDING; GENES	Plant homeodomain finger 2 (PHF2) has a role in epigenetic regulation of gene expression by demethylating H3K9-Me2. Several genome-wide studies have demonstrated that the chromosomal region including the PHF2 gene is often deleted in some cancers including colorectal cancer, and this finding encouraged us to investigate the tumor suppressive role of PHF2. As p53 is a critical tumor suppressor in colon cancer, we tested the possibility that PHF2 is an epigenetic regulator of p53. PHF2 was associated with p53, and thereby, promoted p53-driven gene expression in cancer cells under genotoxic stress. PHF2 converted the chromatin that is favorable for transcription by demethylating the repressive H3K9-Me2 mark. In an HCT116 xenograft model, PHF2 was found to be required for the anticancer effects of oxaliplatin and doxorubicin. In PHF2-deficient xenografts, p53 expression was profoundly induced by both drugs, but its downstream product p21 was not, suggesting that p53 cannot be activated in the absence of PHF2. To find clinical evidence about the role of PHF2, we analyzed the expressions of PHF2, p53 and p21 in human colon cancer tissues and adjacent normal tissues from patients. PHF2 was downregulated in cancer tissues and PHF2 correlated with p21 in cancers expressing functional p53. Colon and stomach cancer tissue arrays showed a positive correlation between PHF2 and p21 expressions. Informatics analyses using the Oncomine database also supported our notion that PHF2 is downregulated in colon and stomach cancers. On the basis of these findings, we propose that PHF2 acts as a tumor suppressor in association with p53 in cancer development and ensures p53-mediated cell death in response to chemotherapy.	[Lee, K-H; Park, J-W; Shin, H-W; Youn, H-D; Kim, S. J.; Chun, Y-S] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul 110799, South Korea; [Park, J-W; Sung, H-S; Choi, Y-J; Chung, H-J; Cho, C-H; Li, S-H; Youn, H-D; Kim, S. J.; Chun, Y-S] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 110799, South Korea; [Kim, W. H.; Lee, H. S.] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110799, South Korea; [Kim, T-Y] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110799, South Korea; [Kim, S. J.; Chun, Y-S] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chun, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Physiol, 103 Daehak Ro, Seoul 110799, South Korea.	chunys@snu.ac.kr	Lee, Kyoung-Hwa/AAJ-5213-2021	Kim, Sang Jeong/0000-0001-8931-3713	Korean Health Technology RD grant [A121106, A120476]; National Research Foundation grants of Korea [2009-0066985, 20110008634, 2011-0030737]; Seoul National University Hospital Research Fund [0320110180]	Korean Health Technology RD grant; National Research Foundation grants of Korea; Seoul National University Hospital Research Fund	This work was supported by a Korean Health Technology R&D grant (A121106, A120476), National Research Foundation grants of Korea (2009-0066985, 20110008634 and 2011-0030737) and by a grant from the Seoul National University Hospital Research Fund 2011 (0320110180).	Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fortschegger K, 2011, EPIGENETICS-US, V6, P4, DOI 10.4161/epi.6.1.13297; Ghosh A, 2012, ANN SURG ONCOL, V19, pS528, DOI 10.1245/s10434-011-1991-x; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hasenpusch-Theil K, 1999, MAMM GENOME, V10, P294, DOI 10.1007/s003359900989; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Jaskelioff M, 2003, NAT CELL BIOL, V5, P395, DOI 10.1038/ncb0503-395; Jin LH, 2013, BIOCHEM J, V449, P459, DOI 10.1042/BJ20121360; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Mungamuri SK, 2012, NAT STRUCT MOL BIOL, V19, P478, DOI 10.1038/nsmb.2271; Munro AJ, 2005, BRIT J CANCER, V92, P434, DOI 10.1038/sj.bjc.6602358; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Ogino S, 2009, CANCER EPIDEM BIOMAR, V18, P2513, DOI 10.1158/1055-9965.EPI-09-0451; Okuno Y, 2013, DIABETES, V62, P1426, DOI 10.2337/db12-0628; Qiu JH, 2010, CELL RES, V20, P908, DOI 10.1038/cr.2010.81; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Sinha S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-84; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Stender JD, 2012, MOL CELL, V48, P28, DOI 10.1016/j.molcel.2012.07.020; Wen H, 2010, J BIOL CHEM, V285, P9322, DOI 10.1074/jbc.C109.097667; Wiesner GL, 2003, P NATL ACAD SCI USA, V100, P12961, DOI 10.1073/pnas.2132286100; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Zirbes TK, 2000, INT J CANCER, V89, P14, DOI 10.1002/(SICI)1097-0215(20000120)89:1<14::AID-IJC3>3.0.CO;2-L	34	44	48	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2015	34	22					2897	2909		10.1038/onc.2014.219	http://dx.doi.org/10.1038/onc.2014.219			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CJ2OM	25043306				2022-12-25	WOS:000355324300009
J	Zhang, Z; Liang, X; Gao, L; Ma, H; Liu, X; Pan, Y; Yan, W; Shan, H; Wang, Z; Chen, YH; Ma, C				Zhang, Z.; Liang, X.; Gao, L.; Ma, H.; Liu, X.; Pan, Y.; Yan, W.; Shan, H.; Wang, Z.; Chen, Y. H.; Ma, C.			TIPE1 induces apoptosis by negatively regulating Rac1 activation in hepatocellular carcinoma cells	ONCOGENE			English	Article							DEATH PATHWAYS; RHO-GTPASES; EXPRESSION; SCC-S2; CANCER; LIVER; PROLIFERATION; METASTASIS; MODULATION; IMMUNITY	TIPE1 (tumor necrosis factor-alpha-induced protein 8-like 1 or TNFAIP8L1) is a newly identified member of the TIPE (TNFAIP8) family, which play roles in regulating cell death. However, the biologic functions of TIPE1 in physiologic and pathologic conditions are largely unknown. Here, we report the roles of TIPE1 in hepatocellular carcinoma (HCC). Evaluated by immunohistochemical staining, HCC tissues showed significantly downregulated TIPE1 expression compared with adjacent non-tumor tissues, which positively correlated with tumor pathologic grades and patient survival. Using a homograft tumor model in Balb/c mice, we discovered that TIPE1 significantly diminished the growth and tumor weight of murine liver cancer homografts. Consistently, TIPE1 inhibited both cell growth and colony formation ability of cultured HCC cell lines, which was further identified to be due to TIPE1-inducing apoptosis in a caspase-independent, necrostatin-1 (Nec-1)-insensitive manner. Furthermore, mechanistic investigations revealed that TIPE1 interacted with Rac1, and inhibited the activation of Rac1 and its downstream p65 and c-Jun N-terminal kinase pathway. Moreover, overexpression of constitutively active Rac1 partially rescued the apoptosis induced by TIPE1, and Rac1 knockdown significantly restored the deregulated cell growth induced by TIPE1 small interfering RNA. Our findings revealed that TIPE1 induced apoptosis in HCC cells by negatively regulating Rac1 pathway, and loss of TIPE1 might be a new prognostic indicator for HCC patients.	[Zhang, Z.; Liang, X.; Gao, L.; Ma, H.; Liu, X.; Pan, Y.; Yan, W.; Shan, H.; Ma, C.] Shandong Univ, Sch Med, Key Lab Expt Teratol, Minist Educ, Jinan 250012, Shandong, Peoples R China; [Wang, Z.; Chen, Y. H.] Shandong Univ, Sch Med, Dept Immunol, Jinan 250012, Shandong, Peoples R China; [Wang, Z.; Chen, Y. H.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Shandong University; Shandong University; University of Pennsylvania	Chen, YH (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 713 Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.	yhc@mail.med.upenn.edu; machunhong@sdu.edu.cn	Wang, Zhaojun/GKS-9141-2022; Chen, Youhai/AAJ-4031-2021; ma, chunhong/C-6043-2008	Wang, Zhaojun/0000-0003-2853-1850; ma, chunhong/0000-0002-8121-4718	National Science Foundation of China [81172353, 81372211]; Cultivating Project, Major Research Plan of National Natural Science Foundation of China [91129704]; Shandong Provincial Nature Science Foundation [JQ200907]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20110131110034];  [NCET-10-0524]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cultivating Project, Major Research Plan of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Nature Science Foundation; Research Fund for the Doctoral Program of Higher Education of China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); 	This work was supported by grants from the National Science Foundation of China (Nos. 81172353, 81372211), Cultivating Project, Major Research Plan of National Natural Science Foundation of China (91129704), Programme for NCET-10-0524, Research Fund for the Doctoral Program of Higher Education of China (RFDP) (20110131110034) and Shandong Provincial Nature Science Foundation for Distinguished Young Scholars JQ200907.	Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Chaigne-Delalande B, 2008, ONCOGENE, V27, P1876, DOI 10.1038/sj.onc.1210830; Cui J, 2011, MOL IMMUNOL, V48, P1548, DOI 10.1016/j.molimm.2011.04.023; Debidda M, 2006, J BIOL CHEM, V281, P38519, DOI 10.1074/jbc.M604607200; Delavallee L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432; Dong QZ, 2010, CANCER SCI, V101, P1562, DOI 10.1111/j.1349-7006.2010.01557.x; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Filmus Jorge, 2004, Mol Diagn, V8, P207, DOI 10.2165/00066982-200408040-00002; Gomez J, 1998, IMMUNOL CELL BIOL, V76, P125, DOI 10.1046/j.1440-1711.1998.00723.x; Gus-Brautbar Y, 2012, MOL CELL, V45, P610, DOI 10.1016/j.molcel.2012.01.006; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Ishak KG, 2000, AM J CLIN PATHOL, V113, P40, DOI 10.1309/42D6-W7PL-FX0A-LBXF; Joneson T, 1999, MOL CELL BIOL, V19, P5892; Kumar D, 2004, ONCOGENE, V23, P612, DOI 10.1038/sj.onc.1207123; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Luan F, 2009, GUT, V58, P1528, DOI 10.1136/gut.2008.174029; Ma CH, 2004, WORLD J GASTROENTERO, V10, P2874; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; MATHEWS MB, 1984, NATURE, V309, P374, DOI 10.1038/309374a0; Miao ZF, 2012, TUMOR BIOL, V33, P2099, DOI 10.1007/s13277-012-0469-1; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Ozen C, 2013, NEW BIOTECHNOL, V30, P381, DOI 10.1016/j.nbt.2013.01.007; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sasi N, 2009, MOL CANCER THER, V8, P1421, DOI 10.1158/1535-7163.MCT-08-0895; Shi TY, 2013, CARCINOGENESIS, V34, P770, DOI 10.1093/carcin/bgt001; Shiraha H, 2013, INT J ONCOL, V42, P1133, DOI 10.3892/ijo.2013.1829; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Sun HH, 2012, J IMMUNOL, V189, P2768, DOI 10.4049/jimmunol.1103477; Wang ZJ, 2012, P NATL ACAD SCI USA, V109, P15413, DOI 10.1073/pnas.1204525109; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wilson KD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002609; Woodward MJ, 2010, CELL DEATH DIFFER, V17, P316, DOI 10.1038/cdd.2009.125; Yue XT, 2012, GASTROENTEROLOGY, V142, P1559, DOI 10.1053/j.gastro.2012.02.049; Zhang CB, 2006, MOL THER, V13, P947, DOI 10.1016/j.ymthe.2005.11.020	37	45	51	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2015	34	20					2566	2574		10.1038/onc.2014.208	http://dx.doi.org/10.1038/onc.2014.208			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI1YN	25043299				2022-12-25	WOS:000354541300003
J	Olivola, E; Pierantozzi, M; Imbriani, P; Liguori, C; Bassi, MS; Conti, M; D'Angelo, V; Mercuri, NB; Stefani, A				Olivola, Enrica; Pierantozzi, Mariangela; Imbriani, Paola; Liguori, Claudio; Bassi, Mario Stampanoni; Conti, Marco; D'Angelo, Vincenza; Mercuri, Nicola Biagio; Stefani, Alessandro			Serotonin Impairment in CSF of PD Patients, without an Apparent Clinical Counterpart	PLOS ONE			English	Article							DOPA-INDUCED DYSKINESIAS; PARKINSONS-DISEASE; DEPRESSIVE SYMPTOMS; CEREBROSPINAL-FLUID; DYSFUNCTION; MOTOR; METABOLISM; BINDING; SYSTEM; PET	In Parkinson's disease (PD), several studies have detected an impaired serotonin (5-HT) pathway, likely affecting both motor and non-motor domains. However, the precise impact of 5-HT impairment is far from established. Here, we have used a HPLC chromatographic method, in a homogenous cohort (n = 35) of non fluctuating, non dyskinetic PD patients, to assess the concentration of 5-HT and its metabolite 5-HIAA in peripheral cerebrospinal fluid (CSF) obtained from lumbar puncture (LP). LP was performed following three days of therapy withdrawal, in order to vanish the effects of prolonged released dopamine agonists (DA), and in absence of any serotonergic agent. The PD patient group showed a significantly reduced CSF level of both 5-HT and 5-HIAA compared to either age-matched control subjects (n = 18), or Alzheimer's disease patients (n = 20). However, no correlation emerged between 5-HT/5-HIAA concentrations and UPDRS-III (r = -0.12), disease duration (r = -0.1), age (r = -0.27) and MMSE (r = 0.11). Intriguingly, low CSF 5-HT levels did not differ for gender or for motor phenotype (in terms of non-tremor dominant subtype and tremor dominant subtype). Further, low CSF 5-HT levels did not correlate with the presence of depression, apathy or sleep disturbance. Our findings support the contention that 5-HT impairment is a cardinal feature of stable PD, probably representing a hallmark of diffuse Lewy bodies deposition in the brainstem. However, clinical relevance remains uncertain. Given these findings, an add-on therapy with serotonergic agents seems questionable in PD patients, or should be individually tailored, unless severe depression is present.	[Olivola, Enrica; Pierantozzi, Mariangela; Imbriani, Paola; Bassi, Mario Stampanoni; Conti, Marco; D'Angelo, Vincenza; Stefani, Alessandro] Univ Roma Tor Vergata, Movement Disorder Ctr, Dept Syst Med, Rome, Italy; [Imbriani, Paola; Mercuri, Nicola Biagio; Stefani, Alessandro] IRCCS Fdn, Rome, Italy; [Liguori, Claudio; Mercuri, Nicola Biagio] Univ Roma Tor Vergata, Dept Syst Med, Neurophysiopathol Unit, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata	Stefani, A (corresponding author), Univ Roma Tor Vergata, Movement Disorder Ctr, Dept Syst Med, Rome, Italy.	stefani@uniroma2.it	Imbriani, Paola/J-2984-2018; Pierantozzi, Mariangela/J-6905-2018; Imbriani, Paola/AAY-8754-2020; Stampanoni Bassi, Mario/ABI-7367-2020; Olivola, Enrica/AAB-3554-2019; Mercuri, Nicola Biagio/K-5348-2016	Imbriani, Paola/0000-0003-3373-5073; Stampanoni Bassi, Mario/0000-0003-4664-850X; Mercuri, Nicola Biagio/0000-0001-6700-7491; Olivola, Enrica/0000-0002-6530-8132; STEFANI, ALESSANDRO/0000-0002-1806-8922; PIERANTOZZI, MARIANGELA/0000-0002-4507-4666; Conti, Marco/0000-0001-8260-4753; D'Angelo, Vincenza/0000-0002-7720-8913	Lundbeck; Medtronic	Lundbeck(Lundbeck Corporation); Medtronic(Medtronic)	The author(s) received no specific funding for this work, asides personnel grants to AS; the grants to AS were liberal contribution from Lundbeck and Medtronic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo WF, 2004, MOVEMENT DISORD, V19, P571, DOI 10.1002/mds.10714; Ballanger B, 2012, MOVEMENT DISORD, V27, P84, DOI 10.1002/mds.23895; Barone P, 2010, LANCET NEUROL, V9, P573, DOI 10.1016/S1474-4422(10)70106-X; Bedard C, 2011, PARKINSONISM RELAT D, V17, P593, DOI 10.1016/j.parkreldis.2011.05.012; Carlsson T, 2007, J NEUROSCI, V27, P8011, DOI 10.1523/JNEUROSCI.2079-07.2007; CHIA LG, 1993, J NEUROL SCI, V116, P125, DOI 10.1016/0022-510X(93)90316-Q; Engelborghs S, 2004, J NEUROL NEUROSUR PS, V75, P1080; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Guttman M, 2007, EUR J NEUROL, V14, P523, DOI 10.1111/j.1468-1331.2007.01727.x; Huot P., 2012, NEUROBIOL AGING, V33; Huot P, 2011, PROG NEUROBIOL, V95, P163, DOI 10.1016/j.pneurobio.2011.08.004; Kerenyi L, 2003, ARCH NEUROL-CHICAGO, V60, P1223, DOI 10.1001/archneur.60.9.1223; Kish SJ, 2003, ADV NEUROL, V91, P39; KOSTIC VS, 1987, J NEUROL, V234, P94, DOI 10.1007/BF00314109; Kuhn W, 1996, J NEURAL TRANSM, V103, P1441, DOI 10.1007/BF01271258; LEWITT PA, 1992, NEUROLOGY, V42, P2111, DOI 10.1212/WNL.42.11.2111; Loane C, 2013, NEUROLOGY, V80, P1850, DOI 10.1212/WNL.0b013e318292a31d; Lunardi G, 2009, PARKINSONISM RELAT D, V15, P383, DOI 10.1016/j.parkreldis.2008.10.001; MAYEUX R, 1984, NEUROLOGY, V34, P642, DOI 10.1212/WNL.34.5.642; Meco G, 2003, CLIN NEUROPHARMACOL, V26, P179, DOI 10.1097/00002826-200307000-00005; Navailles S, 2012, MOL NEUROBIOL, V45, P173, DOI 10.1007/s12035-011-8230-0; Pavese N, 2011, NEUROIMAGE, V56, P1463, DOI 10.1016/j.neuroimage.2011.03.012; Politis M, 2010, NEUROLOGY, V75, P1920, DOI 10.1212/WNL.0b013e3181feb2ab; Politis M, 2010, NEUROBIOL DIS, V40, P216, DOI 10.1016/j.nbd.2010.05.028; Roselli F, 2010, MOVEMENT DISORD, V25, P1853, DOI 10.1002/mds.23179; Rylander Daniella, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS126, DOI 10.1016/S1353-8020(11)70039-6; Solla P, 2012, J NEUROL SCI, V323, P33, DOI 10.1016/j.jns.2012.07.026; Stefani A, 2012, J NEURAL TRANSM, V119, P861, DOI 10.1007/s00702-012-0820-0	28	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101763	10.1371/journal.pone.0101763	http://dx.doi.org/10.1371/journal.pone.0101763			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036938	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200023
J	Stutz, WE; Bolnick, DI				Stutz, William E.; Bolnick, Daniel I.			Stepwise Threshold Clustering: A New Method for Genotyping MHC Loci Using Next-Generation Sequencing Technology	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; FREQUENCY-DEPENDENT SELECTION; CLASS-II GENES; HIGH-THROUGHPUT; NUCLEOTIDE SUBSTITUTION; MULTIVARIATE ANALYSES; COMPARATIVE GENOMICS; GEL-ELECTROPHORESIS; PARASITE RESISTANCE; SEXUAL SELECTION	Genes of the vertebrate major histocompatibility complex (MHC) are of great interest to biologists because of their important role in immunity and disease, and their extremely high levels of genetic diversity. Next generation sequencing (NGS) technologies are quickly becoming the method of choice for high-throughput genotyping of multi-locus templates like MHC in non-model organisms. Previous approaches to genotyping MHC genes using NGS technologies suffer from two problems: 1) a "gray zone" where low frequency alleles and high frequency artifacts can be difficult to disentangle and 2) a similar sequence problem, where very similar alleles can be difficult to distinguish as two distinct alleles. Here were present a new method for genotyping MHC loci - Stepwise Threshold Clustering (STC) - that addresses these problems by taking full advantage of the increase in sequence data provided by NGS technologies. Unlike previous approaches for genotyping MHC with NGS data that attempt to classify individual sequences as alleles or artifacts, STC uses a quasi-Dirichlet clustering algorithm to cluster similar sequences at increasing levels of sequence similarity. By applying frequency and similarity based criteria to clusters rather than individual sequences, STC is able to successfully identify clusters of sequences that correspond to individual or similar alleles present in the genomes of individual samples. Furthermore, STC does not require duplicate runs of all samples, increasing the number of samples that can be genotyped in a given project. We show how the STC method works using a single sample library. We then apply STC to 295 threespine stickleback (Gasterosteus aculeatus) samples from four populations and show that neighboring populations differ significantly in MHC allele pools. We show that STC is a reliable, accurate, efficient, and flexible method for genotyping MHC that will be of use to biologists interested in a variety of downstream applications.	[Stutz, William E.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Bolnick, Daniel I.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA; [Bolnick, Daniel I.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Stutz, WE (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	william.stutz@colorado.edu	Bolnick, Daniel I./G-4440-2015	Bolnick, Daniel I./0000-0003-3148-6296	Howard Hughes Medical Institute; Division Of Environmental Biology [1144773] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding comes from the Howard Hughes Medical Institute (www.hhmi.org). Dan Bolnick (co-author) is an HHMI young investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer Sonia, 2008, P259; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arguello JR, 1998, TISSUE ANTIGENS, V52, P57, DOI 10.1111/j.1399-0039.1998.tb03024.x; Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x; Babik W, 2009, MOL ECOL RESOUR, V9, P713, DOI 10.1111/j.1755-0998.2009.02622.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Berner D, 2009, EVOLUTION, V63, P1740, DOI 10.1111/j.1558-5646.2009.00665.x; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bos DH, 2008, EVOLUTION, V62, P1458, DOI 10.1111/j.1558-5646.2008.00364.x; Bradley RD, 1997, MOL BIOL EVOL, V14, P592, DOI 10.1093/oxfordjournals.molbev.a025797; Bryja J, 2005, MOL ECOL NOTES, V5, P173, DOI 10.1111/j.1471-8286.2004.00855.x; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dijkstra JM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-260; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dunn PO, 2013, EVOLUTION, V67, P679, DOI 10.1111/j.1558-5646.2012.01799.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; Hedrick PW, 2000, EVOLUTION, V54, P2145; HERMEL E, 1995, IMMUNOGENETICS, V42, P136, DOI 10.1007/BF00178588; Hess CM, 2002, BIOSCIENCE, V52, P423, DOI 10.1641/0006-3568(2002)052[0423:TEOTMH]2.0.CO;2; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; Klein J, 1998, ANNU REV ECOL SYST, V29, P1, DOI 10.1146/annurev.ecolsys.29.1.1; KLEIN J, 1986, NATURAL HIST MAJOR H; Kurtz J, 2004, P ROY SOC B-BIOL SCI, V271, P197, DOI 10.1098/rspb.2003.2567; Lenz TL, 2013, EVOLUTION, V67, P2400, DOI 10.1111/evo.12124; Lenz TL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-57; Lenz TL, 2008, GENE, V427, P117, DOI 10.1016/j.gene.2008.09.013; Livant EJ, 2005, ANIM GENET, V36, P432, DOI 10.1111/j.1365-2052.2005.01331.x; Longeri M, 2002, EUR J IMMUNOGENET, V29, P517, DOI 10.1046/j.1365-2370.2002.00356.x; Malaga-Trillo E, 1998, GENETICS, V149, P1527; MCGINNIS MD, 1995, TISSUE ANTIGENS, V46, P173, DOI 10.1111/j.1399-0039.1995.tb03116.x; Meyer D, 2001, ANN HUM GENET, V65, P1, DOI 10.1046/j.1469-1809.2001.6510001.x; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nadachowska-Brzyska K, 2012, MOL ECOL, V21, P887, DOI 10.1111/j.1365-294X.2011.05347.x; Ohta T, 1999, IMMUNOL REV, V167, P319, DOI 10.1111/j.1600-065X.1999.tb01401.x; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Pavey SA, 2013, MOL ECOL, V22, P3833, DOI 10.1111/mec.12358; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; POTTS WK, 1990, TRENDS ECOL EVOL, V5, P181, DOI 10.1016/0169-5347(90)90207-T; Promerova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069135; Promerova M, 2012, MOL ECOL RESOUR, V12, P285, DOI 10.1111/j.1755-0998.2011.03082.x; Prosperi MCF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013619; R Core Team, 2012, R LANG ENV STAT COMP; Radwan J, 2012, MOL ECOL, V21, P2469, DOI 10.1111/j.1365-294X.2012.05547.x; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Reusch TBH, 2005, J MOL EVOL, V61, P531, DOI 10.1007/s00239-004-0340-0; Reusch TBH, 2004, IMMUNOGENETICS, V56, P427, DOI 10.1007/s00251-004-0704-z; Richman AD, 2003, GENET RES, V82, P89, DOI 10.1017/S0016672303006347; Sato A, 1998, MOL MAR BIOL BIOTECH, V7, P221; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; Siddle HV, 2010, P ROY SOC B-BIOL SCI, V277, P2001, DOI 10.1098/rspb.2009.2362; SLADE RW, 1992, GENETICS, V132, P861; SNELL GD, 1968, FOLIA BIOL-PRAGUE, V14, P335; Sommer S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-542; Spurgin LG, 2011, MOL ECOL, V20, P5213, DOI 10.1111/j.1365-294X.2011.05367.x; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Strandh M, 2012, P ROY SOC B-BIOL SCI, V279, P4457, DOI 10.1098/rspb.2012.1562; Stuglik MT, 2011, MOL ECOL RESOUR, V11, P739, DOI 10.1111/j.1755-0998.2011.02997.x; TAKAHATA N, 1990, GENETICS, V124, P967; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; Zagalska-Neubauer M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-395; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zagordi O, 2010, J COMPUT BIOL, V17, P417, DOI 10.1089/cmb.2009.0164	86	27	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e100587	10.1371/journal.pone.0100587	http://dx.doi.org/10.1371/journal.pone.0100587			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036866	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200009
J	Veijola, J; Guo, JY; Moilanen, JS; Jaaskelainen, E; Miettunen, J; Kyllonen, M; Haapea, M; Huhtaniska, S; Alaraisanen, A; Maki, P; Kiviniemi, V; Nikkinen, J; Starck, T; Remes, JJ; Tanskanen, P; Tervonen, O; Wink, AM; Kehagia, A; Suckling, J; Kobayashi, H; Barnett, JH; Barnes, A; Koponen, HJ; Jones, PB; Isohanni, M; Murray, GK				Veijola, Juha; Guo, Joyce Y.; Moilanen, Jani S.; Jaaskelainen, Erika; Miettunen, Jouko; Kyllonen, Merja; Haapea, Marianne; Huhtaniska, Sanna; Alaraisanen, Antti; Maki, Pirjo; Kiviniemi, Vesa; Nikkinen, Juha; Starck, Tuomo; Remes, Jukka J.; Tanskanen, Paivikki; Tervonen, Osmo; Wink, Alle-Meije; Kehagia, Angie; Suckling, John; Kobayashi, Hiroyuki; Barnett, Jennifer H.; Barnes, Anna; Koponen, Hannu J.; Jones, Peter B.; Isohanni, Matti; Murray, Graham K.			Longitudinal Changes in Total Brain Volume in Schizophrenia: Relation to Symptom Severity, Cognition and Antipsychotic Medication	PLOS ONE			English	Article							NEGATIVE-SYNDROME-SCALE; VENTRICULAR SIZE; BIRTH COHORT; METAANALYSIS; EXPOSURE; ACCURATE; PANSS	Studies show evidence of longitudinal brain volume decreases in schizophrenia. We studied brain volume changes and their relation to symptom severity, level of function, cognition, and antipsychotic medication in participants with schizophrenia and control participants from a general population based birth cohort sample in a relatively long follow-up period of almost a decade. All members of the Northern Finland Birth Cohort 1966 with any psychotic disorder and a random sample not having psychosis were invited for a MRI brain scan, and clinical and cognitive assessment during 1999-2001 at the age of 33-35 years. A follow-up was conducted 9 years later during 2008-2010. Brain scans at both time points were obtained from 33 participants with schizophrenia and 71 control participants. Regression models were used to examine whether brain volume changes predicted clinical and cognitive changes over time, and whether antipsychotic medication predicted brain volume changes. The mean annual whole brain volume reduction was 0.69% in schizophrenia, and 0.49% in controls (p = 0.003, adjusted for gender, educational level, alcohol use and weight gain). The brain volume reduction in schizophrenia patients was found especially in the temporal lobe and periventricular area. Symptom severity, functioning level, and decline in cognition were not associated with brain volume reduction in schizophrenia. The amount of antipsychotic medication (dose years of equivalent to 100 mg daily chlorpromazine) over the follow-up period predicted brain volume loss (p = 0.003 adjusted for symptom level, alcohol use and weight gain). In this population based sample, brain volume reduction continues in schizophrenia patients after the onset of illness, and antipsychotic medications may contribute to these reductions.	[Veijola, Juha; Moilanen, Jani S.; Jaaskelainen, Erika; Miettunen, Jouko; Kyllonen, Merja; Haapea, Marianne; Huhtaniska, Sanna; Alaraisanen, Antti; Maki, Pirjo; Isohanni, Matti] Univ Oulu, Inst Clin Med, Dept Psychiat, Oulu, Finland; [Veijola, Juha; Moilanen, Jani S.; Jaaskelainen, Erika; Haapea, Marianne; Huhtaniska, Sanna; Alaraisanen, Antti; Maki, Pirjo; Isohanni, Matti] Oulu Univ, Cent Hosp, Dept Psychiat, SF-90220 Oulu, Finland; [Guo, Joyce Y.; Wink, Alle-Meije; Suckling, John; Kobayashi, Hiroyuki; Barnett, Jennifer H.; Barnes, Anna; Jones, Peter B.; Murray, Graham K.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Wink, Alle-Meije; Suckling, John; Murray, Graham K.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Miettunen, Jouko] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Miettunen, Jouko] Oulu Univ, Cent Hosp, Unit Gen Practice, SF-90220 Oulu, Finland; [Kiviniemi, Vesa; Nikkinen, Juha; Starck, Tuomo; Remes, Jukka J.; Tanskanen, Paivikki; Tervonen, Osmo] Oulu Univ, Cent Hosp, Dept Diagnost Radiol, SF-90220 Oulu, Finland; [Wink, Alle-Meije] Vrije Univ Amsterdam, Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Kehagia, Angie] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London, England; [Kobayashi, Hiroyuki] Toho Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Barnett, Jennifer H.] Cambridge Cognit Ltd, Cambridge, England; [Barnes, Anna] Univ Coll London Hosp, NHS Fdn Trust, Inst Nucl Med, London, England; [Koponen, Hannu J.] Univ Eastern Finland, Fac Hlth Sci, Inst Clin Med, Kuopio, Finland; [Koponen, Hannu J.] Univ Kuopio, Cent Hosp, Dept Psychiat, Kuopio, Finland	University of Oulu; University of Oulu; University of Cambridge; University of Cambridge; University of Oulu; University of Oulu; University of Oulu; Vrije Universiteit Amsterdam; University of London; King's College London; Toho University; Oxford University Hospitals NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Veijola, J (corresponding author), Univ Oulu, Inst Clin Med, Dept Psychiat, Oulu, Finland.	juha.veijola@oulu.fi	Haapea, Marianne/I-3291-2016; Guo, Joyce/AAY-2946-2020; Miettunen, Jouko/AAC-4334-2019; Barnes, Anna/AAV-8780-2021; Wink, Alle Meije/R-6403-2017; Remes, Jukka J/E-4217-2015; Suckling, John/ABD-7246-2021	Haapea, Marianne/0000-0002-3989-9354; Guo, Joyce/0000-0001-9388-6688; Miettunen, Jouko/0000-0003-0575-2669; Barnes, Anna/0000-0002-6902-214X; Wink, Alle Meije/0000-0002-8197-0118; Remes, Jukka J/0000-0003-1685-8346; Suckling, John/0000-0002-5098-1527; Koponen, Hannu/0000-0002-7368-1869; Nikkinen, Juha/0000-0001-6355-3444; Murray, Graham/0000-0001-8296-1742; Jones, Peter Brian/0000-0002-0387-880X	Academy of Finland; Medical Research Council; Sigrid Juselius Foundation; Stanley Foundation; NARSAD; Brain and Behavior Research Fund; MRC [G0701911] Funding Source: UKRI; Medical Research Council [G0001354B, G0701911, G0001354, G1000183B] Funding Source: researchfish	Academy of Finland(Academy of Finland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Stanley Foundation; NARSAD(NARSAD); Brain and Behavior Research Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the following sources of funding: Academy of Finland, Medical Research Council, Sigrid Juselius Foundation, Stanley Foundation, NARSAD, and the Brain and Behavior Research Fund. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andreasen NC, 2013, AM J PSYCHIAT, V170, P609, DOI 10.1176/appi.ajp.2013.12050674; Andreasen NC, 2011, BIOL PSYCHIAT, V70, P672, DOI 10.1016/j.biopsych.2011.05.017; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Arajarvi R, 2005, SOC PSYCH PSYCH EPID, V40, P808, DOI 10.1007/s00127-005-0951-9; de Bresser J, 2011, NEUROIMAGE, V54, P760, DOI 10.1016/j.neuroimage.2010.09.060; Delis DC., 2000, CALIFORNIA VERBAL LE; Dorph-Petersen KA, 2005, NEUROPSYCHOPHARMACOL, V30, P1649, DOI 10.1038/sj.npp.1300710; First M, 2002, COMMUNICATION; Fusar-Poli P, 2013, NEUROSCI BIOBEHAV R, V37, P1680, DOI 10.1016/j.neubiorev.2013.06.001; Glahn D, 2008, EUR PSYCHIAT, V23, P315, DOI 10.1016/j.eurpsy.2007.09.014; Glahn DC, 2000, BIOL PSYCHIAT, V47, P34, DOI 10.1016/S0006-3223(99)00187-0; Glahn DC, 1997, NEUROPSYCHOLOGY, V11, P602, DOI 10.1037/0894-4105.11.4.602; Haapea M, 2007, SOC PSYCH PSYCH EPID, V42, P403, DOI 10.1007/s00127-007-0178-z; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Isohanni M, 1997, SOC PSYCH PSYCH EPID, V32, P303, DOI 10.1007/BF00789044; JOHNSTONE EC, 1976, LANCET, V2, P924; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kraepelin E, 1986, PSYCHIAT LEHRBUCH ST; Lauronen E, 2005, J CLIN PSYCHIAT, V66, P375, DOI 10.4088/JCP.v66n0315; Leucht S, 2005, SCHIZOPHR RES, V79, P231, DOI 10.1016/j.schres.2005.04.008; Leucht S, 2012, LANCET, V379, P2063, DOI 10.1016/S0140-6736(12)60239-6; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Lewis DA, 2011, ARCH GEN PSYCHIAT, V68, P126, DOI 10.1001/archgenpsychiatry.2010.187; Lieberman JA, 2005, ARCH GEN PSYCHIAT, V62, P361, DOI 10.1001/archpsyc.62.4.361; Lieberman JA, 1999, BIOL PSYCHIAT, V46, P729, DOI 10.1016/S0006-3223(99)00147-X; MARSDEN CD, 1976, LANCET, V2, P1079; McCormick L, 2005, SCHIZOPHR RES, V80, P73, DOI 10.1016/j.schres.2005.06.022; Moilanen K, 2003, SOC PSYCH PSYCH EPID, V38, P305, DOI 10.1007/s00127-003-0638-z; Olabi B, 2011, BIOL PSYCHIAT, V70, P88, DOI 10.1016/j.biopsych.2011.01.032; Poikolainen K, 1996, AM J EPIDEMIOL, V144, P346, DOI 10.1093/oxfordjournals.aje.a008935; Pol HEH, 2008, SCHIZOPHRENIA BULL, V34, P354, DOI 10.1093/schbul/sbm168; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shin JH, 2012, BIOL PHARM BULL, V35, P1069, DOI 10.1248/bpb.b12-00009; SMITH GN, 1986, LANCET, V1, P1450; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Soreca I, 2009, PSYCHOSOM MED, V71, P485, DOI 10.1097/PSY.0b013e3181a5429d; Spitzer L, 1989, COMMUNICATION; Spitzer RL, 2000, HDB PSYCHIAT MEASURE; Tanskanen P, 2009, PSYCHIAT RES-NEUROIM, V174, P116, DOI 10.1016/j.pscychresns.2009.04.009; van der Gaag M, 2006, SCHIZOPHR RES, V85, P280, DOI 10.1016/j.schres.2006.03.021; van Haren NEM, 2011, ARCH GEN PSYCHIAT, V68, P871, DOI 10.1001/archgenpsychiatry.2011.88; Verbaten MN, 2009, HUM PSYCHOPHARM CLIN, V24, P199, DOI 10.1002/hup.1022; Vernon AC, 2011, BIOL PSYCHIAT, V69, P936, DOI 10.1016/j.biopsych.2010.11.010	45	58	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101689	10.1371/journal.pone.0101689	http://dx.doi.org/10.1371/journal.pone.0101689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036617	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200021
J	Kamoi, S; Pretty, C; Docherty, P; Squire, D; Revie, J; Chiew, YS; Desaive, T; Shaw, GM; Chase, G				Kamoi, Shun; Pretty, Christopher; Docherty, Paul; Squire, Dougie; Revie, James; Chiew, Yeong Shiong; Desaive, Thomas; Shaw, Geoffrey M.; Chase, Geoffrey			Continuous Stroke Volume Estimation from Aortic Pressure Using Zero Dimensional Cardiovascular Model: Proof of Concept Study from Porcine Experiments	PLOS ONE			English	Article							CARDIAC-OUTPUT MEASUREMENT; HEART-FAILURE; ARTERIAL; PULSE; EPIDEMIOLOGY; INDICATOR; DIAGNOSIS; RESERVOIR; PATIENT; SHAPE	Introduction: Accurate, continuous, left ventricular stroke volume (SV) measurements can convey large amounts of information about patient hemodynamic status and response to therapy. However, direct measurements are highly invasive in clinical practice, and current procedures for estimating SV require specialized devices and significant approximation. Method: This study investigates the accuracy of a three element Windkessel model combined with an aortic pressure waveform to estimate SV. Aortic pressure is separated into two components capturing; 1) resistance and compliance, 2) characteristic impedance. This separation provides model-element relationships enabling SV to be estimated while requiring only one of the three element values to be known or estimated. Beat-to-beat SV estimation was performed using population-representative optimal values for each model element. This method was validated using measured SV data from porcine experiments (N = 3 female Pietrain pigs, 29-37 kg) in which both ventricular volume and aortic pressure waveforms were measured simultaneously. Results: The median difference between measured SV from left ventricle (LV) output and estimated SV was 0.6 ml with a 90% range (5th-95th percentile) -12.4 ml-14.3 ml. During periods when changes in SV were induced, cross correlations in between estimated and measured SV were above R = 0.65 for all cases. Conclusion: The method presented demonstrates that the magnitude and trends of SV can be accurately estimated from pressure waveforms alone, without the need for identification of complex physiological metrics where strength of correlations may vary significantly from patient to patient.	[Kamoi, Shun; Pretty, Christopher; Docherty, Paul; Squire, Dougie; Revie, James; Chiew, Yeong Shiong; Chase, Geoffrey] Univ Canterbury, Dept Mech Engn, Christchurch 1, New Zealand; [Desaive, Thomas] Univ Liege, GIGA Cardiovasc Sci, Liege, Belgium; [Shaw, Geoffrey M.] Christchurch Hosp, Intens Care Unit, Christchurch, New Zealand	University of Canterbury; University of Liege; Christchurch Hospital New Zealand	Kamoi, S (corresponding author), Univ Canterbury, Dept Mech Engn, Christchurch 1, New Zealand.	shun.kamoi@pg.canterbury.ac.nz	Squire, Dougie/AAI-6207-2021; Pretty, Christopher G/B-6300-2014; Chiew, Yeong Shiong/AAL-8505-2021; Chiew, Yeong Shiong/M-7028-2016	Squire, Dougie/0000-0003-3271-6874; Pretty, Christopher G/0000-0002-2265-6065; Chiew, Yeong Shiong/0000-0003-3222-2006; Chiew, Yeong Shiong/0000-0003-3222-2006; Docherty, Paul/0000-0003-1661-2573	Fonds National de la Recherche Scientifique (F.R.S.-FNRS, Belgium); University of Liege research grant (Belgium)	Fonds National de la Recherche Scientifique (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); University of Liege research grant (Belgium)	Funding provided by Fonds National de la Recherche Scientifique (F.R.S.-FNRS, Belgium), University of Liege research grant for foreign doctoral student (Belgium). (Both non-commercial source). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL FL, 1981, AM J PHYSIOL, V240, pH676, DOI 10.1152/ajpheart.1981.240.4.H676; Aguado-Sierra J, 2008, P I MECH ENG H, V222, P403, DOI 10.1243/09544119JEIM315; Alastruey J, 2009, J ENG MATH, V64, P331, DOI 10.1007/s10665-009-9275-1; Alhashemi JA, 2011, CRIT CARE, V15, DOI 10.1186/cc9996; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Asfar P, 2014, NEW ENGLAND J MED; Band DM, 1997, J PHYSIOL-LONDON, V498, P225, DOI 10.1113/jphysiol.1997.sp021853; Bridges E, 2013, AM J NURS, V113, P42, DOI 10.1097/01.NAJ.0000429754.15255.eb; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Chase JG, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-11; Cousins TR, 2004, AANA J, V72; Dickstein K, 2005, EUR J HEART FAIL, V7, P303, DOI 10.1016/j.ejheart.2005.01.003; Docherty PD, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-39; Ellender TJ, 2008, EMERG MED CLIN N AM, V26, P759, DOI 10.1016/j.emc.2008.04.001; Felker G M, 2001, Curr Cardiol Rep, V3, P108, DOI 10.1007/s11886-001-0035-8; FRANKLIN C, 1994, CRIT CARE MED, V22, P244, DOI 10.1097/00003246-199402000-00014; HANNON JP, 1990, LAB ANIM SCI, V40, P293; Kruger Grant H, 2011, Anesthesiol Clin, V29, P487, DOI 10.1016/j.anclin.2011.05.004; Luecke T, 2005, CRIT CARE, V9, P607, DOI 10.1186/cc3877; Massoud TF, 1998, FASEB J, V12, P275, DOI 10.1096/fasebj.12.3.275; Montenij LJ, 2011, CURR OPIN ANESTHESIO, V24, P651, DOI 10.1097/ACO.0b013e32834cd2d9; O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x; OROURKE M, 1990, HYPERTENSION, V15, P339, DOI 10.1161/01.HYP.15.4.339; Parker KH, 2012, MED BIOL ENG COMPUT, V50, P419, DOI 10.1007/s11517-012-0872-1; Perkins GD, 2003, CRIT CARE, V7, pR129, DOI 10.1186/cc2359; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Revie JA, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-33; SAGAWA K, 1990, J MOL CELL CARDIOL, V22, P253, DOI 10.1016/0022-2828(90)91459-K; Shi YB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-33; SIEGEL LC, 1992, ANESTH ANALG, V74, P790; Taylor CA, 2009, ANNU REV BIOMED ENG, V11, P109, DOI 10.1146/annurev.bioeng.10.061807.160521; Taylor C A, 1999, Comput Aided Surg, V4, P231, DOI 10.3109/10929089909148176; Thiele RH, 2011, ANESTH ANALG, V113, P766, DOI 10.1213/ANE.0b013e31822773ec; Thom O, 2009, BRIT J ANAESTH, V103, P800, DOI 10.1093/bja/aep296; Tibby SM, 2003, ARCH DIS CHILD, V88, P46, DOI 10.1136/adc.88.1.46; Trankina MF, 1999, SEMINARS ANESTHESIA, V18, P44; van de Vosse FN, 2011, ANNU REV FLUID MECH, V43, P467, DOI 10.1146/annurev-fluid-122109-160730; van Drunen EJ, 2013, BIOMED TECH BERL; van Lieshout JJ, 2003, EUR J APPL PHYSIOL, V90, P131, DOI 10.1007/s00421-003-0901-8; Wang JJ, 2003, AM J PHYSIOL-HEART C, V284, pH1358, DOI 10.1152/ajpheart.00175.2002; WESSELING KH, 1993, J APPL PHYSIOL, V74, P2566, DOI 10.1152/jappl.1993.74.5.2566; Westerhof N, 2009, MED BIOL ENG COMPUT, V47, P131, DOI 10.1007/s11517-008-0359-2; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	43	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102476	10.1371/journal.pone.0102476	http://dx.doi.org/10.1371/journal.pone.0102476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033442	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300054
J	Baron-Cohen, S; Cassidy, S; Auyeung, B; Allison, C; Achoukhi, M; Robertson, S; Pohl, A; Lai, MC				Baron-Cohen, Simon; Cassidy, Sarah; Auyeung, Bonnie; Allison, Carrie; Achoukhi, Maryam; Robertson, Sarah; Pohl, Alexa; Lai, Meng-Chuan			Attenuation of Typical Sex Differences in 800 Adults with Autism vs. 3,900 Controls	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; SPECTRUM QUOTIENT AQ; SYSTEMATIZING QUOTIENT; ASPERGER-SYNDROME; CHILDHOOD AUTISM; EMPATHY QUOTIENT; DISORDERS; GENDER; FEMALES; BRAIN	Sex differences have been reported in autistic traits and systemizing (male advantage), and empathizing (female advantage) among typically developing individuals. In individuals with autism, these cognitive-behavioural profiles correspond to predictions from the "extreme male brain" (EMB) theory of autism (extreme scores on autistic traits and systemizing, below average on empathizing). Sex differences within autism, however, have been under-investigated. Here we show in 811 adults (454 females) with autism and 3,906 age-matched typical control adults (2,562 females) who completed the Empathy Quotient (EQ), the Systemizing Quotient-Revised (SQ-R), and the Autism Spectrum Quotient (AQ), that typical females on average scored higher on the EQ, typical males scored higher on the SQ-R and AQ, and both males and females with autism showed a shift toward the extreme of the "male profile" on these measures and in the distribution of "brain types" (the discrepancy between standardized EQ and SQ-R scores). Further, normative sex differences are attenuated but not abolished in adults with autism. The findings provide strong support for the EMB theory of autism, and highlight differences between males and females with autism.	[Baron-Cohen, Simon; Cassidy, Sarah; Auyeung, Bonnie; Allison, Carrie; Achoukhi, Maryam; Robertson, Sarah; Pohl, Alexa; Lai, Meng-Chuan] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Baron-Cohen, Simon; Lai, Meng-Chuan] Cambridgeshire & Peterborough Natl Hlth Serv Fdn, Cambridge Lifespan Asperger Syndrome Serv CLASS C, Cambridge, England; [Auyeung, Bonnie] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Lai, Meng-Chuan] Natl Taiwan Univ Hosp & Coll Med, Dept Psychiat, Taipei, Taiwan	University of Cambridge; University of Edinburgh; National Taiwan University; National Taiwan University Hospital	Baron-Cohen, S (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England.	sb205@cam.ac.uk; mcl45@cam.ac.uk	Lai, Meng-Chuan/K-7407-2016; Cassidy, Sarah/K-8147-2015	Lai, Meng-Chuan/0000-0002-9593-5508; Cassidy, Sarah/0000-0003-1982-3034; Baron-Cohen, Simon/0000-0001-9217-2544	UK Medical Research Council; Wellcome Trust; Autism Research Trust; William Binks Autism Neuroscience Fellowship; European Autism Interventions - A Multicentre Study for Developing New Medications (EU-AIMS); Wolfson College, Cambridge; Medical Research Council [G0600977] Funding Source: researchfish; MRC [G0600977] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Autism Research Trust; William Binks Autism Neuroscience Fellowship; European Autism Interventions - A Multicentre Study for Developing New Medications (EU-AIMS); Wolfson College, Cambridge; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study received funding from the UK Medical Research Council, the Wellcome Trust, and the Autism Research Trust. Meng-Chuan Lai was supported by the William Binks Autism Neuroscience Fellowship, the European Autism Interventions - A Multicentre Study for Developing New Medications (EU-AIMS), and Wolfson College, Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison C, 2008, J AUTISM DEV DISORD, V38, P1414, DOI 10.1007/s10803-007-0509-7; Auyeung B, 2008, J AUTISM DEV DISORD, V38, P1230, DOI 10.1007/s10803-007-0504-z; Auyeung B, 2009, J AUTISM DEV DISORD, V39, P1509, DOI 10.1007/s10803-009-0772-x; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2015, MOL PSYCHIATR, V20, P369, DOI 10.1038/mp.2014.48; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 2006, J AUTISM DEV DISORD, V36, P343, DOI 10.1007/s10803-006-0073-6; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Beacher FD, 2012, AM J NEURORADIOL, V33, P83, DOI 10.3174/ajnr.A2880; Beacher FDCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038355; Begeer S, 2013, J AUTISM DEV DISORD, V43, P1151, DOI 10.1007/s10803-012-1656-z; Bejerot S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087961; Bejerot S, 2012, BRIT J PSYCHIAT, V201, P116, DOI 10.1192/bjp.bp.111.097899; Bolte S, 2011, AUTISM, V15, P497, DOI 10.1177/1362361310391116; Carter AS, 2007, J AUTISM DEV DISORD, V37, P86, DOI 10.1007/s10803-006-0331-7; Constantino JN, 2012, J AM ACAD CHILD PSY, V51, P756, DOI 10.1016/j.jaac.2012.05.017; Daniels AM, 2011, J AUTISM DEV DISORD, V41, P110, DOI 10.1007/s10803-010-1031-x; Dworzynski K, 2012, J AM ACAD CHILD PSY, V51, P788, DOI 10.1016/j.jaac.2012.05.018; Field A., 2013, DISCOVERING STAT USI; Frazier TW, 2014, J AM ACAD CHILD PSY, V53, P329, DOI 10.1016/j.jaac.2013.12.004; Goldenfeld N, 2005, CLIN NEUROPSYCHIATR, V2, P338; Gould J., 2011, GOOD AUTISM PRACTICE, V12, P34; Harris A., 2011, INT M AUT RES SAN DI; Hinkka-Yli-Salomaki S, 2014, NORD J PSYCHIAT, V68, P472, DOI 10.3109/08039488.2013.861017; Holtmann M, 2007, DEV MED CHILD NEUROL, V49, P361, DOI 10.1111/j.1469-8749.2007.00361.x; Idring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041280; Ingudomnuku E, 2007, HORM BEHAV, V51, P597, DOI 10.1016/j.yhbeh.2007.02.001; Jensen CM, 2014, J AUTISM DEV DISORD, V44, P1808, DOI 10.1007/s10803-014-2053-6; Kirkovski M, 2013, J AUTISM DEV DISORD, V43, P2584, DOI 10.1007/s10803-013-1811-1; Knickmeyer RC, 2008, J AUTISM DEV DISORD, V38, P1028, DOI 10.1007/s10803-007-0475-0; Kreiser NL, 2014, CLIN CHILD FAM PSYCH, V17, P67, DOI 10.1007/s10567-013-0148-9; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lai MC, 2013, BRAIN, V136, P2799, DOI 10.1093/brain/awt216; Lai MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001544; Lai MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047198; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Lemler M, 2012, DISCUSSIONS, V8, P2; Lemon JM, 2011, J AUTISM DEV DISORD, V41, P352, DOI 10.1007/s10803-010-1039-2; Mandy W, 2012, J AUTISM DEV DISORD, V42, P1304, DOI 10.1007/s10803-011-1356-0; Mattila ML, 2011, J AM ACAD CHILD PSY, V50, P583, DOI 10.1016/j.jaac.2011.04.001; MCLENNAN JD, 1993, J AUTISM DEV DISORD, V23, P217, DOI 10.1007/BF01046216; Pilowsky T, 1998, J AUTISM DEV DISORD, V28, P143, DOI 10.1023/A:1026092632466; Pohl A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-27; Ruta L, 2011, PSYCHONEUROENDOCRINO, V36, P1154, DOI 10.1016/j.psyneuen.2011.02.007; Saemundsen E, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002748; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; Schaafsma SM, 2014, FRONT NEUROENDOCRIN, V35, P255, DOI 10.1016/j.yfrne.2014.03.006; Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102; Szatmari P, 2012, AM J MED GENET B, V159B, P5, DOI 10.1002/ajmg.b.31238; Van Wijngaarden-Cremers PJM, 2014, J AUTISM DEV DISORD, V44, P627, DOI 10.1007/s10803-013-1913-9; Werling DM, 2013, CURR OPIN NEUROL, V26, P146, DOI 10.1097/WCO.0b013e32835ee548; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; Wheelwright S, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-10; WING L, 1981, PSYCHIAT RES, V5, P129, DOI 10.1016/0165-1781(81)90043-3	58	99	106	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102251	10.1371/journal.pone.0102251	http://dx.doi.org/10.1371/journal.pone.0102251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25029203	Green Published, gold			2022-12-25	WOS:000341306600051
J	Love, DC; Fry, JP; Genello, L; Hill, ES; Frederick, JA; Li, XM; Semmens, K				Love, David C.; Fry, Jillian P.; Genello, Laura; Hill, Elizabeth S.; Frederick, J. Adam; Li, Ximin; Semmens, Ken			An International Survey of Aquaponics Practitioners	PLOS ONE			English	Article							FISH; AQUACULTURE; WATER; AQUAFEEDS	Aquaponics, a combination of fish farming and soilless plant farming, is growing in popularity and gaining attention as an important and potentially more sustainable method of food production. The aim of this study was to document and analyze the production methods, experiences, motivations, and demographics of aquaponics practitioners in the United States (US) and internationally. The survey was distributed online using a chain sampling method that relied on referrals from initial respondents, with 809 respondents meeting the inclusion criteria. The majority of respondents were from the US (80%), male (78%), and had at least a high school degree (91%). The mean age of respondents was 47613 years old. Most respondents (52%) had three years or less of aquaponics experience. Respondents typically raised tilapia or ornamental fish and a variety of leafy green vegetables, herbs, and fruiting crops. Respondents were most often motivated to become involved in aquaponics to grow their own food, for environmental sustainability reasons, and for personal health reasons. Many respondents employed more than one method to raise crops, and used alternative or environmentally sustainable sources of energy, water, and fish feed. In general, our findings suggest that aquaponics is a dynamic and rapidly growing field with participants who are actively experimenting with and adopting new technologies. Additional research and outreach is needed to evaluate and communicate best practices within the field. This survey is the first large-scale effort to track aquaponics in the US and provides information that can better inform policy, research, and education efforts regarding aquaponics as it matures and possibly evolves into a mainstream form of agriculture.	[Love, David C.; Fry, Jillian P.; Genello, Laura] Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Baltimore, MD 21218 USA; [Love, David C.; Fry, Jillian P.; Genello, Laura] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Hill, Elizabeth S.] Univ Maryland Extens, Baltimore, MD USA; [Frederick, J. Adam] Univ Maryland, Maryland Sea Grant Coll, College Pk, MD 20742 USA; [Li, Ximin] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Semmens, Ken] W Virginia Univ, Agr & Nat Resources Unit, Extens Serv, Morgantown, WV 26506 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; West Virginia University	Love, DC (corresponding author), Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Baltimore, MD 21218 USA.	dlove@jhsph.edu		Li, Ximin/0000-0002-0460-6515	Johns Hopkins Center for a Livable Future with a gift from the GRACE Communications Foundation	Johns Hopkins Center for a Livable Future with a gift from the GRACE Communications Foundation	The work was funded by the Johns Hopkins Center for a Livable Future with a gift from the GRACE Communications Foundation (www.gracelinks.org) who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blidariu F., 2011, Lucrari Stiintifice - Zootehnie si Biotehnologii, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului Timisoara, V44, P1; BOHL M, 1977, AQUACULTURE, V11, P323, DOI 10.1016/0044-8486(77)90081-3; COLLINS MT, 1975, J FISH RES BOARD CAN, V32, P2025, DOI 10.1139/f75-238; Dalrymple D.G., 1973, CONTROLLED ENV AGR G; Falah M. A. F., 2013, International Journal of Agricultural Technology, V9, P769; Florida Fish and Wildlife Conservation Commission, 2014, AQ LIC PERM; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gericke WF, 1940, COMPLETE GUIDE SOILL; Goodman E. R, 2011, AQUAPONICS COMMUNITY; Hardy RW, 2002, RESPONSIBLE MARINE AQUACULTURE, P311, DOI 10.1079/9780851996042.0311; Lennard WA, 2006, AQUACULT INT, V14, P539, DOI 10.1007/s10499-006-9053-2; LEWIS WM, 1978, T AM FISH SOC, V107, P92, DOI 10.1577/1548-8659(1978)107<92:UOHTMQ>2.0.CO;2; Licamele J.D., 2009, BIOMASS PRODUCTION N; McMurtry M, 1992, THESIS N CAROLINA ST; MCMURTRY M R, 1990, Applied Agricultural Research, V5, P280; Metcalf SS, 2011, APPL GEOGR, V31, P1242, DOI 10.1016/j.apgeog.2011.01.008; Mollison B, 1981, PERMACULTURE ONE PER; NAEGEL LCA, 1977, AQUACULTURE, V10, P17, DOI 10.1016/0044-8486(77)90029-1; Naylor R, 2005, ANNU REV ENV RESOUR, V30, P185, DOI 10.1146/annurev.energy.30.081804.121034; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; New South Wales Department of Primary Industries, 2014, TIL; POPMA T. J., 1995, WORLDWIDE PROSPECTS; Rakocy J.E., 2012, AQUACULTURE PRODUCTI, P344, DOI [10.1002/9781118250105.CH14, DOI 10.1002/9781118250105.CH14, 10.1002/9781118250105.ch14]; Rakocy JE, 2006, SRAC PUBL, V454; Rakocy JE, 1984, RECIRCULATING SYSTEM, P103; Shultz RC, 2014, EVOLUTION AQUAPONICS; Smyth JoleneD., 2008, INTERNET MAIL MIXED; Sneed K., 1975, AQUACULTURE FISH FAR, V1, P18; SUTTON RJ, 1982, PROG FISH CULT, V44, P55, DOI 10.1577/1548-8659(1982)44[55:FOOAFP]2.0.CO;2; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Timmons MB., 2010, RECIRCULATING AQUACU; Todd J., 1980, J NEW ALCHEMISTS, V6, P108; Tortorello M, 2010, SPOTLESS GARDEN; US Department of Agriculture (USDA), 2007, CENS AGR FARM AG; *USDA, 2006, CENS AQ 2005, V3; Wardlow George W., 2002, Journal of Natural Resources and Life Sciences Education, V31, P55; Watson AM, 2013, LIPIDS, V48, P899, DOI 10.1007/s11745-013-3814-2; WATTEN BJ, 1984, AQUACULTURE, V41, P271, DOI 10.1016/0044-8486(84)90290-4; Zweig R.D., 1986, AQUAC MAG, V12, P34	39	99	107	6	195	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102662	10.1371/journal.pone.0102662	http://dx.doi.org/10.1371/journal.pone.0102662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029125	Green Submitted, Green Published, gold			2022-12-25	WOS:000341306600090
J	DeFaveri, J; Shikano, T; Merila, J				DeFaveri, Jacquelin; Shikano, Takahito; Merila, Juha			Geographic Variation in Age Structure and Longevity in the Nine-Spined Stickleback (Pungitius pungitius)	PLOS ONE			English	Article							LIFE-HISTORY; NINESPINE STICKLEBACK; GROWTH; FISH; SIZE; POPULATIONS; EVOLUTION; GASTEROSTEUS; FORMALDEHYDE; PARAMETERS	Variation in age and size of mature nine-spined sticklebacks (Pungitius pungitius) within and among 16 Fennoscandian populations were assessed using skeletochronology. The average age of individuals in a given population varied from 1.7 to 4.7 years. Fish from pond populations were on average older than those from lake and marine populations, and females tended to be older than males. Reproduction in marine and lake populations commenced typically at an age of two years, whereas that in ponds at an age of three years. The maximum life span of the fish varied from 3 to 7 years. Mean body size within and among populations increased with increasing age, but the habitat and population differences in body size persisted even after accounting for variation in population age (and sex) structure. Hence, the population differences in mean body size are not explainable by age differences alone. As such, much of the pronounced intraspecific variation in population age structure can be attributed to delayed maturation and extended longevity of the pond fish. The results are contrasted and discussed in the context of similar data from the three-spined stickleback (Gasterosteus aculeatus) occupying the same geographic area.	[DeFaveri, Jacquelin; Shikano, Takahito; Merila, Juha] Univ Helsinki, Ecol Genet Res Unit, Dept Biosci, Helsinki, Finland	University of Helsinki	Merila, J (corresponding author), Univ Helsinki, Ecol Genet Res Unit, Dept Biosci, Helsinki, Finland.	juha.merila@helsinki.fi	Merila, Juha/A-4061-2008; Shikano, Takahito/D-7347-2015	Merila, Juha/0000-0001-9614-0072; 	Academy of Finland [265211]	Academy of Finland(Academy of Finland)	The authors' research was supported by Academy of Finland (grant # 265211 to JM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab Ghani NI, 2012, BIOL J LINN SOC, V107, P521, DOI 10.1111/j.1095-8312.2012.01956.x; ALM GUNNAR, 1959, REPT INST FRESHWATER RES DROTTNINGHOLM, V40, P5; AUSTAD SN, 1993, J ZOOL, V229, P695, DOI 10.1111/j.1469-7998.1993.tb02665.x; Baker J, 1994, EVOLUTIONARY BIOL TH; Baker JA, 2008, BEHAVIOUR, V145, P579, DOI 10.1163/156853908792451539; BECK SD, 1971, ANN ENTOMOL SOC AM, V64, P946, DOI 10.1093/aesa/64.4.946; Bell M.A., 1994, EVOLUTIONARY BIOL TH; BERVEN KA, 1983, AM ZOOL, V23, P85; Beverton R.J.H., 1959, CIBA FDN C AGEING, V5, P142, DOI DOI 10.1002/9780470715253.CH10; BEVERTON RJH, 1992, J FISH BIOL, V41, P137, DOI 10.1111/j.1095-8649.1992.tb03875.x; Campana SE, 2001, J FISH BIOL, V59, P197, DOI 10.1006/jfbi.2001.1668; COAD BW, 1973, AM MIDL NAT, V90, P498, DOI 10.2307/2424479; DeFaveri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080866; DRYER WR, 1966, T AM FISH SOC, V95, P248, DOI 10.1577/1548-8659(1966)95[248:BDOFIT]2.0.CO;2; Fox CJ, 1996, J PLANKTON RES, V18, P483, DOI 10.1093/plankt/18.4.483; FOX MG, 1991, CAN J FISH AQUAT SCI, V48, P1792, DOI 10.1139/f91-211; Gallagher CP, 2011, ECOL FRESHW FISH, V20, P646, DOI 10.1111/j.1600-0633.2011.00516.x; Gambling SJ, 2012, CAN J ZOOL, V90, P284, DOI 10.1139/Z11-133; Ghani NIA, 2013, J EVOLUTION BIOL, V26, P775, DOI 10.1111/jeb.12085; GRISWOLD BL, 1973, FISH B-NOAA, V71, P1039; Heibo E, 2005, ECOLOGY, V86, P3377, DOI 10.1890/04-1620; Herczeg G, 2012, EVOL ECOL, V26, P109, DOI 10.1007/s10682-011-9491-9; Herczeg G, 2009, EVOLUTION, V63, P3190, DOI 10.1111/j.1558-5646.2009.00781.x; HUTCHINGS JA, 1993, ECOLOGY, V74, P673, DOI 10.2307/1940795; JONES JW, 1950, J ANIM ECOL, V19, P59, DOI 10.2307/1571; Jones OR, 2014, NATURE, V505, P169, DOI 10.1038/nature12789; JORDE PE, 1995, GENETICS, V139, P1077; Kainulainen-Immonen T, 1980, THESIS U TURKU; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kristoffersen JB, 1998, SARSIA, V83, P95; Kuusela K, 2006, INT VER THEOR ANGEW, V29, P1409; LEINER M., 1934, ZEITSCH WISS BIOL ABT A ZEITSCH MORPH U OKOL TIERE, V28, P107, DOI 10.1007/BF00424080; Lucek K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049377; Mangel M, 2001, EXP GERONTOL, V36, P765, DOI 10.1016/S0531-5565(00)00240-0; Merila J, 2013, ANN NY ACAD SCI, V1289, P18, DOI 10.1111/nyas.12089; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Morita K, 2006, EVOLUTION, V60, P1516, DOI 10.1111/j.0014-3820.2006.tb01230.x; Moser D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050620; Neat FC, 2008, J FISH BIOL, V73, P2527, DOI 10.1111/j.1095-8649.2008.02107.x; Ostlund-Nilsson S., 2010, BIOL 3 SPINED STICKL; PENCZAK T, 1981, EKOL POL-POL J ECOL, V29, P233; POLICANSKY D, 1983, AM ZOOL, V23, P57; REIMCHEN TE, 1992, CAN FIELD NAT, V106, P122; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; ROFF DA, 1984, CAN J FISH AQUAT SCI, V41, P989, DOI 10.1139/f84-114; Roff Derek A., 1992; SCHRAMM HL, 1989, T AM FISH SOC, V118, P546, DOI 10.1577/1548-8659(1989)118<0546:FOAIOO>2.3.CO;2; Shikano T, 2013, G3-GENES GENOM GENET, V3, P1833, DOI 10.1534/g3.113.007237; Shikano Takahito, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-119; Shikano T, 2010, MOL ECOL, V19, P1147, DOI 10.1111/j.1365-294X.2010.04553.x; Shimada Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028859; SHIRVELL CS, 1981, J FISH BIOL, V18, P377, DOI 10.1111/j.1095-8649.1981.tb03779.x; SMITHGILL SJ, 1979, AM NAT, V113, P563, DOI 10.1086/283413; Teacher AGF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019476; Waples RS, 2010, MOL ECOL RESOUR, V10, P785, DOI 10.1111/j.1755-0998.2010.02876.x; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305	56	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102660	10.1371/journal.pone.0102660	http://dx.doi.org/10.1371/journal.pone.0102660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025183	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400098
J	Stein, P; Gogoll, K; Tenzer, S; Schild, H; Stevanovic, S; Langguth, P; Radsak, MP				Stein, Pamela; Gogoll, Karsten; Tenzer, Stefan; Schild, Hansjoerg; Stevanovic, Stefan; Langguth, Peter; Radsak, Markus P.			Efficacy of Imiquimod-Based Transcutaneous Immunization Using a Nano-Dispersed Emulsion Gel Formulation	PLOS ONE			English	Article							MELANOMA PATIENTS; DENDRITIC CELLS; IMMUNOTHERAPY; VACCINATION; DELIVERY; PEPTIDE; PROTEIN; PERSPECTIVE; ACTIVATION; LIGATION	Background: Transcutaneous immunization (TCI) approaches utilize skin associated lymphatic tissues to elicit specific immune responses. In this context, the imidazoquinoline derivative imiquimod formulated in Aldara applied onto intact skin together with a cytotoxic T lymphocyte (CTL) epitope induces potent CTL responses. However, the feasibility and efficacy of the commercial imiquimod formulation Aldara is limited by its physicochemical properties as well as its immunogenicity. Methodology/Principal Findings: To overcome these obstacles, we developed an imiquimod-containing emulsion gel (IMI-Gel) and characterized it in comparison to Aldara for rheological properties and in vitro mouse skin permeation in a Franz diffusion cell system. Imiquimod was readily released from Aldara, while IMI-Gel showed markedly decreased drug release. Nevertheless, comparing vaccination potency of Aldara or IMI-Gel-based TCI in C57BL/6 mice against the model cytotoxic T-lymphocyte epitope SIINFEKL, we found that IMI-Gel was equally effective in terms of the frequency of peptide-specific T-cells and in vivo cytolytic activity. Importantly, transcutaneous delivery of IMI-Gel for vaccination was clearly superior to the subcutaneous or oral route of administration. Finally, IMI-Gel based TCI was at least equally effective compared to Aldara-based TCI in rejection of established SIINFEKL-expressing E. G7 tumors in a therapeutic setup indicated by enhanced tumor rejection and survival. Conclusion/Significance: In summary, we developed a novel imiquimod formulation with feasible pharmaceutical properties and immunological efficacy that fosters the rational design of a next generation transcutaneous vaccination platform suitable for the treatment of cancer or persistent virus infections.	[Stein, Pamela; Tenzer, Stefan; Schild, Hansjoerg] Johannes Gutenberg Univ Mainz, Inst Immunol, Med Ctr, Mainz, Germany; [Gogoll, Karsten; Langguth, Peter] Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany; [Stevanovic, Stefan] Univ Tubingen, Dept Immunol, Tubingen, Germany; [Radsak, Markus P.] Johannes Gutenberg Univ Mainz, Dept Med 3, Med Ctr, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Johannes Gutenberg University of Mainz	Radsak, MP (corresponding author), Johannes Gutenberg Univ Mainz, Dept Med 3, Med Ctr, D-55122 Mainz, Germany.	radsak@uni-mainz.de	Tenzer, Stefan/AAE-2180-2020; Radsak, Markus P/L-3651-2013	Tenzer, Stefan/0000-0003-3034-0017; Radsak, Markus P/0000-0002-3991-5721	Deutsche Forschungsgemeinschaft [KFO 183, Ra988/4-2]; CI3 Cluster [BMBF 131A035A, GRK 1043]; "Forschungszentrum Immunologie (FZI)'' of the University Medical Center Mainz	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CI3 Cluster; "Forschungszentrum Immunologie (FZI)'' of the University Medical Center Mainz	This work was supported by grants from the Deutsche Forschungsgemeinschaft KFO 183 to M.P.R. and H.S. (Ra988/4-2), CI3 Cluster (BMBF 131A035A, the GRK 1043 International Graduate School of Immunotherapy (H.S.), "Forschungszentrum Immunologie (FZI)'' of the University Medical Center Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2008, J IMMUNOL, V181, P776, DOI 10.4049/jimmunol.181.1.776; Bal SM, 2010, J CONTROL RELEASE, V148, P266, DOI 10.1016/j.jconrel.2010.09.018; De Paula D, 2008, BIOMED CHROMATOGR, V22, P1416, DOI 10.1002/bmc.1075; Edwards L, 1998, ARCH DERMATOL, V134, P25, DOI 10.1001/archderm.134.1.25; Feyerabend S, 2009, PROSTATE, V69, P917, DOI 10.1002/pros.20941; Glenn GM, 1998, NATURE, V391, P851, DOI 10.1038/36014; Gogoll K, 2012, BIOPHARM DRUG DISPOS, V33, P218, DOI 10.1002/bdd.1787; Hilleman MR, 2000, VACCINE, V18, P1436, DOI 10.1016/S0264-410X(99)00434-X; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kermode M, 2004, HEALTH PROMOT INT, V19, P95, DOI 10.1093/heapro/dah110; Knorr F, 2009, EUR J PHARM BIOPHARM, V71, P173, DOI 10.1016/j.ejpb.2008.11.001; Matsuo K, 2013, VACCINE, V31, P2403, DOI 10.1016/j.vaccine.2013.03.022; Matsuo K, 2011, BIOL PHARM BULL, V34, P586, DOI 10.1248/bpb.34.586; Mikszta JA, 2008, EXPERT REV VACCINES, V7, P1329, DOI 10.1586/14760584.7.9.1329; Miller MA, 1999, B WORLD HEALTH ORGAN, V77, P808; Navi Daniel, 2004, Dermatol Online J, V10, P4; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Rechtsteiner G, 2005, J IMMUNOL, V174, P2476, DOI 10.4049/jimmunol.174.5.2476; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Stein P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027911; Stein P, 2011, J INVEST DERMATOL, V131, P211, DOI 10.1038/jid.2010.254; Stoitzner P, 2008, J IMMUNOL, V180, P1991, DOI 10.4049/jimmunol.180.3.1991; van den Berg JH, 2010, J CONTROL RELEASE, V141, P234, DOI 10.1016/j.jconrel.2009.09.005; Walter A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2566; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883; Warger T, 2007, CLIN REV ALLERG IMMU, V32, P57, DOI 10.1007/s12016-007-0020-0; Warger T, 2006, BLOOD, V108, P544, DOI 10.1182/blood-2005-10-4015	28	30	30	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102664	10.1371/journal.pone.0102664	http://dx.doi.org/10.1371/journal.pone.0102664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025233	Green Submitted, gold, Green Published			2022-12-25	WOS:000339992400100
J	Lin, L; Huang, H; Liao, W; Ma, H; Liu, J; Wang, L; Huang, N; Liao, Y; Liao, W				Lin, L.; Huang, H.; Liao, W.; Ma, H.; Liu, J.; Wang, L.; Huang, N.; Liao, Y.; Liao, W.			MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect	ONCOGENE			English	Article							CELL-SURVIVAL; TUMOR-GROWTH; GLUCOSE DEPRIVATION; METASTASIS; KINASE; COLON; MET; DEHYDROGENASE; MITOCHONDRIA; PROGRESSION	Cancer cells mainly metabolize by glycolysis (the Warburg effect) and are better adapted to resist metabolic stress. Metastasis-associated in colon cancer-1 (MACC1) is an oncogene promoting gastric cancer (GC) growth and metastasis, and its expression positively correlates with GC progression. However, it is unknown why MACC1 elevates with GC progression and what is its role in cancer metabolism. In this study, we discovered that MACC1 expression was significantly upregulated via adenosine monophosphate-activated protein kinase signaling in response to glucose deprivation-induced metabolic stress. Clinical observation demonstrates that MACC1 expression was higher in advanced stage GC. MACC1 expression was proved to be positively correlated with the maximum standardized uptake value of F-18-deoxyglucose in the patients, and MACC1 enhanced F-18-deoxyglucose uptake in GC cells and the xenografts. The underlying mechanism was that MACC1 promoted the Warburg effect by upregulating the activities and expressions of a series of glycolytic enzymes, including hexokinase, pyruvate dehydrogenase kinase and lactate dehydrogenase, in GC cells. This metabolic shift enhanced cell viability and resistance to apoptosis by facilitating ATP generation, reducing the reactive oxygen species production and stabilizing the mitochondrial membrane potential. In contrast, MACC1-silenced or the Warburg effect-blocked GC cells were more vulnerable to metabolic stress. In conclusion, metabolic stress is one of the mechanisms that elevate MACC1 expression in GC, and MACC1 upregulation compensatively ensures GC growth against metabolic stress by facilitating the Warburg effect.	[Lin, L.; Huang, H.; Liao, W.; Ma, H.; Liu, J.; Wang, L.; Huang, N.; Liao, W.] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou 510515, Guangdong, Peoples R China; [Liao, Y.] Southern Med Univ, Nanfang Hosp, Dept Cardiol, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Liao, W (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou 510515, Guangdong, Peoples R China.	nfyyliaowj@163.com	Liao, Yulin/AAP-6315-2021	Lin, Li/0000-0002-9719-4539; Wangjun, Liao/0000-0002-1364-8442	National Natural Science Foundation of China [31271564]; Guangzhou science and technology plan [134600108]; Team Program of Natural Science Foundation of Guangdong Province [S2011030003134]; Special Foundation for National Clinical Specialties of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou science and technology plan; Team Program of Natural Science Foundation of Guangdong Province; Special Foundation for National Clinical Specialties of China	This work was supported by the National Natural Science Foundation of China (31271564 to WL), Guangzhou science and technology plan (134600108 to WL), the Team Program of Natural Science Foundation of Guangdong Province (S2011030003134 to WL and YL) and the Special Foundation for National Clinical Specialties of China (to Department of Oncology, Nanfang Hospital). We thank Professor Quanshi Wang and Professor Hubing Wu for helping clinical PET data acquisition, Dr Yanjiang Han for assistance with microPET, Professor Zhenhua Ding for assistance with gamma-radiation activity monitor and Jingwen Zhang for language editing. QW, HW and YH are from PET Center, JZ is from Department of Cardiology, Nanfang Hospital and ZD is from Department of Radiation Medicine, School of Public Health and Tropical Medicine, Southern Medical University.	Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Galimi F, 2011, CLIN CANCER RES, V17, P3146, DOI 10.1158/1078-0432.CCR-10-3377; Gao M, 2014, ONCOGENE, V33, P745, DOI 10.1038/onc.2013.2; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huber AL, 2013, MOL CELL, V49, P1049, DOI 10.1016/j.molcel.2013.01.009; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; Kokoszynska K, 2009, ACTA BIOCHIM POL, V56, P317; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li GQ, 2014, CANCER CELL, V25, P455, DOI 10.1016/j.ccr.2014.02.007; Meng FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060821; Mimeault M, 2013, MOL ASPECTS MED, DOI DOI 10.1016/J.MAM.2013.2008.2001; Miniotis MF, 2013, CANCER RES, V73, P4039, DOI 10.1158/0008-5472.CAN-12-1969; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Pate KT, 2014, EMBO J; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Wang G, 2012, ONCOL LETT, V4, P783, DOI 10.3892/ol.2012.784; Wang L, 2013, INT J CANCER, V133, P1419, DOI 10.1002/ijc.28140; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Wu CA, 2013, BBA-MOL CELL RES, V1833, P1147, DOI 10.1016/j.bbamcr.2013.01.025; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Xie C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064235; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303	32	57	61	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2015	34	21					2700	2710		10.1038/onc.2014.204	http://dx.doi.org/10.1038/onc.2014.204			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI7XN	25043301				2022-12-25	WOS:000354979500003
J	Pritchett, TL; Bader, HL; Henderson, J; Hsu, T				Pritchett, T. L.; Bader, H. L.; Henderson, J.; Hsu, T.			Conditional inactivation of the mouse von Hippel-Lindau tumor suppressor gene results in wide-spread hyperplastic, inflammatory and fibrotic lesions in the kidney	ONCOGENE			English	Article							RENAL-CELL CARCINOMA; MODIFYING GENES; IMAGE-ANALYSIS; URETERAL BUD; CANCER; EXPRESSION; PROTEIN; HYPOXIA; DISEASE; MUTATION	Mutations of the tumor suppressor gene von Hippel-Lindau (VHL) can lead to benign and malignant tumors, including clear-cell renal cell carcinoma (ccRCC). To understand the progression of ccRCC, we generated a novel mouse Vhlh conditional knockout, using Hoxb7-driven Cre that is specific for the collecting ducts and a subset of distal tubules. These mice exhibited wide-spread epithelial disruption and interstitial inflammation as early as 2 months of age with high penetrance. Lesions are cystic, show severe fibrosis and display significant hyperplasia. An abundance of infiltrating macrophages and lymphocytes was detected. Interestingly, the Vhlh mutant lesions could be rescued when Hif-1 alpha, but not Hif-2 alpha, was also knocked out. In addition, administration of a JAK1/2 kinase inhibitor alleviated the Vhlh knockout phenotypes. Taken together, these results suggest that HIF-1 alpha-dependent inflammation and fibrosis may be an early event in the development of ccRCC.	[Pritchett, T. L.; Bader, H. L.; Henderson, J.; Hsu, T.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Henderson, J.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Hsu, T.] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli 32001, Taiwan	Boston University; Boston University; National Central University	Hsu, T (corresponding author), Boston Univ, Sch Med, Hematol Oncol Sect, 650 Albany St,EBRC 440, Boston, MA 02118 USA.	tienh@bu.edu		Hsu, Tien/0000-0003-2308-4297; Pritchett, Tracy/0000-0002-3336-9336	National Institutes of Health, USA [R01CA109860, T32HL007501]; NATIONAL CANCER INSTITUTE [R01CA109860] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007501] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Paraffin embedding and sectioning were performed at the Immunohistochemistry Core of Boston Medical Center. We thank Richard Near (the Boston University School of Medicine) for technical support and Weining Lu (the Boston University School of Medicine) for a gift of the Hoxb7-Cre-EGFP mouse strain. This work was supported by a grant to TH from the National Institutes of Health, USA (#R01CA109860) and a postdoctoral fellowship to HLB from the National Institutes of Health, USA (#T32HL007501).	An JB, 2005, MOL CELL BIOL, V25, P7546, DOI 10.1128/MCB.25.17.7546-7556.2005; Becker LC, 2005, CIRC RES, V96, P812, DOI 10.1161/01.RES.0000165652.82726.d9; Brukamp K, 2007, AM J PHYSIOL-RENAL, V293, pF1397, DOI 10.1152/ajprenal.00133.2007; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Frew IJ, 2008, MOL CELL BIOL, V28, P4536, DOI 10.1128/MCB.02132-07; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Ibragimova I, 2013, EPIGENETICS-US, V8, P486, DOI 10.4161/epi.24552; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin WG, 2009, CANCER-AM CANCER SOC, V115, P2262, DOI 10.1002/cncr.24232; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Khurana KK, 1998, MODERN PATHOL, V11, P339; Kim Nayoung, 2013, Genomics & Informatics, V11, P239, DOI 10.5808/GI.2013.11.4.239; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kimura K, 2008, AM J PHYSIOL-RENAL, V295, pF1023, DOI 10.1152/ajprenal.90209.2008; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Kraus S, 2002, HUM PATHOL, V33, P60, DOI 10.1053/hupa.2002.29682; Kraus S, 2009, CURR OPIN PHARMACOL, V9, P405, DOI 10.1016/j.coph.2009.06.006; Kundu JK, 2012, FREE RADICAL BIO MED, V52, P2013, DOI 10.1016/j.freeradbiomed.2012.02.035; Larkin J, 2012, NAT REV UROL, V9, P147, DOI 10.1038/nrurol.2011.236; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Maher ER, 2011, EUR J HUM GENET, V19, P617, DOI 10.1038/ejhg.2010.175; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Martelli F, 2005, BLOOD, V106, P4102, DOI 10.1182/blood-2005-03-1060; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Nakagawa Naoki, 2013, Curr Pathobiol Rep, V1, DOI 10.1007/s40139-013-0025-8; Ozcan A, 2009, AM J CLIN PATHOL, V131, P393, DOI 10.1309/AJCPM7DW0XFHDHNY; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Ries C, 2014, CELL MOL LIFE SCI, V71, P659, DOI 10.1007/s00018-013-1457-3; Schietke RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031034; Shay JES, 2012, SEMIN CELL DEV BIOL, V23, P389, DOI 10.1016/j.semcdb.2012.04.004; Shen SS, 2005, MODERN PATHOL, V18, P933, DOI 10.1038/modpathol.3800373; Srinivas S, 1999, DEV GENET, V24, P241; Steenhard BM, 2010, AM J PATHOL, V177, P84, DOI 10.2353/ajpath.2010.090767; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wadleigh Martha, 2010, Clin Adv Hematol Oncol, V8, P557; Wu KL, 2007, AM J PHYSIOL-RENAL, V293, pF1836, DOI 10.1152/ajprenal.00096.2007; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Yoshida N, 2002, BRIT J CANCER, V86, P1396, DOI 10.1038/sj.bjc.6600257; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	53	35	35	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2015	34	20					2631	2639		10.1038/onc.2014.197	http://dx.doi.org/10.1038/onc.2014.197			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI1YN	25023703				2022-12-25	WOS:000354541300009
J	Laprairie, RB; Bagher, AM; Kelly, MEM; Dupre, DJ; Denovan-Wright, EM				Laprairie, Robert B.; Bagher, Amina M.; Kelly, Melanie E. M.; Dupre, Denis J.; Denovan-Wright, Eileen M.			Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CB1 RECEPTOR; HUNTINGTONS-DISEASE; ENDOCANNABINOID SYSTEM; DOWN-REGULATION; MAP KINASE; G-PROTEINS; AGONIST; CANNABIDIOL; INTERNALIZATION	Modulation of type 1 cannabinoid receptor (CB1) activity has been touted as a potential means of treating addiction, anxiety, depression, and neurodegeneration. Different agonists of CB1 are known to evoke varied responses in vivo. Functional selectivity is the ligand-specific activation of certain signal transduction pathways at a receptor that can signal through multiple pathways. To understand cannabinoid-specific functional selectivity, different groups have examined the effect of individual cannabinoids on various signaling pathways in heterologous expression systems. In the current study, we compared the functional selectivity of six cannabinoids, including two endocannabinoids (2-arachidonyl glycerol (2-AG) and anandamide (AEA)), two synthetic cannabinoids (WIN55,212-2 and CP55,940), and two phytocannabinoids (cannabidiol (CBD) and Delta(9)-tetrahydrocannabinol (THC)) on arrestin2-, G alpha(i/o)-, G beta gamma-, G alpha(s)-, and G alpha(q)-mediated intracellular signaling in the mouse STHdh(Q7/Q7) cell culture model of striatal medium spiny projection neurons that endogenously express CB1. In this system, 2-AG, THC, and CP55,940 were more potent mediators of arrestin2 recruitment than other cannabinoids tested. 2-AG, AEA, and WIN55,212-2, enhanced G alpha(i/o) and G beta gamma signaling, with 2-AG and AEA treatment leading to increased total CB1 levels. 2-AG, AEA, THC, and WIN55,212-2 also activated G alpha(q)-dependent pathways. CP55,940 and CBD both signaled through G alpha(s). CP55,940, but not CBD, activated downstream G alpha(s) pathways via CB1 targets. THC and CP55,940 promoted CB1 internalization and decreased CB1 protein levels over an 18-h period. These data demonstrate that individual cannabinoids display functional selectivity at CB1 leading to activation of distinct signaling pathways. To effectively match cannabinoids with therapeutic goals, these compounds must be screened for their signaling bias.	[Laprairie, Robert B.; Bagher, Amina M.; Kelly, Melanie E. M.; Dupre, Denis J.; Denovan-Wright, Eileen M.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4R2, Canada	Dalhousie University	Denovan-Wright, EM (corresponding author), Dalhousie Univ, Dept Pharmacol, Rm 6E,5850 Coll St, Halifax, NS B3H 4R2, Canada.	emdenova@dal.ca	Bagher, Amina M/GRF-5174-2022; Dupre, Denis J/AAI-2631-2021; Bagher, Amina/F-1702-2018; Bagher, Amina M./AAF-1099-2021	Bagher, Amina M/0000-0002-1850-5686; Dupre, Denis J/0000-0001-6401-6157; Bagher, Amina/0000-0002-1850-5686; 	Canadian Institutes of Health Research (CIHR) [ROP-97185]; Nova Scotia Health Research Foundation; Huntington Society of Canada (HSC); CIHR [MOP-97768]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-355310-2013]; HSC; Killam Trusts; Canadian Consortium for the Investigation of Cannabinoids; Dalhousie University; King Abdull Aziz University, Jeddah, Saudi Arabia	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation; Huntington Society of Canada (HSC); CIHR(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); HSC; Killam Trusts; Canadian Consortium for the Investigation of Cannabinoids; Dalhousie University; King Abdull Aziz University, Jeddah, Saudi Arabia	This work was supported by Partnership Grant ROP-97185 from the Canadian Institutes of Health Research (CIHR), the Nova Scotia Health Research Foundation, and the Huntington Society of Canada (HSC) (to E. M. D.-W.), Operating Grant MOP-97768 from CIHR (to M. E. M. K.), and Grant RGPIN-355310-2013 from the Natural Sciences and Engineering Research Council of Canada (NSERC) (to D. J. D.).; Supported by studentships from CIHR, HSC, Killam Trusts, the Nova Scotia Health Research Foundation, and the Canadian Consortium for the Investigation of Cannabinoids.; Supported by scholarships from Dalhousie University and King Abdull Aziz University, Jeddah, Saudi Arabia.	Anavi-Goffer S, 2007, J BIOL CHEM, V282, P25100, DOI 10.1074/jbc.M703388200; Bagher AM, 2013, EUR J PHARMACOL, V721, P341, DOI 10.1016/j.ejphar.2013.09.002; Bakshi K, 2007, FEBS LETT, V581, P5009, DOI 10.1016/j.febslet.2007.09.030; Blazquez C, 2011, BRAIN, V134, P119, DOI 10.1093/brain/awq278; Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884; Bosier B, 2008, BRIT J PHARMACOL, V155, P24, DOI 10.1038/bjp.2008.230; Bosier B, 2007, J NEUROCHEM, V102, P1996, DOI 10.1111/j.1471-4159.2007.04679.x; Bosier B, 2010, BIOCHEM PHARMACOL, V80, P1, DOI 10.1016/j.bcp.2010.02.013; Bosier B, 2008, FEBS LETT, V582, P3861, DOI 10.1016/j.febslet.2008.10.022; Breivogel CS, 1998, J BIOL CHEM, V273, P16865, DOI 10.1074/jbc.273.27.16865; Costa B, 2007, EUR J PHARMACOL, V556, P75, DOI 10.1016/j.ejphar.2006.11.006; Cota D, 2003, INT J OBESITY, V27, P289, DOI 10.1038/sj.ijo.0802250; Coutts AA, 2001, J NEUROSCI, V21, P2425; Cupini LM, 2008, NEUROBIOL DIS, V30, P186, DOI 10.1016/j.nbd.2008.01.003; Daigle TL, 2008, NEUROPHARMACOLOGY, V54, P36, DOI 10.1016/j.neuropharm.2007.06.005; Dalton GD, 2012, BRIT J PHARMACOL, V165, P2497, DOI 10.1111/j.1476-5381.2011.01455.x; Devinsky O, 2014, EPILEPSIA, V55, P791, DOI 10.1111/epi.12631; Dupre DJ, 2007, CELL SIGNAL, V19, P2068, DOI 10.1016/j.cellsig.2007.05.015; Falenski KW, 2010, NEUROPSYCHOPHARMACOL, V35, P1775, DOI 10.1038/npp.2010.44; Fernandez-Ruiz J, 2004, NEUROTOX RES, V6, P389, DOI 10.1007/BF03033314; Georgieva T, 2008, EUR J PHARMACOL, V581, P19, DOI 10.1016/j.ejphar.2007.11.053; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Gu GB, 1996, J NEUROSCI, V16, P3035; Hudson BD, 2010, BRIT J PHARMACOL, V160, P627, DOI 10.1111/j.1476-5381.2010.00681.x; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jin WZ, 1999, J NEUROSCI, V19, P3773; Jones NA, 2010, J PHARMACOL EXP THER, V332, P569, DOI 10.1124/jpet.109.159145; Kearn CS, 1999, J NEUROCHEM, V72, P2379, DOI 10.1046/j.1471-4159.1999.0722379.x; Kinsey SG, 2011, PHARMACOL BIOCHEM BE, V99, P718, DOI 10.1016/j.pbb.2011.06.022; Knowles RB, 1999, J NEUROPATH EXP NEUR, V58, P1090, DOI 10.1097/00005072-199910000-00007; Kondo S, 1998, FEBS LETT, V429, P152, DOI 10.1016/S0014-5793(98)00581-X; Laprairie RB, 2012, BRIT J PHARMACOL, V167, P1583, DOI 10.1111/j.1476-5381.2012.02175.x; Laprairie RB, 2013, NEUROPHARMACOLOGY, V72, P47, DOI 10.1016/j.neuropharm.2013.04.006; Lauckner JE, 2005, P NATL ACAD SCI USA, V102, P19144, DOI 10.1073/pnas.0509588102; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Lazenka MF, 2013, LIFE SCI, V92, P446, DOI 10.1016/j.lfs.2012.08.023; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Magen I, 2009, J HEPATOL, V51, P528, DOI 10.1016/j.jhep.2009.04.021; McIntosh BT, 2007, BRIT J PHARMACOL, V152, P1111, DOI 10.1038/sj.bjp.0707495; MCKENZIE FR, 1991, BIOCHEM J, V275, P175, DOI 10.1042/bj2750175; Mechoulam R, 2007, CHEM BIODIVERS, V4, P1678, DOI 10.1002/cbdv.200790147; MILLIGAN G, 1989, BIOCHEM J, V262, P643, DOI 10.1042/bj2620643; Mukhopadhyay S, 2005, MOL PHARMACOL, V67, P2016, DOI 10.1124/mol.104.003558; Nguyen PT, 2012, BIOL PSYCHIAT, V71, P714, DOI 10.1016/j.biopsych.2011.11.027; Obara Y, 2008, CELL SIGNAL, V20, P1275, DOI 10.1016/j.cellsig.2008.02.016; Pazos MR, 2008, CURR PHARM DESIGN, V14, P2317, DOI 10.2174/138161208785740108; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2008, ADDICT BIOL, V13, P147, DOI 10.1111/j.1369-1600.2008.00108.x; Przybyla JA, 2010, J PHARMACOL EXP THER, V332, P710, DOI 10.1124/jpet.109.162701; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Rubino T, 2006, MOL NEUROBIOL, V33, P199, DOI 10.1385/MN:33:3:199; RYAN W, 1995, LIFE SCI, V56, P2013, DOI 10.1016/0024-3205(95)00183-7; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Sim-Selley LJ, 2006, MOL PHARMACOL, V70, P986, DOI 10.1124/mol.105.019612; SIMPSON JN, 1995, SYNAPSE, V19, P151, DOI 10.1002/syn.890190302; Singh SN, 2011, BIOCHEMISTRY-US, V50, P2223, DOI 10.1021/bi1018144; SMITH PB, 1994, J PHARMACOL EXP THER, V270, P219; Sugiura T, 1999, J BIOL CHEM, V274, P2794, DOI 10.1074/jbc.274.5.2794; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; van der Lee MMC, 2009, J BIOMOL SCREEN, V14, P811, DOI 10.1177/1087057109337937; Varga E V, 2008, Curr Mol Pharmacol, V1, P273; Vrecl M, 2009, J BIOMOL SCREEN, V14, P371, DOI 10.1177/1087057109333101; Wiley JL, 1998, J PHARMACOL EXP THER, V285, P995; Wu DF, 2008, J NEUROCHEM, V104, P1132, DOI 10.1111/j.1471-4159.2007.05063.x; Wu HY, 2012, J NEUROSCI, V32, P5298, DOI 10.1523/JNEUROSCI.0227-12.2012	66	97	98	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24845	24862		10.1074/jbc.M114.557025	http://dx.doi.org/10.1074/jbc.M114.557025			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25037227	Green Published, hybrid			2022-12-25	WOS:000341985300011
J	Kikkas, I; Mallone, R; Larger, E; Volland, H; Morel, N				Kikkas, Ingrid; Mallone, Roberto; Larger, Etienne; Volland, Herve; Morel, Nathalie			A Rapid Lateral Flow Immunoassay for the Detection of Tyrosine Phosphatase-Like Protein IA-2 Autoantibodies in Human Serum	PLOS ONE			English	Article							ASSAYS; DIAGNOSIS; RISK	Type 1 diabetes (T1D) results from the destruction of pancreatic insulin-producing beta cells and is strongly associated with the presence of islet autoantibodies. Autoantibodies to tyrosine phosphatase-like protein IA-2 (IA-2As) are considered to be highly predictive markers of T1D. We developed a novel lateral flow immunoassay (LFIA) based on a bridging format for the rapid detection of IA-2As in human serum samples. In this assay, one site of the IA-2As is bound to HA-tagged-IA-2, which is subsequently captured on the anti-HA-Tag antibody-coated test line on the strip. The other site of the IA-2As is bound to biotinylated IA-2, allowing the complex to be visualized using colloidal gold nanoparticle-conjugated streptavidin. For this study, 35 serum samples from T1D patients and 44 control sera from non-diabetic individuals were analyzed with our novel assay and the results were correlated with two IA-2A ELISAs. Among the 35 serum samples from T1D patients, the IA-2A LFIA, the in-house IA-2A ELISA and the commercial IA-2A ELISA identified as positive 21, 29 and 30 IA-2A-positive sera, respectively. The major advantages of the IA-2A LFIA are its rapidity and simplicity.	[Kikkas, Ingrid; Volland, Herve; Morel, Nathalie] CEA, iBiTec S, Serv Pharmacol & Immunoanal, Lab Etud & Rech Immunoanal, Gif Sur Yvette, France; [Mallone, Roberto] INSERM, U1016, Cochin Inst, DeAR Lab, Paris, France; [Mallone, Roberto; Larger, Etienne] Paris Descartes Univ, Sorbonne Paris Cite, Fac Med, Paris, France; [Mallone, Roberto; Larger, Etienne] Hop Cochin, AP HP, Serv Diabetol, F-75674 Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Morel, N (corresponding author), CEA, iBiTec S, Serv Pharmacol & Immunoanal, Lab Etud & Rech Immunoanal, Gif Sur Yvette, France.	nathalie.morel@cea.fr	Mallone, Roberto/H-4430-2013	Mallone, Roberto/0000-0002-9846-8861				Achenbach P, 2013, DIABETOLOGIA, V56, P1615, DOI 10.1007/s00125-013-2896-y; Achenbach P, 2004, DIABETES, V53, P384, DOI 10.2337/diabetes.53.2.384; Biagini RE, 2006, CLIN VACCINE IMMUNOL, V13, P541, DOI 10.1128/CVI.13.5.541-546.2006; Chen S, 2005, CLIN CHIM ACTA, V357, P74, DOI 10.1016/j.cccn.2005.02.006; Decochez K, 2002, DIABETOLOGIA, V45, P1658, DOI 10.1007/s00125-002-0949-8; Jahromi MM, 2007, CELL MOL LIFE SCI, V64, P865, DOI 10.1007/s00018-007-6469-4; Kikkas I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069021; Knip M, 2003, REV ENDOCR METAB DIS, V4, P213, DOI 10.1023/A:1025121510678; Lampasona V, 1996, J IMMUNOL, V157, P2707; Larsson HE, 2014, PEDIATR DIABETES, V15, P118, DOI 10.1111/pedi.12066; Lobner K, 1999, HORM METAB RES, V31, P686, DOI 10.1055/s-2007-978821; Masuda M, 2000, CLIN CHIM ACTA, V291, P53, DOI 10.1016/S0009-8981(99)00199-0; Mdluli P, 2014, BIOSENS BIOELECTRON, V54, P1, DOI 10.1016/j.bios.2013.10.019; Morgenthaler NG, 1998, HORM METAB RES, V30, P559, DOI 10.1055/s-2007-978933; Parikka V, 2012, DIABETOLOGIA, V55, P1926, DOI 10.1007/s00125-012-2523-3; Renger F, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3057; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; Silpasakorn S, 2012, AM J TROP MED HYG, V87, P148, DOI 10.4269/ajtmh.2012.11-0583; Torn C, 2008, DIABETOLOGIA, V51, P846, DOI 10.1007/s00125-008-0967-2; Westerlund-Karlsson A, 2003, CLIN CHEM, V49, P916, DOI 10.1373/49.6.916; Winter WE, 2011, CLIN CHEM, V57, P168, DOI 10.1373/clinchem.2010.148205; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	22	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103088	10.1371/journal.pone.0103088	http://dx.doi.org/10.1371/journal.pone.0103088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047039	gold, Green Submitted, Green Published			2022-12-25	WOS:000339558100106
J	Cai, YH; Chen, XJ; Xie, K; Xing, QK; Wu, YW; Li, J; Du, CH; Sun, ZX; Guo, ZJ				Cai, Yuhui; Chen, Xujun; Xie, Ke; Xing, Qikai; Wu, Yawen; Li, Jing; Du, Caihong; Sun, Zongxiu; Guo, Zejian			Dlf1, a WRKY Transcription Factor, Is Involved in the Control of Flowering Time and Plant Height in Rice	PLOS ONE			English	Article							DISEASE RESISTANCE; NATURAL VARIATION; DWARF MUTANT; HEADING DATE; GENE; ARABIDOPSIS; ENCODES; EXPRESSION; PROTEIN; TOLERANCE	Flowering time and plant height are important agronomic traits for crop production. In this study, we characterized a semi-dwarf and late flowering (dlf1) mutation of rice that has pleiotropic effects on these traits. The dlf1 mutation was caused by a T-DNA insertion and the cloned Dlf1 gene was found to encode a WRKY transcription factor (OsWRKY11). The dlf1 mutant contains a T-DNA insertion at the promoter region, leading to enhanced accumulation of Dlf1 transcripts, resulting in a semidominant mutation. The dlf1 mutation suppressed the transcription of Ehd2/RID1/OsId1 and its downstream flowering-time genes including Hd1, Ehd1 and Hd3a under both long-day (LD) and short-day (SD) conditions. Knock-down of Dlf1 expression exhibited early flowering at LD condition related to the wild-type plants. Accumulation of Dlf1 mRNA was observed in most tissues, and two splicing forms of Dlf1 cDNAs were obtained (OsWRKY11.1 and OsWRKY11.2). These two proteins showed transactivation activity in yeast cells. Dlf1 protein was found to be localized in the nucleus. Enhanced expression of OsWRKY11.2 or its 59 truncated gene showed similar phenotypes to the dlf1 mutant, suggesting that it might function as a negative regulator. We conclude that Dlf1 acts as a transactivator to downregulate Ehd2/RID1/OsId1 in the signal transduction pathway of flowering and plays an important role in the regulation of plant height in rice.	[Cai, Yuhui; Chen, Xujun; Xing, Qikai; Guo, Zejian] China Agr Univ, Key Lab Plant Pathol, Beijing 100094, Peoples R China; [Wu, Yawen; Sun, Zongxiu] China Natl Rice Res Inst, Hangzhou, Zhejiang, Peoples R China; [Xie, Ke; Li, Jing; Du, Caihong; Guo, Zejian] Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang University	Guo, ZJ (corresponding author), China Agr Univ, Key Lab Plant Pathol, Beijing 100094, Peoples R China.	sunzx405@163.com; guozj@cau.edu.cn	Li, Jing/F-5934-2014	Li, Jing/0000-0002-0989-7622	National Nature Science of Foundation [31171833, 31272025]; Program for Changjiang Scholars and Innovative Research Team in University [IRT042]; 111 project [B13006]	National Nature Science of Foundation(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 project(Ministry of Education, China - 111 Project)	This research was financially supported by National Nature Science of Foundation (31171833 and 31272025), the Program for Changjiang Scholars and Innovative Research Team in University (IRT042), and the 111 project (B13006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Chen YF, 2009, PLANT CELL, V21, P3554, DOI 10.1105/tpc.108.064980; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; EIMERT K, 1995, PLANT CELL, V7, P1703, DOI 10.1105/tpc.7.10.1703; Franco-Zorrilla JM, 2009, PLANT J, V59, P840, DOI 10.1111/j.1365-313X.2009.03904.x; Fujino K, 2013, THEOR APPL GENET, V126, P611, DOI 10.1007/s00122-012-2005-5; Gao H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003281; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kim SL, 2007, PLANT PHYSIOL, V145, P1484, DOI 10.1104/pp.107.103291; Kim WY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2357; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Kurepa J, 1998, PLANT GROWTH REGUL, V26, P91, DOI 10.1023/A:1006043914056; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Matsubara K, 2008, PLANT PHYSIOL, V148, P1425, DOI 10.1104/pp.108.125542; Matsubara K, 2012, PLANT CELL PHYSIOL, V53, P709, DOI 10.1093/pcp/pcs028; Matsubara K, 2011, PLANT J, V66, P603, DOI 10.1111/j.1365-313X.2011.04517.x; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Park SJ, 2008, PLANT J, V56, P1018, DOI 10.1111/j.1365-313X.2008.03667.x; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Riboni M, 2013, PLANT PHYSIOL, V162, P1706, DOI 10.1104/pp.113.217729; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Saito H, 2012, PLANT CELL PHYSIOL, V53, P717, DOI 10.1093/pcp/pcs029; Seo E, 2009, PLANT CELL, V21, P3185, DOI 10.1105/tpc.108.063883; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Wu CF, 2008, J NEUROGENET, V22, P1, DOI 10.1080/01677060801918016; Wu XL, 2009, PLANT CELL REP, V28, P21, DOI 10.1007/s00299-008-0614-x; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104	45	55	76	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102529	10.1371/journal.pone.0102529	http://dx.doi.org/10.1371/journal.pone.0102529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036785	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200065
J	Droguett, A; Krall, P; Burgos, ME; Valderrama, G; Carpio, D; Ardiles, L; Rodriguez-Diez, R; Kerr, B; Walz, K; Ruiz-Ortega, M; Egido, J; Mezzano, S				Droguett, Alejandra; Krall, Paola; Burgos, M. Eugenia; Valderrama, Graciela; Carpio, Daniel; Ardiles, Leopoldo; Rodriguez-Diez, Raquel; Kerr, Bredford; Walz, Katherina; Ruiz-Ortega, Marta; Egido, Jesus; Mezzano, Sergio			Tubular Overexpression of Gremlin Induces Renal Damage Susceptibility in Mice	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; MORPHOGENETIC PROTEIN ANTAGONIST; TRANSGENIC MICE; DIABETIC-NEPHROPATHY; PROXIMAL TUBULE; ANGIOTENSINOGEN GENE; BLOOD-PRESSURE; HIGH GLUCOSE; FACTOR-BETA; EXPRESSION	A growing number of patients are recognized worldwide to have chronic kidney disease. Glomerular and interstitial fibrosis are hallmarks of renal progression. However, fibrosis of the kidney remains an unresolved challenge, and its molecular mechanisms are still not fully understood. Gremlin is an embryogenic gene that has been shown to play a key role in nephrogenesis, and its expression is generally low in the normal adult kidney. However, gremlin expression is elevated in many human renal diseases, including diabetic nephropathy, pauci-immune glomerulonephritis and chronic allograft nephropathy. Several studies have proposed that gremlin may be involved in renal damage by acting as a downstream mediator of TGF-beta. To examine the in vivo role of gremlin in kidney pathophysiology, we generated seven viable transgenic mouse lines expressing human gremlin (GREM1) specifically in renal proximal tubular epithelial cells under the control of an androgen-regulated promoter. These lines demonstrated 1.2- to 200-fold increased GREM1 expression. GREM1 transgenic mice presented a normal phenotype and were without proteinuria and renal function involvement. In response to the acute renal damage cause by folic acid nephrotoxicity, tubule-specific GREM1 transgenic mice developed increased proteinuria after 7 and 14 days compared with wild-type treated mice. At 14 days tubular lesions, such as dilatation, epithelium flattening and hyaline casts, with interstitial cell infiltration and mild fibrosis were significantly more prominent in transgenic mice than wild-type mice. Tubular GREM1 overexpression was correlated with the renal upregulation of profibrotic factors, such as TGF-beta and alpha SMA, and with increased numbers of monocytes/macrophages and lymphocytes compared to wild-type mice. Taken together, our results suggest that GREM1-overexpressing mice have an increased susceptibility to renal damage, supporting the involvement of gremlin in renal damage progression. This transgenic mouse model could be used as a new tool for enhancing the knowledge of renal disease progression.	[Droguett, Alejandra; Krall, Paola; Burgos, M. Eugenia; Valderrama, Graciela; Ardiles, Leopoldo; Mezzano, Sergio] Univ Austral Chile, Sch Med, Div Nephrol, Valdivia, Chile; [Kerr, Bredford; Walz, Katherina] Ctr Estudios Cient, Valdivia, Chile; [Carpio, Daniel] Univ Austral Chile, Sch Med, Hystopathol Div, Valdivia, Chile; [Rodriguez-Diez, Raquel; Ruiz-Ortega, Marta; Egido, Jesus] Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Madrid, Spain	Universidad Austral de Chile; Universidad Austral de Chile; Autonomous University of Madrid	Mezzano, S (corresponding author), Univ Austral Chile, Sch Med, Div Nephrol, Valdivia, Chile.	smezzano@uach.cl	Ortega, Marta Ruiz/AAN-2136-2020; Ardiles, Leopoldo/K-8238-2019; Díez, Raquel Rodrigues/ABE-9703-2020; Ardiles, Leopoldo/AAR-3058-2020; Ruiz-Ortega, Marta/D-3584-2012; ruiz-ortega, marta/D-3584-2012	Ortega, Marta Ruiz/0000-0002-1495-6535; Díez, Raquel Rodrigues/0000-0002-6348-1505; Ardiles, Leopoldo/0000-0002-6197-0954; Ruiz-Ortega, Marta/0000-0002-1495-6535; Droguett, Alejandra/0000-0002-4782-650X; ruiz-ortega, marta/0000-0002-1403-2690; Kerr, Bredford/0000-0001-8714-8726	Ciberdem; Redinren; Fondecyt [1120480, 1080083]; Fondecyt, Chile [1100821]	Ciberdem; Redinren; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Supported by Ciberdem, Redinren, Fondecyt 1120480, Fondecyt 1080083, Fondecyt 1100821, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro MP, 2013, LAB INVEST, V93, P81, DOI 10.1038/labinvest.2012.162; Bonniaud P, 2003, AM J RESP CRIT CARE, V168, P770, DOI 10.1164/rccm.200210-1254OC; Cahill E, 2012, CIRCULATION, V125, P920, DOI 10.1161/CIRCULATIONAHA.111.038125; Carvajal G, 2008, TRANSPL P, V40, P734, DOI 10.1016/j.transproceed.2008.02.064; Costello CM, 2010, AM J RESP CELL MOL, V42, P517, DOI 10.1165/rcmb.2009-0101TR; Ding YM, 2001, AM J PHYSIOL-RENAL, V280, pF54, DOI 10.1152/ajprenal.2001.280.1.F54; Ding YM, 1997, J BIOL CHEM, V272, P28142, DOI 10.1074/jbc.272.44.28142; Dolan V, 2005, AM J KIDNEY DIS, V45, P1034, DOI 10.1053/j.ajkd.2005.03.014; Farkas L, 2011, AM J RESP CELL MOL, V44, P870, DOI 10.1165/rcmb.2010-0070OC; Gentle ME, 2013, J AM SOC NEPHROL, V24, P787, DOI 10.1681/ASN.2012101024; Guimei Maha, 2012, BMC Res Notes, V5, P390, DOI 10.1186/1756-0500-5-390; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Karagiannis GS, 2013, MOL ONCOL, V7, P826, DOI 10.1016/j.molonc.2013.04.002; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; Lappin DWP, 2002, NEPHROL DIAL TRANSPL, V17, P65, DOI 10.1093/ndt/17.suppl_9.65; Lavoie JL, 2004, AM J PHYSIOL-RENAL, V286, pF965, DOI 10.1152/ajprenal.00402.2003; Li GY, 2013, J CELL BIOCHEM, V114, P2101, DOI 10.1002/jcb.24559; Li HP, 2008, AM J PHYSIOL-RENAL, V294, pF1481, DOI 10.1152/ajprenal.00064.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McMahon R, 2000, J BIOL CHEM, V275, P9901, DOI 10.1074/jbc.275.14.9901; Mezzano S, 2007, NEPHROL DIAL TRANSPL, V22, P1882, DOI 10.1093/ndt/gfm145; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Murphy M, 1999, J BIOL CHEM, V274, P5830, DOI 10.1074/jbc.274.9.5830; Ortega A, 2006, J AM SOC NEPHROL, V17, P1594, DOI 10.1681/ASN.2005070690; Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316; Rodrigues-Diez R, 2012, NEPHRON EXP NEPHROL, V122, P62, DOI 10.1159/000346575; Roxburgh SA, 2006, NEPHRON PHYSIOL, V103, P139, DOI 10.1159/000092453; Roxburgh SA, 2009, DIABETES, V58, P1641, DOI 10.2337/db08-1365; Sachetelli S, 2006, KIDNEY INT, V69, P1016, DOI 10.1038/sj.ki.5000210; Topol LZ, 2000, J BIOL CHEM, V275, P8785, DOI 10.1074/jbc.275.12.8785; Topol LZ, 1997, MOL CELL BIOL, V17, P4801, DOI 10.1128/MCB.17.8.4801; Yokoi H, 2008, KIDNEY INT, V73, P446, DOI 10.1038/sj.ki.5002722; Zhang QX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011709; Zoja C, 2002, J AM SOC NEPHROL, V13, P2898, DOI 10.1097/01.ASN.0000034912.55186.EC	35	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101879	10.1371/journal.pone.0101879	http://dx.doi.org/10.1371/journal.pone.0101879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036148	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200026
J	Gleicher, N; McAlpine, JN; Gilks, CB; Kushnir, VA; Lee, HJ; Wu, YG; Lazzaroni-Tealdi, E; Barad, DH				Gleicher, Norbert; McAlpine, Jessica N.; Gilks, C. Blake; Kushnir, Vitaly A.; Lee, Ho-Joon; Wu, Yan-Guang; Lazzaroni-Tealdi, Emanuela; Barad, David H.			Absence of BRCA/FMR1 Correlations in Women with Ovarian Cancers	PLOS ONE			English	Article							BRCA1/2 MUTATIONS; ALLELES; BREAST; CARRIERS; RESCUE; RISKS; P53	Previously reported findings in Austrian BRCA1/2 mutation carriers suggested a possible dependency of embryos with BRCA1/2 mutations on so-called low alleles of the fragile X mental retardation 1 (FMR1) gene, characterized by less than 26 CGG repeats (CGGn, 26). The hypothesis arose from a study reporting highly statistically significant enrichment of low FMR1 alleles, significantly exceeding low allele prevalence in a general population, suggesting embryo lethality of BRCA1/2 mutations, "rescued" by presence of low FMR1 alleles. Such a dependency would also offer an explanation for the so-called "BRCA-paradox," characterized by BRCA1/2 deficient embryonic tissues being anti-proliferative (thereby potentially causing embryo-lethality) but proliferative in malignant tumors, including breast and ovarian cancers. Follow up investigations by other investigators, however, at most demonstrated trends towards enrichment but, mostly, no enrichment at all, raising questions about the original observation and hypothesis. We in this study, therefore, investigated CGGn of the FMR1 gene of 86 anonymized DNA samples from women with various forms of ovarian cancer, and were unable to demonstrate differences in prevalence of low FMR1 alleles either between positive and negative ovarian cancer patients for BRCA1/2 or between ovarian cancer patients and reported rates in non-cancer populations. This raises further questions about a suggested dependency between BRCA1/2 and FMR1, but also raises the possibility that investigated Austrian BRCA1/2 carrier populations differ from those in other countries. Either only selected BRCA1/2 mutations, therefore, interact with low FMR1 alleles or the Austrian data reflect only coincidental observations.	[Gleicher, Norbert; Kushnir, Vitaly A.; Lee, Ho-Joon; Wu, Yan-Guang; Lazzaroni-Tealdi, Emanuela; Barad, David H.] Ctr Human Reprod, New York, NY 10021 USA; [Gleicher, Norbert; Barad, David H.] Fdn Reprod Med, New York, NY USA; [McAlpine, Jessica N.] Univ British Columbia, Dept Gynecol & Obstet, Div Gynecol Oncol, Vancouver, BC V5Z 1M9, Canada; [McAlpine, Jessica N.; Gilks, C. Blake] BC Canc Agcy, OvCaRe Gynecol Tissue Bank, Vancouver, BC, Canada; [Gilks, C. Blake] Univ British Columbia, Dept Pathol & Lab Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Gleicher, N (corresponding author), Ctr Human Reprod, New York, NY 10021 USA.	ngleicher@thechr.com	Barad, David/AAF-4332-2021		not-for-profit Foundation for Reproductive Medicine (FRM), New York, N.Y., USA; Center for Human Reproduction (CHR) - New York, N.Y., USA	not-for-profit Foundation for Reproductive Medicine (FRM), New York, N.Y., USA; Center for Human Reproduction (CHR) - New York, N.Y., USA	This study was supported by funds from the not-for-profit Foundation for Reproductive Medicine (FRM), New York, N.Y. 10021, USA, and intramural funds from the Center for Human Reproduction (CHR) - New York, N.Y. 10021, USA, a for-profit fertility and research center. The FRM had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript, even though N. G. and D. H. B. are members of the foundation's Board. Since staff makes funding decisions at CHR, independent of CHR's ownership, funders at CHR had also no role in study design, data collection, analysis, decision to publish or preparation of the manuscript. All of those responsibilities were exclusively the authors', among which N. G., CHR's owner, is one. The funders at CHR only provided support in form of salaries to N. G., V. A. K. and D. H. B. The specific roles of these authors are articulated in the author contribution section.	Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Brandao RD, 2013, HUM REPROD, V28, P2308, DOI 10.1093/humrep/det254; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Crook T, 1997, LANCET, V350, P638, DOI 10.1016/S0140-6736(05)63327-2; Dagan E, 2014, EUR J HUM GENET, V22, P277, DOI 10.1038/ejhg.2013.281; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; Gleicher N, 2014, EUR J HUM GENET, V22, P155, DOI 10.1038/ejhg.2013.213; Gleicher N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018781; Gleicher N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015303; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Janavivicius R, 2010, EPMA J, V1, P297; Lose F, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn345; Ludwig T, 1997, GENE DEV, V97, P764; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Oktay K, 2010, J CLIN ONCOL, V28, P240, DOI 10.1200/JCO.2009.24.2057; Ramus SJ, 2012, HUM MUTAT, V33, P690, DOI 10.1002/humu.22025; Ricci MT, 2014, EUR J HUM GENET, V22, P280, DOI 10.1038/ejhg.2013.193; Stone C, 2003, CURR BIOL, V13, pR63, DOI 10.1016/S0960-9822(02)01430-6; Tea MK, 2013, MATURITAS, V75; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Verhoog LC, 2001, EUR J CANCER, V37, P2082, DOI 10.1016/S0959-8049(01)00244-1; Weghofer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044753; Xu CF, 1997, GENE CHROMOSOME CANC, V18, P102, DOI 10.1002/(SICI)1098-2264(199702)18:2<102::AID-GCC4>3.3.CO;2-A	24	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102370	10.1371/journal.pone.0102370	http://dx.doi.org/10.1371/journal.pone.0102370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036526	gold, Green Published, Green Submitted			2022-12-25	WOS:000339615200049
J	Patel, EU; Frank, MA; Hsieh, YH; Rothman, RE; Baker, AEO; Kraus, CK; Shahan, J; Gaydos, CA; Kelen, GD; Quinn, TC; Laeyendecker, O				Patel, Eshan U.; Frank, Melanie A.; Hsieh, Yu-Hsiang; Rothman, Richard E.; Baker, Amy E. O.; Kraus, Chadd K.; Shahan, Judy; Gaydos, Charlotte A.; Kelen, Gabor D.; Quinn, Thomas C.; Laeyendecker, Oliver			Prevalence and Factors Associated with Herpes Simplex Virus Type 2 Infection in Patients Attending a Baltimore City Emergency Department	PLOS ONE			English	Article							GENITAL HERPES; UNITED-STATES; INNER-CITY; SEROPREVALENCE; TRENDS; EPIDEMIOLOGY; TRANSMISSION; VALACYCLOVIR; SUPPRESSION; POPULATION	Objectives: Herpes simplex virus type 2 (HSV-2) is a common sexually transmitted disease, but there is limited data on its epidemiology among urban populations. The urban Emergency Department (ED) is a potential venue for surveillance as it predominantly serves an inner city minority population. We evaluate the seroprevalence and factors associated with HSV-2 infection among patients attending the Johns Hopkins Hospital Adult Emergency Department (JHH ED). Methods: An identity unlinked-serosurvey was conducted between 6/2007 and 9/2007 in the JHH ED; sera were tested by the Focus HerpeSelect ELISA. Prevalence risk ratios (PRR) were used to determine factors associated with HSV-2 infection. Results: Of 3,408 serum samples, 1,853 (54.4%) were seropositive for HSV-2. Females (adjPRR = 1.47, 95% CI 1.38-1.56), non-Hispanic blacks (adjPRR = 2.03, 95% CI 1.82-2.27), single (adjPRR = 1.15, 95% CI 1.07-1.25), divorced (adjPRR = 1.28, 95% CI 1.15-1.41), and unemployed patients (adjPRR = 1.13, 95% CI 1.05-1.21) had significantly higher rates of HSV-2 infection. Though certain zip codes had significantly higher seroprevalence of HSV-2, this effect was completely attenuated when controlling for age and gender. Conclusions: Seroprevalence of HSV-2 in the JHH ED was higher than U. S. national estimates; however, factors associated with HSV-2 infection were similar. The high seroprevalence of HSV-2 in this urban ED highlights the need for targeted testing and treatment. Cross-sectional serosurveys in the urban ED may help to examine the epidemiology of HSV-2.	[Patel, Eshan U.; Frank, Melanie A.; Quinn, Thomas C.; Laeyendecker, Oliver] NIAID, Div Intramural Res, NIH, Baltimore, MD 21201 USA; [Hsieh, Yu-Hsiang; Rothman, Richard E.; Baker, Amy E. O.; Kraus, Chadd K.; Shahan, Judy; Gaydos, Charlotte A.; Kelen, Gabor D.; Quinn, Thomas C.; Laeyendecker, Oliver] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Johns Hopkins University	Laeyendecker, O (corresponding author), NIAID, Div Intramural Res, NIH, Baltimore, MD 21201 USA.	olaeyen1@jhmi.edu	Gaydos, Charlotte A./E-9937-2010	Kiener, Melanie/0000-0001-6456-4313; Kelen, Gabor/0000-0002-3236-8286; Laeyendecker, Oliver/0000-0002-6429-4760; Patel, Eshan/0000-0003-2174-5004; Rothman, Richard/0000-0002-1017-9505	Division of Intramural Research; NIH Award from NIAID [5K01AI100681]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI100681, ZIAAI000361] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Award from NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported in part by the Division of Intramural Research and Dr. Hsieh is supported in part by an NIH Award, 5K01AI100681 from NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Corey L, 2000, JAMA-J AM MED ASSOC, V283, P791, DOI 10.1001/jama.283.6.791; Corey Lawrence, 2004, Herpes, V11 Suppl 3, p170A; Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633; Dickson N, 2013, SEX TRANSM INFECT; Fanfair RN, 2013, SEX TRANSM DIS, V40, P860, DOI 10.1097/OLQ.0000000000000043; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Force USPST, 2005, SCREEN GEN HERP REC; Gupta R, 2004, J INFECT DIS, V190, P1374, DOI 10.1086/424519; Jenkins WD, 2013, SEX TRANSM INFECT; KELEN GD, 1989, JAMA-J AM MED ASSOC, V262, P516, DOI 10.1001/jama.262.4.516; KELEN GD, 1995, CLIN INFECT DIS, V21, P867, DOI 10.1093/clinids/21.4.867; KELEN GD, 1988, NEW ENGL J MED, V318, P1645, DOI 10.1056/NEJM198806233182503; Mehta SD, 2003, SEX TRANSM DIS, V30, P143, DOI 10.1097/00007435-200302000-00010; Page WF, 2012, SEX TRANSM DIS, V39, P241, DOI 10.1097/OLQ.0b013e3182401a17; Schillinger JA, 2008, SEX TRANSM DIS, V35, P599, DOI 10.1097/OLQ.0b013e3181666fb1; SIEGEL D, 1992, JAMA-J AM MED ASSOC, V268, P1702, DOI 10.1001/jama.268.13.1702; Summerton J, 2007, CLIN VACCINE IMMUNOL, V14, P1545, DOI 10.1128/CVI.00120-07; Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881; Wald A, 1996, ANN INTERN MED, V124, P8, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00002; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Wald A, 2002, CLIN INFECT DIS, V35, pS173, DOI 10.1086/342104; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	26	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102422	10.1371/journal.pone.0102422	http://dx.doi.org/10.1371/journal.pone.0102422			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036862	gold, Green Published, Green Submitted			2022-12-25	WOS:000339615200058
J	Wasowicz, P; Pasierbinski, A; Przedpelska-Wasowicz, EM; Kristinsson, H				Wasowicz, Pawel; Pasierbinski, Andrzej; Przedpelska-Wasowicz, Ewa Maria; Kristinsson, Hordur			Distribution Patterns in the Native Vascular Flora of Iceland	PLOS ONE			English	Article							VACCINIUM MYRTILLUS; CLIMATE; BRITISH	The aim of our study was to reveal biogeographical patterns in the native vascular flora of Iceland and to define ecological factors responsible for these patterns. We analysed dataset of more than 500,000 records containing information on the occurrence of vascular plants. Analysis of ecological factors included climatic (derived from WORLDCLIM data), topographic (calculated from digital elevation model) and geological (bedrock characteristics) variables. Spherical k-means clustering and principal component analysis were used to detect biogeographical patterns and to study the factors responsible for them. We defined 10 biotic elements exhibiting different biogeographical patterns. We showed that climatic (temperature-related) and topographic variables were the most important factors contributing to the spatial patterns within the Icelandic vascular flora and that these patterns are almost completely independent of edaphic factors (bedrock type). Our study is the first one to analyse the biogeographical differentiation of the native vascular flora of Iceland.	[Wasowicz, Pawel; Kristinsson, Hordur] Iceland Inst Nat Hist, Akureyri, Iceland; [Pasierbinski, Andrzej] Silesian Univ, Fac Biol & Environm Protect, Dept Plant Systemat, Katowice, Poland; [Przedpelska-Wasowicz, Ewa Maria] Univ Warsaw, Inst Bot, Warsaw, Poland	University of Silesia in Katowice; University of Warsaw	Wasowicz, P (corresponding author), Iceland Inst Nat Hist, Akureyri, Iceland.	pawel@ni.is	Wasowicz, Pawel/A-7295-2013; Przedpelska-Wasowicz, Ewa/AAP-9310-2021	Wasowicz, Pawel/0000-0002-6864-6786; Przedpelska-Wasowicz, Ewa Maria/0000-0002-0481-7953	Icelandic Institute of Natural History	Icelandic Institute of Natural History	Study was funded by Icelandic Institute of Natural History. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babington CC., 1871, J LINNEAN SOC BOT, V11, P282, DOI [10.1111/j.1095-8339.1870.tb00067.x, DOI 10.1111/J.1095-8339.1870.TB00067.X]; Beck PSA, 2005, REMOTE SENS ENVIRON, V98, P110, DOI 10.1016/j.rse.2005.07.002; BIRKS HJB, 1976, NEW PHYTOL, V77, P257, DOI 10.1111/j.1469-8137.1976.tb01517.x; BIRKS HJB, 1987, ANN ZOOL FENN, V24, P165; Bohner J, 2009, DEV SOIL SCI, V33, P195, DOI 10.1016/S0166-2481(08)00008-1; Bohner J., 2002, EUR SOIL BUR, V7, P213; CAFF, 2013, ARCTIC BIODIVERSITY; Callaghan TV, 2004, AMBIO, V33, P404, DOI 10.1639/0044-7447(2004)033[0404:BDAAOA]2.0.CO;2; Crawford R.M.M., 1989, STUDIES PLANT SURVIV; CURL H, 1972, ECOLOGY, V53, P1189, DOI 10.2307/1935433; Elven R, 2011, CHECKLIST PANARCTIC; Gallant JC, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001426; Gronlund Ch., 1881, ISLANDS FLORA; Hallgrimsson H, 1971, NATTURUFRAEDINGURINN, V40, P233; Hallgrimsson H, 1969, NATTURUFRAEDINGURINN, V39, P17; Heino J, 2001, J BIOGEOGR, V28, P69, DOI 10.1046/j.1365-2699.2001.00538.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, DIVA GIS VERS 7 5 MA; Hill M.O., 1979, TWINSPAN FORTRAN PRO; Hill M.O., 2004, ATTRIBUTES BRIT IRIS; HILL MO, 1991, J BIOGEOGR, V18, P247, DOI 10.2307/2845395; Hill MO, 1979, DECORANA A FORTRAN P; Hugo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036269; Ingadottir A, 1996, PLONTUR; Jakobsson S, 1980, JOKULL, V29, P57; Jakobsson SP, 2008, JOKULL, V58, P117; Jaleska SD, 2009, GEOMORPHOMETRY CONCE; Kristinsson H., 2008, FJOLRIT NATTURUFRAEO, V51, P1; Kristinsson H, 1998, KVISKERKJABOK, P82; Kristinsson H, 1986, GUIDE FLOWERING PLAN; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; MOORE ID, 1991, HYDROL PROCESS, V5, P3, DOI 10.1002/hyp.3360050103; Nucci A, 2012, PLANT BIOSYST, V146, P564, DOI 10.1080/11263504.2012.670669; Ogren E, 1996, FUNCT ECOL, V10, P724, DOI 10.2307/2390507; Ogren E, 1997, TREE PHYSIOL, V17, P724; Pawlowska S, 1966, VEGETATION POLAND, P138; Pearson RG, 2013, NAT CLIM CHANGE, V3, P673, DOI [10.1038/NCLIMATE1858, 10.1038/nclimate1858]; Preston C. D., 2013, New Journal of Botany, V3, P96, DOI 10.1179/2042349713Y.0000000024; Preston CD, 1997, BOT J LINN SOC, V124, P1, DOI 10.1006/bojl.1996.0084; Preston CD, 2013, J BRYOL, V35, P71, DOI 10.1179/1743282012Y.0000000045; R Core Team, 2021, R LANG ENV STAT COMP; RAUNKIAER C., 1934; Riley SJ., 1999, INTERMOUNT J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; SALISBURY EJ, 1932, T NORFOLK NORWICH NA, V13, P191; Stefansson S., 1901, FLORA ISLANDS; Steindorsson S, 1962, SOCIETAS SCIENTIARUM, V35, P5; Sveinbjornsson J, 2002, AMBIO, P23; Taulavuori K, 1997, ENVIRON POLLUT, V98, P91, DOI 10.1016/S0269-7491(97)00115-2; Trueman I, 1995, FLORA MONTGOMERYSHIR; Van de Ven CM, 2007, EARTH INTERACT, V11, DOI 10.1175/EI205.1; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Wasowicz P, 2013, FLORA, V208, P648, DOI 10.1016/j.flora.2013.09.009; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wilson J.P., 2000, TERRAIN ANAL PRINCIP; WOODWARD FI, 1987, VEGETATIO, V69, P189, DOI 10.1007/BF00038700; YURTSEV BA, 1994, J VEG SCI, V5, P765, DOI 10.2307/3236191	57	9	9	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102916	10.1371/journal.pone.0102916	http://dx.doi.org/10.1371/journal.pone.0102916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036368	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200097
J	Boonstra, TA; van Vugt, JPP; van der Kooij, H; Bloem, BR				Boonstra, Tjitske A.; van Vugt, Jeroen P. P.; van der Kooij, Herman; Bloem, Bastiaan R.			Balance Asymmetry in Parkinson's Disease and Its Contribution to Freezing of Gait	PLOS ONE			English	Article							FRONTAL ASSESSMENT BATTERY; BILATERAL COORDINATION; SYSTEM-IDENTIFICATION; STANDING BALANCE; POSTURAL SWAY; LEVODOPA; STANCE; RHYTHMICITY; DYNAMICS; WALKING	Balance control (the ability to maintain an upright posture) is asymmetrically controlled in a proportion of patients with Parkinson's disease. Gait asymmetries have been linked to the pathophysiology of freezing of gait. We speculate that asymmetries in balance could contribute to freezing by a) hampering the unloading of the stepping leg and/or b) leading to a preferred stance leg during gait, which then results in asymmetric gait. To investigate this, we examined the relationship between balance control and weight-bearing asymmetries and freezing. We included 20 human patients with Parkinson (tested OFF medication; nine freezers) and nine healthy controls. Balance was perturbed in the sagittal plane, using continuous multi-sine perturbations, applied by a motion platform and by a force at the sacrum. Applying closed-loop system identification techniques, relating the body sway angle to the joint torques of each leg separately, determined the relative contribution of each ankle and hip joint to the total amount of joint torque. We also calculated weight-bearing asymmetries. We determined the 99-percent confidence interval of weight-bearing and balance-control asymmetry using the responses of the healthy controls. Freezers did not have larger asymmetries in weight bearing (p = 0.85) nor more asymmetrical balance control compared to non-freezers (p = 0.25). The healthy linear one-to-one relationship between weight bearing and balance control was significantly different for freezers and non-freezers (p = 0.01). Specifically, non-freezers had a significant relationship between weight bearing and balance control (p = 0.02), whereas this relation was not significant for freezers (p = 0.15). Balance control is asymmetrical in most patients (about 75 percent) with Parkinson's disease, but this asymmetry is not related to freezing. The relationship between weight bearing and balance control seems to be less pronounced in freezers, compared to healthy controls and non-freezers. However, this relationship should be investigated further in larger groups of patients.	[Boonstra, Tjitske A.; van der Kooij, Herman] Univ Twente, Dept Biomech Engn, MIRA Inst Biomech Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [van Vugt, Jeroen P. P.] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands; [van der Kooij, Herman] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands; [Bloem, Bastiaan R.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	University of Twente; Medical Spectrum Twente; Delft University of Technology; Radboud University Nijmegen	Boonstra, TA (corresponding author), Univ Twente, Dept Biomech Engn, MIRA Inst Biomech Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.	t.a.boonstra@gmail.com	Bloem, Bastiaan/H-8013-2014	Bloem, Bastiaan/0000-0002-6371-3337; van der kooij, herman/0000-0002-7926-3262	BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science; Dutch Parkinson Patient Foundation; Netherlands Organization for Scientific Research (NWO) [016076352]	BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science; Dutch Parkinson Patient Foundation; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science (www.nici.ru.nl/braingain); the Dutch Parkinson Patient Foundation (http://www.parkinson-vereniging.nl/; to T.A.B.) and the Netherlands Organization for Scientific Research (NWO) (#016076352 to B.R.B.; www.nwo.nl). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker LC, 2008, GAIT POSTURE, V27, P471, DOI 10.1016/j.gaitpost.2007.06.002; Asai Y, 2003, BIOL CYBERN, V88, P152, DOI 10.1007/s00422-002-0371-9; Baltadjieva R, 2006, EUR J NEUROSCI, V24, P1815, DOI 10.1111/j.1460-9568.2006.05033.x; BECKLEY DJ, 1995, J NEUROL SCI, V132, P133, DOI 10.1016/0022-510X(95)00130-T; Bloem BR, 2008, TREATMENT GAIT BALAN; Boonstra TA, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-23; BurleighJacobs A, 1997, MOVEMENT DISORD, V12, P206, DOI 10.1002/mds.870120211; Cohen OS, 2012, J GERIATR PSYCH NEUR, V25, P71, DOI 10.1177/0891988712445087; Cook RD, 1982, RESIDUALS INFLUENCE; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Danoudis M, 2012, PARKINSONISM RELAT D, V18, P543, DOI 10.1016/j.parkreldis.2012.02.005; de Vlugt E, 2003, J NEUROSCI METH, V122, P123, DOI 10.1016/S0165-0270(02)00303-5; Djaldetti R, 2006, LANCET NEUROL, V5, P796, DOI 10.1016/S1474-4422(06)70549-X; Doherty KM, 2011, LANCET NEUROL; Engelhart D, 2013, J AM MED DIR ASS; Fasano A, 2011, MOVEMENT DISORD, V26, P844, DOI 10.1002/mds.23583; Fling BW, 2013, BRAIN; Frazzitta G, 2012, J NEUROL; Geurts ACH, 2011, GAIT POSTURE, V33, P143, DOI 10.1016/j.gaitpost.2010.09.018; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hendrickson J, 2014, GAIT POSTURE, V39, P177, DOI 10.1016/j.gaitpost.2013.06.022; Hill KD, 1996, ARCH PHYS MED REHAB, V77, P1025, DOI 10.1016/S0003-9993(96)90063-5; Jacobs JV, 2009, EXP NEUROL, V215, P334, DOI 10.1016/j.expneurol.2008.10.019; Jenkins G. M., 1969, SPECTRAL ANAL ITS AP; Kiemel T, 2008, J NEUROPHYSIOL, V100, P3394, DOI 10.1152/jn.01272.2007; King LA, 2010, ARCH PHYS MED REHAB, V91, P1332, DOI 10.1016/j.apmr.2010.05.013; KOOPMAN B, 1995, J BIOMECH, V28, P1369, DOI 10.1016/0021-9290(94)00185-7; Koopman HFJM, 1989, 3 DIMENSIONAL ANAL P; Lewek MD, 2010, GAIT POSTURE, V31, P256, DOI 10.1016/j.gaitpost.2009.10.013; Mancini M, 2008, CLIN BIOMECH, V23, P450, DOI 10.1016/j.clinbiomech.2007.11.007; Nanhoe-Mahabier W, 2011, NEUROSCIENCE, V182, P217, DOI 10.1016/j.neuroscience.2011.02.061; Nieuwboer A, 2009, GAIT POSTURE, V30, P459, DOI 10.1016/j.gaitpost.2009.07.108; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Pasma JH, 2014, NEUROSCIENCE, V267, P157, DOI 10.1016/j.neuroscience.2014.02.030; Pasma JH, 2012, J NEUROPHYSIOL, V108, P1138, DOI 10.1152/jn.01008.2011; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Peterson DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090634; Peterson DS, 2012, PARKINSONISM RELAT D; Pintelon R., 2001, SYSTEM IDENTIFICATIO; Plotnik M, 2005, ANN NEUROL, V57, P656, DOI 10.1002/ana.20452; Plotnik M, 2008, MOVEMENT DISORD, V23, pS444, DOI 10.1002/mds.21984; Plotnik M, 2008, EUR J NEUROSCI, V27, P1999, DOI 10.1111/j.1460-9568.2008.06167.x; Preuss R, 2004, J BIOMECH, V37, P1177, DOI 10.1016/j.jbiomech.2003.12.007; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Royall DR, 2001, NEUROLOGY, V57, P565, DOI 10.1212/WNL.57.3.565; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Singh NB, 2012, J ELECTROMYOGR KINES, V22, P131, DOI 10.1016/j.jelekin.2011.10.007; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Spildooren J, 2012, NEUROSCIENCE, V207, P298, DOI 10.1016/j.neuroscience.2012.01.024; Uitti RJ, 2005, PARKINSONISM RELAT D, V11, P139, DOI 10.1016/j.parkreldis.2004.10.007; van Asseldonk EHF, 2006, EXP NEUROL, V201, P441, DOI 10.1016/j.expneurol.2006.04.036; van der Kooij H, 2007, J NEURAL TRANSM, V114, P1333, DOI 10.1007/s00702-007-0801-x; van der Kooij H, 2005, J PHYSIOL-LONDON, V569, P705, DOI 10.1113/jphysiol.2005.569001; van der Kooij H, 2005, J NEUROSCI METH, V145, P175, DOI 10.1016/j.jneumeth.2005.01.003; van der Kooij H, 2007, J NEUROPHYSIOL, V98, P730, DOI 10.1152/jn.00457.2006; van der Kooij H, 2011, J COMPUT NEUROSCI, V30, P759, DOI 10.1007/s10827-010-0291-y; Wright WG, 2010, EXP NEUROL, V225, P202, DOI 10.1016/j.expneurol.2010.06.016	58	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102493	10.1371/journal.pone.0102493	http://dx.doi.org/10.1371/journal.pone.0102493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032994	Green Published, gold			2022-12-25	WOS:000339418300057
J	Yehia, BR; Herati, RS; Fleishman, JA; Gallant, JE; Agwu, AL; Berry, SA; Korthuis, PT; Moore, RD; Metlay, JP; Gebo, KA				Yehia, Baligh R.; Herati, Ramin S.; Fleishman, John A.; Gallant, Joel E.; Agwu, Allison L.; Berry, Stephen A.; Korthuis, P. Todd; Moore, Richard D.; Metlay, Joshua P.; Gebo, Kelly A.		HIV Res Network	Hepatitis C Virus Testing in Adults Living with HIV: A Need for Improved Screening Efforts	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; MEDICINE ASSOCIATION; FREQUENT ATTENDERS; PRIMARY-CARE; HEALTH; INTERVENTION; GUIDELINES; RECOMMENDATIONS; PREVENTION; ADHERENCE	Objectives: Guidelines recommend hepatitis C virus (HCV) screening for all people living with HIV (PLWH). Understanding HCV testing practices may improve compliance with guidelines and can help identify areas for future intervention. Methods: We evaluated HCV screening and unnecessary repeat HCV testing in 8,590 PLWH initiating care at 12 U.S. HIV clinics between 2006 and 2010, with follow-up through 2011. Multivariable logistic regression examined the association between patient factors and the outcomes: HCV screening (>= 1 HCV antibody tests during the study period) and unnecessary repeat HCV testing (>= 1 HCV antibody tests in patients with a prior positive test result). Results: Overall, 82% of patients were screened for HCV, 18% of those screened were HCV antibody-positive, and 40% of HCV antibody-positive patients had unnecessary repeat HCV testing. The likelihood of being screened for HCV increased as the number of outpatient visits rose (adjusted odds ratio 1.02, 95% confidence interval 1.01-1.03). Compared to men who have sex with men (MSM), patients with injection drug use (IDU) were less likely to be screened for HCV (0.63, 0.52-0.78); while individuals with Medicaid were more likely to be screened than those with private insurance (1.30, 1.04-1.62). Patients with heterosexual (1.78, 1.20-2.65) and IDU (1.58, 1.06-2.34) risk compared to MSM, and those with higher numbers of outpatient (1.03, 1.01-1.04) and inpatient (1.09, 1.01-1.19) visits were at greatest risk of unnecessary HCV testing. Conclusions: Additional efforts to improve compliance with HCV testing guidelines are needed. Leveraging health information technology may increase HCV screening and reduce unnecessary testing.	[Yehia, Baligh R.; Herati, Ramin S.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Yehia, Baligh R.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Fleishman, John A.] Agcy Healthcare Res & Qual, Ctr Financing Access & Cost Trends, Rockville, MD USA; [Gallant, Joel E.] Southwest Care Ctr, Santa Fe, NM USA; [Agwu, Allison L.; Berry, Stephen A.; Moore, Richard D.; Gebo, Kelly A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Korthuis, P. Todd] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Metlay, Joshua P.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Agency for Healthcare Research & Quality; Johns Hopkins University; Oregon Health & Science University; Harvard University; Massachusetts General Hospital	Yehia, BR (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.	byehia@upenn.edu	Gebo, Kelly/AHA-7533-2022	Gebo, Kelly/0000-0003-4010-398X; Sedaghat Herati, Ramin/0000-0001-7713-2587; Herati, Ramin/0000-0003-2613-4050; Korthuis, Philip/0000-0001-5556-3597	Agency for Healthcare Research and Quality [HHSA290201100007C]; National Institutes of Health [K23-MH097647-01A1, K23AI084854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069918, K23AI084854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH097647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA036935] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Agency for Healthcare Research and Quality, www.ahrq.gov, [HHSA290201100007C] and the National Institutes of Health, www.nih.gov, [K23-MH097647-01A1 to BRY, K23AI084854 to SAB]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Asonganyi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072712; Baron RC, 2010, AM J PREV MED, V38, P110, DOI 10.1016/j.amepre.2009.09.031; Bates DW, 1999, AM J MED, V106, P144, DOI 10.1016/S0002-9343(98)00410-0; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Boohaker EA, 1996, ARCH INTERN MED, V156, P327, DOI 10.1001/archinte.156.3.327; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Chander G, 2006, DRUGS, V66, P769, DOI 10.2165/00003495-200666060-00004; Community Preventive Serv Task, 2012, AM J PREV MED, V43, P92, DOI [10.1016/j.amepre.2012.04.008, 10.1016/j.amepre.2012.08.013]; Getchell JP, 2013, MMWR-MORBID MORTAL W, V62, P362; Grebely J, 2013, CLIN INFECT DIS, V57, P1014, DOI 10.1093/cid/cit377; Groom H, 2008, J CLIN GASTROENTEROL, V42, P97, DOI 10.1097/MCG.0b013e31802dc56f; Hoover KW, 2012, SEX TRANSM DIS, V39, P349, DOI 10.1097/OLQ.0b013e318244a923; Jonckheere S, 2013, AIDS PATIENT CARE ST, V27, P317, DOI 10.1089/apc.2013.0096; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kerr T, 2005, J PUBLIC HEALTH-UK, V27, P62, DOI 10.1093/pubmed/fdh189; Kim AY, 2007, J INFECT DIS S1, V1, pS1; Knowlton AR, 2001, DRUG ALCOHOL DEPEN, V64, P55, DOI 10.1016/S0376-8716(00)00228-3; Krusi A, 2010, INT J DRUG POLICY, V21, P4, DOI 10.1016/j.drugpo.2009.08.003; Kwok J, 2005, J CLIN PATHOL, V58, P457, DOI 10.1136/jcp.2004.021691; Lambers FAE, 2014, AIDS CARE, V26, P416, DOI 10.1080/09540121.2013.832721; Lefevre F, 1999, J GEN INTERN MED, V14, P425, DOI 10.1046/j.1525-1497.1999.07238.x; Legorreta AP, 1997, DIABETES CARE, V20, P520, DOI 10.2337/diacare.20.4.520; Linas BP, 2014, AM J MED, V127, P398, DOI 10.1016/j.amjmed.2014.01.012; Liu P, 1997, TRANSFUSION, V37, P732, DOI 10.1046/j.1537-2995.1997.37797369450.x; McGregor MJ, 2012, CAN FAM PHYSICIAN, V58, P1191; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Neal RD, 2000, BRIT J GEN PRACT, V50, P972; Nies J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-70; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2009, GUIDELINES USE ANTIR, P1; Reed M, 2013, JAMA-J AM MED ASSOC, V310, P1060, DOI 10.1001/jama.2013.276733; Scaife B, 2000, FAM PRACT, V17, P298, DOI 10.1093/fampra/17.4.298; Taylor LE, 2011, AIDS PATIENT CARE ST, V25, P571, DOI 10.1089/apc.2011.0106; Valenstein P, 1998, ARCH PATHOL LAB MED, V112, P238; Veterans Health Administration, 2009, STAT CAR VET HIV AID; White P, 2013, J LOW GENIT TRACT DI, V17, P175, DOI 10.1097/LGT.0b013e3182607137; Yaphe S, 2012, SEX TRANSM INFECT, V88, P558, DOI 10.1136/sextrans-2012-050566; Yehia BR, 2013, AIDS, V27, P1529, DOI 10.1097/QAD.0b013e328360104e; Yehia BR, 2013, AIDS PATIENT CARE ST, V27, P272, DOI 10.1089/apc.2013.0007; Yehia BR, 2008, AIDS PATIENT CARE ST, V22, P1007, DOI 10.1089/apc.2008.0093; Yehia BR, 2013, AIDS BEHAV	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102766	10.1371/journal.pone.0102766	http://dx.doi.org/10.1371/journal.pone.0102766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032989	Green Submitted, Green Published, gold			2022-12-25	WOS:000339418300089
J	Kang, YY; Hodges, A; Ong, E; Roberts, W; Piermarocchi, C; Paternostro, G				Kang, Yunyi; Hodges, Andrew; Ong, Edison; Roberts, William; Piermarocchi, Carlo; Paternostro, Giovanni			Identification of Drug Combinations Containing Imatinib for Treatment of BCR-ABL plus Leukemias	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITOR; PHILADELPHIA-CHROMOSOME; POSITIVE LEUKEMIA; CANCER-CELLS; STEM-CELLS; IN-VITRO; RESISTANCE	The BCR-ABL translocation is found in chronic myeloid leukemia (CML) and in Ph+ acute lymphoblastic leukemia (ALL) patients. Although imatinib and its analogues have been used as front-line therapy to target this mutation and control the disease for over a decade, resistance to the therapy is still observed and most patients are not cured but need to continue the therapy indefinitely. It is therefore of great importance to find new therapies, possibly as drug combinations, which can overcome drug resistance. In this study, we identified eleven candidate anti-leukemic drugs that might be combined with imatinib, using three approaches: a kinase inhibitor library screen, a gene expression correlation analysis, and literature analysis. We then used an experimental search algorithm to efficiently explore the large space of possible drug and dose combinations and identified drug combinations that selectively kill a BCR-ABL+ leukemic cell line (K562) over a normal fibroblast cell line (IMR-90). Only six iterations of the algorithm were needed to identify very selective drug combinations. The efficacy of the top forty-nine combinations was further confirmed using Ph+ and Ph- ALL patient cells, including imatinib-resistant cells. Collectively, the drug combinations and methods we describe might be a first step towards more effective interventions for leukemia patients, especially those with the BCR-ABL translocation.	[Kang, Yunyi; Hodges, Andrew; Paternostro, Giovanni] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Ong, Edison] Salgomed Inc, Del Mar, CA USA; [Roberts, William] Univ Calif San Diego, Dept Pediat, Rady Childrens Hosp, San Diego, CA 92103 USA; [Piermarocchi, Carlo] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA	Sanford Burnham Prebys Medical Discovery Institute; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Michigan State University	Paternostro, G (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	giovanni@burnham.org	Piermarocchi, Carlo/AAH-2162-2019	Piermarocchi, Carlo/0000-0003-2762-8562; Ong, Edison/0000-0002-5159-414X	National Science Foundation [0829891]; NATIONAL CANCER INSTITUTE [P30CA023100, P30CA030199] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Science Foundation (Grant No. 0829891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Calzolari D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000249; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Feala JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029374; Gambacorti-Passerini CB, 2003, LANCET ONCOL, V4, P75, DOI 10.1016/S1470-2045(03)00979-3; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Goff DJ, 2013, CELL STEM CELL, V12, P316, DOI 10.1016/j.stem.2012.12.011; Gorre ME, 2002, BLOOD, V100, P3041, DOI 10.1182/blood-2002-05-1361; Hawkins LM, 2005, PEDIATR RES, V57, P430, DOI 10.1203/01.PDR.0000153871.45184.19; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hwang SH, 2008, MOL CANCER THER, V7, P559, DOI 10.1158/1535-7163.MCT-07-0548; Kuroda J, 2007, CELL DEATH DIFFER, V14, P1667, DOI 10.1038/sj.cdd.4402168; Kuroda J, 2008, BRIT J HAEMATOL, V140, P181, DOI 10.1111/j.1365-2141.2007.06899.x; La Rosee P, 2002, EXP HEMATOL, V30, P729, DOI 10.1016/S0301-472X(02)00836-6; Lancet JE, 2010, LEUKEMIA, V24, P699, DOI 10.1038/leu.2009.292; Melo JV, 1996, LEUKEMIA, V10, P751; Nguyen TK, 2006, CLIN CANCER RES, V12, P2239, DOI 10.1158/1078-0432.CCR-05-2282; Packer LM, 2011, CANCER CELL, V20, P715, DOI 10.1016/j.ccr.2011.11.004; Quentmeier H, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-6; Radujkovic A, 2005, LEUKEMIA, V19, P1198, DOI 10.1038/sj.leu.2403764; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schneider J. J., 2006, STOCHASTIC OPTIMIZAT; Schrag D, 2004, J CLIN ONCOL, V22, P3631, DOI 10.1200/JCO.2004.05.065; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Sun CP, 2009, INTEGR BIOL-UK, V1, P123, DOI 10.1039/b815225j; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Tipping AJ, 2002, LEUKEMIA, V16, P2349, DOI 10.1038/sj.leu.2402775; Tiziani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082859; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Tsutsui H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1165; von Bubnoff N, 2003, LEUKEMIA, V17, P829, DOI 10.1038/sj.leu.2402889; Wang H, 2006, CANCER RES, V66, P9722, DOI 10.1158/0008-5472.CAN-05-4602; WESTBROOK CA, 1992, BLOOD, V80, P2983; Wong PK, 2008, P NATL ACAD SCI USA, V105, P5105, DOI 10.1073/pnas.0800823105	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102221	10.1371/journal.pone.0102221	http://dx.doi.org/10.1371/journal.pone.0102221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029499	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600047
J	Lin, CW; Lo, S; Hsu, C; Hsieh, CH; Chang, YF; Hou, BS; Kao, YH; Lin, CC; Yu, ML; Yuan, SS; Hsieh, YC				Lin, Chih-Wen; Lo, Steven; Hsu, Chin; Hsieh, Chi-Hsun; Chang, Ya-Fang; Hou, Bao-Sheng; Kao, Ying-Hsien; Lin, Chih-Che; Yu, Ming-Lung; Yuan, Shyng-Shiou; Hsieh, Ya-Ching			T-Cell Autophagy Deficiency Increases Mortality and Suppresses Immune Responses after Sepsis	PLOS ONE			English	Article							PROTEIN-ACTIVATING ENZYME; MYCOBACTERIUM-TUBERCULOSIS; IMPROVES SURVIVAL; CECAL LIGATION; SEPTIC MICE; IFN-GAMMA; APOPTOSIS; CLEARANCE; INFECTION; INJURY	Background: Although the role of autophagy in sepsis has been characterized in several organs, its role in the adaptive immune system remains to be ascertained. This study aimed to investigate the role of autophagy in sepsis-induced T cell apoptosis and immunosuppression, using knockout mice with T cell specific deletion of autophagy essential gene Atg7. Methods and Results: Sepsis was induced in a cecal ligation and puncture (CLP) model, with T-cell-specific Atg7-knockout mice compared to control mice. Autophagic vacuoles examined by electron microscopy were decreased in the spleen after CLP. Autophagy proteins LC3-II and ATG7, and autophagosomes and autolysosomes stained by Cyto-ID Green and acridine orange were decreased in CD4(+) and CD8(+) splenocytes at 18 h and 24 h after CLP. This decrease in autophagy was associated with increased apoptosis of CD4(+) and CD8(+) after CLP. Moreover, mice lacking Atg7 in T lymphocytes showed an increase in sepsis-induced mortality, T cell apoptosis and loss of CD4(+) and CD8(+) T cells, in comparison to control mice. This was accompanied by suppressed cytokine production of Th1/Th2/Th17 by CD4(+) T cells, reduced phagocytosis in macrophages and decreased bacterial clearance in the spleen after sepsis. Conclusion: These results indicated that sepsis led to down-regulation of autophagy in T lymphocytes, which may result in enhanced apoptosis induction and decreased survival in sepsis. Autophagy may therefore play a protective role against sepsis-induced T lymphocyte apoptosis and immunosuppression.	[Lin, Chih-Wen; Hou, Bao-Sheng] I Shou Univ, E Da Hosp, Dept Med, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan; [Lo, Steven] I Shou Univ, E Da Hosp, Dept Plast & Reconstruct Surg, Kaohsiung, Taiwan; [Chang, Ya-Fang; Hou, Bao-Sheng; Kao, Ying-Hsien; Yuan, Shyng-Shiou; Hsieh, Ya-Ching] I Shou Univ, E Da Hosp, Dept Med Res, Kaohsiung, Taiwan; [Lin, Chih-Wen] I Shou Univ, E Da Hosp, Hlth Examinat Ctr, Kaohsiung, Taiwan; [Lo, Steven] Royal Infirm, Canniesburn Plast Surg Unit, Glasgow G31 2ER, Lanark, Scotland; [Lin, Chih-Wen; Yu, Ming-Lung] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Hsu, Chin] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Physiol, Kaohsiung, Taiwan; [Yu, Ming-Lung] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan; [Yuan, Shyng-Shiou] Kaohsiung Med Univ Hosp, Translat Res Ctr, Kaohsiung, Taiwan; [Yuan, Shyng-Shiou] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Yuan, Shyng-Shiou] Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Hsieh, Chi-Hsun] China Med Univ, China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Hsieh, Chi-Hsun] Benq Med Ctr Suzhou, Dept Surg, Suzhou, Peoples R China; [Lin, Chih-Che] Kaohsiung Chang Gung Mem Hosp, Div Gen Surg, Dept Surg, Kaohsiung, Taiwan; [Lin, Chih-Che] Chang Gung Univ, Coll Med, Gueishan, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; Royal Infirmary of Edinburgh; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung Memorial Hospital; Chang Gung University	Yuan, SS (corresponding author), I Shou Univ, E Da Hosp, Dept Med Res, Kaohsiung, Taiwan.	yuanssf@ms33.hinet.net	Yu, Ming-Lung/AAZ-4306-2020; Kao, Ying-Hsien/H-4134-2019	Yu, Ming-Lung/0000-0001-8145-1900; Lin, Chih-Wen/0000-0003-2344-5056; Kao, Ying-Hsien/0000-0001-7803-9384; yuan, shyng-shiou/0000-0002-4753-788X	E-Da hospital [EDAHT101030, EDAHT101023, EDAHT100023, NSC 102-2320-B-037-022-]	E-Da hospital	This work was supported by E-Da hospital grants EDAHT101030, EDAHT101023, EDAHT100023 and NSC 102-2320-B-037-022-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala A, 1999, SHOCK, V11, P211, DOI 10.1097/00024382-199903000-00010; Ayala A, 1996, BLOOD, V87, P4261, DOI 10.1182/blood.V87.10.4261.bloodjournal87104261; BAKER CC, 1983, SURGERY, V94, P331; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Chien WS, 2011, SHOCK, V35, P506, DOI 10.1097/SHK.0b013e31820b2f05; D'Elios MM, 2011, J INFECT DEV COUNTR, V5, P640, DOI 10.3855/jidc.2019; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Gao WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073229; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Holley MM, 2012, J IMMUNOL, V188, P1360, DOI 10.4049/jimmunol.1101660; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hsiao HW, 2012, SHOCK, V37, P289, DOI 10.1097/SHK.0b013e318240b52a; Hsieh CH, 2011, ANN SURG, V253, P1190, DOI 10.1097/SLA.0b013e318214b67e; Hsieh YC, 2009, TRENDS MOL MED, V15, P129, DOI 10.1016/j.molmed.2009.01.002; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Lee JS, 2012, METHODS, V56, P375, DOI 10.1016/j.ymeth.2011.11.006; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lin CW, 2014, SHOCK, V41, P241, DOI 10.1097/SHK.0000000000000111; Liu MS, 2012, CRIT CARE MED, V40, P2132, DOI 10.1097/CCM.0b013e31824e1e20; Lo S, 2012, ANN SURG; Lo S, 2013, ANN SURG, V257, P352, DOI 10.1097/SLA.0b013e318269d0e2; Ma N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069779; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Seto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0086017; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Vogel TR, 2010, ANN SURG, V252, P1065, DOI 10.1097/SLA.0b013e3181dcf36e; Watanabe E, 2009, LAB INVEST, V89, P549, DOI 10.1038/labinvest.2009.8; Weil BR, 2011, SHOCK, V36, P235, DOI 10.1097/SHK.0b013e318225f6ae; Zhang YB, 2013, J IMMUNOL, V190, P4725, DOI 10.4049/jimmunol.1203024	41	30	47	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102066	10.1371/journal.pone.0102066	http://dx.doi.org/10.1371/journal.pone.0102066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029098	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600034
J	Lippman, SA; Treves-Kagan, S; Gilvydis, JM; Naidoo, E; Khumalo-Sakutukwa, G; Darbes, L; Raphela, E; Ntswane, L; Barnhart, S				Lippman, Sheri A.; Treves-Kagan, Sarah; Gilvydis, Jennifer M.; Naidoo, Evasen; Khumalo-Sakutukwa, Gertrude; Darbes, Lynae; Raphela, Elsie; Ntswane, Lebogang; Barnhart, Scott			Informing Comprehensive HIV Prevention: A Situational Analysis of the HIV Prevention and Care Context, North West Province South Africa	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; CONDOM USE; TRANSACTIONAL SEX; PROJECT ACCEPT; YOUNG-PEOPLE; RISK-FACTORS; HPTN 043; HEALTH; STIGMA; INTERVENTIONS	Objective: Building a successful combination prevention program requires understanding the community's local epidemiological profile, the social community norms that shape vulnerability to HIV and access to care, and the available community resources. We carried out a situational analysis in order to shape a comprehensive HIV prevention program that address local barriers to care at multiple contextual levels in the North West Province of South Africa. Method: The situational analysis was conducted in two sub-districts in 2012 and guided by an adaptation of WHO's Strategic Approach, a predominantly qualitative method, including observation of service delivery points and in-depth interviews and focus groups with local leaders, providers, and community members, in order to recommend context-specific HIV prevention strategies. Analysis began during fieldwork with nightly discussions of findings and continued with coding original textual data from the fieldwork notebooks and a select number of recorded interviews. Results: We conducted over 200 individual and group interviews and gleaned four principal social barriers to HIV prevention and care, including: HIV fatalism, traditional gender norms, HIV-related stigma, and challenges with communication around HIV, all of which fuel the HIV epidemic. At the different levels of response needed to stem the epidemic, we found evidence of national policies and programs that are mitigating the social risk factors but little community-based responses that address social risk factors to HIV. Conclusions: Understanding social and structural barriers to care helped shape our comprehensive HIV prevention program, which address the four 'themes' identified into each component of the program. Activities are underway to engage communities, offer community-based testing in high transmission areas, community stigma reduction, and a positive health, dignity and prevention program for stigma reduction and improve communication skills. The situational analysis process successfully shaped key programmatic decisions and cultivated a deeper collaboration with local stakeholders to support program implementation.	[Lippman, Sheri A.; Treves-Kagan, Sarah; Khumalo-Sakutukwa, Gertrude; Darbes, Lynae] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Gilvydis, Jennifer M.; Naidoo, Evasen; Raphela, Elsie; Ntswane, Lebogang] Univ Washington, Int Training & Educ Ctr Hlth ITECH South Africa, Pretoria, South Africa; [Barnhart, Scott] Univ Washington, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA	University of California System; University of California San Francisco; University of Washington; University of Washington Seattle	Lippman, SA (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	sheri.lippman@ucsf.edu		Lippman, Sheri/0000-0003-3152-9372; Darbes, Lynae/0000-0003-4738-6812	Centers for Disease Control and Prevention [5U2GGH000324-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was funded by the Cooperative Agreement 5U2GGH000324-02 from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the views of CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach JD, 2011, GLOB PUBLIC HEALTH, V6, P11; Campbell C, 2005, AIDS CARE, V17, P471, DOI 10.1080/09540120412331319705; Campbell C, 2002, SOC SCI MED, V55, P331, DOI 10.1016/S0277-9536(01)00289-1; Campbell C., 2003, LETTING DIE WHY HIV; Campbell C, 2007, AM J COMMUN PSYCHOL, V39, P347, DOI 10.1007/s10464-007-9116-1; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Darbes LA, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-64; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2007, SOC SCI MED, V65, P1235, DOI 10.1016/j.socscimed.2007.04.029; Dworkin SL, 2013, AIDS BEHAV, V17, P2845, DOI 10.1007/s10461-013-0565-2; Dworkin SL, 2011, AM J PUBLIC HEALTH, V101, P995, DOI 10.2105/AJPH.2009.191106; Fitch, 2000, Int J Drug Policy, V11, P63, DOI 10.1016/S0955-3959(99)00056-0; Fredman S., 2012, COMP STUDY ANTIDISCR; Freire P., 1999, PEDAGOGY OPPRESSED; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Greig A, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327435.28538.18; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Jewkes R, 2008, BMJ, V337; Jewkes R, 2006, LANCET, V368, P430, DOI 10.1016/S0140-6736(06)69130-7; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024256; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Johnson LF, 2012, ACCESS ANTIRETROVIRA; Kalichman SC, 2007, AIDS CARE, V19, P20, DOI 10.1080/09540120600984003; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Kalichman SC, 2009, PREV SCI, V10, P260, DOI 10.1007/s11121-009-0129-x; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kaufman CE, 2004, CULT HEALTH SEX, V6, P377, DOI 10.1080/13691050410001680492; Kevany S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-459; Kinsler JJ, 2007, AIDS PATIENT CARE ST, V21, P584, DOI 10.1089/apc.2006.0202; Lambert H, 2005, CULT HEALTH SEX, V7, P527, DOI 10.1080/13691050500245818; Leclerc-Madlala S, 1997, Med Anthropol, V17, P363, DOI 10.1080/01459740.1997.9966146; Lippman SA, 2007, SOC SCI MED, V64, P2464, DOI 10.1016/j.socscimed.2007.02.048; Lippman SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078208; MacPhail C, 2001, SOC SCI MED, V52, P1613, DOI 10.1016/S0277-9536(00)00272-0; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; MANDERSON L, 1992, SOC SCI MED, V35, P839, DOI 10.1016/0277-9536(92)90098-B; Mantell JE, 2009, CULT HEALTH SEX, V11, P139, DOI 10.1080/13691050802521155; Medley A, 2013, AIDS CARE, V25, P1569, DOI 10.1080/09540121.2013.793269; Merson M, 2008, LANCET, V372, P1805, DOI 10.1016/S0140-6736(08)61752-3; Miles M. B., 2019, QUALITATIVE DATA ANA, V4th; Mosavel M, 2012, HEALTH PROMOT INT, V27, P323, DOI 10.1093/heapro/dar041; National Department of Health, 2012, NAT ANT SENT HIV SYP; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Peacock D, 2009, J ACQUIR IMMUNE DEFI, V1; Pettifor A, 2009, EFFECTS CASH TRANSFE; Pitpitan EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045631; President's Emergency Plan for AIDS Relief (PEPFAR), 2011, GUID PREV SEX TRANSM; Pulerwitz J., 2004, PROMOTING HLTH RELAT; Rodriguez-Garcia R, 2013, AIDS CARE, V25, pS7, DOI 10.1080/09540121.2013.764395; Rosenberg NE, 2013, JAIDS-J ACQ IMM DEF, V62, P226, DOI 10.1097/QAI.0b013e31827971ca; Shisana RT, 2014, S AFRICAN NATL HIV P; SHOOP DM, 1994, J ADOLESCENCE, V17, P137, DOI 10.1006/jado.1994.1014; Skinner D, 2004, SAHARA J, V1, P157; South Africa, 1996, CONSTITUTION REPUBLI, DOI DOI 10.1017/S0021855300011499; South African National AIDS Council, 2010, NAT HIV COUNS TEST C; South African National Department of Health, 2012, CLIN GUID MAN HIV AI; Spicehandler J, 1994, EXPANDING FAMILY PLA; StatsSA, 2007, COMM SURV LAB FORC; StatsSA, 2011, COMM SURV; Stemple L, 2008, AIDS, P22; Sumartojo E, 2000, AIDS, V14, pS3, DOI 10.1097/00002030-200006001-00002; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; Treves-Kagan S, RAPID ASSES IN PRESS; Trotter R.T., 2001, FIELD METHOD, V13, P137, DOI [10.1177/1525822X0101300202, DOI 10.1177/1525822X0101300202]; Ulin PR, 2005, QUALITATIVE METHODS; UNAIDS, 2010, GLOB REP UNAIDS REP; UNAIDS, 2012, UNAIDS COUNTR PROF S; Underwood C, 2011, J COMMUN, V61, P197, DOI 10.1111/j.1460-2466.2011.01537.x; Vandenhoudt H, 2010, AIDS EDUC PREV, V22, P328, DOI 10.1521/aeap.2010.22.4.328; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; WHO, 2002, MAK DEC CONTR INTR G; World Health Organization, 2005, STRAT APPR IMPR QUAL; World Health Organization, 2013, GLOB TUB REP WHO; Zuch M, 2012, AIDS BEHAV, V16, P564, DOI 10.1007/s10461-011-0089-6	77	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102904	10.1371/journal.pone.0102904	http://dx.doi.org/10.1371/journal.pone.0102904			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25028976	Green Published, gold			2022-12-25	WOS:000341306600105
J	Prufer, J; Schuchardt, M; Tolle, M; Prufer, N; Hohne, M; Zidek, W; van der Giet, M				Pruefer, Jasmin; Schuchardt, Mirjam; Toelle, Markus; Pruefer, Nicole; Hoehne, Matthias; Zidek, Walter; van der Giet, Markus			Harmful Effects of the Azathioprine Metabolite 6-Mercaptopurine in Vascular Cells: Induction of Mineralization	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; PREDICTS CARDIOVASCULAR EVENTS; PULSE-WAVE VELOCITY; ALL-CAUSE MORTALITY; OXIDATIVE STRESS; RISK-FACTORS; OSTEOBLASTIC DIFFERENTIATION; MOLECULAR-MECHANISMS; TRANSCRIPTION FACTOR; DISEASE	Vascular mineralization contributes to the high cardiovascular morbidity and mortality in patients who suffer from chronic kidney disease and in individuals who have undergone solid organ transplantation. The immunosuppressive regimen used to treat these patients appears to have an impact on vascular alterations. The effect of 6-mercaptopurine (6-MP) on vascular calcification has not yet been determined. This study investigates the effect of 6-MP on vascular mineralization by the induction of trans-differentiation of rat vascular smooth muscle cells in vitro. 6-MP not only induces the expression of osteochondrocyte-like transcription factors and proteins but also activates alkaline phosphatase enzyme activity and produces calcium deposition in in vitro and ex vivo models. These processes are dependent on 6-MP-induced production of reactive oxygen species, intracellular activation of mitogen-activated kinases and phosphorylation of the transcription factor Cbfa1. Furthermore, the metabolic products of 6-MP, 6-thioguanine nucleotides and 6-methyl-thio-inosine monophosphate have major impacts on cellular calcification. These data provide evidence for a possible harmful effect of the immunosuppressive drug 6-MP in vascular diseases, such as arteriosclerosis.	[Pruefer, Jasmin; Schuchardt, Mirjam; Toelle, Markus; Pruefer, Nicole; Zidek, Walter; van der Giet, Markus] Charite, Charite Ctr 13, Dept Nephrol, D-13353 Berlin, Germany; [Pruefer, Jasmin] Free Univ Berlin, Fachbereich Biochem, Berlin, Germany; [Pruefer, Nicole] Univ Potsdam, Dept Nutr Sci, Potsdam, Germany; [Hoehne, Matthias] Novartis Germany GmbH, Nurnberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; University of Potsdam	van der Giet, M (corresponding author), Charite, Charite Ctr 13, Dept Nephrol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	Markus.vanderGiet@charite.de	Schuchardt, Mirjam/AAS-3704-2021; Tölle, Markus/GPP-7157-2022	Schuchardt, Mirjam/0000-0001-7388-9611; van der Giet, Markus/0000-0003-3590-5451	Else Kroner-Fresenius-Stiftung; Sonnenfeld Stiftung; Peter and Traudl Engelhorn Stiftung	Else Kroner-Fresenius-Stiftung; Sonnenfeld Stiftung; Peter and Traudl Engelhorn Stiftung	This work was supported by grants from Else Kroner-Fresenius-Stiftung [M.vdG], Sonnenfeld Stiftung [J.P, M. S, M. T] and Peter and Traudl Engelhorn Stiftung [M. S]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnol M, 2008, TRANSPLANTATION, V86, P1844, DOI 10.1097/TP.0b013e31818ffec0; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Bottomley MJ, 2013, BRIT MED BULL, V106, P117, DOI 10.1093/bmb/ldt012; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; DeLoach SS, 2009, NEPHROL DIAL TRANSPL, V24, P1314, DOI 10.1093/ndt/gfn753; Deshpande AJ, 2010, MOL PATHOL LIB, P3, DOI 10.1007/978-1-4419-5698-9_1; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Gearry RB, 2005, J GASTROEN HEPATOL, V20, P1149, DOI 10.1111/j.1440-1746.2005.03832.x; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Haque S, 2010, J RHEUMATOL, V37, P322, DOI 10.3899/jrheum.090306; Jardine AG, 2011, LANCET, V378, P1419, DOI 10.1016/S0140-6736(11)61334-2; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Liberman M, 2008, ARTERIOSCL THROM VAS, V28, P463, DOI 10.1161/ATVBAHA.107.156745; Liefeldt L, 2010, TRANSPL INT, V23, P1191, DOI 10.1111/j.1432-2277.2010.01159.x; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Mardini HE, 2003, J CLIN GASTROENTEROL, V36, P390, DOI 10.1097/00004836-200305000-00005; Marechal C, 2012, AM J KIDNEY DIS, V59, P258, DOI 10.1053/j.ajkd.2011.07.019; McGrath LT, 1997, CLIN CHIM ACTA, V264, P1, DOI 10.1016/S0009-8981(97)00088-0; Miller LW, 2002, AM J TRANSPLANT, V2, P807, DOI 10.1034/j.1600-6143.2002.20902.x; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Mori K, 1999, ARTERIOSCL THROM VAS, V19, P2112, DOI 10.1161/01.ATV.19.9.2112; Nguyen PTH, 2010, NEPHROL DIAL TRANSPL, V25, P3773, DOI 10.1093/ndt/gfq268; O'Donovan P, 2005, SCIENCE, V309, P1871, DOI 10.1126/science.1114233; Pires NMM, 2007, CIRCULATION, V115, P493, DOI 10.1161/CIRCULATIONAHA.106.626838; Polifka JE, 2002, TERATOLOGY, V65, P240, DOI 10.1002/tera.10043; Pols TWH, 2010, ARTERIOSCL THROM VAS, V30, P1591, DOI 10.1161/ATVBAHA.110.205674; Roe P, 2010, ATHEROSCLEROSIS, V212, P589, DOI 10.1016/j.atherosclerosis.2010.05.016; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Schuchardt M, 2012, KIDNEY INT, V81, P256, DOI 10.1038/ki.2011.326; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; SHIOI A, 1995, ARTERIOSCL THROM VAS, V15, P2003, DOI 10.1161/01.ATV.15.11.2003; Solomon DH, 2006, ARTHRITIS RHEUM-US, V54, P3790, DOI 10.1002/art.22255; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Symmons DPM, 2011, NAT REV RHEUMATOL, V7, P399, DOI 10.1038/nrrheum.2011.75; Taverne YJHJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/862423; van den Dorpel MA, 1999, ARTERIOSCL THROM VAS, V19, P1555, DOI 10.1161/01.ATV.19.6.1555; vandenDorpel MA, 1997, KIDNEY INT, V51, P1608, DOI 10.1038/ki.1997.221; Vanrenterghem YFC, 2008, TRANSPLANTATION, V85, P209, DOI 10.1097/TP.0b013e318160254f; Wang AYM, 2003, J AM SOC NEPHROL, V14, P159, DOI 10.1097/01.ASN.0000038685.95946.83; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453	45	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101709	10.1371/journal.pone.0101709	http://dx.doi.org/10.1371/journal.pone.0101709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029363	Green Published, gold			2022-12-25	WOS:000341306600021
J	Rizwani, W; Schaal, C; Kunigal, S; Coppola, D; Chellappan, S				Rizwani, Wasia; Schaal, Courtney; Kunigal, Sateesh; Coppola, Domenico; Chellappan, Srikumar			Mammalian Lysine Histone Demethylase KDM2A Regulates E2F1-Mediated Gene Transcription in Breast Cancer Cells	PLOS ONE			English	Article							RETINOBLASTOMA PROTEIN; REPRESSES TRANSCRIPTION; MYOEPITHELIAL CELLS; GROWTH; RB; MECHANISM; E2F; PROLIFERATION; DEACETYLASE; TRANSITION	It is established that histone modifications like acetylation, methylation, phosphorylation and ubiquitination affect chromatin structure and modulate gene expression. Lysine methylation/demethylation on Histone H3 and H4 is known to affect transcription and is mediated by histone methyl transferases and histone demethylases. KDM2A/JHDM1A/FBXL11 is a JmjC-containing histone demethylase that targets mono-and dimethylated Lys36 residues of Histone H3; its function in breast cancer is not fully understood. Here we show that KDM2A is strongly expressed in myoepithelial cells (MEPC) in breast cancer tissues by immunohistochemistry. Ductal cells from ductal carcinoma in situ (DCIS) and infiltrating ductal carcinoma (IDC) show positive staining for KDM2A, the expression decreases with disease progression to metastasis. Since breast MEPCs have tumor-suppressive and anti-angiogenic properties, we hypothesized that KDM2A could be contributing to some of these functions. Silencing KDM2A with small interfering RNAs demonstrated increased invasion and migration of breast cancer cells by suppressing a subset of matrix metalloproteinases (MMP-2, -9, -14 and -15), as seen by real-time PCR. HUVEC cells showed increased angiogenic tubule formation ability in the absence of KDM2A, with a concomitant increase in the expression of VEGF receptors, FLT-1 and KDR. KDM2A physically bound to both Rb and E2F1 in a cell cycle dependent manner and repressed E2F1 transcriptional activity. Chromatin immunoprecipitation (ChIP) assays revealed that KDM2A associates with E2F1-regulated proliferative promoters CDC25A and TS in early G-phase and dissociates in S-phase. Further, KDM2A could also be detected on MMP9, 14 and 15 promoters, as well as promoters of FLT1 and KDR. KDM2A could suppress E2F1-mediated induction of these promoters in transient transfection experiments. These results suggest a regulatory role for KDM2A in breast cancer cell invasion and migration, through the regulation of E2F1 function.	[Rizwani, Wasia; Schaal, Courtney; Kunigal, Sateesh; Chellappan, Srikumar] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA; [Coppola, Domenico] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Anat Pathol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Chellappan, S (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA.	Srikumar.Chellappan@moffitt.org			NIH [CA77301]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA077301] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the grant CA77301 from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2007, CANCER RES, V67, P3286, DOI 10.1158/0008-5472.CAN-06-3831; Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Belotti D, 2003, CANCER RES, V63, P5224; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Chau CM, 2008, J VIROL, V82, P3428, DOI 10.1128/JVI.01412-07; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Dasgupta P, 2011, JNCI-J NATL CANCER I, V103, P317, DOI 10.1093/jnci/djq541; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Frescas D, 2008, CELL CYCLE, V7, P3539, DOI 10.4161/cc.7.22.7062; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; Hayami S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-59; Johnson JL, 2012, CANCER RES, V72, P516, DOI 10.1158/0008-5472.CAN-11-2647; Kato H, 2001, J CLIN MICROBIOL, V39, P1391, DOI 10.1128/JCM.39.4.1391-1395.2001; Liu QY, 2012, INORG CHEM, V51, P2381, DOI 10.1021/ic2023727; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Nguyen M, 2000, ONCOGENE, V19, P3449, DOI 10.1038/sj.onc.1203677; Nijwening JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025235; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Pandey PR, FRONT BIOSCI, V15, P226; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Pillai S, 2011, MOL CELL BIOL, V31, P3052, DOI 10.1128/MCB.01311-10; Pillai S, 2010, CANCER RES, V70, P4931, DOI 10.1158/0008-5472.CAN-10-0501; Pillai Smitha, 2009, V523, P323, DOI 10.1007/978-1-59745-190-1_22; Rastogi S, 2012, CELL DEATH DIFFER, V19, P274, DOI 10.1038/cdd.2011.93; Reed SI, 1997, CANCER SURV, V29, P7; Rizwani W, 2009, CELL CYCLE, V8, P1621, DOI 10.4161/cc.8.10.8578; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Ross JF, 1999, MOL CELL, V3, P195, DOI 10.1016/S1097-2765(00)80310-X; RUDLAND PS, 1987, CANCER METAST REV, V6, P55, DOI 10.1007/BF00047609; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Simpson PT, 2004, J PATHOL, V202, P274, DOI 10.1002/path.1530; Smith AE, 2009, GENOME RES, V19, P1325, DOI 10.1101/gr.085530.108; Strober BE, 1996, MOL CELL BIOL, V16, P1576; Tavassoli F, 1999, NORMAL DEV ANOMALIES, P1; Tavassoli FA, 2001, VIRCHOWS ARCH, V438, P221; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Wagner KW, 2013, J CLIN INVEST, V123, P5231, DOI 10.1172/JCI68642; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Zhang RR, 2003, BREAST CANCER RES, V5, pR151, DOI 10.1186/bcr635; Zhou JC, 2012, MOL CELL BIOL, V32, P479, DOI 10.1128/MCB.06332-11	47	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e100888	10.1371/journal.pone.0100888	http://dx.doi.org/10.1371/journal.pone.0100888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029110	gold, Green Published, Green Submitted			2022-12-25	WOS:000341306600010
J	Yang, CY; Wang, LL; Wang, JJ; Jiang, QF; Qiu, LM; Zhang, H; Song, LS				Yang, Chuanyan; Wang, Lingling; Wang, Jingjing; Jiang, Qiufen; Qiu, Limei; Zhang, Huan; Song, Linsheng			The Polymorphism in the Promoter of HSP70 Gene Is Associated with Heat Tolerance of Two Congener Endemic Bay Scallops (Argopecten irradians irradians and A. i. concentricus)	PLOS ONE			English	Article							SHOCK PROTEINS; INTERSPECIFIC VARIATION; CPG ODNS; EXPRESSION; THERMOTOLERANCE; STRESS; HEAT-SHOCK-PROTEIN-70; RESPONSES; EVOLUTIONARY; ARABIDOPSIS	Background: The heat shock protein 70 (HSP70) is one kind of molecular chaperones, which plays a key role in protein metabolism under normal and stress conditions. Methodology: In the present study, the mRNA expressions of HSP70 under normal physiological condition and after acute heat stress were investigated in gills of two bay scallop populations (Argopecten irradians irradians and A.i. concentricus). The heat resistant scallops A.i. concentricus showed significantly lower basal level and higher induction of HSP70 compared with that of the heat sensitive scallops A. i. irradians. The promoter sequence of HSP70 gene from bay scallop (AiHSP70) was cloned and the polymorphisms within this region were investigated to analyze their association with heat tolerance. Totally 11 single nucleotide polymorphisms (SNPs) were identified, and four of them (2967, 2480, 2408 and 283) were associated with heat tolerance after HWE analysis and association analysis. Based on the result of linkage disequilibrium analysis, the in vitro transcriptional activities of AiHSP70 promoters with different genotype were further determined, and the results showed that promoter from A. i. concentricus exhibited higher transcriptional activity than that from A. i. irradians (P < 0.05). Conclusions: The results provided insights into the molecular mechanisms underlying the thermal adaptation of different congener endemic bay scallops, which suggested that the increased heat tolerance of A. i. concentricus (compared with A. i. irradians) was associated with the higher expression of AiHSP70. Meanwhile, the 2967 GG, 2480 AA, 2408 TT and 283 AG genotypes could be potential markers for scallop selection breeding with higher heat tolerance.	[Yang, Chuanyan; Wang, Lingling; Wang, Jingjing; Jiang, Qiufen; Qiu, Limei; Zhang, Huan; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Jiang, Qiufen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Jingjing] Qingdao Agr Univ, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao Agricultural University	Wang, LL (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn			National Basic Research Program of China (973 Program) from the Chinese Ministry of Science and Technology [2010CB126404]; National Science Foundation of China [JQ201110]; Shandong Provincial Natural Science Foundation	National Basic Research Program of China (973 Program) from the Chinese Ministry of Science and Technology(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This research was supported by National Basic Research Program of China (973 Program, No. 2010CB126404) from the Chinese Ministry of Science and Technology, and grants (JQ201110) from National Science Foundation of China and Shandong Provincial Natural Science Foundation, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; Basirico L, 2011, CELL STRESS CHAPERON, V16, P441, DOI 10.1007/s12192-011-0257-7; Bedulina DS, 2013, MOL ECOL, V22, P1416, DOI 10.1111/mec.12136; Cellura C, 2006, DEV COMP IMMUNOL, V30, P984, DOI 10.1016/j.dci.2005.12.009; Dahlgaard J, 1998, FUNCT ECOL, V12, P786, DOI 10.1046/j.1365-2435.1998.00246.x; De Maio A, 2014, CURR PROTEIN PEPT SC, V15, P225, DOI 10.2174/1389203715666140331113057; Deb R, 2013, GENE, V532, P230, DOI 10.1016/j.gene.2013.09.037; Dong YW, 2008, BIOL BULL-US, V215, P173, DOI 10.2307/25470698; Evgen'ev MB, 2007, J BIOSCIENCES, V32, P489, DOI 10.1007/s12038-007-0048-6; Evgen'ev MB, 2004, CHROMOSOMA, V113, P223, DOI 10.1007/s00412-004-0312-6; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Garbuz D, 2003, J EXP BIOL, V206, P2399, DOI 10.1242/jeb.00429; Garbuz DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-74; Hofmann GE, 1996, MAR BIOL, V126, P65, DOI 10.1007/BF00571378; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; Lee JH, 1996, MOL GEN GENET, V252, P11, DOI 10.1007/BF02173200; Li L, 2009, FISH SHELLFISH IMMUN, V27, P136, DOI 10.1016/j.fsi.2008.12.005; Liu Xiao, 2006, Oceanologia et Limnologia Sinica, V37, P61; Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094; Lu J, 2009, FASEB J, V23, P3459, DOI 10.1096/fj.09-136549; Mizrahi T, 2012, CELL STRESS CHAPERON, V17, P523, DOI 10.1007/s12192-012-0341-7; Oda S, 2010, ZOOL SCI, V27, P410, DOI 10.2108/zsj.27.410; Park H, 2007, CELL STRESS CHAPERON, V12, P275, DOI 10.1379/CSC-271.1; Qu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089040; Schaid DJ, 1999, AM J EPIDEMIOL, V149, P706; Schwerin M, 2001, BBA-GENE STRUCT EXPR, V1522, P108, DOI 10.1016/S0167-4781(01)00313-X; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Singh R, 2006, CELL STRESS CHAPERON, V11, P208, DOI 10.1379/CSC-184R.1; Song LS, 2006, FISH SHELLFISH IMMUN, V21, P335, DOI 10.1016/j.fsi.2005.12.011; Sun R, 2014, DEV COMP IMMUNOL, V43, P15, DOI 10.1016/j.dci.2013.10.005; Sung DY, 2003, PLANT PHYSIOL, V132, P979, DOI 10.1104/pp.102.019398; Taldone T, 2014, EXPERT OPIN THER PAT, V24, P501, DOI 10.1517/13543776.2014.887681; Tanguy A, 2001, GENE, V273, P123, DOI 10.1016/S0378-1119(01)00577-7; Tomanek L, 1999, J EXP BIOL, V202, P2925; Wang L, 2013, ISJ-INVERT SURVIV J, V10, P77; Xiong Q, 2013, CELL STRESS CHAPERON, V18, P711, DOI 10.1007/s12192-013-0421-3; Yang CY, 2013, GENE, V526, P429, DOI 10.1016/j.gene.2013.05.033; Yang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032012; Yang YN, 2013, CELL STRESS CHAPERON, V18, P475, DOI 10.1007/s12192-013-0402-6; Zatsepina OG, 2000, J EXP BIOL, V203, P1017; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang F., 1999, MAR SCI-CHINA, V1, P47; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang LL, 2014, FISH PHYSIOL BIOCHEM, V40, P221, DOI 10.1007/s10695-013-9838-y; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P418, DOI 10.1016/j.dci.2009.11.012; Zhou YJ, 2014, CANCER IMMUNOL RES, V2, P217, DOI 10.1158/2326-6066.CIR-13-0132	46	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102332	10.1371/journal.pone.0102332	http://dx.doi.org/10.1371/journal.pone.0102332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028964	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600065
J	Fang, WF; Douglas, IS; Wang, CC; Kao, HC; Chang, YT; Tseng, CC; Huang, KT; Chang, HC; Lin, MC				Fang, Wen-Feng; Douglas, Ivor S.; Wang, Chin-Chou; Kao, Hsu-Ching; Chang, Ya-Ting; Tseng, Chia-Cheng; Huang, Kuo-Tung; Chang, Huang-Chih; Lin, Meng-Chih			5-Lipoxygenase Activating Protein (FLAP) Dependent Leukotriene Biosynthesis Inhibition (MK591) Attenuates Lipid A Endotoxin-Induced Inflammation	PLOS ONE			English	Article							ACUTE LUNG INJURY; SEPTIC SHOCK; SEPSIS; MICE; LIPOPOLYSACCHARIDE; MECHANISMS; RECEPTORS; PATHWAY; TLR4; GENE	The Lipid A moiety of endotoxin potently activates TLR-4 dependent host innate immune responses. We demonstrate that Lipid-A mediated leukotriene biosynthesis regulates pathogen-associated molecular patterns (PAMP)-dependent macrophage activation. Stimulation of murine macrophages (RAW264.7) with E. coli 0111:B4 endotoxin (LPS) or Kdo2-lipid A (Lipid A) induced inflammation and Lipid A was sufficient to induce TLR-4 mediated macrophage inflammation and rapid ERK activation. The contribution of leukotriene biosynthesis was evaluated with a 5-lipoxygenase activating protein (FLAP) inhibitor, MK591. MK591 pre-treatment not only enhanced but also sustained ERK activation for up to 4 hours after LPS and Lipid A stimulation while inhibiting cell proliferation and enhancing cellular apoptosis. Leukotriene biosynthesis inhibition attenuated inflammation induced by either whole LPS or the Lipid A fraction. These responses were regulated by inhibition of the key biosynthesis enzymes for the proinflammatory eicosanoids, 5-lipoxygenase (5-LO), and cyclooxygenase-2 (COX-2) quantified by immunoblotting. Inhibition of leukotriene biosynthesis differentially regulated TLR-2 and TLR-4 cell surface expression assessed by flow cytometry, suggesting a close mechanistic association between TLR expression and 5-LO associated eicosanoid activity in activated macrophages. Furthermore, MK591 pre-treatment enhanced ERK activation and inhibited cell proliferation after LPS or Lipid A stimulation. These effects were regulated in part by increased apoptosis and modulation of cell surface TLR expression. Together, these data clarify the mechanistic association between 5-lipoxygenase activating protein-mediated leukotriene biosynthesis and 5-LO dependent eicosanoid metabolites in mediating the TLR-dependent inflammatory response after endotoxin exposure typical of bacterial sepsis.	[Fang, Wen-Feng; Wang, Chin-Chou; Kao, Hsu-Ching; Chang, Ya-Ting; Tseng, Chia-Cheng; Huang, Kuo-Tung; Chang, Huang-Chih; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Div Pulm & Crit Care Med, Dept Internal Med,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Fang, Wen-Feng; Wang, Chin-Chou; Lin, Meng-Chih] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi, Taiwan; [Douglas, Ivor S.] Univ Colorado, Div Pulm Sci & Crit Care Med, Denver, CO 80202 USA; [Douglas, Ivor S.] Denver Hlth Med Ctr, Denver, CO USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; University of Colorado System; University of Colorado Denver; Denver Health Medical Center	Fang, WF (corresponding author), Chang Gung Univ, Coll Med, Div Pulm & Crit Care Med, Dept Internal Med,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan.	wenfengfang@yahoo.com.tw; idouglas@dhha.org; mengchih@adm.cgmh.org.tw	Fang, Wen-Feng/AAT-6296-2021; Douglas, Ivor S/AAC-6245-2021	Fang, Wen-Feng/0000-0003-0350-9059; Douglas, Ivor S/0000-0002-4541-1431	Taiwan National Science Council Grant [NSC 97-2314-B-182A-082-, NSC 101-2314-B-182A-094-]; MSD IISP (Investigator-Initiated Study Program) [37346]; Chang Gung Memorial Hospital Grant [CMRPG890661, CMRPG890662, CMRPG8C0551]	Taiwan National Science Council Grant; MSD IISP (Investigator-Initiated Study Program); Chang Gung Memorial Hospital Grant(Chang Gung Memorial Hospital)	The work was supported in part by Taiwan National Science Council Grant (NSC 97-2314-B-182A-082-, NSC 101-2314-B-182A-094-), MSD IISP (Investigator-Initiated Study Program #37346), and Chang Gung Memorial Hospital Grant (CMRPG890661, CMRPG890662, CMRPG8C0551) to Wen-Feng Fang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Caironi P, 2005, AM J RESP CRIT CARE, V172, P334, DOI 10.1164/rccm.200501-034OC; David MD, 2005, J IMMUNOL, V175, P8236, DOI 10.4049/jimmunol.175.12.8236; Eun JC, 2011, SHOCK, V35, P240, DOI 10.1097/SHK.0b013e3181faceb3; Fang W, 2008, AM J RESP CRIT CARE, V177, pA282; Fang WF, 2007, AM J PHYSIOL-LUNG C, V293, pL336, DOI 10.1152/ajplung.00011.2007; Gao HM, 2008, SEMIN IMMUNOPATHOL, V30, P29, DOI 10.1007/s00281-007-0101-4; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jeyaseelan S, 2005, INFECT IMMUN, V73, P1754, DOI 10.1128/IAI.73.3.1754-1763.2005; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; Mendis C, 2008, FEBS J, V275, P3088, DOI 10.1111/j.1742-4658.2008.06462.x; Monteiro APT, 2014, AM J RESP CELL MOL, V50, P87, DOI 10.1165/rcmb.2012-0525OC; Nduka OO, 2009, CRIT CARE CLIN, V25, P677, DOI 10.1016/j.ccc.2009.08.002; Park MS, 2012, AM J RESP CRIT CARE, V186, P72, DOI 10.1164/rccm.201109-1593OC; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Petersen B, 2011, ANESTHESIOLOGY, V115, P804, DOI 10.1097/ALN.0b013e31822e94bd; Phua J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3245; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; RIETSCHEL ET, 1973, INFECT IMMUN, V8, P173, DOI 10.1128/IAI.8.2.173-177.1973; Spiller S, 2008, J EXP MED, V205, P1747, DOI 10.1084/jem.20071990; Wu TT, 2009, TOXICOL LETT, V191, P195, DOI 10.1016/j.toxlet.2009.08.025; Zhang Wei, 2004, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V16, P622	27	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102622	10.1371/journal.pone.0102622	http://dx.doi.org/10.1371/journal.pone.0102622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025775	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400095
J	Kamtchueng, C; Stebenne, ME; Delannoy, A; Wilhelm, E; Leger, H; Benecke, AG; Bell, B				Kamtchueng, Catherine; Stebenne, Marie-Eve; Delannoy, Aurelie; Wilhelm, Emmanuelle; Leger, Helene; Benecke, Arndt G.; Bell, Brendan			Alternative Splicing of TAF6: Downstream Transcriptome Impacts and Upstream RNA Splice Control Elements	PLOS ONE			English	Article							PRE-MESSENGER-RNA; GENE-EXPRESSION ANALYSIS; SECONDARY STRUCTURE; IN-VIVO; IDENTIFICATION; APOPTOSIS; COMPLEX; CANCER; PROGRESSION; PROTEINS	The TAF6 delta pathway of apoptosis can dictate life versus death decisions independently of the status of p53 tumor suppressor. TAF6 delta is an inducible pro-apoptotic subunit of the general RNA polymerase II (Pol II) transcription factor TFIID. Alternative splice site choice of TAF6 delta has been shown to be a pivotal event in triggering death via the TAF6 delta pathway, yet nothing is currently known about the mechanisms that promote TAF6 delta splicing. Furthermore the transcriptome impact of the gain of function of TAF6 delta versus the loss of function of the major TAF6 alpha splice form remains undefined. Here we employ comparative microarray analysis to show that TAF6 delta drives a transcriptome profile distinct from that resulting from depletion of TAF6 alpha. To define the cis-acting RNA elements responsible for TAF6 delta alternative splicing we performed a mutational analysis of a TAF6 minigene system. The data point to several new RNA elements that can modulate TAF6 delta and also reveal a role for RNA secondary structure in the selection of TAF6 delta.	[Kamtchueng, Catherine; Stebenne, Marie-Eve; Delannoy, Aurelie; Wilhelm, Emmanuelle; Bell, Brendan] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA Grp, Sherbrooke, PQ J1K 2R1, Canada; [Kamtchueng, Catherine; Stebenne, Marie-Eve; Delannoy, Aurelie; Wilhelm, Emmanuelle; Bell, Brendan] CHUS, Ctr Rech, Sherbrooke, PQ, Canada; [Leger, Helene; Benecke, Arndt G.] CNRS, Inst Hautes Etud Sci, Bures Sur Yvette, France; [Benecke, Arndt G.] Univ Paris 06, CNRS, UMR8246, Paris, France	University of Sherbrooke; University of Sherbrooke; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Bell, B (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA Grp, Pavillon Rech Appl Canc,3201 Rue Jean Migneault, Sherbrooke, PQ J1K 2R1, Canada.	Brendan.Bell@USherbrooke.ca	Léger, Hélène/AAX-5076-2020; Benecke, Arndt G./T-1079-2019	Leger, Helene/0000-0003-1116-8637	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the award of a NSERC Discover Grant to B. Bell. The funding agency website is http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Aoyagi N, 2001, MOL CELL BIOL, V21, P6808, DOI 10.1128/MCB.21.20.6808-6819.2001; Aviel-Ronen S, 2008, P NATL ACAD SCI USA, V105, P10155, DOI 10.1073/pnas.0709618105; Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Bieniossek C., 2013, NATURE; Brysbaert Guillaume, 2010, Genomics Proteomics & Bioinformatics, V8, P57, DOI 10.1016/S1672-0229(10)60006-X; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Campbell JM, 2008, GENOME, V51, P1032, DOI 10.1139/G08-086; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; Dressman HK, 2006, CLIN CANCER RES, V12, P819, DOI 10.1158/1078-0432.CCR-05-1447; Expert-Bezancon A, 2002, J BIOL CHEM, V277, P16614, DOI 10.1074/jbc.M201083200; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; Jin YF, 2011, RNA BIOL, V8, P450, DOI 10.4161/rna.8.3.15388; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; McManus CJ, 2011, CURR OPIN GENET DEV, V21, P373, DOI 10.1016/j.gde.2011.04.001; Michel B, 1998, MOL CELL, V2, P663, DOI 10.1016/S1097-2765(00)80164-1; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Noth S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-307; Noth Sebastian, 2006, Genomics Proteomics & Bioinformatics, V4, P90, DOI 10.1016/S1672-0229(06)60021-1; Noth Sebastian, 2006, Genomics Proteomics & Bioinformatics, V4, P212, DOI 10.1016/S1672-0229(07)60002-3; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; POON D, 1995, P NATL ACAD SCI USA, V92, P8224, DOI 10.1073/pnas.92.18.8224; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; Rasmussen AL, 2012, HEPATOLOGY, V56, P17, DOI 10.1002/hep.25612; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; Roca X, 2013, GENE DEV, V27, P129, DOI 10.1101/gad.209759.112; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Tchitchek Nicolas, 2012, Genomics Proteomics & Bioinformatics, V10, P127, DOI 10.1016/j.gpb.2012.06.002; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang W, 2004, MOL CANCER RES, V2, P442; Warf MB, 2010, TRENDS BIOCHEM SCI, V35, P169, DOI 10.1016/j.tibs.2009.10.004; Watson J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120144; Wilhelm E, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-10; Wilhelm Emmanuelle, 2008, BMC Res Notes, V1, P94, DOI 10.1186/1756-0500-1-94; Wilhelm E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002721; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; YANG XM, 1994, P NATL ACAD SCI USA, V91, P6924, DOI 10.1073/pnas.91.15.6924; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	55	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102399	10.1371/journal.pone.0102399	http://dx.doi.org/10.1371/journal.pone.0102399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025302	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400070
J	McClure, DL; Kieke, BA; Sundaram, ME; Simpson, MD; Meece, JK; Sifakis, F; Gasser, RA; Belongia, EA				McClure, David L.; Kieke, Burney A.; Sundaram, Maria E.; Simpson, Melissa D.; Meece, Jennifer K.; Sifakis, Frangiscos; Gasser, Robert A., Jr.; Belongia, Edward A.			Seasonal Incidence of Medically Attended Respiratory Syncytial Virus Infection in a Community Cohort of Adults >= 50 Years Old	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; INFLUENZA VACCINES; RISK-FACTORS; OUTCOMES; ILLNESS	Background: Diagnostic testing for respiratory syncytial virus (RSV) is not routinely performed in adults. We estimated medically attended RSV seasonal incidence in a community cohort of adults >= 50 years old during four influenza seasons (2006-07 through 2009-10). Methods: Patients seeking care for acute respiratory illness (ARI) were prospectively enrolled and tested for RSV by multiplex RT-PCR. Results from enrolled patients were used to estimate projected cases among non-enrolled patients with ARI. The seasonal incidence of medically attended RSV was the sum of actual and projected cases divided by the community cohort denominator. Since each enrollment period did not include the entire RSV season, incidence estimates were adjusted to account for the statewide proportion of RSV occurring outside the study enrollment period. Results: There were 16,088 to 17,694 adults in the cohort each season and 164 RSV cases in all 4 seasons. The overall seasonal incidence of medically attended RSV was 154 episodes (95% CI, 132-180) per 10,000 persons; the incidence was highest in 2007-08 (179) and lowest in 2006-07 (110). Among persons 50-59, 60-69, and >= 70 years old, RSV incidence was 124 (95% CI, 99-156), 147 (95% CI, 110-196), and 199 (95% CI, 153-258), respectively. Conclusions: The incidence of medically attended RSV increased with age and was similar during four seasons.	[McClure, David L.; Kieke, Burney A.; Sundaram, Maria E.; Simpson, Melissa D.; Meece, Jennifer K.; Belongia, Edward A.] Marshfield Clin Res Fdn, Marshfield, WI 54449 USA; [Sifakis, Frangiscos; Gasser, Robert A., Jr.] MedImmune LLC, Gaithersburg, MD USA	AstraZeneca; Medimmune	McClure, DL (corresponding author), Marshfield Clin Res Fdn, Marshfield, WI 54449 USA.	Mcclure.david@marshfieldclinic.org	Sundaram, Maria/W-2575-2019	Sundaram, Maria/0000-0001-8056-3302; Belongia, Edward/0000-0001-7478-0415	MedImmune LLC.	MedImmune LLC.(AstraZenecaMedimmune)	Funding for this research was provided by MedImmune LLC. The funders had no role in study design, data collection and analysis, or decision to publish. They had a coauthor role in preparation of the manuscript.	Belongia EA, 2011, VACCINE, V29, P6558, DOI 10.1016/j.vaccine.2011.07.002; Belongia EA, 2010, JAMA-J AM MED ASSOC, V304, P1091, DOI 10.1001/jama.2010.1277; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Duncan CB, 2009, J INFECT DIS, V200, P1242, DOI 10.1086/605948; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fleming DM, 2007, EPIDEMIOL INFECT, V135, P1099, DOI 10.1017/S0950268807007881; Fry AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015098; Greenlee Robert T, 2003, Clin Med Res, V1, P273; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Pierce VM, 2012, J CLIN MICROBIOL, V50, P3458, DOI 10.1128/JCM.01384-12; Sirri L, 2013, PSYCHOTHER PSYCHOSOM, V82, P74, DOI 10.1159/000343508; Sundaram ME, 2014, CLIN INFECT DIS, V58, P342, DOI 10.1093/cid/cit767; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574; Walsh EE, 2013, J INFECT DIS, V207, P1424, DOI 10.1093/infdis/jit038; Walsh EE, 2004, J INFECT DIS, V189, P233, DOI 10.1086/380907; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Yu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032174; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	22	45	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102586	10.1371/journal.pone.0102586	http://dx.doi.org/10.1371/journal.pone.0102586			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025344	gold, Green Submitted, Green Published			2022-12-25	WOS:000339992400092
J	Sato, D; Yamashiro, K; Onishi, H; Baba, Y; Nakazawa, S; Shimoyama, Y; Maruyama, A				Sato, Daisuke; Yamashiro, Koya; Onishi, Hideaki; Baba, Yasuhiro; Nakazawa, Sho; Shimoyama, Yoshimitsu; Maruyama, Atsuo			Whole-Body Water Flow Stimulation to the Lower Limbs Modulates Excitability of Primary Motor Cortical Regions Innervating the Hands: A Transcranial Magnetic Stimulation Study	PLOS ONE			English	Article							CORTEX EXCITABILITY; ELECTRICAL-STIMULATION; CORTICOCORTICAL INHIBITION; CUTANEOMOTOR INTEGRATION; INTRINSIC CONNECTIONS; SOMATOSENSORY INPUT; EVOKED POTENTIALS; HUMANS; PLASTICITY; FACILITATION	Whole-body water immersion (WI) has been reported to change sensorimotor integration. However, primary motor cortical excitability is not affected by low-intensity afferent input. Here we explored the effects of whole-body WI and water flow stimulation (WF) on corticospinal excitability and intracortical circuits. Eight healthy subjects participated in this study. We measured the amplitude of motor-evoked potentials (MEPs) produced by single transcranial magnetic stimulation (TMS) pulses and examined conditioned MEP amplitudes by paired-pulse TMS. We evaluated short-interval intracortical inhibition (SICI) and intracortical facilitation (ICF) using the paired-TMS technique before and after 15-min intervention periods. Two interventions used were whole-body WI with water flow to the lower limbs (whole-body WF) and whole-body WI without water flow to the lower limbs (whole-body WI). The experimental sequence included a baseline TMS assessment (T0), intervention for 15 min, a second TMS assessment immediately after intervention (T1), a 10 min resting period, a third TMS assessment (T2), a 10 min resting period, a fourth TMS assessment (T3), a 10 min resting period, and the final TMS assessment (T4). SICI and ICF were evaluated using a conditioning stimulus of 90% active motor threshold and a test stimulus adjusted to produce MEPs of approximately 1-1.2 mV, and were tested at intrastimulus intervals of 3 and 10 ms, respectively. Whole-body WF significantly increased MEP amplitude by single-pulse TMS and led to a decrease in SICI in the contralateral motor cortex at T1, T2 and T3. Whole-body WF also induced increased corticospinal excitability and decreased SICI. In contrast, whole-body WI did not change corticospinal excitability or intracortical circuits.	[Sato, Daisuke; Yamashiro, Koya; Onishi, Hideaki; Maruyama, Atsuo] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan; [Sato, Daisuke; Yamashiro, Koya; Baba, Yasuhiro; Nakazawa, Sho; Shimoyama, Yoshimitsu; Maruyama, Atsuo] Niigata Univ Hlth & Welf, Dept Hlth & Sports, Niigata, Japan; [Onishi, Hideaki] Niigata Univ Hlth & Welf, Dept Phys Therapy, Niigata, Japan	Niigata University; Niigata University; Niigata University	Sato, D (corresponding author), Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan.	daisuke@nuhw.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Niigata University of Health and Welfare	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Niigata University of Health and Welfare	This study was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. It was also supported by a Grant-in-Aid for Advanced Research from the Niigata University of Health and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANUMA H, 1973, EXP BRAIN RES, V16, P507, DOI 10.1007/BF00234477; Bertolasi L, 1998, J PHYSIOL-LONDON, V511, P947, DOI 10.1111/j.1469-7793.1998.947bg.x; Bressel E, 2011, MED SCI SPORTS EXERC; Chen R, 1999, EXP BRAIN RES, V129, P77, DOI 10.1007/s002210050938; Chipchase LS, 2011, CLIN NEUROPHYSIOL, V122, P456, DOI 10.1016/j.clinph.2010.07.025; Christova M, 2011, EUR J APPL PHYSIOL, V111, P3051, DOI 10.1007/s00421-011-1933-0; Classen J, 2000, EXP BRAIN RES, V130, P48, DOI 10.1007/s002210050005; DENOORDHOUT AM, 1992, J PHYSIOL-LONDON, V447, P535, DOI 10.1113/jphysiol.1992.sp019016; DEUSCHL G, 1991, EXP BRAIN RES, V83, P403; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; GATTER KC, 1978, BRAIN, V101, P513, DOI 10.1093/brain/101.3.513; Golaszewski SM, 2012, CLIN NEUROPHYSIOL, V123, P193, DOI 10.1016/j.clinph.2011.06.010; Golaszewski SM, 2010, CLIN NEUROPHYSIOL, V121, P248, DOI 10.1016/j.clinph.2009.09.024; Hallett M, 1999, EEG CL N SU, V50, P85; Hanajima R, 1998, J PHYSIOL-LONDON, V509, P607, DOI 10.1111/j.1469-7793.1998.607bn.x; HESS G, 1994, J NEUROPHYSIOL, V71, P2543, DOI 10.1152/jn.1994.71.6.2543; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; Ilic TV, 2002, NEUROSCI LETT, V319, P116, DOI 10.1016/S0304-3940(01)02563-0; JONES EG, 1993, CEREB CORTEX, V3, P361, DOI 10.1093/cercor/3.5.361-a; JONES EG, 1980, BRAIN RES REV, V2, P1, DOI 10.1016/0165-0173(80)90002-8; Kaelin-Lang A, 2002, J PHYSIOL-LONDON, V540, P623, DOI 10.1113/jphysiol.2001.012801; KELLER A, 1993, CEREB CORTEX, V3, P430, DOI 10.1093/cercor/3.5.430; Koch G, 2009, J PHYSIOL-LONDON, V587, P4281, DOI 10.1113/jphysiol.2009.174086; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Liepert J, 1997, J NEURAL TRANSM, V104, P1207, DOI 10.1007/BF01294721; Man IOW, 2003, MED SCI SPORT EXER, V35, P630, DOI 10.1249/01.MSS.0000058432.29149.08; Mileva KN, 2009, EXP PHYSIOL, V94, P103, DOI 10.1113/expphysiol.2008.042689; Naito E, 2007, EUR J NEUROSCI, V25, P3476, DOI 10.1111/j.1460-9568.2007.05587.x; Perini R, 2003, EUR J APPL PHYSIOL, V90, P317, DOI 10.1007/s00421-003-0953-9; Ridding MC, 2001, J PHYSIOL-LONDON, V537, P623, DOI 10.1111/j.1469-7793.2001.00623.x; RIDDING MC, 1995, J PHYSIOL-LONDON, V487, P541, DOI 10.1113/jphysiol.1995.sp020898; Rocco MM, 2007, J NEUROSCI METH, V162, P139, DOI 10.1016/j.jneumeth.2007.01.002; Rosenkranz K, 2003, J PHYSIOL-LONDON, V551, P649, DOI 10.1113/jphysiol.2003.043752; Rossini PM, 1996, MUSCLE NERVE, V19, P1302; Sato D, 2013, CLIN NEUROPHYSIOL; Sato D, 2012, BRAIN TOPOGR, V25, P220, DOI 10.1007/s10548-011-0204-z; Sato D, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-13; Takahashi K, 2011, BRAIN STIMUL, V4, P90, DOI 10.1016/j.brs.2010.07.001; Tamburin S, 2001, EXP BRAIN RES, V141, P232, DOI 10.1007/s002210100859; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; White E.L., 1989, CORTICAL CIRCUITS SY; Wilcock IM, 2006, SPORTS MED, V36, P747, DOI 10.2165/00007256-200636090-00003; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; Ziemann U, 2002, CLIN NEUROPHYSIOL, V113, P1308, DOI 10.1016/S1388-2457(02)00171-2; Ziemann U, 1996, EXP BRAIN RES, V109, P127	46	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102472	10.1371/journal.pone.0102472	http://dx.doi.org/10.1371/journal.pone.0102472			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025129	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400077
J	Testa, ML; Chojniak, R; Sene, LS; Damascena, AS; Guimaraes, MD; Szklaruk, J; Marchiori, E				Testa, Maria Luiza; Chojniak, Rubens; Sene, Leticia Silva; Damascena, Aline Santos; Guimaraes, Marcos Duarte; Szklaruk, Janio; Marchiori, Edson			Is DWI/ADC a Useful Tool in the Characterization of Focal Hepatic Lesions Suspected of Malignancy?	PLOS ONE			English	Article							LIVER-LESIONS; METASTASIS; DIAGNOSIS; MRI	Objective: Apparent diffusion coefficient (ADC) values calculated through magnetic resonance imaging have been proposed as a useful tool to distinguish benign from malignant liver lesions. Most studies however included simple cysts in their analysis. Liver cysts are easy to diagnose, have very high ADC values and their inclusion facilitates differentiation in the ADC values between benign and malignant liver lesions groups. We prospectively evaluated the ability of ADC values to differentiate metastatic liver lesions from all benign or only solid benign liver lesions. Material and Methods: Sixty-seven adult cancer patients with 188 liver lesions were evaluated. Lesions were categorized as metastatic or benign throughout imaging and clinical evaluation. One hundred and five (105) metastatic lesions and 83 benign lesions including hemangiomas (37), cysts (42), adenomas (2) and focal nodular hyperplasias (2) were evaluated. ADC values were calculated for each lesion utilizing two b values (0 and 600 sec/mm(2)). Results: The average ADC value for cysts was 2.4x10(-3) mm(2)/sec (CI: 2.1-2.6), for solid benign lesions was 1.4x10(-3) mm(2)/sec (CI: 1.1-1.7) and for metastases was 1.0x10(-3) mm(2)/sec (CI: 0.8-1.3). There was a difference between the ADC values of metastases and benign solid lesions (p<0.0001). With the ADC value of 1.5x10(-3) mm(2)/sec as a cut off it is possible to distinguish metastatic from benign liver lesions, including cysts, with an accuracy of 78%. But to distinguish metastatic from benign solid liver lesions the best ADC cut off value was 1.2x10(-3) mm(2)/sec and the accuracy drops to 71%. Conclusions: ADC values proved to be helpful in the distinction between metastasis and benign solid hepatic lesions. But the exclusion of cysts in the analysis point out to a lower cut off value and lower accuracy than previously reported.	[Testa, Maria Luiza; Chojniak, Rubens; Sene, Leticia Silva; Guimaraes, Marcos Duarte] AC Camargo Canc Ctr, Dept Diagnost Radiol, Sao Paulo, Brazil; [Damascena, Aline Santos] AC Camargo Canc Ctr, CIPE Int Ctr Res, Sao Paulo, Brazil; [Szklaruk, Janio] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA; [Marchiori, Edson] Univ Fed Rio de Janeiro, Dept Radiol, Rio De Janeiro, Brazil	A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Universidade Federal do Rio de Janeiro	Chojniak, R (corresponding author), AC Camargo Canc Ctr, Dept Diagnost Radiol, Sao Paulo, Brazil.	chojniak@uol.com.br	Guimaraes, Marcos/N-8412-2013; Chojniak, Rubens/L-3770-2013; Marchiori, Edson/C-1205-2013	Guimaraes, Marcos/0000-0002-4662-5845; Chojniak, Rubens/0000-0002-8096-252X; Marchiori, Edson/0000-0001-8797-7380				Bruegel M, 2008, AM J ROENTGENOL, V191, P1421, DOI 10.2214/AJR.07.3279; Bruegel M, 2008, EUR RADIOL, V18, P477, DOI 10.1007/s00330-007-0785-9; Coenegrachts K, 2007, BRIT J RADIOL, V80, P524, DOI 10.1259/bjr/33156643; Estorch Montserrat, 2013, Recent Results Cancer Res, V187, P403, DOI 10.1007/978-3-642-10853-2_14; Figueras J, 2009, CIR ESPAN, V85, P325, DOI 10.1016/j.ciresp.2008.09.014; Fowler KJ, 2011, HEPATOLOGY, V54, P2227, DOI 10.1002/hep.24679; Galea N, 2013, J MAGN RESON IMAGING, V37, P1260, DOI 10.1002/jmri.23947; Goel A K, 1994, Trop Gastroenterol, V15, P37; Holzapfel K, 2012, ABDOM IMAGING, V37, P74, DOI 10.1007/s00261-011-9758-1; Kele PG, 2010, WORLD J GASTROENTERO, V16, P1567, DOI 10.3748/wjg.v16.i13.1567; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Neter J, 2004, APPL LINEAR STAT MOD, P1030; Parikh T, 2008, RADIOLOGY, V246, P812, DOI 10.1148/radiol.2463070432; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P133, DOI DOI 10.1007/0-387-22747-4_4; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P57, DOI [DOI 10.1198/JASA.2001.S411, 10.1007/0- 387-22747-4]; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Taouli B, 2010, RADIOLOGY, V254, P47, DOI 10.1148/radiol.09090021; Taouli B, 2009, J MAGN RESON IMAGING, V30, P561, DOI 10.1002/jmri.21876; Xu JM, 2011, J CANCER RES CLIN, V137, P1379, DOI 10.1007/s00432-011-0999-8	19	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101944	10.1371/journal.pone.0101944	http://dx.doi.org/10.1371/journal.pone.0101944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025151	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400027
J	Vanderlinde, EM; Zhong, S; Li, G; Martynowski, D; Grochulski, P; Howard, SP				Vanderlinde, Elizabeth M.; Zhong, Su; Li, Gang; Martynowski, Dariusz; Grochulski, Pawel; Howard, S. Peter			Assembly of the Type Two Secretion System in Aeromonas hydrophila Involves Direct Interaction between the Periplasmic Domains of the Assembly Factor ExeB and the Secretin ExeD	PLOS ONE			English	Article							II SECRETION; PROTEIN SECRETION; COMPLEX-FORMATION; MEMBRANE-PROTEIN; OUTER-MEMBRANE; MACHINERY; PEPTIDOGLYCAN; MUTAGENESIS; TRANSPORT; INSIGHTS	The type two secretion system is a large, trans-envelope apparatus that secretes toxins across the outer membrane of many Gram-negative bacteria. In Aeromonas hydrophila, ExeA interacts with peptidoglycan and forms a heteromultimeric complex with ExeB that is required for assembly of the ExeD secretin of the secretion system in the outer membrane. While the peptidoglycan-ExeAB (PG-AB) complex is required for ExeD assembly, the assembly mechanism remains unresolved. We analyzed protein-protein interactions to address the hypothesis that ExeD assembly in the outer membrane requires direct interaction with the PG-AB complex. Yeast and bacterial two hybrid analyses demonstrated an interaction between the periplasmic domains of ExeB and ExeD. Two-codon insertion mutagenesis of exeD disrupted lipase secretion, and immunoblotting of whole cells demonstrated significantly reduced secretin in mutant cells. Mapping of the two-codon insertions and deletion analysis showed that the ExeB-ExeD interaction involves the N0 and N1 subdomains of ExeD. Rotational anisotropy using the purified periplasmic domains of ExeB and ExeD determined that the apparent dissociation constant of the interaction is 1.19+/-0.16 mu M. These results contribute important support for a putative mechanism by which the PG-AB complex facilitates assembly of ExeD through direct interaction between ExeB and ExeD. Furthermore, our results provide novel insight into the assembly function of ExeB that may contribute to elucidating the role of homologous proteins in secretion of toxins from other Gram negative pathogens.	[Vanderlinde, Elizabeth M.; Zhong, Su; Li, Gang; Martynowski, Dariusz; Howard, S. Peter] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada; [Grochulski, Pawel] Canadian Light Source, Saskatoon, SK, Canada; [Grochulski, Pawel] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Howard, SP (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada.	peter.howard@usask.ca	Martynowski, Dariusz/AAU-6083-2020	Martynowski, Dariusz/0000-0001-7617-7716; Vanderlinde, Elizabeth/0000-0002-6002-1861	Natural Sciences and Engineering Research Council [203383]; Saskatchewan Health Research Foundation (SHRF) [2700]; SHRF Postdoctoral Fellowship Award [2720]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Saskatchewan Health Research Foundation (SHRF); SHRF Postdoctoral Fellowship Award	This work was supported by Natural Sciences and Engineering Research Council Discovery Grant # 203383, and Saskatchewan Health Research Foundation (SHRF) grant # 2700. EMV was supported by SHRF Postdoctoral Fellowship Award #2720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aragon V, 2000, INFECT IMMUN, V68, P1855, DOI 10.1128/IAI.68.4.1855-1863.2000; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ast VM, 2002, MOL MICROBIOL, V44, P217, DOI 10.1046/j.1365-2958.2002.02870.x; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Condemine G, 2000, MICROBIOL-UK, V146, P639, DOI 10.1099/00221287-146-3-639; Douet V, 2004, RES MICROBIOL, V155, P71, DOI 10.1016/j.resmic.2003.10.001; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng YQ, 2011, J BIOL CHEM, V286, P11415, DOI 10.1074/jbc.M110.199604; Fu Y, 2003, DNA REPAIR, V2, P1435, DOI 10.1016/j.dnarep.2003.08.013; Howard SP, 2013, RES MICROBIOL, V164, P535, DOI 10.1016/j.resmic.2013.03.018; Howard SP, 2006, MOL MICROBIOL, V59, P1062, DOI 10.1111/j.1365-2958.2005.05003.x; Howard SP, 1996, MOL MICROBIOL, V22, P595, DOI 10.1046/j.1365-2958.1996.d01-1713.x; JAHAGIRDAR R, 1994, J BACTERIOL, V176, P6819, DOI 10.1128/JB.176.22.6819-6826.1994; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Korotkov KV, 2013, J STRUCT BIOL, V183, P354, DOI 10.1016/j.jsb.2013.06.013; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Li G, 2011, J BACTERIOL, V193, P197, DOI 10.1128/JB.00882-10; Li G, 2010, MOL MICROBIOL, V76, P772, DOI 10.1111/j.1365-2958.2010.07138.x; Login FH, 2010, MOL MICROBIOL, V76, P944, DOI 10.1111/j.1365-2958.2010.07149.x; Martynowski D, 2013, ACTA CRYSTALLOGR D, V69, P142, DOI 10.1107/S0907444912042710; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Pastushok L, 2005, J BIOL CHEM, V280, P17891, DOI 10.1074/jbc.M410469200; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Rondelet A, 2013, RES MICROBIOL, V164, P556, DOI 10.1016/j.resmic.2013.03.005; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Schoenhofen IC, 1998, MOL MICROBIOL, V29, P1237, DOI 10.1046/j.1365-2958.1998.01011.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SLAUCH JM, 1991, METHOD ENZYMOL, V204, P213; Strozen TG, 2011, J BACTERIOL, V193, P2322, DOI 10.1128/JB.01413-10; Van der Meeren R, 2013, J BIOL CHEM, V288, P1214, DOI 10.1074/jbc.M112.432096; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Wang XH, 2012, J BIOL CHEM, V287, P19082, DOI 10.1074/jbc.M112.346338	41	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102038	10.1371/journal.pone.0102038	http://dx.doi.org/10.1371/journal.pone.0102038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025769	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992400036
J	Wang, Y; Xue, J; Zhou, XD; You, M; Du, Q; Yang, X; He, JZ; Zou, J; Cheng, L; Li, MY; Li, YQ; Zhu, YP; Li, JY; Shi, WY; Xu, X				Wang, Yan; Xue, Jing; Zhou, Xuedong; You, Meng; Du, Qin; Yang, Xue; He, Jingzhi; Zou, Jing; Cheng, Lei; Li, Mingyun; Li, Yuqing; Zhu, Yiping; Li, Jiyao; Shi, Wenyuan; Xu, Xin			Oral Microbiota Distinguishes Acute Lymphoblastic Leukemia Pediatric Hosts from Healthy Populations	PLOS ONE			English	Article							ABIOTROPHIA-DEFECTIVA; BLOOD-STREAM; CHILDREN; CHEMOTHERAPY; BACTERIA; SALIVA; FLORA; PERIODONTITIS; INFECTIONS; MICROFLORA	In leukemia, oral manifestations indicate aberrations in oral microbiota. Microbiota structure is determined by both host and environmental factors. In human hosts, how health status shapes the composition of oral microbiota is largely unknown. Taking advantage of advances in high-throughput sequencing, we compared the composition of supragingival plaque microbiota of acute lymphoblastic leukemia (ALL) pediatric patients with healthy controls. The oral microbiota of leukemia patients had lower richness and less diversity compared to healthy controls. Microbial samples clustered into two major groups, one of ALL patients and another of healthy children, with different structure and composition. Abundance changes of certain taxa including the Phylum Firmicutes, the Class Bacilli, the Order Lactobacillales, the Family Aerococcaceae and Carnobacteriaceae, as well as the Genus Abiotrophia and Granulicatella were associated with leukemia status. ALL patients demonstrated a structural imbalance of the oral microbiota, characterized by reduced diversity and abundance alterations, possibly involved in systemic infections, indicating the importance of immune status in shaping the structure of oral microbiota.	[Wang, Yan; Xue, Jing; Zhou, Xuedong; You, Meng; Du, Qin; He, Jingzhi; Cheng, Lei; Li, Mingyun; Li, Yuqing; Li, Jiyao; Xu, Xin] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China; [Yang, Xue; Zhu, Yiping] Sichuan Univ, Dept Pediat Hematol & Oncol, West China Univ Hosp 2, Chengdu 610064, Peoples R China; [Zou, Jing] Sichuan Univ, Dept Pediat Dent, West China Hosp Stomatol, Chengdu 610064, Peoples R China; [Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	Sichuan University; Sichuan University; Sichuan University; University of California System; University of California Los Angeles	Xu, X (corresponding author), Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China.	nixux1982@hotmail.com	SHI, wen/GPW-9531-2022; ZHOU, XUE/F-6129-2013	Cheng, Lei/0000-0002-2762-4740; Zou, Jing/0000-0002-3618-9672; Zhou, Xuedong/0000-0002-9319-7302; Xu, Xin/0000-0003-4608-4556; You, Meng/0000-0001-6189-1845; Wang, Yan/0000-0002-7136-9353	International S&T Cooperation Program of China [2011DFA30940]; National Basic Research Program of China ("973 Pilot Research Program") [2011CB512108]; National Science & Technology Pillar Program [2012BAI07B03]; National Natural Science Foundation of China [81200782]; Doctoral Fund of Ministry of Education of China [20120181120002]	International S&T Cooperation Program of China; National Basic Research Program of China ("973 Pilot Research Program")(National Basic Research Program of China); National Science & Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported by the International S&T Cooperation Program of China (grant number: 2011DFA30940), the National Basic Research Program of China ("973 Pilot Research Program," grant Number: 2011CB512108), the National Science & Technology Pillar Program during the 12th Five-year Plan Period (grant number: 2012BAI07B03), National Natural Science Foundation of China (grant number: 81200782) and Doctoral Fund of Ministry of Education of China (grant number: 20120181120002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT AP, 1986, J PERIODONTOL, V57, P579, DOI 10.1902/jop.1986.57.9.579; Belstrom D, 2014, J CLIN PERIODONTOL, V41, P104, DOI 10.1111/jcpe.12190; Cargill JS, 2012, J MED MICROBIOL, V61, P755, DOI 10.1099/jmm.0.039693-0; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; GALILI D, 1992, ORAL SURG ORAL MED O, V74, P459, DOI 10.1016/0030-4220(92)90295-2; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; GREENBERG MS, 1982, ORAL SURG ORAL MED O, V53, P32, DOI 10.1016/0030-4220(82)90483-2; Hague Anne L, 2008, J Dent Hyg, V82, P22; Hegde AM, 2011, J CLIN PEDIATR DENT, V35, P319, DOI 10.17796/jcpd.35.3.u5kx28q33m760834; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hou G L, 1997, Oral Dis, V3, P31; Hu YJ, 2013, INT J ORAL SCI, V5, P21, DOI 10.1038/ijos.2013.15; Hu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056343; Javed F, 2012, CRIT REV ONCOL HEMAT, V83, P303, DOI 10.1016/j.critrevonc.2011.11.003; Khan S A, 2001, J Natl Cancer Inst Monogr, P31, DOI 10.1093/oxfordjournals.jncimonographs.a003437; KITCHINGMAN GR, 1985, BLOOD, V65, P725; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Krych L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062578; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068157, 10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057, 10.1371/journal.pone.0067018, 10.1371/journal.pone.0063139]; Liao CH, 2004, CLIN INFECT DIS, V38, P452, DOI 10.1086/381098; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lucas VS, 1997, J INFECTION, V35, P135, DOI 10.1016/S0163-4453(97)91545-0; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer U, 2000, J ORAL PATHOL MED, V29, P153, DOI 10.1034/j.1600-0714.2000.290402.x; OSULLIVAN EA, 1993, ORAL SURG ORAL MED O, V76, P161, DOI 10.1016/0030-4220(93)90198-D; Paunica SC, 2009, HEMATOLOGY, V14, P341, DOI 10.1179/102453309X12473408860505; Phulpin-Weibel A, 2013, J MED MICROBIOL, V62, P789, DOI 10.1099/jmm.0.047191-0; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Saber MH, 2012, J ENDODONT, V38, P1484, DOI 10.1016/j.joen.2012.06.037; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P2379, DOI 10.1128/AEM.72.4.2379-2384.2006; Senn L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-9; Sixou JL, 1998, ORAL ONCOL, V34, P476, DOI 10.1016/S1368-8375(98)00062-1; Tjwa E, 2008, NEW ENGL J MED, V359, pE21, DOI 10.1056/NEJMicm064633; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; van Vliet MJ, 2009, CLIN INFECT DIS, V49, P262, DOI 10.1086/599346; von Rosenvinge EC, 2013, ISME J, V7, P1354, DOI 10.1038/ismej.2013.33; WAHLIN YB, 1991, ORAL SURG ORAL MED O, V72, P300, DOI 10.1016/0030-4220(91)90219-3; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang XL, 2000, CANCER IMMUNOL IMMUN, V49, P165, DOI 10.1007/s002620050616	49	34	35	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102116	10.1371/journal.pone.0102116	http://dx.doi.org/10.1371/journal.pone.0102116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025462	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400043
J	Zhang, WW; Shen, L; Deng, ZT; Ding, YB; Mo, XM; Xu, ZF; Gao, Q; Yi, L				Zhang, Wenwen; Shen, Li; Deng, Zhantao; Ding, Yibing; Mo, Xuming; Xu, Zhengfeng; Gao, Qian; Yi, Long			Novel Missense Variants of ZFPM2/FOG2 Identified in Conotruncal Heart Defect Patients Do Not Impair Interaction with GATA4	PLOS ONE			English	Article							TETRALOGY; GENE; MUTATIONS; FALLOT; FOG-2; MORPHOGENESIS; ANOMALIES	Conotruncal heart defect (CTD) is a complex form of congenital heart disease and usually has a poor prognosis. ZFPM2/FOG2 encodes a transcription cofactor that interacts with GATA4 to regulate cardiac development. This regulation has been established in knockout mouse models that display a range of heart malformations, especially CTD. Although previous studies have identified several missense variants in ZFPM2/FOG2 that may cause CTD, it remains unclear whether they are involved in CTD pathogenesis because the study populations were limited and the functional status was unknown. In this report, we screened a larger CTD population, which comprised 145 tetralogy of Fallot (TOF), 37 double-outlet ventricle outflow (DORV), and 18 transposition of the great artery (TGA), to investigate exon mutations as well as copy number variations in ZFPM2/FOG2. Four variants (p.V339I in one DORV, p.A426T in one DORV, p.M703L in three TOF, p.T843M in one TOF) were found in six patients, of which two are reported here for the first time. No copy number variations of the gene were detected. GST pull-down assays demonstrated that all potentially deleterious variants, including those previously reported, did not impair the interaction with GATA4, except for variant p.M544I and p.K737E, which subtly impaired the binding. Thus, these missense variants may be involved in other mechanisms underlying CTD or may be unrelated to CTD occurrence.	[Zhang, Wenwen; Deng, Zhantao; Ding, Yibing; Gao, Qian; Yi, Long] Nanjing Univ, Sch Med, Ctr Translat Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Wenwen; Deng, Zhantao; Ding, Yibing; Gao, Qian; Yi, Long] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Shen, Li] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Cardiothorac Surg, Shanghai 200030, Peoples R China; [Mo, Xuming] Nanjing Childrens Hosp, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China; [Xu, Zhengfeng] Nanjing Matern & Child Hlth Hosp, Ctr Prenatal Diag, Nanjing Med Sch, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Shanghai Jiao Tong University	Gao, Q (corresponding author), Nanjing Univ, Sch Med, Ctr Translat Med, Nanjing 210008, Jiangsu, Peoples R China.	qian_gao@nju.edu.cn; yilong@nju.edu.cn			National Natural Science Foundation of China [81170002, 81030013, 81371449]; Jiangsu Province Health Department of Medicine leading talent and innovation team project [LJ201109]; Nanjing University Undergraduate Innovation Program [G1210284109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Health Department of Medicine leading talent and innovation team project; Nanjing University Undergraduate Innovation Program	The National Natural Science Foundation of China (81170002,81030013,81371449). Jiangsu Province Health Department of Medicine leading talent and innovation team project (LJ201109). Nanjing University Undergraduate Innovation Program (G1210284109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen C, 2013, EUR J HUM GENET, V21, P918, DOI 10.1038/ejhg.2012.283; Bashamboo A, 2014, HUM MOL GENET, V23, P3657, DOI 10.1093/hmg/ddu074; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; De Luca A, 2011, CLIN GENET, V80, P184, DOI 10.1111/j.1399-0004.2010.01523.x; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Finelli P, 2007, CLIN GENET, V71, P195, DOI 10.1111/j.1399-0004.2007.00752.x; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Hatayama M, 2008, HUM MOL GENET, V17, P3459, DOI 10.1093/hmg/ddn239; Holmes M, 1999, J BIOL CHEM, V274, P23491, DOI 10.1074/jbc.274.33.23491; Huang XM, 2014, MOL BIOL REP, V41, P2671, DOI 10.1007/s11033-014-3126-5; Momma K, 2010, AM J CARDIOL, V105, P1617, DOI 10.1016/j.amjcard.2010.01.333; Nemer Georges, 2006, Hum Mutat, V27, P293, DOI 10.1002/humu.9410; OMalley CD, 1996, TERATOLOGY, V53, P374; Pizzuti A, 2003, HUM MUTAT, V22, P372, DOI 10.1002/humu.10261; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Stern RF, 2004, BIOTECHNIQUES, V37, P399, DOI 10.2144/04373ST04; Svensson EC, 2000, NAT GENET, V25, P353, DOI 10.1038/77146; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Tan ZP, 2012, CLIN GENET, V82, P466, DOI 10.1111/j.1399-0004.2011.01787.x; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; Yang C, 2009, ELECTROPHORESIS, V30, P465, DOI 10.1002/elps.200800321	25	16	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102379	10.1371/journal.pone.0102379	http://dx.doi.org/10.1371/journal.pone.0102379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025186	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400068
J	Arora, G; Tiwari, P; Mandal, RS; Gupta, A; Sharma, D; Saha, S; Singh, R				Arora, Garima; Tiwari, Prabhakar; Mandal, Rahul Shubhra; Gupta, Arpit; Sharma, Deepak; Saha, Sudipto; Singh, Ramandeep			High Throughput Screen Identifies Small Molecule Inhibitors Specific for Mycobacterium tuberculosis Phosphoserine Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYROMONAS-GINGIVALIS; ESCHERICHIA-COLI; D-3-PHOSPHOGLYCERATE DEHYDROGENASE; SERINE BIOSYNTHESIS; CRYSTAL-STRUCTURE; PROTEIN; ENZYMES; PATHWAY; GROWTH; DISCOVERY	The emergence of drug-resistant strains of Mycobacterium tuberculosis makes identification and validation of newer drug targets a global priority. Phosphoserine phosphatase (PSP), a key essential metabolic enzyme involved in conversion of O-phospho-L-serine to L-serine, was characterized in this study. The M. tuberculosis genome harbors all enzymes involved in L-serine biosynthesis including two PSP homologs: Rv0505c (SerB1) and Rv3042c (SerB2). In the present study, we have biochemically characterized SerB2 enzyme and developed malachite green-based high throughput assay system to identify SerB2 inhibitors. We have identified 10 compounds that were structurally different from known PSP inhibitors, and few of these scaffolds were highly specific in their ability to inhibit SerB2 enzyme, were noncytotoxic against mammalian cell lines, and inhibited M. tuberculosis growth in vitro. Surface plasmon resonance experiments demonstrated the relative binding for these inhibitors. The two best hits identified in our screen, clorobiocin and rosaniline, were bactericidal in activity and killed intracellular bacteria in a dose-dependent manner. We have also identified amino acid residues critical for these SerB2-small molecule interactions. This is the first study where we validate that M. tuberculosis SerB2 is a drug-gable and suitable target to pursue for further high throughput assay system screening.	[Arora, Garima; Tiwari, Prabhakar; Singh, Ramandeep] Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Gurgaon 122016, Haryana, India; [Arora, Garima] Symbiosis Int Univ, Symbiosis Sch Biomed Sci, Lavale 412115, Maharashtra, India; [Mandal, Rahul Shubhra] Natl Inst Cholera & Enter Dis, Biomed Informat Ctr, Kolkata 700010, W Bengal, India; [Gupta, Arpit; Sharma, Deepak] CSIR Inst Microbial Technol, Chandigarh 160036, India; [Saha, Sudipto] Bose Inst, Bioinformat Ctr, Kolkata 700054, W Bengal, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Symbiosis International University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Department of Science & Technology (India); Bose Institute	Singh, R (corresponding author), Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, 496 UdyogVihar,Phase 3, Gurgaon 122016, Haryana, India.	ramandeep@thsti.res.in	International, Symbiosis School of Biological Sciences Symbiosis/AAD-7708-2019; Saha, Sudipto/AAF-1034-2020	Mandal, Rahul/0000-0001-8939-3362; Singh, Ramandeep/0000-0003-2705-3826; Saha, Sudipto/0000-0001-9433-8894	Department of Biotechnology (DBT) of the Government of India; Department of Biotechnology [BT/HRD/35/02/18/2009, BT/RLF/Re-entry/11/2011]; DBT Research Fellowship [BT/HRD/35/02/18/2009, BT/PR15074/GBD/27/297/2011]; Indian Council of Medical Research (ICMR) (IRIS) [2013: 19440]; DBT Research Fellowship; ICMR Grant IRIS [2013-1551G]	Department of Biotechnology (DBT) of the Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology; DBT Research Fellowship; Indian Council of Medical Research (ICMR) (IRIS); DBT Research Fellowship; ICMR Grant IRIS	This work was supported by intramural funding to Translational Health Science and Technology Institute from the Department of Biotechnology (DBT) of the Government of India, Department of Biotechnology Ramalingaswamy fellowships BT/HRD/35/02/18/2009 (to R. S.) and BT/RLF/Re-entry/11/2011 (to S. S.), DBT Research Fellowship BT/HRD/35/02/18/2009 (to G. A.), Indian Council of Medical Research (ICMR) fellowship (IRIS ID 2013: 19440 to G. A.), DBT Research Fellowship BT/PR15074/GBD/27/297/2011 (to P. T.), and ICMR Grant IRIS ID: 2013-1551G (to R. S. M.).	Anderle C, 2008, ANTIMICROB AGENTS CH, V52, P1982, DOI 10.1128/AAC.01235-07; Anthony KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020374; Awasthy D, 2012, MICROBIOL-SGM, V158, P319, DOI 10.1099/mic.0.054064-0; Bai G, 2011, MOL MICROBIOL, V82, P180, DOI 10.1111/j.1365-2958.2011.07806.x; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Chiba Y, 2012, J BIOL CHEM, V287, P11934, DOI 10.1074/jbc.M111.330621; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Dey S, 2005, J BIOL CHEM, V280, P14892, DOI 10.1074/jbc.M414489200; Dey S, 2005, J BIOL CHEM, V280, P14884, DOI 10.1074/jbc.M414488200; Durrant JD, 2010, J MED CHEM, V53, P5025, DOI 10.1021/jm100456a; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Green KD, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00208; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Hawkinson JE, 1996, EUR J PHARMACOL, V307, P219, DOI 10.1016/0014-2999(96)00253-1; Hawkinson JE, 1997, EUR J PHARMACOL, V337, P315, DOI 10.1016/S0014-2999(97)01304-6; Helgadottir S, 2007, J BACTERIOL, V189, P575, DOI 10.1128/JB.01269-06; Hirabayashi Y, 2008, PROG LIPID RES, V47, P188, DOI 10.1016/j.plipres.2008.01.003; Ho CL, 1999, J BIOL CHEM, V274, P11007, DOI 10.1074/jbc.274.16.11007; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Jung SK, 2012, BIOORG MED CHEM LETT, V22, P2084, DOI 10.1016/j.bmcl.2012.01.011; Kishor C, 2013, J MED CHEM, V56, P5295, DOI 10.1021/jm400395p; Kitabatake M, 2000, J BACTERIOL, V182, P143, DOI 10.1128/JB.182.1.143-145.2000; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; LARGEN M, 1975, J BACTERIOL, V121, P239, DOI 10.1128/JB.121.1.239-249.1975; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lee Y, 2013, BIOCHEM PHARMACOL, V86, P222, DOI 10.1016/j.bcp.2013.05.004; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Moffatt CE, 2012, CELL MICROBIOL, V14, P577, DOI 10.1111/j.1462-5822.2011.01743.x; Peeraer Y, 2003, ACTA CRYSTALLOGR D, V59, P971, DOI 10.1107/S0907444903005407; PIZER LI, 1965, J BACTERIOL, V89, P1145, DOI 10.1128/JB.89.4.1145-1150.1965; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Poyraz O, 2013, J MED CHEM, V56, P6457, DOI 10.1021/jm400710k; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SAITOU N, 1987, BIOL EVOL, V4, P406; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHIRCH V, 1985, J BACTERIOL, V163, P1; Seifried A, 2013, FEBS J, V280, P549, DOI 10.1111/j.1742-4658.2012.08633.x; Shen HB, 2009, FEBS J, V276, P144, DOI 10.1111/j.1742-4658.2008.06763.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh SK, 2004, J BIOL CHEM, V279, P13166, DOI 10.1074/jbc.M311393200; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; Snyder SH, 2000, NEUROCHEM RES, V25, P553, DOI 10.1023/A:1007586314648; Takeuchi H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003326; Tribble GD, 2006, P NATL ACAD SCI USA, V103, P11027, DOI 10.1073/pnas.0509813103; ULANE R, 1972, J BACTERIOL, V109, P34, DOI 10.1128/JB.109.1.34-43.1972; Wang D, 2013, J CHEM INF MODEL, V53, P343, DOI 10.1021/ci3004545; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X	54	23	25	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25149	25165		10.1074/jbc.M114.597682	http://dx.doi.org/10.1074/jbc.M114.597682			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25037224	hybrid, Green Published			2022-12-25	WOS:000341985300036
J	Barentsz, MW; Wessels, H; van Diest, PJ; Pijnappel, RM; van der Pol, CC; Witkamp, AJ; van den Bosch, MAAJ; Verkooijen, HM				Barentsz, Maarten W.; Wessels, Hester; van Diest, Paul J.; Pijnappel, Ruud M.; van der Pol, Carmen C.; Witkamp, Arjen J.; van den Bosch, Maurice A. A. J.; Verkooijen, Helena M.			Same-Day Diagnosis Based on Histology for Women Suspected of Breast Cancer: High Diagnostic Accuracy and Favorable Impact on the Patient	PLOS ONE			English	Article							CORE-NEEDLE-BIOPSY; FINE-NEEDLE; ASPIRATION-CYTOLOGY; DISTRESS; ANXIETY; COSTS	Background: Same-day diagnosis based on histology is increasingly being offered to patients suspected of breast cancer. We evaluated to which extent same-day diagnosis affected diagnostic accuracy and patients' anxiety levels during the diagnostic phase. Patients and methods: All 759 women referred for same-day evaluation of suspicious breast lesions between November 2011-March 2013 were included. Diagnostic accuracy was assessed by linking all patients to the national pathology database to identify diagnostic discrepancies, in which case slides were reviewed. Patients' anxiety was measured in 127 patients by the State Trait and Anxiety Inventory on six moments during the diagnostic workup and changes over time (, = 1 week) were analyzed by mixed effect models. Results: Core-needle biopsy was indicated in 374/759 patients (49.3%) and in 205/759 (27%) patients, invasive or in situ cancer was found. Final diagnosis on the same day was provided for 606/759 (79.8%) patients. Overall, 3/759 (0.4%) discordant findings were identified. Anxiety levels decreased significantly over time from 45.2 to 30.0 (P =, 0.001). Anxiety levels decreased from 44.4 to 25.9 (P = <0.001) for patients with benign disease, and remained unchanged for patients diagnosed with malignancies (48.6 to 46.7, P = 0.933). Time trends in anxiety were not affected by other patient or disease characteristics like age, education level or (family) history of breast cancer. Conclusion: Same-day histological diagnosis is feasible in the vast majority of patients, without impairing diagnostic accuracy. Patients' anxiety rapidly decreased in patients with a benign diagnosis and remained constant in patients with malignancy.	[Barentsz, Maarten W.; Pijnappel, Ruud M.; van den Bosch, Maurice A. A. J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Wessels, Hester] Univ Med Ctr Utrecht, Dept Corp Commun, Utrecht, Netherlands; [van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van der Pol, Carmen C.; Witkamp, Arjen J.] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands; [Verkooijen, Helena M.] Univ Med Ctr Utrecht, Imaging Div, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Barentsz, MW (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	m.barentsz@umcutrecht.nl		Pijnappel, Ruud/0000-0002-6912-9414	Alpe d'HuZes; Dutch Cancer Society	Alpe d'HuZes; Dutch Cancer Society(KWF Kankerbestrijding)	Same-day diagnosis for breast cancer was implemented in the University Medical Center Utrecht with the financial support of Alpe d'HuZes, partner of the Dutch Cancer Society. http://www.opgevenisgeenoptie.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, IARC CANCERBASE; Brancato B, 2012, BREAST, V21, P449, DOI 10.1016/j.breast.2011.10.008; Bulte JP, 2013, BREAST CANCER RES TR, V137, P609, DOI 10.1007/s10549-012-2372-2; Clarke D, 2001, ANN ROY COLL SURG, V83, P110; Crystal P, 2005, J CLIN ULTRASOUND, V33, P47, DOI 10.1002/jcu.20089; Dey P, 2002, BRIT MED J, V324, P507, DOI 10.1136/bmj.324.7336.507; Flory N, 2011, RADIOLOGY, V260, P166, DOI 10.1148/radiol.11102211; Harcourt D, 1999, PSYCHOL HEALTH MED, V4, P14; Hatada T, 2000, J AM COLL SURGEONS, V190, P299, DOI 10.1016/S1072-7515(99)00300-2; Hedeker D., 2006, LONGITUDINAL DATA AN; Henselmans Inge, 2010, Ned Tijdschr Geneeskd, V154, pB491; Hukkinen K, 2008, ACTA ONCOL, V47, P1037, DOI 10.1080/02841860802001442; Kerlikowske K, 2003, ANN INTERN MED, V139, P274, DOI 10.7326/0003-4819-139-4-200308190-00010; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Strong V, 2007, BRIT J CANCER, V96, P868, DOI 10.1038/sj.bjc.6603626; Ubhi SS, 1996, ANN ROY COLL SURG, V78, P466; van der Bij Akke K, 2003, Community Genet, V6, P84, DOI 10.1159/000073003; Willems SM, 2012, J CLIN PATHOL, V65, P287, DOI 10.1136/jclinpath-2011-200410; Zabora J, 2001, PSYCHO-ONCOL, V10, P19, DOI 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.0.CO;2-6	19	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103105	10.1371/journal.pone.0103105	http://dx.doi.org/10.1371/journal.pone.0103105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047134	gold, Green Published, Green Submitted			2022-12-25	WOS:000339558100108
J	Wang, CR; Zhang, YN; Zhang, L; Hou, XH; Lu, HJ; Shen, YX; Chen, RH; Fang, PY; Yu, H; Li, M; Zhang, F; Chen, HB; Yu, HY; Zhou, J; Liu, F; Bao, YQ; Jia, WP				Wang, Congrong; Zhang, Yinan; Zhang, Lei; Hou, Xuhong; Lu, Huijuan; Shen, Yixie; Chen, Ruihua; Fang, Pingyan; Yu, Hong; Li, Ming; Zhang, Feng; Chen, Haibing; Yu, Haoyong; Zhou, Jian; Liu, Fang; Bao, Yuqian; Jia, Weiping			Prevalence of Type 2 Diabetes among High-Risk Adults in Shanghai from 2002 to 2012	PLOS ONE			English	Article							CHINESE ADULTS; POPULATION; TRENDS	Objective: The objective of this study was to evaluate the trend and prevalence of prediabetes and diabetes among high-risk adults in Shanghai from 2002 to 2012. Methods: From 2002 to 2012, 10043 subjects with known risk factors for diabetes participated in the diabetes-screening project at the Shanghai Sixth People's Hospital of Shanghai Jiao Tong University. All participants were asked to complete a nurse-administered standard questionnaire concerning age, sex, smoking status, and personal and family histories of diabetes, cardiovascular disease, stroke, hypertension and other diseases. The participants' body mass index scores, blood pressures and blood glucose levels at 0, 30, 60, 120 and 180 min were measured in response to a 75 g oral glucose tolerance test. Results: The overall prevalence of diabetes increased from 27.93% to 34.78% between 2002 and 2012 in high-risk subjects. The study also showed that the prevalence increased much faster in male compared to female subjects. Specifically, an increased rate was seen in middle-aged men, with no change observed in middle-aged females over the eleven-year period. Conclusion: This study showed that sex, age, parental diabetic history, and being overweight were associated with an increased risk for diabetes in high-risk people. Therefore, as prediabetes and diabetes are highly prevalent in people with multiple diabetes risk factors in Shanghai, screening programs targeting these individuals may be beneficial.	[Wang, Congrong; Hou, Xuhong; Lu, Huijuan; Shen, Yixie; Chen, Ruihua; Fang, Pingyan; Yu, Hong; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6,Shanghai Clin Med Ctr Di, Shanghai Key Clin Ctr Diabet,Shanghai Key Lab Dia, Dept Endocrinol & Metab,Metab Dis Biobank, Shanghai 200030, Peoples R China; [Zhang, Yinan] Shanghai Jiao Tong Univ, Shanghai Key Lab Diabet, Dept Endocrinol & Metab,Metab Dis Biobank, Ctr Translat Med,Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Zhang, Lei; Li, Ming; Zhang, Feng; Chen, Haibing; Yu, Haoyong; Zhou, Jian; Liu, Fang; Bao, Yuqian] Shanghai Jiao Tong Univ, Shanghai Clin Med Ctr Diabet,Shanghai Diabet Inst, Shanghai Key Clin Ctr Diabet,Shanghai Key Lab Dia, Dept Endocrinol & Metab,Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6,Shanghai Clin Med Ctr Di, Shanghai Key Clin Ctr Diabet,Shanghai Key Lab Dia, Dept Endocrinol & Metab,Metab Dis Biobank, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Jia, Weiping/B-7483-2012; Wang, Congrong/AAL-8178-2020; 王, 从容/HDM-0959-2022	王, 从容/0000-0002-8645-1114	Drug Innovation Program of National Science and Technology Project [2011ZX09307-001-02]; Shanghai Science and Technology funds [12DZ2295004]	Drug Innovation Program of National Science and Technology Project; Shanghai Science and Technology funds	Funding provided by Drug Innovation Program of National Science and Technology Project (2011ZX09307-001-02) WPJ and Shanghai Science and Technology funds (12DZ2295004) CRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Department of Noncommunicable Disease Surveillance, 1999, DEF DIAGN CLASS DI 1; Guariguata L, 2012, DIABETES RES CLIN PR, V98, P524, DOI 10.1016/j.diabres.2012.11.006; Hou XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057319; Jansson SPO, 2007, DIABETOLOGIA, V50, P703, DOI 10.1007/s00125-007-0593-4; Li R, 2012, DIABETES CARE, V35, P1028, DOI 10.2337/dc11-1212; Lin CC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-318; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Liu SQ, 2011, PREV CHRONIC DIS, V8; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Redondo-Sendino A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-155; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wong KC, 2006, DIABETES RES CLIN PR, V73, P126, DOI 10.1016/j.diabres.2006.01.007; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	19	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102926	10.1371/journal.pone.0102926	http://dx.doi.org/10.1371/journal.pone.0102926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047241	Green Published, gold, Green Submitted			2022-12-25	WOS:000339558100089
J	McCormack, SW; Witzel, U; Watson, PJ; Fagan, MJ; Groning, F				McCormack, Steven W.; Witzel, Ulrich; Watson, Peter J.; Fagan, Michael J.; Groening, Flora			The Biomechanical Function of Periodontal Ligament Fibres in Orthodontic Tooth Movement	PLOS ONE			English	Article							FINITE-ELEMENT MODELS; MECHANICAL-PROPERTIES; PAGES 1831-1838; VOLUME 44; ISSUE 10; BONE; BEHAVIOR; STRESS; STRAIN; SIMPLIFICATIONS	Orthodontic tooth movement occurs as a result of resorption and formation of the alveolar bone due to an applied load, but the stimulus responsible for triggering orthodontic tooth movement remains the subject of debate. It has been suggested that the periodontal ligament (PDL) plays a key role. However, the mechanical function of the PDL in orthodontic tooth movement is not well understood as most mechanical models of the PDL to date have ignored the fibrous structure of the PDL. In this study we use finite element (FE) analysis to investigate the strains in the alveolar bone due to occlusal and orthodontic loads when PDL is modelled as a fibrous structure as compared to modelling PDL as a layer of solid material. The results show that the tension-only nature of the fibres essentially suspends the tooth in the tooth socket and their inclusion in FE models makes a significant difference to both the magnitude and distribution of strains produced in the surrounding bone. The results indicate that the PDL fibres have a very important role in load transfer between the teeth and alveolar bone and should be considered in FE studies investigating the biomechanics of orthodontic tooth movement.	[McCormack, Steven W.; Watson, Peter J.; Fagan, Michael J.] Univ Hull, Sch Engn, Med & Biol Engn Res Grp, Kingston Upon Hull HU6 7RX, N Humberside, England; [Witzel, Ulrich] Ruhr Univ Bochum, Fak Maschinenbau, Bochum, Germany; [Groening, Flora] Univ Aberdeen, Sch Med & Dent, Musculoskeletal Res Programme, Aberdeen AB9 1FX, Scotland	University of Hull; Ruhr University Bochum; University of Aberdeen	Groning, F (corresponding author), Univ Aberdeen, Sch Med & Dent, Musculoskeletal Res Programme, Aberdeen AB9 1FX, Scotland.	f.groening@abdn.ac.uk	Groning, Flora/C-2220-2012	Groning, Flora/0000-0002-8127-4112	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I008462/1]; Marie Curie Actions Integration Grant [FP7-PEOPLE PERG7-GA-2010-268430]; Biotechnology and Biological Sciences Research Council [BB/I008462/1] Funding Source: researchfish; BBSRC [BB/I008462/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Actions Integration Grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (www.bbsrc.ac.uk; BB/I008462/1) and Marie Curie Actions Integration Grant (ec.europa.eu/research/mariecurieactions; FP7-PEOPLE PERG7-GA-2010-268430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATMARAM GH, 1981, J DENT RES, V60, P873, DOI 10.1177/00220345810600050301; BAUMRIND S, 1969, AMER J ORTHODONTICS, V55, P12, DOI 10.1016/S0002-9416(69)90170-5; BERKOVITZ BKB, 1990, EUR J ORTHODONT, V12, P51, DOI 10.1093/ejo/12.1.51; Borak L, 2011, DENT MATER J, V30, P448, DOI 10.4012/dmj.2010-170; Boryor A, 2008, J BIOMECH, V41, P376, DOI 10.1016/j.jbiomech.2007.08.016; Bourauel C, 1999, J Orofac Orthop, V60, P136, DOI 10.1007/BF01298963; Bourauel C, 2000, J Orofac Orthop, V61, P266, DOI 10.1007/s000560050012; Cattaneo PM, 2009, ORTHOD CRANIOFAC RES, V12, P120, DOI 10.1111/j.1601-6343.2009.01445.x; Cattaneo PM, 2008, AM J ORTHOD DENTOFAC, V133, P681, DOI 10.1016/j.ajodo.2006.05.038; Cattaneo PM, 2005, J DENT RES, V84, P428, DOI 10.1177/154405910508400506; Chen JN, 2014, J BIOMECH, V47, P1689, DOI 10.1016/j.jbiomech.2014.02.030; Currey J.D., 2002, BONES STRUCTURE MECH; CURREY JD, 1984, CALCIFIED TISSUE INT, V36, pS7, DOI 10.1007/BF02406127; CURREY JD, 1968, J THEOR BIOL, V20, P91, DOI 10.1016/0022-5193(68)90094-5; Daegling DJ, 1997, J HUM EVOL, V33, P705, DOI 10.1006/jhev.1997.0164; Dorow Christina, 2003, J Orofac Orthop, V64, P100, DOI 10.1007/s00056-003-0225-7; Dorow Christina, 2002, J Orofac Orthop, V63, P94, DOI 10.1007/s00056-002-0107-4; Fill TS, 2012, J BIOMECH, V45, P9, DOI 10.1016/j.jbiomech.2011.09.020; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Frost HM., 1964, LAWS BONE STRUCTURE; Gautieri A, 2012, MATRIX BIOL, V31, P141, DOI 10.1016/j.matbio.2011.11.005; Groning F, 2012, J BIOMECH, V45, P1749, DOI 10.1016/j.jbiomech.2011.10.042; Groning F, 2012, J BIOMECH, V45, P1498, DOI 10.1016/j.jbiomech.2012.02.009; Groning F, 2011, J BIOMECH, V44, P1304, DOI 10.1016/j.jbiomech.2011.01.008; Groning F, 2012, ANAT REC, V295, P853, DOI 10.1002/ar.22455; Groning F, 2009, J BIOMECH, V42, P1224, DOI 10.1016/j.jbiomech.2009.03.025; Grosse IR, 2012, J BIOMECH, V45, P1750, DOI 10.1016/j.jbiomech.2012.01.047; Hall Brian K., 2005, P338, DOI 10.1016/B978-012319060-4/50027-0; Jones M L, 2001, J Orthod, V28, P29; Kato H, 1982, J JPN PROSTHODONT SO, V26, P133; Katona TR, 2001, AM J ORTHOD DENTOFAC, V120, P263, DOI 10.1067/mod.2001.116086; Limbert Georges, 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P337, DOI 10.1080/10255840310001637572; Marinescu R, 2005, ANAT REC PART A, V283A, P300, DOI 10.1002/ar.a.20166; McCulloch CAG, 2000, PERIODONTOL 2000, V24, P56, DOI 10.1034/j.1600-0757.2000.2240104.x; Melsen B, 2001, EUR J ORTHODONT, V23, P671, DOI 10.1093/ejo/23.6.671; Meyer BN, 2010, AM J ORTHOD DENTOFAC, V137, P354, DOI 10.1016/j.ajodo.2008.03.029; Middleton J, 1996, AM J ORTHOD DENTOFAC, V109, P155, DOI 10.1016/S0889-5406(96)70176-2; Misch CE, 1999, J ORAL MAXIL SURG, V57, P700, DOI 10.1016/S0278-2391(99)90437-8; O'Connor CF, 2005, AM J PHYS ANTHROPOL, V127, P129, DOI 10.1002/ajpa.20025; Poppe Mathias, 2002, J Orofac Orthop, V63, P358, DOI 10.1007/s00056-002-0067-8; Provatidis CG, 2000, MED ENG PHYS, V22, P359, DOI 10.1016/S1350-4533(00)00055-2; Qian HH, 2001, AM J ORTHOD DENTOFAC, V120, P272, DOI 10.1067/mod.2001.116085; Qian YL, 2010, INT J NUMER METH BIO, V26, P157, DOI 10.1002/cnm.1179; Rees JS, 1997, BIOMATERIALS, V18, P995, DOI 10.1016/S0142-9612(97)00021-5; SLOAN P, 1979, J ROY SOC MED, V72, P188, DOI 10.1177/014107687907200308; Toms SR, 2002, J BIOMECH, V35, P1411, DOI 10.1016/S0021-9290(02)00166-5; Toms SR, 2002, AM J ORTHOD DENTOFAC, V122, P174, DOI 10.1067/mod.2002.124997; van Driel WD, 2000, P I MECH ENG H, V214, P497, DOI 10.1243/0954411001535525; Witzel U, 1998, TARGET, V1, P10	49	47	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102387	10.1371/journal.pone.0102387	http://dx.doi.org/10.1371/journal.pone.0102387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036099	gold, Green Published, Green Submitted			2022-12-25	WOS:000339615200053
J	Chen, YX; Williams, E; Kirk, M				Chen, Yingxi; Williams, Emlyn; Kirk, Martyn			Risk Factors for Acute Respiratory Infection in the Australian Community	PLOS ONE			English	Article							VIRAL-INFECTIONS; DAY-CARE; CHILDREN; ILLNESS; INFLUENZA; TRANSMISSION; EPIDEMIOLOGY; SEASONALITY; RHINOVIRUS; MORTALITY	Objectives: The objective of this study was to identify the risk factors for ARI in the Australian community. Methods: We used a national survey of 7578 randomly selected respondents in 2008-2009 to identify the risk factors of ARI. A case was defined as a person experiencing cold or flu with one or more symptoms of: fever, chills, sore throat, runny nose, or cough in the previous four weeks. Results: There were 19.8% (1505/7578) of respondents who reported ARI in the four weeks prior to the survey. Age was an independent risk factor for ARI, with the risk of acquiring ARI decreasing as age increased. Respondents reporting asthma (OR 1.4, 95% CI: 1.2-1.7) or having someone in their house attending childcare (OR 1.6, 95% CI: 1.2-2.1) were more likely to report ARI. Conclusions: It is important to identify ways of interrupting transmission of ARI amongst children. Improving identification of risk factors will enable targeted interventions for this exceedingly common syndrome.	[Chen, Yingxi; Kirk, Martyn] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Williams, Emlyn] Australian Natl Univ, Stat Consulting Unit, Canberra, ACT, Australia	Australian National University; Australian National University	Kirk, M (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	martyn.kirk@anu.edu.au	Chen, Yingxi/ABF-2593-2020	Chen, Yingxi/0000-0002-3565-1052; Kirk, Martyn/0000-0001-5432-5984	Commonwealth Department of Health	Commonwealth Department of Health	The study was funded by the Commonwealth Department of Health, and study conduct was overseen by a committee comprised of representatives from Australian government agencies and departments. The funding agency had no role in data collection or analysis, decision to publish or preparation of the manuscript.	Albarbi S, 2012, BMC INFECT DIS, V12, P55; Azizi B. H. O., 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P280; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Chen Y, 2013, EPIDEMIOL INFECT, P1; DENNY FW, 1986, REV INFECT DIS, V8, P527; EDWARDS B, RESP INFECT DIS BURD; Einarsson O, 1996, J CLIN INVEST, V97, P915, DOI 10.1172/JCI118514; Fleming DM, 2005, ARCH DIS CHILD, V90, P741, DOI 10.1136/adc.2004.063461; Fuhrmann C, 2010, GEOGR COMPASS, V4, DOI 10.1111/j.1749-8198.2010.00343.x; GARIBALDI RA, 1985, AM J MED, V78, P32, DOI 10.1016/0002-9343(85)90361-4; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hall GV, 2006, EPIDEMIOL INFECT, V134, P111, DOI 10.1017/S0950268805004656; Hope-Simpson RE, 1992, TRANSMISSION EPIDEMI, V275; Hu XJ, 2005, CHIN J DIS PREV, V9, P166; HURWITZ ES, 1991, PEDIATRICS, V87, P62; Johnson C, 2005, FAM PRACT, V22, P608, DOI 10.1093/fampra/cmi072; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; KamperJorgensen M, 2006, PEDIATRICS, V118, P8; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lambert SB, 2005, J PAEDIATR CHILD H, V41, P125, DOI 10.1111/j.1440-1754.2005.00561.x; Lee GM, 2005, PEDIATRICS, V115, P852, DOI 10.1542/peds.2004-0856; Lee SL, 2011, EUR J PEDIATR, V170, P1317, DOI 10.1007/s00431-011-1446-1; Lofgren E, 2007, J VIROL, V13, P220; LOUHIALA PJ, 1995, AM J PUBLIC HEALTH, V85, P1109, DOI 10.2105/AJPH.85.8_Pt_1.1109; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McCaw JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-345; Monto AS, 1995, AM J MED, V99, pS24, DOI 10.1016/S0002-9343(99)80307-6; Moore HC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-757; Peltola V, 2008, J INFECT DIS, V197, P382, DOI 10.1086/525542; Rakes GP, 1999, AM J RESP CRIT CARE, V12, P321; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Roberts L, 2000, PEDIATRICS, V105, P738, DOI 10.1542/peds.105.4.738; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; SMYTH AR, 1995, ARCH DIS CHILD, V73, P117, DOI 10.1136/adc.73.2.117; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; WANG JB, 1994, CHINESE J EPIDEMIOLO, V15, P141; Weber MW, 1999, INT J EPIDEMIOL, V28, P157, DOI 10.1093/ije/28.1.157; WOODWARD A, 1990, J EPIDEMIOL COMMUN H, V44, P224, DOI 10.1136/jech.44.3.224; Zhang GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044568; Zomer TP, 2013, AM J INFECT CONTROL, V41, P497, DOI 10.1016/j.ajic.2012.06.005; 2010, ASTHMA SERIES	44	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101440	10.1371/journal.pone.0101440	http://dx.doi.org/10.1371/journal.pone.0101440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032810	Green Submitted, Green Published, gold			2022-12-25	WOS:000339418300016
J	Fujii, T; Matsuo, K; Abe, Y; Yukawa, J; Tokuda, M				Fujii, Tomohisa; Matsuo, Kazunori; Abe, Yoshihisa; Yukawa, Junichi; Tokuda, Makoto			An Endoparasitoid Avoids Hyperparasitism by Manipulating Immobile Host Herbivore to Modify Host Plant Morphology	PLOS ONE			English	Article							BEHAVIORAL MANIPULATION; PARASITOIDS; CATERPILLARS; USURPATION; DIPTERA; GALLS	Many parasitic organisms have an ability to manipulate their hosts to increase their own fitness. In parasitoids, behavioral changes of mobile hosts to avoid or protect against predation and hyperparasitism have been intensively studied, but host manipulation by parasitoids associated with endophytic or immobile hosts has seldom been investigated. We examined the interactions between a gall inducer Masakimyia pustulae (Diptera: Cecidomyiidae) and its parasitoids. This gall midge induces dimorphic leaf galls, thick and thin types, on Euonymus japonicus (Celastraceae). Platygaster sp. was the most common primary parasitoid of M. pustulae. In galls attacked by Platygaster sp., whole gall thickness as well as thicknesses of upper and lower gall wall was significantly larger than unparasitized galls, regardless of the gall types, in many localities. In addition, localities and tree individuals significantly affected the thickness of gall. Galls attacked by Platygaster sp. were seldom hyperparasitized in the two gall types. These results strongly suggest that Platygaster sp. manipulates the host plant's development to avoid hyperparasitism by thickening galls.	[Fujii, Tomohisa; Abe, Yoshihisa] Kyushu Univ, Biosyst Lab, Grad Sch Social & Cultural Studies, Fukuoka 812, Japan; [Fujii, Tomohisa; Matsuo, Kazunori] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Matsuo, Kazunori] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Entomol Lab, Fukuoka 812, Japan; [Yukawa, Junichi] Kyushu Univ, Fac Agr, Entomol Lab, Fukuoka 812, Japan; [Tokuda, Makoto] Saga Univ, Fac Agr, Lab Syst Ecol, Saga 840, Japan	Kyushu University; Japan Society for the Promotion of Science; Kyushu University; Kyushu University; Saga University	Tokuda, M (corresponding author), Saga Univ, Fac Agr, Lab Syst Ecol, Saga 840, Japan.	tokudam@cc.saga-u.ac.jp		Tokuda, Makoto/0000-0001-7162-0715	Robert T. Huang Entrepreneurship Center of Kyushu University, Japan; JSPS fellows [24-6016]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21780052]; New Technology Development Foundation	Robert T. Huang Entrepreneurship Center of Kyushu University, Japan; JSPS fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Technology Development Foundation	This study was supported in part by the Academic Challenge 2010 from Robert T. Huang Entrepreneurship Center of Kyushu University, Japan to TF, a Grant-in-aid for JSPS fellows (24-6016) to TF, a Grant-in-aid for Young Scientists (B, 21780052) from Ministry of Education, Culture, Sports, Science and Technology, Japan to MT and Research Grant for Plant Science from The New Technology Development Foundation to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2012, HOST MANIPULATION BY PARASITES, P36; Askew R.R., 1975, P130; Askew R. R., 1961, Proceedings of the Royal Entomological Society of London, V36, P103; BRODEUR J, 1992, ECOL ENTOMOL, V17, P97, DOI 10.1111/j.1365-2311.1992.tb01164.x; BRODEUR J, 1989, SCIENCE, V244, P226, DOI 10.1126/science.244.4901.226; Brodeur J, 2004, ANNU REV ENTOMOL, V49, P27, DOI 10.1146/annurev.ento.49.061703.153618; BRODEUR J, 1994, ANIM BEHAV, V48, P187, DOI 10.1006/anbe.1994.1225; Buhl Peter Neerup, 2006, Steenstrupia, V29, P127; CORNELL HV, 1983, AM MIDL NAT, V110, P225, DOI 10.2307/2425263; Grandgirard J, 2002, ENTOMOL EXP APPL, V103, P239, DOI 10.1023/A:1021193329749; Grosman AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002276; Harvey JA, 2008, ANIM BEHAV, V76, P701, DOI 10.1016/j.anbehav.2008.03.016; HOLM S, 1979, SCAND J STAT, V6, P65; Ito M, 2005, J FOR RES, V9, P355; Janssen A, 2010, BEHAV ECOL, V21, P33, DOI 10.1093/beheco/arp153; Langellotto GA, 2006, OECOLOGIA, V150, P291, DOI 10.1007/s00442-006-0514-0; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; MAEDA N, 1982, Kontyu, V50, P44; Marchosky RJ, 2004, ENVIRON ENTOMOL, V33, P709, DOI 10.1603/0046-225X-33.3.709; Maure F, 2013, J EXP BIOL, V216, P36, DOI 10.1242/jeb.073130; Moore J., 2002, PARASITES BEHAV ANIM; Paik Jong-Cheol, 2004, Esakia, V44, P57; Poelman EH, 2011, ECOL LETT, V14, P670, DOI 10.1111/j.1461-0248.2011.01629.x; PRICE PW, 1987, ENVIRON ENTOMOL, V16, P15, DOI 10.1093/ee/16.1.15; R Development Core Team, 2010, R VERS 2 12 1 LANG E; Seyahooei MA, 2009, OIKOS, V118, P1148, DOI 10.1111/j.1600-0706.2009.17508.x; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; SUNOSE T, 1985, Kontyu, V53, P677; SUNOSE T, 1984, Kontyu, V52, P557; SUNOSE T, 1985, RES POPUL ECOL, V27, P287, DOI 10.1007/BF02515467; Tabuchi K, 2004, EVOL ECOL RES, V6, P695; Tanaka S, 2006, ECOL RES, V21, P570, DOI 10.1007/s11284-006-0153-2; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; VINSON SB, 1980, Q REV BIOL, V55, P143, DOI 10.1086/411731; YUKAWA J, 1976, Kontyu, V44, P159; Yukawa J., 1996, INSECT MITE GALLS JA; Yukawa J, 1983, MEM FAC AGR KAGOSHIM, V19, P89	37	10	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102508	10.1371/journal.pone.0102508	http://dx.doi.org/10.1371/journal.pone.0102508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033216	Green Submitted, Green Published, gold			2022-12-25	WOS:000339418300059
J	Oslund, KL; Zhou, X; Lee, B; Zhu, LX; Duong, T; Shih, R; Baumgarth, N; Hung, LY; Wu, R; Chen, Y				Oslund, Karen L.; Zhou, Xu; Lee, Boram; Zhu, Lingxiang; Trang Duong; Shih, Robert; Baumgarth, Nicole; Hung, Li-Yin; Wu, Reen; Chen, Yin			Synergistic Up-Regulation of CXCL10 by Virus and IFN gamma in Human Airway Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INTERFERON-GAMMA; GENE-EXPRESSION; TNF-ALPHA; HUMAN KERATINOCYTES; 10 KDA; MACROPHAGES; INDUCTION; INFECTION; IP-10	Airway epithelial cells are the first line of defense against viral infections and are instrumental in coordinating the inflammatory response. In this study, we demonstrate the synergistic stimulation of CXCL10 mRNA and protein, a key chemokine responsible for the early immune response to viral infection, following treatment of airway epithelial cells with IFN gamma and influenza virus. The synergism also occurred when the cells were treated with IFN gamma and a viral replication mimicker (dsRNA) both in vitro and in vivo. Despite the requirement of type I interferon (IFNAR) signaling in dsRNA-induced CXCL10, the synergism was independent of the IFNAR pathway since it wasn't affected by the addition of a neutralizing IFNAR antibody or the complete lack of IFNAR expression. Furthermore, the same synergistic effect was also observed when a CXCL10 promoter reporter was examined. Although the responsive promoter region contains both ISRE and NF kappa B sites, western blot analysis indicated that the combined treatment of IFN gamma and dsRNA significantly augmented NF kappa B but not STAT1 activation as compared to the single treatment. Therefore, we conclude that IFN gamma and dsRNA act in concert to potentiate CXCL10 expression in airway epithelial cells via an NF kappa B-dependent but IFNAR-STAT independent pathway and it is at least partly regulated at the transcriptional level.	[Oslund, Karen L.; Trang Duong; Shih, Robert; Hung, Li-Yin; Wu, Reen] Univ Calif Davis, Dept Internal Med, Ctr Comparat Resp Biol & Med, Davis, CA 95616 USA; [Oslund, Karen L.; Trang Duong; Baumgarth, Nicole] Univ Calif Davis, Sch Vet Med, Dept Pathol Immunol & Microbiol, Davis, CA 95616 USA; [Zhou, Xu; Lee, Boram; Zhu, Lingxiang; Chen, Yin] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Arizona	Chen, Y (corresponding author), Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.	ychen@pharmacy.arizona.edu	Baumgarth, Nicole/AAI-6949-2020; Hung, Li-Yin/L-6758-2019	Hung, Li-Yin/0000-0001-7623-1946	National Institute of Health [AI061695, HL077902, HL077315, HL096373, ES00628]; American Lung Association; Fly Attendant Medical Research Institute [123055_CIA]; Arizona Biomedical Research Commission;  [ES012441]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096373, R01HL077902, R01HL077315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061695, R21AI113526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K08ES012441] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; Fly Attendant Medical Research Institute; Arizona Biomedical Research Commission; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by R01 grants from National Institute of Health (AI061695 to YC; HL077902, HL077315, HL096373, ES00628 to RW), a KO8 (ES012441) to KLO, a grant from the American Lung Association to KLO, a Fly Attendant Medical Research Institute grant (123055_CIA) to YC, and an Arizona Biomedical Research Commission grant to YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus JL, 2006, EXP BIOL MED, V231, P1283, DOI 10.1177/153537020623100801; Butowski N, 2009, J NEURO-ONCOL, V91, P183, DOI 10.1007/s11060-008-9705-3; Chen J, 2010, J VIROL, V84, P1289, DOI 10.1128/JVI.01281-09; Chen Y, 2006, AM J RESP CELL MOL, V34, P192, DOI 10.1165/rcmb.2004-0417OC; Chen Y, 2001, AM J RESP CELL MOL, V25, P542, DOI 10.1165/ajrcmb.25.5.4298; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; COLAMONICI OR, 1993, J BIOL CHEM, V268, P10895; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Dhillon N, 2008, J NEUROVIROL, V14, P196, DOI 10.1080/13550280801993648; Dhillon NK, 2007, J IMMUNOL, V179, P2722, DOI 10.4049/jimmunol.179.5.2722; Hardaker EL, 2004, FASEB J, V18, P191, DOI 10.1096/fj.03-0170fje; Horton MR, 1998, J BIOL CHEM, V273, P35088, DOI 10.1074/jbc.273.52.35088; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Kanda N, 2002, J INVEST DERMATOL, V119, P1290, DOI 10.1046/j.1523-1747.2002.19626.x; Kanda N, 2007, ENDOCRINOLOGY, V148, P2317, DOI 10.1210/en.2006-1639; Kraft M, 2001, CLIN EXP IMMUNOL, V126, P474, DOI 10.1046/j.1365-2249.2001.01634.x; Lindell DM, 2008, EUR J IMMUNOL, V38, P2168, DOI 10.1002/eji.200838155; Lombardi A, 2009, EUR J CELL BIOL, V88, P731, DOI 10.1016/j.ejcb.2009.07.004; Majumder S, 1998, J IMMUNOL, V161, P4736; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Tao SS, 2012, AM J RESP CELL MOL, V46, P660, DOI 10.1165/rcmb.2011-0340OC; Williams R, 2009, GLIA, V57, P734, DOI 10.1002/glia.20801; Wong JP, 2009, CURR PHARM DESIGN, V15, P1269, DOI 10.2174/138161209787846775; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6; Yu DF, 2011, AM J PHYSIOL-LUNG C, V301, pL31, DOI 10.1152/ajplung.00301.2010; Zeng XY, 2005, J INTERF CYTOK RES, V25, P103, DOI 10.1089/jir.2005.25.103; Zhu L, 2009, AM J RESP CELL MOL, V40, P610, DOI 10.1165/rcmb.2008-0223OC	28	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100978	10.1371/journal.pone.0100978	http://dx.doi.org/10.1371/journal.pone.0100978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033426	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300013
J	Shapiro, LJ; Cole, WG; Young, JW; Raichlen, DA; Robinson, SR; Adolph, KE				Shapiro, Liza J.; Cole, Whitney G.; Young, Jesse W.; Raichlen, David A.; Robinson, Scott R.; Adolph, Karen E.			Human Quadrupeds, Primate Quadrupedalism, and Uner Tan Syndrome	PLOS ONE			English	Article							DIAGONAL-SEQUENCE WALKING; SYMMETRICAL GAITS; INTERLIMB COORDINATION; CEREBELLAR HYPOPLASIA; MENTAL-RETARDATION; MONKEY LOCOMOTION; FOOTFALL PATTERNS; TREADMILL; EVOLUTION; MUTATIONS	Since 2005, an extensive literature documents individuals from several families afflicted with "Uner Tan Syndrome (UTS)," a condition that in its most extreme form is characterized by cerebellar hypoplasia, loss of balance and coordination, impaired cognitive abilities, and habitual quadrupedal gait on hands and feet. Some researchers have interpreted habitual use of quadrupedalism by these individuals from an evolutionary perspective, suggesting that it represents an atavistic expression of our quadrupedal primate ancestry or "devolution." In support of this idea, individuals with "UTS" are said to use diagonal sequence quadrupedalism, a type of quadrupedal gait that distinguishes primates from most other mammals. Although the use of primate-like quadrupedal gait in humans would not be sufficient to support the conclusion of evolutionary "reversal," no quantitative gait analyses were presented to support this claim. Using standard gait analysis of 518 quadrupedal strides from video sequences of individuals with "UTS", we found that these humans almost exclusively used lateral sequence-not diagonal sequence-quadrupedal gaits. The quadrupedal gait of these individuals has therefore been erroneously described as primate-like, further weakening the "devolution" hypothesis. In fact, the quadrupedalism exhibited by individuals with UTS resembles that of healthy adult humans asked to walk quadrupedally in an experimental setting. We conclude that quadrupedalism in healthy adults or those with a physical disability can be explained using biomechanical principles rather than evolutionary assumptions.	[Shapiro, Liza J.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Cole, Whitney G.; Robinson, Scott R.; Adolph, Karen E.] NYU, Dept Psychol, New York, NY 10003 USA; [Young, Jesse W.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA; [Raichlen, David A.] Univ Arizona, Sch Anthropol, Tucson, AZ USA	University of Texas System; University of Texas Austin; New York University; Northeast Ohio Medical University (NEOMED); University of Arizona	Shapiro, LJ (corresponding author), Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA.	liza.shapiro@austin.utexas.edu		Cole, Whitney/0000-0002-0637-4738	Eunice Kennedy Shriver National Institute of Child Health & Human Development [R37-HD033486]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD033486] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by Award Number R37-HD033486 to KEA from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph KE, 1998, CHILD DEV, V69, P1299, DOI 10.2307/1132267; Alton F, 1998, CLIN BIOMECH, V13, P434, DOI 10.1016/S0268-0033(98)00012-6; [Anonymous], 1966, FOLIA BIOTHEORETICA; BLASZCZYK J, 1993, PHYSIOL BEHAV, V53, P501, DOI 10.1016/0031-9384(93)90144-5; Blumberg MS, 2010, FREAKS NATURE WHAT A; Boycott KM, 2009, J CHILD NEUROL, V24, P1310, DOI 10.1177/0883073809332696; BUCHNER HHF, 1994, VET QUART, V16, pS87; Burnside LH, 1927, GENET PSYCHOL MONOGR, V2; Cartmill M, 2002, ZOOL J LINN SOC-LOND, V136, P401, DOI 10.1046/j.1096-3642.2002.00038.x; Cartmill Matt, 2007, P403, DOI 10.1007/978-0-387-33507-0_12; FREEDLAND RL, 1994, PSYCHOL SCI, V5, P26, DOI 10.1111/j.1467-9280.1994.tb00609.x; Gulsuner S, 2011, GENOME RES, V21, P1995, DOI 10.1101/gr.126110.111; HEGLUND NC, 1974, SCIENCE, V186, P1112, DOI 10.1126/science.186.4169.1112; Herbin M, 2007, BEHAV BRAIN RES, V181, P173, DOI 10.1016/j.bbr.2007.04.001; Herz Joachim, 2008, Proc Natl Acad Sci U S A, V105, pE25, DOI 10.1073/pnas.0802584105; HILDEBRAND M, 1967, AM J PHYS ANTHROPOL, V26, P119, DOI 10.1002/ajpa.1330260203; HILDEBRAND M, 1968, J MORPHOL, V124, P353, DOI 10.1002/jmor.1051240308; HILDEBRAND M, 1980, AM ZOOL, V20, P255; Hildebrand M., 1976, NEURAL CONTROL LOCOM, V18, P202, DOI DOI 10.1007/978-1-4757-0964-3_9; Hirasaki E, 2004, J HUM EVOL, V46, P739, DOI 10.1016/j.jhevol.2004.04.004; Humphrey Nicholas, 2008, Proc Natl Acad Sci U S A, V105, pE26, DOI 10.1073/pnas.0802839105; HUROV JR, 1982, AM J PRIMATOL, V2, P211, DOI 10.1002/ajp.1350020210; Ivanenko YP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00020; Karaca S, 2013, DEV DISABILITIES MOL; Karaca Sibel, 2012, Front Neurol, V3, P154, DOI 10.3389/fneur.2012.00154; Larson SG, 1998, PRIMATE LOCOMOTION, P157; Lemelin P, 2003, J ZOOL, V260, P423, DOI 10.1017/S0952836903003856; Lemelin Pierre, 2007, P329, DOI 10.1007/978-0-387-33507-0_10; MacLellan MJ, 2012, J NEUROPHYSIOL, V107, P114, DOI 10.1152/jn.00693.2011; Muybridge E, 1955, HUMAN FIGURE MOTION; Muybridge E., 1887, ANIMAL LOCOMOTION EL; Muybridge Eadweard, 1902, ANIMALS MOTION, P20; Nakano Y, 1996, FOLIA PRIMATOL, V66, P113, DOI 10.1159/000157189; NELSON RC, 1972, MED SCI SPORT EXER, V4, P233, DOI 10.1249/00005768-197200440-00029; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Nyakatura JA, 2008, AM J PHYS ANTHROPOL, V135, P13, DOI 10.1002/ajpa.20699; Nyakatura JA, 2010, J HUM EVOL, V58, P242, DOI 10.1016/j.jhevol.2009.11.010; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; Ozcelik T, 2008, P NATL ACAD SCI USA, V105, P4232, DOI 10.1073/pnas.0804078105; Patrick SK, 2009, J NEUROPHYSIOL, V101, P603, DOI 10.1152/jn.91125.2008; Pereira JE, 2006, BEHAV BRAIN RES, V172, P212, DOI 10.1016/j.bbr.2006.04.027; PRIDMORE PA, 1994, AUST J ZOOL, V42, P679, DOI 10.1071/ZO9940679; PROST JH, 1969, AM J PHYS ANTHROPOL, V31, P53, DOI 10.1002/ajpa.1330310107; Reilly SM, 2006, P ROY SOC B-BIOL SCI, V273, P1563, DOI 10.1098/rspb.2006.3489; REYNOLDS TR, 1987, AM J PHYS ANTHROPOL, V72, P101, DOI 10.1002/ajpa.1330720113; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Shapiro LJ, 2006, J ZOOL, V269, P191, DOI 10.1111/j.1469-7998.2006.00082.x; Shapiro LJ, 2011, DEV PRIMATOL-PROG PR, P335, DOI 10.1007/978-1-4419-1420-0_17; Shapiro LJ, 2005, AM J PHYS ANTHROPOL, V126, P205, DOI 10.1002/ajpa.20049; Slijper EJ, 1942, P K NED AKAD WETENSC, V45, P288; SPARROW WA, 1989, AM J PHYS ANTHROPOL, V78, P387, DOI 10.1002/ajpa.1330780307; Stevens NJ, 2008, AM J PRIMATOL, V70, P356, DOI 10.1002/ajp.20499; Stevens NJ, 2006, J EXP ZOOL PART A, V305A, P953, DOI 10.1002/jez.a.336; STEVENS NJ, 2003, THESIS STONY BROOK U; Tan M, 2010, MOVEMENT DISORD, V25, P652, DOI 10.1002/mds.22951; Tan ner, 2012, LATEST FIND INTELLEC, V1, P1; Tan U, 2006, INT J NEUROSCI, V116, P361, DOI 10.1080/00207450500455330; Tan U, 2005, NEUROQUANTOLOGY, V4, P250; Tan U, 2010, WEBMEDCENTRAL NEUROL, V1, P1; Tan U, 2008, INT J NEUROSCI, V118, P1, DOI 10.1080/00207450701667857; Tan U, 2008, INT J NEUROSCI, V118, P313, DOI 10.1080/00207450701667766; Tan U, 2008, INT J NEUROSCI, V118, P211, DOI 10.1080/00207450701667808; Tan U, 2006, INT J NEUROSCI, V116, P1539, DOI 10.1080/10623320600934325; Tan U, 2006, INT J NEUROSCI, V116, P763, DOI 10.1080/00207450600588733; Tan U, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00084; Tan Uner, 2010, Open Neurol J, V4, P78, DOI 10.2174/1874205X01004010078; Tan U, 2009, INT J NEUROSCI, V119, P909, DOI 10.1080/00207450902828050; Turkmen S, 2008, EUR J HUM GENET, V16, P1070, DOI 10.1038/ejhg.2008.73; Turkmen S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000487; VILENSKY JA, 1989, ANNU REV ANTHROPOL, V18, P17, DOI 10.1146/annurev.an.18.100189.000313; VILENSKY JA, 1989, AM J PRIMATOL, V17, P11, DOI 10.1002/ajp.1350170103; VILENSKY JA, 1994, J HUM EVOL, V26, P375, DOI 10.1006/jhev.1994.1024; Wallace IJ, 2008, J HUM EVOL, V54, P783, DOI 10.1016/j.jhevol.2007.10.008; Webb D, 2007, PRIMATES, V48, P277, DOI 10.1007/s10329-007-0043-4; West-Eberhard Mary Jane, 2003, pi; WHITE TD, 1990, J MAMMAL, V71, P79, DOI 10.2307/1381321; Young JW, 2007, J HUM EVOL, V53, P26, DOI 10.1016/j.jhevol.2007.01.005; Young JW, 2012, AM J PHYS ANTHROPOL, V147, P580, DOI 10.1002/ajpa.22016	78	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101758	10.1371/journal.pone.0101758	http://dx.doi.org/10.1371/journal.pone.0101758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029457	Green Submitted, Green Published			2022-12-25	WOS:000341306600022
J	Vishal, LA; Nazeer, Y; Ravishankaran, R; Mahalakshmi, N; Kaliraj, P				Vishal, Lawrence Ansel; Nazeer, Y.; Ravishankaran, Rajendran; Mahalakshmi, Natarajan; Kaliraj, Perumal			Evaluation of Rapid Blood Sample Collection in the Detection of Circulating Filarial Antigens for Epidemiological Survey by rWbSXP-1 Capture Assay	PLOS ONE			English	Article							WUCHERERIA-BANCROFTI ANTIGEN; LYMPHATIC FILARIASIS; ESCHERICHIA-COLI; FIELD-EVALUATION; DIAGNOSIS; INFECTION; ANTIBODY; MICROFILAREMIA; INDIVIDUALS; FILTRATION	Background: Lymphatic filariasis is a neglected tropical disease leading to profound disfiguring causing socio economic burden in the tropics. Current diagnosis strategies available during field surveys and epidemics are based on traditional microscopic detections and a few antigen/antibody assays. We have compared different sampling methodologies and standardized the highly sensitive and reliable rWbSXP-1 antigen detection assay to our new sampling methodology. Methodology: Samples collected as serum, whole blood, whole blood on filter paper and whole blood on microscopic slides from patients belonging to various clinical groups of filariasis [endemic normal(EN), chronic pathology(CP), microfilaraemic(MF) and non-endemic normal(NEN)] were collected and standardized the rWbSXP-1 antigen detection assay using monoclonal antibody raised against rWbSXP-1 protein. The whole blood collected on microscopic slide based sampling method was employed in the field and the presence of circulating filarial antigen (CFA) was assessed using the rWbSXP-1 assay. Principal Findings: The sampling methods were compared and no significant difference was observed for the detection of CFA (MF, P = 0.304, EN, P = 0.675, CP, P = 0.5698, NEN, P = 0.4494). Further the optimized sampling method was utilized to collect the 1106 samples from Polur, Tiruvannamalai. The rWbSXP-1 assay gave 98 antigen positive results whereas the microscopic method gave only 17. Conclusions: Four sampling methodologies were analyzed and the new sampling methodology of whole blood collected on microscopic slide was found to be convenient for the detection of CFA using rWbSXP-1 antigen detection assay. The 1106 samples from Polur were collected using the new method. The rWbSXP-1 antigen assay perceived a 7.32% increased result which was read as false negatives on the conventional microscopic staining method. This new sampling methodology coupled with the rWbSXP-1 antigen assay can be used in epidemiological surveys for lymphatic filariasis and the same sampling methodology can be expanded to other antigen based high affinity assays.	[Vishal, Lawrence Ansel; Nazeer, Y.; Ravishankaran, Rajendran; Mahalakshmi, Natarajan; Kaliraj, Perumal] Anna Univ, Ctr Biotechnol, Chennai 600025, Tamil Nadu, India	Anna University; Anna University Chennai	Kaliraj, P (corresponding author), Anna Univ, Ctr Biotechnol, Chennai 600025, Tamil Nadu, India.	kaliraj55@yahoo.co.in		Sharif, Nazeer/0000-0001-6732-3662; Lawrance, Ansel Vishal/0000-0002-2795-1303	Indian Council of Medical Research [80/810/13-ECDI]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The research was funded by Indian Council of Medical Research vide the Senior Research Fellowship granted to Mr. Ansel Vishal L. File No: 80/810/13-ECDI, url: www.icmr.nic.in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Rahman Rohana, 2007, Filaria J, V6, P10; Baskar LKV, 2004, MICROBIOL IMMUNOL, V48, P519, DOI 10.1111/j.1348-0421.2004.tb03547.x; Bhandari P, 1997, J BACTERIOL, V179, P4403, DOI 10.1128/jb.179.13.4403-4406.1997; CHANTEAU S, 1994, J INFECT DIS, V170, P247, DOI 10.1093/infdis/170.1.247; CLSI (formerly NCCLS), 2000, M15A CLSI NCCLS, P15; Garcia-Meras Lydia, 2007, DIAGNOSTIC MED PARAS, P15; Gyapong JO, 1998, T ROY SOC TROP MED H, V92, P407, DOI 10.1016/S0035-9203(98)91068-9; HARLOW E, 1998, USING ANTIBODIES LAB; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hoti SL, 2002, NATL MED J INDIA, V15, P263; Jamail M, 2005, TROP MED INT HEALTH, V10, P99, DOI 10.1111/j.1365-3156.2004.01334.x; Janardhan S, 2007, J IND MICROBIOL BIOT, V34, P675, DOI 10.1007/s10295-007-0243-3; Jawaharlal JP, 2013, DIAGN MICROBIOL INFE; Lammie Patrick J, 2004, Filaria J, V3, P9, DOI 10.1186/1475-2883-3-9; Mahalakshmi N, 2013, PARASITOL RES, V112, P3203, DOI 10.1007/s00436-013-3496-y; MCMAHON JE, 1979, ANN TROP MED PARASIT, V73, P457, DOI 10.1080/00034983.1979.11687285; OTTESEN EA, 1982, AM J TROP MED HYG, V31, P953, DOI 10.4269/ajtmh.1982.31.953; Pandey V, 2011, CLIN CHIM ACTA, V412, P1867, DOI 10.1016/j.cca.2011.06.029; Pandiaraja P, 2010, EXP PARASITOL, V125, P236, DOI 10.1016/j.exppara.2010.01.027; Ravichandran M, 1997, PARASITE IMMUNOL, V19, P69, DOI 10.1046/j.1365-3024.1997.d01-185.x; Rocha A, 2004, MEM I OSWALDO CRUZ, V99, P101, DOI 10.1590/S0074-02762004000100018; Sabesan S, 2010, J POSTGRAD MED, V56, P232, DOI 10.4103/0022-3859.68650; SANTHANAM S, 1989, TROP MED PARASITOL, V40, P440; SINGH J, 1956, Indian J Malariol, V10, P117; Southgate B A, 1984, Trans R Soc Trop Med Hyg, V78 Suppl, P19, DOI 10.1016/0035-9203(84)90310-9; Suba S., 2000, Biomedical Research (Aligarh), V11, P321; Tisch DJ, 2008, AM J TROP MED HYG, V78, P289, DOI 10.4269/ajtmh.2008.78.289; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER P, 1993, TROP MED PARASITOL, V44, P45; Weil GJ, 2007, TRENDS PARASITOL, V23, P78, DOI 10.1016/j.pt.2006.12.001; Weil GJ, 2013, AM J TROP MED HYG, V89, P11, DOI 10.4269/ajtmh.13-0089; Weil GJ, 2011, ACTA TROP, V120, pS19, DOI 10.1016/j.actatropica.2010.04.010; Weil GJ, 1996, AM J TROP MED HYG, V55, P333, DOI 10.4269/ajtmh.1996.55.333; Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7; World Health Organisation Division of Tropical Disease, 1998, WHOCTDFIL974	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102260	10.1371/journal.pone.0102260	http://dx.doi.org/10.1371/journal.pone.0102260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025711	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400055
J	Zhang, CL; Yu, ZQ; Li, XP; Xu, YJ; Liu, D				Zhang, Chengliang; Yu, Zaoqin; Li, Xiping; Xu, Yanjiao; Liu, Dong			Chronopharmacodynamics and Chronopharmacokinetics of Pethidine in Mice	PLOS ONE			English	Article							MEPERIDINE; MORPHINE; TOLERANCE; PHARMACOKINETICS; DISPOSITION; AGONISTS; PLASMA; RHYTHM; PAIN; TIME	Background: Many studies have demonstrated that the pharmacokinetics and pharmacodynamics of analgesic drugs vary according to the circadian time of drug administration. This study aims at determining whether the analgesic effect and pharmacokinetics of pethidine in male BALB/c mice are influenced by administration time. Methods: A hot-plate test was used to evaluate the analgesic effect after pethidine (20 mg/kg) or saline injection at different dosing times. Mouse blood samples were collected at different intervals after dosing at 9: 00 am and 9: 00 pm, and were determined via liquid chromatography-tandem mass spectrometry (LC-MS/MS). Results: A significant 24-h rhythm was observed in the latency to thermal response at 30 min after dosing, with the peak during the dark phase and the nadir during the light phase. Tolerance to analgesic effect was produced after chronic pethidine injection at 9: 00 am or 9: 00 pm, and the recovery from tolerance was faster during the dark phase. The peak concentration (C-max) and area under the concentration-time curve (AUC) of pethidine and its metabolite norpethidine were significantly higher during the dark phase than during the light phase, but the total serum clearance (CL/F) exhibited the opposite trend. The rhythm of drug plasma concentration was positively correlated with the analgesic effect. Conclusion: These results suggest that the pharmacodynamics and pharmacokinetics of pethidine in mice vary significantly according to the dosing time, which implies that the time of administration should be considered in the rational clinical use of pethidine to maximise analgesia and minimise the adverse effects.	[Zhang, Chengliang; Yu, Zaoqin; Li, Xiping; Xu, Yanjiao; Liu, Dong] Huazhong Univ Sci & Technol, Dept Pharm, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Yu, Zaoqin] China Pharmaceut Univ, Coll Pharmacol, Dept Clin Pharm, Nanjing, Jiangsu, Peoples R China	Huazhong University of Science & Technology; China Pharmaceutical University	Liu, D (corresponding author), Huazhong Univ Sci & Technol, Dept Pharm, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	ld2069@outlook.com	Zhang, Cheng/GRS-8698-2022					Boom Merel, 2010, J Pain Res, V3, P183, DOI 10.2147/JPR.S13616; Boulamery A, 2007, CHRONOBIOL INT, V24, P961, DOI 10.1080/07420520701648309; Bruguerolle B, 2007, ADV DRUG DELIVER REV, V59, P883, DOI 10.1016/j.addr.2006.06.001; Clark Richard F., 1995, Journal of Emergency Medicine, V13, P797, DOI 10.1016/0736-4679(95)02002-0; CLARKE JM, 1976, LANCET, V2, P508, DOI 10.1016/S0140-6736(76)90801-1; Cui Y, 2005, CHRONOBIOL INT, V22, P515, DOI 10.1081/CBI-200062397; DAHLSTROM BE, 1979, DRUG METAB DISPOS, V7, P108; DANZIGER LH, 1994, PHARMACOTHERAPY, V14, P235; DEGAUTE JP, 1991, HYPERTENSION, V18, P199, DOI 10.1161/01.HYP.18.2.199; EBERT B, 1995, NEUROSCI LETT, V187, P165, DOI 10.1016/0304-3940(95)11364-3; Erstad BL, 1997, ANN PHARMACOTHER, V31, P23, DOI 10.1177/106002809703100102; FRANCE CP, 1990, J PHARMACOL EXP THER, V254, P626; Fu CY, 2007, BEHAV BRAIN RES, V184, P39, DOI 10.1016/j.bbr.2007.06.019; Hashimoto T, 2006, ANESTHESIOLOGY, V105, P574, DOI 10.1097/00000542-200609000-00023; HUMMEL T, 1995, CHRONOBIOL INT, V12, P62, DOI 10.3109/07420529509064501; KAIKO RF, 1983, ANN NEUROL, V13, P180, DOI 10.1002/ana.410130213; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; Kanasaki Y, 2012, J PHARMACOL SCI, V120, P112, DOI 10.1254/jphs.12059FP; Kennaway DJ, 1998, J CLIN ENDOCR METAB, V83, P1013, DOI 10.1210/jc.83.3.1013; Koczmara Christine, 2005, Dynamics, V16, P8; Latta Kenneth S, 2002, Am J Ther, V9, P53, DOI 10.1097/00045391-200201000-00010; Liu Xiao-ping, 2001, Yaoxue Xuebao, V36, P561; Liu YW, 2011, J PHARMACOL SCI, V115, P196, DOI 10.1254/jphs.10284FP; Maronde E, 2007, TRENDS ENDOCRIN MET, V18, P142, DOI 10.1016/j.tem.2007.03.001; Paech MJ, 2008, ANESTH ANALG, V106, P278, DOI 10.1213/01.ane.0000287650.75027.11; PARONIS CA, 1992, J PHARMACOL EXP THER, V262, P1; Ramirez J, 2004, DRUG METAB DISPOS, V32, P930; RITSCHEL WA, 1983, INT J CLIN PHARM TH, V21, P218; STEVENS CW, 1989, J PHARMACOL EXP THER, V251, P216; Tabuchi M, 2005, CANCER RES, V65, P8448, DOI 10.1158/0008-5472.CAN-05-1161; Ushijima K, 2005, J PHARMACOL EXP THER, V315, P764, DOI 10.1124/jpet.105.088849; Vranken JH, 2005, ACTA ANAESTH SCAND, V49, P665, DOI 10.1111/j.1399-6576.2005.00667.x; Weed MR, 2006, PHARMACOL BIOCHEM BE, V84, P487, DOI 10.1016/j.pbb.2006.06.012; Yamakura T, 1999, ANESTHESIOLOGY, V91, P1053, DOI 10.1097/00000542-199910000-00026; Yillar D. O., 2009, Journal of Basic and Clinical Physiology and Pharmacology, V20, P159; Yoshida M, 2003, J PHARMACOL EXP THER, V305, P1200, DOI 10.1124/jpet.103.049031; Zhang CL, 2013, J ANAL TOXICOL, V37, P351, DOI 10.1093/jat/bkt043	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102054	10.1371/journal.pone.0102054	http://dx.doi.org/10.1371/journal.pone.0102054			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025283	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400040
J	Yun, EJ; Baek, ST; Xie, D; Tseng, SF; Dobin, T; Hernandez, E; Zhou, J; Zhang, L; Yang, J; Sun, H; Xiao, G; He, D; Kittler, R; Hsieh, JT				Yun, E-J; Baek, S. T.; Xie, D.; Tseng, S-F; Dobin, T.; Hernandez, E.; Zhou, J.; Zhang, L.; Yang, J.; Sun, H.; Xiao, G.; He, D.; Kittler, R.; Hsieh, J-T			DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1	ONCOGENE			English	Article							ABERRANT PROMOTER METHYLATION; PROTEIN HDAB2IP GENE; PROSTATE-CANCER; C-KIT; TYROSINE KINASE; PROSPECTIVE IDENTIFICATION; MESENCHYMAL TRANSITION; MAMMALIAN TARGET; DOWN-REGULATION; GROWTH-FACTOR	Cancer stem cell (CSC), the primary source of cancer-initiating population, is involved in cancer recurrence and drug-resistant phenotypes. This study demonstrates that the loss of DAB2IP, a novel Ras-GTPase activating protein frequently found in many cancer types, is associated with CSC properties. Mechanistically, DAB2IP is able to suppress stem cell factor receptor (c-kit or CD117) gene expression by interacting with a newly identified silencer in the c-kit gene. Moreover, DAB2IP is able to inhibit c-kit-PI3K-Akt-mTOR signaling pathway that increases c-myc protein to activate ZEB1 gene expression leading to the elevated CSC phenotypes. An inverse correlation between CD117 or ZEB1 and DAB2IP is also found in clinical specimens. Similarly, Elevated expression of ZEB1 and CD117 are found in the prostate basal cell population of DAB2IP knockout mice. Our study reveals that DAB2IP has a critical role in modulating CSC properties via CD117-mediated ZEB1 signaling pathway.	[Yun, E-J; Tseng, S-F; Dobin, T.; Hernandez, E.; Zhou, J.; Zhang, L.; Hsieh, J-T] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Baek, S. T.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Xie, D.] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Canc Res Inst, Dept Gen Surg, Wuhan 430074, Hubei, Peoples R China; [Zhou, J.; Zhang, L.; He, D.] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Urol, Xian 710049, Peoples R China; [Yang, J.; Sun, H.; Xiao, G.] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Kittler, R.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Kittler, R.] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth, Dallas, TX 75390 USA; [Kittler, R.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dev, Dallas, TX 75390 USA; [Hsieh, J-T] China Med Univ Hosp, Grad Inst Canc Biol, Taichung, Taiwan	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Huazhong University of Science & Technology; Xi'an Jiaotong University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; China Medical University Taiwan; China Medical University Hospital - Taiwan	Hsieh, JT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Urol, J8-134 Dallas,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jt.hsieh@utsouthwestern.edu	Kittler, Ralf/AAD-4258-2020; Kittler, Ralf/I-4662-2013	Kittler, Ralf/0000-0002-0098-6792; Kittler, Ralf/0000-0002-0098-6792; Baek, Seung Tae/0000-0003-0040-1501	United States Army [W81XWH-11-1-0491]; National Institutes of Health [CA182670]; NATIONAL CANCER INSTITUTE [R01CA182670] Funding Source: NIH RePORTER	United States Army(United States Department of DefenseUnited States Army); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Mrs Mary Barnes for editing this manuscript. This work was supported in part by grants from the United States Army (W81XWH-11-1-0491 to J-TH) and National Institutes of Health (CA182670 to J-TH).	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Chambeyron S, 2004, CURR OPIN CELL BIOL, V16, P256, DOI 10.1016/j.ceb.2004.03.004; Chen H, 2006, DNA CELL BIOL, V25, P232, DOI 10.1089/dna.2006.25.232; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dote H, 2004, CLIN CANCER RES, V10, P2082, DOI 10.1158/1078-0432.CCR-03-0236; Dote H, 2005, BRIT J CANCER, V92, P1117, DOI 10.1038/sj.bjc.6602458; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Feng LX, 2000, J BIOL CHEM, V275, P25572, DOI 10.1074/jbc.M002218200; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hassan HT, 1996, ACTA HAEMATOL-BASEL, V95, P257; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Huang S, 1998, EMBO J, V17, P4358, DOI 10.1093/emboj/17.15.4358; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Joensuu H, 2001, ANN MED, V33, P451, DOI 10.3109/07853890109002093; Kim M, 2002, CLIN CANCER RES, V8, P22; Klonisch T, 2008, TRENDS MOL MED, V14, P450, DOI 10.1016/j.molmed.2008.08.003; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kong ZL, 2010, INT J RADIAT ONCOL, V78, P1210, DOI 10.1016/j.ijrobp.2010.06.019; Kong ZL, 2010, CANCER RES, V70, P2829, DOI 10.1158/0008-5472.CAN-09-2919; Kyprianou N, 2010, P NATL ACAD SCI USA, V107, P2731, DOI 10.1073/pnas.0914721107; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Li JM, 2007, AM J PHYSIOL-ENDOC M, V293, pE475, DOI 10.1152/ajpendo.00172.2007; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Ma FX, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/948683; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Munugalavadla V, 2005, MOL CELL BIOL, V25, P6747, DOI 10.1128/MCB.25.15.6747-6759.2005; NAGLE RB, 1987, CANCER RES, V47, P281; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rangel EB, 2013, STEM CELLS, V31, P1644, DOI 10.1002/stem.1412; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; STROBL H, 1992, BRIT J HAEMATOL, V82, P287, DOI 10.1111/j.1365-2141.1992.tb06420.x; Sundstrom M, 2003, IMMUNOLOGY, V108, P89, DOI 10.1046/j.1365-2567.2003.01559.x; Van der Poel HG, 2004, J UROLOGY, V172, P1333, DOI 10.1097/01.ju.0000138829.97838.19; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wright JL, 2010, J UROLOGY, V183, P2213, DOI 10.1016/j.juro.2010.02.017; Wu K, 2013, ONCOGENE, V33, P1954; Wu KJ, 2013, CLIN CANCER RES, V19, P4740, DOI 10.1158/1078-0432.CCR-13-0954; Xie DX, 2010, P NATL ACAD SCI USA, V107, P2485, DOI 10.1073/pnas.0908133107; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; YAMAMOTO K, 1993, JPN J CANCER RES, V84, P1136, DOI 10.1111/j.1349-7006.1993.tb02813.x; Yano M, 2005, INT J CANCER, V113, P59, DOI 10.1002/ijc.20531; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689; Yu M, 2009, GENE DEV, V23, P1737, DOI 10.1101/gad.1809309; Zhang HF, 2008, J CLIN INVEST, V118, P3904, DOI 10.1172/JCI36168; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	60	42	43	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2015	34	21					2741	2752		10.1038/onc.2014.215	http://dx.doi.org/10.1038/onc.2014.215			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI7XN	25043300				2022-12-25	WOS:000354979500007
J	Gomez-Maldonado, L; Tiana, M; Roche, O; Prado-Cabrero, A; Jensen, L; Fernandez-Barral, A; Guijarro-Munoz, I; Favaro, E; Moreno-Bueno, G; Sanz, L; Aragones, J; Harris, A; Volpert, O; Jimenez, B; del Peso, L				Gomez-Maldonado, L.; Tiana, M.; Roche, O.; Prado-Cabrero, A.; Jensen, L.; Fernandez-Barral, A.; Guijarro-Munoz, I.; Favaro, E.; Moreno-Bueno, G.; Sanz, L.; Aragones, J.; Harris, A.; Volpert, O.; Jimenez, B.; del Peso, L.			EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination	ONCOGENE			English	Article							GENE-EXPRESSION; INDUCIBLE FACTORS; EPH RECEPTORS; MASTER REGULATORS; CELL-ADHESION; HIF-ALPHA; CANCER; IDENTIFICATION; MICRORNA-210; SIGNATURE	The presence of hypoxic regions in solid tumors is an adverse prognostic factor for patient outcome. Here, we show that hypoxia induces the expression of Ephrin-A3 through a novel hypoxia-inducible factor (HIF)-mediated mechanism. In response to hypoxia, the coding EFNA3 mRNA levels remained relatively stable, but HIFs drove the expression of previously unknown long noncoding (lnc) RNAs from EFNA3 locus and these lncRNA caused Ephrin-A3 protein accumulation. Ephrins are cell surface proteins that regulate diverse biological processes by modulating cellular adhesion and repulsion. Mounting evidence implicates deregulated ephrin function in multiple aspects of tumor biology. We demonstrate that sustained expression of both Ephrin-A3 and novel EFNA3 lncRNAs increased the metastatic potential of human breast cancer cells, possibly by increasing the ability of tumor cells to extravasate from the blood vessels into surrounding tissue. In agreement, we found a strong correlation between high EFNA3 expression and shorter metastasis-free survival in breast cancer patients. Taken together, our results suggest that hypoxia could contribute to metastatic spread of breast cancer via HIF-mediated induction of EFNA3 lncRNAs and subsequent Ephrin-A3 protein accumulation.	[Gomez-Maldonado, L.; Tiana, M.; Roche, O.; Prado-Cabrero, A.; Fernandez-Barral, A.; Moreno-Bueno, G.; Jimenez, B.; del Peso, L.] Univ Autonoma Madrid, Dept Bioquim, Madrid, Spain; [Gomez-Maldonado, L.; Tiana, M.; Roche, O.; Prado-Cabrero, A.; Fernandez-Barral, A.; Moreno-Bueno, G.; Jimenez, B.; del Peso, L.] Alberto Sols CSIC UAM, Inst Invest Biomed, Madrid 28029, Spain; [Roche, O.; del Peso, L.] Hosp Univ La Paz, Inst Invest Sanitaria, IdiPaz, Madrid, Spain; [Jensen, L.] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Jensen, L.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Guijarro-Munoz, I.; Sanz, L.] Hosp Univ Puerta Hierro Majadahonda, Mol Immunol Unit, Madrid, Spain; [Favaro, E.; Harris, A.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Mol Oncol Labs, Oxford OX3 9DU, England; [Aragones, J.] Autonomous Univ Madrid, Res Inst Princesa, Hosp Univ Santa Cristina, Res Unit, E-28049 Madrid, Spain; [Volpert, O.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Universitario La Paz; Linkoping University; Karolinska Institutet; Hospital Puerta de Hierro-Majadahonda; University of Oxford; Autonomous University of Madrid; Northwestern University; Feinberg School of Medicine	del Peso, L (corresponding author), Alberto Sols Univ Autonoma Madrid, Inst Invest Biomed, Fac Med, Dept Biochem,CSIC UAM, Arturo Duperier 4, Madrid 28029, Spain.	luis.peso@uam.es	Roche, UCLM/F-5697-2019; Harris, Adrian L/ABA-3343-2020; Prado-Cabrero, Alfonso/M-2504-2019; tiana, maria/G-4240-2016; Favaro, Elena/Q-4566-2016; Fernández-Barral, Asunión/O-8133-2015; del Peso, Luis/K-9391-2014; Prado-Cabrero, Alfonso/F-2823-2015; Tiana, María/AAA-1868-2020; Sanz, Laura/F-8542-2010; Moreno-Bueno, Gema/K-9354-2016; Cuenca, Benilde Jimenez/K-9959-2014	Roche, UCLM/0000-0003-1884-8256; Harris, Adrian L/0000-0003-1376-8409; Prado-Cabrero, Alfonso/0000-0001-8268-5362; tiana, maria/0000-0003-0678-1154; Favaro, Elena/0000-0001-5376-5515; Fernández-Barral, Asunión/0000-0002-1278-4645; del Peso, Luis/0000-0003-4014-5688; Prado-Cabrero, Alfonso/0000-0001-8268-5362; Tiana, María/0000-0003-0678-1154; Sanz, Laura/0000-0002-3119-3218; Moreno-Bueno, Gema/0000-0002-5030-6687; Jensen, Lasse/0000-0003-2338-357X; Jimenez Cuenca, Benilde/0000-0002-1806-6636	Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation, MICINN) [SAF2008-03147, SAF2011_24225, SAF-2010-19256]; Comunidad Autonoma de Madrid [S2010/BMD-2542]; European Union (METOXIA project) [HEALTH-F2-2009-222741]; CSIC [JAE DOC 2010/FSE2007-2013]; Fondo de Investigacion Sanitaria/Instituto de Salud Carlos III [PI08/90856, PS09/00227]; Cancer Research UK [16466, 11359, 18974] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA172669] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation, MICINN); Comunidad Autonoma de Madrid(Comunidad de Madrid); European Union (METOXIA project); CSIC; Fondo de Investigacion Sanitaria/Instituto de Salud Carlos III(Instituto de Salud Carlos III); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Amparo Acker-Palmer for expert advice on ephrin detection and Ignacio Palmero DGCR8 reagents. This work was supported by Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation, MICINN) (grant numbers SAF2008-03147 and SAF2011_24225 to LdeIP and SAF-2010-19256 to BJ); by Comunidad Autonoma de Madrid (grant numbers S2010/BMD-2542 to LdeIP), by the 7th Research Framework Programme of the European Union (grant number METOXIA project ref. HEALTH-F2-2009-222741 to LdeIP); by CSIC (JAE DOC 2010/FSE2007-2013 to OR) and by Fondo de Investigacion Sanitaria/Instituto de Salud Carlos III (grants PI08/90856 and PS09/00227 to LS).	Barderas R, 2013, MOL CELL PROTEOMICS, V12, P1602, DOI 10.1074/mcp.M112.022848; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen J, 2012, ADV CANCER RES, V114, P1, DOI 10.1016/B978-0-12-386503-8.00001-6; Cheng YM, 2006, BIOINFORMATICS, V22, P2320, DOI 10.1093/bioinformatics/btl394; Choudhry H, 2014, EMBO REP, V15, P70, DOI 10.1002/embr.201337642; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miro-Murillo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022589; Nallamshetty S, 2013, FREE RADICAL BIO MED, V64, P20, DOI 10.1016/j.freeradbiomed.2013.05.022; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Nie L, 2012, AM J TRANSL RES, V4, P127; Nievergall E, 2012, CELL MOL LIFE SCI, V69, P1813, DOI 10.1007/s00018-011-0900-6; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Rouhi P, 2010, NAT PROTOC, V5, P1911, DOI 10.1038/nprot.2010.150; Rouhi P, 2010, CELL CYCLE, V9, P913, DOI 10.4161/cc.9.5.10853; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Sims D, 2010, BREAST CANCER RES TR, V124, P567, DOI 10.1007/s10549-010-0945-5; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; TEAM RC, 2010, R LANG ENV STAT COMP; Tiana M, 2012, NUCLEIC ACIDS RES, V40, P1916, DOI 10.1093/nar/gkr842; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; Villar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045708; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Xiao F, 2013, GLYCOBIOLOGY, V23, P524, DOI 10.1093/glycob/cwt004; Yamashita T, 2008, J BIOL CHEM, V283, P18926, DOI 10.1074/jbc.M709133200; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365	54	75	82	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2015	34	20					2609	2620		10.1038/onc.2014.200	http://dx.doi.org/10.1038/onc.2014.200			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI1YN	25023702	Green Accepted, Green Submitted			2022-12-25	WOS:000354541300007
J	Gaudette, BT; Iwakoshi, NN; Boise, LH				Gaudette, Brian T.; Iwakoshi, Neal N.; Boise, Lawrence H.			Bcl-x(L) Protein Protects from C/EBP Homologous Protein (CHOP)-dependent Apoptosis during Plasma Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bcl-2 Proteins; Differentiation; ER Stress; Lymphocyte; UPR; Plasma Cell	ENDOPLASMIC-RETICULUM STRESS; ER STRESS; MESSENGER-RNA; TRANSCRIPTION FACTORS; B-CELLS; KINASE; MCL-1; XBP-1; DEATH; ATF6	Background: UPR-associated death signals are activated during plasma cell differentiation. Results: Bcl-x(L) sequesters Bim during plasma cell differentiation, preventing apoptosis. Conclusion: Bcl-x(L) dependence during plasma cell differentiation protects the cell from the UPR activation necessary for ER remodeling. Significance: Bcl-2 family dynamics are crucial for both the development of plasma cells and the treatment of diseases of abnormal plasma cells. Although it is known that the unfolded protein response (UPR) plays a significant role in the process of plasma cell differentiation, the contribution of the individual sensors of the UPR to this process remains unclear. In this study we examine the death signals and compensatory survival signals activated during B cell activation and the first stages of plasma cell differentiation. During in vitro differentiation of both primary murine B cells and the Bcl1 cell line, we demonstrate that in addition to activation of the physiological UPR, changes in the expression of several Bcl-2 proteins occur, which are consistent with a lowering of the apoptotic threshold of the cell. Specifically, we observed decreased expression of Bcl-2 and Mcl-1 and increased expression of the proapoptotic protein Bim. However, these changes were countered by Bcl-x(L) induction, which is necessary to protect differentiating cells both from ER stress-induced death by tunicamycin and from the death signals inherent in differentiation. Consistent with differentiating cells becoming dependent on Bcl-x(L) for survival, the addition of ABT-737 resulted in apoptosis in differentiating cells through the inhibition of sequestration of Bim. Confirming this result, differentiation in the context of RNAi-mediated Bcl-x(L) knockdown also induced apoptosis. This cell death is C/EBP homologous protein (CHOP)-dependent, connecting these events to the UPR. Thus plasma cell differentiation proceeds through a Bcl-x(L)-dependent intermediate.	[Gaudette, Brian T.; Boise, Lawrence H.] Emory Univ, Dept Hematol & Med Oncol, Dept Cell Biol, Atlanta, GA 30322 USA; [Gaudette, Brian T.; Boise, Lawrence H.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Iwakoshi, Neal N.] Emory Univ, Dept Surg, Atlanta, GA 30322 USA; [Iwakoshi, Neal N.] Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Boise, LH (corresponding author), Emory Univ, Dept Hematol & Med Oncol, Dept Cell Biol, 1365C Clifton Rd NE,Ste C4012, Atlanta, GA 30322 USA.	lboise@emory.edu	Boise, Lawrence/AAD-2314-2019	Gaudette, Brian/0000-0001-6627-3085; Boise, Lawrence/0000-0001-9436-8815	National Institutes of Health [R01 CA127910, R01 CA129968]; T. J. Martell Foundation; NATIONAL CANCER INSTITUTE [R01CA127910, R01CA129968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T. J. Martell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA127910 and R01 CA129968 as well as funding from the T. J. Martell Foundation (to L. H. B.).	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrington EM, 2010, P NATL ACAD SCI USA, V107, P10967, DOI 10.1073/pnas.1005256107; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Gass JN, 2008, MOL IMMUNOL, V45, P1035, DOI 10.1016/j.molimm.2007.07.029; Gass JN, 2004, TRENDS IMMUNOL, V25, P17, DOI 10.1016/j.it.2003.11.004; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Gunn KE, 2004, MOL IMMUNOL, V41, P919, DOI 10.1016/j.molimm.2004.04.023; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Liu CY, 2003, J BIOL CHEM, V278, P17680, DOI 10.1074/jbc.M300418200; Ma YJ, 2010, CELL STRESS CHAPERON, V15, P281, DOI 10.1007/s12192-009-0142-9; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Masciarelli S, 2010, MOL IMMUNOL, V47, P1356, DOI 10.1016/j.molimm.2009.12.003; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; MITA S, 1988, J EXP MED, V168, P863, DOI 10.1084/jem.168.3.863; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; Morales AA, 2011, BLOOD, V118, P1329, DOI 10.1182/blood-2011-01-327197; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Strasser A, 2003, IMMUNOL REV, V193, P82, DOI 10.1034/j.1600-065X.2003.00036.x; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	41	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23629	23640		10.1074/jbc.M114.569376	http://dx.doi.org/10.1074/jbc.M114.569376			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25023286	hybrid, Green Published			2022-12-25	WOS:000341505000031
J	Allen, RM; Marshall, D				Allen, Richard M.; Marshall, Dustin			Egg Size Effects across Multiple Life-History Stages in the Marine Annelid Hydroides diramphus	PLOS ONE			English	Article							OFFSPRING SIZE; LARVAL DEVELOPMENT; PROPAGULE SIZE; REPRODUCTIVE STRATEGIES; BENTHIC INVERTEBRATES; VARIABLE ENVIRONMENTS; FERTILIZATION SUCCESS; EVOLUTIONARY ECOLOGY; DIANTHUS POLYCHAETA; MATERNAL INVESTMENT	The optimal balance of reproductive effort between offspring size and number depends on the fitness of offspring size in a particular environment. The variable environments offspring experience, both among and within life-history stages, are likely to alter the offspring size/fitness relationship and favor different offspring sizes. Hence, the many environments experienced throughout complex life-histories present mothers with a significant challenge to optimally allocate their reproductive effort. In a marine annelid, we tested the relationship between egg size and performance across multiple life-history stages, including: fertilization, larval development, and post-metamorphosis survival and size in the field. We found evidence of conflicting effects of egg size on performance: larger eggs had higher fertilization under sperm-limited conditions, were slightly faster to develop pre-feeding, and were larger post-metamorphosis; however, smaller eggs had higher fertilization when sperm was abundant, and faster planktonic development; and egg size did not affect post-metamorphic survival. The results indicate that egg size effects are conflicting in H. diramphus depending on the environments within and among life-history stages. We suggest that offspring size in this species may be a compromise between the overall costs and benefits of egg sizes in each stage and that performance in any one stage is not maximized.	[Allen, Richard M.; Marshall, Dustin] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Queensland	Allen, RM (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada.	richard.allen@uqconnect.edu.au	Allen, Richard/B-7373-2015	Marshall, Dustin/0000-0001-6651-6219	Australian Research Council [DPO556552]; Australian Post-Graduate Award	Australian Research Council(Australian Research Council); Australian Post-Graduate Award(Australian Government)	This project was funded by Australian Research Council (DPO556552) to Dustin J. Marshall. R. M. A. was supported by an Australian Post-Graduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Allen RM, 2013, FUNCT ECOL, V27, P1358, DOI 10.1111/1365-2435.12117; Allen RM, 2010, OIKOS, V119, P1977, DOI 10.1111/j.1600-0706.2010.18682.x; Auer SK, 2010, ECOL LETT, V13, P998, DOI 10.1111/j.1461-0248.2010.01491.x; Bernardo J, 1996, AM ZOOL, V36, P216; BERVEN KA, 1988, OECOLOGIA, V75, P67, DOI 10.1007/BF00378815; BROCKELMAN WY, 1975, AM NAT, V109, P677, DOI 10.1086/283037; Crean AJ, 2011, EVOLUTION, V65, P3079, DOI 10.1111/j.1558-5646.2011.01372.x; Dias GM, 2010, OIKOS, V119, P154, DOI 10.1111/j.1600-0706.2009.17725.x; Einum S, 2003, ENVIRON BIOL FISH, V67, P263, DOI 10.1023/A:1025818627731; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; Fox CW, 1997, EVOLUTION, V51, P1005, DOI 10.1111/j.1558-5646.1997.tb03683.x; FOX CW, 1994, HEREDITY, V73, P509, DOI 10.1038/hdy.1994.149; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Gomez JM, 2004, EVOLUTION, V58, P71, DOI 10.1111/j.0014-3820.2004.tb01574.x; HART MW, 1995, AM NAT, V146, P415, DOI 10.1086/285807; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; Hendry AP, 2003, EVOL ECOL RES, V5, P421; Hendry AP, 2001, AM NAT, V157, P387, DOI 10.1086/319316; Hollows CF, 2007, MAR ECOL PROG SER, V333, P51, DOI 10.3354/meps333051; Jaeckle William B., 1995, P49; Johnston TA, 2002, ECOLOGY, V83, P1777, DOI 10.2307/3071764; KAPLAN RH, 1992, ECOLOGY, V73, P280, DOI 10.2307/1938739; Kiflawi M, 2006, OIKOS, V113, P168, DOI 10.1111/j.0030-1299.2001.14378.x; KINGHORN BP, 1983, AQUACULTURE, V31, P283, DOI 10.1016/0044-8486(83)90320-4; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; LEVITAN DR, 1993, AM NAT, V141, P517, DOI 10.1086/285489; Lindholm AK, 2006, BIOL LETTERS, V2, P586, DOI 10.1098/rsbl.2006.0546; Marshall DJ, 2006, ECOLOGY, V87, P214, DOI 10.1890/05-0350; Marshall DJ, 2003, ECOLOGY, V84, P3131, DOI 10.1890/02-0311; Marshall DJ, 2002, ECOL LETT, V5, P173, DOI 10.1046/j.1461-0248.2002.00257.x; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; Marshall DJ, 2008, ADV MAR BIOL, V53, P1, DOI 10.1016/S0065-2881(07)53001-4; Marshall DJ, 2011, CURR BIOL, V21, pR718, DOI 10.1016/j.cub.2011.08.022; McEdward LR, 2003, MAR ECOL PROG SER, V256, P111, DOI 10.3354/meps256111; MCGINLEY MA, 1987, AM NAT, V130, P370, DOI 10.1086/284716; MCGURK MD, 1986, MAR ECOL PROG SER, V34, P227, DOI 10.3354/meps034227; Miles CM, 2009, GENETICA, V135, P289, DOI 10.1007/s10709-008-9277-3; Moran AL, 2001, ECOLOGY, V82, P1597, DOI 10.2307/2679803; Moran AL, 2009, BIOL BULL-US, V216, P226, DOI 10.1086/BBLv216n3p226; MORAN NA, 1994, ANNU REV ECOL SYST, V25, P573, DOI 10.1146/annurev.es.25.110194.003041; Morgan Steven G., 1995, P279; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; PENNINGTON JT, 1985, BIOL BULL-US, V169, P417, DOI 10.2307/1541492; Phillips NE, 2002, ECOLOGY, V83, P2562, DOI 10.2307/3071815; Podolsky RD, 2006, INTEGR COMP BIOL, V46, P577, DOI 10.1093/icb/icl026; Qian PY, 1998, J EXP MAR BIOL ECOL, V227, P169, DOI 10.1016/S0022-0981(97)00267-0; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rius M, 2010, FUNCT ECOL, V24, P685, DOI 10.1111/j.1365-2435.2009.01668.x; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; SCHELTEMA RS, 1981, MAR ECOL PROG SER, V5, P69, DOI 10.3354/meps005069; SCHLUTER D, 1991, P ROY SOC B-BIOL SCI, V246, P11, DOI 10.1098/rspb.1991.0118; SEWELL MA, 1992, B MAR SCI, V51, P161; SIBLY R, 1988, J THEOR BIOL, V133, P13, DOI 10.1016/S0022-5193(88)80021-3; SINERVO B, 1988, EVOLUTION, V42, P885, DOI 10.1111/j.1558-5646.1988.tb02509.x; SINERVO B, 1990, EVOLUTION, V44, P279, DOI 10.1111/j.1558-5646.1990.tb05198.x; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; STANTON ML, 1984, ECOLOGY, V65, P1105, DOI 10.2307/1938318; STRATHMANN RR, 1977, AM NAT, V111, P373, DOI 10.1086/283168; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; Toonen RJ, 2001, MAR ECOL PROG SER, V224, P115, DOI 10.3354/meps224115; Unabia CRC, 1999, MAR BIOL, V133, P55, DOI 10.1007/s002270050442; VANCE RR, 1973, AM NAT, V107, P339, DOI 10.1086/282838; VOGEL H, 1982, MATH BIOSCI, V58, P189, DOI 10.1016/0025-5564(82)90073-6; Wilson AJ, 2006, AM NAT, V167, pE23, DOI 10.1086/498138; YUND PO, 1990, J EXP ZOOL, V253, P102, DOI 10.1002/jez.1402530114	67	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102253	10.1371/journal.pone.0102253	http://dx.doi.org/10.1371/journal.pone.0102253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036850	gold, Green Published, Green Submitted			2022-12-25	WOS:000339615200044
J	Engel, AS; Gupta, AA				Engel, Annette Summers; Gupta, Axita A.			Regime Shift in Sandy Beach Microbial Communities following Deepwater Horizon Oil Spill Remediation Efforts	PLOS ONE			English	Article							HYDROCARBON-DEGRADING BACTERIA; GRAIN-SIZE DISTRIBUTION; BARRIER-ISLAND; AROMATIC-HYDROCARBONS; MULTIVARIATE ANALYSES; MARINE-SEDIMENTS; FRESH-WATER; DIVERSITY; BIODEGRADATION; VARIABILITY	Sandy beaches support a wide variety of underappreciated biodiversity that is critical to coastal ecosystems. Prior to the 2010 Deepwater Horizon oil spill, the diversity and function of supratidal beach sediment microbial communities along Gulf of Mexico coastlines were not well understood. As such, it was unclear if microbial community compositional changes would occur following exposure to beached oil, if indigenous communities could biodegrade oil, or how cleanup efforts, such as sand washing and sediment redistribution, would impact microbial ecosystem resiliency. Transects perpendicular to the shoreline were sampled from public beaches on Grand Isle, Louisiana, and Dauphin Island, Alabama, over one year. Prior to oil coming onshore, elevated levels of bacteria associated with fecal contamination were detected (e.g., Enterobacteriales and Campylobacterales). Over time, significant shifts within major phyla were identified (e.g., Proteobacteria, Firmicutes, Actinobacteria) and fecal indicator groups were replaced by taxa affiliated with open-ocean and marine systems (e.g., Oceanospirillales, Rhodospirillales, and Rhodobacterales). These new bacterial groups included putative hydrocarbon degraders, similar to those identified near the oil plume offshore. Shifts in the microbial community composition strongly correlated to more poorly sorted sediment and grain size distributional changes. Natural oceanographic processes could not account for the disrupted sediment, especially from the backshore well above the maximum high-tide levels recorded at these sites. Sand washing and tilling occurred on both open beaches from August through at least December 2010, which were mechanisms that could replace fecal indicator groups with open-ocean groups. Consequently, remediation efforts meant to return beaches to pre-spill compositions caused a regime shift that may have added potential ecosystem function, like hydrocarbon degradation, to the sediment. Future research will need to assess the persistence and impact of the newly formed microbial communities to the overall sandy beach ecosystems.	[Engel, Annette Summers; Gupta, Axita A.] Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA; [Engel, Annette Summers] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA	Louisiana State University System; Louisiana State University; University of Tennessee System; University of Tennessee Knoxville	Engel, AS (corresponding author), Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA.	aengel1@utk.edu	Engel, Annette Summers/GNM-8161-2022; Engel, Annette S/E-3662-2016	Engel, Annette Summers/0000-0003-2469-744X; Engel, Annette S/0000-0003-2469-744X	Louisiana State University Gulf of Mexico Oil Spill Research Program; BP Exploration and Production Inc.; National Science Foundation [DEB-1044599]; Jones Endowment fund at the University of Tennessee-Knoxville	Louisiana State University Gulf of Mexico Oil Spill Research Program; BP Exploration and Production Inc.; National Science Foundation(National Science Foundation (NSF)); Jones Endowment fund at the University of Tennessee-Knoxville	This research was financially supported by the Louisiana State University Gulf of Mexico Oil Spill Research Program (funded by BP Exploration and Production Inc.) and the National Science Foundation (DEB-1044599). Continued support has been provided by the BP/Gulf of Mexico Research Initiative through the Coastal Waters Consortium and the Jones Endowment fund at the University of Tennessee-Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuodha JOZ, 2003, J AFR EARTH SCI, V36, P41, DOI 10.1016/S0899-5362(03)00016-2; Allan SE, 2012, ENVIRON SCI TECHNOL, V46, P2033, DOI 10.1021/es202942q; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bascom WN, 1959, T AM GEOPHYS UNION, V32, P866; Beazley MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041305; Bertics VJ, 2009, ISME J, V3, P1269, DOI 10.1038/ismej.2009.62; Bianchi TS, 2011, MAR ENVIRON RES, V72, P248, DOI 10.1016/j.marenvres.2011.09.007; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Bolton FJ, 1999, EPIDEMIOL INFECT, V122, P7, DOI 10.1017/S0950268898001915; Boudreau BP., 2001, EOS T AM GEOPHYS UNI, V82, P133; Chakraborty R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00357; CHAO A, 1984, SCAND J STAT, V11, P265; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collie JS, 2004, PROG OCEANOGR, V60, P281, DOI 10.1016/j.pocean.2004.02.013; CONATSER WE, 1971, GEOL SOC AM BULL, V82, P3049, DOI 10.1130/0016-7606(1971)82[3049:GIABII]2.0.CO;2; CPRA, 2010, INT ECOS REST HURR P; Dave D., 2011, American Journal of Environmental Sciences, V7, P423, DOI 10.3844/ajessp.2011.424.440; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Delille D, 2000, MAR ENVIRON RES, V49, P403, DOI 10.1016/S0141-1136(99)00080-X; Devine J, 2012, TESTING WATERS GUIDE; Dixon CR, 2011, DAUPHM ISL BEACH BAR; Dorfman M., 2011, TESTING WATERS GUIDE; Dorfman M, 2010, TESTING WATERS GUIDE; DOUGLASS SL, 1994, J COASTAL RES, V10, P306; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; EPA U, 2012, EPAS BEACH REP AL 20; EPA U, 2011, EPAS BEACH REP AL 20; EPA U, 2010, EPAS BEACH REP AL 20; FINDLAY RH, 1990, MAR ECOL PROG SER, V62, P121, DOI 10.3354/meps062121; Foght J, 2008, J MOL MICROB BIOTECH, V15, P93, DOI 10.1159/000121324; Garrity GM., 2005, BERGEYS MANUAL SYSTE, P270, DOI DOI 10.1007/0-387-28022-7_8; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Glasby TM, 1996, ENVIRON MONIT ASSESS, V42, P241, DOI 10.1007/BF00414371; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Gopalakrishnan S, 2011, J ENVIRON ECON MANAG, V61, P297, DOI 10.1016/j.jeem.2010.09.003; GUNDLACH ER, 1978, MAR TECHNOL SOC J, V12, P18; Halliday E, 2011, ENVIRON SCI TECHNOL, V45, P370, DOI 10.1021/es102747s; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Heaney CD, 2012, EPIDEMIOLOGY, V23, P95, DOI 10.1097/EDE.0b013e31823b504c; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hernandez RJ, 2014, WATER RES, V48, P579, DOI 10.1016/j.watres.2013.10.020; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Horel A, 2012, WATER AIR SOIL POLL, V223, P3145, DOI 10.1007/s11270-012-1097-5; Horel A, 2012, ENVIRON TOXICOL CHEM, V31, P1004, DOI 10.1002/etc.1770; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; IMHOFF JF, 2005, BERGEYS MANUAL SYSTE, V2, P1, DOI DOI 10.1099/00207713-34-3-338; Komar P., 1997, BEACH PROCESSES SEDI; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Labud V, 2007, CHEMOSPHERE, V66, P1863, DOI 10.1016/j.chemosphere.2006.08.021; LEAHY JG, 1990, MICROBIOL REV, V54, P305, DOI 10.1128/MMBR.54.3.305-315.1990; Lisle J, 2011, 2011115 USGS; Lisle J. T., 2011, 20111059 USGS; Looper JK, 2013, ENVIRON SCI-PROC IMP, V15, P2068, DOI 10.1039/c3em00200d; Louisiana Department of Health and Hospitals (LDHH), 2011, LOU BEACH PROGR QUAL; Louisiana Department of Health and Hospitals (LDHH), 2012, LOU BEACH GRANT REP; Louisiana Department of Health and Hospitals (LDHH), 2010, LOU BEACH GRANT REP; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Martinez ML, 2011, FRONT ECOL ENV; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; McLachlan A., 1983, Developments in Hydrobiology, V19, P321; McLachlan A, 1996, MAR ECOL PROG SER, V131, P205, DOI 10.3354/meps131205; MEADOWS PS, 1966, NATURE, V212, P1059, DOI 10.1038/2121059a0; Michel J, 1999, P 1999 INT OIL SPILL; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Mills HJ, 2008, APPL ENVIRON MICROB, V74, P4440, DOI 10.1128/AEM.02692-07; Mitchell KR, 2008, J IND MICROBIOL BIOT, V35, P1139, DOI 10.1007/s10295-008-0393-y; Mortazavi B, 2013, J HAZARD MATER, V244, P537, DOI 10.1016/j.jhazmat.2012.10.038; Morton R.A., 2004, US GEOLOGICAL SURVEY, V1043, P45, DOI [10.3133/ofr20041043, DOI 10.3133/OFR20041043]; Morton RA, 2008, J COASTAL RES, V24, P1587, DOI 10.2112/07-0953.1; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Newton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074265; NOAA, 2000, 20001 HAZMAT NOAA; Owens E. H., 2011, INT OIL SPILL C P, V2011, P265, DOI DOI 10.7901/2169-3358-2011-1-265; PALACAS JG, 1976, GEOLOGY, V4, P81, DOI 10.1130/0091-7613(1976)4<81:BCOHIB>2.0.CO;2; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Petersen J, 2002, NOSORR11 NOAA; Phillips MC, 2011, WATER RES, V45, P6763, DOI 10.1016/j.watres.2011.10.028; Piggot AM, 2012, APPL ENVIRON MICROB, V78, P5973, DOI 10.1128/AEM.00603-12; Podgorska B, 2007, POL J ECOL, V55, P15; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Scheffer M, 2003, TRENDS ECOL EVOL, V18; Schlacher TA, 2007, DIVERS DISTRIB, V13, P556, DOI 10.1111/j.1472-4642.2007.00363.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; SOMERVILLE CC, 1989, APPL ENVIRON MICROB, V55, P548, DOI 10.1128/AEM.55.3.548-554.1989; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Sul WJ, 2011, P NATL ACAD SCI USA, V108, P14637, DOI 10.1073/pnas.1111435108; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Tao Z, 2011, ECOHEALTH, V8, P507, DOI 10.1007/s10393-011-0720-z; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; US EPA, 2011, EPAS BEACH REP LOU 2; US EPA, 2010, NAT LIST BEACH, P165; US EPS, 1999, 600R98079 US EPS, P27; Wang P, 2013, J COASTAL RES, V29, P144, DOI 10.2112/JCOASTRES-D-12-00198.1; Zhang CL, 1998, GEOMICROBIOL J, V15, P171, DOI 10.1080/01490459809378074; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	106	20	21	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102934	10.1371/journal.pone.0102934	http://dx.doi.org/10.1371/journal.pone.0102934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036744	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200099
J	Franciosi, L; Postma, DS; Van den Berge, M; Govorukhina, N; Horvatovich, PL; Fusetti, F; Poolman, B; Lodewijk, ME; Timens, W; Bischoff, R; Ten Hacken, NHT				Franciosi, Lorenza; Postma, Dirkje S.; Van den Berge, Maarten; Govorukhina, Natalia; Horvatovich, Peter L.; Fusetti, Fabrizia; Poolman, Bert; Lodewijk, Monique E.; Timens, Wim; Bischoff, Rainer; Ten Hacken, Nick H. T.			Susceptibility to COPD: Differential Proteomic Profiling after Acute Smoking	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BRONCHOALVEOLAR LAVAGE; PROTEIN EXPRESSION; SPUTUM PROTEOMICS; OXIDATIVE STRESS; SMOKERS; SERUM; BIOMARKERS; CELLS; FLUID	Cigarette smoking is the main risk factor for COPD (Chronic Obstructive Pulmonary Disease), yet only a subset of smokers develops COPD. Family members of patients with severe early-onset COPD have an increased risk to develop COPD and are therefore defined as "susceptible individuals". Here we perform unbiased analyses of proteomic profiles to assess how "susceptible individuals" differ from age-matched "non-susceptible individuals" in response to cigarette smoking. Epithelial lining fluid (ELF) was collected at baseline and 24 hours after smoking 3 cigarettes in young individuals susceptible or non-susceptible to develop COPD and older subjects with established COPD. Controls at baseline were older healthy smoking and non-smoking individuals. Five samples per group were pooled and analysed by stable isotope labelling (iTRAQ) in duplicate. Six proteins were selected and validated by ELISA or immunohistochemistry. After smoking, 23 proteins increased or decreased in young susceptible individuals, 7 in young non-susceptible individuals, and 13 in COPD in the first experiment; 23 proteins increased or decreased in young susceptible individuals, 32 in young non-susceptible individuals, and 11 in COPD in the second experiment. SerpinB3 and Uteroglobin decreased after acute smoke exposure in young non-susceptible individuals exclusively, whereas Peroxiredoxin I, S100A9, S100A8, ALDH3A1 (Aldehyde dehydrogenase 3A1) decreased both in young susceptible and non-susceptible individuals, changes being significantly different between groups for Uteroglobin with iTRAQ and for Serpin B3 with iTRAQ and ELISA measures. Peroxiredoxin I, SerpinB3 and ALDH3A1 increased in COPD patients after smoking. We conclude that smoking induces a differential protein response in ELF of susceptible and non-susceptible young individuals, which differs from patients with established COPD. This is the first study applying unbiased proteomic profiling to unravel the underlying mechanisms that induce COPD. Our data suggest that SerpinB3 and Uteroglobin could be interesting proteins in understanding the processes leading to COPD.	[Franciosi, Lorenza; Govorukhina, Natalia; Horvatovich, Peter L.; Bischoff, Rainer] Univ Groningen, Dept Pharm Analyt Biochem, Groningen, Netherlands; [Postma, Dirkje S.; Van den Berge, Maarten; Ten Hacken, Nick H. T.] Univ Groningen, Univ Med Ctr Groningen, GRIAC, Dept Pulm Dis, Groningen, Netherlands; [Fusetti, Fabrizia; Poolman, Bert] Univ Groningen, Dept Biochem, Netherlands Prote Ctr, Dept Biochem, Groningen, Netherlands; [Lodewijk, Monique E.; Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, GRIAC, Dept Pathol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Ten Hacken, NHT (corresponding author), Univ Groningen, Univ Med Ctr Groningen, GRIAC, Dept Pulm Dis, Groningen, Netherlands.	n.h.t.ten.hacken@umcg.nl	Bischoff, Rainer/H-5404-2011; Timens, Wim/K-5570-2013; Horvatovich, P.L./J-2154-2012	Bischoff, Rainer/0000-0001-9849-0121; Timens, Wim/0000-0002-4146-6363; Horvatovich, P.L./0000-0003-2218-1140; van den Berge, Maarten/0000-0002-9336-7340	Top Institute Pharma project [T1-108]	Top Institute Pharma project	This research was done in the framework of the Top Institute Pharma project T1-108 "Acute and chronic inflammatory responses-COPD and smoking", with partners University Medical Centre Groningen, Nycomed BV, GlaxoSmithKline, University of Groningen, University Medical Centre Utrecht and Foundation TI Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD A, 1992, EUR RESPIR J, V5, P1231; Braido F, 2007, RESP MED, V101, P2119, DOI 10.1016/j.rmed.2007.05.023; Casado B, 2007, J PROTEOME RES, V6, P4615, DOI 10.1021/pr070440q; Celedon JC, 1999, EUR RESPIR J, V14, P1009, DOI 10.1183/09031936.99.14510099; Chen H, 2010, J PROTEOME RES, V9, P2798, DOI 10.1021/pr100063r; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; de Torre C, 2006, PROTEOMICS, V6, P3949, DOI 10.1002/pmic.200500693; Dijkstra A, 2009, VIRCHOWS ARCH, V454, P441, DOI 10.1007/s00428-009-0748-4; Pastor MD, 2013, INT J MOL SCI, V14, P3440, DOI 10.3390/ijms14023440; Du Rand IA, 2011, THORAX, V66, P1, DOI 10.1136/thoraxjnl-2011-200713; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Franciosi L, 2011, METHODS MOL BIOL, V790, P17, DOI 10.1007/978-1-61779-319-6_2; Fumagalli M, 2012, INT J MOL SCI, V13, P13894, DOI 10.3390/ijms131113894; Gray RD, 2008, AM J RESP CRIT CARE, V178, P444, DOI 10.1164/rccm.200703-409OC; Kipnis E, 2008, CHEST, V134, P338, DOI 10.1378/chest.07-1643; Kwon HS, 2012, LIFE SCI, V90, P502, DOI 10.1016/j.lfs.2012.01.003; Lakind JS, 2007, BIOMARKERS, V12, P445, DOI 10.1080/13547500701359327; Landi Claudia, 2011, J Clin Bioinforma, V1, P31, DOI 10.1186/2043-9113-1-31; Loi ATL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002178; Lomas DA, 2008, THORAX, V63, P1058, DOI 10.1136/thx.2008.102574; Lorenz E, 2008, RESP MED, V102, P567, DOI 10.1016/j.rmed.2007.11.011; LUMSDEN AB, 1984, THORAX, V39, P844, DOI 10.1136/thx.39.11.844; Lunardi F, 2011, LAB INVEST, V91, P945, DOI 10.1038/labinvest.2011.1; McCloskey SC, 2001, AM J RESP CRIT CARE, V164, P1419, DOI 10.1164/ajrccm.164.8.2105002; Merkel D, 2005, PROTEOMICS, V5, P2972, DOI 10.1002/pmic.200401180; Nicholas B, 2006, PROTEOMICS, V6, P4390, DOI 10.1002/pmic.200600011; Nicholas BL, 2009, COPD, V6, P298, DOI 10.1080/15412550903049140; O'Neil SE, 2011, J PROTEOMICS, V75, P192, DOI 10.1016/j.jprot.2011.10.008; Ohlmeier S, 2012, J PROTEOME RES, V11, P599, DOI 10.1021/pr2006395; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; Plymoth A, 2006, CLIN CHEM, V52, P671, DOI 10.1373/clinchem.2005.060715; Plymoth A, 2007, CLIN CHEM, V53, P636, DOI 10.1373/clinchem.2006.076075; Sabroe I, 2007, THORAX, V62, P733, DOI 10.1136/thx.2007.077768; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Shijubo N, 1997, EUR RESPIR J, V10, P1108, DOI 10.1183/09031936.97.10051108; Shijubo N, 1998, LUNG, V176, P257, DOI 10.1007/PL00007608; SIAFAKAS NM, 1995, EUR RESPIR J, V8, P1398, DOI 10.1183/09031936.95.08081398; Siafakas NM, 2002, RESP MED, V96, P615, DOI 10.1053/rmed.2002.1318; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Steen A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000052-MCP200; Tu CJ, 2014, J PROTEOME RES, V13, P627, DOI 10.1021/pr4007602; Tzortzaki EG, 2009, EUR RESPIR J, V34, P310, DOI 10.1183/09031936.00067008; van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V293, pL1156, DOI 10.1152/ajplung.00081.2007; van der Vaart H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-22; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Van Miert E, 2005, TOXICOL LETT, V159, P115, DOI 10.1016/j.toxlet.2005.05.007	46	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102037	10.1371/journal.pone.0102037	http://dx.doi.org/10.1371/journal.pone.0102037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036363	Green Submitted, gold, Green Published			2022-12-25	WOS:000339615200034
J	Khanna, R; Powe, AC; Lun, Y; Soska, R; Feng, J; Dhulipala, R; Frascella, M; Garcia, A; Pellegrino, LJ; Xu, S; Brignol, N; Toth, MJ; Do, HV; Lockhart, DJ; Wustman, BA; Valenzano, KJ				Khanna, Richie; Powe, Allan C., Jr.; Lun, Yi; Soska, Rebecca; Feng, Jessie; Dhulipala, Rohini; Frascella, Michelle; Garcia, Anadina; Pellegrino, Lee J.; Xu, Su; Brignol, Nastry; Toth, Matthew J.; Do, Hung V.; Lockhart, David J.; Wustman, Brandon A.; Valenzano, Kenneth J.			The Pharmacological Chaperone AT2220 Increases the Specific Activity and Lysosomal Delivery of Mutant Acid Alpha-Glucosidase, and Promotes Glycogen Reduction in a Transgenic Mouse Model of Pompe Disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; LONG-TERM; ALGLUCOSIDASE ALPHA; BETA-GLUCOSIDASE; FIBROBLASTS; INFANTILE; MUTATION; MICE; GALACTOSIDASE; ENHANCEMENT	Pompe disease is an inherited lysosomal storage disorder that results from a deficiency in acid a-glucosidase (GAA) activity due to mutations in the GAA gene. Pompe disease is characterized by accumulation of lysosomal glycogen primarily in heart and skeletal muscles, which leads to progressive muscle weakness. We have shown previously that the small molecule pharmacological chaperone AT2220 (1-deoxynojirimycin hydrochloride, duvoglustat hydrochloride) binds and stabilizes wild-type as well as multiple mutant forms of GAA, and can lead to higher cellular levels of GAA. In this study, we examined the effect of AT2220 on mutant GAA, in vitro and in vivo, with a primary focus on the endoplasmic reticulum (ER)-retained P545L mutant form of human GAA (P545L GAA). AT2220 increased the specific activity of P545L GAA toward both natural (glycogen) and artificial substrates in vitro. Incubation with AT2220 also increased the ER export, lysosomal delivery, proteolytic processing, and stability of P545L GAA. In a new transgenic mouse model of Pompe disease that expresses human P545L on a Gaa knockout background (Tg/KO) and is characterized by reduced GAA activity and elevated glycogen levels in disease-relevant tissues, daily oral administration of AT2220 for 4 weeks resulted in significant and dose-dependent increases in mature lysosomal GAA isoforms and GAA activity in heart and skeletal muscles. Importantly, oral administration of AT2220 also resulted in significant glycogen reduction in disease-relevant tissues. Compared to daily administration, less-frequent AT2220 administration, including repeated cycles of 4 or 5 days with AT2220 followed by 3 or 2 days without drug, respectively, resulted in even greater glycogen reductions. Collectively, these data indicate that AT2220 increases the specific activity, trafficking, and lysosomal stability of P545L GAA, leads to increased levels of mature GAA in lysosomes, and promotes glycogen reduction in situ. As such, AT2220 may warrant further evaluation as a treatment for Pompe disease.	[Khanna, Richie; Powe, Allan C., Jr.; Lun, Yi; Soska, Rebecca; Feng, Jessie; Dhulipala, Rohini; Frascella, Michelle; Garcia, Anadina; Pellegrino, Lee J.; Xu, Su; Brignol, Nastry; Toth, Matthew J.; Do, Hung V.; Lockhart, David J.; Wustman, Brandon A.; Valenzano, Kenneth J.] Amicus Therapeut Inc, Cranbury, NJ 08512 USA		Valenzano, KJ (corresponding author), Amicus Therapeut Inc, Cranbury, NJ 08512 USA.	kvalenzano@amicusrx.com			Amicus Therapeutics	Amicus Therapeutics	Amicus Therapeutics funded the research. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijvoet AGA, 1998, HUM MOL GENET, V7, P1815, DOI 10.1093/hmg/7.11.1815; Cardone Monica, 2008, Pathogenetics, V1, P6, DOI 10.1186/1755-8417-1-6; Chen LR, 2009, J PEDIATR-US, V155, P271, DOI 10.1016/j.jpeds.2009.03.015; de Vries JM, 2010, MOL GENET METAB, V101, P338, DOI 10.1016/j.ymgme.2010.08.009; DeRuisseau LR, 2009, P NATL ACAD SCI USA, V106, P9419, DOI 10.1073/pnas.0902534106; Fan JQ, 2008, BIOL CHEM, V389, P1, DOI 10.1515/BC.2008.009; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; Flanagan JJ, 2009, HUM MUTAT, V30, P1683, DOI 10.1002/humu.21121; Fukuda T, 2006, AUTOPHAGY, V2, P318, DOI 10.4161/auto.2984; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Hagemans MLC, 2005, NEUROLOGY, V64, P2139, DOI 10.1212/01.WNL.0000165979.46537.56; HASILIK A, 1980, J BIOL CHEM, V255, P4946; Hawes ML, 2007, MOL GENET METAB, V91, P343, DOI 10.1016/j.ymgme.2007.04.018; HERMANS MMP, 1994, HUM MOL GENET, V3, P2213, DOI 10.1093/hmg/3.12.2213; Hirschhorn R, 2001, METABOLIC MOL BASES, P3389; HUIE ML, 1994, HUM MOL GENET, V3, P2231; Ishii S, 2004, BBA-MOL BASIS DIS, V1690, P250, DOI 10.1016/j.bbadis.2004.07.001; Khanna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040776; Khanna R, 2010, MOL THER, V18, P23, DOI 10.1038/mt.2009.220; Kikuchi T, 1998, J CLIN INVEST, V101, P827, DOI 10.1172/JCI1722; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; Kishnani PS, 2006, GENET MED, V8, P267, DOI 10.1097/01.gim.0000218152.87434.f3; Kishnani PS, 2010, MOL GENET METAB, V99, P26, DOI 10.1016/j.ymgme.2009.08.003; Kishnani PS, 2006, J PEDIATR-US, V149, P89, DOI 10.1016/j.jpeds.2006.02.035; Kishnani PS, 2004, J PEDIATR-US, V144, pS35, DOI 10.1016/j.jpeds.2004.01.053; Lee CJ, 2011, J CARDIOL, V57, P115, DOI 10.1016/j.jjcc.2010.08.003; Lynch CM, 2005, J HISTOCHEM CYTOCHEM, V53, P63, DOI 10.1369/jhc.4A6365.2005; Montalvo ALE, 2006, HUM MUTAT, V27, P999, DOI 10.1002/humu.20374; Moreland RJ, 2005, J BIOL CHEM, V280, P6780, DOI 10.1074/jbc.M404008200; Nicolino M, 2009, GENET MED, V11, P210, DOI 10.1097/GIM.0b013e31819d0996; Okumiya T, 2007, MOL GENET METAB, V90, P49, DOI 10.1016/j.ymgme.2006.09.010; Parenti G, 2007, MOL THER, V15, P508, DOI 10.1038/sj.mt.6300074; Pittis M G, 2008, Hum Mutat, V29, pE27, DOI 10.1002/humu.20753; Porto C, 2009, MOL THER, V17, P964, DOI 10.1038/mt.2009.53; Raben N, 2003, MOL GENET METAB, V80, P159, DOI 10.1016/j.ymgme.2003.08.022; Raben N, 2002, MOL THER, V6, P601, DOI 10.1006/mthe.2002.0716; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; Raben Nina, 2002, Current Molecular Medicine (Hilversum), V2, P145, DOI 10.2174/1566524024605789; REUSER AJJ, 1984, EXP CELL RES, V155, P178, DOI 10.1016/0014-4827(84)90779-1; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Shimmoto M, 1997, FEBS LETT, V417, P89, DOI 10.1016/S0014-5793(97)01263-5; Sidman RL, 2008, J NEUROPATH EXP NEUR, V67, P803, DOI 10.1097/NEN.0b013e3181815994; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Strothotte S, 2010, J NEUROL, V257, P91, DOI 10.1007/s00415-009-5275-3; Takikita S, 2009, MOL GENET METAB, V96, P208, DOI 10.1016/j.ymgme.2008.12.012; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Van den Hout JMP, 2004, PEDIATRICS, V113, pE448, DOI 10.1542/peds.113.5.e448; van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; WISSELAAR HA, 1993, J BIOL CHEM, V268, P2223; Zhu YX, 2005, BIOCHEM J, V389, P619, DOI 10.1042/BJ20050364	51	24	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102092	10.1371/journal.pone.0102092	http://dx.doi.org/10.1371/journal.pone.0102092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036864	gold, Green Published, Green Submitted			2022-12-25	WOS:000339615200037
J	Liu, JJ; Witkin, AJ; Adhi, M; Grulkowski, I; Kraus, MF; Dhalla, AH; Lu, CD; Hornegger, J; Duker, JS; Fujimoto, JG				Liu, Jonathan J.; Witkin, Andre J.; Adhi, Mehreen; Grulkowski, Ireneusz; Kraus, Martin F.; Dhalla, Al-Hafeez; Lu, Chen D.; Hornegger, Joachim; Duker, Jay S.; Fujimoto, James G.			Enhanced Vitreous Imaging in Healthy Eyes Using Swept Source Optical Coherence Tomography	PLOS ONE			English	Article							VITREOMACULAR TRACTION; ANTERIOR SEGMENT; OCT	Purpose: To describe enhanced vitreous imaging for visualization of anatomic features and microstructures within the posterior vitreous and vitreoretinal interface in healthy eyes using swept-source optical coherence tomography (SS-OCT). The study hypothesis was that long-wavelength, high-speed, volumetric SS-OCT with software registration motion correction and vitreous window display or high-dynamic-range (HDR) display improves detection sensitivity of posterior vitreous and vitreoretinal features compared to standard OCT logarithmic scale display. Design: Observational prospective cross-sectional study. Methods: Multiple wide-field three-dimensional SS-OCT scans (500x500A-scans over 12x12 mm(2)) were obtained using a prototype instrument in 22 eyes of 22 healthy volunteers. A registration motion-correction algorithm was applied to compensate motion and generate a single volumetric dataset. Each volumetric dataset was displayed in three forms: (1) standard logarithmic scale display, enhanced vitreous imaging using (2) vitreous window display and (3) HDR display. Each dataset was reviewed independently by three readers to identify features of the posterior vitreous and vitreoretinal interface. Detection sensitivities for these features were measured for each display method. Results: Features observed included the bursa premacularis (BPM), area of Martegiani, Cloquet's/BPM septum, Bergmeister papilla, posterior cortical vitreous (hyaloid) detachment, papillomacular hyaloid detachment, hyaloid attachment to retinal vessel(s), and granular opacities within vitreous cortex, Cloquet's canal, and BPM. The detection sensitivity for these features was 75.0% (95% CI: 67.8%-81.1%) using standard logarithmic scale display, 80.6% (95% CI: 73.8%-86.0%) using HDR display, and 91.9% (95% CI: 86.6%-95.2%) using vitreous window display. Conclusions: SS-OCT provides non-invasive, volumetric and measurable in vivo visualization of the anatomic microstructural features of the posterior vitreous and vitreoretinal interface. The vitreous window display provides the highest sensitivity for posterior vitreous and vitreoretinal interface analysis when compared to HDR and standard OCT logarithmic scale display. Enhanced vitreous imaging with SS-OCT may help assess the natural history and treatment response in vitreoretinal interface diseases.	[Liu, Jonathan J.; Grulkowski, Ireneusz; Kraus, Martin F.; Dhalla, Al-Hafeez; Fujimoto, James G.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Liu, Jonathan J.; Grulkowski, Ireneusz; Kraus, Martin F.; Dhalla, Al-Hafeez; Fujimoto, James G.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Witkin, Andre J.; Adhi, Mehreen; Dhalla, Al-Hafeez; Duker, Jay S.] Tufts Med Ctr, New England Eye Ctr, Boston, MA USA; [Kraus, Martin F.; Hornegger, Joachim] Univ Erlangen Nurnberg, Pattern Recognit Lab, D-91054 Erlangen, Germany; [Kraus, Martin F.; Hornegger, Joachim] Grad Sch Adv Opt Technol SAOT, Erlangen, Germany	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Tufts Medical Center; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Fujimoto, JG (corresponding author), MIT, Dept Elect Engn & Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jgfuji@mit.edu	Hornegger, Joachim/H-2465-2017; Adhi, Mehreen/AAS-9733-2021; Grulkowski, Ireneusz/N-9655-2013	Hornegger, Joachim/0000-0002-1834-8844; Grulkowski, Ireneusz/0000-0001-7688-1826	National Institutes of Health [R01- EY11289-28, R01-CA075289-16, R44-EY022864-01]; Air Force Office of Scientific Research [FA9550-10-1-0551, FA9550-12-1-0499]; German Research Foundation [DFG-HO-1791/11-1]; DFG Research Training Group 1773; Massachusetts Lions Club; Champalimaud Vision Award Fund; Research to Prevent Blindness;  [DFG-GSC80-SAOT]; NATIONAL CANCER INSTITUTE [R01CA075289] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011289, R44EY022864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); German Research Foundation(German Research Foundation (DFG)); DFG Research Training Group 1773; Massachusetts Lions Club; Champalimaud Vision Award Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health (www.nih.gov/): R01- EY11289-28 (JGF), R01-CA075289-16 (JGF), R44-EY022864-01 (JGF); Air Force Office of Scientific Research (http://www.wpafb.af.mil/afrl/afosr/): FA9550-10-1-0551(JGF), FA9550-12-1-0499 (JGF); German Research Foundation (http://www.dfg.de/en/): DFG-HO-1791/11-1 (JH), DFG Research Training Group 1773 (JH), and DFG-GSC80-SAOT (JH); the Massachusetts Lions Club (http://lions33a.org/) (JSD); Champalimaud Vision Award Fund (http://www.fchampalimaud.org/) (JGF); and a Research to Prevent Blindness (http://www.rpbusa.org/rpb/) unrestricted grant to the New England Eye Center/Department of Ophthalmology, Tufts University School of Medicine (JSD). The sponsors or funding organizations had no role in the design or conduct of this research.	Barak Y, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/876472; Barteselli G, 2013, AM J OPHTHALMOL, V155, P727, DOI 10.1016/j.ajo.2012.10.019; Brezinski ME, 2006, OPTICAL COHERENCE TO, Vxxvii; Chang LK, 2008, AM J OPHTHALMOL, V146, P121, DOI 10.1016/j.ajo.2008.03.001; Grulkowski I, 2012, BIOMED OPT EXPRESS, V3, P2733, DOI 10.1364/BOE.3.002733; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Itakura H, 2013, ALTERATIONS POSTERIO; Itakura H, 2013, INVEST OPHTH VIS SCI, V54, P3102, DOI 10.1167/iovs.13-11769; Itakura H, 2011, RETINA-J RET VIT DIS, V31, P1400, DOI 10.1097/IAE.0b013e318206cb43; Johnson MW, 2010, AM J OPHTHALMOL, V149, P371, DOI 10.1016/j.ajo.2009.11.022; Koizumi H, 2008, AM J OPHTHALMOL, V145, P509, DOI 10.1016/j.ajo.2007.10.014; Kraus MF, 2012, BIOMED OPT EXPRESS, V3, P1182, DOI 10.1364/BOE.3.001182; Mirza RG, 2007, SURV OPHTHALMOL, V52, P397, DOI 10.1016/j.survophthal.2007.04.007; Mojana F, 2010, AM J OPHTHALMOL, V149, P641, DOI 10.1016/j.ajo.2009.11.016; Mori K, 2012, OPHTHALMOLOGY, V119, P2600, DOI 10.1016/j.ophtha.2012.06.027; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; Potsaid B, 2010, OPT EXPRESS, V18, P20029, DOI 10.1364/OE.18.020029; Saalfeld S, 2009, ENHANCE LOCAL CONTRA; Sebag J, 2002, EYE, V16, P429, DOI 10.1038/sj.eye.6700201; Sebag J, 1989, VITREOUS STRUCTURE F; Shimada Hiroyuki, 2011, International Ophthalmology, V31, P51, DOI 10.1007/s10792-010-9398-4; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Stanga PE, 2013, AM J OPHTHALMOL; Unterhuber A, 2005, OPT EXPRESS, V13, P3252, DOI 10.1364/OPEX.13.003252; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	25	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102950	10.1371/journal.pone.0102950	http://dx.doi.org/10.1371/journal.pone.0102950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036044	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200101
J	Pandit, H; Gopal, S; Sonawani, A; Yadav, AK; Qaseem, AS; Warke, H; Patil, A; Gajbhiye, R; Kulkarni, V; Al-Mozaini, MA; Idicula-Thomas, S; Kishore, U; Madan, T				Pandit, Hrishikesh; Gopal, Sandhya; Sonawani, Archana; Yadav, Ajit Kumar; Qaseem, Asif S.; Warke, Himangi; Patil, Anushree; Gajbhiye, Rahul; Kulkarni, Vijay; Al-Mozaini, Maha Ahmed; Idicula-Thomas, Susan; Kishore, Uday; Madan, Taruna			Surfactant Protein D Inhibits HIV-1 Infection of Target Cells via Interference with gp120-CD4 Interaction and Modulates Pro-Inflammatory Cytokine Production	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CARBOHYDRATE-BINDING AGENTS; SP-A; U1 CELLS; T-CELLS; TYPE-1; EXPRESSION; REPLICATION; NEUTRALIZATION; INDUCTION	Surfactant Protein SP-D, a member of the collectin family, is a pattern recognition protein, secreted by mucosal epithelial cells and has an important role in innate immunity against various pathogens. In this study, we confirm that native human SP-D and a recombinant fragment of human SP-D (rhSP-D) bind to gp120 of HIV-1 and significantly inhibit viral replication in vitro in a calcium and dose-dependent manner. We show, for the first time, that SP-D and rhSP-D act as potent inhibitors of HIV-1 entry in to target cells and block the interaction between CD4 and gp120 in a dose-dependent manner. The rhSP-D-mediated inhibition of viral replication was examined using three clinical isolates of HIV-1 and three target cells: Jurkat T cells, U937 monocytic cells and PBMCs. HIV-1 induced cytokine storm in the three target cells was significantly suppressed by rhSP-D. Phosphorylation of key kinases p38, Erk1/2 and AKT, which contribute to HIV-1 induced immune activation, was significantly reduced in vitro in the presence of rhSP-D. Notably, anti-HIV-1 activity of rhSP-D was retained in the presence of biological fluids such as cervico-vaginal lavage and seminal plasma. Our study illustrates the multi-faceted role of human SP-D against HIV-1 and potential of rhSP-D for immunotherapy to inhibit viral entry and immune activation in acute HIV infection.	[Pandit, Hrishikesh; Gopal, Sandhya; Yadav, Ajit Kumar; Madan, Taruna] Natl Inst Res Reprod Hlth ICMR, Dept Innate Immun, Bombay, Maharashtra, India; [Sonawani, Archana; Idicula-Thomas, Susan] Natl Inst Res Reprod Hlth ICMR, Ctr Informat Biol, Bombay, Maharashtra, India; [Qaseem, Asif S.; Kishore, Uday] Brunel Univ, Ctr Infect Immun & Dis Mech, London, England; [Warke, Himangi] Seth GS Med Coll, Dept Obstet & Gynecol, Bombay, Maharashtra, India; [Warke, Himangi] King Edward Mem Hosp, Bombay, Maharashtra, India; [Patil, Anushree; Gajbhiye, Rahul; Kulkarni, Vijay] Natl Inst Res Reprod Hlth ICMR, Dept Clin Res, Bombay, Maharashtra, India; [Al-Mozaini, Maha Ahmed] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Immunocompromised Host Res Sect, Riyadh 11211, Saudi Arabia	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Brunel University; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); King Faisal Specialist Hospital & Research Center	Madan, T (corresponding author), Natl Inst Res Reprod Hlth ICMR, Dept Innate Immun, Bombay, Maharashtra, India.	taruna_m@hotmail.com	Pandit, Hrishikesh/AGZ-4050-2022; Gajbhiye, Rahul/AAE-6889-2022; Kishore, Uday/Y-7976-2018; Pandit, Hrishikesh/GON-8428-2022	Pandit, Hrishikesh/0000-0003-0994-6778; Gajbhiye, Rahul/0000-0003-3864-1818; Kishore, Uday/0000-0002-6033-6759; 	Medical Innovation Fund of Indian Council of Medical Research, New Delhi, India [2011-16850]	Medical Innovation Fund of Indian Council of Medical Research, New Delhi, India	The work (Project no. 2011-16850) was supported by Medical Innovation Fund of Indian Council of Medical Research, New Delhi, India (www.icmr.nic.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Ascherl G, 1999, BLOOD, V93, P4232; Bahbouhi B, 2004, BLOOD, V103, P4581, DOI 10.1182/blood-2003-12-4172; Balzarini J, 2005, J BIOL CHEM, V280, P41005, DOI 10.1074/jbc.M508801200; Balzarini Jan, 2007, Antiviral Chemistry & Chemotherapy, V18, P1; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; BISWAS P, 1994, J VIROL, V68, P2598, DOI 10.1128/JVI.68.4.2598-2604.1994; Borron PJ, 1998, J IMMUNOL, V161, P4599; Borron PJ, 2002, J IMMUNOL, V169, P5844, DOI 10.4049/jimmunol.169.10.5844; Chirmule N, 1996, MICROBIOL REV, V60, P386, DOI 10.1128/MMBR.60.2.386-406.1996; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; CIMINALE V, 1990, AIDS RES HUM RETROV, V6, P1281, DOI 10.1089/aid.1990.6.1281; Clark H, 2003, ARCH DIS CHILD, V88, P981, DOI 10.1136/adc.88.11.981; Clevestig P, 2006, J GEN VIROL, V87, P607, DOI 10.1099/vir.0.81510-0; Dodagatta-Marri E, 2014, METHODS MOL BIOL, V1100, P273, DOI 10.1007/978-1-62703-724-2_22; Esser MT, 1999, J VIROL, V73, P4360, DOI 10.1128/JVI.73.5.4360-4371.1999; Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003; Furler RL, 2010, IMMUNOL RES, V48, P99, DOI 10.1007/s12026-010-8170-1; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Graziosi C, 1996, P NATL ACAD SCI USA, V93, P4386, DOI 10.1073/pnas.93.9.4386; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Jakel A, 2013, FRONT BIOSCI-LANDMRK, V18, P1129, DOI 10.2741/4168; Jambo KC, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-42; Kankavi O, 2008, FERTIL STERIL, V90, P1904, DOI 10.1016/j.fertnstert.2007.09.064; Kankavi O, 2006, THERIOGENOLOGY, V66, P1057, DOI 10.1016/j.theriogenology.2006.02.047; Keller MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008781; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kunisaki KM, 2011, HIV MED, V12, P580, DOI 10.1111/j.1468-1293.2011.00920.x; Leth-Larsen R, 2004, MOL HUM REPROD, V10, P149, DOI 10.1093/molehr/gah022; LeVine AM, 2004, AM J RESP CELL MOL, V31, P193, DOI 10.1165/rcmb.2003-0107OC; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Lin KW, 2010, J IMMUNOL, V184, P6343, DOI 10.4049/jimmunol.0901947; LONGO N, 1993, J ACQ IMMUN DEF SYND, V6, P1017; Madsen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059047; Mahajan L, 2008, INT IMMUNOL, V20, P993, DOI 10.1093/intimm/dxn058; Mahajan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085046; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mengozzi M, 1999, BLOOD, V93, P1851, DOI 10.1182/blood.V93.6.1851.406k12_1851_1857; Meschi J, 2005, J GEN VIROL, V86, P3097, DOI 10.1099/vir.0.80764-0; Nayak A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00131; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Parren PWHI, 1998, J VIROL, V72, P3512, DOI 10.1128/JVI.72.5.3512-3519.1998; POLI G, 1994, P NATL ACAD SCI USA, V91, P108, DOI 10.1073/pnas.91.1.108; Popik W, 1998, J VIROL, V72, P6406, DOI 10.1128/JVI.72.8.6406-6413.1998; Rychert J, 2010, AIDS RES HUM RETROV, V26, P1139, DOI 10.1089/aid.2009.0290; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Strong P, 1998, J IMMUNOL METHODS, V220, P139, DOI 10.1016/S0022-1759(98)00160-4; Swanson MD, 2010, J BIOL CHEM, V285, P8646, DOI 10.1074/jbc.M109.034926; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Zaitseva M, 2000, BLOOD, V96, P3109, DOI 10.1182/blood.V96.9.3109.h8003109_3109_3117	57	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102395	10.1371/journal.pone.0102395	http://dx.doi.org/10.1371/journal.pone.0102395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036364	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200055
J	Sikorski, C; Luppa, M; Weyerer, S; Konig, HH; Maier, W; Schon, G; Petersen, JJ; Gensichen, J; Fuchs, A; Bickel, H; Wiese, B; Hansen, H; van den Bussche, H; Scherer, M; Riedel-Heller, SG				Sikorski, Claudia; Luppa, Melanie; Weyerer, Siegfried; Koenig, Hans-Helmut; Maier, Wolfgang; Schoen, Gerhard; Petersen, Juliana J.; Gensichen, Jochen; Fuchs, Angela; Bickel, Horst; Wiese, Birgitt; Hansen, Heike; van den Bussche, Hendrik; Scherer, Martin; Riedel-Heller, Steffi G.			Obesity and Associated Lifestyle in a Large Sample of Multi-Morbid German Primary Care Attendees	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY QUESTIONNAIRE; WAIST CIRCUMFERENCE; MORTALITY RISK; ALCOHOL INTAKE; OLDER-ADULTS; WEIGHT; MULTIMORBIDITY; PREVALENCE; RELIABILITY	Background: Obesity and the accompanying increased morbidity and mortality risk is highly prevalent among older adults. As obese elderly might benefit from intentional weight reduction, it is necessary to determine associated and potentially modifiable factors on senior obesity. This cross-sectional study focuses on multi-morbid patients which make up the majority in primary care. It reports on the prevalence of senior obesity and its associations with lifestyle behaviors. Methods: A total of 3,189 non-demented, multi-morbid participants aged 65-85 years were recruited in primary care within the German MultiCare-study. Physical activity, smoking, alcohol consumption and quantity and quality of nutritional intake were classified as relevant lifestyle factors. Body Mass Index (BMI, general obesity) and waist circumference (WC, abdominal obesity) were used as outcome measures and regression analyses were conducted. Results: About one third of all patients were classified as obese according to BMI. The prevalence of abdominal obesity was 73.5%. Adjusted for socio-demographic variables and objective and subjective disease burden, participants with low physical activity had a 1.6 kg/m(2) higher BMI as well as a higher WC (4.9 cm, p<0.001). Current smoking and high alcohol consumption were associated with a lower BMI and WC. In multivariate logistic regression, using elevated WC and BMI as categorical outcomes, the same pattern in lifestyle factors was observed. Only for WC, not current but former smoking was associated with a higher probability for elevated WC. Dietary intake in quantity and quality was not associated with BMI or WC in either model. Conclusions: Further research is needed to clarify if the huge prevalence discrepancy between BMI and WC also reflects a difference in obesity-related morbidity and mortality. Yet, age-specific thresholds for the BMI are needed likewise. Encouraging and promoting physical activity in older adults might a starting point for weight reduction efforts.	[Sikorski, Claudia; Luppa, Melanie; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany; [Sikorski, Claudia] Leipzig Univ Med Ctr, IFB AdiposityDis, Leipzig, Germany; [Weyerer, Siegfried] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Mannheim, Germany; [Koenig, Hans-Helmut] Hamburg Eppendorf Univ Med Ctr, Dept Med Sociol Social Med & Hlth Econ, Hamburg, Germany; [Maier, Wolfgang] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [Schoen, Gerhard] Hamburg Eppendorf Univ Med Ctr, Dept Med Biometry & Epidemiol, Hamburg, Germany; Goethe Univ Frankfurt, Inst Gen Practice, D-60054 Frankfurt, Germany; [Gensichen, Jochen] Jena Univ Hosp, Dept Gen Practice, Jena, Germany; [Fuchs, Angela] Univ Dusseldorf, Fac Med, Dept Gen Practice, Dusseldorf, Germany; [Bickel, Horst] Tech Univ Munich, Dept Psychiat, D-80290 Munich, Germany; [Wiese, Birgitt] Hannover Med Sch, Inst Biometry, Hannover, Germany; [Hansen, Heike; van den Bussche, Hendrik; Scherer, Martin] Univ Hamburg, Med Ctr, Dept Primary Med Care, Hamburg, Germany	Leipzig University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; Goethe University Frankfurt; Friedrich Schiller University of Jena; Heinrich Heine University Dusseldorf; Technical University of Munich; University of Munich; Hannover Medical School; University of Hamburg	Sikorski, C (corresponding author), Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany.	Claudia.Sikorski@medizin.uni-leipzig.de	Luppa, Melanie/AAQ-7338-2021; König, Hans-Helmut/P-1211-2018; Riedel-Heller, Steffi/ABG-1537-2021	König, Hans-Helmut/0000-0001-5711-6862; 	German Federal Ministry of Education and Research [01ET0725-31, 01ET1006A-K]; German Research Foundation (DFG); Leipzig University within the program of Open Access Publishing	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University within the program of Open Access Publishing	The study is funded by the German Federal Ministry of Education and Research (grant numbers 01ET0725-31 and 01ET1006A-K). The authors acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funding body had no further role in study design; in the collection, analysis and interpretation of data; in writing of the report; and the decision to submit the paper for publication.	Aertgeerts B, 2001, BRIT J GEN PRACT, V51, P206; [Anonymous], 2000, WHO TECHN REP SER; Atlantis E, 2008, AM J CLIN NUTR, V88, P95; Benecke A, 2003, OVERWEIGHT OBESITY; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Brauns H, 1999, ZUMA NACHRICHTEN, V23, P7; Bullo M, 2011, PREV MED, V53, P155, DOI 10.1016/j.ypmed.2011.06.008; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chiolero A, 2007, OBESITY, V15, P1311, DOI 10.1038/oby.2007.153; Collin C, 1988, Int Disabil Stud, V10, P61; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davis SR, 2012, CLIMACTERIC, V15, P419, DOI 10.3109/13697137.2012.707385; Deutsche Gesellschaft fur Ernahrung, 2011, NUTR GUID; Dombrowski SU, 2010, OBESITY FACTS, V3, P377, DOI 10.1159/000323076; Faeh D, 2011, EUR J EPIDEMIOL; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Freedman David S., 2011, Morbidity and Mortality Weekly Report, V60, P73; Gomez-Cabello A, 2011, OBES REV, V12, P583, DOI 10.1111/j.1467-789X.2011.00878.x; Gomez-Cabello A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041752; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; IPAQ Research Committee, 2005, GUID DAT PROC AN INT; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Basterra-Gortari FJ, 2010, REV ESP CARDIOL, V63, P20, DOI 10.1016/S0300-8932(10)70005-1; Jensen GL, 2010, CURR OPIN CLIN NUTR, V13, P46, DOI 10.1097/MCO.0b013e32833309cf; Kristal Alan R, 1992, FOOD FREQUENCY QUEST; Lahti-Koski M, 2002, AM J CLIN NUTR, V75, P809, DOI 10.1093/ajcn/75.5.809; Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975; Lovejoy JC, 2003, PRIMARY CARE, V30, P317, DOI 10.1016/S0095-4543(03)00012-5; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Maske UE, 2014, PSYCHIAT PRAX; Merrill DA, 2011, PSYCHIAT CLIN N AM, V34, P249, DOI 10.1016/j.psc.2010.11.009; National Nutrition Survey II, 2008, REP RES 1; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Post RE, 2011, ARCH INTERN MED, V171, P316, DOI 10.1001/archinternmed.2010.549; Price GM, 2006, AM J CLIN NUTR, V84, P449; Reichert FF, 2009, SPORTS MED, V39, P279, DOI 10.2165/00007256-200939040-00002; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Schafer I, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-145; Schafer I, 2011, 1 RESULTS M IN PRESS; Schunkert H, 2008, CLIN RES CARDIOL, V97, P827, DOI 10.1007/s00392-008-0694-1; Sharma AM, 2011, EVID BASED MED; StataCorp, 2009, STAT STAT SOFTW REL; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Verweij LM, 2013, PUBLIC HEALTH NUTR, V16, P281, DOI 10.1017/S1368980012002741; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yeomans MR, 2010, PHYSIOL BEHAV, V100, P82, DOI 10.1016/j.physbeh.2010.01.012	51	11	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102587	10.1371/journal.pone.0102587	http://dx.doi.org/10.1371/journal.pone.0102587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036102	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200074
J	Araujo, AC; Marques, S; Belo, JA				Araujo, Ana Carolina; Marques, Sara; Belo, Jose Antonio			Targeted Inactivation of Cerberus Like-2 Leads to Left Ventricular Cardiac Hyperplasia and Systolic Dysfunction in the Mouse	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; CELL-CYCLE REGULATION; EMBRYONIC STEM-CELLS; ECHOCARDIOGRAPHIC-ASSESSMENT; TRANSCRIPTION FACTORS; GENE-EXPRESSION; ARTERIAL POLE; CHICK-EMBRYO; FIELD; CARDIOMYOGENESIS	Previous analysis of the Cerberus like 2 knockout (Cerl2(-/-)) mouse revealed a significant mortality during the first day after birth, mostly due to cardiac defects apparently associated with randomization of the left-right axis. We have however, identified Cerl2-associated cardiac defects, particularly a large increase in the left ventricular myocardial wall in neonates that cannot be explained by laterality abnormalities. Therefore, in order to access the endogenous role of Cerl2 in cardiogenesis, we analyzed the embryonic and neonatal hearts of Cerl2 null mutants that did not display a laterality phenotype. Neonatal mutants obtained from the compound mouse line Cer2(-/-) :: Mlc1v-nLacZ24(+), in which the pulmonary ventricle is genetically marked, revealed a massive enlargement of the ventricular myocardium in animals without laterality defects. Echocardiography analysis in Cerl2(-/-) neonates showed a left ventricular systolic dysfunction that is incompatible with a long lifespan. We uncovered that the increased ventricular muscle observed in Cerl2(-/-) mice is caused by a high cardiomyocyte mitotic index in the compact myocardium which is mainly associated with increased Ccnd1 expression levels in the left ventricle at embryonic day (E) 13. Interestingly, at this stage we found augmented left ventricular expression of Cerl2 levels when compared with the right ventricle, which may elucidate the regionalized contribution of Cerl2 to the left ventricular muscle formation. Importantly, we observed an increase of phosphorylated Smad2 (pSmad2) levels in embryonic (E13) and neonatal hearts indicating a prolonged TGF beta s/Nodal-signaling activation. Concomitantly, we detected an increase of Baf60c levels, but only in Cerl2(-/-) embryonic hearts. These results indicate that independently of its well-known role in left-right axis establishment Cerl2 plays an important role during heart development in the mouse, mediating Baf60c levels by exerting an important control of the TGFbs/Nodal-signaling pathway.	[Araujo, Ana Carolina; Marques, Sara; Belo, Jose Antonio] Univ Algarve, Dept Ciencias Biomed & Med, Regenerat Med Program, Lab Embryol & Genet Manipulat, Faro, Portugal; [Araujo, Ana Carolina; Marques, Sara; Belo, Jose Antonio] Univ Algarve, Ctr Biomed Mol & Estrutural, Inst Biotechnol & Bioengn, Faro, Portugal; [Araujo, Ana Carolina] Univ Algarve, PhD Program Biomed Sci, Faro, Portugal; [Belo, Jose Antonio] Univ Nova Lisboa, Fac Ciencias Med, CEDOC Chron Dis Res Ctr, P-1200 Lisbon, Portugal	Universidade do Algarve; Universidade do Algarve; Universidade do Algarve; Universidade Nova de Lisboa	Belo, JA (corresponding author), Univ Algarve, Dept Ciencias Biomed & Med, Regenerat Med Program, Lab Embryol & Genet Manipulat, Campus Gambelas, Faro, Portugal.	jose.belo@fcm.unl.pt	Belo, José A. A/F-4444-2012	Belo, José A. A/0000-0001-7384-0949; Marques, Sara/0000-0001-6784-5612	Fundacao para a Ciencia e Tecnologia (FCT); IBB/CBME [PEst-OE/EQB/LA0023/2011]; FCT [SFRH/BD/62081/2009]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); IBB/CBME(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by research grants from Fundacao para a Ciencia e Tecnologia (FCT), and the IBB/CBME, LA in the frame of project ref. PEst-OE/EQB/LA0023/2011. A.C. Araujo is a doctoral fellow (SFRH/BD/62081/2009) from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; BENSHACHAR G, 1985, CIRC RES, V57, P759, DOI 10.1161/01.RES.57.5.759; Bento M, 2011, GENE EXPR PATTERNS, V11, P437, DOI 10.1016/j.gep.2011.07.002; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai WQ, 2013, GENE DEV, V27, P2332, DOI 10.1101/gad.225144.113; Cai WQ, 2012, CIRC RES, V111, P876, DOI 10.1161/CIRCRESAHA.112.270272; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Christoffels VM, 2004, TRENDS CARDIOVAS MED, V14, P301, DOI 10.1016/j.tcm.2004.09.002; Clark KL, 2006, ANNU REV PHYSIOL, V68, P97, DOI 10.1146/annurev.physiol.68.040104.113828; D'Aniello C, 2013, CARDIOVASC RES, V100, P95, DOI 10.1093/cvr/cvt166; DERUITER MC, 1992, ANAT EMBRYOL, V185, P461; Foley AC, 2007, DEV BIOL, V303, P57, DOI 10.1016/j.ydbio.2006.10.033; Franco D, 2001, EUR J MORPHOL, V39, P3, DOI 10.1076/ejom.39.1.3.7982; Franco D, 2006, DEV BIOL, V294, P366, DOI 10.1016/j.ydbio.2006.02.045; Francou A, 2013, BBA-MOL CELL RES, V1833, P795, DOI 10.1016/j.bbamcr.2012.10.003; Garne E, 2012, CONGENIT HEART DIS, V7, P46, DOI 10.1111/j.1747-0803.2011.00581.x; Garry DJ, 2006, CELL, V127, P1101, DOI 10.1016/j.cell.2006.11.031; Ghanem A, 2006, ECHOCARDIOGR-J CARD, V23, P900, DOI 10.1111/j.1540-8175.2006.00323.x; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ikenishi A, 2012, DEV GROWTH DIFFER, V54, P731, DOI 10.1111/j.1440-169X.2012.01373.x; Inacio JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060406; Kathiriya IS, 2000, AM J MED GENET, V97, P271, DOI 10.1002/1096-8628(200024)97:4<271::AID-AJMG1277>3.0.CO;2-O; Kelly RG, 2002, TRENDS GENET, V18, P210, DOI 10.1016/S0168-9525(02)02642-2; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kitamura R, 2007, CIRC RES, V101, P78, DOI 10.1161/CIRCRESAHA.106.147264; Lamba DA, 2008, DEV DYNAM, V237, P3016, DOI 10.1002/dvdy.21697; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li JM, 1999, EUR HEART J, V20, P406, DOI 10.1053/euhj.1998.1308; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Marques S, 2004, GENE DEV, V18, P2342, DOI 10.1101/gad.306504; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Mysliwiec MR, 2011, J BIOL CHEM, V286, P17193, DOI 10.1074/jbc.M110.205146; Nakamura T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2319; Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Perez-Pomares JM, 2009, INT J DEV BIOL, V53, P1427, DOI 10.1387/ijdb.072409jp; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Qiu ZZ, 2010, P NATL ACAD SCI USA, V107, P1136, DOI 10.1073/pnas.0913131107; Risebro CA, 2006, THESCIENTIFICWORLDJO, V6, P1862, DOI 10.1100/tsw.2006.316; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Sedmera D, 2011, DEV DYNAM, V240, P1322, DOI 10.1002/dvdy.22650; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Stypmann J, 2009, LAB ANIM-UK, V43, P127, DOI 10.1258/la.2007.06001e; Tan SY, 2007, J CLIN INVEST, V117, P3742, DOI 10.1172/JCI33284; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Zheng B, 2003, BIOCHEMISTRY-MOSCOW+, V68, P650, DOI 10.1023/A:1024617826469; Zheng-Fischhofer Q, 2006, J CELL SCI, V119, P693, DOI 10.1242/jcs.02800	63	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102716	10.1371/journal.pone.0102716	http://dx.doi.org/10.1371/journal.pone.0102716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033293	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300084
J	Lattanzio, MS; Metro, KJ; Miles, DB				Lattanzio, Matthew S.; Metro, Kevin J.; Miles, Donald B.			Preference for Male Traits Differ in Two Female Morphs of the Tree Lizard, Urosaurus ornatus	PLOS ONE			English	Article							SIDE-BLOTCHED LIZARD; MATE CHOICE; COLOR POLYMORPHISM; CORRELATIONAL SELECTION; CHEMICAL POLYMORPHISM; MALE-AGGRESSION; MALE QUALITY; EVOLUTION; SIGNALS; MAINTENANCE	Non-random female mating preferences may contribute to the maintenance of phenotypic variation in color polymorphic species. However, the effect of female preference depends on the types of male traits used as signals by receptive females. If preference signals derive from discrete male traits (i.e., morph-specific), female preferences may rapidly fix to a morph. However, female preference signals may also include condition-dependent male traits. In this scenario, female preference may differ depending on the social context (i.e., male morph availability). Male tree lizards (Urosaurus ornatus) exhibit a dewlap color polymorphism that covaries with mating behavior. Blue morph males are aggressive and defend territories, yellow males are less aggressive and defend smaller territories, and orange males are typically nomadic. Female U. ornatus are also polymorphic in dewlap color, but the covariation between dewlap color and female behavior is unknown. We performed an experiment to determine how female mate choice depends on the visual and chemical signals produced by males. We also tested whether female morphs differ in their preferences for these signals. Female preferences involved both male dewlap color and size of the ventral color patch. However, the female morphs responded to these signals differently and depended on the choice between the types of male morphs. Our experiment revealed that females may be capable of distinguishing among the male morphs using chemical signals alone. Yellow females exhibit preferences based on both chemical and visual signals, which may be a strategy to avoid ultra-dominant males. In contrast, orange females may prefer dominant males. We conclude that female U. ornatus morphs differ in mating behavior. Our findings also provide evidence for a chemical polymorphism among male lizards in femoral pore secretions.	[Lattanzio, Matthew S.; Metro, Kevin J.; Miles, Donald B.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University	Lattanzio, MS (corresponding author), Christopher Newport Univ, Dept Organismal & Environm Biol, Newport News, VA 23606 USA.	ML195406@ohio.edu	Miles, Donald B./AFW-0480-2022	Miles, Donald/0000-0001-5768-179X	Ariel-Appleton Research Fund; Ohio University Graduate Student Senate Original Work Grant; Ohio University Program	Ariel-Appleton Research Fund; Ohio University Graduate Student Senate Original Work Grant; Ohio University Program	Support for this research was provided by an Ariel-Appleton Research Fund and an Ohio University Graduate Student Senate Original Work Grant, both awarded to MSL, and a stipend from the Ohio University Program to Aid in Career Exploration awarded to KJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALBERTS AC, 1991, COPEIA, P69, DOI 10.2307/1446249; Alonzo SH, 2001, BEHAV ECOL SOCIOBIOL, V49, P176, DOI 10.1007/s002650000265; Aragon P, 2001, BEHAV ECOL SOCIOBIOL, V50, P128, DOI 10.1007/s002650100344; Bleay C, 2007, BEHAV ECOL, V18, P304, DOI 10.1093/beheco/arl101; Calsbeek B, 2010, J EVOLUTION BIOL, V23, P1138, DOI 10.1111/j.1420-9101.2010.01978.x; Calsbeek R, 2002, OECOLOGIA, V132, P468, DOI 10.1007/s00442-002-0975-8; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; CARPENTER CC, 1961, ECOLOGY, V42, P199, DOI 10.2307/1933292; CARPENTER GC, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P88; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Fisher R.A., 1930, GENETICAL THEORY NAT; Forsman A, 2002, EVOLUTION, V56, P349, DOI 10.1111/j.0014-3820.2002.tb01345.x; FRETWELL S D, 1972, P217; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Hamilton PS, 2005, ANIM BEHAV, V69, P219, DOI 10.1016/j.anbehav.2004.03.011; Healey M, 2008, ETHOLOGY, V114, P231, DOI 10.1111/j.1439-0310.2007.01469.x; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Huyghe K, 2007, INTEGR COMP BIOL, V47, P211, DOI 10.1093/icb/icm043; Huyghe K, 2012, ZOOLOGY, V115, P217, DOI 10.1016/j.zool.2011.11.001; Kingston JJ, 2003, ANIM BEHAV, V65, P735, DOI 10.1006/anbe.2003.2110; Knapp R, 2003, HORM BEHAV, V43, P83, DOI 10.1016/S0018-506X(02)00018-1; Kopena R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019410; Lancaster LT, 2009, BEHAV ECOL, V20, P993, DOI 10.1093/beheco/arp088; Lewontin RC, 1966, SYST ZOOL, V15, P141, DOI DOI 10.2307/2411632; Loew ER, 2002, J EXP BIOL, V205, P927; Lopez P, 2005, BIOL LETT-UK, V1, P404, DOI 10.1098/rsbl.2005.0360; Lopez P, 2006, J CHEM ECOL, V32, P473, DOI 10.1007/s10886-005-9012-9; Lopez P, 2009, CHEM SENSES, V34, P723, DOI 10.1093/chemse/bjp059; MANSON JH, 1994, ANIM BEHAV, V48, P473, DOI 10.1006/anbe.1994.1262; Martin J, 2006, FUNCT ECOL, V20, P1087, DOI 10.1111/j.1365-2435.2006.01183.x; Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030108; Martin M, 2013, BIOL J LINN SOC, V110, P128, DOI 10.1111/bij.12104; McElroy EJ, 2007, ETHOLOGY, V113, P1113, DOI 10.1111/j.1439-0310.2007.01420.x; Mennill DJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P350, DOI 10.1007/s00265-003-0581-8; Meyers JJ, 2006, FUNCT ECOL, V20, P709, DOI 10.1111/j.1365-2435.2006.01152.x; Moore AJ, 2001, P ROY SOC B-BIOL SCI, V268, P517, DOI 10.1098/rspb.2000.1399; Morrison RL, 1996, COPEIA, P804, DOI 10.2307/1447641; Ophir AG, 2003, ANIM BEHAV, V66, P399, DOI 10.1006/anbe.2003.2230; Pellitteri-Rosa D, 2014, CHEMOECOLOGY, V24, P67, DOI 10.1007/s00049-014-0148-3; de Lanuza GPI, 2013, BEHAV ECOL, V24, P273, DOI 10.1093/beheco/ars164; Pryke SR, 2007, J EVOLUTION BIOL, V20, P1512, DOI 10.1111/j.1420-9101.2007.01332.x; Pryke SR, 2006, P ROY SOC B-BIOL SCI, V273, P949, DOI 10.1098/rspb.2005.3362; Quinn VS, 2005, J HERPETOL, V39, P496, DOI 10.1670/207-04N.1; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; R Development Core Team, 2012, R LANG ENV STAT COMP; Robertson JM, 2009, BIOL J LINN SOC, V98, P243, DOI 10.1111/j.1095-8312.2009.01291.x; Rosenblum EB, 2006, AM NAT, V167, P1, DOI 10.1086/498397; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; San-Jose LM, 2013, AM NAT, V181, P396, DOI 10.1086/669159; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 2002, HEREDITY, V89, P329, DOI 10.1038/sj.hdy.6800148; Sinervo B, 2001, EVOLUTION, V55, P2040; Sinervo B, 2007, AM NAT, V170, P663, DOI 10.1086/522092; THOMPSON CW, 1991, ANIM BEHAV, V42, P745, DOI 10.1016/S0003-3472(05)80120-4; Thompson JT, 2008, ANIM BEHAV, V76, P113, DOI 10.1016/j.anbehav.2007.12.015; Vercken E, 2007, J EVOLUTION BIOL, V20, P221, DOI 10.1111/j.1420-9101.2006.01208.x; Villaverde GA, 1998, SOUTHWEST NAT, V43, P92; WARD G, 1987, J FISH BIOL, V30, P679, DOI 10.1111/j.1095-8649.1987.tb05797.x	61	18	19	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101515	10.1371/journal.pone.0101515	http://dx.doi.org/10.1371/journal.pone.0101515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033282	Green Submitted, gold, Green Published			2022-12-25	WOS:000339418300020
J	Lou, B; Dong, JB; Li, YL; Ding, TB; Bi, TT; Li, Y; Deng, XD; Ye, DY; Jiang, XC				Lou, Bin; Dong, Jibin; Li, Yali; Ding, Tingbo; Bi, Tingting; Li, Yue; Deng, Xiaodong; Ye, Deyong; Jiang, Xian-Cheng			Pharmacologic Inhibition of Sphingomyelin Synthase (SMS) Activity Reduces Apolipoprotein-B Secretion from Hepatocytes and Attenuates Endotoxin-Mediated Macrophage Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; CORONARY-ARTERY-DISEASE; TO-RETENTION HYPOTHESIS; LOW-DENSITY-LIPOPROTEIN; COMBINED HYPERLIPIDEMIA; MEMBRANE SPHINGOMYELIN; CERAMIDE HOMEOSTASIS; DEFICIENT MICE; HEART-DISEASE; RISK-FACTOR	Sphingomyelin synthase (SMS) plays an important role in plasma atherogenic lipoprotein metabolism, inflammation, and the development of atherosclerosis. To understand whether the impaired apoB secretion and inflammation response is a direct result from lack of SMS activity, in this study, we prepared a series of compounds that inhibit SMS activity. Further, we characterized Dy105, the most potent inhibitor. We found that Dy105 treatment significantly reduces SM levels in SM-rich microdomain on cell membranes. Moreover, we found that SMS inhibition reduces apoB secretion in a human hepatoma cell line and reduces the activation of NF kappa B and p38, a MAP kinase, in bone marrow derived macrophages. These studies provided further evidence that SMS activity regulates atherogenic lipoprotein metabolism and inflammatory responses. Pharmacologic inhibition of SMS may be a new therapy for atherosclerosis by reducing apoB secretion, and reducing inflammation.	[Lou, Bin; Dong, Jibin; Li, Yali; Ding, Tingbo; Bi, Tingting; Li, Yue; Deng, Xiaodong; Ye, Deyong; Jiang, Xian-Cheng] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Jiang, Xian-Cheng] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA	Fudan University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Lou, B (corresponding author), Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China.	blou@shmu.edu.cn; dyye@shmu.edu.cn	Ye, Deyong/AAE-2173-2022	Ye, Deyong/0000-0003-0498-3019	Department of Radiologic Medicine, School of Pharmacy, Fudan University	Department of Radiologic Medicine, School of Pharmacy, Fudan University	We thank Prof. Jianhua Zhu (Department of Radiologic Medicine, School of Pharmacy, Fudan University) for his support.	Arca M, 2011, DIABETES METAB SYNDR, V4, P155, DOI 10.2147/DMSO.S11244; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; BRUNZELL JD, 1983, J LIPID RES, V24, P147; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; Davenport P, 2003, AM J PATHOL, V163, P1117, DOI 10.1016/S0002-9440(10)63471-2; Deng XD, 2014, EUR J MED CHEM, V73, P1, DOI 10.1016/j.ejmech.2013.12.002; Duvillard L, 2000, EUR J CLIN INVEST, V30, P685, DOI 10.1046/j.1365-2362.2000.00702.x; Fan YF, 2010, ARTERIOSCL THROM VAS, V30, P2114, DOI 10.1161/ATVBAHA.110.213363; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GRILLI M, 1993, INT REV CYTOL, V143, P1; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-71; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Keating AJ, 2013, ANN PHARMACOTHER, V47, P398, DOI 10.1345/aph.1R509; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; KJEKSHUS J, 1995, AM J CARDIOL, V76, pC64, DOI 10.1016/S0002-9149(99)80473-1; Li Y, 2013, ARTERIOSCL THROM VAS, V33, P1513, DOI 10.1161/ATVBAHA.113.301498; Li Z, 2012, ARTERIOSCLER THROMB; Li ZQ, 2007, BBA-MOL CELL BIOL L, V1771, P1186, DOI 10.1016/j.bbalip.2007.05.007; Li ZQ, 2012, ARTERIOSCL THROM VAS, V32, P1577, DOI 10.1161/ATVBAHA.112.251538; Li ZQ, 2011, MOL CELL BIOL, V31, P4205, DOI 10.1128/MCB.05893-11; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu J, 2009, CIRC RES, V105, P295, DOI 10.1161/CIRCRESAHA.109.194613; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Maher V, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199754010-00001; Matteucci E, 2013, CURR MED CHEM, V20, P1397, DOI 10.2174/0929867311320110004; Mayo MW, 2000, BBA-REV CANCER, V1470, pM55, DOI 10.1016/S0304-419X(00)00002-0; McKenney JM, 2006, AM J CARDIOL, V97, p89C, DOI 10.1016/j.amjcard.2006.02.030; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; Nilsson A, 2006, J LIPID RES, V47, P154, DOI 10.1194/jlr.M500357-JLR200; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Riches FM, 1998, INT J OBESITY, V22, P414, DOI 10.1038/sj.ijo.0800602; RODRIGUEZ JL, 1976, ATHEROSCLEROSIS, V23, P73, DOI 10.1016/0021-9150(76)90119-2; Schlitt A, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-5; Senokuchi T, 2004, ATHEROSCLEROSIS, V176, P233, DOI 10.1016/j.atherosclerosis.2004.05.019; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; van der Luit AH, 2007, BIOCHEM J, V401, P541, DOI 10.1042/BJ20061178; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Whitman SC, 2002, J INTERF CYTOK RES, V22, P661, DOI 10.1089/10799900260100141; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002; Zhao M, 2002, APMIS, V110, P458, DOI 10.1034/j.1600-0463.2002.100604.x; ZILVERSMIT D, 1961, CIRCULATION, V23, P370, DOI 10.1161/01.CIR.23.3.370	52	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102641	10.1371/journal.pone.0102641	http://dx.doi.org/10.1371/journal.pone.0102641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032960	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300073
J	Micallef, L; Rodgers, P				Micallef, Luana; Rodgers, Peter			eulerAPE: Drawing Area-Proportional 3-Venn Diagrams Using Ellipses	PLOS ONE			English	Article							OBSTRUCTIVE LUNG-DISEASE; VENN-DIAGRAM; MICROBIAL DIVERSITY; MONTE-CARLO; TRANSCRIPTOME; GENES; SET; INTEGRATION; SEDIMENT; PROTEOME	Venn diagrams with three curves are used extensively in various medical and scientific disciplines to visualize relationships between data sets and facilitate data analysis. The area of the regions formed by the overlapping curves is often directly proportional to the cardinality of the depicted set relation or any other related quantitative data. Drawing these diagrams manually is difficult and current automatic drawing methods do not always produce appropriate diagrams. Most methods depict the data sets as circles, as they perceptually pop out as complete distinct objects due to their smoothness and regularity. However, circles cannot draw accurate diagrams for most 3-set data and so the generated diagrams often have misleading region areas. Other methods use polygons to draw accurate diagrams. However, polygons are non-smooth and non-symmetric, so the curves are not easily distinguishable and the diagrams are difficult to comprehend. Ellipses are more flexible than circles and are similarly smooth, but none of the current automatic drawing methods use ellipses. We present eulerAPE as the first method and software that uses ellipses for automatically drawing accurate area-proportional Venn diagrams for 3-set data. We describe the drawing method adopted by eulerAPE and we discuss our evaluation of the effectiveness of eulerAPE and ellipses for drawing random 3-set data. We compare eulerAPE and various other methods that are currently available and we discuss differences between their generated diagrams in terms of accuracy and ease of understanding for real world data.	[Micallef, Luana; Rodgers, Peter] Univ Kent, Sch Comp, Canterbury, Kent, England	University of Kent	Micallef, L (corresponding author), Aalto Univ, Helsinki Inst Informat Technol, Helsinki, Finland.	L.Micallef@kent.ac.uk		Rodgers, Peter/0000-0002-4100-3596	School of Computing, University of Kent, UK	School of Computing, University of Kent, UK	The authors are employed by the School of Computing, University of Kent, UK (http://www.cs.kent.ac.uk) and thus, this research was fully funded by the School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey NW, 2013, G3-GENES GENOM GENET, V3, P225, DOI 10.1534/g3.112.004341; Benoy F, 2007, IEEE INT CONF INF VI, P771; Bielecki P, 2013, ENVIRON MICROBIOL, V15, P570, DOI 10.1111/1462-2920.12024; Blake A, 2014, P 8 INT C DIAGR REPR; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; Burdon FJ, 2013, ECOL APPL, V23, P1036, DOI 10.1890/12-1190.1; Card S. K., 1991, Human Factors in Computing Systems. Reaching Through Technology. CHI '91. Conference Proceedings, P181, DOI 10.1145/108844.108874; Carvalho PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-316; Chow S, 2004, LECT NOTES COMPUT SC, V2912, P466; Chow S, 2005, P 2 INT WORKSH EUL D; Chow S, 2007, MATH MAG, V80, P91; Chow SC, 2007, THESIS U VICTORIA VI; Chow S, 2005, ELECTRON NOTES THEOR, V134, P3, DOI 10.1016/j.entcs.2005.02.017; Chun HB, 2011, J CEREBR BLOOD F MET, V31, P2267, DOI 10.1038/jcbfm.2011.104; Cibella F, 2011, PEDIAT ALLERG IMM-UK, V22, P60, DOI 10.1111/j.1399-3038.2010.01097.x; CLARK AK, 1976, PSYCHOMETRIKA, V41, P401, DOI 10.1007/BF02293563; Dang TN, 2012, LECT NOTES COMPUT SC, V7431, P348, DOI 10.1007/978-3-642-33179-4_34; Dzeing-Ella A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-1; Farrell G, 2001, CRIME PREVENTION STU, V12, P221; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Gresnigt MS, 2013, J IMMUNOL, V190, P5629, DOI 10.4049/jimmunol.1202601; Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jepsen JU, 2012, ECOSYSTEMS, P1; Kang Y, 2011, GENOME RES, V21, P925, DOI 10.1101/gr.116103.110; Kestler HA, 2005, BIOINFORMATICS, V21, P1592, DOI 10.1093/bioinformatics/bti169; Kestler HA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-67; Kim B, 2007, INTERACT COMPUT, V19, P630, DOI 10.1016/j.intcom.2007.05.004; Klees RF, 2007, MATRIX BIOL, V26, P106, DOI 10.1016/j.matbio.2006.10.001; Koffka K, 1935, PRINCIPLES GESTALT P; Lam HT, 2011, CLIN TRANSLATIONAL A, P1; Lenz O, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-30; Liao L, 2011, FEMS MICROBIOL ECOL, V78, P565, DOI 10.1111/j.1574-6941.2011.01186.x; Ma X, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-23; Mann K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-7; Marshall RJ, 2005, J CLIN EPIDEMIOL, V58, P974, DOI 10.1016/j.jclinepi.2005.01.018; Martin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036911; Mathioni SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-49; McNamara C, 2011, SMITHSONIAN CONTRIBU, V2, P29; Micallef L, 2013, THESIS U KENT CANTER; Miller RB, 1968, P DEC 9 11 1968 AFIP, P267; Montello Daniel R., 2002, CARTOGR GEOGR INF SC, V29, P283, DOI DOI 10.1559/152304002782008503; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; PALMER SE, 1992, COGNITIVE PSYCHOL, V24, P436, DOI 10.1016/0010-0285(92)90014-S; Regenbrecht CRA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-49; Reid RJD, 2011, GENOME RES, V21, P477, DOI 10.1101/gr.109033.110; Rochman M, 2011, NUCLEIC ACIDS RES, V39, P4076, DOI 10.1093/nar/gkq1343; Rodgers P, 2014, IEEE T VISUALIZATION, P20; Rodgers P, 2012, IEEE T VIS COMPUT GR, V18, P1089, DOI 10.1109/TVCG.2011.143; Rodgers P, 2010, LECT NOTES ARTIF INT, V6170, P54, DOI 10.1007/978-3-642-14600-8_9; Rodrigues FA, 2012, GENET MOL BIOL, V35, P304, DOI 10.1590/S1415-47572012000200011; Shiqun LS, 2009, P 22 NE SAS US GROUP; Soriano JB, 2003, CHEST, V124, P474, DOI 10.1378/chest.124.2.474; SPENCE I, 1978, PSYCHOMETRIKA, V43, P115, DOI 10.1007/BF02294095; Stapleton G, 2011, J VISUAL LANG COMPUT, V22, P426, DOI 10.1016/j.jvlc.2011.07.001; Szeles L, 2010, MOL ENDOCRINOL, V24, P2218, DOI 10.1210/me.2010-0215; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; TREISMAN A, 1985, COMPUT VISION GRAPH, V31, P156, DOI 10.1016/S0734-189X(85)80004-9; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Viegi G, 2004, CHEST, V126, P1093, DOI 10.1378/chest.126.4.1093; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Ware C., 2012, INFORM VISUALIZATION; Wieland B, 2006, J APPL MICROBIOL, V100, P316, DOI 10.1111/j.1365-2672.2005.02788.x; Wilkinson L, 2012, IEEE T VIS COMPUT GR, V18, P321, DOI 10.1109/TVCG.2011.56; Won JY, 2014, EXP EYE RES, V118, P30, DOI 10.1016/j.exer.2013.10.020; Zielinski J, 2006, EUR RESPIR J, V27, P833, DOI 10.1183/09031936.06.00025905	67	355	358	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101717	10.1371/journal.pone.0101717	http://dx.doi.org/10.1371/journal.pone.0101717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032825	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000339418300024
J	Noh, KK; Chung, KW; Choi, YJ; Park, MH; Jang, EJ; Park, CH; Yoon, C; Kim, ND; Kim, MK; Chung, HY				Noh, Kyung Kyun; Chung, Ki Wung; Choi, Yeon Ja; Park, Min Hi; Jang, Eun Ji; Park, Chan Hum; Yoon, Changshin; Kim, Nam Deuk; Kim, Mi Kyung; Chung, Hae Young			beta-Hydroxy beta-Methylbutyrate Improves Dexamethasone-Induced Muscle Atrophy by Modulating the Muscle Degradation Pathway in SD Rat	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; SIGNALING PATHWAYS; UBIQUITIN LIGASES; PROTEIN-SYNTHESIS; MECHANISMS; ATTENUATION; MYOD; PROTEOLYSIS; PROTEASOME	Skeletal muscle atrophy results from various conditions including high levels of glucocorticoids, and beta-hydroxy beta-methylbutyrate (HMB; a metabolite of leucine) is a potent therapeutical supplement used to treat various muscle disorders. Recent studies have demonstrated that HMB inhibits dexamethasone-induced atrophy in cultured myotubes, but its effect on dexamethasone-induced muscle atrophy has not been determined in vivo. In the present study, we investigated the effect of HMB on dexamethasone-induced muscle atrophy in rats. Treatment with dexamethasone weakened grip strengths and increased muscle damage as determined by increased serum creatine kinase levels and by histological analysis. Dexamethasone treatment also reduced both soleus and gastrocnemius muscle masses. However, HMB supplementation significantly prevented reductions in grip strengths, reduced muscle damage, and prevented muscle mass and protein concentration decrease in soleus muscle. Biochemical analysis demonstrated that dexamethasone markedly increased levels of MuRF1 protein, which causes the ubiquitination and degradation of MyHC. Indeed, dexamethasone treatment decreased MyHC protein expression and increased the ubiquitinated-MyHC to MyHC ratio. However, HMB supplementation caused the down-regulations of MuRF1 protein and of ubiquitinated-MyHC. Furthermore, additional experiments provided evidence that HMB supplementation inhibited the nuclear translocation of FOXO1 induced by dexamethasone, and showed increased MyoD expression in the nuclear fractions of soleus muscles. These findings suggest that HMB supplementation attenuates dexamethasone-induced muscle wasting by regulating FOXO1 transcription factor and subsequent MuRF1 expression. Accordingly, our results suggest that HMB supplementation could be used to prevent steroid myopathy.	[Noh, Kyung Kyun; Chung, Ki Wung; Choi, Yeon Ja; Park, Min Hi; Jang, Eun Ji; Park, Chan Hum; Yoon, Changshin; Kim, Nam Deuk; Chung, Hae Young] Pusan Natl Univ, Dept Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan, South Korea; [Kim, Mi Kyung] Pusan Natl Univ, Longev Life Sci & Technol Inst, Pusan, South Korea	Pusan National University; Pusan National University	Chung, HY (corresponding author), Pusan Natl Univ, Dept Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan, South Korea.	hyjung@pusan.ac.kr	Park, Min Hi/AAL-9880-2020		Korean National Research Foundation - Korean Ministry of Education, Science and Technology [2009-0083538]; R&D program of MKE/KEIT (Development of Functional Food Materials and Device for Prevention of Aging-associated Muscle Function Decrease) [0040391]	Korean National Research Foundation - Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); R&D program of MKE/KEIT (Development of Functional Food Materials and Device for Prevention of Aging-associated Muscle Function Decrease)	This work was supported by the Korean National Research Foundation funded by the Korean Ministry of Education, Science and Technology (Grant no. 2009-0083538), and by the R&D program of MKE/KEIT (Grant no. 10040391, Development of Functional Food Materials and Device for Prevention of Aging-associated Muscle Function Decrease). In addition, we thank the Aging Tissue Bank for providing research materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aversa Z, 2012, BIOCHEM BIOPH RES CO, V423, P739, DOI 10.1016/j.bbrc.2012.06.029; Aversa Z, 2011, INT J ONCOL, V38, P713, DOI 10.3892/ijo.2010.885; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; BOWYER SL, 1985, J ALLERGY CLIN IMMUN, V76, P234, DOI 10.1016/0091-6749(85)90708-0; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carroll TB, 2010, REV ENDOCR METAB DIS, V11, P147, DOI 10.1007/s11154-010-9143-3; Clark RH, 2000, JPEN-PARENTER ENTER, V24, P133, DOI 10.1177/0148607100024003133; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Daitoku H, 2011, BBA-MOL CELL RES, V1813, P1954, DOI 10.1016/j.bbamcr.2011.03.001; Eley HL, 2007, AM J PHYSIOL-ENDOC M, V293, pE923, DOI 10.1152/ajpendo.00314.2007; Eley HL, 2008, AM J PHYSIOL-ENDOC M, V295, pE1409, DOI 10.1152/ajpendo.90530.2008; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Giannaki CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025180; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; Kim JS, 2010, J NUTR BIOCHEM, V21, P1, DOI 10.1016/j.jnutbio.2009.06.014; Kornasio R, 2009, BBA-MOL CELL RES, V1793, P755, DOI 10.1016/j.bbamcr.2008.12.017; Kovarik M, 2010, J PHYSIOL BIOCHEM, V66, P311, DOI 10.1007/s13105-010-0037-3; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Magal M, 2010, J SPORT SCI, V28, P257, DOI 10.1080/02640410903440892; Marcora S, 2005, CLIN NUTR, V24, P442, DOI 10.1016/j.clnu.2005.01.006; Markowitz JA, 2012, PEDIATR NEUROL, V46, P1, DOI 10.1016/j.pediatrneurol.2011.09.001; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Nissen S, 1996, J APPL PHYSIOL, V81, P2095, DOI 10.1152/jappl.1996.81.5.2095; Nissen SL, 1997, J NUTR BIOCHEM, V8, P300, DOI 10.1016/S0955-2863(97)00048-X; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Romanick M, 2013, BBA-MOL BASIS DIS, V1832, P1410, DOI 10.1016/j.bbadis.2013.03.011; Russell ST, 2009, MOL CELL BIOCHEM, V330, P171, DOI 10.1007/s11010-009-0130-5; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Smith HJ, 2005, CANCER RES, V65, P277; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vazeille E, 2012, J NUTR BIOCHEM, V23, P245, DOI 10.1016/j.jnutbio.2010.11.021; Vukovich MD, 2001, J NUTR, V131, P2049, DOI 10.1093/jn/131.7.2049; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Yamamoto D, 2010, MUSCLE NERVE, V41, P819, DOI 10.1002/mus.21621; Zanchi NE, 2011, AMINO ACIDS, V40, P1015, DOI 10.1007/s00726-010-0678-0	40	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102947	10.1371/journal.pone.0102947	http://dx.doi.org/10.1371/journal.pone.0102947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032690	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300111
J	Reinhold, WC; Varma, S; Sousa, F; Sunshine, M; Abaan, OD; Davis, SR; Reinhold, SW; Kohn, KW; Morris, J; Meltzer, PS; Doroshow, JH; Pommier, Y				Reinhold, William C.; Varma, Sudhir; Sousa, Fabricio; Sunshine, Margot; Abaan, Ogan D.; Davis, Sean R.; Reinhold, Spencer W.; Kohn, Kurt W.; Morris, Joel; Meltzer, Paul S.; Doroshow, James H.; Pommier, Yves			NCI-60 Whole Exome Sequencing and Pharmacological CellMiner Analyses	PLOS ONE			English	Article							CELL-LINES; DRUG-SENSITIVITY; GENE-EXPRESSION; CANCER; DNA; PANEL; IDENTIFICATION; INHIBITOR; MUTATIONS; PATTERNS	Exome sequencing provides unprecedented insights into cancer biology and pharmacological response. Here we assess these two parameters for the NCI-60, which is among the richest genomic and pharmacological publicly available cancer cell line databases. Homozygous genetic variants that putatively affect protein function were identified in 1,199 genes (approximately 6% of all genes). Variants that are either enriched or depleted compared to non-cancerous genomes, and thus may be influential in cancer progression and differential drug response were identified for 2,546 genes. Potential gene knockouts are made available. Assessment of cell line response to 19,940 compounds, including 110 FDA-approved drugs, reveals approximate to 80-fold range in resistance versus sensitivity response across cell lines. 103,422 gene variants were significantly correlated with at least one compound (at p<0.0002). These include genes of known pharmacological importance such as IGF1R, BRAF, RAD52, MTOR, STAT2 and TSC2 as well as a large number of candidate genes such as NOM1, TLL2, and XDH. We introduce two new web-based CellMiner applications that enable exploration of variant-to-compound relationships for a broad range of researchers, especially those without bioinformatics support. The first tool, "Genetic variant versus drug visualization'', provides a visualization of significant correlations between drug activity-gene variant combinations. Examples are given for the known vemurafenib-BRAF, and novel ifosfamide-RAD52 pairings. The second, "Genetic variant summation'' allows an assessment of cumulative genetic variations for up to 150 combined genes together; and is designed to identify the variant burden for molecular pathways or functional grouping of genes. An example of its use is provided for the EGFR-ERBB2 pathway gene variant data and the identification of correlated EGFR, ERBB2, MTOR, BRAF, MEK and ERK inhibitors. The new tools are implemented as an updated web-based CellMiner version, for which the present publication serves as a compendium.	[Reinhold, William C.; Varma, Sudhir; Sousa, Fabricio; Sunshine, Margot; Reinhold, Spencer W.; Kohn, Kurt W.; Morris, Joel; Doroshow, James H.; Pommier, Yves] NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Varma, Sudhir] HiThru Analyt LLC, Laurel, MD USA; [Sousa, Fabricio] Univ Fed Mato Grosso do Sul, Ctr Estudos Celulas Tronco Terapia Celular & Gene, Programa Posgrad Farm, Campo Grande, MS, Brazil; [Sunshine, Margot] SRA Int, Fairfax, VA USA; [Abaan, Ogan D.; Davis, Sean R.; Meltzer, Paul S.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade Federal de Mato Grosso do Sul; SRA International; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Reinhold, WC (corresponding author), NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	wcr@mail.nih.gov; pommier@nih.gov	Varma, Sudhir/N-8763-2014; Sousa, Fabricio G/O-8878-2015; Davis, Sean/AAD-1801-2021; Reinhold, William/J-6704-2017	Varma, Sudhir/0000-0002-4096-4782; Sousa, Fabricio G/0000-0003-0444-754X; Davis, Sean/0000-0002-8991-6458; Reinhold, William/0000-0001-5513-9323	Center for Cancer Research, Intramural Program of the National Cancer Institute [Z01 BC 006150]; NATIONAL CANCER INSTITUTE [Z01BC006150, ZICBC011509, ZICBC011475] Funding Source: NIH RePORTER	Center for Cancer Research, Intramural Program of the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Our studies are supported by the Center for Cancer Research, Intramural Program of the National Cancer Institute (Z01 BC 006150). The funders had no role had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Adams S, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-11; Algeciras-Schimnich A, 2003, P NATL ACAD SCI USA, V100, P11445, DOI 10.1073/pnas.2034995100; Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; Choi BO, 2012, HUM MUTAT; Cromer MK, 2012, J CLIN ENDOCRINOL ME; Cronin M, 2011, BIOMARK MED, V5, P293, DOI [10.2217/BMM.11.37, 10.2217/bmm.11.37]; Cunningham L, 2012, P NATL ACAD SCI USA, V109, P14592, DOI 10.1073/pnas.1200037109; Doherty D, 2012, NEUROLOGY; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Dyment DA, 2012, NEUROLOGY; Gao R, 2013, DNA REPAIR IN PRESS; Garner KM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-206; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Gillis N, 2013, CLIN PHARM THER; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Hertz DL, 2013, PHARMACOGENOMICS, V14, P1065, DOI [10.2217/PGS.13.90, 10.2217/pgs.13.90]; Holbeck S, 2010, MOL ENDOCRINOL, V24, P1287, DOI 10.1210/me.2010-0040; Holbeck SL, 2010, MOL CANCER THER, V9, P1451, DOI 10.1158/1535-7163.MCT-10-0106; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Johnston JJ, 2012, AM J HUM GENET; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Koo GC, 2012, CANC DISCOV; LEE JS, 1994, MOL PHARMACOL, V46, P627; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Moldovan F, 2012, STUD HEALTH TECHNOL, V176, P453; NCBI GEO website, AG 012750 HUM GEN CG; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Patrawala S, 2012, FUTURE ONCOL, V8, P509, DOI [10.2217/FON.12.31, 10.2217/fon.12.31]; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Reinhold WC, 2012, CANC RES; Reinhold WC, 2010, CANCER RES, V70, P2191, DOI 10.1158/0008-5472.CAN-09-3528; Roschke AV, 2003, CANCER RES, V63, P8634; Ruan XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031628; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; SELL C, 1995, CANCER RES, V55, P303; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Stuelten CH, 2010, STEM CELLS, V28, P649, DOI 10.1002/stem.324; Stults DM, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-23; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Tanaka H, 1999, JPN J CANCER RES, V90, P1139, DOI 10.1111/j.1349-7006.1999.tb00688.x; Uluer ET, 2011, ACTA HISTOCHEM; Varma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092047; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weinstein JN, 2012, NATURE, V483, P544, DOI 10.1038/483544a; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Zoppoli G, 2012, P NATL ACAD SCI USA, V109, P15030, DOI 10.1073/pnas.1205943109	54	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101670	10.1371/journal.pone.0101670	http://dx.doi.org/10.1371/journal.pone.0101670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032700	Green Submitted, gold, Green Published			2022-12-25	WOS:000339418300023
J	Woldehaimanot, TE; Eshetie, TC; Kerie, MW				Woldehaimanot, Tewodros Eyob; Eshetie, Tesfahun Chanie; Kerie, Mirkuzie Woldie			Postoperative Pain Management among Surgically Treated Patients in an Ethiopian Hospital	PLOS ONE			English	Article							OUTCOME QUESTIONNAIRE; NARCOTIC ANALGESICS; MEDICAL INPATIENTS; PALLIATIVE CARE; QUALITY; PERCEPTION; EXPERIENCE; CANCER; SATISFACTION; EVALUATE	Background: Incidence of postoperative pain has been reported to be between 47-100%. Ineffective postoperative pain management results in tangible and intangible costs. The purpose of this study was to assess the processes and outcomes of pain management in the surgical wards of Jimma University Specialized Hospital, Ethiopia. Methods and Findings: A prospective cross sectional study was conducted among 252 postoperative patients during February 13 to April 30, 2012. A contextually modified and validated (Cronbach's alpha coefficient of 0.78) American Pain Society Patient Outcome Questionnaire was used to assess pain experience of patients. Patients' charts were reviewed to assess the pattern of analgesic use. Incidence of postoperative pain was 91.4%, and remained high over 3 measurements (McNemar's; p<0.05), and 80.1% of the patients were undertreated. The mean pain intensity, and pain interference on functional status were 6.72 +/- 1.44 and 5.61 +/- 1.13 on a 10 point Numerical rating scale respectively; both being strongly correlated(r = 0.86: p<0.001). Pain intensity was varied by ethnicity, education and preoperative information (ANOVA; P<0.05). Only 50% of the patients were adequately satisfied with their pain management. As needed (prn), solo analgesic, null analgesic, and intramuscular orders were noted for 31.3%, 89.29%, 9.7% and 20.1% of the prescription orders respectively. Though under dose, diclofenac and tramadol were the top prescribed medications, and only 57% of their dose was administered. Linear regression model showed that the predictors of satisfaction were sex of an individual and pain interference with functional status. Conclusion: Despite patients' paradoxical high satisfaction with pain management, the majority of patients were inadequately and inappropriately treated. Thus, further research is needed to determine how best to break down current barriers to effective pain management.	[Woldehaimanot, Tewodros Eyob; Eshetie, Tesfahun Chanie] Jimma Univ, Dept Pharm, Jimma, Ethiopia; [Kerie, Mirkuzie Woldie] Jimma Univ, Dept Hlth Serv Management, Jimma, Ethiopia	Jimma University; Jimma University	Woldehaimanot, TE (corresponding author), Jimma Univ, Dept Pharm, Jimma, Ethiopia.	teda.eyob@gmail.com	Eshetie, Tesfahun/AAO-2224-2020; Woldie, Mirkuzie/S-4086-2017	Eshetie, Tesfahun/0000-0001-7253-988X; Woldie, Mirkuzie/0000-0002-1777-0816	hosting Jimma University	hosting Jimma University	This research was conducted as a partial fulfillment for a Master of Science in Clinical Pharmacy awarded to the primary author Tewodros Eyob Woldehaimanot and it was solely sponsored by the hosting Jimma University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KO, 2005, PAIN, V113, P5, DOI 10.1016/j.pain.2004.10.024; Barak M, 2006, ACUTE PAIN, V8, P155; Bedard D, 2006, PAIN MANAG NURS, V7, P80, DOI 10.1016/j.pmn.2006.06.001; BENDELOW G, 1993, SOCIOL HEALTH ILL, V15, P273, DOI 10.1111/1467-9566.ep10490526; Botti Mari, 2004, Int J Nurs Pract, V10, P257, DOI 10.1111/j.1440-172x.2004.00487.x; Breivik H, 1998, EUR J ANAESTH, V15, P748, DOI 10.1097/00003643-199811000-00022; Chung Joanne W Y, 2003, Nurs Health Sci, V5, P13, DOI 10.1046/j.1442-2018.2003.00130.x; Cleary J, 2013, ANN ONCOL, V24, P14, DOI 10.1093/annonc/mdt499; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; Cohen E, 2008, CANCER NURS, V31, pE1, DOI 10.1097/01.NCC.0000305693.67131.7d; Colman I, 2004, NEUROLOGY, V62, P1695, DOI 10.1212/01.WNL.0000127304.91605.BA; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Dawson R, 2002, J PAIN SYMPTOM MANAG, V23, P211, DOI 10.1016/S0885-3924(01)00399-2; Dekker Annette M, 2012, J Pain Palliat Care Pharmacother, V26, P334, DOI 10.3109/15360288.2012.734897; Dihle A, 2006, J PAIN, V7, P272, DOI 10.1016/j.jpain.2005.11.005; Donnelly AJ, 2009, APPL THERAPEUTICS CL; Edwards H E, 2001, Nurs Health Sci, V3, P35, DOI 10.1046/j.1442-2018.2001.00069.x; Faponle A F, 2001, Cent Afr J Med, V47, P70; Gordon DB, 2005, ARCH INTERN MED, V165, P1574, DOI 10.1001/archinte.165.14.1574; Gordon Debra B, 2002, Pain Manag Nurs, V3, P116, DOI 10.1053/jpmn.2002.127570; Gordon DB, 2010, J PAIN, V11, P1172, DOI 10.1016/j.jpain.2010.02.012; Helfand M, 2009, PAIN MED, V10, P1183, DOI 10.1111/j.1526-4637.2009.00718.x; Human Rights Watch, 2011, GLOB STAT PAINTR ACC; JAMES FR, 1991, PAIN, V44, P279, DOI 10.1016/0304-3959(91)90097-H; Klopper Hester, 2006, Intensive Crit Care Nurs, V22, P12, DOI 10.1016/j.iccn.2005.05.001; Lin CC, 2000, PAIN, V87, P43, DOI 10.1016/S0304-3959(00)00267-0; Lorentzen V, 2012, EUR J PAIN, V16, P278, DOI 10.1016/j.ejpain.2011.06.004; Manias Elizabeth, 2005, Pain Manag Nurs, V6, P18, DOI 10.1016/j.pmn.2004.12.004; MARKS RM, 1973, ANN INTERN MED, V78, P173, DOI 10.7326/0003-4819-78-2-173; McNeill J A, 2001, Pain Manag Nurs, V2, P25, DOI 10.1053/jpmn.2001.22039; McNeill JA, 2004, J PAIN SYMPTOM MANAG, V28, P47, DOI 10.1016/j.jpainsymman.2003.11.005; MoH, 2007, NAT PAIN MAN GUID; Ocitti EF, 2000, E AFR MED J, V77, P299; Ogboli-Nwasor Elizabeth, 2012, J Pain Res, V5, P117, DOI 10.2147/JPR.S28198; Olayemi O, 2009, J OBSTET GYNAECOL RE, V35, P277, DOI 10.1111/j.1447-0756.2008.00937.x; Powell RA, 2013, FAILING NUMB PAIN UN; Selman L, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-35; Shen Q, 2008, WESTERN J NURS RES, V30, P975, DOI 10.1177/0193945908319576; Sherwood G. D., 2003, AORN J, V77, P377; Sherwood G. D., 2003, AORN J, V77, P384; Sherwood G, 2005, J RES NURS, V10, P403, DOI 10.1177/174498710501000404; Sherwood Gwen D, 2003, AORN J, V77, P377, DOI 10.1016/S0001-2092(06)61206-4; Size M, 2007, ANAESTHESIA, V62, P38, DOI 10.1111/j.1365-2044.2007.05296.x; Soyannwo O A, 1999, West Afr J Med, V18, P207; Stephens J, 2003, RHEUMATOLOGY, V42, P40, DOI 10.1093/rheumatology/keg497; Tan EC, 2008, J PAIN, V9, P849, DOI 10.1016/j.jpain.2008.04.004; Tsui S L, 1995, Acta Anaesthesiol Sin, V33, P137; Vijayan R., 2011, MANAGING ACUTE PAIN; Ward SE, 1996, J PAIN SYMPTOM MANAG, V11, P242, DOI 10.1016/0885-3924(95)00190-5; Yates P, 1998, J CLIN NURS, V7, P521, DOI 10.1046/j.1365-2702.1998.00192.x	50	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102835	10.1371/journal.pone.0102835	http://dx.doi.org/10.1371/journal.pone.0102835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8VR	25033399	Green Submitted, Green Published, gold			2022-12-25	WOS:000339418300101
J	Wu, JC; Rostami, MR; Olaya, DPC; Tzanakakis, ES				Wu, Jincheng; Rostami, Mahboubeh Rahmati; Olaya, Diana P. Cadavid; Tzanakakis, Emmanuel S.			Oxygen Transport and Stem Cell Aggregation in Stirred-Suspension Bioreactor Cultures	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; TUMOR-GROWTH; DIFFERENTIATION; HYPOXIA; COAGULATION; EXPANSION; EQUATION; DENSITY; BODIES; SYSTEM	Stirred-suspension bioreactors are a promising modality for large-scale culture of 3D aggregates of pluripotent stem cells and their progeny. Yet, cells within these clusters experience limitations in the transfer of factors and particularly O-2 which is characterized by low solubility in aqueous media. Cultured stem cells under different O-2 levels may exhibit significantly different proliferation, viability and differentiation potential. Here, a transient diffusion-reaction model was built encompassing the size distribution and ultrastructural characteristics of embryonic stem cell (ESC) aggregates. The model was coupled to experimental data from bioreactor and static cultures for extracting the effective diffusivity and kinetics of consumption of O-2 within mouse (mESC) and human ESC (hESC) clusters. Under agitation, mESC aggregates exhibited a higher maximum consumption rate than hESC aggregates. Moreover, the reaction-diffusion model was integrated with a population balance equation (PBE) for the temporal distribution of ESC clusters changing due to aggregation and cell proliferation. Hypoxia was found to be negligible for ESCs with a smaller radius than 100 mu m but became appreciable for aggregates larger than 300 mu m. The integrated model not only captured the O-2 profile both in the bioreactor bulk and inside ESC aggregates but also led to the calculation of the duration that fractions of cells experience a certain range of O-2 concentrations. The approach described in this study can be employed for gaining a deeper understanding of the effects of O-2 on the physiology of stem cells organized in 3D structures. Such frameworks can be extended to encompass the spatial and temporal availability of nutrients and differentiation factors and facilitate the design and control of relevant bioprocesses for the production of stem cell therapeutics.	[Wu, Jincheng; Rostami, Mahboubeh Rahmati; Tzanakakis, Emmanuel S.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA; [Olaya, Diana P. Cadavid] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA	Tufts University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Tzanakakis, ES (corresponding author), Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.	Emmanuel.Tzanakakis@tufts.edu	Tzanakakis, Emmanuel/S-7617-2019; Tzanakakis, Emmanuel S/F-6868-2015	Tzanakakis, Emmanuel/0000-0002-6677-352X; Tzanakakis, Emmanuel S/0000-0002-6677-352X	National Institutes of Health (NHLBI) [R01HL103709]; New York Stem Cell Science Trust (NYSTEM) [C024355, C026714]; Mark Diamond Research Foundation award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103709] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); New York Stem Cell Science Trust (NYSTEM); Mark Diamond Research Foundation award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding support has been provided by the National Institutes of Health (NHLBI, R01HL103709) and the New York Stem Cell Science Trust (NYSTEM, contracts C024355 and C026714) to EST. JW is the recipient of a Mark Diamond Research Foundation award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci HE, 2010, AM J PHYSIOL-CELL PH, V298, pC1527, DOI 10.1152/ajpcell.00484.2009; Adelman DM, 1999, GENE DEV, V13, P2478, DOI 10.1101/gad.13.19.2478; Aldous DJ, 1999, BERNOULLI, V5, P3, DOI 10.2307/3318611; ANDERSON EC, 1970, BIOPHYS J, V10, P630, DOI 10.1016/S0006-3495(70)86325-1; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; BELVAL TK, 1986, BIOPHYS J, V50, P479, DOI 10.1016/S0006-3495(86)83485-3; BRUNTON GF, 1980, CELL TISSUE KINET, V13, P455, DOI 10.1111/j.1365-2184.1980.tb00486.x; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Cadavid Olaya DP, 2012, BIOREACTOR CULTURE E; Cameron CM, 2006, BIOTECHNOL BIOENG, V94, P938, DOI 10.1002/bit.20919; Cochran DM, 2006, ANN BIOMED ENG, V34, P1247, DOI 10.1007/s10439-006-9134-4; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; Frossling N., 1938, GERL BEITR GEOPHYS, V52, P170; Gassmann M, 1996, P NATL ACAD SCI USA, V93, P2867, DOI 10.1073/pnas.93.7.2867; Groebe K, 1989, Adv Exp Med Biol, V248, P175; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Jing DH, 2010, CELL TRANSPLANT, V19, P1397, DOI 10.3727/096368910X513955; Kehoe DE, 2010, TISSUE ENG PT A, V16, P405, DOI [10.1089/ten.tea.2009.0454, 10.1089/ten.TEA.2009.0454]; Kehoe DE, 2008, BIOTECHNOL PROGR, V24, P1342, DOI 10.1002/btpr.57; Khoury M, 2010, BIOMED MICRODEVICES, V12, P1001, DOI 10.1007/s10544-010-9454-x; Koay EJ, 2008, OSTEOARTHR CARTILAGE, V16, P1450, DOI 10.1016/j.joca.2008.04.007; Lee SH, 2008, CELL PROLIFERAT, V41, P230, DOI 10.1111/j.1365-2184.2008.00516.x; Lock LT, 2009, TISSUE ENG PT A, V15, P2051, DOI 10.1089/ten.tea.2008.0455; LOKEN MR, 1984, J CELL PHYSIOL, V118, P22, DOI 10.1002/jcp.1041180106; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; PANTEN U, 1982, ENDOCRINOLOGY, V111, P1595, DOI 10.1210/endo-111-5-1595; Powers DE, 2008, BIOTECHNOL BIOENG, V101, P241, DOI 10.1002/bit.21986; Powers DE, 2010, BIOTECHNOL PROGR, V26, P805, DOI 10.1002/btpr.359; Prado-Lopez S, 2010, STEM CELLS, V28, P407, DOI 10.1002/stem.295; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; SMIT DJ, 1994, CHEM ENG SCI, V49, P1025, DOI 10.1016/0009-2509(94)80009-X; TOBIN T, 1990, CHEM ENG SCI, V45, P3491, DOI 10.1016/0009-2509(90)87154-K; TOSAKA N, 1982, B MATH BIOL, V44, P841; Tzanakakis ES, 2001, CELL MOTIL CYTOSKEL, V48, P175, DOI 10.1002/1097-0169(200103)48:3<175::AID-CM1007>3.0.CO;2-2; Van Winkle AP, 2012, CELLS TISSUES ORGANS, V196, P34, DOI 10.1159/000330691; von Smoluchowski M, 1917, Z PHYS CHEM-STOCH VE, V92, P129; Wartenberg M, 2001, FASEB J, V15, P995, DOI 10.1096/fj.00-0350com; WRIGHT H, 1990, J STAT PHYS, V61, P843, DOI 10.1007/BF01027303; zur Nieden NI, 2007, J BIOTECHNOL, V129, P421, DOI 10.1016/j.jbiotec.2007.01.006	43	53	54	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102486	10.1371/journal.pone.0102486	http://dx.doi.org/10.1371/journal.pone.0102486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032842	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300056
J	Arilla, M; Rosell, J; Blasco, R; Dominguez-Rodrigo, M; Pickering, TR				Arilla, Maite; Rosell, Jordi; Blasco, Ruth; Dominguez-Rodrigo, Manuel; Pickering, Travis Rayne			The "Bear" Essentials: Actualistic Research on Ursus arctos arctos in the Spanish Pyrenees and Its Implications for Paleontology and Archaeology	PLOS ONE			English	Article							MULTIPLE CARNIVORE TAXA; PESTERA CU OASE; SPOTTED HYENA; NATIONAL-PARK; CAVE BEARS; FLK ZINJ; MULTIVARIATE APPROACH; TAPHONOMIC ANALYSIS; BONE ACCUMULATIONS; MARK FREQUENCIES	Neotaphonomic studies of large carnivores are used to create models in order to explain the formation of terrestrial vertebrate fossil faunas. The research reported here adds to the growing body of knowledge on the taphonomic consequences of large carnivore behavior in temperate habitats and has important implications for paleontology and archaeology. Using photo-and videotrap data, we were able to describe the consumption of 17 ungulate carcasses by wild brown bears (Ursus arctos arctos) ranging the Spanish Pyrenees. Further, we analyzed the taphonomic impact of these feeding bouts on the bones recovered from those carcasses. The general sequence of consumption that we charted starts with separation of a carcass's trunk; viscera are generally eaten first, followed by musculature of the humerus and femur. Long limb bones are not broken open for marrow extraction. Bears did not transport carcasses or carcass parts from points of feeding and did not disperse bones appreciably (if at all) from their anatomical positions. The general pattern of damage that resulted from bear feeding includes fracturing, peeling, crenulation, tooth pitting and scoring of axial and girdle elements and furrowing of the upper long limb bones. As predicted from observational data, the taphonomic consequences of bear feeding resemble those of other non-durophagus carnivores, such as felids, and are distinct from those of durophagus carnivores, such as hyenids. Our results have paleontological and archaeological relevance. Specifically, they may prove useful in building analogical models for interpreting the formation of fossil faunas for which bears are suspected bone accumulators and/or modifiers. More generally, our comparative statistical analyses draw precise quantitative distinctions between bone damage patterns imparted respectively by durophagus (modelled here primarily by spotted hyenas [Crocuta crocuta] and wolves [Canis lupus]) and non-durophagus (modelled here by brown bears and lions [Panthera leo]) carnivorans.	[Arilla, Maite; Rosell, Jordi] Univ Rovira & Virgili, Area Prehist, E-43007 Tarragona, Spain; [Arilla, Maite; Rosell, Jordi] Inst Catala Palaeoecol Humana & Evolucio Social, IPHES, Tarragona, Spain; [Blasco, Ruth] Gibraltar Museum, Gibraltar, Gibraltar, England; [Dominguez-Rodrigo, Manuel] Museo Origenes, IDEA Inst Evoluc Africa, Madrid, Spain; [Dominguez-Rodrigo, Manuel] Univ Complutense, Dept Prehist, E-28040 Madrid, Spain; [Pickering, Travis Rayne] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Pickering, Travis Rayne] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Pickering, Travis Rayne] Transvaal Museum, Plio Pleistocene Palaeontol Sect, Dept Vertebrates, Ditsong Natl Museum Nat Hist, ZA-0001 Pretoria, South Africa	Universitat Rovira i Virgili; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Complutense University of Madrid; University of Wisconsin System; University of Wisconsin Madison; University of Witwatersrand	Blasco, R (corresponding author), Gibraltar Museum, Gibraltar, Gibraltar, England.	rblascolopez@gmail.com	Blasco, Ruth/AAG-8200-2019; Rosell, Jordi/G-8705-2015	Blasco, Ruth/0000-0001-9804-739X; Rosell, Jordi/0000-0002-6758-6291; Arilla, Maite/0000-0001-5994-678X	Ministerio de Ciencia e Innovacion [CGL2012-38434-C03-03, CGL2012-38358, CGL-BOS-2012-34717, HAR2010-18952-C02-01]; Generalitat de Catalunya; EU	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); EU(European Commission)	This research was supported with funding from the Ministerio de Ciencia e Innovacion, project nos. CGL2012-38434-C03-03, CGL2012-38358, CGL-BOS-2012-34717, HAR2010-18952-C02-01. Ruth Blasco is a Beatriu de Pinos-A post-doctoral research fellowship from Generalitat de Catalunya and COFUND Marie Curie Actions, EU-FP7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres M, 2012, ARCHAEOL ANTHROP SCI, V4, P209, DOI 10.1007/s12520-012-0093-4; [Anonymous], 2004, ESPAC TIEMPO FORMA S, DOI DOI 10.5944/ETFI.16-17.2003.4751; Arroyo ABM, 2009, J ARCHAEOL SCI, V36, P284, DOI 10.1016/j.jas.2008.09.007; Bachler E, 1940, ALPINE PALAOLITHIKUM; Bachler E, 1923, JB ST GALLISCHEN NAT, V59, P79; Baquedano E, 2012, J ARCHAEOL SCI, V39, P1728, DOI 10.1016/j.jas.2012.01.010; Bergounioux F.M., 1958, HUNDERT JAHRE NEANDE, P151; Binford L.R., 1981, BONES ANCIENT MEN MO; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brain C. K., 1981, HUNTERS HUNTED INTRO; BUNGE M, 1981, INT J GEN SYST, V7, P221, DOI 10.1080/03081078108934823; BUNN HT, 1988, J ANTHROPOL ARCHAEOL, V7, P412, DOI 10.1016/0278-4165(88)90004-9; Camaros E, 2013, J ARCHAEOL SCI, V40, P1361, DOI 10.1016/j.jas.2012.09.037; Christiansen P, 1999, ANN ZOOL FENN, V36, P93; Costamagno S, 2008, ANN PALEONTOL, V94, P245, DOI 10.1016/j.annpal.2008.09.003; Couturier MAJ, 1954, OURS BRUN URSUS ARCO; d'Errico F., 1998, EC PREHISTORIQUE COM, P85; DARLINGTON RB, 1973, REV EDUC RES, V43, P433, DOI 10.3102/00346543043004433; de Ruiter DJ, 2000, J ARCHAEOL SCI, V27, P665, DOI 10.1006/jasc.1999.0470; Delaney-Rivera C, 2009, J ARCHAEOL SCI, V36, P2597, DOI 10.1016/j.jas.2009.08.001; Dienes I., 1968, STATION PALEOLITHIQU, P111; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2003, J ARCHAEOL SCI, V30, P1385, DOI 10.1016/S0305-4403(03)00027-X; Dominguez-Rodrigo M, 1999, PALAEOGEOGR PALAEOCL, V149, P373, DOI 10.1016/S0031-0182(98)00213-2; Dominguez-Rodrigo Manuel, 2012, Journal of Taphonomy, V10, P147; Dominguez-Rodrigo M, 2014, QUATERN INT, V322, P32, DOI 10.1016/j.quaint.2013.09.042; Dominguez-Rodrigo Manuel, 2010, Journal of Taphonomy, V8, P155; DominguezRodrigo M, 2007, VERTEBR PALEOBIOL PA, P1; Egeland Amy G., 2008, Journal of Taphonomy, V6, P275; Elgmork K, 1995, WILDLIFE BIOL, V1, P239, DOI 10.2981/wlb.1995.0029; Faith JT, 2007, J ARCHAEOL SCI, V34, P872, DOI 10.1016/j.jas.2006.08.007; Fernandez-Jalvo Y, 2011, J HUM EVOL, V60, P117, DOI 10.1016/j.jhevol.2010.08.003; Fosse P, 2000, OURS HOMME, V100, P1; Gargett R.H., 1996, CAVE BEARS MODERN HU; Gidna A, 2013, J ARCHAEOL SCI, V40, P1903, DOI 10.1016/j.jas.2012.11.023; Gidna AO, 2014, QUATERN INT, V322, P167, DOI 10.1016/j.quaint.2013.08.059; Grandal-d'Anglade A, 2010, CR PALEVOL, V9, P31, DOI 10.1016/j.crpv.2009.10.003; Grandal-dAnglade A., 2005, MITT KOMM QUARTARFOR, V14, P41; HAYNES G, 1982, ARCTIC, V35, P266; HAYNES G, 1983, PALEOBIOLOGY, V9, P164, DOI 10.1017/S0094837300007545; HAYNES G, 1980, PALEOBIOLOGY, V6, P341, DOI 10.1017/S0094837300006849; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hill A., 1989, BONE MODIFICATION, P169; Kerbis-Peterhans J C, 1990, ROLE PORCUPINES LEOP; KOBY F.-ED, 1949, REV SUISSE ZOOL, V56, P675; KRUUK H., 1967, MAMMALIA, V31, P1, DOI 10.1515/mamm.1967.31.1.1; Kuhn BF, 2009, J ARCHAEOL SCI, V36, P297, DOI 10.1016/j.jas.2008.09.008; Kurten B, 1976, CAVE BEAR STORY LIFE; la Grange A, 2009, J STAT SOFTW, V30, P1; Lansing SW, 2009, PALEOBIOLOGY, V35, P289, DOI 10.1666/08009.1; Maguire J.M., 1980, Palaeontologia Africana, V23, P75; Mazza P., 1995, ASPECTS DENT BIOL PA, P147; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; Patou-Mathis M, 1988, ANTHROPOZOOLOGICA, P17; Pickering TR, 1997, J ARCHAEOL SCI, V24, P1115, DOI 10.1006/jasc.1996.0191; Pickering TR, 2004, J HUM EVOL, V46, P595, DOI 10.1016/j.jhevol.2004.03.002; Pickering TR, 2013, J ARCHAEOL SCI, V40, P1295, DOI 10.1016/j.jas.2012.09.025; Pickering Travis Rayne, 2011, Journal of Taphonomy, V9, P117; Pinto AC, 2002, TAPHONOMY PALAEOCOLO; Pinto AC, 2005, TAFONOMIA PALEOECOLO; Pinto Ana C., 2004, Revue de Paleobiologie, V23, P845; Pinto Llona A.C., 2001, Cadernos Laboratorio Xeoloxico de Laxe, V26, P423; Pinto-Llona AC, 2013, PALAEOGEOGR PALAEOCL, V370, P41, DOI 10.1016/j.palaeo.2012.11.017; Pobiner BL, 2007, J HUM EVOL, V52, P614, DOI 10.1016/j.jhevol.2006.11.007; Prendergast Mary E., 2008, Journal of Taphonomy, V6, P301; Quiles J, 2006, CR PALEVOL, V5, P927, DOI 10.1016/j.crpv.2006.09.005; Rabal-Garces R, 2012, LETHAIA, V45, P96, DOI 10.1111/j.1502-3931.2011.00260.x; Richards MP, 2008, P NATL ACAD SCI USA, V105, P600, DOI 10.1073/pnas.0711063105; Robert I, 2002, J ARCHAEOL SCI, V29, P763, DOI 10.1006/jasc.2001.0778; Sacco T, 2004, J ZOOL, V263, P41, DOI 10.1017/S0952836904004856; Sala N, 2013, J ARCHAEOL SCI, V40, P1389, DOI 10.1016/j.jas.2012.10.018; Saladie P, 2013, INT J OSTEOARCHAEOL, V23, P13, DOI 10.1002/oa.1237; Schaller G. B., 1972, SERENGETI LION; Selvaggio MM, 2001, J ARCHAEOL SCI, V28, P465, DOI 10.1006/jasc.2000.0557; Skinner J.D., 1980, Palaeontologia Africana, V23, P99; Skinner JD, 1998, J ARCHAEOL SCI, V25, P69, DOI 10.1006/jasc.1997.0200; Smith DL, 2010, PALAIOS, V25, P318, DOI 10.2110/palo.2009.p09-115r; Stiner M.C., 1998, EC PREHISTORIQUE COM, P73; Stiner MC, 1998, J HUM EVOL, V34, P303, DOI 10.1006/jhev.1997.0198; Stiner MC., 1996, GEOARCHAEOLOGY, V11, P279, DOI [10.1002/(SICI)1520-6548(199607)11:43.0.CO;2-Z, DOI 10.1002/(SICI)1520-6548(199607)11:43.0.CO;2-Z, DOI 10.1002/(SICI)1520-6548(199607)11:4<279::AID-GEA1>3.0.CO;2-Z]; SUTCLIFFE AJ, 1970, NATURE, V227, P1110, DOI 10.1038/2271110a0; Tappen M, 2000, AM J PHYS ANTHROPOL, V113, P217, DOI 10.1002/1096-8644(200010)113:2<217::AID-AJPA6>3.0.CO;2-G; Torres T., 1984, THESIS ESCUELA TECNI; Torres T, 2007, J HUM EVOL, V52, P1, DOI 10.1016/j.jhevol.2006.07.013; Weaver TD, 2011, J ARCHAEOL SCI, V38, P2420, DOI 10.1016/j.jas.2011.05.009; White T.D., 1992, PREHISTORIC CANNIBAL; Yravedra Jose, 2011, Journal of Taphonomy, V9, P37	87	49	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102457	10.1371/journal.pone.0102457	http://dx.doi.org/10.1371/journal.pone.0102457			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029167	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600074
J	Chang, Z; Ju, HQ; Ling, JH; Zhuang, ZN; Li, ZK; Wang, HM; Fleming, JB; Freeman, JW; Yu, DH; Huang, P; Chiao, PJ				Chang, Zhe; Ju, Huaiqiang; Ling, Jianhua; Zhuang, Zhuonan; Li, Zhongkui; Wang, Huamin; Fleming, Jason B.; Freeman, James W.; Yu, Dihua; Huang, Peng; Chiao, Paul J.			Cooperativity of Oncogenic K-Ras and Downregulated p16/INK4A in Human Pancreatic Tumorigenesis (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							HBP1 TRANSCRIPTIONAL REPRESSOR; EPITHELIAL-CELL LINES; CANCER-CELLS; EGF RECEPTOR; KINASE; TRANSFORMATION; ACTIVATION; EXPRESSION; INVASION; PATHWAY	Activation of K-ras and inactivation of p16 are the most frequently identified genetic alterations in human pancreatic epithelial adenocarcinoma (PDAC). Mouse models engineered with mutant K-ras and deleted p16 recapitulate key pathological features of PDAC. However, a human cell culture transformation model that recapitulates the human pancreatic molecular carcinogenesis is lacking. In this study, we investigated the role of p16 in hTERT-immortalized human pancreatic epithelial nestin-expressing (HPNE) cells expressing mutant K-ras (K-ras(G12V)). We found that expression of p16 was induced by oncogenic K-ras in these HPNE cells and that silencing of this induced p16 expression resulted in tumorigenic transformation and development of metastatic PDAC in an orthotopic xenograft mouse model. Our results revealed that PI3K/Akt, ERK1/2 pathways and TGF alpha signaling were activated by K-ras and involved in the malignant transformation of human pancreatic cells. Also, p38/MAPK pathway was involved in p16 up-regulation. Thus, our findings establish an experimental cell-based model for dissecting signaling pathways in the development of human PDAC. This model provides an important tool for studying the molecular basis of PDAC development and gaining insight into signaling mechanisms and potential new therapeutic targets for altered oncogenic signaling pathways in PDAC.	[Chang, Zhe; Ju, Huaiqiang; Ling, Jianhua; Zhuang, Zhuonan; Li, Zhongkui; Yu, Dihua; Chiao, Paul J.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Ju, Huaiqiang; Huang, Peng] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Fleming, Jason B.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Freeman, James W.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol & Med Oncol, San Antonio, TX 78229 USA	University of Texas System; UTMD Anderson Cancer Center; State Key Lab Oncology South China; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health San Antonio	Chiao, PJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	pjchiao@mdanderson.org		Yu, Dihua/0000-0001-6231-9381	National Institutes of Health through The University of Texas MD Anderson's Cancer Center [CA016672, CA097159, CA142674, CA109405]; Viragh Family Foundation; NATIONAL CANCER INSTITUTE [R01CA109405, R01CA097159, R01CA142674, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health through The University of Texas MD Anderson's Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Viragh Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported in part by the National Institutes of Health through The University of Texas MD Anderson's Cancer Center Support Grant CA016672 and through grants CA097159, CA142674, and CA109405 (to P.J.C.); grants from Viragh Family Foundation to P.J.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bera A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082282; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chang Z, 2013, CLIN CANCER RES, V19, P549, DOI 10.1158/1078-0432.CCR-12-0032; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Goessel G, 2005, P NATL ACAD SCI USA, V102, P15599, DOI 10.1073/pnas.0409730102; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hara E, 1996, MOL CELL BIOL, V16, P859; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban Ralph H, 2008, Gastrointest Cancer Res, V2, pS10; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Leung L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084366; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Niu JG, 2007, J BIOL CHEM, V282, P6001, DOI 10.1074/jbc.M606878200; Qian JY, 2005, CANCER RES, V65, P5045, DOI 10.1158/0008-5472.CAN-04-3208; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Schutte M, 1997, CANCER RES, V57, P3126; Serra RW, 2014, ELIFE, V3, DOI 10.7554/eLife.02313; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; TSAO MS, 1987, EXP CELL RES, V168, P365, DOI 10.1016/0014-4827(87)90009-7; Ueki T, 2000, CANCER RES, V60, P1835; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Xiu M, 2003, MOL CELL BIOL, V23, P8890, DOI 10.1128/MCB.23.23.8890-8901.2003; Xu DP, 2011, CARCINOGENESIS, V32, P488, DOI 10.1093/carcin/bgr007; Yee AS, 2004, GENE, V336, P1, DOI 10.1016/j.gene.2004.04.004; Zhang XW, 2006, MOL CELL BIOL, V26, P8252, DOI 10.1128/MCB.00604-06; Zhao S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.36; Zhao SJ, 2010, INT J CANCER, V127, P2076, DOI 10.1002/ijc.25412	40	39	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101452	10.1371/journal.pone.0101452	http://dx.doi.org/10.1371/journal.pone.0101452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029561	gold, Green Published			2022-12-25	WOS:000341306600015
J	Guo, F; Chen, Y; Yang, SL; Xia, H; Li, XW; Tong, ZH				Guo, Fei; Chen, Yong; Yang, Shuang-Li; Xia, Huan; Li, Xing-Wang; Tong, Zhao-Hui			Pneumocystis Pneumonia in HIV-Infected and Immunocompromised Non-HIV Infected Patients: A Retrospective Study of Two Centers in China	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; CARINII-PNEUMONIA; JIROVECII PNEUMONIA; TRANSPLANT RECIPIENTS; RHEUMATOID-ARTHRITIS; DIAGNOSIS; PROGNOSIS; DISEASES; MANAGEMENT; MORTALITY	Background: Pneumocystis pneumonia (PCP) is an emerging infectious disease in immunocompromised hosts. However, the clinical characteristics of these patients are poorly understood in mainland China. Methods: We performed a retrospective study of PCP from 2008 to 2012. Information was collected regarding clinical manifestations, hospitalization, and outcome. A prognostic analysis was performed using a Cox regression model. Results: 151 cases of PCP were included; 46 non-HIV and 105 HIV cases. All-cause mortality (15.2% vs. 12.4%, p = 0.64) and the results of time-to-event analysis (log-rank test, p = 0.62) were similar between non-HIV and HIV infected cases, respectively. From 2008 to 2012, time from admission to initial treatment in non-HIV infected PCP patients showed declining trend [median (range) 20 (9-44) vs. 12 (4-24) vs. 9 (2-23) vs. 7 (2-22) vs. 7 (1-14) days]. A similar trend was observed for all-cause mortality (33.3% vs. 20.0% vs. 14.3% vs. 14.3% vs. 6.7%). Patients with four or more of the following clinical manifestations (cough, dyspnea, fever, chest pain, and weight loss) [adjusted HR (AHR) 29.06, 95% CI 2.13-396.36, P = 0.01] and admission to intensive care unit (ICU) [AHR 22.55, 95% CI 1.36-375.06, P = 0.03] were independently associated with all-cause mortality in non-HIV infected PCP patients. Variables associated with mortality in HIV infected PCP patients were admission to ICU (AHR 72.26, 95% CI 11.76-443.87, P<0.001) and albumin <= 30 g/L (AHR 9.93 95% CI 1.69-58.30, P = 0.01). Conclusions: Upon admission comprehensive clinical assessment including assessment of four or more clinical manifestations (cough, dyspnea, fever, chest pain, and weight loss) in non-HIV infected PCP patients and albumin <= 30 g/L in HIV infected patients might improve prognosis.	[Guo, Fei; Yang, Shuang-Li; Xia, Huan; Tong, Zhao-Hui] Capital Med Univ, Beijing Chaoyang Hosp, Beijing Inst Resp Med, Dept Resp & Crit Care Med, Beijing, Peoples R China; [Chen, Yong; Li, Xing-Wang] Capital Med Univ, Beijing Ditan Hosp, Ctr Infect Dis, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Li, XW (corresponding author), Capital Med Univ, Beijing Ditan Hosp, Ctr Infect Dis, Beijing, Peoples R China.	ditanlxw@163.com; tongzhaohuicy@sina.com			National Natural Science Foundation of China [81370102]; Beijing High-Grade Talents Health Technology Fund [2011-2-06]; Beijing Natural Science Foundation Program; Scientific Research Key Program of Beijing Municipal Commission of Education [KZ20140025026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing High-Grade Talents Health Technology Fund; Beijing Natural Science Foundation Program(Beijing Natural Science Foundation); Scientific Research Key Program of Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	This work was supported by a grant from National Natural Science Foundation of China (NO. 81370102), in part by a grant from the Beijing High-Grade Talents Health Technology Fund (NO. 2011-2-06), and in part by a grant from Beijing Natural Science Foundation Program and Scientific Research Key Program of Beijing Municipal Commission of Education (NO. KZ20140025026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arozullah AM, 2000, AM J RESP CRIT CARE, V161, P1081, DOI 10.1164/ajrccm.161.4.9906072; Asai N, 2012, J INFECT CHEMOTHER, V18, P898, DOI 10.1007/s10156-012-0441-4; Azoulay E, 2004, MEDICINE, V83, P360, DOI 10.1097/01.md.0000145370.63676.fb; Barbounis V, 2005, ANTICANCER RES, V25, P651; Calderon EJ, 2010, EXPERT REV ANTI-INFE, V8, P683, DOI [10.1586/eri.10.42, 10.1586/eri.10.11, 10.1586/ERI.10.42]; Carmona Eva M, 2011, Ther Adv Respir Dis, V5, P41, DOI 10.1177/1753465810380102; Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Cruciani M, 2002, EUR RESPIR J, V20, P982, DOI 10.1183/09031936.02.01372002; de Boer MGJ, 2011, J INFECTION, V62, P93, DOI 10.1016/j.jinf.2010.10.007; Held J, 2011, CLIN MICROBIOL INFEC, V17, P595, DOI 10.1111/j.1469-0691.2010.03318.x; Huang Laurence, 2011, Proc Am Thorac Soc, V8, P294, DOI 10.1513/pats.201009-062WR; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kasiske BL, 2010, KIDNEY INT, V77, P299, DOI 10.1038/ki.2009.377; Kovacs JA, 2009, JAMA-J AM MED ASSOC, V301, P2578, DOI 10.1001/jama.2009.880; Mansharamani NG, 2000, CHEST, V118, P704, DOI 10.1378/chest.118.3.704; McKinnell JA, 2012, TRANSPL INFECT DIS, V14, P510, DOI 10.1111/j.1399-3062.2012.00739.x; Mori S, 2012, RHEUMATOLOGY, V51, P2120, DOI 10.1093/rheumatology/kes244; Nuesch R, 1999, CLIN INFECT DIS, V29, P1519, DOI 10.1086/313534; Overgaard UM, 2007, SCAND J INFECT DIS, V39, P589, DOI 10.1080/00365540601150497; Overgaard UM, 2000, MMWR RECOMM REP, V49, pE1; Overgaard UM, 2000, MMWR RECOMM REP, V49, P1; Roblot F, 2002, EUR J CLIN MICROBIOL, V21, P523, DOI 10.1007/s10096-002-0758-5; Sax PE, 2011, CLIN INFECT DIS, V53, P197, DOI 10.1093/cid/cir335; Segal Brahm H, 2008, J Natl Compr Canc Netw, V6, P122; Su YS, 2008, J MICROBIOL IMMUNOL, V41, P478; Tasaka S, 2007, CHEST, V131, P1173, DOI 10.1378/chest.06-1467; Tasaka S, 2012, J INFECT CHEMOTHER, V18, P793, DOI 10.1007/s10156-012-0453-0; Thomas C F Jr, 1998, Semin Respir Infect, V13, P289; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Walzer PD, 2008, CLIN INFECT DIS, V46, P625, DOI 10.1086/526778; Wang EHZ, 2012, TRANSPL INFECT DIS, V14, P519, DOI 10.1111/j.1399-3062.2012.00740.x; Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5; Yoshida Y, 2012, MOD RHEUMATOL, V22, P509, DOI 10.1007/s10165-011-0523-7; ZAMAN MK, 1988, ANN INTERN MED, V109, P7, DOI 10.7326/0003-4819-109-1-7	34	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101943	10.1371/journal.pone.0101943	http://dx.doi.org/10.1371/journal.pone.0101943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029342	Green Submitted, gold, Green Published			2022-12-25	WOS:000341306600028
J	Helajarvi, H; Rosenstrom, T; Pahkala, K; Kahonen, M; Lehtimaki, T; Heinonen, OJ; Oikonen, M; Tammelin, T; Viikari, JSA; Raitakari, OT				Helajarvi, Harri; Rosenstrom, Tom; Pahkala, Katja; Kahonen, Mika; Lehtimaki, Terho; Heinonen, Olli J.; Oikonen, Mervi; Tammelin, Tuija; Viikari, Jorma S. A.; Raitakari, Olli T.			Exploring Causality between TV Viewing and Weight Change in Young and Middle-Aged Adults. The Cardiovascular Risk in Young Finns Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; ALL-CAUSE MORTALITY; BODY-MASS INDEX; SEDENTARY BEHAVIORS; DISEASE RISK; PHYSICAL-ACTIVITY; SITTING TIME; OBESITY; ASSOCIATION; MARKERS	Background: Television viewing time (TV time) is associated with increased weight and obesity, but it is unclear whether this relation is causal. Methods and Results: We evaluated changes in TV time, waist circumference (waist) and body mass index (BMI) in participants of the population-based Cardiovascular Risk in Young Finns study (761 women, 626 men aged 33-50 years in 2011). Waist and BMI were measured, and TV time was self-reported in 2001, 2007, and 2011. Changes in waist and BMI between 2001 and 2011 were studied a) for the whole group, b) in groups with constantly low (<= 1 h/d), moderate (1-3 h/d), or high (>= 3 h/d) TV time, and c) in groups with >= 1 hour in-/decrease in daily TV time between 2001 and 2011. BMIs in 1986 were also evaluated. We explored the causal relationship of TV time with waist and BMI by classical temporality criterion and recently introduced causal-discovery algorithms (pairwise causality measures). Both methods supported the hypothesis that TV time is causative to weight gain, and no evidence was found for reverse or bidirectional causality. Constantly low TV time was associated with less pronounced increase in waist and BMI, and waist and BMI increase was lower with decreased TV time (P<0.05). The increase in waist and BMI was at least 2-fold in the high TV time group compared to the low TV time group (P<0.05). Adjustment for age, sex, BMI/waist in 2001, physical activity, energy intake, or smoking did not change the results. Conclusions: In young and middle-aged adults, constantly high TV time is temporally antecedent to BMI and waist increase.	[Helajarvi, Harri; Pahkala, Katja; Heinonen, Olli J.] Univ Turku, Dept Physiol, Paavo Nurmi Ctr, Turku, Finland; [Helajarvi, Harri; Pahkala, Katja; Heinonen, Olli J.] Univ Turku, Dept Hlth & Phys Act, Paavo Nurmi Ctr, Turku, Finland; [Rosenstrom, Tom] Univ Helsinki, Unit Personal Work & Hlth Psychol, Helsinki, Finland; [Pahkala, Katja; Oikonen, Mervi; Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Kahonen, Mika] Tampere Univ Hosp, Tampere, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, Fimlab Labs, FIN-33521 Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Tammelin, Tuija] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Viikari, Jorma S. A.] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland	University of Turku; University of Turku; University of Helsinki; University of Turku; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University; University of Turku; University of Turku	Helajarvi, H (corresponding author), Univ Turku, Dept Physiol, Paavo Nurmi Ctr, Turku, Finland.	harri.helajarvi@utu.fi	Pahkala, Katja/D-7449-2013; Pahkala, Katja/GPX-7471-2022; Raitakari, Olli/AAQ-7389-2021; Lehtimäki, Terho/AAD-1094-2022; Heinonen, Olli/AAG-7298-2019	Pahkala, Katja/0000-0001-9338-4397; Lehtimäki, Terho/0000-0002-2555-4427; Heinonen, Olli/0000-0002-1722-1729; Kahonen, Mika/0000-0002-4510-7341; Rosenstrom, Tom/0000-0001-8277-3776	Academy of Finland [126925, 121584, 124282, 129378, 117797, 41071]; Social Insurance Institution of Finland, Kuopio, Tampere; Turku University Hospital Medical Funds; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation; Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); Social Insurance Institution of Finland, Kuopio, Tampere; Turku University Hospital Medical Funds; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere Tuberculosis Foundation; Emil Aaltonen Foundation	The Young Finns Study has been financially supported by the Academy of Finland: grants 126925, 121584, 124282, 129378, 117797, and 41071; the Social Insurance Institution of Finland, Kuopio, Tampere and Turku University Hospital Medical Funds, Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research and Finnish Cultural Foundation, Sigrid Juselius Foundation, Tampere Tuberculosis Foundation and Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach FR, 2003, J MACH LEARN RES, V3, P1, DOI 10.1162/153244303768966085; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Cleland VJ, 2008, AM J CLIN NUTR, V87, P1148, DOI 10.1093/ajcn/87.5.1148; Dunstan DW, 2011, CURR OPIN CARDIOL, V26, P412, DOI 10.1097/HCO.0b013e3283496605; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Efron B., 1994, INTRO BOOTSTRAP; Ekelund U, 2008, AM J CLIN NUTR, V88, P612, DOI 10.1093/ajcn/88.3.612; Epstein LH, 2008, ARCH PEDIAT ADOL MED, V162, P239, DOI 10.1001/archpediatrics.2007.45; Finnpanel website, RES TV AUD MEAS VIEW; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hansen ALS, 2012, DIABETIC MED, V29, P918, DOI 10.1111/j.1464-5491.2012.03656.x; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Heinonen I, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002901; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hoyer PO, 2008, INT J APPROX REASON, V49, P362, DOI 10.1016/j.ijar.2008.02.006; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Hyvarinen A, 2013, J MACH LEARN RES, V14, P111; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Latouche C, 2013, J APPL PHYSIOL, V114, P453, DOI 10.1152/japplphysiol.00978.2012; Luckner H, 2011, EUR J PUBLIC HEALTH, V4, P491; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Otten JJ, 2009, ARCH INTERN MED, V169, P2109, DOI 10.1001/archinternmed.2009.430; Paalanen L, 2006, J CLIN EPIDEMIOL, V59, P994, DOI 10.1016/j.jclinepi.2006.01.002; Pulsford RM, 2013, AM J PREV MED, V44, P132, DOI 10.1016/j.amepre.2012.10.009; R Core Team, 2012, R LANG ENV STAT COMP; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Rosenstrom T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050841; Saunders TJ, 2013, METABOLISM, V62, P1423, DOI 10.1016/j.metabol.2013.05.010; Shimizu S, 2006, J MACH LEARN RES, V7, P2003; Shimizu S, 2011, J MACH LEARN RES, V12, P1225; Stamatakis E, 2012, DIABETOLOGIA, V55, P311, DOI 10.1007/s00125-011-2358-3; Stamatakis E, 2009, BRIT J NUTR, V101, P765, DOI 10.1017/S0007114508035939; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Wahi G, 2011, ARCH PEDIAT ADOL MED, V165, P979, DOI 10.1001/archpediatrics.2011.122; Wijndaele K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020058; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	41	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101860	10.1371/journal.pone.0101860	http://dx.doi.org/10.1371/journal.pone.0101860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028965	gold, Green Published, Green Submitted			2022-12-25	WOS:000341306600025
J	Pinskaya, M; Ghavi-Helm, Y; Mariotte-Labarre, S; Morillon, A; Soutourina, J; Werner, M				Pinskaya, Marina; Ghavi-Helm, Yad; Mariotte-Labarre, Sylvie; Morillon, Antonin; Soutourina, Julie; Werner, Michel			PHD and TFIIS- Like Domains of the Bye1 Transcription Factor Determine Its Multivalent Genomic Distribution	PLOS ONE			English	Article							ESS1 PROLYL ISOMERASE; ELONGATION-FACTOR TFIIS; EXPRESSION; INITIATION; BINDING; METHYLATION; TERMINATION; INDUCTION; COMPLEXES; COMPONENT	The BYpass of Ess1 (Bye1) protein is a putative S. cerevisiae transcription factor homologous to the human cancer-associated PHF3/DIDO family of proteins. Bye1 contains a Plant Homeodomain (PHD) and a TFIIS-like domain. The Bye1 PHD finger interacts with tri-methylated lysine 4 of histone H3 (H3K4me3) while the TFIIS-like domain binds to RNA polymerase (Pol) II. Here, we investigated the contribution of these structural features to Bye1 recruitment to chromatin as well as its function in transcriptional regulation. Genome-wide analysis of Bye1 distribution revealed at least two distinct modes of association with actively transcribed genes: within the core of Pol II- and Pol III-transcribed genes concomitant with the presence of the TFIIS transcription factor and, additionally, with promoters of a subset of Pol II-transcribed genes. Specific loss of H3K4me3 abolishes Bye1 association to gene promoters, but doesn't affect its binding within gene bodies. Genetic interactions suggested an essential role of Bye1 in cell fitness under stress conditions compensating the absence of TFIIS. Furthermore, BYE1 deletion resulted in the attenuation of GAL genes expression upon galactose-mediated induction indicating its positive role in transcription regulation. Together, these findings point to a bimodal role of Bye1 in regulation of Pol II transcription. It is recruited via its PHD domain to H3K4 tri-methylated promoters at early steps of transcription. Once Pol II is engaged into elongation, Bye1 binds directly to the transcriptional machinery, modulating its progression along the gene.	[Pinskaya, Marina; Ghavi-Helm, Yad; Mariotte-Labarre, Sylvie; Soutourina, Julie; Werner, Michel] iBiTec S CEA, FRE3377, Gif Sur Yvette, France; [Pinskaya, Marina; Ghavi-Helm, Yad; Mariotte-Labarre, Sylvie; Soutourina, Julie; Werner, Michel] CNRS, FRE3377, Gif Sur Yvette, France; [Pinskaya, Marina; Ghavi-Helm, Yad; Mariotte-Labarre, Sylvie; Soutourina, Julie; Werner, Michel] Univ Paris 11, FRE3377, Gif Sur Yvette, France; [Pinskaya, Marina; Morillon, Antonin] Univ Paris 06, ncRNA, Inst Curie, Ctr Rech,CNRS,UMR3244, Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Pinskaya, M (corresponding author), iBiTec S CEA, FRE3377, Gif Sur Yvette, France.	marina.pinskaya@curie.fr; michel.werner@cea.fr	Soutourina, Julie/F-8305-2014; Morillon, Antonin/M-4751-2017; Werner, Michel/B-7316-2009	Soutourina, Julie/0000-0001-5218-2350; Morillon, Antonin/0000-0002-0575-5264; Ghavi-Helm, Yad/0000-0003-2397-9576; Pinskaya, Marina/0000-0003-1992-0264; Werner, Michel/0000-0002-2965-5858	"Contrat de Formation par la Recherche" from the CEA; "Plasticity and Integrity of genome" from the CEA; ERC "EpincRNA" starting grant	"Contrat de Formation par la Recherche" from the CEA; "Plasticity and Integrity of genome" from the CEA; ERC "EpincRNA" starting grant	YG and MP were supported by a "Contrat de Formation par la Recherche" and "Plasticity and Integrity of genome, respectively, from the CEA. MP and AM benefited a financial support from ERC "EpincRNA" starting grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008; Carriere L, 2012, NUCLEIC ACIDS RES, V40, P270, DOI 10.1093/nar/gkr737; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Fischer U, 2001, CYTOGENET CELL GENET, V94, P131, DOI 10.1159/000048804; Futterer A, 2005, J CLIN INVEST, V115, P2351, DOI 10.1172/JCI24177; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Gatchalian J, 2013, CELL REP, V4, P148, DOI 10.1016/j.celrep.2013.06.014; Ghavi-Helm Y, 2008, GENE DEV, V22, P1934, DOI 10.1101/gad.471908; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Guglielmi B, 2007, P NATL ACAD SCI USA, V104, P16062, DOI 10.1073/pnas.0704534104; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Kinkelin K, 2013, P NATL ACAD SCI USA, V110, P15277, DOI 10.1073/pnas.1311010110; Krishnamurthy S, 2009, MOL CELL BIOL, V29, P2925, DOI 10.1128/MCB.01655-08; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042965; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Prather DA, 2005, MOL CELL BIOL, V25, P2650, DOI 10.1128/MCB.25.7.2650-2659.2005; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Trachana V, 2007, P NATL ACAD SCI USA, V104, P2691, DOI 10.1073/pnas.0611132104; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; WERNER M, 1993, J BIOL CHEM, V268, P20721; Wery M, 2004, EMBO J, V23, P4232, DOI 10.1038/sj.emboj.7600326; Wu XY, 2003, GENETICS, V165, P1687	35	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102464	10.1371/journal.pone.0102464	http://dx.doi.org/10.1371/journal.pone.0102464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029256	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600075
J	Villacis, RAR; Silveira, SM; Barros, MC; Marchi, FA; Domingues, MAC; Scapulatempo-Neto, C; Aguiar, S; Lopes, A; Cunha, IW; Rogatto, SR				Villacis, Rolando A. R.; Silveira, Sara M.; Barros-Filho, Mateus C.; Marchi, Fabio A.; Domingues, Maria A. C.; Scapulatempo-Neto, Cristovam; Aguiar, Samuel, Jr.; Lopes, Ademar; Cunha, Isabela W.; Rogatto, Silvia R.			Gene Expression Profiling in Leiomyosarcomas and Undifferentiated Pleomorphic Sarcomas: SRC as a New Diagnostic Marker	PLOS ONE			English	Article							SOFT-TISSUE SARCOMAS; CANCER; CLASSIFICATION; PREDICTION; PATTERNS; TUMORS	Background: Undifferentiated Pleomorphic Sarcoma (UPS) and high-grade Leiomyosarcoma (LMS) are soft tissue tumors with an aggressive clinical behavior, frequently developing local recurrence and distant metastases. Despite several gene expression studies involving soft tissue sarcomas, the potential to identify molecular markers has been limited, mostly due to small sample size, in-group heterogeneity and absence of detailed clinical data. Materials and Methods: Gene expression profiling was performed for 22 LMS and 22 UPS obtained from untreated patients. To assess the relevance of the gene signature, a meta-analysis was performed using five published studies. Four genes (BAD, MYOCD, SRF and SRC) selected from the gene signature, meta-analysis and functional in silico analysis were further validated by quantitative PCR. In addition, protein-protein interaction analysis was applied to validate the data. SRC protein immunolabeling was assessed in 38 UPS and 52 LMS. Results: We identified 587 differentially expressed genes between LMS and UPS, of which 193 corroborated with other studies. Cluster analysis of the data failed to discriminate LMS from UPS, although it did reveal a distinct molecular profile for retroperitoneal LMS, which was characterized by the over-expression of smooth muscle-specific genes. Significantly higher levels of expression for BAD, SRC, SRF, and MYOCD were confirmed in LMS when compared with UPS. SRC was the most value discriminator to distinguish both sarcomas and presented the highest number of interaction in the in silico protein-protein analysis. SRC protein labeling showed high specificity and a positive predictive value therefore making it a candidate for use as a diagnostic marker in LMS. Conclusions: Retroperitoneal LMS presented a unique gene signature. SRC is a putative diagnostic marker to differentiate LMS from UPS.	[Villacis, Rolando A. R.; Silveira, Sara M.; Barros-Filho, Mateus C.; Rogatto, Silvia R.] AC Camargo Canc Ctr, Res Ctr CIPE, Neogene Lab, Sao Paulo, Brazil; [Marchi, Fabio A.] Univ Sao Paulo, Interinst Grad Program Bioinformat, Math & Stat Inst, Sao Paulo, Brazil; [Domingues, Maria A. C.] UNESP Sao Paulo State Univ, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Scapulatempo-Neto, Cristovam] Barretos Canc Hosp, Mol Oncol Res Ctr, Sao Paulo, Brazil; [Aguiar, Samuel, Jr.; Lopes, Ademar] AC Camargo Canc Ctr, Dept Pelv Surg, Sao Paulo, Brazil; [Cunha, Isabela W.] AC Camargo Canc Ctr, Dept Pathol, Sao Paulo, Brazil; [Rogatto, Silvia R.] UNESP Sao Paulo State Univ, Sch Med, Dept Urol, Sao Paulo, Brazil	A.C.Camargo Cancer Center; Universidade de Sao Paulo; Universidade Estadual Paulista; Hospital de Cancer de Barretos; A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; Universidade Estadual Paulista	Rogatto, SR (corresponding author), AC Camargo Canc Ctr, Res Ctr CIPE, Neogene Lab, Sao Paulo, Brazil.	silvia.rogatto@cipe.accamargo.org.br	Filho, Mateus C Barros/J-1544-2015; Marchi, Fabio A/N-9288-2018; Lopes, Ademar/G-8526-2014; Cunha, Isabela/H-3013-2012; Junior, Samuel Aguiar/A-7388-2011; Rogatto, Silvia R/E-6535-2012	Filho, Mateus C Barros/0000-0003-3893-5269; Marchi, Fabio A/0000-0001-5815-8423; Lopes, Ademar/0000-0002-8317-3817; Cunha, Isabela/0000-0002-2029-5139; Junior, Samuel Aguiar/0000-0003-3476-727X; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579; Villacis, Rolando/0000-0003-3851-2696; Rogatto, Silvia/0000-0003-4637-5687; Custodio Domingues, Maria Aparecida/0000-0002-4023-3410	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Pesquisa (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Pesquisa (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Beck AH, 2010, ONCOGENE, V29, P845, DOI 10.1038/onc.2009.381; Boccardo E, 2010, CARCINOGENESIS, V31, P521, DOI 10.1093/carcin/bgp333; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Carneiro A, 2009, LAB INVEST, V89, P668, DOI 10.1038/labinvest.2009.18; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; Dickson BC, 2013, HUM PATHOL, V44, P1125, DOI 10.1016/j.humpath.2012.10.001; Fletcher CD., 2002, WHO CLASSIFICATION T; Gibault L, 2011, J PATHOL, V223, P64, DOI 10.1002/path.2787; Guillou L, 1997, J CLIN ONCOL, V15, P350, DOI 10.1200/JCO.1997.15.1.350; Guillou L, 2010, VIRCHOWS ARCH, V456, P201, DOI 10.1007/s00428-009-0853-4; Italiano A, 2013, CLIN CANCER RES, V19, P1190, DOI 10.1158/1078-0432.CCR-12-2970; Kresse SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015378; Larramendy ML, 2008, CANCER GENET CYTOGEN, V187, P1, DOI 10.1016/j.cancergencyto.2008.06.005; Mills AM, 2011, AM J SURG PATHOL, V35, P583, DOI 10.1097/PAS.0b013e318211abd6; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Nielsen TO, 2010, J CLIN ONCOL, V28, P1796, DOI 10.1200/JCO.2009.26.1917; Perot G, 2009, CANCER RES, V69, P2269, DOI 10.1158/0008-5472.CAN-08-1443; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Cirilo PDR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057901; Robin YM, 2013, MODERN PATHOL, V26, P502, DOI 10.1038/modpathol.2012.192; Silveira SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067643; Sioletic S, 2013, HISTOPATHOLOGY, V62, P287, DOI 10.1111/j.1365-2559.2012.04348.x; Toro JR, 2006, INT J CANCER, V119, P2922, DOI 10.1002/ijc.22239; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; West RB, 2010, ADV ANAT PATHOL, V17, P366, DOI 10.1097/PAP.0b013e3181ec7428	32	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102281	10.1371/journal.pone.0102281	http://dx.doi.org/10.1371/journal.pone.0102281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028927	Green Submitted, Green Published, gold			2022-12-25	WOS:000341306600056
J	Burkard, C; Bloyet, LM; Wicht, O; van Kuppeveld, FJ; Rottier, PJM; de Haan, CAM; Bosch, BJ				Burkard, Christine; Bloyet, Louis-Marie; Wicht, Oliver; van Kuppeveld, Frank J.; Rottier, Peter J. M.; de Haan, Cornelis A. M.; Bosch, Berend Jan			Dissecting Virus Entry: Replication-Independent Analysis of Virus Binding, Internalization, and Penetration Using Minimal Complementation of beta-Galactosidase	PLOS ONE			English	Article							VESICULAR STOMATITIS; ELECTRON-MICROSCOPY; SENSITIVE DETECTION; INFLUENZA-VIRUS; CORONAVIRUS; FUSION; CELLS; ASSAY; PROTEIN; ENDOCYTOSIS	Studies of viral entry into host cells often rely on the detection of post-entry parameters, such as viral replication or the expression of a reporter gene, rather than on measuring entry per se. The lack of assays to easily detect the different steps of entry severely hampers the analysis of this key process in virus infection. Here we describe novel, highly adaptable viral entry assays making use of minimal complementation of the E. coli beta-galactosidase in mammalian cells. Enzyme activity is reconstituted when a small intravirion peptide (alpha-peptide) is complementing the inactive mutant form Delta M15 of beta-galactosidase. The method allows to dissect and to independently detect binding, internalization, and fusion of viruses during host cell entry. Here we use it to confirm and extend current knowledge on the entry process of two enveloped viruses: vesicular stomatitis virus (VSV) and murine hepatitis coronavirus (MHV).	[Burkard, Christine; Bloyet, Louis-Marie; Wicht, Oliver; van Kuppeveld, Frank J.; Rottier, Peter J. M.; de Haan, Cornelis A. M.; Bosch, Berend Jan] Univ Utrecht, Dept Infect Dis & Immunol, Div Virol, Fac Vet Med, Utrecht, Netherlands	Utrecht University	Bosch, BJ (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Div Virol, Fac Vet Med, Utrecht, Netherlands.	b.j.bosch@uu.nl	Bloyet, Louis-Marie/AAB-6244-2022; Bosch, Berend/ABD-8740-2021; Wicht, Oliver/L-8714-2013	Bloyet, Louis-Marie/0000-0002-5648-3190; Wicht, Oliver/0000-0003-3266-8075; Tait-Burkard, Christine/0000-0002-0471-3230; de Haan, Cornelis/0000-0002-4459-9874; van Kuppeveld, Frank/0000-0001-5800-749X	EU [235649]	EU(European Commission)	Support was provided by the EU Seventh Framework Program (Virus Entry, project 235649, to PJMR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Brandenburg B, 2007, PLOS BIOL, V5, P1543, DOI 10.1371/journal.pbio.0050183; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; CHEN YD, 1989, BIOPHYS CHEM, V34, P283, DOI 10.1016/0301-4622(89)80065-1; de Haan Cornelis A. M., 2008, V454, P229, DOI 10.1007/978-1-59745-181-9_17; DUNNEBACKE TH, 1969, J VIROL, V4, P505, DOI 10.1128/JVI.4.4.505-513.1969; Engel S, 2011, J VIROL, V85, P4198, DOI 10.1128/JVI.02179-10; Ewers H, 2012, METHOD ENZYMOL, V506, P63, DOI 10.1016/B978-0-12-391856-7.00028-7; Fero M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000455; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Kolokoltsov AA, 2004, J VIROL, V78, P5124, DOI 10.1128/JVI.78.10.5124-5132.2004; Kuo LL, 2000, J VIROL, V74, P1393, DOI 10.1128/JVI.74.3.1393-1406.2000; Laliberte JP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002446; LANGLEY KE, 1975, P NATL ACAD SCI USA, V72, P1254, DOI 10.1073/pnas.72.4.1254; Libersou S, 2010, J CELL BIOL, V191, P199, DOI 10.1083/jcb.201006116; LOWY RJ, 1990, P NATL ACAD SCI USA, V87, P1850, DOI 10.1073/pnas.87.5.1850; MADSHUS IH, 1987, J CELL PHYSIOL, V131, P14, DOI 10.1002/jcp.1041310104; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; MATLIN KS, 1982, J MOL BIOL, V156, P609, DOI 10.1016/0022-2836(82)90269-8; Matula P, 2009, CYTOM PART A, V75A, P309, DOI 10.1002/cyto.a.20662; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; MESSING J, 1977, P NATL ACAD SCI USA, V74, P3642, DOI 10.1073/pnas.74.9.3642; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Raviv Y, 2002, VIROLOGY, V293, P243, DOI 10.1006/viro.2001.1237; Rodriguez LL, 2002, VIRUS RES, V85, P211, DOI 10.1016/S0168-1702(02)00026-6; Roingeard P, 2008, BIOL CELL, V100, P491, DOI 10.1042/BC20070173; ROTTIER PJM, 1981, J VIROL, V40, P350, DOI 10.1128/JVI.40.2.350-357.1981; Saeed MF, 2006, J VIROL METHODS, V135, P143, DOI 10.1016/j.jviromet.2006.02.011; Schickli JH, 1997, J VIROL, V71, P9499, DOI 10.1128/JVI.71.12.9499-9507.1997; SCHLEGEL R, 1981, BIOCHEM BIOPH RES CO, V102, P992, DOI 10.1016/0006-291X(81)91636-3; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; SUMMERS MD, 1971, J ULTRA MOL STRUCT R, V35, P606, DOI 10.1016/S0022-5320(71)80014-X; Tani H, 2007, J VIROL, V81, P8601, DOI 10.1128/JVI.00608-07; Tscherne DM, 2010, J VIROL METHODS, V163, P336, DOI 10.1016/j.jviromet.2009.10.020; VENNEMA H, 1990, J VIROL, V64, P339, DOI 10.1128/JVI.64.1.339-346.1990; Wehrman TS, 2005, NAT METHODS, V2, P521, DOI 10.1038/NMETH771; Wolf MC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-119; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	42	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101762	10.1371/journal.pone.0101762	http://dx.doi.org/10.1371/journal.pone.0101762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025332	Green Published, gold			2022-12-25	WOS:000339992400021
J	Jen, CP; Amstislavskaya, TG; Kuo, CC; Chen, YH				Jen, Chun-Ping; Amstislavskaya, Tamara G.; Kuo, Chen-Chi; Chen, Yu-Hung			Protein Preconcentration Using Nanofractures Generated by Nanoparticle-Assisted Electric Breakdown at Junction Gaps	PLOS ONE			English	Article							SAMPLE PRECONCENTRATION; STACKING; DEVICE	Sample preconcentration is an important step that increases the accuracy of subsequent detection, especially for samples with extremely low concentrations. Due to the overlapping of electrical double layers in the nanofluidic channel, the concentration polarization effect can be generated by applying an electric field. Therefore, a nonlinear electrokinetic flow is induced, which results in the fast accumulation of proteins in front of the induced ionic depletion zone, the so-called exclusion-enrichment effect. Nanofractures were created in this work to preconcentrate proteins via the exclusion-enrichment effect. The protein sample was driven by electroosmotic flow and accumulated at a specific location. The preconcentration chip for proteins was fabricated using simple standard soft lithography with a polydimethylsiloxane replica. Nanofractures were formed by utilizing nanoparticle-assisted electric breakdown. The proposed method for nanofracture formation that utilizes nanoparticle deposition at the junction gap between microchannels greatly decreases the required electric breakdown voltage. The experimental results indicate that a protein sample with an extremely low concentration of 1 nM was concentrated to 1.5x10(4)-fold in 60 min using the proposed chip.	[Jen, Chun-Ping; Kuo, Chen-Chi] Natl Chung Cheng Univ, Dept Mech Engn, Chiayi, Taiwan; [Jen, Chun-Ping; Kuo, Chen-Chi] Natl Chung Cheng Univ, Adv Inst Mfg High Tech Innovat, Chiayi, Taiwan; [Amstislavskaya, Tamara G.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Chen, Yu-Hung] Natl Cheng Kung Univ, Dept Med, Tainan 70101, Taiwan; [Chen, Yu-Hung] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 70101, Taiwan	National Chung Cheng University; National Chung Cheng University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; National Cheng Kung University; National Cheng Kung University	Jen, CP (corresponding author), Natl Chung Cheng Univ, Dept Mech Engn, Chiayi, Taiwan.	imecpj@ccu.edu.tw; second@mail.ncku.edu.tw	Jen, Chun-Ping/P-3275-2018; Amstislavskaya, Tamara G/K-4149-2018; Chen, Yu-Hung/GLU-7365-2022; Chen, Yu-Hung/F-4167-2010	Jen, Chun-Ping/0000-0001-5558-5817; Chen, Yu-Hung/0000-0003-3524-629X; 	National Science Council of the Republic of China, Taiwan [NSC 101-2221-E-194-027, NSC 102-2221-E-194-001]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Science Council of the Republic of China, Taiwan, for its financial support of this research under grants NSC 101-2221-E-194-027 and NSC 102-2221-E-194-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAUDHURY MK, 1991, LANGMUIR, V7, P1013, DOI 10.1021/la00053a033; Chiang PJ, 2014, MICROELECTRON ENG, V115, P39, DOI 10.1016/j.mee.2013.10.024; Chun HG, 2010, ANAL CHEM, V82, P6287, DOI 10.1021/ac101297t; Duan CH, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4794973; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008; Hayt W.H., 1989, ENG ELECTROMAGNETICS, V5th ed.; Hofmann O, 1999, ANAL CHEM, V71, P678, DOI 10.1021/ac9806660; Jung B, 2006, ANAL CHEM, V78, P2319, DOI 10.1021/ac051659w; Kim SM, 2006, ANAL CHEM, V78, P4779, DOI 10.1021/ac060031y; Kim SJ, 2008, ANAL CHEM, V80, P3507, DOI 10.1021/ac800157q; Ko SH, 2011, LAB CHIP, V11, P1351, DOI 10.1039/c0lc00349b; Lee JH, 2008, LAB CHIP, V8, P596, DOI 10.1039/b717900f; Lee JH, 2007, ANAL CHEM, V79, P6868, DOI 10.1021/ac071162h; Lichtenberg J, 2001, ELECTROPHORESIS, V22, P258, DOI 10.1002/1522-2683(200101)22:2<258::AID-ELPS258>3.0.CO;2-4; Lin CC, 2011, MICROFLUID NANOFLUID, V10, P481, DOI 10.1007/s10404-010-0661-9; Liu V, 2010, LAB CHIP, V10, P1485, DOI 10.1039/b923214a; Mao P, 2005, LAB CHIP, V5, P837, DOI 10.1039/b502809d; Pu QS, 2004, NANO LETT, V4, P1099, DOI 10.1021/nl0494811; Ross D, 2002, ANAL CHEM, V74, P2556, DOI 10.1021/ac025528w; Song S, 2004, ANAL CHEM, V76, P4589, DOI 10.1021/ac0497151; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901; Wang YC, 2005, ANAL CHEM, V77, P4293, DOI 10.1021/ac050321z; Wu DP, 2009, LAB CHIP, V9, P1890, DOI 10.1039/b823409d; Yu H, 2008, LAB CHIP, V8, P1496, DOI 10.1039/b802778a	25	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102050	10.1371/journal.pone.0102050	http://dx.doi.org/10.1371/journal.pone.0102050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025205	gold, Green Published			2022-12-25	WOS:000339992400038
J	Kamthan, M; Nalla, VK; Ruhela, D; Kamthan, A; Maiti, P; Datta, A				Kamthan, Mohan; Nalla, Vijaya Kumar; Ruhela, Deepa; Kamthan, Ayushi; Maiti, Protiti; Datta, Asis			Characterization of a Putative Spindle Assembly Checkpoint Kinase Mps1, Suggests Its Involvement in Cell Division, Morphogenesis and Oxidative Stress Tolerance in Candida albicans	PLOS ONE			English	Article							POLE BODY DUPLICATION; SPECIFICITY PROTEIN-KINASES; BREAST-CANCER CELLS; SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL INSTABILITY; MITOTIC CHECKPOINT; FILAMENTOUS GROWTH; PATHOGENIC YEAST; BUDDING YEAST; CYCLE ARREST	In Saccharomyces cerevisiae MPS1 is one of the major protein kinase that governs the spindle checkpoint pathway. The S. cerevisiae structural homolog of opportunistic pathogen Candida albicans CaMPS1, is indispensable for the cell viability. The essentiality of Mps1 was confirmed by Homozygote Trisome test. To determine its biological function in this pathogen conditional mutant was generated through regulatable MET3 promoter. Examination of heterozygous and conditional (+ Met/Cys) mps1 mutants revealed a mitosis specific arrest phenotype, where mutants showed large buds with undivided nuclei. Flowcytometry analysis revealed abnormal ploidy levels in mps1mutant. In presence of anti-microtubule drug Nocodazole, mps1 mutant showed a dramatic loss of viability suggesting a role of Mps1 in Spindle Assembly Checkpoint (SAC) activation. These mutants were also defective in microtubule organization. Moreover, heterozygous mutant showed defective in-vitro yeast to hyphae morphological transition. Growth defect in heterozygous mutant suggest haploinsufficiency of this gene. qRT PCR analysis showed around 3 fold upregulation of MPS1 in presence of serum. This expression of MPS1 is dependent on Efg1and is independent of other hyphal regulators like Ras1 and Tpk2. Furthermore, mps1 mutants were also sensitive to oxidative stress. Heterozygous mps1 mutant did not undergo morphological transition and showed 5-Fold reduction in colony forming units in response to macrophage. Thus, the vital checkpoint kinase, Mps1 besides cell division also has a role in morphogenesis and oxidative stress tolerance, in this pathogenic fungus.	[Kamthan, Mohan; Ruhela, Deepa; Kamthan, Ayushi; Maiti, Protiti; Datta, Asis] Natl Inst Plant Genome Res, New Delhi, India; [Nalla, Vijaya Kumar] Univ Delhi, Dept Microbiol, Bhaskaracharya Coll, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Bhaskaracharya College of Applied Sciences; University of Delhi	Datta, A (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	asis_datta@rediffmail.com		Kamthan, Mohan/0000-0001-8859-4699	Department of Biotechnology, the Ministry of Science and Technology, Government of India	Department of Biotechnology, the Ministry of Science and Technology, Government of India	This work was supported by the Department of Biotechnology, the Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud MB, 2005, NUCLEIC ACIDS RES, V33, pD358, DOI 10.1093/nar/gki003; Bachewich C, 2005, MOL MICROBIOL, V57, P942, DOI 10.1111/j.1365-2958.2005.04727.x; Bai C, 2002, MOL MICROBIOL, V45, P31, DOI 10.1046/j.1365-2958.2002.02995.x; Barelle CJ, 2003, EUKARYOT CELL, V2, P398, DOI 10.1128/EC.2.3.398-410.2003; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Berman J, 2006, CURR OPIN MICROBIOL, V9, P595, DOI 10.1016/j.mib.2006.10.007; Biswas S, 2003, MICROBIOL-SGM, V149, P2597, DOI 10.1099/mic.0.26215-0; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Chen CY, 1998, MICROBIOL-UK, V144, P2941, DOI 10.1099/00221287-144-11-2941; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Daum JR, 2000, CURR BIOL, V10, P1375, DOI 10.1016/S0960-9822(00)00780-6; Enloe B, 2000, J BACTERIOL, V182, P5730, DOI 10.1128/JB.182.20.5730-5736.2000; Feng QH, 1999, J BACTERIOL, V181, P6339, DOI 10.1128/JB.181.20.6339-6346.1999; Finley KR, 2008, J CELL SCI, V121, P466, DOI 10.1242/jcs.015172; Fisk HA, 2004, CELL CYCLE, V3, P439; FONZI WA, 1993, GENETICS, V134, P717; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; He XW, 1998, J CELL SCI, V111, P1635; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Jemaa M, 2013, CELL DEATH DIFFER, V20, P1532, DOI 10.1038/cdd.2013.105; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LINDBERG RA, 1992, TRENDS BIOCHEM SCI, V17, P114, DOI 10.1016/0968-0004(92)90248-8; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; ODDS FC, 1994, J MED VET MYCOL, V32, P1; Russell K D, 2005, CURR BIOL, V15, P1070; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanyal K, 2002, P NATL ACAD SCI USA, V99, P12969, DOI 10.1073/pnas.162488299; SHERMAN F, 1991, METHODS ENZYMOL, V194, P3; Tsuda K, 2011, BIOCHEM BIOPH RES CO, V409, P418, DOI 10.1016/j.bbrc.2011.05.010; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; Watanabe S, 2008, EMBO J, V27, P1085, DOI 10.1038/emboj.2008.32; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903	43	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101517	10.1371/journal.pone.0101517	http://dx.doi.org/10.1371/journal.pone.0101517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025778	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400016
J	O'Callaghan, JP; Kelly, KA; VanGilder, RL; Sofroniew, MV; Miller, DB				O'Callaghan, James P.; Kelly, Kimberly A.; VanGilder, Reyna L.; Sofroniew, Michael V.; Miller, Diane B.			Early Activation of STAT3 Regulates Reactive Astrogliosis Induced by Diverse Forms of Neurotoxicity	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; UP-REGULATION; SUBSTITUTED AMPHETAMINES; MICROGLIAL ACTIVATION; QUANTITATIVE ASPECTS; SIGNALING PATHWAY; BRAIN; INFLAMMATION; LIPOPOLYSACCHARIDE; ASTROCYTES	Astrogliosis, a cellular response characterized by astrocytic hypertrophy and accumulation of GFAP, is a hallmark of all types of central nervous system (CNS) injuries. Potential signaling mechanisms driving the conversion of astrocytes into "reactive'' phenotypes differ with respect to the injury models employed and can be complicated by factors such as disruption of the blood-brain barrier (BBB). As denervation tools, neurotoxicants have the advantage of selective targeting of brain regions and cell types, often with sparing of the BBB. Previously, we found that neuroinflammation and activation of the JAK2-STAT3 pathway in astrocytes precedes up regulation of GFAP in the MPTP mouse model of dopaminergic neurotoxicity. Here we show that multiple mechanistically distinct mouse models of neurotoxicity (MPTP, AMP, METH, MDA, MDMA, KA, TMT) engender the same neuroinflammatory and STAT3 activation responses in specific regions of the brain targeted by each neurotoxicant. The STAT3 effects seen for TMT in the mouse could be generalized to the rat, demonstrating cross-species validity for STAT3 activation. Pharmacological antagonists of the neurotoxic effects blocked neuroinflammatory responses, pSTAT3(tyr705) and GFAP induction, indicating that damage to neuronal targets instigated astrogliosis. Selective deletion of STAT3 from astrocytes in STAT3 conditional knockout mice markedly attenuated MPTP-induced astrogliosis. Monitoring STAT3 translocation in GFAP-positive cells indicated that effects of MPTP, METH and KA on pSTAT3(tyr705) were localized to astrocytes. These findings strongly implicate the STAT3 pathway in astrocytes as a broadly triggered signaling pathway for astrogliosis. We also observed, however, that the acute neuroinflammatory response to the known inflammogen, LPS, can activate STAT3 in CNS tissue without inducing classical signs of astrogliosis. Thus, acute phase neuroinflammatory responses and neurotoxicity-induced astrogliosis both signal through STAT3 but appear to do so through different modules, perhaps localized to different cell types.	[O'Callaghan, James P.; Kelly, Kimberly A.; Miller, Diane B.] NIOSH, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA; [VanGilder, Reyna L.] W Virginia Univ, Sch Pharm, Morgantown, WV 26506 USA; [Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); West Virginia University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	O'Callaghan, JP (corresponding author), NIOSH, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA.	Jdo5@cdc.gov	Kelly, Kimberly/J-9834-2012; Sofroniew, Michael/ABE-8857-2020	Kelly, Kimberly/0000-0002-1146-3137; 	Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health	Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This study was funded by intramural funds from the Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; AL-amri JS, 2013, INDIAN J EXP BIOL, V51, P357; Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054; Bengmark S, 2004, CLIN NUTR, V23, P1256, DOI 10.1016/j.clnu.2004.07.016; Benkovic SA, 2004, BRAIN RES, V1024, P59, DOI 10.1016/j.brainres.2004.07.021; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; BROCK TO, 1987, J NEUROSCI, V7, P931; Buttini M, 1996, NEUROCHEM INT, V29, P25, DOI 10.1016/0197-0186(95)00141-7; Chen E, 2013, CURR MOL MED, V13, P1474; Choi JS, 2003, GLIA, V41, P237, DOI 10.1002/glia.10186; Cromey DW, 2010, SCI ENG ETHICS, V16, P639, DOI 10.1007/s11948-010-9201-y; Dantzer R, 2004, EUR J PHARMACOL, V500, P399, DOI 10.1016/j.ejphar.2004.07.040; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Datta SC, 2008, J NEUROSCI METH, V175, P119, DOI 10.1016/j.jneumeth.2008.08.007; Dawn B, 2004, CARDIOVASC RES, V64, P61, DOI 10.1016/j.cardiores.2004.05.011; Deng H, 2003, STROKE, V34, P2495, DOI 10.1161/01.STR.0000091269.67384.E7; DiNapoli VA, 2010, NEUROSCIENCE, V170, P633, DOI 10.1016/j.neuroscience.2010.07.011; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; FULLER TA, 1981, NEUROBEH TOXICOL TER, V3, P355; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Gautron L, 2002, NEUROSCIENCE, V112, P717, DOI 10.1016/S0306-4522(02)00115-X; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Ifuku M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-197; Kaya M, 2004, BRAIN RES, V1019, P105, DOI 10.1016/j.brainres.2004.05.102; Kelly KA, 2012, J NEUROCHEM, V122, P995, DOI 10.1111/j.1471-4159.2012.07864.x; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lebel E, 2000, ENDOCRINOLOGY, V141, P3749, DOI 10.1210/en.141.10.3749; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Little AR, 2002, NEUROSCIENCE, V115, P307, DOI 10.1016/S0306-4522(02)00359-7; Meddahi A, 2002, J BIOMED MATER RES, V62, P525, DOI 10.1002/jbm.10283; MILLER DB, 1994, J PHARMACOL EXP THER, V270, P752; Miscia S, 2002, CELL GROWTH DIFFER, V13, P13; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nicolas Celine S, 2013, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Norenberg MD, 2005, METAB BRAIN DIS, V20, P303, DOI 10.1007/s11011-005-7911-7; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; O'Callaghan James P, 2005, Expert Opin Drug Saf, V4, P433, DOI 10.1517/14740338.4.3.433; O'Callaghan James P, 2002, Curr Protoc Toxicol, VChapter 12, DOI 10.1002/0471140856.tx1208s11; O'Callaghan JP, 2010, METABOLISM, V59, pS21, DOI 10.1016/j.metabol.2010.07.011; O'Callaghan JP, 2008, ANN NY ACAD SCI, V1139, P318, DOI 10.1196/annals.1432.032; O'Callaghan JP, 2004, J NEUROSCI METH, V135, P159, DOI 10.1016/j.jneumeth.2003.12.006; OCALLAGHAN JP, 1990, BRAIN RES, V521, P73, DOI 10.1016/0006-8993(90)91526-M; OCALLAGHAN JP, 1994, J PHARMACOL EXP THER, V270, P741; OCALLAGHAN JP, 1991, NEUROTOXICOL TERATOL, V13, P275, DOI 10.1016/0892-0362(91)90073-6; OCALLAGHAN JP, 1995, NEUROCHEM INT, V26, P115, DOI 10.1016/0197-0186(94)00106-5; OCALLAGHAN JP, 1993, ANN NY ACAD SCI, V679, P195, DOI 10.1111/j.1749-6632.1993.tb18299.x; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Qin LY, 2013, GLIA, V61, P855, DOI 10.1002/glia.22479; Rivest S, 2000, P SOC EXP BIOL MED, V223, P22, DOI 10.1046/j.1525-1373.2000.22304.x; Scharf MT, 2008, J NEUROCHEM, V105, P833, DOI 10.1111/j.1471-4159.2007.05182.x; Sedgewick J, 2013, IMAGE INTEGRITY SCI; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sosunov AA, 2014, J NEUROSCI, V34, P2285, DOI 10.1523/JNEUROSCI.4037-13.2014; Sriram K, 2006, J NEUROCHEM, V96, P706, DOI 10.1111/j.1471-4159.2005.03566.x; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Stella N, 2012, SCIENCE, V338, P1303, DOI 10.1126/science.1232331; Takeda K, 1998, J IMMUNOL, V161, P4652; Thomas DM, 2004, J NEUROCHEM, V88, P380, DOI 10.1046/j.1471-4159.2003.02182.x; Nguyen T, 2013, J COAT TECHNOL RES, V10, P1, DOI 10.1007/s11998-012-9455-1; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Turner RC, 2012, NEUROLOGICAL DISORDE, P27; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Xia HS, 2002, ULTRASON SONOCHEM, V9, P151, DOI 10.1016/S1350-4177(01)00118-3; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	77	95	96	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102003	10.1371/journal.pone.0102003	http://dx.doi.org/10.1371/journal.pone.0102003			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025494	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400034
J	Pedergnana, V; Syx, L; Cobat, A; Guergnon, J; Brice, P; Ferme, C; Carde, P; Hermine, O; Le-Pendeven, C; Amiel, C; Taoufik, Y; Alcais, A; Theodorou, I; Besson, C; Abel, L				Pedergnana, Vincent; Syx, Laurene; Cobat, Aurelie; Guergnon, Julien; Brice, Pauline; Ferme, Christophe; Carde, Patrice; Hermine, Olivier; Le-Pendeven, Catherine; Amiel, Corinne; Taoufik, Yassine; Alcais, Alexandre; Theodorou, Ioannis; Besson, Caroline; Abel, Laurent			Combined Linkage and Association Studies Show that HLA Class II Variants Control Levels of Antibodies against Epstein-Barr Virus Antigens	PLOS ONE			English	Article							LIKELIHOOD-BINOMIAL METHOD; QUANTITATIVE TRAITS; HODGKINS LYMPHOMA; RELATIVES; SIBSHIPS	Over 95% of the adult population worldwide is infected with Epstein-Barr virus (EBV). EBV infection is associated with the development of several cancers, including Hodgkin lymphoma (HL). Elevated levels of anti-EBV antibodies have been associated with increased risk of HL. There is growing evidence that genetic factors control the levels of antibodies against EBV antigens. Here, we conducted linkage and association studies to search for genetic factors influencing either anti-viral capsid antigen (VCA) or anti-Epstein Barr nuclear antigen-1 (EBNA-1) IgG levels in a unique cohort of 424 individuals of European origin from 119 French families recruited through a Hodgkin lymphoma (HL) patient. No major locus controlling anti-VCA antibody levels was identified. However, we found that the HLA region influenced anti-EBNA-1 IgG titers. Refined association studies in this region identified a cluster of HLA class II variants associated with anti-EBNA-1 IgG titers (e.g. p = 5x10-5 for rs9268403). The major allele of rs9268403 conferring a predisposition to high anti-EBNA-1 antibody levels was also associated with an increased risk of HL (p = 0.02). In summary, this study shows that HLA class II variants influenced anti-EBNA-1 IgG titers in a European population. It further shows the role of the same variants in the risk of HL.	[Pedergnana, Vincent; Syx, Laurene; Cobat, Aurelie; Alcais, Alexandre; Abel, Laurent] INSERM, Lab Human Genet Infect Dis, Necker Branch, Paris, France; [Pedergnana, Vincent; Syx, Laurene; Cobat, Aurelie; Alcais, Alexandre; Abel, Laurent] Univ Paris 05, Sorbonne Paris Cite, Imagine Inst, Paris, France; [Guergnon, Julien; Theodorou, Ioannis] Univ Paris 06, INSERM, Lab Immun & Infect, UMR S 945,Grp Hosp Pitie Salpetriere,AP HP, Paris, France; [Brice, Pauline] Hop St Louis, Serv Oncohematol, Paris, France; [Ferme, Christophe; Carde, Patrice] Hop Gustave Roussy, Dept Med, Villejuif, France; [Hermine, Olivier] Hop Necker Enfants Malad, AP HP, Serv Hematol, Paris, France; [Le-Pendeven, Catherine; Amiel, Corinne] Hop Tenon, AP HP, Lab Virol, F-75970 Paris, France; [Taoufik, Yassine; Besson, Caroline] CHU Bicetre, AP HP, Serv Hematol & Immunol Biol, Le Kremlin Bicetre, France; [Taoufik, Yassine; Besson, Caroline] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France; [Taoufik, Yassine; Besson, Caroline] INSERM, U1012, F-94275 Le Kremlin Bicetre, France; [Abel, Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Rockefeller University	Besson, C (corresponding author), CHU Bicetre, AP HP, Serv Hematol & Immunol Biol, Le Kremlin Bicetre, France.	caroline.besson@bct.aphp.fr; laurent.abel@inserm.fr	Hermine, Olivier/Q-7072-2018; Besson, Caroline/H-4648-2018; Alcais, Alexandre/J-5882-2017; Abel, Laurent/H-8888-2017; Cobat, Aurélie/H-4722-2017	Besson, Caroline/0000-0003-4364-7173; Alcais, Alexandre/0000-0002-1012-2226; Abel, Laurent/0000-0001-7016-6493; Cobat, Aurélie/0000-0001-7209-6257; Hermine, Olivier/0000-0003-2574-3874; Pedergnana, Vincent/0000-0002-7852-5339	Association pour la Recherche contre le Cancer; Ligue Nationale contre le cancer; Fondation de France; Inserm	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale contre le cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from the Association pour la Recherche contre le Cancer, Ligue Nationale contre le cancer, Fondation de France, and Inserm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcais A, 1999, GENET EPIDEMIOL, V17, P102, DOI 10.1002/(SICI)1098-2272(1999)17:2<102::AID-GEPI2>3.0.CO;2-6; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Besson C, 2006, J CLIN MICROBIOL, V44, P47, DOI 10.1128/JCM.44.1.47-50.2006; Besson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000406; Besson C, 2009, J INFECT DIS, V199, P1121, DOI 10.1086/597424; Cobat A, 2014, GENET EPIDE IN PRESS; Cobat A, 2011, GENET EPIDEMIOL, V35, P46, DOI 10.1002/gepi.20548; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MUELLER N, 1989, NEW ENGL J MED, V320, P689, DOI 10.1056/NEJM198903163201103; Rubicz R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003147; Urayama KY, 2012, JNCI-J NATL CANCER I, V104, P240, DOI 10.1093/jnci/djr516; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18	15	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102501	10.1371/journal.pone.0102501	http://dx.doi.org/10.1371/journal.pone.0102501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025336	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400080
J	Shiino, T; Hattori, J; Yokomaku, Y; Iwatani, Y; Sugiura, W				Shiino, Teiichiro; Hattori, Junko; Yokomaku, Yoshiyuki; Iwatani, Yasumasa; Sugiura, Wataru		Japanese Drug Resistance HIV-1	Phylodynamic Analysis Reveals CRF01_AE Dissemination between Japan and Neighboring Asian Countries and the Role of Intravenous Drug Use in Transmission	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV TYPE-1; SUBTYPE E; SEXUAL TRANSMISSION; RESISTANT HIV-1; MEN MSM; EPIDEMIOLOGY; CHINA; PROGRESSION; PREVALENCE	Background: One major circulating HIV-1 subtype in Southeast Asian countries is CRF01_AE, but little is known about its epidemiology in Japan. We conducted a molecular phylodynamic study of patients newly diagnosed with CRF01_AE from 2003 to 2010. Methods: Plasma samples from patients registered in Japanese Drug Resistance HIV-1 Surveillance Network were analyzed for protease-reverse transcriptase sequences; all sequences undergo subtyping and phylogenetic analysis using distance-matrix-based, maximum likelihood and Bayesian coalescent Markov Chain Monte Carlo (MCMC) phylogenetic inferences. Transmission clusters were identified using interior branch test and depth-first searches for sub-tree partitions. Times of most recent common ancestor (tMRCAs) of significant clusters were estimated using Bayesian MCMC analysis. Results: Among 3618 patient registered in our network, 243 were infected with CRF01_AE. The majority of individuals with CRF01_AE were Japanese, predominantly male, and reported heterosexual contact as their risk factor. We found 5 large clusters with >= 5 members and 25 small clusters consisting of pairs of individuals with highly related CRF01_AE strains. The earliest cluster showed a tMRCA of 1996, and consisted of individuals with their known risk as heterosexual contacts. The other four large clusters showed later tMRCAs between 2000 and 2002 with members including intravenous drug users (IVDU) and non-Japanese, but not men who have sex with men (MSM). In contrast, small clusters included a high frequency of individuals reporting MSM risk factors. Phylogenetic analysis also showed that some individuals infected with HIV strains spread in East and South-eastern Asian countries. Conclusions: Introduction of CRF01_AE viruses into Japan is estimated to have occurred in the 1990s. CFR01_AE spread via heterosexual behavior, then among persons connected with non-Japanese, IVDU, and MSM. Phylogenetic analysis demonstrated that some viral variants are largely restricted to Japan, while others have a broad geographic distribution.	[Shiino, Teiichiro] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Hattori, Junko; Yokomaku, Yoshiyuki; Iwatani, Yasumasa; Sugiura, Wataru] Nagoya Med Ctr, Dept Infect Dis & Immunol, Clin Res Ctr, Nagoya, Aichi, Japan; [Iwatani, Yasumasa; Sugiura, Wataru] Nagoya Univ, Dept AIDS Res, Grad Sch Med, Nagoya, Aichi 4648601, Japan	National Institute of Infectious Diseases (NIID); Nagoya Medical Center; Nagoya University	Sugiura, W (corresponding author), Nagoya Med Ctr, Dept Infect Dis & Immunol, Clin Res Ctr, Nagoya, Aichi, Japan.	wsugiura@nnh.hosp.go.jp	Iwatani, Yasumasa/A-8675-2016	Iwatani, Yasumasa/0000-0001-9269-4828	Ministry of Health, Labour, and Welfare of Japan [H22-AIDS-004]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for AIDS research from the Ministry of Health, Labour, and Welfare of Japan [H22-AIDS-004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MH, 2012, J VIROL, V86, P12402, DOI 10.1128/JVI.00262-12; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Beyrer C, 1998, AIDS RES HUM RETROV, V14, P1687, DOI 10.1089/aid.1998.14.1687; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Drummond A, 2001, MOL BIOL EVOL, V18, P1365, DOI 10.1093/oxfordjournals.molbev.a003920; Drummond A, 2000, MOL BIOL EVOL, V17, P1807, DOI 10.1093/oxfordjournals.molbev.a026281; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Feng Y, 2013, AIDS, V27, P1793, DOI 10.1097/QAD.0b013e328360db2d; Gatanaga H, 2007, ANTIVIR RES, V75, P75, DOI 10.1016/j.antiviral.2006.11.012; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hattori J, 2010, ANTIVIR RES, V88, P72, DOI 10.1016/j.antiviral.2010.07.008; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Infectious Diseases Surveillance Center, 2011, IASR, V32, P282; Kato S, 2003, AIDS RES HUM RETROV, V19, P1057, DOI 10.1089/088922203322588431; Kihara M, 1997, J ACQ IMMUN DEF SYND, V14, pS3, DOI 10.1097/00042560-199700002-00002; Kondo M, 2013, J VIROL, V87, P5351, DOI 10.1128/JVI.02370-12; Kusagawa S, 1999, AIDS RES HUM RETROV, V15, P91, DOI 10.1089/088922299311772; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau KA, 2007, AIDS REV, V9, P218; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Li L, 2010, AIDS RES HUM RETROV, V26, P699, DOI 10.1089/aid.2010.0026; Liao HA, 2009, VIROLOGY, V391, P51, DOI 10.1016/j.virol.2009.05.023; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Menu E, 1996, AIDS RES HUM RETROV, V12, P629, DOI 10.1089/aid.1996.12.629; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Nerurkar VR, 1997, CELL MOL BIOL, V43, P959; Nylander J, 2004, MR MODELTEST V2 PROG; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; OU CY, 1992, AIDS RES HUM RETROV, V8, P1471, DOI 10.1089/aid.1992.8.1471; Porter KR, 1997, J ACQ IMMUN DEF SYND, V14, P1, DOI 10.1097/00042560-199701010-00001; Prosperi MCF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1325; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011170; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; UNGASS, 2012, NAT COMM POL INSTR N; Wang WH, 2008, AIDS RES HUM RETROV, V24, P1245, DOI 10.1089/aid.2008.0095; Wang WH, 2011, CURR HIV RES, V9, P136, DOI 10.2174/157016211795569096; WENIGER BG, 1994, AIDS, V8, pS13; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yamanaka T, 1997, AIDS RES HUM RETROV, V13, P317, DOI 10.1089/aid.1997.13.317; Ye JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054238; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zhang XY, 2007, AIDS, V21, pS59, DOI 10.1097/01.aids.0000304698.47261.b1	51	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102633	10.1371/journal.pone.0102633	http://dx.doi.org/10.1371/journal.pone.0102633			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025900	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992400096
J	Tran, BX; Ohinmaa, A; Kuhle, S; Johnson, JA; Veugelers, PJ				Tran, Bach Xuan; Ohinmaa, Arto; Kuhle, Stefan; Johnson, Jeffrey A.; Veugelers, Paul J.			Life Course Impact of School-Based Promotion of Healthy Eating and Active Living to Prevent Childhood Obesity	PLOS ONE			English	Article							ASSESSING COST-EFFECTIVENESS; BODY-MASS INDEX; PHYSICAL-ACTIVITY; FOLLOW-UP; ADULTHOOD; OVERWEIGHT; TRAJECTORIES; INTERVENTIONS; CONSEQUENCES; PARTICIPANTS	Background: The Alberta Project Promoting active Living and healthy Eating in Schools (APPLE Schools) is a comprehensive school health program that is proven feasible and effective in preventing obesity among school aged children. To support decision making on expanding this program, evidence on its long-term health and economic impacts is particularly critical. In the present study we estimate the life course impact of the APPLE Schools programs in terms of future body weights and avoided health care costs. Method: We modeled growth rates of body mass index (BMI) using longitudinal data from the National Population Health Survey collected between 1996-2008. These growth rate characteristics were used to project BMI trajectories for students that attended APPLE Schools and for students who attended control schools (141 randomly selected schools) in the Canadian province of Alberta. Results: Throughout the life course, the prevalence of overweight (including obesity) was 1.2% to 2.8% (1.7 on average) less among students attending APPLE Schools relative to their peers attending control schools. The life course prevalence of obesity was 0.4% to 1.4% (0.8% on average) less among APPLE Schools students. If the APPLE Schools program were to be scaled up, the potential cost savings would be $33 to 82 million per year for the province of Alberta, or $150 to 330 million per year for Canada. Conclusions: These projected health and economic benefits seem to support broader implementation of school-based health promotion programs.	[Tran, Bach Xuan; Ohinmaa, Arto; Johnson, Jeffrey A.; Veugelers, Paul J.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Kuhle, Stefan] Dalhousie Univ, Dept Pediat Obstet & Gynecol, Halifax, NS, Canada	University of Alberta; Dalhousie University	Veugelers, PJ (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	paul.veugelers@ualberta.ca	Kuhle, Stefan/X-5815-2019	Kuhle, Stefan/0000-0001-9417-3727; Veugelers, Paul/0000-0001-8996-0822; Johnson, Jeffrey/0000-0001-8290-2857	Alberta Health; University of Alberta; Canadian Institutes for Health Research [FRN: 91061]; Heart and Stroke Foundation of Canada; Canadian Population Health Initiative; Canadian Institutes for Health Research; Alberta Innovates Health Solutions (AIHS); Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention; AIHS; Alberta Innovates [201300671] Funding Source: researchfish	Alberta Health; University of Alberta(University of Alberta); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Population Health Initiative; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions (AIHS); Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention; AIHS; Alberta Innovates	The Provincial evaluation was funded through a contract with Alberta Health. The APPLE Schools program was funded through a donation to the School of Public Health at the University of Alberta. The research was funded by an operating grant by the Canadian Institutes for Health Research (FRN: 91061), Heart and Stroke Foundation of Canada and Canadian Population Health Initiative, and through Canadian Institutes for Health Research and Alberta Innovates Health Solutions (AIHS) postdoctoral fellowships to Dr. Bach Tran, and a Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention and AIHS Health Scholarship to Dr. Paul J. Veugelers. Dr. J. A. Johnson is a Centennial Professor at the University of Alberta and a Senior Health Scholar with AIHS. All interpretations and opinions in the present study are those of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman-Farinelli MA, 2007, MED J AUSTRALIA, V187, P314, DOI 10.5694/j.1326-5377.2007.tb01253.x; Anis AH, 2010, OBES REV, V11, P31, DOI 10.1111/j.1467-789X.2009.00579.x; [Anonymous], 2008, AHIP COVER; Asakawa K, 2012, J HEALTH ECON, V31, P207, DOI 10.1016/j.jhealeco.2011.10.002; Atkinson W, 2008, AHIP COVER, V49, P32; Atkinson William, 2008, AHIP Cover, V49, P26; Brown HS, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-47; Ng C, 2012, AM J HUM BIOL, V24, P170, DOI 10.1002/ajhb.22216; Carter R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-419; Dietz WH, 2005, NEW ENGL J MED, V352, P2100, DOI 10.1056/NEJMcp043052; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Fung C, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-27; Greening L, 2011, OBESITY, V19, P1213, DOI 10.1038/oby.2010.329; Guyer B, 2009, ACAD PEDIATR, V9, P142, DOI 10.1016/j.acap.2008.12.007; Herman KM, 2009, INT J PEDIATR OBES, V4, P281, DOI 10.3109/17477160802596171; Katzmarzyk PT, 2004, CAN J PUBLIC HEALTH, V95, P16, DOI 10.1007/BF03403627; Kuhle S, 2011, THESIS U ALBERTA; Lehnert T, 2012, OBES REV, V13, P537, DOI 10.1111/j.1467-789X.2011.00980.x; Lhachimi SK, 2013, OBES REV, V14, P523, DOI 10.1111/obr.12029; Magarey AM, 2003, INT J OBESITY, V27, P505, DOI 10.1038/sj.ijo.0802251; McAuley KA, 2010, OBESITY, V18, P131, DOI 10.1038/oby.2009.148; Moodie M, 2011, J PHYS ACT HEALTH, V8, P503, DOI 10.1123/jpah.8.4.503; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; Pryor LE, 2011, ARCH PEDIAT ADOL MED, V165, P906, DOI 10.1001/archpediatrics.2011.153; Saha AK, 2011, INDIAN J PEDIATR, V78, P1349, DOI 10.1007/s12098-011-0489-7; Starc G, 2011, PUBLIC HEALTH NUTR, V14, P49, DOI 10.1017/S1368980010000741; Tran Bach Xuan, 2013, Cost Eff Resour Alloc, V11, P3, DOI 10.1186/1478-7547-11-3; Trasande L, 2011, EXPERT REV PHARM OUT, V11, P47, DOI 10.1586/ERP.10.86; Venn AJ, 2007, MED J AUSTRALIA, V186, P458, DOI 10.5694/j.1326-5377.2007.tb00997.x; Verstraeten R, 2012, AM J CLIN NUTR, V96, P415, DOI 10.3945/ajcn.112.035378; Veugelers PJ, 2005, AM J PUBLIC HEALTH, V95, P432, DOI 10.2105/AJPH.2004.045898; Wang LY, 2010, J ADOLESCENT HEALTH, V46, P467, DOI 10.1016/j.jadohealth.2009.11.204; Wang LY, 2008, J SCHOOL HEALTH, V78, P619, DOI 10.1111/j.1746-1561.2008.00357.x; Wang YC, 2007, OBESITY, V15, P2855, DOI 10.1038/oby.2007.339; Wu JF, 2013, PEDIATR NEONATOL, V54, P71, DOI 10.1016/j.pedneo.2013.01.002; Zenzen W, 2009, J PEDIATR HEALTH CAR, V23, P242, DOI 10.1016/j.pedhc.2008.04.008	37	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102242	10.1371/journal.pone.0102242	http://dx.doi.org/10.1371/journal.pone.0102242			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025581	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400054
J	Zhai, HH; Pan, JC; Pang, E; Bai, B				Zhai, Haohan; Pan, Jianchao; Pang, En; Bai, Bo			Lavage with Allicin in Combination with Vancomycin Inhibits Biofilm Formation by Staphylococcus epidermidis in a Rabbit Model of Prosthetic Joint Infection	PLOS ONE			English	Article							SEPTIC ARTHRITIS; IRRIGATION; MANAGEMENT; DIAGNOSIS; ARTHROPLASTY; DEBRIDEMENT; PREVENTION; EFFICACY; THERAPY	Background and Aim: The present anti-infection strategy for prosthetic joint infections (PJI) includes the use of antibiotics and surgical treatments, but the bacterial eradication rates are still low. One of the major challenges is the formation of biofilm causing poor bacterial eradication. Recently it has been reported that allicin (diallyl thiosulphinate), an antibacterial principle of garlic, can inhibit bacteria adherence and prevent biofilm formation in vitro. However, whether allicin could inhibit biofilm formation in vivo is unknown. The aim of this study was to investigate the effects of allicin on biofilm formation, and whether allicin could potentiate the bactericidal effect of vancomycin in a rabbit PJI model. Methods: A sterile stainless-steel screw with a sterile ultra-high molecular weight polyethylene washer was inserted into the lateral femoral condyle of the right hind knee joint of rabbit, and 1 mL inoculum containing 10(4) colony-forming units of Staphylococcus epidermidis was inoculated into the knee joint (n = 32). Fourteen days later, rabbits randomly received one of the following 4 treatments using continuous lavages: normal saline, vancomycin (20 mcg/mL), allicin (4 mg/L), or allicin (4 mg/L) plus vancomycin (20 mcg/mL). Three days later, the washer surface biofilm formation was examined by scanning electron microscopy (SEM). The bacterial counts within the biofilm of implanted screws were determined by bacterial culture. Results: The lowest number of viable bacterial counts of Staphylococcus epidermidis recovered from the biofilm was in the rabbits treated with allicin plus vancomycin (P < 0.01 vs. all other groups). The biofilm formation was significantly reduced or undetectable by SEM in rabbits receiving allicin or allicin plus vancomycin. Conclusion: Intra-articular allicincan inhibit biofilm formation and enhance the bactericidal effect of vancomycin on implant surface in vivo. Allicin in combination with vancomycin may be a useful anti-infection strategy for the treatment of PJI.	[Zhai, Haohan; Pan, Jianchao; Bai, Bo] Guangzhou Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Guangzhou, Guangdong, Peoples R China; [Pang, En] Kingmed Diagnost Ctr Co Ltd, Dept Microbiol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Bai, B (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Guangzhou, Guangdong, Peoples R China.	drbobai@126.com						Arciola CR, 2011, INT J ARTIF ORGANS, V34, P727, DOI 10.5301/IJAO.2011.8784; Bahrs C, 2003, J SURG RES, V112, P26, DOI 10.1016/S0022-4804(03)00150-1; Barrett J, 2005, J BONE JOINT SURG AM, V87A, P1965, DOI 10.2106/JBJS.D.02440; Beswick AD, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-18; Bradbury T, 2009, J ARTHROPLASTY, V24, P101, DOI 10.1016/j.arth.2009.04.028; Brown NM, 2012, J ARTHROPLASTY, V27, P27, DOI 10.1016/j.arth.2011.03.034; Chaudhry H, 2014, CLIN ORTHOP RELAT R, V472, P22, DOI 10.1007/s11999-013-3333-8; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Craig MR, 2005, J ORTHOP RES, V23, P1100, DOI 10.1016/j.orthres.2005.03.007; Cruz-Villalon G, 2011, J APPL MICROBIOL, V110, P723, DOI 10.1111/j.1365-2672.2010.04929.x; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Dodwell ER, 2013, CURR OPIN PEDIATR, V25, P58, DOI 10.1097/MOP.0b013e32835c2b42; Fujimura S, 2009, J ORTHOP SCI, V14, P658, DOI 10.1007/s00776-009-1366-3; Gallo Jiri, 2003, Biomedical Papers (Olomouc), V147, P27; Haerdi-Landerer MC, 2010, VET J, V184, P14, DOI 10.1016/j.tvjl.2009.02.013; Iarikov D, 2012, CLIN INFECT DIS, V55, P1474, DOI 10.1093/cid/cis735; Isiklar ZU, 1996, CLIN ORTHOP RELAT R, P184; Kirr R, 2006, ZBL CHIR, V131, pS79, DOI 10.1055/s-2005-921501; Kurtz SM, 2010, CLIN ORTHOP RELAT R, V468, P52, DOI 10.1007/s11999-009-1013-5; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; LETTIN AWF, 1990, J BONE JOINT SURG BR, V72, P220, DOI 10.1302/0301-620X.72B2.2312559; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Malloy KM, 2009, ORTHOPEDICS, V32, P499, DOI 10.3928/01477447-20090527-18; Manadan Augustine M, 2004, Am J Ther, V11, P412, DOI 10.1097/01.mph.0000087296.80768.1e; Meijer MC, 2000, J VET MED A, V47, P351, DOI 10.1046/j.1439-0442.2000.00290.x; MELLASCHMIDT C, 1989, CHIRURG, V60, P791; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Odum SM, 2011, J ARTHROPLASTY, V26, P114, DOI 10.1016/j.arth.2011.03.031; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; PARISIEN JS, 1992, CLIN ORTHOP RELAT R, P243; Parvizi Javad, 2012, J Bone Joint Surg Am, V94, pe104, DOI 10.2106/JBJS.K.01417; Parvizi J, 2009, CLIN ORTHOP RELAT R, V467, P1732, DOI 10.1007/s11999-009-0857-z; Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103; Peel TN, 2012, CURR OPIN INFECT DIS, V25, P670, DOI 10.1097/QCO.0b013e32835915db; Perez-Giraldo C, 2003, J APPL MICROBIOL, V95, P709, DOI 10.1046/j.1365-2672.2003.02030.x; Sampedro MF, 2010, SPINE, V35, P1218, DOI 10.1097/BRS.0b013e3181c3b2f3; Shuman EK, 2012, INFECT DIS CLIN N AM, V26, P29, DOI 10.1016/j.idc.2011.09.011; Tsumura H, 2005, INT ORTHOP, V29, P113, DOI 10.1007/s00264-004-0626-2; Vos LM, 2013, J OROFAC PAIN, V27, P171, DOI 10.11607/jop.1007; Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863; Yang L, 2011, ENVIRON MICROBIOL, V13, P1705, DOI 10.1111/j.1462-2920.2011.02503.x; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zimmerli W, 2012, FEMS IMMUNOL MED MIC, V65, P158, DOI 10.1111/j.1574-695X.2012.00938.x; Zmistowski B, 2011, J ARTHROPLASTY, V26, P104, DOI 10.1016/j.arth.2011.03.044	45	35	36	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102760	10.1371/journal.pone.0102760	http://dx.doi.org/10.1371/journal.pone.0102760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025650	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992400104
J	Li, MWM; Wang, JL; Zhao, YO; Fikrig, E				Li, Michelle W. M.; Wang, Jiuling; Zhao, Yang O.; Fikrig, Erol			Innexin AGAP001476 Is Critical for Mediating Anti-Plasmodium Responses in Anopheles Mosquitoes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR COMMUNICATION; MALARIA; COMPLEMENT; IMMUNITY; MIDGUT; TRANSMISSION; INFECTION; DEFENSE	The Toll and IMD pathways are known to be induced upon Plasmodium berghei and Plasmodium falciparum infection, respectively. It is unclear how Plasmodium or other pathogens in the blood meal and their invasion of the midgut epithelium would trigger the innate immune responses in immune cells, in particular hemocytes. Gap junctions, which can mediate both cell-to-cell and cell-to-extracellular communication, may participate in this signal transduction. This study examined whether innexins, gap junction proteins in insects, are involved in anti-Plasmodium responses in Anopheles gambiae. Inhibitor studies using carbenoxolone indicated that blocking innexons resulted in an increase in Plasmodium oocyst number and infection prevalence. This was accompanied by a decline in TEP1 levels in carbenoxolone-treated mosquitoes. Innexin AGAP001476 mRNA levels in midguts were induced during Plasmodium infection and a knockdown of AGAP001476, but not AGAP006241, caused an induction in oocyst number. Silencing AGAP001476 caused a concurrent increase in vitellogenin levels, a TEP1 inhibitor, in addition to a reduced level of TEP1-LRIM1-APL1C complex in hemolymph. Both vitellogenin and TEP1 are regulated by Cactus under the Toll pathway. Simultaneous knockdown of cactus and AGAP001476 failed to reverse the near refractoriness induced by the knockdown of cactus, suggesting that the AGAP001476-mediated anti-Plasmodium response is Cactus-dependent. These data demonstrate a critical role for innexin AGAP001476 in mediating innate immune responses against Plasmodium through Toll pathway in mosquitoes.	[Li, Michelle W. M.; Wang, Jiuling; Zhao, Yang O.; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; [Li, Michelle W. M.; Zhao, Yang O.; Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Howard Hughes Medical Institute	Li, MWM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA.	wingmanmichelle.li@yale.edu	Li, Michelle W M/N-4914-2019; Li, Wing Man Michelle/B-8295-2008	Li, Michelle W M/0000-0002-9778-984X; Li, Wing Man Michelle/0000-0002-9778-984X				Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; Angrisano F, 2012, INT J PARASITOL, V42, P519, DOI 10.1016/j.ijpara.2012.02.004; [Anonymous], METH AN RES MAN; Bao L, 2007, FEBS LETT, V581, P5703, DOI 10.1016/j.febslet.2007.11.030; Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107; Billingsley PF, 2008, TRENDS PARASITOL, V24, P396, DOI 10.1016/j.pt.2008.06.003; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Bohrmann J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-111; Butcher GA, 1997, INT J PARASITOL, V27, P975, DOI 10.1016/S0020-7519(97)00079-9; Castillo M, 2006, VET MICROBIOL, V114, P165, DOI 10.1016/j.vetmic.2005.11.055; Cirimotich CM, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/891342; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Clayton AM, 2014, J INNATE IMMUN, V6, P169, DOI 10.1159/000353602; Dahl G, 2013, NEUROPHARMACOLOGY, V75, P583, DOI 10.1016/j.neuropharm.2013.02.019; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Garver Lindsey, 2007, J Vis Exp, P230, DOI 10.3791/230; Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070; Hillyer JF, 2010, ADV EXP MED BIOL, V708, P218; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Li MWM, 2013, ADV EXP MED BIOL, V763, P260; Luo KJ, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0106; Magnusson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021572; Mead EA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-366; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Neijssen J, 2007, PROG BIOPHYS MOL BIO, V94, P207, DOI 10.1016/j.pbiomolbio.2007.03.008; Ojo KK, 2012, J CLIN INVEST, V122, P2301, DOI 10.1172/JCI61822; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Raghavendra K, 2011, PARASITOL RES, V108, P757, DOI 10.1007/s00436-010-2232-0; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Stone WJR, 2013, SCI REP-UK, V3, DOI 10.1038/srep03418; VANDERBE.JP, 1966, J PARASITOL, V52, P559, DOI 10.2307/3276326; Verselis VK, 2013, NEUROPHARMACOLOGY, V75, P517, DOI 10.1016/j.neuropharm.2013.03.020; WHO, 2012, WORLD MALARIA REPORT 2012, P1	36	11	11	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24885	24897		10.1074/jbc.M114.554519	http://dx.doi.org/10.1074/jbc.M114.554519			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25035430	Green Published, hybrid			2022-12-25	WOS:000341985300014
J	Kirschner, KM; Braun, JF; Jacobi, CL; Rudigier, LJ; Persson, AB; Scholz, H				Kirschner, Karin M.; Braun, Julian F. W.; Jacobi, Charlotte L.; Rudigier, Lucas J.; Persson, Anja Bondke; Scholz, Holger			Amine Oxidase Copper-containing 1 (AOC1) Is a Downstream Target Gene of the Wilms Tumor Protein, WT1, during Kidney Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Gene Expression; Polyamine; Transcription Regulation; Tumor Suppressor Gene	AMILORIDE-BINDING-PROTEIN; TRKB NEUROTROPHIN RECEPTOR; DIAMINE OXIDASE; SUPPRESSOR WT1; ORNITHINE-DECARBOXYLASE; SEX DETERMINATION; TRANSCRIPTIONAL ACTIVATOR; PROGENITOR CELLS; PORCINE KIDNEY; BOVINE SERUM	Background: Polyamines and their diamine precursor putrescine are ubiquitous organic polycations involved in cell growth and proliferation. Results: The Wilms tumor suppressor, WT1, stimulates transcription of the AOC1 gene, which encodes the key enzyme for putrescine breakdown. Conclusion: WT1-dependent regulation of putrescine degradation, mediated by AOC1, has a role in kidney morphogenesis. Significance: The findings provide novel insights into transcriptional mechanisms controlling genitourinary development. Amine oxidase copper-containing 1 (AOC1; formerly known as amiloride-binding protein 1) is a secreted glycoprotein that catalyzes the degradation of putrescine and histamine. Polyamines and their diamine precursor putrescine are ubiquitous to all organisms and fulfill pivotal functions in cell growth and proliferation. Despite the importance of AOC1 in regulating polyamine breakdown, very little is known about the molecular mechanisms that control its expression. We report here that the Wilms tumor protein, WT1, which is necessary for normal kidney development, activates transcription of the AOC1 gene. Expression of a firefly luciferase reporter under control of the proximal AOC1 promoter was significantly enhanced by co-transfection of a WT1 expression construct. Binding of WT1 protein to a cis-regulatory element in the AOC1 promoter was confirmed by electrophoretic mobility shift assay and chromatin immunoprecipitation. Antisense inhibition of WT1 protein translation strongly reduced Aoc1 transcripts in cultured murine embryonic kidneys and gonads. Aoc1 mRNA levels correlated with WT1 protein in several cell lines. Double immunofluorescent staining revealed a co-expression of WT1 and AOC1 proteins in the developing genitourinary system of mice and rats. Strikingly, induced changes in polyamine homeostasis affected branching morphogenesis of cultured murine embryonic kidneys in a developmental stage-specific manner. These findings suggest that WT1-dependent control of polyamine breakdown, which is mediated by changes in AOC1 expression, has a role in kidney organogenesis.	[Kirschner, Karin M.; Braun, Julian F. W.; Jacobi, Charlotte L.; Rudigier, Lucas J.; Persson, Anja Bondke; Scholz, Holger] Charite, Inst Vegetat Physiol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Scholz, H (corresponding author), Charite, Inst Vegetat Physiol, Charitepl 1, D-10117 Berlin, Germany.	holger.scholz@charite.de		Kirschner, Karin/0000-0003-0226-8636; Jacobi, Charlotte/0000-0001-6398-2812	Deutsche Forschungsgemeinschaft [Scho634/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Scho634/8-1.	Abdulhussein AA, 2014, AMINO ACIDS, V46, P655, DOI 10.1007/s00726-013-1553-6; Balitskaya O. V., 1992, Voprosy Onkologii (St. Petersburg), V38, P674; BARBRY P, 1990, P NATL ACAD SCI USA, V87, P7347, DOI 10.1073/pnas.87.19.7347; BEAVEN MA, 1980, BIOCHEM PHARMACOL, V29, P2897, DOI 10.1016/0006-2952(80)90033-7; BIEGANSKI T, 1982, INT J BIOCHEM, V14, P949, DOI 10.1016/0020-711X(82)90080-5; BIEGANSKI T, 1983, BIOCHIM BIOPHYS ACTA, V756, P196, DOI 10.1016/0304-4165(83)90092-2; Bor YC, 2006, GENE DEV, V20, P1597, DOI 10.1101/gad.1402306; CHASSANDE O, 1994, J BIOL CHEM, V269, P14484; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; Dame C, 2006, BLOOD, V107, P4282, DOI 10.1182/blood-2005-07-2889; Davies JA, 2004, HUM MOL GENET, V13, P235, DOI 10.1093/hmg/ddh015; Elmore BO, 2002, J BIOL INORG CHEM, V7, P565, DOI 10.1007/s00775-001-0331-1; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; FEUERSTEIN BG, 1991, J CELL BIOCHEM, V46, P37, DOI 10.1002/jcb.240460107; GAHL WA, 1982, BIOCHEM J, V202, P603, DOI 10.1042/bj2020603; Gao F, 2014, HUM MOL GENET, V23, P333, DOI 10.1093/hmg/ddt423; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HAMILTON TB, 1995, NUCLEIC ACIDS RES, V23, P277, DOI 10.1093/nar/23.2.277; Hartwig S, 2010, DEVELOPMENT, V137, P1189, DOI 10.1242/dev.045732; Herzer U, 1999, CURR BIOL, V9, P837, DOI 10.1016/S0960-9822(99)80369-8; Jacobi CLJ, 2013, J BIOL CHEM, V288, P18811, DOI 10.1074/jbc.M113.464644; Karlstedt K, 2001, DEV DYNAM, V221, P81, DOI 10.1002/dvdy.1127; Kim GH, 2009, CAN J NEUROL SCI, V36, P14, DOI 10.1017/S0317167100006247; Kirschner KM, 2008, FASEB J, V22, P2690, DOI 10.1096/fj.07-097576; Klattig J, 2007, MOL CELL BIOL, V27, P4355, DOI 10.1128/MCB.01780-06; Klocker J, 2005, INFLAMM RES, V54, pS54, DOI 10.1007/s00011-004-0425-7; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Kusano T, 2008, PLANTA, V228, P367, DOI 10.1007/s00425-008-0772-7; Laity JH, 2000, P NATL ACAD SCI USA, V97, P11932, DOI 10.1073/pnas.97.22.11932; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Lefevre PLC, 2011, ENDOCR REV, V32, P694, DOI 10.1210/er.2011-0012; Li RS, 1999, EXP CELL RES, V247, P257, DOI 10.1006/excr.1998.4361; Liang XH, 2010, ENDOCRINOLOGY, V151, P5007, DOI 10.1210/en.2010-0170; Loikkanen I, 2005, DIFFERENTIATION, V73, P303, DOI 10.1111/j.1432-0436.2005.00036.x; MADDEN SL, 1991, SCIENCE, V253, P1550, DOI 10.1126/science.1654597; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; MATTHEWS HR, 1993, BIOESSAYS, V15, P561, DOI 10.1002/bies.950150811; Michos O, 2009, CURR OPIN GENET DEV, V19, P484, DOI 10.1016/j.gde.2009.09.003; MIZUGUCHI H, 1994, J BIOCHEM-TOKYO, V116, P631, DOI 10.1093/oxfordjournals.jbchem.a124572; Moinard C, 2005, CLIN NUTR, V24, P184, DOI 10.1016/j.clnu.2004.11.001; Moore AW, 1999, DEVELOPMENT, V126, P1845; MOREL F, 1992, BIOCHEM BIOPH RES CO, V187, P178, DOI 10.1016/S0006-291X(05)81476-7; Moshier JA, 1996, NUCLEIC ACIDS RES, V24, P1149, DOI 10.1093/nar/24.6.1149; NOVOTNY WF, 1994, J BIOL CHEM, V269, P9921; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Quinn A, 2012, SEMIN REPROD MED, V30, P351, DOI 10.1055/s-0032-1324718; Raithel M, 1999, INFLAMM RES, V48, pS75; Schwelberger HG, 1998, INFLAMM RES, V47, pS58; Schwelberger HG, 1997, BBA-PROTEIN STRUCT M, V1340, P152, DOI 10.1016/S0167-4838(97)00039-3; Sciesielski LK, 2010, FEBS LETT, V584, P4665, DOI 10.1016/j.febslet.2010.10.045; Sebela M, 2007, J NEURAL TRANSM, V114, P793, DOI 10.1007/s00702-007-0690-z; Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z; Shantz LM, 2007, AMINO ACIDS, V33, P213, DOI 10.1007/s00726-007-0531-2; Sharmin S, 2001, BIOCHEM BIOPH RES CO, V282, P228, DOI 10.1006/bbrc.2001.4569; Soda K, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-95; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tantini B, 2006, J MOL CELL CARDIOL, V40, P775, DOI 10.1016/j.yjmcc.2006.03.002; Wagner KD, 2001, J AM SOC NEPHROL, V12, P1188, DOI 10.1681/ASN.V1261188; Wagner KD, 2002, EMBO J, V21, P1398, DOI 10.1093/emboj/21.6.1398; Wagner N, 2005, DEVELOPMENT, V132, P1327, DOI 10.1242/dev.01682; Wagner N, 2005, GENE DEV, V19, P2631, DOI 10.1101/gad.346405; WOLFF DJ, 1995, ARCH BIOCHEM BIOPHYS, V316, P290, DOI 10.1006/abbi.1995.1040; Zahedi K, 2011, METHODS MOL BIOL, V720, P379, DOI 10.1007/978-1-61779-034-8_24; Zheng QS, 2014, REPRODUCTION, V147, P45, DOI 10.1530/REP-13-0299	67	17	18	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24452	24462		10.1074/jbc.M114.564336	http://dx.doi.org/10.1074/jbc.M114.564336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25037221	Green Published, hybrid			2022-12-25	WOS:000341505600038
J	Wang, C; Song, J; Ma, ZQ; Yang, WF; Li, CQ; Zhang, XP; Hou, XG; Sun, Y; Lin, P; Liang, K; Gong, L; Wang, MJ; Liu, FQ; Li, WJ; Yan, F; Yang, JP; Wang, LS; Tian, M; Liu, JD; Zhao, RX; Chen, L				Wang, Chuan; Song, Jun; Ma, Zeqiang; Yang, Weifang; Li, Chengqiao; Zhang, Xiuping; Hou, Xinguo; Sun, Yu; Lin, Peng; Liang, Kai; Gong, Lei; Wang, Meijian; Liu, Fuqiang; Li, Wenjuan; Yan, Fei; Yang, Junpeng; Wang, Lingshu; Tian, Meng; Liu, Jidong; Zhao, Ruxing; Chen, Li			Fluctuation between Fasting and 2-H Postload Glucose State Is Associated with Chronic Kidney Disease in Previously Diagnosed Type 2 Diabetes Patients with HbA1c >= 7%	PLOS ONE			English	Article							GLYCEMIC VARIABILITY; HBA(1C) VARIABILITY; RISK; COMPLICATIONS; POPULATION; PREVALENCE	Objective: To investigate how the glucose variability between fasting and a 2-h postload glucose state (2-h postload plasma glucose [2hPG]-fasting plasma glucose [FPG]) is associated with chronic kidney disease (CKD) in middle-aged and elderly Chinese patients previously diagnosed with type 2 diabetes. Design and Methods: This cross-sectional study included 1054 previously diagnosed type 2 diabetes patients who were 40 years of age and older. First, the subjects were divided into two groups based on a glycated hemoglobin (HbA1c) value of 7%. Each group was divided into two subgroups, with or without CKD. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation was used to estimate the glomerular filtration rate (GFR). CKD was defined as eGFR < 60 mL/min/1.73 m(2). Multiple linear regression analysis was used to estimate the association between the 2hPG-FPG and eGFR. The 2hPG-FPG value was divided into four groups increasing in increments of 36 mg/dl (2.0 mmol/L): 0-72, 72-108, 108-144 and >= 144 mg/dl, based on the quartiles of patients with HbA1c levels >= 7%; then, binary logistic regression analysis was used to investigate the association between 2hPG-FPG and the risk of CKD. Results: In the patients with HbA1c levels >= 7%, the 2hPG-FPG was significantly associated with decreased eGFR and an increased risk of CKD independent of age, gender, body mass index (BMI), systolic blood pressure (BP), diastolic BP, smoking, and drinking, as well as fasting insulin, cholesterol, triglyceride, and HbA1c levels. The patients with 2hPG-FPG values >= 144 mg/dl showed an increased odds ratio (OR) of 2.640 (P = 0.033). Additionally, HbA1c was associated with an increased risk of CKD in patients with HbA1c values >= 7%. Conclusions: The short-term glucose variability expressed by 2hPG-FPG is closely associated with decreased eGFR and an increased risk of CKD in patients with poor glycemic control (HbA1c >= 7%).	[Wang, Chuan; Song, Jun; Hou, Xinguo; Sun, Yu; Lin, Peng; Liang, Kai; Gong, Lei; Wang, Meijian; Liu, Fuqiang; Li, Wenjuan; Yan, Fei; Yang, Junpeng; Wang, Lingshu; Tian, Meng; Liu, Jidong; Zhao, Ruxing; Chen, Li] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan 250100, Shandong, Peoples R China; [Ma, Zeqiang] China Natl Heavy Duty Truck Grp Corp Hosp, Jinan, Shandong, Peoples R China; [Yang, Weifang] Lukang Hosp Jining, Jining, Shandong, Peoples R China; [Li, Chengqiao] Second Peoples Hosp Jining, Dept Endocrinol, Jining, Shandong, Peoples R China; [Zhang, Xiuping] Shantui Community Hlth Ctr, Jining, Shandong, Peoples R China	Shandong University	Chen, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan 250100, Shandong, Peoples R China.	wangchuansdu.edu@163.com		hou, xinguo/0000-0003-2045-1290	Chinese Society of Endocrinology; National Natural Science Foundation of China [81100617]; Medical and Health Science and Technology Development Projects of Shandong Province [2011HD005]; National Science and Technology Support Plan [2009BAI80B04]; Natural Science Foundation of Shandong Province [ZR2012HM014]; International Science and Technology Projects of Shandong Province [2012GGE27126]; Business Plan of Jinan Students Studying Abroad [20110407]; special scientific research fund of clinical medicine of Chinese Medical Association [12030420342]	Chinese Society of Endocrinology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical and Health Science and Technology Development Projects of Shandong Province; National Science and Technology Support Plan; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); International Science and Technology Projects of Shandong Province; Business Plan of Jinan Students Studying Abroad; special scientific research fund of clinical medicine of Chinese Medical Association	This study was supported by grants from the Chinese Society of Endocrinology, the National Natural Science Foundation of China (No. 81100617), the Medical and Health Science and Technology Development Projects of Shandong Province (2011HD005), the National Science and Technology Support Plan (2009BAI80B04), the Natural Science Foundation of Shandong Province (ZR2012HM014), the International Science and Technology Projects of Shandong Province (2012GGE27126), the Business Plan of Jinan Students Studying Abroad (20110407), and the special scientific research fund of clinical medicine of Chinese Medical Association (12030420342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Brownlee M, 2006, JAMA-J AM MED ASSOC, V295, P1707, DOI 10.1001/jama.295.14.1707; Cameron Fergus J, 2010, Pediatr Endocrinol Rev, V7 Suppl 3, P432; Chen W, 2009, NEPHROL DIAL TRANSPL, V24, P1205, DOI 10.1093/ndt/gfn604; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036332; Cheng XY, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/463740; Collins AJ, 2011, AM J KIDNEY DIS, V57, pA8, DOI 10.1053/j.ajkd.2010.10.007; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Frontoni S, 2013, DIABETES RES CLIN PR, V102, P86, DOI 10.1016/j.diabres.2013.09.007; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Jessani S, 2014, AM J KIDNEY DIS, V63, P49, DOI 10.1053/j.ajkd.2013.07.023; Kilpatrick ES, 2006, DIABETES CARE, V29, P1486, DOI 10.2337/dc06-0293; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luk AOY, 2013, DIABETES-METAB RES, V29, P384, DOI 10.1002/dmrr.2404; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ning G, 2012, J DIABETES, V4, P172, DOI 10.1111/j.1753-0407.2012.00182.x; Penno G, 2013, DIABETES CARE, V36, P2301, DOI 10.2337/dc12-2264; Pyram R, 2012, MATURITAS, V71, P94, DOI 10.1016/j.maturitas.2011.11.009; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Siegelaar SE, 2010, ENDOCR REV, V31, P171, DOI 10.1210/er.2009-0021; Tomonaga Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067848; Wang Huanjun, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P818, DOI 10.3969/j.issn.1672-7347.2013.08.010; Weber C, 2009, DIABETES TECHNOL THE, V11, P623, DOI 10.1089/dia.2009.0043; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	25	9	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102941	10.1371/journal.pone.0102941	http://dx.doi.org/10.1371/journal.pone.0102941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047354	gold, Green Published, Green Submitted			2022-12-25	WOS:000339558100090
J	Ebsen, H; Lettau, M; Kabelitz, D; Janssen, O				Ebsen, Henriette; Lettau, Marcus; Kabelitz, Dieter; Janssen, Ottmar			Identification of SH3 Domain Proteins Interacting with the Cytoplasmic Tail of the A Disintegrin and Metalloprotease 10 (ADAM10)	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CYTOSOLIC POLYPROLINE REGION; ALPHA CONVERTING-ENZYME; NECROSIS-FACTOR-ALPHA; FAS LIGAND; INTERACTION PARTNERS; MEMBRANE CURVATURE; TYROSINE KINASE; BINDING-PROTEIN; SORTING NEXINS	The a disintegrin and metalloproteases (ADAMs) play a pivotal role in the control of development, adhesion, migration, inflammation and cancer. Although numerous substrates of ADAM10 have been identified, the regulation of its surface expression and proteolytic activity is still poorly defined. One current hypothesis is that both processes are in part modulated by protein-protein interactions mediated by the intracellular portion of the protease. For related proteases, especially proline-rich regions serving as docking sites for Src homology domain 3 (SH3) domain-containing proteins proved to be important for mediating regulatory interactions. In order to identify ADAM10-binding SH3 domain proteins, we screened the All SH3 Domain Phager library comprising 305 human SH3 domains using a GST fusion protein with the intracellular region of human ADAM10 as a bait for selection. Of a total of 291 analyzed phage clones, we found 38 SH3 domains that were precipitated with the ADAM10-derived fusion protein but not with GST. We verified the binding to the cytosolic portion of ADAM10 for several candidates by co-immunoprecipitation and/or pull down analyses. Intriguingly, several of the identified proteins have been implicated in regulating surface appearance and/or proteolytic activity of related ADAMs. Thus, it seems likely that they also play a role in ADAM10 biology.	[Ebsen, Henriette; Lettau, Marcus; Kabelitz, Dieter; Janssen, Ottmar] Univ Kiel, Univ Hosp Schleswig Holstein, Inst Immunol, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Janssen, O (corresponding author), Univ Kiel, Univ Hosp Schleswig Holstein, Inst Immunol, Campus Kiel, Kiel, Germany.	ottmar.janssen@uksh.de	Lettau, Marcus/H-7595-2019; Janssen, Ottmar/E-9735-2010; Kabelitz, Dieter/AAB-4199-2021; Janssen, Ottmar/N-8769-2019; Kabelitz, Dieter/A-2757-2010; Ebsen, Henriette/B-1886-2015	Lettau, Marcus/0000-0002-3824-9923; Janssen, Ottmar/0000-0002-9612-8900; Janssen, Ottmar/0000-0002-9612-8900; 	German Research Foundation (DFG) [DFG CRC 877, DFG LE2571/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	Funding for this study was provided by the German Research Foundation (DFG), www.dfg.de, DFG CRC 877 project B4 - OJ; DFG CRC 877 project A7 - DK; Individual funding DFG LE2571/3-1 - ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Aguera-Gonzales S, 2011, EUR J IMMUNOL, V41, P3667, DOI [10.1002/eji.201141645, 10.1002/eji.20114165]; Albrechtsen R, 2011, EXP CELL RES, V317, P195, DOI 10.1016/j.yexcr.2010.10.003; Aspenstrom P, 2009, INT REV CEL MOL BIO, V272, P1, DOI 10.1016/S1937-6448(08)01601-8; Baum W, 2005, J BIOL CHEM, V280, P40012, DOI 10.1074/jbc.M502222200; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Boutet P, 2009, J IMMUNOL, V182, P49, DOI 10.4049/jimmunol.182.1.49; Cao Y, 2001, BIOCHEM J, V357, P353, DOI 10.1042/0264-6021:3570353; CHARDIN P, 1995, FEBS LETT, V369, P47, DOI 10.1016/0014-5793(95)00578-W; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Cousin H, 2000, DEV BIOL, V227, P197, DOI 10.1006/dbio.2000.9871; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Ebsen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076853; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Galliano MF, 2000, J BIOL CHEM, V275, P13933, DOI 10.1074/jbc.275.18.13933; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Ghadimi MP, 2002, FEBS LETT, V519, P50, DOI 10.1016/S0014-5793(02)02709-6; Guardiola-Serrano F, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.62; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Jacob M, 2009, CELL SIGNAL, V21, P1308, DOI 10.1016/j.cellsig.2009.03.016; Kang Q, 2001, J BIOL CHEM, V276, P24466, DOI 10.1074/jbc.M101162200; Kang Q, 2000, BIOCHEM J, V352, P883, DOI 10.1042/0264-6021:3520883; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kleino I, 2009, J CELL BIOCHEM, V108, P877, DOI 10.1002/jcb.22317; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Leo A, 2002, J CLIN INVEST, V109, P301; Lettau M, 2006, P NATL ACAD SCI USA, V103, P5911, DOI 10.1073/pnas.0508562103; Lettau M, 2014, EXP CELL RES, V320, P290, DOI 10.1016/j.yexcr.2013.11.016; Lettau M, 2011, EUR J CELL BIOL, V90, P456, DOI 10.1016/j.ejcb.2010.10.006; Li BJ, 2002, J BIOL CHEM, V277, P28870, DOI 10.1074/jbc.M202388200; Lin Q, 2002, J BIOL CHEM, V277, P10134, DOI 10.1074/jbc.M110329200; Linkermann A, 2005, EXPERT OPIN THER TAR, V9, P119, DOI 10.1517/14728222.9.1.119; Lowell CA, 2011, COLD SPRING HARB PER, V3; Lua BL, 2005, J CELL SCI, V118, P2707, DOI 10.1242/jcs.02383; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Modregger J, 2000, J CELL SCI, V113, P4511; Mori S, 2003, J BIOL CHEM, V278, P46029, DOI 10.1074/jbc.M306393200; Moss ML, 1997, J NEUROIMMUNOL, V72, P127, DOI 10.1016/S0165-5728(96)00180-4; Peiretti F, 2003, J CELL SCI, V116, P1949, DOI 10.1242/jcs.00415; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Poggi M, 2013, BBA-MOL CELL RES, V1833, P602, DOI 10.1016/j.bbamcr.2012.11.009; Poghosyan Z, 2002, J BIOL CHEM, V277, P4999, DOI 10.1074/jbc.M107430200; QIAN J, 2005, SIGNAL TRANSDUCT, V5, P195; Qian J, 2006, CELL SIGNAL, V18, P1327, DOI 10.1016/j.cellsig.2005.10.015; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ritter B, 1999, FEBS LETT, V454, P356, DOI 10.1016/S0014-5793(99)00830-3; Rose-John S, 2013, PHARMACOL RES, V71, P19, DOI 10.1016/j.phrs.2013.01.012; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Sanzenbacher R, 1999, J IMMUNOL, V163, P3143; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; Stautz D, 2012, TRAFFIC, V13, P1532, DOI 10.1111/j.1600-0854.2012.01405.x; Stautz D, 2010, EXP CELL RES, V316, P55, DOI 10.1016/j.yexcr.2009.09.017; Suzuki A, 2000, ONCOGENE, V19, P5842, DOI 10.1038/sj.onc.1203986; Tanaka M, 2004, J BIOL CHEM, V279, P41950, DOI 10.1074/jbc.M400086200; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Thornhill PB, 2007, FEBS LETT, V581, P4455, DOI 10.1016/j.febslet.2007.08.025; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Voss M, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-53; Wenzel J, 2001, FEBS LETT, V509, P255, DOI 10.1016/S0014-5793(01)03174-X; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Zuccato E, 2007, J CELL SCI, V120, P191, DOI 10.1242/jcs.03315	72	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102899	10.1371/journal.pone.0102899	http://dx.doi.org/10.1371/journal.pone.0102899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036101	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200095
J	Poongavanam, V; Madala, PK; Hojland, T; Veedu, RN				Poongavanam, Vasanthanathan; Madala, Praveen K.; Hojland, Torben; Veedu, Rakesh N.			Computational Investigation of Locked Nucleic Acid (LNA) Nucleotides in the Active Sites of DNA Polymerases by Molecular Docking Simulations	PLOS ONE			English	Article							CRYSTAL-STRUCTURES; DRUG-RESISTANCE; EMERGING CLASS; APTAMERS; ANALOGS; COMPLEX; THERAPEUTICS; RECOGNITION; DIAGNOSTICS; PREDICTION	Aptamers constitute a potential class of therapeutic molecules typically selected from a large pool of oligonucleotides against a specific target. With a scope of developing unique shorter aptamers with very high biostability and affinity, locked nucleic acid (LNA) nucleotides have been investigated as a substrate for various polymerases. Various reports showed that some thermophilic B-family DNA polymerases, particularly KOD and Phusion DNA polymerases, accepted LNA-nucleoside 5'-triphosphates as substrates. In this study, we investigated the docking of LNA nucleotides in the active sites of RB69 and KOD DNA polymerases by molecular docking simulations. The study revealed that the incoming LNA-TTP is bound in the active site of the RB69 and KOD DNA polymerases in a manner similar to that seen in the case of dTTP, and with LNA structure, there is no other option than the locked C3'-endo conformation which in fact helps better orienting within the active site.	[Poongavanam, Vasanthanathan; Hojland, Torben; Veedu, Rakesh N.] Univ Southern Denmark, Nucle Acid Ctr, Odense M, Denmark; [Poongavanam, Vasanthanathan; Hojland, Torben; Veedu, Rakesh N.] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense M, Denmark; [Madala, Praveen K.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Veedu, Rakesh N.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Southern Denmark; University of Southern Denmark; University of Queensland; University of Queensland	Veedu, RN (corresponding author), Univ Southern Denmark, Nucle Acid Ctr, Odense M, Denmark.	rakesh@uq.edu.au	Poongavanam, Vasanthanathan/O-3945-2017	Poongavanam, Vasanthanathan/0000-0002-8880-9247; Hojland, Torben Rene/0000-0003-3087-4262	Nucleic Acid Center, University of Southern Denmark; University of Queensland	Nucleic Acid Center, University of Southern Denmark; University of Queensland(University of Queensland)	This work is supported by the Nucleic Acid Center, University of Southern Denmark. RNV also acknowledges the Fellowship from the University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; Bergen K, 2013, CHEMBIOCHEM, V14, P1058, DOI 10.1002/cbic.201300175; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; ChemBioDraw, PERK INF; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Filee J, 2002, J MOL EVOL, V54, P763, DOI 10.1007/s00239-001-0078-x; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gardner AF, 2004, J BIOL CHEM, V279, P11834, DOI 10.1074/jbc.M308286200; Hojland Torben, 2012, Artif DNA PNA XNA, V3, P14, DOI 10.4161/adna.19272; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jayasena SD, 1999, CLIN CHEM, V45, P1628; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kore AR, 2008, NUCLEOS NUCLEOT NUCL, V27, P1, DOI 10.1080/15257770701571693; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Kuwahara M, 2008, NUCLEIC ACIDS RES, V36, P4257, DOI 10.1093/nar/gkn404; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Obika S, 1998, TETRAHEDRON LETT, V39, P5401, DOI 10.1016/S0040-4039(98)01084-3; Petersen M, 2003, TRENDS BIOTECHNOL, V21, P74, DOI 10.1016/S0167-7799(02)00038-0; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Sarafianos SG, 1999, CHEM BIOL, V6, pR137, DOI 10.1016/S1074-5521(99)80071-4; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; STEITZ TA, 1993, CURR OPIN STRUC BIOL, V3, P31, DOI 10.1016/0959-440X(93)90198-T; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Veedu RN, 2008, J AM CHEM SOC, V130, P8124, DOI 10.1021/ja801389n; Veedu RN, 2007, NUCLEOS NUCLEOT NUCL, V26, P1207, DOI 10.1080/15257770701527844; Veedu RN, 2007, CHEMBIOCHEM, V8, P490, DOI 10.1002/cbic.200600501; Veedu RN, 2010, BIOORG MED CHEM LETT, V20, P6565, DOI 10.1016/j.bmcl.2010.09.044; Veedu RN, 2010, NEW J CHEM, V34, P877, DOI 10.1039/b9nj00628a; Veedu RN, 2010, CHEM BIODIVERS, V7, P536, DOI 10.1002/cbdv.200900343; Veedu RN, 2009, RNA BIOL, V6, P321, DOI 10.4161/rna.6.3.8807; Veedu RN, 2009, ORG BIOMOL CHEM, V7, P1404, DOI 10.1039/b819946a; Veedu RN, 2009, MOL BIOSYST, V5, P787, DOI 10.1039/b905513b; Wang J, 2001, CELL, V105, P657; Wengel J, 1999, ACCOUNTS CHEM RES, V32, P301, DOI 10.1021/ar980051p	43	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102126	10.1371/journal.pone.0102126	http://dx.doi.org/10.1371/journal.pone.0102126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036012	Green Published, gold			2022-12-25	WOS:000339615200038
J	Saldana, Z; De la Cruz, MA; Carrillo-Casas, EM; Duran, L; Zhang, YS; Hernandez-Castro, R; Puente, JL; Daaka, Y; Giron, JA				Saldana, Zeus; De la Cruz, Miguel A.; Margarita Carrillo-Casas, Erika; Duran, Laura; Zhang, Yushan; Hernandez-Castro, Rigoberto; Puente, Jose L.; Daaka, Yehia; Giron, Jorge A.			Production of the Escherichia coli Common Pilus by Uropathogenic E. coli Is Associated with Adherence to HeLa and HTB-4 Cells and Invasion of Mouse Bladder Urothelium	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; BUNDLE-FORMING PILUS; EPITHELIAL-CELLS; BIOFILM FORMATION; COLONIZATION; FIMBRIAE; ADHESION; STRAINS; K-12	Uropathogenic Escherichia coli (UPEC) strains cause urinary tract infections and employ type 1 and P pili in colonization of the bladder and kidney, respectively. Most intestinal and extra-intestinal E. coli strains produce a pilus called E. coli common pilus (ECP) involved in cell adherence and biofilm formation. However, the contribution of ECP to the interaction of UPEC with uroepithelial cells remains to be elucidated. Here, we report that prototypic UPEC strains CFT073 and F11 mutated in the major pilin structural gene ecpA are significantly deficient in adherence to cultured HeLa (cervix) and HTB-4 (bladder) epithelial cells in vitro as compared to their parental strains. Complementation of the ecpA mutant restored adherence to wild-type levels. UPEC strains produce ECP upon growth in Luria-Bertani broth or DMEM tissue culture medium preferentially at 26 degrees C, during incubation with cultured epithelial cells in vitro at 37 degrees C, and upon colonization of mouse bladder urothelium ex vivo. ECP was demonstrated on and inside exfoliated bladder epithelial cells present in the urine of urinary tract infection patients. The ability of the CFT073 ecpA mutant to invade the mouse tissue was significantly reduced. The presence of ECP correlated with the architecture of the biofilms produced by UPEC strains on inert surfaces. These data suggest that ECP can potentially be produced in the bladder environment and contribute to the adhesive and invasive capabilities of UPEC during its interaction with the host bladder. We propose that along with other known adhesins, ECP plays a synergistic role in the multi-step infection of the urinary tract.	[Saldana, Zeus; De la Cruz, Miguel A.; Duran, Laura; Giron, Jorge A.] Univ Florida, Emerging Pathogens Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA; [Zhang, Yushan; Daaka, Yehia] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL USA; [Margarita Carrillo-Casas, Erika; Hernandez-Castro, Rigoberto] Hosp Gen Dr Manuel Gea Gonzalez, Dept Ecol Agentes Patogenos, Mexico City, DF, Mexico; [Puente, Jose L.] Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidad Nacional Autonoma de Mexico	Saldana, Z (corresponding author), Univ Florida, Emerging Pathogens Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA.	jagiron@ufl.edu	Saldana, Zeus/GLR-4422-2022	Saldana, Zeus/0000-0002-2710-2846; Puente, Jose/0000-0002-8411-4974; De la Cruz, Miguel A./0000-0001-6909-2941	National Institute of Allergy and Infectious Diseases/National Institutes of Health [AI66012, AI079014]; Consejo Nacional de Ciencia y Tecnologia [154287, 87586]; Direccion General de Asuntos del Personal Academico [IN209713]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079014, R01AI066012] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases/National Institutes of Health (www.niaid.nih.gov) (AI66012 to JAG and AI079014 to YD), from the Consejo Nacional de Ciencia y Tecnologia(www.conacyt.gob.mx) (154287 to JLP and 87586 to RHC), and from Direccion General de Asuntos del Personal Academico (www.http://dgapa.unam.mx/) (IN209713 to JLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantar-Curiel MD, 2013, VIRULENCE, V4, P129, DOI 10.4161/viru.22974; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Avelino F, 2010, INT J MED MICROBIOL, V300, P440, DOI 10.1016/j.ijmm.2010.02.002; Berry RE, 2009, INFECT IMMUN, V77, P2762, DOI 10.1128/IAI.00323-09; Bishop BL, 2007, NAT MED, V13, P625, DOI 10.1038/nm1572; Blackburn D, 2009, J CLIN MICROBIOL, V47, P1781, DOI 10.1128/JCM.00260-09; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BRINTON CC, 1959, NATURE, V183, P782, DOI 10.1038/183782a0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; de Oliveira-Garcia D, 2003, CELL MICROBIOL, V5, P625, DOI 10.1046/j.1462-5822.2003.00306.x; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Garnett JA, 2012, P NATL ACAD SCI USA, V109, P3950, DOI 10.1073/pnas.1106733109; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehti TA, 2013, MOL MICROBIOL, V87, P1200, DOI 10.1111/mmi.12161; Lehti TA, 2012, MICROBIOL-SGM, V158, P1444, DOI 10.1099/mic.0.056499-0; Lehti TA, 2010, MICROBIOL-SGM, V156, P2408, DOI 10.1099/mic.0.039610-0; Martinez-Santos VI, 2012, J BACTERIOL, V194, P5020, DOI 10.1128/JB.00915-12; MCMICHAEL JC, 1979, J BACTERIOL, V138, P969, DOI 10.1128/JB.138.3.969-975.1979; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Mulvey MA, 2002, CELL MICROBIOL, V4, P257, DOI 10.1046/j.1462-5822.2002.00193.x; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Nougayrede JP, 2003, CELL MICROBIOL, V5, P359, DOI 10.1046/j.1462-5822.2003.00281.x; Pouttu R, 2001, J BACTERIOL, V183, P4727, DOI 10.1128/JB.183.16.4727-4736.2001; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329; Saldana Z, 2009, J BACTERIOL, V191, P3451, DOI 10.1128/JB.01539-08; Schilling JD, 2003, INFECT IMMUN, V71, P1470, DOI 10.1128/IAI.71.3.1470-1480.2003; Schilling Joel D, 2002, Int Rev Immunol, V21, P291, DOI 10.1080/08830180213275; Song JM, 2007, CELL HOST MICROBE, V1, P287, DOI 10.1016/j.chom.2007.05.007; STAPLETON A, 1991, J INFECT DIS, V163, P773, DOI 10.1093/infdis/163.4.773; Wang ZM, 2011, J CELL BIOL, V192, P101, DOI 10.1083/jcb.201003027; Xicohtencatl-Cortes J, 2009, J BACTERIOL, V191, P411, DOI 10.1128/JB.01306-08	37	25	25	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101200	10.1371/journal.pone.0101200	http://dx.doi.org/10.1371/journal.pone.0101200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036370	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200013
J	Wijnen, JP; Jiang, L; Greenwood, TR; van der Kemp, WJM; Klomp, DWJ; Glunde, K				Wijnen, Jannie P.; Jiang, Lu; Greenwood, Tiffany R.; van der Kemp, Wybe J. M.; Klomp, Dennis W. J.; Glunde, Kristine			H-1/P-31 Polarization Transfer at 9.4 Tesla for Improved Specificity of Detecting Phosphomonoesters and Phosphodiesters in Breast Tumor Models	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; P-31 MR SPECTROSCOPY; IN-VIVO; RELAXATION-TIMES; HUMAN BRAIN; MALIGNANT-TRANSFORMATION; PHOSPHOLIPID-METABOLISM; NMR-SPECTROSCOPY; CANCER CELLS; 7 T	Purpose: To assess the ability of a polarization transfer (PT) magnetic resonance spectroscopy (MRS) technique to improve the detection of the individual phospholipid metabolites phosphocholine (PC), phosphoethanolamine (PE), glycerophosphocholine (GPC), and glycerophosphoethanolamine (GPE) in vivo in breast tumor xenografts. Materials and Methods: The adiabatic version of refocused insensitive nuclei enhanced by polarization transfer (BINEPT) MRS was tested at 9.4 Tesla in phantoms and animal models. BINEPT and pulse-acquire (PA) P-31 MRS was acquired consecutively from the same orthotopic MCF-7 (n = 10) and MDA-MB-231 (n = 10) breast tumor xenografts. After in vivo MRS measurements, animals were euthanized, tumors were extracted and high resolution (HR)-MRS was performed. Signal to noise ratios (SNRs) and metabolite ratios were compared for BINEPT and PA MRS, and were also measured and compared with that from HR-MRS. Results: BINEPT exclusively detected metabolites with H-1-P-31 coupling such as PC, PE, GPC, and GPE, thereby creating a significantly improved, flat baseline because overlapping resonances from immobile and partly mobile phospholipids were removed without loss of sensitivity. GPE and GPC were more accurately detected by BINEPT in vivo, which enabled a reliable quantification of metabolite ratios such as PE/GPE and PC/GPC, which are important markers of tumor aggressiveness and treatment response. Conclusion: BINEPT is advantageous over PA for detecting and quantifying the individual phospholipid metabolites PC, PE, GPC, and GPE in vivo at high magnetic field strength. As BINEPT can be used clinically, alterations in these phospholipid metabolites can be assessed in vivo for cancer diagnosis and treatment monitoring.	[Wijnen, Jannie P.; Jiang, Lu; Greenwood, Tiffany R.; Glunde, Kristine] Johns Hopkins Univ, Sch Med, Vivo Cellular & Mol Imaging Ctr, Russell H Morgan Dept Radiol & Radiol Sci,Div Can, Baltimore, MD 21218 USA; [Wijnen, Jannie P.; Jiang, Lu; van der Kemp, Wybe J. M.; Klomp, Dennis W. J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Glunde, Kristine] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University; Utrecht University; Utrecht University Medical Center; Johns Hopkins University	Glunde, K (corresponding author), Johns Hopkins Univ, Sch Med, Vivo Cellular & Mol Imaging Ctr, Russell H Morgan Dept Radiol & Radiol Sci,Div Can, Baltimore, MD 21218 USA.	kglunde@mri.jhu.edu		Wijnen, Jannie/0000-0003-2352-3667; Jiang, Lu/0000-0002-8767-5742	Niels Stensen Foundation (Dutch private institute); National Institutes of Health (NIH) [R01 CA134695]; NATIONAL CANCER INSTITUTE [R01CA134695] Funding Source: NIH RePORTER	Niels Stensen Foundation (Dutch private institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge financial support from the Niels Stensen Foundation (Dutch private institute) and the National Institutes of Health (NIH) grant R01 CA134695. Both funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye EO, 1999, CANCER RES, V59, P80; Arias-Mendoza F, 2006, NMR BIOMED, V19, P504, DOI 10.1002/nbm.1057; Bathen TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061578; Bolan PJ, 2002, MAGNET RESON MED, V48, P215, DOI 10.1002/mrm.10224; BRYANT DJ, 1988, J COMPUT ASSIST TOMO, V12, P770, DOI 10.1097/00004728-198809010-00010; Cao MD, 2012, NMR BIOMED, V25, P369, DOI 10.1002/nbm.1762; CERDAN S, 1986, MAGNET RESON MED, V3, P432, DOI 10.1002/mrm.1910030308; Choi IY, 2000, MAGNET RESON MED, V44, P387, DOI 10.1002/1522-2594(200009)44:3<387::AID-MRM8>3.0.CO;2-3; Cudalbu C, 2009, MAGN RESON MED, V62, P862, DOI 10.1002/mrm.22022; De Graaf R.A, 2008, VIVO NMR SPECTROSCOP, VSecond; de Haan JH, 2003, MAGNET RESON MED, V50, P1302, DOI 10.1002/mrm.10630; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; DODD NJF, 1989, BRIT J CANCER, V60, P164, DOI 10.1038/bjc.1989.244; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Glunde K, 2005, CANCER RES, V65, P11034, DOI 10.1158/0008-5472.CAN-05-1807; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Gonen O, 1997, MAGNET RESON MED, V37, P301, DOI 10.1002/mrm.1910370228; Haddadin IS, 2009, NMR BIOMED, V22, P65, DOI 10.1002/nbm.1217; Jiang L, 2012, NEOPLASIA, V14, P732, DOI 10.1593/neo.12858; KALRA R, 1993, BRIT J CANCER, V67, P1145, DOI 10.1038/bjc.1993.211; Klomp DWJ, 2008, MAGN RESON MED, V60, P1298, DOI 10.1002/mrm.21733; Klomp DWJ, 2011, NMR BIOMED, V24, P1337, DOI 10.1002/nbm.1696; Lagemaat MW, 2013, INT SOC MAGN RES MED; Leach MO, 1998, NMR BIOMED, V11, P314, DOI 10.1002/(SICI)1099-1492(1998110)11:7<314::AID-NBM522>3.0.CO;2-Z; Mancini L, 2005, MAGN RESON MED, V54, P1065, DOI 10.1002/mrm.20659; Mancini L, 2003, MAGNET RESON MED, V50, P578, DOI 10.1002/mrm.10551; Marjanska M, 2012, NMR BIOMED, V25, P332, DOI 10.1002/nbm.1754; Meisamy S, 2005, RADIOLOGY, V236, P465, DOI 10.1148/radiol.2362040836; Morse DL, 2009, NMR BIOMED, V22, P114, DOI 10.1002/nbm.1318; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; NEGENDANK W, 1992, NMR BIOMED, V5, P303, DOI 10.1002/nbm.1940050518; OSBAKKEN MD, 1986, MAGNET RESON MED, V3, P1, DOI 10.1002/mrm.1910030102; REDMOND OM, 1992, MAGNET RESON MED, V25, P30, DOI 10.1002/mrm.1910250104; Schiller J, 2002, MED SCI MONITOR INT, V8, pMT205; SMITH TAD, 1993, NMR BIOMED, V6, P318, DOI 10.1002/nbm.1940060506; SMITH TAD, 1991, BRIT J CANCER, V63, P514, DOI 10.1038/bjc.1991.122; Solivera J, 2009, NMR BIOMED, V22, P663, DOI 10.1002/nbm.1387; Stehouwer BL, 2014, BREAST CANCER RES TR, V144, P583, DOI 10.1007/s10549-014-2889-7; Tyagi RK, 1996, MAGN RESON MED, V35, P194, DOI 10.1002/mrm.1910350210; van der Kemp WJM, 2013, NMR BIOMED, V26, P1299, DOI 10.1002/nbm.2952; van der Kemp WJM, 2012, MAGN RESON MED, V68, P353, DOI 10.1002/mrm.23260; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wijnen JP, 2010, NMR BIOMED, V23, P968, DOI 10.1002/nbm.1523; Wijnen JP, 2012, MAGN RESON MED, V68, P339, DOI 10.1002/mrm.23249; Xin L, 2012, MAGNETIC RESONANCE M	46	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102256	10.1371/journal.pone.0102256	http://dx.doi.org/10.1371/journal.pone.0102256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036036	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200045
J	Gonzalez-Bernal, E; Brown, GP; Shine, R				Gonzalez-Bernal, Edna; Brown, Gregory P.; Shine, Richard			Invasive Cane Toads: Social Facilitation Depends upon an Individual's Personality	PLOS ONE			English	Article							RISK-TAKING BEHAVIOR; BUFO-MARINUS; FORAGING SUCCESS; TRADE-OFFS; DISPERSAL; BOLDNESS; POPULATIONS; AGGRESSION; TRAITS; EVOLUTION	Individual variation in behavioural traits (including responses to social cues) may influence the success of invasive populations. We studied the relationship between sociality and personality in invasive cane toads (Rhinella marina) from a recently established population in tropical Australia. In our field experiments, we manipulated social cues (the presence of a feeding conspecific) near a food source. We captured and compared toads that only approached feeding sites where another toad was already present, with conspecifics that approached unoccupied feeding sites. Subsequent laboratory trials showed correlated personality differences (behavioural syndromes) between these two groups of toads. For example, toads that approached already-occupied rather than unoccupied feeding sites in the field, took longer to emerge from a shelter-site in standardized trials, suggesting these individuals are 'shy' (whereas toads that approached unoccupied feeding stations tended to be 'bold'). Manipulating hunger levels did not abolish this difference. In feeding trials, a bold toad typically outcompeted a shy toad under conditions of low prey availability, but the outcome was reversed when multiple prey items were present. Thus, both personality types may be favored under different circumstances. This invasive population of toads contains individuals that exhibit a range of personalities, hinting at the existence of a wide range of social dynamics in taxa traditionally considered to be asocial.	[Gonzalez-Bernal, Edna; Brown, Gregory P.; Shine, Richard] Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia	University of Sydney	Gonzalez-Bernal, E (corresponding author), Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia.	ednagbernal@gmail.com	Brown, Gregory P./F-9897-2011; González-Bernal, Edna/AAH-9372-2021	Brown, Gregory P./0000-0002-2924-9040; Gonzalez-Bernal, Edna/0000-0001-7817-4156	Australian Research Council [FF561365]; Mexican National Science and Technology Council (CONACyT); University of Sydney	Australian Research Council(Australian Research Council); Mexican National Science and Technology Council (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Sydney(University of Sydney)	The work was funded by the Australian Research Council (grant number FF561365), the Mexican National Science and Technology Council (CONACyT) and the University of Sydney. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018277; Beauchamp G, 2000, BEHAVIOUR, V137, P301, DOI 10.1163/156853900502097; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Biro PA, 2006, J ANIM ECOL, V75, P1165, DOI 10.1111/j.1365-2656.2006.01137.x; Blackburn Tim, 2009, pi; Bowcock H, 2008, ANIM BEHAV, V75, P1571, DOI 10.1016/j.anbehav.2007.10.011; Brown C, 2005, ANIM BEHAV, V70, P1003, DOI 10.1016/j.anbehav.2004.12.022; Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; Brown GP, 2006, BIOL CONSERV, V133, P88, DOI 10.1016/j.biocon.2006.05.020; Cervantes MC, 2007, NEUROSCIENCE, V150, P511, DOI 10.1016/j.neuroscience.2007.09.034; Chapple DG, 2012, TRENDS ECOL EVOL, V27, P57, DOI 10.1016/j.tree.2011.09.010; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Cote J, 2011, P ROY SOC B-BIOL SCI, V278, P1670, DOI 10.1098/rspb.2010.1892; Cote J, 2010, P ROY SOC B-BIOL SCI, V277, P1571, DOI 10.1098/rspb.2009.2128; Damsgard B, 1998, BEHAV ECOL, V9, P26, DOI 10.1093/beheco/9.1.26; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Duckworth RA, 2007, P NATL ACAD SCI USA, V104, P15017, DOI 10.1073/pnas.0706174104; Dyer JRG, 2009, BEHAV ECOL, V20, P165, DOI 10.1093/beheco/arn129; Fernandez-Juricic E, 2004, BEHAV ECOL SOCIOBIOL, V55, P502, DOI 10.1007/s00265-003-0698-9; Fogarty S, 2011, AM NAT, V177, P273, DOI 10.1086/658174; FREELAND WJ, 1986, AUST WILDLIFE RES, V13, P321, DOI 10.1071/WR9860321; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Gonzalez-Bernal E, 2011, BEHAV ECOL SOCIOBIOL, V65, P1367, DOI 10.1007/s00265-011-1147-9; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hedrick AV, 2000, P ROY SOC B-BIOL SCI, V267, P671, DOI 10.1098/rspb.2000.1054; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Koolhaas JM, 2007, BRAIN BEHAV EVOLUT, V70, P218, DOI 10.1159/000105485; Kurvers RHJM, 2010, ECOL LETT, V13, P829, DOI 10.1111/j.1461-0248.2010.01473.x; Kurvers RHJM, 2010, P ROY SOC B-BIOL SCI, V277, P601, DOI 10.1098/rspb.2009.1474; Lampo M, 1998, ECOL APPL, V8, P388, DOI 10.2307/2641079; LEVER C., 2001, CANE TOAD HIST ECOLO; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Pintor LM, 2008, OIKOS, V117, P1629, DOI 10.1111/j.1600-0706.2008.16578.x; Pintor LM, 2009, ECOLOGY, V90, P581, DOI 10.1890/08-0552.1; R Core Team, 2021, R LANG ENV STAT COMP; Rehage JS, 2004, BIOL INVASIONS, V6, P379, DOI 10.1023/B:BINV.0000034618.93140.a5; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Short KH, 2008, ANIM BEHAV, V76, P429, DOI 10.1016/j.anbehav.2008.04.008; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Trompf L, 2014, ANIM BEHAV, V88, P99, DOI 10.1016/j.anbehav.2013.11.022; Urban MC, 2008, AM NAT, V171, pE134, DOI 10.1086/527494; van Oers K, 2005, BEHAV ECOL, V16, P716, DOI 10.1093/beheco/ari045; Veenema AH, 2005, PSYCHOPHARMACOLOGY, V178, P151, DOI 10.1007/s00213-004-2005-5; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; ZUG G.R., 1979, SMITHSON CONTRIB ZOO, V284, P1	50	24	25	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102880	10.1371/journal.pone.0102880	http://dx.doi.org/10.1371/journal.pone.0102880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033047	Green Submitted, Green Published, gold			2022-12-25	WOS:000339418300106
J	Roschanski, N; Fischer, J; Guerra, B; Roesler, U				Roschanski, Nicole; Fischer, Jennie; Guerra, Beatriz; Roesler, Uwe			Development of a Multiplex Real-Time PCR for the Rapid Detection of the Predominant Beta-Lactamase Genes CTX-M, SHV, TEM and CIT-Type AmpCs in Enterobacteriaceae	PLOS ONE			English	Article							ESCHERICHIA-COLI; PUBLIC-HEALTH; ANTIMICROBIAL RESISTANCE; ANIMALS; EPIDEMIOLOGY; PERSPECTIVE; STRAINS; FRANCE; FOOD	Beta-lactamase resistant bacteria and especially ESBL producing Enterobacteriaceae are an increasing problem worldwide. For this reason a major interest in efficient and reliable methods for rapid screening of high sample numbers is recognizable. Therefore, a multiplex real-time PCR was developed to detect the predominant class A beta-lactamase genes bla(CTX-M), bla(SHV), bla(TEM) and CIT-type AmpCs in a one-step reaction. A set of 114 Enterobacteriaceae containing previously identified resistance gene subtypes and in addition 20 undefined animal and environmental isolates were used for the validation of this assay. To confirm the accessibility in variable settings, the real-time runs were performed analogous in two different laboratories using different real-time cyclers. The obtained results showed complete accordance between the real-time data and the predetermined genotypes. Even if sequence analyses are further necessary for a comprehensive characterization, this method was proofed to be reliable for rapid screening of high sample numbers and therefore could be an important tool for e.g. epidemiological purposes or support infection control measures.	[Roschanski, Nicole; Roesler, Uwe] Free Univ Berlin, Inst Anim Hyg & Environm Hlth, Berlin, Germany; [Fischer, Jennie; Guerra, Beatriz] Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany	Free University of Berlin; Federal Institute for Risk Assessment	Roschanski, N (corresponding author), Free Univ Berlin, Inst Anim Hyg & Environm Hlth, Berlin, Germany.	nicole.roschanski@fu-berlin.de			German Federal Ministry of Education and Research [FKZ01Kl1013C, FKZ01Kl1013B]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was performed within the scope of the Research consortium RESET (http://www.reset-verbund.de/); funded by the German Federal Ministry of Education and Research; funding number FKZ01Kl1013C to UR and FKZ01Kl1013B to BG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Carattoli A, 2008, J CLIN MICROBIOL, V46, P103, DOI 10.1128/JCM.01542-07; Chia JH, 2005, J CLIN MICROBIOL, V43, P4486, DOI 10.1128/JCM.43.9.4486-4491.2005; CLSI, 2012, PERF STAND ANT SUSC; EFSA, 2012, EFSA J, V10; European Food Safety Authority (EFSA), 1975, EFSA J, V9; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Fluit AC, 2001, CLIN MICROBIOL REV, V14, P836, DOI 10.1128/CMR.14.4.836-871.2001; Hartmann A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00083; Helfand Marion S., 2003, Current Drug Targets - Infectious Disorders, V3, P9, DOI 10.2174/1568005033342181; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kojima A, 2005, ANTIMICROB AGENTS CH, V49, P3533, DOI 10.1128/AAC.49.8.3533-3537.2005; Leclercq R, 2013, Clin Microbiol Infect, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Lupo A, 2013, DIAGN MICR INFEC DIS, V77, P179, DOI 10.1016/j.diagmicrobio.2013.06.001; Naas T, 2007, ANTIMICROB AGENTS CH, V51, P223, DOI 10.1128/AAC.00611-06; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poirel L, 2012, INFECT GENET EVOL, V12, P883, DOI 10.1016/j.meegid.2012.02.008; Polsfuss S, 2011, J CLIN MICROBIOL, V49, P2798, DOI 10.1128/JCM.00404-11; Randegger CC, 2001, ANTIMICROB AGENTS CH, V45, P1730, DOI 10.1128/AAC.45.6.1730-1736.2001; Weill FX, 2004, J CLIN MICROBIOL, V42, P2432, DOI 10.1128/JCM.42.6.2432-2437.2004; WHO, 2011, CRIT IMP ANT HUM MED; Woodford N, 2007, J ANTIMICROB CHEMOTH, V59, P102, DOI 10.1093/jac/dkl456	27	118	121	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100956	10.1371/journal.pone.0100956	http://dx.doi.org/10.1371/journal.pone.0100956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033234	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300011
J	Bundela, S; Sharma, A; Bisen, PS				Bundela, Saurabh; Sharma, Anjana; Bisen, Prakash S.			Potential Therapeutic Targets for Oral Cancer: ADM, TP53, EGFR, LYN, CTLA4, SKIL, CTGF, CD70	PLOS ONE			English	Article							EXPRESSION; RESISTANCE; THERAPIES; GENES	In India, oral cancer has consistently ranked among top three causes of cancer-related deaths, and it has emerged as a top cause for the cancer-related deaths among men. Lack of effective therapeutic options is one of the main challenges in clinical management of oral cancer patients. We interrogated large pool of samples from oral cancer gene expression studies to identify potential therapeutic targets that are involved in multiple cancer hallmark events. Therapeutic strategies directed towards such targets can be expected to effectively control cancer cells. Datasets from different gene expression studies were integrated by removing batch-effects and was used for downstream analyses, including differential expression analysis. Dependency network analysis was done to identify genes that undergo marked topological changes in oral cancer samples when compared with control samples. Causal reasoning analysis was carried out to identify significant hypotheses, which can explain gene expression profiles observed in oral cancer samples. Text-mining based approach was used to detect cancer hallmarks associated with genes significantly expressed in oral cancer. In all, 2365 genes were detected to be differentially expressed genes, which includes some of the highly differentially expressed genes like matrix metalloproteinases (MMP-1/3/10/13), chemokine (C-X-C motif) ligands (IL8, CXCL-10/-11), PTHLH, SERPINE1, NELL2, S100A7A, MAL, CRNN, TGM3, CLCA4, keratins (KRT-3/4/13/76/78), SERPINB11 and serine peptidase inhibitors (SPINK-5/7). XIST, TCEAL2, NRAS and FGFR2 are some of the important genes detected by dependency and causal network analysis. Literature mining analysis annotated 1014 genes, out of which 841 genes were statistically significantly annotated. The integration of output of various analyses, resulted in the list of potential therapeutic targets for oral cancer, which included targets such as ADM, TP53, EGFR, LYN, CTLA4, SKIL, CTGF and CD70.	[Bundela, Saurabh; Bisen, Prakash S.] Govt India, Def Res Dev Estab, Def Res Dev Org, Minist Def, Gwalior, Madhya Pradesh, India; [Bundela, Saurabh; Sharma, Anjana] Rani Durgavati Univ, Dept Postgrad Studies & Res Biol Sci, Jabalpur 482001, Madhya Pradesh, India; [Bisen, Prakash S.] Jiwaji Univ, Sch Studies Biotechnol, Gwalior, Madhya Pradesh, India	Defence Research & Development Organisation (DRDO); Defence Research & Development Establishment (DRDE); Jiwaji University Gwalior	Bisen, PS (corresponding author), Govt India, Def Res Dev Estab, Def Res Dev Org, Minist Def, Gwalior, Madhya Pradesh, India.	psbisen@gmail.com	Bisen, Prakash S/H-3392-2019	Bisen, Prakash S/0000-0002-2818-7829	Council of Scientific and Industrial Research (CSIR), New Delhi under Emeritus Scientist scheme	Council of Scientific and Industrial Research (CSIR), New Delhi under Emeritus Scientist scheme	Financial assistance was awarded by the Council of Scientific and Industrial Research (CSIR), New Delhi under Emeritus Scientist scheme to Professor P.S. Bisen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambatipudi S, 2012, GENE CHROMOSOME CANC, V51, P161, DOI 10.1002/gcc.20940; Awada A, 2013, CURR OPIN ONCOL, V25, P296, DOI 10.1097/CCO.0b013e32835ff318; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisen P.S., 2013, BIOL ORAL CANC KEY A; Bonferroni CE, 1935, STUDI ONORE PROFESSO, P13; Bonferroni CE, 1936, PUBBLICAZIONI R I SU, V8, P3; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Chindelevitch L, 2012, BIOINFORMATICS, V28, P1114, DOI 10.1093/bioinformatics/bts090; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Ding J, 2002, Pac Symp Biocomput, P326; Ellis LM, 2009, CLIN CANCER RES, V15, P7471, DOI 10.1158/1078-0432.CCR-09-1070; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fisher R., 1970, STAT METHODS RES WOR; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoaglin D. C, 2000, UNDERSTANDING ROBUST; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Lackner MR, 2012, FUTURE ONCOL, V8, P999, DOI [10.2217/fon.12.86, 10.2217/FON.12.86]; Mittal AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070352; Pearson H, 2001, NATURE, V411, P631, DOI 10.1038/35079694; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Raffoul F, 2010, AUTOPHAGY, V6, P955, DOI 10.4161/auto.6.7.13041; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rudy J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-467; Sayers E, 2014, NCBI SHORT COURSES; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Shabalin AA, 2008, BIOINFORMATICS, V24, P1154, DOI 10.1093/bioinformatics/btn083; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Turnbull AK, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-35; Warnes GR, 2006, SAMPLE SIZE ESTIMATI; Wheeler SE, 2012, CLIN CANCER RES, V18, P2850, DOI 10.1158/1078-0432.CCR-11-2486; Xu C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-143; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	39	24	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102610	10.1371/journal.pone.0102610	http://dx.doi.org/10.1371/journal.pone.0102610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029526	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600087
J	Yang, H; Li, YM; Wu, W; Sun, QW; Zhang, YZ; Zhao, W; Lv, HB; Xia, Q; Hu, PJ; Li, HH; Qian, JM				Yang, Hong; Li, Yumei; Wu, Wei; Sun, Qingwen; Zhang, Yunzhong; Zhao, Wei; Lv, Hongbo; Xia, Qing; Hu, Pinjin; Li, Haihua; Qian, Jiaming			The Incidence of Inflammatory Bowel Disease in Northern China: A Prospective Population-Based Study	PLOS ONE			English	Article							CROHNS-DISEASE; EPIDEMIOLOGY; PREVALENCE	Aims & Backgrounds: Although inflammatory bowel diseases (IBD) are emerging and increasing in China, epidemiologic data are rarely available. This study was to investigate the epidemiological and clinical characteristics of IBD in Northern China. Methods: This is a prospective, population-based study of incidence of IBD in Daqing, Heilongjiang province of Northern China from March 1, 2012 to February 28, 2013. All incident patients with IBD were clinically identified by IBD specialist group from five main General Hospitals covering the healthcare service for 1,343,364 residents in the urban areas of Daqing. IBD cases included in this study were followed-up for three months for diagnosis confirmation. Results: A total of 27 new IBD cases including 25 cases of ulcerative colitis (UC) and 2 cases of Crohn's disease (CD) were identified. The population at risk was 1,343,364 person years. Age-adjusted incidence for total IBD, CD and UC were 1.77, 0.13, and 1.64 per 100,000population, respectively. A male predominance was found in CD patients (male to female ratio was 2: 0). In contrast, no obvious gender predominance was found in UC patients (male to female ratio was 1:1.1). CD patients were diagnosed at an average age of 39.5 years. The main disease phenotypes of UC were distal colitis with a 24% of proctitis and 56% of left-sided colitis. The mean diagnostic age of UC patients was 48.9 years. Conclusions: This is the first report on the incidence of IBD in the Northern Chinese population. A lower incidence of IBD, similar male predominance for CD, similar disease phenotype of UC, and lower disease activity was observed in Daqing compared to that in Southern China.	[Yang, Hong; Qian, Jiaming] Beijing Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Li, Yumei; Sun, Qingwen; Lv, Hongbo; Xia, Qing; Li, Haihua] Daqing Longnan Hosp, Dept Gastroenterol, Daqing, Peoples R China; [Wu, Wei] Daqing Oilfield Gen Hosp, Dept Gastroenterol, Daqing, Peoples R China; [Zhang, Yunzhong] Daqing People Hosp, Dept Gastroenterol, Daqing, Peoples R China; [Zhao, Wei] Daqing Fourth Hosp, Dept Gastroenterol, Daqing, Peoples R China; [Hu, Pinjin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Sun Yat Sen University	Qian, JM (corresponding author), Beijing Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China.	qianjiaming1957@126.com			Health Research & Special Projects Grant [201002020]	Health Research & Special Projects Grant	This study was supported by Health Research & Special Projects Grant(No. 201002020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein CN, 2006, AM J GASTROENTEROL, V101, P1559, DOI 10.1111/j.1572-0241.2006.00603.x; Green C, 2006, AM J EPIDEMIOL, V164, P615, DOI 10.1093/aje/kwj260; HARVEY RF, 1980, LANCET, V1, P514; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P6102, DOI 10.3748/wjg.v12.i38.6102; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Ananthakrishnan Ashwin N, 2013, Gastroenterol Hepatol (N Y), V9, P367; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Prideaux L, 2012, J GASTROEN HEPATOL, V27, P1266, DOI 10.1111/j.1440-1746.2012.07150.x; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Zeng ZR, 2013, J GASTROEN HEPATOL, V28, P1148, DOI 10.1111/jgh.12164; Zhao J, 2013, INFLAMM BOWEL DIS, V19, P1839, DOI 10.1097/MIB.0b013e31828a6551	13	53	80	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101296	10.1371/journal.pone.0101296	http://dx.doi.org/10.1371/journal.pone.0101296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029440	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600013
J	Dezzutti, CS; Russo, J; Wang, L; Abebe, KZ; Li, J; Friend, DR; McGowan, IM; Rohan, LC				Dezzutti, Charlene S.; Russo, Julie; Wang, Lin; Abebe, Kaleab Z.; Li, Jie; Friend, David R.; McGowan, Ian M.; Rohan, Lisa C.			Development of HIV-1 Rectal-Specific Microbicides and Colonic Tissue Evaluation	PLOS ONE			English	Article							CD4(+) T-CELLS; VAGINAL GEL; IMMUNODEFICIENCY-VIRUS; TOPICAL MICROBICIDES; IN-VITRO; EX-VIVO; LYMPHOID FOLLICLES; CONTROLLED-TRIAL; UNITED-STATES; DC-SIGN	The gastrointestinal tract is structurally and functionally different from the vagina. Thus, the paradigm of topical microbicide development and evaluation has evolved to include rectal microbicides (RMs). Our interest was to create unique RM formulations to safely and effectively deliver antiretroviral drugs to mucosal tissue. RMs were designed to include those that spread and coat all surfaces of the rectum and distal colon rapidly (liquid) and those that create a deformable, erodible barrier and remain localized at the administration site (gel). Tenofovir (TFV) (1%) was formulated as an aqueous thermoreversible fluid and a carbopol-based aqueous hydrogel. Lipid-based liquid and gel formulations were prepared for UC781 (0.1%) using isopropyl myristate and GTCC (Caprylic/Capric Triglycerides), respectively. Formulations were characterized for pH, viscosity, osmolality, and drug content. Pre-clinical testing incorporated ex vivo colonic tissue obtained through surgical resections and flexible sigmoidoscopy (flex sig). As this was the first time using tissue from both sources side-by-side, the ability to replicate HIV-1 was compared. Efficacy of the RM formulations was tested by applying the products with HIV-1 directly to polarized colonic tissue and following viral replication. Safety of the formulations was determined by MTT assay and histology. All products had a neutral pH and were isoosmolar. While HIV-1(BaL) and HIV-1(JR-CSF) alone and in the presence of semen had similar replication trends between surgically resected and flex sig tissues, the magnitude of viral replication was significantly better in flex sig tissues. Both TFV and UC781 formulations protected the colonic tissue, regardless of tissue source, from HIV-1 and retained tissue viability and architecture. Our in vitro and ex vivo results show successful formulation of unique RMs. Moreover, the results of flex sig and surgically resected tissues were comparable suggesting the incorporation of both in pre-clinical testing algorithms.	[Dezzutti, Charlene S.; Russo, Julie; Wang, Lin; McGowan, Ian M.; Rohan, Lisa C.] Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Dezzutti, Charlene S.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Abebe, Kaleab Z.; Li, Jie] Univ Pittsburgh, Dept Med, Div Gen Internal Med, Pittsburgh, PA USA; [Friend, David R.] CONRAD, Arlington, VA USA; [McGowan, Ian M.] Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Rohan, Lisa C.] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dezzutti, CS (corresponding author), Magee Womens Res Inst, Pittsburgh, PA 15213 USA.	cdezzutti@mwri.magee.edu	M, Ian/AAP-1032-2021; M, i/HCI-9242-2022; Abebe, Kaleab/K-4400-2019	M, Ian/0000-0002-6470-8476; Abebe, Kaleab/0000-0002-3644-8419; Dezzutti, Charlene/0000-0001-5902-5841	U.S. National Institutes of Health (NIH), Division of AIDS - Combination HIV Antiviral Rectal Microbicide (CHARM) Program [U19 AI082637]; amfAR [106749-41-RGMC]; U.S. NIH; National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Development; National Institute of Mental Health - the Microbicide Trials Network [UM1 AI068633, UM1 AI106707]; CONRAD; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082637, UM1AI106707, UM1AI068633] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), Division of AIDS - Combination HIV Antiviral Rectal Microbicide (CHARM) Program; amfAR; U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health - the Microbicide Trials Network; CONRAD(United States Agency for International Development (USAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. National Institutes of Health (NIH), Division of AIDS - Combination HIV Antiviral Rectal Microbicide (CHARM) Program (U19 AI082637), to CSD, LCR, DF, and IMM. Additional funding was from amfAR (#106749-41-RGMC) to CSD and from the U.S. NIH, the National Institute of Allergy and Infectious Diseases, the National Institute of Child Health and Development, and the National Institute of Mental Health - the Microbicide Trials Network (UM1 AI068633 and UM1 AI106707) to CSD, LCR, and IMM. Co-author, David R. Friend, is an employee of CONRAD which provided the drug substance used for manufacture of the rectal microbicide gels. CONRAD is also holder of the IND for the vaginal TFV 1% gel that is in clinical trial and provided the salary for author DRF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; Anderson DJ, 2010, AIDS, V24, P1, DOI 10.1097/QAD.0b013e328333acfb; [Anonymous], 2011, GLOB HIV AIDS RESP; Anton PA, 2012, AIDS RES HUM RETROV, V28, P1412, DOI [10.1089/aid.2012.0262, 10.1089/AID.2012.0262]; Anton PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023243; Balandya E, 2010, J IMMUNOL, V185, P7596, DOI 10.4049/jimmunol.1002846; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, CLIN INFECT DIS, V50, pS108, DOI 10.1086/651481; Buckheit RW, 2012, CURR HIV RES, V10, P97, DOI 10.2174/157016212799304698; Denison FC, 1999, MOL HUM REPROD, V5, P220, DOI 10.1093/molehr/5.3.220; Dezzutti CS, 2013, CURR HIV-AIDS REP, V10, P12, DOI 10.1007/s11904-012-0148-2; Dezzutti CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048328; El-Sadr WM, 2010, NEW ENGL J MED, V362, P967, DOI 10.1056/NEJMp1000069; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Fletcher PS, 2006, AIDS, V20, P1237, DOI 10.1097/01.aids.0000232230.96134.80; Fuchs EJ, 2007, J INFECT DIS, V195, P703, DOI 10.1086/511279; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gorbach PM, 2009, SEX TRANSM DIS, V36, P193, DOI 10.1097/OLQ.0b013e3181901ccf; Grivel JC, 2007, AIDS, V21, P1263, DOI 10.1097/QAD.0b013e3281864667; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784; Herbenick D, 2010, J SEX MED, V7, P255, DOI 10.1111/j.1743-6109.2010.02012.x; Herrera C, 2009, ANTIMICROB AGENTS CH, V53, P1797, DOI 10.1128/AAC.01096-08; Introini A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003148; Kalichman SC, 2009, SEX TRANSM INFECT, V85, P411, DOI 10.1136/sti.2008.035287; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Koboziev I, 2010, ANN NY ACAD SCI, V1207, pE86, DOI 10.1111/j.1749-6632.2010.05711.x; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; Lackman-Smith CS, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-22; LANGMAN JM, 1992, J CLIN GASTROENTEROL, V14, P81; LANGMAN JM, 1986, J ANAT, V149, P189; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Martellini JA, 2009, FASEB J, V23, P3609, DOI 10.1096/fj.09-131961; Mayer KH, 2006, AIDS, V20, P543, DOI 10.1097/01.aids.0000210608.70762.c3; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; OCONNOR TJ, 1995, INT J STD AIDS, V6, P267, DOI 10.1177/095646249500600409; Politch JA, 2007, HUM REPROD, V22, P2928, DOI 10.1093/humrep/dem281; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Sabatte J, 2007, J VIROL, V81, P13723, DOI 10.1128/JVI.01079-07; Schwartz JL, 2008, SEX TRANSM DIS, V35, P414, DOI 10.1097/OLQ.0b013e318162c4d8; Stax MJ, 2009, VIROLOGY, V391, P203, DOI 10.1016/j.virol.2009.06.011; STEIN ZA, 1990, AM J PUBLIC HEALTH, V80, P460, DOI 10.2105/AJPH.80.4.460; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Wang L, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-12; WOLTERSEVERHARDT E, 1986, FERTIL STERIL, V46, P114; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	55	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102585	10.1371/journal.pone.0102585	http://dx.doi.org/10.1371/journal.pone.0102585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025306	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400091
J	Wang, S; Dong, Y; Zhang, Y; Wang, X; Xu, L; Yang, S; Li, X; Dong, H; Xu, L; Su, L; Ng, SSM; Chang, Z; Sung, JJ; Zhang, X; Yu, J				Wang, S.; Dong, Y.; Zhang, Y.; Wang, X.; Xu, L.; Yang, S.; Li, X.; Dong, H.; Xu, L.; Su, L.; Ng, S. S. M.; Chang, Z.; Sung, J. J.; Zhang, X.; Yu, J.			DACT2 is a functional tumor suppressor through inhibiting Wnt/beta-catenin pathway and associated with poor survival in colon cancer	ONCOGENE			English	Article							BETA-CATENIN; COLORECTAL-CANCER; SIGNALING-PATHWAY; WNT; EPIGENETICS; ROLES; TRANSCRIPTION; MECHANISMS; PROTEINS; DAPPER	Dapper homolog (DACT) 2 is one of the Dact gene family members, which are important modulators of Wnt signaling pathway. We aim to clarify its epigenetic inactivation, biological function and clinical implication in colon cancer. DACT2 was silenced in five out of eight colon cancer cell lines, but robustly expressed in normal colon tissues. The loss of DACT2 expression was regulated by promoter hypermethylation. Restoring DACT2 expression in colon cancer cell lines suppressed tumor cell growth by inducing cell apoptosis and inhibiting cell proliferation both in vitro and in vivo. Moreover, DACT2 overexpression effectively reduced lung metastasis of colon cancer cells in nude mice. These effects by DACT2 were attributed to inhibition of Wnt/beta-catenin signaling. Reexpression of DACT2 significantly suppressed the transcriptional activity of both wild-type beta-catenin and degradation-resistant form mutant beta-catenin (S33Y). DACT2 could actively shuttle into and out of nuclei, with its predominant steady-state localization in the cytoplasm dependent on its nuclear export signal. Co-immunoprecipitation results indicated that DACT2 strongly associated beta-catenin as well as lymphoid enhancer-binding factor 1 (LEF1) and directly disrupted the formation of the beta-catenin-LEF1 complex in the nucleus. Whereas in the cytoplasm, DACT2 restored junctional localization of E-cadherin-beta-catenin complexes and prevented beta-catenin nuclear translocation through direct interaction with beta-catenin. DACT2 methylation was detected in 43.3% (29/67) of colon cancer tissues, but none in normal controls. Multivariate analysis revealed that patients with DACT2 methylation had a significant decrease in overall survival (P = 0.006). Kaplan-Meier survival curves showed that DACT2 methylation was significantly associated with shortened survival in stage I-III colon cancer patients. In conclusion, DACT2 acts as a functional tumor suppressor in colon cancer through inhibiting Wnt/beta-catenin signaling. Its methylation at early stages of colon carcinogenesis is an independent prognostic factor.	[Wang, S.; Dong, H.; Xu, L.; Su, L.; Zhang, X.] Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Res Ctr Bioengn & Sensing Technol, Beijing 100083, Peoples R China; [Wang, S.; Dong, Y.; Wang, X.; Xu, L.; Li, X.; Sung, J. J.; Yu, J.] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, Inst Digest Dis,Dept Med & Therapeut,State Key La, Shatin, Hong Kong, Peoples R China; [Dong, Y.; Ng, S. S. M.] Chinese Univ Hong Kong, Dept Surg, Shatin, Hong Kong, Peoples R China; [Zhang, Y.; Yang, S.; Chang, Z.] Tsinghua Univ, Sch Life Sci, Sch Med, State Key Lab Biomembrane & Membrane Biotechnol,N, Beijing 100084, Peoples R China	University of Science & Technology Beijing; Chinese University of Hong Kong; Chinese University of Hong Kong; Tsinghua University	Yu, J (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Inst Digest Dis, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	zhangxueji@ustb.edu.cn; junyu@cuhk.edu.hk	Zhang, Yanquan/D-5615-2017; zhang, xueji/ABE-6497-2020; Yu, Jun/D-8569-2015; Sung, Joseph J. Y./R-3203-2018; Li, Xiao-xing/B-9114-2008; Ng, Simon S. M./M-1219-2018; Chang, Zhijie/AAH-8109-2019	Zhang, Yanquan/0000-0003-3527-9972; zhang, xueji/0000-0002-0035-3821; Yu, Jun/0000-0001-5008-2153; Sung, Joseph J. Y./0000-0003-3125-5199; Li, Xiao-xing/0000-0001-8791-7505; Ng, Simon S. M./0000-0002-5389-9297; Hou, Jian/0000-0003-1590-4013; Chang, Zhijie/0000-0003-1567-3227	Postdoctoral Special Foundation [2012M510317]; National Natural Science Foundation of China [81301775]; Chinese Central Universities Funds [FRF-TP-12-172A]; 863 Program China [2012AA02A506]; 973 Program China [2013CB531401]; Technology and Innovation Project Fund Shenzhen [JSGG20130412171021059]	Postdoctoral Special Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Central Universities Funds; 863 Program China(National High Technology Research and Development Program of China); 973 Program China(National Basic Research Program of China); Technology and Innovation Project Fund Shenzhen	This project was supported by Postdoctoral Special Foundation (2012M510317), National Natural Science Foundation of China (81301775), the Chinese Central Universities Funds (FRF-TP-12-172A), National Natural Science Foundation of China (81301775), 863 Program China (2012AA02A506), 973 Program China (2013CB531401) and Technology and Innovation Project Fund Shenzhen (JSGG20130412171021059).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Brott BK, 2005, DIFFERENTIATION, V73, P323, DOI 10.1111/j.1432-0436.2005.00032.x; Cadigan K.M., 2012, COLD SPRING HARB PER, V4; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; Choi SW, 2010, ADV NUTR, V1, P8, DOI 10.3945/an.110.1004; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hsieh CJ, 1998, CANCER RES, V58, P3942; Ikenoue T, 2002, JPN J CANCER RES, V93, P1213, DOI 10.1111/j.1349-7006.2002.tb01226.x; Jia Y, 2013, J PATHOL, V230, P194, DOI 10.1002/path.4073; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katsurano M, 2012, ONCOGENE, V31, P342, DOI 10.1038/onc.2011.241; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Kivimae S, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-33; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Neufeld KL, 2000, P NATL ACAD SCI USA, V97, P12085, DOI 10.1073/pnas.220401797; Neufeld KL, 2009, ADV EXP MED BIOL, V656, P13, DOI 10.1007/978-1-4419-1145-2_2; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Suriben R, 2009, NAT GENET, V41, P977, DOI 10.1038/ng.435; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wang SY, 2013, GUT, V62, P833, DOI 10.1136/gutjnl-2011-301776; Wang SY, 2012, MOL MED, V18, P1402, DOI 10.2119/molmed.2012.00243; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Yu J, 2006, HEPATOLOGY, V43, P826, DOI 10.1002/hep.21108; Yu J, 2010, ONCOGENE, V29, P6464, DOI 10.1038/onc.2010.370; Yuan GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034004; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200	39	39	43	0	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2015	34	20					2575	2585		10.1038/onc.2014.201	http://dx.doi.org/10.1038/onc.2014.201			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI1YN	25023701	Green Published, hybrid			2022-12-25	WOS:000354541300004
J	Bai, Q; Parris, RS; Burton, EA				Bai, Qing; Parris, Ritika S.; Burton, Edward A.			Different Mechanisms Regulate Expression of Zebrafish Myelin Protein Zero (P0) in Myelinating Oligodendrocytes and Its Induction following Axonal Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Axon; Myelin; Oligodendrocyte; Regenerative Medicine; Transcription Regulation; Protein Zero; Zebrafish	RETINAL GANGLION-CELLS; CENTRAL-NERVOUS-SYSTEM; ADULT ZEBRAFISH; OPTIC-NERVE; TRANSGENIC ZEBRAFISH; REGENERATION; NEURONS; GROWTH; GENE; PROMOTER	Background: Zebrafish CNS oligodendrocytes up-regulate axon growth-promoting genes following axonal injury. Results: Separate cis-regulatory elements mediate mpz expression in myelinating oligodendrocytes and its transcriptional induction by axonal damage. Conclusion: Different mechanisms specify oligodendroglial mpz expression in the intact and injured CNS. Significance: Mechanisms underlying the zebrafish repair response might be exploited to enhance axonal regeneration in the mammalian CNS. Zebrafish CNS axons regenerate robustly following injury; it is thought that CNS oligodendrocytes contribute to this response by expressing growth-promoting molecules. We characterized the mpz gene, which encodes myelin protein zero and is up-regulated in oligodendroglia following axonal injury. The 2.5-kb mpz mRNA is expressed from a single TATA box promoter. Four independent Tg(mpz:egfp) transgenic zebrafish lines, in which GFP was expressed under the mpz promoter and 10 kb of genomic 5-flanking sequence, showed transgene expression in CNS oligodendrocytes from larval development through adulthood. Following optic nerve crush injury, the mpz:egfp transgene was strongly up-regulated in oligodendrocytes along the regenerating retinotectal projection, mirroring up-regulation of endogenous mpz mRNA. GFP-expressing oligodendroglia were significantly more abundant in the regenerating optic pathway, resulting from both transgene induction in oligodendroglial precursors and the birth of new cells. Up-regulation of the mpz:egfp transgene was not dependent on axonal regeneration, suggesting that the primary signal may be axonal loss, debris, or microglial infiltration. Deletion experiments indicated that an oligodendroglial enhancer located in the region from -6 to -10 kb with respect to the mpz transcriptional start site is dissociable from the cis-regulatory element mediating the mpz transcriptional response to axonal injury, which is located between -1 and -4 kb. These data show that different mechanisms regulate expression of zebrafish mpz in myelinating oligodendrocytes and its induction following axonal injury. The underlying molecular events could potentially be exploited to enhance axonal repair following mammalian CNS injury. The transgenic lines and cis-regulatory constructs reported here will facilitate identification of the relevant signaling pathways.	[Bai, Qing; Parris, Ritika S.; Burton, Edward A.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15213 USA; [Bai, Qing; Parris, Ritika S.; Burton, Edward A.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15213 USA; [Burton, Edward A.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Burton, Edward A.] Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15240 USA; [Burton, Edward A.] Pittsburgh Vet Affairs Healthcare Syst, Dept Neurol, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Geriatric Research Education & Clinical Center	Burton, EA (corresponding author), Univ Pittsburgh, Dept Neurol, 7015 BST 3,3501 Fifth Ave, Pittsburgh, PA 15213 USA.	eab25@pitt.edu	Burton, Edward/ABB-1324-2021; Burton, Edward/AAO-9677-2021	Burton, Edward/0000-0002-8072-4636; 	National Institutes of Health, NINDS [NS058369]; Ethel Vincent Charitable Trust; National Institutes of Health Training Grant [AG21885]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058369] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ethel Vincent Charitable Trust; National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant NS058369. This work was also supported by the Ethel Vincent Charitable Trust.; Supported by National Institutes of Health Training Grant AG21885.	Ankerhold R, 1999, J NEUROBIOL, V41, P572, DOI 10.1002/(SICI)1097-4695(199912)41:4<572::AID-NEU12>3.3.CO;2-#; Bai Q, 2009, NEUROSCIENCE, V164, P1138, DOI 10.1016/j.neuroscience.2009.09.014; Bai Q, 2007, NUCLEIC ACIDS RES, V35, P6501, DOI 10.1093/nar/gkm608; Bai Q, 2006, BRAIN RES, V1113, P33, DOI 10.1016/j.brainres.2006.07.057; Bai Q, 2011, J COMP NEUROL, V519, P1580, DOI 10.1002/cne.22587; Bai Q, 2009, NEUROSCI LETT, V449, P252, DOI 10.1016/j.neulet.2008.10.101; BASTMEYER M, 1991, J NEUROSCI, V11, P626; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Becker CG, 2004, J NEUROSCI, V24, P7837, DOI 10.1523/JNEUROSCI.2420-04.2004; Becker CG, 2002, J NEUROSCI, V22, P842, DOI 10.1523/JNEUROSCI.22-03-00842.2002; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Bernhardt RR, 1996, J COMP NEUROL, V376, P253, DOI 10.1002/(SICI)1096-9861(19961209)376:2<253::AID-CNE7>3.0.CO;2-2; Bormann P, 1998, J NEUROSCI RES, V52, P405, DOI 10.1002/(SICI)1097-4547(19980515)52:4<405::AID-JNR4>3.0.CO;2-D; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Chung AY, 2013, MOL CELLS, V36, P82, DOI 10.1007/s10059-013-0087-9; Diekmann H, 2005, MOL BIOL EVOL, V22, P1635, DOI 10.1093/molbev/msi158; Goldman D, 2000, NEUROREPORT, V11, P3859, DOI 10.1097/00001756-200011270-00051; Goldman D, 2001, TRANSGENIC RES, V10, P21, DOI 10.1023/A:1008998832552; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Kusik BW, 2010, DEV DYNAM, V239, P482, DOI 10.1002/dvdy.22190; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Marz M, 2010, DEV DYNAM, V239, P3336, DOI 10.1002/dvdy.22455; Milanese C, 2012, J BIOL CHEM, V287, P2971, DOI 10.1074/jbc.M111.308312; Munzel EJ, 2012, GLIA, V60, P253, DOI 10.1002/glia.21260; Park HC, 2005, J NEUROSCI, V25, P6836, DOI 10.1523/JNEUROSCI.0981-05.2005; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schweitzer J, 2003, GLIA, V41, P301, DOI 10.1002/glia.10192; Schweitzer J, 2007, MOL CELL NEUROSCI, V35, P194, DOI 10.1016/j.mcn.2007.02.018; Senut MC, 2004, J NEUROSCI, V24, P7663, DOI 10.1523/JNEUROSCI.2281-04.2004; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Thisse Thisse Christine B, 2004, FAST RELEASE CLONES; Udvadia AJ, 2008, GENE EXPR PATTERNS, V8, P382, DOI 10.1016/j.gep.2008.05.002; YAZAKI T, 1994, NEUROSCI LETT, V176, P13, DOI 10.1016/0304-3940(94)90859-1; Yoshida M, 2005, J NEUROSCI RES, V81, P1, DOI 10.1002/jnr.20516	37	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24114	24128		10.1074/jbc.M113.545426	http://dx.doi.org/10.1074/jbc.M113.545426			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25028515	Green Published, hybrid			2022-12-25	WOS:000341505600011
J	Bernues, A; Rodriguez-Ortega, T; Ripoll-Bosch, R; Alfnes, F				Bernues, Alberto; Rodriguez-Ortega, Tamara; Ripoll-Bosch, Raimon; Alfnes, Frode			Socio-Cultural and Economic Valuation of Ecosystem Services Provided by Mediterranean Mountain Agroecosystems	PLOS ONE			English	Article							CONSERVATION; LANDSCAPE; EUROPE; PREFERENCES; GRASSLAND; FRAMEWORK; PRODUCTS; SYSTEMS; CHOICE	The aim of this work was to elucidate the socio-cultural and economic value of a number of ecosystem services delivered by mountain agroecosystems (mostly grazing systems) in Euro-Mediterranean regions. We combined deliberative (focus groups) and survey-based stated-preference methods (choice modelling) to, first, identify the perceptions of farmers and other citizens on the most important ecosystem services and, second, to value these in economic terms according to the willingness to pay of the local (residents of the study area) and general (region where the study area is located) populations. Cultural services (particularly the aesthetic and recreational values of the landscape), supporting services (biodiversity maintenance) and some regulating services (particularly fire risk prevention) were clearly recognized by both farmers and citizens, with different degrees of importance according to their particular interests and objectives. The prevention of forest fires (approximate to 50% of total willingness to pay) was valued by the general population as a key ecosystem service delivered by these agroecosystems, followed by the production of specific quality products linked to the territory (approximate to 20%), biodiversity (approximate to 20%) and cultural landscapes (approximate to 10%). The value given by local residents to the last two ecosystem services differed considerably (approximate to 10 and 25% for biodiversity and cultural landscape, respectively). The Total Economic Value of mountain agroecosystems was approximate to 120 (sic) person(-1) year(-1), three times the current level of support of agro-environmental policies. By targeting and quantifying the environmental objectives of the European agri-environmental policy and compensating farmers for the public goods they deliver, the so-called "green'' subsidies may become true Payments for Ecosystems Services.	[Bernues, Alberto] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway; [Bernues, Alberto; Rodriguez-Ortega, Tamara; Ripoll-Bosch, Raimon] Ctr Invest & Tecnol Agroalimentaria Aragon, Dept Tecnol Prod Anim, Zaragoza, Spain; [Ripoll-Bosch, Raimon] Wageningen Univ, Anim Prod Syst Grp, NL-6700 AP Wageningen, Netherlands; [Alfnes, Frode] Norwegian Univ Life Sci, Sch Business & Econ, As, Norway	Norwegian University of Life Sciences; Wageningen University & Research; Norwegian University of Life Sciences	Bernues, A (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway.	alberto.bernues@nmbu.no	Bosch, Raimon Ripoll/AAB-5177-2022; Bernués, Alberto/C-1393-2010; Alfnes, Frode/AAD-8398-2020; Alfnes, Frode/I-8970-2016	Bosch, Raimon Ripoll/0000-0002-1234-7015; Bernués, Alberto/0000-0002-3237-9751; Alfnes, Frode/0000-0002-3072-9308; Alfnes, Frode/0000-0002-3072-9308; Rodriguez-Ortega, Tamara/0000-0002-8592-2754	European Commission [299794]; Spanish Ministry of Economy and Competitiveness, Government of Aragon [INIA-RTA2011-00133-C02-02]; Spanish Ministry of Economy and Competitiveness, Government of Aragon FEDER [INIA-RTA2011-00133-C02-02]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness, Government of Aragon; Spanish Ministry of Economy and Competitiveness, Government of Aragon FEDER	The research was funded by: Marie Curie FP7-PEOPLE-2011 IEF, Contract no. 299794 (European Commission) and INIA-RTA2011-00133-C02-02 (Spanish Ministry of Economy and Competitiveness, Government of Aragon and FEDER). TR-O and RR-B acknowledge the doctoral financial support of INIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfnes F., 2011, The Oxford Handbook of the economics of food consumption and policy, P215; [Anonymous], 2005, EC HUM WELL BEING SY; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bernues A, 2005, LIVEST PROD SCI, V96, P75, DOI 10.1016/j.livprodsci.2005.05.023; Bernues A, 2011, LIVEST SCI, V139, P44, DOI 10.1016/j.livsci.2011.03.018; Bernues A, 2003, FOOD QUAL PREFER, V14, P265, DOI 10.1016/S0950-3293(02)00085-X; Chan KMA, 2012, BIOSCIENCE, V62, P744, DOI 10.1525/bio.2012.62.8.7; Cooper T., 2009, PROVISION PUBLIC GOO; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; De Groot R.S., 2010, INTEGRATING ECOLOGIC; Garcia-Llorente M, 2012, ENVIRON SCI POLICY, V19-20, P136, DOI 10.1016/j.envsci.2012.01.006; Gibon A, 2005, LIVEST PROD SCI, V96, P11, DOI 10.1016/j.livprodsci.2005.05.009; Gomez-Baggethun E, 2011, PROG PHYS GEOG, V35, P613, DOI 10.1177/0309133311421708; Guerrero L, 2010, FOOD QUAL PREFER, V21, P225, DOI 10.1016/j.foodqual.2009.06.003; Guerrero L, 2009, APPETITE, V52, P345, DOI 10.1016/j.appet.2008.11.008; Hartter J, 2010, SOC NATUR RESOUR, V23, P207, DOI 10.1080/08941920903360372; Hazeu GW, 2010, 62010 EUR ENV AG; Hensher D. A., 2005, APPL CHOICE EC PRIME; Kumar Pushpam, 2010, EC ECOSYSTEMS BIODIV, DOI DOI 10.1017/S1355770X11000088; Lamarque P, 2011, REG ENVIRON CHANGE, V11, P791, DOI 10.1007/s10113-011-0214-0; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lenglet F, 2014, FOOD QUAL PREFER, V32, P264, DOI 10.1016/j.foodqual.2013.09.003; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Martin-Lopez B, 2008, CONSERV BIOL, V22, P624, DOI 10.1111/j.1523-1739.2008.00921.x; Martin-Lopez B, 2014, ECOL INDIC, V37, P220, DOI 10.1016/j.ecolind.2013.03.003; Martin-Lopez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038970; McCracken D. I., 2005, Global change and mountain regions: an overview of current knowledge, P573; Oteros-Rozas E, 2013, REG ENVIRON CHANGE, P1; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Parks S, 2013, ECOSYST SERV, V3, pE1, DOI 10.1016/j.ecoser.2012.12.002; Pascual U., 2010, EC ECOSYSTEMS BIODIV, P184; Pearce D, 1993, EC VALUES NATURAL WO; Pereira E, 2005, ECOL SOC, V10; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; Riedel JL, 2007, LIVEST SCI, V111, P153, DOI 10.1016/j.livsci.2006.12.013; Riedel JL, 2013, RANGELAND ECOL MANAG, V66, P224, DOI 10.2111/REM-D-11-00196.1; Rodriguez-Ortega T, 2014, ANIMAL, V8, P1361, DOI 10.1017/S1751731114000421; Rodriguez-Ortega T, 2013, FARMERS CITIZENS PER, P121; Ruiz-Mirazo J, 2011, AGR ECOSYST ENVIRON, V141, P13, DOI 10.1016/j.agee.2011.02.002; SAS Institute Inc, 2014, SAS ETS 9 3 US GUID; Sayadi S, 2009, LAND USE POLICY, V26, P334, DOI 10.1016/j.landusepol.2008.04.003; Scarpa R, 2009, EUR REV AGRIC ECON, V36, P151, DOI 10.1093/erae/jbp012; Soini K, 2007, LAND USE POLICY, V24, P311, DOI 10.1016/j.landusepol.2006.03.001; Strijker D, 2005, BASIC APPL ECOL, V6, P99, DOI 10.1016/j.baae.2005.01.001; Swinton SM, 2007, ECOL ECON, V64, P245, DOI 10.1016/j.ecolecon.2007.09.020; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; van Oudenhoven APE, 2012, ECOL INDIC, V21, P110, DOI 10.1016/j.ecolind.2012.01.012; Zander KK, 2013, ECOL ECON, V93, P219, DOI 10.1016/j.ecolecon.2013.06.002	48	108	108	5	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102479	10.1371/journal.pone.0102479	http://dx.doi.org/10.1371/journal.pone.0102479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036276	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200062
J	Borges, P; Valente, LMP; Veron, V; Dias, K; Panserat, S; Medale, F				Borges, Pedro; Valente, Luisa M. P.; Veron, Vincent; Dias, Karine; Panserat, Stephane; Medale, Francoise			High Dietary Lipid Level Is Associated with Persistent Hyperglycaemia and Downregulation of Muscle Akt-mTOR Pathway in Senegalese Sole (Solea senegalensis)	PLOS ONE			English	Article							GLUCONEOGENIC ENZYME EXPRESSION; FAT/LOW-CARBOHYDRATE DIET; LOW-PROTEIN INTAKE; RAINBOW-TROUT; INSULIN-RESISTANCE; NUTRIENT UTILIZATION; GLUCOSE-INTOLERANCE; GROWTH-PERFORMANCE; FATTY-ACIDS; SIGNALING SYSTEM	High levels of dietary lipids are incorporated in feeds for most teleost fish to promote growth and reduce nitrogen waste. However, in Senegalese sole (Solea senegalensis) previous studies revealed that increasing the level of dietary lipids above 8% negatively affect growth and nutrient utilization regardless of dietary protein content. It has been shown that glucose regulation and metabolism can be impaired by high dietary fat intake in mammals, but information in teleost fish is scarce. The aim of this study was to assess the possible effect of dietary lipids on glucose metabolism in Senegalese sole with special emphasis on the regulation of proteins involved in the muscle insulin-signalling pathway. Senegalese sole juveniles (29 g) were fed two isonitrogenous diets (53% dry matter) for 88 days. These two diets were one with a high lipid level (similar to 17%, HL) and a moderate starch content (similar to 14%, LC), and the other being devoid of fish oil (4% lipid, LL) and with high starch content (similar to 23%, HC). Surprisingly, feeding Senegalese sole the HL/LC diet resulted in prolonged hyperglycaemia, while fish fed on LL/HC diet restored basal glycaemia 2 h after feeding. The hyperglycaemic phenotype was associated with greater glucose-6-phosphatase activity (a key enzyme of hepatic glucose production) and lower citrate synthase activity in the liver, with significantly higher liver glycogen content. Sole fed on HL/LC diet also had significantly lower hexokinase activity in muscle, although hexokinase activity was low with both dietary treatments. The HL/LC diet was associated with significant reductions in muscle AKT, p70 ribosomal S6-K1 Kinase (S6K-1) and ribosomal protein S6 (S6) 2 h after feeding, suggesting down regulation of the AKT-mTOR nutrient signalling pathway in these fish. The results of this study show for the first time that high level of dietary lipids strongly affects glucose metabolism in Senegalese sole.	[Borges, Pedro; Valente, Luisa M. P.] Univ Porto, CIMAR CIIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, P-4100 Oporto, Portugal; [Borges, Pedro; Valente, Luisa M. P.] Univ Porto, ICBAS, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal; [Borges, Pedro; Veron, Vincent; Dias, Karine; Panserat, Stephane; Medale, Francoise] Pole Hydrobiol, INRA UR 1067, St Pee Sur Nivelle, France	Universidade do Porto; Universidade do Porto; INRAE; Universite de Pau et des Pays de l'Adour	Medale, F (corresponding author), Pole Hydrobiol, INRA UR 1067, St Pee Sur Nivelle, France.	medale@st-pee.inra.fr	Quality, Aquaculture Seafood/AAD-7718-2019; Borges, Pedro/G-4172-2015; Valente, Luisa/A-3769-2010	Panserat, Stephane/0000-0002-4479-9868; Borges, Pedro/0000-0002-2328-1576; Medale, Francoise/0000-0002-8083-1298; Valente, Luisa/0000-0002-2496-4854	Fundacao para a Ciencia e Tecnologia of Portugal [SFRH/BD/47780/2008]	Fundacao para a Ciencia e Tecnologia of Portugal(Portuguese Foundation for Science and Technology)	The present study was supported by Fundacao para a Ciencia e Tecnologia of Portugal (PhD grant SFRH/BD/47780/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEGRE M, 1988, ANAL BIOCHEM, V173, P185, DOI 10.1016/0003-2697(88)90176-5; BARZILAI N, 1993, J BIOL CHEM, V268, P25019; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Blasco J, 1996, J COMP PHYSIOL B, V165, P534, DOI 10.1007/BF00387514; Borges P, 2013, COMP BIOCHEM PHYS A, V166, P26, DOI 10.1016/j.cbpa.2013.05.007; Borges P, 2013, BRIT J NUTR, V109, P1373, DOI 10.1017/S0007114512003418; Borges P, 2009, BRIT J NUTR, V102, P1007, DOI 10.1017/S0007114509345262; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruce CR, 2003, J CLIN ENDOCR METAB, V88, P5444, DOI 10.1210/jc.2003-030791; Caruso MA, 2011, GEN COMP ENDOCR, V173, P227, DOI 10.1016/j.ygcen.2011.06.014; Cheng AC, 2006, ZOOL STUD, V45, P492; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; CHO CY, 1994, AQUACULTURE, V124, P293, DOI 10.1016/0044-8486(94)90403-0; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Dias J, 1998, AQUACULTURE, V161, P169, DOI 10.1016/S0044-8486(97)00268-8; Dias J, 2004, AQUAC RES, V35, P1122, DOI 10.1111/j.1365-2109.2004.01135.x; Diaz M, 2007, J EXP BIOL, V210, P2346, DOI 10.1242/jeb.002857; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Enes P, 2011, REV FISH SCI, V19, P201, DOI 10.1080/10641262.2011.579363; Enes P, 2009, FISH PHYSIOL BIOCHEM, V35, P519, DOI 10.1007/s10695-008-9259-5; Figueiredo-Silva AC, 2012, J EXP BIOL, V215, P169, DOI 10.1242/jeb.063933; Flamment M, 2008, BIOCHIMIE, V90, P1407, DOI 10.1016/j.biochi.2008.05.003; Funes V, 2006, GEN COMP ENDOCR, V149, P166, DOI 10.1016/j.ygcen.2006.05.017; Guerreiro I, 2012, AQUACULT NUTR, V18, P98, DOI 10.1111/j.1365-2095.2011.00884.x; Guerreiro I, 2014, AQUAC RES, V45, P289, DOI 10.1111/j.1365-2109.2012.03226.x; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hemre G.-I., 1995, Aquaculture Research, V26, P149, DOI 10.1111/j.1365-2109.1995.tb00896.x; Hemre GI, 1999, AQUACULT NUTR, V5, P9; Hildreth KL, 2012, OBESITY, V20, P1549, DOI 10.1038/oby.2012.19; HILLESTAD M, 1994, AQUACULTURE, V124, P109, DOI 10.1016/0044-8486(94)90366-2; Hinault C, 2004, FASEB J, V18, P1894, DOI 10.1096/fj.03-1409fje; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Hutchins CG, 1998, AQUACULTURE, V161, P187, DOI 10.1016/S0044-8486(97)00269-X; Keppler D., 1974, METHOD ENZYMAT AN, V3, P1127, DOI DOI 10.1242/JEB.037275; Kirchner S, 2005, COMP BIOCHEM PHYS B, V140, P333, DOI 10.1016/j.cbpc.2004.10.019; Kirchner S, 2003, J NUTR, V133, P2561; Kusunoki M, 2002, METABOLISM, V51, P792, DOI 10.1053/meta.2002.32732; LEE DJ, 1973, J NUTR, V103, P916, DOI 10.1093/jn/103.6.916; Massillon D, 1997, DIABETES, V46, P153, DOI 10.2337/diabetes.46.1.153; Mediavilla D, 2007, BBA-GEN SUBJECTS, V1770, P706, DOI 10.1016/j.bbagen.2006.11.014; Meton I, 1999, BRIT J NUTR, V82, P223, DOI 10.1017/S0007114599001403; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; MOMMSEN TP, 1991, REV AQUAT SCI, V4, P225; Moon TW, 2001, COMP BIOCHEM PHYS B, V129, P243, DOI 10.1016/S1096-4959(01)00316-5; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Ortenblad N, 2005, BBA-MOL BASIS DIS, V1741, P206, DOI 10.1016/j.bbadis.2005.04.001; PALMER TN, 1972, J FISH BIOL, V4, P311, DOI 10.1111/j.1095-8649.1972.tb05680.x; Panserat S, 2002, J NUTR, V132, P137, DOI 10.1093/jn/132.2.137; Planas JV, 2000, AM ZOOL, V40, P223, DOI 10.1668/0003-1569(2000)040[0223:FIIIAI]2.0.CO;2; Polakof S, 2011, COMP BIOCHEM PHYS B, V160, P123, DOI 10.1016/j.cbpb.2011.07.006; Polakof S, 2010, J EXP BIOL, V213, P1443, DOI 10.1242/jeb.037689; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; Seiliez I, 2011, GEN COMP ENDOCR, V172, P363, DOI 10.1016/j.ygcen.2011.03.026; SINGER TD, 1990, CAN J FISH AQUAT SCI, V47, P873, DOI 10.1139/f90-100; Skiba-Cassy S, 2009, AM J PHYSIOL-REG I, V297, pR1421, DOI 10.1152/ajpregu.00312.2009; Stone DAJ, 2003, REV FISH SCI, V11, P337, DOI 10.1080/10641260390260884; SU JY, 1995, INT J BIOCHEM CELL B, V27, P1277, DOI 10.1016/1357-2725(95)00104-W; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Valente LMP, 2011, AQUACULTURE, V318, P128, DOI 10.1016/j.aquaculture.2011.05.026; Vergara JM, 1996, FISHERIES SCI, V62, P624, DOI 10.2331/fishsci.62.624; Wang Y, 2003, ENDOCRINE, V22, P85, DOI 10.1385/ENDO:22:2:85; Wang Y, 2002, ENDOCRINE, V17, P185, DOI 10.1385/ENDO:17:3:185; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; WILSON RP, 1994, AQUACULTURE, V124, P67, DOI 10.1016/0044-8486(94)90363-8; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wise S, 1997, J CLIN ENDOCR METAB, V82, P1828, DOI 10.1210/jc.82.6.1828; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002	73	25	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102196	10.1371/journal.pone.0102196	http://dx.doi.org/10.1371/journal.pone.0102196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036091	gold, Green Published, Green Submitted			2022-12-25	WOS:000339615200039
J	Kurppa, KJ; Rokavec, M; Sundvall, M; Kellokumpu-Lehtinen, PL; Joensuu, H; Brauch, H; Elenius, K				Kurppa, Kari J.; Rokavec, Matjaz; Sundvall, Maria; Kellokumpu-Lehtinen, Pirkko-Liisa; Joensuu, Heikki; Brauch, Hiltrud; Elenius, Klaus			ERBB4 Promoter Polymorphism Is Associated with Poor Distant Disease-Free Survival in High-Risk Early Breast Cancer	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; GENOME-WIDE ASSOCIATION; MUTATIONS; AMPLIFICATION; TRASTUZUMAB; GROWTH	A number of genetic variants have been linked to increased risk of breast cancer. Little is, however, known about the prognostic significance of hereditary factors. Here, we investigated the frequency and prognostic significance of two ERBB4 promoter region variants, -782G>T (rs62626348) and -815A>T (rs62626347), in a cohort of 1010 breast cancer patients. The frequency of nine previously described somatic ERBB4 kinase domain mutations was also analyzed. Clinical material used in the study consisted of samples from the phase III, adjuvant, FinHer breast cancer trial involving 1010 women. Tumor DNA samples were genotyped for ERBB4 variants and somatic mutations using matrix-assisted laser desorption ionization/time of flight mass spectrometry. Paraffin-embedded tumor sections from all patients were immunohistochemically stained for ErbB4 expression. Association of ERBB4 genotype to distant disease-free survival (DDFS) was assessed using Kaplan-Meier and Cox regression analyses. Genotyping was successful for 91-93% of the 1010 samples. Frequencies observed for the ERBB4 variants were 2.5% and 1.3% for -782G>T and -815A>T, respectively. Variant -815A>T was significantly associated with poor survival (HR = 2.86 [95% CI 1.15-6.67], P = 0.017). In contrast, variant -782G>T was associated with well-differentiated cancer (P = 0.019). Two (0.2%) ERBB4 kinase domain mutations were found, both of which have previously been shown to be functional and promote cancer cell growth in vitro. These data present the germ-line ERBB4 variant -815A>T as a novel prognostic marker in high-risk early breast cancer and indicate the presence of rare but potentially oncogenic somatic ERBB4 mutations in breast cancer.	[Kurppa, Kari J.; Sundvall, Maria; Elenius, Klaus] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Kurppa, Kari J.; Sundvall, Maria; Elenius, Klaus] Univ Turku, Medicity Res Labs, Turku, Finland; [Kurppa, Kari J.] Turku Doctoral Programme Mol Med, Turku, Finland; [Rokavec, Matjaz; Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Rokavec, Matjaz; Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Sundvall, Maria; Elenius, Klaus] Turku Univ Hosp, Dept Oncol, FIN-20520 Turku, Finland; [Kellokumpu-Lehtinen, Pirkko-Liisa] Tampere Univ Hosp, Dept Oncol, Tampere, Finland; [Brauch, Hiltrud] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland	University of Turku; University of Turku; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Turku; Tampere University; Tampere University Hospital; University of Helsinki; Helsinki University Central Hospital	Elenius, K (corresponding author), Univ Turku, Dept Med Biochem & Genet, Turku, Finland.	klaus.elenius@utu.fi	Elenius, Klaus/AAI-7594-2021; Rokavec, Matjaz/J-4518-2019	Elenius, Klaus/0000-0001-5700-0827; Sundvall, Maria H/0000-0002-0494-2965; Brauch, Hiltrud/0000-0001-7531-2736; Joensuu, Heikki/0000-0003-0281-2507; Kurppa, Kari/0000-0001-8286-2429; Rokavec, Matjaz/0000-0002-2540-877X	Academy of Finland [137845]; Finnish Cancer Organizations; Sigrid Juselius Foundation; Turku University Hospital [13785]; Finnish Cultural Foundation; Ida Montin Foundation; Jenny and Antti Wihuri Foundation; Cancer Foundation Finland sr [130077, 120084, 130093, 110071] Funding Source: researchfish	Academy of Finland(Academy of Finland); Finnish Cancer Organizations; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Hospital; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Ida Montin Foundation; Jenny and Antti Wihuri Foundation; Cancer Foundation Finland sr	This work was supported by the following sources of funding: The Academy of Finland (ref. 137845; http://www.aka.fi; KE); Finnish Cancer Organizations (http://www.cancer.fi; KE); Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation; KE); Turku University Hospital (ref. 13785; http://www.vsshp.fi/fi/evo-rahoitus; KE); Finnish Cultural Foundation (http://www.skr.fi; KK); Ida Montin Foundation (http://www.idamontininsaatio.fi; KK); and the Jenny and Antti Wihuri Foundation (http://www.wihurinrahasto.fi; KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacus SS, 1996, AM J PATHOL, V148, P549; Bieche I, 2003, INT J CANCER, V106, P758, DOI 10.1002/ijc.11273; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Hollmen M, 2009, ONCOGENE, V28, P1309, DOI 10.1038/onc.2008.481; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joensuu H, 2003, CLIN CANCER RES, V9, P923; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Joensuu H, 2009, J CLIN ONCOL, V27, P5685, DOI 10.1200/JCO.2008.21.4577; Kew TY, 2000, BRIT J CANCER, V82, P1163, DOI 10.1054/bjoc.1999.1057; Kim HC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3158; Koutras AK, 2008, BRIT J CANCER, V99, P1775, DOI 10.1038/sj.bjc.6604769; Lalloo F, 2012, CLIN GENET, V82, P105, DOI 10.1111/j.1399-0004.2012.01859.x; Lodge AJ, 2003, J CLIN PATHOL, V56, P300, DOI 10.1136/jcp.56.4.300; Loi S, 2013, JNCI-J NATL CANCER I, V105, P960, DOI 10.1093/jnci/djt121; Murabito JM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S6; Muraoka-Cook RS, 2009, MOL CELL BIOL, V29, P4935, DOI 10.1128/MCB.01705-08; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Rokavec M, 2007, CLIN CANCER RES, V13, P7506, DOI 10.1158/1078-0432.CCR-07-0457; Sassen A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1843; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200	23	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102388	10.1371/journal.pone.0102388	http://dx.doi.org/10.1371/journal.pone.0102388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036186	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200054
J	Shi, SB; Liang, JJ; Liu, T; Yuan, XR; Ruan, B; Sun, LF; Tang, YH; Yang, B; Hu, D; Huang, CX				Shi, Shaobo; Liang, Jinjun; Liu, Tao; Yuan, Xiaoran; Ruan, Bing; Sun, Lifang; Tang, Yanhong; Yang, Bo; Hu, Dan; Huang, Congxin			Depression Increases Sympathetic Activity and Exacerbates Myocardial Remodeling after Myocardial Infarction: Evidence from an Animal Experiment	PLOS ONE			English	Article							CHRONIC MILD STRESS; SUDDEN CARDIAC DEATH; VENTRICULAR-ARRHYTHMIAS; HEART-FAILURE; PROGNOSTIC ASSOCIATION; CARDIOVASCULAR-DISEASE; NERVOUS-SYSTEM; RODENT MODEL; RAT STRAINS; SYMPTOMS	Depression is an independent risk factor for cardiovascular events and mortality in patients with myocardial infarction (MI). Excessive sympathetic activation and serious myocardial remodeling may contribute to this association. The aim of this study was to discuss the effect of depression on sympathetic activity and myocardial remodeling after MI. Wild-type (WT) rats were divided into a sham group (Sham), a myocardial infarction group (MI), a depression group (D), and a myocardial infarction plus depression group (MI+D). Compared with controls, the MI+D animals displayed depression-like behaviors and attenuated body weight gain. The evaluation of sympathetic activity showed an increased level in plasma concentrations of epinephrine and norepinephrine and higher expression of myocardial tyrosine hydroxylase in the MI+D group than the control groups (p<0.05 for all). Cardiac function and morphologic analyses revealed a decreased fractional shortening accompanied by increased left ventricular dimensions, thinning myocardium wall, and reduced collagen repair in the MI+D group compared with the MI group (p<0.05 for all). Frequent premature ventricular contractions, prolonged QT duration and ventricular repolarization duration, shorted effective refractory period, and increased susceptibility to ventricular arrhythmia were displayed in MI+D rats. These results indicate that sympathetic hyperactivation and exacerbated myocardial remodeling may be a plausible mechanism linking depression to an adverse prognosis after MI.	[Shi, Shaobo; Liang, Jinjun; Liu, Tao; Yuan, Xiaoran; Ruan, Bing; Sun, Lifang; Tang, Yanhong; Yang, Bo; Huang, Congxin] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China; [Shi, Shaobo; Liang, Jinjun; Liu, Tao; Yuan, Xiaoran; Ruan, Bing; Sun, Lifang; Tang, Yanhong; Huang, Congxin] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430072, Peoples R China; [Hu, Dan] Masonic Med Res Lab, Utica, NY USA	Wuhan University; Wuhan University; Masonic Medical Research Laboratory	Shi, SB (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China.	sanshisanshi@126.com; huangcongxin1951@163.com		Hu, Dan/0000-0002-0994-8434	National Key Basic Research Development Program of China (The 973 Program) [2012CB518604]; Natural Science Foundation of China [81200139]; Fundamental Research Funds for the Central Universities, China [2014302020201]	National Key Basic Research Development Program of China (The 973 Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key Basic Research Development Program of China (The 973 Program, grant number: 2012CB518604), the Natural Science Foundation of China Grants (Grant number: 81200139) and the Fundamental Research Funds for the Central Universities, China (grant number: 2014302020201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bekris S, 2005, BEHAV BRAIN RES, V161, P45, DOI 10.1016/j.bbr.2005.01.005; Bouzinova EV, 2012, PSYCHOSOM MED, V74, P278, DOI 10.1097/PSY.0b013e31824c40a9; Brugada J, 2012, EUR HEART J, V33, P687, DOI 10.1093/eurheartj/ehr405; Carnevali L, 2013, PSYCHOSOM MED, V75, P42, DOI 10.1097/PSY.0b013e318276cb0d; Cherry EM, 2012, AM J PHYSIOL-HEART C, V302, pH2451, DOI 10.1152/ajpheart.00770.2011; Ciarka A, 2008, EXPERT OPIN INV DRUG, V17, P1315, DOI [10.1517/13543780802303805, 10.1517/13543784.17.9.1315 ]; Du XJ, 1999, CARDIOVASC RES, V43, P919, DOI 10.1016/S0008-6363(99)00139-X; Grippo AJ, 2004, AM J PHYSIOL-HEART C, V286, pH619, DOI 10.1152/ajpheart.00450.2003; Gronli J, 2005, PHYSIOL BEHAV, V84, P571, DOI 10.1016/j.physbeh.2005.02.007; Henze M, 2013, AM J PHYSIOL-HEART C, V304, pH444, DOI 10.1152/ajpheart.00763.2012; Huang CJ, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00314; Huffman JC, 2013, EVID-BASED MENT HEAL, V16, P110, DOI 10.1136/eb-2013-101537; Jokinen J, 2009, J AFFECT DISORDERS, V116, P88, DOI 10.1016/j.jad.2008.10.025; Kim YH, 2012, HEART, V98, P1378, DOI 10.1136/heartjnl-2012-302180; Koschke M, 2009, PSYCHOSOM MED, V71, P852, DOI 10.1097/PSY.0b013e3181b8bb7a; Lee TM, 2009, AM J PHYSIOL-HEART C, V297, pH512, DOI 10.1152/ajpheart.00077.2009; Li LF, 2012, PHYTOTHER RES, V26, P1189, DOI 10.1002/ptr.3706; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Meijer A, 2013, BRIT J PSYCHIAT, V203, P90, DOI 10.1192/bjp.bp.112.111195; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; Neelakantan S, 2013, NATURE, V493, pS16, DOI 10.1038/493S16a; Nemeroff CB, 2012, NAT REV CARDIOL, V9, P526, DOI 10.1038/nrcardio.2012.91; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; Qin M, 2013, J CARDIOL, V61, P162, DOI 10.1016/j.jjcc.2012.08.016; Rimmele U, 2009, PSYCHONEUROENDOCRINO, V34, P190, DOI 10.1016/j.psyneuen.2008.08.023; Sanchez-Gonzalez MA, 2013, AM J HYPERTENS, V26, P1389, DOI 10.1093/ajh/hpt131; Smolderen KG, 2009, CIRC-CARDIOVASC QUAL, V2, P328, DOI 10.1161/CIRCOUTCOMES.109.868588; Spijkerman TA, 2005, J PSYCHOSOM RES, V58, P425, DOI 10.1016/j.jpsychores.2005.02.005; Tseliou E, 2013, J AM COLL CARDIOL, V61, P1108, DOI 10.1016/j.jacc.2012.10.052; van Melle JP, 2005, EUR HEART J, V26, P2650, DOI 10.1093/eurheartj/ehi480; Wang YM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-32; Whang W, 2005, J AM COLL CARDIOL, V45, P1090, DOI 10.1016/j.jacc.2004.12.053; Whang W, 2009, J AM COLL CARDIOL, V53, P950, DOI 10.1016/j.jacc.2008.10.060; Zhang WG, 1999, AM J PHYSIOL-HEART C, V276, pH1608, DOI 10.1152/ajpheart.1999.276.5.H1608	35	33	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101734	10.1371/journal.pone.0101734	http://dx.doi.org/10.1371/journal.pone.0101734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036781	Green Submitted, gold, Green Published			2022-12-25	WOS:000339615200022
J	Zhu, Y; Yang, JY; Yeh, F; Cole, SA; Haack, K; Lee, ET; Howard, BV; Zhao, JY				Zhu, Yun; Yang, Jingyun; Yeh, Fawn; Cole, Shelley A.; Haack, Karin; Lee, Elisa T.; Howard, Barbara V.; Zhao, Jinying			Joint Association of Nicotinic Acetylcholine Receptor Variants with Abdominal Obesity in American Indians: The Strong Heart Family Study	PLOS ONE			English	Article							61 GENETIC-VARIANTS; BODY-FAT; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; RISK-FACTORS; MASS; HYPERTENSION; OVERWEIGHT; DEPENDENCE; CHILDREN	Cigarette smoke is a strong risk factor for obesity and cardiovascular disease. The effect of genetic variants involved in nicotine metabolism on obesity or body composition has not been well studied. Though many genetic variants have previously been associated with adiposity or body fat distribution, a single variant usually confers a minimal individual risk. The goal of this study is to evaluate the joint association of multiple variants involved in cigarette smoke or nicotine dependence with obesity-related phenotypes in American Indians. To achieve this goal, we genotyped 61 tagSNPs in seven genes encoding nicotine acetylcholine receptors (nAChRs) in 3,665 American Indians participating in the Strong Heart Family Study. Single SNP association with obesity-related traits was tested using family-based association, adjusting for traditional risk factors including smoking. Joint association of all SNPs in the seven nAChRs genes were examined by gene-family analysis based on weighted truncated product method (TPM). Multiple testing was controlled by false discovery rate (FDR). Results demonstrate that multiple SNPs showed weak individual association with one or more measures of obesity, but none survived correction for multiple testing. However, gene-family analysis revealed significant associations with waist circumference (p = 0.0001) and waist-to-hip ratio (p = 0.0001), but not body mass index (p = 0.20) and percent body fat (p = 0.29), indicating that genetic variants are jointly associated with abdominal, but not general, obesity among American Indians. The observed combined genetic effect is independent of cigarette smoking per se. In conclusion, multiple variants in the nAChR gene family are jointly associated with abdominal obesity in American Indians, independent of general obesity and cigarette smoking per se.	[Zhu, Yun; Zhao, Jinying] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA; [Yang, Jingyun] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL USA; [Yeh, Fawn; Lee, Elisa T.] Univ Oklahoma, Hlth Sci Ctr, Ctr Amer Indian Hlth Res, Oklahoma City, OK USA; [Cole, Shelley A.; Haack, Karin] Texas Biomed Res Inst, San Antonio, TX USA; [Howard, Barbara V.] MedStar Hlth Res Inst, Hyattsville, MD USA; [Howard, Barbara V.] Georgetown Univ, Washington, DC USA; [Howard, Barbara V.] Howard Univ, Ctr Translat Sci, Washington, DE USA	Tulane University; Rush University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Texas Biomedical Research Institute; MedStar Health Research Institute; Georgetown University	Zhao, JY (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA.		Zhu, Yun/N-3403-2014; Zhu, Yun/AAD-5474-2020; Yang, Jingyun/D-5361-2009	Zhu, Yun/0000-0002-9500-5415; Zhu, Yun/0000-0002-9500-5415; Yang, Jingyun/0000-0002-3495-3710	seed grant from the Oklahoma Tobacco Research Center; National Institutes of Health [K01AG034259, R21HL092363, R01DK091369];  [U01HL65520];  [U01HL41642];  [U01HL41652];  [U01HL41654];  [U01HL6552]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092363, U01HL041642, R01HL109301, U01HL041652, U01HL041654, U01HL065520, U01HL065521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG034259] Funding Source: NIH RePORTER	seed grant from the Oklahoma Tobacco Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a seed grant from the Oklahoma Tobacco Research Center and National Institutes of Health Grants K01AG034259, R21HL092363, R01DK091369 and Cooperative Agreement Grants U01HL65520, U01HL41642, U01HL41652, U01HL41654, and U01HL65521. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audrain-McGovern J, 2011, CLIN PHARMACOL THER, V90, P164, DOI 10.1038/clpt.2011.105; Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Chiolero A, 2007, OBESITY, V15, P1311, DOI 10.1038/oby.2007.153; Clair C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-23; Daley CM, 2010, ETHNIC DIS, V20, P334; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Freathy RM, 2011, INT J EPIDEMIOL, V40, P1617, DOI 10.1093/ije/dyr077; Gavin JR, 1999, DIABETES CARE, V22, pS5; Goran MI, 2003, J CLIN ENDOCR METAB, V88, P1417, DOI 10.1210/jc.2002-021442; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; HOFSTETTER A, 1986, NEW ENGL J MED, V314, P79, DOI 10.1056/NEJM198601093140204; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; HOWARD BV, 1992, DIABETES, V41, P4, DOI 10.2337/diab.41.2.S4; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; John U, 2005, INT J OBESITY, V29, P1289, DOI 10.1038/sj.ijo.0803028; Kim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045815; LEE ET, 1990, AM J EPIDEMIOL, V132, P1141, DOI 10.1093/oxfordjournals.aje.a115757; Li MD, 2010, AM J MED GENET B, V153B, P745, DOI 10.1002/ajmg.b.31043; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Low YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001012; Malis C, 2005, OBES RES, V13, P2139, DOI 10.1038/oby.2005.265; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Millar NS, 2008, MOL MEMBR BIOL, V25, P279, DOI 10.1080/09687680802035675; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Pasquali R, 2000, INT J OBESITY, V24, pS47, DOI 10.1038/sj.ijo.0801277; Rahmouni K, 2005, HYPERTENSION, V45, P9, DOI 10.1161/01.HYP.0000151325.83008.b4; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Sheng XG, 2013, OXFORD B ECON STAT, V75, P624, DOI 10.1111/j.1468-0084.2012.00705.x; SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Sorof J, 2002, HYPERTENSION, V40, P441, DOI 10.1161/01.HYP.0000032940.33466.12; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Yang JY, 2013, CIRC-CARDIOVASC GENE, V6, P89, DOI 10.1161/CIRCGENETICS.112.963967; Yang JY, 2012, DIABETES, V61, P1888, DOI 10.2337/db11-1393; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Yoshida T, 1999, INT J OBESITY, V23, P570, DOI 10.1038/sj.ijo.0800870; Yun Ji Eun, 2012, J Prev Med Public Health, V45, P316, DOI 10.3961/jpmph.2012.45.5.316	49	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102220	10.1371/journal.pone.0102220	http://dx.doi.org/10.1371/journal.pone.0102220			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036316	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200041
J	Zizic, M; Zivic, M; Maksimovic, V; Stanic, M; Krizak, S; Antic, TC; Zakrzewska, J				Zizic, Milan; Zivic, Miroslav; Maksimovic, Vuk; Stanic, Marina; Krizak, Strahinja; Antic, Tijana Cvetic; Zakrzewska, Joanna			Vanadate Influence on Metabolism of Sugar Phosphates in Fungus Phycomyces blakesleeanus	PLOS ONE			English	Article							NUCLEAR MAGNETIC-RESONANCE; FRUCTOSE 2,6-BISPHOSPHATE; SOLUBLE EXOPOLYPHOSPHATASE; SACCHAROMYCES-CEREVISIAE; CARBOHYDRATE-METABOLISM; NEUROSPORA-CRASSA; VANADIUM; INHIBITION; YEAST; TRANSPORT	The biological and chemical basis of vanadium action in fungi is relatively poorly understood. In the present study, we investigate the influence of vanadate (V5+) on phosphate metabolism of Phycomyces blakesleeanus. Addition of V5+ caused increase of sugar phosphates signal intensities in P-31 NMR spectra in vivo. HPLC analysis of mycelial phosphate extracts demonstrated increased concentrations of glucose 6 phosphate, fructose 6 phosphate, fructose 1, 6 phosphate and glucose 1 phosphate after V5+ treatment. Influence of V5+ on the levels of fructose 2, 6 phosphate, glucosamine 6 phosphate and glucose 1, 6 phosphate (HPLC), and polyphosphates, UDPG and ATP (P-31 NMR) was also established. Increase of sugar phosphates content was not observed after addition of vanadyl (V4+), indicating that only vanadate influences its metabolism. Obtained results from in vivo experiments indicate catalytic/inhibitory vanadate action on enzymes involved in reactions of glycolysis and glycogenesis i.e., phosphoglucomutase, phosphofructokinase and glycogen phosphorylase in filamentous fungi.	[Zizic, Milan; Maksimovic, Vuk; Stanic, Marina; Krizak, Strahinja] Univ Belgrade, Inst Multidisciplinary Res, Dept Life Sci, Belgrade, Serbia; [Zivic, Miroslav; Antic, Tijana Cvetic] Univ Belgrade, Fac Biol, Dept Physiol & Biophys, Belgrade, Serbia; [Zakrzewska, Joanna] NMR Lab, Inst Gen & Phys Chem, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Zizic, M (corresponding author), Univ Belgrade, Inst Multidisciplinary Res, Dept Life Sci, Belgrade, Serbia.	mzizic@imsi.rs	Zizic, Milan/T-9537-2019; Živić, Miroslav/GMW-7405-2022	Živić, Miroslav/0000-0002-0314-5032; Cvetic Antic, Tijana/0000-0003-1676-7508; Maksimovic, Vuk/0000-0002-9883-186X; Stanic, Marina/0000-0002-2779-7932; Zizic, Milan/0000-0003-1268-6698	Ministry of Education, Science and Technologic Development of Republic of Serbia [173040]	Ministry of Education, Science and Technologic Development of Republic of Serbia	This work was supported by Grant of Ministry of Education, Science and Technologic Development of Republic of Serbia, 173040, www.mpn.gov.rs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksieva P, 2003, Z NATURFORSCH C, V58, P239; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barany M., 1984, PHOSPHORUS 31 NMR PR, P511; BARTRONS R, 1982, FEBS LETT, V143, P137, DOI 10.1016/0014-5793(82)80290-1; BENABE JE, 1987, J BIOL CHEM, V262, P9555; Berry RE, 1999, ANGEW CHEM INT EDIT, V38, P795, DOI 10.1002/(SICI)1521-3773(19990315)38:6<795::AID-ANIE795>3.0.CO;2-7; BOWMAN BJ, 1983, J BACTERIOL, V153, P286, DOI 10.1128/JB.153.1.286-291.1983; BOWMAN BJ, 1983, J BACTERIOL, V153, P292, DOI 10.1128/JB.153.1.292-296.1983; CARRERAS J, 1982, BIOCHIM BIOPHYS ACTA, V705, P238, DOI 10.1016/0167-4838(82)90183-2; CARRERAS M, 1988, ARCH BIOCHEM BIOPHYS, V264, P155, DOI 10.1016/0003-9861(88)90580-2; CATALAN RE, 1980, BIOCHEM BIOPH RES CO, V96, P672, DOI 10.1016/0006-291X(80)91407-2; CHASTEEN ND, 1990, VANADIUM BIOL SYSTEM; CLIMENT F, 1981, BIOCHEM BIOPH RES CO, V101, P570, DOI 10.1016/0006-291X(81)91297-3; COHEN MD, 1987, INORG CHIM A-BIOINOR, V138, P179, DOI 10.1016/S0020-1693(00)81220-7; CRANS DC, 1992, J AM CHEM SOC, V114, P4926, DOI 10.1021/ja00038a081; Crans DC, 2004, CHEM REV, V104, P849, DOI 10.1021/cr020607t; CRANS DC, 1990, J AM CHEM SOC, V112, P427, DOI 10.1021/ja00157a063; CRANS DC, 1990, BIOCHEMISTRY-US, V29, P6698, DOI 10.1021/bi00480a020; DIEZ M, 1988, INT J BIOCHEM, V20, P801, DOI 10.1016/0020-711X(88)90067-5; Dreuckhammer GD, 1999, J ORG CHEM, V54, P70; EVANS FE, 1977, P NATL ACAD SCI USA, V74, P4909, DOI 10.1073/pnas.74.11.4909; Francois J, 1984, EUR J BIOCHEM, V164, P369; GOMEZFOIX AM, 1988, BIOCHEM J, V255, P507; Gordon J, 2001, METHOD ENZYMOL, V201, P477; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guranowski A, 1998, BBA-GEN SUBJECTS, V1380, P232, DOI 10.1016/S0304-4165(97)00147-5; Han CC, 2009, BIOL TRACE ELEM RES, V127, P278, DOI 10.1007/s12011-008-8246-0; Jolly L, 2000, J BACTERIOL, V182, P1280, DOI 10.1128/JB.182.5.1280-1285.2000; Kalac P, 2000, FOOD CHEM, V69, P273, DOI 10.1016/S0308-8146(99)00264-2; KLEIN G, 1989, J CELL SCI, V94, P127; LORENZ B, 1994, J BIOL CHEM, V269, P22198; Mannazzu I, 2001, ANN MICROBIOL, V51, P1; Mannazzu I, 1997, FEMS MICROBIOL LETT, V147, P23, DOI 10.1016/S0378-1097(96)00497-1; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Milewski S, 2006, YEAST, V23, P1, DOI 10.1002/yea.1337; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; NOURELDEEN AF, 1985, J BIOL CHEM, V260, P6836; OKAR DA, 1995, BIOCHEM J, V308, P189, DOI 10.1042/bj3080189; REHDER D, 1992, BIOMETALS, V5, P3, DOI 10.1007/BF01079691; Rehder D, 2003, INORG CHEM COMMUN, V6, P604, DOI 10.1016/S1387-7003(03)00050-9; Rehder D., 2008, BIOINORGANIC VANADIU; RIDER MH, 1990, EUR J BIOCHEM, V190, P53, DOI 10.1111/j.1432-1033.1990.tb15544.x; RUA J, 1993, J GEN MICROBIOL, V139, P217, DOI 10.1099/00221287-139-2-217; Rua J, 2008, RES MICROBIOL, V159, P200, DOI 10.1016/j.resmic.2008.01.002; RUDOLPH H, 1970, ARCH MIKROBIOL, V72, P175, DOI 10.1007/BF00409522; SCHWABE U, 1979, NATURE, V277, P143, DOI 10.1038/277143a0; SHANKS JV, 1988, BIOTECHNOL BIOENG, V32, P1138, DOI 10.1002/bit.260320907; Stanic M, 2013, RES MICROBIOL, V164, P770, DOI 10.1016/j.resmic.2013.03.002; STANKIEWICZ PJ, 1995, MET IONS BIOL SYST, V31, P287; SUTTER RP, 1975, P NATL ACAD SCI USA, V72, P127, DOI 10.1073/pnas.72.1.127; Tsiani E, 1997, TEM, V8, P52; TU JC, 1977, CYTOBIOS, V20, P121; VANDERCAMMEN A, 1990, J GEN MICROBIOL, V136, P137, DOI 10.1099/00221287-136-1-137; VANLAERE A, 1983, P NATL ACAD SCI-BIOL, V80, P6601; VANLAERE AJ, 1983, J GEN MICROBIOL, V129, P3281; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P2861; Voet D, 1995, BIOCHEMISTRY-US, P497; WURST H, 1994, J BIOL CHEM, V269, P10996; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995; Zivic M, 2007, ANTON LEEUW INT J G, V91, P169, DOI 10.1007/s10482-006-9108-4; Zizic M, 2013, THESIS U BELGRADE; Zizic M, 2013, RES MICROBIOL, V164, P61, DOI 10.1016/j.resmic.2012.08.007	62	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102849	10.1371/journal.pone.0102849	http://dx.doi.org/10.1371/journal.pone.0102849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036378	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200090
J	Broker, MEE; Ijzermans, JNM; Witjes, CDM; van Vuuren, HJ; de Man, RA				Broker, Mirelle E. E.; Ijzermans, Jan N. M.; Witjes, Caroline D. M.; van Vuuren, Hanneke J.; de Man, Robert A.			The Predictive Value of Golgi Protein 73 in Differentiating Benign from Malignant Liver Tumors	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; SERUM MARKER; ALPHA-FETOPROTEIN; GP73; EXPRESSION; BIOMARKERS; HEPATITIS; CORRELATE; GOLPH2	Introduction: In the work up of primary solid liver lesions it is essential to differentiate correctly between benign and malignant tumors, such as hepatocellular adenoma (HCA) and hepatocellular carcinoma (HCC) respectively. A promising new marker to detect HCC is Golgi Protein 73 (GP73). Studies comparing patients with HCC and cirrhosis with normal controls suggested that GP73 is specific for patients with HCC; however, patients with other liver tumors were not included. We therefore studied the predictive value of GP73 in differentiating between solid benign and malignant liver tumors. Materials and Methods: This study included 264 patients: 88 patients with HCC, 88 with hepatocellular adenoma (HCA), and 88 with focal nodal hyperplasia (FNH). A blood sample was collected from each patient to measure GP73 levels using a quantitative ELISA assay and differences in outcome between subgroups were compared. The receiver operating characteristic (ROC) curve, sensitivity and specificity of GP73 were calculated and compared to alpha-fetoprotein (AFP) levels. Results: When comparing malignant and benign liver tumors the area under ROC was 0.701 and 0.912 for GP73 and AFP respectively. Test characteristics revealed a sensitivity of 60% for GP73 and 65% for AFP; in addition the specificity was 77% for GP73 and 96% for AFP. Conclusion: Although the literature suggests that GP73 is a valuable serum marker in patients with HCC, the serum concentration may also be increased in patients with solid benign liver tumors. Therefore, a GP73 assay is less suitable for discriminating between primary malignant and benign tumors of the liver.	[Broker, Mirelle E. E.; Ijzermans, Jan N. M.; Witjes, Caroline D. M.] Erasmus MC, Dept Surg, Rotterdam, Netherlands; [van Vuuren, Hanneke J.; de Man, Robert A.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Broker, MEE (corresponding author), Erasmus MC, Dept Surg, Rotterdam, Netherlands.	m.broker@erasmusmc.nl						Assy N, 2009, WORLD J GASTROENTERO, V15, P3217, DOI 10.3748/wjg.15.3217; Block TM, 2005, P NATL ACAD SCI USA, V102, P779, DOI 10.1073/pnas.0408928102; Cardinale V, 2012, HEPATOLOGY, V55, DOI 10.1002/hep.25587; Comunale MA, 2004, PROTEOMICS, V4, P826, DOI 10.1002/pmic.200300625; Ehrl Denis, 2012, HPB Surg, V2012, P891787, DOI 10.1155/2012/891787; Evers ACC, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5639; Gu YL, 2009, ANN CLIN BIOCHEM, V46, P38, DOI 10.1258/acb.2008.008088; Hou SC, 2013, ONCOL LETT, V6, P1152, DOI 10.3892/ol.2013.1522; Hu JS, 2010, MED ONCOL, V27, P339, DOI 10.1007/s12032-009-9215-y; Kladney RD, 2002, HEPATOLOGY, V35, P1431, DOI 10.1053/jhep.2002.32525; LITTLE JM, 1990, WORLD J SURG, V14, P448, DOI 10.1007/BF01658665; Mao YL, 2010, GUT, V59, P1687, DOI 10.1136/gut.2010.214916; Marrero JA, 2005, J HEPATOL, V43, P1007, DOI 10.1016/j.jhep.2005.05.028; Morota K, 2011, CLIN CHEM LAB MED, V49, P711, DOI 10.1515/CCLM.2011.097; Riener MO, 2009, HEPATOLOGY, V49, P1602, DOI 10.1002/hep.22843; Sarbah SA, 2004, DIGEST DIS SCI, V49, P850, DOI 10.1023/B:DDAS.0000030098.75759.32; Shan SG, 2013, HEPATOL RES; Shi Y, 2011, TECHNOL CANCER RES T, V10, P287, DOI 10.7785/tcrt.2012.500205; Tian LY, 2011, INT J CANCER, V129, P1923, DOI 10.1002/ijc.25838; Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980; Wise J, 2008, BRIT MED J, V336, P1041, DOI 10.1136/bmj.39560.444468.AD; Witjes CDM, 2013, HEPATOL INT, V7, P59, DOI 10.1007/s12072-012-9374-3; Zhou Y, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-17	23	14	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100187	10.1371/journal.pone.0100187	http://dx.doi.org/10.1371/journal.pone.0100187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033446	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300006
J	Quaiser, A; Bodi, X; Dufresne, A; Naquin, D; Francez, AJ; Dheilly, A; Coudouel, S; Pedrot, M; Vandenkoornhuyse, P				Quaiser, Achim; Bodi, Xavier; Dufresne, Alexis; Naquin, Delphine; Francez, Andre-Jean; Dheilly, Alexandra; Coudouel, Sophie; Pedrot, Mathieu; Vandenkoornhuyse, Philippe			Unraveling the Stratification of an Iron-Oxidizing Microbial Mat by Metatranscriptomics	PLOS ONE			English	Article							SEQUENCE; METHANOTROPHS; METAGENOMICS; SEDIMENT; SOFTWARE; DENMARK; AARHUS; SEA	A metatranscriptomic approach was used to study community gene expression in a naturally occurring iron-rich microbial mat. Total microbial community RNA was reversely transcribed and sequenced by pyrosequencing. Characterization of expressed gene sequences provided accurate and detailed information of the composition of the transcriptionally active community and revealed phylogenetic and functional stratifications within the mat. Comparison of 16S rRNA reads and delineation of OTUs showed significantly lower values of metatranscriptomic-based richness and diversity in the upper parts of the mat than in the deeper regions. Taxonomic affiliation of rRNA sequences and mRNA genome recruitments indicated that iron-oxidizing bacteria affiliated to the genus Leptothrix, dominated the community in the upper layers of the mat. Surprisingly, type I methanotrophs contributed to the majority of the sequences in the deep layers of the mat. Analysis of mRNA expression patterns showed that genes encoding the three subunits of the particulate methane monooxygenase (pmoCAB) were the most highly expressed in our dataset. These results provide strong hints that iron-oxidation and methane-oxidation occur simultaneously in microbial mats and that both groups of microorganisms are major players in the functioning of this ecosystem.	[Quaiser, Achim; Bodi, Xavier; Dufresne, Alexis; Francez, Andre-Jean; Vandenkoornhuyse, Philippe] Univ Rennes 1, CNRS EcoBio UMR6553, Rennes, France; [Naquin, Delphine] CNRS FRC3115 Ctr Recherches Gif Sur Yvette, Gif Sur Yvette, France; [Dheilly, Alexandra; Coudouel, Sophie] Univ Rennes 1, CNRS OSUR UMS3343, Plateforme Genom Environm & Fonct, Rennes, France; [Pedrot, Mathieu] Univ Rennes 1, CNRS Geosci UMR6118, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes	Quaiser, A (corresponding author), Univ Rennes 1, CNRS EcoBio UMR6553, Rennes, France.	Achim.Quaiser@univ-rennes1.fr	Pédrot, Mathieu/AAG-5794-2020	Naquin, Delphine/0000-0001-9174-4686; Pedrot, Mathieu/0000-0001-5215-3808; Dufresne, Alexis/0000-0001-8231-9098	INSU-CNRS EC2CO program; University of Rennes/CNRS; council of "Region Bretagne''; Observatoire des Sciences de l'Univers de Rennes'	INSU-CNRS EC2CO program; University of Rennes/CNRS; council of "Region Bretagne''; Observatoire des Sciences de l'Univers de Rennes'	This work was supported by funding from the INSU-CNRS EC2CO program, a grant from the University of Rennes/CNRS, from the council of "Region Bretagne'' and from the "Observatoire des Sciences de l'Univers de Rennes'' to A. Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bodelier PLE, 2012, ECOL EVOL, V2, P106, DOI 10.1002/ece3.34; Bruun AM, 2010, GEOMICROBIOL J, V27, P15, DOI 10.1080/01490450903232165; Chan CS, 2009, GEOCHIM COSMOCHIM AC, V73, P3807, DOI 10.1016/j.gca.2009.02.036; Chan CS, 2004, SCIENCE, V303, P1656, DOI 10.1126/science.1092098; Davis RE, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005413; Dopheide A, 2011, APPL ENVIRON MICROB, V77, P4564, DOI 10.1128/AEM.02421-10; EMERSON D, 1994, APPL ENVIRON MICROB, V60, P4022, DOI 10.1128/AEM.60.11.4022-4031.1994; EMERSON D, 1994, APPL ENVIRON MICROB, V60, P4032, DOI 10.1128/AEM.60.11.4032-4038.1994; Fleming EJ, 2014, ISME J, V8, P804, DOI 10.1038/ismej.2013.197; Fleming EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017769; Han JI, 2004, ENVIRON MICROBIOL, V6, P388, DOI 10.1111/j.1462-2920.2004.00572.x; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488; Kato S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00089; Kato S, 2009, ENVIRON MICROBIOL, V11, P3210, DOI 10.1111/j.1462-2920.2009.02031.x; KOMADEL P, 1988, CLAY CLAY MINER, V36, P379, DOI 10.1346/CCMN.1988.0360415; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Liu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00037; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Omoregie EO, 2008, APPL ENVIRON MICROB, V74, P3198, DOI 10.1128/AEM.01751-07; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Radax R, 2012, ENVIRON MICROBIOL, V14, P1308, DOI 10.1111/j.1462-2920.2012.02714.x; Reim A, 2012, ISME J, V6, P2128, DOI 10.1038/ismej.2012.57; Roden EE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00172; Schloss PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-34; Semrau JD, 2010, FEMS MICROBIOL REV, V34, P496, DOI 10.1111/j.1574-6976.2010.00212.x; SINGER PC, 1970, SCIENCE, V167, P1121, DOI 10.1126/science.167.3921.1121; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Svenning MM, 2011, J BACTERIOL, V193, P6418, DOI 10.1128/JB.05380-11; Trotsenko YA, 2008, ADV APPL MICROBIOL, V63, P183, DOI 10.1016/S0065-2164(07)00005-6; Urich T, 2011, HDB MOL MICROBIAL EC, P587; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Vollrath S, 2012, GEOMICROBIOL J, V29, P550, DOI 10.1080/01490451.2011.594147; Wang JJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00064; Weber KA, 2006, ENVIRON MICROBIOL, V8, P100, DOI 10.1111/j.1462-2920.2005.00873.x; WR-PO, 2010, R LANG ENV STAT COMP	41	25	25	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102561	10.1371/journal.pone.0102561	http://dx.doi.org/10.1371/journal.pone.0102561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033299	Green Published, gold			2022-12-25	WOS:000339418300060
J	Xie, XS; Zubarev, RA				Xie, Xueshu; Zubarev, Roman A.			Effects of Low-Level Deuterium Enrichment on Bacterial Growth	PLOS ONE			English	Article							HEAVY-WATER; BIOLOGICAL PROCESSES; STABLE-ISOTOPES; CULTIVATION; SPECIFICITY; CELLS; D2O	Using very precise (+/- 0.05%) measurements of the growth parameters for bacteria E. coli grown on minimal media, we aimed to determine the lowest deuterium concentration at which the adverse effects that are prominent at higher enrichments start to become noticeable. Such a threshold was found at 0.5% D, a surprisingly high value, while the ultralow deuterium concentrations (<= 0.25% D) showed signs of the opposite trend. Bacterial adaptation for 400 generations in isotopically different environment confirmed preference for ultralow (<= 0.25% D) enrichment. This effect appears to be similar to those described in sporadic but multiple earlier reports. Possible explanations include hormesis and isotopic resonance phenomena, with the latter explanation being favored.	[Xie, Xueshu; Zubarev, Roman A.] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 1, Stockholm, Sweden	Karolinska Institutet	Zubarev, RA (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 1, Stockholm, Sweden.	Roman.Zubarev@ki.se	Zubarev, Roman A/W-7891-2018	Zubarev, Roman A/0000-0001-9839-2089; Xie, Xueshu/0000-0002-5605-1961	Swedish Research Council [2011-3726]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (Grant # 2011-3726). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes TC, 1934, SCIENCE, V79, P370, DOI 10.1126/science.79.2051.370; Barnes T. C, 1935, PROTOPLASMA, V22, P431; Barnes T. C, 1933, J AM CHEM SOC, V55, P4332; Barnes T. C, 1933, J AM CHEM SOC, V55, P5059; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P667, DOI 10.1177/0960327109358917; Curry J, 1935, SCIENCE, V81, P275, DOI 10.1126/science.81.2098.275; Ernest B, 1960, PROC NATL ACAD SCI, V46, P777; FOWLER EB, 1972, BIOTECHNOL BIOENG, V14, P819, DOI 10.1002/bit.260140511; Hammel SC, 2013, REJUV RES, V16, P98, DOI 10.1089/rej.2012.1368; Katz J. J., 1971, ISOTOPE EFFECTS CHEM, P286; KATZ JJ, 1966, SCIENCE, V151, P1187, DOI 10.1126/science.151.3715.1187; KATZ JJ, 1957, JNCI-J NATL CANCER I, V18, P641; Koletzko B, 1997, EUR J PEDIATR, V156, pS12, DOI 10.1007/PL00014267; Kreuzer-Martin HW, 2007, APPL ENVIRON MICROB, V73, P3896, DOI 10.1128/AEM.02906-06; Kreuzer-Martin HW, 2006, BIOCHEMISTRY-US, V45, P13622, DOI 10.1021/bi0609164; LOBYSHEV VI, 1983, BIOFIZIKA+, V28, P666; LOBYSHEV VI, 1982, BIOFIZIKA+, V27, P595; LOBYSHEV VI, 1978, BIOFIZIKA+, V23, P390; Lockemann G, 1934, BER DTSCH CHEM GES, V67, P1299, DOI 10.1002/cber.19340670733; Madigan M.T., 2012, BROCK BIOLOGY OF MIC; Nikitin DI, 2003, BIOFIZIKA+, V48, P678; Paliy O, 2003, J APPL MICROBIOL, V94, P580, DOI 10.1046/j.1365-2672.2003.01866.x; ROKOP S, 1969, BIOCHIM BIOPHYS ACTA, V191, P707, DOI 10.1016/0005-2744(69)90365-9; Sambrook J., 2001, MOL CLONING LAB MANU; SOMLYAI G, 1993, FEBS LETT, V317, P1, DOI 10.1016/0014-5793(93)81479-J; UPHAUS RA, 1967, BIOCHIM BIOPHYS ACTA, V141, P625, DOI 10.1016/0304-4165(67)90191-2; Urey HC, 1932, PHYS REV, V39, P164, DOI 10.1103/PhysRev.39.164; Zubarev Roman A., 2011, Genomics Proteomics & Bioinformatics, V9, P15, DOI 10.1016/S1672-0229(11)60003-X; Zubarev RA, 2010, CENT EUR J BIOL, V5, P190, DOI 10.2478/s11535-009-0069-2	29	15	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102071	10.1371/journal.pone.0102071	http://dx.doi.org/10.1371/journal.pone.0102071			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033078	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300034
J	Zhang, J; Zhang, M; Tian, SK; Lu, LL; Shohag, MJI; Yang, XE				Zhang, Jie; Zhang, Min; Tian, Shengke; Lu, Lingli; Shohag, M. J. I.; Yang, Xiaoe			Metallothionein 2 (SaMT2) from Sedum alfredii Hance Confers Increased Cd Tolerance and Accumulation in Yeast and Tobacco	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; COLOCASIA-ESCULENTA; CADMIUM TOLERANCE; GENE FAMILY; HYPERACCUMULATOR; EXPRESSION; COPPER; MECHANISMS; ECOTYPES; ENZYMES	Metallothioneins are cysteine-rich metal-binding proteins. In the present study, SaMT2, a type 2 metallothionein gene, was isolated from Cd/Zn co-hyperaccumulator Sedum alfredii Hance. SaMT2 encodes a putative peptide of 79 amino acid residues including two cysteine-rich domains. The transcript level of SaMT2 was higher in shoots than in roots of S. alfredii, and was significantly induced by Cd and Zn treatments. Yeast expression assay showed SaMT2 significantly enhanced Cd tolerance and accumulation in yeast. Ectopic expression of SaMT2 in tobacco enhanced Cd and Zn tolerance and accumulation in both shoots and roots of the transgenic plants. The transgenic plants had higher antioxidant enzyme activities and accumulated less H2O2 than wild-type plants under Cd and Zn treatment. Thus, SaMT2 could significantly enhance Cd and Zn tolerance and accumulation in transgenic tobacco plants by chelating metals and improving antioxidant system.	[Zhang, Jie; Zhang, Min; Tian, Shengke; Lu, Lingli; Shohag, M. J. I.; Yang, Xiaoe] Zhejiang Univ, Coll Environm & Resource Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yang, XE (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	xyang@zju.edu.cn	Shohag, Md. J. I./I-3060-2014; Tian, Shengke/G-8307-2016; Zhang, Jie/E-4768-2013	Shohag, Md. J. I./0000-0002-8799-4401; Tian, Shengke/0000-0001-8242-3581; Zhang, Jie/0000-0002-8344-5907	Fundamental Research Funds for the Central Universities [2013FZA6005]; National Natural Science Foundation of China [31372128, 21177107]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study was supported by the Fundamental Research Funds for the Central Universities (No. 2013FZA6005), National Natural Science Foundation of China (No. 31372128; 21177107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks RR, 1998, PLANTS THAT HYPERACCUMULATE HEAVY METALS: THEIR ROLE IN PHYTOREMEDIATION, MICROBIOLOGY, ARCHAEOLOGY, MINERAL EXPLORATION AND PHYTOMINING, P55; CAKMAK I, 1993, J EXP BOT, V44, P127, DOI 10.1093/jxb/44.1.127; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Guo WJ, 2003, NEW PHYTOL, V159, P369, DOI 10.1046/j.1469-8137.2003.00813.x; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Hassinen VH, 2011, PLANT BIOLOGY, V13, P225, DOI 10.1111/j.1438-8677.2010.00398.x; Hassinen VH, 2009, J EXP BOT, V60, P187, DOI 10.1093/jxb/ern287; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hsieh HM, 1996, PLANT MOL BIOL, V32, P525, DOI 10.1007/BF00019104; HSIEH HM, 1995, PLANT MOL BIOL, V28, P381, DOI 10.1007/BF00020388; Jin XF, 2008, J HAZARD MATER, V156, P387, DOI 10.1016/j.jhazmat.2007.12.064; Jin XF, 2008, ENVIRON TOXICOL, V23, P517, DOI 10.1002/tox.20362; Kim YO, 2013, PLANT PHYSIOL BIOCH, V64, P25, DOI 10.1016/j.plaphy.2012.12.009; Kim YO, 2011, BIOSCI BIOTECH BIOCH, V75, P1912, DOI 10.1271/bbb.110289; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Lv YY, 2013, PLANT SOIL, V367, P507, DOI 10.1007/s11104-012-1486-y; McGrath SP, 2003, CURR OPIN BIOTECH, V14, P277, DOI 10.1016/S0958-1669(03)00060-0; Mir G, 2004, J EXP BOT, V55, P2483, DOI 10.1093/jxb/erh254; Roosens NH, 2004, FEBS LETT, V577, P9, DOI 10.1016/j.febslet.2004.08.084; Sekhar K, 2011, ENVIRON EXP BOT, V72, P131, DOI 10.1016/j.envexpbot.2011.02.017; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; Xia Y, 2012, ACTA PHYSIOL PLANT, V34, P1819, DOI 10.1007/s11738-012-0980-4; Xia Y, 2012, J HAZARD MATER, V233, P65, DOI 10.1016/j.jhazmat.2012.06.047; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Yang X, 2002, CHINESE SCI BULL, V47, P1634, DOI 10.1360/02tb9359; Yang XE, 2004, PLANT SOIL, V259, P181, DOI 10.1023/B:PLSO.0000020956.24027.f2; Zhao FJ, 2009, CURR OPIN PLANT BIOL, V12, P373, DOI 10.1016/j.pbi.2009.04.005; ZHENG X, 1992, PLANT SCI, V81, P47, DOI 10.1016/0168-9452(92)90023-F; ZHOU JM, 1995, MOL GEN GENET, V248, P318, DOI 10.1007/BF02191599	32	55	61	7	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102750	10.1371/journal.pone.0102750	http://dx.doi.org/10.1371/journal.pone.0102750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032704	Green Submitted, gold, Green Published			2022-12-25	WOS:000339418300087
J	Afonso, P; McGinty, N; Machete, M				Afonso, Pedro; McGinty, Niall; Machete, Miguel			Dynamics of Whale Shark Occurrence at Their Fringe Oceanic Habitat	PLOS ONE			English	Article							RHINCODON-TYPUS; NORTH-ATLANTIC; CLIMATE-CHANGE; NURSERY AREAS; INDIAN-OCEAN; ECOLOGY; CONSERVATION; OSCILLATION; FISHERIES; BYCATCH	Studies have shown that the whale shark (Rhincodon typus), a vulnerable large filter feeder, seasonally aggregates at highly productive coastal sites and that individuals can perform large, trans-boundary migrations to reach these locations. Yet, the whereabouts of the whale shark when absent from these sites and the potential oceanographic and biological drivers involved in shaping their present and future habitat use, including that located at the fringes of their suitable oceanic habitat, are largely unknown. We analysed a 16-year (1998-2013) observer dataset from the pole-and-line tuna fishery across the Azores (mid-North Atlantic) and used GAM models to investigate the spatial and temporal patterns of whale shark occurrence in relation to oceanographic features. Across this period, the whale shark became a regular summer visitor to the archipelago after a sharp increase in sighting frequency seen in 2008. We found that SST helps predicting their occurrence in the region associated to the position of the seasonal 22 degrees C isotherm, showing that the Azores are at a thermal boundary for this species and providing an explanation for the post 2007 increase. Within the region, whale shark detections were also higher in areas of increased bathymetric slope and closer to the seamounts, coinciding with higher chla biomass, a behaviour most probably associated to increased feeding opportunities. They also showed a tendency to be clustered around the southernmost island of Santa Maria. This study shows that the region integrates the oceanic habitat of adult whale shark and suggests that an increase in its relative importance for the Atlantic population might be expected in face of climate change.	[Afonso, Pedro; McGinty, Niall] Univ Azores, IMAR Inst Marine Res, Dept Oceanog & Fisheries, Horta, Portugal; [Machete, Miguel] LARSyS Lab Robot & Syst Engn & Sci, Lisbon, Portugal; [McGinty, Niall] Univ Iceland, Dept Life & Hlth Sci, MARICE Marine Acad Res Iceland, Reykjavik, Iceland	Universidade dos Acores; University of Iceland	Afonso, P (corresponding author), Univ Azores, IMAR Inst Marine Res, Dept Oceanog & Fisheries, Horta, Portugal.	afonso@uac.pt	Afonso, Pedro/B-7815-2013	Afonso, Pedro/0000-0002-4618-2589	Portuguese Foundation for Science and Technology/Ministry of Education and Science (FCT/MCTES-MEC) through Ciencia POPH/QREN; LARSyS Strategic Project [PEst/OE/EEI/LA00009/2011]; MADE project [EU/FP7-KBBE-2007-1]	Portuguese Foundation for Science and Technology/Ministry of Education and Science (FCT/MCTES-MEC) through Ciencia POPH/QREN; LARSyS Strategic Project; MADE project	This research was partially supported by the Portuguese Foundation for Science and Technology/Ministry of Education and Science (FCT/MCTES-MEC) through individual support to P. A. (Ciencia 2008/POPH/QREN) and the LARSyS Strategic Project (PEst/OE/EEI/LA00009/2011) 2011-2012, and by the MADE project (EU/FP7-KBBE-2007-1) through individual support to N.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amande MJ, 2010, AQUAT LIVING RESOUR, V23, P353, DOI 10.1051/alr/2011003; [Anonymous], 2010, R LANG ENV STAT COMP; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bashmachnikov I, 2004, P SOC PHOTO-OPT INS, V5569, P148, DOI 10.1117/12.565596; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Brunnschweiler JM, 2011, AM FISHERIES SOC S, V76, P1; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cardenas-Palomo N, 2010, REV BIOL TROP, V58, P399; Clarke M.R., 1995, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V13A, P53; Clarke M.R., 1996, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V14A, P41; Compagno LJV, 2001, SHARKS WORLD ANNOT; Venegas RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018994; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; Granadeiro JP, 1998, MAR ECOL PROG SER, V166, P267, DOI 10.3354/meps166267; Henson SA, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005139; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Ketchum JT, 2013, ENVIRON BIOL FISH, V96, P779, DOI 10.1007/s10641-012-0071-9; Kinney MJ, 2009, CONSERV LETT, V2, P53, DOI 10.1111/j.1755-263X.2008.00046.x; Leterme SC, 2005, LIMNOL OCEANOGR, V50, P1244, DOI 10.4319/lo.2005.50.4.1244; Marra G, 2011, COMPUT STAT DATA AN, V55, P2372, DOI 10.1016/j.csda.2011.02.004; Martin RA, 2007, FISH RES, V84, P10, DOI 10.1016/j.fishres.2006.11.010; Martinez E, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006836; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Norman B, 2005, IUCN 2012 IUCN RED L; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pravin P, 2000, CURR SCI INDIA, V79, P310; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Romanov EV, 2002, FISH B-NOAA, V100, P90; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; Sequeira AMM, 2013, J FISH BIOL, V82, P367, DOI 10.1111/jfb.12017; Sequeira A, 2012, DIVERS DISTRIB, V18, P504, DOI 10.1111/j.1472-4642.2011.00853.x; Sequeira AMM, 2014, GLOBAL CHANGE BIOL, V20, P778, DOI 10.1111/gcb.12343; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Sleeman JC, 2010, J EXP MAR BIOL ECOL, V382, P77, DOI 10.1016/j.jembe.2009.10.015; Stevens JD, 2007, FISH RES, V84, P4, DOI 10.1016/j.fishres.2006.11.008; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wiafe G, 2008, ICES J MAR SCI, V65, P318, DOI 10.1093/icesjms/fsn042; Wilson SG, 2001, ENVIRON BIOL FISH, V61, P1, DOI 10.1023/A:1011069914753; Wolfson F.H., 1986, P208; Yochanan K, 2010, J CLIMATE, V23, P5610; ZWEIG MH, 1993, CLIN CHEM, V39, P561	44	26	27	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102060	10.1371/journal.pone.0102060	http://dx.doi.org/10.1371/journal.pone.0102060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028929	Green Submitted, gold, Green Published			2022-12-25	WOS:000341306600032
J	Kim, SC; Park, SW; Ryoo, I; Jung, SC; Yun, TJ; Choi, SH; Kim, JH; Sohn, CH				Kim, Soo Chin; Park, Sun-Won; Ryoo, Inseon; Jung, Seung Chai; Yun, Tae Jin; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho			Contrast-Enhanced FLAIR (Fluid-Attenuated Inversion Recovery) for Evaluating Mild Traumatic Brain Injury	PLOS ONE			English	Article							DIFFUSE AXONAL INJURY; HEAD-INJURY; SUBDURAL-HEMATOMA; MR; MENINGES; SEQUELAE; RESECTION; SPACE; SITE	Purpose: To evaluate whether adding a contrast-enhanced fluid-attenuated inversion recovery (FLAIR) sequence to routine magnetic resonance imaging (MRI) can detect additional abnormalities in the brains of symptomatic patients with mild traumatic brain injury. Materials and Methods: Fifty-four patients with persistent symptoms following mild closed head injury were included in our retrospective study (M:F = 32: 22, mean age: 59.8 +/- 16.4, age range: 26-84 years). All MRI examinations were obtained within 14 days after head trauma (mean: 3.2 +/- 4.1 days, range: 0.2-14 days). Two neuroradiologists recorded (1) the presence of traumatic brain lesions on MR images with and without contrast-enhanced FLAIR images and (2) the pattern and location of meningeal enhancement depicted on contrast-enhanced FLAIR images. The number of additional traumatic brain lesions diagnosed with contrast-enhanced FLAIR was recorded. Correlations between meningeal enhancement and clinical findings were also evaluated. Results: Traumatic brain lesions were detected on routine image sequences in 25 patients. Three additional cases of brain abnormality were detected with the contrast-enhanced FLAIR images. Meningeal enhancement was identified on contrast-enhanced FLAIR images in 9 cases while the other routine image sequences showed no findings of traumatic brain injury. Overall, the additional contrast-enhanced FLAIR images revealed more extensive abnormalities than routine imaging in 37 cases (p<0.001). In multivariate logistic regression analysis, subdural hematoma and posttraumatic loss of consciousness showed a significant association with meningeal enhancement on contrast-enhanced FLAIR images, with odds ratios 13.068 (95% confidence interval 2.037 to 83.852), and 15.487 (95% confidence interval 2.545 to 94.228), respectively. Conclusion: Meningeal enhancement on contrast-enhanced FLAIR images can help detect traumatic brain lesions as well as additional abnormalities not identified on routine unenhanced MRI. Therefore contrast-enhanced FLAIR MR imaging is recommended when a contrast MR study is indicated in a patient with a symptomatic prior closed mild head injury.	[Kim, Soo Chin; Park, Sun-Won] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Radiol, Seoul, South Korea; [Kim, Soo Chin; Park, Sun-Won; Ryoo, Inseon; Jung, Seung Chai; Yun, Tae Jin; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Ryoo, Inseon] Korea Univ, Guro Hosp, Dept Radiol, Seoul, South Korea; [Jung, Seung Chai] Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Yun, Tae Jin; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Asan Medical Center; Seoul National University (SNU); Seoul National University Hospital	Park, SW (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Radiol, Seoul, South Korea.	swpark8802@gmail.com	Sohn, ChulHo/AAV-4565-2021	Choi, Seung Hong/0000-0002-0412-2270				Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Atkinson JLD, 2003, J MAGN RESON IMAGING, V17, P484, DOI 10.1002/jmri.10275; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; BURKE JW, 1990, RADIOLOGY, V174, P99, DOI 10.1148/radiology.174.1.2294579; Dolinskas CA, 1998, AM J NEURORADIOL, V19, P419; Domenicucci M, 1998, NEUROSURGERY, V42, P51, DOI 10.1097/00006123-199801000-00010; ELSTER AD, 1990, RADIOLOGY, V174, P93, DOI 10.1148/radiology.174.1.2294578; Ercan N, 2004, AM J NEURORADIOL, V25, P761; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Fukuoka H, 2010, AM J NEURORADIOL, V31, P868, DOI 10.3174/ajnr.A1937; Gasparotti R, 2011, INSIGHTS IMAGING, V2, P335, DOI 10.1007/s13244-011-0086-3; Goo HW, 2003, PEDIATR RADIOL, V33, P843, DOI 10.1007/s00247-003-1057-8; HAINES DE, 1991, ANAT RECORD, V230, P3, DOI 10.1002/ar.1092300103; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Henegar MM, 1996, J NEUROSURG, V84, P174, DOI 10.3171/jns.1996.84.2.0174; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Mathews VP, 1999, RADIOLOGY, V211, P257, DOI 10.1148/radiology.211.1.r99mr25257; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Rapana A, 1997, CLIN NEUROL NEUROSUR, V99, P124, DOI 10.1016/S0303-8467(96)00585-9; Romano Valerie A., 1994, Journal of Emergency Medicine, V12, P369, DOI 10.1016/0736-4679(94)90280-1; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Sato N, 1997, RADIOLOGY, V204, P839, DOI 10.1148/radiology.204.3.9280269; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Smirniotopoulos JG, 2007, RADIOGRAPHICS, V27, P525, DOI 10.1148/rg.272065155; Soman S, 2013, AM J NEURORADIOL, V34, P2092, DOI 10.3174/ajnr.A3595; SZE G, 1993, AM J ROENTGENOL, V160, P727, DOI 10.2214/ajr.160.4.8456653; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	33	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102229	10.1371/journal.pone.0102229	http://dx.doi.org/10.1371/journal.pone.0102229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028975	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600049
J	Rosler, TW; Matusch, A; Librizzi, D; Arias-Carrion, O; Freundlieb, N; Hoeffken, H; Oertel, WH; Depboylu, C; Hoglinger, GU				Roesler, Thomas W.; Matusch, Andreas; Librizzi, Damiano; Arias-Carrion, Oscar; Freundlieb, Nils; Hoeffken, Helmut; Oertel, Wolfgang H.; Depboylu, Candan; Hoeglinger, Guenter U.			Diesterified Derivatives of 5-Iodo-2 '-Deoxyuridine as Cerebral Tumor Tracers	PLOS ONE			English	Article							FLUORINATED THYMIDINE DERIVATIVES; IMAGING CELL-PROLIFERATION; BRAIN-TUMORS; IODODEOXYURIDINE; GLIOMAS; ANALOG; MOUSE; PET	With the aim to develop beneficial tracers for cerebral tumors, we tested two novel 5-iodo-2'-deoxyuridine (IUdR) derivatives, diesterified at the deoxyribose residue. The substances were designed to enhance the uptake into brain tumor tissue and to prolong the availability in the organism. We synthesized carrier added 5-[I-125]iodo-3',5'-di-O-acetyl-2'-deoxyuridine (Ac-2[I-125]IUdR), 5-[I-125]iodo-3',5'-di-O-pivaloyl-2'-deoxyuridine (Piv(2)[I-125]IUdR) and their respective precursor molecules for the first time. HPLC was used for purification and to determine the specific activities. The iodonucleoside tracer were tested for their stability against human thymidine phosphorylase. DNA integration of each tracer was determined in 2 glioma cell lines (Gl261, CRL2397) and in PC12 cells in vitro. In mice, we measured the relative biodistribution and the tracer uptake in grafted brain tumors. Ac-2[I-125]IUdR, Piv(2)[I-125]IUdR and [I-125]IUdR (control) were prepared with labeling yields of 31-47% and radiochemical purities of >99% (HPLC). Both diesterified iodonucleoside tracers showed a nearly 100% resistance against degradation by thymidine phosphorylase. Ac-2[I-125]IUdR and Piv(2)[I-125]IUdR were specifically integrated into the DNA of all tested tumor cell lines but to a less extend than the control [I-125]IUdR. In mice, 24 h after i.p. injection, brain radioactivity uptakes were in the following order Piv(2)[I-125]IUdR > Ac-2[I-125]IUdR>[I-125]IUdR. For Ac-2[I-125]IUdR we detected lower amounts of radioactivities in the thyroid and stomach, suggesting a higher stability toward deiodination. In mice bearing unilateral graft-induced brain tumors, the uptake ratios of tumor-bearing to healthy hemisphere were 51, 68 and 6 for [I-125]IUdR, Ac-2[I-125]IUdR and Piv(2)[I-125]IUdR, respectively. Esterifications of both deoxyribosyl hydroxyl groups of the tumor tracer IUdR lead to advantageous properties regarding uptake into brain tumor tissue and metabolic stability.	[Roesler, Thomas W.; Matusch, Andreas; Arias-Carrion, Oscar; Freundlieb, Nils; Oertel, Wolfgang H.; Depboylu, Candan; Hoeglinger, Guenter U.] Univ Marburg, Dept Neurol, Marburg, Germany; [Roesler, Thomas W.; Hoeglinger, Guenter U.] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Matusch, Andreas] Res Ctr Julich, Inst Neurosci & Med INM 2, Julich, Germany; [Librizzi, Damiano; Hoeffken, Helmut] Univ Marburg, Dept Nucl Med, Marburg, Germany; [Arias-Carrion, Oscar; Hoeglinger, Guenter U.] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany; [Freundlieb, Nils] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Brain Imaging & Neurostimulat BINS Lab, Hamburg, Germany	Philipps University Marburg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; Research Center Julich; Philipps University Marburg; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Rosler, TW (corresponding author), Univ Marburg, Dept Neurol, Marburg, Germany.	thomas.roesler@dzne.de	Arias-Carrion, Oscar/A-4248-2018; Höglinger, Günter U/F-2388-2015	Arias-Carrion, Oscar/0000-0002-9982-7571; Höglinger, Günter U/0000-0001-7587-6187	Else Kroner-Fresenius Foundation [P35/08//A75/07]; German Research Foundation (DFG) [HO2402/6-1]	Else Kroner-Fresenius Foundation; German Research Foundation (DFG)(German Research Foundation (DFG))	This project was funded by the Else Kroner-Fresenius Foundation P35/08//A75/07. Gunter U. Hoglinger was supported by the German Research Foundation (DFG, HO2402/6-1). Wolfgang H. Oertel is senior research professor of the Charitable Hertie Foundation, Frankfurt/Main, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSMAN JI, 1970, CANCER RES, V30, P2394; Blasberg RG, 2000, CANCER RES, V60, P624; Bronckaers A, 2009, MED RES REV, V29, P903, DOI 10.1002/med.20159; FOULON CF, 1995, APPL RADIAT ISOTOPES, V46, P1039, DOI 10.1016/0969-8043(95)00214-X; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gosh MK, 1992, PHARM RES, V9, P1173; HUGHES WL, 1964, FED PROC, V23, P640; Jacobs AH, 2005, J NUCL MED, V46, P1948; KAWAGUCHI T, 1985, CHEM PHARM BULL, V33, P1652; Langen KJ, 1997, J NUCL MED, V38, P517; Langen KJ, 2006, NUCL MED BIOL, V33, P287, DOI 10.1016/j.nucmedbio.2006.01.002; Larock RC, 2005, TETRAHEDRON, V61, P11427, DOI 10.1016/j.tet.2005.08.065; Machein MR, 2003, BRAIN PATHOL, V13, P582; Pauleit D, 2005, BRAIN, V128, P678, DOI 10.1093/brain/awh399; PRUSOFF WH, 1959, BIOCHIM BIOPHYS ACTA, V32, P295, DOI 10.1016/0006-3002(59)90597-9; PRUSOFF WH, 1960, BIOCHEM PHARMACOL, V3, P110, DOI 10.1016/0006-2952(60)90027-7; QUACKENBUSH RC, 1988, CELL TISSUE KINET, V21, P381, DOI 10.1111/j.1365-2184.1988.tb00797.x; Toyohara J, 2003, NUCL MED BIOL, V30, P687, DOI 10.1016/S0969-8051(03)00081-7; Toyohara J, 2002, J NUCL MED, V43, P1218; Toyohara J, 2006, NUCL MED BIOL, V33, P751, DOI 10.1016/j.nucmedbio.2006.06.003; Toyohara J, 2006, NUCL MED BIOL, V33, P765, DOI 10.1016/j.nucmedbio.2006.06.001	21	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102397	10.1371/journal.pone.0102397	http://dx.doi.org/10.1371/journal.pone.0102397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028935	gold, Green Published, Green Submitted			2022-12-25	WOS:000341306600072
J	Aparna, V; Dineshkumar, K; Mohanalakshmi, N; Velmurugan, D; Hopper, W				Aparna, Vasudevan; Dineshkumar, Kesavan; Mohanalakshmi, Narasumani; Velmurugan, Devadasan; Hopper, Waheeta			Identification of Natural Compound Inhibitors for Multidrug Efflux Pumps of Escherichia coli and Pseudomonas aeruginosa Using In Silico High-Throughput Virtual Screening and In Vitro Validation	PLOS ONE			English	Article							P-GLYCOPROTEIN; RESISTANCE; DOCKING; BERBERINE; PRODUCTS; PROTEIN; ASSAY; SITE	Pseudomonas aeruginosa and Escherichia coli are resistant to wide range of antibiotics rendering the treatment of infections very difficult. A main mechanism attributed to the resistance is the function of efflux pumps. MexAB-OprM and AcrAB-TolC are the tripartite efflux pump assemblies, responsible for multidrug resistance in P. aeruginosa and E. coli respectively. Substrates that are more susceptible for efflux are predicted to have a common pharmacophore feature map. In this study, a new criterion of excluding compounds with efflux substrate-like features was used, thereby refining the selection process and enriching the inhibitor identification process. An in-house database of phytochemicals was created and screened using high-throughput virtual screening against AcrB and MexB proteins and filtered by matching with the common pharmacophore models (AADHR, ADHNR, AAHNR, AADHN, AADNR, AAADN, AAADR, AAANR, AAAHN, AAADD and AAADH) generated using known efflux substrates. Phytochemical hits that matched with any one or more of the efflux substrate models were excluded from the study. Hits that do not have features similar to the efflux substrate models were docked using XP docking against the AcrB and MexB proteins. The best hits of the XP docking were validated by checkerboard synergy assay and ethidium bromide accumulation assay for their efflux inhibition potency. Lanatoside C and diadzein were filtered based on the synergistic potential and validated for their efflux inhibition potency using ethidium bromide accumulation study. These compounds exhibited the ability to increase the accumulation of ethidium bromide inside the bacterial cell as evidenced by these increase in fluorescence in the presence of the compounds. With this good correlation between in silico screening and positive efflux inhibitory activity in vitro, the two compounds, lanatoside C and diadzein could be promising efflux pump inhibitors and effective to use in combination therapy against drug resistant strains of P. aeruginosa and E. coli.	[Aparna, Vasudevan; Dineshkumar, Kesavan; Mohanalakshmi, Narasumani; Hopper, Waheeta] SRM Univ, Dept Bioinformat, Sch Bioengn, Fac Engn & Technol, Kattankulathur, Tamil Nadu, India; [Velmurugan, Devadasan] Univ Madras, Ctr Adv Study Crystallog & Biophys, Madras, Tamil Nadu, India	SRM Institute of Science & Technology Chennai; University of Madras	Hopper, W (corresponding author), SRM Univ, Dept Bioinformat, Sch Bioengn, Fac Engn & Technol, Kattankulathur, Tamil Nadu, India.	hod.bioinfo@ktr.srmuniv.ac.in	Hopper, Waheeta/P-8453-2016; Kesavan, Dinesh Kumar/AAW-1831-2020	Hopper, Waheeta/0000-0001-6912-4835; Kumar Kesavan, Dinesh/0000-0003-2906-8386	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India; SRM University, India	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); SRM University, India	This study was supported by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India, for funding the research and SRM University, India for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askoura M, 2011, LIBYAN J MED, V6, DOI 10.3402/ljm.v6i0.5870; Ball AR, 2006, ACS CHEM BIOL, V1, P594, DOI 10.1021/cb600238x; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Chung SY, 2005, ARCH PHARM RES, V28, P823, DOI 10.1007/BF02977349; CLSI, 2012, M100S22 CLSI; Coldham NG, 2010, J ANTIMICROB CHEMOTH, V65, P1655, DOI 10.1093/jac/dkq169; Du J, 2011, J COMPUT CHEM, V32, P2800, DOI 10.1002/jcc.21859; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Hemaiswarya S, 2008, PHYTOMEDICINE, V15, P639, DOI 10.1016/j.phymed.2008.06.008; Hirakata Y, 2009, INT J ANTIMICROB AG, V34, P343, DOI 10.1016/j.ijantimicag.2009.06.007; Jatana N, 2013, J MOL GRAPH MODEL, V39, P145, DOI 10.1016/j.jmgm.2012.10.010; Kumar A, 2008, J ANTIMICROB CHEMOTH, V61, P1270, DOI 10.1093/jac/dkn088; Lechner D, 2008, J ANTIMICROB CHEMOTH, V62, P345, DOI 10.1093/jac/dkn178; Limtrakul P, 2005, J CHEMOTHERAPY, V17, P86, DOI 10.1179/joc.2005.17.1.86; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Melero CP, 2000, MOLECULES, V5, P51, DOI 10.3390/50100051; Nakashima R, 2013, NATURE, V500, P102, DOI 10.1038/nature12300; Nelson Mark L., 2002, Current Medicinal Chemistry - Anti-Infective Agents, V1, P35, DOI 10.2174/1568012023355054; Peach ML, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-6; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; POISSON J, 1954, CR HEBD ACAD SCI, V238, P1607; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schrodinger, 2011, VERS 9 2; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Stavri M, 2007, J ANTIMICROB CHEMOTH, V59, P1247, DOI 10.1093/jac/dkl460; Stermitz FR, 2001, BIOCHEM SYST ECOL, V29, P793, DOI 10.1016/S0305-1978(01)00025-4; Stermitz FR, 2000, J NAT PROD, V63, P1146, DOI 10.1021/np990639k; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; Vasudevan A., 2014, INT J PHARM PHARM SC, V6, P84; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wise R, 1998, BMJ-BRIT MED J, V317, P609, DOI 10.1136/bmj.317.7159.609; Zhang Z, 2010, WORLD J GASTROENTERO, V16, P1279, DOI 10.3748/wjg.v16.i10.1279	35	72	76	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101840	10.1371/journal.pone.0101840	http://dx.doi.org/10.1371/journal.pone.0101840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025665	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992400024
J	Piacente, F; De Castro, C; Jeudy, S; Molinaro, A; Salis, A; Damonte, G; Bernardi, C; Abergel, C; Tonetti, MG				Piacente, Francesco; De Castro, Cristina; Jeudy, Sandra; Molinaro, Antonio; Salis, Annalisa; Damonte, Gianluca; Bernardi, Cinzia; Abergel, Chantal; Tonetti, Michela G.			Giant Virus Megavirus chilensis Encodes the Biosynthetic Pathway for Uncommon Acetamido Sugars	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycosylation; Virus Structure; Nuclear Magnetic Resonance (NMR); Mass Spectrometry (MS); Gas Chromatography-Mass Spectrometry (GC-MS); Carbohydrate Metabolism; N-Acetyl-L-Rhamnosamine; Megavirus Chilensis; UDP-N-acetylglucosamine	GDP-L-FUCOSE; PSEUDOMONAS-AERUGINOSA; HELICOBACTER-PYLORI; PSEUDAMINIC ACID; D-GLUCOSE; MIMIVIRUS; ENZYMES; 4,6-DEHYDRATASE; IDENTIFICATION; BACILLOSAMINE	Background: Much evidence indicates that giant viruses, including Megavirus chilensis, possibly encode autonomous glycosylation systems. Results: The Megavirus genome encodes proteins involved in the synthesis of 2-acetamido-2,6-dideoxy hexoses. Conclusion:N-Acetyl-rhamnosamine that is found in the virion glycans is produced by a novel viral biosynthetic pathway. Significance: These results will help in understanding the origin and function of the virally encoded glycosylation machineries. Giant viruses mimicking microbes, by the sizes of their particles and the heavily glycosylated fibrils surrounding their capsids, infect Acanthamoeba sp., which are ubiquitous unicellular eukaryotes. The glycans on fibrils are produced by virally encoded enzymes, organized in gene clusters. Like Mimivirus, Megavirus glycans are mainly composed of virally synthesized N-acetylglucosamine (GlcNAc). They also contain N-acetylrhamnosamine (RhaNAc), a rare sugar; the enzymes involved in its synthesis are encoded by a gene cluster specific to Megavirus close relatives. We combined activity assays on two enzymes of the pathway with mass spectrometry and NMR studies to characterize their specificities. Mg534 is a 4,6-dehydratase 5-epimerase; its three-dimensional structure suggests that it belongs to a third subfamily of inverting dehydratases. Mg535, next in the pathway, is a bifunctional 3-epimerase 4-reductase. The sequential activity of the two enzymes leads to the formation of UDP-l-RhaNAc. This study is another example of giant viruses performing their glycan synthesis using enzymes different from their cellular counterparts, raising again the question of the origin of these pathways.	[Piacente, Francesco; Salis, Annalisa; Damonte, Gianluca; Bernardi, Cinzia; Tonetti, Michela G.] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy; [Piacente, Francesco; Salis, Annalisa; Damonte, Gianluca; Bernardi, Cinzia; Tonetti, Michela G.] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [De Castro, Cristina; Molinaro, Antonio] Univ Naples Federico II, Dept Chem Sci, Naples, Italy; [Jeudy, Sandra; Abergel, Chantal] Aix Marseille Univ, CNRS, UMR7256, Struct & Genom Informat Lab,IMM, FR-13288 Marseille, France; [Salis, Annalisa] Univ Genoa, Dept Hearth Environm & Life Sci DISTAV, I-16132 Genoa, Italy	University of Genoa; University of Genoa; University of Naples Federico II; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Genoa	Abergel, C (corresponding author), CNRS UPR 2589, Case 934, FR-13288 Marseille, France.	Chantal.Abergel@igs.cnrs-mrs.fr; tonetti@unige.it	Bernardi, Cinzia/K-3416-2018; De Castro, Cristina/I-5899-2012; Tonetti, Michela/F-3039-2018; Piacente, Francesco/J-8295-2016; TONETTI, MICHELA/AAF-3404-2021; Salis, Annalisa/R-9241-2018	Bernardi, Cinzia/0000-0001-9342-5929; De Castro, Cristina/0000-0002-5147-1756; Piacente, Francesco/0000-0001-5470-5987; TONETTI, MICHELA/0000-0002-8829-7173; Salis, Annalisa/0000-0002-3082-2908; Molinaro, Antonio/0000-0002-3456-7369; Abergel, Chantal/0000-0003-1875-4049; jeudy, sandra/0000-0002-5297-0135	CNRS; IBISA; Provence-Alpes-Cote d'Azur region; Regione Liguria; Regione Liguria (P.O. C.R.O. FSE, Asse IV Capitale umano, ob. specifico I/6 programma) [20]	CNRS(Centre National de la Recherche Scientifique (CNRS)); IBISA; Provence-Alpes-Cote d'Azur region(Region Provence-Alpes-Cote d'Azur); Regione Liguria(Regione Liguria); Regione Liguria (P.O. C.R.O. FSE, Asse IV Capitale umano, ob. specifico I/6 programma)	This work was supported in part by CNRS, IBISA, and the Provence-Alpes-Cote d'Azur region (to C. A.). This work was also supported in part by Regione Liguria (to M. T.).; Supported by a fellowship from Regione Liguria (P.O. C.R.O. FSE 2007-2013, Asse IV Capitale umano, ob. specifico I/6 programma n. 20).	ABERGEL C, 1991, J BIOL CHEM, V266, P20131; Abergel Chantal, 2003, Journal of Structural and Functional Genomics, V4, P141, DOI 10.1023/A:1026177202925; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Audic S, 1997, PROTEINS, V29, P252, DOI 10.1002/(SICI)1097-0134(199710)29:2<252::AID-PROT12>3.0.CO;2-N; BECKER A, 1993, MOL GEN GENET, V238, P145, DOI 10.1007/BF00279541; Bunkoczi G, 2013, ACTA CRYSTALLOGR D, V69, P2276, DOI 10.1107/S0907444913022750; Chothi MP, 2010, J VIROL, V84, P8829, DOI 10.1128/JVI.00770-10; Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6; Creuzenet C, 2002, J BIOL CHEM, V277, P26769, DOI 10.1074/jbc.M202882200; De Castro C, 2013, P NATL ACAD SCI USA, V110, P13956, DOI 10.1073/pnas.1313005110; Dong C, 2003, BIOCHEM SOC T, V31, P532, DOI 10.1042/BST0310532; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P. R., 1997, RECENT ADV PHASING, P97; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107; Fruscione F, 2008, J BIOL CHEM, V283, P184, DOI 10.1074/jbc.M706614200; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ishiyama N, 2006, J BIOL CHEM, V281, P24489, DOI 10.1074/jbc.M602393200; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; Kneidinger B, 2003, BIOCHEM J, V371, P989, DOI 10.1042/BJ20030099; Kneidinger B, 2003, J BIOL CHEM, V278, P3615, DOI 10.1074/jbc.M203867200; Lau STB, 2008, J AM CHEM SOC, V130, P17593, DOI 10.1021/ja807799k; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; McNally DJ, 2006, CHEMBIOCHEM, V7, P1865, DOI 10.1002/cbic.200600298; Miyafusa T, 2013, FEBS LETT, V587, P3824, DOI 10.1016/j.febslet.2013.10.009; Miyafusa T, 2013, BIOSCIENCE REP, V33, P463, DOI 10.1042/BSR20130017; Miyafusa T, 2012, BIOCHEM J, V443, P671, DOI 10.1042/BJ20112049; Morrison JP, 2008, BIOORG CHEM, V36, P312, DOI 10.1016/j.bioorg.2008.08.004; Morrison MJ, 2014, BIOCHEMISTRY-US, V53, P624, DOI 10.1021/bi401546r; Mulrooney EF, 2005, J BIOL CHEM, V280, P19535, DOI 10.1074/jbc.M500612200; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piacente F, 2014, GLYCOBIOLOGY, V24, P51, DOI 10.1093/glycob/cwt089; Piacente F, 2012, J BIOL CHEM, V287, P3009, DOI 10.1074/jbc.M111.314559; Remko M, 2006, J CHEM INF MODEL, V46, P1194, DOI 10.1021/ci0504667; Saadi H, 2013, CLIN INFECT DIS, V57, pE127, DOI 10.1093/cid/cit354; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; Tonetti M, 1996, J BIOL CHEM, V271, P27274, DOI 10.1074/jbc.271.44.27274; Tonetti M, 2003, J BIOL CHEM, V278, P21559, DOI 10.1074/jbc.M301543200; Van Etten JL, 2010, BBA-GEN SUBJECTS, V1800, P152, DOI 10.1016/j.bbagen.2009.07.024; Yoosuf N, 2014, VIRUS GENES, V48, P218, DOI 10.1007/s11262-013-1016-x	43	17	18	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24428	24439		10.1074/jbc.M114.588947	http://dx.doi.org/10.1074/jbc.M114.588947			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25035429	Green Published, hybrid			2022-12-25	WOS:000341505600036
J	McNair, A; Nakagawa, S; Grimm, V				McNair, Alistair Senior; Nakagawa, Shinichi; Grimm, Volker			The Evolutionary Consequences of Disrupted Male Mating Signals: An Agent-Based Modelling Exploration of Endocrine Disrupting Chemicals in the Guppy	PLOS ONE			English	Article							RUNAWAY SEXUAL SELECTION; COSTLY MATE PREFERENCES; REDUCING MUTATION LOAD; POECILIA-RETICULATA; BEHAVIORAL-RESPONSES; GENETIC-VARIATION; TRAITS; CHOICE; RESOLUTION; INFECTION	Females may select a mate based on signalling traits that are believed to accurately correlate with heritable aspects of male quality. Anthropogenic actions, in particular chemicals released into the environment, are now disrupting the accuracy of mating signals to convey information about male quality. The long-term prediction for disrupted mating signals is most commonly loss of female preference. Yet, this prediction has rarely been tested using quantitative models. We use agent-based models to explore the effects of rapid disruption of mating signals. In our model, a gene determines survival. Males signal their level of genetic quality via a signal trait, which females use to select a mate. We allowed this system of sexual selection to become established, before introducing a disruption between the male signal trait and quality, which was similar in nature to that induced by exogenous chemicals. Finally, we assessed the capacity of the system to recover from this disruption. We found that within a relatively short time frame, disruption of mating signals led to a lasting loss of female preference. Decreases in mean viability at the population-level were also observed, because sexual-selection acting against newly arising deleterious mutations was relaxed. The ability of the population to recover from disrupted mating signals was strongly influenced by the mechanisms that promoted or maintained genetic diversity in traits under sexual selection. Our simple model demonstrates that environmental perturbations to the accuracy of male mating signals can result in a long-term loss of female preference for those signals within a few generations. What is more, the loss of this preference can have knock-on consequences for mean population fitness.	[McNair, Alistair Senior; Nakagawa, Shinichi] Univ Otago, Dept Zool, Dunedin, Otago, New Zealand; [McNair, Alistair Senior] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [McNair, Alistair Senior] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Grimm, Volker] Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Saxony, Germany; [Grimm, Volker] Univ Potsdam, Inst Biochem & Biol, Potsdam, Brandenburg, Germany	University of Otago; University of Sydney; University of Sydney; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Potsdam	McNair, A (corresponding author), Univ Otago, Dept Zool, Dunedin, Otago, New Zealand.	alistair.senior1985@gmail.com	Nakagawa, Shinichi/B-5571-2011	Nakagawa, Shinichi/0000-0002-7765-5182	DAAD (German Academic Exchange Program); Helmholtz Centre for Environmental Research - UFZ, Leipzig; Marsden Fund, New Zealand [UOO0812]	DAAD (German Academic Exchange Program)(Deutscher Akademischer Austausch Dienst (DAAD)); Helmholtz Centre for Environmental Research - UFZ, Leipzig; Marsden Fund, New Zealand(Royal Society of New ZealandMarsden Fund (NZ))	The authors would like to thank the DAAD (German Academic Exchange Program; https://www.daad.de/en/), the Helmholtz Centre for Environmental Research - UFZ, Leipzig, and the Marsden Fund (http://royalsociety.org.nz/programmes/funds/marsden/; UOO0812), New Zealand, for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; [Anonymous], 2003, ANIMAL SIGNALS; [Anonymous], 1994, SEXUAL SELECTION; Arbuthnott D, 2012, EVOLUTION, V66, P2127, DOI 10.1111/j.1558-5646.2012.01584.x; Baatrup E, 2001, ENVIRON HEALTH PERSP, V109, P1063, DOI 10.2307/3454962; Barrett RDH, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P216; Bonduriansky R, 2013, J EVOLUTION BIOL, V26, P76, DOI 10.1111/jeb.12028; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Candolin U, 2009, J FISH BIOL, V75, P2108, DOI 10.1111/j.1095-8649.2009.02405.x; Candolin U, 2007, J EVOLUTION BIOL, V20, P233, DOI 10.1111/j.1420-9101.2006.01207.x; Candolin U, 2008, TRENDS ECOL EVOL, V23, P446, DOI 10.1016/j.tree.2008.04.008; Candolin U, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P201; Chandler CH, 2013, EVOLUTION, V67, P110, DOI 10.1111/j.1558-5646.2012.01750.x; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; DEJONG MCM, 1991, J EVOLUTION BIOL, V4, P637, DOI 10.1046/j.1420-9101.1991.4040637.x; Eeva T, 1998, FUNCT ECOL, V12, P607, DOI 10.1046/j.1365-2435.1998.00221.x; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Eshel I, 2000, EVOL ECOL RES, V2, P509; Gordon SP, 2012, EVOLUTION, V66, P912, DOI 10.1111/j.1558-5646.2011.01495.x; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hall DW, 2000, EVOLUTION, V54, P1862, DOI 10.1111/j.0014-3820.2000.tb01233.x; Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1992, BEHAV ECOL, V3, P346, DOI 10.1093/beheco/3.4.346; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI 10.1111/j.1558-5646.1991.tb02646.x; Jarzebowska M, 2010, EVOLUTION, V64, P1283, DOI 10.1111/j.1558-5646.2009.00905.x; Jasarevic E, 2011, P NATL ACAD SCI USA, V108, P11715, DOI 10.1073/pnas.1107958108; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jennions MD, 2001, Q REV BIOL, V76, P3, DOI 10.1086/393743; Karino K, 2010, J FISH BIOL, V77, P299, DOI 10.1111/j.1095-8649.2010.02688.x; KAVUMPURATH S, 1993, AQUACULTURE, V116, P83, DOI 10.1016/0044-8486(93)90224-M; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; Kokko H, 2005, EVOLUTION, V59, P1876; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kokko H, 2003, ANN ZOOL FENN, V40, P207; Kolluru GR, 2009, BEHAV ECOL, V20, P131, DOI 10.1093/beheco/arn124; Kotiaho JS, 2008, TRENDS ECOL EVOL, V23, P1, DOI 10.1016/j.tree.2007.09.012; Kotiaho JS, 2001, NATURE, V410, P684, DOI 10.1038/35070557; Kuijper B, 2012, ANNU REV ECOL EVOL S, V43, P287, DOI 10.1146/annurev-ecolsys-110411-160245; Lane JE, 2011, ANIM BEHAV, V81, P909, DOI 10.1016/j.anbehav.2011.02.003; Lehtonen TK, 2010, BIOL LETTERS, V6, P21, DOI 10.1098/rsbl.2009.0558; Lenth R., 2019, Journal of Statistical Software, V60, P1; LODI E, 1978, CARYOLOGIA, V31, P475, DOI 10.1080/00087114.1978.10796767; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; McGuigan K, 2011, EVOLUTION, V65, P2816, DOI 10.1111/j.1558-5646.2011.01346.x; Mcnair A, 2012, BIOL REV, V87, P900, DOI 10.1111/j.1469-185X.2012.00230.x; Miller CW, 2007, P ROY SOC B-BIOL SCI, V274, P1279, DOI 10.1098/rspb.2006.0413; Muir WM, 1999, P NATL ACAD SCI USA, V96, P13853, DOI 10.1073/pnas.96.24.13853; POMIANKOWSKI A, 1991, EVOLUTION, V45, P1422, DOI 10.1111/j.1558-5646.1991.tb02645.x; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rankin DJ, 2011, AM NAT, V177, P780, DOI 10.1086/659947; Rempel MA, 2008, INT REV CEL MOL BIO, V267, P207, DOI 10.1016/S1937-6448(08)00605-9; Rice WR, 1998, GENETICA, V102-3, P71, DOI 10.1023/A:1017055429755; Robertson B, 2013, TRENDS ECOLOGY EVOLU; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Senior AM, 2013, FISH FISH, V14, P60, DOI 10.1111/j.1467-2979.2011.00446.x; Shenoy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030611; Shenoy K, 2011, FUNCT ECOL, V25, P433, DOI 10.1111/j.1365-2435.2010.01787.x; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Tinghitella RM, 2009, EVOLUTION, V63, P2087, DOI 10.1111/j.1558-5646.2009.00698.x; Tuomainen U, 2011, EVOL ECOL RES, V13, P697; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Vergara P, 2012, J EVOLUTION BIOL, V25, P20, DOI 10.1111/j.1420-9101.2011.02399.x; Whitlock MC, 2009, EVOLUTION, V63, P569, DOI 10.1111/j.1558-5646.2008.00558.x; Wilensky U, 1999, NETLOGO; Zhan SH, 2014, J EVOLUTION BIOL, V27, P391, DOI 10.1111/jeb.12308	75	2	2	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103100	10.1371/journal.pone.0103100	http://dx.doi.org/10.1371/journal.pone.0103100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047080	Green Submitted, Green Published, gold			2022-12-25	WOS:000339558100107
J	Deng, H; Sun, J; Ma, J; Li, L; Fang, LX; Zhang, QJ; Liu, YH; Liao, XP				Deng, Hui; Sun, Jian; Ma, Jun; Li, Liang; Fang, Liang-Xing; Zhang, Qijing; Liu, Ya-Hong; Liao, Xiao-Ping			Identification of the Multi-Resistance Gene cfr in Escherichia coli Isolates of Animal Origin	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; BACILLUS STRAIN; 1ST REPORT; CONFERS RESISTANCE; PLASMID; SWINE; OXAZOLIDINONES; ENVIRONMENT; PHENICOLS; CHINA	Previous study indicated that the multi-resistance gene cfr was mainly found in gram-positive bacteria, such as Staphylococcus and Enterococcus, and was sporadically detected in Escherichia coli. Little is known about the prevalence and transmission mechanism of cfr in E. coli. In this study, the presence of cfr in E. coli isolates collected during 2010-2012 from food-producing animals in Guangdong Province of China was investigated, and the cfr-positive E. coli isolates were characterized by PFGE, plasmid profiling, and genetic environment analysis. Of the 839 E. coli isolates, 10 isolates from pig were cfr positive. All the cfr-positive isolates presented a multi-resistance phenotype and were genetically divergent as determined by PFGE. In 8 out of the 10 strains, the cfr gene was located on plasmids of similar to 30 kb. Restriction digestion of the plasmids with EcoRI and sequence hybridization with a cfr-specific probe revealed that the cfr-harboring fragments ranged from 6 to 23 kb and a similar to 18 kb cfr-carrying fragment was common for the plasmids that were similar to 30 kb. Four different genetic environments of cfr were detected, in which cfr is flanked by two identical copies of IS26, which may loop out the intervening sequence through homologous recombination. Among the 8 plasmids of similar to 30 kb, 7 plasmids shared the same genetic environment. These results demonstrate plasmid-carried cfr in E. coli and suggest that transposition and homologous recombination mediated by IS26 might have played a rule in the transfer of the cfr gene in E. coli.	[Deng, Hui; Sun, Jian; Ma, Jun; Li, Liang; Fang, Liang-Xing; Zhang, Qijing; Liu, Ya-Hong; Liao, Xiao-Ping] South China Agr Univ, Natl Reference Lab Vet Drug Residues SCAU, Coll Vet Med, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Liao, XP (corresponding author), South China Agr Univ, Natl Reference Lab Vet Drug Residues SCAU, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	xpliao@scau.edu.cn		Li, Liang/0000-0003-3571-8058	National Science Fund for Distinguished Young Scholars [31125026]; National Natural Science Foundation [31272609]; Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China [IRT13063]; Science and Technology Program of Guangzhou, China [2011J2200054]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China; Science and Technology Program of Guangzhou, China	This work was supported by the National Science Fund for Distinguished Young Scholars (Grant No. 31125026), the National Natural Science Foundation (Grant No. 31272609), Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China (Grant No. IRT13063) and Science and Technology Program of Guangzhou, China (Grant No. 2011J2200054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L, 2007, J ANTIMICROB CHEMOTH, V59, P880, DOI 10.1093/jac/dkm065; CLSI, 2012, M100S22 CLSI; Dai L, 2010, ANTIMICROB AGENTS CH, V54, P3953, DOI 10.1128/AAC.00169-10; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P1005, DOI 10.1093/jac/dkr041; Diaz L, 2012, ANTIMICROB AGENTS CH, V56, P3917, DOI 10.1128/AAC.00419-12; Gautom RK, 1997, J CLIN MICROBIOL, V35, P2977, DOI 10.1128/JCM.35.11.2977-2980.1997; Kehrenberg C, 2006, ANTIMICROB AGENTS CH, V50, P1156, DOI 10.1128/AAC.50.4.1156-1163.2006; Liu Y, 2014, J ANTIMICROB CHEMOTH, V69, P892, DOI 10.1093/jac/dkt459; Liu Y, 2013, ANTIMICROB AGENTS CH, V57, P42, DOI 10.1128/AAC.01605-12; Liu Y, 2012, ANTIMICROB AGENTS CH, V56, P1650, DOI 10.1128/AAC.06091-11; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Schwarz S, 2000, ANTIMICROB AGENTS CH, V44, P2530, DOI 10.1128/AAC.44.9.2530-2533.2000; Shen JZ, 2013, J ANTIMICROB CHEMOTH, V68, P1697, DOI 10.1093/jac/dkt092; Smith LK, 2008, ANTIMICROB AGENTS CH, V52, P1703, DOI 10.1128/AAC.01583-07; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Wang Y, 2013, ANTIMICROB AGENTS CH, V57, P4061, DOI 10.1128/AAC.00713-13; Wang Y, 2012, J ANTIMICROB CHEMOTH, V67, P1824, DOI 10.1093/jac/dks163; Wang Y, 2012, J ANTIMICROB CHEMOTH, V67, P1547, DOI 10.1093/jac/dks075; Wang Y, 2012, J ANTIMICROB CHEMOTH, V67, P1094, DOI 10.1093/jac/dks020; Wang Y, 2012, ANTIMICROB AGENTS CH, V56, P1485, DOI 10.1128/AAC.05827-11; Wang Y, 2011, J ANTIMICROB CHEMOTH, V66, P2521, DOI 10.1093/jac/dkr322; Zhang WJ, 2014, J ANTIMICROB CHEMOTH, V69, P385, DOI 10.1093/jac/dkt355; Zhang WJ, 2011, J ANTIMICROB CHEMOTH, V66, P1174, DOI 10.1093/jac/dkr037	23	24	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102378	10.1371/journal.pone.0102378	http://dx.doi.org/10.1371/journal.pone.0102378			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036029	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200052
J	Zhang, Y; Liu, J; Peng, X; Zhu, CC; Han, J; Luo, J; Rui, R				Zhang, Yu; Liu, Jun; Peng, Xu; Zhu, Cheng-Cheng; Han, Jun; Luo, Jia; Rui, Rong			KIF20A Regulates Porcine Oocyte Maturation and Early Embryo Development	PLOS ONE			English	Article							KINESIN-LIKE PROTEIN; CENTRAL SPINDLE; PASSENGER COMPLEX; AURORA-B; CYTOKINESIS; MEIOSIS; MITOSIS; ORGANIZATION; KINETOCHORE; CHROMOSOMES	KIF20A (Kinesin-like family member 20A), also called mitotic kinesin-like proteins 2 (MKLP2), is a mammalian mitotic kinesin-like motor protein of the Kinesin superfamily proteins (KIFs), which was originally involved in Golgi apparatus dynamics and thought to essential for cell cycle regulation during successful cytokinesis. In the present study, we investigated whether KIF20A has roles on porcine oocyte meiotic maturation and subsequent early embryo development. By immunofluorescence staining, KIF20A was found to exhibit a dynamic localization pattern during meiosis. KIF20A was restricted to centromeres after germinal vesicle breakdown (GVBD), transferred to the midbody at telophase I (TI), and again associated with centromeres at metaphase II (MII). Inhibition of endogenous KIF20A via a specific inhibitor, Paprotrain, resulted in failure of polar body extrusion. Further cell cycle analysis showed that the percentage of oocytes that arrested at early metaphase I (MI) stage increased after KIF20A activity inhibition; however, the proportion of oocytes at anaphase/telophase I (ATI) and MII stages decreased significantly. Our results also showed that KIF20A inhibition did not affect spindle morphology. In addition, KIF20A was localized at the nucleus of early embryos, and KIF20A inhibition resulted in failure of early parthenogenetic embryo development. These results demonstrated that KIF20A is critical for porcine oocyte meiotic maturation and subsequent early embryo development.	[Zhang, Yu; Peng, Xu; Rui, Rong] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Yu; Liu, Jun; Zhu, Cheng-Cheng; Han, Jun] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Luo, Jia] Technol Ctr Guangxi Entry Exit Inspect & Quaranti, Nanning, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Rui, R (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	rrui@njau.edu.cn			National Basic Research Program of China [2014CB138503]; Ministry of Education of China [20120097120007, 20130097110020]	National Basic Research Program of China(National Basic Research Program of China); Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Basic Research Program of China (2014CB138503), and Research Fund for the Doctoral Program of the Ministry of Education of China (20120097120007 and 20130097110020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Allan VJ, 1999, CURR OPIN CELL BIOL, V11, P476, DOI 10.1016/S0955-0674(99)80068-4; Cesario JM, 2006, J CELL SCI, V119, P4770, DOI 10.1242/jcs.03235; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Fontijn RD, 2001, MOL CELL BIOL, V21, P2944, DOI 10.1128/MCB.21.8.2944-2955.2001; Fukagawa T, 2008, FRONT BIOSCI-LANDMRK, V13, P2705, DOI 10.2741/2877; Gasnereau I, 2012, AM J PATHOL, V180, P131, DOI 10.1016/j.ajpath.2011.09.040; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Jang JK, 2005, MOL BIOL CELL, V16, P4684, DOI 10.1091/mbc.E04-11-0964; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lee SH, 2010, J CELL BIOL, V191, P1069, DOI 10.1083/jcb.201003095; Maro B, 2002, NAT CELL BIOL, V4, pE281, DOI 10.1038/ncb1202-e281; Matuliene J, 2002, MOL BIOL CELL, V13, P1832, DOI 10.1091/mbc.01-10-0504; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; NISLOW C, 1990, J CELL BIOL, V111, P511, DOI 10.1083/jcb.111.2.511; Nislow C, 1992, PLUS END DIRECTED MO; Radford SJ, 2012, GENETICS, V192, P417, DOI 10.1534/genetics.112.143495; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Sharif B, 2010, J CELL SCI, V123, P4292, DOI 10.1242/jcs.067447; Shuda K, 2009, MOL REPROD DEV, V76, P1094, DOI 10.1002/mrd.21075; Vernos I, 1996, CURR OPIN CELL BIOL, V8, P4, DOI 10.1016/S0955-0674(96)80041-X; Yin S, 2008, CELL CYCLE, V7, P2997, DOI 10.4161/cc.7.19.6809; Yu T, 2007, J VIROL, V81, P1736, DOI 10.1128/JVI.01638-06	33	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102898	10.1371/journal.pone.0102898	http://dx.doi.org/10.1371/journal.pone.0102898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036038	gold, Green Published, Green Submitted			2022-12-25	WOS:000339615200094
J	Danielewska, ME; Krzyzanowska-Berkowska, P; Iskander, DR				Danielewska, Monika E.; Krzyzanowska-Berkowska, Patrycja; Iskander, D. Robert			Glaucomatous and Age-Related Changes in Corneal Pulsation Shape. The Ocular Dicrotism	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; BLOOD-FLOW; INTRAOCULAR-PRESSURE; PULSE-WAVE; ARTERIAL STIFFNESS; EYE-MOVEMENTS; FUNDUS PULSE; RIGIDITY; HEMODYNAMICS	Purpose: To ascertain whether the incidence of ocular dicrotic pulse (ODP) increases with age, it is more pronounced in glaucomatous than in normal eyes and whether it is related to cardiovascular activity. Methods: 261 subjects aged 47 to 78 years were included in the study and classified into four groups: primary open angle glaucoma (POAG), primary angle-closure glaucoma (PACG), glaucoma suspects with glaucomatous optic disc appearance (GODA) and the controls (CG). Additionally, in each group, subjects with ODP were divided into two age subgroups around the median age. A non-contact ultrasonic method was used to measure corneal indentation pulse (CIP) synchronically with the acquisition of electrocardiography (ECG) and blood pulse signals. ODP was assessed from the acquired signals that were numerically processed in a custom written program. Results: ODP incidence was about 78%, 66%, 66% and 84% for CG, GODA, POAG, and PACG group, respectively. With advancing age, the ODP incidence increased for all subjects (Delta = 12%), the highest being for the PACG and POAG groups (Delta = 30%). GODA group did not show an age-related increase in the incidence of ODP. Conclusions: The ocular dicrotism, measured with non-contact ultrasonic method, was found to be a common phenomenon in elderly subjects. The increased ODP incidence in PACG and POAG group may correspond to either higher stiffness of glaucoma eyes, biochemical abnormalities in eye tissues, changes in ocular hemodynamics, may reflect the effect of medications or be a combination of all those factors. The results of GODA group suggest different mechanisms governing their ocular pulse that makes them less susceptible to generating ODP and having decreased predisposition to glaucoma.	[Danielewska, Monika E.; Iskander, D. Robert] Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, PL-50370 Wroclaw, Poland; [Krzyzanowska-Berkowska, Patrycja] Wroclaw Med Univ, Dept Ophthalmol, Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw Medical University	Danielewska, ME (corresponding author), Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, PL-50370 Wroclaw, Poland.	monika.danielewska@pwr.edu.pl	Iskander, D Robert/E-3576-2017	Iskander, D Robert/0000-0002-5962-6206; Krzyzanowska-Berkowska, Patrycja/0000-0001-8034-2534	National Science Centre grant [UMO-2011/01/N/ST7/05391]; Foundation for Polish Science [VENTURES/2011-7/4]	National Science Centre grant(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	Supported, in part, by the National Science Centre grant, number UMO-2011/01/N/ST7/05391 to MED (www.ncn.gov.pl/?language=en) and funds from the Foundation for Polish Science project numer VENTURES/2011-7/4 to MED (www.fnp.org.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2003, PHYSIOL MEAS, V24, P297, DOI 10.1088/0967-3334/24/2/306; Altan-Yaycioglu R, 2001, EUR J OPHTHALMOL, V11, P37, DOI 10.1177/112067210101100108; ANGELONE A, 1964, J APPL PHYSIOL, V19, P479, DOI 10.1152/jappl.1964.19.3.479; Berisha F, 2010, ACTA OPHTHALMOL, V88, P766, DOI 10.1111/j.1755-3768.2009.01577.x; Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; BOSLEY TM, 1993, STROKE, V24, P6, DOI 10.1161/01.STR.24.1.6; Boudaoud S, 2005, IEEE T SIGNAL PROCES, V53, P3644, DOI 10.1109/TSP.2005.855106; Caprioli J, 2010, AM J OPHTHALMOL, V149, P704, DOI 10.1016/j.ajo.2010.01.018; CARTER JE, 1983, J GERONTOL, V38, P318, DOI 10.1093/geronj/38.3.318; Chung HS, 1990, SURV OPHTHALMOL, V43, pS43; Conover MB, 2003, MOSBYS POCKET GUIDE; Cook C, 2012, CAN J OPHTHALMOL, V47, P223, DOI 10.1016/j.jcjo.2012.02.003; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Danielewska ME, 2012, IOVS, P53; Danielewska ME, 2014, OPTOMETRY VISION SCI, V91, P54, DOI 10.1097/OPX.0000000000000113; Danielewska ME, 2012, CLIN EXP OPTOM, V95, P631, DOI 10.1111/j.1444-0938.2012.00775.x; Dastiridou AI, 2009, INVEST OPHTH VIS SCI, V50, P5718, DOI 10.1167/iovs.09-3760; Daxer A, 1998, INVEST OPHTH VIS SCI, V39, P644; Dion C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054207; DRANCE SM, 1960, ARCH OPHTHALMOL-CHIC, V63, P668; Duijm HFA, 1997, AM J OPHTHALMOL, V123, P644; Ebneter A, 2009, EYE, V23, P606, DOI 10.1038/eye.2008.47; Elsheikh A, 2007, CURR EYE RES, V32, P11, DOI 10.1080/02713680601077145; Evans DW, 2002, GRAEF ARCH CLIN EXP, V240, P475, DOI 10.1007/s00417-002-0460-4; EWY GA, 1969, CIRCULATION, V39, P655, DOI 10.1161/01.CIR.39.5.655; Findl O, 2000, AM J OPHTHALMOL, V130, P589, DOI 10.1016/S0002-9394(00)00636-X; Fleming W J, 1881, J Anat Physiol, V15, P278; Fontana ST, 1984, ARCH OPHTHALMOL-CHIC, V102, P46; Friedenwald J.S., 1937, AM J OPHTHALMOL, V20, P985, DOI [DOI 10.1016/S0002-9394(37)90425-2, 10.1016/S0002-9394(37)90425-2, 10.1016/s0002-9394(37)90425-2]; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Galabin A L, 1873, J Anat Physiol, V8, P1; Galassi F, 2003, ARCH OPHTHALMOL-CHIC, V121, P1711, DOI 10.1001/archopht.121.12.1711; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P5656, DOI 10.1167/iovs.10-6927; Grunwald JE, 1998, ARCH OPHTHALMOL-CHIC, V116, P150; Harris A, 1998, SURV OPHTHALMOL, V42, P509, DOI 10.1016/S0039-6257(98)00011-3; Harris A, 2008, CAN J OPHTHALMOL, V43, P328, DOI 10.3129/i08-051; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P595, DOI 10.1016/S1350-9462(01)00005-2; Hommer A, 2008, INVEST OPHTH VIS SCI, V49, P4046, DOI 10.1167/iovs.07-1342; HORVEN I, 1971, ARCH OPHTHALMOL-CHIC, V86, P5, DOI 10.1001/archopht.1971.01000010007002; Hulsman CAA, 2007, ARCH OPHTHALMOL-CHIC, V125, P805, DOI 10.1001/archopht.125.6.805; Iskander DR, 2006, OPHTHAL PHYSL OPT, V26, P572, DOI 10.1111/j.1475-1313.2006.00415.x; KANAI A, 1973, Annals of Ophthalmology, V5, P285; Kanngiesser HE, 2005, J GLAUCOMA, V14, P344, DOI 10.1097/01.ijg.0000176936.16015.4e; Kasprzak HT, 2007, EYE, V21, P1212, DOI 10.1038/sj.eye.6702578; Kasprzak HT, 2010, IEEE T INSTRUM MEAS, V59, P164, DOI 10.1109/TIM.2009.2022431; KELLY R, 1989, CIRCULATION, V80, P1652, DOI 10.1161/01.CIR.80.6.1652; Kiel J.W., 2010, OCULAR CIRCULATION; Kiss B, 2001, MICROVASC RES, V61, P1, DOI 10.1006/mvre.2000.2269; Kowalska MA, 2011, IEEE T BIO-MED ENG, V58, P674, DOI 10.1109/TBME.2010.2100819; LAKATTA EG, 1987, J AM COLL CARDIOL, V10, pA42, DOI 10.1016/S0735-1097(87)80447-3; Lam AKC, 2003, OPTOMETRY VISION SCI, V80, P305, DOI 10.1097/00006324-200304000-00008; LANGHAM ME, 1989, ACTA OPHTHALMOL, V67, P9; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leske MC, 2007, OPHTHALMOLOGY, V114, P1058, DOI 10.1016/j.ophtha.2006.08.051; Lewis T, 1906, J PHYSIOL-LONDON, V34, P414; Licznerski TJ, 2011, ULTRASONICS, V51, P960, DOI 10.1016/j.ultras.2011.05.011; Mackenzie J, 1902, STUDY PULSE ARTERIAL; MALIK NS, 1992, BIOCHIM BIOPHYS ACTA, V1138, P222, DOI 10.1016/0925-4439(92)90041-K; MCDONALD PT, 1979, ANN SURG, V189, P44, DOI 10.1097/00000658-197901000-00009; McDowell CM, 2012, EXP EYE RES, V100, P65, DOI 10.1016/j.exer.2012.04.016; MEADOWS WR, 1971, AM HEART J, V82, P596, DOI 10.1016/0002-8703(71)90328-0; Millasseau SC, 2002, CLIN SCI, V103, P371, DOI 10.1042/cs1030371; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Moore D, 2008, CLIN OPHTHALMOL, V2, P849; Nichols W, 1998, MCDONALDS BLOOD FLOW; NORTHROP RB, 1977, IEEE T BIO-MED ENG, V24, P139, DOI 10.1109/TBME.1977.326118; ORCHARD RC, 1980, CIRCULATION, V62, P1107, DOI 10.1161/01.CIR.62.5.1107; ORourke MF, 1996, J HYPERTENS, V14, pS147; Pallikaris IG, 2005, INVEST OPHTH VIS SCI, V46, P409, DOI 10.1167/iovs.04-0162; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Piltz-Seymour IR, 2001, AM J OPHTHALMOL, V132, P63, DOI 10.1016/S0002-9394(01)00871-6; Quigley HA, 2003, J GLAUCOMA, V12, P167, DOI 10.1097/00061198-200304000-00013; Quigley HA, 2009, AM J OPHTHALMOL, V148, P657, DOI 10.1016/j.ajo.2009.08.009; Ravalico G, 1996, INVEST OPHTH VIS SCI, V37, P2645; Roberts MD, 2010, INVEST OPHTH VIS SCI, V51, P5675, DOI 10.1167/iovs.10-5411; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; Satilmis M, 2003, AM J OPHTHALMOL, V135, P664, DOI 10.1016/S0002-9394(02)02156-6; Schultz DS, 2008, INVEST OPHTH VIS SCI, V49, P4232, DOI 10.1167/iovs.08-1970; Seo JH, 2012, OPHTHALMOLOGY, V119, P2254, DOI 10.1016/j.ophtha.2012.06.007; SHEREBRIN MH, 1990, IEEE T BIO-MED ENG, V37, P313, DOI 10.1109/10.52332; Sherwood L, 2006, FUNDAMENTALS PHYSIOL; Silver D M, 1994, Surv Ophthalmol, V38 Suppl, pS72, DOI 10.1016/0039-6257(94)90049-3; SILVER DM, 1989, ACTA OPHTHALMOL, V67, P25; SMITH D, 1986, BRIT HEART J, V56, P531; Steinhart MR, 2012, MOL VIS, V18, P1093; Szkulmowska A, 2009, OPT EXPRESS, V17, P10584, DOI 10.1364/OE.17.010584; TENGROTH B, 1984, ACTA OPHTHALMOL, V62, P999; Toris CB, 1999, AM J OPHTHALMOL, V127, P407, DOI 10.1016/S0002-9394(98)00436-X; TREW DR, 1991, GRAEF ARCH CLIN EXP, V229, P553, DOI 10.1007/BF00203321; Uebaba K, 1999, CIRCULATION, V33, p211A; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4; Zink JM, 2003, BRIT J OPHTHALMOL, V87, P1487, DOI 10.1136/bjo.87.12.1487; ZUCKERMAN JL, 1977, INVEST OPHTH VIS SCI, V16, P1018	94	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102814	10.1371/journal.pone.0102814	http://dx.doi.org/10.1371/journal.pone.0102814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032962	Green Submitted, gold, Green Published			2022-12-25	WOS:000339418300097
J	Muthu, M; Cheriyan, VT; Munie, S; Levi, E; Frank, J; Ashour, AE; Singh, M; Rishi, AK				Muthu, Magesh; Cheriyan, Vino T.; Munie, Sara; Levi, Edi; Frank, John; Ashour, Abdelkader E.; Singh, Mandip; Rishi, Arun K.			Mechanisms of Neuroblastoma Cell Growth Inhibition by CARP-1 Functional Mimetics	PLOS ONE			English	Article							NF-KAPPA-B; APOPTOSIS-REGULATORY PROTEIN-1; ANAPHASE-PROMOTING COMPLEX; HIGH-RISK NEUROBLASTOMA; DOWN-REGULATION; BREAST-CANCER; IN-VITRO; CYCLE; ACTIVATION; EXPRESSION	Neuroblastomas (NBs) are a clinically heterogeneous group of extra cranial pediatric tumors. Patients with high-risk, metastatic NBs have a long-term survival rate of below 40%, and are often resistant to current therapeutic modalities. Due to toxic side effects associated with radiation and chemotherapies, development of new agents is warranted to overcome resistance and effectively treat this disease in clinic. CARP-1 functional mimetics (CFMs) are an emerging class of small molecule compounds that inhibit growth of diverse cancer cell types. Here we investigated NB inhibitory potential of CFMs and the molecular mechanisms involved. CFM-1, -4, and -5 inhibited NB cell growth, in vitro, independent of their p53 and MYCN status. CFM-4 and -5 induced apoptosis in NB cells in part by activating pro-apoptotic stress-activated kinases (SAPKs) p38 and JNK, stimulating CARP-1 expression and cleavage of PARP1, while promoting loss of the oncogenes C and N-myc as well as mitotic cyclin B1. Treatments of NB cells with CFM-4 or -5 also resulted in loss of Inhibitory kappa B (I kappa B) alpha and beta proteins. Micro-RNA profiling revealed upregulation of XIAP-targeting miR513a-3p in CFM-4-treated NB, mesothelioma, and breast cancer cells. Moreover, exposure of NB and breast cancer cells to CFM-4 or -5 resulted in diminished expression of antiapoptotic XIAP1, cIAP1, and Survivin proteins. Expression of anti-miR513a-5p or miR513a-5p mimic, however, interfered with or enhanced, respectively, the breast cancer cell growth inhibition by CFM-4. CFMs also impacted biological properties of the NB cells by blocking their abilities to migrate, form colonies in suspension, and invade through the matrix-coated membranes. Our studies indicate anti-NB properties of CFM-4 and 5, and suggest that these CFMs and/or their future analogs have potential as anti-NB agents.	[Muthu, Magesh; Cheriyan, Vino T.; Munie, Sara; Levi, Edi; Frank, John; Rishi, Arun K.] Wayne State Univ, John D Dingell VA Med Ctr, Detroit, MI 48202 USA; [Rishi, Arun K.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Muthu, Magesh; Cheriyan, Vino T.; Munie, Sara; Rishi, Arun K.] Wayne State Univ, Dept Oncol, Detroit, MI USA; [Levi, Edi] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [Ashour, Abdelkader E.] King Saud Univ, Dept Pharmacol & Toxicol, Coll Pharm, Riyadh, Saudi Arabia; [Singh, Mandip] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; King Saud University; State University System of Florida; Florida A&M University	Rishi, AK (corresponding author), Wayne State Univ, John D Dingell VA Med Ctr, Detroit, MI 48202 USA.	Rishia@Karmanos.org	Ashour, Abdelkader/ABH-8235-2020; muthu, magesh/N-6987-2017	Ashour, Abdelkader/0000-0003-3978-8045; muthu, magesh/0000-0003-3311-8120; Levi, Edi/0000-0003-1809-2866	Department of Veterans Affairs Merit Review grant; NCI/NIH Cancer Center; National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia [MED-1768-02]	Department of Veterans Affairs Merit Review grant(US Department of Veterans Affairs); NCI/NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia	This work was supported by the Department of Veterans Affairs Merit Review grant (AKR), and the NCI/NIH Cancer Center Support Grant to Karmanos Cancer Institute, Detroit, Michigan, and a grant from the National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia (Grant No. MED-1768-02; AEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ara T, 2006, CANCER METAST REV, V25, P645, DOI 10.1007/s10555-006-9028-9; Ashour AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066733; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berger R, 2011, MOL CANCER THER, V10, P1867, DOI 10.1158/1535-7163.MCT-11-0218; Bianchi F, 2011, EMBO MOL MED, V3, P495, DOI 10.1002/emmm.201100154; Bourboulia D, 2013, ONCOTARGET, V4, P166; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Endo Y, 2013, ENDOCR-RELAT CANCER, V20, P91, DOI 10.1530/ERC-12-0207; George RE, 2006, J CLIN ONCOL, V24, P2891, DOI 10.1200/JCO.2006.05.6986; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jamal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089146; Jiang Yan, 2010, J Mol Signal, V5, P7, DOI 10.1186/1750-2187-5-7; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Keshelava N, 1998, CANCER RES, V58, P5396; Kim HC, 2014, ONCOTARGET; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Li AG, 2013, CLIN CANCER RES, V19, P3600, DOI 10.1158/1078-0432.CCR-12-3092; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Liu WK, 2004, BIOCHEM J, V378, P867, DOI 10.1042/BJ20031736; Luo PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027298; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Olshan AF, 2000, NEUROBLASTOMA, P33; Osone S, 2004, INT J CANCER, V112, P219, DOI 10.1002/ijc.20412; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Puliyappadamba VT, 2011, J BIOL CHEM, V286, P38000, DOI 10.1074/jbc.M111.222398; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shaw Leslie M., 2004, V294, P97; Shin S, 2012, BIOCHIMIE, V94, P1431, DOI 10.1016/j.biochi.2012.03.023; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Van Maerken T, 2011, MOL CANCER THER, V10, P983, DOI 10.1158/1535-7163.MCT-10-1090; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009; Wang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076662; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Yelamanchili SV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.498; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653	57	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102567	10.1371/journal.pone.0102567	http://dx.doi.org/10.1371/journal.pone.0102567			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033461	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000339418300062
J	Persson, BD; Jaffe, AB; Fearns, R; Danahay, H				Persson, B. David; Jaffe, Aron B.; Fearns, Rachel; Danahay, Henry			Respiratory Syncytial Virus Can Infect Basal Cells and Alter Human Airway Epithelial Differentiation	PLOS ONE			English	Article							MUCOCILIARY DIFFERENTIATION; BRONCHIAL EPITHELIUM; BARRIER FUNCTION; RSV; ASTHMA; IL-13; BRONCHIOLITIS; INTERFERON; MECHANISMS; TARGET	Respiratory syncytial virus (RSV) is a major cause of morbidity and mortality worldwide, causing severe respiratory illness in infants and immune compromised patients. The ciliated cells of the human airway epithelium have been considered to be the exclusive target of RSV, although recent data have suggested that basal cells, the progenitors for the conducting airway epithelium, may also become infected in vivo. Using either mechanical or chemical injury models, we have demonstrated a robust RSV infection of p63(+) basal cells in air-liquid interface (ALI) cultures of human bronchial epithelial cells. In addition, proliferating basal cells in 2D culture were also susceptible to RSV infection. We therefore tested the hypothesis that RSV infection of this progenitor cell would influence the differentiation status of the airway epithelium. RSV infection of basal cells on the day of seeding (MOI <= 0.0001), resulted in the formation of an epithelium that showed a profound loss of ciliated cells and gain of secretory cells as assessed by acetylated alpha-tubulin and MUC5AC/MUC5B immunostaining, respectively. The mechanism driving the switch in epithelial phenotype is in part driven by the induced type I and type III interferon response that we demonstrate is triggered early following RSV infection. Neutralization of this response attenuates the RSV-induced loss of ciliated cells. Together, these data show that through infection of proliferating airway basal cells, RSV has the potential to influence the cellular composition of the airway epithelium. The resulting phenotype might be expected to contribute towards both the severity of acute infection, as well as to the longer-term consequences of viral exacerbations in patients with pre-existing respiratory diseases.	[Persson, B. David; Jaffe, Aron B.] Novartis Inst BioMed Res, Cambridge, MA USA; [Fearns, Rachel] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Danahay, Henry] Novartis Inst BioMed Res, Resp Dis Area, Horsham, W Sussex, England	Novartis; Boston University; Novartis	Danahay, H (corresponding author), Novartis Inst BioMed Res, Resp Dis Area, Horsham, W Sussex, England.	henry.danahay@novartis.com		Fearns, Rachel/0000-0003-0783-7498; Jaffe, Aron/0000-0002-6220-0476	Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	This study was funded by Novartis Institutes for Biomedical Research. Authors B. D. Persson, A. B. Jaffe and H. Danahay are employees of Novartis Institutes for BioMedical Research. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black Craig Patrick, 2003, Respir Care, V48, P209; Bueno SM, 2008, INT IMMUNOPHARMACOL, V8, P1320, DOI 10.1016/j.intimp.2008.03.012; Castilow EM, 2008, J IMMUNOL, V180, P2376, DOI 10.4049/jimmunol.180.4.2376; Chung KF, 2001, EUR RESPIR J, V18, p50S, DOI 10.1183/09031936.01.00229701; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Collins PL, 2007, FIELDS VIROLOGY, P1601; Ebbert JO, 2005, RESPIRATION, V72, P263, DOI 10.1159/000085367; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Garofalo RP, 2004, J MED VIROL, V73, P289, DOI 10.1002/jmv.20089; Gonzalez PA, 2012, REV MED VIROL, V22, P230, DOI 10.1002/rmv.1704; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Harris J, 2003, CELL MICROBIOL, V5, P671, DOI 10.1046/j.1462-5822.2003.00313.x; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; Johnson TR, 1999, J VIROL, V73, P8485, DOI 10.1128/JVI.73.10.8485-8495.1999; Lai H, 2010, J AEROSOL MED PULM D, V23, P219, DOI 10.1089/jamp.2009.0802; Laoukili J, 2001, J CLIN INVEST, V108, P1817, DOI 10.1172/JCI13557; Lasfar A, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/349575; LEVENSON RM, 1987, ARCH INTERN MED, V147, P791, DOI 10.1001/archinte.147.4.791; Lotz MT, 2012, CURR ALLERGY ASTHM R, V12, P380, DOI 10.1007/s11882-012-0278-z; Maggon K, 2004, REV MED VIROL, V14, P149, DOI 10.1002/rmv.423; Mata M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048037; Meyerholz DK, 2004, MICROBES INFECT, V6, P1312, DOI 10.1016/j.micinf.2004.08.006; MLB.com, 2013, 1 4 GAM 2013 WORLD S; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Okabayashi T, 2011, VIRUS RES, V160, P360, DOI 10.1016/j.virusres.2011.07.011; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Oshansky CM, 2009, FUTURE MICROBIOL, V4, P279, DOI 10.2217/FMB.09.1; OTaUF Power, 2011, CELLULAR MOL CHARACT; Papin JF, 2013, AM J PHYSL LUNG CELL; Ramaswamy M, 2009, COPD, V6, P64, DOI 10.1080/15412550902724024; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sethi S, 2012, AM J MED, V125, P1162, DOI 10.1016/j.amjmed.2012.06.024; Smith CM, 2013, EUR RESP J; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; Swindle EJ, 2009, J ALLERGY CLIN IMMUN, V124, P23, DOI 10.1016/j.jaci.2009.05.037; van Benten IJ, 2003, J MED VIROL, V71, P290, DOI 10.1002/jmv.10482; Vermeer PD, 2003, AM J RESP CELL MOL, V28, P286, DOI 10.1165/rcmb.4887; Villenave R, 2013, TRENDS MICROBIOL; Villenave R, 2012, P NATL ACAD SCI USA, V109, P5040, DOI 10.1073/pnas.1110203109; Westerly BD, 2010, IMMUNOL ALLERGY CLIN, V30, P523, DOI 10.1016/j.iac.2010.08.006; Wong JYW, 2005, THORAX, V60, P582, DOI 10.1136/thx.2004.024638; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zdrenghea MT, 2012, EUR RESPIR J, V39, P712, DOI 10.1183/09031936.00099811; Zhang LQ, 2011, VIROLOGY, V421, P67, DOI 10.1016/j.virol.2011.08.020; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	54	40	40	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102368	10.1371/journal.pone.0102368	http://dx.doi.org/10.1371/journal.pone.0102368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033192	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300051
J	Figliolini, F; Cantaluppi, V; De Lena, M; Beltramo, S; Romagnoli, R; Salizzoni, M; Melzi, R; Nano, R; Piemonti, L; Tetta, C; Biancone, L; Camussi, G				Figliolini, Federico; Cantaluppi, Vincenzo; De Lena, Michela; Beltramo, Silvia; Romagnoli, Renato; Salizzoni, Mauro; Melzi, Raffaella; Nano, Rita; Piemonti, Lorenzo; Tetta, Ciro; Biancone, Luigi; Camussi, Giovanni			Isolation, Characterization and Potential Role in Beta Cell-Endothelium Cross-Talk of Extracellular Vesicles Released from Human Pancreatic Islets	PLOS ONE			English	Article							VEGF-A; GENE-EXPRESSION; MICROVESICLES; PROLIFERATION; DIFFERENTIATION; MEMBRANE; VASCULARIZATION; ANGIOGENESIS; MASS	The cross-talk between beta cells and endothelium plays a key role in islet physiopathology and in the revascularization process after islet transplantation. However, the molecular mechanisms involved in this cross-talk are not fully elucidated. Extracellular vesicles (EVs) are secreted membrane nanoparticles involved in inter-cellular communication through the transfer of proteins and nucleic acids. The aims of this study were: 1) isolation and characterization of EVs from human islets; 2) evaluation of the pro-angiogenic effect of islet-derived EVs on human islet endothelial cells (IECs). EVs were isolated by ultracentrifugation from conditioned medium of human islets and characterized by nanotrack analysis (Nanosight), FACS, western blot, bioanalyzer, mRNA/microRNA RT-PCR array. On IECs, we evaluated EV-induced insulin mRNA transfer, proliferation, resistance to apoptosis, in vitro angiogenesis, migration, gene and protein profiling. EVs sized 236 +/- 54 nm, expressed different surface molecules and islet-specific proteins (insulin, C-peptide, GLP1R) and carried several mRNAs (VEGFa, eNOS) and microRNAs (miR-27b, miR-126, miR-130 and miR-296) involved in beta cell function, insulin secretion and angiogenesis. Purified EVs were internalized into IECs inducing insulin mRNA expression, protection from apoptosis and enhancement of angiogenesis. Human islets release biologically active EVs able to shuttle specific mRNAs and microRNAs (miRNAs) into target endothelial cells. These results suggest a putative role for islet-derived EVs in beta cell-endothelium cross-talk and in the neoangiogenesis process which is critical for engraftment of transplanted islets.	[Figliolini, Federico; Cantaluppi, Vincenzo; De Lena, Michela; Beltramo, Silvia; Biancone, Luigi; Camussi, Giovanni] Univ Turin, Dept Med Sci, Turin, Italy; [Romagnoli, Renato; Salizzoni, Mauro] Univ Turin, Liver Transplantat Ctr, Turin, Italy; [Melzi, Raffaella; Nano, Rita; Piemonti, Lorenzo] Ist Sci San Raffaele, Diabet Res Inst HSR DRI, I-20132 Milan, Italy; [Tetta, Ciro] Fresenius Med Care, Bad Homburg, Germany	University of Turin; University of Turin; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Camussi, G (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	giovanni.camussi@unito.it	Melzi, Raffaella/AAN-3825-2020; Cantaluppi, Vincenzo/K-8531-2016; Piemonti, Lorenzo/P-7605-2017; Camussi, Giovanni/J-7624-2016; Nano, Rita/AAC-1934-2019; Romagnoli, Renato/AAB-9311-2019; Figliolini, Federico/AAQ-4983-2021	Cantaluppi, Vincenzo/0000-0002-4120-3555; Piemonti, Lorenzo/0000-0002-2172-2198; Camussi, Giovanni/0000-0003-2795-232X; Nano, Rita/0000-0003-4520-8481; Romagnoli, Renato/0000-0001-8340-8885; Salizzoni, Mauro/0000-0002-5480-8705; BIANCONE, Luigi/0000-0002-7700-6350; Figliolini, Federico/0000-0002-6142-2261	Regione Piemonte, Piattaforme Biotecnologiche PiSTEM project; Local University Grants	Regione Piemonte, Piattaforme Biotecnologiche PiSTEM project(Regione Piemonte); Local University Grants	This work was supported by Regione Piemonte, Piattaforme Biotecnologiche PiSTEM project (GC) and Local University Grants (VC, LB and GC). The sponsors did not contribute to the design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Alvarez ML, 2012, DIABETES RES CLIN PR; Ansa-Addo EA, 2010, J IMMUNOL, V185, P5236, DOI 10.4049/jimmunol.1001656; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Camussi G, 2013, CURR MOL MED, V13, P58, DOI 10.2174/156652413804486304; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Cantaluppi V, 2006, AM J TRANSPLANT, V6, P2601, DOI 10.1111/j.1600-6143.2006.01534.x; Cantaluppi V, 2012, CELL TRANSPLANT, V21, P1305, DOI 10.3727/096368911X627534; Crawford LA, 2009, MOL ENDOCRINOL, V23, P324, DOI 10.1210/me.2008-0045; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Deregibus MC, 2010, HISTOL HISTOPATHOL, V25, P397, DOI 10.14670/HH-25.397; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Emamaullee JA, 2007, CELL TRANSPLANT, V16, P1, DOI 10.3727/000000007783464461; Golocheikine A, 2010, TRANSPLANTATION, V90, P725, DOI 10.1097/TP.0b013e3181ef8a63; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Jabs N, 2008, EXP CLIN ENDOCR DIAB, V116, pS46, DOI 10.1055/s-2008-1081486; Jiang FX, 1999, DIABETES, V48, P722, DOI 10.2337/diabetes.48.4.722; Johansson A, 2009, DIABETOLOGIA, V52, P2385, DOI 10.1007/s00125-009-1485-6; Johansson A, 2009, TRANSPL INT, V22, P1182, DOI 10.1111/j.1432-2277.2009.00939.x; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Johansson M, 2006, J ANAT, V208, P191, DOI 10.1111/j.1469-7580.2006.00520.x; Jorfi S, 2013, BIOCHEM SOC T, V41, P293, DOI 10.1042/BST20120273; Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Melzi R, 2010, CELL TRANSPLANT, V19, P1031, DOI 10.3727/096368910X514639; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Quesenberry PJ, 2010, EXP HEMATOL, V38, P581, DOI 10.1016/j.exphem.2010.03.021; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ricordi C, 2004, NAT REV IMMUNOL, V4, P258, DOI 10.1038/nri1332; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; Tetta C, 2011, ORGANOGENESIS, V7, P105, DOI 10.4161/org.7.2.15782; Vasir B, 2001, TRANSPLANTATION, V71, P924, DOI 10.1097/00007890-200104150-00018; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Watada H, 2010, ENDOCR J, V57, P185, DOI 10.1507/endocrj.K09E-035	38	69	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102521	10.1371/journal.pone.0102521	http://dx.doi.org/10.1371/journal.pone.0102521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028931	gold, Green Published, Green Submitted			2022-12-25	WOS:000341306600080
J	Lattin, CR; Ngai, HM; Romero, LM				Lattin, Christine R.; Ngai, Heather M.; Romero, L. Michael			Evaluating the Stress Response as a Bioindicator of Sub-Lethal Effects of Crude Oil Exposure in Wild House Sparrows (Passer domesticus)	PLOS ONE			English	Article							DUCKS ANAS-PLATYRHYNCHOS; ENDOCRINE-DISRUPTING CHEMICALS; MALLARD DUCKS; SEASONAL-CHANGES; ADRENOCORTICAL ACTIVITY; BLOOD PARAMETERS; TREE SWALLOWS; CORTICOSTERONE; SPILL; PETROLEUM	Petroleum can disrupt endocrine function in humans and wildlife, and interacts in particularly complex ways with the hypothalamus-pituitary-adrenal (HPA) axis, responsible for the release of the stress hormones corticosterone and cortisol (hereafter CORT). Ingested petroleum can act in an additive fashion with other stressors to cause increased mortality, but it is not clear exactly why-does petroleum disrupt feedback mechanisms, stress hormone production, or both? This laboratory study aimed to quantify the effects of ingested Gulf of Mexico crude oil on the physiological stress response of house sparrows (Passer domesticus). We examined baseline and stress-induced CORT, negative feedback, and adrenal sensitivity in house sparrows given a 1% oil or control diet (n = 12 in each group). We found that four weeks on a 1% oil diet did not alter baseline CORT titers or efficacy of negative feedback, but significantly reduced sparrows' ability to secrete CORT in response to a standardized stressor and adrenocorticotropin hormone injection, suggesting that oil damages the steroid-synthesizing cells of the adrenal. In another group of animals on the same 1% oil (n = 9) or control diets (n = 8), we examined concentrations of eight different blood chemistry parameters, and CORT in feathers grown before and during the feeding experiments as other potential biomarkers of oil exposure. None of the blood chemistry parameters differed between birds on the oil and control diets after two or four weeks of feeding, nor did feather CORT differ between the two groups. Overall, this study suggests that the response of CORT to stressors, but not baseline HPA function, may be a particularly sensitive bioindicator of sub-lethal chronic effects of crude oil exposure.	[Lattin, Christine R.; Ngai, Heather M.; Romero, L. Michael] Tufts Univ, Dept Biol, Medford, MA 02155 USA	Tufts University	Lattin, CR (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	Christine.Lattin@tufts.edu	Lattin, Christine/E-5662-2013	Lattin, Christine/0000-0003-4030-4212	National Science Foundation [IOS-1048529]; Tufts Institute for the Environment undergraduate summer grant; Environmental Protection Agency's Science to Achieve Results fellowship; Direct For Biological Sciences [1048529] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Tufts Institute for the Environment undergraduate summer grant; Environmental Protection Agency's Science to Achieve Results fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by the following: National Science Foundation grant IOS-1048529 to LMR (www.nsf.gov); Tufts Institute for the Environment undergraduate summer grant to HMN and fellowship to CRL (environment.tufts.edu); and The Environmental Protection Agency's Science to Achieve Results fellowship to CRL (www.epa.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers PH, 2006, AVIAN POULT BIOL REV, V17, P125, DOI 10.3184/147020606783438740; Alonso-Alvarez C, 2007, AQUAT TOXICOL, V84, P103, DOI 10.1016/j.aquatox.2007.06.004; Anderson TR., 2006, BIOL UBIQUITOUS HOUS; Andres BA, 1997, J WILDLIFE MANAGE, V61, P1322, DOI 10.2307/3802132; Awerman JL, 2010, COMP BIOCHEM PHYS A, V156, P136, DOI 10.1016/j.cbpa.2010.01.010; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Bortolotti GR, 2009, J EXP BIOL, V212, P1477, DOI 10.1242/jeb.022152; Breuner CW, 2001, J NEUROENDOCRINOL, V13, P412, DOI 10.1046/j.1365-2826.2001.00646.x; BURNS KA, 1994, ESTUAR COAST SHELF S, V38, P349, DOI 10.1006/ecss.1994.1025; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; CHEN J, 2011, JYI, V21, P84; Cray C, 2011, J AVIAN MED SURG, V25, P14, DOI 10.1647/2010-004.1; Crossin GT, 2013, GEN COMP ENDOCR, V193, P112, DOI 10.1016/j.ygcen.2013.07.011; DARLINGTON DN, 1990, ENDOCRINOLOGY, V127, P759, DOI 10.1210/endo-127-2-759; Dickens MJ, 2009, P R SOC B, V276, P2051, DOI 10.1098/rspb.2008.1778; Dickens MJ, 2009, GEN COMP ENDOCR, V160, P76, DOI 10.1016/j.ygcen.2008.10.023; Drake KR, 2001, CONDOR, V103, P259, DOI 10.1650/0010-5422(2001)103[0259:MHUASO]2.0.CO;2; Fairhurst GD, 2013, J EXP BIOL, V216, P4071, DOI 10.1242/jeb.091280; Fowler GS, 1995, AUK, V112, P382, DOI 10.2307/4088725; Franceschini MD, 2008, ENVIRON TOXICOL CHEM, V27, P2326, DOI 10.1897/07-602.1; Franceschini MD, 2009, ECOTOXICOLOGY, V18, P514, DOI 10.1007/s10646-009-0309-2; Gagnon A, 2006, AQUAT TOXICOL, V78, P59, DOI 10.1016/j.aquatox.2006.02.004; Geraci J, 2012, SEA MAMMALS OIL CONF, P298; GORSLINE J, 1981, ARCH ENVIRON CON TOX, V10, P765, DOI 10.1007/BF01054860; GORSLINE J, 1982, ARCH ENVIRON CON TOX, V11, P497, DOI 10.1007/BF01056078; Greenacre CB, 2008, J AVIAN MED SURG, V22, P291, DOI 10.1647/2007-034.1; Harr KE, 2002, VET CLIN PATH, V31, P140, DOI 10.1111/j.1939-165X.2002.tb00295.x; HARVEY S, 1981, GEN COMP ENDOCR, V45, P372, DOI 10.1016/0016-6480(81)90077-0; Hinson JP, 2006, BEST PRACT RES CL EN, V20, P111, DOI 10.1016/j.beem.2005.09.006; Hinson JP, 1999, ENDOCRINE AND HORMONAL TOXICOLOGY, P67; HOLMES WN, 1979, ENVIRON RES, V20, P425, DOI 10.1016/0013-9351(79)90017-3; Karr KE, 2006, CLIN AVIAN MED, P611; Lattin CR, 2012, GEN COMP ENDOCR, V178, P494, DOI 10.1016/j.ygcen.2012.07.013; Lattin CR, 2011, J AVIAN BIOL, V42, P247, DOI 10.1111/j.1600-048X.2010.05310.x; Leighton Frederick A., 1993, Environmental Reviews, V1, P92; Lendvai AZ, 2011, J EXP BIOL, V214, P821, DOI 10.1242/jeb.047712; Levene H., 1960, CONTRIBUTIONS PROBAB, P278, DOI DOI 10.1137/1003016; Love OP, 2003, ECOTOXICOLOGY, V12, P199, DOI 10.1023/A:1022502826800; Lumeij J. T., 1997, Clinical biochemistry of domestic animals., P857, DOI 10.1016/B978-012396305-5/50031-2; Massey JG, 2007, 9 INT EFF OIL WILDL, P169; Newman SH, 2000, ENVIRON POLLUT, V107, P295, DOI 10.1016/S0269-7491(99)00171-2; Nichols JW, 2011, ENVIRON TOXICOL CHEM, V30, P39, DOI 10.1002/etc.376; Norris DO, 2000, AM ZOOL, V40, P393, DOI 10.1668/0003-1569(2000)040[0393:EDOTSA]2.0.CO;2; Perez-Cadahia B, 2007, ENVIRON INT, V33, P176, DOI 10.1016/j.envint.2006.09.006; Quinn G.P., 2002, EXPT DESIGN DATA ANA, P173, DOI [10.1017/CBO9780511806384.009, DOI 10.1017/CBO9780511806384]; RATTNER BA, 1981, COMP BIOCHEM PHYS C, V68, P103, DOI 10.1016/0306-4492(81)90002-2; Reavill D.R., 2000, LAB MED AVIAN EXOTIC, V1st ed., P353; Reddy CM, 2002, ENVIRON SCI TECHNOL, V36, P4754, DOI 10.1021/es020656n; Romero LM, 2006, GEN COMP ENDOCR, V149, P66, DOI 10.1016/j.ygcen.2006.05.011; Romero LM, 2010, P ROY SOC B-BIOL SCI, V277, P3157, DOI 10.1098/rspb.2010.0678; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Rosskopf Jr WJ, 1996, DIS CAGE AVIARY BIRD; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051; SAPOLSKY RM, 1991, BIOL PSYCHIAT, V30, P1008, DOI 10.1016/0006-3223(91)90121-2; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Seiser PE, 2000, MAR POLLUT BULL, V40, P152, DOI 10.1016/S0025-326X(99)00194-0; Short JW, 2004, ENVIRON SCI TECHNOL, V38, P19, DOI 10.1021/es0348694; Wada H, 2009, ENVIRON SCI TECHNOL, V43, P6031, DOI 10.1021/es803707f; WINGFIELD JC, 1992, J EXP ZOOL, V264, P419, DOI 10.1002/jez.1402640407	61	22	22	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102106	10.1371/journal.pone.0102106	http://dx.doi.org/10.1371/journal.pone.0102106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029334	gold, Green Published, Green Submitted			2022-12-25	WOS:000341306600036
J	Luostari, K; Hartikainen, JM; Tengstrom, M; Palvimo, JJ; Kataja, V; Mannermaa, A; Kosma, VM				Luostari, Kaisa; Hartikainen, Jaana M.; Tengstrom, Maria; Palvimo, Jorma J.; Kataja, Vesa; Mannermaa, Arto; Kosma, Veli-Matti			Type II Transmembrane Serine Protease Gene Variants Associate with Breast Cancer	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; TUMOR-CELLS EXPRESS; PROSTATE-CANCER; OVARIAN-CANCER; THERAPEUTIC INTERVENTION; POTENTIAL CANDIDATE; COLORECTAL CANCERS; HEPSIN GENE; MATRIPTASE; SURVIVAL	Type II transmembrane serine proteases (TTSPs) are related to tumor growth, invasion, and metastasis in cancer. Genetic variants in these genes may alter their function, leading to cancer onset and progression, and affect patient outcome. Here, 464 breast cancer cases and 370 controls were genotyped for 82 single-nucleotide polymorphisms covering eight genes. Association of the genotypes was estimated against breast cancer risk, breast cancer-specific survival, and survival in different treatment groups, and clinicopathological variables. SNPs in TMPRSS3 (rs3814903 and rs11203200), TMPRSS7 (rs1844925), and HGF (rs5745752) associated significantly with breast cancer risk (P-trend = 0.008-0.042). SNPs in TMPRSS1 (rs12151195 and rs12461158), TMPRSS2 (rs2276205), TMPRSS3 (rs3814903), and TMPRSS7 (rs2399403) associated with prognosis (P = 0.004-0.046). When estimating the combined effect of the variants, the risk of breast cancer was higher with 4-5 alleles present compared to 0-2 alleles (P = 0.0001; OR, 2.34; 95% CI, 1.39-3.94). Women with 6-8 survival-associating alleles had a 3.3 times higher risk of dying of breast cancer compared to women with 1-3 alleles (P = 0.001; HR, 3.30; 95% CI, 1.58-6.88). The results demonstrate the combined effect of variants in TTSPs and their related genes in breast cancer risk and patient outcome. Functional analysis of these variants will lead to further understanding of this gene family, which may improve individualized risk estimation and development of new strategies for treatment of breast cancer.	[Luostari, Kaisa; Hartikainen, Jaana M.; Mannermaa, Arto; Kosma, Veli-Matti] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Luostari, Kaisa; Hartikainen, Jaana M.; Palvimo, Jorma J.; Mannermaa, Arto; Kosma, Veli-Matti] Univ Eastern Finland, Bioctr Kuopio, Kuopio, Finland; [Luostari, Kaisa; Hartikainen, Jaana M.; Palvimo, Jorma J.; Mannermaa, Arto; Kosma, Veli-Matti] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland; [Luostari, Kaisa; Hartikainen, Jaana M.; Mannermaa, Arto; Kosma, Veli-Matti] Kuopio Univ Hosp, Imaging Ctr, SF-70210 Kuopio, Finland; [Tengstrom, Maria; Kataja, Vesa] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland; [Tengstrom, Maria; Kataja, Vesa] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland; [Palvimo, Jorma J.] Univ Eastern Finland, Inst Biomed, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Mannermaa, A (corresponding author), Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland.	arto.mannermaa@uef.fi	Hartikainen, Jaana M/E-6256-2015	Hartikainen, Jaana M/0000-0001-8267-1905; Kataja, Vesa/0000-0003-4846-4843; Palvimo, Jorma/0000-0003-2373-0578	special Government Funding (EVO) of Kuopio University Hospital; Cancer Fund of Northern Savo; Finnish Cancer Organizations; Academy of Finland; strategic funding of the University of Eastern Finland	special Government Funding (EVO) of Kuopio University Hospital; Cancer Fund of Northern Savo; Finnish Cancer Organizations; Academy of Finland(Academy of Finland); strategic funding of the University of Eastern Finland	The KBCP was financially supported by grants from the special Government Funding (EVO) of Kuopio University Hospital (www.psshp.fi), the Cancer Fund of Northern Savo (www.pohjois-savonsyopayhdistys.fi), the Finnish Cancer Organizations (www.cancer.fi), the Academy of Finland (www.aka.fi), and by the strategic funding of the University of Eastern Finland (www.uef.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Bahcall OG, 2013, NAT GENET, V45, P343, DOI 10.1038/ng.2592; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bergum C, 2012, J CELL PHYSIOL, V227, P1604, DOI 10.1002/jcp.22877; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Burmester JK, 2004, HUM HERED, V57, P172, DOI 10.1159/000081443; Burton H, 2013, NAT GENET, V45, P349, DOI 10.1038/ng.2582; Castells A, 2000, CANCER RES, V60, P2836; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Guerrero K, 2012, GYNECOL ONCOL, V125, P720, DOI 10.1016/j.ygyno.2012.03.026; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hartikainen JM, 2012, CANCER RES, V72, P5537, DOI 10.1158/0008-5472.CAN-12-1474; Hartikainen JM, 2006, CLIN CANCER RES, V12, P1454, DOI 10.1158/1078-0432.CCR-05-1417; Hartikainen JM, 2005, CANCER EPIDEM BIOMAR, V14, P75; Hirano A, 2001, CLIN CANCER RES, V7, P876; Holt SK, 2010, PROSTATE, V70, P1012, DOI 10.1002/pros.21135; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Huang LL, 2011, INT J CLIN EXP PATHO, V4, P644; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kauppinen JM, 2010, CANCER EPIDEM BIOMAR, V19, P2133, DOI 10.1158/1055-9965.EPI-10-0418; Kotsopoulos J, 2012, STEROIDS, V77, P1, DOI 10.1016/j.steroids.2011.10.002; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Mendes-Pereira AM, 2012, P NATL ACAD SCI USA, V109, P2730, DOI 10.1073/pnas.1018872108; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Owen KA, 2010, BIOCHEM J, V426, P219, DOI 10.1042/BJ20091448; Pal P, 2006, HUM GENET, V120, P187, DOI 10.1007/s00439-006-0204-3; Partanen JI, 2012, P NATL ACAD SCI USA, V109, pE388, DOI 10.1073/pnas.1120421109; Pellikainen MJ, 2003, J CLIN PATHOL, V56, P214, DOI 10.1136/jcp.56.3.214; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Sawasaki T, 2004, TUMOR BIOL, V25, P141, DOI 10.1159/000079146; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; Tanimoto H, 2001, TUMOR BIOL, V22, P104, DOI 10.1159/000050604; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Tuhkanen H, 2013, INT J CANCER, V133, P2334, DOI 10.1002/ijc.28254; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Underwood LJ, 2000, BBA-MOL BASIS DIS, V1502, P337, DOI 10.1016/S0925-4439(00)00058-2; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; Viloria CG, 2007, BRIT J CANCER, V97, P201, DOI 10.1038/sj.bjc.6603856; Xing P, 2011, J INVEST MED, V59, P803, DOI 10.2310/JIM.0b013e31821451a1; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	50	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102519	10.1371/journal.pone.0102519	http://dx.doi.org/10.1371/journal.pone.0102519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029565	Green Submitted, gold, Green Published			2022-12-25	WOS:000341306600079
J	Pollock, FJ; Lamb, JB; Field, SN; Heron, SF; Schaffelke, B; Shedrawi, G; Bourne, DG; Willis, BL				Pollock, F. Joseph; Lamb, Joleah B.; Field, Stuart N.; Heron, Scott F.; Schaffelke, Britta; Shedrawi, George; Bourne, David G.; Willis, Bette L.			Sediment and Turbidity Associated with Offshore Dredging Increase Coral Disease Prevalence on Nearby Reefs	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORALS; INDO-PACIFIC; BAND DISEASE; NUTRIENT ENRICHMENT; WATER-QUALITY; CLIMATE; ECOLOGY; RUNOFF; TERRESTRIAL	In recent decades, coral reef ecosystems have declined to the extent that reefs are now threatened globally. While many water quality parameters have been proposed to contribute to reef declines, little evidence exists conclusively linking specific water quality parameters with increased disease prevalence in situ. Here we report evidence from in situ coral health surveys confirming that chronic exposure to dredging-associated sediment plumes significantly increase the prevalence of white syndromes, a devastating group of globally important coral diseases. Coral health surveys were conducted along a dredging-associated sediment plume gradient to assess the relationship between sedimentation, turbidity and coral health. Reefs exposed to the highest number of days under the sediment plume (296 to 347 days) had two-fold higher levels of disease, largely driven by a 2.5-fold increase in white syndromes, and a six-fold increase in other signs of compromised coral health relative to reefs with little or no plume exposure (0 to 9 days). Multivariate modeling and ordination incorporating sediment exposure level, coral community composition and cover, predation and multiple thermal stress indices provided further confirmation that sediment plume exposure level was the main driver of elevated disease and other compromised coral health indicators. This study provides the first evidence linking dredging-associated sedimentation and turbidity with elevated coral disease prevalence in situ. Our results may help to explain observed increases in global coral disease prevalence in recent decades and suggest that minimizing sedimentation and turbidity associated with coastal development will provide an important management tool for controlling coral disease epizootics.	[Pollock, F. Joseph; Lamb, Joleah B.; Willis, Bette L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Pollock, F. Joseph; Lamb, Joleah B.; Willis, Bette L.] Australian Inst Marine Sci, AIMS JCU, Townsville, Qld 4810, Australia; [Pollock, F. Joseph; Lamb, Joleah B.; Willis, Bette L.] James Cook Univ, Townsville, Qld 4811, Australia; [Pollock, F. Joseph; Schaffelke, Britta; Bourne, David G.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Field, Stuart N.; Shedrawi, George] Marine Sci Program, Dept Pk & Wildlife, Kensington, WA, Australia; [Field, Stuart N.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Heron, Scott F.] NOAA Coral Reef Watch, Townsville, Qld, Australia; [Heron, Scott F.] James Cook Univ, Marine Geophys Lab, Sch Engn & Phys Sci, Townsville, Qld 4811, Australia	James Cook University; Australian Institute of Marine Science; James Cook University; Australian Institute of Marine Science; University of Western Australia; National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University	Pollock, FJ (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	Frederic.Pollock1@jcu.edu.au	Lamb, Joleah/D-1994-2018; Heron, Scott F/E-7928-2011; Bourne, David G/B-5073-2008	Lamb, Joleah/0000-0002-7005-9994; Bourne, David G/0000-0002-1492-8710; Shedrawi, George/0000-0002-4507-7293; Pollock, Joseph/0000-0001-5467-8499; Heron, Scott/0000-0001-5262-6978	Australian National Network in Marine Science (ANNiMS) PhD mobility scholarship awarded; ANNiMS Industry Research grant awarded; project through DPaW's Dredging Audit and Surveillance Program as part of environmental offsets	Australian National Network in Marine Science (ANNiMS) PhD mobility scholarship awarded; ANNiMS Industry Research grant awarded; project through DPaW's Dredging Audit and Surveillance Program as part of environmental offsets	This work was partially funded by an Australian National Network in Marine Science (ANNiMS) PhD mobility scholarship awarded to FJP and an ANNiMS Industry Research grant awarded to JBL. The Gorgon Joint Venture (http://www.chevronaustralia.com/our-businesses/gorgon) also largely funded the project through DPaW's Dredging Audit and Surveillance Program as part of environmental offsets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Beeden R, 2008, UNDERWATER CARDS ASE; Bourne DG, 2008, APPL ENVIRON MICROB, V74, P883, DOI 10.1128/AEM.01124-07; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; BROWN BE, 1985, ADV MAR BIOL, V22, P1, DOI 10.1016/S0065-2881(08)60049-8; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L., 2011, REEFS RISK REVISITED; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Douvere F., 2012, MISSION REPORT REACT; Evans RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051668; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Falkowski P.G., 1990, P89; Flores F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037795; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Haapkyla J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016893; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Hayes ML, 2001, HYDROBIOLOGIA, V460, P213, DOI 10.1023/A:1013121503937; Heron S., 2012, P 12 INT COR REEF S; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; HODGSON G, 1990, MAR BIOL, V104, P493, DOI 10.1007/BF01314355; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Masini R, 2011, NODE 1 DREDGING SCI, P23; Maynard JA, 2011, CORAL REEFS, V30, P485, DOI 10.1007/s00338-010-0708-0; Nearing MA, 2005, CATENA, V61, P131, DOI 10.1016/j.catena.2005.03.007; Onton K, 2011, MAR ECOL PROG SER, V433, P75, DOI 10.3354/meps09156; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; PETERS EC, 1985, J EXP MAR BIOL ECOL, V92, P215, DOI 10.1016/0022-0981(85)90096-6; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; Pocock YP, 1972, GEOL RUNDSCH, V61, P598, DOI DOI 10.1007/BF01896337; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Ravindran J, 2006, MAR BIOL, V149, P347, DOI 10.1007/s00227-005-0192-1; RICHMOND RH, 1993, AM ZOOL, V33, P524; RIEGL B, 1995, J EXP MAR BIOL ECOL, V186, P259, DOI 10.1016/0022-0981(94)00164-9; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; ROGERS CS, 1983, MAR POLLUT BULL, V14, P378, DOI 10.1016/0025-326X(83)90602-1; Rosenberg E, 2007, OCEANOGRAPHY, V20, P146, DOI 10.5670/oceanog.2007.60; STAFFORDSMITH MG, 1993, MAR BIOL, V115, P229, DOI 10.1007/BF00346340; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; The World Association for Waterborne Transport Infrastructure, 2010, DREDG PORT CONSTR CO, P75; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; unep/gpa (United Nations Environmental Programme and Global Programme of Action for the Protection of Marine Environment from Land-based Pollution), 2006, PROT COAST MAR ENV L; Vollmer SV, 2008, BIOL FAC PUBL; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Weil E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P465, DOI 10.1007/978-94-007-0114-4_27; Western Australia Department of Environment and Conservation, 2007, MAN PLAN MONT BARR I; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wooldridge S, 2006, MAR POLLUT BULL, V52, P1467, DOI 10.1016/j.marpolbul.2006.05.009; Wooldridge SA, 2009, ECOL APPL, V19, P1492, DOI 10.1890/08-0963.1	57	135	140	3	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102498	10.1371/journal.pone.0102498	http://dx.doi.org/10.1371/journal.pone.0102498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029525	Green Published, gold, Green Accepted			2022-12-25	WOS:000341306600078
J	Heard, D; Bobashev, GV; Morris, RJ				Heard, Daniel; Bobashev, Georgiy V.; Morris, Robert J.			Reducing the Complexity of an Agent-Based Local Heroin Market Model	PLOS ONE			English	Article							DRUG MARKETS; STATISTICS	This project explores techniques for reducing the complexity of an agent-based model ( ABM). The analysis involved a model developed from the ethnographic research of Dr. Lee Hoffer in the Larimer area heroin market, which involved drug users, drug sellers, homeless individuals and police. The authors used statistical techniques to create a reduced version of the original model which maintained simulation fidelity while reducing computational complexity. This involved identifying key summary quantities of individual customer behavior as well as overall market activity and replacing some agents with probability distributions and regressions. The model was then extended to allow external market interventions in the form of police busts. Extensions of this research perspective, as well as its strengths and limitations, are discussed.	[Heard, Daniel] Duke Univ, Dept Stat Sci, Durham, NC 27708 USA; [Bobashev, Georgiy V.; Morris, Robert J.] RTI Int, Res Triangle Pk, NC USA	Duke University; Research Triangle Institute	Heard, D (corresponding author), Duke Univ, Dept Stat Sci, Durham, NC 27708 USA.	dph11@stat.duke.edu			NIDA [R01DA025163-01A1]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025163] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work has been funded by a grant R01DA025163-01A1 from NIDA (Hoffer and Bobashev PIs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre BE, 2011, CONTEMP SOC SCI, V6, P415, DOI 10.1080/21582041.2011.609380; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Baldwin B, 2013, HEROINS DEADLY  0717; Bouchard M, 2005, J DRUG ISSUES, V35, P733, DOI 10.1177/002204260503500404; Burden R. L., 2010, NUMERICAL ANAL; Cox DD, 2008, BIOMETRIKA, V95, P621, DOI 10.1093/biomet/asn021; Curtis R, 2000, ILLEGAL DRUG MARKETS, P241; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Gilbert N., 1999, SIMULATION SOCIAL SC; Hoffer L, 2011, COMPUTATIONAL NEUROS, P313; Hoffer L.D., 2006, JUNKIE BUSINESS EVOL; Hoffer LD, 2009, AM J COMMUN PSYCHOL, V44, P273, DOI 10.1007/s10464-009-9268-2; Karayanakis N., 1993, COMPUTER ASSISTED SI; Leger D, 2013, US TODAY        0723; Lehmann E. L., 2006, TESTING STAT HYPOTHE; May T, 2004, ADDICT RES THEORY, V12, P549, DOI 10.1080/16066350412331323119; McKenna SM, 1995, 1 INT C DIG POW SYST, P3; Perez P, 2006, SMART INFRASTRUCTURE, P193; Rahmandad H, 2012, SYST DYNAM REV, V28, P396, DOI 10.1002/sdr.1481; Ritter A, 2005, AUSTR ILLICIT DRUG M; Seelye KW, 2013, NY TIMES        0718; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Wellek S., 2003, TESTING STAT HYPOTHE; Zou Y, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066106	24	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102263	10.1371/journal.pone.0102263	http://dx.doi.org/10.1371/journal.pone.0102263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025132	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992400057
J	Kaur, H; Jajodia, A; Grover, S; Baghel, R; Gupta, M; Jain, S; Kukreti, R				Kaur, Harpreet; Jajodia, Ajay; Grover, Sandeep; Baghel, Ruchi; Gupta, Meenal; Jain, Sanjeev; Kukreti, Ritushree			Genetic Variations of PIP4K2A Confer Vulnerability to Poor Antipsychotic Response in Severely Ill Schizophrenia Patients	PLOS ONE			English	Article							DOPAMINE TRANSPORTER GENE; NEUROTROPHIC FACTOR; DISEQUILIBRIUM TESTS; HAPLOTYPE BLOCKS; ENZYME-ACTIVITY; SINGLE MARKER; BDNF GENE; ASSOCIATION; POPULATION; VARIANTS	Literature suggests that disease severity and neurotransmitter signaling pathway genes can accurately identify antipsychotic response in schizophrenia patients. However, putative role of signaling molecules has not been tested in schizophrenia patients based on severity of illness, despite its biological plausibility. In the present study we investigated the possible association of polymorphisms from five candidate genes RGS4, SLC6A3, PIP4K2A, BDNF, PI4KA with response to antipsychotic in variably ill schizophrenia patients. Thus in present study, a total 53 SNPs on the basis of previous reports and functional grounds were examined for their association with antipsychotic response in 423 schizophrenia patients segregated into low and high severity groups. Additionally, haplotype, diplotype, multivariate logistic regression and multifactor-dimensionality reduction (MDR) analyses were performed. Furthermore, observed associations were investigated in atypical monotherapy (n = 355) and risperidone (n = 260) treated subgroups. All associations were estimated as odds ratio (OR) and 95% confidence interval (CI) and test for multiple corrections was applied. Single locus analysis showed significant association of nine variants from SLC6A3, PIP4K2A and BDNF genes with incomplete antipsychotic response in schizophrenia patients with high severity. We identified significant association of six marker diplotype ATTGCT/ATTGCT (rs746203-rs10828317-rs7094131-rs2296624-rs11013052-rs1409396) of PIP4K2A gene in incomplete responders (corrected p-value = 0.001; adjusted-OR = 3.19, 95%-CI = 1.46-6.98) with high severity. These associations were further observed in atypical monotherapy and risperidone sub-groups. MDR approach identified gene-gene interaction among BDNF_rs7103411-BDNF_rs1491851-SLC6A3_rs40184 in severely ill incomplete responders (OR = 7.91, 95%-CI = 4.08-15.36). While RGS4_rs2842026-SLC6A3_rs2975226 interacted synergistically in incomplete responders with low severity (OR = 4.09, 95%-CI = 2.09-8.02). Our findings provide strong evidence that diplotype ATTGCT/ATTGCT of PIP4K2A gene conferred approximately three-times higher incomplete responsiveness towards antipsychotics in severely ill patients. These results are consistent with the known role of phosphatidyl-inositol-signaling elements in antipsychotic action and outcome. Findings have implication for future molecular genetic studies as well as personalized medicine. However more work is warranted to elucidate underlying causal biological pathway.	[Kaur, Harpreet; Jajodia, Ajay; Grover, Sandeep; Baghel, Ruchi; Gupta, Meenal; Kukreti, Ritushree] CSIR Inst Genom & Integrat Biol, Delhi, India; [Jain, Sanjeev] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Bengaluru, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); National Institute of Mental Health & Neurosciences - India	Kukreti, R (corresponding author), CSIR Inst Genom & Integrat Biol, Delhi, India.	ritus@igib.res.in	Kaur, Harpreet/ABH-9527-2020	Kaur, Harpreet/0000-0002-2836-7053; Grover, Sandeep/0000-0003-2615-4916; jain, sanjeev/0000-0002-9508-351X	Council of Scientific and Industrial Research [BSC0123]; Indian Council of Medical Research (ICMR); Council of Scientific and Industrial Research (CSIR)	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Financial support from the BSC0123 project (Council of Scientific and Industrial Research) is duly acknowledged. HK, RB are thankful to Indian Council of Medical Research (ICMR) and AJ, SG, MG are thankful to Council of Scientific and Industrial Research (CSIR) for providing senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Abou Jamra R, 2006, AM J MED GENET B, V141B, P663, DOI 10.1002/ajmg.b.30358; Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Anttila S, 2005, J NEURAL TRANSM, V112, P885, DOI 10.1007/s00702-004-0233-9; Bakker SC, 2007, GENES BRAIN BEHAV, V6, P113, DOI 10.1111/j.1601-183X.2006.00234.x; Bannon MJ, 2001, EUR NEUROPSYCHOPHARM, V11, P449, DOI 10.1016/S0924-977X(01)00122-5; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chen L, 2009, SCHIZOPHR RES, V113, P34, DOI 10.1016/j.schres.2009.06.001; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Clarke JH, 2013, PSYCHOPHARMACOLOGY, V230, P329, DOI 10.1007/s00213-013-3299-y; CONN PJ, 1986, J NEUROSCI, V6, P3669; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dominguez E, 2007, SCHIZOPHR RES, V90, P123, DOI 10.1016/j.schres.2006.09.022; DUPONT WD, 1988, BIOMETRICS, V44, P1157, DOI 10.2307/2531743; Fedorenko OY, 2013, ZH NEVROL PSIKHIATR, V113, P58; Fedorenko O, 2008, PSYCHOPHARMACOLOGY, V199, P47, DOI 10.1007/s00213-008-1095-x; Fedorenko O, 2009, PSYCHOPHARMACOLOGY, V206, P429, DOI 10.1007/s00213-009-1621-5; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Green MJ, 2011, MOL PSYCHIATR, V16, P960, DOI 10.1038/mp.2010.88; Gupta M, 2009, PHARMACOGENOMICS, V10, P385, DOI 10.2217/14622416.10.3.385; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; Haro JM, 2005, ACTA PSYCHIAT SCAND, V111, P220, DOI 10.1111/j.1600-0447.2004.00450.x; He ZD, 2007, SCHIZOPHR RES, V94, P359, DOI 10.1016/j.schres.2007.04.013; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Huang SY, 2010, SCHIZOPHR RES, V116, P68, DOI 10.1016/j.schres.2009.10.004; Jeong SH, 2004, PROG NEURO-PSYCHOPH, V28, P975, DOI 10.1016/j.pnpbp.2004.05.015; Jha P, 2012, INFECT GENET EVOL, V12, P142, DOI 10.1016/j.meegid.2011.11.001; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Jungerius BJ, 2008, MOL PSYCHIATR, V13, P1060, DOI 10.1038/sj.mp.4002080; Kamatani N, 2004, AM J HUM GENET, V75, P190, DOI 10.1086/422853; Kirov G, 2005, J CLIN INVEST, V115, P1440, DOI 10.1172/JCI24759; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Lipska BK, 2006, HUM MOL GENET, V15, P2804, DOI 10.1093/hmg/ddl222; Luoni A, 2014, PHARMACOL RES, V80, P1, DOI 10.1016/j.phrs.2013.11.008; Mas S, 2009, PROG NEURO-PSYCHOPH, V33, P1064, DOI 10.1016/j.pnpbp.2009.06.001; McGuffin P, 2004, PSYCHIAT PRAX, V31, pS189, DOI 10.1055/s-2004-834565; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Pae CU, 2012, NEUROPSYCHOBIOLOGY, V65, P1, DOI 10.1159/000327605; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Riddle EL, 2005, AAPS J, V7, pE847, DOI 10.1208/aapsj070481; Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705; Saggers-Gray L, 2008, AM J MED GENET B, V147B, P1310, DOI 10.1002/ajmg.b.30736; Sakata K, 2014, NEUROSCIENCE, V260, P265, DOI 10.1016/j.neuroscience.2013.12.013; Schwab SG, 2006, MOL PSYCHIATR, V11, P837, DOI 10.1038/sj.mp.4001864; Sjoholm H, 2004, PSYCHOPHARMACOLOGY, V173, P27, DOI 10.1007/s00213-003-1700-y; Sotnikova Tatyana D., 2006, CNS & Neurological Disorders-Drug Targets, V5, P45, DOI 10.2174/187152706784111579; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Talkowski ME, 2008, HUM MOL GENET, V17, P747, DOI 10.1093/hmg/ddm347; Thiselton DL, 2010, AM J MED GENET B, V153B, P323, DOI 10.1002/ajmg.b.30982; Ullah AZD, 2012, NUCLEIC ACIDS RES, V40, pW65, DOI 10.1093/nar/gks364; UNDIE AS, 1992, NEUROBIOL AGING, V13, P505, DOI 10.1016/0197-4580(92)90079-D; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Watanabe Y, 2013, PSYCHIAT CLIN NEUROS, V67, P123, DOI 10.1111/pcn.12018; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Xu MQ, 2010, EUR J HUM GENET, V18, P707, DOI 10.1038/ejhg.2009.238; Zai GCM, 2012, PROG NEURO-PSYCHOPH, V39, P96, DOI 10.1016/j.pnpbp.2012.05.014; Zandi PP, 2010, CLIN LAB MED, V30, P931, DOI 10.1016/j.cll.2010.07.004	69	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102556	10.1371/journal.pone.0102556	http://dx.doi.org/10.1371/journal.pone.0102556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025909	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400086
J	Khsheibun, R; Paperna, T; Volkowich, A; Lejbkowicz, I; Avidan, N; Miller, A				Khsheibun, Rana; Paperna, Tamar; Volkowich, Anat; Lejbkowicz, Izabella; Avidan, Nili; Miller, Ariel			Gene Expression Profiling of the Response to Interferon Beta in Epstein-Barr-Transformed and Primary B Cells of Patients with Multiple Sclerosis	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-4; IFN-BETA; DIAGNOSTIC-CRITERIA; RECEPTOR; LINES; GROWTH; AUTOIMMUNITY; ACTIVATION; ANTIBODIES; INFECTION	The effects of interferon-beta (IFN-beta), one of the key immunotherapies used in multiple sclerosis (MS), on peripheral blood leukocytes and T cells have been extensively studied. B cells are a less abundant leukocyte type, and accordingly less is known about the B cell-specific response to IFN-beta. To identify gene expression changes and pathways induced by IFN-beta in B cells, we studied the in vitro response of human Epstein Barr-transformed B cells (lymphoblast cell lines-LCLs), and validated our results in primary B cells. LCLs were derived from an MS patient repository. Whole genome expression analysis identified 115 genes that were more than two-fold differentially up-regulated following IFN-beta exposure, with over 50 previously unrecognized as IFN-beta response genes. Pathways analysis demonstrated that IFN-beta affected LCLs in a similar manner to other cell types by activating known IFN-beta canonical pathways. Additionally, IFN-beta increased the expression of innate immune response genes, while down-regulating many B cell receptor pathway genes and genes involved in adaptive immune responses. Novel response genes identified herein, NEXN, DDX60L, IGFBP4, and HAPLN3, B cell receptor pathway genes, CD79B and SYK, and lymphocyte activation genes, LAG3 and IL27RA, were validated as IFN-beta response genes in primary B cells. In this study new IFN-beta response genes were identified in B cells, with possible implications to B cell-specific functions. The study's results emphasize the applicability of LCLs for studies of human B cell drug response. The usage of LCLs from patient-based repositories may facilitate future studies of drug response in MS and other immune-mediated disorders with a B cell component.	[Khsheibun, Rana; Paperna, Tamar; Lejbkowicz, Izabella; Avidan, Nili; Miller, Ariel] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Volkowich, Anat; Miller, Ariel] Carmel Hosp, Div Neuroimmunol, Haifa, Israel; [Volkowich, Anat; Miller, Ariel] Carmel Hosp, Multiple Sclerosis Ctr, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Clalit Health Services; Carmel Medical Center; Clalit Health Services; Carmel Medical Center	Miller, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel.	millera@tx.technion.ac.il		Miller, Ariel/0000-0001-5843-6841	National Multiple Sclerosis Society of the United States of America [RG 3520A1/1]; Wolfson Family Charitable Trust; Sacta-Rashi Foundation; Technion's Vice-President for Research funds; E. & S. Kronovet Fund for Medical Research; American Technion Society; Association Technion France; Israeli Ministry of Science and Technology fellowship for Arabs, Druze and Cherkessians; Gerald and Una Yakatan Fellowship; Sondra and Robert Berk Fellowship	National Multiple Sclerosis Society of the United States of America(National Multiple Sclerosis Society); Wolfson Family Charitable Trust; Sacta-Rashi Foundation; Technion's Vice-President for Research funds; E. & S. Kronovet Fund for Medical Research; American Technion Society; Association Technion France; Israeli Ministry of Science and Technology fellowship for Arabs, Druze and Cherkessians; Gerald and Una Yakatan Fellowship; Sondra and Robert Berk Fellowship	This work was supported by the National Multiple Sclerosis Society of the United States of America (RG 3520A1/1 to AM); and the Wolfson Family Charitable Trust, the Sacta-Rashi Foundation, the Technion's Vice-President for Research funds, the E. & S. Kronovet Fund for Medical Research, the American Technion Society, and the Association Technion France (to AM). RK was a recipient of the following fellowships: Israeli Ministry of Science and Technology fellowship for Arabs, Druze and Cherkessians, Gerald and Una Yakatan Fellowship, and Sondra and Robert Berk Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOVICH C, 1994, CYTOKINE, V6, P414, DOI 10.1016/1043-4666(94)90066-3; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Bolotin E, 2014, HUM MOL GENET, V23, P1202, DOI 10.1093/hmg/ddt512; Buchwalder PA, 2000, J INTERF CYTOK RES, V20, P857, DOI 10.1089/10799900050163226; Buck D, 2011, J NEUROL, V258, P1747, DOI 10.1007/s00415-011-6101-2; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Casiraghi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002715; Chesik D, 2006, EUR J NEUROSCI, V24, P1645, DOI 10.1111/j.1460-9568.2006.05034.x; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; Comabella M, 2011, CURR NEUROL NEUROSCI, V11, P484, DOI 10.1007/s11910-011-0211-1; Croze E, 2013, PHARMACOGENOMICS J, V13, P443, DOI 10.1038/tpj.2012.27; Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100; Disanto G, 2012, NEUROLOGY, V78, P823, DOI 10.1212/WNL.0b013e318249f6f0; Disanto G, 2012, HUM MOL GENET, V21, P3575, DOI 10.1093/hmg/dds189; Disanto G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032281; Dorner M, 2008, J VIROL, V82, P4400, DOI 10.1128/JVI.02630-07; Durai R, 2006, INT J ONCOL, V28, P1317; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Green NM, 2009, J IMMUNOL, V183, P1569, DOI 10.4049/jimmunol.0803899; Harker JA, 2013, IMMUNITY, V39, P548, DOI 10.1016/j.immuni.2013.08.010; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Hecker M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029648; Henig N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062366; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Khan OA, 1998, NEUROLOGY, V51, P738, DOI 10.1212/WNL.51.3.738; Kisielow M, 2005, EUR J IMMUNOL, V35, P2081, DOI 10.1002/eji.200526090; Krumbholz M, 2008, BRAIN, V131, P1455, DOI 10.1093/brain/awn077; Krumbholz M, 2012, NAT REV NEUROL, V8, P613, DOI 10.1038/nrneurol.2012.203; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee JE, 2010, CELL PROLIFERAT, V43, P378, DOI 10.1111/j.1365-2184.2010.00687.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandel I, 2012, J CELL MOL MED, V16, P765, DOI 10.1111/j.1582-4934.2011.01380.x; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller A, 2008, J NEUROL SCI, V274, P68, DOI 10.1016/j.jns.2008.07.028; Min JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022070; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Molnarfi N, 2013, J EXP MED, V210, P2921, DOI 10.1084/jem.20130699; Monson NL, 2008, CURR OPIN NEUROL, V21, pS3, DOI 10.1097/01.wco.0000313358.53553.c7; Morag A, 2013, J MOL NEUROSCI, V49, P554, DOI 10.1007/s12031-012-9852-z; Morag A, 2011, PHARMACOGENOMICS, V12, P171, DOI 10.2217/PGS.10.185; Morag A, 2010, PHARMACOGENOMICS, V11, P327, DOI [10.2217/pgs.10.27, 10.2217/PGS.10.27]; Ohtsuka T, 1998, J CELL BIOL, V143, P1227, DOI 10.1083/jcb.143.5.1227; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Pieper K, 2013, J ALLERGY CLIN IMMUN, V131, P959, DOI 10.1016/j.jaci.2013.01.046; Pone EJ, 2010, CRIT REV IMMUNOL, V30, P1; Poovassery JS, 2012, J IMMUNOL, V189, P1757, DOI 10.4049/jimmunol.1200624; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Ramgolam VS, 2011, J IMMUNOL, V186, P4518, DOI 10.4049/jimmunol.1000271; Rogge L, 1998, J IMMUNOL, V161, P6567; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sanders AR, 2013, HUM MOL GENET, V22, P5001, DOI 10.1093/hmg/ddt350; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Serafini B, 2010, J NEUROPATH EXP NEUR, V69, P677, DOI 10.1097/NEN.0b013e3181e332ec; Sie L, 2009, J NEUROSCI RES, V87, P1953, DOI 10.1002/jnr.22000; Sierro S, 2011, EXPERT OPIN THER TAR, V15, P91, DOI 10.1517/14712598.2011.540563; Spicer AP, 2003, J BIOL CHEM, V278, P21083, DOI 10.1074/jbc.M213100200; Squassina A, 2013, PHARMACOL RES, V73, P1, DOI 10.1016/j.phrs.2013.04.004; van Boxel-Dezaire AHH, 2010, J IMMUNOL, V185, P5888, DOI 10.4049/jimmunol.0902314; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; von Budingen HC, 2012, J CLIN INVEST, V122, P4533, DOI 10.1172/JCI63842; von Budingen HC, 2011, CURR OPIN IMMUNOL, V23, P713, DOI 10.1016/j.coi.2011.09.003; Walsh ER, 2012, P NATL ACAD SCI USA, V109, P16276, DOI 10.1073/pnas.1209372109; Weber MS, 2011, BBA-MOL BASIS DIS, V1812, P239, DOI 10.1016/j.bbadis.2010.06.009; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Winkelmann R, 2011, P NATL ACAD SCI USA, V108, P710, DOI 10.1073/pnas.1012858108; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Wroblewski JM, 2002, J IMMUNOL METHODS, V264, P19, DOI 10.1016/S0022-1759(01)00565-8; Yoshimoto T, 2004, J IMMUNOL, V173, P2479, DOI 10.4049/jimmunol.173.4.2479; Zhou R, 2004, J MOL ENDOCRINOL, V32, P349, DOI 10.1677/jme.0.0320349	77	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102331	10.1371/journal.pone.0102331	http://dx.doi.org/10.1371/journal.pone.0102331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025430	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400064
J	Manka, P; Olliges, V; Bechmann, LP; Schlattjan, M; Jochum, C; Treckmann, JW; Saner, FH; Gerken, G; Syn, WK; Canbay, A				Manka, Paul; Olliges, Verena; Bechmann, Lars P.; Schlattjan, Martin; Jochum, Christoph; Treckmann, Juergen W.; Saner, Fuat H.; Gerken, Guido; Syn, Wing-Kin; Canbay, Ali			Low Levels of Blood Lipids Are Associated with Etiology and Lethal Outcome in Acute Liver Failure	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE; REGENERATION; PATTERNS	Background/Aims: Emerging data links different aspects of lipid metabolism to liver regeneration. In patients with acute liver failure (ALF), low levels of lipids may correlate with disease severity. Thus, we determined whether there is an etiology-specific link between lipid levels in patients suffering from ALF and aimed to investigate an effect of lipid levels on the prognosis of ALF. Methods: In this retrospective single center study, we reviewed 89 consecutive ALF patients, who met the criteria of the "Acute Liver Failure Study Group''. Patient characteristics, clinical data and laboratory parameters were individually analyzed at admission and correlated with the patients' outcome after a four week follow up. Possible endpoints were either discharge, or death or liver transplantation. Results: High-density lipoprotein (HDL), cholesterol and triglyceride levels were significantly lower in patients who died or required a liver transplant. HDL levels were significantly higher in patients with ALF caused by acetaminophen intoxication, compared to fulminant HBV infection or drug induced liver injury. HDL levels correlated with hepatic injury by ALT levels, and Albumin, and inversely correlated with the MELD score, INR, and bilirubin. Conclusion: In our cohort of patients with ALF, we could show that HDL and cholesterol are suppressed. In addition novel etiology specific patterns between acteminophen and non-acteminophen induced liver failure were detected for serum lipid components. Further studies are needed to address the role of cholesterol and lipid metabolism and the according pathways in different etiologies of ALF.	[Manka, Paul; Olliges, Verena; Bechmann, Lars P.; Schlattjan, Martin; Jochum, Christoph; Gerken, Guido; Canbay, Ali] Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany; [Treckmann, Juergen W.; Saner, Fuat H.] Univ Duisburg Essen, Univ Hosp, Dept Gen Visceral & Transplantat Surg, Essen, Germany; [Syn, Wing-Kin] Fdn Liver Res, Inst Hepatol, London, England; [Syn, Wing-Kin] Barts Hlth NHS Trust, Dept Hepatol, London, England	University of Duisburg Essen; University of Duisburg Essen; University of London; University College London; Barts Health NHS Trust	Canbay, A (corresponding author), Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany.	ali.canbay@uni-due.de	Manka, Paul/AAN-1261-2021; Manka, Paul/ABH-2421-2020; Jochum, Christoph/AAC-5402-2020; Syn, Wing-Kin/AAB-8406-2020; Saner, Fuat H/W-8024-2019; Bechmann, Lars/AAZ-7141-2020; Canbay, Ali/AAL-9620-2020	Manka, Paul/0000-0001-8589-7280; Canbay, Ali/0000-0001-6069-7899; Bechmann, Lars/0000-0003-3487-9810	Deutsche Forschungsgemeinschaft (DFG) [CA267/8-1, CA267/13-1, BE3967/3-1]; Wilhelm Laupitz Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wilhelm Laupitz Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (DFG grant CA267/8-1 and CA267/13-1 to AC and DFG grant BE3967/3-1 to LPB), and the Wilhelm Laupitz Foundation to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisqueta L, 2013, BBA-MOL CELL BIOL L, V1831, P1357, DOI 10.1016/j.bbalip.2013.04.015; Barylski M, 2014, BEST PRACT RES CL EN, V28, P453, DOI 10.1016/j.beem.2013.11.001; BAUMBERGER C, 1991, PATHOBIOLOGY, V59, P378, DOI 10.1159/000163681; Best J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00258; Cicognani C, 1997, ARCH INTERN MED, V157, P792, DOI 10.1001/archinte.157.7.792; Delgado-Coello B, 2011, LIVER INT, V31, P1271, DOI 10.1111/j.1478-3231.2011.02542.x; Etogo-Asse FE, 2012, LIVER INT, V32, P523, DOI [10.1111/j.1478-3231.2012.02758.x, 10.1111/j.1478-3231.2011.02657.x]; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Galbois A, 2009, HEPATOLOGY, V49, P175, DOI 10.1002/hep.22582; Guo L, 2013, J BIOL CHEM, V288, P17947, DOI 10.1074/jbc.M112.442699; Hadem J, 2012, CLIN GASTROENTEROL H, V10, P664, DOI 10.1016/j.cgh.2012.02.016; Hoover-Plow J, 2013, METABOLISM, V62, P479, DOI 10.1016/j.metabol.2012.07.024; Kraemer FB, 2007, MOL CELL ENDOCRINOL, V265, P42, DOI 10.1016/j.mce.2006.12.001; Liu ML, 2012, ARTERIOSCL THROM VAS, V32, P2113, DOI 10.1161/ATVBAHA.112.255471; MILLER JP, 1990, BAILLIERE CLIN ENDOC, V4, P807; Sydor S, 2013, LAB INVEST, V93, P20, DOI 10.1038/labinvest.2012.142; Tsai MH, 2009, J HEPATOL, V50, P906, DOI 10.1016/j.jhep.2008.12.024; ULEVITCH RJ, 1979, J CLIN INVEST, V64, P1516, DOI 10.1172/JCI109610; Wang GQ, 2004, MOL CELL BIOCHEM, V262, P41, DOI 10.1023/B:MCBI.0000038214.52184.82	19	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102351	10.1371/journal.pone.0102351	http://dx.doi.org/10.1371/journal.pone.0102351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025159	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400067
J	Ho, PWM; Goradia, A; Russell, MR; Chalk, AM; Milley, KM; Baker, EK; Danks, JA; Slavin, JL; Walia, M; Crimeen-Irwin, B; Dickins, RA; Martin, TJ; Walkley, CR				Ho, P. W. M.; Goradia, A.; Russell, M. R.; Chalk, A. M.; Milley, K. M.; Baker, E. K.; Danks, J. A.; Slavin, J. L.; Walia, M.; Crimeen-Irwin, B.; Dickins, R. A.; Martin, T. J.; Walkley, C. R.			Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo	ONCOGENE			English	Article							HORMONE-RELATED PROTEIN; SMOOTH-MUSCLE-CELLS; PARATHYROID-HORMONE; BONE-FORMATION; PTH/PTHRP RECEPTOR; ANGIOTENSIN-II; RAT; EXPRESSION; LOCALIZATION; OSTEOBLAST	Osteosarcoma (OS) is the most common cancer of bone. Parathyroid hormone (PTH) regulates calcium homeostasis and bone development, while the paracrine/autocrine PTH-related protein (PTHrP) has central roles in endochondral bone formation and bone remodeling. Using a murine OS model, we found that OS cells express PTHrP and the common PTH/PTHrP receptor (PTHR1). To investigate the role of PTHR1 signaling in OS cell behavior, we used shRNA to reduce PTHR1 expression. This only mildly inhibited proliferation in vitro, but markedly reduced invasion through collagen and reduced expression of RANK ligand (RANKL). Administration of PTH(1-34) did not stimulate OS proliferation in vivo but, strikingly, PTHR1 knockdown resulted in a profound growth inhibition and increased differentiation/mineralization of the tumors. Treatment with neutralizing antibody to PTHrP did not recapitulate the knockdown of PTHR1. Consistent with this lack of activity, PTHrP was predominantly intracellular in OS cells. Knockdown of PTHR1 resulted in increased expression of late osteoblast differentiation genes and upregulation of Wnt antagonists. RANKL production was reduced in knockdown tumors, providing for reduced homotypic signaling through the receptor, RANK. Loss of PTHR1 resulted in the coordinated loss of gene signatures associated with the polycomb repressive complex 2 (PRC2). Using Ezh2 inhibitors, we demonstrate that the increased expression of osteoblast maturation markers is in part mediated by the loss of PRC2 activity. Collectively these results demonstrate that PTHR1 signaling is important in maintaining OS proliferation and undifferentiated state. This is in part mediated by intracellular PTHrP and through regulation of the OS epigenome.	[Ho, P. W. M.; Goradia, A.; Russell, M. R.; Chalk, A. M.; Baker, E. K.; Walia, M.; Crimeen-Irwin, B.; Martin, T. J.; Walkley, C. R.] Univ Melbourne, St Vincents Hosp, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Ho, P. W. M.; Goradia, A.; Russell, M. R.; Chalk, A. M.; Baker, E. K.; Walia, M.; Crimeen-Irwin, B.; Martin, T. J.; Walkley, C. R.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Milley, K. M.; Danks, J. A.] RMIT Univ, Sch Med Sci, Bundoora, Vic, Australia; [Slavin, J. L.] St Vincents Hosp, Dept Pathol, Fitzroy, Vic 3065, Australia; [Dickins, R. A.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3050, Australia	St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Royal Melbourne Institute of Technology (RMIT); St Vincent's Hospital Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Walkley, CR (corresponding author), St Vincents Inst, Stem Cell Regulat Unit, 9 Princes St, Fitzroy, Vic 3065, Australia.	jmartin@svi.edu.au; cwalkley@svi.edu.au	Milley, Kristi/ADF-2413-2022; Walkley, Carl/AAO-6021-2020; Dickins, Ross A/K-2852-2012; Chalk, Alistair/B-3019-2008	Walkley, Carl/0000-0002-4784-9031; Dickins, Ross A/0000-0003-4112-5304; Chalk, Alistair/0000-0002-9630-6236; Milley, Kristi/0000-0002-3615-4648	National Health and Medical Research Council of Australia (NHMRC); Cancer Council of Victoria; NHMRC Career Development Award; Cure Cancer Australia Foundation Fellowship; Victorian State Government	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); Cure Cancer Australia Foundation Fellowship; Victorian State Government	We thank the SVH BioResources Centre; P Kocovski and S Taylor for technical assistance, L Purton and J Heierhorst for comments and discussion. This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC; to CRW and CRW/TJM); Cancer Council of Victoria (to CRW and EKB); NHMRC Career Development Award (CRW); Cure Cancer Australia Foundation Fellowship (EKB); in part by the Victorian State Government Operational Infrastructure Support Program (to St. Vincent's Institute). CRW is the Philip Desbrow Senior Research Fellow of the Leukaemia Foundation. The authors thank Chugai Pharmaceutical Company for providing the alpha-PTHrP neutralizing antibody; The Structural Genomics Consortium for generously providing GSK343 and UNC1999.	Akiyama T, 2010, CLIN EXP METASTAS, V27, P207, DOI 10.1007/s10585-010-9319-y; Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI [10.1359/jbmr.080324, 10.1359/JBMR.080324]; Allison Daniel C., 2012, Sarcoma, V2012, P704872, DOI 10.1155/2012/704872; Andrews EB, 2012, J BONE MINER RES, V27, P2429, DOI 10.1002/jbmr.1768; Beristain AG, 2012, J CELL SCI, V125, P943, DOI 10.1242/jcs.094029; DANKS JA, 1989, J BONE MINER RES, V4, P273; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Gardella TJ, 2001, TRENDS ENDOCRIN MET, V12, P210, DOI 10.1016/S1043-2760(01)00409-X; Gopalakrishnan R, 2005, CELLS TISSUES ORGANS, V181, P166, DOI 10.1159/000091378; Gorlick R, 2013, PEDIATR BLOOD CANCER, V60, P1009, DOI 10.1002/pbc.24429; HENDERSON JE, 1995, MOL CELL BIOL, V15, P4064; INGLETON PM, 1977, LAB ANIM SCI, V27, P748; Janeway KA, 2010, LANCET ONCOL, V11, P670, DOI 10.1016/S1470-2045(10)70062-0; Jans DA, 1997, FEBS LETT, V410, P368, DOI 10.1016/S0014-5793(97)00622-4; JIANG BB, 1995, MINER ELECTROL METAB, V21, P157; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kuijjer ML, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-245; Kuijjer ML, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-66; Lam MHC, 1997, J CELL PHYSIOL, V173, P433, DOI 10.1002/(SICI)1097-4652(199712)173:3<433::AID-JCP16>3.0.CO;2-C; Lamoureux F, 2007, CANCER RES, V67, P7308, DOI 10.1158/0008-5472.CAN-06-4130; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; Maeda S, 1996, ENDOCRINOLOGY, V137, P3154, DOI 10.1210/en.137.8.3154; MAJESKA RJ, 1980, ENDOCRINOLOGY, V107, P1494, DOI 10.1210/endo-107-5-1494; MARTIN TJ, 1976, NATURE, V260, P436, DOI 10.1038/260436a0; Martin TJ, 2005, J CLIN INVEST, V115, P2322, DOI 10.1172/JCI26239; Massfelder T, 1997, P NATL ACAD SCI USA, V94, P13630, DOI 10.1073/pnas.94.25.13630; McCauley LK, 2012, J BONE MINER RES, V27, P1231, DOI 10.1002/jbmr.1617; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Molyneux SD, 2010, J CLIN INVEST, V120, P3310, DOI 10.1172/JCI42391; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Mutsaers AJ, 2013, BONE, V55, P166, DOI 10.1016/j.bone.2013.02.016; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; OKANO K, 1994, ENDOCRINOLOGY, V135, P1093, DOI 10.1210/en.135.3.1093; Onuma E, 2004, ANTICANCER RES, V24, P2665; PIROLA CJ, 1993, J BIOL CHEM, V268, P1987; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Takiguchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054009; Tashjian AH, 2008, J BONE MINER RES, V23, P803, DOI 10.1359/JBMR.080208; Thompson DL, 2002, J BONE MINER RES, V17, P311, DOI 10.1359/jbmr.2002.17.2.311; Vargas MA, 2003, ENDOCRINOLOGY, V144, P4876, DOI 10.1210/en.2003-0253; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Watson PH, 2000, J BONE MINER RES, V15, P1033, DOI 10.1359/jbmr.2000.15.6.1033; Yang R, 2007, INT J CANCER, V121, P943, DOI 10.1002/ijc.22749	46	37	37	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2015	34	22					2922	2933		10.1038/onc.2014.217	http://dx.doi.org/10.1038/onc.2014.217			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CJ2OM	25043296				2022-12-25	WOS:000355324300011
J	Shanmugasundaram, K; Nayak, B; Shim, EH; Livi, CB; Block, K; Sudarshan, S				Shanmugasundaram, Karthigayan; Nayak, Bijaya; Shim, Eun-Hee; Livi, Carolina B.; Block, Karen; Sudarshan, Sunil			The Oncometabolite Fumarate Promotes Pseudohypoxia Through Noncanonical Activation of NF-kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cell Metabolism; Hypoxia-inducible Factor (HIF); NF-B (NF-KB); Small Molecule; Small	RENAL-CELL CANCER; PROLINE HYDROXYLATION; PROLYL HYDROXYLATION; KIDNEY CANCER; HIF-ALPHA; HYPOXIA; HYDRATASE; HEREDITARY; KINASES; TBK1	Background: We examined alternative mechanisms by which fumarate levels contribute to hypoxia inducible factor (HIF)-1 accumulation and fumarate hydratase (FH)-deficient renal carcinogenesis. Results: Fumarate promotes HIF-1 transcription through Tank binding kinase 1 (TBK1)-dependent noncannonical activation of NF-B signaling. Conclusion: Fumarate-mediated, TBK-dependent accumulation of HIF-1 mediates cell invasion in FH-deficient RCC. Significance: TBK is a novel putative therapeutic target for the treatment of aggressive fumarate-driven tumors. Inactivating mutations of the gene encoding the tricarboxylic acid cycle enzyme fumarate hydratase (FH) have been linked to an aggressive variant of hereditary kidney cancer (hereditary leiomyomatosis and renal cell cancer). These tumors accumulate markedly elevated levels of fumarate. Fumarate is among a growing list of oncometabolites identified in cancers with mutations of genes involved in intermediary metabolism. FH-deficient tumors are notable for their pronounced accumulation of the transcription factor hypoxia inducible factor-1 (HIF-1) and aggressive behavior. To date, HIF-1 accumulation in hereditary leiomyomatosis and renal cell cancer tumors is thought to result from fumarate-dependent inhibition of prolyl hydroxylases and subsequent evasion from von Hippel-Lindau-dependent degradation. Here, we demonstrate a novel mechanism by which fumarate promotes HIF-1 mRNA and protein accumulation independent of the von Hippel-Lindau pathway. Here we demonstrate that fumarate promotes p65 phosphorylation and p65 accumulation at the HIF-1 promoter through non-canonical signaling via the upstream Tank binding kinase 1 (TBK1). Consistent with these data, inhibition of the TBK1/p65 axis blocks HIF-1 accumulation in cellular models of FH loss and markedly reduces cell invasion of FH-deficient RCC cancer cells. Collectively, our data demonstrate a novel mechanism by which pseudohypoxia is promoted in FH-deficient tumors and identifies TBK1 as a novel putative therapeutic target for the treatment of aggressive fumarate-driven tumors.	[Shanmugasundaram, Karthigayan; Nayak, Bijaya; Block, Karen] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Livi, Carolina B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Shim, Eun-Hee; Sudarshan, Sunil] Univ Alabama Birmingham, Dept Urol, Birmingham, AL 35294 USA; [Block, Karen] South Texas Vet Hlth Care Syst, Audie L Murphy Mem Hosp Div, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Block, K (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	block@uthscsa.edu; sudarshan@uab.edu		Livi, Carolina/0000-0001-8389-2830; Shim, Eun-Hee/0000-0002-5151-3901	National Institutes of Health [K08 CA138774]; Urology Care Foundation; Astellas Pharma Rising Star Award; America Cancer Society [RSG-12-127-01 CNE]; Veterans Affairs Merit Grants [CPRIT RP120190, P30CA054174]; NATIONAL CANCER INSTITUTE [P30CA054174, K08CA138774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Urology Care Foundation; Astellas Pharma Rising Star Award(Astellas Pharmaceuticals); America Cancer Society; Veterans Affairs Merit Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant K08 CA138774 (to S. S.), Urology Care Foundation and Astellas Pharma Rising Star Award, and America Cancer Society RSG-12-127-01 CNE (to S. S.) and Veterans Affairs Merit Grants CPRIT RP120190 and P30CA054174 (to K. B).	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Grubb RL, 2007, J UROLOGY, V177, P2074, DOI 10.1016/j.juro.2007.01.155; Hutti JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041494; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kaelin WG, 2003, J AM SOC NEPHROL, V14, P2703, DOI 10.1097/01.ASN.0000092803.69761.41; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Korherr C, 2006, P NATL ACAD SCI USA, V103, P4240, DOI 10.1073/pnas.0511319103; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049321; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; O'Flaherty L, 2010, HUM MOL GENET, V19, P3844, DOI 10.1093/hmg/ddq305; O'Mahony AM, 2004, J BIOL CHEM, V279, P18137, DOI 10.1074/jbc.M401397200; Ooi A, 2011, CANCER CELL, V20, P511, DOI 10.1016/j.ccr.2011.08.024; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shu C, 2013, STRUCTURE, V21, P1137, DOI 10.1016/j.str.2013.04.025; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Tong WH, 2011, CANCER CELL, V20, P315, DOI 10.1016/j.ccr.2011.07.018; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zheng L, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-12	35	33	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24691	24699		10.1074/jbc.M114.568162	http://dx.doi.org/10.1074/jbc.M114.568162			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25028521	Green Published, hybrid			2022-12-25	WOS:000341505600058
J	Fu, YX; Zhou, HL; Wang, SY; Wei, Q				Fu, Yanxia; Zhou, Hailing; Wang, Shuangyan; Wei, Qun			Glycyrol Suppresses Collagen-Induced Arthritis by Regulating Autoimmune and Inflammatory Responses	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; CALCINEURIN; CYCLOSPORINE; PROGRESSION; TACROLIMUS; CYTOKINES; PATHWAYS; FUTURE; ONSET; IL-17	Glycyrol is a natural compound extracted from Glycyrrhiza uralensis, first reported by us to be a new immunosuppressant. Here, we demonstrate its beneficial effect in collagen-induced arthritis (CIA) in mice, a model for rheumatoid arthritis (RA) in man, and we document the underlying mechanisms. Peroral administration of glycyrol significantly reduced clinical scores, alleviated cartilage and bone erosion and reduced levels of serum inflammatory cytokines. Glycyrol also decreased delayed-type hypersensitivity, improved carbon clearance and reduced acetic acid-induced capillary permeability. Furthermore, glycyrol decreased NF-kappa B and NFAT transcriptional activities and inhibited IL-2 expression. The therapeutic effect of glycyrol was associated with down-regulation of both autoimmune and inflammatory reactions. In addition, we demonstrated that glycyrol has minimal acute toxicity in mice. Therefore, we propose that glycyrol may hold promise for future treatment of RA.	[Fu, Yanxia; Zhou, Hailing; Wang, Shuangyan; Wei, Qun] Beijing Normal Univ, Dept Biochem & Mol Biol, Gene Engn & Biotechnol Beijing Key Lab, Beijing, Peoples R China	Beijing Normal University	Wei, Q (corresponding author), Beijing Normal Univ, Dept Biochem & Mol Biol, Gene Engn & Biotechnol Beijing Key Lab, Beijing, Peoples R China.				National Natural Science Foundation of China; National Important Novel Medicine Research Project; Fundamental Research Funds for the Central Universities; Beijing Education Committee	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Important Novel Medicine Research Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Education Committee	The work was supported by the National Natural Science Foundation of China, the National Important Novel Medicine Research Project, the Fundamental Research Funds for the Central Universities and the special fund of the co-construction project from the Beijing Education Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksh S, 2000, SEMIN IMMUNOL, V12, P405, DOI 10.1006/smim.2000.0221; BENNETT WM, 1986, ANNU REV MED, V37, P215; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Cen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066503; Feng YH, 2002, ACTA PHARMACOL SIN, V23, P893; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Gorman CL, 2008, BEST PRACT RES CL RH, V22, P221, DOI 10.1016/j.berh.2008.01.003; Hong JC, 2000, SEMIN NEPHROL, V20, P108; Hua YL, 2012, FOOD CHEM, V132, P739, DOI 10.1016/j.foodchem.2011.11.010; Huang LJ, 2010, J AGR FOOD CHEM, V58, P8983, DOI 10.1021/jf101390q; Jin YL, 2008, TETRAHEDRON LETT, V49, P6835, DOI 10.1016/j.tetlet.2008.09.070; Kim HS, 2011, J ETHNOPHARMACOL, V136, P392, DOI 10.1016/j.jep.2011.01.016; Kitahara K, 2007, CURR OPIN RHEUMATOL, V19, P238, DOI 10.1097/BOR.0b013e328099af80; Kockx M, 2010, PHARMACOL THERAPEUT, V128, P106, DOI 10.1016/j.pharmthera.2010.06.001; Li JY, 2010, PHARM BIOL, V48, P1177, DOI 10.3109/13880200903573169; Lubberts E, 2003, J IMMUNOL, V170, P2655, DOI 10.4049/jimmunol.170.5.2655; Mauri C, 1996, EUR J IMMUNOL, V26, P1511, DOI 10.1002/eji.1830260716; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Nishikawa M, 2003, ARTHRITIS RHEUM-US, V48, P2670, DOI 10.1002/art.11227; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Pierer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023539; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; STALLARD N, 1995, HUM EXP TOXICOL, V14, P315, DOI 10.1177/096032719501400401; Strid J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000387; THOMSON AW, 1984, AGENTS ACTIONS, V15, P307, DOI 10.1007/BF01972366; Umar S., 2012, INT J DRUG DEV RES, V4, P210; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Venkatesha SH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/986797; Vinay DS, 2012, CYTOKINE, V57, P305, DOI 10.1016/j.cyto.2011.12.005; Wang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031368; Yocum DE, 2003, ARTHRITIS RHEUM-US, V48, P3328, DOI 10.1002/art.11363; Yoo SA, 2006, J IMMUNOL, V177, P2681, DOI 10.4049/jimmunol.177.4.2681	34	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e98137	10.1371/journal.pone.0098137	http://dx.doi.org/10.1371/journal.pone.0098137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036817	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200001
J	Yu, CL; Deng, M; Zheng, L; He, RL; Yang, J; Yau, SST				Yu, Chenglong; Deng, Mo; Zheng, Lu; He, Rong Lucy; Yang, Jie; Yau, Stephen S. -T.			DFA7, a New Method to Distinguish between Intron-Containing and Intronless Genes	PLOS ONE			English	Article							PROTEIN MAP; GENOME; REPRESENTATION; SPACE	Intron-containing and intronless genes have different biological properties and statistical characteristics. Here we propose a new computational method to distinguish between intron-containing and intronless gene sequences. Seven feature parameters alpha, beta, gamma, lambda, theta, phi, and sigma based on detrended fluctuation analysis (DFA) are fully used, and thus we can compute a 7-dimensional feature vector for any given gene sequence to be discriminated. Furthermore, support vector machine (SVM) classifier with Gaussian radial basis kernel function is performed on this feature space to classify the genes into intron-containing and intronless. We investigate the performance of the proposed method in comparison with other state-of-the-art algorithms on biological datasets. The experimental results show that our new method significantly improves the accuracy over those existing techniques.	[Yu, Chenglong] South Australian Hlth & Med Res Inst, Mind Brain Theme, Adelaide, SA, Australia; [Deng, Mo] Huashang Fund Management Co Ltd, Quant Investment Dept, Beijing, Peoples R China; [Zheng, Lu] Carnegie Mellon Univ, Elect & Comp Engn & CyLab Mobil Res Ctr, Moffett Field, CA USA; [He, Rong Lucy] Chicago State Univ, Dept Biol Sci, Chicago, IL 60628 USA; [Yang, Jie] Univ Illinois, Dept Math Stat & Comp Sci, Chicago, IL USA; [Yau, Stephen S. -T.] Tsinghua Univ, Dept Math Sci, Beijing 100084, Peoples R China	South Australian Health & Medical Research Institute (SAHMRI); Carnegie Mellon University; Chicago State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tsinghua University	He, RL (corresponding author), Chicago State Univ, Dept Biol Sci, Chicago, IL 60628 USA.	rhe@csu.edu; jyang06@uic.edu; yau@uic.edu		Yu, Chenglong/0000-0002-0546-2779; Yang, Jie/0000-0002-9034-4223	U.S. National Science Foundation [DMS-1120824]; China National Science Foundation [31271408]; Direct For Mathematical & Physical Scien [1120824] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); China National Science Foundation(National Natural Science Foundation of China (NSFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research is supported by the U.S. National Science Foundation grant DMS-1120824, China National Science Foundation grant 31271408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SM, 2005, BIOCHEM BIOPH RES CO, V337, P1192, DOI 10.1016/j.bbrc.2005.09.172; Agarwal SM, 2005, BIOCHEM BIOPH RES CO, V331, P512, DOI 10.1016/j.bbrc.2005.03.209; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Brent MR, 2005, GENOME RES, V15, P1777, DOI 10.1101/gr.3866105; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carr K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009550; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Deng M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017293; Gross SS, 2006, J COMPUT BIOL, V13, P379, DOI 10.1089/cmb.2006.13.379; Gunther F, 2010, R J, V2, P30; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Kak S, 2002, INFORM SCIENCES, V148, P97, DOI 10.1016/S0020-0255(02)00281-5; Lanier W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002171; Louhichi A, 2011, GENE, V488, P35, DOI 10.1016/j.gene.2011.08.013; Ma BG, 2007, BIOSYSTEMS, V90, P20, DOI 10.1016/j.biosystems.2006.06.004; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; PRABHU VV, 1992, NATURE, V359, P782, DOI 10.1038/359782a0; Shabalina SA, 2010, MOL BIOL EVOL, V27, P1745, DOI 10.1093/molbev/msq086; Shu JH, 2005, P 2005 ACM S APPL CO, P202; Yau SST, 2003, NUCLEIC ACIDS RES, V31, P3078, DOI 10.1093/nar/gkg432; Yau SST, 2008, DNA CELL BIOL, V27, P241, DOI 10.1089/dna.2007.0676; Yu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064328; Yu CL, 2013, J THEOR BIOL, V318, P197, DOI 10.1016/j.jtbi.2012.11.005; Yu CL, 2011, GENE, V486, P110, DOI 10.1016/j.gene.2011.07.002; Yu CL, 2011, INFORM SCIENCES, V181, P1484, DOI 10.1016/j.ins.2010.12.010; Yu CL, 2010, DNA RES, V17, P155, DOI 10.1093/dnares/dsq008; Zhang CQ, 2008, INT C COMP ELEC ENG, P169, DOI 10.1109/ICCEE.2008.35; Zhang CT, 1998, J THEOR BIOL, V192, P467, DOI 10.1006/jtbi.1998.0671; Zhang CT, 2003, BIOINFORMATICS, V19, P593, DOI 10.1093/bioinformatics/btg041	30	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101363	10.1371/journal.pone.0101363	http://dx.doi.org/10.1371/journal.pone.0101363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036549	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200014
J	Bilcke, J; Coenen, S; Beutels, P				Bilcke, Joke; Coenen, Samuel; Beutels, Philippe			Influenza-Like-Illness and Clinically Diagnosed Flu: Disease Burden, Costs and Quality of Life for Patients Seeking Ambulatory Care or No Professional Care at All	PLOS ONE			English	Article							HEALTHY-CHILDREN; VACCINATION; IMPACT	This is one of the first studies to (1) describe the out-of-hospital burden of influenza-like-illness (ILI) and clinically diagnosed flu, also for patients not seeking professional medical care, (2) assess influential background characteristics, and (3) formally compare the burden of ILI in patients with and without a clinical diagnosis of flu. A general population sample with recent ILI experience was recruited during the 2011-2012 influenza season in Belgium. Half of the 2250 respondents sought professional medical care, reported more symptoms (especially more often fever), a longer duration of illness, more use of medication (especially antibiotics) and a higher direct medical cost than patients not seeking medical care. The disease and economic burden were similar for ambulatory ILI patients, irrespective of whether they received a clinical diagnosis of flu. On average, they experienced 5-6 symptoms over a 6-day period; required 1.6 physician visits and 86-91% took medication. An average episode amounted to is an element of 51-is an element of 53 in direct medical costs, 4 days of absence from work or school and the loss of 0.005 quality-adjusted life-years. Underlying illness led to greater costs and lower quality-of-life. The costs of ILI patients with clinically diagnosed flu tended to increase, while those of ILI patients without clinically diagnosed flu tended to decrease with age. Recently vaccinated persons experienced lower costs and a higher quality-of-life, but this was only the case for patients not seeking professional medical care. This information can be used directly to evaluate the implementation of cost-effective prevention and control measures for influenza. In particular to inform the evaluation of more widespread seasonal influenza vaccination, including in children, which is currently considered by many countries.	[Bilcke, Joke; Beutels, Philippe] Univ Antwerp, Fac Med & Hlth Sci, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst VAXINFECTIO,WHO Collabo, B-2020 Antwerp, Belgium; [Coenen, Samuel] Univ Antwerp, Fac Med & Hlth Sci, Ctr Gen Practice Primary & Interdisciplinary Care, B-2020 Antwerp, Belgium; [Coenen, Samuel] Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Med Microbiol,WHO Collaborating Ctr, B-2020 Antwerp, Belgium; [Beutels, Philippe] Sch Publ Hlth & Community Med, Sydney, NSW, Australia	University of Antwerp; University of Antwerp; University of Antwerp; World Health Organization	Bilcke, J (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst VAXINFECTIO,WHO Collabo, B-2020 Antwerp, Belgium.	joke.bilcke@uantwerp.be	Coenen, Samuel JA/A-6410-2011; Bilcke, Joke/AAC-8932-2019; Beutels, Philippe/A-1919-2010; Geurts, José W/O-3673-2014	Coenen, Samuel JA/0000-0002-1238-8052; Bilcke, Joke/0000-0001-5720-5291; Beutels, Philippe/0000-0001-5034-3595; 	Belgian Health Care Knowledge Centre; Research Foundation - Flanders (FWO) [G.0274.08N]; European Commission Framework Programme 6	Belgian Health Care Knowledge Centre; Research Foundation - Flanders (FWO)(FWO); European Commission Framework Programme 6(European Commission)	This study was funded by the Belgian Health Care Knowledge Centre. JB is supported by a postdoctoral grant from the Research Foundation - Flanders (FWO). GRACE is funded via European Commission Framework Programme 6 and Research Foundation - Flanders (FWO G.0274.08N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonova EN, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-968; Beutels P, 2013, SEASONAL INFLUENZA 2; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Cleemput I, 2012, HLTH TECHNOLOGY ASSE, V2nd; Esposito S, 2011, J INFECTION, V62, P379, DOI 10.1016/j.jinf.2011.02.015; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Hollmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060477; Jit M, 2013, HUM VACC IMMUNOTHER, V9, P834, DOI 10.4161/hv.23637; Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6; Michiels B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060348; Michiels B, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-4; Newall AT, 2013, PHARMACOECONOMICS, V31, P693, DOI 10.1007/s40273-013-0060-7; Nicholson K G, 1992, Semin Respir Infect, V7, P26; O'Brien BJ, 2003, VALUE HEALTH, V6, P116, DOI 10.1046/j.1524-4733.2003.00213.x; Ortega-Sanchez IR, 2012, VACCINE, V30, P4175, DOI 10.1016/j.vaccine.2012.04.057; Payne L, 2005, Euro Surveill, V10, P241; Pitman RJ, 2013, VACCINE, V31, P927, DOI 10.1016/j.vaccine.2012.12.010; Ploin D, 2003, PEDIATR INFECT DIS J, V22, pS218, DOI 10.1097/01.inf.0000092191.78339.1a; Ploin D, 2007, PEDIATR INFECT DIS J, V26, P142, DOI 10.1097/01.inf.0000253062.41648.60; Principi N, 2004, ARCH DIS CHILD, V89, P1002, DOI 10.1136/adc.2003.045401; Sander B, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000256; Savy V, 2013, INFLUENZA OTHER RESP, V7, P1017, DOI 10.1111/irv.12036; van Hoek AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017030; Yin JK, 2013, INFLUENZA OTHER RESP, V7, P1103, DOI 10.1111/irv.12138; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063788	25	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102634	10.1371/journal.pone.0102634	http://dx.doi.org/10.1371/journal.pone.0102634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032688	Green Submitted, Green Published, gold			2022-12-25	WOS:000339418300071
J	Jung, J; Shin, H; Bang, S; Mok, HJ; Suh, CS; Kim, KP; Lim, HJ				Jung, Jaehun; Shin, Hyejin; Bang, Soyoung; Mok, Hyuck Jun; Suh, Chang Suk; Kim, Kwang Pyo; Lim, Hyunjung Jade			Analysis of the Phospholipid Profile of Metaphase II Mouse Oocytes Undergoing Vitrification	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; LIPID PHASE-TRANSITION; SINGLE-EMBRYO; CHILLING SENSITIVITY; CELL REGULATION; BOVINE OOCYTES; CERAMIDE; PHOSPHOINOSITIDES; APOPTOSIS; DYNAMICS	Oocyte freezing confers thermal and chemical stress upon the oolemma and various other intracellular structures due to the formation of ice crystals. The lipid profiles of oocytes and embryos are closely associated with both, the degrees of their membrane fluidity, as well as the degree of chilling and freezing injuries that may occur during cryopreservation. In spite of the importance of lipids in the process of cryopreservation, the phospholipid status in oocytes and embryos before and after freezing has not been investigated. In this study, we employed mass spectrometric analysis to examine if vitrification has an effect on the phospholipid profiles of mouse oocytes. Freshly prepared metaphase II mouse oocytes were vitrified using copper grids and stored in liquid nitrogen for 2 weeks. Fresh and vitrified-warmed oocytes were subjected to phospholipid extraction procedure. Mass spectrometric analyses revealed that multiple species of phospholipids are reduced in vitrified-warmed oocytes. LIFT analyses identified 31 underexpressed and 5 overexpressed phospholipids in vitrified mouse oocytes. The intensities of phosphatidylinositol (PI) {18:2/16:0} [M-H]- and phosphatidylglycerol (PG) {14:0/18:2} [M-H]- were decreased the most with fold changes of 30.5 and 19.1 in negative ion mode, respectively. Several sphingomyelins (SM) including SM {d38:3} [M+H]+ and SM {d34:0} [M+K]+ were decreased significantly in positive ion mode. Overall, the declining trend of multiple phospholipids demonstrates that vitrification has a marked effect on phospholipid profiles of oocytes. These results show that the identified phospholipids can be used as potential biomarkers of oocyte undergoing vitrification and will allow for the development of strategies to preserve phospholipids during oocyte cryopreservation.	[Jung, Jaehun] Konkuk Univ, Sch Med, Dept Pharmacol, Seoul, South Korea; [Shin, Hyejin; Bang, Soyoung; Lim, Hyunjung Jade] Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea; [Jung, Jaehun; Mok, Hyuck Jun; Kim, Kwang Pyo] Kyung Hee Univ, Coll Appl Sci, Dept Appl Chem, Yongin, Gyeonggi Do, South Korea; [Suh, Chang Suk] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Songnam, Gyeonggi Do, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Kyung Hee University; Seoul National University (SNU)	Kim, KP (corresponding author), Kyung Hee Univ, Coll Appl Sci, Dept Appl Chem, Yongin, Gyeonggi Do, South Korea.	kimkp@khu.ac.kr; hlim@konkuk.ac.kr	Kim, Kwang Pyo/AAG-1815-2020; Lim, Hyunjung/D-5343-2011	Lim, Hyunjung/0000-0003-2191-666X; Kim, Kwang Pyo/0000-0003-0095-3787	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0055]	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0055, https://www.htdream.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P37, DOI 10.1016/j.fertnstert.2012.09.028; Apparicio M, 2012, REPROD DOMEST ANIM, V47, P113, DOI 10.1111/rda.12003; Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062; Arav A, 2000, CRYO-LETT, V21, P179; Bang S, 2014, REPRODUCTION, V148, P11, DOI 10.1530/REP-14-0036; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boldt J, 2011, REPROD BIOMED ONLINE, V23, P314, DOI 10.1016/j.rbmo.2010.11.019; Castaneda CA, 2013, THERIOGENOLOGY, V79, P417, DOI 10.1016/j.theriogenology.2012.10.006; Cha Soo Kyung, 2011, Clin Exp Reprod Med, V38, P24, DOI 10.5653/cerm.2011.38.1.24; Combelles CMH, 2012, INT J DEV BIOL, V56, P919, DOI 10.1387/ijdb.120132cc; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Edwards JL, 2005, ANAL CHEM, V77, P2201, DOI 10.1021/ac048323r; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferreira CR, 2012, J MASS SPECTROM, V47, P29, DOI 10.1002/jms.2022; Ferreira CR, 2012, ANAL BIOANAL CHEM, V404, P2915, DOI 10.1007/s00216-012-6426-4; Ferreira CR, 2010, J LIPID RES, V51, P1218, DOI 10.1194/jlr.D001768; Fuchs B, 2011, PROG LIPID RES, V50, P132, DOI 10.1016/j.plipres.2010.10.001; Ghetler Y, 2005, HUM REPROD, V20, P3385, DOI 10.1093/humrep/dei236; Gibb S, 2012, BIOINFORMATICS, V28, P2270, DOI 10.1093/bioinformatics/bts447; Gomes CM, 2008, FERTIL STERIL, V90, P1396, DOI 10.1016/j.fertnstert.2007.08.025; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Kang HS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-465; Kang S, 2011, INT J GYNECOL CANCER, V21, P1566, DOI 10.1097/IGC.0b013e318226c5f5; Katz-Jaffe MG, 2008, FERTIL STERIL, V89, P1441, DOI 10.1016/j.fertnstert.2007.03.098; Kim Y, 2010, EXP MOL MED, V42, P1, DOI 10.3858/emm.2010.42.1.001; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Lee GK, 2012, LUNG CANCER, V76, P197, DOI 10.1016/j.lungcan.2011.10.016; LOEWENSTEIN JE, 1964, J EMBRYOL EXP MORPH, V12, P113; Monzo C, 2012, HUM REPROD, V27, P2160, DOI 10.1093/humrep/des153; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Park YS, 2011, CLIN CHIM ACTA, V412, P1978, DOI 10.1016/j.cca.2011.07.008; Perez GI, 2005, FASEB J, V19, P860, DOI 10.1096/fj.04-2903fje; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Riggs R, 2010, FERTIL STERIL, V93, P109, DOI 10.1016/j.fertnstert.2008.09.084; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823; Shanta SR, 2011, ANAL CHEM, V83, P1252, DOI 10.1021/ac1029659; Spangenburg EE, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/598358; Sturmey RG, 2009, REPROD DOMEST ANIM, V44, P50, DOI 10.1111/j.1439-0531.2009.01402.x; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Sudano MJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102897; Tata A, 2013, J MASS SPECTROM, V48, P844, DOI 10.1002/jms.3231; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Yan J, 2011, J ASSIST REPROD GEN, V28, P643, DOI 10.1007/s10815-011-9563-3	45	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102620	10.1371/journal.pone.0102620	http://dx.doi.org/10.1371/journal.pone.0102620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033391	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300069
J	Fechter, D; Storch, I				Fechter, Dominik; Storch, Ilse			How Many Wolves (Canis lupus) Fit into Germany? The Role of Assumptions in Predictive Rule-Based Habitat Models for Habitat Generalists	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; SPECIES DISTRIBUTION; WOLF DISTRIBUTION; HOME RANGES; CONSERVATION; ROADS; SUITABILITY; PREDATION; PACK; RECOLONIZATION	Due to legislative protection, many species, including large carnivores, are currently recolonizing Europe. To address the impending human-wildlife conflicts in advance, predictive habitat models can be used to determine potentially suitable habitat and areas likely to be recolonized. As field data are often limited, quantitative rule based models or the extrapolation of results from other studies are often the techniques of choice. Using the wolf (Canis lupus) in Germany as a model for habitat generalists, we developed a habitat model based on the location and extent of twelve existing wolf home ranges in Eastern Germany, current knowledge on wolf biology, different habitat modeling techniques and various input data to analyze ten different input parameter sets and address the following questions: (1) How do a priori assumptions and different input data or habitat modeling techniques affect the abundance and distribution of potentially suitable wolf habitat and the number of wolf packs in Germany? (2) In a synthesis across input parameter sets, what areas are predicted to be most suitable? (3) Are existing wolf pack home ranges in Eastern Germany consistent with current knowledge on wolf biology and habitat relationships? Our results indicate that depending on which assumptions on habitat relationships are applied in the model and which modeling techniques are chosen, the amount of potentially suitable habitat estimated varies greatly. Depending on a priori assumptions, Germany could accommodate between 154 and 1769 wolf packs. The locations of the existing wolf pack home ranges in Eastern Germany indicate that wolves are able to adapt to areas densely populated by humans, but are limited to areas with low road densities. Our analysis suggests that predictive habitat maps in general, should be interpreted with caution and illustrates the risk for habitat modelers to concentrate on only one selection of habitat factors or modeling technique.	[Fechter, Dominik; Storch, Ilse] Univ Freiburg, Chair Wildlife Ecol & Management, Baden Wurttemberg, Germany	University of Freiburg	Fechter, D (corresponding author), Univ Freiburg, Chair Wildlife Ecol & Management, Baden Wurttemberg, Germany.	dominik.fechter@wildlife.uni-freiburg.de	Storch, Ilse/N-7478-2019; Storch, Ilse/P-6806-2019	Storch, Ilse/0000-0002-3252-2036	Evanglisches Studienwerk Villigst e.V.; German Research Foundation (DFG); Albert Ludwigs University Freiburg	Evanglisches Studienwerk Villigst e.V.; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This project was funded by the Evanglisches Studienwerk Villigst e.V. (www.evstudienwerk.de). The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens V, 2006, ECOL MODEL, V195, P3, DOI 10.1016/j.ecolmodel.2005.11.043; [Anonymous], 1986, CONSERVATION BIOL SC; Ansorge Hermann, 2007, Berichte der Naturforschenden Gesellschaft Oberlausitz, V15, P105; BALLARD WB, 1987, WILDLIFE MONOGR, P1; Beck JL, 2009, MODELS FOR PLANNING WILDLIFE CONSERVATION IN LARGE LANDSCAPES, P251, DOI 10.1016/B978-0-12-373631-4.00010-1; Berg W.E., 1982, P4; Blanco JC, 2005, CAN J ZOOL, V83, P312, DOI 10.1139/Z05-016; BLANCO JC, 1992, BIOL CONSERV, V60, P73, DOI 10.1016/0006-3207(92)91157-N; Boitani L., 1982, P158; Boitani L, 2000, CONV CONS EUR WILDL, V113; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Burgman MA, 2001, ECOL APPL, V11, P70, DOI 10.1890/1051-0761(2001)011[0070:SRBOHS]2.0.CO;2; Ciucci P, 1997, J ZOOL, V243, P803, DOI 10.1111/j.1469-7998.1997.tb01977.x; Corsi F, 1999, CONSERV BIOL, V13, P150, DOI 10.1046/j.1523-1739.1999.97269.x; Cushman SA, 2013, TECHNICAL GUIDE MONI, P135; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Eggermann J, 2009, IMPACT HEBITAT FRAGM; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Falcucci A, 2013, BIOL CONSERV, V158, P63, DOI 10.1016/j.biocon.2012.08.029; Findo S, 2004, FOLIA ZOOL, V53, P17; Fritts SH, 1981, WILDLIFE MONOGR, V80, P1; FULLER TK, 1989, WILDLIFE MONOGR, P1; FULLER TK, 1992, WILDLIFE SOC B, V20, P42; Fuller TK, 1995, INT WOLF CTR TECHNIC, V27; Glenz C, 2001, LANDSCAPE URBAN PLAN, V55, P55, DOI 10.1016/S0169-2046(01)00119-0; Gros PM, 1999, BIODIVERS CONSERV, V8, P1561, DOI 10.1023/A:1008950114827; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hagen R, 2014, SCI TOTAL ENVIRON, V468, P140, DOI 10.1016/j.scitotenv.2013.08.022; Hegel TM, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P273, DOI 10.1007/978-4-431-87771-4_16; Hovens JPM, 2005, MAMM BIOL, V70, P210, DOI 10.1016/j.mambio.2004.12.003; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; Jedrzejewska B, 1996, MAMMAL REV, V26, P103; Jedrzejewski W, 2008, ANIM CONSERV, V11, P377, DOI 10.1111/j.1469-1795.2008.00193.x; Jedrzejewski W, 2000, J MAMMAL, V81, P197, DOI 10.1644/1545-1542(2000)081&lt;0197:PSAPBW&gt;2.0.CO;2; Kaartinen S, 2005, ANN ZOOL FENN, V42, P523; Kaczensky P, 2013, STATUS MANAGEMENT DI; Kaczensky P, 2006, MEDIENPRASENS AKZEPT, P9; Kilgo JC, 2002, WILDLIFE SOC B, V30, P783; Kissling WD, 2009, ECOGRAPHY, V32, P807, DOI 10.1111/j.1600-0587.2009.05781.x; Kusak J, 2005, EUR J WILDLIFE RES, V51, P254, DOI 10.1007/s10344-005-0111-2; Kusak J., 2002, THESIS U ZAGREB; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Ludwig I, 2011, LECT NOTES GEOINF CA, V1, P65, DOI 10.1007/978-3-642-19789-5_4; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Mech LD, 2006, WILDLIFE SOC B, V34, P874, DOI 10.2193/0091-7648(2006)34[874:PFOAWL]2.0.CO;2; MECH LD, 1995, CONSERV BIOL, V9, P270, DOI 10.1046/j.1523-1739.1995.9020270.x; MECH LD, 1988, WILDLIFE SOC B, V16, P85; MECH LD, 1977, J MAMMAL, V58, P559, DOI 10.2307/1380004; MECH LD, 1989, AM MIDL NAT, V121, P387, DOI 10.2307/2426043; Mech LD., 1998, WOLVES DENALI; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; MESSIER F, 1985, CAN J ZOOL, V63, P1068, DOI 10.1139/z85-160; Mladenoff DJ, 1999, ECOL APPL, V9, P37, DOI 10.1890/1051-0761(1999)009[0037:PGWLRL]2.0.CO;2; MLADENOFF DJ, 1995, CONSERV BIOL, V9, P279, DOI 10.1046/j.1523-1739.1995.9020279.x; Molinari-Jobin A, 2012, ANIM CONSERV, V15, P266, DOI 10.1111/j.1469-1795.2011.00511.x; Morrison ML., 2006, WILDLIFE HABITAT REL; Mouton AM, 2009, ENVIRON MODELL SOFTW, V24, P982, DOI 10.1016/j.envsoft.2009.02.005; Nelson ME, 2000, CAN FIELD NAT, V114, P503; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Nowak S, 2005, ACTA THERIOL, V50, P263, DOI 10.1007/BF03194489; Okarma H, 1998, J MAMMAL, V79, P842, DOI 10.2307/1383092; Okarma H, 1997, WOLF OKOLOGIE VERHAL; PAQUET P, 1996, TRANSPORTATION WILDL, P46; Peterson R.O., 1988, PIT PENDULUM ISSUES, P105; PETERSON RO, 1984, J WILDLIFE MANAGE, P1; Peterson Rolf O., 2003, P104; Promberger C, 1996, ANN REPORT, V1, P1; Reinhardt I., 2007, FACHKONZEPT LEBEN WO, V201, P5; ROGERS LL, 1980, J WILDLIFE MANAGE, V44, P253; Ryabov LS, 1987, OTDELENE BIOL, V92, P3; Rykiel EJ, 1996, ECOL MODEL, V90, P229, DOI 10.1016/0304-3800(95)00152-2; Sathyakumar S, 2001, URSUS-SERIES, V12, P21; Schadt S, 2002, ECOL APPL, V12, P1469; Starfield AM, 1997, J WILDLIFE MANAGE, V61, P261, DOI 10.2307/3802581; STARFIELD AM, 1990, BIOSCIENCE, V40, P601, DOI 10.2307/1311300; Switalski TA, 2006, WINTER SOLSTICE, V11, P6; Theuerkauf J, 2003, J WILDLIFE MANAGE, V67, P706, DOI 10.2307/3802677; Theuerkauf J, 2003, CAN J ZOOL, V81, P163, DOI 10.1139/Z02-190; Theuerkauf J, 2007, ANN ZOOL FENN, V44, P225; Thiel RP, 1998, CAN FIELD NAT, V112, P340; THIEL RP, 1985, AM MIDL NAT, V113, P404, DOI 10.2307/2425590; THURBER JM, 1994, WILDLIFE SOC B, V22, P61; Vila Carles, 1995, Canadian Circumpolar Institute Occasional Publication, V35, P335; Wagner C, 2012, MAMM BIOL, V77, P196, DOI 10.1016/j.mambio.2011.12.004; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; Wotschikowsky Ulrich, 2010, P201	87	25	26	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101798	10.1371/journal.pone.0101798	http://dx.doi.org/10.1371/journal.pone.0101798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029506	Green Published, gold			2022-12-25	WOS:000341306600023
J	Liang, YY; Chen, MY; Hua, YJ; Chen, S; Zheng, LS; Cao, X; Peng, LX; Xie, P; Huang, BJ; Sun, R; Wang, L; Xiang, YQ; Guo, X; Qian, CN				Liang, Ying-Ying; Chen, Ming-Yuan; Hua, Yi-Jun; Chen, Shi; Zheng, Li-Sheng; Cao, Xue; Peng, Li-Xia; Xie, Ping; Huang, Bi-Jun; Sun, Rui; Wang, Lin; Xiang, Yan-Qun; Guo, Xiang; Qian, Chao-Nan			Downregulation of Ras Association Domain Family Member 6 (RASSF6) Underlies the Treatment Resistance of Highly Metastatic Nasopharyngeal Carcinoma Cells	PLOS ONE			English	Article							EMERGING TREATMENT OPTIONS; CANCER STEM-CELLS; TUMOR-SUPPRESSOR; BREAST-CANCER; CISPLATIN SENSITIVITY; HIPPO PATHWAY; LYMPH-NODE; APOPTOSIS; EXPRESSION; PROTEIN	Radiation and cisplatin-based chemotherapy are major treatments for nasopharyngeal carcinoma (NPC). However, a major impediment for further improving the cure rate is the development of treatment resistance with an undetermined molecular mechanism in metastatic NPC cells. Our established, highly metastatic NPC cells have been reported to be more resistant to cisplatin chemotherapy. In the present study, we found that Ras association domain family member 6 (RASSF6) was downregulated in highly metastatic cells but upregulated in low metastatic cells in comparison to their parental cell line. Ectopic-expression of RASSF6 enhanced the sensitivity of highly metastatic NPC cells to cisplatin or radiation by enhancing apoptosis. RASSF6 depletion conversely reduced treatment sensitivity by decreasing the apoptosis rate. Overexpression of RASSF6 in highly metastatic NPC cells could enhance the phosphorylation of JNK when exposed to cisplatin or radiation treatment, while knocking down RASSF6 in low metastatic NPC cells could reduce the level of phospho-JNK when exposed to the same treatments. The activation of JNK signaling by RASSF6 and its subsequent sensitivity to apoptosis in NPC cells could be inhibited by applying the JNK inhibitor SP600125. In conclusion, the downregulation of RASSF6 in highly metastatic NPC cells contributed to their treatment resistance, and over-expression of RASSF6 conferred treatment sensitivity to highly metastatic NPC cells by activating JNK signaling. RASSF6 could be a valuable molecular marker for identifying sensitive metastatic NPC tumors during cisplatin treatment or radiotherapy.	[Liang, Ying-Ying; Zheng, Li-Sheng; Cao, Xue; Peng, Li-Xia; Xie, Ping; Huang, Bi-Jun; Qian, Chao-Nan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Ying-Ying; Zheng, Li-Sheng; Cao, Xue; Peng, Li-Xia; Xie, Ping; Huang, Bi-Jun; Qian, Chao-Nan] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Ming-Yuan; Hua, Yi-Jun; Sun, Rui; Wang, Lin; Xiang, Yan-Qun; Guo, Xiang; Qian, Chao-Nan] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Shi] Sun Yat Sen Univ, Dept Gastroesophageal Surg, Affliated Hosp 6, Gastrointestinal & Anal Hosp, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Qian, CN (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	qianchn@sysucc.org.cn	Huang, Bi-Jun/GSD-2430-2022; Chen, Ming/GVU-8412-2022		National Natural Science Foundation of China [81030043, 81272340]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81030043 and No. 81272340) for these authors: Chao-Nan Qian, Li-Xia Peng, Shi Chen, Ying-Ying Liang, and Xue Cao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2012, CHIN J CANCER, V31, P185, DOI 10.5732/cjc.011.10328; Akino K, 2005, GASTROENTEROLOGY, V129, P156, DOI 10.1053/j.gastro.2005.03.051; Allen NPC, 2007, ONCOGENE, V26, P6203, DOI 10.1038/sj.onc.1210440; Brozovic A, 2007, CANCER LETT, V251, P1, DOI 10.1016/j.canlet.2006.10.007; Burger H, 2011, DRUG RESIST UPDATE, V14, P22, DOI 10.1016/j.drup.2010.12.002; Duru N, 2013, J CANC RES CLIN ONCO; El Kamar FG, 2003, ONCOLOGIST, V8, P18, DOI 10.1634/theoncologist.8-1-18; Ferrari P, 2013, BIOMED PHARMACOTHER, V67, P543, DOI 10.1016/j.biopha.2013.03.006; Furukawa T, 2000, ANTICANCER RES, V20, P3657; Gebauer G, 2000, INT J ONCOL, V16, P321; Ikeda M, 2007, EXP CELL RES, V313, P1484, DOI 10.1016/j.yexcr.2007.02.013; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Iwasa H, 2013, J BIOL CHEM; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Kitagawa D, 2006, EMBO J, V25, P3286, DOI 10.1038/sj.emboj.7601212; Kudo T, 2012, CANCER RES, V72, P2901, DOI 10.1158/0008-5472.CAN-12-0572; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Liu RY, 2011, ONCOGENE, V30, P4814, DOI 10.1038/onc.2011.189; Liu RY, 2013, MOL CANCER THER, V12, P2157, DOI 10.1158/1535-7163.MCT-12-1190; Lock FE, 2010, ONCOGENE, V29, P4307, DOI 10.1038/onc.2010.192; Ma BBY, 2008, CANCER SCI, V99, P1311, DOI 10.1111/j.1349-7006.2008.00836.x; Moncharmont C, 2012, CANCER LETT, V322, P139, DOI 10.1016/j.canlet.2012.03.024; Moshnikova A, 2006, J BIOL CHEM, V281, P8143, DOI 10.1074/jbc.M511837200; MS Wu, 2013, MOL CANC THER; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; Reu FJ, 2006, CANCER RES, V66, P2785, DOI 10.1158/0008-5472.CAN-05-2303; Sampieri K, 2012, SEMIN CANCER BIOL, V22, P187, DOI 10.1016/j.semcancer.2012.03.002; Sarmiento MP, 2013, CHIN J CANC; Spratt DE, 2012, ONCOTARGETS THER, V5, P297, DOI 10.2147/OTT.S28032; Thaler S, 2009, CANCER RES, V69, P1748, DOI 10.1158/0008-5472.CAN-08-1377; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Vermorken JB, 2010, ANN ONCOL, V21, P252, DOI 10.1093/annonc/mdq453; Withanage K, 2012, J BIOCHEM, V152, P111, DOI 10.1093/jb/mvs056; Zhang Linjie, 2002, Zhonghua Zhongliu Zazhi, V24, P430; Zhang L, 2013, DRUG DES DEV THER, V7, P37, DOI 10.2147/DDDT.S30753	37	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e100843	10.1371/journal.pone.0100843	http://dx.doi.org/10.1371/journal.pone.0100843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028967	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600009
J	Patenaude-Monette, M; Belisle, M; Giroux, JF				Patenaude-Monette, Martin; Belisle, Marc; Giroux, Jean-Francois			Balancing Energy Budget in a Central-Place Forager: Which Habitat to Select in a Heterogeneous Environment?	PLOS ONE			English	Article							BEHAVIORAL ECOLOGY; MULTIPLE SCALES; GULLS; MOVEMENT; LANDSCAPES; SEARCH; URBAN; INFORMATION; DIET	Foraging animals are influenced by the distribution of food resources and predation risk that both vary in space and time. These constraints likely shape trade-offs involving time, energy, nutrition, and predator avoidance leading to a sequence of locations visited by individuals. According to the marginal-value theorem (MVT), a central-place forager must either increase load size or energy content when foraging farther from their central place. Although such a decision rule has the potential to shape movement and habitat selection patterns, few studies have addressed the mechanisms underlying habitat use at the landscape scale. Our objective was therefore to determine how Ring-billed gulls (Larus delawarensis) select their foraging habitats while nesting in a colony located in a heterogeneous landscape. Based on locations obtained by fine-scale GPS tracking, we used resource selection functions (RSFs) and residence time analyses to identify habitats selected by gulls for foraging during the incubation and brood rearing periods. We then combined this information to gull survey data, feeding rates, stomach contents, and calorimetric analyses to assess potential trade-offs. Throughout the breeding season, gulls selected landfills and transhipment sites that provided higher mean energy intake than agricultural lands or riparian habitats. They used landfills located farther from the colony where no deterrence program had been implemented but avoided those located closer where deterrence measures took place. On the other hand, gulls selected intensively cultured lands located relatively close to the colony during incubation. The number of gulls was then greater in fields covered by bare soil and peaked during soil preparation and seed sowing, which greatly increase food availability. Breeding Ring-billed gulls thus select habitats according to both their foraging profitability and distance from their nest while accounting for predation risk. This supports the predictions of the MVT for central-place foraging over large spatial scales.	[Patenaude-Monette, Martin; Giroux, Jean-Francois] Univ Quebec, Dept Sci Biol, Grp Rech Ecol Comportementale & Anim, Montreal, PQ H3C 3P8, Canada; [Belisle, Marc] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	University of Quebec; University of Quebec Montreal; University of Sherbrooke	Giroux, JF (corresponding author), Univ Quebec, Dept Sci Biol, Grp Rech Ecol Comportementale & Anim, CP 8888, Montreal, PQ H3C 3P8, Canada.	giroux.jean-francois@uqam.ca	Giroux, Jean-François/L-7945-2019	Giroux, Jean-François/0000-0002-6732-489X; Belisle, Marc/0000-0003-0657-6724; Patenaude-Monette, Martin/0000-0001-7272-2115	Natural Sciences and Engineering Research Council of Canada; Canadian Wildlife Service; ICI Environnement; Falcon Environmental Services; Chamard et Associes; Waste Management; BFI Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Wildlife Service; ICI Environnement; Falcon Environmental Services; Chamard et Associes; Waste Management; BFI Canada	The research was supported by grants to JFG and MB from the Natural Sciences and Engineering Research Council of Canada, the Canadian Wildlife Service, ICI Environnement, Falcon Environmental Services, Chamard et Associes, Waste Management, and BFI Canada. MPM was supported by a scholarship from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Amano T, 2006, ECOL MONOGR, V76, P601, DOI 10.1890/0012-9615(2006)076[0601:DIGFWI]2.0.CO;2; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Bastille-Rousseau G, 2010, J ANIM ECOL, V79, P1157, DOI 10.1111/j.1365-2656.2010.01737.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Batschelet E, 1981, CIRCULAR STAT BIOL; Beauchamp G, 1997, J ANIM ECOL, V66, P671, DOI 10.2307/5920; Belant JL, 1997, LANDSCAPE URBAN PLAN, V38, P245, DOI 10.1016/S0169-2046(97)00037-6; Belant JL, 1998, LANDSCAPE URBAN PLAN, V43, P11, DOI 10.1016/S0169-2046(98)00100-5; Bellier E, 2010, OIKOS, V119, P988, DOI 10.1111/j.1600-0706.2009.17808.x; BERNSTEIN C, 1991, J ANIM ECOL, V60, P205, DOI 10.2307/5455; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Brousseau P, 1996, COLON WATERBIRD, V19, P22, DOI 10.2307/1521803; Bukacinska M, 1996, AUK, V113, P300; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Environment Canada, 2010, NAT CLIM DAT INF ARC; ESRI, 2009, ARCGIS VERS 9 3 1; FADQ, 2010, BAS DONN CULT ASS 20; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Freitas C, 2008, J APPL ECOL, V45, P1213, DOI 10.1111/j.1365-2664.2008.01505.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gaston Anthony J., 2007, Marine Ornithology, V35, P119; Giraldeau L.A., 2000, MG BEH ECOL; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Maciusik B, 2010, ECOL RES, V25, P263, DOI 10.1007/s11284-009-0649-7; Manly B.F.J., 2002, RESOURCE SELECTION A; Matthiopoulos J, 2003, ECOL MODEL, V159, P239, DOI 10.1016/S0304-3800(02)00293-4; Mueller T, 2008, OIKOS, V117, P654, DOI 10.1111/j.0030-1299.2008.16291.x; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Natural Resources Canada, 2009, LAND COV CIRC 2000 V, V1.0; Natural Resources Canada, 2010, CANVEC VERS 1 1; Nonacs P, 2001, BEHAV ECOL, V12, P71, DOI 10.1093/oxfordjournals.beheco.a000381; Olsson O, 2008, THEOR POPUL BIOL, V74, P22, DOI 10.1016/j.tpb.2008.04.005; Orians G.H., 1979, P155; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Pallet I.L., 2012, BIRDS N AM ONLINE; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Racine F, 2012, ANIM BEHAV, V84, P175, DOI 10.1016/j.anbehav.2012.04.028; Rosenberg DK, 1999, J WILDLIFE MANAGE, V63, P1028, DOI 10.2307/3802818; SCHOENER TW, 1979, AM NAT, V114, P902, DOI 10.1086/283537; Schwemmer P, 2008, LANDSCAPE ECOL, V23, P355, DOI 10.1007/s10980-008-9194-y; Searle KR, 2008, BEHAV ECOL, V19, P475, DOI 10.1093/beheco/arn004; Shaffer SA, 2003, FUNCT ECOL, V17, P66, DOI 10.1046/j.1365-2435.2003.00705.x; Shamoun-Baranes J, 2006, J EXP BIOL, V209, P3489, DOI 10.1242/jeb.02385; SIBLY RM, 1983, J ANIM ECOL, V52, P51, DOI 10.2307/4587; Stephen D., 1986, FORAGING BEHAV; Thieriot E, 2012, APPL ANIM BEHAV SCI, V142, P109, DOI 10.1016/j.applanim.2012.09.008; Wilson RP, 2012, P ROY SOC B-BIOL SCI, V279, P975, DOI 10.1098/rspb.2011.1544; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035	55	34	35	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102162	10.1371/journal.pone.0102162	http://dx.doi.org/10.1371/journal.pone.0102162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029498	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600038
J	Suari, Y; Brenner, S				Suari, Yair; Brenner, Steve			RGB Plots as a Tool for the Simultaneous Visualization of Multiple Data Layers in a Two Dimensional Space	PLOS ONE			English	Article							PHOSPHORUS LIMITATION; MEDITERRANEAN-SEA; RATIO	Visualization of multidimensional data helps in understanding complex systems and environments. We present here a red, green, blue (RGB) visualization method that can serve to display environmental properties. The saturation of each color is used to represent the concentration of a given property. The implementation of that figure is illustrated through visualization of three dissolved inorganic nutrient concentrations along a vertical transect of the Mediterranean, as well as through a vertical time series of three phytoplankton group cell numbers. The RGB figures show well known properties of the water column. In addition, they reveal some lesser-known properties, such as regions in shallow water in which the ratio of phosphorus and silica to nitrogen is high, and a deep eukariotic phytoplankton community. Visualization of such data is usually performed with three separate contour or surface plots, and occasionally two properties are presented as an overlay in a single figure. The RGB figure offers a better way to visualize the interactions among the three separate plots than is commonly available.	[Suari, Yair; Brenner, Steve] Bar Ilan Univ, Dept Geog & Environm, Ramat Gan, Israel	Bar Ilan University	Suari, Y (corresponding author), Ruppin Acad Ctr, Sch Marine Sci & Marine Environm, Michmoret, Israel.	yairsuari@gmail.com		Suari, Yair/0000-0002-7632-2423	European Commission through the Sixth Framework Program European Coastal Sea Operational Observing and Forecasting System (ECOOP) [36355]	European Commission through the Sixth Framework Program European Coastal Sea Operational Observing and Forecasting System (ECOOP)	This research was supported by the European Commission through the Sixth Framework Program European Coastal Sea Operational Observing and Forecasting System (ECOOP) Contract Number 36355. The sampling cruises were supported by Andreas Weill and Eco-Ocean Association of Herzlyia, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; AZOV Y, 1991, MAR POLLUT BULL, V23, P225, DOI 10.1016/0025-326X(91)90679-M; Bouman HA, 2011, ENV MICROBIOL REP, V3, P473, DOI 10.1111/j.1758-2229.2011.00241.x; Brown M, 2002, VLIZ SPECIAL PUBLICA, P10; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Kaye NR, 2012, GEOSCI MODEL DEV, V5, P245, DOI 10.5194/gmd-5-245-2012; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Kurzweil R, 2004, ALAN TURING: LIFE AND LEGACY OF A GREAT THINKER, P381; Marie D, 1999, APPL ENV MICROBIOL; MATLAB, 2012, MATLAB; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Pahlow M, 2005, MAR ECOL PROG SER, V287, P33, DOI 10.3354/meps287033; Redfield A. C., 1934, PROPORTIONS ORGANIC, P176; Roederer M, 2008, CYTOM A; RYTHER JH, 1971, SCIENCE, V171, P1008, DOI 10.1126/science.171.3975.1008; Saadatinejad MR, 2011, J GEOPHYS ENG, V8, P412, DOI 10.1088/1742-2132/8/3/002; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Smol J.P., 2010, DIATOMS APPL ENV EAR; Sommer U, 2002, HYDROBIOLOGIA, V484, P11, DOI 10.1023/A:1021340601986; The free encyclopedia, 2014, RGB COL MOD; Thingstad TF, 2005, SCIENCE, V309, P1068, DOI 10.1126/science.1112632; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941	22	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102903	10.1371/journal.pone.0102903	http://dx.doi.org/10.1371/journal.pone.0102903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028934	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600104
J	Sustr, V; Chronakova, A; Semanova, S; Tajovsky, K; Simek, M				Sustr, Vladimir; Chronakova, Alica; Semanova, Stanislava; Tajovsky, Karel; Simek, Miloslav			Methane Production and Methanogenic Archaea in the Digestive Tracts of Millipedes (Diplopoda)	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; INTESTINAL MICROBIOTA; SYMBIOTIC METHANOGENS; ECOLOGICAL DIVERSITY; SOIL; COMMUNITY; BACTERIA; GUT; ENVIRONMENTS; PHYLOGENY	Methane production by intestinal methanogenic Archaea and their community structure were compared among phylogenetic lineages of millipedes. Tropical and temperate millipedes of 35 species and 17 families were investigated. Species that emitted methane were mostly in the juliform orders Julida, Spirobolida, and Spirostreptida. The irregular phylogenetic distribution of methane production correlated with the presence of the methanogen-specific mcrA gene. The study brings the first detailed survey of methanogens' diversity in the digestive tract of millipedes. Sequences related to Methanosarcinales, Methanobacteriales, Methanomicrobiales and some unclassified Archaea were detected using molecular profiling (DGGE). The differences in substrate preferences of the main lineages of methanogenic Archaea found in different millipede orders indicate that the composition of methanogen communities may reflect the differences in available substrates for methanogenesis or the presence of symbiotic protozoa in the digestive tract. We conclude that differences in methane production in the millipede gut reflect differences in the activity and proliferation of intestinal methanogens rather than an absolute inability of some millipede taxa to host methanogens. This inference was supported by the general presence of methanogenic activity in millipede faecal pellets and the presence of the 16S rRNA gene of methanogens in all tested taxa in the two main groups of millipedes, the Helminthophora and the Pentazonia.	[Sustr, Vladimir; Chronakova, Alica; Semanova, Stanislava; Tajovsky, Karel; Simek, Miloslav] Biol Ctr AS CR, Inst Soil Biol, Vvi, Ceske Budejovice, Czech Republic; [Semanova, Stanislava; Simek, Miloslav] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Sustr, V (corresponding author), Biol Ctr AS CR, Inst Soil Biol, Vvi, Ceske Budejovice, Czech Republic.	sustr@upb.cas.cz	Šimek, Miloslav/G-1532-2014; Tajovsky, Karel/G-2815-2014; Šustr, Vladimír/G-1495-2014; Chronakova, Alica/G-1422-2014; Chroňáková, Alica/AAS-1476-2020	Chronakova, Alica/0000-0002-3316-6862; Chroňáková, Alica/0000-0002-3316-6862	Czech Science Foundation [526/09/1570]	Czech Science Foundation(Grant Agency of the Czech Republic)	This research was supported by the Czech Science Foundation (Spots of methane production and consumption in terrestrial ecosystems: key for understanding methane turmover, No 526/09/1570). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Website of the Czech Science Foundation: http://www.gacr.cz/.	Angel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020453; BIGNELL DE, 1984, J INSECT PHYSIOL, V30, P169, DOI 10.1016/0022-1910(84)90122-7; Bijnen FGC, 1996, APPL OPTICS, V35, P5357, DOI 10.1364/AO.35.005357; BREZNAK JA, 1982, ANNU REV MICROBIOL, V36, P323, DOI 10.1146/annurev.mi.36.100182.001543; Brune A, 2010, MICROBIOL MONOGR, V19, P81, DOI 10.1007/978-3-642-13615-3_6; Byzov BA, 2006, SOIL BIOL, P89; CRUDEN DL, 1987, ANNU REV MICROBIOL, V41, P617, DOI 10.1146/annurev.mi.41.100187.003153; CRUTZEN P J, 1986, Tellus Series B Chemical and Physical Meteorology, V38, P271; Dighe AS, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-20; Dlugokencky EJ, 2011, PHILOS T R SOC A, V369, P2058, DOI 10.1098/rsta.2010.0341; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; Ehhalt D, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P239; EHHALT DH, 1974, TELLUS, V26, P58, DOI 10.1111/j.2153-3490.1974.tb01952.x; Embley TM, 1998, NATURE, V396, P517, DOI 10.1038/24994; Enghoff Henrik, 1992, Berichte des Naturwissenschaftlich-Medizinischen Vereins in Innsbruck Supplementum, V10, P47; Environmental Protection Agency (EPA United States), 2010, 430R10001 EPA; FERRY JG, 1992, CRIT REV BIOCHEM MOL, V27, P473, DOI 10.3109/10409239209082570; Garcia JL, 2000, ANAEROBE, V6, P205, DOI 10.1006/anae.2000.0345; GIJZEN HJ, 1991, APPL ENVIRON MICROB, V57, P1630, DOI 10.1128/AEM.57.6.1630-1634.1991; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; HACKSTEIN JHP, 1994, P NATL ACAD SCI USA, V91, P5441, DOI 10.1073/pnas.91.12.5441; Hackstein JHP, 2010, MICROBIOL MONOGR, V19, P13, DOI 10.1007/978-3-642-13615-3_2; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hara Kurt, 2002, Microbes and Environments, V17, P185, DOI 10.1264/jsme2.17.185; HOFFMAN RL, 1969, ECOLOGY, V50, P1096, DOI 10.2307/1936905; Hopkin P.S., 1992, BIOL MILLIPEDES; Jamali H, 2011, AGR FOREST METEOROL, V151, P1471, DOI 10.1016/j.agrformet.2010.06.009; Kim SY, 2008, SOIL BIOL BIOCHEM, V40, P2874, DOI 10.1016/j.soilbio.2008.08.004; Knapp BA, 2009, PEDOBIOLOGIA, V52, P325, DOI 10.1016/j.pedobi.2008.11.005; Koubova A, 2012, EUR J SOIL BIOL, V48, P32, DOI 10.1016/j.ejsobi.2011.09.007; Kusar D, 2010, FEMS MICROBIOL ECOL, V74, P623, DOI 10.1111/j.1574-6941.2010.00980.x; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Makkar H.P.S., 2007, MEASURING METHANE PR; MAYER HP, 1990, FEMS MICROBIOL ECOL, V73, P103; Mikhajlova EV, 2004, GOLOVATCH PENSOFT SE; Morozova D, 2007, ORIGINS LIFE EVOL B, V37, P189, DOI 10.1007/s11084-006-9024-7; Moss AR, 2000, ANN ZOOTECH, V49, P231, DOI 10.1051/animres:2000119; Mwabvu T, 2010, ZOOTAXA, P1; Ohkuma M, 1999, FEMS MICROBIOL LETT, V171, P147, DOI 10.1111/j.1574-6968.1999.tb13425.x; OHKUMA M, 1995, FEMS MICROBIOL LETT, V134, P45, DOI 10.1111/j.1574-6968.1995.tb07912.x; Orsolya O, 2002, EUR J SOIL BIOL, V38, P67, DOI 10.1016/S1164-5563(01)01128-1; Paul K, 2012, APPL ENVIRON MICROB, V78, P8245, DOI 10.1128/AEM.02193-12; PETERS V, 1995, APPL ENVIRON MICROB, V61, P1673, DOI 10.1128/AEM.61.4.1673-1676.1995; Ramaswamy V, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P349; RASMUSSEN RA, 1983, NATURE, V301, P700, DOI 10.1038/301700a0; Regier JC, 2005, MOL PHYLOGENET EVOL, V34, P147, DOI 10.1016/j.ympev.2004.09.005; Rosenberg J, 1995, VERHANDLUGEN WESTDEU, P67; Sarmiento BF, 2011, METHOD ENZYMOL, V494, P43, DOI 10.1016/B978-0-12-385112-3.00003-2; SIMEK M, 1995, SOIL BIOL BIOCHEM, V27, P1227, DOI 10.1016/0038-0717(95)00037-F; Sprenger WW, 2000, INT J SYST EVOL MICR, V50, P1989, DOI 10.1099/00207713-50-6-1989; Stoev Pavel, 2008, Steenstrupia, V30, P47; Sustr V, 2009, SOIL BIOL BIOCHEM, V41, P1684, DOI 10.1016/j.soilbio.2009.05.007; Tokura M, 2000, FEMS MICROBIOL ECOL, V33, P233, DOI 10.1111/j.1574-6941.2000.tb00745.x; Tree of Life Web Project, 2002, DIPL MILL VERS 01 JA; van Hoek AHAM, 2000, MOL BIOL EVOL, V17, P251, DOI 10.1093/oxfordjournals.molbev.a026304; Watanabe T, 2004, FEMS MICROBIOL LETT, V232, P153, DOI 10.1016/S0378-1097(04)00045-X; Wilkinson J. M., 2012, UK Vet: Livestock, V17, P33; ZINDER SH, 1985, INT J SYST BACTERIOL, V35, P522, DOI 10.1099/00207713-35-4-522	61	12	12	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102659	10.1371/journal.pone.0102659	http://dx.doi.org/10.1371/journal.pone.0102659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028969	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600089
J	Al-khattawi, A; Alyami, H; Townsend, B; Ma, XH; Mohammed, AR				Al-khattawi, Ali; Alyami, Hamad; Townsend, Bill; Ma, Xianghong; Mohammed, Afzal R.			Evidence-Based Nanoscopic and Molecular Framework for Excipient Functionality in Compressed Orally Disintegrating Tablets	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; MICROCRYSTALLINE CELLULOSE; PARTICLE-SIZE; SOLID-STATE; COMPACTION PROPERTIES; PUNCH VELOCITY; CRYSTAL HABIT; THEOPHYLLINE; ADHESION; BEHAVIOR	The work investigates the adhesive/cohesive molecular and physical interactions together with nanoscopic features of commonly used orally disintegrating tablet (ODT) excipients microcrystalline cellulose (MCC) and D-mannitol. This helps to elucidate the underlying physico-chemical and mechanical mechanisms responsible for powder densification and optimum product functionality. Atomic force microscopy (AFM) contact mode analysis was performed to measure nano-adhesion forces and surface energies between excipient-drug particles (6-10 different particles per each pair). Moreover, surface topography images (100 nm(2)-10 mu m(2)) and roughness data were acquired from AFM tapping mode. AFM data were related to ODT macro/microscopic properties obtained from SEM, FTIR, XRD, thermal analysis using DSC and TGA, disintegration testing, Heckel and tabletability profiles. The study results showed a good association between the adhesive molecular and physical forces of paired particles and the resultant densification mechanisms responsible for mechanical strength of tablets. MCC micro roughness was 3 times that of D-mannitol which explains the high hardness of MCC ODTs due to mechanical interlocking. Hydrogen bonding between MCC particles could not be established from both AFM and FTIR solid state investigation. On the contrary, D-mannitol produced fragile ODTs due to fragmentation of surface crystallites during compression attained from its weak crystal structure. Furthermore, AFM analysis has shown the presence of extensive micro fibril structures inhabiting nano pores which further supports the use of MCC as a disintegrant. Overall, excipients (and model drugs) showed mechanistic behaviour on the nano/micro scale that could be related to the functionality of materials on the macro scale.	[Al-khattawi, Ali; Alyami, Hamad; Mohammed, Afzal R.] Aston Univ, Aston Sch Pharm, Birmingham B4 7ET, W Midlands, England; [Townsend, Bill; Ma, Xianghong] Aston Univ, Sch Engn & Appl Sci, Birmingham B4 7ET, W Midlands, England; [Al-khattawi, Ali; Townsend, Bill; Ma, Xianghong; Mohammed, Afzal R.] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England	Aston University; Aston University; Aston University	Mohammed, AR (corresponding author), Aston Univ, Aston Sch Pharm, Birmingham B4 7ET, W Midlands, England.	a.u.r.mohammed@aston.ac.uk		Ma, Xianghong/0000-0003-4957-2942; Al-khattawi, Ali/0000-0002-2498-2817; Mohammed, Afzal-Ur-Rahman/0000-0002-5212-3040; Alyami, Hamad/0000-0003-3513-4976	Aston University through a Post graduate overseas bursary awarded	Aston University through a Post graduate overseas bursary awarded	The work was funded by Aston University through a Post graduate overseas bursary awarded to Ali Al-Khattawi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson A, 1999, DRUG DEV IND PHARM, V25, P753, DOI 10.1081/DDC-100102235; Al-Khattawi A, 2014, CURR DRUG DELIV, V11, P486, DOI 10.2174/1567201811666140323201650; Al-khattawi A, 2013, EXPERT OPIN DRUG DEL, V10, P651, DOI 10.1517/17425247.2013.769955; ALDERBORN G, 1988, ACTA PHARM SUEC, V25, P31; ALDERBORN G, 2008, PHARM POWDER COMPACT, V1; AMIDON GE, 1995, PHARMACEUT RES, V12, P923, DOI 10.1023/A:1016233725612; Burger A, 2000, J PHARM SCI-US, V89, P457, DOI 10.1002/(SICI)1520-6017(200004)89:4<457::AID-JPS3>3.0.CO;2-G; Busignies V, 2006, EUR J PHARM BIOPHARM, V64, P66, DOI 10.1016/j.ejpb.2006.03.004; BUTT HJ, 1991, BIOPHYS J, V60, P1438, DOI 10.1016/S0006-3495(91)82180-4; Camesano TA, 2000, ENVIRON SCI TECHNOL, V34, P3354, DOI 10.1021/es9913176; Chattoraj S, 2010, CRYSTENGCOMM, V12, P2466, DOI 10.1039/c000614a; Chaw KC, 2005, ANTIMICROB AGENTS CH, V49, P4853, DOI 10.1128/AAC.49.12.4853-4859.2005; Convention USP, 2005, DISINTEGRATION, V701; Davies MJ, 2011, INT J PHARMACEUT, V421, P1, DOI 10.1016/j.ijpharm.2011.09.004; Di Martino P, 2002, J CRYST GROWTH, V243, P345, DOI 10.1016/S0022-0248(02)01523-3; Eve JK, 2002, INT J PHARMACEUT, V238, P17, DOI 10.1016/S0378-5173(02)00055-8; Fox CD, 1963, DRUG COSMET IND, V92, P161; Garekani HA, 2001, DRUG DEV IND PHARM, V27, P803, DOI 10.1081/DDC-100107243; Gohel MC., 2007, AAPS PHARMSCITECH, V8, pE94, DOI [10.1208/pt0801013, DOI 10.1208/PT0801013]; Gonnissen Y, 2007, EUR J PHARM BIOPHARM, V67, P220, DOI 10.1016/j.ejpb.2006.12.021; Grierson DS, 2005, J ADHES SCI TECHNOL, V19, P291, DOI 10.1163/1568561054352685; Hancock BC, 1997, J PHARM SCI, V86, P1, DOI 10.1021/js9601896; HECKEL RW, 1961, T METALL SOC AIME, V221, P671; Herting MG, 2007, INT J PHARM, V338, P110, DOI 10.1016/j.ijpharm.2007.01.035; Hinterstoisser B, 2003, BIOMACROMOLECULES, V4, P1232, DOI 10.1021/bm030017k; HUTTENRA.R, 1971, PHARMAZIE, V26, P645; Inghelbrecht S, 1998, INT J PHARM, V161, P215, DOI 10.1016/S0378-5173(97)00356-6; Janardhnan S, 2011, INT J POLYM SCI, V2011, DOI 10.1155/2011/279610; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Kaialy W, 2010, COLLOID SURFACE B, V79, P345, DOI 10.1016/j.colsurfb.2010.04.016; KAREHILL PG, 1990, INT J PHARM, V64, P35, DOI 10.1016/0378-5173(90)90176-5; KAREHILL PG, 1990, INT J PHARM, V61, P251, DOI 10.1016/0378-5173(90)90216-Q; LAM KK, 1992, POWDER TECHNOL, V73, P117, DOI 10.1016/0032-5910(92)80072-5; LIANG CY, 1959, J POLYM SCI, V37, P385, DOI 10.1002/pol.1959.1203713209; MARSHALL PV, 1993, POWDER TECHNOL, V74, P171, DOI 10.1016/0032-5910(93)87009-D; NESIC M, 1990, ACTA PHARM JUGOSL, V40, P545; Oh SY, 2005, CARBOHYD RES, V340, P2376, DOI 10.1016/j.carres.2005.08.007; Pather SI, 1998, INT J PHARM, V164, P1, DOI 10.1016/S0378-5173(97)00348-7; Picker KM, 1999, EUR J PHARM BIOPHARM, V48, P27, DOI 10.1016/S0939-6411(99)00009-0; Picker KM, 2002, J PHARM SCI-US, V91, P342, DOI 10.1002/jps.10018; Pifferi G, 1999, FARMACO, V54, P1, DOI 10.1016/S0014-827X(98)00101-3; RICHMAN MD, 1965, J PHARM SCI, V54, P447, DOI 10.1002/jps.2600540323; Roberts CJ, 2005, EUR J PHARM SCI, V24, P153, DOI 10.1016/j.ejps.2004.11.002; ROBERTS RJ, 1985, J PHARM PHARMACOL, V37, P377, DOI 10.1111/j.2042-7158.1985.tb03019.x; ROBERTS RJ, 1987, INT J PHARM, V36, P205, DOI 10.1016/0378-5173(87)90157-8; ROMERO AJ, 1993, INT J PHARMACEUT, V99, P125, DOI 10.1016/0378-5173(93)90354-I; Seton L, 2010, CRYST GROWTH DES, V10, P3879, DOI 10.1021/cg100165t; Soh JLP, 2013, PHARM DEV TECHNOL, V18, P172, DOI 10.3109/10837450.2012.685658; Sonnergaard JM, 1999, INT J PHARM, V193, P63, DOI 10.1016/S0378-5173(99)00319-1; Suihko E, 2001, INT J PHARM, V217, P225, DOI 10.1016/S0378-5173(01)00607-X; Suihko E, 1997, INT J PHARM, V158, P47, DOI 10.1016/S0378-5173(97)00239-1; SUZUKI E, 1989, CHEM PHARM BULL, V37, P493; Szczesniak L, 2008, CELLULOSE, V15, P445, DOI 10.1007/s10570-007-9192-2; van Veen B, 2000, INT J PHARM, V203, P71, DOI 10.1016/S0378-5173(00)00450-6; Whelan MR, 2002, J PHARMACEUT BIOMED, V30, P1355, DOI 10.1016/S0731-7085(02)00394-1; YORK P, 1983, INT J PHARMACEUT, V14, P1, DOI 10.1016/0378-5173(83)90111-4; Yoshinari T, 2003, INT J PHARM, V258, P121, DOI 10.1016/S0378-5173(03)00157-1; Yvonne P., 2012, DRUG DELIV LETT, V2, P195	58	10	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101369	10.1371/journal.pone.0101369	http://dx.doi.org/10.1371/journal.pone.0101369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025427	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000339992400013
J	Francis, SC; Ao, TT; Vanobberghen, FM; Chilongani, J; Hashim, R; Andreasen, A; Watson-Jones, D; Changalucha, J; Kapiga, S; Hayes, RJ				Francis, Suzanna C.; Ao, Trong T.; Vanobberghen, Fiona M.; Chilongani, Joseph; Hashim, Ramadhan; Andreasen, Aura; Watson-Jones, Deborah; Changalucha, John; Kapiga, Saidi; Hayes, Richard J.			Epidemiology of Curable Sexually Transmitted Infections among Women at Increased Risk for HIV in Northwestern Tanzania: Inadequacy of Syndromic Management	PLOS ONE			English	Article							FEMALE SEX WORKERS; CHLAMYDIA-TRACHOMATIS INFECTION; SIMPLEX-VIRUS TYPE-2; TRICHOMONAS-VAGINALIS; BACTERIAL VAGINOSIS; DISEASES; TRANSMISSION; ACQUISITION; SYPHILIS; COHORT	Background: Curable, non-viral pathogens account for a significant burden of sexually transmitted infections (STIs), and there is established evidence that STIs increase both HIV acquisition and transmission. We investigated the prevalence, trends, and factors associated with Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Treponema pallidum, and the performance of syndromic management, among a cohort of women working in bars, hotels, and other food and recreational facilities near large-scale mines in northwestern Tanzania. Methods: HIV-negative women aged 18-44 years (N = 966) were enrolled and followed for 12 months in a microbicides feasibility study. We collected sociodemographic and behavioural data, performed clinical examinations, and tested for STIs, at enrolment and 3-monthly. Risk factors for STIs were investigated using logistic regression models with random effects. Sensitivity, specificity and predictive values of syndromic management were calculated. Results: At enrolment, the prevalences of C. trachomatis, N. gonorrhoeae, T. vaginalis, and high-titre active syphilis were 111/956 (12%), 42/955 (4%), 184/945 (19%) and 46/965 (5%), respectively. There were significant decreases over time for C. trachomatis and T. vaginalis (OR trend per month: 0.94 [95% CI 0.91, 0.97]; and 0.95 [0.93, 0.98], respectively; both p < 0.001). The majority of these infections were not diagnosed by the corresponding syndrome; therefore, most participants were not treated at the diagnosis visit. Syndromic management was poorly predictive of laboratory-diagnosed infections. We identified a number of risk factors for STIs, including low educational level, some sexual behaviours, and ever having been pregnant. Conclusions: This analysis demonstrates that the prevalences of curable STIs are high among women who work in food and recreational facilities in northwestern Tanzania. Most of these infections are missed by syndromic management. Accurate and affordable rapid-point-of-care tests and innovative interventions are needed to reduce the burden of STIs in this population which is at increased risk for HIV.	[Francis, Suzanna C.; Ao, Trong T.; Vanobberghen, Fiona M.; Kapiga, Saidi; Hayes, Richard J.] Univ London London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1E 7HT, England; [Francis, Suzanna C.; Ao, Trong T.; Vanobberghen, Fiona M.; Chilongani, Joseph; Hashim, Ramadhan; Andreasen, Aura; Watson-Jones, Deborah; Kapiga, Saidi] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Chilongani, Joseph; Changalucha, John] Natl Inst Med Res, Mwanza, Tanzania; [Andreasen, Aura; Watson-Jones, Deborah] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine	Francis, SC (corresponding author), Univ London London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Keppel St, London WC1E 7HT, England.	suzanna.francis@lshtm.ac.uk		Francis, Suzanna Carter/0000-0002-3724-4813; Kapiga, Saidi/0000-0003-1753-4060; Andreasen, Aura/0000-0003-0664-7342; Hayes, Richard/0000-0002-1729-9892	European and Developing Countries Clinical Trials Partnership [CT_ct_05_32070_002]; Medical Research Council (MRC); Department for International Development (DFID) [G0901756, G1002369, G0700837]; MRC [G0901756, G0700837, G0701039, G1002369] Funding Source: UKRI; Medical Research Council [G0700837, G1002369, MR/K012126/1, G0701039, G0901756] Funding Source: researchfish	European and Developing Countries Clinical Trials Partnership; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development (DFID); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support was provided by the European and Developing Countries Clinical Trials Partnership (project code: CT_ct_05_32070_002) and from the Medical Research Council (MRC) and Department for International Development (DFID) with S. Kapiga (G0901756), S. C. Francis (G1002369), R.J. Hayes, and F. Vanobberghen (G0700837) receiving MRC & DFID support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary M., 2001, GUIDELINES MANAGEMEN; Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862; Batteiger BE, 2010, J INFECT DIS, V201, pS178, DOI 10.1086/652400; Celum Connie L, 2010, Top HIV Med, V18, P138; Clift S, 2003, SEX TRANSM INFECT, V79, P307, DOI 10.1136/sti.79.4.307; Cook RL, 2005, SEX TRANSM DIS, V32, P156, DOI 10.1097/01.olq.0000151418.03899.97; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Das A, 2013, SEX TRANSM INFECT, V89, P5, DOI 10.1136/sextrans-2012-050472; Desai VK, 2003, SEX TRANSM INFECT, V79, P111, DOI 10.1136/sti.79.2.111; Duncan S, 2012, NEW ENGL J MED, V366, P2136, DOI 10.1056/NEJMc1203138; Duncan S, 2011, SEX TRANSM INFECT, V87, P231, DOI 10.1136/sti.2010.048777; Feldblum PJ, 2010, SEX TRANSM DIS, V37, P594, DOI 10.1097/OLQ.0b013e3181e15f0b; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Heffron R, 2011, LANCET INFECT DIS, V3099, P1; Huppert JS, 2007, CLIN INFECT DIS, V45, P194, DOI 10.1086/518851; Iqbal SM, 2008, AM J REPROD IMMUNOL, V59, P44; Johnson HL, 2011, SEX TRANSM DIS, V38, P167, DOI 10.1097/OLQ.0b013e3181f2e85f; Kapiga S, 2009, SEX TRANSM DIS, V36, P199, DOI 10.1097/OLQ.0b013e318191ba01; Kapiga SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068825; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; Lagace-Wiens PRS, 2012, SEX TRANSM DIS, V39, P332, DOI 10.1097/OLQ.0b013e318248a85f; Mahony JB, 2001, J CLIN MICROBIOL, V39, P1429, DOI 10.1128/JCM.39.4.1429-1435.2001; Masese L, 2013, SEX TRANSM DIS, V40, P221, DOI 10.1097/OLQ.0b013e318272fe45; Mavedzenge SN, 2010, SEX TRANSM DIS, V37, P460, DOI 10.1097/OLQ.0b013e3181cfcc4b; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Ministry of Health and Social Welfare, 2007, NAT GUID MAN SEX TRA; Mlisana K, 2012, J INFECT DIS, V206, P6, DOI 10.1093/infdis/jis298; Moodley P, 2002, CLIN INFECT DIS, V34, P519, DOI 10.1086/338399; Moodley P, 2002, J INFECT DIS, V185, P69, DOI 10.1086/338027; Morrison CS, 2004, SEX TRANSM DIS, V31, P561, DOI 10.1097/01.olq.0000137904.56037.70; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Nye MB, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.005; Peeling RW, 2006, NAT REV MICROBIOL, V4, P909, DOI 10.1038/nrmicro1555; Pettifor A, 2009, CONTRACEPTION, V80, P555, DOI 10.1016/j.contraception.2009.06.007; Polis CB, 2013, LANCET INFECT DIS, V13, P797, DOI 10.1016/S1473-3099(13)70155-5; Riedner G, 2006, AIDS, V20, P609, DOI 10.1097/01.aids.0000210616.90954.47; Rours GIJG, 2011, EUR J EPIDEMIOL, V26, P493, DOI 10.1007/s10654-011-9586-1; Schmid G, 2005, PREVALENCE INCIDENCE; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Tapsall JW, 2005, CLIN INFECT DIS, V41, pS263, DOI 10.1086/430787; Taylor-Robinson D, 2012, INT J STD AIDS, V23, P18, DOI 10.1258/ijsa.2011.011066; Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881; Vallely A, 2007, SEX TRANSM DIS, V34, P638, DOI 10.1097/OLQ.0b013e3180325120; Vickerman P, 2006, SEX TRANSM INFECT, V82, pV38, DOI 10.1136/sti.2006.021824; Watson-Jones D, 2002, J INFECT DIS, V186, P940, DOI 10.1086/342952; Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	49	34	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101221	10.1371/journal.pone.0101221	http://dx.doi.org/10.1371/journal.pone.0101221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025338	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000339992400011
J	Jansson, S; Bendahl, PO; Grabau, DA; Falck, AK; Ferno, M; Aaltonen, K; Ryden, L				Jansson, Sara; Bendahl, Par-Ola; Grabau, Dorthe Aamand; Falck, Anna-Karin; Ferno, Marten; Aaltonen, Kristina; Ryden, Lisa			The Three Receptor Tyrosine Kinases c-KIT, VEGFR2 and PDGFR alpha, Closely Spaced at 4q12, Show Increased Protein Expression in Triple-Negative Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GLIOBLASTOMA-MULTIFORME; TISSUE MICROARRAYS; TARGETED THERAPIES; RANDOMIZED-TRIAL; FOLLOW-UP; BASAL; PHENOTYPE; AMPLIFICATION; SUNITINIB	Background: Triple-negative breast cancer (TNBC) is a heterogeneous subgroup of breast cancer with poor prognosis and no targeted therapy available. Receptor tyrosine kinases (RTKs) are emerging targets in anticancer therapy and many RTK-inhibiting drugs are currently being developed. The aim of this study was to elucidate if there is a correlation between the protein expression of three RTKs c-KIT, VEGFR2 and PDGFR alpha, their gene copy number, and prognosis in TNBC compared to non-TNBC. Methods: Tumor tissue samples from patients diagnosed with primary breast cancer were stained with immunohistochemistry (IHC) for protein assessment, and with fluorescence in situ hybridization (FISH) for gene copy number determination. Breast cancer mortality (BCM), measured from the date of surgery to death, was used as endpoint. Results: The cohort included 464 patients, out of which 34 (7.3%) had a TNBC. High expression of the three RTKs was more common in TNBC compared to non-TNBC: c-KIT 49% vs. 10% (P<0.001), PDGFR alpha 32% vs. 19% (P = 0.07) and VEGFR2 32% vs. 6% (P<0.001). The odds ratio (OR) of c-KIT, VEGFR2 and PDGFR alpha positivity, adjusted for tumor characteristics, was 6.8, 3.6 and 1.3 times higher for TNBC than for non-TNBC. 73.5% of the TNBC had high expression of at least one of the three investigated receptors, compared to 30.0% of the non-TNBC (P<0.001). Survival analysis showed no significant difference in BCM for TNBC patients with high vs. low c-KIT, PDGFR alpha or VEGFR2 protein expression. 193 (42%) tumors were evaluated with FISH. No correlation was seen between increased gene copy number and TNBC, or between increased gene copy number and high protein expression of the RTK. Conclusion: c-KIT, VEGFR2 and PDGFR alpha show higher protein expression in TNBC compared to non-TNBC. Further investigation clarifying the importance of these RTKs in TNBC is encouraged, as they are possible targets for anticancer therapy.	[Jansson, Sara; Bendahl, Par-Ola; Grabau, Dorthe Aamand; Ferno, Marten; Aaltonen, Kristina] Lund Univ, Div Oncol & Pathol, Dept Clin Sci, Lund, Sweden; [Falck, Anna-Karin] Hosp Helsingborg, Dept Surg, Helsingborg, Sweden; [Ryden, Lisa] Skane Univ Hosp, Dept Clin Sci Lund, Div Surg, Lund, Sweden	Lund University; Helsingborgs Hospital; Lund University; Skane University Hospital	Jansson, S (corresponding author), Lund Univ, Div Oncol & Pathol, Dept Clin Sci, Lund, Sweden.	sara.jansson@med.lu.se			Swedish Cancer Society; Swedish Research Council; Swedish Medical Association; Gunnar Nilsson Cancer Foundation; Mrs. Berta Kamprad Foundation; Stig and Ragna Gorthons Stiftelse; University Hospital of Lund Research Foundation; Skane Country Council's Research and Development Foundation; National Health Service	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Medical Association; Gunnar Nilsson Cancer Foundation; Mrs. Berta Kamprad Foundation; Stig and Ragna Gorthons Stiftelse; University Hospital of Lund Research Foundation; Skane Country Council's Research and Development Foundation; National Health Service	The work was supported by Swedish Cancer Society, Swedish Research Council, Swedish Medical Association, the Gunnar Nilsson Cancer Foundation, the Mrs. Berta Kamprad Foundation, Stig and Ragna Gorthons Stiftelse, the University Hospital of Lund Research Foundation, Skane Country Council's Research and Development Foundation and Governmental Funding of Clinical Research within the National Health Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Barrios CH, 2010, BREAST CANCER RES TR, V121, P121, DOI 10.1007/s10549-010-0788-0; Bertucci F, 2008, INT J CANCER, V123, P236, DOI 10.1002/ijc.23518; Brown LA, 2007, J MOL HISTOL, V38, P151, DOI 10.1007/s10735-006-9069-y; Burford A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071777; Burstein HJ, 2008, J CLIN ONCOL, V26, P1810, DOI 10.1200/JCO.2007.14.5375; Carvalho I, 2005, BREAST CANCER RES, V7, pR788, DOI 10.1186/bcr1304; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; de Ruijter TC, 2011, J CANCER RES CLIN, V137, P183, DOI 10.1007/s00432-010-0957-x; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dhakal HP, 2012, HISTOPATHOLOGY, V61, P350, DOI 10.1111/j.1365-2559.2012.04223.x; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Falck AK, 2013, BREAST CANCER RES TR, V140, P93, DOI 10.1007/s10549-013-2617-8; Falck AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-403; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gazinska P, 2013, MODERN PATHOL, V26, P955, DOI 10.1038/modpathol.2012.244; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hahtola S, 2008, GENE CHROMOSOME CANC, V47, P107, DOI 10.1002/gcc.20513; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Holtkamp N, 2007, NEURO-ONCOLOGY, V9, P291, DOI 10.1215/15228517-2007-009; Joensuu H, 2005, J PATHOL, V207, P224, DOI 10.1002/path.1823; Johansson I, 2012, GENE CHROMOSOME CANC, V51, P375, DOI 10.1002/gcc.21922; Kashiwagi S, 2013, BRIT J SURG, V100, P490, DOI 10.1002/bjs.9021; Kozloff M, 2010, ANN ONCOL, V21, P1436, DOI 10.1093/annonc/mdp565; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Nassar A, 2012, BREAST J, V18, P399, DOI 10.1111/j.1524-4741.2012.01279.x; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Nupponen NN, 2008, MODERN PATHOL, V21, P265, DOI 10.1038/modpathol.3800989; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Puputti M, 2006, MOL CANCER RES, V4, P927, DOI 10.1158/1541-7786.MCR-06-0085; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Ryden L, 2010, BREAST CANCER RES TR, V120, P491, DOI 10.1007/s10549-010-0758-6; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tibes R, 2005, ANNU REV PHARMACOL, V45, P357, DOI 10.1146/annurev.pharmtox.45.120403.100124; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065; Zietsch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011858	45	29	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102176	10.1371/journal.pone.0102176	http://dx.doi.org/10.1371/journal.pone.0102176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025175	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400048
J	Manicam, C; Pitz, S; Brochhausen, C; Grus, FH; Pfeiffer, N; Gericke, A				Manicam, Caroline; Pitz, Susanne; Brochhausen, Christoph; Grus, Franz H.; Pfeiffer, Norbert; Gericke, Adrian			Effective Melanin Depigmentation of Human and Murine Ocular Tissues: An Improved Method for Paraffin and Frozen Sections	PLOS ONE			English	Article							DILUTE HYDROGEN-PEROXIDE; UVEAL MELANOMA; CILIARY BODY; PATHOLOGY; IMMUNOHISTOCHEMISTRY; CYTOSKELETON; LESIONS; CELLS; EYE; DOG	Purpose: The removal of excessive melanin pigments that obscure ocular tissue morphology is important to address scientific questions and for differential diagnosis of ocular tumours based on histology. Thus, the goal of the present study was to establish an effective and fast melanin bleaching method for paraffin and frozen mouse and human ocular tissues. Methods: Paraffin-embedded and frozen ocular specimens from mice and human donors were subjected to bleaching employing two methods. The first employed potassium permanganate (KMnO4) with oxalic acid, and the second 10% hydrogen peroxide (H2O2). To determine optimal bleaching conditions, depigmentation was carried out at various incubation times. The effect of diluents used for 10% H2O2 was assessed using phosphate-buffered saline (PBS), and deionized water. Three different slide types and two fixatives, which were ice-cold acetone with 80% methanol, and 4% paraformaldehyde (PFA) were used to determine the optimal conditions for better tissue adherence during bleaching. All tissues were stained in hematoxylin and eosin for histological evaluation. Results: Optimal bleaching was achieved using warm 10% H2O2 diluted in PBS at 65 degrees C for 120 minutes. Chromium-gelatin-coated slides prevented tissue detachment. Adherence of cryosections was also improved with post-fixation using 4% PFA and overnight air-drying at RT after cryosectioning. Tissue morphology was preserved under these conditions. Conversely, tissues bleached in KMnO4/oxalic acid demonstrated poor depigmentation with extensive tissue damage. Conclusions: Warm dilute H2O2 at 65 degrees C for 120 minutes rapidly and effectively bleached both cryo-and paraffin sections of murine and human ocular tissues.	[Manicam, Caroline; Pitz, Susanne; Grus, Franz H.; Pfeiffer, Norbert; Gericke, Adrian] Johannes Gutenberg Univ Mainz, Dept Ophthalmol, Univ Med Ctr, Mainz, Germany; [Brochhausen, Christoph] Johannes Gutenberg Univ Mainz, Inst Pathol, Univ Med Ctr, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Manicam, C (corresponding author), Johannes Gutenberg Univ Mainz, Dept Ophthalmol, Univ Med Ctr, Mainz, Germany.	cmjc_82@yahoo.com	Pfeiffer, Norbert/AAO-7586-2020		Gertraud Maria Rzehulka Foundation; internal grant from the University Medical Center [MAIFOR2013-2014]	Gertraud Maria Rzehulka Foundation; internal grant from the University Medical Center	This study was supported by a grant from the Gertraud Maria Rzehulka Foundation and an internal grant from the University Medical Center (MAIFOR2013-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jamal RT, 2006, CURR EYE RES, V31, P57, DOI 10.1080/02713680500478535; Alexander RA, 1996, BRIT J BIOMED SCI, V53, P170; ALEXANDER RA, 1986, MED LAB SCI, V43, P121; Ansorge M, 1996, PIGM CELL RES, V9, P142, DOI 10.1111/j.1600-0749.1996.tb00102.x; BOMANJI J, 1987, BRIT J OPHTHALMOL, V71, P647, DOI 10.1136/bjo.71.9.647; Chesterman W, 1958, Q J MICROSCOPICAL SC, V3, P65; FLUGELKOCH C, 1994, INVEST OPHTH VIS SCI, V35, P4268; FOSS AJE, 1995, BRIT J BIOMED SCI, V52, P22; FRANGIONI G, 1986, STAIN TECHNOL, V61, P239, DOI 10.3109/10520298609109944; FUCHS U, 1991, INVEST OPHTH VIS SCI, V32, P3178; FUCHS U, 1992, AM J PATHOL, V141, P169; Hu DN, 2008, PHOTOCHEM PHOTOBIOL, V84, P639, DOI 10.1111/j.1751-1097.2008.00316.x; JEBB AH, 1977, STAIN TECHNOL, V52, P315, DOI 10.3109/10520297709116805; Kivela T, 1995, BRIT J BIOMED SCI, V52, P325; KIVELA T, 1992, J HISTOCHEM CYTOCHEM, V40, P1517, DOI 10.1177/40.10.1382090; Kligora CJ, 1999, MODERN PATHOL, V12, P1143; KORYTOWSKI W, 1990, J BIOL CHEM, V265, P12410; Li LXL, 1999, HISTOCHEM J, V31, P237; Liu CH, 2013, APPL IMMUNOHISTO M M, V21, P275, DOI 10.1097/PAI.0b013e31826d81db; MCLEOD DS, 1994, INVEST OPHTH VIS SCI, V35, P3799; Momose M, 2011, PATHOL INT, V61, P345, DOI 10.1111/j.1440-1827.2011.02667.x; Mudhar HS, 2013, BRIT J OPHTHALMOL, V97, P924, DOI 10.1136/bjophthalmol-2013-303291; Orchard GE, 2007, BRIT J BIOMED SCI, V64, P89, DOI 10.1080/09674845.2007.11978097; Orchard GE, 1998, AM J DERMATOPATH, V20, P357, DOI 10.1097/00000372-199808000-00006; Roels S, 1999, J COMP PATHOL, V121, P13, DOI 10.1053/jcpa.1998.0291; Seagle BLL, 2005, P NATL ACAD SCI USA, V102, P8978, DOI 10.1073/pnas.0501971102; Shi SR, 2008, AM J CLIN PATHOL, V129, P358, DOI 10.1309/7CXUYXT23E5AL8KQ; Sompuram SR, 2004, AM J CLIN PATHOL, V121, P190, DOI 10.1309/BRN7CTX1E84NWWPL; Thurby C, 2009, J HISTOTECHNOL, V32, P198, DOI 10.1179/his.2009.32.4.198; Toivonen P, 2012, ACTA OPHTHALMOL, V90, P341, DOI 10.1111/j.1755-3768.2010.01985.x; Tyni T, 2004, PEDIATR RES, V56, P744, DOI 10.1203/01.PDR.0000141967.52759.83; van de Sandt RROM, 2003, VET OPHTHALMOL, V6, P273, DOI 10.1111/j.1463-5224.2003.00306.x	32	16	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102512	10.1371/journal.pone.0102512	http://dx.doi.org/10.1371/journal.pone.0102512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025426	gold, Green Submitted, Green Published			2022-12-25	WOS:000339992400082
J	Zou, HX; Pang, QY; Lin, LD; Zhang, AQ; Li, N; Lin, YQ; Li, LM; Wu, QQ; Yan, XF				Zou, Hui-Xi; Pang, Qiu-Ying; Lin, Li-Dong; Zhang, Ai-Qin; Li, Nan; Lin, Yan-Qing; Li, Lu-Min; Wu, Qin-Qin; Yan, Xiu-Feng			Behavior of the Edible Seaweed Sargassum fusiforme to Copper Pollution: Short-Term Acclimation and Long-Term Adaptation	PLOS ONE			English	Article							CLAM RUDITAPES-PHILIPPINARUM; INDUCED OXIDATIVE STRESS; BROWN ALGA; NITRATE REDUCTASE; D-ASPARTATE; DIFFERENTIAL RESPONSES; METABOLIC-RESPONSES; NITROGEN-METABOLISM; ANTIOXIDANT ENZYMES; HIZIKIA-FUSIFORMIS	Aquatic agriculture in heavy-metal-polluted coastal areas faces major problems due to heavy metal transfer into aquatic organisms, leading to various unexpected changes in nutrition and primary and/or secondary metabolism. In the present study, the dual role of heavy metal copper (Cu) played in the metabolism of photosynthetic organism, the edible seaweed Sargassum fusiforme, was evaluated by characterization of biochemical and metabolic responses using both H-1 NMR and GC-MS techniques under acute (47 mu M, 1 day) and chronic stress (8 mu M, 7 days). Consequently, photosynthesis may be seriously inhibited by acute Cu exposure, resulting in decreasing levels of carbohydrates, e. g., mannitol, the main products of photosynthesis. Ascorbate may play important roles in the antioxidant system, whose content was much more seriously decreased under acute than that under chronic Cu stress. Overall, these results showed differential toxicological responses on metabolite profiles of S. fusiforme subjected to acute and chronic Cu exposures that allowed assessment of impact of Cu on marine organisms.	[Zou, Hui-Xi; Li, Nan; Lin, Yan-Qing; Li, Lu-Min; Wu, Qin-Qin; Yan, Xiu-Feng] Wenzhou Univ, Coll Life & Environm Sci, Zhejiang Prov Key Lab Subtrop Water Environm & Ma, Wenzhou, Peoples R China; [Pang, Qiu-Ying; Lin, Li-Dong; Zhang, Ai-Qin] Northeast Forest Univ, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Harbin, Peoples R China	Wenzhou University; Northeast Forestry University - China	Yan, XF (corresponding author), Wenzhou Univ, Coll Life & Environm Sci, Zhejiang Prov Key Lab Subtrop Water Environm & Ma, Wenzhou, Peoples R China.	yanxiufeng@wzu.edu.cn	Zou, Hui-Xi/GPS-6496-2022	Zou, Hui-Xi/0000-0002-8141-8059; Yan, Xiufeng/0000-0001-5127-494X	Zhejiang Provincial Natural Science Foundation of China [LQ13C030005]; Natural Science Foundation of China [31270541]; Plan for Qianjiang Talent of Zhejiang [QJD1202014]; Program for Wenzhou Science & Technology Innovative Research Team of China [C20120007-08]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan for Qianjiang Talent of Zhejiang; Program for Wenzhou Science & Technology Innovative Research Team of China	This material is based upon work funded by Zhejiang Provincial Natural Science Foundation of China (LQ13C030005, http://www.zjnsf.gov.cn), Natural Science Foundation of China (31270541, http://www.nsfc.gov.cn), Plan for Qianjiang Talent of Zhejiang (QJD1202014), and Program for Wenzhou Science & Technology Innovative Research Team of China (C20120007-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada K., 1987, PHOTOINHIBITION, P227; Barding GA, 2013, J PROTEOME RES, V12, P898, DOI 10.1021/pr300953k; Barding GA, 2012, J PROTEOME RES, V11, P320, DOI 10.1021/pr200919b; Bischoff K., 2012, SEAWEED BIOL, P109, DOI [10.1007/978-3-642-28451-9_6, DOI 10.1007/978-3-642-28451-9_6]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burzynski M, 1997, ACTA PHYSIOL PLANT, V19, P3, DOI 10.1007/s11738-997-0015-8; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Campbell WH, 1999, ANNU REV PLANT PHYS, V50, P277, DOI 10.1146/annurev.arplant.50.1.277; Chen CL, 2013, PLANT J, V75, P891, DOI 10.1111/tpj.12262; Collen J, 1999, J PHYCOL, V35, P62, DOI 10.1046/j.1529-8817.1999.3510062.x; Contreras L, 2005, J PHYCOL, V41, P1184, DOI 10.1111/j.1529-8817.2005.00151.x; Contreras L, 2009, AQUAT TOXICOL, V94, P94, DOI 10.1016/j.aquatox.2009.06.004; Diaz J, 2001, PLANT SCI, V161, P179, DOI 10.1016/S0168-9452(01)00410-1; Doubnerova V, 2011, PLANT SCI, V180, P575, DOI 10.1016/j.plantsci.2010.12.005; Dowling VA, 2006, PROTEOMICS, V6, P5597, DOI 10.1002/pmic.200600274; Dunn WB, 2013, METABOLOMICS, V9, pS44, DOI 10.1007/s11306-012-0434-4; Fan JH, 1996, ASTRON ASTROPHYS SUP, V116, P409, DOI 10.1051/aas:1996124; Fang J, 2004, B ENVIRON CONTAM TOX, V73, P583, DOI 10.1007/s00128-004-0468-z; Farag MA, 2012, PHYTOCHEMISTRY, V76, P60, DOI 10.1016/j.phytochem.2011.12.010; Fernandez E, 2008, EUKARYOT CELL, V7, P555, DOI 10.1128/EC.00431-07; FLYNN KJ, 1989, J PLANKTON RES, V11, P165, DOI 10.1093/plankt/11.1.165; Fontaine JX, 2006, PLANT CELL PHYSIOL, V47, P410, DOI 10.1093/pcp/pcj008; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Funakoshi M, 2008, FEBS J, V275, P1188, DOI 10.1111/j.1742-4658.2008.06279.x; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; Gonzalez A, 2010, PLANT CELL ENVIRON, V33, P1627, DOI 10.1111/j.1365-3040.2010.02169.x; Gouia H, 2000, PLANT PHYSIOL BIOCH, V38, P629, DOI 10.1016/S0981-9428(00)00775-0; HARRISON WG, 1977, B MAR SCI, V27, P44; Hassan HM, 1990, STRESS RESPONSES PLA, P178; Iwamoto K, 2005, MAR BIOTECHNOL, V7, P407, DOI 10.1007/s10126-005-0029-4; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Kawamitsu Y, 1999, MAR BIOL, V133, P361, DOI 10.1007/s002270050475; Kunhikrishnan A, 2013, J HAZARD MATER, V261, P784, DOI 10.1016/j.jhazmat.2012.10.015; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu XL, 2011, ECOTOXICOLOGY, V20, P1422, DOI 10.1007/s10646-011-0699-9; Liu XL, 2011, ENVIRON TOXICOL PHAR, V31, P323, DOI 10.1016/j.etap.2010.12.003; Llorens N, 2000, PLANT SCI, V160, P159, DOI 10.1016/S0168-9452(00)00379-4; Luna CM, 1997, PHYSIOL PLANTARUM, V101, P103, DOI 10.1034/j.1399-3054.1997.1010114.x; Macfarlane GR, 2001, MAR POLLUT BULL, V42, P233, DOI 10.1016/S0025-326X(00)00147-8; Mellado M, 2012, PLANT PHYSIOL BIOCH, V51, P102, DOI 10.1016/j.plaphy.2011.10.007; NAGAHISA E, 1994, FISHERIES SCI, V60, P777, DOI 10.2331/fishsci.60.777; Niu JF, 2010, CHIN J OCEANOL LIMN, V28, P26, DOI 10.1007/s00343-010-9120-4; Okamoto OK, 2001, ARCH ENVIRON CON TOX, V40, P18; OVERNELL J, 1975, MAR BIOL, V29, P99; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; Pang SJ, 2008, AQUAC RES, V39, P1408, DOI 10.1111/j.1365-2109.2008.02010.x; Pelletreau K. N., 2008, P121, DOI 10.1007/978-3-540-74181-7_6; Pinto E, 2003, J PHYCOL, V39, P1008, DOI 10.1111/j.0022-3646.2003.02-193.x; Purohit PV, 2004, OMICS, V8, P118, DOI 10.1089/1536231041388348; Ratkevicius N, 2003, PLANT CELL ENVIRON, V26, P1599, DOI 10.1046/j.1365-3040.2003.01073.x; REED RH, 1985, PHYCOLOGIA, V24, P35, DOI 10.2216/i0031-8884-24-1-35.1; Ritter A, 2010, PROTEOMICS, V10, P2074, DOI 10.1002/pmic.200900004; Romanowska E, 2002, PHYSIOLOGY AND BIOCHEMISTRY OF METAL TOXICITY AND TOLERANCE IN PLANTS, P257; Shen B, 1997, PLANT PHYSIOL, V113, P1177, DOI 10.1104/pp.113.4.1177; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; SMITH TA, 1971, BIOL REV, V46, P201, DOI 10.1111/j.1469-185X.1971.tb01182.x; SUNDA WG, 1983, LIMNOL OCEANOGR, V28, P924, DOI 10.4319/lo.1983.28.5.0924; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; van Lipzig MMH, 2005, CHEM RES TOXICOL, V18, P1691, DOI 10.1021/tx0501233; Wickens G, 2001, ECON BOT, P127; Wu HF, 2005, J INORG BIOCHEM, V99, P644, DOI 10.1016/j.jinorgbio.2004.11.021; Wu HF, 2013, J PLANT GROWTH REGUL, V32, P353, DOI 10.1007/s00344-012-9305-5; Wu HF, 2013, ECOTOX ENVIRON SAFE, V90, P1, DOI 10.1016/j.ecoenv.2012.02.022; Wu HF, 2012, ECOTOXICOLOGY, V21, P2363, DOI 10.1007/s10646-012-0992-2; Wu HF, 2012, ECOTOX ENVIRON SAFE, V85, P64, DOI 10.1016/j.ecoenv.2012.03.016; Wu HF, 2011, MAR DRUGS, V9, P1566, DOI 10.3390/md9091566; Wu HF, 2011, ENVIRON TOXICOL CHEM, V30, P806, DOI 10.1002/etc.446; Wu TM, 2009, AQUAT TOXICOL, V94, P275, DOI 10.1016/j.aquatox.2009.07.010; Wu TM, 2008, PHYCOLOGIA, V47, P346, DOI 10.2216/PH07-77.1; Xie XJ, 2014, PHYCOLOGIA, V53, P10, DOI 10.2216/13-161.1; Xu JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037438; Yokoyama T, 2011, BIOSCI BIOTECH BIOCH, V75, P1481, DOI 10.1271/bbb.110184; Zeier J, 2013, PLANT CELL ENVIRON, V36, P2085, DOI 10.1111/pce.12122; Zhang L, 2011, ENVIRON TOXICOL PHAR, V32, P218, DOI 10.1016/j.etap.2011.05.006; Zhang LB, 2011, MAR ENVIRON RES, V72, P33, DOI 10.1016/j.marenvres.2011.04.002; Zhu XF, 2011, BOT MAR, V54, P431, DOI 10.1515/BOT.2011.054	77	13	13	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101960	10.1371/journal.pone.0101960	http://dx.doi.org/10.1371/journal.pone.0101960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025229	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400029
J	Cunnick, JM; Kim, S; Hadsell, J; Collins, S; Cerra, C; Reiser, P; Flynn, DC; Cho, Y				Cunnick, J. M.; Kim, S.; Hadsell, J.; Collins, S.; Cerra, C.; Reiser, P.; Flynn, D. C.; Cho, Y.			Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland	ONCOGENE			English	Article							SRC FAMILY KINASES; C-SRC; PROLACTIN RECEPTOR; AFAP-110; CANCER; PHOSPHORYLATION; EXPRESSION; INTEGRITY; ABILITY; IDENTIFICATION	Actin filament-associated protein 1 (AFAP1) is an adaptor protein of cSrc that binds to filamentous actin and regulates the activity of this tyrosine kinase to affect changes to the organization of the actin cytoskeleton. In breast and prostate cancer cells, AFAP1 has been shown to regulate cellular responses requiring actin cytoskeletal changes such as adhesion, invadopodia formation and invasion. However, a normal physiologic role for AFAP1 has remained elusive. In this study, we generated an AFAP1 knockout mouse model that establishes a novel physiologic role for AFAP1 in lactation. Specifically, these animals displayed a defect in lactation that resulted in an inability to nurse efficiently. Histologically, the mammary glands of the lactating knockout mice were distinguished by the accumulation of large cytoplasmic lipid droplets in the alveolar epithelial cells. There was a reduction in lipid synthesis and the expression of lipogenic genes without a corresponding reduction in the production of beta-casein, a milk protein. Furthermore, these defects were associated with histologic and biochemical signs of precocious involution. This study also demonstrated that AFAP1 responds to prolactin, a lactogenic hormone, by forming a complex with cSrc and becoming tyrosine phosphorylated. Taken together, these observations pointed to a defect in secretory activation. Certain characteristics of this phenotype mirrored the defect in secretory activation in the cSrc knockout mouse, but most importantly, the activity of cSrc in the mammary gland was reduced during early lactation in the AFAP1-null mouse and the localization of active cSrc at the apical surface of luminal epithelial cells during lactation was selectively lost in the absence of AFAP1. These data define, for the first time, the requirement of AFAP1 for the spatial and temporal regulation of cSrc activity in the normal breast, specifically for milk production.	[Cunnick, J. M.; Cho, Y.] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA 18509 USA; [Kim, S.] Commonwealth Med Coll, Grad Sch Med, Scranton, PA 18509 USA; [Hadsell, J.] Fortis Inst Scranton, Scranton, PA USA; [Cerra, C.; Reiser, P.] Pocono Hlth Syst, Dept Pathol, East Stroudsburg, PA USA; [Flynn, D. C.] Univ Delaware, Coll Hlth Sci, Newark, DE USA	Geisinger Commonwealth School of Medicine; Geisinger Commonwealth School of Medicine; University of Delaware	Cho, Y (corresponding author), Commonwealth Med Coll, Dept Basic Sci, 525 Pine St, Scranton, PA 18509 USA.	ycho@tcmedc.org	Cunnick, Jess/F-1715-2018	Collins, Stephen/0000-0003-4515-5412	NIH [R01CA060731-15A1]; NATIONAL CANCER INSTITUTE [R01CA060731] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by NIH Grant R01CA060731-15A1. We thank Victor Malloy for his care of the mice and Wafa Atamna for cell sorting. We also thank Raj Kumar and John Arnott for the careful reading of our manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Acosta JJ, 2003, MOL ENDOCRINOL, V17, P2268, DOI 10.1210/me.2002-0422; Aksamitiene E, 2011, CELL SIGNAL, V23, P1794, DOI 10.1016/j.cellsig.2011.06.014; AMATO PA, 1981, CELL MOTIL CYTOSKEL, V1, P329, DOI 10.1002/cm.970010305; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Baisden JM, 2001, ONCOGENE, V20, P6607, DOI 10.1038/sj.onc.1204802; Baisden JM, 2001, ONCOGENE, V20, P6435, DOI 10.1038/sj.onc.1204784; BERLANGA JJ, 1995, MOL ENDOCRINOL, V9, P1461, DOI 10.1210/me.9.11.1461; Bourguignon LYW, 2011, CYTOSKELETON, V68, P671, DOI 10.1002/cm.20544; Clump DA, 2010, TRANSL ONCOL, V3, P276, DOI 10.1593/tlo.10106; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Dorfleutner A, 2008, J CELL SCI, V121, P2394, DOI 10.1242/jcs.026187; Dorfleutner A, 2007, J CELL PHYSIOL, V213, P740, DOI 10.1002/jcp.21143; FLYNN DC, 1993, MOL CELL BIOL, V13, P7892, DOI 10.1128/MCB.13.12.7892; FRANKE WW, 1981, J CELL BIOL, V89, P485, DOI 10.1083/jcb.89.3.485; Gatesman A, 2004, MOL CELL BIOL, V24, P7578, DOI 10.1128/MCB.24.17.7578-7597.2004; Guappone AC, 1998, MOL CARCINOGEN, V22, P110, DOI 10.1002/(SICI)1098-2744(199806)22:2<110::AID-MC6>3.0.CO;2-Q; Guappone AC, 1997, MOL CELL BIOCHEM, V175, P243, DOI 10.1023/A:1006840104666; Hughes K, 2012, J PATHOL, V227, P106, DOI 10.1002/path.3961; Kabotyanski EB, 2003, J BIOL CHEM, V278, P17218, DOI 10.1074/jbc.M301578200; Kim H, 2005, ONCOGENE, V24, P5629, DOI 10.1038/sj.onc.1208718; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Liu Y, 2002, ARTERIOSCL THROM VAS, V22, P76, DOI 10.1161/hq0102.101822; Garcia-Martinez JM, 2010, CELL SIGNAL, V22, P415, DOI 10.1016/j.cellsig.2009.10.013; Marcotte R, 2012, P NATL ACAD SCI USA, V109, P2808, DOI 10.1073/pnas.1018861108; McManaman JL, 2004, ADV EXP MED BIOL, V554, P263; Mirmohammadsadegh A, 2006, J INVEST DERMATOL, V126, P2272, DOI 10.1038/sj.jid.5700385; Naylor MJ, 2005, MOL ENDOCRINOL, V19, P1868, DOI 10.1210/me.2004-0254; Naylor MJ, 2005, J CELL BIOL, V171, P717, DOI 10.1083/jcb.200503144; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Palmer CA, 2006, J MAMMARY GLAND BIOL, V11, P269, DOI 10.1007/s10911-006-9023-3; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Piazza TM, 2009, MOL ENDOCRINOL, V23, P202, DOI 10.1210/me.2008-0341; Qian Y, 1998, ONCOGENE, V16, P2185, DOI 10.1038/sj.onc.1201753; Qian Y, 2000, EXP CELL RES, V255, P102, DOI 10.1006/excr.1999.4795; Qian Y, 2002, MOL BIOL CELL, V13, P2311, DOI 10.1091/mbc.E01-12-0148; Reynolds AB, 2014, ONCOGENE, V33, P4537, DOI 10.1038/onc.2013.416; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; Scott KEN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029761; Shackleford TJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2902; Shimizu A, 2005, BIOL REPROD, V73, P1219, DOI 10.1095/biolreprod.105.041616; Snyder BN, 2011, EUR J CELL BIOL, V90, P376, DOI 10.1016/j.ejcb.2010.11.016; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Vara JAF, 2000, BIOCHEM J, V345, P17, DOI 10.1042/0264-6021:3450017; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; Watkin H, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-6; Watson CJ, 2011, INT J DEV BIOL, V55, P757, DOI 10.1387/ijdb.113414cw; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang J, 2007, J CLIN INVEST, V117, P2962, DOI 10.1172/JCI30710	53	8	8	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2015	34	20					2640	2649		10.1038/onc.2014.205	http://dx.doi.org/10.1038/onc.2014.205			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI1YN	25043309	Green Accepted			2022-12-25	WOS:000354541300010
J	Dash, B; Li, MD; Lukas, RJ				Dash, Bhagirathi; Li, Ming D.; Lukas, Ronald J.			Roles for N-terminal Extracellular Domains of Nicotinic Acetylcholine Receptor (nAChR) beta 3 Subunits in Enhanced Functional Expression of Mouse alpha 6 beta 2 beta 3-and alpha 6 beta 4 beta 3-nAChRs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTRAL TEGMENTAL AREA; MODULATE DOPAMINE RELEASE; IN-VIVO; REPORTER MUTATION; ALPHA-6 SUBUNITS; BINDING-SITE; PHARMACOLOGY; RECOMBINANT; LOCOMOTION; SUBTYPES	Functional heterologous expression of naturally expressed mouse alpha 6*-nicotinic acetylcholine receptors (m alpha 6*-nAChRs; where "*" indicates the presence of additional subunits) has been difficult. Here we expressed and characterized wild-type (WT), gain-of-function, chimeric, or gain-of-function chimeric nAChR subunits, sometimes as hybrid nAChRs containing both human (h) and mouse (m) subunits, in Xenopus oocytes. Hybrid m alpha 6m beta 4h beta 3- (similar to 5-8-fold) or WT m alpha 6m beta 4m beta 3-nAChRs (similar to 2-fold) yielded higher function than m alpha 6m beta 4-nAChRs. Function was not detected when m alpha 6 and m beta 2 subunits were expressed together or in the additional presence of h beta 3 or m beta 3 subunits. However, function emerged upon expression of m alpha 6m beta 2m beta 3(V9'S)-nAChRs containing beta 3 subunits having gain-of- function V9'S (valine to serine at the 9'-position) mutations in transmembrane domain II and was further elevated 9-fold when h beta 3(V9'S) subunits were substituted for m beta 3(V9'S) subunits. Studies involving WT or gain-of-function chimeric mouse/human beta 3 subunits narrowed the search for domains that influence functional expression of m alpha 6*-nAChRs. Using h beta 3 subunits as templates for site-directed mutagenesis studies, substitution with m beta 3 subunit residues in extracellular N-terminal domain loops "C" (Glu(221) and Phe(223)), "E" (Ser(144) and Ser(148)), and "beta 2-beta 3" (Gln(94) and Glu(101)) increased function of m alpha 6m beta 2*-(similar to 2-3-fold) or m alpha 6m beta 4* (similar to 2-4-fold)-nAChRs. EC50 values for nicotine acting at m alpha 6m beta 4*-nAChR were unaffected by beta 3 subunit residue substitutions in loop C or E. Thus, amino acid residues located in primary (loop C) or complementary (loops beta 2-beta 3 and E) interfaces of beta 3 subunits are some of the molecular impediments for functional expression of m alpha 6m beta 2 beta 3- or m alpha 6m beta 4 beta 3-nAChRs.	[Dash, Bhagirathi; Li, Ming D.] Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22911 USA; [Lukas, Ronald J.] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA	University of Virginia; Barrow Neurological Institute	Lukas, RJ (corresponding author), Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	Ronald.Lukas@DignityHealth.org		Dash, Bhagirathi/0000-0002-5314-5372	National Institutes of Health [R01 DA012844, DA026356, DA015389]; Barrow Neurological Foundation; External Research Program of Philip Morris USA Inc.; Philip Morris International; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015389, R01DA026356, R01DA012844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barrow Neurological Foundation; External Research Program of Philip Morris USA Inc.; Philip Morris International; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA012844 and DA026356 (to M. D. L.) and DA015389 (to R. J. L.). This work was also supported by endowment and capitalization funds from the Barrow Neurological Foundation (to R. J. L.) and the External Research Program of Philip Morris USA Inc. and Philip Morris International (to R. J. L.). Portions of this work have been presented in abstract form: Dash, B., Bhakta, M., Whiteaker, P., Stitzel, J. A., Chang, Y., and Lukas, R. J. (2009) Gain-of-function mutants in human or mouse nAChR beta 3 subunits interchangeably activate either human or mouse alpha 6 beta 4*-nAChR but not human or mouse alpha 6 beta 2*-nAChR. Soc. Neurosci. Abstr. 35, 34.7.	Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Brown RWB, 2007, J NEUROCHEM, V103, P204, DOI 10.1111/j.1471-4159.2007.04700.x; Capelli AM, 2011, BRIT J PHARMACOL, V163, P313, DOI 10.1111/j.1476-5381.2011.01213.x; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Cox BC, 2008, J NEUROCHEM, V105, P1924, DOI 10.1111/j.1471-4159.2008.05282.x; Cui CH, 2003, J NEUROSCI, V23, P11045; Dash B, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-35; Dash B, 2012, J BIOL CHEM, V287, P14259, DOI 10.1074/jbc.M111.322610; Dash B, 2012, J NEUROCHEM, V121, P349, DOI 10.1111/j.1471-4159.2012.07685.x; Dash B, 2011, J BIOL CHEM, V286, P37976, DOI 10.1074/jbc.M111.263673; Dash B, 2011, J BIOL CHEM, V286, P37905, DOI 10.1074/jbc.M111.264044; Dederer H, 2013, INSECT MOL BIOL, V22, P183, DOI 10.1111/imb.12014; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Drenan RM, 2010, J NEUROSCI, V30, P9877, DOI 10.1523/JNEUROSCI.2056-10.2010; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; Evans NM, 2003, EUR J PHARMACOL, V466, P31, DOI 10.1016/S0014-2999(03)01540-1; Exley R, 2008, NEUROPSYCHOPHARMACOL, V33, P2158, DOI 10.1038/sj.npp.1301617; Exley R, 2011, P NATL ACAD SCI USA, V108, P7577, DOI 10.1073/pnas.1103000108; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Grinevich VP, 2005, J PHARMACOL EXP THER, V312, P619, DOI 10.1124/jpet.104.075069; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hone AJ, 2012, FASEB J, V26, P917, DOI 10.1096/fj.11-195883; Jackson KJ, 2010, J PHARMACOL EXP THER, V334, P137, DOI 10.1124/jpet.110.165738; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le Novere N, 1999, NEUROREPORT, V10, P2497, DOI 10.1097/00001756-199908200-00012; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Meyer EL, 2008, J NEUROCHEM, V105, P1761, DOI 10.1111/j.1471-4159.2008.05266.x; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Parker JC, 2003, BRIT J PHARMACOL, V138, P801, DOI 10.1038/sj.bjp.0705124; Perez-Alvarez A, 2012, FASEB J, V26, P346, DOI 10.1096/fj.11-190223; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Quik M, 2006, J PHARMACOL EXP THER, V316, P481, DOI 10.1124/jpet.105.094375; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Steinbach JH, 2011, MOL PHARMACOL, V79, P337, DOI 10.1124/mol.110.070102; Tomizawa M, 2005, INSECT BIOCHEM MOLEC, V35, P1347, DOI 10.1016/j.ibmb.2005.08.006; Tumkosit P, 2006, MOL PHARMACOL, V70, P1358, DOI 10.1124/mol.106.027326; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Wu J, 2011, BIOCHEM PHARMACOL, V82, P800, DOI 10.1016/j.bcp.2011.07.067; Xiao C, 2011, BIOCHEM PHARMACOL, V82, P852, DOI 10.1016/j.bcp.2011.05.005; Yang KC, 2011, J NEUROSCI, V31, P2537, DOI 10.1523/JNEUROSCI.3003-10.2011; Zwart R, 1997, MOL PHARMACOL, V52, P886, DOI 10.1124/mol.52.5.886	55	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28338	28351		10.1074/jbc.M114.566018	http://dx.doi.org/10.1074/jbc.M114.566018			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25028511	Green Published, hybrid			2022-12-25	WOS:000343765400028
J	Kock, J; Kreher, S; Lehmann, K; Riedel, R; Bardua, M; Lischke, T; Jargosch, M; Haftmann, C; Bendfeldt, H; Hatam, F; Mashreghi, MF; Baumgrass, R; Radbruch, A; Chang, HD				Koeck, Juliana; Kreher, Stephan; Lehmann, Katrin; Riedel, Rene; Bardua, Markus; Lischke, Timo; Jargosch, Manja; Haftmann, Claudia; Bendfeldt, Hanna; Hatam, Farahnaz; Mashreghi, Mir-Farzin; Baumgrass, Ria; Radbruch, Andreas; Chang, Hyun-Dong			Nuclear Factor of Activated T Cells Regulates the Expression of Interleukin-4 in Th2 Cells in an All-or-none Fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NFAT1; LOCUS-CONTROL REGION; GENE-EXPRESSION; PROBABILISTIC REGULATION; IL-4 EXPRESSION; HELPER-CELLS; GATA-3; LYMPHOCYTES; MEMORY; DEPHOSPHORYLATION	Th2 memory lymphocytes have imprinted their Il4 genes epigenetically for expression in dependence of T cell receptor restimulation. However, in a given restimulation, not all Th cells with a memory for IL-4 expression express IL-4. Here, we show that in reactivated Th2 cells, the transcription factors NFATc2, NF-kB p65, c-Maf, p300, Brg1, STAT6, andGATA-3assemble at the Il4 promoter in Th2 cells expressing IL-4 but not in Th2 cells not expressing it. NFATc2 is critical for assembly of this transcription factor complex. Because NFATc2 translocation into the nucleus occurs in an all-or-none fashion, dependent on complete dephosphorylation by calcineurin, NFATc2 controls the frequencies of cells reexpressing Il4, translates analog differences in T cell receptor stimulation into a digital decision for Il4 reexpression, and instructs all reexpressing cells to express the same amount of IL-4. This analog-to-digital conversion may be critical for the immune system to respond to low concentrations of antigens.	[Koeck, Juliana; Kreher, Stephan; Lehmann, Katrin; Riedel, Rene; Bardua, Markus; Lischke, Timo; Jargosch, Manja; Haftmann, Claudia; Bendfeldt, Hanna; Hatam, Farahnaz; Mashreghi, Mir-Farzin; Baumgrass, Ria; Radbruch, Andreas; Chang, Hyun-Dong] German Rheumatism Res Ctr Berlin, D-10117 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ)	Chang, HD (corresponding author), German Rheumatism Res Ctr Berlin, Charitepl 1, D-10117 Berlin, Germany.	chang@drfz.de	Mashreghi, Mir-Farzin/S-2911-2019; Chang, Hyun-Dong/T-3697-2017	Mashreghi, Mir-Farzin/0000-0002-8015-6907; Chang, Hyun-Dong/0000-0002-7341-4533; Radbruch, Andreas/0000-0001-5753-0000; Lischke, Timo/0000-0003-0413-4252; Baumgrass, Ria/0000-0002-3289-1608; Riedel, Rene/0000-0003-4752-0196	German Research Council (Deutsche Forschungsgemeinschaft) [SFB618, SFB TRR52]; European Research Council Advanced Grants [ERC-2010-AdG_20100317, 268987]; German Ministry of Education and Research Grant "IMPAM" [01EC1008B]; German Ministry of Education and Research e:Bio-Innovationswettbewerb Systembiologie	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); European Research Council Advanced Grants; German Ministry of Education and Research Grant "IMPAM"; German Ministry of Education and Research e:Bio-Innovationswettbewerb Systembiologie	This work was supported by the German Research Council (Deutsche Forschungsgemeinschaft SFB618 and SFB TRR52), the European Research Council Advanced Grants ERC-2010-AdG_20100317 and 268987, and the German Ministry of Education and Research Grant "IMPAM" (01EC1008B) and e:Bio-Innovationswettbewerb Systembiologie."	Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Chang HD, 2007, EUR J IMMUNOL, V37, P807, DOI 10.1002/eji.200636385; Frischbutter S, 2012, CYTOM PART A, V81A, P1005, DOI 10.1002/cyto.a.22204; Frischbutter S, 2011, EUR J IMMUNOL, V41, P2349, DOI 10.1002/eji.201041052; Guo LY, 2005, IMMUNITY, V23, P89, DOI 10.1016/j.immuni.2005.05.008; Guo LY, 2004, IMMUNITY, V20, P193, DOI 10.1016/S1074-7613(04)00025-1; Hofer T, 2002, P NATL ACAD SCI USA, V99, P9364, DOI 10.1073/pnas.142284699; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P4691, DOI 10.1073/pnas.1220865110; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; Lee DU, 2004, P NATL ACAD SCI USA, V101, P16010, DOI 10.1073/pnas.0407031101; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lohning M, 2003, P NATL ACAD SCI USA, V100, P12307, DOI 10.1073/pnas.2035254100; Mariani L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.13; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Podtschaske M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000935; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Salazar C, 2005, FEBS LETT, V579, P621, DOI 10.1016/j.febslet.2004.12.029; Scheinman EJ, 2009, J BIOL CHEM, V284, P3037, DOI 10.1074/jbc.M807302200; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Trevillyan JM, 2001, J BIOL CHEM, V276, P48118, DOI 10.1074/jbc.M107919200; Tykocinski LO, 2005, J BIOL CHEM, V280, P28177, DOI 10.1074/jbc.M502038200; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wurster AL, 2008, MOL CELL BIOL, V28, P7274, DOI 10.1128/MCB.00835-08; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	35	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26752	26761		10.1074/jbc.M114.587865	http://dx.doi.org/10.1074/jbc.M114.587865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25037220	Green Published, hybrid			2022-12-25	WOS:000342853900008
J	Backus, KM; Dolan, MA; Barry, CS; Joe, M; McPhie, P; Boshoff, HIM; Lowary, TL; Davis, BG; Barry, CE				Backus, Keriann M.; Dolan, Michael A.; Barry, Conor S.; Joe, Maju; McPhie, Peter; Boshoff, Helena I. M.; Lowary, Todd L.; Davis, Benjamin G.; Barry, Clifton E., III			The Three Mycobacterium tuberculosis Antigen 85 Isoforms Have Unique Substrates and Activities Determined by Non-active Site Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; CORYNEBACTERIUM-GLUTAMICUM; MYCOLYL TRANSFERASE; MOLECULAR-DYNAMICS; SMEGMATIS; COMPLEX; ARABINOGALACTAN; FIBRONECTIN; COMPONENTS; INHIBITION	The three isoforms of antigen 85 (A, B, and C) are the most abundant secreted mycobacterial proteins and catalyze transesterification reactions that synthesize mycolated arabinogalactan, trehalose monomycolate (TMM), and trehalose dimycolate (TDM), important constituents of the outermost layer of the cellular envelope of Mycobacterium tuberculosis. These three enzymes are nearly identical at the active site and have therefore been postulated to exist to evade host immunity. Distal to the active site is a second putative carbohydrate-binding site of lower homology. Mutagenesis of the three isoforms at this second site affected both substrate selectivity and overall catalytic activity in vitro. Using synthetic and natural substrates, we show that these three enzymes exhibit unique selectivity; antigen 85A more efficiently mycolates TMM to form TDM, whereas C (and to a lesser extent B) has a higher rate of activity using free trehalose to form TMM. This difference in substrate selectivity extends to the hexasaccharide fragment of cell wall arabinan. Mutation of secondary site residues from the most active isoform (C) into those present in A or B partially interconverts this substrate selectivity. These experiments in combination with molecular dynamics simulations reveal that differences in the N-terminal helix alpha 9, the adjacent Pro(216)-Phe(228) loop, and helix alpha 5 are the likely cause of changes in activity and substrate selectivity. These differences explain the existence of three isoforms and will allow for future work in developing inhibitors.	[Backus, Keriann M.; Boshoff, Helena I. M.; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Dolan, Michael A.] NIAID, Bioinformat & Computat Biosci Branch, NIH, Bethesda, MD 20892 USA; [Backus, Keriann M.; Barry, Conor S.; Davis, Benjamin G.] Univ Oxford, Chem Res Lab, Dept Chem, Oxford OX1 3TA, England; [Joe, Maju; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Joe, Maju; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [McPhie, Peter] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford; University of Alberta; University of Alberta; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Davis, BG (corresponding author), Univ Oxford, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England.	Ben.Davis@chem.ox.ac.uk; cbarry@niaid.nih.gov	JOE, MAJU/W-4332-2019; Barry, III, Clifton/H-3839-2012; Davis, Benjamin G/C-5281-2011; Lowary, Todd L/F-9608-2019; Barry, Clifton E/ABE-7992-2020	JOE, MAJU/0000-0003-0664-5275; Barry, III, Clifton/0000-0002-2927-270X; Davis, Benjamin G/0000-0002-5056-407X; Lowary, Todd L/0000-0002-8331-8211; Barry, Clifton E/0000-0002-2927-270X	Colorado State University [HHSN266200400091c]; National Institutes of Health, NIGMS [9P41GM103311]; Biotechnology and Biological Sciences Research Council [BB/E004350/1, BB/J009725/1, BB/C510824/1, EGA17763] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/T26542/01, EP/I500200/1, EP/G026688/1, EP/D023343/1, EP/D023335/1, EP/E000614/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER; BBSRC [BB/E004350/1, BB/J009725/1] Funding Source: UKRI; EPSRC [EP/G026688/1, EP/E000614/1, EP/I500200/1] Funding Source: UKRI	Colorado State University; National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Plasmids were obtained from Colorado State University tuberculosis research contract HHSN266200400091c. Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health, NIGMS, Grant 9P41GM103311). Protein structures were analyzed in PyMOL (38).	Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Backus KM, 2011, NAT CHEM BIOL, V7, P228, DOI 10.1038/NCHEMBIO.539; Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Barry CS, 2011, J AM CHEM SOC, V133, P13232, DOI 10.1021/ja204249p; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Bentley-Hibbert SI, 1999, INFECT IMMUN, V67, P581, DOI 10.1128/IAI.67.2.581-588.1999; BESRA GS, 1994, P NATL ACAD SCI USA, V91, P12735, DOI 10.1073/pnas.91.26.12735; Brand S, 2003, ARCH MICROBIOL, V180, P33, DOI 10.1007/s00203-003-0556-1; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; D'Souza FW, 2000, J AM CHEM SOC, V122, P1251, DOI 10.1021/ja993543l; Daffe M, 2000, TRENDS MICROBIOL, V8, P438, DOI 10.1016/S0966-842X(00)01844-8; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DENG LY, 1995, ANTIMICROB AGENTS CH, V39, P694, DOI 10.1128/AAC.39.3.694; Favrot L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3748; FUKUI Y, 1965, BIKEN J, V8, P189; Harth G, 2002, P NATL ACAD SCI USA, V99, P15614, DOI 10.1073/pnas.242612299; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Joe M, 2007, J AM CHEM SOC, V129, P9885, DOI 10.1021/ja072892+; Kacem R, 2004, MICROBIOL-SGM, V150, P73, DOI 10.1099/mic.0.26583-0; Kuo CJ, 2012, J BIOL CHEM, V287, P1892, DOI 10.1074/jbc.M111.298687; Lim JH, 1999, INFECT IMMUN, V67, P6187, DOI 10.1128/IAI.67.11.6187-6190.1999; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; MCNEIL M, 1991, J BIOL CHEM, V266, P13217; McPhie P, 2008, ANAL BIOCHEM, V375, P379, DOI 10.1016/j.ab.2008.01.024; Nguyen L, 2005, J BACTERIOL, V187, P6603, DOI 10.1128/JB.187.19.6603-6611.2005; Pathan AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001052; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Puech V, 2000, MOL MICROBIOL, V35, P1026, DOI 10.1046/j.1365-2958.2000.01738.x; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Sanki AK, 2009, MOL BIOSYST, V5, P945, DOI 10.1039/b902284h; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SATHYAMOORTHY N, 1987, J BIOL CHEM, V262, P13417; Slayden RA, 2000, MICROBES INFECT, V2, P659, DOI 10.1016/S1286-4579(00)00359-2; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; TAKAYAMA K, 1979, ANTIMICROB AGENTS CH, V16, P240, DOI 10.1128/AAC.16.2.240; TAKAYAMA K, 1989, ANTIMICROB AGENTS CH, V33, P1493, DOI 10.1128/AAC.33.9.1493; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; World Health Organization, 2013, GLOB TUB CONTR REP 2; Xin Y, 1999, BBA-GEN SUBJECTS, V1473, P267, DOI 10.1016/S0304-4165(99)00204-4	51	42	42	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25041	25053		10.1074/jbc.M114.581579	http://dx.doi.org/10.1074/jbc.M114.581579			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25028517	hybrid, Green Published			2022-12-25	WOS:000341985300028
J	Harrington, JM; Nishanova, T; Pena, SR; Hess, M; Scelsi, CL; Widener, J; Hajduk, SL				Harrington, John M.; Nishanova, Tuiumkan; Pena, Savannah Rose; Hess, Matthew; Scelsi, Chris L.; Widener, Justin; Hajduk, Stephen L.			A Retained Secretory Signal Peptide Mediates High Density Lipoprotein (HDL) Assembly and Function of Haptoglobin-related Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; TRYPANOSOME LYTIC FACTOR; RECEPTOR CLASS-B; HIGH-AFFINITY; HUMAN PLASMA; HUMAN SERUM; APOA-I; BINDING; PARAOXONASE-1; HEMOGLOBIN	Haptoglobin-related protein (Hpr) is a component of a minor subspecies of high density lipoproteins (HDL) that function in innate immunity. Here we show that assembly of Hpr into HDL is mediated by its retained N-terminal signal peptide, an unusual feature for a secreted protein and the major difference between Hpr and the soluble acute phase protein haptoglobin (Hp). The 18-amino acid signal peptide is necessary for binding to HDL and interacts directly with the hydrocarbon region of lipids. Utilizing model liposomes, we show that the rate of assembly and steady-state distribution of Hpr in lipid particles is mediated by the physical property of lipid fluidity. Dye release assays reveal that Hpr interacts more rapidly with fluid liposomes. Conversely, steady-state binding assays indicate that more rigid lipid compositions stabilize Hpr association. Lipid association also plays a role in facilitating hemoglobin binding by Hpr. Our data may offer an explanation for the distinct distribution of Hpr among HDL subspecies. Rather than protein-protein interactions mediating localization, direct interaction with phospholipids and sensitivity to lipid fluidity may be sufficient for localization of Hpr and may represent a mechanism of HDL subspeciation.	[Harrington, John M.; Nishanova, Tuiumkan; Pena, Savannah Rose; Hess, Matthew; Scelsi, Chris L.; Widener, Justin; Hajduk, Stephen L.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Hajduk, SL (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, 120 Green St, Athens, GA 30602 USA.	shajduk@bmb.uga.edu			National Institutes of Health [AI039033]; National Institutes of Health National Research Service Award (NRSA); T32 training grant through the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039033, R01AI039033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 training grant through the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI039033 (to S. L. H.).; Supported by a National Institutes of Health National Research Service Award (NRSA) and a T32 training grant through the NIAID.	Ahnstrom J, 2010, PROTEIN PEPTIDE LETT, V17, P1285, DOI 10.2174/092986610792231410; Axler O, 2008, FEBS LETT, V582, P826, DOI 10.1016/j.febslet.2008.02.007; Bishop JR, 2001, MOL BIOCHEM PARASIT, V118, P33, DOI 10.1016/S0166-6851(01)00361-9; DAVIDSON WS, 1995, J BIOL CHEM, V270, P5882, DOI 10.1074/jbc.270.11.5882; Deakin S, 2002, J BIOL CHEM, V277, P4301, DOI 10.1074/jbc.M107440200; Deakin SP, 2011, FREE RADICAL BIO MED, V50, P102, DOI 10.1016/j.freeradbiomed.2010.09.002; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Gordon SM, 2010, J PROTEOME RES, V9, P5239, DOI 10.1021/pr100520x; Guha M, 2008, BIOCHEMISTRY-US, V47, P11393, DOI 10.1021/bi8014746; Gursky O, 2005, CURR OPIN LIPIDOL, V16, P287, DOI 10.1097/01.mol.0000169348.61191.ac; HAJDUK SL, 1989, J BIOL CHEM, V264, P5210; Harrington JM, 2008, BIOCHEM J, V413, P305, DOI 10.1042/BJ20071357; Harrington JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044384; Harrington JM, 2010, J BIOL CHEM, V285, P28659, DOI 10.1074/jbc.M110.151886; Harrington JM, 2009, J BIOL CHEM, V284, P13505, DOI 10.1074/jbc.M900151200; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; HWANG PK, 1979, J BIOL CHEM, V254, P2265; IBDAH JA, 1989, BIOCHEMISTRY-US, V28, P1126, DOI 10.1021/bi00429a029; James RW, 2010, ARTERIOSCL THROM VAS, V30, P2121, DOI 10.1161/ATVBAHA.110.209122; Jiang ZHG, 2006, BIOCHEMISTRY-US, V45, P11799, DOI 10.1021/bi060600w; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; MCEVOY SM, 1988, J BIOL CHEM, V263, P15740; NAGEL RL, 1967, J BIOL CHEM, V242, P3428; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; POWNALL HJ, 1974, BIOCHEM BIOPH RES CO, V60, P779, DOI 10.1016/0006-291X(74)90308-8; Raper J, 1999, INFECT IMMUN, V67, P1910; Rosenblat M, 2006, ATHEROSCLEROSIS, V187, P74, DOI 10.1016/j.athersclerosis.2005.08.026; Shanthalingam S, 2009, P NATL ACAD SCI USA, V106, P15448, DOI 10.1073/pnas.0906775106; Shiflett AM, 2005, J BIOL CHEM, V280, P32578, DOI 10.1074/jbc.M503510200; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Sorenson RC, 1999, ARTERIOSCL THROM VAS, V19, P2214, DOI 10.1161/01.ATV.19.9.2214; Svetlovics JA, 2012, BIOPHYS J, V102, P2526, DOI 10.1016/j.bpj.2012.04.017; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; Wang LB, 2014, J LIPID RES, V55, P478, DOI 10.1194/jlr.M044743; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4	39	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24811	24820		10.1074/jbc.M114.567578	http://dx.doi.org/10.1074/jbc.M114.567578			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25037218	hybrid, Green Published			2022-12-25	WOS:000341985300008
J	Mao, HZ; Ehrhardt, N; Bedoya, C; Gomez, JA; DeZwaan-McCabe, D; Mungrue, IN; Kaufman, RJ; Rutkowski, DT; Peterfy, M				Mao, Hui Z.; Ehrhardt, Nicole; Bedoya, Candy; Gomez, Javier A.; DeZwaan-McCabe, Diane; Mungrue, Imran N.; Kaufman, Randal J.; Rutkowski, D. Thomas; Peterfy, Miklos			Lipase Maturation Factor 1 (Lmf1) Is Induced by Endoplasmic Reticulum Stress Through Activating Transcription Factor 6 alpha (Atf6 alpha) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chaperone; Endoplasmic Reticulum (ER); Endoplasmic Reticulum Stress (ER Stress); Lipase; Unfolded Protein Response (UPR); Activating Transcription Factor 6; Lipase Maturation Factor 1	UNFOLDED PROTEIN RESPONSE; LIPOPROTEIN-LIPASE; LIPID-METABOLISM; HEPATIC LIPOGENESIS; CELL-DEATH; EXPRESSION; DEFICIENCY; INDUCTION; SECRETION; GENES	Background: Lipase maturation factor 1 (Lmf1) plays an important role in plasma lipid metabolism, but its regulation remains uncharacterized. Results: Endoplasmic reticulum (ER) stress induces Lmf1 expression in cell lines and mouse liver. Atf6 deficiency abolishes, whereas active Atf6 stimulates this response. Conclusion: Lmf1 is an unfolded protein response (UPR) target through Atf6 signaling. Significance: Lmf1 regulation by the UPR suggests a possible role in ER homeostasis. Lipase maturation factor 1 (Lmf1) is a critical determinant of plasma lipid metabolism, as demonstrated by severe hypertriglyceridemia associated with its mutations in mice and human subjects. Lmf1 is a chaperone localized to the endoplasmic reticulum (ER) and required for the post-translational maturation and activation of several vascular lipases. Despite its importance in plasma lipid homeostasis, the regulation of Lmf1 remains unexplored. We report here that Lmf1 expression is induced by ER stress in various cell lines and in tunicamycin (TM)-injected mice. Using genetic deficiencies in mouse embryonic fibroblasts and mouse liver, we identified the Atf6 arm of the unfolded protein response as being responsible for the up-regulation of Lmf1 in ER stress. Experiments with luciferase reporter constructs indicated that ER stress activates the Lmf1 promoter through a GC-rich DNA sequence 264 bp upstream of the transcriptional start site. We demonstrated that Atf6 is sufficient to induce the Lmf1 promoter in the absence of ER stress, and this effect is mediated by the TM-responsive cis-regulatory element. Conversely, Atf6 deficiency induced by genetic ablation or a dominant-negative form of Atf6 abolished TM stimulation of the Lmf1 promoter. In conclusion, our results indicate that Lmf1 is an unfolded protein response target gene, and Atf6 signaling is sufficient and necessary for activation of the Lmf1 promoter. Importantly, the induction of Lmf1 by ER stress appears to be a general phenomenon not restricted to lipase-expressing cells, which suggests a lipase-independent cellular role for this protein in ER homeostasis.	[Mao, Hui Z.; Ehrhardt, Nicole; Peterfy, Miklos] Cedars Sinai Med Ctr, Med Genet Res Inst, Los Angeles, CA 90048 USA; [Bedoya, Candy; Peterfy, Miklos] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Gomez, Javier A.; DeZwaan-McCabe, Diane; Rutkowski, D. Thomas] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Gomez, Javier A.; DeZwaan-McCabe, Diane; Rutkowski, D. Thomas] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Mungrue, Imran N.] Louisiana State Univ, Sch Med, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Kaufman, Randal J.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Peterfy, Miklos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Iowa; University of Iowa; Louisiana State University System; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Peterfy, M (corresponding author), Cedars Sinai Med Ctr, 8700 Beverly Blvd,D-2067, Los Angeles, CA 90048 USA.	mpeterfy@ucla.edu		Mungrue, Imran/0000-0002-0870-7161; Rutkowski, Thomas/0000-0001-6586-4449	National Institutes of Health [HL094709, DK084058, DK088227, DK042394, HL052173, HL28481]; University of Iowa Cardiovascular Center Institutional Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, R01HL052173, K99HL094709, R00HL094709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042394, R01DK088227, R01DK084058, R37DK042394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa Cardiovascular Center Institutional Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants HL094709 (to I. N. M.), DK084058 (to D. T. R.), DK088227, DK042394, HL052173 (to R. J. K.), and HL28481 (to M. P.) and a University of Iowa Cardiovascular Center Institutional Training Grant (to D. D.-M.)	Abdelrahim M, 2005, J BIOL CHEM, V280, P16508, DOI 10.1074/jbc.C500030200; Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Arensdorf Angela M., 2013, Frontiers in Genetics, V4, P256, DOI 10.3389/fgene.2013.00256; Arensdorf Angela M., 2013, Frontiers in Genetics, V4, P188, DOI 10.3389/fgene.2013.00188; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Ben-Zeev O, 2004, J BIOL CHEM, V279, P6171, DOI 10.1074/jbc.M310051200; Ben-Zeev O, 2002, J BIOL CHEM, V277, P10727, DOI 10.1074/jbc.M108128200; Ben-Zeev O, 2011, J LIPID RES, V52, P1162, DOI 10.1194/jlr.M011155; BENZEEV O, 1992, J BIOL CHEM, V267, P6219; Briquet-Laugier V, 1999, J LIPID RES, V40, P2044; Cefalu AB, 2009, J CLIN ENDOCR METAB, V94, P4584, DOI 10.1210/jc.2009-0594; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; DAVIS RC, 1990, J BIOL CHEM, V265, P17960; Doolittle MH, 2010, CURR OPIN LIPIDOL, V21, P198, DOI 10.1097/MOL.0b013e32833854c0; Doolittle MH, 2010, CLIN LIPIDOL, V5, P117, DOI 10.2217/CLP.09.84; Doolittle MH, 2009, J BIOL CHEM, V284, P33623, DOI 10.1074/jbc.M109.049395; Doolittle MH, 2009, J LIPID RES, V50, P1173, DOI 10.1194/jlr.M800603-JLR200; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hirata K, 1999, J BIOL CHEM, V274, P14170, DOI 10.1074/jbc.274.20.14170; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hosseini M, 2012, ARTERIOSCL THROM VAS, V32, P1204, DOI 10.1161/ATVBAHA.112.245696; Kroupa Olessia, 2012, BMC Physiology, V12, P13, DOI 10.1186/1472-6793-12-13; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; PATERNITI JR, 1983, SCIENCE, V221, P167, DOI 10.1126/science.6857276; Peterfy M, 2007, NAT GENET, V39, P1483, DOI 10.1038/ng.2007.24; Peterfy M, 2012, BBA-MOL CELL BIOL L, V1821, P790, DOI 10.1016/j.bbalip.2011.10.006; Racek T, 2008, J BIOL CHEM, V283, P34305, DOI 10.1074/jbc.M803925200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; So JS, 2012, CELL METAB, V16, P487, DOI 10.1016/j.cmet.2012.09.004; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Thuerauf DJ, 2004, J BIOL CHEM, V279, P21078, DOI 10.1074/jbc.M400713200; Wang SY, 2014, CURR OPIN LIPIDOL, V25, P125, DOI 10.1097/MOL.0000000000000056; Wang SY, 2012, CELL METAB, V16, P473, DOI 10.1016/j.cmet.2012.09.003; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	49	10	10	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24417	24427		10.1074/jbc.M114.588764	http://dx.doi.org/10.1074/jbc.M114.588764			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25035425	Green Published, hybrid			2022-12-25	WOS:000341505600035
J	Ohara, K; Unno, H; Oshima, Y; Hosoya, M; Fujino, N; Hirooka, K; Takahashi, S; Yamashita, S; Kusunoki, M; Nakayama, T				Ohara, Kazuhiro; Unno, Hideaki; Oshima, Yasuhiro; Hosoya, Miho; Fujino, Naoto; Hirooka, Kazutake; Takahashi, Seiji; Yamashita, Satoshi; Kusunoki, Masami; Nakayama, Toru			Structural Insights into the Low pH Adaptation of a Unique Carboxylesterase from Ferroplasma ALTERING THE pH OPTIMA OF TWO CARBOXYLESTERASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Carboxylesterase; Enzyme Mechanism; Enzyme Structure; Hydrolase; Ferroplasma acidiphilum; pH Adaptation; Serine Hydrolase	HORMONE-SENSITIVE LIPASE; CRYSTAL-STRUCTURE; ENZYMES; ACIDIPHILUM; ESTERASE; ARCHAEON; TOOLS	Background: Carboxylesterases typically have an alkaline pH optima, which limits their industrial application. Results: An acidophilic carboxylesterase was crystallized and changed into an alkaliphilic enzyme via quadruple mutations. Conclusion: The extended hydrogen bonds in the active site were important for adaptation to a low pH. Significance: The first structure of an acidophilic carboxylesterase revealed a novel strategy for the low pH adaptation of carboxylesterase. To investigate the mechanism for low pH adaptation by a carboxylesterase, structural and biochemical analyses of EstFa_R (a recombinant, slightly acidophilic carboxylesterase from Ferroplasma acidiphilum) and SshEstI (an alkaliphilic carboxylesterase from Sulfolobus shibatae DSM5389) were performed. Although a previous proteomics study by another group showed that the enzyme purified from F. acidiphilum contained an iron atom, EstFa_R did not bind to iron as analyzed by inductively coupled plasma MS and isothermal titration calorimetry. The crystal structures of EstFa_R and SshEstI were determined at 1.6- and 1.5- resolutions, respectively. EstFa_R had a catalytic triad with an extended hydrogen bond network that was not observed in SshEstI. Quadruple mutants of both proteins were created to remove or introduce the extended hydrogen bond network. The mutation on EstFa_R enhanced its catalytic efficiency and gave it an alkaline pH optimum, whereas the mutation on SshEstI resulted in opposite effects (i.e. a decrease in the catalytic efficiency and a downward shift in the optimum pH). Our experimental results suggest that the low pH optimum of EstFa_R activity was a result of the unique extended hydrogen bond network in the catalytic triad and the highly negatively charged surface around the active site. The change in the pH optimum of EstFa_R happened simultaneously with a change in the catalytic efficiency, suggesting that the local flexibility of the active site in EstFa_R could be modified by quadruple mutation. These observations may provide a novel strategy to elucidate the low pH adaptation of serine hydrolases.	[Takahashi, Seiji; Yamashita, Satoshi; Nakayama, Toru] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Unno, Hideaki] Nagasaki Univ, Grad Sch Engn, Nagasaki 8528521, Japan; [Kusunoki, Masami] Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi 4008511, Japan	Tohoku University; Nagasaki University; University of Yamanashi	Yamashita, S (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aobayama 6-6-11, Sendai, Miyagi 9808579, Japan.	satoshi0207@gmail.com	Hideaki, UNNO/ABG-9471-2020; Takahashi, Seiji/AAE-1509-2019; Hirooka, Kazutake/K-9827-2017	Hideaki, UNNO/0000-0001-5917-269X; Takahashi, Seiji/0000-0002-2288-4340; Hirooka, Kazutake/0000-0001-5879-936X				Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; De Simone G, 2001, J MOL BIOL, V314, P507, DOI 10.1006/jmbi.2001.5152; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ejima K, 2004, J BIOSCI BIOENG, V98, P445, DOI 10.1263/jbb.98.445; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer M, 2008, P NATL ACAD SCI USA, V105, P8878, DOI 10.1073/pnas.0800071105; Ferrer M, 2007, NATURE, V445, P91, DOI 10.1038/nature05362; Golyshina OV, 2006, ENVIRON MICROBIOL, V8, P416, DOI 10.1111/j.1462-2920.2005.00907.x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0; LEATHERBARROW RJ, 1990, TRENDS BIOCHEM SCI, V15, P455, DOI 10.1016/0968-0004(90)90295-M; Liu P, 2004, J MOL BIOL, V342, P551, DOI 10.1016/j.jmb.2004.06.069; Mandrich L, 2008, PROTEINS, V71, P1721, DOI 10.1002/prot.21877; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oda K, 2012, J BIOCHEM, V151, P13, DOI 10.1093/jb/mvr129; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wei YY, 1999, NAT STRUCT BIOL, V6, P340; Wlodawer A, 2004, J BIOL CHEM, V279, P21500, DOI 10.1074/jbc.M401141200; ZHONG S, 1995, J AM CHEM SOC, V117, P7048, DOI 10.1021/ja00132a002	25	22	22	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24499	24510		10.1074/jbc.M113.521856	http://dx.doi.org/10.1074/jbc.M113.521856			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25043762	Green Published, hybrid			2022-12-25	WOS:000341505600042
J	Atkinson, PJ; Wise, AK; Flynn, BO; Nayagam, BA; Richardson, RT				Atkinson, Patrick J.; Wise, Andrew K.; Flynn, Brianna O.; Nayagam, Bryony A.; Richardson, Rachael T.			Hair Cell Regeneration after ATOH1 Gene Therapy in the Cochlea of Profoundly Deaf Adult Guinea Pigs	PLOS ONE			English	Article							MAMMALIAN COCHLEA; IN-VIVO; MATH1; HEARING; EXPRESSION; NEURONS; NEUROTROPHIN-3; EPITHELIUM; TRAUMA	The degeneration of hair cells in the mammalian cochlea results in permanent sensorineural hearing loss. This study aimed to promote the regeneration of sensory hair cells in the mature cochlea and their reconnection with auditory neurons through the introduction of ATOH1, a transcription factor known to be necessary for hair cell development, and the introduction of neurotrophic factors. Adenoviral vectors containing ATOH1 alone, or with neurotrophin-3 and brain derived neurotrophic factor were injected into the lower basal scala media of guinea pig cochleae four days post ototoxic deafening. Guinea pigs treated with ATOH1 gene therapy, alone, had a significantly greater number of cells expressing hair cell markers compared to the contralateral non-treated cochlea when examined 3 weeks post-treatment. This increase, however, did not result in a commensurate improvement in hearing thresholds, nor was there an increase in synaptic ribbons, as measured by CtBP2 puncta after ATOH1 treatment alone, or when combined with neurotrophins. However, hair cell formation and synaptogenesis after co-treatment with ATOH1 and neurotrophic factors remain inconclusive as viral transduction was reduced due to the halving of viral titres when the samples were combined. Collectively, these data suggest that, whilst ATOH1 alone can drive non-sensory cells towards an immature sensory hair cell phenotype in the mature cochlea, this does not result in functional improvements after aminoglycoside-induced deafness.	[Atkinson, Patrick J.; Wise, Andrew K.; Flynn, Brianna O.; Nayagam, Bryony A.; Richardson, Rachael T.] Bion Inst, East Melbourne, Vic, Australia; [Atkinson, Patrick J.; Wise, Andrew K.; Nayagam, Bryony A.; Richardson, Rachael T.] Univ Melbourne, Dept Otolaryngol, East Melbourne, Vic, Australia; [Wise, Andrew K.; Richardson, Rachael T.] Univ Melbourne, Dept Med Bion, East Melbourne, Vic, Australia; [Nayagam, Bryony A.] Univ Melbourne, Dept Audiol & Speech Pathol, Parkville, Vic 3052, Australia	Bionics Institute; University of Melbourne; University of Melbourne; University of Melbourne	Richardson, RT (corresponding author), Bion Inst, East Melbourne, Vic, Australia.	rrichardson@bionicsinstitute.org	Wise, Andrew/B-5943-2014	Wise, Andrew/0000-0001-9715-8784; Nayagam, Bryony/0000-0003-1069-6059; Richardson, Rachael/0000-0002-2412-8354	Garnett Passe and Rodney Williams Memorial Foundation; National Health and Medical Research Council [GNT1024350]; Action on Hearing Loss; Royal Victorian Eye and Ear Hospital; University of Melbourne; Victorian Government through its Operational Infrastructure Support Program; RNID [G39] Funding Source: researchfish	Garnett Passe and Rodney Williams Memorial Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Action on Hearing Loss; Royal Victorian Eye and Ear Hospital; University of Melbourne(University of Melbourne); Victorian Government through its Operational Infrastructure Support Program; RNID	The authors wish to acknowledge the generous support of the Garnett Passe and Rodney Williams Memorial Foundation (PJA), the National Health and Medical Research Council (GNT1024350) (RTR), Action on Hearing Loss (RTR), the Royal Victorian Eye and Ear Hospital (PJA) and the University of Melbourne (PJA). The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052338; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Chen P, 2002, DEVELOPMENT, V129, P2495; Feghali J G, 1998, Ear Nose Throat J, V77, P282; Feghali JG, 1998, ENT-EAR NOSE THROAT, V77, P282; Feghali JG, 1998, ENT-EAR NOSE THROAT, V77, P280; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P19, DOI 10.1007/s10162-004-5024-3; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Izumikawa M, 2008, HEARING RES, V240, P52, DOI 10.1016/j.heares.2008.02.007; James DP, 2008, AUDIOL NEURO-OTOL, V13, P86, DOI 10.1159/000111780; Kawamoto K, 2003, J NEUROSCI, V23, P4395; Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Kelly MC, 2009, CURR OPIN NEUROBIOL, V19, P395, DOI 10.1016/j.conb.2009.07.010; Kong YY, 2004, EAR HEARING, V25, P173, DOI 10.1097/01.AUD.0000120365.97792.2F; Kraft S, 2013, LARYNGOSCOPE, V123, P992, DOI 10.1002/lary.22171; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Liu ZY, 2012, J NEUROSCI, V32, P6600, DOI 10.1523/JNEUROSCI.0818-12.2012; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015; Wang Q, 2011, J NEUROSCI, V31, P7938, DOI 10.1523/JNEUROSCI.1434-10.2011; Wise AK, 2005, J COMP NEUROL, V487, P147, DOI 10.1002/cne.20563; Wise AK, 2010, MOL THER, V18, P1111, DOI 10.1038/mt.2010.28; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Yang JM, 2013, NEUROSCI LETT, V549, P7, DOI 10.1016/j.neulet.2013.04.053; Yang JM, 2012, J NEUROSCI, V32, P3712, DOI 10.1523/JNEUROSCI.6093-11.2012; Yang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046355	27	55	56	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102077	10.1371/journal.pone.0102077	http://dx.doi.org/10.1371/journal.pone.0102077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036727	Green Published, gold			2022-12-25	WOS:000339615200036
J	Delisle, VC; Kwakkenbos, L; Hudson, M; Baron, M; Thombs, BD				Delisle, Vanessa C.; Kwakkenbos, Linda; Hudson, Marie; Baron, Murray; Thombs, Brett D.		Canadian Scleroderma Res Grp	An Assessment of the Measurement Equivalence of English and French Versions of the Center for Epidemiologic Studies Depression (CES-D) Scale in Systemic Sclerosis	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; POSITIVE AFFECT; SYMPTOMS; RELIABILITY; PREVALENCE; CLASSIFICATION; VALIDITY; CRITERIA	Objectives: Center for Epidemiologic Studies Depression (CES-D) Scale scores in English-and French-speaking Canadian systemic sclerosis (SSc) patients are commonly pooled in analyses, but no studies have evaluated the metric equivalence of the English and French CES-D. The study objective was to examine the metric equivalence of the CES-D in English-and French-speaking SSc patients. Methods: The CES-D was completed by 1007 English-speaking and 248 French-speaking patients from the Canadian Scleroderma Research Group Registry. Confirmatory factor analysis (CFA) was used to assess the factor structure in both samples. The Multiple-Indicator Multiple-Cause (MIMIC) model was utilized to assess differential item functioning (DIF). Results: A two-factor model (Positive and Negative affect) showed excellent fit in both samples. Statistically significant, but small-magnitude, DIF was found for 3 of 20 CES-D items, including items 3 (Blues), 10 (Fearful), and 11 (Sleep). Prior to accounting for DIF, French-speaking patients had 0.08 of a standard deviation (SD) lower latent scores for the Positive factor (95% confidence interval [CI]-0.25 to 0.08) and 0.09 SD higher scores (95% CI-0.07 to 0.24) for the Negative factor than English-speaking patients. After DIF correction, there was no change on the Positive factor and a non-significant increase of 0.04 SD on the Negative factor for French-speaking patients (difference = 0.13 SD, 95% CI-0.03 to 0.28). Conclusions: The English and French versions of the CES-D, despite minor DIF on several items, are substantively equivalent and can be used in studies that combine data from English-and French-speaking Canadian SSc patients.	[Delisle, Vanessa C.; Thombs, Brett D.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Kwakkenbos, Linda; Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada; [Delisle, Vanessa C.; Kwakkenbos, Linda; Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University	Thombs, BD (corresponding author), McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada.	brett.thombs@mcgill.ca	Kwakkenbos, Linda/GXH-2756-2022; Baron, Murray/AAF-9486-2019; Pope, Janet/G-3342-2011	Kwakkenbos, Linda/0000-0002-1573-4504; Pope, Janet/0000-0003-1479-5302	Canadian Institutes of Health Research; Fonds de la Recherche en Sante Quebec; Arthritis Society; Actelion; Pfizer pharmaceuticals	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec); Arthritis Society; Actelion; Pfizer pharmaceuticals(Pfizer)	Ms. Delisle is supported by a Canadian Institutes of Health Research doctoral award. Dr. Kwakkenbos is supported by a Fonds de la Recherche en Sante Quebec postdoctoral fellowship. Dr. Thombs is supported by an Investigator Salary Award from the Arthritis Society. Dr. Baron is the director of the Canadian Scleroderma Research Group (CSRG) and the CSRG has received educational grants from Actelion and Pfizer pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhajeri H, 2013, ARTHRITIS RHEUM S, VS10, P772; [Anonymous], 2005, KELLEYS TXB RHEUMATO; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Buck U, 2010, MUSCULOSKELET CARE, V8, P197, DOI 10.1002/msc.181; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Contrada RJ, 2006, PSYCHOSOM MED, V68, P922, DOI 10.1097/01.psy.0000244391.56598.10; Fuhrer R, 1989, EUROPEAN PSYCHIAT, V4, P163, DOI DOI 10.1037/T10444-000; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; Hoogeboom TJ, 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2012-001161, 10.1136/bmjopen-2013-003563]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hunt SM, 2004, J EPIDEMIOL COMMUN H, V58, P618, DOI 10.1136/jech.2003.010074; Jewett LR, 2013, RHEUMATOLOGY, V52, P669, DOI 10.1093/rheumatology/kes347; KLEINMAN A, 1987, BRIT J PSYCHIAT, V151, P447, DOI 10.1192/bjp.151.4.447; Kwakkenbos L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053923; Kwakkenbos L, 2012, J PSYCHOSOM RES, V72, P199, DOI 10.1016/j.jpsychores.2011.12.005; LEROY EC, 1988, J RHEUMATOL, V15, P202; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Milette K, 2010, RHEUMATOLOGY, V49, P789, DOI 10.1093/rheumatology/kep443; Moskowitz JT, 2003, PSYCHOSOM MED, V65, P620, DOI 10.1097/01.PSY.0000073873.74829.23; Muller H, 2012, BRIT J DERMATOL, V166, P343, DOI 10.1111/j.1365-2133.2011.10624.x; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Newton EG, 2012, QUAL HEALTH RES, V22, P1195, DOI 10.1177/1049732312449207; Nietert PJ, 2005, J RHEUMATOL, V32, P51; O'Rourke N, 2003, CAN J AGING, V22, P323, DOI 10.1017/S0714980800003937; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552; Rhee SH, 1999, ARTHRIT CARE RES, V12, P392, DOI 10.1002/1529-0131(199912)12:6<392::AID-ART7>3.0.CO;2-9; Rogler LH, 1999, AM PSYCHOL, V54, P424, DOI 10.1037/0003-066X.54.6.424; Schroevers MJ, 2000, QUAL LIFE RES, V9, P1015, DOI 10.1023/A:1016673003237; Stansbury JP, 2006, J PERS ASSESS, V86, P10, DOI 10.1207/s15327752jpa8601_03; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Teresi JA, 2006, MED CARE, V44, pS39, DOI 10.1097/01.mlr.0000245452.48613.45; Thombs BD, 2012, CLIN EXP RHEUMATOL, V30, pS23; Thombs BD, 2008, ARTHRIT RHEUM-ARTHR, V59, P504, DOI 10.1002/art.23524; Thombs BD, 2008, ARTHRIT RHEUM-ARTHR, V59, P431, DOI 10.1002/art.23328; Thombs BD, 2008, ARTHRIT RHEUM-ARTHR, V59, P438, DOI 10.1002/art.23329; Thombs BD, 2007, ARTHRIT RHEUM-ARTHR, V57, P1089, DOI 10.1002/art.22910; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tyndall A, 2005, Ann Rheum Dis, V64, P1107, DOI 10.1136/ard.2005.036038; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; Wigley FM, 2003, RHEUMATOLOGY, P1463; Zumbo BD, 1999, HDB THEORY METHODS D	45	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102897	10.1371/journal.pone.0102897	http://dx.doi.org/10.1371/journal.pone.0102897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036894	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200093
J	Liew, G; Wang, JJ; Rochtchina, E; Wong, TY; Mitchell, P				Liew, Gerald; Wang, Jie Jin; Rochtchina, Elena; Wong, Tien Yin; Mitchell, Paul			Complete Blood Count and Retinal Vessel Calibers	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; AGE-RELATED MACULOPATHY; CHRONIC KIDNEY-DISEASE; VASCULAR CALIBER; MICROVASCULAR ABNORMALITIES; LEUKOCYTE COUNT; CELL COUNT; ARTERIOLAR; RISK; DIAMETERS	Objective: The influence of hematological indices such as complete blood count on microcirculation is poorly understood. Retinal microvasculature can be directly visualized and vessel calibers are associated with a range of ocular and systemic diseases. We examined the association of complete blood count with retinal vessel calibers. Methods: Cross-sectional population-based Blue Mountains Eye Study, n = 3009, aged 49+ years. Complete blood count was measured from fasting blood samples taken at baseline examination, 1992-4. Retinal arteriolar and venular calibers were measured from digitized retinal photographs using a validated semi-automated computer program. Results: All analyses adjusted for age, sex, systolic blood pressure, diabetes, smoking and fellow vessel caliber. Higher hematocrit, white cell count and platelet count were associated with narrower arteriolar caliber (p = 0.02, 0.03 and 0.001 respectively), while higher hemoglobin, hematocrit, red cell count, white cell count and platelet count were associated with wider venular caliber (p < 0.0001 for all). Each quintile increase in hematocrit, white cell count and platelet count was associated with approximately 0.5 mu m narrower arteriolar caliber; whereas each quintile increase in all of the complete blood count components was associated with approximately 1-2 mm wider venular caliber. Conclusions: These associations show that elevated levels of hematological indices can have adverse effects on the microcirculation.	[Liew, Gerald; Wang, Jie Jin; Rochtchina, Elena; Mitchell, Paul] Univ Sydney, Ctr Vis Res, Sydney, NSW, Australia; [Liew, Gerald; Wang, Jie Jin; Wong, Tien Yin] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Wong, Tien Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore Eye Res Inst, Singapore, Singapore	University of Sydney; Centre for Eye Research Australia; University of Melbourne; National University of Singapore; Singapore National Eye Center	Wang, JJ (corresponding author), Univ Sydney, Ctr Vis Res, Sydney, NSW, Australia.	jiejin_wang@wmi.usyd.edu.au	Wang, Jie Jin/P-1499-2014; Liew, Gerald/AAB-6870-2022; Wong, Tien Yin/AAC-9724-2020; wang, jie/GRS-0942-2022; Mitchell, Paul/P-1498-2014	Wang, Jie Jin/0000-0001-9491-4898; Wong, Tien Yin/0000-0002-8448-1264; 	Australian National Health & Medical Research Council (NHMRC) [153948, 211069, 302068]	Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Support was provided by the Australian National Health & Medical Research Council (NHMRC, Project grant IDs: 153948, 211069 & 302068). The funder had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Cheung ATW, 2002, BLOOD, V99, P3999, DOI 10.1182/blood.V99.11.3999; Cheung N, 2007, HYPERTENSION, V50, P617, DOI 10.1161/HYPERTENSIONAHA.107.091926; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; De Jong FJ, 2008, OPHTHALMOLOGY, V115, P887, DOI 10.1016/j.ophtha.2007.06.036; Elkind MSV, 2005, ATHEROSCLEROSIS, V181, P329, DOI 10.1016/j.atherosclerosis.2005.01.013; Elkind MSV, 2002, STROKE, V33, P2587, DOI 10.1161/01.STR.0000034400.71491.10; Gangaputra S, 2012, AM J OPHTHALMOL, V153, P434, DOI 10.1016/j.ajo.2011.08.028; Grunwald JE, 2012, AM J CARDIOL, V110, P246, DOI 10.1016/j.amjcard.2012.03.014; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2006, DIABETES, V55, P506, DOI 10.2337/diabetes.55.02.06.db05-0546; Ikram MK, 2006, BRAIN, V129, P182, DOI 10.1093/brain/awh688; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Jones JG, 2000, BRIT J ANAESTH, V84, P226, DOI 10.1093/oxfordjournals.bja.a013407; Kifley A, 2008, MICROCIRCULATION, V15, P373, DOI 10.1080/10739680701812220; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Klein BEK, 2011, ARCH OPHTHALMOL-CHIC, V129, P490, DOI 10.1001/archophthalmol.2011.57; Kofoed PK, 2009, INVEST OPHTH VIS SCI, V50, P3960, DOI 10.1167/iovs.08-3217; Li LJ, 2011, INT J PEDIATR OBES, V6, P267, DOI 10.3109/17477166.2011.583657; Liew G, 2012, KIDNEY BLOOD PRESS R, V35, P589, DOI 10.1159/000339173; Liew G, 2008, ARCH OPHTHALMOL-CHIC, V126, P1404, DOI 10.1001/archopht.126.10.1404; Liew G, 2007, INVEST OPHTH VIS SCI, V48, P52, DOI 10.1167/iovs.06-0672; Martin-Ventura JL, 2012, THROMB HAEMOSTASIS, V108, P435, DOI 10.1160/TH12-04-0248; MAILATH L, 1976, KLIN MONATSBL AUGENH, V169, P343; Metivier F, 2000, NEPHROL DIAL TRANSPL, V15, P14, DOI 10.1093/oxfordjournals.ndt.a027970; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Nguyen TT, 2006, TRENDS ENDOCRIN MET, V17, P262, DOI 10.1016/j.tem.2006.07.006; Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528; Nicholson GT, 2011, J PEDIATR-US, V159, P789, DOI 10.1016/j.jpeds.2011.05.013; Patel KN, 2008, ARTERIOSCL THROM VAS, V28, P2225, DOI 10.1161/ATVBAHA.108.175679; Salvi SM, 2005, EYE, V19, P928, DOI 10.1038/sj.eye.6701683; Schiffrin EL, 2012, BASIC CLIN PHARMACOL, V110, P70, DOI 10.1111/j.1742-7843.2011.00760.x; Sherry LM, 2002, CLIN EXP OPHTHALMOL, V30, P179, DOI 10.1046/j.1442-9071.2002.00520.x; Stokes KY, 2006, MICROCIRCULATION, V13, P377, DOI 10.1080/10739680600745877; Tanabe Y, 2010, MICROCIRCULATION, V17, P94, DOI 10.1111/j.1549-8719.2009.00006.x; TAYLOR GA, 1994, INVEST RADIOL, V29, P188, DOI 10.1097/00004424-199402000-00013; Tedeschi-Reiner E, 2005, AM J CARDIOL, V96, P1107, DOI 10.1016/j.amjcard.2005.05.070; Told R, 2012, EXP EYE RES, V97, P49, DOI 10.1016/j.exer.2012.01.010; Wang JJ, 2004, BRIT J OPHTHALMOL, V88, P104, DOI 10.1136/bjo.88.1.104; Wang L, 2008, HYPERTENSION, V51, P119, DOI 10.1161/HYPERTENSIONAHA.107.098343; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2004, NEW ENGL J MED, V351, P2310, DOI 10.1056/NEJMra032865; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P1007, DOI 10.1136/bjo.86.9.1007	43	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102230	10.1371/journal.pone.0102230	http://dx.doi.org/10.1371/journal.pone.0102230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036459	Green Published, gold			2022-12-25	WOS:000339615200042
J	Sahin, U; Lapaquette, P; Andrieux, A; Faure, G; Dejean, A				Sahin, Umut; Lapaquette, Pierre; Andrieux, Alexandra; Faure, Guilhem; Dejean, Anne			Sumoylation of Human Argonaute 2 at Lysine-402 Regulates Its Stability	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; POSTTRANSLATIONAL MODIFICATIONS; PML DEGRADATION; SMALL RNAS; SUMO; PATHWAY; PROTEINS; PHOSPHORYLATION; BIOGENESIS; CANCER	Gene silencing by small RNAs has emerged as a powerful post-transcriptional regulator of gene expression, however processes underlying regulation of the small RNA pathway in vivo are still largely elusive. Here, we identified sumoylation as a novel post-translational modification acting on Ago2, the main effector of small RNA-mediated gene silencing. We demonstrate that Ago2 can be modified by SUMO1 and SUMO2/3 and identified Lys402 as the major Ago2 sumoylation site in vivo. Ago2 physically interacts with the SUMO E2 conjugating enzyme Ubc9 and the E3 ligase RanBP2 facilitates Ago2 sumoylation in vitro. Mutation of Lys402 enhances the stability of Ago2 protein and impairment of cellular sumoylation by siRNA-or shRNA-mediated extinction of Ubc9 or in Ubc9 knockout mouse tissues results in increased steady-state levels and enhanced stability of Ago2. Similarly, knockdown of RanBP2 or of the SAE2 E1 enzyme enhances Ago2 protein levels. Lys402 is located in the L2g1 loop linking the PAZ and PIWI domains of Ago2, in the immediate vicinity of Tyr393 which can be phosphorylated, implying that the L2g1 linker represents an easily accessible hot spot for post-translational modifications. Altogether, our results show that sumoylation of Ago2 at Lys402 negatively regulates its stability, thereby establishing a first link between SUMO and the small RNA machinery.	[Sahin, Umut; Lapaquette, Pierre; Andrieux, Alexandra; Dejean, Anne] Inst Pasteur, Lab Nucl Org & Oncogenesis, Paris, France; [Sahin, Umut; Lapaquette, Pierre; Andrieux, Alexandra; Dejean, Anne] Inst Natl Sante & Rech Med, U993, Paris, France; [Sahin, Umut; Lapaquette, Pierre; Andrieux, Alexandra; Dejean, Anne] Equipe Labellise Ligue Natl Contre Canc, Paris, France; [Faure, Guilhem] Univ Paris 06, CNRS, UMR7590, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD)	Sahin, U (corresponding author), Inst Pasteur, Lab Nucl Org & Oncogenesis, Paris, France.	umut.sahin@inserm.fr; anne.dejean@pasteur.fr	Sahin, Umut Kivanc/P-5872-2018; Dejean, Anne/L-5145-2018; Lapaquette, Pierre/AAF-5537-2020; Sahin, Umut/AAO-3948-2020	Sahin, Umut Kivanc/0000-0003-3074-3633; Sahin, Umut/0000-0002-4100-5751; Lapaquette, Pierre/0000-0002-2680-351X; Faure, Guilhem/0000-0001-9537-2277	Ligue Nationale Contre le Cancer (LNCC, Equipe Labellisee); Odyssey-RE; Institut National du Cancer; L'Agence Nationale de la Recherche; European Research Council; LNCC	Ligue Nationale Contre le Cancer (LNCC, Equipe Labellisee); Odyssey-RE; Institut National du Cancer(Institut National du Cancer (INCA) France); L'Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); LNCC	This work was supported by grants from Ligue Nationale Contre le Cancer (LNCC, Equipe Labellisee), Odyssey-RE, Institut National du Cancer, L'Agence Nationale de la Recherche and European Research Council. P.L. was supported by the LNCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameyar-Zazoua M, 2012, NAT STRUCT MOL BIOL, V19, P998, DOI 10.1038/nsmb.2373; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Demarque MD, 2011, GASTROENTEROLOGY, V140, P286, DOI 10.1053/j.gastro.2010.10.002; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Erker Y, 2013, MOL CELL BIOL, V33, P2163, DOI 10.1128/MCB.01019-12; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gu Shuo, 2010, Silence, V1, P11, DOI 10.1186/1758-907X-1-11; Heo I, 2009, CELL, V139, P28, DOI 10.1016/j.cell.2009.09.013; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Maison C, 2011, NAT GENET, V43, P220, DOI 10.1038/ng.765; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mo YY, 2005, EXPERT OPIN THER TAR, V9, P1203, DOI 10.1517/14728222.9.6.1203; Neyret-Kahn H, 2013, GENOME RES, V23, P1563, DOI 10.1101/gr.154872.113; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Ulrich HD, 2012, J CELL SCI, V125, P249, DOI 10.1242/jcs.091801; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Voller D, 2013, BR J CANC; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599	39	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102957	10.1371/journal.pone.0102957	http://dx.doi.org/10.1371/journal.pone.0102957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036361	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200103
J	Tabatadze, N; Sato, SM; Woolley, CS				Tabatadze, Nino; Sato, Satoru M.; Woolley, Catherine S.			Quantitative Analysis of Long-Form Aromatase mRNA in the Male and Female Rat Brain	PLOS ONE			English	Article							GENE-EXPRESSION; SYNAPTIC-TRANSMISSION; ADULT MALE; ESTROGEN; ESTRADIOL; CYP19; CYTOCHROME-P450; HIPPOCAMPUS; ANDROGENS; ALPHA	In vitro studies show that estrogens acutely modulate synaptic function in both sexes. These acute effects may be mediated in vivo by estrogens synthesized within the brain, which could fluctuate more rapidly than circulating estrogens. For this to be the case, brain regions that respond acutely to estrogens should be capable of synthesizing them. To investigate this question, we used quantitative real-time PCR to measure expression of mRNA for the estrogen-synthesizing enzyme, aromatase, in different brain regions of male and female rats. Importantly, because brain aromatase exists in two forms, a long form with aromatase activity and a short form with unknown function, we targeted a sequence found exclusively in long-form aromatase. With this approach, we found highest expression of aromatase mRNA in the amygdala followed closely by the bed nucleus of the stria terminalis (BNST) and preoptic area (POA); we found moderate levels of aromatase mRNA in the dorsal hippocampus and cingulate cortex; and aromatase mRNA was detectable in brainstem and cerebellum, but levels were very low. In the amygdala, gonadal/hormonal status regulated aromatase expression in both sexes; in the BNST and POA, castration of males down-regulated aromatase, whereas there was no effect of estradiol in ovariectomized females. In the dorsal hippocampus and cingulate cortex, there were no differences in aromatase levels between males and females or effects of gonadal/hormonal status. These findings demonstrate that long-form aromatase is expressed in brain regions that respond acutely to estrogens, such as the dorsal hippocampus, and that gonadal/hormonal regulation of aromatase differs among different brain regions.	[Tabatadze, Nino; Sato, Satoru M.; Woolley, Catherine S.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Northwestern University	Tabatadze, N (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	n-tabatadze@northwestern.edu		Woolley, Catherine/0000-0002-8069-2646	National Institutes of Health (National Institute of Neurological Disorders and Stroke) [NS037324]; National Institute of Mental Health [MH095248]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037324, R29NS037324] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (National Institute of Neurological Disorders and Stroke; http://www.ninds.nih.gov/; NS037324; CSW and National Institute of Mental Health; http://www.nimh.nih.gov/; MH095248; CSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELGADIR SE, 1994, ENDOCRINOLOGY, V135, P395, DOI 10.1210/en.135.1.395; Caradec J, 2010, BRIT J CANCER, V103, P1475, DOI 10.1038/sj.bjc.6605851; Enjuanes A, 2003, EUR J ENDOCRINOL, V148, P519, DOI 10.1530/eje.0.1480519; FLORES F, 1973, SCIENCE, V180, P1074, DOI 10.1126/science.180.4090.1074; GERSTENFELD LC, 1985, MOL CELL BIOL, V5, P1425, DOI 10.1128/MCB.5.6.1425; Golovine K, 2003, BIOL REPROD, V68, P978, DOI 10.1095/biolreprod.102.008037; HARADA N, 1990, BIOCHEM BIOPH RES CO, V166, P365, DOI 10.1016/0006-291X(90)91954-Q; HARADA N, 1993, BRAIN RES, V622, P243, DOI 10.1016/0006-8993(93)90825-8; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; HONDA S, 1994, BIOCHEM BIOPH RES CO, V198, P1153, DOI 10.1006/bbrc.1994.1163; Huang GZ, 2012, NEURON, V74, P801, DOI 10.1016/j.neuron.2012.03.035; Iivonen S, 2006, NEUROSCIENCE, V137, P1143, DOI 10.1016/j.neuroscience.2005.10.023; JAKAB RL, 1993, J STEROID BIOCHEM, V44, P481, DOI 10.1016/0960-0760(93)90253-S; Kramar EA, 2009, J NEUROSCI, V29, P12982, DOI 10.1523/JNEUROSCI.3059-09.2009; Lephart ED, 1996, BRAIN RES REV, V22, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEANS GD, 1989, J BIOL CHEM, V264, P19385; NAFTOLIN F, 1972, ENDOCRINOLOGY, V90, P295, DOI 10.1210/endo-90-1-295; Paxinos G, 2004, RAT BRAIN STEROTAXIC; Pietranera L, 2011, NEUROSCIENCE, V174, P151, DOI 10.1016/j.neuroscience.2010.11.044; ROSELLI C E, 1987, Steroids, V50, P495, DOI 10.1016/0039-128X(87)90034-1; ROSELLI CE, 1984, ENDOCRINOLOGY, V114, P192, DOI 10.1210/endo-114-1-192; Roselli CE, 1998, BIOL REPROD, V58, P79, DOI 10.1095/biolreprod58.1.79; ROSELLI CE, 1985, ENDOCRINOLOGY, V117, P2471, DOI 10.1210/endo-117-6-2471; Sakurada Y, 2006, HISTOCHEM CELL BIOL, V126, P735, DOI 10.1007/s00418-006-0205-2; SANGHERA MK, 1991, ENDOCRINOLOGY, V129, P2834, DOI 10.1210/endo-129-6-2834; SCHUMACHER M, 1987, BRAIN RES, V422, P137, DOI 10.1016/0006-8993(87)90548-8; SELMANOFF MK, 1977, ENDOCRINOLOGY, V101, P841, DOI 10.1210/endo-101-3-841; SHINODA K, 1989, J COMP NEUROL, V290, P502, DOI 10.1002/cne.902900405; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; Simpson ER, 1997, FASEB J, V11, P29, DOI 10.1096/fasebj.11.1.9034163; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Smejkalova T, 2010, J NEUROSCI, V30, P16137, DOI 10.1523/JNEUROSCI.4161-10.2010; Sorwell KG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.004; Stocco C, 2008, STEROIDS, V73, P473, DOI 10.1016/j.steroids.2008.01.017; Stoffel-Wagner B, 1998, BIOCHEM BIOPH RES CO, V244, P768, DOI 10.1006/bbrc.1998.8337; Stoffel-Wagner B, 1999, J STEROID BIOCHEM, V70, P237, DOI 10.1016/S0960-0760(99)00114-4; TEYLER TJ, 1980, SCIENCE, V209, P1017, DOI 10.1126/science.7190730; TODA K, 1990, EUR J BIOCHEM, V193, P559, DOI 10.1111/j.1432-1033.1990.tb19372.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WONG M, 1992, J NEUROSCI, V12, P3217, DOI 10.1523/JNEUROSCI.12-08-03217.1992; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; YamadaMouri N, 1997, J STEROID BIOCHEM, V60, P325, DOI 10.1016/S0960-0760(96)00222-1; Zhao CJ, 2007, J COMP NEUROL, V500, P557, DOI 10.1002/cne.21193; Zhu SJ, 2002, J ENDOCRINOL, V172, P31, DOI 10.1677/joe.0.1720031	47	48	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e100628	10.1371/journal.pone.0100628	http://dx.doi.org/10.1371/journal.pone.0100628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036039	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200010
J	Upadhyay, RK; Gupta, A; Ranjan, S; Singh, R; Pathre, UV; Nath, P; Sane, AP				Upadhyay, Rakesh Kumar; Gupta, Asmita; Ranjan, Sanjay; Singh, Ruchi; Pathre, Uday V.; Nath, Pravendra; Sane, Aniruddha P.			The EAR Motif Controls the Early Flowering and Senescence Phenotype Mediated by Over-Expression of SlERF36 and Is Partly Responsible for Changes in Stomatal Density and Photosynthesis	PLOS ONE			English	Article							ACTIVE TRANSCRIPTIONAL REPRESSOR; WATER-USE EFFICIENCY; GENOME-WIDE ANALYSIS; DROUGHT TOLERANCE; ETHYLENE BIOSYNTHESIS; CO2 CONCENTRATION; STRESS RESPONSES; GENE-EXPRESSION; ABSCISIC-ACID; SALT STRESS	The EAR motif is a small seven amino acid motif associated with active repression of several target genes. We had previously identified SlERF36 as an EAR motif containing gene from tomato and shown that its over-expression results in early flowering and senescence and a 25-35% reduction of stomatal density, photosynthesis and stomatal conductance in transgenic tobacco. In order to understand the role of the EAR motif in governing the phenotypes, we have expressed the full-length SlERF36 and a truncated form, lacking the EAR motif under the CaMV35S promoter, in transgenic Arabidopsis. Plants over-expressing the full-length SlERF36 show prominent early flowering under long day as well as short day conditions. The early flowering leads to an earlier onset of senescence in these transgenic plants which in turn reduces vegetative growth, affecting rosette, flower and silique sizes. Stomatal number is reduced by 38-39% while photosynthesis and stomatal conductance decrease by about 30-40%. Transgenic plants over-expressing the truncated version of SlERF36 (lacking the C-terminal EAR motif), show phenotypes largely matching the control with normal flowering and senescence indicating that the early flowering and senescence is governed by the EAR motif. On the other hand, photosynthetic rates and stomatal number were also reduced in plants expressing SlERF36DEAR although to a lesser degree compared to the full-length version indicating that these are partly controlled by the EAR motif. These studies show that the major phenotypic changes in plant growth caused by over-expression of SlERF36 are actually mediated by the EAR motif.	[Upadhyay, Rakesh Kumar; Gupta, Asmita; Nath, Pravendra; Sane, Aniruddha P.] Natl Bot Res Inst, CSIR, Plant Gene Express Lab, Lucknow 226001, Uttar Pradesh, India; [Ranjan, Sanjay; Pathre, Uday V.] Natl Bot Res Inst, CSIR, Dept Plant Physiol, Lucknow 226001, Uttar Pradesh, India; [Upadhyay, Rakesh Kumar] USDA ARS, Beltsville Agr Res Ctr, Sustainable Agr Syst Lab, Beltsville, MD 20705 USA; [Upadhyay, Rakesh Kumar] Penn State Univ, Dept Biol, Harrisburg, PA USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Sane, AP (corresponding author), Natl Bot Res Inst, CSIR, Plant Gene Express Lab, Lucknow 226001, Uttar Pradesh, India.	saneanil@rediffmail.com	Upadhyay, Rakesh K./J-3926-2019	Upadhyay, Rakesh K./0000-0001-6742-5853; SINGH, RUCHI/0000-0003-4696-5150	Department of Biotechnology, Government of India [GAP244525]; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by a grant (GAP244525) from the Department of Biotechnology, Government of India, to A. P. S. Senior Research Fellowship was provided by the Council of Scientific and Industrial Research, Government of India, to R. K. U., A. S., R. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adamczyk BJ, 2007, PLANT J, V50, P1007, DOI 10.1111/j.1365-313X.2007.03105.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Brodribb TJ, 2009, NEW PHYTOL, V183, P839, DOI 10.1111/j.1469-8137.2009.02844.x; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Doheny-Adams T, 2012, PHILOS T R SOC B, V367, P547, DOI 10.1098/rstb.2011.0272; Dong CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-47; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Hill K, 2008, PLANT J, V53, P172, DOI 10.1111/j.1365-313X.2007.03336.x; Hiratsu K, 2004, BIOCHEM BIOPH RES CO, V321, P172, DOI 10.1016/j.bbrc.2004.06.115; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kagale S, 2011, EPIGENETICS-US, V6, P141, DOI 10.4161/epi.6.2.13627; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Kazan K, 2006, TRENDS PLANT SCI, V11, P109, DOI 10.1016/j.tplants.2006.01.004; Koyama T, 2013, PLANT PHYSIOL, V162, P991, DOI 10.1104/pp.113.218115; Li ZF, 2011, PLANT J, V68, P88, DOI 10.1111/j.1365-313X.2011.04670.x; Lu J, 2011, PLANT J, V68, P583, DOI 10.1111/j.1365-313X.2011.04709.x; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nilson SE, 2010, PLANT PHYSIOL, V152, P2067, DOI 10.1104/pp.109.148262; Ogata T, 2012, J GEN PLANT PATHOL, V78, P8, DOI 10.1007/s10327-011-0355-5; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Pan IC, 2010, PLANTA, V232, P1075, DOI 10.1007/s00425-010-1235-5; Pirrello J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-190; Royer DL, 2001, REV PALAEOBOT PALYNO, V114, P1, DOI 10.1016/S0034-6667(00)00074-9; Sharma MK, 2010, MOL GENET GENOMICS, V284, P455, DOI 10.1007/s00438-010-0580-1; Shimada T, 2011, CELL MOL LIFE SCI, V68, P2081, DOI 10.1007/s00018-011-0685-7; Song CP, 2006, PLANT MOL BIOL, V60, P241, DOI 10.1007/s11103-005-3880-9; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Tsukagoshi H, 2005, PLANT PHYSIOL, V138, P675, DOI 10.1104/pp.104.057752; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Upadhyay RK, 2013, J EXP BOT, V64, P3237, DOI 10.1093/jxb/ert162; WOODWARD FI, 1995, NEW PHYTOL, V131, P311, DOI 10.1111/j.1469-8137.1995.tb03067.x; Woodward FI, 2002, NEW PHYTOL, V153, P477, DOI 10.1046/j.0028-646X.2001.00338.x; Wu K, 2008, J EXP BOT, V59, P225, DOI 10.1093/jxb/erm300; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5; Yoo CY, 2010, PLANT CELL, V22, P4128, DOI 10.1105/tpc.110.078691; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Zhang HW, 2013, PLANTA, V237, P1443, DOI 10.1007/s00425-013-1852-x	42	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101995	10.1371/journal.pone.0101995	http://dx.doi.org/10.1371/journal.pone.0101995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036097	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200032
J	Wu, MJ; Zhao, YF; Wang, R; Zheng, WX; Guo, XJ; Wu, SQ; Ma, XQ; He, J				Wu, Meijing; Zhao, Yanfang; Wang, Rui; Zheng, Wenxin; Guo, Xiaojing; Wu, Shunquan; Ma, Xiuqiang; He, Jia			Epidemiology of Functional Abdominal Bloating and Its Impact on Health Related Quality of Life: Male-Female Stratified Propensity Score Analysis in a Population Based Survey in Mainland China	PLOS ONE			English	Article							PROSTATE-CANCER OUTCOMES; BOWEL DISORDERS; GASTROINTESTINAL-DISEASES; ASSOCIATIONS; DEPRESSION; PREVALENCE; VALIDATION; SILC	Background: The epidemiology of Functional abdominal bloating (FAB) and its impact on health-related quality of life (HRQoL) in Chinese people remains unclear. Methods: Randomised, stratified, multi-stage sampling methodology was used to select a representative sample of the general population from five cities in China (n = 16,078). All respondents completed the modified Rome II questionnaire; 20% were asked to complete the 36-item Short Form (SF-36). The associated factors of FAB were analyzed. The effects of FAB on HRQoL were estimated with gender stratification using propensity score techniques in 20% subsample. Results: Overall, 643 individuals (4.00%) had FAB and it was more prevalent in males than in females (4.87% vs. 3.04%, P, 0.001). For males, self-reported history of dyspepsia was most strongly associated with FAB (OR = 2.78; 95% CI: 1.59, 4.72). However, the most strongly associated factor was self-reported health status for females (moderate health vs. good health: OR = 2.06, 95% CI: 1.07, 3.96. P = 0.030; poor health vs. good health: OR = 5.71, 95% CI: 2.06, 15.09). Concerning HRQoL, FAB was found to be related to two domains: role limitation due to physical problems (P = 0.030) and bodily pain (P, 0.001) in females. While, in males, there were significant differences in multiple domains between those with and without FAB. Conclusion: The prevalence of FAB in China was lower than previous reports. Males who had ever been diagnosed with dyspepsia and females who were in a poor self-reported health status were correlated with a higher prevalence of FAB. FAB affected only physical health in females, but impaired both physical and mental health in males.	[Wu, Meijing; Zhao, Yanfang; Wang, Rui; Guo, Xiaojing; Wu, Shunquan; Ma, Xiuqiang; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Zheng, Wenxin] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA	Naval Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	He, J (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yeah.net	zhao, yan/GWC-9174-2022	He, Jia/0000-0002-2338-9501	key discipline construction of evidence-based public health in Shanghai [12GWZX0602]; National Natural Science Foundation of China [81373105]	key discipline construction of evidence-based public health in Shanghai; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the key discipline construction of evidence-based public health in Shanghai (no. 12GWZX0602), and the National Natural Science Foundation of China (no. 81373105). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fang H, 2010, NICOTINE TOB RES, V12, P1211, DOI 10.1093/ntr/ntq170; Hansen B, 2009, OPTMATCH FUNCTIONS O; Harder VS, 2008, AM J EPIDEMIOL, V168, P592, DOI 10.1093/aje/kwn184; Harder VS, 2010, PSYCHOL METHODS, V15, P234, DOI 10.1037/a0019623; HO D SE, 2011, MATCHIT 2 4 20 NONPA; Hoffman RM, 2006, AM J MED, V119, P418, DOI 10.1016/j.amjmed.2005.06.072; JOHNSEN R, 1986, BRIT MED J, V292, P1633, DOI 10.1136/bmj.292.6536.1633; Kutner NG, 2005, NEPHROL DIAL TRANSPL, V20, P2159, DOI 10.1093/ndt/gfh973; Lee BK, 2010, STAT MED, V29, P337, DOI 10.1002/sim.3782; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Nie Y, 2001, FOREIGN MED SCI, V28, P4; Penson DF, 2003, J CLIN ONCOL, V21, P1147, DOI 10.1200/JCO.2003.07.139; Ping L, 2003, PRACTICAL MED, V19, P3; Reeve BB, 2009, JNCI-J NATL CANCER I, V101, P860, DOI 10.1093/jnci/djp123; Ridgeway G MD, 2012, TWANG 1 2 4 TOOLKIT; Schmulson M, 2011, ALIMENT PHARM THER, V33, P1071, DOI 10.1111/j.1365-2036.2011.04637.x; Sullivan Stephen Norman, 2012, ISRN Gastroenterol, V2012, P721820, DOI 10.5402/2012/721820; Thompson WG, 1999, GUT, V45, P43; Tuteja AK, 2008, AM J GASTROENTEROL, V103, P1241, DOI 10.1111/j.1572-0241.2007.01755.x; WALKER EA, 1992, AM J MED, V92, pS26, DOI 10.1016/0002-9343(92)90133-V; Xia J, 2012, J NAVAL GEN HOSP, V23, P3; Yan XY, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-86; Zhang M, 2011, NAUTICAL MED HYPERBA, V18, P4; Zhao YF, 2011, ALIMENT PHARM THER, V34, P1020, DOI 10.1111/j.1365-2036.2011.04809.x	27	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102320	10.1371/journal.pone.0102320	http://dx.doi.org/10.1371/journal.pone.0102320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036100	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200046
J	Bortolamiol, S; Cohen, M; Potts, K; Pennec, F; Rwaburindore, P; Kasenene, J; Seguya, A; Vignaud, Q; Krief, S				Bortolamiol, Sarah; Cohen, Marianne; Potts, Kevin; Pennec, Flora; Rwaburindore, Protase; Kasenene, John; Seguya, Andrew; Vignaud, Quentin; Krief, Sabrina			Suitable Habitats for Endangered Frugivorous Mammals: Small-Scale Comparison, Regeneration Forest and Chimpanzee Density in Kibale National Park, Uganda	PLOS ONE			English	Article							PAN-TROGLODYTES SCHWEINFURTHII; PRIMATE COMMUNITY DYNAMICS; SYMPATRIC LOWLAND GORILLAS; OLD-GROWTH FOREST; BUDONGO-FOREST; ECOLOGICAL CONSTRAINTS; FEMALE CHIMPANZEES; LOPE RESERVE; GROUP-SIZE; DIET	Landscape patterns and chimpanzee (Pan troglodytes schweinfurthii) densities in Kibale National Park show important variation among communities that are geographically close to one another (from 1.5 to 5.1 chimpanzees/km(2)). Anthropogenic activities inside the park (past logging activities, current encroachment) and outside its limits (food and cash crops) may impact the amount and distribution of food resources for chimpanzees (frugivorous species) and their spatial distribution within the park. Spatial and temporal patterns of fruit availability were recorded over 18 months at Sebitoli (a site of intermediate chimpanzee density and higher anthropic pressure) with the aim of understanding the factors explaining chimpanzee density there, in comparison to results from two other sites, also in Kibale: Kanyawara (low chimpanzee density) and Ngogo (high density, and furthest from Sebitoli). Because of the post-logging regenerating status of the forest in Sebitoli and Kanyawara, smaller basal area (BA) of fruiting trees most widely consumed by the chimpanzees in Kanyawara and Sebitoli was expected compared to Ngogo (not logged commercially). Due to the distance between sites, spatial and temporal fruit abundance in Sebitoli was expected to be more similar to Kanyawara than to Ngogo. While species functional classes consumed by Sebitoli chimpanzees (foods eaten during periods of high or low fruit abundance) differ from the two other sites, Sebitoli is very similar to Kanyawara in terms of land-cover and consumed species. Among feeding trees, Ficus species are particularly important resources for chimpanzees at Sebitoli, where their basal area is higher than at Kanywara or Ngogo. Ficus species provided a relatively consistent supply of food for chimpanzees throughout the year, and we suggest that this could help to explain the unusually high density of chimpanzees in such a disturbed site.	[Bortolamiol, Sarah; Cohen, Marianne] Paris Diderot Univ, Sorbonne Paris Cite, Labe Dynam Sociales & Recomposit Espaces, UMR 7533, Paris, France; [Bortolamiol, Sarah; Pennec, Flora; Vignaud, Quentin; Krief, Sabrina] UMR 7206 Ecoanthropol & Ethnobiol MNHN CNRS Paris, Paris, France; [Cohen, Marianne; Vignaud, Quentin] Paris Diderot Univ, Sorbonne Paris Cite, Paris, France; [Potts, Kevin] Augsburg Coll, Dept Biol, Minneapolis, MN USA; [Rwaburindore, Protase; Kasenene, John] Makerere Univ, Dept Bot, Kampala, Uganda; [Bortolamiol, Sarah; Krief, Sabrina] Kibale Natl Pk, Sebitoli UWA Stn, Great Ape Conservat Project PCGS, Ft Portal, Uganda; [Seguya, Andrew] Uganda Wildlife Author, Kampala, Uganda	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Augsburg University; Makerere University	Bortolamiol, S (corresponding author), Paris Diderot Univ, Sorbonne Paris Cite, Labe Dynam Sociales & Recomposit Espaces, UMR 7533, Paris, France.	bortolamiol.sarah@gmail.com	Marianne, Cohen/GPX-5979-2022	Marianne, Cohen/0000-0002-3411-2647	National Museum of Natural History/ATM 16; ANR JC-JC SAFAPE; Projet pour la Conservation des Grands Singes and Societe Francophone de Primatologie	National Museum of Natural History/ATM 16; ANR JC-JC SAFAPE(French National Research Agency (ANR)); Projet pour la Conservation des Grands Singes and Societe Francophone de Primatologie	Field trips have been granted by the National Museum of Natural History/ATM 16, ANR JC-JC SAFAPE, Projet pour la Conservation des Grands Singes and Societe Francophone de Primatologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsler SJ, 2009, THESIS U MICHIGAN AN; Anderson DP, 2005, BIOTROPICA, V37, P631, DOI 10.1111/j.1744-7429.2005.00080.x; [Anonymous], 2001, FORET TROPICALE HUMI; BROWN JH, 1981, AM ZOOL, V21, P877; BUTYNSKI TM, 1990, ECOL MONOGR, V60, P1, DOI 10.2307/1943024; Caldecott JO, 2005, ATLAS MONDIAL GRANDS; Cannon CH, 2007, ECOL LETT, V10, P956, DOI 10.1111/j.1461-0248.2007.01089.x; CANT J G H, 1980, Primates, V21, P538, DOI 10.1007/BF02373842; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Chapman CA, 2000, CONSERV BIOL, V14, P207, DOI 10.1046/j.1523-1739.2000.98592.x; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Chapman CA, 2005, Tropical Fruits and Frugivores: The Search for Strong Interactors, P75, DOI 10.1007/1-4020-3833-X_5; Chapman CA, 1997, AFR J ECOL, V35, P287, DOI 10.1111/j.1365-2028.1997.083-89083.x; Chapman CA, 1997, BIOTROPICA, V29, P396, DOI 10.1111/j.1744-7429.1997.tb00035.x; Chapman CA, 2000, AM J PRIMATOL, V50, P169, DOI 10.1002/(SICI)1098-2345(200003)50:3&lt;169::AID-AJP1&gt;3.0.CO;2-P; Chapman CA, 2000, INT J PRIMATOL, V21, P565, DOI 10.1023/A:1005557002854; Chapman Colin A., 1994, P41; Chapman CA, 2010, ECOL APPL, V20, P179, DOI 10.1890/09-0128.1; CONKLIN NL, 1994, BIOCHEM SYST ECOL, V22, P137, DOI 10.1016/0305-1978(94)90004-3; *FOOD AGR ORG, 2000, GLOB FOR RES ASS 200; GANZHORN JU, 1995, ECOLOGY, V76, P2084, DOI 10.2307/1941683; Goodall J., 1986, CHIMPANZEES GOMBE PA; Green R.H., 1966, RES POPUL ECOL, V8, P1, DOI [10.1007/BF02524740, DOI 10.1007/BF02524740]; Greig Smith P, 1983, QUANTITATIVE PLANT E; Hartter J.N., 2007, LANDSCAPE CHANGE KIB; Hartter J, 2011, LANDSCAPE ECOL, V26, P877, DOI 10.1007/s10980-011-9616-0; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Hockings KJ, 2011, PRIMATOL MONOGR, P221, DOI 10.1007/978-4-431-53921-6_24; IVES AR, 1995, ECOL MONOGR, V65, P217, DOI 10.2307/2937138; Janmaat KRL, 2013, ANIM COGN, V16, P851, DOI 10.1007/s10071-013-0617-z; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; Kasenene J. M., 1980, THESIS MAKERERE U KA; LEIGHTON M, 1983, P181; Lwanga JS, 2006, PRIMATES, V47, P230, DOI 10.1007/s10329-005-0173-5; Marsh KL, 2003, PRIMATES FRAGMENTS E; Masi S, 2012, PHYSIOL BEHAV, V105, P337, DOI 10.1016/j.physbeh.2011.08.012; Matsumoto-Oda A, 1999, FOLIA PRIMATOL, V70, P154, DOI 10.1159/000021688; Matsumoto-Oda A, 1998, INT J PRIMATOL, V19, P999, DOI 10.1023/A:1020322203166; Mitani JC, 2005, ANIM BEHAV, V70, P1079, DOI 10.1016/j.anbehav.2005.02.012; Mitani JC, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P102, DOI 10.1017/CBO9780511606397.011; Mitani JC, 2000, INT J PRIMATOL, V21, P269, DOI 10.1023/A:1005477504728; Mulley BG, 2004, J ENVIRON MANAGE, V71, P193, DOI 10.1016/j.jenvman.2004.02.002; Narat V, 2012, PRIMATOLOGIE, P4; Naughton-Treves L, 1998, J APPL ECOL, V35, P596, DOI 10.1046/j.1365-2664.1998.3540596.x; Newton-Fisher NE, 1999, AFR J ECOL, V37, P344, DOI 10.1046/j.1365-2028.1999.00186.x; Ohashi G, 2011, PRIMATES, V52, P1, DOI 10.1007/s10329-010-0212-8; Onderdonk DA, 2000, INT J PRIMATOL, V21, P587, DOI 10.1023/A:1005509119693; Osmaston H.A., 1959, WORKING PLAN KIBALE; Pontzer H, 2006, INT J PRIMATOL, V27, P295, DOI 10.1007/s10764-005-9011-2; Potts KB, 2011, INT J PRIMATOL, V32, P669, DOI 10.1007/s10764-011-9494-y; Potts KB, 2011, BIOTROPICA, V43, P256, DOI 10.1111/j.1744-7429.2010.00671.x; Potts KB, 2009, J ANIM ECOL, V78, P1269, DOI 10.1111/j.1365-2656.2009.01578.x; Quiatt D, 2002, AFR J ECOL, V40, P303, DOI 10.1046/j.1365-2028.2002.00356.x; Remis MJ, 2002, INT J PRIMATOL, V23, P231, DOI 10.1023/A:1013837426426; Reynolds V, 1998, OECOLOGIA, V115, P331, DOI 10.1007/s004420050524; Skorupa J.P., 1988, THESIS U CALIFORNIA; Stanford CB, 2003, INT J PRIMATOL, V24, P901, DOI 10.1023/A:1024689008159; Struhsaker T.T., 1975, RED COLOBUS MONKEY; STRUHSAKER T. T., 1997, ECOLOGY AFRICAN RAIN; Thompson ME, 2008, AM J PHYS ANTHROPOL, V135, P171, DOI 10.1002/ajpa.20718; Thompson ME, 2007, ANIM BEHAV, V73, P501, DOI 10.1016/j.anbehav.2006.09.007; TUTIN CEG, 1991, PHILOS T ROY SOC B, V334, P179, DOI 10.1098/rstb.1991.0107; TUTIN CEG, 1993, AM J PRIMATOL, V30, P195, DOI 10.1002/ajp.1350300305; Tweheyo M, 2003, AFR J ECOL, V41, P306, DOI 10.1111/j.1365-2028.2003.00475.x; Tweheyo M, 2004, FOREST ECOL MANAG, V188, P267, DOI 10.1016/j.foreco.2003.07.028; Uganda Wildlife Authority, 2005, GROUND CENS MAMM KIB; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Wanyama F, 2010, AFR J ECOL, V48, P953, DOI 10.1111/j.1365-2028.2009.01197.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wrangham Richard W., 1996, P45, DOI 10.1017/CBO9780511752414.006; Wrangham RW, 2000, PRIMATE MALES, P248; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; WRANGHAM RW, 1993, INT J PRIMATOL, V14, P243, DOI 10.1007/BF02192634; Yamakoshi G, 1998, AM J PHYS ANTHROPOL, V106, P283, DOI 10.1002/(SICI)1096-8644(199807)106:3<283::AID-AJPA2>3.0.CO;2-O	74	26	26	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102177	10.1371/journal.pone.0102177	http://dx.doi.org/10.1371/journal.pone.0102177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033459	gold, Green Published			2022-12-25	WOS:000339418300038
J	Kamath, U; De Jong, K; Shehu, A				Kamath, Uday; De Jong, Kenneth; Shehu, Amarda			Effective Automated Feature Construction and Selection for Classification of Biological Sequences	PLOS ONE			English	Article							FACTOR-BINDING SITES; I-HYPERSENSITIVE SITE; HIDDEN MARKOV-MODELS; GENETIC ALGORITHMS; ACCURATE RECOGNITION; FEATURE GENERATION; NEURAL NETWORK; PREDICTION; IDENTIFICATION; DNA	Background: Many open problems in bioinformatics involve elucidating underlying functional signals in biological sequences. DNA sequences, in particular, are characterized by rich architectures in which functional signals are increasingly found to combine local and distal interactions at the nucleotide level. Problems of interest include detection of regulatory regions, splice sites, exons, hypersensitive sites, and more. These problems naturally lend themselves to formulation as classification problems in machine learning. When classification is based on features extracted from the sequences under investigation, success is critically dependent on the chosen set of features. Methodology: We present an algorithmic framework (EFFECT) for automated detection of functional signals in biological sequences. We focus here on classification problems involving DNA sequences which state-of-the-art work in machine learning shows to be challenging and involve complex combinations of local and distal features. EFFECT uses a two-stage process to first construct a set of candidate sequence-based features and then select a most effective subset for the classification task at hand. Both stages make heavy use of evolutionary algorithms to efficiently guide the search towards informative features capable of discriminating between sequences that contain a particular functional signal and those that do not. Results: To demonstrate its generality, EFFECT is applied to three separate problems of importance in DNA research: the recognition of hypersensitive sites, splice sites, and ALU sites. Comparisons with state-of-the-art algorithms show that the framework is both general and powerful. In addition, a detailed analysis of the constructed features shows that they contain valuable biological information about DNA architecture, allowing biologists and other researchers to directly inspect the features and potentially use the insights obtained to assist wet-laboratory studies on retainment or modification of a specific signal.	[Kamath, Uday; De Jong, Kenneth; Shehu, Amarda] George Mason Univ, Fairfax, VA 22030 USA; [De Jong, Kenneth] George Mason Univ, Krasnow Inst, Fairfax, VA 22030 USA; [Shehu, Amarda] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA	George Mason University; George Mason University; George Mason University	De Jong, K (corresponding author), George Mason Univ, Fairfax, VA 22030 USA.	kdejong@gmu.edu; amarda@gmu.edu		Shehu, Amarda/0000-0001-5230-4610				Anwar F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-414; Bajic V, 2006, GENOME BIOL, V489, P457; Barash Y, 2003, RECOMB INT C RES COM, P1; Ben-Gal I, 2005, BIOINFORMATICS, V21, P2657, DOI 10.1093/bioinformatics/bti410; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Bernal A, 2003, PLOS COMPUT BIOL, V3, pe54; Bins J, 2000, THESIS COLORADO STAT; Bishop C. M., 2007, BAYESIAN STAT, P3; Bishop C. M., 2006, PATTERN RECOGNITION; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; BLUM AL, 1992, NEURAL NETWORKS, V5, P117, DOI 10.1016/S0893-6080(05)80010-3; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BRILL FZ, 1992, IEEE T NEURAL NETWOR, V3, P324, DOI 10.1109/72.125874; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Bystroff Christopher, 2008, V413, P173; Cai DY, 2000, BIOINFORMATICS, V16, P152, DOI 10.1093/bioinformatics/16.2.152; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Chuzhanova NA, 1998, BIOINFORMATICS, V14, P139, DOI 10.1093/bioinformatics/14.2.139; Claverie J, NATURE, V752, P752; CLAVERIE JM, 1994, NATURE, V371, P752, DOI 10.1038/371752a0; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cramer NL, 1985, 1 INT C GENETIC ALGO, P183; Cui F, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-2; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Davis RA, 2006, CHEMOMETR INTELL LAB, V81, P50, DOI 10.1016/j.chemolab.2005.09.006; De Jong K. A., 2001, EVOLUTIONARY COMPUTA; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Dharmasaroja P., 2011, 2011 4th International Conference on Biomedical Engineering and Informatics, P1664, DOI 10.1109/BMEI.2011.6098522; Dogan RI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-410; Dosin CD, 1997, EVOL COMPUT, V5, P1; ENCODE Consortium, 2012, NATURE, V489, P457; Fletez-Brant C, 2013, NUCLEIC ACIDS RES, V41, pW544, DOI 10.1093/nar/gkt519; Gershenzon NI, 2005, NUCLEIC ACIDS RES, V33, P2290, DOI 10.1093/nar/gki519; Grau J, 2012, J MACH LEARN RES, V13, P1967; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Habib T, 2008, BMC GENOMICS, V9, pS1; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Huang JJ, 2007, PATTERN RECOGN LETT, V28, P1825, DOI 10.1016/j.patrec.2007.05.011; Hyafil L., 1976, Information Processing Letters, V5, P15, DOI 10.1016/0020-0190(76)90095-8; Islamaj R, 2006, LECT NOTES ARTIF INT, V4213, P553; IUPAC Committee, 1985, BIOCHEMISTRY-US, V229, P75; Ivankov DN, 2004, P NATL ACAD SCI USA, V101, P8942, DOI 10.1073/pnas.0402659101; Iwamoto S, 2000, J BIOL CHEM, V275, P27324; Jiang B, 2007, BIOINFORMATICS, V23, P2823, DOI 10.1093/bioinformatics/btm473; JURKA J, 1993, NUCLEIC ACIDS RES, V21, P2252, DOI 10.1093/nar/21.9.2252; Kamath U, 2010, P 12 ANN C GEN EV CO, P179; Kamath U, 2010, P INT C BIOINSP MOD, P213; Kamath U, 2010, P IEEE C EV COMP JUL, P1; Kamath U, 2012, IEEE ACM T COMPUT BI, V9, P1387, DOI 10.1109/TCBB.2012.53; Kamath U, 2011, J BIOINF COMPUT BIOL, V9, P399, DOI 10.1142/S0219720011005586; Karchin R, 2003, PROTEINS, V51, P504, DOI 10.1002/prot.10369; Keilwagen J, 2010, BMC BIOINFORMATICS, V11, P1; Keilwagen J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001070; Kernytsky A, 2009, PROTEINS, V75, P75, DOI 10.1002/prot.22211; Kim W, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P390; King OD, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng117; Kittler J., 1978, Pattern Recognition and Signal Processing, P41; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Koza J.R., 1992, PROGRAMMING COMPUTER; Kuncheva LI, 1999, PATTERN RECOGN LETT, V20, P1149, DOI 10.1016/S0167-8655(99)00082-3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEARDI R, 1992, J CHEMOMETR, V6, P267, DOI 10.1002/cem.1180060506; LESLIE C, 2002, P PSB, V7, P566; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66; LOWREY CH, 1992, P NATL ACAD SCI USA, V89, P1143, DOI 10.1073/pnas.89.3.1143; Luke S, 2010, ECJ JAV BAS EV COMP; Luque-Escamilla PL, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061925; Majoros WH, 2003, NUCLEIC ACIDS RES, V31, P3601, DOI 10.1093/nar/gkg527; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Mathe C, 2002, NUCLEIC ACIDS RES, V30, P4103, DOI 10.1093/nar/gkf543; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Muni DP, 2006, IEEE T SYST MAN CY B, V36, P106, DOI 10.1109/TSMCB.2005.854499; Ng AY, 2002, NEURAL INFORM PROCES, P1; Noble W.S., 2004, KERNEL METHODS COMPU, P71; Noble WS, 2005, BIOINFORMATICS, V21, pI338, DOI 10.1093/bioinformatics/bti1047; Oh IS, 2004, IEEE T PATTERN ANAL, V26, P1424, DOI 10.1109/TPAMI.2004.105; Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185; Qicheng Ma, 1998, Joint Conference on Intelligent Systems 1999 (JCIS'98), P392; Ramirez R, 2007, LECT NOTES COMPUT SC, V4448, P311; Randou E. G., 2013, 2013 IEEE 3 INT C CO, P1; Ratsch G., 2004, KERNEL METHODS COMPU, P277; Raymer ML, 2000, IEEE T EVOLUT COMPUT, V4, P164, DOI 10.1109/4235.850656; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rish I, 2001, IJCAI 2001 WORKSH EM, P41; Rish I, 2001, TECHNICAL REPORT; Riviere R, 2008, J DISCRET ALGORITHMS, V6, P192, DOI 10.1016/j.jda.2007.06.001; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Schmidhuber J, 1987, THESIS; Schultheiss SJ, 2010, METHODS MOL BIOL, V674, P213, DOI 10.1007/978-1-60761-854-6_13; Schweikert G, 2009, GENOME RES, V19, P2133, DOI 10.1101/gr.090597.108; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Siedlecki W., 1988, International Journal of Pattern Recognition and Artificial Intelligence, V2, P197, DOI 10.1142/S0218001488000145; SIEDLECKI W, 1989, PATTERN RECOGN LETT, V10, P335, DOI 10.1016/0167-8655(89)90037-8; Sinha S, 2002, NUCLEIC ACIDS RES, V30, P5549, DOI 10.1093/nar/gkf669; Smialowski P, 2006, PROTEINS, V62, P343, DOI 10.1002/prot.20789; Smith Stephen Frederick, 1980, LEARNING SYSTEM BASE; Sonnenburg S, 2002, LECT NOTES COMPUT SC, V2415, P329; Sonnenburg S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S10-S7; Sonnenburg S, 2008, BIOINFORMATICS, V24, pI6, DOI 10.1093/bioinformatics/btn170; Sonnenburg S, 2006, BIOINFORMATICS, V22, pE472, DOI 10.1093/bioinformatics/btl250; Sonnenburg S, 2010, J MACH LEARN RES, V11, P1799; Spears WM, 1992, FDN GENETIC ALGORITH, V2, P221; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; Stamatoyannopoulos JA, 2012, GENOME RES, V22, P1602, DOI 10.1101/gr.146506.112; Taher Leila, 2007, Journal of Physics: Conference Series, V90, DOI 10.1088/1742-6596/90/1/012004; Tech M, 2005, BIOINFORMATICS, V21, P3568, DOI 10.1093/bioinformatics/bti563; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; TUAN D, 1984, P NATL ACAD SCI-BIOL, V81, P2718, DOI 10.1073/pnas.81.9.2718; Veltri D, 2013, INT C BIOINF COMP BI, P1; Venkatraman V, 2004, J CHEM INF COMP SCI, V44, P1686, DOI 10.1021/ci049933v; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Xing E. P., 2002, ADV NEURAL INFORM PR, P200; Yakhnenko O., 2005, ICDM IEEE INT C DAT, P1; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yu JJ, 2007, NEOPLASIA, V9, P292, DOI 10.1593/neo.07121; Zhang WS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-157; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	120	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e99982	10.1371/journal.pone.0099982	http://dx.doi.org/10.1371/journal.pone.0099982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033270	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300004
J	Ortiz, RH; Maitre, A; Barbeau, D; Lafontaine, M; Bouchard, M				Ortiz, Roberto Heredia; Maitre, Anne; Barbeau, Damien; Lafontaine, Michel; Bouchard, Michele			Use of Physiologically-Based Pharmacokinetic Modeling to Simulate the Profiles of 3-Hydroxybenzo(a) pyrene in Workers Exposed to Polycyclic Aromatic Hydrocarbons	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; URINARY-EXCRETION; PARTITION-COEFFICIENTS; METABOLITES; BENZO(A)PYRENE; 1-HYDROXYPYRENE; RISK; DISPOSITION; BIOMARKER; KINETICS	Biomathematical modeling has become an important tool to assess xenobiotic exposure in humans. In the present study, we have used a human physiologically-based pharmacokinetic (PBPK) model and an simple compartmental toxicokinetic model of benzo(a) pyrene (BaP) kinetics and its 3-hydroxybenzo(a) pyrene (3-OHBaP) metabolite to reproduce the time-course of this biomarker of exposure in the urine of industrially exposed workers and in turn predict the most plausible exposure scenarios. The models were constructed from in vivo experimental data in rats and then extrapolated from animals to humans after assessing and adjusting the most sensitive model parameters as well as species specific physiological parameters. Repeated urinary voids from workers exposed to polycyclic aromatic hydrocarbons (PAHs) have been collected over the course of a typical workweek and during subsequent days off work; urinary concentrations of 3-OHBaP were then determined. Based on the information obtained for each worker (BaP air concentration, daily shift hours, tasks, protective equipment), the time courses of 3-OHBaP in the urine of the different workers have been simulated using the PBPK and toxicokinetic models, considering the various possible exposure routes, oral, dermal and inhalation. Both models were equally able to closely reproduce the observed time course of 3-OHBaP in the urine of workers and predicted similar exposure scenarios. Simulations of various scenarios suggest that the workers under study were exposed mainly by the dermal route. Comparison of measured air concentration levels of BaP with simulated values needed to obtain a good approximation of observed time course further pointed out that inhalation was not the main route of exposure for most of the studied workers. Both kinetic models appear as a useful tool to interpret biomonitoring data of PAH exposure on the basis of 3-OHBaP levels.	[Ortiz, Roberto Heredia; Bouchard, Michele] Univ Montreal, Chaire Anal & Gest Risques Toxicol, Dept Sante Environm & Sante Travail, Montreal, PQ, Canada; [Ortiz, Roberto Heredia; Bouchard, Michele] Univ Montreal, Inst Rech Sante Publ, Montreal, PQ, Canada; [Maitre, Anne; Barbeau, Damien] Univ Grenoble 1, CHU Grenoble, Equipe Environm & Predict Sante Populat, Lab TIMC,UMR 5525, La Tronche, France; [Lafontaine, Michel] Inst Natl Rech & Secur, Vandoeuvre Les Nancy, France	Universite de Montreal; Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Bouchard, M (corresponding author), Univ Montreal, Chaire Anal & Gest Risques Toxicol, Dept Sante Environm & Sante Travail, Montreal, PQ, Canada.	michele.bouchard@umontreal.ca		Barbeau, Damien/0000-0002-7071-096X	Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail (ANSES) [2011-CRD-13]; Chair in Toxicological Risk Assessment and Management of the University of Montreal	Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail (ANSES)(French National Research Agency (ANR)); Chair in Toxicological Risk Assessment and Management of the University of Montreal	This work was supported by the Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail (ANSES) [grant number 2011-CRD-13] and the Chair in Toxicological Risk Assessment and Management of the University of Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATSDR (Agency for Toxic Substances and Disease Registry), 1995, TOX PROF POL AR HYDR; Barbeau D, 2011, ANALYST, V136, P1183, DOI 10.1039/c0an00428f; Bevington P. R., 2003, DATA REDUCTION ERROR, DOI 10.2307/2284752; Bouchard M, 2003, TOXICOL SCI, V73, P182, DOI 10.1093/toxsci/kfg061; Bouchard M, 2001, TOXICOL SCI, V64, P169, DOI 10.1093/toxsci/64.2.169; Bouchard M, 1996, TOXICOL APPL PHARM, V139, P301, DOI 10.1006/taap.1996.0169; Bouchard M, 2008, INT ARCH OCC ENV HEA, V81, P355, DOI 10.1007/s00420-007-0220-1; Bouchard M, 2006, ANN OCCUP HYG, V50, P505, DOI [10.1093/annhyg/mel005, 10.1093/annhyg/me1005]; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; Campo L, 2010, TOXICOL LETT, V192, P72, DOI 10.1016/j.toxlet.2008.12.018; Cao DX, 2005, J TOXICOL ENV HEAL A, V68, P2227, DOI 10.1080/15287390500182164; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Forster K, 2008, OCCUP ENVIRON MED, V65, P224, DOI 10.1136/oem.2006.030809; Gendre C, 2004, POLYCYCL AROMAT COMP, V24, P433, DOI 10.1080/10406630490468766; GERLOWSKI LE, 1983, J PHARM SCI, V72, P1103, DOI 10.1002/jps.2600721003; Gundel J, 2000, INT ARCH OCC ENV HEA, V73, P270, DOI 10.1007/s004200050427; Heredia-Ortiz R, 2013, J PHARMACOKINET PHAR, V40, P669, DOI 10.1007/s10928-013-9338-9; Heredia-Ortiz R, 2011, TOXICOL SCI, V122, P275, DOI 10.1093/toxsci/kfr135; Humans I.W.G.o.t.E.o.C.R.t., 2010, IARC MONOGR EVAL CAR, V94, P1; JONGENEELEN FJ, 1986, SCAND J WORK ENV HEA, V12, P137, DOI 10.5271/sjweh.2166; JONGENEELEN FJ, 1987, J CHROMATOGR-BIOMED, V413, P227, DOI 10.1016/0378-4347(87)80230-X; Jongeneelen F, 2012, INT ARCH OCC ENV HEA, V85, P689, DOI 10.1007/s00420-011-0713-9; Lafontaine M, 2004, POLYCYCL AROMAT COMP, V24, P441, DOI 10.1080/10406630490471447; Lafontaine M, 2000, ANN OCCUP HYG, V44, P89, DOI 10.1093/annhyg/44.2.89; Lafontaine M, 2002, POLYCYCL AROMAT COMP, V22, P579, DOI 10.1080/10406630290103753; LIKHACHEV AJ, 1992, ENVIRON HEALTH PERSP, V98, P211, DOI 10.2307/3431273; Lipscomb JC, 2012, ADV EXP MED BIOL, V745, P76, DOI 10.1007/978-1-4614-3055-1_6; Marie C, 2010, J APPL TOXICOL, V30, P402, DOI 10.1002/jat.1511; MORIMOTO Y, 1992, J PHARM PHARMACOL, V44, P634, DOI 10.1111/j.2042-7158.1992.tb05484.x; Payan JP, 2009, ARCH TOXICOL, V83, P873, DOI 10.1007/s00204-009-0440-0; Peters SA, 2011, PHYSIOLOGICALLY BASE, Vxvii; Peyret T, 2010, TOXICOL APPL PHARM, V249, P197, DOI 10.1016/j.taap.2010.09.010; Rey-Salgueiro L, 2008, SCI TOTAL ENVIRON, V406, P279, DOI 10.1016/j.scitotenv.2008.07.059; Saltelli A, 2004, SENSITIVITY ANAL PRA, pxi; Saltelli A, 2008, GLOBAL SENSITIVITY A, px; SANGSTER J, 1989, J PHYS CHEM REF DATA, V18, P1111, DOI 10.1063/1.555833; Scheepers PTJ, 2009, SCAND J WORK ENV HEA, V35, P212, DOI 10.5271/sjweh.1326; Schmitt W, 2008, TOXICOL IN VITRO, V22, P457, DOI 10.1016/j.tiv.2007.09.010; Scientific Committee on Food, 2002, POL AR HYDR OCC FOOD; Simon P, 2000, J CHROMATOGR B, V748, P337, DOI 10.1016/S0378-4347(00)00350-9; WEYAND EH, 1986, CANCER RES, V46, P5655	41	11	11	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102570	10.1371/journal.pone.0102570	http://dx.doi.org/10.1371/journal.pone.0102570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032692	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300063
J	Mantella, NM; Youngentob, SL				Mantella, Nicole M.; Youngentob, Steven L.			Prenatal Alcohol Exposure Increases Postnatal Acceptability of Nicotine Odor and Taste in Adolescent Rats	PLOS ONE			English	Article							GESTATIONAL ETHANOL EXPOSURE; NEUROPHYSIOLOGIC OLFACTORY RESPONSE; SOLITARY CHEMOSENSORY CELLS; FETAL-ETHANOL; RECEPTOR; SMOKING; SENSITIVITY; TOBACCO; EXPRESSION; DESENSITIZATION	Human studies indicate that alcohol exposure during gestation not only increases the chance for later alcohol abuse, but also nicotine dependence. The flavor attributes of both alcohol and nicotine can be important determinants of their initial acceptance and they both share the component chemosensory qualities of an aversive odor, bitter taste and oral irritation. There is a growing body of evidence demonstrating epigenetic chemosensory mechanisms through which fetal alcohol exposure increases adolescent alcohol acceptance, in part, by decreasing the aversion to alcohol's bitter and oral irritation qualities, as well as its odor. Given that alcohol and nicotine have noteworthy chemosensory qualities in common, we investigated whether fetal exposure to alcohol increased the acceptability of nicotine's odor and taste in adolescent rats. Study rats were alcohol-exposed during fetal development via the dams' liquid diet. Control animals received ad lib access to an iso-caloric, iso-nutritive diet throughout gestation. Odorant-induced innate behavioral responses to nicotine odor (Experiment 1) or orosensory-mediated responses to nicotine solutions (Experiment 2) were obtained, using whole-body plethysmography and brief access lick tests, respectively. Compared to controls, rats exposed to fetal alcohol showed an enhanced nicotine odor response that was paralleled by increased oral acceptability of nicotine. Given the common aversive component qualities imbued in the flavor profiles of both drugs, our findings demonstrate that like postnatal alcohol avidity, fetal alcohol exposure also influences nicotine acceptance, at a minimum, by decreasing the aversion of both its smell and taste. Moreover, they highlight potential chemosensory-based mechanism(s) by which fetal alcohol exposure increases the later initial risk for nicotine use, thereby contributing to the co-morbid expression with enhanced alcohol avidity. Where common chemosensory mechanisms are at play, our results suggest broader implications related to the consequence of fetal exposure with one substance of abuse and initial acceptability of others.	[Mantella, Nicole M.; Youngentob, Steven L.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Youngentob, Steven L.] SUNY Syracuse, Dev Exposure Alcohol Res Ctr, Syracuse, NY USA; [Youngentob, Steven L.] SUNY Binghamton, Dev Exposure Alcohol Res Ctr, Binghamton, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Youngentob, SL (corresponding author), SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA.	youngens@upstate.edu			NIH-NIDA [1R21DA027740-01]; NIH-NIAAA [AA014871, AA017823]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017823, R01AA014871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027740] Funding Source: NIH RePORTER	NIH-NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH-NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH-NIDA Grant # 1R21DA027740-01 and NIH-NIAAA Grants AA014871 and AA017823 to S.L. Youngentob. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlaouiIsmaili O, 1997, CHEM SENSES, V22, P237, DOI 10.1093/chemse/22.3.237; Alati R, 2006, ARCH GEN PSYCHIAT, V63, P1009, DOI 10.1001/archpsyc.63.9.1009; Bachmanov AA, 2003, ALCOHOL CLIN EXP RES, V27, P220, DOI 10.1097/01.ALC.0000051021.99641.19; Baer JS, 1998, J STUD ALCOHOL, V59, P533, DOI 10.15288/jsa.1998.59.533; Baer JS, 2003, ARCH GEN PSYCHIAT, V60, P377, DOI 10.1001/archpsyc.60.4.377; BATEL P, 1995, ADDICTION, V90, P977, DOI 10.1111/j.1360-0443.1995.tb03507.x; BECKER HC, 1995, NEUROTOXICOL TERATOL, V17, P57, DOI 10.1016/0892-0362(94)00055-I; BILKO A, 1994, PHYSIOL BEHAV, V56, P907, DOI 10.1016/0031-9384(94)90322-0; Bobo JK, 2000, ALCOHOL RES HEALTH, V24, P225; BRESLAU N, 1995, BEHAV GENET, V25, P95, DOI 10.1007/BF02196920; Bryant B, 2010, ACS CHEM NEUROSCI, V1, P246, DOI 10.1021/cn900042c; CAIN WS, 1980, NATURE, V284, P255, DOI 10.1038/284255a0; Cannon DS, 2005, NICOTINE TOB RES, V7, P853, DOI 10.1080/14622200500330209; Carstens E, 2007, CHEM SENSES, V32, P811, DOI 10.1093/chemse/bjm048; Chotro MG, 2003, ALCOHOL, V30, P19, DOI 10.1016/S0741-8329(03)00037-5; Collins AC, 1996, ALCOHOL CLIN EXP RES, V20, P990, DOI 10.1111/j.1530-0277.1996.tb01936.x; Dani JA, 2005, NAT NEUROSCI, V8, P1465, DOI 10.1038/nn1580; Dessirier JM, 1999, CHEM SENSES, V24, P405, DOI 10.1093/chemse/24.4.405; DIFRANZA JR, 1990, J STUD ALCOHOL, V51, P130, DOI 10.15288/jsa.1990.51.130; DOTY RL, 1975, PHYSIOL BEHAV, V14, P855, DOI 10.1016/0031-9384(75)90081-5; Doyon WM, 2013, BIOCHEM PHARMACOL, V86, P1181, DOI 10.1016/j.bcp.2013.07.007; DRISCOLL CD, 1990, NEUROTOXICOL TERATOL, V12, P231, DOI 10.1016/0892-0362(90)90094-S; Eade AM, 2010, ALCOHOL CLIN EXP RES, V34, P206, DOI 10.1111/j.1530-0277.2009.01083.x; Eade AM, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-3; EDWARDS DA, 1987, EXPERIENTIA, V43, P868, DOI 10.1007/BF01951644; Ellingson J, 2009, BEHAV GENET, V39, P62, DOI 10.1007/s10519-008-9232-1; Enoch MA, 2001, ADDICT BEHAV, V26, P399, DOI 10.1016/S0306-4603(00)00117-9; Fertig JB, 2002, ALCOHOL CLIN EXP RES, V26, P1909, DOI 10.1097/01.ALC.0000040845.55554.69; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Glendinning JI, 2012, EXP BIOL MED, V237, P236, DOI 10.1258/ebm.2011.011345; GULLIVER SB, 1995, J STUD ALCOHOL, V56, P202, DOI 10.15288/jsa.1995.56.202; Hannigan JH, 1999, ALCOHOL ALCOHOLISM E; HILL DL, 1987, J NEUROPHYSIOL, V57, P481, DOI 10.1152/jn.1987.57.2.481; HILL DL, 1988, SCIENCE, V241, P1826, DOI 10.1126/science.3175625; HILL DL, 1986, BEHAV NEUROSCI, V100, P390, DOI 10.1037/0735-7044.100.3.390; Hill DL, 2004, NUTR REV, V62, pS208, DOI 10.1111/j.1753-4887.2004.tb00101.x; Hudson R, 1998, ANN NY ACAD SCI, V855, P109, DOI 10.1111/j.1749-6632.1998.tb10552.x; Hudson R, 1999, J COMP PHYSIOL A, V185, P297, DOI 10.1007/s003590050390; Hudson Robyn, 1993, Current Opinion in Neurobiology, V3, P548, DOI 10.1016/0959-4388(93)90054-3; HUMMEL T, 1992, CHEM SENSES, V17, P13, DOI 10.1093/chemse/17.1.13; Istavan J, 1984, PSYCH B, V95; Jackson KM, 2002, ADDICTION, V97, P517, DOI 10.1046/j.1360-0443.2002.00082.x; KAPLAN AR, 1964, NATURE, V202, P1366, DOI 10.1038/2021366a0; Kichko TI, 2013, J PHARMACOL EXP THER, V347, P529, DOI 10.1124/jpet.113.205971; Kim U, 2003, SCIENCE, V229; Larsson A, 2005, ALCOHOL ALCOHOLISM, V40, P349, DOI 10.1093/alcalc/agh180; Larsson A, 2004, ALCOHOL, V34, P239, DOI 10.1016/j.alcohol.2004.10.002; Larsson A, 2002, ALCOHOL, V28, P157, DOI 10.1016/S0741-8329(02)00244-6; LICHTENSTEIGER W, 1988, PROG BRAIN RES, V73, P137, DOI 10.1016/S0079-6123(08)60502-6; Lin WH, 2008, J NEUROPHYSIOL, V99, P1451, DOI 10.1152/jn.01195.2007; Lovinger DM, 2005, NAT NEUROSCI, V8, P1471, DOI 10.1038/nn1581; Mantella NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084989; Middleton FA, 2009, BRAIN RES, V1252, P105, DOI 10.1016/j.brainres.2008.11.023; MILLER MW, 1992, BRAIN RES, V595, P17, DOI 10.1016/0006-8993(92)91447-M; MILLER MW, 1987, J COMP NEUROL, V257, P372, DOI 10.1002/cne.902570306; Muneoka K, 1999, NEUROTOXICOL TERATOL, V21, P603, DOI 10.1016/S0892-0362(99)00028-8; OLEY N, 1975, J COMP PHYSIOL PSYCH, V88, P477, DOI 10.1037/h0076401; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; Pfinder M, 2014, ALCOHOL ALCOHOLISM, V49, P143, DOI 10.1093/alcalc/agt166; Prestia LT, 2013, ALCOHOL CLIN EXP RES, V37, p64A; Prestia LT, 2011, ALCOHOL CLIN EXP RES, V35, p259A; Pritchard WS, 1996, PSYCHOPHARMACOLOGY, V127, P55, DOI 10.1007/BF02805975; ROSE JE, 1985, PHARMACOL BIOCHEM BE, V23, P289, DOI 10.1016/0091-3057(85)90572-6; San-Emeterio EP, 2006, NEUROSCI LETT, V403, P276, DOI 10.1016/j.neulet.2006.04.053; Saunders C J, 2013, F1000Res, V2, P74, DOI 10.12688/f1000research.2-74.v1; SEMKE E, 1995, NATURWISSENSCHAFTEN, V82, P148; Silver WL, 2006, CHEM SENSES, V31, P807, DOI 10.1093/chemse/bjl022; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; Snedecor SM, 2006, ADDICT BEHAV, V31, P2309, DOI 10.1016/j.addbeh.2006.02.016; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Streissguth AP, 2004, J DEV BEHAV PEDIATR, V25, P228, DOI 10.1097/00004703-200408000-00002; Streissguth AP, 1998, ALCOHOL CLIN EXP RES, V22, P325, DOI 10.1111/j.1530-0277.1998.tb03656.x; Substance Abuse and Mental Health Services Administration (SAMHSA), 2013, HHS PUBL; Thuerauf N, 2006, NEUROPSYCHOPHARMACOL, V31, P450, DOI 10.1038/sj.npp.1300842; Thuerauf N, 2000, J CLIN PSYCHOPHARM, V20, P472, DOI 10.1097/00004714-200008000-00012; Tizzano M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-3; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; US Department of Health and Human Services, 2007, ALCOHOL ALERT 71, V71, P1; VAVROUSEKJAKUBA EM, 1991, ALCOHOL CLIN EXP RES, V15, P129, DOI 10.1111/j.1530-0277.1991.tb00530.x; Walker JC, 1996, DRUG DEVELOP RES, V38, P160, DOI 10.1002/(SICI)1098-2299(199607/08)38:3/4<160::AID-DDR4>3.0.CO;2-K; YAMAGUCHI K, 1984, AM J PUBLIC HEALTH, V74, P668, DOI 10.2105/AJPH.74.7.668; Yamaguchi K, 1984, AM J PUB HLTH, V74; Yates WR, 1998, ALCOHOL ALCOHOLISM, V33, P488, DOI 10.1093/alcalc/33.5.488; Yates WR, 1998, ALCOHOL CLIN EXP RES, V22, P914, DOI 10.1111/j.1530-0277.1998.tb03889.x; Youngentob SL, 2005, CHEM SENSES, V30, P219, DOI 10.1093/chemse/bji017; Youngentob SL, 2007, BEHAV NEUROSCI, V121, P1293, DOI 10.1037/0735-7044.121.6.1293; Youngentob SL, 2007, BEHAV NEUROSCI, V121, P1306, DOI 10.1037/0735-7044.121.6.1306; Youngentob SL, 2012, EXP BIOL MED, V237, P1197, DOI 10.1258/ebm.2012.012132; Youngentob SL, 2009, P NATL ACAD SCI USA, V106, P5359, DOI 10.1073/pnas.0809804106; Zacny JP, 1990, BEHAV ASPECTS ALCOHO	90	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102255	10.1371/journal.pone.0102255	http://dx.doi.org/10.1371/journal.pone.0102255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029285	gold, Green Submitted, Green Published			2022-12-25	WOS:000341306600052
J	Paul, MC; Gilbert, M; Desvaux, S; Andriamanivo, HR; Peyre, M; Khong, NV; Thanapongtharm, W; Chevalier, V				Paul, Mathilde C.; Gilbert, Marius; Desvaux, Stephanie; Andriamanivo, Harena Rasamoelina; Peyre, Marisa; Nguyen Viet Khong; Thanapongtharm, Weerapong; Chevalier, Veronique			Agro-Environmental Determinants of Avian Influenza Circulation: A Multisite Study in Thailand, Vietnam and Madagascar	PLOS ONE			English	Article							RISK-FACTORS; SOUTHEAST-ASIA; HPAI H5N1; VIRUS; INFECTION; OUTBREAKS; DUCKS; PATTERNS; BACKYARD; CLUSTERS	Outbreaks of highly pathogenic avian influenza have occurred and have been studied in a variety of ecological systems. However, differences in the spatial resolution, geographical extent, units of analysis and risk factors examined in these studies prevent their quantitative comparison. This study aimed to develop a high-resolution, comparative study of a common set of agro-environmental determinants of avian influenza viruses (AIV) in domestic poultry in four different environments: (1) lower-Northern Thailand, where H5N1 circulated in 2004-2005, (2) the Red River Delta in Vietnam, where H5N1 is circulating widely, (3) the Vietnam highlands, where sporadic H5N1 outbreaks have occurred, and (4) the Lake Alaotra region in Madagascar, which features remarkable similarities with Asian agro-ecosystems and where low pathogenic avian influenza viruses have been found. We analyzed H5N1 outbreak data in Thailand in parallel with serological data collected on the H5 subtype in Vietnam and on low pathogenic AIV in Madagascar. Several agro-environmental covariates were examined: poultry densities, landscape dominated by rice cultivation, proximity to a water body or major road, and human population density. Relationships between covariates and AIV circulation were explored using spatial generalized linear models. We found that AIV prevalence was negatively associated with distance to the closest water body in the Red River Delta, Vietnam highlands and Madagascar. We also found a positive association between AIV and duck density in the Vietnam highlands and Thailand, and with rice landscapes in Thailand and Madagascar. Our findings confirm the important role of wetlands-rice-ducks ecosystems in the epidemiology of AI in diverse settings. Variables influencing circulation of the H5 subtype in Southeast Asia played a similar role for low pathogenic AIV in Madagascar, indicating that this area may be at risk if a highly virulent strain is introduced.	[Paul, Mathilde C.; Desvaux, Stephanie; Peyre, Marisa; Chevalier, Veronique] UR AGIRs, Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France; [Paul, Mathilde C.] Univ Toulouse, INP ENVT, UMR ENVT INRA IHAP 1225, Toulouse, France; [Gilbert, Marius] Univ Libre Bruxelles, Brussels, Belgium; [Gilbert, Marius] Fonds Natl Rech Sci, B-1050 Brussels, Belgium; [Desvaux, Stephanie] Direct Reg Alimentat Agr & Foret Languedoc Roussi, Montpellier, France; [Andriamanivo, Harena Rasamoelina] FOFIFA DRZV, Antananarivo, Madagascar; [Andriamanivo, Harena Rasamoelina] Fac Med Antananarivo, Dept Vet, Antananarivo, Madagascar; [Nguyen Viet Khong] Natl Inst Vet Res, Hanoi, Vietnam; [Thanapongtharm, Weerapong] Dept Livestock Dev, Bangkok, Thailand	CIRAD; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS	Paul, MC (corresponding author), UR AGIRs, Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France.	m.paul@envt.fr		Gilbert, Marius/0000-0003-3708-3359; Peyre, Marisa/0000-0002-0887-3418; PAUL, Mathilde C./0000-0003-2940-8547; Thanapongtharm, Weerapong/0000-0002-9957-2011	French Ministry of Foreign and European Affairs; French Research Agency project EcoFlu [ANR-06-SEST-12]; French-Thai PHC program	French Ministry of Foreign and European Affairs; French Research Agency project EcoFlu; French-Thai PHC program	This work was part of the FSP GRIPAVI project and was funded by the French Ministry of Foreign and European Affairs. The authors thank the French Research Agency project EcoFlu (ANR-06-SEST-12) and the French-Thai PHC program which provided additional support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SSU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033938; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Andriamanivo HR, 2012, PREV VET MED, V104, P114, DOI 10.1016/j.prevetmed.2011.10.008; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Cecchi G, 2008, GEOSPATIAL HEALTH, V3, P7, DOI 10.4081/gh.2008.227; Chaichoune K, 2009, J GEN VIROL, V90, P216, DOI 10.1099/vir.0.005660-0; Claes G, 2013, EPIDEMIOLOGY INFECT, P1; De Visscher M-N, 2013, EMPRES ANIMAL HLTH, V360, P26; Desvaux S, 2013, EPIDEMIOL INFECT, V141, P776, DOI 10.1017/S0950268812001628; Desvaux S, 2011, TRANSBOUND EMERG DIS, V58, P492, DOI 10.1111/j.1865-1682.2011.01227.x; Desvaux S, 2012, EPIDEMIOLOGY HIGHLY; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2011, ECOHEALTH, P1; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Goutard FL, 2012, PREV VET MED, V105, P223, DOI 10.1016/j.prevetmed.2011.12.020; Guerrini L, 2014, GEOSPATIAL HEALTH, V8, P445, DOI 10.4081/gh.2014.33; Henning J, 2009, VET RES, V40, DOI 10.1051/vetres:2008053; Hogerwerf L, 2010, ECOHEALTH; International B, 2012, IMP BIRD AR FACTSH L; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; Leo L, 2011, PREV VET MED, V102, P50, DOI 10.1016/j.prevetmed.2011.06.006; Loth L, 2010, PREV VET MED, V96, P104, DOI 10.1016/j.prevetmed.2010.05.013; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Minh PQ, 2009, PREV VET MED, V89, P16, DOI 10.1016/j.prevetmed.2009.01.004; Morens D. M., 2013, MBIO, V4; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Paul M, 2011, ACTA TROP, V118, P209, DOI 10.1016/j.actatropica.2011.03.009; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Souris M, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-3; Thanapongtharm W, 2013, GEOSPATIAL HEALTH, V8, P193, DOI 10.4081/gh.2013.66; Tiensin T, 2009, J INFECT DIS, V199, P1735, DOI 10.1086/599207; Tombari W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053524; Tran A, 2010, INT J APPL EARTH OBS, V12, P1, DOI 10.1016/j.jag.2009.09.014; Tran CC, 2013, ISPRS INT J GEO-INF, V2, P1106, DOI 10.3390/ijgi2041106; Trevennec K, 2011, ACTA TROP, V120, P160, DOI 10.1016/j.actatropica.2011.07.010; Van Boeckel TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049528; Van Boeckel TP, 2011, AGR ECOSYST ENVIRON, V141, P373, DOI 10.1016/j.agee.2011.04.013; Wang LY, 2013, EMERG INFECT DIS, V19, P1898, DOI 10.3201/eid1911.130815; Ward M, 2008, ENV ANTHROPOGENIC RI; Williams RAJ, 2008, T ROY SOC TROP MED H, V102, P471, DOI 10.1016/j.trstmh.2008.01.016; World Health Organization (WHO), 2014, 10 WHO; Xiao XM, 2006, REMOTE SENS ENVIRON, V100, P95, DOI 10.1016/j.rse.2005.10.004	46	13	14	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101958	10.1371/journal.pone.0101958	http://dx.doi.org/10.1371/journal.pone.0101958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029441	Green Submitted, gold, Green Published			2022-12-25	WOS:000341306600029
J	Sakamoto, JM; Goddard, J; Rasgon, JL				Sakamoto, Joyce M.; Goddard, Jerome; Rasgon, Jason L.			Population and Demographic Structure of Ixodes scapularis Say in the Eastern United States	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; BLACKLEGGED TICK; LYME-DISEASE; ACARI IXODIDAE; GEOGRAPHICAL VARIATION; BORRELIA-BURGDORFERI; EVOLUTIONARY HISTORY; PRINCIPAL VECTOR; DAMMINI ACARI; IDENTIFICATION	Introduction: The most significant vector of tick-borne pathogens in the United States is Ixodes scapularis Say (the blacklegged tick). Previous studies have identified significant genetic, behavioral and morphological differences between northern vs. southern populations of this tick. Because tick-borne pathogens are dependent on their vectors for transmission, a baseline understanding of the vector population structure is crucial to determining the risks and epidemiology of pathogen transmission. Methods: We investigated population genetic variation of I. scapularis populations in the eastern United States using a multilocus approach. We sequenced and analyzed the mitochondrial COI and 16S genes and three nuclear genes (serpin2, ixoderin B and lysozyme) from wild specimens. Results: We identified a deep divergence (3-7%) in I. scapularis COI gene sequences from some southern specimens, suggesting we had sampled a different Ixodes species. Analysis of mitochondrial 16S rRNA sequences did not support this hypothesis and indicated that all specimens were I. scapularis. Phylogenetic analysis and analysis of molecular variance (AMOVA) supported significant differences between northern vs. southern populations. Demographic analysis suggested that northern populations had experienced a bottleneck/expansion event sometime in the past, possibly associated with Pleistocene glaciation events. Conclusions: Similar to other studies, our data support the division of northern vs. southern I. scapularis genetic lineages, likely due to differences in the demographic histories between these geographic regions. The deep divergence identified in some COI gene sequences highlights a potential hazard of relying solely on COI for species identification ("barcoding") and population genetics in this important vector arthropod.	[Sakamoto, Joyce M.; Rasgon, Jason L.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Sakamoto, Joyce M.; Rasgon, Jason L.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Goddard, Jerome] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Mississippi State University	Sakamoto, JM (corresponding author), Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	jms1198@psu.edu		Rasgon, Jason/0000-0002-4050-8429	Huck Institutes of the Life Sciences	Huck Institutes of the Life Sciences	This research was supported by funds from the Huck Institutes of the Life Sciences to JMS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2009, GENETICS, V183, P249, DOI 10.1534/genetics.109.104042; APPERSON CS, 1993, EXP APPL ACAROL, V17, P719; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Black WC, 2009, INSECT MOL BIOL, V18, P705, DOI 10.1111/j.1365-2583.2009.00925.x; BLACK WC, 1994, P NATL ACAD SCI USA, V91, P10034, DOI 10.1073/pnas.91.21.10034; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporale DA, 1995, MOL PHYLOGENET EVOL, V4, P361, DOI 10.1006/mpev.1995.1033; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; Carver T, 2003, BIOINFORMATICS, V19, P1837, DOI 10.1093/bioinformatics/btg251; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P531; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Durden LA, 2002, EXP APPL ACAROL, V26, P257, DOI 10.1023/A:1021199914816; Dyke A.S., 1987, GEOGR PHYS QUATERNAI, V2, P237, DOI [10.7202/032681ar, DOI 10.7202/032681AR]; Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felz MW, 1996, J PARASITOL, V82, P505, DOI 10.2307/3284095; FU YX, 1993, GENETICS, V133, P693; Goddard J, 2006, J VECTOR ECOL, V31, P421, DOI 10.3376/1081-1710(2006)31[421:NROIIS]2.0.CO;2; Goddard Jerome, 2002, J Agromedicine, V8, P25, DOI 10.1300/J096v08n02_06; Goltz L, 2013, SYST APPL ACAROL-UK, V18, P212, DOI 10.11158/saa.18.3.2; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hill CA, 2005, TRENDS PARASITOL, V21, P151, DOI 10.1016/j.pt.2005.02.004; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Hutcheson HJ, 1998, EXP APPL ACAROL, V22, P51, DOI 10.1023/A:1006085424796; HUTCHESON HJ, 1995, J MED ENTOMOL, V32, P827, DOI 10.1093/jmedent/32.6.827; Keirans JE, 1996, J MED ENTOMOL, V33, P297, DOI 10.1093/jmedent/33.3.297; Kempf F, 2009, MOL ECOL, V18, P4450, DOI 10.1111/j.1365-294X.2009.04356.x; McCoy KD, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00057; MCLAIN DK, 1995, HEREDITY, V75, P303, DOI 10.1038/hdy.1995.139; McLain DK, 2001, HEREDITY, V86, P234, DOI 10.1046/j.1365-2540.2001.00835.x; MCLAIN DK, 1995, J MED ENTOMOL, V32, P353, DOI 10.1093/jmedent/32.3.353; Mechai S, 2013, J MED ENTOMOL, V50, P560, DOI 10.1603/ME12178; Norris DE, 1996, J MED ENTOMOL, V33, P78, DOI 10.1093/jmedent/33.1.78; Noureddine R, 2011, INT J PARASITOL, V41, P183, DOI 10.1016/j.ijpara.2010.08.010; OLIVER JH, 1993, J MED ENTOMOL, V30, P54, DOI 10.1093/jmedent/30.1.54; Oliver JH, 1996, J PARASITOL, V82, P926, DOI 10.2307/3284201; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Poucher KL, 1999, J PARASITOL, V85, P623, DOI 10.2307/3285734; Qiu WG, 2002, GENETICS, V160, P833; Rasgon JL, 2006, P ROY SOC B-BIOL SCI, V273, P1603, DOI 10.1098/rspb.2006.3493; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; RICH SM, 1995, P NATL ACAD SCI USA, V92, P6284, DOI 10.1073/pnas.92.14.6284; Rich SM, 1997, INSECT MOL BIOL, V6, P123, DOI 10.1111/j.1365-2583.1997.tb00080.x; Rounds MA, 2012, J MED ENTOMOL, V49, P843, DOI 10.1603/ME12038; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Scarpassa VM, 2011, AM J TROP MED HYG, V85, P857, DOI 10.4269/ajtmh.2011.11-0150; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; SPIELMAN A, 1979, J MED ENTOMOL, V15, P218, DOI 10.1093/jmedent/15.3.218; Steiner FE, 2008, J MED ENTOMOL, V45, P289, DOI 10.1603/0022-2585(2008)45[289:IACROA]2.0.CO;2; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Van Zee J, 2013, TICKS TICK-BORNE DIS, V4, P63, DOI 10.1016/j.ttbdis.2012.07.005; Venkatesan M, 2007, MOL BIOL EVOL, V24, P1208, DOI 10.1093/molbev/msm040; WESSON DM, 1993, P NATL ACAD SCI USA, V90, P10221, DOI 10.1073/pnas.90.21.10221; Wolff JN, 2013, HEREDITY, V110, P57, DOI 10.1038/hdy.2012.60; Xiong HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073329	60	34	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101389	10.1371/journal.pone.0101389	http://dx.doi.org/10.1371/journal.pone.0101389			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025532	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400014
J	Wilson, HB; Meijaard, E; Venter, O; Ancrenaz, M; Possingham, HP				Wilson, Howard B.; Meijaard, Erik; Venter, Oscar; Ancrenaz, Marc; Possingham, Hugh P.			Conservation Strategies for Orangutans: Reintroduction versus Habitat Preservation and the Benefits of Sustainably Logged Forest	PLOS ONE			English	Article							IMPACT; SUMATRA; RESERVE; WILD	The Sumatran orangutan is currently listed by the IUCN as critically endangered and the Bornean species as endangered. Unless effective conservation measures are enacted quickly, most orangutan populations without adequate protection face a dire future. Two main strategies are being pursued to conserve orangutans: (i) rehabilitation and reintroduction of excaptive or displaced individuals; and (ii) protection of their forest habitat to abate threats like deforestation and hunting. These strategies are often mirrored in similar programs to save other valued and endangered mega-fauna. Through GIS analysis, collating data from across the literature, and combining this information within a modelling and decision analysis framework, we analysed which strategy or combination of strategies is the most cost-effective at maintaining wild orangutan populations, and under what conditions. We discovered that neither strategy was optimal under all circumstances but was dependent on the relative cost per orangutan, the timescale of management concern, and the rate of deforestation. Reintroduction, which costs twelve times as much per animal as compared to protection of forest, was only a cost-effective strategy at very short timescales. For time scales longer than 10-20 years, forest protection is the more cost-efficient strategy for maintaining wild orangutan populations. Our analyses showed that a third, rarely utilised strategy is intermediate: introducing sustainable logging practices and protection from hunting in timber production forest. Maximum long-term cost-efficiency is achieved by working in conservation forest. However, habitat protection involves addressing complex conservation issues and conflicting needs at the landscape level. We find a potential resolution in that well-managed production forests could achieve intermediate conservation outcomes. This has broad implications for sustaining biodiversity more generally within an economically productive landscape. Insights from this analysis should provide a better framework to prioritize financial investments, and facilitate improved integration between the organizations that implement these strategies.	[Wilson, Howard B.; Meijaard, Erik; Venter, Oscar; Possingham, Hugh P.] Univ Queensland, Australian Res Council Ctr Excellence Environm De, Sch Biol Sci, Brisbane, Qld, Australia; [Meijaard, Erik] People & Nat Consulting Int, Jakarta, Indonesia; [Venter, Oscar] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Australia; [Venter, Oscar] James Cook Univ, Sch Marine & Trop Biol, Cairns, Australia; [Ancrenaz, Marc] Kinabatangan Orangutan Conservat Project, Sandakan, Malaysia	University of Queensland; People & Nature Consulting International; James Cook University; James Cook University	Wilson, HB (corresponding author), Univ Queensland, Australian Res Council Ctr Excellence Environm De, Sch Biol Sci, Brisbane, Qld, Australia.	h.wilson1@uq.edu.au	Venter, Oscar/ABE-1477-2021; Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019; Meijaard, Erik/A-2687-2016	Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; Meijaard, Erik/0000-0001-8685-3685	Centre for Applied Environmental Decision Analysis, a Commonwealth Environmental Research Facility Hub - Australian Government Department of Environment, Water, Heritage and the Arts	Centre for Applied Environmental Decision Analysis, a Commonwealth Environmental Research Facility Hub - Australian Government Department of Environment, Water, Heritage and the Arts	This work was supported by the Centre for Applied Environmental Decision Analysis, a Commonwealth Environmental Research Facility Hub funded by the Australian Government Department of Environment, Water, Heritage and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Applegate GB, 2002, APPL REDUCED IMPACT; Aveling R., 1982, Oryx, V16, P263; BOS, 2008, IND AUD REP FIN STAT; Caldecott J.O., 2005, WORLD ATLAS GREAT AP; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Davis JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075373; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Gaveau DLA, 2012, CONSERV LETT, V5, P142, DOI 10.1111/j.1755-263X.2011.00220.x; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Grundmann E, 2006, SOC SCI INFORM, V45, P265, DOI 10.1177/0539018406063643; Hartig F, 2008, BIOL CONSERV, V141, P2625, DOI 10.1016/j.biocon.2008.07.028; Husson Simon J., 2009, P77; Jepson P, 2002, NAT AREA J, V22, P28; Lagan P, 2007, ECOL RES, V22, P414, DOI 10.1007/s11284-007-0362-3; LardeuxGilloux I, 1995, NEGLECTED APE, P61; Linkie M, 2008, CONSERV BIOL, V22, P683, DOI 10.1111/j.1523-1739.2008.00906.x; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Marshall Andrew J., 2009, P311; McQuistan C. I., 2006, PROT AR FUND IND STU; Meijaard E, 2012, ANN NY ACAD SCI, V1249, P29, DOI 10.1111/j.1749-6632.2011.06288.x; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027491; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012813; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012042; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Pressey RL, 2004, ECOL LETT, V7, P1035, DOI 10.1111/j.1461-0248.2004.00672.x; Putz FE, 2008, FOREST ECOL MANAG, V256, P1427, DOI 10.1016/j.foreco.2008.03.036; Rijksen HD, 1999, OUR VANISHING RELATI; Rijksen HD, 1982, ORANGUTAN ITS BIOL C, P317; Ruslandi, 2011, FRONT ECOL ENVIRON, V9, P542, DOI 10.1890/11.WB.030; Russon Anne E., 2009, P327; Singleton I., 2004, ORANGUTAN POPULATION; Soehartono Tonny., 2007, STRATEGI DAN RENCANA; Tutin CEG, 2001, CONSERV BIOL, V15, P1247, DOI 10.1046/j.1523-1739.2001.00046.x; Venter O, 2013, CONSERV LETT, V6, P116, DOI 10.1111/j.1755-263X.2012.00287.x; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; Wilson HB, 2011, ECOL LETT, V14, P886, DOI 10.1111/j.1461-0248.2011.01652.x	38	28	29	4	265	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102174	10.1371/journal.pone.0102174	http://dx.doi.org/10.1371/journal.pone.0102174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025134	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000339992400047
J	Fuchs, D; Metzig, M; Bickeboller, M; Brandel, C; Roth, W				Fuchs, D.; Metzig, M.; Bickeboeller, M.; Brandel, C.; Roth, W.			The G beta 5 protein regulates sensitivity to TRAIL-induced cell death in colon carcinoma	ONCOGENE			English	Article							NF-KAPPA-B; X-LINKED INHIBITOR; SMALL-MOLECULE DISRUPTION; GROWTH-FACTOR RECEPTOR; BETA-GAMMA SUBUNITS; NUCLEAR-LOCALIZATION; APOPTOSIS PROTEIN; CANCER-CELLS; COUPLED RECEPTORS; ADENYLYL-CYCLASE	Aberrant signaling via G protein-coupled receptors (GPCRs) is implicated in numerous diseases including colon cancer. The heterotrimeric G proteins transduce signals from GPCRs to various effectors. So far, the G protein subunit G beta 5 has not been studied in the context of cancer. Here we demonstrate that G beta 5 protects colon carcinoma cells from apoptosis induced by the death ligand TRAIL via different routes. The G beta 5 protein (i) causes a decrease in the cell surface expression of the TRAIL-R2 death receptor, (ii) induces the expression of the anti-apoptotic protein XIAP and (iii) activates the NF-kappa B signaling pathway. The intrinsic resistance to TRAIL-triggered apoptosis of colon cancer cells is overcome by antagonization of G beta 5. Based on these results, targeting of G proteins emerges as a novel therapeutic approach in the experimental treatment of colon cancer.	[Fuchs, D.; Metzig, M.; Bickeboeller, M.; Brandel, C.; Roth, W.] German Canc Res Ctr, Mol Tumor Pathol, D-69120 Heidelberg, Germany; [Metzig, M.; Roth, W.] Heidelberg Univ, Inst Pathol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Roth, W (corresponding author), German Canc Res Ctr, Mol Tumor Pathol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	W.Roth@dkfz.de			Else Kroner-Fresenius Foundation [2012_A20]	Else Kroner-Fresenius Foundation	We thank William F Simonds (National Institute of Diabetes and Digestive and Kidney Diseases, USA) for providing pcDNA3-G beta 5-HA and Muxiang Zhou (Emory University School of Medicine, USA) for providing pc-cmv-I kappa B-am. This study was supported by a grant from the Else Kroner-Fresenius Foundation (2012_A20).	Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; Bayewitch ML, 1998, FASEB J, V12, P1019, DOI 10.1096/fasebj.12.11.1019; Bayewitch ML, 1998, J BIOL CHEM, V273, P2273, DOI 10.1074/jbc.273.4.2273; Behrens J, 2004, INT J DEV BIOL, V48, P477, DOI 10.1387/ijdb.041815jb; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bernard D, 2001, J BIOL CHEM, V276, P27322, DOI 10.1074/jbc.M011183200; Bhola NE, 2008, FRONT BIOSCI-LANDMRK, V13, P1857, DOI 10.2741/2805; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bookout AL, 2003, J BIOL CHEM, V278, P37569, DOI 10.1074/jbc.M306276200; Braeuer SJ, 2006, MOL CANCER RES, V4, P715, DOI 10.1158/1541-7786.MCR-05-0231; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Cummins JM, 2004, CANCER RES, V64, P3006, DOI 10.1158/0008-5472.CAN-04-0046; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Ehrhardt H, 2003, ONCOGENE, V22, P3842, DOI 10.1038/sj.onc.1206520; Fassl A, 2012, ONCOGENE, V31, P4698, DOI 10.1038/onc.2011.615; Frieze DA, 2006, ANN PHARMACOTHER, V40, P241, DOI 10.1345/aph.1G191; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Gutkind J S, 2000, Sci STKE, V2000, pre1, DOI 10.1126/stke.2000.40.re1; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Hepler John R, 2005, Sci STKE, V2005, ppe38, DOI 10.1126/stke.2942005pe38; Hintersteiner M, 2010, ACS CHEM BIOL, V5, P967, DOI 10.1021/cb100094k; Hofer-Warbinek R, 2000, J BIOL CHEM, V275, P22064, DOI 10.1074/jbc.M910346199; Holubec L, 2012, ANTICANCER RES, V32, P4007; Hull MA, 2004, MOL CANCER THER, V3, P1031; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Karashima T, 2003, CLIN CANCER RES, V9, P2786; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Kim EH, 2005, ONCOGENE, V24, P838, DOI 10.1038/sj.onc.1208241; Kim TH, 2005, ONCOGENE, V24, P597, DOI 10.1038/sj.onc.1208237; Kojima Y, 2011, J BIOL CHEM, V286, P43383, DOI 10.1074/jbc.M111.309377; Krispel CM, 2003, J NEUROSCI, V23, P6965, DOI 10.1523/JNEUROSCI.23-18-06965.2003; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Leithner K, 2009, LUNG CANCER, V65, P98, DOI 10.1016/j.lungcan.2008.10.015; Liang JJ, 1998, J NEUROCHEM, V71, P345; Lin-Lee YC, 2006, J BIOL CHEM, V281, P18878, DOI 10.1074/jbc.M513315200; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; McClanahan T, 2006, CANCER BIOL THER, V5, P419, DOI 10.4161/cbt.5.4.2521; McManus DC, 2004, ONCOGENE, V23, P8105, DOI 10.1038/sj.onc.1207967; Rojkova AM, 2003, J BIOL CHEM, V278, P12507, DOI 10.1074/jbc.M207302200; Roman DL, 2011, J MED CHEM, V54, P7433, DOI 10.1021/jm101572n; Rosato R, 2004, LEUKEMIA, V18, P1780, DOI 10.1038/sj.leu.2403491; Saif MW, 2010, EXPERT OPIN INV DRUG, V19, P357, DOI 10.1517/13543781003593962; Sakamoto K, 2010, EXPERT OPIN THER TAR, V14, P593, DOI 10.1517/14728221003769903; Schimmer AD, 2009, J CLIN ONCOL, V27, P4741, DOI 10.1200/JCO.2009.21.8172; Shirley S, 2011, RECENT PAT ANTI-CANC, V6, P311, DOI 10.2174/157489211796957757; Slepak VZ, 2009, PROG MOL BIOL TRANSL, V86, P157, DOI 10.1016/S1877-1173(09)86006-7; Smirnov AS, 2001, CELL DEATH DIFFER, V8, P621, DOI 10.1038/sj.cdd.4400853; Smrcka AV, 2013, TRENDS PHARMACOL SCI, V34, P290, DOI 10.1016/j.tips.2013.02.006; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Straszewski-Chavez SL, 2010, BIOL REPROD, V82, P146, DOI 10.1095/biolreprod.109.078972; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Vogelzang NJ, 2004, CANCER, V100, P65, DOI 10.1002/cncr.11867; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Xie P, 2000, J BIOL CHEM, V275, P24907, DOI 10.1074/jbc.M001051200; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhang JH, 2001, J BIOL CHEM, V276, P10284, DOI 10.1074/jbc.M009247200; Zhang JH, 2011, J NEUROCHEM, V119, P544, DOI 10.1111/j.1471-4159.2011.07457.x; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	68	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2015	34	21					2753	2763		10.1038/onc.2014.213	http://dx.doi.org/10.1038/onc.2014.213			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI7XN	25043307				2022-12-25	WOS:000354979500008
J	Ergel, B; Gill, ML; Brown, L; Yu, BM; Palmer, AG; Hunt, JF				Ergel, Burce; Gill, Michelle L.; Brown, Lewis; Yu, Bomina; Palmer, Arthur G., III; Hunt, John F.			Protein Dynamics Control the Progression and Efficiency of the Catalytic Reaction Cycle of the Escherichia coli DNA-Repair Enzyme AlkB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Repair; Enzyme Mechanism; Nuclear Magnetic Resonance (NMR); Protein Dynamic; X-ray Crystallography; AlkB; Fe-2OG Dioxygenase; Catalytic Efficiency; Fluorescence Spectroscopy	ALPHA-KETOGLUTARATE DIOXYGENASE; SPIN FE(IV) INTERMEDIATE; TRIOSEPHOSPHATE ISOMERASE; NMR-SPECTROSCOPY; OXIDATIVE DEMETHYLATION; OXYGEN ACTIVATION; SUBSTRATE-BINDING; KINETIC-ANALYSIS; LOOP MOTION; HYDROXYLASE	Background: AlkB is an iron/2-oxoglutarate dioxygenase that repairs alkylated DNA. Results: Enzymological and biophysical methods are used to develop a quantitative mechanistic scheme. Conclusion: A conformational transition controls the order of substrate binding and the coupling of the two sequential sub-reactions catalyzed by AlkB. Significance: These results provide a striking example of the importance of protein dynamics for efficient catalysis of a multistep reaction. A central goal of enzymology is to understand the physicochemical mechanisms that enable proteins to catalyze complex chemical reactions with high efficiency. Recent methodological advances enable the contribution of protein dynamics to enzyme efficiency to be explored more deeply. Here, we utilize enzymological and biophysical studies, including NMR measurements of conformational dynamics, to develop a quantitative mechanistic scheme for the DNA repair enzyme AlkB. Like other iron/2-oxoglutarate-dependent dioxygenases, AlkB employs a two-step mechanism in which oxidation of 2-oxoglutarate generates a highly reactive enzyme-bound oxyferryl intermediate that, in the case of AlkB, slowly hydroxylates an alkylated nucleobase. Our results demonstrate that a microsecond-to-millisecond time scale conformational transition facilitates the proper sequential order of substrate binding to AlkB. Mutations altering the dynamics of this transition allow generation of the oxyferryl intermediate but promote its premature quenching by solvent, which uncouples 2-oxoglutarate turnover from nucleobase oxidation. Therefore, efficient catalysis by AlkB depends upon the dynamics of a specific conformational transition, establishing another paradigm for the control of enzyme function by protein dynamics.	[Ergel, Burce; Brown, Lewis; Yu, Bomina; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Gill, Michelle L.; Palmer, Arthur G., III] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Columbia University	Hunt, JF (corresponding author), Columbia Univ, Dept Biol Sci, Fairchild Ctr, 702A,MC2434, New York, NY 10027 USA.	jfhunt@biology.columbia.edu		Gill, Michelle/0000-0002-2861-355X	National Institutes of Health; Keck Foundation (New York State); New York City Economic Development Corp.; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050291, F32GM089047, U54GM094597, U54GM074958, R01GM077360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation (New York State)(W.M. Keck Foundation); New York City Economic Development Corp.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Victor Wong for technical assistance and Brent Stockwell and Scott Banta for instrumentation access. We thank Christie Brouillette and Wendy Yang of the University of Alabama and Chi Wang and other members of the Hunt and Palmer laboratories for advice. The 900 MHz spectrometers were purchased with funds from the National Institutes of Health, the Keck Foundation (New York State), and the New York City Economic Development Corp.	ARAVIND L, 2001, GENOME BIOL, V2, DOI DOI 10.1186/gb-2001-2-3-research0007; Barrett P, 2004, ASTRONOMICAL DATA AN; Besley NA, 1999, J AM CHEM SOC, V121, P9636, DOI 10.1021/ja990627l; Bleijlevens B, 2008, EMBO REP, V9, P872, DOI 10.1038/embor.2008.120; Bleijlevens B, 2012, BIOCHEMISTRY-US, V51, P3334, DOI 10.1021/bi201699e; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dinglay S, 2000, GENE DEV, V14, P2097; Doucet N, 2009, BIOCHEMISTRY-US, V48, P7160, DOI 10.1021/bi900830g; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Eser BE, 2007, J AM CHEM SOC, V129, P11334, DOI 10.1021/ja074446s; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Farid S, 2011, J AM CHEM SOC, V133, P11580, DOI 10.1021/ja2024367; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Flashman E, 2010, FEBS J, V277, P4089, DOI 10.1111/j.1742-4658.2010.07804.x; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gill ML, 2011, J BIOMOL NMR, V51, P245, DOI 10.1007/s10858-011-9533-1; Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n; Hammes GG, 2011, BIOCHEMISTRY-US, V50, P10422, DOI 10.1021/bi201486f; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Helmus JJ, 2013, J BIOMOL NMR, V55, P355, DOI 10.1007/s10858-013-9718-x; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Holland PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008680; HOLME E, 1975, BIOCHEMISTRY-US, V14, P4999, DOI 10.1021/bi00693a033; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Khare D, 2010, P NATL ACAD SCI USA, V107, P14099, DOI 10.1073/pnas.1006738107; Koivisto P, 2003, J BIOL CHEM, V278, P44348, DOI 10.1074/jbc.M307361200; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P334; Liu HN, 2009, J PHYS CHEM B, V113, P4887, DOI 10.1021/jp810715t; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Massi F, 2006, BIOCHEMISTRY-US, V45, P10787, DOI 10.1021/bi060764c; McClendon S, 2005, BIOPHYS J, V89, P2024, DOI 10.1529/biophysj.105.062604; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; MYLLYLA R, 1977, EUR J BIOCHEM, V80, P349, DOI 10.1111/j.1432-1033.1977.tb11889.x; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; NICHOLSON LK, 1995, NAT STRUCT BIOL, V2, P274, DOI 10.1038/nsb0495-274; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Panay AJ, 2011, BIOCHEMISTRY-US, V50, P1928, DOI 10.1021/bi1019868; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2005, BIOCHEMISTRY-US, V44, P8138, DOI 10.1021/bi050227c; Price JC, 2003, J AM CHEM SOC, V125, P13008, DOI 10.1021/ja037400h; Proshlyakov DA, 2004, J AM CHEM SOC, V126, P1022, DOI 10.1021/ja039113j; RICCI RW, 1976, J PHYS CHEM-US, V80, P974, DOI 10.1021/j100550a011; Riggs-Gelasco PJ, 2004, J AM CHEM SOC, V126, P8108, DOI 10.1021/ja048255q; Ryle MJ, 1999, BIOCHEMISTRY-US, V38, P15278, DOI 10.1021/bi9912746; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Sillen A, 2000, PROTEIN SCI, V9, P158; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stafford KA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003218; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tugarinov V, 2007, J AM CHEM SOC, V129, P1743, DOI 10.1021/ja067827z; WILLIAMS JC, 1995, BIOCHEMISTRY-US, V34, P8309, DOI 10.1021/bi00026a012; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Wong C, 2009, J AM CHEM SOC, V131, P4872, DOI 10.1021/ja8097355; Xu YM, 2010, J MOL BIOL, V397, P233, DOI 10.1016/j.jmb.2009.10.043; Yi CQ, 2010, NATURE, V468, P330, DOI 10.1038/nature09497; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Yu B, 2009, P NATL ACAD SCI USA, V106, P14315, DOI 10.1073/pnas.0812938106; Zhou J, 1998, J AM CHEM SOC, V120, P13539, DOI 10.1021/ja983534x	68	29	38	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29584	29601		10.1074/jbc.M114.575647	http://dx.doi.org/10.1074/jbc.M114.575647			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25043760	Green Published, hybrid			2022-12-25	WOS:000344370800010
J	Morales-Lazaro, SL; Serrano-Flores, B; Llorente, I; Hernandez-Garcia, E; Gonzalez-Ramirez, R; Banerjee, S; Miller, D; Gududuru, V; Fells, J; Norman, D; Tigyi, G; Escalante-Alcalde, D; Rosenbaum, T				Morales-Lazaro, Sara L.; Serrano-Flores, Barbara; Llorente, Itzel; Hernandez-Garcia, Enrique; Gonzalez-Ramirez, Ricardo; Banerjee, Souvik; Miller, Duane; Gududuru, Veeresh; Fells, James; Norman, Derek; Tigyi, Gabor; Escalante-Alcalde, Diana; Rosenbaum, Tamara			Structural Determinants of the Transient Receptor Potential 1 (TRPV1) Channel Activation by Phospholipid Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ion Channel; Lysophospholipid; Membrane Lipid; Physiology; Transient Receptor Potential Channels (TRP Channels)	CYCLIC PHOSPHATIDIC-ACID; LYSOPHOSPHATIDIC ACID; DIACYLGLYCEROL PYROPHOSPHATE; NEUROPATHIC PAIN; POTASSIUM CHANNELS; PIP2 ACTIVATION; ION-CHANNEL; FATTY-ACIDS; DOUBLE-BOND; PPAR-GAMMA	Background: The TRPV1 ion channel can be regulated by negatively charged lipids. Results: TRPV1 shows specificity for LPA analogs containing monounsaturated hydrocarbon chains with a negatively charged phosphate, cyclic phosphate, and thiophosphate headgroup. Conclusion: TRPV1 activation is highly restricted to natural lipids with oleyl or oleoyl side chains. Significance: Production of endogenous C18:1 lysophospholipids can selectively trigger activation of TRPV1 and nociceptive neuronal responses. The transient receptor potential vanilloid 1 (TRPV1) ion channel is a polymodal protein that responds to various stimuli, including capsaicin (the pungent compound found in chili peppers), extracellular acid, and basic intracellular pH, temperatures close to 42 degrees C, and several lipids. Lysophosphatidic acid (LPA), an endogenous lipid widely associated with neuropathic pain, is an agonist of the TRPV1 channel found in primary afferent nociceptors and is activated by other noxious stimuli. Agonists or antagonists of lipid and other chemical natures are known to possess specific structural requirements for producing functional effects on their targets. To better understand how LPA and other lipid analogs might interact and affect the function of TRPV1, we set out to determine the structural features of these lipids that result in the activation of TRPV1. By changing the acyl chain length, saturation, and headgroup of these LPA analogs, we established strict requirements for activation of TRPV1. Among the natural LPA analogs, we found that only LPA 18:1, alkylglycerophosphate 18:1, and cyclic phosphatidic acid 18:1, all with a monounsaturated C18 hydrocarbon chain activate TRPV1, whereas polyunsaturated and saturated analogs do not. Thus, TRPV1 shows a more restricted ligand specificity compared with LPA G-protein-coupled receptors. We synthesized fatty alcohol phosphates and thiophosphates and found that many of them with a single double bond in position 9, 10, or 11 and 9 cyclopropyl group can activate TRPV1 with efficacy similar to capsaicin. Finally, we developed a pharmacophore and proposed a mechanistic model for how these lipids could induce a conformational change that activates TRPV1.	[Morales-Lazaro, Sara L.; Serrano-Flores, Barbara; Llorente, Itzel; Hernandez-Garcia, Enrique; Escalante-Alcalde, Diana; Rosenbaum, Tamara] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neurodesarrollo & Fisiol, Div Neurociencias, Mexico City 04510, DF, Mexico; [Gonzalez-Ramirez, Ricardo] Hosp Gen Dr Manuel Gea Gonzalez, Dept Biol Mol & Histocompatibilidad, Mexico City 14080, DF, Mexico; [Banerjee, Souvik; Miller, Duane] Univ Tennessee, Dept Pharmaceut Sci, Hlth Sci Ctr, Memphis, TN 38163 USA; [Gududuru, Veeresh] RxBio Inc, Memphis, TN 38163 USA; [Fells, James; Norman, Derek; Tigyi, Gabor] Univ Tennessee, Dept Physiol, Hlth Sci Ctr, Memphis, TN 38163 USA	Universidad Nacional Autonoma de Mexico; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Rosenbaum, T (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neurodesarrollo & Fisiol, Div Neurociencias, Mexico City 04510, DF, Mexico.	trosenba@ifc.unam.mx	Morales-Lázaro, Sara Luz/B-7333-2016; González-Ramírez, Ricardo/O-1792-2014	González-Ramírez, Ricardo/0000-0003-1399-8036; Escalante-Alcalde, Diana/0000-0003-0325-6602; Rosenbaum, Tamara/0000-0002-4791-3195	National Institutes of Health [CA-092160]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN204111]; Consejo Nacional de Ciencia y Tecnologia [129474]; Fundacion Miguel Aleman; Fundacion Marcos Moshinsky; Consejo Nacional de Ciencia y Tecnologia Grant [165897]; Van Vleet Endowment; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development [I01BX007080];  [U01-AI-107331]; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI107331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Miguel Aleman; Fundacion Marcos Moshinsky; Consejo Nacional de Ciencia y Tecnologia Grant; Van Vleet Endowment; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-092160 (to G. T.). This work was also supported by grants from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) IN204111, Consejo Nacional de Ciencia y Tecnologia 129474, Fundacion Miguel Aleman and Fundacion Marcos Moshinsky (to T. R.), Consejo Nacional de Ciencia y Tecnologia Grant 165897 (to D. E.-A.), Grant U01-AI-107331, the Van Vleet Endowment (to G. T.), and by Award I01BX007080 from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development (to G. T.)	Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Bartlett GJ, 2010, NAT CHEM BIOL, V6, P615, DOI [10.1038/NCHEMBIO.406, 10.1038/nchembio.406]; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng WWL, 2011, BIOPHYS J, V100, P620, DOI 10.1016/j.bpj.2010.12.3724; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Durgam GG, 2005, J MED CHEM, V48, P4919, DOI 10.1021/jm049609r; Engler A, 2007, BIOCHEM BIOPH RES CO, V359, P884, DOI 10.1016/j.bbrc.2007.05.178; Gududuru V, 2014, U. S. Patent, Patent No. [8, 686,177 B2, 8686177]; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4816, DOI 10.1073/pnas.1221997110; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Kakiuchi Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-33; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Kobayashi T, 1999, LIFE SCI, V65, P2185, DOI 10.1016/S0024-3205(99)00483-X; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Liu GX, 2001, CIRC RES, V88, P918, DOI 10.1161/hh0901.089881; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Ma L, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-29; Martinez-Seara H, 2007, J PHYS CHEM B, V111, P11162, DOI 10.1021/jp071894d; Morales-Lazaro SL, 2013, J PHYSIOL-LONDON, V591, P3109, DOI 10.1113/jphysiol.2013.251751; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Movahed P, 2005, J BIOL CHEM, V280, P38496, DOI 10.1074/jbc.M507429200; Nieto-Posadas A, 2012, NAT CHEM BIOL, V8, P78, DOI 10.1038/nchembio.712; Oshiro J, 2003, BBA-MOL CELL BIOL L, V1635, P1, DOI 10.1016/j.bbalip.2003.10.002; Pan HL, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-85; Perillo VL, 2012, BBA-BIOMEMBRANES, V1818, P2511, DOI 10.1016/j.bbamem.2012.06.001; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; Rosenbaum Tamara, 2007, P69; Sadofsky LR, 2012, EXP LUNG RES, V38, P75, DOI 10.3109/01902148.2011.644027; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Senning EN, 2014, J BIOL CHEM, V289, P10999, DOI 10.1074/jbc.M114.553180; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Telezhkin V, 2012, J GEN PHYSIOL, V140, P41, DOI 10.1085/jgp.201210796; Telezhkin V, 2012, J BIOL CHEM, V287, P10001, DOI 10.1074/jbc.M111.322552; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Ueda H, 2013, BBA-MOL CELL BIOL L, V1831, P61, DOI 10.1016/j.bbalip.2012.08.014; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; van Schooten B, 2006, BBA-MOL CELL BIOL L, V1761, P151, DOI 10.1016/j.bbalip.2005.12.010; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; WISSING JB, 1993, FEBS LETT, V315, P95, DOI 10.1016/0014-5793(93)81141-L; Xu XY, 2009, PROSTAG OTH LIPID M, V89, P140, DOI 10.1016/j.prostaglandins.2009.07.006	48	23	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24079	24090		10.1074/jbc.M114.572503	http://dx.doi.org/10.1074/jbc.M114.572503			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25035428	Green Published, hybrid			2022-12-25	WOS:000341505600008
J	Suzuki, Y; Jin, CH; Iwase, T; Yazawa, I				Suzuki, Yasuyo; Jin, Chenghua; Iwase, Tamaki; Yazawa, Ikuru			beta-III Tubulin Fragments Inhibit alpha-Synuclein Accumulation in Models of Multiple System Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-Synuclein; Neurodegeneration; Protein Aggregation; Protein-Protein Interaction; Tubulin; Multiple System Atrophy	DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; GLIAL CYTOPLASMIC INCLUSIONS; MOUSE MODEL; NEURODEGENERATIVE DISEASES; NEURONAL DEGENERATION; THERAPEUTIC PEPTIDES; PARKINSONS-DISEASE; FIBRIL FORMATION; OLIGODENDROCYTES; DELIVERY	Background: Neuronal and oligodendrocytic aggregation of insoluble -synuclein contributes to neuropathology in multiple system atrophy. Results: -Synuclein binds directly to -III tubulin. A fragment carrying the -synuclein-binding site inhibited -synuclein-III tubulin complex formation and intracellular -synuclein accumulation. Conclusion: Inhibition of -synuclein binding to -III tubulin may be an effective strategy for preventing -synuclein accumulation. Significance: Small -III tubulin fragments may inhibit neurodegeneration in multiple system atrophy. Multiple system atrophy (MSA) is a neurodegenerative disease caused by -synuclein aggregation in oligodendrocytes and neurons. Using a transgenic mouse model overexpressing human -synuclein in oligodendrocytes, we previously demonstrated that oligodendrocytic -synuclein inclusions induce neuronal -synuclein accumulation and progressive neuronal degeneration. -Synuclein binds to -III tubulin, leading to the neuronal accumulation of insoluble -synuclein in an MSA mouse model. The present study demonstrates that -synuclein co-localizes with -III tubulin in the brain tissue from patients with MSA and MSA model transgenic mice as well as neurons cultured from these mice. Accumulation of insoluble -synuclein in MSA mouse neurons was blocked by the peptide fragment -III tubulin (residues 235-282). We have determined the -synuclein-binding domain of -III tubulin and demonstrated that a short fragment containing this domain can suppress -synuclein accumulation in the primary cultured cells. Administration of a short -synuclein-binding fragment of -III tubulin may be a novel therapeutic strategy for MSA.	[Suzuki, Yasuyo; Jin, Chenghua; Yazawa, Ikuru] Natl Ctr Geriatr & Gerontol, Res Inst, Lab Res Resources, Obu, Aichi 4748511, Japan; [Iwase, Tamaki] Nagoya City Koseiin Med Welf Ctr, Dept Neurol, Nagoya, Aichi 4658610, Japan	National Center for Geriatrics & Gerontology	Yazawa, I (corresponding author), Natl Ctr Geriatr & Gerontol, Res Inst, Lab Res Resources, 35 Gengo, Obu, Aichi 4748511, Japan.	yazawaik@ncgg.go.jp		Suzuki, Yasuyo/0000-0002-5732-4888	Japan Foundation for Neuroscience and Mental Health; Japan Society for the Promotion of Science KAKENHI [25430058, 25830045]	Japan Foundation for Neuroscience and Mental Health(Japan Foundation for Neuroscience and Mental Health); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japan Foundation for Neuroscience and Mental Health and by Japan Society for the Promotion of Science KAKENHI Grants 25430058 and 25830045.	Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; Alim MA, 2002, J BIOL CHEM, V277, P2112, DOI 10.1074/jbc.M102981200; Arima K, 1998, ACTA NEUROPATHOL, V96, P439, DOI 10.1007/s004010050917; Asi YT, 2014, GLIA, V62, P964, DOI 10.1002/glia.22653; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Divinski I, 2006, J NEUROCHEM, V98, P973, DOI 10.1111/j.1471-4159.2006.03936.x; El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje; Fleming SM, 2011, MOL CELL NEUROSCI, V46, P597, DOI 10.1016/j.mcn.2010.12.011; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; GRAHAM JG, 1969, J NEUROL NEUROSUR PS, V32, P28, DOI 10.1136/jnnp.32.1.28; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Ito H, 2012, BIOCHEM BIOPH RES CO, V428, P348, DOI 10.1016/j.bbrc.2012.10.057; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kajikawa M, 2012, J VIROL, V86, P5288, DOI 10.1128/JVI.00219-12; LANTOS PL, 1994, J NEUROL NEUROSUR PS, V57, P129, DOI 10.1136/jnnp.57.2.129; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee HJ, 2006, EUR J NEUROSCI, V24, P3153, DOI 10.1111/j.1460-9568.2006.05210.x; Lien S, 2003, TRENDS BIOTECHNOL, V21, P556, DOI 10.1016/j.tibtech.2003.10.005; Nakayama K, 2012, BIOCHEM BIOPH RES CO, V417, P1170, DOI 10.1016/j.bbrc.2011.12.092; Nakayama K, 2009, AM J PATHOL, V174, P1471, DOI 10.2353/ajpath.2009.080503; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; Payton JE, 2001, MOL BRAIN RES, V95, P138, DOI 10.1016/S0169-328X(01)00257-1; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Suzuki Y, 2014, AM J PATHOL, V184, P790, DOI 10.1016/j.ajpath.2013.11.018; Suzuki Y, 2010, FEBS J, V277, P4873, DOI 10.1111/j.1742-4658.2010.07893.x; Tiwari Sandip B., 2006, Current Drug Delivery, V3, P219, DOI 10.2174/156720106776359230; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yazawa I, 1999, BIOCHEM BIOPH RES CO, V260, P133, DOI 10.1006/bbrc.1999.0839	36	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24374	24382		10.1074/jbc.M114.557215	http://dx.doi.org/10.1074/jbc.M114.557215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25028513	Green Published, hybrid			2022-12-25	WOS:000341505600032
J	Ambrosini, R; Borgoni, R; Rubolini, D; Sicurella, B; Fiedler, W; Bairlein, F; Baillie, SR; Robinson, RA; Clark, JA; Spina, F; Saino, N				Ambrosini, Roberto; Borgoni, Riccardo; Rubolini, Diego; Sicurella, Beatrice; Fiedler, Wolfgang; Bairlein, Franz; Baillie, Stephen R.; Robinson, Robert A.; Clark, Jacquie A.; Spina, Fernando; Saino, Nicola			Modelling the Progression of Bird Migration with Conditional Autoregressive Models Applied to Ringing Data	PLOS ONE			English	Article							SWALLOW HIRUNDO-RUSTICA; RECENT CLIMATE-CHANGE; LONG-TERM TRENDS; SPRING MIGRANTS; ARRIVAL; RESPONSES; GEOLOCATORS; REGRESSION; PHENOLOGY	Migration is a fundamental stage in the life history of several taxa, including birds, and is under strong selective pressure. At present, the only data that may allow for both an assessment of patterns of bird migration and for retrospective analyses of changes in migration timing are the databases of ring recoveries. We used ring recoveries of the Barn Swallow Hirundo rustica collected from 1908-2008 in Europe to model the calendar date at which a given proportion of birds is expected to have reached a given geographical area ('progression of migration') and to investigate the change in timing of migration over the same areas between three time periods (1908-1969, 1970-1990, 1991-2008). The analyses were conducted using binomial conditional autoregressive (CAR) mixed models. We first concentrated on data from the British Isles and then expanded the models to western Europe and north Africa. We produced maps of the progression of migration that disclosed local patterns of migration consistent with those obtained from the analyses of the movements of ringed individuals. Timing of migration estimated from our model is consistent with data on migration phenology of the Barn Swallow available in the literature, but in some cases it is later than that estimated by data collected at ringing stations, which, however, may not be representative of migration phenology over large geographical areas. The comparison of median migration date estimated over the same geographical area among time periods showed no significant advancement of spring migration over the whole of Europe, but a significant advancement of autumn migration in southern Europe. Our modelling approach can be generalized to any records of ringing date and locality of individuals including those which have not been recovered subsequently, as well as to geo-referenced databases of sightings of migratory individuals.	[Ambrosini, Roberto; Sicurella, Beatrice] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Borgoni, Riccardo] Univ Milano Bicocca, Dipartimento Econ Metodi Quantitativi & Strategie, Milan, Italy; [Rubolini, Diego; Saino, Nicola] Univ Milano Bicocca, Dipartimento Biosci, Milan, Italy; [Fiedler, Wolfgang] Max Plank Inst Ornithol, Vogelwarte Radolfzell, Radolfzell, Germany; [Bairlein, Franz] Inst Avian Res Vogelwarte Helgoland, Wilhelmshaven, Germany; [Baillie, Stephen R.; Robinson, Robert A.; Clark, Jacquie A.] British Trust Ornithol, Thetford, Norfolk, England; [Spina, Fernando] Ist Super Protez & Ric Ambientale, Ozzano Dellemilia, BO, Italy	University of Milano-Bicocca; University of Milano-Bicocca; University of Milano-Bicocca; Max Planck Society; British Trust for Ornithology	Ambrosini, R (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy.	roberto.ambrosini@unimib.it	Fiedler, Wolfgang/AAG-4510-2021; Ambrosini, Roberto/F-3188-2012; Rubolini, Diego/F-2851-2011; borgoni, riccardo/AAZ-4171-2020; Baillie, Stephen/H-3023-2013; Robinson, Robert/B-8237-2009	Fiedler, Wolfgang/0000-0003-1082-4161; Ambrosini, Roberto/0000-0002-7148-1468; Rubolini, Diego/0000-0003-2703-5783; borgoni, riccardo/0000-0002-2520-3512; Baillie, Stephen/0000-0001-5126-9470; Robinson, Robert/0000-0003-0504-9906; Saino, Nicola/0000-0002-0230-3967				Ambrosini R, 2009, J THEOR BIOL, V257, P203, DOI 10.1016/j.jtbi.2008.11.019; Ambrosini R, 2011, CLIM RES, V49, P131, DOI 10.3354/cr01025; Arlt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082316; Baddeley A, 2010, ELECTRON J STAT, V4, P1151, DOI 10.1214/10-EJS581; Bates D, 2012, LME4 LINEAR MIXED EF; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Bauer S, 2009, BIOL LETTERS, V5, P433, DOI 10.1098/rsbl.2009.0324; Bivand RS, 2008, USE R, P1; Costantini D, 2013, CURR ZOOL, V59, P697, DOI 10.1093/czoolo/59.6.697; Cramp J, 1988, BIRDS W PALEARCTIC, VV; Delmore KE, 2012, P ROY SOC B-BIOL SCI, V279, P4582, DOI 10.1098/rspb.2012.1229; EFRON B, 1978, J AM STAT ASSOC, V73, P113, DOI 10.2307/2286531; Fiedler W, 2003, AVIAN MIGRATION, P21; Gordo O, 2006, GLOBAL CHANGE BIOL, V12, P1993, DOI 10.1111/j.1365-2486.2006.01178.x; Huin N, 1998, BIRD STUDY, V45, P361, DOI 10.1080/00063659809461108; Jenni L, 2003, P ROY SOC B-BIOL SCI, V270, P1467, DOI 10.1098/rspb.2003.2394; Korner-Nievergelt F, 2010, J AVIAN BIOL, V41, P8, DOI 10.1111/j.1600-048X.2009.04907.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Mackay AJ, 2002, LEICESTERSHIRE RUTLA; MASON CF, 1995, BIRD STUDY, V42, P182, DOI 10.1080/00063659509477167; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller Anders Pape, 2010, P33; MOLLER AP, 1994, BEHAV ECOL SOCIOBIOL, V35, P115, DOI 10.1007/BF00171501; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pinheiro JC, 2008, NLME LINEAR NONLINEA, P1; R Core Team, 2012, R LANG ENV STAT COMP; Robinson Robert A., 2009, Endangered Species Research, V7, P87, DOI 10.3354/esr00095; Rubolini D, 2002, J AVIAN BIOL, V33, P15, DOI 10.1034/j.1600-048X.2002.330104.x; Rubolini D, 2007, CLIM RES, V35, P135, DOI 10.3354/cr00720; Rubolini D, 2007, INT J BIOMETEOROL, V51, P553, DOI 10.1007/s00484-007-0094-7; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Scandolara C, 2014, J AVIAN BIO IN PRESS; Schmidt Ernst, 2007, Vogelwarte, V45, P27; Schwartz M.D., 2003, PHENOLOGY INTEGRATIV; SPARKS TH, 1995, J ECOL, V83, P321, DOI 10.2307/2261570; SPINA F, 1994, OSTRICH, V65, P137, DOI 10.1080/00306525.1994.9639676; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Turner A., 2006, BARN SWALLOW; Van Noordwijk, 2001, EURING EXCHANGE CODE; Visser ME, 2009, GLOBAL CHANGE BIOL, V15, P1859, DOI 10.1111/j.1365-2486.2009.01865.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	45	11	13	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102440	10.1371/journal.pone.0102440	http://dx.doi.org/10.1371/journal.pone.0102440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047331	Green Submitted, gold, Green Published			2022-12-25	WOS:000339558100030
J	Estrada-Pena, A; Carreon, D; Almazan, C; de la Fuente, J				Estrada-Pena, Agustin; Carreon, Diana; Almazan, Consuelo; de la Fuente, Jose			Modeling the Impact of Climate and Landscape on the Efficacy of White Tailed Deer Vaccination for Cattle Tick Control in Northeastern Mexico	PLOS ONE			English	Article							BOOPHILUS-ANNULATUS ACARI; IXODES-RICINUS; ANIMAL MOVEMENT; IXODIDAE; HABITAT; INFESTATIONS; MICROPLUS; SIMULATION	Cattle ticks are distributed worldwide and affect animal health and livestock production. White tailed deer (WTD) sustain and spread cattle tick populations. The aim of this study was to model the efficacy of anti-tick vaccination of WTD to control tick infestations in the absence of cattle vaccination in a territory where both host species coexist and sustain cattle tick populations. Agent-based models that included land cover/landscape properties (patch size, distances to patches) and climatic conditions were built in a GIS environment to simulate WTD vaccine effectiveness under conditions where unvaccinated cattle shared the landscape. Published and validated information on tick life cycle was used to build models describing tick mortality and developmental rates. Data from simulations were applied to a large territory in northeastern Mexico where cattle ticks are endemic and WTD and cattle share substantial portions of the habitat. WTD movements were simulated together with tick population dynamics considering the actual landscape and climatic features. The size of the vegetation patches and the distance between patches were critical for the successful control of tick infestations after WTD vaccination. The presence of well-connected, large vegetation patches proved essential for tick control, since the tick could persist in areas of highly fragmented habitat. The continued application of one yearly vaccination on days 1-70 for three years reduced tick abundance/animal/patch by a factor of 40 and 60 for R. annulatus and R. microplus, respectively when compared to non-vaccinated controls. The study showed that vaccination of WTD alone during three consecutive years could result in the reduction of cattle tick populations in northeastern Mexico. Furthermore, the results of the simulations suggested the possibility of using vaccines to prevent the spread and thus the re-introduction of cattle ticks into tick-free areas.	[Estrada-Pena, Agustin] Fac Vet Med, Dept Parasitol, Zaragoza, Spain; [Carreon, Diana] Univ Autonoma Tamaulipas, Inst Ecol Aplicada, Ciudad Victoria, Tamaulipas, Mexico; [Almazan, Consuelo] Univ Autonoma Tamaulipas, Fac Med Vet & Zootecnia, Ciudad Victoria, Tamaulipas, Mexico; [de la Fuente, Jose] Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, SaBio, Ciudad Real, Spain; [de la Fuente, Jose] Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA	Universidad Autonoma de Tamaulipas; Universidad Autonoma de Tamaulipas; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Oklahoma State University System; Oklahoma State University - Stillwater	de la Fuente, J (corresponding author), Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, SaBio, Ciudad Real, Spain.	jose_delafuente@yahoo.com	de la Fuente, José/AAU-1197-2020	de la Fuente, José/0000-0001-7383-9649; Estrada Pena, Agustin/0000-0001-7483-046X	EU [278976]	EU(European Commission)	This research was supported by the EU FP7 ANTIGONE project number 278976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Delfin-Alfonso CA, 2009, TROP CONSERV SCI, V2, P215, DOI 10.1177/194008290900200208; BARNARD DR, 1991, J MED ENTOMOL, V28, P557, DOI 10.1093/jmedent/28.5.557; Carreon D, 2012, VACCINE, V30, P273, DOI 10.1016/j.vaccine.2011.10.099; Castle C., 2006, SERIES-J SPAN ECON; Corson MS, 2004, ECOL MODEL, V180, P487, DOI 10.1016/j.ecolmodel.2004.04.034; De la Fuente J, 2006, PARASITE IMMUNOL, V28, P275, DOI 10.1111/j.1365-3024.2006.00828.x; de la Fuente J, 1998, VACCINE, V16, P366, DOI 10.1016/S0264-410X(97)00208-9; de la Fuente Jose, 2007, Animal Health Research Reviews, V8, P23, DOI 10.1017/S1466252307001193; de la Fuente Jose, 2003, Expert Rev Vaccines, V2, P583; de la Fuente J, 2011, VET PARASITOL, V181, P17, DOI 10.1016/j.vetpar.2011.04.018; de la Vega R., 1984, Revista de Salud Animal, V6, P59; de Leon AAP, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-36; Estrada-Pena A, 2003, ECOGRAPHY, V26, P661, DOI 10.1034/j.1600-0587.2003.03530.x; Estrada-Pena A, 2006, VET PARASITOL, V142, P350, DOI 10.1016/j.vetpar.2006.07.003; Estrada-Pena A, 2014, MED VET ENTOMOL, V28, P35, DOI 10.1111/mve.12009; Felix AB, 2007, J WILDLIFE MANAGE, V71, P804, DOI 10.2193/2006-366; GEORGE J E, 1990, Journal of Agricultural Entomology, V7, P119; GRAHAM OH, 1966, ANN ENTOMOL SOC AM, V59, P450, DOI 10.1093/aesa/59.3.450; Hagerman A., 2010, 102 AGR FOOD POL CTR, P1; Halos L, 2010, APPL ENVIRON MICROB, V76, P4413, DOI 10.1128/AEM.00610-10; Hanks EM, 2012, ARXIV12111992; Hanley T.A., 2012, FORAGE RESOURCE EVAL; Hellickson MW, 2008, SOUTHWEST NAT, V53, P1, DOI 10.1894/0038-4909(2008)53[1:SRASFO]2.0.CO;2; Hooten MB, 2010, J AGR BIOL ENVIR ST, V15, P523, DOI 10.1007/s13253-010-0038-2; Lohmeyer KH, 2011, J MED ENTOMOL, V48, P770, DOI 10.1603/ME10209; Macal CM, 2005, PROCEEDINGS OF THE 2005 WINTER SIMULATION CONFERENCE, VOLS 1-4, P2, DOI 10.1109/WSC.2005.1574234; Marshall C.M., 1993, P 28 N AM WILDL NAT, P226; Merino O, 2011, VACCINE, V29, P8575, DOI 10.1016/j.vaccine.2011.09.023; Morgan ER, 2004, TRENDS ECOL EVOL, V19, P181, DOI 10.1016/j.tree.2004.01.011; MOUNT GA, 1991, J MED ENTOMOL, V28, P223, DOI 10.1093/jmedent/28.2.223; Pound JM, 2010, J ECON ENTOMOL, V103, P211, DOI 10.1603/EC09359; Racelis AE, 2012, J MED ENTOMOL, V49, P410, DOI 10.1603/ME11104; Rodriguez-Vivas RI, 2013, EXP APPL ACAROL, V60, P543, DOI 10.1007/s10493-013-9672-z; Rubel F, 2010, METEOROL Z, V19, P135, DOI 10.1127/0941-2948/2010/0430; STREY OF, 1991, J MED ENTOMOL, V28, P165, DOI 10.1093/jmedent/28.1.165; Tack W, 2012, FOREST ECOL MANAG, V265, P30, DOI 10.1016/j.foreco.2011.10.028; Tang WW, 2010, GEOGR COMPASS, V4, pCP7, DOI 10.1111/j.1749-8198.2010.00337.x; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Vuilleumier S, 2006, ECOL MODEL, V190, P159, DOI 10.1016/j.ecolmodel.2005.04.017; Walter WD, 2009, LANDSCAPE ECOL, V24, P1405, DOI 10.1007/s10980-009-9374-4; Wang HH, 2012, ECOL MODEL, V243, P42, DOI 10.1016/j.ecolmodel.2012.06.007; Willadsen P, 2006, VET PARASITOL, V138, P161, DOI 10.1016/j.vetpar.2006.01.050	42	16	16	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102905	10.1371/journal.pone.0102905	http://dx.doi.org/10.1371/journal.pone.0102905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047078	Green Published, gold			2022-12-25	WOS:000339558100087
J	Li, L; Yan, HF; Niu, M; Tu, TY; Li, SJ; Xing, FW				Li, Lin; Yan, Hai-Fei; Niu, Miao; Tu, Tie-Yao; Li, Shi-Jin; Xing, Fu-Wu			Re-Establishment of the Genus Ania Lindl. (Orchidaceae)	PLOS ONE			English	Article							CHLOROPLAST DNA; MOLECULAR PHYLOGENETICS; SEQUENCES; NUCLEAR; EVOLUTION; REGIONS	Ania Lindl. is a small genus of the tribe Collabieae subtribe Collabiinae (Orchidaceae). For the last 150 years, it has generally been treated as a synonym of Tainia Blume. In this study, we critically re-examined morphological characters that have been used to distinguish Ania from Tainia, and assessed the phylogeny of Tainia using morphological and palynological characters. Sequences of the nuclear ribosomal ITS, chloroplast trnL intron and combined DNA data sets were analysed to clarify the delimitation and the phylogeny of these groups. The morphological and palynological survey revealed a number of useful diagnostic characters which permit a clear definition of Ania, after the exclusion of a single taxonomically questionable species. Results confirmed that Ania is distinct from Tainia. Phylogenetic reconstructions based on molecular data provided the greatest resolution and produced a morphologically well differentiated clade of Ania. In addition to morphological and suggested palynological characters, the phylogenies were also supported by karyological evidence. Our results support the independent generic status of Ania. The genus name Ania is revived and re-established.	[Li, Lin; Yan, Hai-Fei; Niu, Miao; Tu, Tie-Yao; Li, Shi-Jin; Xing, Fu-Wu] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Niu, Miao] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	lisj@scib.ac.cn; xinfw@scib.ac.cn		Tu, Tieyao/0000-0001-7385-008X	National Natural Science Foundation of China [31100149, 31270248]; Special Foundation for National Basic Research of the Ministry of Science and Technology, China [2013FY112100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation for National Basic Research of the Ministry of Science and Technology, China	This research has been financially supported by grants from the National Natural Science Foundation of China (Grant Nos. 31100149 and 31270248) and Special Foundation for National Basic Research of the Ministry of Science and Technology, China (Grant No. 2013FY112100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama Mikio, 1992, Journal of Japanese Botany, V67, P330; Bentham G., 1883, GENERA PLANTARUM, V3, DOI 10.5962/bhl.title.747; Bentham G, 1881, BOT J LINNEAN SOC, V18, P281, DOI DOI 10.1111/J.1095-8339.1881.TB01258.X; BISWAS BK, 1980, TAXON, V29, P163; Blume CL, 1828, FLORA JAVAE NEC NONI, P1; Blume CL, 1856, MUSEUM BOT LUGDANO B, V2, P185; Blume CL, 1825, BUJDRAGEN FLORA NEDE, V7, P354; Brandham PE, 1999, GENERA ORCHIDACEARUM, V1, P67; Chen SC, 2009, FLORA CHINA, V25, P281; Douzery EJP, 1999, AM J BOT, V86, P887, DOI 10.2307/2656709; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Dressler RL, 1981, ORCHIDS NATURAL HIST; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gene Codes Corporation, 2005, SEQ VERS 4 5; Hooker J.D., 1887, FLORA BRIT INDIA, V5, DOI 10.5962/bhl.title.678; Hu SY, 1977, THESIS; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; Kocyan A, 2004, PLANT SYST EVOL, V247, P203, DOI 10.1007/s00606-004-0133-3; Kolaczkowski B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007891; Li L, 2009, SYSTEMATICS TAINIA; Lindley J, 1830, GENERA SPECIES ORC 2; Mehra P.N, 1976, TAXON, V25, P631; NELSON G, 1979, SYST ZOOL, V28, P1, DOI 10.2307/2412995; Pearce NR, 2002, FLORA BHUTAN 3, V3; Pfitzer EHH, 1889, NATURL PFLANZ, P147; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pridgeon Alec M., 1997, Lindleyana, V12, P89; Radhamoni G, 1985, NEW BOT, V12, P77; Rambaut A, 2007, SE AL SEQUENCE ALIGN; Reichenbach HG, 1857, BONPLANDIA, V5, P31; Ridley HN, 1907, MAT FLORA MALAYAN PE, V1, P114; ROHLF FJ, 1982, MATH BIOSCI, V59, P131; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCHILL R, 1977, Pollen et Spores, V19, P5; Schlechter R, 1915, HDB ORCHIDEENLIEBHAB, p[127, 316]; Schlechter R, 1919, REPERT SP NOV REGNI, V4, P179; Schlechter R, 1919, REPERT SP NOV REGNI, V4, P246; Seidenfaden G, 1992, OPERA BOT, V114, P78; Seidenfaden G, 1986, OPERA BOT, V89, P24; Senghas K, 1984, SCHLECHTER R ORCHIDE, V1, P852; SHARMA AK, 1966, NUCLEUS CALCUTTA, V9, P177; Smith JJ, 1910, B DEP AGR IND NEERL, V43, P18; Smith JJ, 1912, B JARD BOT BUITENZ 2, V8, P5; Soliva M, 2001, MOL PHYLOGENET EVOL, V20, P78, DOI 10.1006/mpev.2001.0953; Summerhayes VS, 1939, BOT MAG, V161, P9553; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TANAKA R, 1972, BOT MAG TOKYO, V85, P43, DOI 10.1007/BF02489199; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turner H, 1992, ORCHID MONOGRAPHS, V6, P43; van den Berg C, 2005, AM J BOT, V92, P613, DOI 10.3732/ajb.92.4.613; Vogel de EF, 2005, GENERA ORCHIDACEARUM, Vvol. 4, P158; Xiang XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087625; Zwickl DJ, 2006, THESIS UT AUSTIN	56	3	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103129	10.1371/journal.pone.0103129	http://dx.doi.org/10.1371/journal.pone.0103129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047255	Green Submitted, Green Published, gold			2022-12-25	WOS:000339558100109
J	Korucuoglu, M; Isci, S; Ozgur, A; Otu, HH				Korucuoglu, Melike; Isci, Senol; Ozgur, Arzucan; Otu, Hasan H.			Bayesian Pathway Analysis of Cancer Microarray Data	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; TUMOR-SUPPRESSOR P53; GENE-SET APPROACH; METASTASIS; PROGRESSION; DISCOVERY; GROWTH; MODEL	High Throughput Biological Data (HTBD) requires detailed analysis methods and from a life science perspective, these analysis results make most sense when interpreted within the context of biological pathways. Bayesian Networks (BNs) capture both linear and nonlinear interactions and handle stochastic events in a probabilistic framework accounting for noise making them viable candidates for HTBD analysis. We have recently proposed an approach, called Bayesian Pathway Analysis (BPA), for analyzing HTBD using BNs in which known biological pathways are modeled as BNs and pathways that best explain the given HTBD are found. BPA uses the fold change information to obtain an input matrix to score each pathway modeled as a BN. Scoring is achieved using the Bayesian-Dirichlet Equivalent method and significance is assessed by randomization via bootstrapping of the columns of the input matrix. In this study, we improve on the BPA system by optimizing the steps involved in "Data Preprocessing and Discretization'', "Scoring'', "Significance Assessment'', and "Software and Web Application''. We tested the improved system on synthetic data sets and achieved over 98% accuracy in identifying the active pathways. The overall approach was applied on real cancer microarray data sets in order to investigate the pathways that are commonly active in different cancer types. We compared our findings on the real data sets with a relevant approach called the Signaling Pathway Impact Analysis (SPIA).	[Korucuoglu, Melike; Ozgur, Arzucan] Bogazici Univ Bebek, Dept Comp Engn, Istanbul, Turkey; [Isci, Senol] Sci & Technol Res Council Turkey TUBITAK, Informat & Informat Secur Res Ctr, Gebze, Kocaeli, Turkey; [Otu, Hasan H.] Istanbul Bilgi Univ, Dept Genet & Bioengn, Istanbul, Turkey; [Otu, Hasan H.] Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA	Bogazici University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Istanbul Bilgi University; University of Nebraska System; University of Nebraska Lincoln	Otu, HH (corresponding author), Istanbul Bilgi Univ, Dept Genet & Bioengn, Santral Campus, Istanbul, Turkey.	hotu2@unl.edu	Ozgur, Arzucan/I-3147-2012	Ozgur, Arzucan/0000-0001-8376-1056; Otu, Hasan/0000-0002-9253-8152	Scientific and Technological Research Council of Turkey (TUBITAK) [111E042]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by the Scientific and Technological Research Council of Turkey (TUBITAK) grant number 111E042 (HHO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Assaily W, 2011, MOL CELL, V44, P491, DOI 10.1016/j.molcel.2011.08.038; Bauer S, 2010, NUCLEIC ACIDS RES, V38, P3523, DOI 10.1093/nar/gkq045; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bronder JL, 2003, J BIOL CHEM, V278, P48861, DOI 10.1074/jbc.M304844200; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chaker S, 2013, THYROID, V23, P201, DOI 10.1089/thy.2012.0405; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; Drier Y, 2013, P NATL ACAD SCI USA, V110, P6388, DOI 10.1073/pnas.1219651110; Edwards D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-167; England B, 2013, TUMOR BIOL, V34, P2063, DOI 10.1007/s13277-013-0871-3; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Griffiths TRL, 1996, BRIT J CANCER, V74, P579, DOI 10.1038/bjc.1996.404; Hase T, 2011, CANCER SCI, V102, P1493, DOI 10.1111/j.1349-7006.2011.01973.x; Hayakawa K, 2009, ANTICANCER RES, V29, P1211; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Imoto Seiya, 2003, J Bioinform Comput Biol, V1, P231, DOI 10.1142/S0219720003000071; Isci S, 2011, BIOINFORMATICS, V27, P1667, DOI 10.1093/bioinformatics/btr269; Jagannathan L, 2012, GENE, V494, P130, DOI 10.1016/j.gene.2011.11.031; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khutornenko AA, 2010, P NATL ACAD SCI USA, V107, P12828, DOI 10.1073/pnas.0910885107; Kontkanen P, 2007, INFORM PROCESS LETT, V103, P227, DOI 10.1016/j.ipl.2007.04.003; Krupp M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-53; Lane N., 2009, LIFE ASCENDING 10 GR; Lang K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-27; Li DM, 2011, BREAST CANCER RES TR, V128, P7, DOI 10.1007/s10549-011-1499-x; Li J, 2012, J HUM GENET, V57, P642, DOI 10.1038/jhg.2012.86; Li SZ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r115; Li Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-520; Lu M, 2014, FEBS LETT; Lu Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn434; Martini P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks866; Mieczkowski J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041541; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Murase D, 2009, J BIOL CHEM, V284, P4343, DOI 10.1074/jbc.M805570200; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Neapolitan R.E., 2004, LEARNING BAYESIAN NE; Okegawa T, 2004, ACTA BIOCHIM POL, V51, P445; Paschos KA, 2009, CELL SIGNAL, V21, P665, DOI 10.1016/j.cellsig.2009.01.006; Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Rissanen JJ, 1996, IEEE T INFORM THEORY, V42, P40, DOI 10.1109/18.481776; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sehgal A, 1998, INT J CANCER, V76, P451, DOI 10.1002/(SICI)1097-0215(19980518)76:4<451::AID-IJC1>3.0.CO;2-Q; Silander T, 2010, INT J APPROX REASON, V51, P544, DOI 10.1016/j.ijar.2010.01.012; Spirtes P., 1995, P 11 C UNC ART INT, P491; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Wang PI, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r125; Watanabe M, 2014, IMMUNITY, V40, P681, DOI 10.1016/j.immuni.2014.04.006; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Zastre JA, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-16; [No title captured]; [No title captured]	60	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102803	10.1371/journal.pone.0102803	http://dx.doi.org/10.1371/journal.pone.0102803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036210	Green Published, gold			2022-12-25	WOS:000339615200089
J	Zanardelli, M; Micheli, L; Cinci, L; Failli, P; Ghelardini, C; Mannelli, LD				Zanardelli, Matteo; Micheli, Laura; Cinci, Lorenzo; Failli, Paola; Ghelardini, Carla; Mannelli, Lorenzo Di Cesare			Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPAR gamma Agonism as Preventive Pharmacological Approach	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; INDUCED OXIDATIVE STRESS; DOPAMINERGIC NEURODEGENERATION; 1ST-LINE TREATMENT; COLORECTAL-CANCER; NERVOUS-SYSTEM; ROSIGLITAZONE; BRAIN; RAT; INFLAMMATION	The development of neuropathic syndromes is an important, dose limiting side effect of anticancer agents like platinum derivates, taxanes and vinca alkaloids. The causes of neurotoxicity are still unclear but the impairment of the oxidative equilibrium is strictly related to pain. Two intracellular organelles, mitochondria and peroxisomes cooperate to the maintaining of the redox cellular state. Whereas a relationship between chemotherapy-dependent mitochondrial alteration and neuropathy has been established, the role of peroxisome is poor explored. In order to study the mechanisms of oxaliplatin-induced neurotoxicity, peroxisomal involvement was evaluated in vitro and in vivo. In primary rat astrocyte cell culture, oxaliplatin (10 mu M for 48 h or 1 mu M for 5 days) increased the number of peroxisomes, nevertheless expression and functionality of catalase, the most important antioxidant defense enzyme in mammalian peroxisomes, were significantly reduced. Five day incubation with the selective Peroxisome Proliferator Activated Receptor-gamma (PPAR-gamma) antagonist G3335 (30 mu M) induced a similar peroxisomal impairment suggesting a relationship between PPAR gamma signaling and oxaliplatin neurotoxicity. The PPAR gamma agonist rosiglitazone (10 mu M) reduced the harmful effects induced both by G3335 and oxaliplatin. In vivo, in a rat model of oxaliplatin induced neuropathy, a repeated treatment with rosiglitazone (3 and 10 mg kg(-1) per os) significantly reduced neuropathic pain evoked by noxious (Paw pressure test) and non-noxious (Cold plate test) stimuli. The behavioral effect paralleled with the prevention of catalase impairment induced by oxaliplatin in dorsal root ganglia. In the spinal cord, catalase protection was showed by the lower rosiglitazone dosage without effect on the astrocyte density increase induced by oxaliplatin. Rosiglitazone did not alter the oxaliplatin-induced mortality of the human colon cancer cell line HT-29. These results highlight the role of peroxisomes in oxaliplatin-dependent nervous damage and suggest PPAR gamma stimulation as a candidate to counteract oxaliplatin neurotoxicity.	[Zanardelli, Matteo; Micheli, Laura; Cinci, Lorenzo; Failli, Paola; Ghelardini, Carla; Mannelli, Lorenzo Di Cesare] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Neurofarba Pharmacol & Toxicol Sect, Florence, Italy	University of Florence	Mannelli, LD (corresponding author), Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Neurofarba Pharmacol & Toxicol Sect, Florence, Italy.	lorenzo.mannelli@unifi.it	; Di Cesare Mannelli, Lorenzo/A-1641-2015	GHELARDINI, CARLA/0000-0001-9856-8144; Di Cesare Mannelli, Lorenzo/0000-0001-8374-4432; Micheli, Laura/0000-0001-8834-5801; Cinci, Lorenzo/0000-0002-1799-4828; Failli, Paola/0000-0003-3879-9068	Italian Ministry of Instruction, University and Research (MIUR); University of Florence	Italian Ministry of Instruction, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Florence	This research was funded by the Italian Ministry of Instruction, University and Research (MIUR) and by the University of Florence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Benedusi V, 2012, J BIOL CHEM, V287, P35899, DOI 10.1074/jbc.M112.366419; Bernardo A, 2008, PPAR RES, V2008, DOI 10.1155/2008/864140; Blanquicett Carmelo, 2008, Cancer Ther, V6, P25; Boivin A, 2007, J NEUROSCI, V27, P12565, DOI 10.1523/JNEUROSCI.3027-07.2007; Bottelbergs A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-61; Carniglia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057313; Cavaletti G, 2001, EUR J CANCER, V37, P2457, DOI 10.1016/S0959-8049(01)00300-8; Cavaletti G, 2010, NAT REV NEUROL, V6, P657, DOI 10.1038/nrneurol.2010.160; Chen YM, 2001, GLIA, V33, P343, DOI 10.1002/1098-1136(20010315)33:4<343::AID-GLIA1033>3.0.CO;2-H; Choi JH, 2007, EUR J PHARMACOL, V571, P106, DOI 10.1016/j.ejphar.2007.06.042; Cimini A, 2009, J ALZHEIMERS DIS, V18, P935, DOI 10.3233/JAD-2009-1199; Crosby MB, 2006, CLIN IMMUNOL, V118, P276, DOI 10.1016/j.clim.2005.09.018; D'Amico A, 2013, HAND CLINIC, V113, P1437, DOI 10.1016/B978-0-444-59565-2.00013-7; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; Diab A, 2002, J IMMUNOL, V168, P2508, DOI 10.4049/jimmunol.168.5.2508; ELLIOTT BM, 1986, CARCINOGENESIS, V7, P795, DOI 10.1093/carcin/7.5.795; Feinstein DL, 2002, ANN NEUROL, V51, P694, DOI 10.1002/ana.10206; Festuccia WT, 2008, ENDOCRINOLOGY, V149, P2121, DOI 10.1210/en.2007-1553; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Gao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Goulle JP, 2005, FORENSIC SCI INT, V153, P39, DOI 10.1016/j.forsciint.2005.04.020; Graham MA, 2000, CLIN CANCER RES, V6, P1205; Gray E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-63; Grisold W, 2012, NEURO-ONCOLOGY, V14, P45, DOI 10.1093/neuonc/nos203; Han CH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-495; Heneka MT, 2007, NAT CLIN PRACT NEURO, V3, P496, DOI 10.1038/ncpneuro0586; Hunter RL, 2007, J NEUROCHEM, V100, P1375, DOI 10.1111/j.1471-4159.2006.04327.x; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Joshi H, 2014, EXPERT OPIN INV DRUG, V23, P501, DOI 10.1517/13543784.2014.884708; Kamboj SS, 2010, J NEUROCHEM, V112, P77, DOI 10.1111/j.1471-4159.2009.06435.x; Kannarkat G, 2007, CURR OPIN NEUROL, V20, P719; Khan MM, 2010, BRAIN RES, V1328, P139, DOI 10.1016/j.brainres.2010.02.031; Kou JQ, 2011, ACTA NEUROPATHOL, V122, P271, DOI 10.1007/s00401-011-0836-9; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; Lee EY, 2012, TOXICOL LETT, V213, P332, DOI 10.1016/j.toxlet.2012.07.016; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; LEIGHTON GE, 1988, BRIT J PHARMACOL, V93, P553, DOI 10.1111/j.1476-5381.1988.tb10310.x; Lourenco MV, 2013, J NEUROSCI, V33, P5083, DOI 10.1523/JNEUROSCI.0172-13.2013; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Mannelli LD, 2013, FREE RADICAL BIO MED, V61, P143, DOI 10.1016/j.freeradbiomed.2013.03.019; Mannelli LD, 2014, NEUROPHARMACOLOGY, V79, P37, DOI 10.1016/j.neuropharm.2013.10.034; Mannelli LD, 2012, J PAIN, V13, P276, DOI 10.1016/j.jpain.2011.11.009; Masoud A, 2012, HUM EXP TOXICOL, V31, P1214, DOI 10.1177/0960327112446842; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Morrison JG, 2000, J PHARMACEUT BIOMED, V24, P1, DOI 10.1016/S0731-7085(00)00377-0; Napolitano M, 2011, BRAIN RES BULL, V85, P231, DOI 10.1016/j.brainresbull.2011.03.011; Perdomo MC, 2011, DOMEST ANIM ENDOCRIN, V41, P118, DOI 10.1016/j.domaniend.2011.05.005; Powers JM, 1998, BRAIN PATHOL, V8, P101; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Powers SK, 1999, P NUTR SOC, V58, P1025, DOI 10.1017/S0029665199001342; Putnam CD, 2000, J MOL BIOL, V296, P295, DOI 10.1006/jmbi.1999.3458; Raikwar HP, 2006, J NEUROIMMUNOL, V178, P76, DOI 10.1016/j.jneuroim.2006.05.013; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ribeiro D, 2012, HISTOL HISTOPATHOL, V27, P661, DOI 10.14670/HH-27.661; Salvemini D, 2010, LIFE SCI, V86, P604, DOI 10.1016/j.lfs.2009.06.011; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Sheu WHH, 2011, J PHARMACEUT BIOMED, V54, P759, DOI 10.1016/j.jpba.2010.10.008; Souglakos J, 2002, J CLIN ONCOL, V20, P2651, DOI 10.1200/JCO.2002.08.015; Stolz DB, 2002, HEPATOLOGY, V36, P81, DOI 10.1053/jhep.2002.33716; Strum JC, 2007, J ALZHEIMERS DIS, V11, P45; Sun H, 2012, NEUROL SCI, V33, P559, DOI 10.1007/s10072-011-0774-2; Swanson CR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-91; Trompier D, 2014, BIOCHIMIE, V98, P102, DOI 10.1016/j.biochi.2013.09.009; Venkateshappa C, 2012, NEUROCHEM RES, V37, P1601, DOI 10.1007/s11064-012-0755-8; Wang B, 2013, FREE RADICAL BIO MED, V65, P882, DOI 10.1016/j.freeradbiomed.2013.08.173; Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018; Ye F, 2006, CHEMBIOCHEM, V7, P74, DOI 10.1002/cbic.200500186; Zanardelli M, 2013, P 36 C IT SOC PHARM; Zheng HE, 2011, EXP NEUROL, V232, P154, DOI 10.1016/j.expneurol.2011.08.016; ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x	78	59	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102758	10.1371/journal.pone.0102758	http://dx.doi.org/10.1371/journal.pone.0102758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036594	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200084
J	Depiereux, S; Liagre, M; Danis, L; De Meulder, B; Depiereux, E; Segner, H; Kestemont, P				Depiereux, Sophie; Liagre, Melanie; Danis, Lorraine; De Meulder, Bertrand; Depiereux, Eric; Segner, Helmut; Kestemont, Patrick			Intersex Occurrence in Rainbow Trout (Oncorhynchus mykiss) Male Fry Chronically Exposed to Ethynylestradiol	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; ENDOCRINE DISRUPTING CHEMICALS; MOLECULAR SEX-DIFFERENTIATION; GENE-EXPRESSION; MESSENGER-RNA; SALMO-TRUTTA; ENVIRONMENTAL CONCENTRATIONS; GONADAL DIFFERENTIATION; PLASMA VITELLOGENIN; ESTROGENIC EXPOSURE	This study aimed to investigate the male-to-female morphological and physiological transdifferentiation process in rainbow trout (Oncorhynchus mykiss) exposed to exogenous estrogens. The first objective was to elucidate whether trout develop intersex gonads under exposure to low levels of estrogen. To this end, the gonads of an all-male population of fry exposed chronically (from 60 to 136 days post fertilization - dpf) to several doses (from environmentally relevant 0.01 mu g/L to supra-environmental levels: 0.1, 1 and 10 mu g/L) of the potent synthetic estrogen ethynylestradiol (EE2) were examined histologically. The morphological evaluations were underpinned by the analysis of gonad steroid (testosterone, estradiol and 11-ketotestosterone) levels and of brain and gonad gene expression, including estrogen-responsive genes and genes involved in sex differentiation in (gonads: cyp19a1a, ER isoforms, vtg, dmrt1, sox9a2; sdY; cyp11b; brain: cyp19a1b, ER isoforms). Intersex gonads were observed from the first concentration used (0.01 mu g EE2/L) and sexual inversion could be detected from 0.1 mg EE2/L. This was accompanied by a linear decrease in 11-KT levels, whereas no effect on E2 and T levels was observed. Q-PCR results from the gonads showed downregulation of testicular markers (dmrt1, sox9a2; sdY; cyp11b) with increasing EE2 exposure concentrations, and upregulation of the female vtg gene. No evidence was found for a direct involvement of aromatase in the sex conversion process. The results from this study provide evidence that gonads of male trout respond to estrogen exposure by intersex formation and, with increasing concentration, by morphological and physiological conversion to phenotypic ovaries. However, supra-environmental estrogen concentrations are needed to induce these changes.	[Depiereux, Sophie; Liagre, Melanie; Danis, Lorraine; Kestemont, Patrick] Univ Namur, Lab Ecophysiol & Ecotoxicol, Unit Res Environm & Evolutionary Biol URBE NARILI, Namur, Belgium; [De Meulder, Bertrand; Depiereux, Eric] Univ Namur, Unit Res Mol Biol URBM NARILIS, Namur, Belgium; [Segner, Helmut] Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth, Bern, Switzerland	University of Namur; University of Namur; University of Bern	Depiereux, S (corresponding author), Univ Namur, Lab Ecophysiol & Ecotoxicol, Unit Res Environm & Evolutionary Biol URBE NARILI, Namur, Belgium.	sophiedepiereux@gmail.com; patrick.kestemont@unamur.be	PANIS, CAROLINA/AAM-7214-2021	PANIS, CAROLINA/0000-0002-0104-4369	Fonds de la Recherche Scientifique - FNRS, Belgium [FC 83738]	Fonds de la Recherche Scientifique - FNRS, Belgium(Fonds de la Recherche Scientifique - FNRS)	Fonds de la Recherche Scientifique - FNRS, Belgium, grant number: FC 83738 (http://www.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann GE, 2002, AQUAT TOXICOL, V60, P203, DOI 10.1016/S0166-445X(02)00003-6; Aguayo S, 2004, SCI TOTAL ENVIRON, V328, P69, DOI 10.1016/j.scitotenv.2004.02.013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Auriol M, 2006, PROCESS BIOCHEM, V41, P525, DOI 10.1016/j.procbio.2005.09.017; Babin Patrick J., 2007, P39, DOI 10.1007/978-1-4020-6235-3_2; Baron D, 2005, BIOL REPROD, V73, P959, DOI 10.1095/biolreprod.105.041830; Baron D, 2005, MOL REPROD DEV, V71, P471, DOI 10.1002/mrd.20229; Bernet D, 2004, DIS AQUAT ORGAN, V61, P137, DOI 10.3354/dao061137; BILLARD R, 1992, AQUACULTURE, V100, P263, DOI 10.1016/0044-8486(92)90385-X; Billard R, 1973, C AQ BREST FRANC, P161; Bjerregaard LB, 2006, ECOTOXICOLOGY, V15, P315, DOI 10.1007/s10646-006-0061-9; Bjerregaard LB, 2008, ECOTOXICOLOGY, V17, P252, DOI 10.1007/s10646-008-0192-2; Bogdal C, 2009, CHEMOSPHERE, V74, P434, DOI 10.1016/j.chemosphere.2008.09.058; Bon E, 1997, COMP BIOCHEM PHYS B, V117, P75, DOI 10.1016/S0305-0491(96)00252-0; Boyce-Derricott J, 2009, GEN COMP ENDOCR, V161, P73, DOI 10.1016/j.ygcen.2008.11.022; Boyce-Derricott J, 2010, MOL CELL ENDOCRINOL, V315, P277, DOI 10.1016/j.mce.2009.09.032; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Brown KH, 2007, REPRODUCTION, V134, P659, DOI 10.1530/REP-07-0169; Burki R, 2006, ENVIRON TOXICOL CHEM, V25, P2077, DOI 10.1897/05-545R.1; Caldwell DJ, 2008, ENVIRON SCI TECHNOL, V42, P7046, DOI 10.1021/es800633q; Cavileer T, 2009, SEX DEV, V3, P214, DOI 10.1159/000228722; Chakraborty T, 2011, MOL CELL ENDOCRINOL, V333, P47, DOI 10.1016/j.mce.2010.12.002; Cheshenko K, 2008, GEN COMP ENDOCR, V155, P31, DOI 10.1016/j.ygcen.2007.03.005; Christiansen LB, 1998, MAR ENVIRON RES, V46, P137, DOI 10.1016/S0141-1136(97)00047-0; Cousin M, 1988, EFFETS METHYLTESTOST; D'Cotta H, 2001, MOL REPROD DEV, V59, P265, DOI 10.1002/mrd.1031; Dagnelie P., 1998, STAT THEORIQUE APPL; Dalla Valle L, 2005, J STEROID BIOCHEM, V94, P49, DOI 10.1016/j.jsbmb.2005.01.010; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Dietrich DR, 2009, HISTOLOGICAL ANAL EN; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; Filby AL, 2005, BIOL REPROD, V73, P648, DOI 10.1095/biolreprod.105.039701; Filby AL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-10; FOSTIER A, 1986, FISH PHYSIOL BIOCHEM, V2, P87, DOI 10.1007/BF02264076; Grier H. J., 1993, SERTOLI CELL, P704; Grier HJ, 2007, J MORPHOL, V268, P293, DOI 10.1002/jmor.10518; Grier HJ, 2002, 53 GCFI, V53; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Hecker M, 2006, REV ENVIRON CONTAM T, V187, P103, DOI 10.1007/0-387-32885-8_3; Hirakawa I, 2012, CHEMOSPHERE, V87, P668, DOI 10.1016/j.chemosphere.2011.12.047; Jalabert B, 2010, TRUITE ARC EN CIEL B; Jobling S, 1996, ENVIRON TOXICOL CHEM, V15, P194, DOI [10.1002/etc.5620150218, 10.1897/1551-5028(1996)015&lt;0194:IOTGIR&gt;2.3.CO;2]; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Jobling S, 2002, BIOL REPROD, V66, P272, DOI 10.1095/biolreprod66.2.272; JOHNSTONE R, 1978, AQUACULTURE, V13, P115, DOI 10.1016/0044-8486(78)90106-0; Katsu Y, 2007, ENVIRON SCI TECHNOL, V41, P3368, DOI 10.1021/es062797l; Kazeto Y, 2004, AQUAT TOXICOL, V69, P25, DOI 10.1016/j.aquatox.2004.04.008; KESTEMONT P, 1989, J APPL ICHTHYOL, V5, P111, DOI 10.1111/j.1439-0426.1989.tb00482.x; Kishida M, 2001, COMP BIOCHEM PHYS B, V129, P261, DOI 10.1016/S1096-4959(01)00319-0; Korner O, 2007, AQUAT SCI, V69, P26, DOI 10.1007/s00027-006-0842-5; Kortner TM, 2009, GEN COMP ENDOCR, V164, P91, DOI 10.1016/j.ygcen.2009.05.009; Krisfalusi M, 2000, MOL REPROD DEV, V56, P495, DOI 10.1002/1098-2795(200008)56:4&lt;495::AID-MRD7&gt;3.0.CO;2-E; Lange A, 2009, ENVIRON SCI TECHNOL, V43, P1219, DOI 10.1021/es802661p; Lange A, 2008, TOXICOL SCI, V106, P113, DOI 10.1093/toxsci/kfn151; LEBRUN C, 1982, REPROD NUTR DEV, V22, P405, DOI 10.1051/rnd:19820312; Legler J, 2002, SCI TOTAL ENVIRON, V293, P69, DOI 10.1016/S0048-9697(01)01146-9; LEROUX MG, 1993, BIOCHIM BIOPHYS ACTA, V1172, P226, DOI 10.1016/0167-4781(93)90302-T; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Lyssimachou A, 2006, TOXICOL SCI, V91, P82, DOI 10.1093/toxsci/kfj136; MacKay ME, 1996, COMP BIOCHEM PHYS C, V115, P201, DOI 10.1016/S0742-8413(96)00093-X; Marchand O, 2000, BBA-GENE STRUCT EXPR, V1493, P180, DOI 10.1016/S0167-4781(00)00186-X; Marlatt VL, 2008, MOL CELL ENDOCRINOL, V283, P38, DOI 10.1016/j.mce.2007.10.013; McMillan Donald B., 2007, pIX; Melamed P, 2005, MOL ASP FISH MAR BIO; Menuet A, 2005, J COMP NEUROL, V485, P304, DOI 10.1002/cne.20497; Mylonas CC, 2010, GEN COMP ENDOCR, V165, P516, DOI 10.1016/j.ygcen.2009.03.007; Nadzialek S, 2011, ARCH ENVIRON CON TOX, V60, P471, DOI 10.1007/s00244-010-9548-8; Nagler JJ, 2007, GENE, V392, P164, DOI 10.1016/j.gene.2006.12.030; Nagler JJ, 2000, J MOL ENDOCRINOL, V25, P243, DOI 10.1677/jme.0.0250243; Orn S, 2003, AQUAT TOXICOL, V65, P397, DOI 10.1016/S0166-445X(03)00177-2; Palace VP, 2009, CAN J FISH AQUAT SCI, V66, P1920, DOI 10.1139/F09-125; Pandian TJ, 1995, AQUACULTURE, V138, P1, DOI 10.1016/0044-8486(95)01075-0; Pellegrini E, 2005, GEN COMP ENDOCR, V142, P60, DOI 10.1016/j.ygcen.2004.12.003; Piferrer F, 2001, AQUACULTURE, V197, P229, DOI 10.1016/S0044-8486(01)00589-0; Porter CM, 2003, ECOTOX ENVIRON SAFE, V54, P199, DOI 10.1016/S0147-6513(02)00056-8; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; Quillett E, 2004, J FISH BIOL, V64, P1147, DOI 10.1111/j.1095-8649.2004.00373.x; Routledge EJ, 1998, ENVIRON SCI TECHNOL, V32, P1559, DOI 10.1021/es970796a; Rozen S, 2000, Methods Mol Biol, V132, P365; Sabo-Attwood T, 2004, MOL CELL ENDOCRINOL, V218, P107, DOI 10.1016/j.mce.2003.12.007; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholz S, 2000, AQUAT TOXICOL, V50, P363, DOI 10.1016/S0166-445X(00)00090-4; Schubert S, 2008, AQUAT TOXICOL, V90, P65, DOI 10.1016/j.aquatox.2008.08.002; Schwaiger J, 2002, AQUAT TOXICOL, V59, P177, DOI 10.1016/S0166-445X(01)00248-X; Segner H, 2011, REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, P1145, DOI 10.1016/B978-0-12-382032-7.10086-4; Sheahan DA, 1994, CHRONIC EFFECTS POLL, P99; Simpson T, 1976, COUNC EXPLOR SEA, V6; SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529; TAKASHIMA F, 1980, B JPN SOC SCI FISH, V46, P1317; Tarrant H, 2008, ENVIRON TOXICOL CHEM, V27, P1773, DOI 10.1897/07-436; Upadhyay SN, 1977, MORPHOLOGIE GONADES; van Aerle R, 2001, ENVIRON TOXICOL CHEM, V20, P2841, DOI 10.1002/etc.5620201225; VANDENHURK R, 1979, CELL TISSUE RES, V199, P289, DOI 10.1007/BF00236140; Verslycke T, 2002, COMP BIOCHEM PHYS C, V132, P483, DOI 10.1016/S1532-0456(02)00111-4; Vizziano D, 2007, DEV DYNAM, V236, P2198, DOI 10.1002/dvdy.21212; Vizziano-Cantonnet D, 2008, J MOL ENDOCRINOL, V41, P277, DOI 10.1677/JME-08-0039; Watson CS, 2007, STEROIDS, V72, P124, DOI 10.1016/j.steroids.2006.11.002; Weber LP, 2003, AQUAT TOXICOL, V63, P431, DOI 10.1016/S0166-445X(02)00208-4; Yano A, 2012, CURR BIOL NULL	100	35	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e98531	10.1371/journal.pone.0098531	http://dx.doi.org/10.1371/journal.pone.0098531			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033040	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300002
J	Suzukawa, K; Tomlin, J; Pak, K; Chavez, E; Kurabi, A; Baird, A; Wasserman, SI; Ryan, AF				Suzukawa, Keigo; Tomlin, Julia; Pak, Kwang; Chavez, Eduardo; Kurabi, Arwa; Baird, Andrew; Wasserman, Stephen I.; Ryan, Allen F.			A Mouse Model of Otitis Media Identifies HB-EGF as a Mediator of Inflammation-Induced Mucosal Proliferation	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; MIDDLE-EAR MUCOSA; PROHB-EGF; EXPRESSION; RECEPTOR; INDUCTION; DIFFERENTIATION; REGENERATION; PNEUMONIAE	Objective: Otitis media is one of the most common pediatric infections. While it is usually treated without difficulty, up to 20% of children may progress to long-term complications that include hearing loss, impaired speech and language development, academic underachievement, and irreversible disease. Hyperplasia of middle ear mucosa contributes to the sequelae of acute otitis media and is of important clinical significance. Understanding the role of growth factors in the mediation of mucosal hyperplasia could lead to the development of new therapeutic interventions for this disease and its sequelae. Methods: From a whole genome gene array analysis of mRNA expression during acute otitis media, we identified growth factors with expression kinetics temporally related to hyperplasia. We then tested these factors for their ability to stimulate mucosal epithelial growth in vitro, and determined protein levels and histological distribution in vivo for active factors. Results: From the gene array, we identified seven candidate growth factors with upregulation of mRNA expression kinetics related to mucosal hyperplasia. Of the seven, only HB-EGF (heparin-binding-epidermal growth factor) induced significant mucosal epithelial hyperplasia in vitro. Subsequent quantification of HB-EGF protein expression in vivo via Western blot analysis confirmed that the protein is highly expressed from 6 hours to 24 hours after bacterial inoculation, while immunohistochemistry revealed production by middle ear epithelial cells and infiltrating lymphocytes. Conclusion: Our data suggest an active role for HB-EGF in the hyperplasia of the middle ear mucosal epithelium during otitis media. These results imply that therapies targeting HB-EGF could ameliorate mucosal growth during otitis media, and thereby reduce detrimental sequelae of this childhood disease.	[Suzukawa, Keigo; Tomlin, Julia; Pak, Kwang; Chavez, Eduardo; Kurabi, Arwa; Ryan, Allen F.] Univ Calif San Diego, Sch Med, Div Otolaryngol, La Jolla, CA 92093 USA; [Suzukawa, Keigo; Tomlin, Julia; Pak, Kwang; Chavez, Eduardo; Kurabi, Arwa; Baird, Andrew; Wasserman, Stephen I.; Ryan, Allen F.] Vet Adm Med Ctr, La Jolla, CA USA; [Baird, Andrew] Univ Calif San Diego, Sch Med, Dept Surg, Div Trauma, La Jolla, CA 92093 USA; [Wasserman, Stephen I.] Univ Calif San Diego, Sch Med, Dept Med, Div Allergy Immunol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego; University of California System; University of California San Diego	Ryan, AF (corresponding author), Univ Calif San Diego, Sch Med, Div Otolaryngol, La Jolla, CA 92093 USA.	afryan@ucsd.edu		Baird, Andrew/0000-0003-0027-9905; Noel, Julia/0000-0001-9955-3315	National Institute of Health/National Institute on Deafness and Other Communication Disorders [DC000129, DC012595, DC006279]; Research Service of the VA [BX001205, RS000977]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012595, R01DC000129, R01DC006279] Funding Source: NIH RePORTER	National Institute of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Research Service of the VA; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Grants DC000129 and DC012595 [AFR] and DC006279 [SIW] from the National Institute of Health/National Institute on Deafness and Other Communication Disorders, and BX001205 and RS000977 [AFR] from the Research Service of the VA provided funding and resources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIRD A, 1989, BRIT MED BULL, V45, P438, DOI 10.1093/oxfordjournals.bmb.a072333; BAIRD A, 1991, CANCER CELL-MON REV, V3, P239; Basbaum C, 2002, NOVART FDN SYMP, V248, P171; Basbaum C., 2002, NOVART FDN SYMP, V248, P277; Bennett KE, 2001, ARCH DIS CHILD, V85, P91, DOI 10.1136/adc.85.2.91; BESNER G, 1990, CELL REGUL, V1, P811, DOI 10.1091/mbc.1.11.811; BLOTNICK S, 1994, P NATL ACAD SCI USA, V91, P2890, DOI 10.1073/pnas.91.8.2890; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Busiello I, 2004, CELL MICROBIOL, V6, P255, DOI 10.1046/j.1462-5822.2004.00366.x; Daimon E, 2005, BIOL REPROD, V73, P163, DOI 10.1095/biolreprod.104.038539; DLUZ SM, 1993, J BIOL CHEM, V268, P18330; Ebmeyer J, 2005, J ALLERGY CLIN IMMUN, V116, P1129, DOI 10.1016/j.jaci.2005.07.026; El-Sayed Y, 1998, AM J OTOLARYNG, V19, P149; FUKUDA K, 1995, ARTERIOSCL THROM VAS, V15, P1680, DOI 10.1161/01.ATV.15.10.1680; Furukawa M, 2007, INFECT IMMUN, V75, P2562, DOI 10.1128/IAI.01656-06; GOSPODAROWICZ D, 1990, CLIN ORTHOP RELAT R, P231; HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060; Hernandez M, 2008, J INFECT DIS, V198, P1862, DOI 10.1086/593213; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HOMMA T, 1995, J CLIN INVEST, V96, P1018, DOI 10.1172/JCI118087; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Junttila TT, 2000, TRENDS CARDIOVAS MED, V10, P304, DOI 10.1016/S1050-1738(01)00065-2; Kiml V, 2013, AM J RESP CRIT CARE, V187, P228, DOI 10.1164/rccm.201210-1843CI; KISO S, 1995, HEPATOLOGY, V22, P1584, DOI 10.1016/0270-9139(95)90168-X; KOUTNOUYAN HA, 1994, LARYNGOSCOPE, V104, P350; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Kumagai K, 2010, ORAL SURG ORAL MED O, V110, P748, DOI 10.1016/j.tripleo.2010.06.022; Kurabi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061394; LAI WH, 1989, J CELL BIOL, V109, P2741, DOI 10.1083/jcb.109.6.2741; Lee J, 2012, J BIOL CHEM, V287, P22799, DOI 10.1074/jbc.M111.337378; Leibovitz E, 2007, PEDIATR INFECT DIS J, V26, pS8, DOI 10.1097/INF.0b013e318154b24a; Leichtle A, 2010, J IMMUNOL, V184, P3087, DOI 10.4049/jimmunol.0901167; LIM DJ, 1971, ANN OTO RHINOL LARYN, V80, P838, DOI 10.1177/000348947108000611; Lin JQ, 2001, J BIOL CHEM, V276, P30127, DOI 10.1074/jbc.M010237200; Lue HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027720; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; Maw R, 1999, LANCET, V353, P960, DOI 10.1016/S0140-6736(98)05295-7; McCarthy DW, 1996, J INVEST DERMATOL, V106, P49, DOI 10.1111/1523-1747.ep12327214; Melhus A, 2000, INFECT IMMUN, V68, P4024, DOI 10.1128/IAI.68.7.4024-4031.2000; Melhus A, 2003, APMIS, V111, P989, DOI 10.1034/j.1600-0463.2003.1111012.x; Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5; Morita S, 2007, MOL VIS, V13, P2119; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; Nishi E, 2001, EMBO J, V20, P3342, DOI 10.1093/emboj/20.13.3342; Ogihara S, 2000, ALIMENT PHARM THERAP, V14, P183, DOI 10.1046/j.1365-2036.2000.014s1183.x; Palacios SD, 2001, LARYNGOSCOPE, V111, P874, DOI 10.1097/00005537-200105000-00022; Park PW, 2004, J BIOL CHEM, V279, P251, DOI 10.1074/jbc.M308537200; Pawankar R, 2007, CURR ALLERGY ASTHM R, V7, P202, DOI 10.1007/s11882-007-0073-4; Payne AS, 2002, J INVEST DERMATOL, V118, P915, DOI 10.1046/j.1523-1747.2002.01725.x; POWELL PP, 1993, AM J PATHOL, V143, P784; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Rovers MM, 2008, VACCINE, V26, pG2, DOI 10.1016/j.vaccine.2008.11.005; RYAN AF, 1993, ACTA OTO-LARYNGOL, V113, P68, DOI 10.3109/00016489309135769; Ryan AF, 2006, BRAIN RES, V1091, P3, DOI 10.1016/j.brainres.2006.02.004; Sagmeister S, 2008, J HEPATOL, V49, P955, DOI 10.1016/j.jhep.2008.06.031; Schuknecht HF, 1993, PATHOLOGY EAR, Vxv, P672; Shao JY, 2010, ENDOCRINOLOGY, V151, P3728, DOI 10.1210/en.2010-0319; Swanson KV, 2011, CELL MICROBIOL, V13, P1078, DOI 10.1111/j.1462-5822.2011.01603.x; Takenobu H, 2003, J BIOL CHEM, V278, P17255, DOI 10.1074/jbc.M211835200; Tian C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034944; TOS M, 1977, ANN OTO RHINOL LARYN, V86, P209, DOI 10.1177/000348947708600212; Trune DR, 2009, BRAIN RES, V1277, P90, DOI 10.1016/j.brainres.2009.02.047; VANBLITTERSWIJK CA, 1986, ACTA OTO-LARYNGOL, V101, P453, DOI 10.3109/00016488609108632; Vinante F, 1999, BLOOD, V94, P3169, DOI 10.1182/blood.V94.9.3169.421k30_3169_3177; Virok D, 2003, J INFECT DIS, V188, P1310, DOI 10.1086/379047; WILSON SE, 1994, EXP EYE RES, V59, P665, DOI 10.1006/exer.1994.1152; World Health Organization, 2004, CHRON SUPP OT MED BU; WRIGHT CG, 1994, ANN OTO RHINOL LARYN, V103, P24, DOI 10.1177/00034894941030S507; Yamashita T, 2009, J INVEST DERMATOL, V129, P262, DOI 10.1038/jid.2008.366	69	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102739	10.1371/journal.pone.0102739	http://dx.doi.org/10.1371/journal.pone.0102739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033458	Green Published, gold			2022-12-25	WOS:000339418300086
J	Zhang, WX; Ming, QZ; Shi, ZT; Chen, GJ; Niu, J; Lei, GL; Chang, FQ; Zhang, HC				Zhang, Wenxiang; Ming, Qingzhong; Shi, Zhengtao; Chen, Guangjie; Niu, Jie; Lei, Guoliang; Chang, Fengqin; Zhang, Hucai			Lake Sediment Records on Climate Change and Human Activities in the Xingyun Lake Catchment, SW China	PLOS ONE			English	Article							LATE QUATERNARY; ENVIRONMENTAL-CHANGES; ORGANIC-MATTER; LACUSTRINE SEDIMENTS; LATE PLEISTOCENE; GRAIN-SIZE; NW CHINA; PLATEAU; MONSOON; CARBON	Sediments from Xinyun Lake in central Yunnan, southwest China, provide a record of environmental history since the Holocene. With the application of multi-proxy indicators (total organic carbon (TOC), total nitrogen (TN), delta C-13 and delta N-15 isotopes, C/N ratio, grain size, magnetic susceptibility (MS) and CaCO3 content), as well as accelerator mass spectrometry (AMS) C-14 datings, four major climatic stages during the Holocene have been identified in Xingyun's catchment. A marked increase in lacustrine palaeoproductivity occurred from 11.06 to 9.98 cal. ka BP, which likely resulted from an enhanced Asian southwest monsoon and warm-humid climate. Between 9.98 and 5.93 cal. ka BP, a gradually increased lake level might have reached the optimum water depth, causing a marked decline in coverage by aquatic plants and lake productivity of the lake. This was caused by strong Asian southwest monsoon, and coincided with the global Holocene Optimum. During the period of 5.60-1.35 cal. ka BP, it resulted in a warm and dry climate at this stage, which is comparable to the aridification of India during the mid- and late Holocene. The intensifying human activity and land-use in the lake catchment since the early Tang Dynasty(similar to 1.35 cal. ka BP) were associated with the ancient Dian culture within Xingyun's catchment. The extensive deforestation and development of agriculture in the lake catchment caused heavy soil loss. Our study clearly shows that long-term human activities and land-use change have strongly impacted the evolution of the lake environment and therefore modulated the sediment records of the regional climate in central Yunnan for more than one thousand years.	[Zhang, Wenxiang; Ming, Qingzhong; Shi, Zhengtao; Chen, Guangjie; Niu, Jie; Chang, Fengqin; Zhang, Hucai] Yunnan Normal Univ, Key Lab Plateau Lake Ecol & Global Change, Key Lab Plateau Surface Proc & Environm Changes Y, Kunming, Peoples R China; [Lei, Guoliang] Minist Educ, Key Lab Humid Subtrop Ecogeog Proc, Fuzhou, Peoples R China	Yunnan Normal University	Zhang, HC (corresponding author), Yunnan Normal Univ, Key Lab Plateau Lake Ecol & Global Change, Key Lab Plateau Surface Proc & Environm Changes Y, Kunming, Peoples R China.	hucaizhang@yahoo.com	Chen, Guangjie/AEO-1991-2022; Chen, Guangjie/J-3826-2017	Chen, Guangjie/0000-0001-8035-6565	National Natural Science Foundation of China [41201204, U1133601, U0933604, 41101189]; Key Science Research Foundation of the Education Department of Yunnan Province [2012Z014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science Research Foundation of the Education Department of Yunnan Province	This research was supported by the National Natural Science Foundation of China (Grant No. 41201204, U1133601, U0933604 and 41101189) and the Key Science Research Foundation of the Education Department of Yunnan Province (Grant No. 2012Z014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bascomb CL, 1961, CHEM IND, V45, P1826; Bellwood, 2005, 1 FARM OR AGR SOC; Brown R, 1991, ISOTOPES CLIMATES; Chang FQ, 2008, J CHINA UNIV GEOSCI, V19, P1, DOI 10.1016/S1002-0705(08)60019-9; Chen JA, 2004, SCI CHINA SER D, V47, P954, DOI 10.1360/03yd0160; Crawford GW, 2006, BLACKW STUD GLOB ARC, P77, DOI 10.1002/9780470774670.ch5; Dodson JR, 2013, QUATERNARY SCI REV, V72, P108, DOI 10.1016/j.quascirev.2013.04.021; Flad R, 2010, HOLOCENE, V20, P955, DOI 10.1177/0959683609358914; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Higham C, 2011, J WORLD PREHIST, V24, P227, DOI 10.1007/s10963-011-9054-6; Hodell DA, 1998, LIMNOL OCEANOGR, V43, P200, DOI 10.4319/lo.1998.43.2.0200; Hodell DA, 1999, QUATERNARY RES, V52, P369, DOI 10.1006/qres.1999.2072; Hu SY, 2002, CHINESE SCI BULL, V47, P613, DOI 10.1360/02tb9141; IPCC, 2007, CLIM CHANG 2007 PHYS; Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x; KRISHNAMURTHY RV, 1986, NATURE, V323, P150, DOI 10.1038/323150a0; Lamb AL, 2004, QUATERNARY SCI REV, V23, P881, DOI 10.1016/j.quascirev.2003.06.010; Li XC, 2008, ARCHAEOLOGY, V8, P76; Li XZ, 2012, CHEM GEOL, V300, P88, DOI 10.1016/j.chemgeo.2012.01.010; Li XQ, 2007, HOLOCENE, V17, P555, DOI 10.1177/0959683607078978; Li XQ, 2012, J ARCHAEOL SCI, V39, P3141, DOI 10.1016/j.jas.2012.04.052; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Lucke A, 2003, QUATERNARY SCI REV, V22, P569, DOI 10.1016/S0277-3791(02)00187-7; Meyers PA, 2003, ORG GEOCHEM, V34, P261, DOI 10.1016/S0146-6380(02)00168-7; Meyers PA, 1999, J PALEOLIMNOL, V21, P345, DOI 10.1023/A:1008073732192; Nakamura T, 2000, NUCL INSTRUM METH B, V172, P52, DOI 10.1016/S0168-583X(00)00398-0; Ponton C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050722; Prins M, 2000, MAR GEOL, V169, P351, DOI 10.1016/S0025-3227(00)00087-6; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Routh J, 2007, J PALEOLIMNOL, V37, P529, DOI 10.1007/s10933-006-9032-7; Ruddiman WF, 2008, QUATERNARY SCI REV, V27, P1291, DOI 10.1016/j.quascirev.2008.03.007; SHEN J, 2005, SCI CHINA SER D, V48, P353; Shi ZT, 2005, YUNNAN GEOGRAPHIC EN, V17, P24; Sirocko F, 1996, SCIENCE, V272, P526, DOI 10.1126/science.272.5261.526; Sirocko F, 1993, NATURE, V323, P48; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Song L, 2012, CHINESE SCI BULL, V57, P2595, DOI 10.1007/s11434-012-5191-2; Thompson LG, 1997, SCIENCE, V276, P1821, DOI 10.1126/science.276.5320.1821; Thornton C P, 2004, OXFORD J ARCHAEOL, V23, P83, DOI DOI 10.1111/J.1468-0092.2004.00203.X; Vanniere B, 2003, J ARCHAEOL SCI, V30, P1283, DOI 10.1016/S0305-4403(03)00017-7; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Watanabe T, 2004, EARTH PLANET SC LETT, V222, P285, DOI 10.1016/j.epsl.2004.02.009; [吴健 WU Jian], 2010, [沉积学报, Acta Sedimentologica Sinica], V28, P365; Wu WX, 2004, QUATERN INT, V117, P153, DOI 10.1016/S1040-6182(03)00125-3; Xu H, 2014, QUATERNARY SCI REV, V89, P85, DOI 10.1016/j.quascirev.2014.02.011; Yan W M, 1997, ARCHAEOLOGY, V9, P71; Yang DP, 1997, J PALEOLIMNOL, V17, P369; Yu G., 2001, LAKE RECORDS CHINA P; Yu XX, 1987, COLLECTION CHINESE H, V2, P121; 陈敬安, 2002, [中国科学. D辑, 地球科学, Science in China], V32, P73; Zhang HC, 2004, PALAEOGEOGR PALAEOCL, V211, P45, DOI 10.1016/j.palaeo.2004.04.006; Zhang HL, 2010, QUATERN INT, V212, P14, DOI 10.1016/j.quaint.2009.07.007; Zhang ZK, 2001, CHINESE SCI BULL, V46, P80, DOI 10.1007/BF03187241; Zhao KL, 2013, QUATERN INT, V311, P81, DOI 10.1016/j.quaint.2013.06.035	55	33	44	11	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102167	10.1371/journal.pone.0102167	http://dx.doi.org/10.1371/journal.pone.0102167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033404	gold, Green Submitted, Green Published			2022-12-25	WOS:000339418300037
J	Avery, L				Avery, Leon			A Model of the Effect of Uncertainty on the C elegans L2/L2d Decision	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; POPULATION-GROWTH; PHEROMONE; LONGEVITY; SELECTION; STRENGTH; GENETICS; HISTORY; FOOD	At the end of the first larval stage, the C elegans larva chooses between two developmental pathways, an L2 committed to reproductive development and an L2d, which has the option of undergoing reproductive development or entering the dauer diapause. I develop a quantitative model of this choice using mathematical tools developed for pricing financial options. The model predicts that the optimal decision must take into account not only the expected potential for reproductive growth, but also the uncertainty in that expected potential. Because the L2d has more flexibility than the L2, it is favored in unpredictable environments. I estimate that the ability to take uncertainty into account may increase reproductive value by as much as 5%, and discuss possible experimental tests for this ability.	Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA	Virginia Commonwealth University	Avery, L (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA.	lavery3@vcu.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL046154] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL046154] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Artyukhin AB, 2013, J BIOL CHEM; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1993, J EXP BIOL, V175, P283; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Burnell AM, 2005, EXP GERONTOL, V40, P850, DOI 10.1016/j.exger.2005.09.006; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Chen JJ, 2007, J GERONTOL A-BIOL, V62, P126, DOI 10.1093/gerona/62.2.126; Chen JJ, 2004, J NEMATOL, V36, P107; Choe A, 2012, CURR BIOL, V22, P772, DOI 10.1016/j.cub.2012.03.024; Cutter AD, 2004, EVOLUTION, V58, P651, DOI 10.1111/j.0014-3820.2004.tb01687.x; Endler J.A., 1986, Monographs in Population Biology, pviii; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Fisher R.A., 1930, GENETICAL THEORY NAT; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Hoekstra HE, 2001, P NATL ACAD SCI USA, V98, P9157, DOI 10.1073/pnas.161281098; Houston AI, 1999, MODELS ADAPTIVE BEHA; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Knight CG, 2002, EVOL DEV, V4, P16, DOI 10.1046/j.1525-142x.2002.01058.x; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Ludewig Andreas H, 2013, WormBook, P1, DOI 10.1895/wormbook.1.155.1; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Muschiol Daniel, 2009, BMC Ecol, V9, P14, DOI 10.1186/1472-6785-9-14; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Schaedel ON, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001306; Shreve S., 2005, STOCHASTIC CALCULUS; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Wood W.B., 1988, Cold Spring Harbor Monograph Series, V17, P1	35	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e100580	10.1371/journal.pone.0100580	http://dx.doi.org/10.1371/journal.pone.0100580			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029446	Green Submitted, Green Published, gold			2022-12-25	WOS:000341306600006
J	Dally, S; Rupp, S; Lemuth, K; Hartmann, SC; Hiller, E; Bailer, SM; Knabbe, C; Weile, J				Dally, Simon; Rupp, Steffen; Lemuth, Karin; Hartmann, Stefan C.; Hiller, Ekkehard; Bailer, Susanne M.; Knabbe, Cornelius; Weile, Jan			Single-Stranded DNA Catalyzes Hybridization of PCR-Products to Microarray Capture Probes	PLOS ONE			English	Article							OLIGONUCLEOTIDE; STABILITY; SIGNAL	Since its development, microarray technology has evolved to a standard method in the biotechnological and medical field with a broad range of applications. Nevertheless, the underlying mechanism of the hybridization process of PCR-products to microarray capture probes is still not completely understood, and several observed phenomena cannot be explained with current models. We investigated the influence of several parameters on the hybridization reaction and identified ssDNA to play a major role in the process. An increase of the ssDNA content in a hybridization reaction strongly enhanced resulting signal intensities. A strong influence could also be observed when unlabeled ssDNA was added to the hybridization reaction. A reduction of the ssDNA content resulted in a massive decrease of the hybridization efficiency. According to these data, we developed a novel model for the hybridization mechanism. This model is based on the assumption that single stranded DNA is necessary as catalyst to induce the hybridization of dsDNA. The developed hybridization model is capable of giving explanations for several yet unresolved questions regarding the functionality of microarrays. Our findings not only deepen the understanding of the hybridization process, but also have immediate practical use in data interpretation and the development of new microarrays.	[Dally, Simon; Knabbe, Cornelius; Weile, Jan] Heart & Diabet Ctr North Rhine Westphalia, Inst Lab & Transfus Med, Bad Oeynhausen, Germany; [Dally, Simon; Rupp, Steffen; Lemuth, Karin; Hartmann, Stefan C.; Hiller, Ekkehard; Bailer, Susanne M.] Fraunhofer Inst Interfacial Engn & Biotechnol, Dept Mol Biotechnol, Stuttgart, Germany	Ruhr University Bochum; Fraunhofer Gesellschaft	Weile, J (corresponding author), Heart & Diabet Ctr North Rhine Westphalia, Inst Lab & Transfus Med, Bad Oeynhausen, Germany.	jweile@hdz-nrw.de			European Union [241446]; German Federal Ministry for Education and Research [01EZ1113B]	European Union(European Commission); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 241446 (project 'Antiresdev'), and by the German Federal Ministry for Education and Research under grant agreement no 01EZ1113B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chizhikov V, 2001, APPL ENVIRON MICROB, V67, P3258, DOI 10.1128/AEM.67.7.3258-3263.2001; Dally S, 2013, ANTIMICROBIAL AGENTS; Gharaibeh RZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014464; Harrison A, 2013, NUCLEIC ACIDS RES, V41, P2779, DOI 10.1093/nar/gks1358; Kim KT, 2011, MOL CELLS, V32, P367, DOI 10.1007/s10059-011-0121-8; Li SZ, 2008, NUCLEIC ACIDS RES, V36, P6585, DOI 10.1093/nar/gkn740; Peplies J, 2003, APPL ENVIRON MICROB, V69, P1397, DOI 10.1128/AEM.69.3.1397-1407.2003; Peytavi R, 2005, BIOTECHNIQUES, V39, P89, DOI 10.2144/05391RR01; PLUM GE, 1990, P NATL ACAD SCI USA, V87, P9436, DOI 10.1073/pnas.87.23.9436; Pozhitkov AE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1122; Reynaldo LP, 2000, J MOL BIOL, V297, P511, DOI 10.1006/jmbi.2000.3573; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; Stedtfeld RD, 2007, APPL ENVIRON MICROB, V73, P380, DOI 10.1128/AEM.01785-06; Trapp C, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-20; Zhu LX, 2007, ANTIMICROB AGENTS CH, V51, P3707, DOI 10.1128/AAC.01461-06	15	0	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102338	10.1371/journal.pone.0102338	http://dx.doi.org/10.1371/journal.pone.0102338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025686	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400065
J	Hettich, MM; Matthes, F; Ryan, DP; Griesche, N; Schroder, S; Dorn, S; Krauss, S; Ehninger, D				Hettich, Moritz M.; Matthes, Frank; Ryan, Devon P.; Griesche, Nadine; Schroeder, Susanne; Dorn, Stephanie; Krauss, Sybille; Ehninger, Dan			The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex	PLOS ONE			English	Article							AMYLOID-PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; PHOSPHATASE 2A; OPITZ-SYNDROME; UBIQUITIN LIGASE; INSULIN; TAU; TRANSLATION; BETA; PHOSPHORYLATION	Alzheimer's disease (AD), the most common form of dementia in the elderly, is characterized by two neuropathological hallmarks: senile plaques, which are composed of A beta peptides, and neurofibrillary tangles, which are composed of hyperphosphorylated TAU protein. Diabetic patients with dysregulated insulin signalling are at increased risk of developing AD. Further, several animal models of diabetes show increased A beta expression and hyperphosphorylated tau. As we have shown recently, the anti-diabetic drug metformin is capable of dephosphorylating tau at AD-relevant phospho-sites. Here, we investigated the effect of metformin on the main amyloidogenic enzyme BACE1 and, thus, on the production of A beta peptides, the second pathological hallmark of AD. We find similar results in cultures of primary neurons, a human cell line model of AD and in vivo in mice. We show that treatment with metformin decreases BACE1 protein expression by interfering with an mRNA-protein complex that contains the ubiquitin ligase MID1, thereby reducing BACE1 activity. Together with our previous findings these results indicate that metformin may target both pathological hallmarks of AD and may be of therapeutic value for treating and/or preventing AD.	[Hettich, Moritz M.; Matthes, Frank; Ryan, Devon P.; Griesche, Nadine; Schroeder, Susanne; Dorn, Stephanie; Krauss, Sybille; Ehninger, Dan] Deutsch Zentrum Neurodegenerat Erkrankungen eV DZ, Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Krauss, S (corresponding author), Deutsch Zentrum Neurodegenerat Erkrankungen eV DZ, Bonn, Germany.	sybille.krauss@dzne.de; dan.ehninger@dzne.de	Krauss, Sybille/L-5328-2016	Matthes, Frank/0000-0002-5115-8831; Ryan, Devon/0000-0002-8549-0971; Krauss, Sybille/0000-0002-5653-9289	Else Kroner-Fresenius-Stiftung [2012_A304]	Else Kroner-Fresenius-Stiftung	This work was supported by the Else Kroner-Fresenius-Stiftung (2012_A304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; Alzheimer A, 1995, Clin Anat, V8, P429; Aranda-Orgilles B, 2008, HUM GENET, V123, P163, DOI 10.1007/s00439-007-0456-6; Aranda-Orgilles B, 2011, J BIOL CHEM, V286, P39945, DOI 10.1074/jbc.M111.224451; Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Bertrand L, 2008, CARDIOVASC RES, V79, P238, DOI 10.1093/cvr/cvn093; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Deng Y, 2013, EUR J NEUROSCI, V37, P1962, DOI 10.1111/ejn.12235; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Fritsche L, 2008, CURR MED CHEM, V15, P1316, DOI 10.2174/092986708784534956; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033; Jolivalt CG, 2008, J NEUROSCI RES, V86, P3265, DOI 10.1002/jnr.21787; Kickstein E., 2010, P NATL ACAD SCI US; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krauss S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2514; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Li ZG, 2007, DIABETES, V56, P1817, DOI 10.2337/db07-0171; Liu EB, 2011, P NATL ACAD SCI USA, V108, P8680, DOI 10.1073/pnas.1100131108; O'Neill C, 2012, BIOCHEM SOC T, V40, P721, DOI 10.1042/BST20120080; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Southan Christopher, 2013, Frontiers in Genetics, V4, P293, DOI 10.3389/fgene.2013.00293; Strachan MWJ, 1997, DIABETES CARE, V20, P438, DOI 10.2337/diacare.20.3.438; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Tian Q, 2002, NEUROSIGNALS, V11, P262, DOI 10.1159/000067425; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	36	55	57	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102420	10.1371/journal.pone.0102420	http://dx.doi.org/10.1371/journal.pone.0102420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025689	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400074
J	Tong, DL; Boocock, DJ; Dhondalay, GKR; Lemetre, C; Ball, GR				Tong, Dong Ling; Boocock, David J.; Dhondalay, Gopal Krishna R.; Lemetre, Christophe; Ball, Graham R.			Artificial Neural Network Inference (ANNI): A Study on Gene-Gene Interaction for Biomarkers in Childhood Sarcomas	PLOS ONE			English	Article							TROPONIN-T; REGULATORY NETWORKS; EWINGS-SARCOMA; ESTROGEN-RECEPTOR; EXPRESSION; IDENTIFICATION; PROTEIN; MICROARRAY; ALGORITHM; MUTATION	Objective To model the potential interaction between previously identified biomarkers in children sarcomas using artificial neural network inference (ANNI). Method: To concisely demonstrate the biological interactions between correlated genes in an interaction network map, only 2 types of sarcomas in the children small round blue cell tumors (SRBCTs) dataset are discussed in this paper. A backpropagation neural network was used to model the potential interaction between genes. The prediction weights and signal directions were used to model the strengths of the interaction signals and the direction of the interaction link between genes. The ANN model was validated using Monte Carlo cross-validation to minimize the risk of over-fitting and to optimize generalization ability of the model. Results: Strong connection links on certain genes (TNNT1 and FNDC5 in rhabdomyosarcoma (RMS); FCGRT and OLFM1 in Ewing's sarcoma (EWS)) suggested their potency as central hubs in the interconnection of genes with different functionalities. The results showed that the RMS patients in this dataset are likely to be congenital and at low risk of cardiomyopathy development. The EWS patients are likely to be complicated by EWS-FLI fusion and deficiency in various signaling pathways, including Wnt, Fas/Rho and intracellular oxygen. Conclusions: The ANN network inference approach and the examination of identified genes in the published literature within the context of the disease highlights the substantial influence of certain genes in sarcomas.	[Tong, Dong Ling; Boocock, David J.; Ball, Graham R.] Nottingham Trent Univ, John van Geest Canc Res Ctr, Sch Sci & Technol, Nottingham, England; [Dhondalay, Gopal Krishna R.] Univ London Imperial Coll Sci Technol & Med, NHLI, Imperial Ctr Translat & Expt Med, London, England; [Lemetre, Christophe] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, New York, NY 10021 USA	Nottingham Trent University; Imperial College London; Memorial Sloan Kettering Cancer Center	Ball, GR (corresponding author), Nottingham Trent Univ, John van Geest Canc Res Ctr, Sch Sci & Technol, Nottingham, England.	graham.ball@ntu.ac.uk	Dhondalay, Gopal Krishna Ramadas/A-3369-2014; Boocock, David/I-4666-2015	Dhondalay, Gopal Krishna Ramadas/0000-0002-1020-0175; Boocock, David/0000-0002-7333-3549; Ball, Graham/0000-0001-5828-7129; Tong, Dong/0000-0002-6363-7960	John and Lucille van Geest Foundation	John and Lucille van Geest Foundation	This research is funded by the John and Lucille van Geest Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abdelaziz AI, 2005, ADV EXP MED BIOL, V565, P283; Albert R, 2004, LECT NOTES PHYS, V650, P459; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033250; Breidthardt T, 2012, CLIN J AM SOC NEPHRO, V7, P1285, DOI 10.2215/CJN.00460112; Cheng L, 2011, IEEE T NEURAL NETWOR, V22, P714, DOI 10.1109/TNN.2011.2109735; Chipman KC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-17; Christley S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006799; Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Czuchlewski DR, 2008, AM J CLIN PATHOL, V130, P957, DOI 10.1309/AJCP12HIRWSRQLAN; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dhondalay G. K., 2011, Proceedings of the 2011 International Conference on Machine Learning and Cybernetics (ICMLC 2011), P727, DOI 10.1109/ICMLC.2011.6016771; Djavan B, 2002, J CLIN ONCOL, V20, P921, DOI 10.1200/JCO.20.4.921; Fortier M, 2008, CELL DEATH DIFFER, V15, P1221, DOI 10.1038/cdd.2008.34; Geryk-Hall M, 2009, CURR ONCOL REP, V11, P446, DOI 10.1007/s11912-009-0061-z; Giacomantonio CE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000936; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0; Gunther F, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-87; Gupta A, 2013, RECENT PATENTS ENDOC, V7, P138, DOI 10.2174/1872214811307020007; Hartemink AJ, 2002, IEEE INTELL SYST, V17, P37, DOI 10.1109/MIS.2002.999218; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kodithuwakku SP, 2012, LAB INVEST, V92, P256, DOI 10.1038/labinvest.2011.148; Krebs S, 2007, P NATL ACAD SCI USA, V104, P6746, DOI 10.1073/pnas.0607721104; Lancashire LJ, 2010, BREAST CANCER RES TR, V120, P83, DOI 10.1007/s10549-009-0378-1; Lancashire LJ, 2008, ARTIF INTELL MED, V43, P99, DOI 10.1016/j.artmed.2008.03.001; Lancashire LJ, 2009, BRIEF BIOINFORM, V10, P315, DOI 10.1093/bib/bbp012; Lecker SH, 2012, CIRC-HEART FAIL, V5, P812, DOI 10.1161/CIRCHEARTFAILURE.112.969543; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Lemetre C, 2010, ARTIFICIAL NEURAL NE; Lemetre C, 2009, LECT NOTES COMPUT SC, V5517, P877, DOI 10.1007/978-3-642-02478-8_110; Li Q, 2012, BIOCHEM BIOPH RES CO, V423, P895, DOI 10.1016/j.bbrc.2012.06.099; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Li XD, 2010, J CELL BIOCHEM, V111, P933, DOI 10.1002/jcb.22782; Liu WB, 2012, MOL BIOL REP, V39, P4401, DOI 10.1007/s11033-011-1228-x; Lopes DN, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/479242; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Maraziotis IA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-140; Martinez-Abrain A, 2008, ACTA OECOL, V34, P9, DOI 10.1016/j.actao.2008.02.004; Matharoo-Ball B, 2007, J PROTEOME RES, V6, P3321, DOI 10.1021/pr070124b; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Morgan MJ, 1999, BIOCHEM BIOPH RES CO, V255, P245, DOI 10.1006/bbrc.1999.0179; Neumann S, 2006, J BIOL CHEM, V281, P7583, DOI 10.1074/jbc.M508340200; Nishii K, 2008, DEV BIOL, V322, P65, DOI 10.1016/j.ydbio.2008.07.007; O'Neill MC, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-13; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Parkinson NJ, 2008, NEUROMUSCULAR DISORD, V18, P394, DOI 10.1016/j.nmd.2008.01.006; Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071; Pianta TJ, 2012, NEPHROLOGY, V17, P636, DOI 10.1111/j.1440-1797.2012.01625.x; Rajwanshi A, 2009, J CYTOL, V26, P1, DOI 10.4103/0970-9371.54861; Ram R, 2009, LECT N BIOINFORMAT, V5780, P293, DOI 10.1007/978-3-642-04031-3_26; RIMOKH R, 1993, BLOOD, V81, P136; Sainz-Jaspeado M, 2010, MOL CANCER RES, V8, P1489, DOI 10.1158/1541-7786.MCR-10-0060; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sengupta A, 2011, INT J ONCOL, V38, P1259, DOI 10.3892/ijo.2011.963; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharp P, 2006, EXP NEUROL, V198, P511, DOI 10.1016/j.expneurol.2005.12.031; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stock M, 2004, J BONE MINER RES, V19, P959, DOI 10.1359/jbmr.2004.19.6.959; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Tong DL, 2009, P 4 IAPR INT C PATT, P1; Tong DL, 2011, ARTIF INTELL MED, V53, P47, DOI 10.1016/j.artmed.2011.06.008; Tong DL, 2010, INT J MACH LEARN CYB, V1, P75, DOI 10.1007/s13042-010-0004-x; Tong DL, 2009, PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-6, P1082, DOI 10.1109/ICMLC.2009.5212372; Uren A, 2004, PEDIATR BLOOD CANCER, V43, P243, DOI 10.1002/pbc.20124; Wei JS, 2004, CANCER RES, V64, P6883, DOI 10.1158/0008-5472.CAN-04-0695; Wu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010137; Wu ZZ, 2011, J CELL PHYSIOL, V226, P2415, DOI 10.1002/jcp.22589; Xu R, 2004, P ANN INT IEEE EMBS, V26, P2905; Xu R, 2006, LECT NOTES COMPUT SC, V3973, P648	80	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102483	10.1371/journal.pone.0102483	http://dx.doi.org/10.1371/journal.pone.0102483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025207	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400078
J	Tramm, N; Oppenheimer, N; Nagy, S; Efrati, E; Biron, D				Tramm, Nora; Oppenheimer, Naomi; Nagy, Stanislav; Efrati, Efi; Biron, David			Why Do Sleeping Nematodes Adopt a Hockey-Stick-Like Posture?	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; DYNAMICS; MUSCLE; MECHANICS; LETHARGUS; GENETICS; CIRCUIT; CALCIUM; ATPASE	A characteristic posture is considered one of the behavioral hallmarks of sleep, and typically includes functional features such as support for the limbs and shielding of sensory organs. The nematode C. elegans exhibits a sleep-like state during a stage termed lethargus, which precedes ecdysis at the transition between larval stages. A hockey-stick-like posture is commonly observed during lethargus. What might its function be? It was previously noted that during lethargus, C. elegans nematodes abruptly rotate about their longitudinal axis. Plausibly, these `` flips'' facilitate ecdysis by assisting the disassociation of the old cuticle from the new one. We found that body-posture during lethargus was established using a stereotypical motor program and that body bends during lethargus quiescence were actively maintained. Moreover, flips occurred almost exclusively when the animals exhibited a single body bend, preferentially in the anterior or mid section of the body. We describe a simple biomechanical model that imposes the observed lengths of the longitudinally directed body-wall muscles on an otherwise passive elastic rod. We show that this minimal model is sufficient for generating a rotation about the anterior-posterior body axis. Our analysis suggests that posture during lethargus quiescence may serve a developmental role in facilitating flips and that the control of body wall muscles in anterior and posterior body regions are distinct.	[Tramm, Nora; Oppenheimer, Naomi; Efrati, Efi; Biron, David] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Tramm, Nora; Oppenheimer, Naomi; Efrati, Efi; Biron, David] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Nagy, Stanislav; Biron, David] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Biron, D (corresponding author), Univ Chicago, Dept Phys, Chicago, IL 60637 USA.	dbiron@uchicago.edu	Nagy, Stanislav/GXW-2342-2022; Nagy, Stanislav/T-5247-2017		NSF GRFP [DGE-0638477]; Simons fellowship; Burroughs Wellcome Fund; Searle Scholars Program; National Science Foundation [PHYS-1066293]	NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Simons fellowship; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Searle Scholars Program; National Science Foundation(National Science Foundation (NSF))	This work was supported by NSF GRFP #DGE-0638477 (N.T), Simons fellowship (E. E), Burroughs Wellcome Fund (D. B), Searle Scholars Program (D. B). This work was supported in part by the National Science Foundation under Grant No. PHYS-1066293 and the hospitality of the Aspen Center for Physics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2008, ANNU REV GENET, V42, P361, DOI 10.1146/annurev.genet.42.110807.091541; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; Audoly B, 2010, ELASTICITY GEOMETRY; Backholm M, 2013, P NATL ACAD SCI USA, V110, P4528, DOI 10.1073/pnas.1219965110; BRENNER S, 1974, GENETICS, V77, P71; Butler TM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/725207; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Crocker A, 2010, GENE DEV, V24, P1220, DOI 10.1101/gad.1913110; DIJK DJ, 1993, BRAIN RES, V626, P190, DOI 10.1016/0006-8993(93)90579-C; Donnelly JL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001529; Fang-Yen C, 2010, P NATL ACAD SCI USA, V107, P20323, DOI 10.1073/pnas.1003016107; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Hall D.H., 2007, C ELEGANS ATLAS; Hendricks M, 2012, NATURE, V487, P99, DOI 10.1038/nature11081; ISHII N, 1989, SCIENCE, V243, P1367, DOI 10.1126/science.2922614; Iwanir S, 2013, SLEEP, V36, P385, DOI 10.5665/sleep.2456; JEWELL BR, 1959, J PHYSIOL-LONDON, V149, P154, DOI 10.1113/jphysiol.1959.sp006332; Karbowski J, 2008, J COMPUT NEUROSCI, V24, P253, DOI 10.1007/s10827-007-0054-6; Karbowski J, 2006, J THEOR BIOL, V242, P652, DOI 10.1016/j.jtbi.2006.04.012; Loomis AL, 1938, J NEUROPHYSIOL, V1, P413, DOI 10.1152/jn.1938.1.5.413; McDONNELL J, 1946, Br J Phys Med, V9, P46; Nagy S, 2013, ELIFE, V2, DOI 10.7554/eLife.00782; Nelson MD, 2013, CURR OPIN NEUROBIOL, V23, P824, DOI 10.1016/j.conb.2013.02.015; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; Park SJ, 2007, P NATL ACAD SCI USA, V104, P17376, DOI 10.1073/pnas.0702138104; Perseghin P, 2012, TRANSFUSION, P1; Petzold BC, 2011, BIOPHYS J, V100, P1977, DOI 10.1016/j.bpj.2011.02.035; Pujol N, 2001, J BIOL CHEM, V276, P11913, DOI 10.1074/jbc.M009451200; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Schwarz J, 2012, WORM, V1, P0; Singh K, 2011, CURR BIOL, V21, P825, DOI 10.1016/j.cub.2011.04.010; SINGH RN, 1978, NEMATOLOGICA, V24, P63, DOI 10.1163/187529278X00074; Sobel I., 1973, PATTERN CLASSIFICATI, P271; Struik D. J., 1988, LECT CLASSICAL DIFFE; Sznitman J, 2010, BIOPHYS J, V98, P617, DOI 10.1016/j.bpj.2009.11.010; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; Von Stetina SE, 2005, INT REV NEUROBIOL, V69, P125, DOI 10.1016/S0074-7742(05)69005-8; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	39	16	16	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101162	10.1371/journal.pone.0101162	http://dx.doi.org/10.1371/journal.pone.0101162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025212	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400009
J	Mungamuri, S; Wang, S; Manfredi, JJ; Gu, W; Aaronson, SA				Mungamuri, S. K.; Wang, S.; Manfredi, J. J.; Gu, W.; Aaronson, S. A.			Ash2L enables P53-dependent apoptosis by favoring stable transcription pre-initiation complex formation on its pro-apoptotic target promoters	ONCOGENE			English	Article							RNA-POLYMERASE-II; HISTONE H3; STRUCTURAL BASIS; P53; METHYLATION; ACTIVATION; CHROMATIN; TFIIB; SET1; DNA	Chromatin conformation has a major role in all cellular decisions. We showed previously that P53 pro-apoptotic target promoters are enriched with H3K9me3 mark and induction of P53 abrogates this repressive chromatin conformation by downregulating SUV39H1, the writer of this mark present on these promoters. In the present study, we demonstrate that in response to P53 stabilization, its pro-apoptotic target promoters become enriched with the H3K4me3 epigenetic mark as well as its readers, Wdr5, RbBP5 and Ash2L, which were not observed in response to SUV39H1 downregulation alone. Overexpression of Ash2L enhanced P53-dependent apoptosis in response to chemotherapy, associated with increased P53 pro-apoptotic gene promoter occupancy and target gene expression. In contrast, pre-silencing of Ash2L abrogated P53's ability to induce the expression of these transcriptional targets, without affecting P53 or RNAP II recruitment. However, Ash2L pre-silencing, under the same conditions, resulted in reduced RNAP II ser5-CTD phosphorylation on these same pro-apoptotic target promoters, which correlated with reduced promoter occupancy of TFIIB as well as TFIIF (RAP74). Based on these findings, we propose that Ash2L acts in concert with P53 promoter occupancy to activate RNAP II by aiding formation of a stable transcription pre-initiation complex required for its activation.	[Mungamuri, S. K.; Manfredi, J. J.; Aaronson, S. A.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Wang, S.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Gu, W.] Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, Inst Canc Genet, New York, NY USA	Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; Columbia University	Aaronson, SA (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, One Gustave L Levy Pl,Box 1130, New York, NY 10029 USA.	stuart.aaronson@mssm.edu		Mungamuri, Sathish Kumar/0000-0002-0012-5298; Wang, Shaomeng/0000-0002-8782-6950; Manfredi, James/0000-0003-2234-9097	National Cancer Institute [P01CA080058]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P01CA080058] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank SW Lee (MGH, Harvard) for helpful discussions. This research was supported by grants from the National Cancer Institute (P01CA080058) and Breast Cancer Research Foundation (SAA). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the US National Institutes of Health.	Ardehali MB, 2011, EMBO J, V30, P2817, DOI 10.1038/emboj.2011.194; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartkowiak B, 2011, TRANSCR-AUSTIN, V2, P115, DOI 10.4161/trns.2.3.15004; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Bosch-Presegue L, 2011, MOL CELL, V42, P210, DOI 10.1016/j.molcel.2011.02.034; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fu Y, 2009, CURR MED CHEM, V16, P3966, DOI 10.2174/092986709789352277; Gomes NP, 2010, GENE DEV, V24, P111, DOI 10.1101/gad.1893610; Goodman RH, 2000, GENE DEV, V14, P1553; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hosoda H, 2011, CYTOTECHNOLOGY, V63, P211, DOI 10.1007/s10616-011-9335-z; Jaskelioff M, 2003, NAT CELL BIOL, V5, P395, DOI 10.1038/ncb0503-395; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Mandinova A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001366; Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830; Mungamuri SK, 2012, NAT STRUCT MOL BIOL, V19, P478, DOI 10.1038/nsmb.2271; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schmid CD, 2007, CELL, V131, P831, DOI 10.1016/j.cell.2007.11.017; Shandilya J, 2012, P NATL ACAD SCI USA, V109, P18797, DOI 10.1073/pnas.1207483109; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; Tang ZY, 2013, CELL, V154, P297, DOI 10.1016/j.cell.2013.06.027; Thomas A, 1998, GENE DEV, V12, P1975, DOI 10.1101/gad.12.13.1975; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vermeulen M, 2010, EPIGENOMICS-UK, V2, P395, DOI 10.2217/EPI.10.11; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Zhang DW, 2012, GENET RES INT, V2012, DOI 10.1155/2012/347214; Zheng H, 2014, ONCOGENE, V33, P734, DOI 10.1038/onc.2013.6	61	16	16	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2015	34	19					2461	2470		10.1038/onc.2014.198	http://dx.doi.org/10.1038/onc.2014.198			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH7BK	25023704	Green Accepted			2022-12-25	WOS:000354190400005
J	Ivey, RA; Sajan, MP; Farese, RV				Ivey, Robert A.; Sajan, Mini P.; Farese, Robert V.			Requirements for Pseudosubstrate Arginine Residues during Autoinhibition and Phosphatidylinositol 3,4,5-(PO4)(3)-dependent Activation of Atypical PKC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GLUCOSE-TRANSPORT; RAT ADIPOCYTES; INOSITOL PHOSPHATES; INSULIN-RESISTANCE; SKELETAL-MUSCLE; MIXED MICELLES; ZETA; ALPHA; TRANSLOCATION	Atypical PKC (aPKC) isoforms are activated by the phosphatidylinositol 3-kinase product phosphatidylinositol 3,4,5-(PO4)(3) (PIP3). How PIP3 activates aPKC is unknown. Although Akt activation involves PIP3 binding to basic residues in the Akt pleckstrin homology domain, aPKCs lack this domain. Here we examined the role of basic arginine residues common to aPKC pseudosubstrate sequences. Replacement of all five (or certain) arginine residues in the pseudosubstrate sequence of PKC-iota by site-directed mutagenesis led to constitutive activation and unresponsiveness to PIP3 in vitro or insulin in vivo. However, with the addition of the exogenous arginine-containing pseudosubstrate tridecapeptide to inhibit this constitutively active PKC-iota, PIP3-activating effects were restored. A similar restoration of responsiveness to PIP3 was seen when exogenous pseudosubstrate was used to inhibit mouse liver PKC-lambda/zeta maximally activated by insulin or ceramide and a truncated, constitutively active PKC-zeta mutant lacking all regulatory domain elements and containing "activating" glutamate residues at loop and autophosphorylation sites (Delta 1-247/T410E/T560E-PKC-zeta). NMR studies suggest that PIP3 binds directly to the pseudosubstrate. The ability of PIP3 to counteract the inhibitory effects of the exogenous pseudosubstrate suggests that basic residues in the pseudosubstrate sequence are required for maintaining aPKCs in an inactive state and are targeted by PIP3 for displacement from the substrate-binding site during kinase activation.	[Ivey, Robert A.; Sajan, Mini P.; Farese, Robert V.] James A Haley Vet Med Ctr, Med Serv, Tampa, FL 33612 USA; [Ivey, Robert A.; Sajan, Mini P.; Farese, Robert V.] James A Haley Vet Med Ctr, Res Serv, Tampa, FL 33612 USA; [Sajan, Mini P.; Farese, Robert V.] Univ S Florida, Coll Med, Div Endocrinol & Metab, Dept Internal Med, Tampa, FL 33612 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida	Farese, RV (corresponding author), James A Haley Vet Med Ctr, Res Serv, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	rfarese@health.usf.edu	Farese, Robert/B-3605-2015		National Institutes of Health [RO1DK 065969-09]; Department of Veterans Affairs Merit Review Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065969] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Program(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK 065969-09 (to R. V. F.). This work was also supported by funds from the Department of Veterans Affairs Merit Review Program (to R. V. F.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Auguin D, 2004, J BIOMOL NMR, V28, P137, DOI 10.1023/B:JNMR.0000013836.62154.c2; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Bandyopadhyay G, 1999, BIOCHEM J, V337, P461, DOI 10.1042/0264-6021:3370461; Beeson M, 2003, DIABETES, V52, P1926, DOI 10.2337/diabetes.52.8.1926; Fields A. P., 2007, BIOCHEM SOC T, V23, P1996; Graybill C, 2012, J BIOL CHEM, V287, P21003, DOI 10.1074/jbc.M112.360495; HANNUN YA, 1986, J BIOL CHEM, V261, P7184; HANNUN YA, 1985, J BIOL CHEM, V260, P39; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Kim YB, 2003, DIABETES, V52, P1935, DOI 10.2337/diabetes.52.8.1935; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Liu Q, 1998, J IMMUNOL, V160, P1393; Lopez-Garcia LA, 2011, CHEM BIOL, V18, P1463, DOI 10.1016/j.chembiol.2011.08.010; MULLER G, 1995, EMBO J, V14, P1961, DOI 10.1002/j.1460-2075.1995.tb07188.x; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Sajan MP, 2012, DIABETOLOGIA, V55, P1446, DOI 10.1007/s00125-012-2477-5; Sajan MP, 2009, DIABETOLOGIA, V52, P1197, DOI 10.1007/s00125-009-1336-5; Sajan MP, 2006, J BIOL CHEM, V281, P17466, DOI 10.1074/jbc.M510803200; Sajan MP, 2004, J CLIN ENDOCR METAB, V89, P3994, DOI 10.1210/jc.2004-0106; Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Standaert ML, 2002, DIABETES, V51, P2936, DOI 10.2337/diabetes.51.10.2936; Standaert ML, 2001, BIOCHEMISTRY-US, V40, P249, DOI 10.1021/bi0018234; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567	26	16	16	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25021	25030		10.1074/jbc.M114.565671	http://dx.doi.org/10.1074/jbc.M114.565671			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25035426	Green Published, hybrid			2022-12-25	WOS:000341985300026
J	Boswell-Casteel, RC; Johnson, JM; Duggan, KD; Roe-Zurz, Z; Schmitz, H; Burleson, C; Hays, FA				Boswell-Casteel, Rebba C.; Johnson, Jennifer M.; Duggan, Kelli D.; Roe-Zurz, Zygy; Schmitz, Hannah; Burleson, Carter; Hays, Franklin A.			FUN26 (Function Unknown Now 26) Protein from Saccharomyces cerevisiae Is a Broad Selectivity, High Affinity, Nucleoside and Nucleobase Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Membrane Protein; Membrane Transport; Membrane Transporter Reconstitution; Nucleoside; Nucleotide Transport; Transporter	INTEGRAL MEMBRANE-PROTEINS; CHROMOSOME-I DNA; MOLECULAR-CLONING; STREPTOCOCCUS-EQUISIMILIS; INTRACELLULAR MEMBRANES; HYALURONAN SYNTHASE; ENT FAMILY; YEAST; NITROBENZYLTHIOINOSINE; TRANSLOCATION	Background: FUN26 is a nucleoside transporter expressed in yeast vacuoles. Results: Proteoliposome studies of purified FUN26 reveal broad nucleoside and nucleobase uptake that is sensitive to C(2)-ribose modifications. Conclusion: FUN26 is a high affinity and broad selectivity nucleoside and nucleobase transporter. Significance: FUN26 has a unique substrate transport profile relative to other ENTs and retains activity following detergent solubilization and purification. Equilibrative nucleoside transporters (ENTs) are polytopic integral membrane proteins that transport nucleosides and, to a lesser extent, nucleobases across cell membranes. ENTs modulate efficacy for a range of human therapeutics and function in a diffusion-controlled bidirectional manner. A detailed understanding of ENT function at the molecular level has remained elusive. FUN26 (function unknown now 26) is a putative ENT homolog from S. cerevisiae that is expressed in vacuole membranes. In the present system, proteoliposome studies of purified FUN26 demonstrate robust nucleoside and nucleobase uptake into the luminal volume for a broad range of substrates. This transport activity is sensitive to nucleoside modifications in the C(2)- and C(5)-positions on the ribose sugar and is not stimulated by a membrane pH differential. [H-3]Adenine nucleobase transport efficiency is increased approximate to 4-fold relative to nucleosides tested with no observed [H-3]adenosine or [H-3]UTP transport. FUN26 mutational studies identified residues that disrupt (G463A or G216A) or modulate (F249I or L390A) transporter function. These results demonstrate that FUN26 has a unique substrate transport profile relative to known ENT family members and that a purified ENT can be reconstituted in proteoliposomes for functional characterization in a defined system.	[Boswell-Casteel, Rebba C.; Johnson, Jennifer M.; Duggan, Kelli D.; Schmitz, Hannah; Burleson, Carter; Hays, Franklin A.] Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Hays, Franklin A.] Univ Oklahoma, Stephenson Oklahoma Canc Ctr, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Roe-Zurz, Zygy] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Francisco	Hays, FA (corresponding author), Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.	Franklin-Hays@ouhsc.edu	Boswell-Casteel, Rebba/P-8651-2019	Johnson Hays, Jennifer/0000-0001-5855-7352	National Institutes of Health, NIGMS, Institutional Development Award (IDeA) [P20GM103639]; Oklahoma Center for the Advancement of Science [HR11-046]; University of Oklahoma Health Sciences Center College of Medicine Alumni Association seed grant; American Heart Association Predoctoral Fellowship [13PRE17040024]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284, P20GM103639] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS, Institutional Development Award (IDeA); Oklahoma Center for the Advancement of Science; University of Oklahoma Health Sciences Center College of Medicine Alumni Association seed grant; American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health, NIGMS, Institutional Development Award (IDeA) under Grant P20GM103639. This work was also supported by Oklahoma Center for the Advancement of Science Grant HR11-046 (to F. A. H.), a University of Oklahoma Health Sciences Center College of Medicine Alumni Association seed grant (to F. A. H.), and American Heart Association Predoctoral Fellowship 13PRE17040024 (to R. C. B.-C.).	Arastu-Kapur S, 2003, J BIOL CHEM, V278, P33327, DOI 10.1074/jbc.M305141200; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; BARTON AB, 1994, J BACTERIOL, V176, P1872, DOI 10.1128/jb.176.7.1872-1880.1994; Blackburn GM, 2006, NUCLEIC ACIDS IN CHEMISTRY AND BIOLOGY, THIRD EDITION, P77; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Botstein D, 1997, SCIENCE, V277, P1259, DOI 10.1126/science.277.5330.1259; Cass CE, 1998, BIOCHEM CELL BIOL, V76, P761, DOI 10.1139/bcb-76-5-761; CASS CE, 1973, BIOCHIM BIOPHYS ACTA, V291, P734, DOI 10.1016/0005-2736(73)90477-X; CHEVALLIER MR, 1975, J BACTERIOL, V122, P629, DOI 10.1128/JB.122.2.629-641.1975; Clarke M, 2002, DANCING TIMES, V93, P27; COLEMAN KG, 1986, MOL CELL BIOL, V6, P4516, DOI 10.1128/MCB.6.12.4516; Damaraju VL, 2011, CHEMBIOCHEM, V12, P2774, DOI 10.1002/cbic.201100567; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; GATI WP, 1984, BIOCHEM PHARMACOL, V33, P3325, DOI 10.1016/0006-2952(84)90101-1; Greenhalf W, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt347; GRENSON M, 1969, EUR J BIOCHEM, V11, P249, DOI 10.1111/j.1432-1033.1969.tb00767.x; HAMMOND JR, 1994, J PHARMACOL EXP THER, V271, P906; Hammond JR, 1996, ARCH BIOCHEM BIOPHYS, V332, P313, DOI 10.1006/abbi.1996.0347; Hammond JR, 1997, BIOCHEM PHARMACOL, V53, P623, DOI 10.1016/S0006-2952(96)00857-X; Hays FA, 2010, METHOD ENZYMOL, V470, P695, DOI 10.1016/S0076-6879(10)70029-X; Hays Franklin A., 2009, Journal of Structural and Functional Genomics, V10, P9, DOI 10.1007/s10969-008-9046-7; Hyde RJ, 2001, MOL MEMBR BIOL, V18, P53, DOI 10.1080/09687680110033765; Indiveri C, 2010, METHODS MOL BIOL, V606, P55, DOI 10.1007/978-1-60761-447-0_5; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; Jiang X, 2012, BIOCHEMISTRY-US, V51, P9480, DOI 10.1021/bi301329w; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; JUND R, 1977, J MEMBRANE BIOL, V36, P233, DOI 10.1007/BF01868153; Kang N, 2010, J BIOL CHEM, V285, P28343, DOI 10.1074/jbc.M110.109199; Kelly Libusha, 2009, Journal of Structural and Functional Genomics, V10, P269, DOI 10.1007/s10969-009-9069-8; Kumari K, 1997, J BIOL CHEM, V272, P32539, DOI 10.1074/jbc.272.51.32539; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; Li M, 2009, J MOL BIOL, V385, P820, DOI 10.1016/j.jmb.2008.11.021; Lu SP, 2011, J BIOL CHEM, V286, P14271, DOI 10.1074/jbc.M110.217885; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Lum PY, 2000, CANCER CHEMOTH PHARM, V45, P273, DOI 10.1007/s002800050040; MATILE P, 1967, ARCH MIKROBIOL, V56, P148, DOI 10.1007/BF00408765; NAGY M, 1979, BIOCHIM BIOPHYS ACTA, V558, P221, DOI 10.1016/0005-2736(79)90062-2; POLAK A, 1973, EUR J BIOCHEM, V32, P276, DOI 10.1111/j.1432-1033.1973.tb02608.x; Scholfield MR, 2013, PROTEIN SCI, V22, P139, DOI 10.1002/pro.2201; SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; Tlapak-Simmons VL, 2004, BIOCHEMISTRY-US, V43, P9234, DOI 10.1021/bi049468v; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; Valdes R, 2014, J BIOL CHEM, V289, P8799, DOI 10.1074/jbc.M113.546960; Vickers MF, 2000, J BIOL CHEM, V275, P25931, DOI 10.1074/jbc.M000239200; Vickers MF, 2004, NUCLEOS NUCLEOT NUCL, V23, P361, DOI 10.1081/NCN-120028333; VICKERS MF, 2000, EMERGING THERAPEUTIC, V4, P515; Wiederhold E, 2009, MOL CELL PROTEOMICS, V8, P380, DOI 10.1074/mcp.M800372-MCP200; Xie H, 2008, ACTA BIOCH BIOPH SIN, V40, P269, DOI 10.1111/j.1745-7270.2008.00400.x; Yao SYM, 2011, J BIOL CHEM, V286, P32552, DOI 10.1074/jbc.M111.236117; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yao SYM, 1997, J BIOL CHEM, V272, P28423, DOI 10.1074/jbc.272.45.28423; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007	56	11	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24440	24451		10.1074/jbc.M114.553503	http://dx.doi.org/10.1074/jbc.M114.553503			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25035431	Green Published, hybrid			2022-12-25	WOS:000341505600037
J	Lim, LZ; Shi, JH; Mu, YG; Song, JX				Lim, Liangzhong; Shi, Jiahai; Mu, Yuguang; Song, Jianxing			Dynamically-Driven Enhancement of the Catalytic Machinery of the SARS 3C-Like Protease by the S284-T285-I286/A Mutations on the Extra Domain	PLOS ONE			English	Article							RESPIRATORY-SYNDROME CORONAVIRUS; COV MAIN PROTEINASE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; DIMER INTERFACE; ACTIVE-SITE; M-PRO; ENZYME; DIMERIZATION; SIMULATIONS	Previously we revealed that the extra domain of SARS 3CLpro mediated the catalysis via different mechanisms. While the R298A mutation completely abolished the dimerization, thus resulting in the inactive catalytic machinery, N214A inactivated the enzyme by altering its dynamics without significantly perturbing its structure. Here we studied another mutant with S284-T285-I286 replaced by Ala (STI/A) with a 3.6-fold activity increase and slightly enhanced dimerization. We determined its crystal structure, which still adopts the dimeric structure almost identical to that of the wild-type (WT), except for slightly tighter packing between two extra-domains. We then conducted 100-ns molecular dynamics (MD) simulations for both STI/A and WT, the longest reported so far for 3CLpro. In the simulations, two STI/A extra domains become further tightly packed, leading to a significant volume reduction of the nano-channel formed by residues from both catalytic and extra domains. The enhanced packing appears to slightly increase the dynamic stability of the N-finger and the first helix residues, which subsequently triggers the redistribution of dynamics over residues directly contacting them. This ultimately enhances the dynamical stability of the residues constituting the catalytic dyad and substrate-binding pockets. Further correlation analysis reveals that a global network of the correlated motions exists in the protease, whose components include all residues identified so far to be critical for the dimerization and catalysis. Most strikingly, the N214A mutation globally decouples this network while the STI/A mutation alters the correlation pattern. Together with previous results, the present study establishes that besides the classic structural allostery, the dynamic allostery also operates in the SARS 3CLpro, which is surprisingly able to relay the perturbations on the extra domain onto the catalytic machinery to manifest opposite catalytic effects. Our results thus imply a promising avenue to design specific inhibitors for 3CL proteases by disrupting their dynamic correlation network.	[Lim, Liangzhong; Shi, Jiahai; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore; [Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Song, JX (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore.	dbssjx@nus.edu.sg	Shi, Jiahai/AAH-1103-2019; shi, jiahai/D-7650-2013; Song, Jianxing/H-8026-2012	Shi, Jiahai/0000-0002-6467-8289; shi, jiahai/0000-0002-6467-8289; Song, Jianxing/0000-0003-0224-6322	Ministry of Education of Singapore (MOE) [R-154-002-580-112]; Tier 2 Grant [MOE 2011-T2-1-096 (R154-000-525-112)]	Ministry of Education of Singapore (MOE); Tier 2 Grant	This study was supported by Ministry of Education of Singapore (MOE) Tier 3 Grant R-154-002-580-112, and also partly by Tier 2 Grant MOE 2011-T2-1-096 (R154-000-525-112) to Jianxing Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Anand K, 2002, EMBO J, V21, P3213, DOI 10.1093/emboj/cdf327; Bacha U, 2004, BIOCHEMISTRY-US, V43, P4906, DOI 10.1021/bi0361766; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrila J, 2006, BIOCHEMISTRY-US, V45, P14908, DOI 10.1021/bi0616302; Barrila J, 2010, BIOCHEMISTRY-US, V49, P4308, DOI 10.1021/bi1002585; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chang HP, 2007, BIOPHYS J, V92, P1374, DOI 10.1529/biophysj.106.091736; Chen H, 2006, J BIOL CHEM, V281, P13894, DOI 10.1074/jbc.M510745200; Chen S, 2005, J BIOL CHEM, V280, P164, DOI 10.1074/jbc.M408211200; Chen S, 2008, J BIOL CHEM, V283, P554, DOI 10.1074/jbc.M705240200; Cheng SC, 2010, BIOPHYS J, V98, P1327, DOI 10.1016/j.bpj.2009.12.4272; Chou CY, 2004, BIOCHEMISTRY-US, V43, P14958, DOI 10.1021/bi0490237; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Giver L, 1998, P NATL ACAD SCI USA, V95, P12809, DOI 10.1073/pnas.95.22.12809; Graziano V, 2006, BIOCHEMISTRY-US, V45, P14632, DOI 10.1021/bi061746y; Grum-Tokars V, 2008, VIRUS RES, V133, P63, DOI 10.1016/j.virusres.2007.02.015; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Hsu WC, 2005, J BIOL CHEM, V280, P22741, DOI 10.1074/jbc.M502556200; Hu TC, 2009, VIROLOGY, V388, P324, DOI 10.1016/j.virol.2009.03.034; Jiang P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000357; Kamal MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035188; Khosla C, 2001, NATURE, V409, P247, DOI 10.1038/35051723; Kuang WF, 2005, BIOCHEM BIOPH RES CO, V331, P1554, DOI 10.1016/j.bbrc.2005.04.072; Kuo CJ, 2004, BIOCHEM BIOPH RES CO, V318, P862, DOI 10.1016/j.bbrc.2004.04.098; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TW, 2007, J MOL BIOL, V366, P916, DOI 10.1016/j.jmb.2006.11.078; Lee TW, 2005, J MOL BIOL, V353, P1137, DOI 10.1016/j.jmb.2005.09.004; Lehmann M, 2000, BBA-PROTEIN STRUCT M, V1543, P408, DOI 10.1016/S0167-4838(00)00238-7; Ma BY, 2013, TOP CURR CHEM, V337, P123, DOI 10.1007/128_2012_316; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; McClendon CL, 2009, J CHEM THEORY COMPUT, V5, P2486, DOI 10.1021/ct9001812; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mu YG, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3120483; Nemova N. N., 2008, Biomeditsinskaya Khimiya, V54, P42; Pang YP, 2004, PROTEINS, V57, P747, DOI 10.1002/prot.20249; Ren ZL, 2013, PROTEIN CELL, V4, P248, DOI 10.1007/s13238-013-2841-3; Saen-Oon S, 2008, BIOPHYS J, V94, P4078, DOI 10.1529/biophysj.107.121913; Shi JH, 2006, FEBS J, V273, P1035, DOI 10.1111/j.1742-4658.2006.05130.x; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Shi JH, 2008, J VIROL, V82, P4620, DOI 10.1128/JVI.02680-07; Shi JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001084; Silva DA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002054; Tan JZ, 2005, J MOL BIOL, V354, P25, DOI 10.1016/j.jmb.2005.09.012; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007; Verschueren KHG, 2008, CHEM BIOL, V15, P597, DOI 10.1016/j.chembiol.2008.04.011; WARREN LD, 2007, PYMOL MOL GRAPHICS S; Watney JB, 2003, J AM CHEM SOC, V125, P3745, DOI 10.1021/ja028487u; Wei P, 2006, BIOCHEM BIOPH RES CO, V339, P865, DOI 10.1016/j.bbrc.2005.11.102; Xue XY, 2008, J VIROL, V82, P2515, DOI 10.1128/JVI.02114-07; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Yin JA, 2007, J MOL BIOL, V371, P1060, DOI 10.1016/j.jmb.2007.06.001; Zheng KW, 2007, PROTEINS, V66, P467, DOI 10.1002/prot.21160; Zhong N, 2008, J VIROL, V82, P4227, DOI 10.1128/JVI.02612-07; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	63	40	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101941	10.1371/journal.pone.0101941	http://dx.doi.org/10.1371/journal.pone.0101941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036652	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200029
J	Benitez, SG; Castro, AE; Patterson, SI; Munoz, EM; Seltzer, AM				Benitez, Sergio G.; Castro, Analia E.; Patterson, Sean I.; Munoz, Estela M.; Seltzer, Alicia M.			Hypoxic Preconditioning Differentially Affects GABAergic and Glutamatergic Neuronal Cells in the Injured Cerebellum of the Neonatal Rat	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; ACTIVE CASPASE-3 EXPRESSION; ISCHEMIC-INJURY; PURKINJE-CELLS; SELECTIVE VULNERABILITY; POSTNATAL-DEVELOPMENT; TRANSCRIPTION FACTOR; PROGENITOR CELLS; BRAIN-INJURY; PROTEIN	In this study we examined cerebellar alterations in a neonatal rat model of hypoxic-ischemic brain injury with or without hypoxic preconditioning (Pc). Between postnatal days 7 and 15, the cerebellum is still undergoing intense cellular proliferation, differentiation and migration, dendritogenesis and synaptogenesis. The expression of glutamate decarboxylase 1 (GAD67) and the differentiation factor NeuroD1 were examined as markers of Purkinje and granule cells, respectively. We applied quantitative immunohistochemistry to sagittal cerebellar slices, and Western blot analysis of whole cerebella obtained from control (C) rats and rats submitted to Pc, hypoxia-ischemia (L) and a combination of both treatments (PcL). We found that either hypoxia-ischemia or Pc perturbed the granule cells in the posterior lobes, affecting their migration and final placement in the internal granular layer. These effects were partially attenuated when the Pc was delivered prior to the hypoxia-ischemia. Interestingly, whole nuclear NeuroD1 levels in Pc animals were comparable to those in the C rats. However, a subset of Purkinje cells that were severely affected by the hypoxic-ischemic insult-showing signs of neuronal distress at the levels of the nucleus, cytoplasm and dendritic arborization-were not protected by Pc. A monoclonal antibody specific for GAD67 revealed a three-band pattern in cytoplasmic extracts from whole P15 cerebella. A similar to 110 kDa band, interpreted as a potential homodimer of a truncated form of GAD67, was reduced in Pc and L groups while its levels were close to the control animals in PcL rats. Additionally we demonstrated differential glial responses depending on the treatment, including astrogliosis in hypoxiated cerebella and a selective effect of hypoxia-ischemia on the vimentin-immunolabeled intermediate filaments of the Bergmann glia. Thus, while both glutamatergic and GABAergic cerebellar neurons are compromised by the hypoxic-ischemic insult, the former are protected by a preconditioning hypoxia while the latter are not.	[Benitez, Sergio G.; Castro, Analia E.; Munoz, Estela M.] Natl Univ Cuyo, Natl Sci & Tech Res Council CONICET, Natl Agcy Sci & Technol Promot ANPCyT,Sch Med, Lab Neurobiol,Chronobiol Sect,Inst Histol & Embry, Mendoza, Argentina; [Patterson, Sean I.] Natl Univ Cuyo, Natl Sci & Tech Res Council CONICET, Natl Agcy Sci & Technol Promot ANPCyT,Sch Med, Traumat & Tox Les Nervous Syst Sect,Inst Histol &, Mendoza, Argentina; [Seltzer, Alicia M.] Natl Univ Cuyo, Natl Sci & Tech Res Council CONICET, Natl Agcy Sci & Technol Promot ANPCyT,Sch Med, Neonatal Brain Dev Sect,Inst Histol & Embryol Men, Mendoza, Argentina	Centro Nacional Patagonico (CENPAT); University Nacional Cuyo Mendoza; Centro Nacional Patagonico (CENPAT); University Nacional Cuyo Mendoza; Centro Nacional Patagonico (CENPAT); University Nacional Cuyo Mendoza	Seltzer, AM (corresponding author), Natl Univ Cuyo, Natl Sci & Tech Res Council CONICET, Natl Agcy Sci & Technol Promot ANPCyT,Sch Med, Neonatal Brain Dev Sect,Inst Histol & Embryol Men, Mendoza, Argentina.	aseltzer@fcm.uncu.edu.ar		Munoz, Estela/0000-0002-6701-1535	CONICET; ANPCyT; SECTyP-UNCuyo [06/J394]; FCM-UNCuyo [138/11CD]; PICT-CONICET [2006-451, 2007-682, 2012-174]; PIP-CONICET [112-201101-00247, 114-200901-00354]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); SECTyP-UNCuyo; FCM-UNCuyo; PICT-CONICET; PIP-CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The authors were supported by CONICET (http://www.conicet.gov.ar), ANPCyT (http://www.agencia.mincyt.gob.ar), SECTyP-UNCuyo (http://www.uncuyo.edu.ar) and FCM-UNCuyo (http://fcm.uncuyo.edu.ar); PICT-CONICET 2006-451 to AMS and EMM; PICT-CONICET 2007-682 and 2012-174, and PIP-CONICET 112-201101-00247 to EMM; PIP-CONICET 114-200901-00354, SECTyP-UNCuyo 06/J394 and FCM-UNCuyo 138/11CD to SIP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie PN, 2010, EXP PHYSIOL, V95, P251, DOI 10.1113/expphysiol.2008.045575; ALTMAN J, 1985, J COMP NEUROL, V231, P1, DOI 10.1002/cne.902310103; Battaglioli G, 2005, NEUROCHEM RES, V30, P989, DOI 10.1007/s11064-005-6772-0; BAYER SA, 1993, NEUROTOXICOLOGY, V14, P83; Biran V, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/858929; Biran V, 2011, NEUROBIOL DIS, V41, P138, DOI 10.1016/j.nbd.2010.09.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Cai J, 2012, J PATHOL, V226, P495, DOI 10.1002/path.2980; Castillo M, 2007, AM J NEURORADIOL, V28, P20; Cesa R, 2009, NEUROSCIENCE, V162, P624, DOI 10.1016/j.neuroscience.2009.02.061; Chedotal A, 2010, TRENDS NEUROSCI, V33, P163, DOI 10.1016/j.tins.2010.01.004; Cho JH, 2006, DEV BIOL, V290, P125, DOI 10.1016/j.ydbio.2005.11.024; Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J; Consalez GG, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00123; Dore-Duffy P, 2007, ANTIOXID REDOX SIGN, V9, P1363, DOI 10.1089/ars.2007.1713; Savastano LE, 2010, J NEUROSCI METH, V192, P22, DOI 10.1016/j.jneumeth.2010.07.007; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Faiz M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-26; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Ferriero DM, 2010, J ANAT, V217, P429, DOI 10.1111/j.1469-7580.2010.01226.x; Finckbone V, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.003.2009; Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22; Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Huang BY, 2008, RADIOGRAPHICS, V28, P417, DOI 10.1148/rg.282075066; HUANG J, 1994, J APPL PHYSIOL, V77, P1006, DOI 10.1152/jappl.1994.77.2.1006; Ichikawa R, 2011, J NEUROSCI, V31, P16916, DOI 10.1523/JNEUROSCI.2396-11.2011; Johnsen SD, 2002, J CHILD NEUROL, V17, P320, DOI 10.1177/088307380201700502; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Kadam SD, 2008, BRAIN RES, V1208, P35, DOI 10.1016/j.brainres.2008.02.037; Kanaani J, 1999, J BIOL CHEM, V274, P37200, DOI 10.1074/jbc.274.52.37200; Kelley MH, 2008, J NEUROCHEM, V107, P668, DOI 10.1111/j.1471-4159.2008.05617.x; Lai MC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/609813; LARRAMENDL L. M. H., 1967, BRAIN RES, V5, P15, DOI 10.1016/0006-8993(67)90216-8; Lee HT, 2009, J NEUROSCI, V29, P4356, DOI 10.1523/JNEUROSCI.5497-08.2009; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Lopez-Aguilera F, 2012, NEUROSCIENCE, V216, P1, DOI 10.1016/j.neuroscience.2012.04.070; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Luo YQ, 2008, J BIOL CHEM, V283, P24789, DOI 10.1074/jbc.M800649200; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Millen KJ, 2008, CURR OPIN NEUROBIOL, V18, P12, DOI 10.1016/j.conb.2008.05.010; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Munoz EM, 2007, J NEUROCHEM, V102, P887, DOI 10.1111/j.1471-4159.2007.04605.x; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Oomman S, 2005, DEV BRAIN RES, V160, P130, DOI 10.1016/j.devbrainres.2005.07.010; Oomman S, 2004, J COMP NEUROL, V476, P154, DOI 10.1002/cne.20223; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Pan N, 2009, CELL TISSUE RES, V337, P407, DOI 10.1007/s00441-009-0826-6; Peng JHF, 2005, DEV BRAIN RES, V156, P87, DOI 10.1016/j.devbrainres.2005.02.002; Pfenning AR, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-20; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004371; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Riva D, 2013, APPL NEUROPSYCH-CHIL, V2, P97, DOI 10.1080/21622965.2013.791092; Roybon L, 2010, CEREB CORTEX, V20, P1234, DOI 10.1093/cercor/bhp187; Saugstad OD, 2011, NEONATOLOGY, V99, P250, DOI 10.1159/000320332; Sen E, 2011, ASN NEURO, V3, DOI 10.1042/AN20100029; Sgaier SK, 2005, NEURON, V45, P27, DOI 10.1016/S0896-6273(04)00802-5; Sha D, 2005, MOL BRAIN RES, V136, P255, DOI 10.1016/j.molbrainres.2005.02.005; Sha D, 2008, BRAIN RES, V1207, P9, DOI 10.1016/j.brainres.2008.02.033; Sheikh SN, 1996, J NEUROCHEM, V66, P2082; Shrivastava K, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/781512; Sike A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084915; Sizonenko SV, 2008, INT J DEV NEUROSCI, V26, P37, DOI 10.1016/j.ijdevneu.2007.08.014; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; SZABO G, 1994, MOL CELL BIOL, V14, P7535, DOI 10.1128/MCB.14.11.7535; Tang XN, 2010, AGEING RES REV, V9, P61, DOI 10.1016/j.arr.2009.10.002; Tirapu-Ustarroz J, 2011, REV NEUROLOGIA, V53, P301, DOI 10.33588/rn.5305.2010747; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; White ML, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120464; WILLIAMSON S, 1995, J AUTONOM NERV SYST, V55, P18, DOI 10.1016/0165-1838(95)00028-V; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Yan XX, 2001, J COMP NEUROL, V433, P4, DOI 10.1002/cne.1121; Yip J, 2007, ACTA NEUROPATHOL, V113, P559, DOI 10.1007/s00401-006-0176-3; Zhuang JG, 2008, J APPL PHYSIOL, V104, P1351, DOI 10.1152/japplphysiol.00824.2007	82	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102056	10.1371/journal.pone.0102056	http://dx.doi.org/10.1371/journal.pone.0102056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032984	Green Submitted, Green Published, gold			2022-12-25	WOS:000339418300033
J	Mutch, WAC; Ellis, MJ; Graham, MR; Wourms, V; Raban, R; Fisher, JA; Mikulis, D; Leiter, J; Ryner, L				Mutch, W. Alan C.; Ellis, Michael J.; Graham, M. Ruth; Wourms, Vincent; Raban, Roshan; Fisher, Joseph A.; Mikulis, David; Leiter, Jeffrey; Ryner, Lawrence			Brain MRI CO2 Stress Testing: A Pilot Study in Patients with Concussion	PLOS ONE			English	Article							CEREBROVASCULAR RESPONSE; WHITE-MATTER; SPORTS; RECOVERY; KNOWLEDGE; INJURY	Background: There is a real need for quantifiable neuro-imaging biomarkers in concussion. Here we outline a brain BOLD-MRI CO2 stress test to assess the condition. Methods: This study was approved by the REB at the University of Manitoba. A group of volunteers without prior concussion were compared to post-concussion syndrome (PCS) patients - both symptomatic and recovered asymptomatic. Five 3-minute periods of BOLD imaging at 3.0 T were studied - baseline 1 (BL1- at basal CO2 tension), hypocapnia (CO2 decreased similar to 5 mmHg), BL2, hypercapnia (CO2 increased similar to 10 mmHg) and BL3. Data were processed using statistical parametric mapping (SPM) for 1st level analysis to compare each subject's response to the CO2 stress at the p = 0.001 level. A 2nd level analysis compared each PCS patient's response to the mean response of the control subjects at the p = 0.05 level. Results: We report on 5 control subjects, 8 symptomatic and 4 asymptomatic PCS patients. Both increased and decreased response to CO2 was seen in all PCS patients in the 2nd level analysis. The responses were quantified as reactive voxel counts: whole brain voxel counts (2.0 +/- 1.6%, p = 0.012 for symptomatic patients for CO2 response < controls and 3.0 +/- 5.1%, p = 0.139 for CO2 response > controls: 0.49 +/- 0.31%, p = 0.053 for asymptomatic patients for CO2 response < controls and 4.4 +/- 6.8%, p = 0.281 for CO2 response > controls). Conclusions: Quantifiable alterations in regional cerebrovascular responsiveness are present in concussion patients during provocative CO2 challenge and BOLD MRI and not in healthy controls. Future longitudinal studies must aim to clarify the relationship between CO2 responsiveness and individual patient symptoms and outcomes.	[Mutch, W. Alan C.; Graham, M. Ruth; Wourms, Vincent; Raban, Roshan] Univ Manitoba, Hlth Sci Ctr, Dept Anesthesia & Perioperat Med, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Dept Surg, Hlth Sci Ctr, Neurosurg Sect, Winnipeg, MB R3T 2N2, Canada; [Fisher, Joseph A.] Univ Toronto, Toronto Gen Hosp, Dept Anesthesia & Pain Management, Toronto, ON M5G 1L7, Canada; [Mikulis, David] Univ Toronto, Toronto Western Hosp, Dept Radiol, Sect Neuroimaging, Toronto, ON M5T 2S8, Canada; [Leiter, Jeffrey] Univ Manitoba, Dept Surg, Pan Am Clin, Winnipeg, MB R3T 2N2, Canada; [Ryner, Lawrence] Univ Manitoba, Dept Phys & Astron, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Manitoba; University of Manitoba	Mutch, WAC (corresponding author), Univ Manitoba, Hlth Sci Ctr, Dept Anesthesia & Perioperat Med, Winnipeg, MB, Canada.	wacmutch@shaw.ca	Mikulis, David J/H-5167-2019	Mikulis, David/0000-0003-3956-0892; Mutch, W. Alan/0000-0001-7174-7839	Anesthesia Oversight Committee	Anesthesia Oversight Committee	Anesthesia Oversight Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Ashburner J, 2012, NEUROIMAGE, V62, P791, DOI 10.1016/j.neuroimage.2011.10.025; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Burke MJ, 2012, CAN J NEUROL SCI, V39, P763, DOI 10.1017/S0317167100015584; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Fierstra J, 2013, J PHYSIOL-LONDON, V591, P5809, DOI 10.1113/jphysiol.2013.259150; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; He BJ, 2009, TRENDS COGN SCI, V13, P302, DOI 10.1016/j.tics.2009.04.004; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Kiebel SJ, 2004, NEUROIMAGE, V22, P503, DOI 10.1016/j.neuroimage.2004.02.013; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Langlois JA, 2008, J HEAD TRAUMA REHAB, V21, P375; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mardimae A, 2012, PFLUG ARCH EUR J PHY, V464, P345, DOI 10.1007/s00424-012-1148-1; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Mutch WAC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057881; Mutch WAC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047443; Prabhu SP, 2011, CLIN SPORT MED, V30, P103, DOI 10.1016/j.csm.2010.09.003; Prisman E, 2008, J MAGN RESON IMAGING, V27, P185, DOI 10.1002/jmri.21102; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Raichle ME, 2009, J NEUROSCI, V29, P12729, DOI 10.1523/JNEUROSCI.4366-09.2009; Regan RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070751; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Sobczyk O, 2014, NEUROIMAGE, V92, P56, DOI 10.1016/j.neuroimage.2014.01.051; Tormenti M, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12282; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005	38	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102181	10.1371/journal.pone.0102181	http://dx.doi.org/10.1371/journal.pone.0102181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032707	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300039
J	Rodrigue-Gervais, IG; Rigsby, H; Jouan, L; Willems, B; Lamarre, D				Rodrigue-Gervais, Ian Gael; Rigsby, Hawley; Jouan, Loubna; Willems, Bernard; Lamarre, Daniel			Intact Dendritic Cell Pathogen-Recognition Receptor Functions Associate with Chronic Hepatitis C Treatment-Induced Viral Clearance	PLOS ONE			English	Article							PERSISTENT LCMV INFECTION; VIRUS-INFECTION; IN-VIVO; IMMUNE-RESPONSES; VACCINE; BLOCKADE; THERAPY; PEGINTERFERON; EXPRESSION; RIBAVIRIN	Although studies have addressed the exhaustion of the host's immune response to HCV and its role in treatment, there is little information about the possible contribution of innate immunity to treatment-induced clearance. We hypothesized that because intact myeloid dendritic cell (MDC) pathogen sensing functions are associated with improved HCV-specific CD8(+) T cell functionality in some chronically infected patients, it might enhance HCV clearance rate under standard interferon therapy. To investigate this hypothesis, TLR-induced MDC activation and HCV-specific CD8(+) T cell response quality were monitored longitudinally at the single-cell level using polychromatic flow cytometry in chronically infected patients undergoing interferon therapy. We correlated the immunological, biochemical and virological data with response to treatment. We demonstrate that the clinical efficacy of interferon-induced viral clearance is influenced by the extent to which HCV inhibits MDC functions before treatment, rather than solely on a breakdown of the extrinsic T cell immunosuppressive environment. Thus, viral inhibition of MDC functions before treatment emerges as a co-determining factor in the clinical efficacy of interferon therapy during chronic HCV infection.	[Rodrigue-Gervais, Ian Gael; Rigsby, Hawley; Jouan, Loubna; Willems, Bernard; Lamarre, Daniel] Univ Montreal CR CHUM, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada; [Willems, Bernard; Lamarre, Daniel] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Lamarre, D (corresponding author), Univ Montreal CR CHUM, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada.	daniel.lamarre@umontreal.ca			Canadian Institute of Health Research [MOP-79546]; Novartis/Canadian Liver Foundation Hepatology Research Chair	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Novartis/Canadian Liver Foundation Hepatology Research Chair	This work was supported by Canadian Institute of Health Research grant MOP-79546 and by the Novartis/Canadian Liver Foundation Hepatology Research Chair (D.L.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hakeem MS, 2010, J VIROL, V84, P10429, DOI 10.1128/JVI.01094-10; Casazza JP, 2013, J INFECT DI IN PRESS; Dansako H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003345; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fuller MJ, 2013, P NATL ACAD SCI USA, V110, P15001, DOI 10.1073/pnas.1312772110; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hel Z, 2000, NAT MED, V6, P1140, DOI 10.1038/80481; Hersperger AR, 2011, CURR OPIN HIV AIDS, V6, P169, DOI 10.1097/COH.0b013e3283454c39; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Horsmans Y, 2005, HEPATOLOGY, V42, P724, DOI 10.1002/hep.20839; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lauer GM, 2013, J INFECT DIS, V207, pS7, DOI 10.1093/infdis/jis762; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039368; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Lu W, 2003, NAT MED, V9, P27, DOI 10.1038/nm806; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Miyazaki M, 2008, J MED VIROL, V80, P980, DOI 10.1002/jmv.21174; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Ng CT, 2011, CURR OPIN VIROL, V1, P160, DOI 10.1016/j.coviro.2011.05.006; Rodrigue-Gervais IG, 2007, J VIROL, V81, P5537, DOI 10.1128/JVI.01741-06; Rodrigue-Gervais IG, 2010, J IMMUNOL, V184, P3134, DOI 10.4049/jimmunol.0902522; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Schurich A, 2012, PLOS PATHOG, V9; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Thompson AJ, 2012, GASTROENTEROLOGY, V142, P1335, DOI 10.1053/j.gastro.2012.01.046; Tilton JC, 2008, J VIROL, V82, P3997, DOI 10.1128/JVI.01545-07; Tryniszewska E, 2002, J IMMUNOL, V169, P5347, DOI 10.4049/jimmunol.169.9.5347; Walsh KB, 2012, CELL HOST MICROBE, V11, P643, DOI 10.1016/j.chom.2012.04.016; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Welsch C, 2012, GUT, V61, P36, DOI 10.1136/gutjnl-2012-302144; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208	37	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102605	10.1371/journal.pone.0102605	http://dx.doi.org/10.1371/journal.pone.0102605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033043	Green Submitted, Green Published, gold			2022-12-25	WOS:000339418300066
J	Treinys, R; Kaselis, A; Jover, E; Bagnard, D; Satkauskas, S				Treinys, Rimantas; Kaselis, Andrius; Jover, Emmanuel; Bagnard, Dominique; Satkauskas, Saulius			R-Type Calcium Channels Are Crucial for Semaphorin 3A-Induced DRG Axon Growth Cone Collapse	PLOS ONE			English	Article							TRIVALENT METAL-CATIONS; CA2+ CHANNELS; MEMBRANE-TRANSPORT; GUIDANCE MOLECULES; SENSORY NEURONS; SMOOTH-MUSCLE; TRPC CHANNELS; CELLS; SIGNALS; EXPRESSION	Semaphorin 3A (Sema3A) is a secreted protein involved in axon path-finding during nervous system development. Calcium signaling plays an important role during axonal growth in response to different guidance cues; however it remains unclear whether this is also the case for Sema3A. In this study we used intracellular calcium imaging to figure out whether Sema3Ainduced growth cone collapse is a Ca2+ dependent process. Intracellular Ca2+ imaging results using Fura-2 AM showed Ca2+ increase in E15 mice dorsal root ganglia neurons upon Sema3A treatment. Consequently we analyzed Sema3A effect on growth cones after blocking or modifying intracellular and extracellular Ca2+ channels that are expressed in E15 mouse embryos. Our results demonstrate that Sema3A increased growth cone collapse rate is blocked by the non-selective R-and T-type Ca2+ channel blocker NiCl2 and by the selective R-type Ca2+ channel blocker SNX482. These Ca2+ channel blockers consistently decreased the Sema3A-induced intracellular Ca2+ concentration elevation. Overall, our results demonstrate that Sema3A-induced growth cone collapses are intimately related with increase in intracellular calcium concentration mediated by R-type calcium channels.	[Treinys, Rimantas; Kaselis, Andrius; Satkauskas, Saulius] Vytautas Magnus Univ, Dept Biol, Biophys Res Grp, Kaunas, Lithuania; [Treinys, Rimantas] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania; [Jover, Emmanuel] INCI UPR CNRS 3212, Strasbourg, France; [Bagnard, Dominique] Univ Strasbourg, INSERM U1109, Lab MN3t, Labex Medalis, Strasbourg, France	Vytautas Magnus University; Lithuanian University of Health Sciences; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Satkauskas, S (corresponding author), Vytautas Magnus Univ, Dept Biol, Biophys Res Grp, Kaunas, Lithuania.	s.satkauskas@gmf.vdu.lt	Bagnard, Dominique/I-6535-2013; Satkauskas, Saulius/Z-4144-2019; Satkauskas, Saulius/AAD-7045-2020	Satkauskas, Saulius/0000-0002-9001-7767; Bagnard, Dominique/0000-0002-5261-902X; Treinys, Rimantas/0000-0002-7590-7606	Research Council of Lithuania [MOS-7, T40]; Student Research Fellowship Award [SDS-2012-014]	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Student Research Fellowship Award	This work has been supported by Research Council of Lithuania (Grants MOS-7 and T40) and Student Research Fellowship Award for A. Kaselis (SDS-2012-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Akiyama H, 2010, J BIOL CHEM, V285, P41740, DOI 10.1074/jbc.M110.156489; Arroyo G, 2003, EUR J PHARMACOL, V475, P11, DOI 10.1016/S0014-2999(03)02084-3; Bagnard D, 2000, J NEUROSCI, V20, P1030, DOI 10.1523/JNEUROSCI.20-03-01030.2000; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Balemba OB, 2006, AM J PHYSIOL-GASTR L, V290, pG655, DOI 10.1152/ajpgi.00310.2005; Beedle AM, 2002, J MEMBRANE BIOL, V187, P225, DOI 10.1007/s00232-001-0166-2; Behar O, 1999, P NATL ACAD SCI USA, V96, P13501, DOI 10.1073/pnas.96.23.13501; Ben-Zvi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070085; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BIAGI BA, 1990, AM J PHYSIOL, V259, pC515, DOI 10.1152/ajpcell.1990.259.3.C515; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chew LJ, 1998, MOL NEUROBIOL, V18, P175, DOI 10.1007/BF02741300; Chi XX, 2009, J CELL SCI, V122, P4351, DOI 10.1242/jcs.053280; Diaz D, 2005, J MEMBRANE BIOL, V207, P91, DOI 10.1007/s00232-005-0804-1; Engbers JDT, 2011, J PHYSIOL-LONDON, V589, P5391, DOI 10.1113/jphysiol.2011.215632; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; Gross SA, 2009, J BIOL CHEM, V284, P34423, DOI 10.1074/jbc.M109.018192; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hilaire C, 1996, NEUROSCIENCE, V75, P1219, DOI 10.1016/0306-4522(96)00347-8; Hong K, 2010, NEUROSCIENTIST, V16, P65, DOI 10.1177/1073858409340702; Huang ZH, 2011, J CELL SCI, V124, P186, DOI 10.1242/jcs.071357; Itofusa R, 2011, MOL CELL NEUROSCI, V48, P332, DOI 10.1016/j.mcn.2011.03.007; Joddar B, 2013, BIOMATERIALS, V34, P9593, DOI 10.1016/j.biomaterials.2013.08.019; Kaczmarek JS, 2012, P NATL ACAD SCI USA, V109, P7888, DOI 10.1073/pnas.1205869109; KATER SB, 1991, J NEUROSCI, V11, P891; Kerstein PC, 2013, J NEUROSCI, V33, P273, DOI 10.1523/JNEUROSCI.2142-12.2013; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LARMET Y, 1992, NEURON, V9, P563, DOI 10.1016/0896-6273(92)90193-H; Lee J, 2004, P NATL ACAD SCI USA, V101, P18195, DOI 10.1073/pnas.0408089101; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Manns RPC, 2012, J NEUROSCI, V32, P8554, DOI 10.1523/JNEUROSCI.5964-11.2012; Mitchell CB, 2012, J NEUROCHEM, V122, P1155, DOI 10.1111/j.1471-4159.2012.07840.x; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MLINAR B, 1993, J PHYSIOL-LONDON, V469, P639, DOI 10.1113/jphysiol.1993.sp019835; Moreno C, 2011, IUBMB LIFE, V63, P856, DOI 10.1002/iub.547; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; Nishikitani M, 2007, TOHOKU J EXP MED, V211, P151, DOI 10.1620/tjem.211.151; Nishiyama M, 2008, NAT NEUROSCI, V11, P762, DOI 10.1038/nn.2130; Nishiyama M, 2011, NAT CELL BIOL, V13, P676, DOI 10.1038/ncb2255; Plazas PV, 2012, PROCEEDINGS OF THE N, V110, P1524; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; SCROGGS RS, 1992, J PHYSIOL-LONDON, V445, P639, DOI 10.1113/jphysiol.1992.sp018944; Shcheglovitov A, 2005, BIOCHEM PHARMACOL, V69, P841, DOI 10.1016/j.bcp.2004.11.024; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Talley EM, 1999, J NEUROSCI, V19, P1895; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996; Tojima T, 2010, NEURON, V66, P370, DOI 10.1016/j.neuron.2010.04.007; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Wang YJ, 2008, CLIN EXP PHARMACOL P, V35, P1127, DOI 10.1111/j.1440-1681.2008.05018.x; Wen ZX, 2006, CURR OPIN NEUROBIOL, V16, P52, DOI 10.1016/j.conb.2005.12.005; Yamakage M, 2002, CAN J ANAESTH, V49, P151, DOI 10.1007/BF03020488; Yamane M, 2012, BIOCHEM BIOPH RES CO, V422, P333, DOI 10.1016/j.bbrc.2012.05.003; Yan HD, 2009, J NEUROSCI, V29, P10038, DOI 10.1523/JNEUROSCI.1042-09.2009; Zamponi GW, 1996, J MEMBRANE BIOL, V151, P77, DOI 10.1007/s002329900059	66	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102357	10.1371/journal.pone.0102357	http://dx.doi.org/10.1371/journal.pone.0102357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032951	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300049
J	Umeki, H; Tokuyama, R; Ide, S; Okubo, M; Tadokoro, S; Tezuka, M; Tatehara, S; Satomura, K				Umeki, Hirochika; Tokuyama, Reiko; Ide, Shinji; Okubo, Mitsuru; Tadokoro, Susumu; Tezuka, Mitsuki; Tatehara, Seiko; Satomura, Kazuhito			Leptin Promotes Wound Healing in the Oral Mucosa	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR EXPRESSION; GENE-EXPRESSION; PROLIFERATION; LOCALIZATION; ACTIVATION; BRAIN; KERATINOCYTES; METABOLISM; INDUCTION	Introduction: Leptin, a 16 kDa circulating anti-obesity hormone, exhibits many physiological properties. Recently, leptin was isolated from saliva; however, its function in the oral cavity is still unclear. In this study, we investigated the physiological role of leptin in the oral cavity by focusing on its effect on wound healing in the oral mucosa. Methods: Immunohistochemical analysis was used to examine the expression of the leptin receptor (Ob-R) in human/rabbit oral mucosa. To investigate the effect of leptin on wound healing in the oral mucosa, chemical wounds were created in rabbit oral mucosa, and leptin was topically administered to the wound. The process of wound repair was histologically observed and quantitatively analyzed by measuring the area of ulceration and the duration required for complete healing. The effect of leptin on the proliferation, differentiation and migration of human oral mucosal epithelial cells (RT7 cells) was investigated using crystal violet staining, reverse transcription polymerase chain reaction (RT-PCR) and a wound healing assay, respectively. Results: Ob-R was expressed in spinous/granular cells in the epithelial tissue and vascular endothelial cells in the subepithelial connective tissue of the oral mucosa. Topical administration of leptin significantly promoted wound healing and shortened the duration required for complete healing. Histological analysis of gingival tissue beneath the ulceration showed a denser distribution of blood vessels in the leptin-treated group. Although the proliferation and differentiation of RT7 cells were not affected by leptin, the migration of these cells was accelerated in the presence of leptin. Conclusion: Topically administered leptin was shown to promote wound healing in the oral mucosa by accelerating epithelial cell migration and enhancing angiogenesis around the wounded area. These results strongly suggest that topical administration of leptin may be useful as a treatment to promote wound healing in the oral mucosa.	[Umeki, Hirochika; Tokuyama, Reiko; Ide, Shinji; Okubo, Mitsuru; Tadokoro, Susumu; Tezuka, Mitsuki; Tatehara, Seiko; Satomura, Kazuhito] Tsurumi Univ, Sch Dent Med, Dept Oral Med & Stomatol, Yokohama, Kanagawa, Japan	Tsurumi University	Satomura, K (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Oral Med & Stomatol, Yokohama, Kanagawa, Japan.	satomura-k@tsurumi-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24593016, 25293415, 24659905, 23792392, 24593015]; Grants-in-Aid for Scientific Research [25861984] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (No. 24593016, 25293415, 24659905, 23792392, and 24593015) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin S, 2005, PEPTIDES, V26, P647, DOI 10.1016/j.peptides.2004.11.008; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; Bryson JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE417, DOI 10.1152/ajpendo.1999.277.3.E417; Cohen P, 2005, J BIOL CHEM, V280, P10034, DOI 10.1074/jbc.M413684200; De Matteis R, 1998, P NUTR SOC, V57, P441, DOI 10.1079/PNS19980063; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; FEDARKO NS, 1995, J BONE MINER RES, V10, P1705; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Frank S, 2000, J CLIN INVEST, V106, P501, DOI 10.1172/JCI9148; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; GIBRAN NS, 1994, J SURG RES, V56, P226, DOI 10.1006/jsre.1994.1036; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Groschl M, 2005, J MOL ENDOCRINOL, V34, P353, DOI 10.1677/jme.1.01658; Groschl M, 2001, J CLIN ENDOCR METAB, V86, P5234, DOI 10.1210/jc.86.11.5234; Guerra B, 2007, J APPL PHYSIOL, V102, P1786, DOI 10.1152/japplphysiol.01313.2006; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; HATTON MN, 1987, J ORAL MAXIL SURG, V45, P496, DOI 10.1016/S0278-2391(87)80009-5; Hwa JJ, 1996, HORM METAB RES, V28, P659, DOI 10.1055/s-2007-979873; Islam MS, 1997, BIOCHEM BIOPH RES CO, V238, P851, DOI 10.1006/bbrc.1997.7399; Jin L, 1999, J CLIN ENDOCR METAB, V84, P2903, DOI 10.1210/jc.84.8.2903; Keswani SG, 2013, WOUND REPAIR REGEN, V21, P554, DOI 10.1111/wrr.12065; Kume K, 2002, J HISTOCHEM CYTOCHEM, V50, P159, DOI 10.1177/002215540205000204; Le M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048040; MARTIN P, 1993, DEV GENET, V14, P225, DOI 10.1002/dvg.1020140309; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Morash B, 1999, ENDOCRINOLOGY, V140, P5995, DOI 10.1210/en.140.12.5995; Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje; Nauta A, 2011, ORAL DIS, V17, P541, DOI 10.1111/j.1601-0825.2011.01787.x; Ohta K, 2008, J DENT RES, V87, P1160, DOI 10.1177/154405910808701211; ROBERTS AB, 1983, FED PROC, V42, P2621; Santos-Alvarez J, 1999, CELL IMMUNOL, V194, P6, DOI 10.1006/cimm.1999.1490; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Spicer LJ, 1997, ENDOCRINOLOGY, V138, P3374, DOI 10.1210/en.138.8.3374; Squier C A, 2001, J Natl Cancer Inst Monogr, P7; Stallmeyer B, 2001, J INVEST DERMATOL, V117, P98, DOI 10.1046/j.0022-202x.2001.01387.x; Tanabe K, 1997, BIOCHEM BIOPH RES CO, V241, P765, DOI 10.1006/bbrc.1997.7894; Ten Cate AR, 1994, ORAL HISTOLOGY; Tsuchiya T, 1999, EUR J PHARMACOL, V365, P273, DOI 10.1016/S0014-2999(98)00884-X; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	44	30	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101984	10.1371/journal.pone.0101984	http://dx.doi.org/10.1371/journal.pone.0101984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033454	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300030
J	Derakhshan, A; Sardarinia, M; Khalili, D; Momenan, AA; Azizi, F; Hadaegh, F				Derakhshan, Arash; Sardarinia, Mahsa; Khalili, Davood; Momenan, Amir Abbas; Azizi, Fereidoun; Hadaegh, Farzad			Sex Specific Incidence Rates of Type 2 Diabetes and Its Risk Factors over 9 Years of Follow-Up: Tehran Lipid and Glucose Study	PLOS ONE			English	Article							POPULATION-BASED INCIDENCE; 3RD NATIONAL SURVEILLANCE; NUTRITION TRANSITION; SOCIOECONOMIC-STATUS; WAIST CIRCUMFERENCE; PHYSICAL-ACTIVITY; HEALTH BEHAVIORS; CENTRAL OBESITY; LIFE-STYLE; PREVALENCE	Objective: To investigate the population-based incidence of type 2 diabetes and its potential risk factors in a sex-split cohort of Iranian population. Materials and Methods: A total of 8400 non-diabetic participants, aged >= 20 years (3620 men and 4780 women) entered the study. Crude and age standardized incidence rates per 1000 person-years were calculated for whole population and each sex separately. Cox proportional hazard models were used to evaluate hazard ratios (HR) and 95% confidence intervals for all potential risk factors in both uni-variable and multivariable models. Results: During a median follow-up of 9.5 years, 736 new cases of diabetes were identified, including 433 women and 303 men. The annual crude and age-standardized incidence rates (95% CI) of diabetes in the total population were 10.6 (9.92-11.4) and 9.94 (7.39-13.6) per 1000 person-years of follow-up and the corresponding sex specific rates were 10.2 (9.13-11.4) and 9.36 (5.84-14.92) in men and 11.0 (9.99-12.0) and 10.1 (7.24-13.9) in women, respectively. In the multivariable model, the risk for incident diabetes was significantly associated with fasting and 2 hour post challenge plasma glucose as well as family history of diabetes in both men and women. However, among women, only the contribution of wrist circumference to incident diabetes achieved statistical significance [HR: 1.16 (1.03-1.31)] with waist/height ratio being marginally significant [HR: 1.02 (0.99-1.04)]; while among men, only body mass index was a significant predictor [HR: 1.12 (1.02-1.22)]. Additionally, low education level conferred a higher risk for incident diabetes only among men [HR: 1.80 (1.23-2.36); P for interaction with sex = 0.003]. Conclusion: Overall, sex did not significantly modify the impact of risk factors associated with diabetes among Iranian adults; however, among modifiable risk factors, the independent role of lower education and general adiposity in men and central adiposity in women might require different preventive strategies.	[Derakhshan, Arash; Sardarinia, Mahsa; Khalili, Davood; Momenan, Amir Abbas; Hadaegh, Farzad] Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Hadaegh, F (corresponding author), Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Res Inst Endocrine Sci, Tehran, Iran.	fzhadaegh@endocrine.ac.ir	Khalili, Davood/T-2913-2017; Azizi, Fereidoun/ABD-4136-2021; hadaegh, farzad/K-2460-2017; Derakhshan, Arash/AAD-7505-2019	Khalili, Davood/0000-0003-4956-1039; Azizi, Fereidoun/0000-0002-6470-2517; Derakhshan, Arash/0000-0001-7335-1918; hadaegh, farzad/0000-0002-0352-8666; Hadaegh, Farzad/0000-0002-8935-2744	National Research Council of the Islamic Republic of Iran [121]	National Research Council of the Islamic Republic of Iran	This study was supported by grant No. 121 from the National Research Council of the Islamic Republic of Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh EE, 2007, INT J EPIDEMIOL, V36, P84, DOI 10.1093/ije/dyl269; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Auryan S, 2008, DIABETES OBES METAB, V10, P1135, DOI 10.1111/j.1463-1326.2008.00896.x; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Bennet L, 2014, PRIM CARE DIABETES; BERNS MAM, 1988, INT J EPIDEMIOL, V17, P789, DOI 10.1093/ije/17.4.789; Bonora E, 2004, DIABETES, V53, P1782, DOI 10.2337/diabetes.53.7.1782; Bozorgmanesh M, 2012, J ENDOCRINOL INVEST, V35, P14, DOI 10.3275/7728; Bozorgmanesh M, 2011, DIABETIC MED, V28, P1330, DOI 10.1111/j.1464-5491.2011.03343.x; Bozorgmanesh M, 2012, ACTA DIABETOL, V49, P341, DOI 10.1007/s00592-011-0298-5; Committee IR, 2005, GUID DAT PROC AN INT; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Esteghamati A, 2011, J PHYS ACT HEALTH, V8, P27, DOI 10.1123/jpah.8.1.27; Esteghamati A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-167; Franklin SS, 1997, CIRCULATION, V96, P308; Ghassemi H, 2002, PUBLIC HEALTH NUTR, V5, P149, DOI 10.1079/PHN2001287; Gill JMR, 2008, SPORTS MED, V38, P807, DOI 10.2165/00007256-200838100-00002; Ginter E, 2013, ADV EXP MED BIOL, V771, P42; Goto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074699; Green A, 2003, DIABETES-METAB RES, V19, P3, DOI 10.1002/dmrr.340; GREENFIELD MS, 1980, METABOLISM, V29, P1095, DOI 10.1016/0026-0495(80)90221-8; Hadaegh F, 2009, J ENDOCRINOL INVEST, V32, P724, DOI [10.3275/6399, 10.1007/BF03346527]; Hadaegh F, 2007, DIABETES RES CLIN PR, V76, P449, DOI 10.1016/j.diabres.2006.09.030; Hadaegh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076304; Harati H, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-186; Herman WH, 2012, DIABETES CARE, V35, P943, DOI 10.2337/dc12-0298; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Holden SE, 2013, DIABETES OBES METAB, V15, P844, DOI 10.1111/dom.12123; Hosseinpanah F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-426; Jensen MD, 2006, OBESITY, V14, p20S, DOI 10.1038/oby.2006.278; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Langenberg C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001230; Li CY, 2010, DIABETES RES CLIN PR, V89, P79, DOI 10.1016/j.diabres.2010.02.014; Magee MJ, 2013, PREV MED; Magliano DJ, 2008, DIABETES CARE, V31, P267, DOI 10.2337/dc07-0912; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Meisinger C, 2006, AM J CLIN NUTR, V84, P483, DOI 10.1093/ajcn/84.3.483; Mohan V, 2008, J Assoc Physicians India, V56, P152; Noto D, 2012, ACTA DIABETOL, V49, P145, DOI 10.1007/s00592-011-0305-x; Noudeh YJ, 2013, J CLIN ENDOCR METAB, V98, P777, DOI 10.1210/jc.2012-2416; Qiao Q, 2010, EUR J CLIN NUTR, V64, P30, DOI 10.1038/ejcn.2009.93; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Ramachandran A, 2012, WORLD J DIABETES, V3, P110, DOI 10.4239/wjd.v3.i6.110; Robbins JM, 2005, DIABETES RES CLIN PR, V68, P230, DOI 10.1016/j.diabres.2004.09.007; Schulze MB, 2006, DIABETES CARE, V29, P1921, DOI 10.2337/dc06-0895; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Strandberg AY, 2013, ANN MED, V45, P336, DOI 10.3109/07853890.2013.785233; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Thorand B, 2007, DIABETES CARE, V30, P854, DOI 10.2337/dc06-1693; Valdes S, 2007, DIABETES CARE, V30, P2258, DOI 10.2337/dc06-2461; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Williams ED, 2010, DIABETOLOGIA, V53, P2538, DOI 10.1007/s00125-010-1888-4; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Yoon U, 2013, METABOLISM, V62, P303, DOI 10.1016/j.metabol.2012.07.009	56	72	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102563	10.1371/journal.pone.0102563	http://dx.doi.org/10.1371/journal.pone.0102563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029368	gold, Green Submitted, Green Published			2022-12-25	WOS:000341306600085
J	Huang, MY; Yang, W; Wu, Y; Jiang, J; Gao, Y; Chen, Y; Feng, QJ; Chen, WF; Lu, ZT				Huang, Meiyan; Yang, Wei; Wu, Yao; Jiang, Jun; Gao, Yang; Chen, Yang; Feng, Qianjin; Chen, Wufan; Lu, Zhentai			Content-Based Image Retrieval Using Spatial Layout Information in Brain Tumor T1-Weighted Contrast-Enhanced MR Images	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; LESIONS	This study aims to develop content-based image retrieval (CBIR) system for the retrieval of T1-weighted contrast-enhanced MR (CE-MR) images of brain tumors. When a tumor region is fed to the CBIR system as a query, the system attempts to retrieve tumors of the same pathological category. The bag-of-visual-words (BoVW) model with partition learning is incorporated into the system to extract informative features for representing the image contents. Furthermore, a distance metric learning algorithm called the Rank Error-based Metric Learning (REML) is proposed to reduce the semantic gap between low-level visual features and high-level semantic concepts. The effectiveness of the proposed method is evaluated on a brain T1-weighted CE-MR dataset with three types of brain tumors (i.e., meningioma, glioma, and pituitary tumor). Using the BoVW model with partition learning, the mean average precision (mAP) of retrieval increases beyond 4.6% with the learned distance metrics compared with the spatial pyramid BoVW method. The distance metric learned by REML significantly outperforms three other existing distance metric learning methods in terms of mAP. The mAP of the CBIR system is as high as 91.8% using the proposed method, and the precision can reach 93.1% when the top 10 images are returned by the system. These preliminary results demonstrate that the proposed method is effective and feasible for the retrieval of brain tumors in T1-weighted CE-MR Images.	[Huang, Meiyan; Yang, Wei; Wu, Yao; Jiang, Jun; Gao, Yang; Feng, Qianjin; Chen, Wufan; Lu, Zhentai] Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Chen, Yang] Southeast Univ, Lab Image Sci & Technol, Key Lab Comp Network & Informat Integrat, Minist Educ, Nanjing, Jiangsu, Peoples R China	Southern Medical University - China; Southeast University - China	Feng, QJ (corresponding author), Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China.	qianjinfeng08@gmail.com	feng, qianjin/GNM-7856-2022; Feng, Qianjin/Y-5438-2019	feng, qianjin/0000-0002-3830-5120; Jiang, Jun/0000-0003-1147-3666	National Basic Research Program of China (973 Program) [2010CB732505]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAI14B02]; National Natural Science Foundation of China [81101109, 31371009]; National High Technology Research and Development Program of China (863 Program) [2012AA02A616]; Program of Pearl River Young Talents of Science and Technology in Guangzhou [2013J2200065, 2012J2200041]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Program of Pearl River Young Talents of Science and Technology in Guangzhou	This work was supported by the National Basic Research Program of China (973 Program) (http://www.973.gov.cn/) under grant (No. 2010CB732505), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (http://kjzc.jhgl.org/) under grant (No. 2012BAI14B02), the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under grant (No. 81101109 and No. 31371009), the National High Technology Research and Development Program of China (863 Program) (http://www.863.gov.cn/) under grant (No. 2012AA02A616), Program of Pearl River Young Talents of Science and Technology in Guangzhou (http://www.gzsi.gov.cn/) under grant (No. 2013J2200065), and Program of Pearl River Young Talents of Science and Technology in Guangzhou (http://www.gzsi.gov.cn/) under grant (No. 2012J2200041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antel SB, 2003, NEUROIMAGE, V19, P1748, DOI 10.1016/S1053-8119(03)00226-X; Avni U, 2011, IEEE T MED IMAGING, V30, P733, DOI 10.1109/TMI.2010.2095026; Bagci U, 2012, IEEE T MED IMAGING, V31, P777, DOI 10.1109/TMI.2011.2180920; Bagci U, 2010, PATTERN RECOGN LETT, V31, P315, DOI 10.1016/j.patrec.2009.09.010; Bosch A, 2006, MODELING CLASSIFYING, P1552; Burges C.J., 2006, P NEUR INF PROC SYST; Chang H, 2007, IMAGE VISION COMPUT, V25, P695, DOI 10.1016/j.imavis.2006.05.013; Chaplot S, 2006, BIOMED SIGNAL PROCES, V1, P86, DOI 10.1016/j.bspc.2006.05.002; Chen MH, 2013, IEEE T INFORM THEORY, V59, P6301, DOI 10.1109/TIT.2013.2268923; Chu WW, 1998, IEEE T KNOWL DATA EN, V10, P872, DOI 10.1109/69.738355; de Oliveira JEE, 2010, COMPUT METH PROG BIO, V99, P289, DOI 10.1016/j.cmpb.2010.01.005; Dube S, 2006, CONTENT BASED IMAGE, P3337; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Frome A., 2006, NIPS, P417; Guan H, 2009, BRIDGING SEMANTIC GA; Harada T, 2011, PROC CVPR IEEE, P1617, DOI 10.1109/CVPR.2011.5995691; Huang HK, 2005, COMPUT MED IMAG GRAP, V29, P195, DOI 10.1016/j.compmedimag.2004.09.008; Huang KZ, 2011, KNOWL INF SYST, V28, P25, DOI 10.1007/s10115-010-0313-0; Huang MY, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/280538; Iakovidis DK, 2009, IEEE T INF TECHNOL B, V13, P442, DOI 10.1109/TITB.2008.923144; Jegou H, 2010, INT J COMPUT VISION, V87, P316, DOI 10.1007/s11263-009-0285-2; Jiang J, 2013, COMPUT MED IMAG GRAP, V37, P512, DOI 10.1016/j.compmedimag.2013.05.007; Jiang YN, 2012, LECT NOTES COMPUT SC, V7573, P730, DOI 10.1007/978-3-642-33709-3_52; Kloppel S, 2011, NEUROIMAGE, V57, P416, DOI 10.1016/j.neuroimage.2011.04.053; Lahmiri S, 2011, BRAIN MRI CLASSIFICA, P1; Lazebnik S., 2006, P IEEE INT C COMP VI, V2, P2169, DOI DOI 10.1109/CVPR.2006.68; Liu C, 2003, PROC CVPR IEEE, P587; Moustakas J, 2005, IEEE INT C MULT EXP; Muller H, 2004, INT J MED INFORM, V73, P1, DOI 10.1016/j.ijmedinf.2003.11.024; Nazari Mina Rafi, 2010, INT J COMPUTER APPL, V7, P33, DOI DOI 10.5120/1327-1636; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; Petrakis EGM, 1997, IEEE T KNOWL DATA EN, V9, P435, DOI 10.1109/69.599932; Rahman MM, 2008, COMPUT MED IMAG GRAP, V32, P95, DOI 10.1016/j.compmedimag.2007.10.001; Robinson GP, 1996, COMPUT MED IMAG GRAP, V20, P209, DOI 10.1016/S0895-6111(96)00014-6; Rudin C, 2009, J MACH LEARN RES, V10, P2233; Sharma G, 2011, LEARNING DISCRIMINAT; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sugiyama M, 2007, J MACH LEARN RES, V8, P1027; van Gemert JC, 2010, IEEE T PATTERN ANAL, V32, P1271, DOI 10.1109/TPAMI.2009.132; Wang JJ, 2010, PROC CVPR IEEE, P3360, DOI 10.1109/CVPR.2010.5540018; Weinberger KQ, 2009, J MACH LEARN RES, V10, P207; Wu JX, 2011, IEEE T PATTERN ANAL, V33, P1489, DOI 10.1109/TPAMI.2010.224; Xing E., 2002, ADV NEURAL INFORM PR, V15, P505, DOI DOI 10.5555/2968618.2968683; Yang L, 2010, IEEE T PATTERN ANAL, V32, P30, DOI 10.1109/TPAMI.2008.273; Yang W, 2012, J DIGIT IMAGING, V25, P708, DOI 10.1007/s10278-012-9495-1; Yang W, 2012, MED PHYS, V39, P6929, DOI 10.1118/1.4754305; Yang Y, 2011, IEEE I CONF COMP VIS, P1465, DOI 10.1109/ICCV.2011.6126403; Zhang YD, 2011, EXPERT SYST APPL, V38, P10049, DOI 10.1016/j.eswa.2011.02.012	48	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102754	10.1371/journal.pone.0102754	http://dx.doi.org/10.1371/journal.pone.0102754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028970	Green Published, gold			2022-12-25	WOS:000341306600097
J	Amiot, A; Mansour, H; Baumgaertner, I; Delchier, JC; Tournigand, C; Furet, JP; Carrau, JP; Canoui-Poitrine, F; Sobhani, I				Amiot, Aurelien; Mansour, Hicham; Baumgaertner, Isabelle; Delchier, Jean-Charles; Tournigand, Christophe; Furet, Jean-Pierre; Carrau, Jean-Pierre; Canoui-Poitrine, Florence; Sobhani, Iradj		CRC Grp Val De Marne	The Detection of the Methylated Wif-1 Gene Is More Accurate than a Fecal Occult Blood Test for Colorectal Cancer Screening	PLOS ONE			English	Article							DNA METHYLATION; COLON-CANCER; MORTALITY; MARKER; RISK	Background: The clinical benefit of guaiac fecal occult blood tests (FOBT) is now well established for colorectal cancer screening. Growing evidence has demonstrated that epigenetic modifications and fecal microbiota changes, also known as dysbiosis, are associated with CRC pathogenesis and might be used as surrogate markers of CRC. Patients and Methods: We performed a cross-sectional study that included all consecutive subjects that were referred (from 2003 to 2007) for screening colonoscopies. Prior to colonoscopy, effluents (fresh stools, sera-S and urine-U) were harvested and FOBTs performed. Methylation levels were measured in stools, S and U for 3 genes (Wif1, ALX-4, and Vimentin) selected from a panel of 63 genes; Kras mutations and seven dominant and subdominant bacterial populations in stools were quantified. Calibration was assessed with the Hosmer-Lemeshow chi-square, and discrimination was determined by calculating the C-statistic (Area Under Curve) and Net Reclassification Improvement index. Results: There were 247 individuals (mean age 60.8612.4 years, 52% of males) in the study group, and 90 (36%) of these individuals were patients with advanced polyps or invasive adenocarcinomas. A multivariate model adjusted for age and FOBT led to a C-statistic of 0.83 [0.77-0.88]. After supplementary sequential (one-by-one) adjustment, Wif-1 methylation (S or U) and fecal microbiota dysbiosis led to increases of the C-statistic to 0.90 [0.84-0.94] (p = 0.02) and 0.81 [0.74-0.86] (p = 0.49), respectively. When adjusted jointly for FOBT and Wif-1 methylation or fecal microbiota dysbiosis, the increase of the C-statistic was even more significant (0.91 and 0.85, p < 0.001 and p = 0.10, respectively). Conclusion: The detection of methylated Wif-1 in either S or U has a higher performance accuracy compared to guaiac FOBT for advanced colorectal neoplasia screening. Conversely, fecal microbiota dysbiosis detection was not more accurate. Blood and urine testing could be used in those individuals reluctant to undergo stool testing.	[Amiot, Aurelien; Delchier, Jean-Charles; Sobhani, Iradj] Henri Mondor Hosp, AP HP, Dept Gastroenterol, Creteil, France; [Amiot, Aurelien; Delchier, Jean-Charles; Tournigand, Christophe; Canoui-Poitrine, Florence; Sobhani, Iradj] Univ Paris Est Creteil, Creteil, France; [Amiot, Aurelien; Mansour, Hicham; Canoui-Poitrine, Florence; Sobhani, Iradj] Lab Invest Clin EA 4393 EC2M3, Creteil, France; [Mansour, Hicham] King Abdullah Univ Sci & Technol, Biosci Core Labs, Thuwal, Saudi Arabia; [Baumgaertner, Isabelle; Tournigand, Christophe] Henri Mondor Hosp, AP HP, Dept Oncol, Creteil, France; [Delchier, Jean-Charles] INRA, MICALIS Inst, Commensals & Probiot Host Interact Lab, Jouy En Josas, France; [Carrau, Jean-Pierre] CPAM, Lab Anal, Paris, France; [Canoui-Poitrine, Florence] Henri Mondor Hosp, AP HP, Dept Publ Hlth, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); King Abdullah University of Science & Technology; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Sobhani, I (corresponding author), Henri Mondor Hosp, AP HP, Dept Gastroenterol, Creteil, France.	iradj.sobhani@hmn.aphp.fr	Canoui-Poitrine, Florence/R-4474-2018; Tournigand, Christophe/Q-2831-2018; AMIOT, Aurélien/ABL-6373-2022	Canoui-Poitrine, Florence/0000-0001-9970-6051; 	Canceropole Ile de France, CoMiCa project; LNCC (French National League against Cancer), CCR INSERM Promotion	Canceropole Ile de France, CoMiCa project; LNCC (French National League against Cancer), CCR INSERM Promotion	Canceropole Ile de France, CoMiCa 2007-2010 project, (Charles Debray association-ACD); LNCC (French National League against Cancer), CCR INSERM Promotion (2004-2006). The funders had no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baylin SB, 1998, ADV CANCER RES, V72, P141; Boyle P, 2002, BRIT MED BULL, V64, P1, DOI 10.1093/bmb/64.1.1; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Faivre J, 2004, GASTROENTEROLOGY, V126, P1674, DOI 10.1053/j.gastro.2004.02.018; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Grady WM, 2001, CANCER RES, V61, P900; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lee JK, 2014, ANN INTERN MED, V160, P171, DOI 10.7326/M13-1484; Lengauer C, 2003, SCIENCE, V300, P442, DOI 10.1126/science.1084468; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lieberman D, 2009, CURR OPIN GASTROEN, V25, P422, DOI 10.1097/MOG.0b013e32832d1e2a; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mansour H, 2009, Patent No. [WO 2009095596 A2, 2009095596]; Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Muller HM, 2004, LANCET, V363, P1283, DOI 10.1016/S0140-6736(04)16002-9; O'Keefe SJD, 2009, J NUTR, V139, P2044, DOI 10.3945/jn.109.104380; PEINADO MA, 1992, P NATL ACAD SCI USA, V89, P10065, DOI 10.1073/pnas.89.21.10065; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Polakis P, 2000, GENE DEV, V14, P1837; Prorok-Hamon M, 2014, GUT, V63, P761, DOI 10.1136/gutjnl-2013-304739; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Shivapurkar N, 2010, CURR MOL MED, V10, P123, DOI 10.2174/156652410790963303; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Sobhani I, 2011, GUT, V60, pA1; Sobhani I, 2013, THER ADV GASTROENTER, V6, P215, DOI 10.1177/1756283X12473674; Sobhani I, 2011, DIS COLON RECTUM, V54, P876, DOI 10.1007/DCR.0b013e31820fd2bc; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122	41	38	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e99233	10.1371/journal.pone.0099233	http://dx.doi.org/10.1371/journal.pone.0099233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025467	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400002
J	Dong, J; Shi, F; Li, H; Zhang, XM; Hu, XZ; Gong, J				Dong, Jun; Shi, Fei; Li, Han; Zhang, Xiaoming; Hu, Xiaozhong; Gong, Jun			SSU rDNA Sequence Diversity and Seasonally Differentiated Distribution of Nanoplanktonic Ciliates in Neritic Bohai and Yellow Seas as Revealed by T-RFLP	PLOS ONE			English	Article							OPERATIONAL TAXONOMIC UNITS; RIBOSOMAL-RNA GENE; SPATIAL-DISTRIBUTION; MEDITERRANEAN SEA; ANNUAL CYCLE; MARINE; COMMUNITIES; OLIGOTRICH; SUMMER; POLYMORPHISMS	Nanociliates have been frequently found to be important players in the marine microbial loop, however, little is known about their diversity and distribution in coastal ecosystems. We investigated the molecular diversity and distribution patterns of nanoplanktonic oligotrich and choreotrich (OC) ciliates in surface water of three neritic basins of northern China, the South Yellow Sea (SYS), North Yellow Sea (NYS), and Bohai Sea (BS) in June and November 2011. SSU rRNA gene clone libraries generated from three summertime samples (sites B38, B4 and H8) were analyzed and revealed a large novel ribotype diversity, of which many were low-abundant phylotypes belonging to the subclass Oligotrichia, but divergent from described morphospecies. Based on the data of terminal-restriction fragment length polymorphism (T-RFLP) analysis of all 35 samples, we found that the T-RF richness was generally higher in the SYS than in the BS, and negatively correlated with the molar ratio of P to Si. Overall, multidimensional scaling and permutational multivariate analysis of variance of the community turnover demonstrated a distinct seasonal pattern but no basin-to-basin differentiation across all samples. Nevertheless, significant community differences among basins were recognized in the winter dataset. Mantel tests showed that the environmental factors, P: Si ratio, water temperature and concentration of dissolved oxygen (DO), determined the community across all samples. However, both biogeographic distance and environment shaped the community in winter, with DO being the most important physicochemical factor. Our results indicate that the stoichiometric ratio of P: Si is a key factor, through which the phytoplankton community may be shaped, resulting in a cascade effect on the diversity and community composition of OC nanociliates in the N-rich, Si-limited coastal surface waters, and that the Yellow Sea Warm Current drives the nanociliate community, and possibly the microbial food webs, in the coastal ecosystem in winter.	[Dong, Jun; Hu, Xiaozhong] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China; [Dong, Jun; Shi, Fei; Li, Han; Gong, Jun] Chinese Acad Sci, Lab Microbial Ecol & Matter Cycles, Yantai Inst Coastal Zone Res, Yantai, Peoples R China; [Zhang, Xiaoming; Gong, Jun] S China Normal Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	Ocean University of China; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; South China Normal University	Gong, J (corresponding author), Chinese Acad Sci, Lab Microbial Ecol & Matter Cycles, Yantai Inst Coastal Zone Res, Yantai, Peoples R China.	jgong@yic.ac.cn	Gong, Jun/B-1580-2008	Gong, Jun/0000-0002-4402-1263	One Hundred Talent Program of CAS; National Natural Science Foundation of China [41176143]; Strategic Priority Research Program of CAS [XDA11020403]; Natural Science Foundation for Distinguished Young Scholars of Shandong [JQ201210]; Yantai Double Hundred Talent Plan	One Hundred Talent Program of CAS(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of CAS; Natural Science Foundation for Distinguished Young Scholars of Shandong; Yantai Double Hundred Talent Plan	This work was supported by the One Hundred Talent Program of CAS, the National Natural Science Foundation of China (No. 41176143), the Strategic Priority Research Program of CAS (No. XDA11020403), the Natural Science Foundation for Distinguished Young Scholars of Shandong (No. JQ201210), and the Yantai Double Hundred Talent Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatha S, 2005, EUR J PROTISTOL, V41, P65, DOI 10.1016/j.ejop.2004.09.005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson M.J., 2008, PERMANOVA PRIMER GUI; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bachy C, 2013, ISME J, V7, P244, DOI 10.1038/ismej.2012.106; Bachy C, 2012, PROTIST, V163, P873, DOI 10.1016/j.protis.2012.01.001; Balzano S, 2012, ISME J, V6, P1480, DOI 10.1038/ismej.2011.213; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; Carlsson P, 1999, AQUAT MICROB ECOL, V18, P55, DOI 10.3354/ame018055; Caron DA, 1999, J PHYCOL, V35, P824, DOI 10.1046/j.1529-8817.1999.3540824.x; Caron DA, 2012, ANNU REV MAR SCI, V4, P467, DOI 10.1146/annurev-marine-120709-142802; Caron DA, 2009, AQUAT MICROB ECOL, V57, P227, DOI 10.3354/ame01352; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Claessens M, 2008, AQUAT MICROB ECOL, V53, P181, DOI 10.3354/ame01243; Countway PD, 2005, J EUKARYOT MICROBIOL, V52, P95, DOI 10.1111/j.1550-7408.2005.05202006.x; Doherty M, 2007, AQUAT MICROB ECOL, V48, P141, DOI 10.3354/ame048141; Doherty M, 2010, APPL ENVIRON MICROB, V76, P3924, DOI 10.1128/AEM.01604-09; Doherty M, 2010, ENVIRON MICROBIOL, V12, P886, DOI 10.1111/j.1462-2920.2009.02133.x; Dolan J. R., 2012, BIOL ECOLOGY TINTINN, P214; Dolan JR, 1999, DEEP-SEA RES PT I, V46, P2025, DOI 10.1016/S0967-0637(99)00043-6; Dolan JR, 1995, DEEP-SEA RES PT I, V42, P1965, DOI 10.1016/0967-0637(95)00092-5; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fenchel T., 1987, ECOLOGY PROTOZOA, P1, DOI 10.1007/978-3-662-06817-5; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; Gong J, 2005, AQUAT MICROB ECOL, V39, P159, DOI 10.3354/ame039159; Gong J, 2013, PROTIST, V164, P369, DOI 10.1016/j.protis.2012.11.006; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim DY, 2012, J MICROBIOL METH, V91, P527, DOI 10.1016/j.mimet.2012.09.026; Kim YO, 1997, MAR BIOL, V128, P207, DOI 10.1007/s002270050084; Liu WW, 2011, SYST BIODIVERS, V9, P247, DOI 10.1080/14772000.2011.605812; Liu WW, 2011, J EUKARYOT MICROBIOL, V58, P43, DOI 10.1111/j.1550-7408.2010.00519.x; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; Massana R, 2011, ISME J, V5, P184, DOI 10.1038/ismej.2010.104; Mironova E, 2012, J PLANKTON RES, V34, P208, DOI 10.1093/plankt/fbr095; MONTAGNES D J S, 1987, Marine Microbial Food Webs, V2, P83; MONTAGNES DJS, 1989, J PLANKTON RES, V11, P193, DOI 10.1093/plankt/11.2.193; Nebel M, 2011, ENV MICROBIOL REP, V3, P154, DOI 10.1111/j.1758-2229.2010.00200.x; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Nylander J, 2004, MR MODELTEST V2 PROG; Perez MT, 2000, DEEP-SEA RES PT I, V47, P479, DOI 10.1016/S0967-0637(99)00099-0; PIERCE RW, 1992, REV AQUAT SCI, V6, P139; Pitta P, 2001, AQUAT MICROB ECOL, V24, P297, DOI 10.3354/ame024297; Pitta P, 2000, MAR ECOL PROG SER, V194, P269, DOI 10.3354/meps194269; Pomeroy LR, 2007, OCEANOGRAPHY, V20, P28, DOI 10.5670/oceanog.2007.45; RASSOULZADEGAN F, 1986, LIMNOL OCEANOGR, V31, P1010, DOI 10.4319/lo.1986.31.5.1010; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Setala O, 2003, AQUAT MICROB ECOL, V32, P287, DOI 10.3354/ame032287; SHERR EB, 1986, LIMNOL OCEANOGR, V31, P177, DOI 10.4319/lo.1986.31.1.0177; SHERR EB, 1987, NATURE, V325, P710, DOI 10.1038/325710a0; Sherr EB, 2007, MAR ECOL PROG SER, V352, P187, DOI 10.3354/meps07161; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P2657, DOI 10.1128/AEM.69.5.2657-2663.2003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tamura M, 2011, AQUAT MICROB ECOL, V64, P51, DOI 10.3354/ame01509; Tang QS, 2003, LAR MAR ECOSYST, V12, P121; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; WARWICK RM, 1991, J MAR BIOL ASSOC UK, V71, P225, DOI 10.1017/S0025315400037528; Zhang CX, 2008, CHIN J OCEANOL LIMN, V26, P81, DOI 10.1007/s00343-008-0081-9; Zhang Wu-chang, 2002, Chinese Journal of Oceanology and Limnology, V20, P135	64	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102640	10.1371/journal.pone.0102640	http://dx.doi.org/10.1371/journal.pone.0102640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025156	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400097
J	Huang, JS; Dang, JB; Borchert, GM; Eilbeck, K; Zhang, H; Xiong, M; Jiang, WJ; Wu, H; Blake, JA; Natale, DA; Tan, M				Huang, Jingshan; Dang, Jiangbo; Borchert, Glen M.; Eilbeck, Karen; Zhang, He; Xiong, Min; Jiang, Weijian; Wu, Hao; Blake, Judith A.; Natale, Darren A.; Tan, Ming			OMIT: Dynamic, Semi-Automated Ontology Development for the microRNA Domain	PLOS ONE			English	Article							TOOL; UNIFICATION; INFORMATION; PREDICTION; TARGETS	As a special class of short non-coding RNAs, microRNAs (a. k. a. miRNAs or miRs) have been reported to perform important roles in various biological processes by regulating respective target genes. However, significant barriers exist during biologists' conventional miR knowledge discovery. Emerging semantic technologies, which are based upon domain ontologies, can render critical assistance to this problem. Our previous research has investigated the construction of a miR ontology, named Ontology for MIcroRNA Target Prediction (OMIT), the very first of its kind that formally encodes miR domain knowledge. Although it is unavoidable to have a manual component contributed by domain experts when building ontologies, many challenges have been identified for a completely manual development process. The most significant issue is that a manual development process is very labor-intensive and thus extremely expensive. Therefore, we propose in this paper an innovative ontology development methodology. Our contributions can be summarized as: (i) We have continued the development and critical improvement of OMIT, solidly based on our previous research outcomes. (ii) We have explored effective and efficient algorithms with which the ontology development can be seamlessly combined with machine intelligence and be accomplished in a semi-automated manner, thus significantly reducing large amounts of human efforts. A set of experiments have been conducted to thoroughly evaluate our proposed methodology.	[Huang, Jingshan; Zhang, He; Xiong, Min; Jiang, Weijian; Wu, Hao] Univ S Alabama, Sch Comp, Mobile, AL 36688 USA; [Dang, Jiangbo] Siemens Corp, Corp Technol, Princeton, NJ USA; [Borchert, Glen M.] Univ S Alabama, Dept Biol, Mobile, AL 36688 USA; [Eilbeck, Karen] Univ Utah, Sch Med, Salt Lake City, UT USA; [Blake, Judith A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Natale, Darren A.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Tan, Ming] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA	University of South Alabama; Siemens AG; University of South Alabama; Utah System of Higher Education; University of Utah; Jackson Laboratory; Georgetown University; University of South Alabama	Huang, JS (corresponding author), Univ S Alabama, Sch Comp, Mobile, AL 36688 USA.	huang@southalabama.edu	Natale, Darren A/AAE-9303-2019; Tan, Ming/ABD-5847-2021	Natale, Darren A/0000-0001-5809-9523; Tan, Ming/0000-0003-2007-9898; Eilbeck, Karen/0000-0002-0831-6427; borchert, glen/0000-0002-6182-7154; Blake, Judith/0000-0001-8522-334X	NIH [R01-CA149646]; Vincent F. Kilborn, Jr. Cancer Research Foundation; NSF by Division of Molecular and Cellular Biosciences [1350064]; NSF EPSCoR program; NATIONAL CANCER INSTITUTE [U01CA180982, P30CA034196, R01CA149646] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vincent F. Kilborn, Jr. Cancer Research Foundation; NSF by Division of Molecular and Cellular Biosciences; NSF EPSCoR program(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Ming Tan's lab is funded by NIH Grant R01-CA149646 and The Vincent F. Kilborn, Jr. Cancer Research Foundation. Glen M. Borchert was supported by NSF CAREER grant 1350064 awarded by Division of Molecular and Cellular Biosciences, with co-funding provided by the NSF EPSCoR program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre E, 2000, P ONT LEARN WORKSH O; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auer S, 2006, LECT NOTES COMPUT SC, V4273, P736; Balakrishna M, 2010, P 7 INT C LANG RES E, P19; Bao J, 2006, P AAAI 2006 FALL S S; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Biebow B, 1999, P 11 EUR WORKSH KNOW, P49; Bittner T, 2004, P GMDS, P199; Bohring H., 2005, LEIPZ INFORM TAGE LI, V72, P147; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Cho M, 2006, 8th International Conference on Advanced Communication Technology, Vols 1-3, pU1573; Cimiano P., 2006, ONTOLOGY LEARNING PO; Coulet A, 2010, J BIOMED INFORM, V43, P1009, DOI 10.1016/j.jbi.2010.08.005; Courtot M, 2011, APPL ONTOL, V6, P23, DOI 10.3233/AO-2011-0087; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Enright A, 2003, NUCL ACIDS RES, V5; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gasevic D, 2004, 2004 2ND INTERNATIONAL IEEE CONFERENCE INTELLIGENT SYSTEMS, VOLS 1 AND 2, PROCEEDINGS, P485; Gennari JH, 2003, INT J HUM-COMPUT ST, V58, P89, DOI 10.1016/S1071-5819(02)00127-1; Grenon P, 2004, STUD HEALTH TECHNOL, V102, P20; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grun D, 2006, CURR BIOL, V16, P460; Hu H, 2004, PROCEEDINGS OF THE 2004 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-7, P1233; Huang J., 2012, P BHI WORKSH 2012 IE, P16; Huang J, 2010, P 1 ACM INT C BIOINF, P472; Huang JS, 2011, PHARM RES-DORDR, V28, P3101, DOI 10.1007/s11095-011-0573-8; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khan LF, 2002, PROC INT C TOOLS ART, P122, DOI 10.1109/TAI.2002.1180796; Kietz J, 2000, P 12 EUR WORKSH KNOW; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kong H, 2006, P 8 INT C ADV COMM T; Krebs J. E., 2014, LEWINS GENES, VXI; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu ZX, 2013, J BIOL CHEM, V288, P4334, DOI 10.1074/jbc.M112.419168; Lonsdale D, 2005, P 5 INT C KNOWL MAN; Lu ZY, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq036; McGuinness Deborah L, 2001, ONTOLOGY DEV; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Mitchell T.M, 2003, MACH LEARN; Moldovan D., 2000, FLAIRS-2000. Proceedings of the Thirteenth International Florida Artificial Intelligence Research Society Conference, P224; Natale DA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S9-S1; Nobecourt J, 2000, P WORKSH ONT TEXT JU; Pinto HS, 2004, KNOWL INF SYST, V6, P441, DOI 10.1007/s10115-003-0138-1; Pivk A, 2006, AI COMMUN, V19, P83; Ratsch E, 2003, COMP FUNCT GENOM, V4, P85, DOI 10.1002/cfg.244; Reeves GA, 2008, BIOINFORMATICS, V24, P2767, DOI 10.1093/bioinformatics/btn528; Reference Genome Group of the Gene Ontology Consortium, 2009, PLOS COMPUT BIOL, V5; Ritchie W, 2010, BIOINFORMATICS, V26, P223, DOI 10.1093/bioinformatics/btp649; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith B., 2004, P FOIS 2004 INT C FO, P73; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Sure Y, 2002, LECT NOTES COMPUT SC, V2342, P221; Townsend C, 2010, P 9 INT C ONT DAT AP, P1162; Tsang J, 2005, MOL CELL, V38, P140; Uschold M, 1996, KNOWL ENG REV, V11, P93, DOI 10.1017/S0269888900007797; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wachter T, 2010, BIOINFORMATICS, V26, pi88, DOI 10.1093/bioinformatics/btq188; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wilson J., 2008, MOL BIOL CELL; Xiang Zuoshuang, 2010, BMC Res Notes, V3, P175, DOI 10.1186/1756-0500-3-175; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229	67	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e100855	10.1371/journal.pone.0100855	http://dx.doi.org/10.1371/journal.pone.0100855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025130	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400007
J	Wu, CL; Qu, XH; Mao, YQ; Li, HW; Dai, KR; Liu, FX; Zhu, ZA				Wu, Chuanlong; Qu, Xinhua; Mao, Yuanqing; Li, Huiwu; Dai, Kerong; Liu, Fengxiang; Zhu, Zhenan			Utility of Intraoperative Frozen Section in the Diagnosis of Periprosthetic Joint Infection	PLOS ONE			English	Article							C-REACTIVE PROTEIN; RESECTION ARTHROPLASTY; HIP	Purpose: Intraoperative frozen section (FS) is an effective diagnostic test for periprosthetic joint infection (PJI). We evaluated the diagnostic characteristics of single- and multiplex-site intraoperative FS, and evaluated the results of single-site FS combined with those of C-reactive protein (CRP) level and erythrocyte sedimentation rate (ESR) for assessing PJI. Methods: We studied 156 painful joint arthroplasties in 152 consecutive patients presenting for revision total joint arthroplasty due to PJI. Receiver operating characteristic analysis was used to determine the optimal cutoff values for CRP level, ESR, and intraoperative FS histopathology. Sensitivity, specificity, positive and negative predictive values, and accuracy of the diagnostic tests were assessed using a 2x2 table. Results: We investigated the diagnostic utility of polymorphonuclear leukocyte number (PMN) per high-power field (HPF) on FS. Our data showed that 5 PMNs per HPF is a suitable diagnostic threshold, with a high accuracy in single-and multiplex-site FS. Five PMNs in any 1 of 5 sites had the highest sensitivity of 0.86 and a specificity of 0.96. Five PMNs in every 1 of 5 sites had greater diagnostic utility, with a specificity of 1; however, the sensitivity of this measure fell to 0.62. Five PMNs in single-site FS had a sensitivity of 0.70 and a specificity of 0.94. Five PMNs in single-site FS or CRP level >= 15 mg/L increased the sensitivity to 0.92; however, the specificity decreased to 0.79. Conclusion: Compared with single-site FS, any 1 positive site on multiplex-site FS may improve sensitivity, while every 1 positive site on multiplex-site FS may improve specificity. Five PMNs in any 1 of 5 sites on FS has excellent utility for the diagnosis of PJI. Additional systematic large-scale studies are needed to verify this result.	[Wu, Chuanlong; Qu, Xinhua; Mao, Yuanqing; Li, Huiwu; Dai, Kerong; Liu, Fengxiang; Zhu, Zhenan] Shanghai Jiao Tong Univ, Sch Med, Dept Orthopaed, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, FX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Orthopaed, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China.	liu_fengxiang@163.com; zhenan_zhu@126.com	Qu, Xinhua/Q-3950-2016	Qu, Xinhua/0000-0002-8889-0890	National Natural Science Foundation of China [81171729]; Major Basic Research of Science and Technology Commission of Shanghai Municipality [11DJ1400303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81171729) and Major Basic Research of Science and Technology Commission of Shanghai Municipality (Grant No. 11DJ1400303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alijanipour P, 2013, CLIN ORTHOP RELAT RE; Athanasou NA, 1997, J BONE JOINT SURG AM, V79A, P1433, DOI 10.2106/00004623-199709000-00021; Baak JPA, 2009, BREAST CANCER RES TR, V115, P241, DOI 10.1007/s10549-008-0126-y; Baak JPA, 2005, J CLIN ONCOL, V23, P5993, DOI 10.1200/JCO.2005.05.511; Banit DM, 2002, CLIN ORTHOP RELAT R, P230, DOI 10.1097/00003086-200208000-00026; Bori G, 2009, ARCH ORTHOP TRAUM SU, V129, P591, DOI 10.1007/s00402-008-0679-6; Bozic KJ, 2013, J ARTHROPLASTY; Buttaro MA, 2010, CLIN ORTHOP RELAT R, V468, P3263, DOI 10.1007/s11999-010-1451-0; Costa Christopher R, 2012, Am J Orthop (Belle Mead NJ), V41, P160; Fink B, 2013, CLIN ORTHOP RELAT R, V471, P956, DOI 10.1007/s11999-012-2474-5; Ghanem E, 2009, INT J INFECT DIS, V13, pE444, DOI 10.1016/j.ijid.2009.02.017; Ghanem E, 2009, CLIN ORTHOP RELAT R, V467, P1699, DOI 10.1007/s11999-009-0742-9; Liao YY, 2010, J BONE JOINT SURG AM, V92A, P1314; MIRRA JM, 1976, CLIN ORTHOP RELAT R, P221; Muller Michael, 2008, J Orthop Surg Res, V3, P31, DOI 10.1186/1749-799X-3-31; Parvizi Javad, 2012, J Bone Joint Surg Am, V94, pe104, DOI 10.2106/JBJS.K.01417; Parvizi J, 2011, CLIN ORTHOP RELAT R, V469, P1401, DOI 10.1007/s11999-011-1822-1; Parvizi J, 2010, J AM ACAD ORTHOP SUR, V18, P771, DOI 10.5435/00124635-201012000-00007; Piper KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009358; Schwartz AJ, 2012, J ARTHROPLASTY, V27, P46, DOI 10.1016/j.arth.2012.03.033; Shukla SK, 2010, J ARTHROPLASTY, V25, P87, DOI 10.1016/j.arth.2010.05.006; Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008; Tohtz SW, 2010, CLIN ORTHOP RELAT R, V468, P762, DOI 10.1007/s11999-009-1102-5; Tsaras G, 2012, J BONE JOINT SURG AM, V94A, P1700, DOI 10.2106/JBJSJ.00756; Ueng SW, 2013, CLIN ORTHOP RELAT R, DOI [10.1007/s11999-11013-13007-11996, DOI 10.1007/S11999-11013-13007-11996]; Wong YC, 2005, J ARTHROPLASTY, V20, P1015, DOI 10.1016/j.arth.2004.08.003; Zhao X, 2013, J ARTHROPLASTY, V28, P913, DOI 10.1016/j.arth.2012.10.015	27	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102346	10.1371/journal.pone.0102346	http://dx.doi.org/10.1371/journal.pone.0102346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025886	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400066
J	Zhao, SY; Zhang, HG; Cao, DY; Liu, Y; Li, XH				Zhao, Shanyu; Zhang, Haigang; Cao, Dayan; Liu, Ya; Li, Xiaohui			Lipopolysaccharide Exposure during Pregnancy Leads to Aortic Dysfunction in Offspring Rats	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; DIET-INDUCED OBESITY; CARDIOVASCULAR-DISEASE; ANGIOTENSIN-II; PRENATAL EXPOSURE; BLOOD-PRESSURE; CONNEXIN EXPRESSION; PROTEIN RESTRICTION; ENDOTHELIAL-CELLS	Background: Prenatal exposure to Lipopolysaccharide (LPS) produces hypertension in adult offspring rats. The present study was to explore the effects of prenatal inflammation on morphological and functional changes in the aorta from offspring rats and to further assess its susceptibility to cardiovascular diseases. Methods and Results: Pregnant rats were treated intraperitoneally on gestation Days 8, 10 and 12 with saline, LPS (0.79 mg/kg), or pyrrolidine dithiocarbamate (PDTC, 100 mg/kg)+LPS, respectively. Aortic ring reactivity and histopathological alteration were analyzed in offspring at the age of 12 weeks. The detections of connexin (Cx) 37, Cx40, Cx43, and Cx45, including immunofluorescent patterns, protein levels and mRNA expression in the aorta, were performed as well. Furthermore, the expressions of Nuclear factor (NF)-kappa B (p65), I kappa B alpha, phospho-I kappa B alpha and I kappa B beta were determined. The results showed that prenatal LPS exposure leads to morphological abnormalities and impaired aortic reactivity in offspring. Prenatal LPS exposure also decreased the protein and mRNA expression of Cx37 in the aorta from offspring rats. NF-kappa B and phospho-I kappa B alpha levels were both increased, IkBa level, however, was decreased in the aorta of offspring from the maternal LPS exposure compared to the controls. Simultaneously, PDTC treatment markedly reversed the action of LPS. Conclusions: Decreased expression of Cx37 contributed to the aortic dysfunction of prenatal LPS exposure offspring, which should be associated with NF-kappa B activation.	[Zhao, Shanyu; Cao, Dayan; Liu, Ya; Li, Xiaohui] Third Mil Med Univ, Coll Pharm, Inst Mat Med, Chongqing, Peoples R China; [Zhao, Shanyu; Cao, Dayan; Liu, Ya; Li, Xiaohui] Third Mil Med Univ, Coll Pharm, Dept Pharmaceut, Chongqing, Peoples R China; [Zhang, Haigang] Third Mil Med Univ, Dept Pharmacol, Coll Pharm, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Liu, Y (corresponding author), Third Mil Med Univ, Coll Pharm, Inst Mat Med, Chongqing, Peoples R China.	liuya1979@gmail.com; liphsub@gmail.com	Zhao, Shanyu/AAM-2055-2021	Zhao, Shanyu/0000-0002-8863-7019; cao, dayan/0000-0001-7648-3668	National Natural Science Foundation of China [81373420, 81273507, 81072630]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NO 81373420,81273507,81072630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso F, 2010, AM J PHYSIOL-HEART C, V299, pH1365, DOI 10.1152/ajpheart.00029.2010; Barker DJP, 2000, THERIOGENOLOGY, V53, P555, DOI 10.1016/S0093-691X(99)00258-7; BEVAN JA, 1972, AGENTS ACTIONS, V2, P257, DOI 10.1007/BF02087051; Bol VV, 2009, AM J PHYSIOL-REG I, V297, pR291, DOI 10.1152/ajpregu.90497.2008; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Christ GJ, 1996, CIRC RES, V79, P631, DOI 10.1161/01.RES.79.4.631; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; Daviglus Martha L, 2006, Am J Cardiovasc Drugs, V6, P87, DOI 10.2165/00129784-200606020-00003; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Figueroa XF, 2009, ANTIOXID REDOX SIGN, V11, P251, DOI 10.1089/ars.2008.2117; Haefliger JA, 1999, ARTERIOSCL THROM VAS, V19, P1615, DOI 10.1161/01.ATV.19.7.1615; Hampton T, 2004, JAMA-J AM MED ASSOC, V292, P1285, DOI 10.1001/jama.292.11.1285; Hao XQ, 2010, INFLAMMATION, V33, P408, DOI 10.1007/s10753-010-9199-y; Hao XQ, 2010, HYPERTENS RES, V33, P76, DOI 10.1038/hr.2009.185; He Xiao-yan, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P853; Isakson BE, 2006, ARTERIOSCL THROM VAS, V26, P2216, DOI 10.1161/01.ATV.0000237608.19055.53; Jobs A, 2012, HYPERTENSION, V60, P1422, DOI 10.1161/HYPERTENSIONAHA.112.201194; Keelan JA, 2009, J IMMUNOL, V183, P5270, DOI 10.4049/jimmunol.0802660; Kohmura Y, 2000, MICROBIOL IMMUNOL, V44, P897, DOI 10.1111/j.1348-0421.2000.tb02581.x; Liao WQ, 2008, CLIN EXP PHARMACOL P, V35, P1413, DOI 10.1111/j.1440-1681.2008.05062.x; Liu JH, 2009, FEBS J, V276, P4598, DOI 10.1111/j.1742-4658.2009.07165.x; McKinnon RL, 2006, CARDIOVASC RES, V69, P236, DOI 10.1016/j.cardiores.2005.09.003; Muller DN, 2000, HYPERTENSION, V35, P193, DOI 10.1161/01.HYP.35.1.193; Nijdam ME, 2008, AM J HYPERTENS, V21, P388, DOI 10.1038/ajh.2007.89; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; Olzinski AR, 2005, CARDIOVASC RES, V66, P170, DOI 10.1016/j.cardiores.2004.12.021; Palinski W, 2008, CIRCULATION, V117, P341, DOI 10.1161/CIRCULATIONAHA.107.750133; Palinski W, 2009, J CARDIOVASC TRANSL, V2, P277, DOI 10.1007/s12265-009-9108-7; Pfenniger A, 2010, ARTERIOSCL THROM VAS, V30, P827, DOI 10.1161/ATVBAHA.109.200816; Plum A, 2000, CURR BIOL, V10, P1083, DOI 10.1016/S0960-9822(00)00690-4; Rogers LK, 2011, LIFE SCI, V89, P417, DOI 10.1016/j.lfs.2011.07.017; Salminen A, 2008, PEDIATR RES, V63, P280, DOI 10.1203/PDR.0b013e318163a8b2; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Simon AM, 2003, J CELL SCI, V116, P2223, DOI 10.1242/jcs.00429; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Takahashi M, 2008, AM J PHYSIOL-HEART C, V294, pH2879, DOI 10.1152/ajpheart.91406.2007; Tang EHC, 2008, J PHARMACOL EXP THER, V327, P148, DOI 10.1124/jpet.108.140046; Tsai SH, 2013, CARDIOVASC RES, V100, P501, DOI 10.1093/cvr/cvt230; Tsukuda K, 2012, J AM SOC HYPERTENS, V6, P324, DOI 10.1016/j.jash.2012.07.001; van Vliet LS, 2007, ARTERIOSCLER THROMB, V27, P2228; Velten M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024544; Wagner C, 2010, KIDNEY INT, V78, P762, DOI 10.1038/ki.2010.257; Wei YL, 2007, ACTA PHARMACOL SIN, V28, P651, DOI 10.1111/j.1745-7254.2007.00593.x; Weisbrod RM, 2013, HYPERTENSION, V62, P1105, DOI 10.1161/HYPERTENSIONAHA.113.01744; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441; Yeh HI, 2000, J HISTOCHEM CYTOCHEM, V48, P1377, DOI 10.1177/002215540004801008; Yzydorczyk C, 2008, HYPERTENSION, V52, P889, DOI 10.1161/HYPERTENSIONAHA.108.116251; Zhao SY, 2014, ZHONGHUA XIN XUE GUA, V42; Zhou JZ, 2013, MOL MED REP, V8, P95, DOI 10.3892/mmr.2013.1498	50	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102273	10.1371/journal.pone.0102273	http://dx.doi.org/10.1371/journal.pone.0102273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025169	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400058
J	Guerrero, PA; Yin, W; Camacho, L; Marchetti, D				Guerrero, P. A.; Yin, W.; Camacho, L.; Marchetti, D.			Oncogenic role of Merlin/NF2 in glioblastoma	ONCOGENE			English	Article							NF2 TUMOR-SUPPRESSOR; CELL-GROWTH; AKT PHOSPHORYLATION; CONTACT INHIBITION; GENE-PRODUCT; PROTEIN; PROLIFERATION; MUTATIONS; BINDING; KINASE	Glioblastoma is the most common and aggressive primary brain tumor in adults, with a poor prognosis because of its resistance to radiotherapy and chemotherapy. Merlin/NF2 (moesin-ezrin-radixin-like protein/neurofibromatosis type 2) is a tumor suppressor found to be mutated in most nervous system tumors; however, it is not mutated in glioblastomas. Merlin associates with several transmembrane receptors and intracellular proteins serving as an anchoring molecule. Additionally, it acts as a key component of cell motility. By selecting sub-populations of U251 glioblastoma cells, we observed that high expression of phosphorylated Merlin at serine 518 (S518-Merlin), NOTCH1 and epidermal growth factor receptor (EGFR) correlated with increased cell proliferation and tumorigenesis. These cells were defective in cell-contact inhibition with changes in Merlin phosphorylation directly affecting NOTCH1 and EGFR expression, as well as downstream targets HES1 (hairy and enhancer of split-1) and CCND1 (cyclin D1). Of note, we identified a function for S518-Merlin, which is distinct from what has been reported when the expression of Merlin is diminished in relation to EGFR and NOTCH1 expression, providing first-time evidence that demonstrates that the phosphorylation of S518-Merlin in glioblastoma promotes oncogenic properties that are not only the result of inactivation of the tumor suppressor role of Merlin but also an independent process implicating a Merlin-driven regulation of NOTCH1 and EGFR.	[Guerrero, P. A.; Yin, W.; Camacho, L.; Marchetti, D.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Marchetti, D.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Marchetti, D (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Mail Stop 315,BCM Taub Bldg,Suite T240, Houston, TX 77030 USA.	marchett@bcm.edu	Camacho, Laura/M-2071-2015	Camacho, Laura/0000-0002-5911-1616	Shared Resources CPRIJ grant; NCI Grant [CA016672]; NIH [RO1 CA160335]; NATIONAL CANCER INSTITUTE [R01CA160335, P30CA016672] Funding Source: NIH RePORTER	Shared Resources CPRIJ grant; NCI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Drs F Giancotti and D Trono for providing vectors and reagents. We thank Jason Ngo, Andres Espinoza and Flavio Palalon for technical assistance. We also thank BCM Integrated Microscopy Core Facility at BCM supported by Shared Resources CPRIJ grant. The Characterized Cell Line Core at MDACC is supported by NCI Grant CA016672. This work was supported by NIH RO1 CA160335 (to DM).	Alfthan K, 2004, J BIOL CHEM, V279, P18559, DOI 10.1074/jbc.M313916200; BIANCHI AB, 1994, NAT GENET, V6, P185, DOI 10.1038/ng0294-185; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Eldridge R, 1981, Adv Neurol, V29, P57; Fassl A, 2012, ONCOGENE, V31, P4698, DOI 10.1038/onc.2011.615; Fernandez-Valle C, 2002, NAT GENET, V31, P354, DOI 10.1038/ng930; Gonzales AJ, 2005, EXP CELL RES, V303, P56, DOI 10.1016/j.yexcr.2004.08.040; Gronholm M, 2006, ONCOGENE, V25, P4389, DOI 10.1038/sj.onc.1209475; Gutmann DH, 1999, J NEUROSCI RES, V58, P706, DOI 10.1002/(SICI)1097-4547(19991201)58:5<706::AID-JNR12>3.3.CO;2-Q; Houshmandi SS, 2009, MOL CELL BIOL, V29, P1472, DOI 10.1128/MCB.01392-08; Jacoby LB, 1996, GENE CHROMOSOME CANC, V17, P45, DOI 10.1002/(SICI)1098-2264(199609)17:1<45::AID-GCC7>3.0.CO;2-2; Kang CS, 2006, CANCER GENE THER, V13, P530, DOI 10.1038/sj.cgt.7700932; Lau YKI, 2008, CANCER RES, V68, P5733, DOI 10.1158/0008-5472.CAN-08-0190; Laulajainen M, 2008, ONCOGENE, V27, P3233, DOI 10.1038/sj.onc.1210988; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Lino MM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-72; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Morrow KA, 2011, J BIOL CHEM, V286, P40376, DOI 10.1074/jbc.M111.250035; Muranen T, 2005, ONCOGENE, V24, P1150, DOI 10.1038/sj.onc.1208283; Noda N, 2011, GENES CELLS, V16, P704, DOI 10.1111/j.1365-2443.2011.01518.x; Okada M, 2009, CANCER RES, V69, P4043, DOI 10.1158/0008-5472.CAN-08-3931; Okada T, 2007, TRENDS CELL BIOL, V17, P222, DOI 10.1016/j.tcb.2007.03.006; Pecina-Slaus N, 2013, PATHOL ONCOL RES, V19, P365, DOI 10.1007/s12253-013-9644-y; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulze KMM, 2002, HUM MOL GENET, V11, P69, DOI 10.1093/hmg/11.1.69; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Sherman LS, 2001, TRENDS CELL BIOL, V11, P442, DOI 10.1016/S0962-8924(01)02128-6; Stamenkovic I, 2010, CURR PROTEIN PEPT SC, V11, P471, DOI 10.2174/138920310791824011; Surace EI, 2004, ONCOGENE, V23, P580, DOI 10.1038/sj.onc.1207142; Takebe N, 2014, PHARMACOL THERAPEUT, V141, P140, DOI 10.1016/j.pharmthera.2013.09.005; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Thaxton C, 2007, MOL CELL NEUROSCI, V34, P231, DOI 10.1016/j.mcn.2006.11.003; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Visser-Grieve S, 2012, ONCOGENE, V31, P1189, DOI 10.1038/onc.2011.318; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	39	18	19	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2015	34	20					2621	2630		10.1038/onc.2014.185	http://dx.doi.org/10.1038/onc.2014.185			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI1YN	25043298	Green Accepted			2022-12-25	WOS:000354541300008
J	Amano, K; Densmore, M; Nishimura, R; Lanske, B				Amano, Katsuhiko; Densmore, Michael; Nishimura, Riko; Lanske, Beate			Indian Hedgehog Signaling Regulates Transcription and Expression of Collagen Type X via Runx2/Smads Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE DIFFERENTIATION; RUNX2 CONTRIBUTES; GENE-REGULATION; GROWTH; IHH; OSTEOBLAST; CARTILAGE; ENHANCER; PROTEIN; GLI3	Indian hedgehog (Ihh) is essential for chondrocyte differentiation and endochondral ossification and acts with parathyroid hormone-related peptide in a negative feedback loop to regulate early chondrocyte differentiation and entry to hypertrophic differentiation. Independent of this function, we and others recently reported independent Ihh functions to promote chondrocyte hypertrophy and matrix mineralization in vivo and in vitro. However, the molecular mechanisms for these actions and their functional significance are still unknown. We recently discovered that Ihh overexpression in chondrocytes stimulated the expression of late chondrocyte differentiation markers and induced matrix mineralization. Focusing on collagen type X (Col10 alpha 1) expression and transcription, we observed that hedgehog downstream transcription factors GLI-Kruppel family members (Gli) 1/2 increased COL10A1 promoter activity and identified a novel Gli1/2 response element in the 250-bp basic promoter. In addition, we found that Ihh induced Runx2 expression in chondrocytes without up-regulating other modulators of chondrocyte maturation such as Mef2c, Foxa2, and Foxa3. Runx2 promoted Col10 alpha 1 expression in cooperation with Ihh. Further analyses using promoter assays, immunofluorescence, and binding assays showed the interaction of Gli1/2 in a complex with Runx2/Smads induces chondrocyte differentiation. Finally, we could demonstrate that Ihh promotes in vitro matrix mineralization using similar molecular mechanisms. Our data provide an in vitro mechanism for Ihh signaling to positively regulate Col10 alpha 1 transcription. Thus, Ihh signaling could be an important player for not only early chondrocyte differentiation but maturation and calcification of chondrocytes.	[Amano, Katsuhiko; Densmore, Michael; Lanske, Beate] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Amano, Katsuhiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg, Suita, Osaka 5650871, Japan; [Nishimura, Riko] Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, Suita, Osaka 5650871, Japan	Harvard University; Harvard School of Dental Medicine; Osaka University; Osaka University	Lanske, B (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave, Boston, MA 02115 USA.	beate_lanske@hsdm.harvard.edu		Lanske, Beate/0000-0003-4638-804X; Nishimura, Riko/0000-0001-7279-8363	National Institutes of Health [R01AR050560]; Harvard School of Dental Medicine; Japan Society for the Promotion of Science; Uehara Memorial Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard School of Dental Medicine; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AR050560. This work was also supported by institutional funds from Harvard School of Dental Medicine (to B. L.), postdoctoral fellowships for research abroad from the Japan Society for the Promotion of Science (to K. A.), and research fellowship for study abroad from the Uehara Memorial Foundation (to K. A.).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Amano K, 2009, MOL BIOL CELL, V20, P4541, DOI 10.1091/mbc.E09-03-0227; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Drissi MH, 2003, J CELL BIOCHEM, V90, P1287, DOI 10.1002/jcb.10677; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Gebhard S, 2004, MATRIX BIOL, V23, P309, DOI 10.1016/j.matbio.2004.05.010; Hellemans J, 2003, AM J HUM GENET, V72, P1040, DOI 10.1086/374318; Hesse E, 2010, J CELL BIOL, V191, P1271, DOI 10.1083/jcb.201009107; Higashikawa A, 2009, ARTHRITIS RHEUM-US, V60, P166, DOI 10.1002/art.24243; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; Hojo H, 2013, J BIOL CHEM, V288, P9924, DOI 10.1074/jbc.M112.409342; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; Ionescu A, 2012, DEV CELL, V22, P927, DOI 10.1016/j.devcel.2012.03.011; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Koziel L, 2005, DEVELOPMENT, V132, P5249, DOI 10.1242/dev.02097; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Li FF, 2011, J BONE MINER RES, V26, P2899, DOI 10.1002/jbmr.504; Maeda Y, 2010, BONE, V46, P472, DOI 10.1016/j.bone.2009.09.009; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Miao DS, 2004, EXP CELL RES, V294, P210, DOI 10.1016/j.yexcr.2003.10.021; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Minina E, 2001, DEVELOPMENT, V128, P4523; Mo R, 1997, DEVELOPMENT, V124, P113; Morikawa M, 2013, ONCOGENE, V32, P1609, DOI 10.1038/onc.2012.191; Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8; Park HL, 2000, DEVELOPMENT, V127, P1593; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Seriwatanachai D, 2011, FASEB J, V25, P3057, DOI 10.1096/fj.11-183277; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zheng QP, 2009, J BONE MINER RES, V24, P1022, DOI [10.1359/JBMR.081249, 10.1359/jbmr.081249]; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	45	48	54	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24898	24910		10.1074/jbc.M114.570507	http://dx.doi.org/10.1074/jbc.M114.570507			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25028519	Green Published, hybrid			2022-12-25	WOS:000341985300015
J	Rossi, O; Pesce, I; Giannelli, C; Aprea, S; Caboni, M; Citiulo, F; Valentini, S; Ferlenghi, I; MacLennan, CA; D'Oro, U; Saul, A; Gerke, C				Rossi, Omar; Pesce, Isabella; Giannelli, Carlo; Aprea, Susanna; Caboni, Mariaelena; Citiulo, Francesco; Valentini, Sara; Ferlenghi, Ilaria; MacLennan, Calman Alexander; D'Oro, Ugo; Saul, Allan; Gerke, Christiane			Modulation of Endotoxicity of Shigella Generalized Modules for Membrane Antigens (GMMA) by Genetic Lipid A Modifications RELATIVE ACTIVATION OF TLR4 AND TLR2 PATHWAYS IN DIFFERENT MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRUCTURAL BASIS; A BIOSYNTHESIS; LPXL MUTANTS; ACYL CHAINS; LIPOPOLYSACCHARIDE; ACYLATION; VIRULENCE; PROTEIN; HTRB	Outer membrane particles from Gram-negative bacteria are attractive vaccine candidates as they present surface antigens in their natural context. We previously developed a high yield production process for genetically derived particles, called generalized modules for membrane antigens (GMMA), from Shigella. As GMMA are derived from the outer membrane, they contain immunostimulatory components, especially lipopolysaccharide (LPS). We examined ways of reducing their reactogenicity by modifying lipid A, the endotoxic part of LPS, through deletion of late acyltransferase genes, msbB or htrB, in GMMA-producing Shigella sonnei and Shigella flexneri strains. GMMA with resulting penta-acylated lipid A from the msbB mutants showed a 600-fold reduced ability, and GMMA from the S. sonnei Delta htrB mutant showed a 60,000-fold reduced ability compared with GMMA with wild-type lipid A to stimulate human Toll-like receptor 4 (TLR4) in a reporter cell line. In human peripheral blood mononuclear cells, GMMA with penta-acylated lipid A showed a marked reduction in induction of inflammatory cytokines (S. sonnei Delta htrB, 800-fold; Delta msbB mutants, 300-fold). We found that the residual activity of these GMMA is largely due to non-lipid A-related TLR2 activation. In contrast, in the S. flexneri Delta htrB mutant, a compensatory lipid A palmitoleoylation resulted in GMMA with hexa-acylated lipid A with similar to 10-fold higher activity to stimulate peripheral blood mononuclear cells than GMMA with penta-acylated lipid A, mostly due to retained TLR4 activity. Thus, for use as vaccines, GMMA will likely require lipid A penta-acylation. The results identify the relative contributions of TLR4 and TLR2 activation by GMMA, which need to be taken into consideration for GMMA vaccine development.	[Rossi, Omar; Pesce, Isabella; Giannelli, Carlo; Caboni, Mariaelena; Citiulo, Francesco; MacLennan, Calman Alexander; Saul, Allan; Gerke, Christiane] Novartis Vaccines Inst Global Hlth, I-53100 Siena, Italy; [Aprea, Susanna; Valentini, Sara; Ferlenghi, Ilaria; D'Oro, Ugo] Novartis Vaccines, I-53100 Siena, Italy	Novartis; Novartis	Gerke, C (corresponding author), Novartis Vaccines Inst Global Hlth, Via Fiorentina 1, I-53100 Siena, Italy.	christiane.gerke@novartis.com	Rossi, Omar/AAT-6743-2020; Saul, Allan/ABH-2091-2020; Saul, Allan J/I-6968-2013; MacLennan, Calman A/L-9343-2014	Saul, Allan/0000-0003-0665-4091; Saul, Allan J/0000-0003-0665-4091; MacLennan, Calman A/0000-0001-9694-0846; Citiulo, Francesco/0000-0003-2322-6742; Gerke, Christiane/0000-0001-9446-8031; Caboni, Mariaelena/0000-0002-9742-0022	European Union [261472 STOPENTERICS]	European Union(European Commission)	This work was supported by European Union Seventh Framework Programme FP7/2007-2013 under Grant 261472 STOPENTERICS.	Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; BATH UR, 1987, FEMS MICROBIOL LETT, V40, P189; Carty SM, 1999, J BIOL CHEM, V274, P9677, DOI 10.1074/jbc.274.14.9677; Chang ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052515; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; d'Hauteville H, 2002, J IMMUNOL, V168, P5240, DOI 10.4049/jimmunol.168.10.5240; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; FORMAL SB, 1966, J BACTERIOL, V92, P17, DOI 10.1128/JB.92.1.17-22.1966; FORMAL SB, 1958, J BACTERIOL, V75, P604, DOI 10.1128/JB.75.5.604-610.1958; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Jiang Y, 2005, PLASMID, V54, P149, DOI 10.1016/j.plasmid.2005.03.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keiser PB, 2011, VACCINE, V29, P1413, DOI 10.1016/j.vaccine.2010.12.039; Koeberling O, 2008, J INFECT DIS, V198, P262, DOI 10.1086/589308; Koeberling O, 2014, VACCINE, V32, P2688, DOI 10.1016/j.vaccine.2014.03.068; Koeberling O, 2009, CLIN VACCINE IMMUNOL, V16, P156, DOI 10.1128/CVI.00403-08; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lee SR, 2009, J MICROBIOL BIOTECHN, V19, P1271, DOI 10.4014/jmb.0901.055; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Livio S, 2014, CLIN INFECT DIS; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Micoli F, 2013, ANAL BIOCHEM, V434, P136, DOI 10.1016/j.ab.2012.10.038; MORONA R, 1995, MOL MICROBIOL, V18, P209, DOI 10.1111/j.1365-2958.1995.mmi_18020209.x; Netea MG, 2000, CLIN INFECT DIS, V31, pS178, DOI 10.1086/317513; Nichols WA, 1997, J ENDOTOXIN RES, V4, P163, DOI 10.1177/096805199700400301; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ranallo RT, 2010, INFECT IMMUN, V78, P400, DOI 10.1128/IAI.00533-09; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Schilling B, 2014, INNATE IMMUN-LONDON, V20, P269, DOI 10.1177/1753425913490534; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Scorza FB, 2008, MOL CELL PROTEOMICS, V7, P473, DOI 10.1074/mcp.M700295-MCP200; Scorza FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035616; Seubert A, 2011, P NATL ACAD SCI USA, V108, P11169, DOI 10.1073/pnas.1107941108; Seydel U, 2000, EUR J BIOCHEM, V267, P3032; Shah NR, 2013, J BIOL CHEM, V288, P11751, DOI 10.1074/jbc.M112.434365; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Sprong T, 2011, INNATE IMMUN-LONDON, V17, P517, DOI 10.1177/1753425910383999; Stoddard MB, 2010, CLIN VACCINE IMMUNOL, V17, P98, DOI 10.1128/CVI.00342-09; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P3660, DOI 10.1093/nar/18.12.3660; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14194, DOI 10.1074/jbc.M200409200; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14186, DOI 10.1074/jbc.M200408200	50	53	59	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24922	24935		10.1074/jbc.M114.566570	http://dx.doi.org/10.1074/jbc.M114.566570			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25023285	Green Published, hybrid			2022-12-25	WOS:000341985300017
J	Messa, M; Colombo, L; del Favero, E; Cantu, L; Stoilova, T; Cagnotto, A; Rossi, A; Morbin, M; Di Fede, G; Tagliavini, F; Salmona, M				Messa, Massimo; Colombo, Laura; del Favero, Elena; Cantu, Laura; Stoilova, Tatiana; Cagnotto, Alfredo; Rossi, Alessandro; Morbin, Michela; Di Fede, Giuseppe; Tagliavini, Fabrizio; Salmona, Mario			The Peculiar Role of the A2V Mutation in Amyloid-beta (A beta) 1-42 Molecular Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Amyloid Precursor Protein (APP); Amyloid- (A); Protein Aggregation	ABERRANT PROTEIN OLIGOMERS; ALZHEIMERS-DISEASE; CAENORHABDITIS-ELEGANS; CORTICAL-NEURONS; MEMORY LOSS; IN-SILICO; DYNAMICS; PEPTIDE; TOXICITY; NEUROTOXICITY	Background: A2V mutation is associated with early onset AD-type dementia in homozygous individuals. Results: A2V mutation leads to a peculiar kinetics of A oligomerization. Conclusion: The A N-terminal region plays an important role in the molecular assembly. Significance: in the homozygous condition the A2V mutation led to aggregation, whereas in the heterozygous state the evolution and kinetics of the aggregation process was hindered. We recently reported a novel A precursor protein mutation (A673V), corresponding to position 2 of A1-42 peptides (A1-42(A2V)), that caused an early onset AD-type dementia in a homozygous individual. The heterozygous relatives were not affected as an indication of autosomal recessive inheritance of this mutation. We investigated the folding kinetics of native unfolded A1-42(A2V) in comparison with the wild type sequence (A1-42(WT)) and the equimolar solution of both peptides (A1-42(MIX)) to characterize the oligomers that are produced in the early phases. We carried out the structural characterization of the three preparations using electron and atomic force microscopy, fluorescence emission, and x-ray diffraction and described the soluble oligomer formation kinetics by laser light scattering. The mutation promoted a peculiar pathway of oligomerization, forming a connected system similar to a polymer network with hydrophobic residues on the external surface. A1-42(MIX) generated assemblies very similar to those produced by A1-42(WT), albeit with slower kinetics due to the difficulties of A1-42(WT) and A1-42(A2V) peptides in building up of stable intermolecular interaction.	[Messa, Massimo; Colombo, Laura; Stoilova, Tatiana; Cagnotto, Alfredo; Rossi, Alessandro; Salmona, Mario] IRCCS Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, I-20156 Milan, Italy; [del Favero, Elena; Cantu, Laura] Univ Milan, Dept Med Biotechnol & Translat Med, I-20090 Segrate, Italy; [Morbin, Michela; Di Fede, Giuseppe; Tagliavini, Fabrizio] IRCCS Fdn Carlo Besta Neurol Inst, I-20133 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; IRCCS Istituto Neurologico Besta	Salmona, M (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Via Le Masa 19, I-20156 Milan, Italy.	mario.salmona@marionegri.it	Tagliavini, Fabrizio/AAO-7891-2021; salmona, mario/AAA-7116-2020; salmona, mario/ABI-4066-2020; DEL FAVERO, ELENA/R-4991-2017; Di Fede, Giuseppe/A-4471-2019; Cagnotto, Alfredo/AAB-3083-2020; Di Fede, Giuseppe/O-7772-2016; DEL FAVERO, ELENA/AAR-3567-2020; Di Fede, Giuseppe/K-1394-2016; colombo, laura/AAA-6716-2020	Tagliavini, Fabrizio/0000-0003-1039-7315; salmona, mario/0000-0002-9098-9873; DEL FAVERO, ELENA/0000-0002-6584-1869; Di Fede, Giuseppe/0000-0003-3537-6713; Cagnotto, Alfredo/0000-0002-1390-8240; Di Fede, Giuseppe/0000-0003-3537-6713; DEL FAVERO, ELENA/0000-0002-6584-1869; Di Fede, Giuseppe/0000-0003-3537-6713; colombo, laura/0000-0002-3243-0270; Morbin, Michela/0000-0001-8034-3123	Italian Ministry of Health [RF-2009-1473239]; Banca Intesa Sanpaolo Grant; Ministero dell'Istruzione dell'Universita e della Ricerca Grant [RBAP11FRE9]	Italian Ministry of Health(Ministry of Health, Italy); Banca Intesa Sanpaolo Grant; Ministero dell'Istruzione dell'Universita e della Ricerca Grant(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministry of Health (RF-2009-1473239), Banca Intesa Sanpaolo Grant 2012-2013, and Ministero dell'Istruzione dell'Universita e della Ricerca Grant RBAP11FRE9.	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Baumketner A, 2006, PROTEIN SCI, V15, P1239, DOI 10.1110/ps.062076806; Beeg M, 2011, ANAL BIOCHEM, V411, P297, DOI 10.1016/j.ab.2010.12.032; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Borreguero JM, 2005, P NATL ACAD SCI USA, V102, P6015, DOI 10.1073/pnas.0502006102; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen W, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2337628; Coin I, 2010, J PEPT SCI, V16, P223, DOI 10.1002/psc.1224; Cruz L, 2005, P NATL ACAD SCI USA, V102, P18258, DOI 10.1073/pnas.0509276102; Cruz L, 2012, J PHYS CHEM B, V116, P6311, DOI 10.1021/jp301619v; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Di Fede G, 2012, PROG NEUROBIOL, V99, P281, DOI 10.1016/j.pneurobio.2012.06.004; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Diomede L, 2014, NEUROBIOL DIS, V62, P521, DOI 10.1016/j.nbd.2013.10.024; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Fawzi NL, 2008, J AM CHEM SOC, V130, P6145, DOI 10.1021/ja710366c; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Giaccone G, 2010, ACTA NEUROPATHOL, V120, P803, DOI 10.1007/s00401-010-0747-1; Gobbi M, 2006, J BIOL CHEM, V281, P843, DOI 10.1074/jbc.M506164200; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hanson R.J., 1995, SOLVING LEAST SQUARE, V15; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; LAGO P, 1993, REV SCI INSTRUM, V64, P1797, DOI 10.1063/1.1144013; Lam AR, 2008, J AM CHEM SOC, V130, P17413, DOI 10.1021/ja804984h; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lee C, 2011, J COMPUT CHEM, V32, P349, DOI 10.1002/jcc.21628; LeVine H, 2002, ARCH BIOCHEM BIOPHYS, V404, P106; Lindner P., 2002, NEUTRONS XRAYS LIGHT, P391; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; Manzoni C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024909; Manzoni C, 2009, AMYLOID, V16, P71, DOI 10.1080/13506120902879848; Mayeux R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006239; Munz M, 2013, APPL SURF SCI, V279, P300, DOI 10.1016/j.apsusc.2013.04.089; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Scheidt HA, 2012, J BIOL CHEM, V287, P2017, DOI 10.1074/jbc.M111.308619; Sclip A, 2013, J MOL CELL BIOL, V5, P277, DOI 10.1093/jmcb/mjt015; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Stravalaci M, 2012, J BIOL CHEM, V287, P27796, DOI 10.1074/jbc.M111.334979; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Tai LM, 2013, J BIOL CHEM, V288, P5914, DOI 10.1074/jbc.M112.442103; Taniguchi A, 2009, CHEMBIOCHEM, V10, P710, DOI 10.1002/cbic.200800765; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552	53	48	48	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24143	24152		10.1074/jbc.M114.576256	http://dx.doi.org/10.1074/jbc.M114.576256			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25037228	Green Published, hybrid			2022-12-25	WOS:000341505600013
J	Rhein, VF; Carroll, J; He, JY; Ding, SJ; Fearnley, IM; Walker, JE				Rhein, Virginie F.; Carroll, Joe; He, Jiuya; Ding, Shujing; Fearnley, Ian M.; Walker, John E.			Human METTL20 Methylates Lysine Residues Adjacent to the Recognition Loop of the Electron Transfer Flavoprotein in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transport System (ETS); Flavoprotein; Mitochondrial Metabolism; Protein Methylation; Electron Transfer Flavoprotein; Methyltransferase; Trimethyllysine	CULTURED HUMAN-FIBROBLASTS; AMINO-ACID-SEQUENCE; COMPLEX-I; POSTTRANSLATIONAL MODIFICATIONS; UBIQUINONE OXIDOREDUCTASE; PEPTIDE IDENTIFICATION; HISTONE DEMETHYLATION; TRANSFER DISSOCIATION; S-ADENOSYLMETHIONINE; ATP SYNTHASE	Background: The electron transfer flavoprotein (ETF) is a mobile electron carrier coupling mitochondrial fatty acid oxidation to respiration. Results: METTL20 is a mitochondrial lysine protein methylase that modifies Lys-199 and -202 of the electron transfer flavoprotein -subunit. Conclusion: METTL20 is a protein methylase in mitochondria that influences protein-protein interactions with ETF. Significance: Mitochondria contain lysine methyltransferase METTL20. In mammalian mitochondria, protein methylation is a relatively uncommon post-transcriptional modification, and the extent of the mitochondrial protein methylome, the modifying methyltransferases, and their substrates have been little studied. As shown here, the -subunit of the electron transfer flavoprotein (ETF) is one such methylated protein. The ETF is a heterodimer of - and -subunits. Lysine residues 199 and 202 of mature ETF are almost completely trimethylated in bovine heart mitochondria, whereas ETF is not methylated. The enzyme responsible for the modifications was identified as methyltransferase-like protein 20 (METTL20). In human 143B cells, the methylation of ETF is less extensive and is diminished further by suppression of METTL20. Tagged METTL20 expressed in HEK293T cells specifically associates with the ETF and promotes the trimethylation of ETF lysine residues 199 and 202. ETF serves as a mobile electron carrier linking dehydrogenases involved in fatty acid oxidation and one-carbon metabolism to the membrane-associated ubiquinone pool. The methylated residues in ETF are immediately adjacent to a protein loop that recognizes and binds to the dehydrogenases. Suppression of trimethylation of ETF in mouse C2C12 cells oxidizing palmitate as an energy source reduced the consumption of oxygen by the cells. These experiments suggest that the oxidation of fatty acids in mitochondria and the passage of electrons via the ETF may be controlled by modulating the protein-protein interactions between the reduced dehydrogenases and the -subunit of the ETF by trimethylation of lysine residues. METTL20 is the first lysine methyltransferase to be found to be associated with mitochondria.	[Rhein, Virginie F.; Carroll, Joe; He, Jiuya; Ding, Shujing; Fearnley, Ian M.; Walker, John E.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Walker, JE (corresponding author), MRC, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.	walker@mrc-mbu.cam.ac.uk		Walker, John/0000-0001-7929-2162	Medical Research Council (MRC), UK; MRC; Swiss National Funds [PBBSP3-130953]; Swiss Novartis Foundation; MRC [MC_U105663148] Funding Source: UKRI; Medical Research Council [MC_U105663148] Funding Source: researchfish	Medical Research Council (MRC), UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Funds(Swiss National Science Foundation (SNSF)); Swiss Novartis Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (MRC), UK.; Recipient of an MRC Career Development Fellowship and fellowships from the Swiss National Funds (Stipendium PBBSP3-130953) and the Swiss Novartis Foundation.	AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P894; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; BLOXHAM DP, 1982, BIOCHEMISTRY-US, V21, P2028, DOI 10.1021/bi00538a009; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Carroll J, 2005, MOL CELL PROTEOMICS, V4, P693, DOI 10.1074/mcp.M500014-MCP200; Carroll J, 2013, J BIOL CHEM, V288, P24799, DOI 10.1074/jbc.M113.488106; Carroll J, 2009, ANAL BIOCHEM, V395, P249, DOI 10.1016/j.ab.2009.08.006; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Clarke S, 1993, CURR OPIN CELL BIOL, V5, P977, DOI 10.1016/0955-0674(93)90080-A; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Curcoy A, 2003, MOL GENET METAB, V78, P247, DOI 10.1016/S1096-7192(03)00024-6; DELANGE RJ, 1969, J BIOL CHEM, V244, P1385; Erce MA, 2012, PROTEOMICS, V12, P564, DOI 10.1002/pmic.201100397; FRERMAN FE, 1985, P NATL ACAD SCI USA, V82, P4517, DOI 10.1073/pnas.82.13.4517; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; GORELICK RJ, 1982, BIOCHEMISTRY-US, V21, P6936, DOI 10.1021/bi00269a049; Grillo MA, 2005, AMINO ACIDS, V28, P357, DOI 10.1007/s00726-005-0197-6; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; He MA, 2011, MOL GENET METAB, V102, P418, DOI 10.1016/j.ymgme.2010.12.005; Henriques BJ, 2010, BBA-MOL BASIS DIS, V1802, P1070, DOI 10.1016/j.bbadis.2010.07.015; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; IKEDA Y, 1986, J CLIN INVEST, V78, P997, DOI 10.1172/JCI112691; Ishizawa T, 2008, BIOCHEM BIOPH RES CO, V373, P99, DOI 10.1016/j.bbrc.2008.05.176; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; LUNDSTROM K, 1991, DNA CELL BIOL, V10, P181, DOI 10.1089/dna.1991.10.181; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MCKEAN MC, 1983, J BIOL CHEM, V258, P1866; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Rhein VF, 2013, J BIOL CHEM, V288, P33016, DOI 10.1074/jbc.M113.518803; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; SATO K, 1993, J BIOCHEM, V114, P215, DOI 10.1093/oxfordjournals.jbchem.a124157; Schrodinger L., 2020, PYMOL; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; STEENKAMP DJ, 1988, BIOCHEM J, V255, P869, DOI 10.1042/bj2550869; STEENKAMP DJ, 1982, BIOCHEM J, V203, P707, DOI 10.1042/bj2030707; Sun RX, 2010, J PROTEOME RES, V9, P6354, DOI 10.1021/pr100648r; Swaney DL, 2007, ANAL CHEM, V79, P477, DOI 10.1021/ac061457f; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409	65	43	49	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24640	24651		10.1074/jbc.M114.580464	http://dx.doi.org/10.1074/jbc.M114.580464			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023281	Green Published, hybrid			2022-12-25	WOS:000341505600054
J	Shan, JX; Balasubramanian, MN; Donelan, W; Fu, LC; Hayner, J; Lopez, MC; Baker, HV; Kilberg, MS				Shan, Jixiu; Balasubramanian, Mukundh N.; Donelan, William; Fu, Lingchen; Hayner, Jaclyn; Lopez, Maria-Cecilia; Baker, Henry V.; Kilberg, Michael S.			A Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (MEK)-dependent Transcriptional Program Controls Activation of the Early Growth Response 1 (EGR1) Gene during Amino Acid Limitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Gene Transcription; Hepatocellular Carcinoma; Mitogen-activated Protein Kinase (MAPK); Transcription; ATF4; HepG2 Cells; Amino Acid Response; Asparagine Synthetase	HEPATOCELLULAR-CARCINOMA; COMPOSITE SITE; CELL-SURVIVAL; DEPRIVATION; EXPRESSION; BINDING; ATF4; PHOSPHORYLATION; TRANSLATION; INDUCTION	Background: Increased transcription by mammalian amino acid response (AAR) has been linked primarily to the GCN2/eIF2/ATF4 pathway. Results: Some cells contain a GCN2- and ATF4-independent AAR pathway that is MEK-dependent. Conclusion: A novel MEK pathway activates a specific subset of AA-responsive genes. Significance: The mammalian AAR network is more complex than previously thought, extending beyond the GCN2/eIF2/ATF4 pathway. Amino acid (AA) limitation in mammalian cells triggers a collection of signaling cascades jointly referred to as the AA response (AAR). In human HepG2 hepatocellular carcinoma, the early growth response 1 (EGR1) gene was induced by either AA deprivation or endoplasmic reticulum stress. AAR-dependent EGR1 activation was discovered to be independent of the well characterized GCN2-ATF4 pathway and instead dependent on MEK-ERK signaling, one of the MAPK pathways. ChIP showed that constitutively bound ELK1 at the EGR1 proximal promoter region was phosphorylated after AAR activation. Increased p-ELK1 binding was associated with increased de novo recruitment of RNA polymerase II to the EGR1 promoter. EGR1 transcription was not induced in HEK293T cells lacking endogenous MEK activity, but overexpression of exogenous constitutively active MEK in HEK293T cells resulted in increased basal and AAR-induced EGR1 expression. ChIP analysis of the human vascular endothelial growth factor A (VEGF-A) gene, a known EGR1-responsive gene, revealed moderate increases in AAR-induced EGR1 binding within the proximal promoter and highly inducible binding to a site within the first intron. Collectively, these data document a novel AA-activated MEK-ERK-ELK1 signaling mechanism.	[Shan, Jixiu; Balasubramanian, Mukundh N.; Donelan, William; Fu, Lingchen; Hayner, Jaclyn; Kilberg, Michael S.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr, Gainesville, FL 32610 USA; [Shan, Jixiu; Balasubramanian, Mukundh N.; Donelan, William; Fu, Lingchen; Hayner, Jaclyn; Kilberg, Michael S.] Univ Florida, Coll Med, Ctr Nutr Sci, Gainesville, FL 32610 USA; [Lopez, Maria-Cecilia; Baker, Henry V.] Univ Florida, Coll Med, Genet Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kilberg, MS (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Box 100245, Gainesville, FL 32610 USA.	mkilberg@ufl.edu	Lopez, Maria/HHC-3659-2022	Baker, Henry/0000-0002-8273-5320; Donelan, William/0000-0001-7742-8089	National Institutes of Health [DK92062, DK94729]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092062, R01DK094729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK92062 and DK94729 (to M. S. K.).	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; Bunpo P, 2010, J NUTR, V140, P2020, DOI 10.3945/jn.110.129197; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; Chaveroux C, 2010, BIOCHIMIE, V92, P736, DOI 10.1016/j.biochi.2010.02.020; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; Chen CC, 2004, J CELL BIOCHEM, V93, P1063, DOI 10.1002/jcb.20257; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Cheng AL, 2012, EUR J CANCER, V48, P1452, DOI 10.1016/j.ejca.2011.12.006; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; DeZwaan-McCabe D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003937; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fu LC, 2013, PHYSIOL GENOMICS, V45, P127, DOI 10.1152/physiolgenomics.00160.2012; Fu LC, 2011, J BIOL CHEM, V286, P36724, DOI 10.1074/jbc.M111.277673; Gjymishka A, 2008, J BIOL CHEM, V283, P27736, DOI 10.1074/jbc.M803781200; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Kilberg MS, 2012, ADV NUTR, V3, P295, DOI 10.3945/an.112.001891; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kimball S. R., 2005, NUTR SIGNALING MAMMA; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Lee KH, 2009, CLIN EXP METASTAS, V26, P685, DOI 10.1007/s10585-009-9266-7; Liao YJ, 2004, J BIOL CHEM, V279, P43107, DOI 10.1074/jbc.M407969200; Liu LP, 2010, CANCER INVEST, V28, P443, DOI 10.3109/07357900903405959; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Odrowaz Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002694; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ozen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042717; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Peng W, 2012, SCI TRANSL MED, V4; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Scrable H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003738; Shan JX, 2012, J BIOL CHEM, V287, P36393, DOI 10.1074/jbc.M112.399600; Shan JX, 2010, PHYSIOL GENOMICS, V41, P315, DOI 10.1152/physiolgenomics.00217.2009; Shan JX, 2009, J BIOL CHEM, V284, P21241, DOI 10.1074/jbc.M109.011338; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Thiaville MM, 2008, J BIOL CHEM, V283, P10848, DOI 10.1074/jbc.M708320200; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	52	24	24	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24665	24679		10.1074/jbc.M114.565028	http://dx.doi.org/10.1074/jbc.M114.565028			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25028509	hybrid, Green Published			2022-12-25	WOS:000341505600056
J	Alegana, VA; Wright, JA; Nahzat, SM; Butt, W; Sediqi, AW; Habib, N; Snow, RW; Atkinson, PM; Noor, AM				Alegana, Victor A.; Wright, Jim A.; Nahzat, Sami M.; Butt, Waqar; Sediqi, Amad W.; Habib, Naeem; Snow, Robert W.; Atkinson, Peter M.; Noor, Abdisalan M.			Modelling the Incidence of Plasmodium vivax and Plasmodium falciparum Malaria in Afghanistan 2006-2009	PLOS ONE			English	Article							SPACE; TIME; DETERMINANTS; TRANSMISSION; REGRESSION; PROGRESS	Identifying areas that support high malaria risks and where populations lack access to health care is central to reducing the burden in Afghanistan. This study investigated the incidence of Plasmodium vivax and Plasmodium falciparum using routine data to help focus malaria interventions. Methods: To estimate incidence, the study modelled utilisation of the public health sector using fever treatment data from the 2012 national Malaria Indicator Survey. A probabilistic measure of attendance was applied to population density metrics to define the proportion of the population within catchment of a public health facility. Malaria data were used in a Bayesian spatio-temporal conditional-autoregressive model with ecological or environmental covariates, to examine the spatial and temporal variation of incidence. Findings: From the analysis of healthcare utilisation, over 80% of the population was within 2 hours' travel of the nearest public health facility, while 64.4% were within 30 minutes' travel. The mean incidence of P. vivax in 2009 was 5.4 (95% Crl 3.2-9.2) cases per 1000 population compared to 1.2 (95% Crl 0.4-2.9) cases per 1000 population for P. falciparum. P. vivax peaked in August while P. falciparum peaked in November. 32% of the estimated 30.5 million people lived in regions where annual incidence was at least 1 case per 1,000 population of P. vivax; 23.7% of the population lived in areas where annual P. falciparum case incidence was at least 1 per 1000. Conclusion: This study showed how routine data can be combined with household survey data to model malaria incidence. The incidence of both P. vivax and P. falciparum in Afghanistan remain low but the co-distribution of both parasites and the lag in their peak season provides challenges to malaria control in Afghanistan. Future improved case definition to determine levels of imported risks may be useful for the elimination ambitions in Afghanistan.	[Alegana, Victor A.; Snow, Robert W.; Noor, Abdisalan M.] KEMRI Wellcome Trust, Dept Publ Hlth, Spatial Hlth Metr Grp, Nairobi, Kenya; [Alegana, Victor A.; Wright, Jim A.; Atkinson, Peter M.] Univ Southampton, Ctr Geog Hlth Res Geog & Environm, Highfield Southampton, England; [Nahzat, Sami M.; Sediqi, Amad W.] Minist Publ Hlth, Natl Malaria & Leishmaniasis Control Programme, Kabul, Afghanistan; [Butt, Waqar; Habib, Naeem] WHO Off, Kabul, Afghanistan; [Snow, Robert W.; Noor, Abdisalan M.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	University of Southampton; University of Oxford	Alegana, VA (corresponding author), KEMRI Wellcome Trust, Dept Publ Hlth, Spatial Hlth Metr Grp, Nairobi, Kenya.	valegana@kemri-wellcome.org; anoor@kemri-wellcome.org	Alegana, Victor/P-6579-2019; Wright, Jim/C-7881-2013; Snow, Robert William/AFR-1436-2022	Alegana, Victor/0000-0001-5177-9227; Wright, Jim/0000-0002-8842-2181; Snow, Robert William/0000-0003-3725-6088; Atkinson, Peter/0000-0002-5489-6880	Commonwealth fellowship [KECS-2012-601]; Wellcome Trust as an Intermediate Research Fellow [095127]; Wellcome Trust as Principal Research Fellow [079080]; Wellcome Trust Major Overseas Programme grant to the KEMRI/Wellcome Trust Research Programme [092654]	Commonwealth fellowship; Wellcome Trust as an Intermediate Research Fellow(Wellcome Trust); Wellcome Trust as Principal Research Fellow(Wellcome Trust); Wellcome Trust Major Overseas Programme grant to the KEMRI/Wellcome Trust Research Programme(Wellcome Trust)	VAA is supported by a Commonwealth fellowship (KECS-2012-601). AMN is supported by the Wellcome Trust as an Intermediate Research Fellow (#095127). RWS is supported by the Wellcome Trust as Principal Research Fellow (#079080). This work was partly funded by a Wellcome Trust Major Overseas Programme grant to the KEMRI/Wellcome Trust Research Programme (#092654). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegana VA, 2013, SPAT SPATIO-TEMPORAL, V7, P25, DOI 10.1016/j.sste.2013.09.001; Alegana VA, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-6; [Anonymous], J STAT PLANNING INFE; [Anonymous], NAT HLTH MAN INF SYS; [Anonymous], NAT MAL TREATM GUID; [Anonymous], GLOB PUBLIC HLTH; [Anonymous], 2003, BAS PACK HLTH SERV A; [Anonymous], 2008, BESTGLM BEST SUBSET; [Anonymous], 2013, J INFECT DIS; [Anonymous], GUID MAL IND SURV MI; [Anonymous], CHALLENGES OPTIONS; [Anonymous], MAL IND SURV; [Anonymous], AFGHANISTAN ANN MALA; [Anonymous], AFGH RES EV UN BRIEF; [Anonymous], COUNTR PROF; [Anonymous], 2010, BAS PACK HLTH SERV A; [Anonymous], 2009, MAL RAP DIAGN TEST P; [Anonymous], 1998, HUMAN DEV REPORT; [Anonymous], 2011, AFGH MORT SURV 2010; [Anonymous], NAT MAL STRAT PLAN 2; [Anonymous], 2 MAL IND SURV ISL R; [Anonymous], 2010, GUID TREATM MAL; Brooker S, 2006, EMERG INFECT DIS, V12, P1600, DOI 10.3201/eid1210.060051; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Cibulskis RE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001142; Dao NVH, 2007, T ROY SOC TROP MED H, V101, P534, DOI 10.1016/j.trstmh.2007.01.003; DELFINI LF, 1989, T ROY SOC TROP MED H, V83, P316, DOI 10.1016/0035-9203(89)90486-0; Douglas NM, 2011, CLIN INFECT DIS, V52, P612, DOI 10.1093/cid/ciq249; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; DY F J, 1954, Bull World Health Organ, V11, P725; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gaughan AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055882; Gething PW, 2006, PLOS MED, V3, P825, DOI 10.1371/journal.pmed.0030271; Ghosh SK, 2006, J STAT PLAN INFER, V136, P1360, DOI 10.1016/j.jspi.2004.10.008; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Kolaczinski J, 2005, LANCET, V365, P1506, DOI 10.1016/S0140-6736(05)66423-9; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Manh BH, 2011, INT J PARASITOL, V41, P109, DOI 10.1016/j.ijpara.2010.08.005; Nateghpour M, 2011, Bull Soc Pathol Exot, V104, P321, DOI 10.1007/s13149-011-0134-8; Neelon BH, 2010, STAT MODEL, V10, P421, DOI 10.1177/1471082X0901000404; RAMACHANDRA T, 1951, Bull World Health Organ, V3, P639; Rowland M, 1997, T ROY SOC TROP MED H, V91, P252, DOI 10.1016/S0035-9203(97)90065-1; Rowland M, 2002, T ROY SOC TROP MED H, V96, P620, DOI 10.1016/S0035-9203(02)90331-7; Sahu SK, 2012, APPL STOCH MODEL BUS, V28, P395, DOI 10.1002/asmb.1951; Shah I, 1997, ANN TROP MED PARASIT, V91, P591, DOI 10.1080/00034989760680; Sinclair D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008492.pub2; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Steinhardt LC, 2011, HEALTH POLICY PLANN, V26, pII92, DOI 10.1093/heapol/czr069; Tatem AJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-52; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1; World Health Organization, 2007, MAL EL FIELD MAN LOW	53	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102304	10.1371/journal.pone.0102304	http://dx.doi.org/10.1371/journal.pone.0102304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033452	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300046
J	Ding, XC; Zhou, N; Lin, H; Chen, JJ; Zhao, CY; Zhou, GK; Hejtmancik, JF; Qi, YH				Ding, Xuchen; Zhou, Nan; Lin, Hui; Chen, Jianjun; Zhao, Chunyuan; Zhou, Guangkai; Hejtmancik, J. Fielding; Qi, Yanhua			A Novel MIP Gene Mutation Analysis in a Chinese Family Affected with Congenital Progressive Punctate Cataract	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT CATARACT; MAJOR INTRINSIC PROTEIN; SPLICE-SITE MUTATION; NUCLEAR CATARACT; NONSENSE MUTATION; MISSENSE MUTATION; LAMELLAR; LENS; IDENTIFICATION; UNDERLIES	Congenital cataracts are one of the leading causes of visual impairment and blindness in children, and genetic factors play an important role in their development. This study aimed to identify the genetic defects associated with autosomal dominant congenital progressive punctate cataracts in a Chinese family and to explore the potential pathogenesis. Detailed family history and clinical data were recorded, and all the family members' blood samples were collected for DNA extraction. Linkage analysis was performed by microsatellite markers that are associated with punctate cataracts, and logarithm (base 10) of odds (LOD) scores were calculated using the LINKAGE program. Positive two-point LOD scores were obtained at markers D12S1622 (Z(max) = 2.71 at theta = 0.0), D12S1724 (Z(max) = 2.71 at theta = 0.0), and D12S90 (Z(max) = 2.71 at theta = 0.0), which flank the major intrinsic protein of lens fiber (MIP) gene on chromosomal region 12q13. Direct sequencing of the encoding region of the MIP gene revealed a novel mutation (G>D) in exon 4 at nucleotide 644, which caused a substitution of glycine to aspartic acid at codon 215 (p.G215D) for the MIP protein. The mutation cosegregated with all patients with congenital progressive punctate cataracts, but it was absent in the healthy members. Bioinformatics analysis predicted that the mutation affects the function of the MIP protein. The wild type (WT) and G215D mutant of MIP were transfected with green fluorescent protein (GFP) into Hela cells separately, and it was found that the G215D mutant was aberrantly located in the cytoplasm instead of in the plasma membrane. In summary, our study presented genetic and functional evidence linking the new MIP mutation of G215D to autosomal dominant congenital cataracts, which adds to the list of MIP mutations linked to congenital progressive punctate cataracts.	[Ding, Xuchen; Zhou, Nan; Lin, Hui; Zhao, Chunyuan; Zhou, Guangkai; Qi, Yanhua] Harbin Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Harbin, Peoples R China; [Chen, Jianjun] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Ophthalmol, Shanghai 200092, Peoples R China; [Chen, Jianjun] Tongji Univ, Sch Med, Tongji Eye Inst, Shanghai 200092, Peoples R China; [Chen, Jianjun; Hejtmancik, J. Fielding] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA	Harbin Medical University; Tongji University; Tongji University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Qi, YH (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Harbin, Peoples R China.	qi_yanhua@yahoo.com	chen, jianjun/AAG-7572-2019		National Natural Science Foundation of China [81341026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [grant number 81341026]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCALA J, 1975, EXP EYE RES, V21, P581, DOI 10.1016/0014-4835(75)90040-8; Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; Berry V, 2011, MOL VIS, V17, P1249; Billingsley G, 2006, AM J HUM GENET, V79, P702, DOI 10.1086/507712; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Chen Q, 2009, MOL VIS, V15, P1359; Conley YP, 2000, AM J HUM GENET, V66, P1426, DOI 10.1086/302871; Gonen T, 2004, J MOL BIOL, V342, P1337, DOI 10.1016/j.jmb.2004.07.076; Gu F, 2007, MOL VIS, V13, P1651; Hansen L, 2007, MOL VIS, V13, P2019; Jamieson RV, 2007, HUM MUTAT, V28, P968, DOI 10.1002/humu.20545; Jiang J, 2009, MOL VIS, V15, P38; Kumar GS, 2013, EXP EYE RES, V110, P136, DOI 10.1016/j.exer.2012.10.010; Kumari SS, 2009, BIOCHEM BIOPH RES CO, V390, P1034, DOI 10.1016/j.bbrc.2009.10.103; Li FF, 2008, MOL VIS, V14, P750; Li XQ, 2012, HUM MUTAT, V33, P391, DOI 10.1002/humu.21648; Lin H, 2007, MOL VIS, V13, P1822; Mackay DS, 2002, AM J HUM GENET, V71, P1216, DOI 10.1086/344212; Pras E, 2002, AM J HUM GENET, V70, P1363, DOI 10.1086/340318; Qi YH, 2004, HUM GENET, V114, P192, DOI 10.1007/s00439-003-1049-7; Ramachandran RD, 2007, HUM GENET, V121, P475, DOI 10.1007/s00439-006-0319-6; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Shiels A, 2007, AM J HUM GENET, V81, P596, DOI 10.1086/519980; Sindhu Kumari S, 2014, BIOCH BIOPHYS ACTA; Su DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059926; Su DM, 2012, MOL VIS, V18, P3057; Sun H, 2005, J MED GENET, V42, P706, DOI 10.1136/jmg.2004.028274; Vanita V, 2002, MOL CELL BIOCHEM, V368, P167; Varadaraj K, 2008, EXP EYE RES, V87, P9, DOI 10.1016/j.exer.2008.04.001; Wang KJ, 2011, MOL VIS, V17, P70; Watanabe K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050737; Weisschuh N, 2012, MOL VIS, V18, P174; Xiao Xueshan, 2011, Mol Vis, V17, P2049; Yang GX, 2011, MOL VIS, V17, P1320; Yu LC, 2001, BLOOD, V98, P3840, DOI 10.1182/blood.V98.13.3840; Yu YB, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-6; Zeng L, 2013, MOL VIS, V19, P2244; Zhou DA, 2013, MOL VIS, V19, P789	38	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102733	10.1371/journal.pone.0102733	http://dx.doi.org/10.1371/journal.pone.0102733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033405	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300085
J	Kaneko, A; Sankai, Y				Kaneko, Ai; Sankai, Yoshiyuki			Long-Term Culture of Rat Hippocampal Neurons at Low Density in Serum-Free Medium: Combination of the Sandwich Culture Technique with the Three-Dimensional Nanofibrous Hydrogel PuraMatrix	PLOS ONE			English	Article							DISPERSED CELL-CULTURE; IN-VITRO; CEREBRAL METABOLISM; SURVIVAL; 2-MERCAPTOETHANOL; DIFFERENTIATION; NEUROTOXICITY; ADVANTAGES; GROWTH	The primary culture of neuronal cells plays an important role in neuroscience. There has long been a need for methods enabling the long-term culture of primary neurons at low density, in defined serum-free medium. However, the lower the cell density, the more difficult it is to maintain the cells in culture. Therefore, we aimed to develop a method for long-term culture of neurons at low density, in serum-free medium, without the need for a glial feeder layer. Here, we describe the work leading to our determination of a protocol for long-term (>2 months) primary culture of rat hippocampal neurons in serum-free medium at the low density of 3x10(4) cells/mL (8.9x10(3) cells/cm(2)) without a glial feeder layer. Neurons were cultured on a three-dimensional nanofibrous hydrogel, PuraMatrix, and sandwiched under a coverslip to reproduce the in vivo environment, including the three-dimensional extracellular matrix, low-oxygen conditions, and exposure to concentrated paracrine factors. We examined the effects of varying PuraMatrix concentrations, the timing and presence or absence of a coverslip, the timing of neuronal isolation from embryos, cell density at plating, medium components, and changing the medium or not on parameters such as developmental pattern, cell viability, neuronal ratio, and neurite length. Using our method of combining the sandwich culture technique with PuraMatrix in Neurobasal medium/B27/L-glutamine for primary neuron culture, we achieved longer neurites (>= 3,000 mm), greater cell viability (>= 30%) for 2 months, and uniform culture across the wells. We also achieved an average neuronal ratio of 97%, showing a nearly pure culture of neurons without astrocytes. Our method is considerably better than techniques for the primary culture of neurons, and eliminates the need for a glial feeder layer. It also exhibits continued support for axonal elongation and synaptic activity for long periods (>6 weeks).	[Kaneko, Ai; Sankai, Yoshiyuki] Univ Tsukuba, Ctr Cybern Res, Tsukuba, Ibaraki, Japan	University of Tsukuba	Kaneko, A (corresponding author), Univ Tsukuba, Ctr Cybern Res, Tsukuba, Ibaraki, Japan.	kaneko@ccr.tsukuba.ac.jp			Center for Cybernics Research (CCR) - World Leading Human-Assistive Technology Supporting a Long-Lived and Healthy Society; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)	Center for Cybernics Research (CCR) - World Leading Human-Assistive Technology Supporting a Long-Lived and Healthy Society; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Center for Cybernics Research (CCR) - World Leading Human-Assistive Technology Supporting a Long-Lived and Healthy Society granted by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program, http://www.jsps.go.jp/english/e-first/first_reinforcement.html) initiated by the Council for Science and Technology Policy (CSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKER G, 1998, CULTURING NERVE CELL; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Brewer G.J., 1994, FOCUS, V16, P6; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Cook A, 2010, J BIOL CHEM, V285, P10563, DOI 10.1074/jbc.M109.035477; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Goslin K., 1998, CULTURING NERVE CELL, P339; GRILL RJ, 1993, BRAIN RES, V613, P168, DOI 10.1016/0006-8993(93)90470-8; GULATI SC, 1980, ACTA NEUROCHIR, V53, P39, DOI 10.1007/BF02074519; Hansen MB, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00031; HARRIS WA, 1985, J NEUROSCI RES, V13, P101, DOI 10.1002/jnr.490130108; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; ISHII K, 1993, NEUROSCI LETT, V163, P159, DOI 10.1016/0304-3940(93)90371-Q; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Khan MZ, 2005, MOL CELL NEUROSCI, V30, P58, DOI 10.1016/j.mcn.2005.05.007; LaPlaca MC, 2010, ARTECH HSE METH BIOE, P187; LUCIUS R, 1995, ANN ANAT, V177, P447, DOI 10.1016/S0940-9602(11)80152-4; Meucci O, 1996, J NEUROSCI, V16, P4080; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Sango K, 2003, EXP NEUROL, V182, P1, DOI 10.1016/S0014-4886(03)00090-6; SCHERER J, 1995, DEV BRAIN RES, V89, P214, DOI 10.1016/0165-3806(95)00128-Z; Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997; Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046; ZUPPING R, 1972, J NEUROSURG, V36, P451, DOI 10.3171/jns.1972.36.4.0451	29	27	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102703	10.1371/journal.pone.0102703	http://dx.doi.org/10.1371/journal.pone.0102703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032834	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300080
J	Essone, PN; Chegou, NN; Loxton, AG; Stanley, K; Kriel, M; van der Spuy, G; Franken, KL; Ottenhoff, TH; Walzl, G				Essone, Paulin N.; Chegou, Novel N.; Loxton, Andre G.; Stanley, Kim; Kriel, Magdalena; van der Spuy, Gian; Franken, Kees L.; Ottenhoff, Tom H.; Walzl, Gerhard			Host Cytokine Responses Induced after Overnight Stimulation with Novel M-tuberculosis Infection Phase-Dependent Antigens Show Promise as Diagnostic Candidates for TB Disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PULMONARY TUBERCULOSIS; SERUM; BIOMARKER; URINE; ASSAY; DOSR; HIV	Background: We previously identified Mycobacterium tuberculosis (M.tb) antigen-induced host markers that showed promise as TB diagnostic candidates in 7-day whole blood culture supernatants. The aim of the present study was to evaluate the utility of these markers further, and cross-compare results with short-term antigen stimulated and unstimulated culture supernatants. Methods: We recruited 15 culture confirmed TB cases and 15 non-TB cases from a high-TB endemic community in Cape Town, South Africa into a pilot case-control study from an on-going larger study. Blood samples collected from study participants were stimulated with 4 M.tb antigens that were previously identified as promising (ESAT6/CFP10 (early secreted), Rv2029c (latency), Rv2032 (latency) and Rv2389c (rpf)) in a 7-day or overnight culture assay. Supernatants were also collected form the standard QuantiFERON In Tube (QFT-IT) test. The levels of 26 host markers were evaluated in the three culture supernatants using the Luminex platform. Results: The unstimulated levels of CRP, Serum amyloid P (SAP) and serum amyloid A (SAA) and ESAT-6/CFP-10 specific IP-10 and SAA were amongst the best discriminatory markers in all 3 assays, ascertaining TB with AUC of 72-84%. Four-marker models accurately classified up to 92%, 100% and 100% of study participants in the overnight, 7-day and Quantiferon culture supernatants, respectively, after leave-one-out cross validation. Conclusion: Unstimulated and antigen-specific levels of CRP, SAA, IP-10, MMP-2 and sCD40L hold promise as diagnostic candidates for TB disease in short-term stimulation assays. Larger studies are required to validate these findings but the data suggest that antigen-specific cytokine production and in particular mutimarker biosignatures might contribute to future diagnostic strategies.	[Essone, Paulin N.; Chegou, Novel N.; Loxton, Andre G.; Stanley, Kim; Kriel, Magdalena; van der Spuy, Gian; Walzl, Gerhard] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet, Dept Biomed Sci,Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa; [Essone, Paulin N.; Chegou, Novel N.; Loxton, Andre G.; Stanley, Kim; Kriel, Magdalena; van der Spuy, Gian; Walzl, Gerhard] Univ Stellenbosch, MRC Ctr TB Res, Div Mol Biol & Human Genet, Dept Biomed Sci,Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa; [Franken, Kees L.; Ottenhoff, Tom H.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Walzl, G (corresponding author), Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet, Dept Biomed Sci,Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa.	gwalzl@sun.ac.za	Franken, Kees/ABA-7095-2021; van der Spuy, Gian/AAY-7701-2020; Walzl, Gerhard/N-6371-2016	Franken, Kees/0000-0002-4747-6060; van der Spuy, Gian/0000-0002-9067-5903; Walzl, Gerhard/0000-0003-2487-125X; Loxton, Andre/0000-0003-0659-9803; Chegou, Novel N/0000-0002-8690-1699	EDCTP [IP. 09.32040.011]; EC FP7 NEWTBVAC contract [HEALTH.F3.2009 241745]; EC FP7 EURIPRED contract [INFRASTRUCTURES.2012.1 312661]; EC FP7 VACTRAIN; "Agence nationale des bourses du Gabon''	EDCTP; EC FP7 NEWTBVAC contract; EC FP7 EURIPRED contract; EC FP7 VACTRAIN; "Agence nationale des bourses du Gabon''(French National Research Agency (ANR))	The authors acknowledge the EDCTP (grant IP. 09.32040.011), EC FP7 NEWTBVAC contract no. HEALTH.F3.2009 241745, EC FP7 EURIPRED contract no. INFRASTRUCTURES.2012.1 312661 and EC FP7 VACTRAIN (the text represents the authors' views and does not necessarily represent a position of the Commission who will not be liable for the use made of such information). Paulin Essone is funded by "Agence nationale des bourses du Gabon''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; Chegou NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064226; Chegou NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038501; Chegou NN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-10; Chegou NN, 2011, EXPERT REV ANTI-INFE, V9, P457, DOI [10.1586/eri.11.23, 10.1586/ERI.11.23]; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Commandeur S, 2011, CLIN VACCINE IMMUNOL, V18, P676, DOI 10.1128/CVI.00492-10; Corstjens PLAM, 2008, J CLIN MICROBIOL, V46, P171, DOI 10.1128/JCM.00877-07; Corstjens PLAM, 2007, ANN NY ACAD SCI, V1098, P437, DOI 10.1196/annals.1384.016; dos Anjos BL, 2010, CLIN CHEM LAB MED, V48, P493, DOI 10.1515/CCLM.2010.110; Dosanjh DPS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028754; Dowdy DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004057; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; Fujiwara H, 2011, J SURG ONCOL, V103, P62, DOI 10.1002/jso.21751; Kanoh Y, 2013, ONCOL REP, V29, P469, DOI 10.3892/or.2012.2123; Kashino SS, 2008, CLIN EXP IMMUNOL, V153, P56, DOI 10.1111/j.1365-2249.2008.03672.x; Kaufmann SHE, 2008, CELL HOST MICROBE, V4, P219, DOI 10.1016/j.chom.2008.08.002; Kirwan DE, 2012, AM J TROP MED HYG, V87, P197, DOI 10.4269/ajtmh.2012.12-0107; Lin MY, 2008, BIOL CHEM, V389, P497, DOI 10.1515/BC.2008.057; MAASILTA P, 1989, INFECTION, V17, P13, DOI 10.1007/BF01643491; Noh S, 2011, HEPATO-GASTROENTEROL, V58, P2015, DOI 10.5754/hge11209; Pai M, 2007, AM J RESP CRIT CARE, V175, P529, DOI 10.1164/rccm.200701-024ED; Phalane KG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/981984; Riano F, 2012, TUBERCULOSIS, V92, P148, DOI 10.1016/j.tube.2011.12.005; Safranek J, 2009, ANTICANCER RES, V29, P2513; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; Verweij KE, 2010, INT J TUBERC LUNG D, V14, P1127; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2011, US TUB INT GAMM REL; Wu X, 2008, J APPL MICROBIOL, V105, P1121, DOI 10.1111/j.1365-2672.2008.03850.x; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005	36	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102584	10.1371/journal.pone.0102584	http://dx.doi.org/10.1371/journal.pone.0102584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025278	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400090
J	Lawrence, BJ; Gasson, N; Kane, R; Bucks, RS; Loftus, AM				Lawrence, Blake J.; Gasson, Natalie; Kane, Robert; Bucks, Romola S.; Loftus, Andrea M.			Activities of Daily Living, Depression, and Quality of Life in Parkinson's Disease	PLOS ONE			English	Article							BRAZILIAN PATIENTS; DETERMINANTS; CRITIQUE; THERAPY; ANXIETY; SCALES	This study examined whether activities of daily living (ADL) mediate the relationship between depression and health-related quality of life (HR-QOL) in people with Parkinson's disease (PD). A cross-sectional, correlational research design examined data from 174 participants who completed the Geriatric Depression Scale (GDS-15), Parkinson's Disease Questionnaire-39 (PDQ-39), and Unified Parkinson's Disease Rating Scale-section 2 (UPDRS-section 2 [ADL]). Multiple Regression Analysis (MRA) was used to examine the mediator model. Depression and ADL significantly (p<.001) predicted HR-QOL, and depression significantly (p<.001) predicted ADL. Whilst ADL did not impact on the relationship between depression and HR-QOL, there was a significant (p<.001) indirect effect of depression on HR-QOL via ADL, suggesting both direct and indirect (via ADL) effects of depression on HR-QOL. The magnitude of this effect was moderate (R-2=.13). People with PD who report depression also experience greater difficulty completing ADL, which impacts upon their HR-QOL. It is recommended that clinicians adopt a multidisciplinary approach to care by combining pharmacological treatments with psycho/occupational therapy, thereby alleviating the heterogeneous impact of motor and non-motor symptoms on HR-QOL in people with PD.	[Lawrence, Blake J.; Gasson, Natalie; Kane, Robert; Loftus, Andrea M.] Curtin Univ, Sch Psychol & Speech Pathol, Curtin Neurosci Lab, Perth, WA 6845, Australia; [Gasson, Natalie; Bucks, Romola S.; Loftus, Andrea M.] Curtin Univ, Parkinsons Ctr ParkC, Perth, WA 6845, Australia; [Bucks, Romola S.] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia	Curtin University; Curtin University; University of Western Australia	Lawrence, BJ (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Curtin Neurosci Lab, Perth, WA 6845, Australia.	blake.lawrence@postgrad.curtin.edu.au	Bucks, Romola Starr/B-9164-2011; Lawrence, Blake/C-6069-2016	Bucks, Romola Starr/0000-0002-4207-4724; Lawrence, Blake/0000-0002-8772-8226; Gasson, Natalie/0000-0001-6265-9095; Loftus, Andrea/0000-0001-8782-7024	Australian Research Council; Edith Cowan University's Office of Research and Innovation; Parkinson's Association of WA; McCusker Charitable Foundation; Parkinson's Young Onset Support Group (WA); Royal Freshwater Bay Yacht Club	Australian Research Council(Australian Research Council); Edith Cowan University's Office of Research and Innovation; Parkinson's Association of WA; McCusker Charitable Foundation; Parkinson's Young Onset Support Group (WA); Royal Freshwater Bay Yacht Club	All funding for ParkC has been received from the Australian Research Council, Edith Cowan University's Office of Research and Innovation, Parkinson's Association of WA, The McCusker Charitable Foundation, Parkinson's Young Onset Support Group (WA) and the Royal Freshwater Bay Yacht Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Carod-Artal FJ, 2008, PARKINSONISM RELAT D, V14, P102, DOI 10.1016/j.parkreldis.2007.06.011; Carod-Artal FJ, 2007, MOVEMENT DISORD, V22, P1408, DOI 10.1002/mds.21408; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Dissanayaka NNW, 2011, J AFFECT DISORDERS, V132, P82, DOI 10.1016/j.jad.2011.01.021; Dobkin Roseanne DeFronzo, 2008, Expert Rev Neurother, V8, P27, DOI 10.1586/14737175.8.1.27; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Ishihara L, 2006, ACTA NEUROL SCAND, V113, P211, DOI 10.1111/j.1600-0404.2006.00579.x; Keus SHJ, 2007, MOVEMENT DISORD, V22, P451, DOI 10.1002/mds.21244; Kleiner-Fisman G, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-91; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Martinez-Martin P, 2003, MOVEMENT DISORD, V18, P985, DOI 10.1002/mds.10479; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P2371, DOI 10.1002/mds.23834; Meek C, 2010, BRIT J OCCUP THER, V73, P178, DOI 10.4276/030802210X12706313444027; Pagonabarraga J, 2010, ENCYCLOPEDIA OF MOVEMENT DISORDERS, VOL 2: H-P, P405; Papapetropoulos S, 2006, CLIN NEUROL NEUROSUR, V108, P465, DOI 10.1016/j.clineuro.2005.08.002; Peto V, 1998, J NEUROL, V245, pS10, DOI 10.1007/PL00007730; Piccinni A, 2012, COMPR PSYCHIAT, V53, P727, DOI 10.1016/j.comppsych.2011.11.002; Qin ZH, 2009, PARKINSONISM RELAT D, V15, P767, DOI 10.1016/j.parkreldis.2009.05.011; Quelhas R, 2009, J NEUROPSYCH CLIN N, V21, P413, DOI 10.1176/appi.neuropsych.21.4.413; Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Schrag A, 2006, J NEUROL SCI, V248, P151, DOI 10.1016/j.jns.2006.05.030; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; Wichowicz HM, 2006, EUR PSYCHIAT, V21, P516, DOI 10.1016/j.eurpsy.2006.01.012	30	48	49	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102294	10.1371/journal.pone.0102294	http://dx.doi.org/10.1371/journal.pone.0102294			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025280	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400061
J	Yanaka, S; Ueno, T; Shi, Y; Qi, JX; Gao, GF; Tsumoto, K; Sugase, K				Yanaka, Saeko; Ueno, Takamasa; Shi, Yi; Qi, Jianxun; Gao, George F.; Tsumoto, Kouhei; Sugase, Kenji			Peptide-dependent Conformational Fluctuation Determines the Stability of the Human Leukocyte Antigen Class I Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Major Histocompatibility Complex (MHC); Nuclear Magnetic Resonance (NMR); Protein Dynamic; Protein Stability; Thermodynamics	T-CELL-RECEPTOR; MHC CLASS-I; HLA CLASS-I; HEAT-CAPACITY; BINDING; MOLECULES; HLA-B27; HIV-1; HLA-B-ASTERISK-3501; POLYMORPHISM	Background: The stable presentation of HLA is necessary for effective T-cell activity in infectious diseases. Results: Conformational fluctuation analysis revealed a minor state of HLA. Conclusion: The minor state avoids the disintegration of HLA by tightly packing toward the peptide. The minor population correlates with the elongated presentation of HLA on the cell surface. Significance: We revealed the stabilization mechanism for HLA. In immune-mediated control of pathogens, human leukocyte antigen (HLA) class I presents various antigenic peptides to CD8(+) T-cells. Long-lived peptide presentation is important for efficient antigen-specific T-cell activation. Presentation time depends on the peptide sequence and the stability of the peptide-HLA complex (pHLA). However, the determinant of peptide-dependent pHLA stability remains elusive. Here, to reveal the pHLA stabilization mechanism, we examined the crystal structures of an HLA class I allomorph in complex with HIV-derived peptides and evaluated site-specific conformational fluctuations using NMR. Although the crystal structures of various pHLAs were almost identical independent of the peptides, fluctuation analyses identified a peptide-dependent minor state that would be more tightly packed toward the peptide. The minor population correlated well with the thermostability and cell surface presentation of pHLA, indicating that this newly identified minor state is important for stabilizing the pHLA and facilitating T-cell recognition.	[Yanaka, Saeko; Tsumoto, Kouhei] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 2778562, Japan; [Ueno, Takamasa] Kumamoto Univ, Ctr AIDS Res, Kumamoto 8600811, Japan; [Ueno, Takamasa] Kumamoto Univ, IRCMS, Kumamoto 8600811, Japan; [Shi, Yi; Qi, Jianxun; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100101, Peoples R China; [Shi, Yi; Qi, Jianxun; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Tsumoto, Kouhei] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo 1088693, Japan; [Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Med Prote Lab, Tokyo 1088693, Japan; [Sugase, Kenji] Suntory Fdn Life Sci, Bioorgan Res Inst, Osaka 6188503, Japan	University of Tokyo; Kumamoto University; Kumamoto University; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Tokyo; University of Tokyo; Suntory Holdings Ltd	Tsumoto, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 2778562, Japan.	tsumoto@k.u-tokyo.ac.jp; sugase@sunbor.or.jp	Sugase, Kenji/AAF-4552-2021; Gao, George Fu/ABD-5229-2021; Yanaka, Saeko/AAU-4487-2020; Ueno, Takamasa/AAW-9491-2020; Ueno, Takamasa/F-5788-2013; Qi, Jianxun/ABF-1646-2021; Sugase, Kenji/S-3132-2016; Yanaka, Saeko/AAW-5301-2020	Sugase, Kenji/0000-0001-8623-7743; Ueno, Takamasa/0000-0003-4852-4236; Ueno, Takamasa/0000-0003-4852-4236; Sugase, Kenji/0000-0001-8623-7743; Yanaka, Saeko/0000-0002-3513-5701	Japanese Society for the Promotion of Science [11J06193]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japanese Society for the Promotion of Science Research Grant 11J06193.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Archbold JK, 2006, J BIOL CHEM, V281, P34324, DOI 10.1074/jbc.M606755200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker BM, 2012, IMMUNOL REV, V250, P10, DOI 10.1111/j.1600-065X.2012.01165.x; Bowerman NA, 2009, MOL IMMUNOL, V46, P3000, DOI 10.1016/j.molimm.2009.06.012; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escobar H, 2008, J IMMUNOL, V181, P4874, DOI 10.4049/jimmunol.181.7.4874; Garbi N, 2005, IMMUNOL REV, V207, P77, DOI 10.1111/j.0105-2896.2005.00303.x; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Hawse WF, 2013, J BIOL CHEM, V288, P24372, DOI 10.1074/jbc.M113.490664; Hillig RC, 2004, J BIOL CHEM, V279, P652, DOI 10.1074/jbc.M307457200; Hourigan CS, 2006, EUR J IMMUNOL, V36, P3288, DOI 10.1002/eji.200636234; Hulsmeyer M, 2002, J BIOL CHEM, V277, P47844, DOI 10.1074/jbc.M206392200; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; Menssen R, 1999, J MOL BIOL, V285, P645, DOI 10.1006/jmbi.1998.2363; Miles JJ, 2005, J IMMUNOL, V175, P3826, DOI 10.4049/jimmunol.175.6.3826; Miles JJ, 2006, J IMMUNOL, V177, P6804, DOI 10.4049/jimmunol.177.10.6804; Motozono C, 2009, J IMMUNOL, V182, P5528, DOI 10.4049/jimmunol.0803471; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narzi D, 2012, J MOL BIOL, V415, P429, DOI 10.1016/j.jmb.2011.11.021; Oelke M, 2003, NAT MED, V9, P619, DOI 10.1038/nm869; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Probst-Kepper M, 2004, J IMMUNOL, V173, P5610, DOI 10.4049/jimmunol.173.9.5610; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Riquelme E, 2009, EUR J IMMUNOL, V39, P2259, DOI 10.1002/eji.200939341; SCHONBACH C, 1995, J IMMUNOL, V154, P5951; Shi Y, 2011, MOL IMMUNOL, V48, P2198, DOI 10.1016/j.molimm.2011.05.009; SILVER ML, 1991, NATURE, V350, P619, DOI 10.1038/350619a0; Singer DS, 1997, CRIT REV IMMUNOL, V17, P463; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; Streeck H, 2010, J INFECT DIS, V202, pS302, DOI 10.1086/655652; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sugase K, 2013, J BIOMOL NMR, V56, P275, DOI 10.1007/s10858-013-9747-5; Tam LS, 2010, NAT REV RHEUMATOL, V6, P399, DOI 10.1038/nrrheum.2010.79; Todd MJ, 2000, BIOCHEMISTRY-US, V39, P11876, DOI 10.1021/bi001013s; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2005, J EXP MED, V202, P1249, DOI 10.1084/jem.20050864; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Ueno T, 2007, J IMMUNOL, V178, P5513, DOI 10.4049/jimmunol.178.9.5513; Walpole NG, 2010, J MOL BIOL, V397, P467, DOI 10.1016/j.jmb.2010.01.052; Winkler K, 2007, BIOPHYS J, V93, P2743, DOI 10.1529/biophysj.106.096602	61	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24680	24690		10.1074/jbc.M114.566174	http://dx.doi.org/10.1074/jbc.M114.566174			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25028510	Green Published, hybrid			2022-12-25	WOS:000341505600057
J	Brahmbhatt, A; NievesTorres, E; Yang, BX; Edwards, WD; Chaudhury, PR; Lee, MK; Kong, H; Mukhopadhyay, D; Kumar, R; Misra, S				Brahmbhatt, Akshaar; NievesTorres, Evelyn; Yang, Binxia; Edwards, William D.; Chaudhury, Prabir Roy; Lee, Min Kyun; Kong, Hyunjoon; Mukhopadhyay, Debabrata; Kumar, Rajiv; Misra, Sanjay			The Role of Iex-1 in the Pathogenesis of Venous Neointimal Hyperplasia Associated with Hemodialysis Arteriovenous Fistula	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; EARLY RESPONSE GENE; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; HIGH-DOSE CALCITRIOL; B TARGET GENE; INCREASED EXPRESSION; OXIDATIVE STRESS; VASCULAR ACCESS; POLYTETRAFLUOROETHYLENE GRAFTS; MATRIX METALLOPROTEINASE-2	Arteriovenous fistulas (AVFs) used for hemodialysis fail because of venous neointimal hyperplasia (VNH). There are 1,500,000 patients that have end stage renal disease worldwide and the majority requires hemodialysis. In the present study, the role of the intermediate early response gene X-1 (IEX-1), also known as IER-3 in the pathogenesis of VNH was evaluated. In human samples removed from failed AVF, there was a significant increase in IEX-1 expression localized to the adventitia. In Iex-1(-/-) mice and wild type (WT) controls, chronic kidney disease was induced and an AVF placed 28 days later by connecting the carotid artery to jugular vein. The outflow vein was removed three days following the creation of the AVF and gene expression analysis demonstrated a significant decrease in vascular endothelial growth factor-A (Vegf-A) and monocyte chemoattractant protein-1 (Mcp-1) gene expression in Iex-1(-/-) mice when compared to WT mice (P<0.05). At 28 days after AVF placement, histomorphometric and immune-histochemical analyses of the outflow vein demonstrated a significant decrease in neointimal hyperplasia with an increase in average lumen vessel area associated with a decrease in fibroblast, myofibroblast, and Ly6C staining. There was a decrease in proliferation (Ki-67) and an increase in the TUNEL staining in Iex-1 KO mice compared to WT. In addition, there was a decrease in Vegf-A, Mcp-1, and matrix metalloproteiniase9 (Mmp-9) staining. Iex-1 expression was reduced in vivo and in vitro using nanoparticles coated with calcitriol, an inhibitor of Iex-1 that demonstrated that Iex-1 reduction results in decrease in Vegf-A. In aggregate, these results indicate that the absence of IEX-1 gene results in reduced VNH accompanied with a decrease in proliferation, reduced fibroblast, myofibroblast, and Ly6C staining accompanied with increased apoptosis mediated through a reduction in Vegf-A/Mcp-1 axis and Mmp-9. Adventitial delivery of nanoparticles coated with calcitriol reduced Iex-1 and VNH.	[Brahmbhatt, Akshaar; NievesTorres, Evelyn; Yang, Binxia; Misra, Sanjay] Univ Cincinnati, Dept Radiol, Vasc & Intervent Radiol Translat Lab, Cincinnati, OH 45220 USA; [Edwards, William D.] Univ Cincinnati, Dept Lab Med & Pathol, Cincinnati, OH USA; [Chaudhury, Prabir Roy] Univ Cincinnati, Dept Med, Div Nephrol & Hypertens, Cincinnati, OH USA; [Lee, Min Kyun; Kong, Hyunjoon] Univ Illinois, Dept Biomol & Chem Engn, Champaign, IL USA; [Mukhopadhyay, Debabrata; Kumar, Rajiv; Misra, Sanjay] Mayo Clin, Dept Med, Dept Biochem & Mol Biol, Rochester, MN USA; [Kumar, Rajiv] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Illinois System; University of Illinois Urbana-Champaign; Mayo Clinic; Mayo Clinic	Misra, S (corresponding author), Univ Cincinnati, Dept Radiol, Vasc & Intervent Radiol Translat Lab, Cincinnati, OH 45220 USA.	misra.sanjay@mayo.edu		Kumar, Rajiv/0000-0003-3497-3057	National Heart, Lung, And Blood Institute [R01HL098967]; Society of Interventional Radiology Foundation; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098967, R01HL109192] Funding Source: NIH RePORTER	National Heart, Lung, And Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Society of Interventional Radiology Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by a R01HL098967 (SM) from the National Heart, Lung, And Blood Institute, Society of Interventional Radiology Foundation (AB), and Howard Hughes Medical Institute (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jaishi AA, 2014, AM J KIDNEY DIS, V63, P464, DOI 10.1053/j.ajkd.2013.08.023; [Anonymous], 1996, COMMITTEE CARE USE L; Arlt A, 2001, ONCOGENE, V20, P69, DOI 10.1038/sj.onc.1204061; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Beer TM, 2001, SEMIN ONCOL, V28, P49, DOI 10.1053/sonc.2001.26901; Beer TM, 2007, J CLIN ONCOL, V25, P669, DOI 10.1200/JCO.2006.06.8197; Bojakowski K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036482; CHARLES CH, 1993, ONCOGENE, V8, P797; Chen M, 2007, NEPHROL DIAL TRANSPL, V22, P139, DOI 10.1093/ndt/gfl509; Collins A, 2014, AM J KIDNEY DIS, V63, pE1; De Keulenaer GW, 2002, CIRC RES, V90, P690, DOI 10.1161/01.RES.0000012922.40318.05; de Laval B, 2014, BLOOD, V123, P509, DOI 10.1182/blood-2013-07-515874; Hofstra L, 1995, J AM SOC NEPHROL, V6, P1625; Im HJ, 2002, J BIOL CHEM, V277, P14612, DOI 10.1074/jbc.M109414200; Im HJ, 2002, ONCOGENE, V21, P3706, DOI 10.1038/sj.onc.1205450; Janardhanan R, 2013, KIDNEY INT, V84, P338, DOI 10.1038/ki.2013.112; Juncos JP, 2011, J AM SOC NEPHROL, V22, P43, DOI 10.1681/ASN.2010040373; Kobayashi T, 1998, BIOCHEM BIOPH RES CO, V251, P868, DOI 10.1006/bbrc.1998.9556; Krishnamoorthy MK, 2012, KIDNEY INT, V81, P745, DOI 10.1038/ki.2011.468; Kumar R, 1998, BIOCHEM BIOPH RES CO, V253, P336, DOI 10.1006/bbrc.1998.9692; Kumar R, 2003, RECENT RESULTS CANC, V164, P123; Misra S, 2005, KIDNEY INT, V68, P2890, DOI 10.1111/j.1523-1755.2005.00763.x; Misra S, 2008, AM J PHYSIOL-HEART C, V294, pH2219, DOI 10.1152/ajpheart.00650.2007; Misra S, 2008, J VASC INTERV RADIOL, V19, P587, DOI 10.1016/j.jvir.2008.01.005; Misra S, 2008, J VASC INTERV RADIOL, V19, P260, DOI 10.1016/j.jvir.2007.10.029; Misra S, 2008, J VASC INTERV RADIOL, V19, P252, DOI 10.1016/j.jvir.2007.10.031; Misra S, 2006, CARDIOVASC INTER RAD, V29, P624, DOI 10.1007/s00270-005-0168-z; Misra S, 2010, J VASC INTERV RADIOL, V21, P1255, DOI 10.1016/j.jvir.2010.02.043; Misra S, 2010, J VASC INTERV RADIOL, V21, P896, DOI 10.1016/j.jvir.2010.02.030; Nguyen MT, 2003, J IMMUNOL, V170, P3337, DOI 10.4049/jimmunol.170.6.3337; Pawlak K, 2006, MED SCI MONITOR, V12, pCR181; Pietzsch A, 1998, BIOCHEM BIOPH RES CO, V245, P651, DOI 10.1006/bbrc.1998.8500; REKHTER M, 1993, ARTERIOSCLER THROMB, V13, P609, DOI 10.1161/01.ATV.13.4.609; Riella MC, 2013, NAT REV NEPHROL, V9, P348, DOI 10.1038/nrneph.2013.76; Rooijens PPGM, 2004, EUR J VASC ENDOVASC, V28, P583, DOI 10.1016/j.ejvs.2004.08.014; Roy-Chaudhury P, 2006, J AM SOC NEPHROL, V17, P1112, DOI 10.1681/ASN.2005050615; Schafer H, 1999, BIOCHEM BIOPH RES CO, V262, P139, DOI 10.1006/bbrc.1999.1131; Schilling D, 2001, ONCOGENE, V20, P7992, DOI 10.1038/sj.onc.1204965; Schmidt WE, 1999, ANN NY ACAD SCI, V880, P147, DOI 10.1111/j.1749-6632.1999.tb09517.x; Schulze PC, 2003, CIRC RES, V93, P1210, DOI 10.1161/01.RES.0000103635.38096.2F; Shen L, 2009, CELL DEATH DIFFER, V16, P603, DOI 10.1038/cdd.2008.184; Sommer SL, 2006, J APPL PHYSIOL, V100, P707, DOI 10.1152/japplphysiol.00306.2005; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Torres ECN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094510; vanDeursen J, 1996, EMBO J, V15, P5574, DOI 10.1002/j.1460-2075.1996.tb00942.x; Weiss MF, 2001, AM J KIDNEY DIS, V37, P970, DOI 10.1016/S0272-6386(05)80013-7; Wu MX, 2003, APOPTOSIS, V8, P11, DOI 10.1023/A:1021688600370; Yang B, 2014, KIDNEY INT, V85, P289, DOI 10.1038/ki.2013.290; Yang BX, 2009, J VASC INTERV RADIOL, V20, P946, DOI 10.1016/j.jvir.2009.03.044	49	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102542	10.1371/journal.pone.0102542	http://dx.doi.org/10.1371/journal.pone.0102542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036043	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200066
J	Deng, B; Wang, CW; Arnardottir, HH; Li, YS; Cheng, CYC; Dalli, J; Serhan, CN				Deng, Bin; Wang, Chin-Wei; Arnardottir, Hildur H.; Li, Yongsheng; Cheng, Chien-Yee Cindy; Dalli, Jesmond; Serhan, Charles N.			Maresin Biosynthesis and Identification of Maresin 2, a New Anti-Inflammatory and Pro-Resolving Mediator from Human Macrophages	PLOS ONE			English	Article							CYTOSOLIC EPOXIDE HYDROLASE; HUMAN PLATELET 12-LIPOXYGENASE; 5,6-DIHYDROXY-7,9,11,14-EICOSATETRAENOIC ACID; ARACHIDONIC-ACID; DENDRITIC CELLS; HUMAN-BLOOD; RESOLUTION; LEUKOTRIENE-A4; GENERATION; PROTECTINS	Maresins are a new family of anti-inflammatory and pro-resolving lipid mediators biosynthesized from docosahexaenoic acid (DHA) by macrophages. Here we identified a novel pro-resolving product, 13R, 14S-dihydroxy-docosahexaenoic acid (13R, 14S-diHDHA), produced by human macrophages. PCR mapping of 12-lipoxygenase (12-LOX) mRNA sequence in human macrophages and platelet showed that they are identical. This human 12-LOX mRNA and enzyme are expressed in monocyte-derived cell lineage, and enzyme expression levels increase with maturation to macrophages or dendritic cells. Recombinant human 12-LOX gave essentially equivalent catalytic efficiency (k(cat)/K-M) with arachidonic acid (AA) and DHA as substrates. Lipid mediator metabololipidomics demonstrated that human macrophages produce a novel bioactive product 13,14-dihydroxy-docosahexaenoic acid in addition to maresin-1, 7R,14S-dihydroxy-4Z,8E,10E,12Z,16Z,19Z-docosahexaenoic acid (MaR1). Co-incubations with human recombinant 12-LOX and soluble epoxide hydrolase (sEH) demonstrated that biosynthesis of 13,14-dihydroxy-docosahexaenoic acid (13,14-diHDHA) involves the 13S,14S-epoxy-maresin intermediate produced from DHA by 12-LOX, followed by conversion via soluble epoxide hydrolase (sEH). This new 13,14-diHDHA displayed potent anti-inflammatory and pro-resolving actions, and at 1 ng reduced neutrophil infiltration in mouse peritonitis by similar to 40% and at 10 pM enhanced human macrophage phagocytosis of zymosan by similar to 90%. However, MaR1 proved more potent than the 13R,14S-diHDHA at enhancing efferocytosis with human macrophages. Taken together, the present findings demonstrate that macrophages produced a novel bioactive product identified in the maresin metabolome as 13R,14S-dihydroxy-docosahexaenoic acid, from DHA via conversion by human 12-LOX followed by sEH. Given its potent bioactions, we coined 13R,14S-diHDHA maresin 2 (MaR2).	[Deng, Bin; Wang, Chin-Wei; Arnardottir, Hildur H.; Li, Yongsheng; Cheng, Chien-Yee Cindy; Dalli, Jesmond; Serhan, Charles N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Expt Therapeut & Reperfus Injury,Dept Anesthe, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Serhan, CN (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Expt Therapeut & Reperfus Injury,Dept Anesthe, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu		Li, Yongsheng/0000-0003-2175-9449; Arnardottir, Hildur/0000-0002-5163-3946; Dalli, Jesmond/0000-0001-6328-3640	U.S. National Institutes of Health [P01GM095467, R01GM38765]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, P01GM095467] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health grant nos. P01GM095467 and R01GM38765. The content is solely the responsibility of the authors and does not necessarily reflect the official view of NIH/NIGMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00004; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bellora F, 2010, P NATL ACAD SCI USA, V107, P21659, DOI 10.1073/pnas.1007654108; Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8; CHACOS N, 1983, ARCH BIOCHEM BIOPHYS, V223, P639, DOI 10.1016/0003-9861(83)90628-8; CHEN XS, 1993, FASEB J, V7, P694, DOI 10.1096/fasebj.7.8.8500694; Cronin A, 2011, J LIPID RES, V52, P712, DOI 10.1194/jlr.M009639; Dalli J, 2013, FASEB J; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Draper AJ, 1999, TOXICOL SCI, V50, P30, DOI 10.1093/toxsci/50.1.30; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Giera M, 2012, BBA-MOL CELL BIOL L, V1821, P1415, DOI 10.1016/j.bbalip.2012.07.011; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; HAEGGSTROM J, 1988, BIOCHIM BIOPHYS ACTA, V958, P469, DOI 10.1016/0005-2760(88)90233-0; HAEGGSTROM J, 1986, J BIOL CHEM, V261, P6332; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3400, DOI 10.1073/pnas.71.9.3400; IZUMI T, 1990, P NATL ACAD SCI USA, V87, P7477, DOI 10.1073/pnas.87.19.7477; Lu Y, 2010, J LIPID RES, V51, P923, DOI 10.1194/jlr.M000059; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Nordgren TM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-51; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Ohira T, 2003, J IMMUNOL METHODS, V281, P79, DOI 10.1016/S0022-1759(03)00278-3; ROMANO M, 1993, BIOCHEM J, V296, P127, DOI 10.1042/bj2960127; Sampaio A, 2010, FUNDAMENTALS INFLAMM, P488; SEIDEGARD J, 1984, CANCER RES, V44, P3654; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; SERHAN CN, 1990, J CLIN INVEST, V85, P772, DOI 10.1172/JCI114503; SERTH J, 1991, EMBO J, V10, P1325, DOI 10.1002/j.1460-2075.1991.tb07651.x; SHEPPARD KA, 1992, BIOCHIM BIOPHYS ACTA, V1133, P223, DOI 10.1016/0167-4889(92)90073-K; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; TAKAHASHI Y, 1993, J BIOL CHEM, V268, P16443; Tian HB, 2012, STEM CELLS DEV, V21, P1187, DOI 10.1089/scd.2011.0220; Tian HB, 2011, J BIOL CHEM, V286, P4443, DOI 10.1074/jbc.M110.100388; Wuest SJA, 2012, ATHEROSCLEROSIS, V225, P121, DOI 10.1016/j.atherosclerosis.2012.07.022; ZELDIN DC, 1993, J BIOL CHEM, V268, P6402	40	103	107	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102362	10.1371/journal.pone.0102362	http://dx.doi.org/10.1371/journal.pone.0102362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036362	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200048
J	Jiang, Y; Li, LL; Liu, B; Zhang, YH; Chen, Q; Li, CQ				Jiang, Ying; Li, Longling; Liu, Bin; Zhang, Yanhong; Chen, Qian; Li, Changqing			Vagus Nerve Stimulation Attenuates Cerebral Ischemia and Reperfusion Injury via Endogenous Cholinergic Pathway in Rat	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; ISCHEMIA/REPERFUSION INJURY; ANTIINFLAMMATORY PATHWAY; VAGAL-STIMULATION; ARTERY OCCLUSION; HEME OXYGENASE-1; INFARCT SIZE; BLOOD-FLOW; STROKE; ACETYLCHOLINE	Inflammation and apoptosis play critical roles in the acute progression of ischemic injury pathology. Emerging evidence indicates that vagus nerve stimulation (VNS) following focal cerebral ischemia and reperfusion (I/R) may be neuroprotective by limiting infarct size. However, the underlying molecular mechanisms remain unclear. In this study, we investigated whether the protective effects of VNS in acute cerebral I/R injury were associated with anti-inflammatory and anti-apoptotic processes. Male Sprague-Dawley (SD) rats underwent VNS at 30 min after focal cerebral I/R surgery. Twenty-four h after reperfusion, neurological deficit scores, infarct volume, and neuronal apoptosis were evaluated. In addition, the levels of pro-inflammatory cytokines were detected using enzyme-linked immune sorbent assay (ELISA), and immunofluorescence staining for the endogenous "cholinergic anti-inflammatory pathway" was also performed. The protein expression of a7 nicotinic acetylcholine receptor (a7nAchR), phosphorylated Akt (p-Akt), and cleaved caspase 3 in ischemic penumbra were determined with Western blot analysis. I/R rats treated with VNS (I/R+VNS) had significantly better neurological deficit scores, reduced cerebral infarct volume, and decreased number of TdT mediated dUTP nick end labeling (TUNEL) positive cells. Furthermore, in the ischemic penumbra of the I/R+ VNS group, the levels of pro-inflammatory cytokines and cleaved caspase 3 protein were significantly decreased, and the levels of a7nAchR and phosphorylated Akt were significantly increased relative to the I/R alone group. These results indicate that VNS is neuroprotective in acute cerebral I/R injury by suppressing inflammation and apoptosis via activation of cholinergic and a7nAchR/Akt pathways.	[Jiang, Ying; Li, Longling; Liu, Bin; Zhang, Yanhong; Chen, Qian; Li, Changqing] Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, Chongqing, Peoples R China	Chongqing Medical University	Li, CQ (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, Chongqing, Peoples R China.	licq9217@cqmu.edu.cn			National Nature and Science Foundation of China [81271306]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature and Science Foundation of China (Grant NO. 81271306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay I, 2011, BRAIN RES, V1392, P110, DOI 10.1016/j.brainres.2011.03.060; Ay I, 2009, NEUROSCI LETT, V459, P147, DOI 10.1016/j.neulet.2009.05.018; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Boon P, 2006, SEIZURE-EUR J EPILEP, V15, P259, DOI 10.1016/j.seizure.2006.02.014; Borckardt Jeffrey J, 2005, Pain Res Manag, V10, P9; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Burneo JG, 2002, NEUROLOGY, V59, P463, DOI 10.1212/WNL.59.3.463; Calvillo L, 2011, J CARDIOVASC PHARM, V58, P500, DOI 10.1097/FJC.0b013e31822b7204; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Conway CR, 2012, BRAIN STIMUL, V5, P163, DOI 10.1016/j.brs.2011.03.001; Duris K, 2011, STROKE, V42, P3530, DOI 10.1161/STROKEAHA.111.619965; Fanselow MS, 2013, BIOL PSYCHIAT, V73, P1043, DOI 10.1016/j.biopsych.2013.03.025; Fu SH, 2014, N-S ARCH PHARMACOL, V387, P87, DOI 10.1007/s00210-013-0922-8; Furmaga H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034844; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Hiraki T, 2012, J NEUROSCI RES, V90, P887, DOI 10.1002/jnr.22812; Kakinuma Y, 2005, FEBS LETT, V579, P2111, DOI 10.1016/j.febslet.2005.02.065; Kakinuma Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004887; Khodaparast N, 2013, NEUROBIOL DIS, V60, P80, DOI 10.1016/j.nbd.2013.08.002; Kong YH, 2013, NEUROCHEM RES, V38, P815, DOI 10.1007/s11064-013-0984-5; Krafft PR, 2012, STROKE, V43, P844, DOI 10.1161/STROKEAHA.111.639989; Marrero MB, 2009, BRAIN RES, V1256, P1, DOI 10.1016/j.brainres.2008.11.053; Morris GL, 2013, EPILEPSY CURR, V13, P297, DOI 10.5698/1535-7597-13.6.297; Mravec B, 2010, AUTON NEUROSCI-BASIC, V158, P8, DOI 10.1016/j.autneu.2010.08.009; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Parada E, 2013, ANTIOXID REDOX SIGN, V19, P1135, DOI 10.1089/ars.2012.4671; Park J, 2013, EUR J PHARMACOL, V707, P61, DOI 10.1016/j.ejphar.2013.03.026; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Schabitz WR, 1996, J NEUROL SCI, V138, P21, DOI 10.1016/0022-510X(95)00341-X; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Sun ZH, 2012, BRAIN STIMUL, V5, P1, DOI 10.1016/j.brs.2011.01.009; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang JY, 2008, STROKE, V39, P983, DOI 10.1161/STROKEAHA.107.499079; Wang QA, 2011, STROKE, V42, P389, DOI 10.1161/STROKEAHA.110.597336; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; You SJ, 2007, J KOREAN MED SCI, V22, P442, DOI 10.3346/jkms.2007.22.3.442; Zhang L, 2010, BRAIN RES, V1357, P157, DOI 10.1016/j.brainres.2010.08.007	40	67	75	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102342	10.1371/journal.pone.0102342	http://dx.doi.org/10.1371/journal.pone.0102342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036185	gold, Green Published, Green Submitted			2022-12-25	WOS:000339615200047
J	Nie, CJ; Li, HR; Yang, LS; Zhong, GM; Zhang, L				Nie, Chengjing; Li, Hairong; Yang, Linsheng; Zhong, Gemei; Zhang, Lan			Socio-Economic Factors of Bacillary Dysentery Based on Spatial Correlation Analysis in Guangxi Province, China	PLOS ONE			English	Article							METEOROLOGICAL FACTORS; CLIMATE VARIATIONS; EPIDEMICS; DISEASE; QUEENSLAND; REGRESSION; AUSTRALIA; NORTHERN; CITIES; BRAZIL	Background: In the past decade, bacillary dysentery was still a big public health problem in China, especially in Guangxi Province, where thousands of severe diarrhea cases occur every year. Methods: Reported bacillary dysentery cases in Guangxi Province were obtained from local Centers for Diseases Prevention and Control. The 14 socio-economic indexes were selected as potential explanatory variables for the study. The spatial correlation analysis was used to explore the associations between the selected factors and bacillary dysentery incidence at county level, which was based on the software of ArcGIS10.2 and GeoDA 0.9.5i. Results: The proportion of primary industry, the proportion of younger than 5-year-old children in total population, the number of hospitals per thousand persons and the rates of bacillary dysentery incidence show statistically significant positive correlation. But the proportion of secondary industry, per capital GDP, per capital government revenue, rural population proportion, popularization rate of tap water in rural area, access rate to the sanitation toilets in rural, number of beds in hospitals per thousand persons, medical and technical personnel per thousand persons and the rate of bacillary dysentery incidence show statistically significant negative correlation. The socio-economic factors can be divided into four aspects, including economic development, health development, medical development and human own condition. The four aspects were not isolated from each other, but interacted with each other.	[Nie, Chengjing] Hebei Univ Econ & Business, Sch Publ Adm & Policy, Shijiazhuang, Peoples R China; [Nie, Chengjing; Li, Hairong; Yang, Linsheng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Zhong, Gemei] Guangxi Ctr Dis Prevent & Control, Inst Environm Hlth & Endem Dis Prevent, Nanning, Peoples R China; [Zhang, Lan] Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safety, Beijing, Peoples R China	Hebei University of Economics & Business; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention	Yang, LS (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	yangls@igsnrr.ac.cn	Yang, Linsheng/H-4326-2011	Yang, Linsheng/0000-0001-9603-6507	program of national science infrastructure platform [2013FY114600-3-1]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-Q03-01]; National Key Technology RD Program [2008BAK50B05]	program of national science infrastructure platform; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Technology RD Program(National Key Technology R&D Program)	This study was supported by the program of national science infrastructure platform (2013FY114600-3-1), Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-YW-Q03-01), and the National Key Technology R&D Program (2008BAK50B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera R, 2011, AM J TROP MED HYG, V85, P1087, DOI 10.4269/ajtmh.2011.11-0381; China MoHPR, 2005, PLAN NAT SURV BAC DY; Teixeira TRD, 2008, CAD SAUDE PUBLICA, V24, P2160, DOI 10.1590/S0102-311X2008000900022; El Bushra HE, 1999, E AFR MED J, V76, P255; Filipe JAN, 2004, J THEOR BIOL, V226, P125, DOI 10.1016/S0022-5193(03)00278-9; Gao L, 2014, AM J TROP MED HYG, V90, P697, DOI 10.4269/ajtmh.13-0198; Gatton ML, 2004, AM J TROP MED HYG, V71, P629, DOI 10.4269/ajtmh.2004.71.629; GOTTWALD TR, 1992, PHYTOPATHOLOGY, V82, P843, DOI 10.1094/Phyto-82-843; Guan P, 2008, JPN J INFECT DIS, V61, P356; Huang DS, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-130; Li ZJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03239; Lindstrom T, 2011, P ROY SOC B-BIOL SCI, V278, P1564, DOI 10.1098/rspb.2010.1902; Liu G, 2013, ENVIRON MONIT ASSESS, V185, P9549, DOI 10.1007/s10661-013-3272-6; Lue Ye, 2008, Zhonghua Yufang Yixue Zazhi, V42, P342; Ma SL, 2013, CHIN J INTEGR MED, V19, P182, DOI 10.1007/s11655-012-1239-z; Ma WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062122; Mahmoud A A, 1976, Gaz Egypt Paediatr Assoc, V24, P82; Martinez J M, 1973, Bol Oficina Sanit Panam, V75, P213; Mateu J, 2014, BIOM J; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Moya MP, 2012, REV FAC CIEN MED U N, V69, P160; Nicolas X, 2007, PRESSE MED, V36, P1606, DOI 10.1016/j.lpm.2007.03.001; Penatti MPA, 2007, BRAZ J MED BIOL RES, V40, P249, DOI 10.1590/S0100-879X2006005000069; Quinn HE, 2005, J MED ENTOMOL, V42, P882, DOI 10.1603/0022-2585(2005)042[0882:AOBFVD]2.0.CO;2; Savary S, 2001, PLANT PATHOL, V50, P53, DOI 10.1046/j.1365-3059.2001.00531.x; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Wang XY, 2006, B WORLD HEALTH ORGAN, V84, P561, DOI 10.2471/BLT.05.023853; Xu LY, 2013, ENVIRON POLLUT, V178, P102, DOI 10.1016/j.envpol.2013.03.006; Yan WR, 2010, JPN J INFECT DIS, V63, P264; Zhang Y, 2008, PUBLIC HEALTH REP, V123, P61, DOI 10.1177/003335490812300109; Zhang Y, 2007, J INFECTION, V55, P194, DOI 10.1016/j.jinf.2006.12.002; Zhang Y, 2012, J ENVIRON MONITOR, V14, P510, DOI 10.1039/c1em10391a; Zhong Hao-jie, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P304	33	13	14	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102020	10.1371/journal.pone.0102020	http://dx.doi.org/10.1371/journal.pone.0102020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036182	gold, Green Submitted, Green Published			2022-12-25	WOS:000339615200033
J	Roberts, SK; McAinsh, M; Cantopher, H; Sandison, S				Roberts, Stephen K.; McAinsh, Martin; Cantopher, Hanna; Sandison, Sean			Calcium Dependence of Eugenol Tolerance and Toxicity in Saccharomyces cerevisiae	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; CANDIDA-ALBICANS; OXIDATIVE STRESS; MECHANISM; INFLUX; YEAST; CALCINEURIN; AMIODARONE	Eugenol is a plant-derived phenolic compound which has recognised therapeutical potential as an antifungal agent. However little is known of either its fungicidal activity or the mechanisms employed by fungi to tolerate eugenol toxicity. A better exploitation of eugenol as a therapeutic agent will therefore depend on addressing this knowledge gap. Eugenol initiates increases in cytosolic Ca2+ in Saccharomyces cerevisiae which is partly dependent on the plasma membrane calcium channel, Cch1p. However, it is unclear whether a toxic cytosolic Ca2+ elevation mediates the fungicidal activity of eugenol. In the present study, no significant difference in yeast survival was observed following transient eugenol treatment in the presence or absence of extracellular Ca2+. Furthermore, using yeast expressing apoaequorin to report cytosolic Ca2+ and a range of eugenol derivatives, antifungal activity did not appear to be coupled to Ca2+ influx or cytosolic Ca2+ elevation. Taken together, these results suggest that eugenol toxicity is not dependent on a toxic influx of Ca2+. In contrast, careful control of extracellular Ca2+ (using EGTA or BAPTA) revealed that tolerance of yeast to eugenol depended on Ca2+ influx via Cch1p. These findings expose significant differences between the antifungal activity of eugenol and that of azoles, amiodarone and carvacrol. This study highlights the potential to use eugenol in combination with other antifungal agents that exhibit differing modes of action as antifungal agents to combat drug resistant infections.	[Roberts, Stephen K.; Cantopher, Hanna; Sandison, Sean] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England; [McAinsh, Martin] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England	Lancaster University; Lancaster University	Roberts, SK (corresponding author), Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England.	s.k.roberts@lancaster.ac.uk		McAinsh, Martin Robert/0000-0003-4294-6470; roberts, stephen/0000-0003-1740-5330	Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Blankenship JR, 2005, INFECT IMMUN, V73, P5767, DOI 10.1128/IAI.73.9.5767-5774.2005; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Carrasco H, 2012, MOLECULES, V17, P1002, DOI 10.3390/molecules17011002; Cunningham KW, 2011, CELL CALCIUM, V50, P129, DOI 10.1016/j.ceca.2011.01.010; Darvishi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076028; Edlind T, 2002, MOL MICROBIOL, V46, P257, DOI 10.1046/j.1365-2958.2002.03165.x; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Gietz D, 1998, METHOD MICROBIOL, V26, P53; Groppi S, 2011, CELL CALCIUM, V49, P376, DOI 10.1016/j.ceca.2011.03.006; Khan A, 2011, FEMS YEAST RES, V11, P114, DOI 10.1111/j.1567-1364.2010.00697.x; Liu M, 2006, EUKARYOT CELL, V5, P1788, DOI 10.1128/EC.00158-06; Loukin S, 2008, FASEB J, V22, P2405, DOI 10.1096/fj.07-101410; Maresova L, 2009, J BIOL CHEM, V284, P2795, DOI 10.1074/jbc.M806693200; Monk BC, 2008, SCIENCE, V321, P367, DOI 10.1126/science.1159746; Muend S, 2008, FEMS YEAST RES, V8, P425, DOI 10.1111/j.1567-1364.2008.00354.x; Muller EM, 2001, GENETICS, V159, P1527; Popa CV, 2010, FEBS J, V277, P4027, DOI 10.1111/j.1742-4658.2010.07794.x; Rao A, 2010, ANTIMICROB AGENTS CH, V54, P5062, DOI 10.1128/AAC.01050-10; Roberts SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043989; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Zhang YQ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00133; Zore GB, 2011, PHYTOMEDICINE, V18, P1181, DOI 10.1016/j.phymed.2011.03.008	24	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102712	10.1371/journal.pone.0102712	http://dx.doi.org/10.1371/journal.pone.0102712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036027	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000339615200080
J	Sicurella, M; Nicoli, F; Gallerani, E; Volpi, I; Berto, E; Finessi, V; Destro, F; Manservigi, R; Cafaro, A; Ensoli, B; Caputo, A; Gavioli, R; Marconi, PC				Sicurella, Mariaconcetta; Nicoli, Francesco; Gallerani, Eleonora; Volpi, Ilaria; Berto, Elena; Finessi, Valentina; Destro, Federica; Manservigi, Roberto; Cafaro, Aurelio; Ensoli, Barbara; Caputo, Antonella; Gavioli, Riccardo; Marconi, Peggy C.			An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge	PLOS ONE			English	Article							T-CELL RESPONSE; NF-KAPPA-B; HUMORAL IMMUNE-RESPONSE; GLYCOPROTEIN-K GK; GENITAL HERPES; TRANSCRIPTION FACTOR; DENDRITIC CELLS; OCULAR HERPES; VACCINE DEVELOPMENT; BET EXPRESSION	Herpes simplex virus types 1 and 2 (HSV1 and HSV2) are common infectious agents in both industrialized and developing countries. They cause recurrent asymptomatic and/or symptomatic infections, and life-threatening diseases and death in newborns and immunocompromised patients. Current treatment for HSV relies on antiviral medications, which can halt the symptomatic diseases but cannot prevent the shedding that occurs in asymptomatic patients or, consequently, the spread of the viruses. Therefore, prevention rather than treatment of HSV infections has long been an area of intense research, but thus far effective anti-HSV vaccines still remain elusive. One of the key hurdles to overcome in anti-HSV vaccine development is the identification and effective use of strategies that promote the emergence of Th1-type immune responses against a wide range of epitopes involved in the control of viral replication. Since the HIV1 Tat protein has several immunomodulatory activities and increases CTL recognition of dominant and subdominant epitopes of heterologous antigens, we generated and assayed a recombinant attenuated replication-competent HSV1 vector containing the tat gene (HSV1-Tat). In this proof-of-concept study we show that immunization with this vector conferred protection in 100% of mice challenged intravaginally with a lethal dose of wild-type HSV1. We demonstrate that the presence of Tat within the recombinant virus increased and broadened Th1-like and CTL responses against HSV-derived T-cell epitopes and elicited in most immunized mice detectable IgG responses. In sharp contrast, a similarly attenuated HSV1 recombinant vector without Tat (HSV1-LacZ), induced low and different T cell responses, no measurable antibody responses and did not protect mice against the wild-type HSV1 challenge. These findings strongly suggest that recombinant HSV1 vectors expressing Tat merit further investigation for their potential to prevent and/or contain HSV1 infection and dissemination.	[Sicurella, Mariaconcetta; Volpi, Ilaria; Berto, Elena; Manservigi, Roberto; Marconi, Peggy C.] Univ Ferrara, Dept Life Sci & Biotechnol, Sect Appl Microbiol & Pathol, I-44100 Ferrara, Italy; [Nicoli, Francesco; Gallerani, Eleonora; Finessi, Valentina; Destro, Federica; Gavioli, Riccardo] Univ Ferrara, Dept Life Sci & Biotechnol, Sect Biochem & Mol Biol, I-44100 Ferrara, Italy; [Sicurella, Mariaconcetta; Destro, Federica; Caputo, Antonella] Univ Padua, Dept Mol Med, Padua, Italy; [Cafaro, Aurelio; Ensoli, Barbara] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy	University of Ferrara; University of Ferrara; University of Padua; Istituto Superiore di Sanita (ISS)	Gavioli, R (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, Sect Biochem & Mol Biol, I-44100 Ferrara, Italy.	gvr@unife.it; mcy@unife.it	, Francesco/I-8040-2019; Marconi, Peggy/K-7733-2016; Destro, Federica/K-5904-2016; Caputo, Antonella/ABE-7851-2020; Gavioli, Riccardo/K-7594-2016; Cafaro, Aurelio/K-5314-2016; Ensoli, Barbara/J-9169-2016; Sicurella, Mariaconcetta/AAA-7030-2019	, Francesco/0000-0001-6327-5958; Destro, Federica/0000-0002-3014-0165; Caputo, Antonella/0000-0002-1241-0299; Gavioli, Riccardo/0000-0002-7805-4290; Ensoli, Barbara/0000-0002-0545-8737; Sicurella, Mariaconcetta/0000-0003-3996-3667; Marconi, Peggy C. R./0000-0003-3488-0491; MANSERVIGI, Roberto/0000-0002-2827-229X; Cafaro, Aurelio/0000-0001-9675-6344	University of Ferrara; University of Padova; CARIPARO Foundation (Padova)	University of Ferrara; University of Padova; CARIPARO Foundation (Padova)(Fondazione Cariparo)	This work was supported by grants from the University of Ferrara and the University of Padova. AIDS Vaccine Integrated Project (AVIP, VI FP), Italian National Institute of Health (AIDS Program ISS-2009), the Italian Ministry for the University and Scientific Research (PRIN-2009) and FAR (2010 and 2011) from the University of Ferrara. Mariaconcetta Sicurella was recipient of a PhD fellowship from CARIPARO Foundation (Padova) and Federica Destro of a post-doctorate fellowship from the University of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulou E, 2007, J IMMUNOL, V178, P5465, DOI 10.4049/jimmunol.178.9.5465; Akhrameyeva NV, 2011, J VIROL, V85, P5036, DOI 10.1128/JVI.02548-10; ARYA SK, 1985, SCIENCE, V229, P69, DOI 10.1126/science.2990040; Awasthi S, 2008, VACCINE, V26, P1195, DOI 10.1016/j.vaccine.2007.12.032; BANKS TA, 1993, J VIROL, V67, P613, DOI 10.1128/JVI.67.1.613-616.1993; Barnabas RV, 2012, CURR HIV RES, V10, P228, DOI 10.2174/157016212800618156; Battaglia PA, 1997, INT J ONCOL, V11, P1007; Bellino S, 2009, REV RECENT CLIN TRIA, V4, P195, DOI 10.2174/157488709789957529; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Brockman MA, 2002, J VIROL, V76, P3678, DOI 10.1128/JVI.76.8.3678-3687.2002; BUONAGURO L, 1992, J VIROL, V66, P7159, DOI 10.1128/JVI.66.12.7159-7167.1992; Caputo A, 2009, INT REV IMMUNOL, V28, P285, DOI 10.1080/08830180903013026; Chentoufi Aziz Alami, 2012, Curr Trends Immunol, V13, P51; Chentoufi AA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/187585; Chentoufi AA, 2010, FUTURE VIROL, V5, P525, DOI 10.2217/FVL.10.44; Chew T, 2009, VIRUSES-BASEL, V1, P979, DOI 10.3390/v1030979; Chu CF, 2008, J REPROD IMMUNOL, V78, P58, DOI 10.1016/j.jri.2007.08.004; Coleman JL, 2013, HUM VACC IMMUNOTHER, V9; Cunningham AL, 2006, J INFECT DIS, V194, pS11, DOI 10.1086/505359; Dasgupta G, 2012, J VIROL, V86, P4358, DOI 10.1128/JVI.07107-11; Dasgupta G, 2009, EXPERT REV VACCINES, V8, P1023, DOI 10.1586/ERV.09.60; Demarchi F, 1996, J VIROL, V70, P4427, DOI 10.1128/JVI.70.7.4427-4437.1996; Demarchi F, 1999, J VIROL, V73, P7080, DOI 10.1128/JVI.73.8.7080-7086.1999; Dervillez X, 2013, J IMMUNOL, V191, P5124, DOI 10.4049/jimmunol.1301415; Dervillez X, 2012, FUTURE VIROL, V7, P371, DOI 10.2217/FVL.12.22; Dreyfus DH, 2013, J ALLERGY CLIN IMMUN; Dropulic LK, 2012, EXPERT REV VACCINES, V11, P1429, DOI [10.1586/ERV.12.129, 10.1586/erv.12.129]; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Fanales-Belasio E, 2002, J IMMUNOL, V168, P197, DOI 10.4049/jimmunol.168.1.197; Fanales-Belasio E, 2009, J IMMUNOL, V182, P2888, DOI 10.4049/jimmunol.0711406; Fiume G, 2012, NUCLEIC ACIDS RES, V40, P3548, DOI 10.1093/nar/gkr1224; Fraefel C, 2011, METHODS MOL BIOL, V737, P303, DOI 10.1007/978-1-61779-095-9_13; Gadzinski A, 2012, VACCINE, V30, P2859, DOI 10.1016/j.vaccine.2012.02.042; Gavioli R, 2004, J IMMUNOL, V173, P3838, DOI 10.4049/jimmunol.173.6.3838; Gavioli R, 2002, INT J CANCER, V101, P532, DOI 10.1002/ijc.10653; Gavioli R, 2008, VACCINE, V26, P727, DOI 10.1016/j.vaccine.2007.11.040; Ghasemi M, 2013, CYTOTHERAPY, V15, P352, DOI 10.1016/j.jcyt.2012.11.012; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; Nguyen HV, 2012, BLOOD, V119, P4174, DOI 10.1182/blood-2011-09-378182; Halford WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065523; Han X, 2001, J VIROL, V75, P3048, DOI 10.1128/JVI.75.6.3048-3052.2001; Hansen SG, SCIENCE, V340; Haynes JR, 2006, VACCINE, V24, P5016, DOI 10.1016/j.vaccine.2006.03.046; HEBERKATZ E, 1985, J IMMUNOL, V135, P1385; Hofstetter AM, 2014, CURR OPIN INFECT DIS, V27, P75, DOI 10.1097/QCO.0000000000000029; Jamali A, 2007, COMP IMMUNOL MICROB, V30, P71, DOI 10.1016/j.cimid.2006.10.002; Jones Cheryl A, 2004, Herpes, V11, P12; Jungmann E, 2007, CLIN EVID; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Khan AA, 2014, HUM VACC IMMUNOTHER, V10; Khanna KM, 2004, CURR OPIN IMMUNOL, V16, P463, DOI 10.1016/j.coi.2004.05.003; Khanna KM, 2004, TRENDS IMMUNOL, V25, P230, DOI 10.1016/j.it.2004.02.010; Kittiworakarn J, 2006, J BIOL CHEM, V281, P3105, DOI 10.1074/jbc.M509899200; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Koelle DM, 2006, CURR OPIN INVEST DR, V7, P136; KOKEN SEC, 1994, GENE, V144, P243, DOI 10.1016/0378-1119(94)90384-0; Krisky DM, 1998, GENE THER, V5, P1517, DOI 10.1038/sj.gt.3300755; Krisky DM, 1997, GENE THER, V4, P1120, DOI 10.1038/sj.gt.3300497; Kronenberg K, 2010, J INVEST DERMATOL, V130, P2602, DOI 10.1038/jid.2010.171; Kulkarni A, 2005, BIOCHEM BIOPH RES CO, V329, P706, DOI 10.1016/j.bbrc.2005.02.042; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lafrenie RM, 1997, J IMMUNOL, V159, P4077; Lang A, 2005, J IMMUNOL, V174, P2919, DOI 10.4049/jimmunol.174.5.2919; Lauterbach H, 2005, J GEN VIROL, V86, P2401, DOI 10.1099/vir.0.81104-0; Leghmari K, 2008, CELL IMMUNOL, V254, P46, DOI 10.1016/j.cellimm.2008.06.011; Lu ZM, 2009, J INVEST DERMATOL, V129, P1174, DOI 10.1038/jid.2008.349; Lundberg P, 2003, J VIROL, V77, P11661, DOI 10.1128/JVI.77.21.11661-11673.2003; Manservigi Roberto, 2010, Open Virol J, V4, P123, DOI 10.2174/1874357901004030123; Mott KR, 2009, INVEST OPHTH VIS SCI, V50, P2903, DOI 10.1167/iovs.08-2957; Mueller SN, 2003, J VIROL, V77, P2445, DOI 10.1128/JVI.77.4.2445-2451.2003; Nicoli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077746; Nopora K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00348; Osorio Y, 2007, VIRUS RES, V128, P71, DOI 10.1016/j.virusres.2007.04.007; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Ouwendijk WJD, 2013, CURR OPIN VIROL, V3, P452, DOI 10.1016/j.coviro.2013.04.004; PAGLIA P, 1993, J EXP MED, V178, P1893, DOI 10.1084/jem.178.6.1893; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Pepose JS, 2006, AM J OPHTHALMOL, V141, P547, DOI 10.1016/j.ajo.2005.10.008; Podda Audino, 2003, Expert Rev Vaccines, V2, P197, DOI 10.1586/14760584.2.2.197; Posavad CM, 2010, J IMMUNOL, V184, P3250, DOI 10.4049/jimmunol.0900722; Rajcani J, 2006, FOLIA MICROBIOL, V51, P67, DOI 10.1007/BF02932160; Remoli AL, 2006, BIOCHEM J, V396, P371, DOI 10.1042/BJ20051570; Roizman B, 1996, P NATL ACAD SCI USA, V93, P11307, DOI 10.1073/pnas.93.21.11307; Rudd BD, 2010, J IMMUNOL, V184, P2958, DOI 10.4049/jimmunol.0903493; SALVUCCI LA, 1995, J VIROL, V69, P1122, DOI 10.1128/JVI.69.2.1122-1131.1995; Sheridan BS, 2009, J VIROL, V83, P2237, DOI 10.1128/JVI.01699-08; Shin HN, 2013, TRENDS IMMUNOL, V34, P487, DOI 10.1016/j.it.2013.08.001; Shin H, 2013, IMMUNOL REV, V255, P165, DOI 10.1111/imr.12087; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Skoberne M, 2013, J VIROL, V87, P3930, DOI 10.1128/JVI.02745-12; Smith C, 2010, HUM VACCINES, V6, P1062, DOI 10.4161/hv.6.12.13347; St Leger AJ, 2011, J IMMUNOL, V186, P3927, DOI 10.4049/jimmunol.1003735; Stanberry Lawrence R, 2004, Herpes, V11 Suppl 3, p161A; Stefanidou M, 2013, J VIROL, V87, P1443, DOI 10.1128/JVI.01302-12; Svensson A, 2005, J IMMUNOL, V174, P6266, DOI 10.4049/jimmunol.174.10.6266; Svensson A, 2008, J GEN VIROL, V89, P2262, DOI 10.1099/vir.0.2008/001305-0; Tavares F, 2013, VACCINE, V31, P1759, DOI 10.1016/j.vaccine.2013.01.002; Taylor PD, 2010, J SYST PALAEONTOL, V8, P1, DOI 10.1080/14772011003603119; TOGNON M, 1985, INT OPHTHALMOL, V8, P13, DOI 10.1007/BF00136456; Vitagliano L, 2011, BIOCHIMIE, V93, P1592, DOI 10.1016/j.biochi.2011.05.025; Whitley RJ, 2002, J CLIN INVEST, V110, P145, DOI [10.1172/JCI200216126, 10.1172/JCI0216126]; Wilson SS, 2009, EXPERT REV ANTI-INFE, V7, P559, DOI [10.1586/eri.09.34, 10.1586/ERI.09.34]; YAMASHITA K, 1989, J EXP MED, V170, P997, DOI 10.1084/jem.170.3.997; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110; Zhu XP, 2014, VIRUSES-BASEL, V6, P371, DOI 10.3390/v6020371	105	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100844	10.1371/journal.pone.0100844	http://dx.doi.org/10.1371/journal.pone.0100844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033084	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300010
J	Gaveau, DLA; Sloan, S; Molidena, E; Yaen, H; Sheil, D; Abram, NK; Ancrenaz, M; Nasi, R; Quinones, M; Wielaard, N; Meijaard, E				Gaveau, David L. A.; Sloan, Sean; Molidena, Elis; Yaen, Husna; Sheil, Doug; Abram, Nicola K.; Ancrenaz, Marc; Nasi, Robert; Quinones, Marcela; Wielaard, Niels; Meijaard, Erik			Four Decades of Forest Persistence, Clearance and Logging on Borneo	PLOS ONE			English	Article							TROPICAL FORESTS; LOGGED FORESTS; CONSERVATION; BIODIVERSITY; DEFORESTATION; MAMMALS; MODELS; TIMBER	The native forests of Borneo have been impacted by selective logging, fire, and conversion to plantations at unprecedented scales since industrial-scale extractive industries began in the early 1970s. There is no island-wide documentation of forest clearance or logging since the 1970s. This creates an information gap for conservation planning, especially with regard to selectively logged forests that maintain high conservation potential. Analysing LANDSAT images, we estimate that 75.7% (558,060 km(2)) of Borneo's area (737,188 km(2)) was forested around 1973. Based upon a forest cover map for 2010 derived using ALOS-PALSAR and visually reviewing LANDSAT images, we estimate that the 1973 forest area had declined by 168,493 km(2) (30.2%) in 2010. The highest losses were recorded in Sabah and Kalimantan with 39.5% and 30.7% of their total forest area in 1973 becoming non-forest in 2010, and the lowest in Brunei and Sarawak (8.4%, and 23.1%). We estimate that the combined area planted in industrial oil palm and timber plantations in 2010 was 75,480 km(2), representing 10% of Borneo. We mapped 271,819 km of primary logging roads that were created between 1973 and 2010. The greatest density of logging roads was found in Sarawak, at 0.89 km km(-2), and the lowest density in Brunei, at 0.18 km km(- 2). Analyzing MODIS-based tree cover maps, we estimate that logging operated within 700 m of primary logging roads. Using this distance, we estimate that 266,257 km(2) of 1973 forest cover has been logged. With 389,566 km(2) (52.8%) of the island remaining forested, of which 209,649 km(2) remains intact. There is still hope for biodiversity conservation in Borneo. Protecting logged forests from fire and conversion to plantations is an urgent priority for reducing rates of deforestation in Borneo.	[Gaveau, David L. A.; Molidena, Elis; Yaen, Husna; Sheil, Doug; Nasi, Robert; Meijaard, Erik] Ctr Int Forestry Res, Bogor, Indonesia; [Sloan, Sean] James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; [Sheil, Doug] Norwegian Univ Life Sci NMBU, Dept Ecol & Nat Resource Management INA, As, Norway; [Abram, Nicola K.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Abram, Nicola K.; Ancrenaz, Marc; Meijaard, Erik] People & Nat Consulting Int, Borneo Futures Project, Jakarta, Indonesia; [Ancrenaz, Marc] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Ancrenaz, Marc] Kinabatangan Orang Utan Conservat Programme, HUTAN, Kota Kinabalu, Sabah, Malaysia; [Ancrenaz, Marc] Chester Zoo, North England Zool Soc, Chester, Cheshire, England; [Quinones, Marcela; Wielaard, Niels] SarVision, Wageningen, Netherlands; [Meijaard, Erik] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	CGIAR; Center for International Forestry Research (CIFOR); James Cook University; Norwegian University of Life Sciences; University of Kent; People & Nature Consulting International; University of Queensland	Gaveau, DLA (corresponding author), Ctr Int Forestry Res, Bogor, Indonesia.	d.gaveau@cgiar.org	Sheil, Douglas/A-3867-2015; Nasi, Robert/P-2382-2019; Sheil, Douglas/N-3291-2019; Nasi, Robert/A-3549-2015; Meijaard, Erik/A-2687-2016; Sloan, Sean/A-8630-2012; Abram, Nicola/K-2060-2014	Sheil, Douglas/0000-0002-1166-6591; Nasi, Robert/0000-0001-9739-3135; Nasi, Robert/0000-0001-9739-3135; Meijaard, Erik/0000-0001-8685-3685; Sloan, Sean/0000-0002-7834-0203; Abram, Nicola/0000-0003-1886-7297	Arcus foundation; CGIAR Research Program on Forests, Trees, and Agroforestry	Arcus foundation; CGIAR Research Program on Forests, Trees, and Agroforestry	This work was funded by the Arcus foundation and the CGIAR Research Program on Forests, Trees, and Agroforestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram NK, 2014, ECOSYSTEM S IN PRESS; Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; ARONOFF S, 1982, PHOTOGRAMM ENG REM S, V48, P1309; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Billand A., 2008, PRODUCTION FORETS CO; BROOKFIELD H, 1990, GLOBAL ENVIRON CHANG, V1, P42, DOI 10.1016/0959-3780(90)90006-U; Bryan JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069679; Butler R, 2013, TROPICAL RAINFOREST; Carlson KM, 2012, NATURE CLIMATE CHANG; Casson A, 2000, HESITANT BOOM INDONE; Clark CJ, 2009, CONSERV BIOL, V23, P1281, DOI 10.1111/j.1523-1739.2009.01243.x; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Edwards DP, 2013, SCIENCE, V339, P646, DOI 10.1126/science.339.6120.646-b; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fisher B, 2011, CONSERV LETT, V4, P443, DOI 10.1111/j.1755-263X.2011.00198.x; FOODY GM, 1992, PHOTOGRAMM ENG REM S, V58, P1459; Gaveau DLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069887; Giam X, 2011, BIOL CONSERVATION; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Goldammer JG, 1990, IMPACT DROUGHTS FORE, P11; Hoekman DH, 2010, IEEE J-STARS, V3, P605, DOI 10.1109/JSTARS.2010.2070059; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Margono BA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034010; Matricardi E, 2001, BSRSI RES ADV 2003 2; McKinnon K, 1996, ECOLOGY KALIMANTAN; Meijaard E, 2008, ECOL RES, V23, P21, DOI 10.1007/s11284-007-0342-7; Meijaard E, 2007, NATURE, V446, P974, DOI 10.1038/446974a; Meijaard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073008; Meijaard Erik, 2005, RESEARCH-CHINA; Ministry of Forestry, 2011, FOR STAT IND; Ministry of Forestry, 2011, LANDC MAP 2009 2010; Ministry of Forestry, 2000, LANDC MAP 2000; Monteiro AL, 2003, INT J REMOTE SENS, V24, P151, DOI 10.1080/01431160305008; Ngidang D., 2002, ASIA PACIFIC VIEWPOI, V43, P157, DOI DOI 10.1111/1467-8373.00171; Peres CA, 2006, TRENDS ECOL EVOL, V21, P227, DOI 10.1016/j.tree.2006.03.007; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Putz FE, 2012, CONSERVATION LETT; Rulequest, 2007, DAT MIN TOOLS SEE5; Satriastanti FE, 2012, JAKARTA POST; Shearman PL, 2009, BIOTROPICA, V41, P379, DOI 10.1111/j.1744-7429.2009.00495.x; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Souza C, 2000, INT J REMOTE SENS, V21, P173, DOI 10.1080/014311600211064; Souza Jr C, 2013, DEGRADATION MONITORI; Thomlinson JR, 1999, REMOTE SENS ENVIRON, V70, P16, DOI 10.1016/S0034-4257(99)00055-3; Townshead J.R.G., 2011, VEGETATION CONTINUOU; USGS, 2013, GLOB LAND SURV; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Walsh RPD, 1999, PHILOS T R SOC B, V354, P1869, DOI 10.1098/rstb.1999.0528; Wells J.A., 2013, FORESTS FLOODS PEOPL; Wilson K, 2010, MEANJIN, V69, P20	51	240	250	3	179	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101654	10.1371/journal.pone.0101654	http://dx.doi.org/10.1371/journal.pone.0101654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029192	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000341306600019
J	Lobato, FL; Barneche, DR; Siqueira, AC; Liedke, AMR; Lindner, A; Pie, MR; Bellwood, DR; Floeter, SR				Lobato, Fabio L.; Barneche, Diego R.; Siqueira, Alexandre C.; Liedke, Ana M. R.; Lindner, Alberto; Pie, Marcio R.; Bellwood, David R.; Floeter, Sergio R.			Diet and Diversification in the Evolution of Coral Reef Fishes	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; DAMSELFISHES POMACENTRIDAE; ANTIPREDATORY DEFENSES; MOLECULAR PHYLOGENIES; HERBIVOROUS FISHES; BAYESIAN-INFERENCE; CARIBBEAN SPONGES; FAMILY LABRIDAE; RED-SEA; RATES	The disparity in species richness among evolutionary lineages is one of the oldest and most intriguing issues in evolutionary biology. Although geographical factors have been traditionally thought to promote speciation, recent studies have underscored the importance of ecological interactions as one of the main drivers of diversification. Here, we test if differences in species richness of closely related lineages match predictions based on the concept of density-dependent diversification. As radiation progresses, ecological niche-space would become increasingly saturated, resulting in fewer opportunities for speciation. To assess this hypothesis, we tested whether reef fish niche shifts toward usage of low-quality food resources (i.e. relatively low energy/protein per unit mass), such as algae, detritus, sponges and corals are accompanied by rapid net diversification. Using available molecular information, we reconstructed phylogenies of four major reef fish clades (Acanthuroidei, Chaetodontidae, Labridae and Pomacentridae) to estimate the timing of radiations of their subclades. We found that the evolution of species-rich clades was associated with a switch to low quality food in three of the four clades analyzed, which is consistent with a density-dependent model of diversification. We suggest that ecological opportunity may play an important role in understanding the diversification of reef-fish lineages.	[Lobato, Fabio L.; Siqueira, Alexandre C.; Liedke, Ana M. R.; Lindner, Alberto; Floeter, Sergio R.] Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Barneche, Diego R.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Pie, Marcio R.] Univ Fed Parana, Setor Ciencias Biol, BR-80060000 Curitiba, Parana, Brazil; [Bellwood, David R.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bellwood, David R.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	Universidade Federal de Santa Catarina (UFSC); Macquarie University; Universidade Federal do Parana; James Cook University; James Cook University	Floeter, SR (corresponding author), Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil.	sergio.floeter@ufsc.br	Lindner, Alberto/E-1946-2013; Siqueira, Alexandre C./AAJ-5987-2020; Floeter, S. R./B-1438-2012	Siqueira, Alexandre C./0000-0001-7970-4024; Floeter, S. R./0000-0002-3201-6504; Barneche, Diego/0000-0002-4568-2362; Lindner, Alberto/0000-0003-3288-0885	Microsoft Corporation; CNPq [304897/2012-4, 309472/2011-3]; Australian Research Council	Microsoft Corporation(Microsoft); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Australian Research Council(Australian Research Council)	This work benefited from the Computational Biology Service Unit - Cornell University (CBSU Web Computing Interface), funded by Microsoft Corporation. Marcio R. Pie and Sergio R. Floeter were supported by CNPq (http://www.cnpq.br/) (MRP: 304897/2012-4; SRF: 309472/2011-3). David R. Bellwood was supported by the Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2007, EVOLUTION, V61, P2104, DOI 10.1111/j.1558-5646.2007.00182.x; Bannikov A.F., 1990, Studi e Ricerche sui Giacimenti Terziari di Bolca, V6, P133; Bannikov AF, 2004, STUDI RICERCHE GIACI, V13, P55; Bellwood DR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3046; Bellwood D.R., 1990, Studi e Ricerche sui Giacimenti Terziari di Bolca, V6, P149; Bellwood DR, 2010, J EVOLUTION BIOL, V23, P335, DOI 10.1111/j.1420-9101.2009.01904.x; Bellwood DR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4144; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2004, MOL PHYLOGENET EVOL, V33, P140, DOI 10.1016/j.ympev.2004.04.015; Bellwood DR, 1998, CORAL REEFS, V17, P187, DOI 10.1007/s003380050114; Bellwood DR, 1996, CORAL REEFS, V15, P11, DOI 10.1007/BF01626074; BOWEN SH, 1995, ECOLOGY, V76, P899, DOI 10.2307/1939355; BREY T, 1988, J EXP MAR BIOL ECOL, V117, P271, DOI 10.1016/0022-0981(88)90062-7; Brey T, 2010, J SEA RES, V64, P334, DOI 10.1016/j.seares.2010.05.002; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; BRUGGEMANN JH, 1994, MAR ECOL PROG SER, V106, P57, DOI 10.3354/meps106057; Burns E, 2003, MAR ECOL PROG SER, V252, P115, DOI 10.3354/meps252115; Burns E, 2003, MAR ECOL PROG SER, V252, P105, DOI 10.3354/meps252105; Choat J.H., 1991, P39; Choat JH, 1998, ANNU REV ECOL SYST, V29, P375, DOI 10.1146/annurev.ecolsys.29.1.375; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Choat JH, 2012, BIOL J LINN SOC, V107, P529, DOI 10.1111/j.1095-8312.2012.01959.x; Clements KD, 2004, MOL PHYLOGENET EVOL, V32, P575, DOI 10.1016/j.ympev.2004.02.003; Cooper WJ, 2009, MOL PHYLOGENET EVOL, V52, P1, DOI 10.1016/j.ympev.2008.12.010; Cooper WJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-24; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Cowman PF, 2013, J BIOGEOGR, V40, P209, DOI 10.1111/jbi.12003; Cowman PF, 2009, MOL PHYLOGENET EVOL, V52, P621, DOI 10.1016/j.ympev.2009.05.015; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Elliott JP, 2003, J FISH BIOL, V63, P1598, DOI 10.1111/j.1095-8649.2003.00272.x; Eschmeyer WN, 2012, CATALOG FISHES; Espeland M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-254; Ferreira CEL, 1998, J FISH BIOL, V53, P222, DOI 10.1006/jfbi.1998.0824; Ferry-Graham LA, 2001, J MORPHOL, V248, P120, DOI 10.1002/jmor.1024; Fessler JL, 2007, MOL PHYLOGENET EVOL, V45, P50, DOI 10.1016/j.ympev.2007.05.018; Floeter SR, 2004, J FISH BIOL, V64, P1680, DOI 10.1111/j.0022-1112.2004.00428.x; Frederich B, 2013, AM NAT, V181, P94, DOI 10.1086/668599; Harmelin-Vivien Mireille L., 2002, P265, DOI 10.1016/B978-012615185-5/50016-5; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hay M.E., 1991, P96; Hoey AS, 2012, P ROY SOC B-BIOL SCI, V279, P2426, DOI 10.1098/rspb.2011.2679; Horn M.H., 1989, Oceanography and Marine Biology an Annual Review, V27, P167; Horn MH, 1998, PHYSL FISHES, P41; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jones RS, 1968, MICRONESICA, V4, P310; Kazancioglu E, 2009, P ROY SOC B-BIOL SCI, V276, P3439, DOI 10.1098/rspb.2009.0876; Klanten SO, 2004, MOL PHYLOGENET EVOL, V32, P221, DOI 10.1016/j.ympev.2003.11.008; Konow N, 2008, BIOL J LINN SOC, V93, P545, DOI 10.1111/j.1095-8312.2007.00893.x; Kotrschal K, 1988, J ZOOLOG SYST EVOL R, V26, P51; Kramer MJ, 2013, CORAL REEFS, V32, P575, DOI 10.1007/s00338-013-1009-1; Kuiter R. H., 2010, LABRIDAE FISHES WRAS; Kuiter R. H., 2002, BUTTERFLYFISHES BANN; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; Maddison WP, 2011, MESQUITE MODULAR SYS; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Meylan A, 1991, NEW PERSPECTIVES SPO, P472; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paul Valerie J., 1992, P164; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; Price SA, 2010, EVOLUTION, V64, P3057, DOI 10.1111/j.1558-5646.2010.01036.x; PURCELL SW, 1993, ENVIRON BIOL FISH, V37, P139, DOI 10.1007/BF00000589; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Rambaut A, 2013, TRACER VERSION 1 6; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Ricklefs RE, 2003, P ROY SOC B-BIOL SCI, V270, P2285, DOI 10.1098/rspb.2003.2489; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Ruber L, 2005, EVOLUTION, V59, P1119; Sanderson MJ, 1996, AM J BOT, V83, P1488, DOI 10.2307/2446103; SANDERSON MJ, 1994, SOC GEN PHY, V49, P13; Sepkoski JJ, 1998, PHILOS T R SOC B, V353, P315, DOI 10.1098/rstb.1998.0212; Smith LL, 2008, MOL PHYLOGENET EVOL, V49, P136, DOI 10.1016/j.ympev.2008.06.008; Streelman JT, 2002, EVOLUTION, V56, P961; Tang KL, 1999, MOL PHYLOGENET EVOL, V11, P415, DOI 10.1006/mpev.1998.0596; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vermeij GJ, 2000, PALEOBIOLOGY, V26, P419, DOI 10.1666/0094-8373(2000)026<0419:DHATAO>2.0.CO;2; Wainwright PC, 2004, BIOL J LINN SOC, V82, P1, DOI 10.1111/j.1095-8312.2004.00313.x; Wainwright Peter C., 2002, P33, DOI 10.1016/B978-012615185-5/50004-9; WALKER TD, 1984, AM NAT, V124, P887, DOI 10.1086/284322; Westneat MW, 2005, MOL PHYLOGENET EVOL, V36, P370, DOI 10.1016/j.ympev.2005.02.001; White JW, 2010, ECOLOGY, V91, P1949, DOI 10.1890/09-0298.1; Williams ST, 2008, EVOLUTION, V62, P1618, DOI 10.1111/j.1558-5646.2008.00399.x; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279	94	37	38	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102094	10.1371/journal.pone.0102094	http://dx.doi.org/10.1371/journal.pone.0102094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029229	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000341306600035
J	Piszczek, J; Mamdani, M; Antoniou, T; Juurlink, DN; Gomes, T				Piszczek, Jolanta; Mamdani, Muhammad; Antoniou, Tony; Juurlink, David N.; Gomes, Tara			The Impact of Drug Reimbursement Policy on Rates of Testosterone Replacement Therapy among Older Men	PLOS ONE			English	Article							MIDDLE-AGED MEN; BODY-COMPOSITION; TIME-SERIES; TRENDS; ENDOCRINE; AUSTRALIA; MORTALITY; STRENGTH	Background: Despite a lack of data describing the long-term efficacy and safety of testosterone replacement therapy (TRT), prescribing of testosterone to older men has increased with the availability of topical formulations. The magnitude of this increase and the impact of formulary restrictions on testosterone prescribing are poorly characterized. Methods: We conducted a time series analysis using the linked health administrative records of men aged 66 years or older in Ontario, Canada between January 1, 1997 and March 31, 2012. We used interventional autoregressive integrated moving average models to examine the impact of a restrictive drug reimbursement policy on testosterone prescribing and examined the demographic profile of men initiating testosterone in the final 2 years of the study period. Results: A total of 28,477 men were dispensed testosterone over the study period. Overall testosterone prescribing declined 27.9% in the 6 months following the implementation of the restriction policy (9.5 to 6.9 men per 1000 eligible; p<0.01). However, the overall decrease was temporary and testosterone use exceeded pre-policy levels by the end of the study period (11.0 men per 1000 eligible), largely driven by prescriptions for topical testosterone (4.8 men per 1000 eligible). Only 6.3% of men who initiated testosterone had a documented diagnosis of hypogonadism, the main criteria for TRT reimbursement according to the new policy. Conclusion: Government-imposed restrictions did not influence long-term prescribing of testosterone to older men. By 2012, approximately 1 in every 90 men aged 66 or older was being treated with TRT, most with topical formulations.	[Piszczek, Jolanta; Mamdani, Muhammad; Antoniou, Tony; Gomes, Tara] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Mamdani, Muhammad; Juurlink, David N.; Gomes, Tara] ICES, Toronto, ON, Canada; [Antoniou, Tony] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada; [Juurlink, David N.] Sunnybrook Hlth Sci Ctr, Dept Med, Div Clin Pharmacol & Toxicol, Toronto, ON M4N 3M5, Canada; [Mamdani, Muhammad] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Mamdani, Muhammad; Gomes, Tara] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Hospital for Sick Children (SickKids); Sunnybrook Health Science Center; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Gomes, T (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada.	gomest@smh.ca		Gomes, Tara/0000-0002-1468-1965	Ontario Ministry of Health and Long-Term Care (MOHLTC) Drug Innovation Fund; Institute for Clinical Evaluative Sciences (ICES) - Ontario MOHLTC; Ontario HIV Treatment Network	Ontario Ministry of Health and Long-Term Care (MOHLTC) Drug Innovation Fund; Institute for Clinical Evaluative Sciences (ICES) - Ontario MOHLTC; Ontario HIV Treatment Network	This study was supported by a grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC) Drug Innovation Fund and the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario MOHLTC. Tony Antoniou is funded by a post-doctoral fellowship from the Ontario HIV Treatment Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions, results, and conclusions are those of the authors, and no endorsement by Ontario's Ministry of Health and Long-term Care or by the Institute for Clinical Evaluative Sciences is intended or should be inferred.	Baillargeon J, 2013, JAMA INTERN MED, V173, P1465, DOI 10.1001/jamainternmed.2013.6895; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Braun SR, 2013, JAMA INTERN MED, V173, P1458, DOI 10.1001/jamainternmed.2013.6892; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Dobs AS, 1990, J CLIN ENDOCR METAB, V84, P3469; Edelstein Daniel, 2006, Expert Opin Emerg Drugs, V11, P685, DOI 10.1517/14728214.11.4.685; Eggertson L, 2011, CAN MED ASSOC J, V183, pE1161, DOI 10.1503/cmaj.109-4000; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Gomes Tara, 2011, Open Med, V5, pe13; Handelsman DJ, 2013, MED J AUSTRALIA, V199, P548, DOI 10.5694/mja13.10111; Handelsman DJ, 2012, MED J AUSTRALIA, V196, P642, DOI 10.5694/mja11.11277; Handelsman DJ, 2004, MED J AUSTRALIA, V181, P419, DOI 10.5694/j.1326-5377.2004.tb06364.x; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Helfenstein U, 1996, Stat Methods Med Res, V5, P3, DOI 10.1177/096228029600500102; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x; Kenny AM, 2002, J GERONTOL A-BIOL, V57, pM321, DOI 10.1093/gerona/57.5.M321; Kermode-Scott B, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5501; Liverman KT, 2004, TESTOSTERONE AGING C; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Mamdani M, 2007, AM J MED, V120, P893, DOI 10.1016/j.amjmed.2007.02.028; Marshall BL, 2009, MED STUDIES, V1, P249, DOI DOI 10.1007/S12376-009-0019-3; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Quail JM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-146; Schoenfeld MJ, 2013, J SEX MED, V10, P1401, DOI 10.1111/jsm.12114; Schwartz L, 2013, JAMA INTERN MED, V173, P1; Shores MM, 2009, J CLIN PSYCHIAT, V70, P1009, DOI 10.4088/JCP.08m04478; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Snyder PJ, 2000, J CLIN ENDOCR METAB, V85, P2670, DOI 10.1210/jc.85.8.2670; Szeinbach SL, 2012, PATIENT PREFER ADHER, V6, P631, DOI 10.2147/PPA.S35840; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; Wang C, 2008, EUR J ENDOCRINOL, V159, P507, DOI 10.1530/EJE-08-0601; Weeks C., 2012, GLOBE MAIL; Weir MA, 2012, J ONCOL PRACT, V8, P179, DOI 10.1200/JOP.2011.000287	35	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e98003	10.1371/journal.pone.0098003	http://dx.doi.org/10.1371/journal.pone.0098003			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029014	Green Submitted, gold, Green Published			2022-12-25	WOS:000341306600002
J	Salmi, R; Hammerschmidt, K; Doran-Sheehy, DM				Salmi, Roberta; Hammerschmidt, Kurt; Doran-Sheehy, Diane M.			Individual Distinctiveness in Call Types of Wild Western Female Gorillas	PLOS ONE			English	Article							SPEAR-NOSED BATS; VOCAL REPERTOIRE; ACOUSTIC STRUCTURE; CONTACT CALLS; LOWLAND GORILLAS; GEOGRAPHIC VARIATIONS; SAGUINUS-OEDIPUS; MACACA-SYLVANUS; SEX-DIFFERENCES; SOCIAL-FACTORS	Individually distinct vocalizations play an important role in animal communication, allowing call recipients to respond differentially based on caller identity. However, which of the many calls in a species' repertoire should have more acoustic variability and be more recognizable is less apparent. One proposed hypothesis is that calls used over long distances should be more distinct because visual cues are not available to identify the caller. An alternative hypothesis proposes that close calls should be more recognizable because of their importance in social interactions. To examine which hypothesis garners more support, the acoustic variation and individual distinctiveness of eight call types of six wild western gorilla (Gorilla gorilla) females were investigated. Acoustic recordings of gorilla calls were collected at the Mondika Research Center (Republic of Congo). Acoustic variability was high in all gorilla calls. Similar high inter-individual variation and potential for identity coding (PIC) was found for all call types. Discriminant function analyses confirmed that all call types were individually distinct (although for call types with lowest sample size - hum, grumble and scream - this result cannot be generalized), suggesting that neither the distance at which communication occurs nor the call social function alone can explain the evolution of identity signaling in western gorilla communication.	[Salmi, Roberta] Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; [Salmi, Roberta] SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci, Stony Brook, NY 11794 USA; [Hammerschmidt, Kurt] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Doran-Sheehy, Diane M.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA	University System of Georgia; University of Georgia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Deutsches Primatenzentrum (DPZ); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Salmi, R (corresponding author), Univ Georgia, Dept Anthropol, Athens, GA 30602 USA.	roberta.salmi@gmail.com	salmi, roberta/AAD-6267-2021; Doran-Sheehy, Diane/GXV-9571-2022	Salmi, Roberta/0000-0001-5745-2014	Leakey Foundation; Wildlife Direct and Richard Leakey; Primate Action Fund; Primate Conservation Inc.; Sigma Xi; Stony Brook University	Leakey Foundation; Wildlife Direct and Richard Leakey; Primate Action Fund; Primate Conservation Inc.; Sigma Xi; Stony Brook University	The Leakey Foundation, Wildlife Direct and Richard Leakey, the Primate Action Fund, Primate Conservation Inc., Sigma Xi, and Stony Brook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold BD, 2011, BEHAV ECOL SOCIOBIOL, V65, P1581, DOI 10.1007/s00265-011-1168-4; Barros KS, 2011, ETHOLOGY, V117, P83, DOI 10.1111/j.1439-0310.2010.01853.x; Berg KS, 2011, ANIM BEHAV, V81, P241, DOI 10.1016/j.anbehav.2010.10.012; Bergman TJ, 2010, P ROY SOC B-BIOL SCI, V277, P3045, DOI 10.1098/rspb.2010.0580; Bezerra BM, 2010, INT J PRIMATOL, V31, P759, DOI 10.1007/s10764-010-9427-1; Blumstein DT, 1997, ANIM BEHAV, V53, P143, DOI 10.1006/anbe.1996.0285; Bouchet H, 2012, J COMP PSYCHOL, V126, P45, DOI 10.1037/a0025018; Bouchet H, 2010, AM J PRIMATOL, V72, P360, DOI 10.1002/ajp.20791; Boughman JW, 1997, BEHAV ECOL SOCIOBIOL, V40, P61, DOI 10.1007/s002650050316; Boughman JW, 1998, ANIM BEHAV, V55, P1717, DOI 10.1006/anbe.1997.0721; Briefer E, 2011, APPL ANIM BEHAV SCI, V133, P175, DOI 10.1016/j.applanim.2011.05.012; Carter GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038791; Charlton BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020329; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; Charrier I, 2001, POLAR BIOL, V24, P378, DOI 10.1007/s003000100231; Charrier I, 2003, ANIM BEHAV, V65, P543, DOI 10.1006/anbe.2003.2073; Cheney DL, 2004, INT J PRIMATOL, V25, P401, DOI 10.1023/B:IJOP.0000019159.75573.13; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; Cheney DL, 1996, ANIM BEHAV, V52, P507, DOI 10.1006/anbe.1996.0193; Cheney Dorothy L., 2007, BABOON METAPHYSICS; Clay Z, 2011, ETHOLOGY, V117, P1158, DOI 10.1111/j.1439-0310.2011.01975.x; CLEVELAND J, 1982, Z TIERPSYCHOL, V58, P231; Crockford C, 2004, ETHOLOGY, V110, P221, DOI 10.1111/j.1439-0310.2004.00968.x; Crockford C, 2007, ANIM BEHAV, V73, P885, DOI 10.1016/j.anbehav.2006.10.016; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; Digweed SM, 2007, AM J PRIMATOL, V69, P829, DOI 10.1002/ajp.20398; Doran-Sheehy DM, 2007, AM J PRIMATOL, V69, P1354, DOI 10.1002/ajp.20442; Doran-Sheehy DM, 2004, AM J PRIMATOL, V64, P207, DOI 10.1002/ajp.20075; Dunbar RIM, 1996, GROOMING GOSSIP EVOL; Evans CS, 2007, BIOL LETTERS, V3, P8, DOI 10.1098/rsbl.2006.0561; Fichtel C, 2002, ETHOLOGY, V108, P763, DOI 10.1046/j.1439-0310.2002.00816.x; Fischer J, 2004, ANIM BEHAV, V67, P655, DOI 10.1016/j.anbehav.2003.08.006; Fischer J, 2002, FOLIA PRIMATOL, V73, P32, DOI 10.1159/000060417; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fischer J, 2001, ANIM BEHAV, V61, P925, DOI 10.1006/anbe.2000.1687; Fischer J, 2001, ETHOLOGY, V107, P33, DOI 10.1046/j.1439-0310.2001.00630.x; Fischer J, 2013, AM J PRIMATOL, V75, P643, DOI 10.1002/ajp.22153; Fugate JMB, 2008, AM J PRIMATOL, V70, P594, DOI 10.1002/ajp.20533; Gatti S, 2004, AM J PRIMATOL, V63, P111, DOI 10.1002/ajp.20045; Ghazanfar AA, 2004, NAT REV NEUROSCI, V5, P603, DOI 10.1038/nrn1473; Ghazanfar AA, 2007, NATURE, V448, P535, DOI 10.1038/448535a; Griebel U., 2008, EVOLUTION COMMUNICAT, P9, DOI [DOI 10.7551/MITPRESS/9780262151214.003.0002, 10.7551/mitpress/7650.003.0006, DOI 10.7551/MITPRESS/7650.003.0006]; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Hammerschmidt K., 1994, P287; HAMMERSCHMIDT K, 1995, BEHAVIOUR, V132, P381, DOI 10.1163/156853995X00621; Harcourt AH, 1996, BEHAVIOUR, V133, P827, DOI 10.1163/156853996X00260; HARCOURT AH, 1993, BEHAVIOUR, V124, P89, DOI 10.1163/156853993X00524; Harcourt AH, 2007, GORILLA SOC CONFLICT, Vxviii; HAUSER MD, 1991, ETHOLOGY, V89, P29; HAUSER MD, 1992, J ACOUST SOC AM, V91, P2175, DOI 10.1121/1.403676; Hawkins ER, 2010, J ACOUST SOC AM, V128, P924, DOI 10.1121/1.3459837; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hoffmann LS, 2012, ADV EXP MED BIOL, V730, P141, DOI 10.1007/978-1-4419-7311-5_31; Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881; Jansen DAWAM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-97; Jouventin P, 2002, ANIM BEHAV, V64, P747, DOI 10.1006/anbe.2002.4002; Klecka W. R., 1980, DISCRIMINANT ANAL; Kojima S, 2003, PRIMATES, V44, P225, DOI 10.1007/s10329-002-0014-8; Koren L, 2011, BEHAV ECOL SOCIOBIOL, V65, P675, DOI 10.1007/s00265-010-1069-y; Kreiman J., 1997, TALKER VARIABILITY S, P85; Leavesley AJ, 2005, ANIM BEHAV, V70, P365, DOI 10.1016/j.anbehav.2004.10.017; Leighty KA, 2008, ANIM BEHAV, V76, P1601, DOI 10.1016/j.anbehav.2008.06.022; Leliveld LMC, 2011, J ACOUST SOC AM, V129, P2278, DOI 10.1121/1.3559680; Lemasson A, 2011, J ACOUST SOC AM, V129, P3341, DOI 10.1121/1.3569704; Lemasson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045106; Lemasson A, 2011, ADV INTERACT STUD, V1, P39; Levrero F, 2013, AM J PRIMATOL, V75, P324, DOI 10.1002/ajp.22108; MACEDONIA JM, 1993, ETHOLOGY, V93, P177, DOI 10.1111/j.1439-0310.1993.tb00988.x; Maciej P, 2013, BEHAV ECOL SOCIOBIOL, V67, P61, DOI 10.1007/s00265-012-1425-1; Maciej P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023015; Magliocca F, 1999, AM J PRIMATOL, V48, P1, DOI 10.1002/(SICI)1098-2345(1999)48:1<1::AID-AJP1>3.0.CO;2-2; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; MARLER P, 1967, SCIENCE, V157, P769, DOI 10.1126/science.157.3790.769; Marler P., 1976, GROWING POINTS ETHOL, P239; Mathevon N, 2010, BMC BIOL, V10, P3; Miller CT, 2012, J COMP PHYSIOL A, V198, P337, DOI 10.1007/s00359-012-0712-7; Mitani JC, 1996, INT J PRIMATOL, V17, P569, DOI 10.1007/BF02735192; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; OCKLEFORD EM, 1988, EARLY HUM DEV, V18, P27, DOI 10.1016/0378-3782(88)90040-0; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; Owren MJ, 2003, J COMP PSYCHOL, V117, P380, DOI 10.1037/0735-7036.117.4.380; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; PALOMBIT RA, 1992, INT J PRIMATOL, V13, P183, DOI 10.1007/BF02547840; Parnell RJ, 2002, AM J PRIMATOL, V56, P193, DOI 10.1002/ajp.1074; Pfefferle D, 2006, ANIM BEHAV, V72, P43, DOI 10.1016/j.anbehav.2005.08.021; Pollard KA, 2011, BEHAV ECOL, V22, P93, DOI 10.1093/beheco/arq179; Pollard KA, 2011, CURR BIOL, V21, P413, DOI 10.1016/j.cub.2011.01.051; Price T, 2009, BEHAVIOUR, V146, P871, DOI 10.1163/156853908X396610; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Rendall D, 2004, J ACOUST SOC AM, V115, P411, DOI 10.1121/1.1635838; Rendall D, 1998, J ACOUST SOC AM, V103, P602, DOI 10.1121/1.421104; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; Rendall D, 2009, J ACOUST SOC AM, V125, P1792, DOI 10.1121/1.3068453; Riede T, 2003, J ACOUST SOC AM, V114, P1132, DOI 10.1121/1.1580812; ROBINSON J G, 1981, Primates, V22, P161, DOI 10.1007/BF02382607; ROBISSON P, 1993, ETHOLOGY, V94, P279; Salmi R, 2013, ETHOLOGY, V119, P831, DOI 10.1111/eth.12122; Schehka S, 2009, BEHAV BRAIN RES, V203, P223, DOI 10.1016/j.bbr.2009.05.007; Seyfarth RM, 2003, ANN NY ACAD SCI, V1000, P32, DOI 10.1196/annals.1280.004; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; Sharp SP, 2005, NATURE, V434, P1127, DOI 10.1038/nature03522; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Snowdon Charles T., 1997, P234, DOI 10.1017/CBO9780511758843.012; SNOWDON CT, 1980, ANIM BEHAV, V28, P717, DOI 10.1016/S0003-3472(80)80131-X; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Spillmann B, 2010, ETHOLOGY, V116, P385, DOI 10.1111/j.1439-0310.2010.01744.x; Theis KR, 2007, BEHAVIOUR, V144, P557, DOI 10.1163/156853907780713046; van Schaik CP, 2003, LIFE HIST COGNITIVE, P5; Vannoni E, 2007, ETHOLOGY, V113, P223, DOI 10.1111/j.1439-0310.2006.01323.x; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; WATTS DP, 1989, ETHOLOGY, V81, P1; Watts DP, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P351; Watts DP, 1997, BEHAVIOUR, V134, P23, DOI 10.1163/156853997X00269; Weiss DJ, 2001, J COMP PSYCHOL, V115, P258, DOI 10.1037/0735-7036.115.3.258; West B. T., 2006, LINEAR MIXED MODELS, P180; Wittig RM, 2007, P R SOC B, V274, P1109, DOI 10.1098/rspb.2006.0203	117	19	19	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101940	10.1371/journal.pone.0101940	http://dx.doi.org/10.1371/journal.pone.0101940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029238	Green Submitted, Green Published, gold			2022-12-25	WOS:000341306600027
J	Fang, L; Xu, Z; Wang, GS; Ji, FY; Mei, CX; Liu, J; Wu, GM				Fang, Li; Xu, Zhi; Wang, Guan-song; Ji, Fu-yun; Mei, Chun-xia; Liu, Juan; Wu, Guo-ming			Directed Evolution of an LBP/CD14 Inhibitory Peptide and Its Anti-Endotoxin Activity	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN; LPS BINDING-PROTEIN; GRAM-NEGATIVE BACTERIA; ACUTE LUNG INJURY; INFLAMMATORY RESPONSES; ANTI-CD14 ANTIBODY; SEPTIC SHOCK; SOLUBLE CD14; IN-VITRO; LBP	Background: LPS-binding protein (LBP) and its ligand CD14 are located upstream of the signaling pathway for LPS-induced inflammation. Blocking LBP and CD14 binding might prevent LPS-induced inflammation. In previous studies, we obtained a peptide analog (MP12) for the LBP/ CD14 binding site and showed that this peptide analog had anti-endotoxin activity. In this study, we used in vitro directed evolution for this peptide analog to improve its in vivo and in vitro anti-endotoxin activity. Methods: We used error-prone PCR (ep-PCR) and induced mutations in the C-terminus of LBP and attached the PCR products to T7 phages to establish a mutant phage display library. The positive clones that competed with LBP for CD14 binding was obtained by screening. We used both in vivo and in vitro experiments to compare the anti-endotoxin activities of a polypeptide designated P1 contained in a positive clone and MP12. Results: 11 positive clones were obtained from among target phages. Sequencing showed that 9 positive clones had a threonine (T) to methionine (M) mutation in amino acid 287 of LBP. Compared to polypeptide MP12, polypeptide P1 significantly inhibited LPS-induced TNF-alpha expression and NF-kappa B activity in U937 cells (P < 0.05). Compared to MP12, P1 significantly improved arterial oxygen pressure, an oxygenation index, and lung pathology scores in LPS-induced ARDS rats (P < 0.05). Conclusion: By in vitro directed evolution of peptide analogs for the LBP/ CD14 binding site, we established a new polypeptide (P1) with a threonine (T)-to-methionine (M) mutation in amino acid 287 of LBP. This polypeptide had high anti-endotoxin activity in vitro and in vivo, which suggested that amino acid 287 in the C-terminus of LBP may play an important role in LBP binding with CD14.	[Fang, Li; Xu, Zhi; Wang, Guan-song; Ji, Fu-yun; Mei, Chun-xia; Liu, Juan; Wu, Guo-ming] Third Mil Med Univ, Inst Resp Dis, Xinqiao Hosp, Chongqing, Peoples R China	Army Medical University	Wu, GM (corresponding author), Third Mil Med Univ, Inst Resp Dis, Xinqiao Hosp, Chongqing, Peoples R China.	cg2014fl@163.com		Xu, Zhi/0000-0003-1199-6635; Wang, Guansong/0000-0002-5184-0777	National Natural Science Foundation of China [30971189, 81070053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (30971189,81070053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana MD, 2003, J ENDOTOXIN RES, V9, P281, DOI 10.1177/09680519030090050301; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; CHEN KQ, 1993, P NATL ACAD SCI USA, V90, P5618, DOI 10.1073/pnas.90.12.5618; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Fortin PD, 2005, J BIOL CHEM, V280, P42307, DOI 10.1074/jbc.M510456200; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hardin AO, 2006, BIOCHEM BIOPH RES CO, V342, P547, DOI 10.1016/j.bbrc.2006.02.005; HAZIOT A, 1993, J IMMUNOL, V151, P1500; Heumann D, 2003, J ENDOTOXIN RES, V9, P381, DOI 10.1179/0963805103225003312; Heumann D, 2001, J ENDOTOXIN RES, V7, P439, DOI 10.1177/09680519010070060701; Hristova M, 2003, INFLAMM RES, V52, P1, DOI 10.1007/s000110300007; Iovine N, 2002, J BIOL CHEM, V277, P7970, DOI 10.1074/jbc.M109622200; Kitchens RL, 2003, J ENDOTOXIN RES, V9, P113, DOI 10.1179/096805103125001504; Lamping N, 1996, J IMMUNOL, V157, P4648; Le Roy D, 1999, J IMMUNOL, V162, P7454; MARTIN TR, 1994, J LEUKOCYTE BIOL, V56, P1; Olszyna DP, 2003, EUR CYTOKINE NETW, V14, P158; Parsons PE, 2000, CLIN CHEST MED, V21, P467, DOI 10.1016/S0272-5231(05)70159-3; Patel HJ, 2003, J IMMUNOL, V170, P2663, DOI 10.4049/jimmunol.170.5.2663; SCHUMANN RR, 1992, RES IMMUNOL, V143, P11, DOI 10.1016/0923-2494(92)80074-U; Sohn EJ, 2007, VET RES, V38, P95, DOI 10.1051/vetres:2006052; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Su X, 2004, INTENS CARE MED, V30, P133, DOI 10.1007/s00134-003-2001-y; TAYLOR AH, 1995, J BIOL CHEM, V270, P17934, DOI 10.1074/jbc.270.30.17934; THEOFAN G, 1994, J IMMUNOL, V152, P3623; Tobias PS, 1999, CLIN INFECT DIS, V28, P476, DOI 10.1086/515163; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Verbon A, 2001, J IMMUNOL, V166, P3599, DOI 10.4049/jimmunol.166.5.3599; WRIGHT SD, 1989, J EXP MED, V170, P1231, DOI 10.1084/jem.170.4.1231; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025; Xu Z, 2009, INFLAMM RES, V58, P45, DOI 10.1007/s00011-008-8178-3; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zweigner J, 2006, MICROBES INFECT, V8, P946, DOI 10.1016/j.micinf.2005.10.006	36	13	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101406	10.1371/journal.pone.0101406	http://dx.doi.org/10.1371/journal.pone.0101406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025695	gold, Green Submitted, Green Published			2022-12-25	WOS:000339992400015
J	Lee, SM; Choi, HJ; Oh, CH; Oh, JW; Han, JS				Lee, Se-Min; Choi, Hye-Jin; Oh, Cheong-Hae; Oh, Jae-Won; Han, Joong-Soo			Leptin Increases TNF-alpha Expression and Production through Phospholipase D1 in Raw 264.7 Cells	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; INDUCED NEURITE OUTGROWTH; TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; P70 S6 KINASE; PROTEIN-KINASE; MAMMALIAN TARGET; DENDRITIC CELLS; BODY-WEIGHT; H19-7 CELLS	Epidemiological evidence suggests that obesity is associated with inflammation of the respiratory tract and the pathogenesis of asthma. The purpose of this study was to examine the role of phospholipase D1 (PLD1) in leptin-induced expression of the proinflammatory cytokine, tumor necrosis factor (TNF)-alpha, and to suggest a molecular link between obesity and respiratory tract inflammation. We investigated whether leptin, a typical adipocytokine, plays a role in the expression of TNF-alpha through increased PLD1 activity in Raw 264.7. Leptin enhanced the activity of PLD1 through activation of PLC gamma and Src, while PLD1 siRNA decreased the leptin-induced expression and production of TNF-alpha. Leptin-induced PLD activation was also inhibited by a PLCc inhibitor (PAO) and Src kinase inhibitor (PP2), indicating that PLCc and Src kinase are upstream activators of PLD1. Down-regulation of PLD1 also completely blocked activation of p70S6K, an activator of JNK. Leptin-induced expression of TNF-alpha was also prevented by inhibition of p70S6K and JNK. Taken together, these results indicate that PLD1 acts as an important regulator of leptin-induced expression of TNF-alpha by participating in the PLCc/Src/PLD1/PA/ p70S6K/JNK pathway.	[Choi, Hye-Jin; Oh, Cheong-Hae; Han, Joong-Soo] Hanyang Univ, Biomed Res Inst, Coll Med, Seoul 133791, South Korea; [Choi, Hye-Jin; Oh, Cheong-Hae; Han, Joong-Soo] Hanyang Univ, Dept Biochem & Mol Biol, Coll Med, Seoul 133791, South Korea; [Lee, Se-Min; Oh, Jae-Won] Hanyang Univ, Dept Pediat, Coll Med, Seoul 133791, South Korea	Hanyang University; Hanyang University; Hanyang University	Han, JS (corresponding author), Hanyang Univ, Biomed Res Inst, Coll Med, Seoul 133791, South Korea.	jshan@hanyang.ac.kr	Han, Joong-Soo/P-2072-2015	Han, Joong-Soo/0000-0002-0875-6158	Korea Science and Engineering Foundation through the Medical Research Center at Hanyang University College of Medicine, Republic of Korea [NRF-2012R1A5A2A34671243]; National Research Foundation of Korea (NRF) - Mid-career Researcher Program [NRF-2010-0026844]	Korea Science and Engineering Foundation through the Medical Research Center at Hanyang University College of Medicine, Republic of Korea; National Research Foundation of Korea (NRF) - Mid-career Researcher Program	This study was supported by the Korea Science and Engineering Foundation (NRF-2012R1A5A2A34671243) through the Medical Research Center at Hanyang University College of Medicine, Republic of Korea, and the National Research Foundation of Korea (NRF), funded by the Mid-career Researcher Program (NRF-2010-0026844). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Cat MA, 2003, J NEUROCHEM, V84, P413, DOI 10.1046/j.1471-4159.2003.01562.x; Anand AR, 2008, J IMMUNOL, V180, P5636, DOI 10.4049/jimmunol.180.8.5636; Bandyopadhaya A, 2009, MOL IMMUNOL, V46, P1129, DOI 10.1016/j.molimm.2008.11.003; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Choi Y, 2009, BRIT J PHARMACOL, V156, P933, DOI 10.1111/j.1476-5381.2009.00022.x; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hatziieremia S, 2006, BRIT J PHARMACOL, V149, P188, DOI 10.1038/sj.bjp.0706856; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Jones D, 1999, BBA-MOL CELL BIOL L, V1439, P229, DOI 10.1016/S1388-1981(99)00097-9; Kang HK, 2004, INT IMMUNOPHARMACOL, V4, P911, DOI 10.1016/j.intimp.2004.04.001; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Kim JH, 2008, J BIOL CHEM, V283, P708, DOI 10.1074/jbc.M708568200; Kim Sung-Jo, 2010, J Periodontal Implant Sci, V40, P119, DOI 10.5051/jpis.2010.40.3.119; Kraiss LW, 2000, AM J PHYSIOL-HEART C, V278, pH1537, DOI 10.1152/ajpheart.2000.278.5.H1537; Lee CH, 2008, MOL IMMUNOL, V45, P3693, DOI 10.1016/j.molimm.2008.06.007; Lee JS, 2005, J CELL SCI, V118, P4405, DOI 10.1242/jcs.02564; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Lin CI, 2008, CELL SIGNAL, V20, P1804, DOI 10.1016/j.cellsig.2008.06.008; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Mancuso P, 2004, AM J PHYSIOL-LUNG C, V287, pL497, DOI 10.1152/ajplung.00010.2004; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; Mattioli B, 2005, J IMMUNOL, V174, P6820, DOI 10.4049/jimmunol.174.11.6820; Maya-Monteiro CM, 2008, J BIOL CHEM, V283, P2203, DOI 10.1074/jbc.M706706200; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nakashima S, 1999, CHEM PHYS LIPIDS, V98, P153, DOI 10.1016/S0009-3084(99)00027-4; Oh DY, 2008, J NEUROSCI RES, V86, P1557, DOI 10.1002/jnr.21602; Oh DY, 2007, J CELL BIOCHEM, V101, P221, DOI 10.1002/jcb.21166; Okenwa C, 2013, J IMMUNOL, V191, P2589, DOI 10.4049/jimmunol.1300466; Park SY, 2008, CYTOKINE, V44, P126, DOI 10.1016/j.cyto.2008.07.006; Park SY, 2009, J BIOL CHEM, V284, P20099, DOI 10.1074/jbc.M109.010017; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shen JH, 2005, LIFE SCI, V77, P1502, DOI 10.1016/j.lfs.2005.04.004; Shore SA, 2005, J ALLERGY CLIN IMMUN, V115, P103, DOI 10.1016/j.jaci.2004.10.007; Shore SA, 2010, J APPL PHYSIOL, V108, P735, DOI 10.1152/japplphysiol.00749.2009; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Takekoshi K, 2001, ENDOCRINOLOGY, V142, P4861, DOI 10.1210/en.142.11.4861; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; Vaughan T, 2010, MOL IMMUNOL, V47, P2515, DOI 10.1016/j.molimm.2010.06.006; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; YAMAKAWA T, 1995, CLIN IMMUNOL IMMUNOP, V75, P51, DOI 10.1006/clin.1995.1052; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158	50	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102373	10.1371/journal.pone.0102373	http://dx.doi.org/10.1371/journal.pone.0102373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047119	Green Published, gold, Green Submitted			2022-12-25	WOS:000339558100028
J	Ali, MA; Wieczorek, K; Kreil, DP; Bohlmann, H				Ali, Muhammad Amjad; Wieczorek, Krzysztof; Kreil, David P.; Bohlmann, Holger			The Beet Cyst Nematode Heterodera schachtii Modulates the Expression of WRKY Transcription Factors in Syncytia to Favour Its Development in Arabidopsis Roots	PLOS ONE			English	Article							GENE-EXPRESSION; PSEUDOMONAS-SYRINGAE; NEGATIVE REGULATORS; RESISTANCE; SENESCENCE; CAMALEXIN; THALIANA; KINASE; PLANTS; STRESS	Cyst nematodes invade the roots of their host plants as second stage juveniles and induce a syncytium which is the only source of nutrients throughout their life. A recent transcriptome analysis of syncytia induced by the beet cyst nematode Heterodera schachtii in Arabidopsis roots has shown that thousands of genes are up-regulated or down-regulated in syncytia as compared to root segments from uninfected plants. Among the down-regulated genes are many which code for WRKY transcription factors. Arabidopsis contains 66 WRKY genes with 59 represented by the ATH1 GeneChip. Of these, 28 were significantly down-regulated and 6 up-regulated in syncytia as compared to control root segments. We have studied here the down-regulated genes WRKY6, WRKY11, WRKY17 and WRKY33 in detail. We confirmed the down-regulation in syncytia with promoter:: GUS lines. Using various overexpression lines and mutants it was shown that the down-regulation of these WRKY genes is important for nematode development, probably through interfering with plant defense reactions. In case of WRKY33, this might involve the production of the phytoalexin camalexin.	[Ali, Muhammad Amjad; Wieczorek, Krzysztof; Bohlmann, Holger] Univ Nat Resources & Life Sci, Dept Crop Sci, Div Plant Protect, Vienna, Austria; [Ali, Muhammad Amjad] Univ Agr Faisalabad, Ctr Agr Biochem & Biotechnol, Dept Plant Pathol, Faisalabad, Pakistan; [Kreil, David P.] Univ Nat Resources & Life Sci, Dept Biotechnol, Chair Bioinformat, Vienna, Austria; [Kreil, David P.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Natural Resources & Life Sciences, Vienna; University of Agriculture Faisalabad; University of Natural Resources & Life Sciences, Vienna; University of Warwick	Bohlmann, H (corresponding author), Univ Nat Resources & Life Sci, Dept Crop Sci, Div Plant Protect, Vienna, Austria.	holger.bohlmann@boku.ac.at	Wieczorek, Krzysztof/ABD-4894-2020; Ali, Muhammad/GXH-4405-2022; Kreil, D/O-1783-2013; ali, muhammad/GYR-3505-2022; Ali, Muhammad Amjad/D-3335-2013	Ali, Muhammad/0000-0002-1444-7888; Kreil, D/0000-0001-7538-2056; Ali, Muhammad Amjad/0000-0001-5381-7039	Austrian Science Fund [P20471-B11]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (P20471-B11): www.fwf.ac.at. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Ali MA, 2013, PLANT J, V74, P852, DOI 10.1111/tpj.12170; Ali MA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-47; Ali MA, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-37; Andreasson E, 2005, EMBO J, V24, P2579, DOI 10.1038/sj.emboj.7600737; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Babitha KC, 2013, TRANSGENIC RES, V22, P327, DOI 10.1007/s11248-012-9645-8; Bar-Or C, 2005, EUR J PLANT PATHOL, V111, P181, DOI 10.1007/s10658-004-2134-z; Barcala M, 2010, PLANT J, V61, P698, DOI 10.1111/j.1365-313X.2009.04098.x; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Bottcher C, 2009, PLANT CELL, V21, P1830, DOI 10.1105/tpc.109.066670; Chen YF, 2009, PLANT CELL, V21, P3554, DOI 10.1105/tpc.108.064980; EPPLE P, 1995, PLANT PHYSIOL, V109, P813, DOI 10.1104/pp.109.3.813; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Geng XQ, 2012, PLANT CELL, V24, P4763, DOI 10.1105/tpc.112.105312; Goellner M, 2001, PLANT CELL, V13, P2241, DOI 10.1105/tpc.13.10.2241; Grunewald W, 2008, PLANT PHYSIOL, V148, P358, DOI 10.1104/pp.108.119131; Hammes UZ, 2005, MOL PLANT MICROBE IN, V18, P1247, DOI 10.1094/MPMI-18-1247; Holtorf S, 1995, PLANT MOL BIOL, V29, P637, DOI 10.1007/BF00041155; HUANG JS, 1991, PLANT PHYSIOL, V96, P1302, DOI 10.1104/pp.96.4.1302; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510; Jammes F, 2005, PLANT J, V44, P447, DOI 10.1111/j.1365-313X.2005.02532.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Ju rgensen K, 2001, UNTERSUCHUNGEN ZUM A; Kasajima I, 2010, PHYSIOL PLANTARUM, V139, P80, DOI 10.1111/j.1399-3054.2010.01349.x; Li GJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002767; Lippok B, 2007, MOL PLANT MICROBE IN, V20, P420, DOI 10.1094/MPMI-20-4-0420; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logemann E, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-16; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Matthews BF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-96; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Petersen K, 2008, PLANT SIGNAL BEHAV, V3, P1033, DOI 10.4161/psb.6878; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Puthoff DP, 2003, PLANT J, V33, P911, DOI 10.1046/j.1365-313X.2003.01677.x; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Schon M, 2013, MOL PLANT MICROBE IN, V26, P758, DOI 10.1094/MPMI-11-12-0265-R; Schuhegger R, 2006, PLANT PHYSIOL, V141, P1248, DOI 10.1104/pp.106.082024; Siddique S, 2011, PLANT PHYSIOL BIOCH, V49, P1100, DOI 10.1016/j.plaphy.2011.07.005; Siddique S, 2009, NEW PHYTOL, V184, P457, DOI 10.1111/j.1469-8137.2009.02981.x; SIJMONS PC, 1991, PLANT J, V1, P245, DOI 10.1111/j.1365-313X.1991.00245.x; Sobczak M, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P61, DOI 10.1007/978-94-007-0434-3_4; Szakasits D, 2007, PLANT MOL BIOL REP, V25, P115, DOI 10.1007/s11105-007-0013-4; Szakasits D, 2009, PLANT J, V57, P771, DOI 10.1111/j.1365-313X.2008.03727.x; Takemoto D, 2005, PLANT PHYSIOL, V138, P1491, DOI 10.1104/pp.104.058388; VEECH JA, 1982, J NEMATOL, V14, P2; Wang QS, 2011, GENETICA, V139, P973, DOI 10.1007/s10709-011-9599-4; Wieczorek K, 2008, PLANT J, V53, P336, DOI 10.1111/j.1365-313X.2007.03340.x; Wieczorek K, 2006, PLANT J, V48, P98, DOI 10.1111/j.1365-313X.2006.02856.x; Xing DH, 2008, MOL PLANT, V1, P459, DOI 10.1093/mp/ssn020; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x	61	39	43	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102360	10.1371/journal.pone.0102360	http://dx.doi.org/10.1371/journal.pone.0102360			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033038	gold, Green Submitted, Green Published			2022-12-25	WOS:000339418300050
J	Crisan, AF; Oancea, C; Timar, B; Fira-Mladinescu, O; Crisan, A; Tudorache, V				Crisan, Alexandru F.; Oancea, Cristian; Timar, Bogdan; Fira-Mladinescu, Ovidiu; Crisan, Alexandru; Tudorache, Voicu			Cognitive Impairment in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							OLD-AGE; DECLINE; INFLAMMATION; DEMENTIA; MARKERS; PROGRESSION; RISK; COPD	Background/Purpose: Chronic obstructive pulmonary disease (COPD), especially in severe forms, is commonly associated with multiple cognitive problems. Montreal Cognitive Assessment test (MoCA) is used to detect cognitive impairment evaluating several areas: visuospatial, memory, attention and fluency. Our study aim was to evaluate the impact of stable COPD and exacerbation (AECOPD) phases on cognitive status using MoCA questionnaire. Methods: We enrolled 39 patients (pts), smokers with COPD group D (30 stable and 9 in AECOPD) and 13 healthy subjects (control group), having similar level of education and no significant differences regarding the anthropometric measurements. We analyzed the differences in MoCA score between these three groups and also the correlation between this score and inflammatory markers. Results: Patients with AECOPD had a significant (p, 0.001) decreased MoCA score (14.6 +/- 3.4) compared to stable COPD (20.2 +/- 2.4) and controls (24.2 +/- 5.8). The differences between groups were more accentuated for the language abstraction and attention (p<0.001) and delayed recall and orientation (p<0.001) sub-topics. No significant variance of score was observed between groups regarding visuospatial and naming score (p = 0.095). The MoCA score was significantly correlated with forced expiratory volume (r = 0.28) and reverse correlated with C-reactive protein (CRP) (r = -0.57), fibrinogen (r = -0.58), erythrocyte sedimentation rate (ESR) (r = -0.55) and with the partial pressure of CO2 (r = -0.47). Conclusions: According to this study, COPD significantly decreases the cognitive status in advanced and acute stages of the disease.	[Crisan, Alexandru F.; Oancea, Cristian; Fira-Mladinescu, Ovidiu; Tudorache, Voicu] Univ Med & Farm Timisoara, Dept Pulmonol, Timisoara, Romania; [Timar, Bogdan] Univ Med & Farm Timisoara, Dept Biostat & Med Informat, Timisoara, Romania; [Crisan, Alexandru] Univ Med & Farm Timisoara, Dept Infect Dis, Timisoara, Romania	Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Oancea, C (corresponding author), Univ Med & Farm Timisoara, Dept Pulmonol, Timisoara, Romania.	oancea@umft.ro	Crișan, Alexandru/AHE-4031-2022; Fira-Mladinescu, Ovidiu/C-5736-2011	Fira-Mladinescu, Ovidiu/0000-0002-9034-5218				Antonelli-Incalzi R, 2006, CHEST, V130, P1687, DOI 10.1378/chest.130.6.1687; Areza-Fegyveres Renata, 2010, Dement. neuropsychol., V4, P14, DOI 10.1590/S1980-57642010DN40100003; Butterfield DA, 2007, J ALZHEIMERS DIS, V12, P61; Celli BR, 2007, EUR RESPIR J, V29, P1224, DOI 10.1183/09031936.00109906; Di Carlo A, 2007, NEUROLOGY, V68, P1909, DOI 10.1212/01.wnl.0000263132.99055.0d; Dong YH, 2012, INT PSYCHOGERIATR, V24, P1749, DOI 10.1017/S1041610212001068; GRANT I, 1982, ARCH INTERN MED, V142, P1470, DOI 10.1001/archinte.142.8.1470; HEATON RK, 1983, ARCH INTERN MED, V143, P1941, DOI 10.1001/archinte.143.10.1941; Incalzi RA, 1998, RESP MED, V92, P527, DOI 10.1016/S0954-6111(98)90303-1; Isoaho R, 1996, Int Psychogeriatr, V8, P113, DOI 10.1017/S1041610296002517; Jones PW, 2006, EUR RESPIR J, V27, P822, DOI 10.1183/09031936.06.00145104; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rafnsson SB, 2007, J AM GERIATR SOC, V55, P700, DOI 10.1111/j.1532-5415.2007.01158.x; Sabia S, 2012, ARCH GEN PSYCHIAT, V69, P627, DOI 10.1001/archgenpsychiatry.2011.2016; Schram MT, 2007, J AM GERIATR SOC, V55, P708, DOI 10.1111/j.1532-5415.2007.01159.x; Smith T, 2007, CAN J PSYCHIAT, V52, P329, DOI 10.1177/070674370705200508; Solfrizzi V, 2006, CLIN CHIM ACTA, V364, P91, DOI 10.1016/j.cca.2005.06.015; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; Villeneuve S, 2012, CHEST, V142, P1516, DOI 10.1378/chest.11-3035; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x	22	39	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102468	10.1371/journal.pone.0102468	http://dx.doi.org/10.1371/journal.pone.0102468			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033379	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300053
J	Chen, CM; Chen, IC; Huang, YC; Juan, HF; Chen, YL; Chen, YC; Lin, CH; Lee, LC; Lee, CM; Lee-Chen, GJ; Lai, YJ; Wu, YR				Chen, Chiung-Mei; Chen, I-Cheng; Huang, Yi-Cheng; Juan, Hsueh-Fen; Chen, Ying-Lin; Chen, Yi-Chun; Lin, Chih-Hsin; Lee, Li-Ching; Lee, Chi-Mei; Lee-Chen, Guey-Jen; Lai, Yun-Ju; Wu, Yih-Ru			FBXO7 Y52C Polymorphism as a Potential Protective Factor in Parkinson's Disease	PLOS ONE			English	Article							EARLY-ONSET PARKINSONISM; BOX PROTEIN FBXO7; F-BOX; MUTATIONS; ATP13A2; GENE	Mutations in the F-box only protein 7 gene (FBXO7), the substrate-specifying subunit of SCF E3 ubiquitin ligase complex, cause Parkinson's disease (PD)-15 (PARK15). To identify new variants, we sequenced FBXO7 cDNA in 80 Taiwanese early onset PD patients (age at onset <= 50) and only two known variants, Y52C (c.155A>G) and M115I (c.345G> A), were found. To assess the association of Y52C and M115I with the risk of PD, we conducted a case-control study in a cohort of PD and ethnically matched controls. There was a nominal difference in the Y52C G allele frequency between PD and controls (p = 0.045). After combining data from China [1], significant difference in the Y52C G allele frequency between PD and controls (p = 0.012) and significant association of G allele with decreased PD risk (p = 0.017) can be demonstrated. Upon expressing EGFP-tagged Cys52 FBXO7 in cells, a significantly reduced rate of FBXO7 protein decay was observed when compared with cells expressing Tyr52 FBXO7. In silico modeling of Cys52 exhibited a more stable feature than Tyr52. In cells expressing Cys52 FBXO7, the level of TNF receptor-associated factor 2 (TRAF2) was significantly reduced. Moreover, Cys52 FBXO7 showed stronger interaction with TRAF2 and promoted TRAF2 ubiquitination, which may be responsible for the reduced TRAF2 expression in Cys52 cells. After induced differentiation, SH-SY5Y cells expressing Cys52 FBXO7 displayed increased neuronal outgrowth. We therefore hypothesize that Cys52 variant of FBXO7 may contribute to reduced PD susceptibility in Chinese.	[Chen, Chiung-Mei; Chen, I-Cheng; Chen, Yi-Chun; Lin, Chih-Hsin; Wu, Yih-Ru] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan; [Huang, Yi-Cheng; Chen, Ying-Lin; Lee, Li-Ching; Lee, Chi-Mei; Lee-Chen, Guey-Jen; Lai, Yun-Ju] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Juan, Hsueh-Fen] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Taiwan Normal University; National Taiwan University	Lee-Chen, GJ (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	t43019@ntnu.edu.tw; yunjulai@ntnu.edu.tw; yihruwu@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020	Chen, I-Cheng/0000-0001-6235-6289; JUAN, HSUEH-FEN/0000-0003-4876-3309	National Science Council [NSC99-2628-B-182A-063-MY3, NSC100-2325-B-003-001]; Executive Yuan; Chang Gung Memorial Hospital [CMRPG3D005]; National Taiwan Normal University, Taipei, Taiwan [NTNU100-D-02]	National Science Council(Ministry of Science and Technology, Taiwan); Executive Yuan; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Taiwan Normal University, Taipei, Taiwan	This work was supported by grants NSC99-2628-B-182A-063-MY3 and NSC100-2325-B-003-001 from National Science Council, Executive Yuan, CMRPG3D005 from Chang Gung Memorial Hospital, and NTNU100-D-02 from National Taiwan Normal University, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang YF, 2006, BIOCHEM BIOPH RES CO, V342, P1022, DOI 10.1016/j.bbrc.2006.02.061; Chen CM, 2011, AM J MED GENET B, V156B, P720, DOI 10.1002/ajmg.b.31214; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; Flood PM, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/216298; Fung HC, 2006, NEUROSCI LETT, V394, P33, DOI 10.1016/j.neulet.2005.10.005; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Ilyin GP, 2000, GENOMICS, V67, P40, DOI 10.1006/geno.2000.6211; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; Kirk R, 2008, J BIOL CHEM, V283, P22325, DOI 10.1074/jbc.M709900200; Kuiken HJ, 2012, J CELL MOL MED, V16, P2140, DOI 10.1111/j.1582-4934.2012.01524.x; Laman H, 2006, CELL CYCLE, V5, P279, DOI 10.4161/cc.5.3.2403; Lee LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035302; Lin CH, 2013, NEUROBIOL AGING, V34; Luo LZ, 2010, NEUROSCI LETT, V482, P86, DOI 10.1016/j.neulet.2010.06.083; Matsuda N, 2010, J ALZHEIMERS DIS, V19, P1, DOI 10.3233/JAD-2010-1231; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; Paisan-Ruiz C, 2010, MOVEMENT DISORD, V25, P1791, DOI 10.1002/mds.23221; Phani Sudarshan, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS207, DOI 10.1016/S1353-8020(11)70064-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shojaee S, 2008, AM J HUM GENET, V82, P1375, DOI 10.1016/j.ajhg.2008.05.005; SIDELL N, 1982, J NATL CANCER I, V68, P589; Spatola M., 2014, PARKINSONISM RELA S1, V20, pS35, DOI DOI 10.1016/S1353-8020(13)70011-7; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vilarino-Guell C, 2014, HUM MOL GENET, V23, P1794, DOI 10.1093/hmg/ddt570; Wu YR, 2010, AM J MED GENET B, V153B, P229, DOI 10.1002/ajmg.b.30977; Zhao T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048911; Zhao TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016983; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	30	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101392	10.1371/journal.pone.0101392	http://dx.doi.org/10.1371/journal.pone.0101392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029497	gold, Green Published, Green Submitted			2022-12-25	WOS:000341306600014
J	Cui, JH; Du, XL; Liu, H; Hu, GC; Lv, GP; Xu, BH; Yang, XR; Li, W; Cui, ZG				Cui, Jinghua; Du, Xiaoli; Liu, Hui; Hu, Guangchun; Lv, Guoping; Xu, Baohong; Yang, Xiaorong; Li, Wei; Cui, Zhigang			The Genotypic Characterization of Cronobacter spp. Isolated in China	PLOS ONE			English	Article							ENTEROBACTER-SAKAZAKII; INFANT FORMULA; GENUS; TURICENSIS; INFECTION; OUTBREAK; PROPOSAL; MILK; NOV.; FOOD	Cronobacter spp. (Enterobacter sakazakii) is an important pathogen contaminating powdered infant formula (PIF). To describe the genotypic diversity of Cronobacter isolated in China, we identified the isolates using fusA allele sequencing, and subtyped all of the isolates using pulsed-field gel electrophoresis (PFGE), multi-locus sequence typing (MLST), and multiple-locus variable-number tandem-repeat analysis (MLVA). A total of 105 isolates were identified, which included C. sakazakii (58 isolates), C. malonaticus (30 isolates), C. dublinensis (11 isolates), C. turicensis (5 isolates), and C. muytjensii (1 isolate). These isolates were showed to have 85 PFGE-patterns, 71 sequence types (STs), and 55 MLVA-patterns. Comparisons among the three molecular subtyping methods revealed that the PFGE method was the most distinguishable tool in identifying clusters of Cronobacter spp. through DNA fingerprinting, and MLST method came second. However, ESTR-1, ESTR-2, ESTR-3, and ESTR-4 were not effective loci for subtyping Cronobacter spp. such that the MLVA method requires further improvement.	[Cui, Jinghua; Du, Xiaoli; Li, Wei; Cui, Zhigang] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Liu, Hui; Hu, Guangchun] Jinan Municipal Ctr Dis Control & Prevent, Jinan, Peoples R China; [Lv, Guoping; Xu, Baohong] Shijiazhuang Municipal Ctr Dis Control & Prevent, Shijiazhuang, Peoples R China; [Yang, Xiaorong] Sichuan Prov Ctr Dis Control & Prevent, Chengdu, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Cui, ZG (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	cuizhigang@icdc.cn			National Science and Technology Key Project, China [2012ZX10004-215]	National Science and Technology Key Project, China	This study was supported by the National Science and Technology Key Project, China (No. 2012ZX10004-215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARSENI A, 1987, J HOSP INFECT, V9, P143, DOI 10.1016/0195-6701(87)90052-1; BIERING G, 1989, J CLIN MICROBIOL, V27, P2054, DOI 10.1128/JCM.27.9.2054-2056.1989; Brady C, 2013, SYST APPL MICROBIOL, V36, P309, DOI 10.1016/j.syapm.2013.03.005; Brengi SP, 2012, FOODBORNE PATHOG DIS, V9, P861, DOI 10.1089/fpd.2012.1161; Caubilla-Barron J, 2007, J CLIN MICROBIOL, V45, P3979, DOI 10.1128/JCM.01075-07; Edelson-Mammel SG, 2005, J FOOD PROTECT, V68, P1900, DOI 10.4315/0362-028X-68.9.1900; El-Sharoud WM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-24; Farber JM, 2004, LANCET, V363, P5, DOI 10.1016/S0140-6736(03)15244-0; Friedemann M, 2009, EUR J CLIN MICROBIOL, V28, P1297, DOI 10.1007/s10096-009-0779-4; Friedemann M, 2007, INT J FOOD MICROBIOL, V116, P1, DOI 10.1016/j.ijfoodmicro.2006.12.018; GALLAGHER PG, 1991, PEDIATR RADIOL, V21, P135, DOI 10.1007/BF02015629; Gosney MA, 2006, EUR J INTERN MED, V17, P185, DOI 10.1016/j.ejim.2005.11.010; Grim CJ, 2012, APPL ENVIRON MICROB, V78, P6035, DOI 10.1128/AEM.01457-12; Iversen C, 2004, INT J FOOD MICROBIOL, V96, P133, DOI 10.1016/j.ijfoodmicro.2004.01.024; Iversen C, 2008, INT J SYST EVOL MICR, V58, P1442, DOI 10.1099/ijs.0.65577-0; Joseph S, 2012, J CLIN MICROBIOL, V50, P3031, DOI 10.1128/JCM.00905-12; Joseph S, 2013, MOL CELL PROBE, V27, P137, DOI 10.1016/j.mcp.2013.02.002; Joseph S, 2012, INT J SYST EVOL MICR, V62, P1277, DOI 10.1099/ijs.0.032292-0; Joseph S, 2011, EMERG INFECT DIS, V17, P1713, DOI 10.3201/eid1709.110260; Kim JB, 2008, YONSEI MED J, V49, P1017, DOI 10.3349/ymj.2008.49.6.1017; Kim JB, 2011, J MICROBIOL BIOTECHN, V21, P509, DOI 10.4014/jmb.1007.07059; Lai KK, 2001, MEDICINE, V80, P113, DOI 10.1097/00005792-200103000-00004; Miled-Bennour R, 2010, INT J FOOD MICROBIOL, V139, P116, DOI 10.1016/j.ijfoodmicro.2010.01.045; Mullane NR, 2008, APPL ENVIRON MICROB, V74, P1223, DOI 10.1128/AEM.01726-07; Mullane NR, 2007, INT J FOOD MICROBIOL, V116, P73, DOI 10.1016/j.ijfoodmicro.2006.12.036; Proudy I, 2008, J APPL MICROBIOL, V104, P26, DOI 10.1111/j.1365-2672.2007.03526.x; See KC, 2007, AGE AGEING, V36, P595, DOI 10.1093/ageing/afm092; Seo KH, 2005, J FOOD PROTECT, V68, P59, DOI 10.4315/0362-028X-68.1.59; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	29	15	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102179	10.1371/journal.pone.0102179	http://dx.doi.org/10.1371/journal.pone.0102179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029018	gold, Green Submitted, Green Published			2022-12-25	WOS:000341306600042
J	DosSantos, MF; Martikainen, IK; Nascimento, TD; Love, TM; DeBoer, MD; Schambra, HM; Bikson, M; Zubieta, JK; DaSilva, AF				DosSantos, Marcos F.; Martikainen, Ilkka K.; Nascimento, Thiago D.; Love, Tiffany M.; DeBoer, Misty D.; Schambra, Heidi M.; Bikson, Marom; Zubieta, Jon-Kar; DaSilva, Alexandre F.			Building up Analgesia in Humans via the Endogenous mu-Opioid System by Combining Placebo and Active tDCS: A Preliminary Report	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; MEDIAL PREFRONTAL CORTEX; MOTOR CORTEX; PERIAQUEDUCTAL GRAY; NEUROPATHIC PAIN; BACK-PAIN; BRAIN; MODULATION; ANTICIPATION	Transcranial Direct Current Stimulation (tDCS) is a method of non-invasive brain stimulation that has been frequently used in experimental and clinical pain studies. However, the molecular mechanisms underlying tDCS-mediated pain control, and most important its placebo component, are not completely established. In this pilot study, we investigated in vivo the involvement of the endogenous mu-opioid system in the global tDCS-analgesia experience. Nine healthy volunteers went through positron emission tomography (PET) scans with [C-11] carfentanil, a selective m-opioid receptor (MOR) radiotracer, to measure the central MOR activity during tDCS in vivo (non-displaceable binding potential, BPND) - one of the main analgesic mechanisms in the brain. Placebo and real anodal primary motor cortex (M1/2mA) tDCS were delivered sequentially for 20 minutes each during the PET scan. The initial placebo tDCS phase induced a decrease in MOR BPND in the periaqueductal gray matter (PAG), precuneus, and thalamus, indicating activation of endogenous mu-opioid neurotransmission, even before the active tDCS. The subsequent real tDCS also induced MOR activation in the PAG and precuneus, which were positively correlated to the changes observed with placebo tDCS. Nonetheless, real tDCS had an additional MOR activation in the left prefrontal cortex. Although significant changes in the MOR BPND occurred with both placebo and real tDCS, significant analgesic effects, measured by improvements in the heat and cold pain thresholds, were only observed after real tDCS, not the placebo tDCS. This study gives preliminary evidence that the analgesic effects reported with M1-tDCS, can be in part related to the recruitment of the same endogenous MOR mechanisms induced by placebo, and that such effects can be purposely optimized by real tDCS.	[DosSantos, Marcos F.; Martikainen, Ilkka K.; Nascimento, Thiago D.; DeBoer, Misty D.; DaSilva, Alexandre F.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [DosSantos, Marcos F.; Martikainen, Ilkka K.; Nascimento, Thiago D.; DeBoer, Misty D.; DaSilva, Alexandre F.] Univ Michigan, Sch Dent, MCOHR, Ann Arbor, MI 48109 USA; [Martikainen, Ilkka K.; Love, Tiffany M.; Zubieta, Jon-Kar; DaSilva, Alexandre F.] Univ Michigan, Translat Neuroimaging Lab, MBNI, Ann Arbor, MI 48109 USA; [Schambra, Heidi M.] Columbia Univ, Dept Neurol, New York, NY USA; [Schambra, Heidi M.] Columbia Univ, Dept Rehabil & Regenerat Med, New York, NY USA; [Bikson, Marom] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; Columbia University; City University of New York (CUNY) System; City College of New York (CUNY)	DaSilva, AF (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	adasilva@umich.edu	DosSantos, Marcos/AAR-7308-2020; Zubieta, Jon-Kar/AAB-5565-2022; Nascimento, Thiago/GNH-3833-2022; Love, Tiffany/W-8427-2019; DosSantos, Marcos/E-8913-2014	DosSantos, Marcos/0000-0002-5997-9693; Nascimento, Thiago/0000-0003-0910-9005; Love, Tiffany/0000-0001-9299-3190; DosSantos, Marcos/0000-0002-5997-9693	Michigan Institute for Clinical & Health Research Clinical Trial Planning Program/CTSA, University of Michigan [UL1RR024986]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil; University of Michigan, Ann Arbor, United States of America; Swedish Cultural Foundation in Finland, Helsinki, Finland; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER	Michigan Institute for Clinical & Health Research Clinical Trial Planning Program/CTSA, University of Michigan; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); University of Michigan, Ann Arbor, United States of America; Swedish Cultural Foundation in Finland, Helsinki, Finland; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the following grants: Dr. DaSilva, the principal investigator of the study, was supported by Michigan Institute for Clinical & Health Research Clinical Trial Planning Program/CTSA high-tech funding UL1RR024986, University of Michigan. Dr. Santos was also supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil, and by the University of Michigan, Ann Arbor, United States of America. Dr. Martikainen was supported by the Swedish Cultural Foundation in Finland, Helsinki, Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Amer Assoc Electrodiagnost Med, 2004, MUSCLE NERVE, V29, P734, DOI 10.1002/mus.20053; Antal A, 2011, NEUROIMAGE, V55, P590, DOI 10.1016/j.neuroimage.2010.11.085; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Bachmann CG, 2010, CLIN NEUROPHYSIOL, V121, P2083, DOI 10.1016/j.clinph.2010.05.005; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Boggio PS, 2009, NEUROPSYCHOLOGIA, V47, P212, DOI 10.1016/j.neuropsychologia.2008.07.022; DANNALS RF, 1985, INT J APPL RADIAT IS, V36, P303, DOI 10.1016/0020-708X(85)90089-4; DaSilva AF, 2012, HEADACHE; DaSilva AF, 2011, JOVE-J VIS EXP, DOI 10.3791/2744; DaSilva AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003396; DaSilva AFM, 2007, NEUROREPORT, V18, P301, DOI 10.1097/WNR.0b013e32801776bb; de Andrade DC, 2011, PAIN, V152, P320, DOI 10.1016/j.pain.2010.10.032; DosSantos Marcos Fabio, 2012, Front Psychiatry, V3, P93, DOI 10.3389/fpsyt.2012.00093; Essick GK, 2004, J OROFAC PAIN, V18, P345; Fregni F, 2006, ARTHRITIS RHEUM-US, V54, P3988, DOI 10.1002/art.22195; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Garcia-Larrea L, 1999, PAIN, V83, P259, DOI 10.1016/S0304-3959(99)00114-1; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hansson P, 2007, PAIN, V129, P256, DOI 10.1016/j.pain.2007.03.030; Harris RE, 2009, NEUROIMAGE, V47, P1077, DOI 10.1016/j.neuroimage.2009.05.083; Jewett DM, 2001, NUCL MED BIOL, V28, P733, DOI 10.1016/S0969-8051(01)00226-8; Jin CW, 2013, NMR BIOMED, V26, P58, DOI 10.1002/nbm.2819; Johnson S, 2006, PAIN, V123, P187, DOI 10.1016/j.pain.2006.02.030; Jurgens TP, 2012, EUR J PAIN, V16, P1251, DOI 10.1002/j.1532-2149.2012.00135.x; Kano M, 2013, AM J PHYSL GASTROINT; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Leppa M, 2006, NEUROIMAGE, V31, P661, DOI 10.1016/j.neuroimage.2005.12.019; LEVINE JD, 1978, LANCET, V2, P654, DOI 10.1016/S0140-6736(78)92762-9; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lorenz J, 2002, NEURON, V35, P383, DOI 10.1016/S0896-6273(02)00767-5; Luedtke K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048857; Maarrawi J, 2007, NEUROLOGY, V69, P827, DOI 10.1212/01.wnl.0000269783.86997.37; Mainero C, 2011, ANN NEUROL, V70, P838, DOI 10.1002/ana.22537; Maleki N, 2013, NMR BIOMED; Metz AE, 2009, P NATL ACAD SCI USA, V106, P2423, DOI 10.1073/pnas.0809897106; MINOSHIMA S, 1993, J NUCL MED, V34, P322; Moloney TM, 2013, NEUROSCI LETT, V534, P289, DOI 10.1016/j.neulet.2012.11.049; Mylius V, 2012, PAIN, V153, P1350, DOI 10.1016/j.pain.2012.04.009; Nahmias F, 2009, PAIN, V147, P224, DOI 10.1016/j.pain.2009.09.016; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; O'Connell NE, 2013, CLIN J PAIN, V29, P26, DOI 10.1097/AJP.0b013e318247ec09; O'Connell NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047514; O'Connell NE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008208.pub2; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Porro CA, 2002, J NEUROSCI, V22, P3206, DOI 10.1523/JNEUROSCI.22-08-03206.2002; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Schestatsky P, 2011, ARQ NEURO-PSIQUIAT, V69, P943, DOI 10.1590/S0004-282X2011000700019; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Stagg CJ, 2013, J NEUROSCI, V33, P11425, DOI 10.1523/JNEUROSCI.3887-12.2013; Summers J, 2004, NEUROSCI LETT, V368, P197, DOI 10.1016/j.neulet.2004.07.008; Taylor JJ, 2013, NEUROPSYCHOPHARMACOL; Taylor JJ, 2012, PAIN, V153, P1219, DOI 10.1016/j.pain.2012.02.030; Villamar MF, 2013, JOVE-J VIS EXP, DOI 10.3791/50309; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027; Watson A, 2009, PAIN, V145, P24, DOI 10.1016/j.pain.2009.04.003; Wrigley PJ, 2013, PAIN, V154, P2178, DOI 10.1016/j.pain.2013.06.045; Wu D, 2013, EXP BRAIN RES; YARNITSKY D, 1994, J NEUROL SCI, V125, P39, DOI 10.1016/0022-510X(94)90239-9; Youssef AM, 2013, PAIN; Zheng X, 2011, NEUROIMAGE, V58, P26, DOI 10.1016/j.neuroimage.2011.06.018; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005; Zubieta JK, 2009, ANN NY ACAD SCI, V1156, P198, DOI 10.1111/j.1749-6632.2009.04424.x; Zyloney CE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-80	69	52	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102350	10.1371/journal.pone.0102350	http://dx.doi.org/10.1371/journal.pone.0102350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029273	Green Published, gold			2022-12-25	WOS:000341306600068
J	Edmonds, MD; Eischen, CM				Edmonds, Mick D.; Eischen, Christine M.			Differences in miRNA Expression in Early Stage Lung Adenocarcinomas that Did and Did Not Relapse	PLOS ONE			English	Article							COMPARING CANCER TISSUES; MICRORNA EXPRESSION; TUMOR MICROENVIRONMENT; GENE-EXPRESSION; CELL CARCINOMA; FREE SURVIVAL; SIGNATURE; METAANALYSIS; MIGRATION; INVASION	Relapse of adenocarcinoma, the most common non-small cell lung cancer (NSCLC), is a major clinical challenge to improving survival. To gain insight into the early molecular events that contribute to lung adenocarcinoma relapse, and taking into consideration potential cell type specificity, we used stringent criteria for sample selection. We measured miRNA expression only from flash frozen stage I lung adenocarcinomas, excluding other NSCLC subtypes. We compared miRNA expression in lung adenocarcinomas that relapsed within two years to those that did not relapse within three years after surgical resection prior to adjuvant therapy. The most significant differences in mRNA expression for recurrent tumors compared to non-recurrent tumors were decreases in miR-106b*, -187, -205, -449b, -774* and increases in miR-151-3p, let-7b, miR-215, -520b, and -512-3p. A unique comparison between adjacent normal lung tissue from relapse and non-relapse groups revealed dramatically different miRNA expression, suggesting dysregulation of miRNA in the environment around the tumor. To assess patient-to-patient variability, miRNA levels in the tumors were normalized to levels in matched adjacent normal lung tissue. This analysis revealed a different set of significantly altered miRNA in tumors that recurred compared to tumors that did not. Together our analyses elucidated miRNA not previously linked to lung adenocarcinoma that likely have important roles in its development and progression. Our results also highlight the differences in miRNA expression in normal lung tissue in adenocarcinomas that do and do not recur. Most notably, our data identified those miRNA that distinguish early stage tumors likely to relapse prior to treatment and miRNA that could be further studied for use as biomarkers for prognosis, patient monitoring, and/or treatment decisions.	[Edmonds, Mick D.; Eischen, Christine M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA	Vanderbilt University	Eischen, CM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.	christine.eischen@vanderbilt.edu			American Cancer Society-Kirby Foundations Fund Postdoctoral Fellowship [PF-13-088-01-CSM]; Vanderbilt-Ingram Cancer Center Thoracic Program from the National Center for Advancing Translational Sciences [CTSA UL1TR000445]; National Cancer Institute [P50CA090949, P30CA068485]; Vanderbilt Department of Pathology, Microbiology and Immunology; NATIONAL CANCER INSTITUTE [P50CA090949, T32CA119925, P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER	American Cancer Society-Kirby Foundations Fund Postdoctoral Fellowship; Vanderbilt-Ingram Cancer Center Thoracic Program from the National Center for Advancing Translational Sciences; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt Department of Pathology, Microbiology and Immunology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the American Cancer Society-Kirby Foundations Fund Postdoctoral Fellowship PF-13-088-01-CSM (MDE), the Vanderbilt-Ingram Cancer Center Thoracic Program, CTSA UL1TR000445 from the National Center for Advancing Translational Sciences, National Cancer Institute P50CA090949 SPORE in Lung Cancer, National Cancer Institute P30CA068485 Cancer Center Support Grant that supports the Vanderbilt Technologies for Advanced Genomic Analysis and Research Design, and the Vanderbilt Department of Pathology, Microbiology and Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Bishop JA, 2010, CLIN CANCER RES, V16, P610, DOI 10.1158/1078-0432.CCR-09-2638; Cai CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029750; Cai JC, 2013, CANCER RES, V73, P5402, DOI 10.1158/0008-5472.CAN-13-0297; Cazzoli R, 2013, J THORAC ONCOL, V8, P1156, DOI 10.1097/JTO.0b013e318299ac32; Chang KW, 2008, J DENT RES, V87, P1063, DOI 10.1177/154405910808701116; Chu TH, 2013, CANCER LETT, V337, P115, DOI 10.1016/j.canlet.2013.05.032; Edmonds MD, 2009, CELL CYCLE, V8, P2673, DOI 10.4161/cc.8.17.9303; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Fassina A, 2011, CHEST, V140, P1305, DOI 10.1378/chest.11-0708; Fuse M, 2012, J HUM GENET, V57, P691, DOI 10.1038/jhg.2012.95; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Gao B, 2013, BIOMED PHARMACOTHER; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Graves EE, 2010, SEMIN RADIAT ONCOL, V20, P156, DOI 10.1016/j.semradonc.2010.01.003; Guan P, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-54; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hu HJ, 2012, ACTA BIOCH BIOPH SIN, V44, P424, DOI [10.1093/abbs/gms018, 10.1093/abbs/gms018.]; Huang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072615; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Jang JS, 2012, CLIN CANCER RES, V18, P3658, DOI 10.1158/1078-0432.CCR-11-2857; Jia AY, 2013, AM J PATHOL, V182, P1171, DOI 10.1016/j.ajpath.2013.01.006; Jiang L, 2010, BMC CANCER, V10, P318; Jiang LL, 2013, CANCER INVEST, V31, P538, DOI 10.3109/07357907.2013.820314; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kanaan Z, 2013, ANN SURG, V258, P400, DOI 10.1097/SLA.0b013e3182a15bcc; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Lee K, 2011, RNA, V17, P1076, DOI 10.1261/rna.2701111; Liang Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-61; Liu LX, 2012, FEBS J, V279, P3800, DOI 10.1111/j.1742-4658.2012.08741.x; Liu SG, 2013, ONCOL LETT, V5, P1639, DOI 10.3892/ol.2013.1251; Lu Y, 2012, CARCINOGENESIS, V33, P1046, DOI 10.1093/carcin/bgs100; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Markou A, 2013, LUNG CANCER, V81, P388, DOI 10.1016/j.lungcan.2013.05.007; Mitra R, 2014, REPRODUCIBLE COMBINA; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Mulrane L, 2012, CLIN CANCER RES, V18, P6702, DOI 10.1158/1078-0432.CCR-12-1420; Munker R, 2011, CLIN SCI, V121, P141, DOI 10.1042/CS20110005; Nadal E, 2013, CLIN CANCER RES, V19, P6842, DOI 10.1158/1078-0432.CCR-13-0736; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Rani S, 2013, CANCER BIOL THER, V14; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Roa WH, 2012, CLIN INVEST MED, V35, pE271, DOI 10.25011/cim.v35i5.18700; Schneider S, 2006, PHARMACOGENET GENOM, V16, P555, DOI 10.1097/01.fpc.0000220563.44724.6d; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sugimura K, 2012, CLIN CANCER RES, V18, P5144, DOI 10.1158/1078-0432.CCR-12-0701; Tam S, 2014, LAB INVEST, V94, P350, DOI 10.1038/labinvest.2013.157; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Trevino V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016492; Trujillo RD, 2010, EMBO J, V29, P3272, DOI 10.1038/emboj.2010.208; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wu XF, 2013, CANCER PREV RES, V6, P196, DOI 10.1158/1940-6207.CAPR-12-0276; Xing LX, 2010, MODERN PATHOL, V23, P1157, DOI 10.1038/modpathol.2010.111; Xu M, 2013, ONCOL REP, V30, P1398, DOI 10.3892/or.2013.2548; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang QH, 2013, GENE, V527, P26, DOI 10.1016/j.gene.2013.06.006; Zhao J, 2013, BIOCHEM BIOPH RES CO, V438, P439, DOI 10.1016/j.bbrc.2013.07.095; Zhu WY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-393	62	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101802	10.1371/journal.pone.0101802	http://dx.doi.org/10.1371/journal.pone.0101802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028925	gold, Green Published, Green Submitted			2022-12-25	WOS:000341306600024
J	Forsdahl, S; Kiselev, Y; Hogseth, R; Mjelle, JE; Mikkola, I				Forsdahl, Siri; Kiselev, Yury; Hogseth, Rune; Mjelle, Janne E.; Mikkola, Ingvild			Pax6 Regulates the Expression of Dkk3 in Murine and Human Cell Lines, and Altered Responses to Wnt Signaling Are Shown in FlpIn-3T3 Cells Stably Expressing Either the Pax6 or the Pax6(5a) Isoform	PLOS ONE			English	Article							PAIRED DOMAIN; BETA-CATENIN; SEQUENCE RECOGNITION; MOUSE TELENCEPHALON; CRYSTALLIN GENE; DNA-BINDING; PROTEINS; IDENTIFICATION; REIC/DKK-3; DIFFERENTIATION	Pax6 is a transcription factor important for early embryo development. It is expressed in several cancer cell lines and tumors. In glioblastoma, PAX6 has been shown to function as a tumor suppressor. Dickkopf 3 (Dkk3) is well established as a tumor suppressor in several tumor types, but not much is known about the regulation of its expression. We have previously found that Pax6 and Pax6(5a) increase the expression of the Dkk3 gene in two stably transfected mouse fibroblast cell lines. In this study the molecular mechanism behind this regulation is looked at. Western blot and reverse transcriptase quantitative PCR (RT-qPCR) confirmed higher level of Dkk3 expression in both Pax6 and Pax6(5a) expressing cell lines compared to the control cell line. By the use of bioinformatics and electrophoretic mobility shift assay (EMSA) we have mapped a functional Pax6 binding site in the mouse Dkk3 promoter. The minimal Dkk3 promoter fragment required for transcriptional activation by Pax6 and Pax6(5a) was a 200 bp region just upstream of the transcriptional start site. Mutation of the evolutionary conserved binding site in this region abrogated transcriptional activation and binding of Pax6/Pax6(5a) to the mouse Dkk3 promoter. Since the identified Pax6 binding site in this promoter is conserved, RT-qPCR and Western blot were used to look for regulation of Dkk3/REIC expression in human cell lines. Six of eight cell lines tested showed changes in Dkk3/REIC expression after PAX6 siRNA knockdown. Interestingly, we observed that the Pax6/Pax6(5a) expressing mouse fibroblast cell lines were less responsive to canonical Wnt pathway stimulation than the control cell line when TOP/FOP activity and the levels of active beta-catenin and GSK3-beta Ser9 phosphorylation were measured after LiCl stimulation.	[Forsdahl, Siri; Kiselev, Yury; Hogseth, Rune; Mjelle, Janne E.; Mikkola, Ingvild] UiT Artic Univ Norway, Res Grp Pharmacol, Dept Pharm, Tromso, Norway; [Kiselev, Yury] UiT Artic Univ Norway, Norwegian Translat Canc Res Ctr, Dept Med Biol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Mikkola, I (corresponding author), UiT Artic Univ Norway, Res Grp Pharmacol, Dept Pharm, Tromso, Norway.	ingvild.mikkola@uit.no		Mikkola, Ingvild/0000-0001-6442-7626; Kiselev, Yury/0000-0002-6753-8572	Norwegian Research Council [160293]; University of Tromso, Norway; University Hospital of North Norway	Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Tromso, Norway; University Hospital of North Norway	This work was funded by the Norwegian Research Council (grant#160293) for I. M, a PhD position funded by the University of Tromso, Norway, for S. F, and a post doc position funded by the University Hospital of North Norway for Y.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSLEN LA, 1988, ANTICANCER RES, V8, P797; Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Bruun JA, 2005, NUCLEIC ACIDS RES, V33, P2661, DOI 10.1093/nar/gki562; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; CVEKL A, 1994, MOL CELL BIOL, V14, P7363, DOI 10.1128/MCB.14.11.7363; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Davis J, 2011, INVEST OPHTH VIS SCI, V52, P4158, DOI 10.1167/iovs.10-6726; De Brouwer S, 2012, INT J CANCER, V130, P2591, DOI 10.1002/ijc.26295; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Fujii M, 2011, J MOL HISTOL, V42, P499, DOI 10.1007/s10735-011-9357-z; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Grocott T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1269; Haug BH, 2011, CARCINOGENESIS, V32, P1005, DOI 10.1093/carcin/bgr073; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Hsieh SY, 2004, ONCOGENE, V23, P9183, DOI 10.1038/sj.onc.1208138; Jung IL, 2010, INT J MOL MED, V26, P33, DOI 10.3892/ijmm_00000431; Karamariti E, 2013, CIRC RES, V112, P1433, DOI 10.1161/CIRCRESAHA.111.300415; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; Kiselev Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031915; Kobayashi K, 2002, GENE, V282, P151, DOI 10.1016/S0378-1119(01)00838-1; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Lang D, 2008, MOL CARCINOGEN, V47, P148, DOI 10.1002/mc.20375; Lee EJ, 2009, INT J CANCER, V124, P287, DOI 10.1002/ijc.23913; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Machon O, 2010, GENESIS, V48, P86, DOI 10.1002/dvg.20583; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mayes DA, 2006, CANCER RES, V66, P9809, DOI 10.1158/0008-5472.CAN-05-3877; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; Nakamura RE, 2007, BMC CELL BIOL, V8, P52; Nakamura REI, 2010, GROWTH FACTORS, V28, P232, DOI 10.3109/08977191003738832; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Tsuji T, 2001, BIOCHEM BIOPH RES CO, V289, P257, DOI 10.1006/bbrc.2001.5972; Tudzarova S, 2010, EMBO J, V29, P3381, DOI 10.1038/emboj.2010.201; Ueno K, 2011, MOL CARCINOGEN, V50, P449, DOI 10.1002/mc.20729; Valdora F, 2013, INT J MOL SCI, V14, P7492, DOI 10.3390/ijms14047492; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; Xie Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054507; Zhang K, 2010, INT J ONCOL, V37, P1495, DOI 10.3892/ijo_00000802; Zhong XF, 2007, INT J CANCER, V121, P2125, DOI 10.1002/ijc.22880	51	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102559	10.1371/journal.pone.0102559	http://dx.doi.org/10.1371/journal.pone.0102559			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029272	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600084
J	Furriel, A; Campos-Silva, P; Silva, PCGP; Costa, WS; Sampaio, FJB; Gregorio, BM				Furriel, Angelica; Campos-Silva, Pamella; Guedes Picarote Silva, Paola Cariello; Costa, Waldemar Silva; Barcellos Sampaio, Francisco Jose; Gregorio, Bianca Martins			Diets Rich in Saturated and Polyunsaturated Fatty Acids Induce Morphological Alterations in the Rat Ventral Prostate	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; HYPERPLASIA; CHOLESTEROL; THERAPY; OBESITY; CANCER; MACRONUTRIENTS; NUTRITION; ANDROGENS	Aim: To evaluate the influence of dietary lipid quality on the body mass, carbohydrate metabolism and morphology of the rat ventral prostate. Materials and Methods: Wistar rats were divided into four groups: SC (standard chow), HF-S (high-fat diet rich in saturated fatty acids), HF-P (high-fat diet rich in polyunsaturated fatty acids) and HF-SP (high-fat diet rich in saturated and polyunsaturated fatty acids). We analyzed body mass, fat mass deposits, plasma blood, insulin resistance and the ventral prostate structure. Results: Groups that received high-fat diets were heavier and presented larger fat deposits than SC group. The HF-S and HF-SP groups had higher glucose, insulin and total cholesterol serum levels and insulin resistance compared with the SC. The acinar area, epithelium height and area density of the lumen were higher in the HF-SP than in the other groups. The epithelium area density and epithelial cell proliferation were greater in the HF-P and HF-SP than in the SC group. All of the groups that received high-fat diets had greater area density of the stroma, area density of smooth muscle cells and stromal cell proliferation compared with the SC group. Conclusion: Diets rich in saturated and/or polyunsaturated fatty acids induced overweight. Independently of insulin resistance, polyunsaturated fatty acids increased prostate stromal and epithelial cell proliferation. Saturated fatty acids influenced only stromal cellular proliferation. These structural and morphometric alterations may be considered risk factors for the development of adverse remodeling process in the rat ventral	[Furriel, Angelica; Campos-Silva, Pamella; Guedes Picarote Silva, Paola Cariello; Costa, Waldemar Silva; Barcellos Sampaio, Francisco Jose; Gregorio, Bianca Martins] Univ Estado Rio De Janeiro, Dept Anat, Urogenital Res Unit, Biomed Ctr, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Gregorio, BM (corresponding author), Univ Estado Rio De Janeiro, Dept Anat, Urogenital Res Unit, Biomed Ctr, Rio De Janeiro, Brazil.	bmgregorio.uerj@gmail.com	Sampaio, Francisco/AAS-2479-2020; Gregório, Bianca Martins/O-4359-2014	Gregório, Bianca Martins/0000-0001-8138-7734; BARCELLOS SAMPAIO, FRANCISCO JOSE/0000-0001-9087-9319	FAPERJ; CNPq; CAPES	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by FAPERJ, CNPq and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravi F, 2006, UROLOGY, V67, P1205, DOI 10.1016/j.urology.2006.01.007; Coelho DF, 2011, BRAZ J MED BIOL RES, V44, P966, DOI 10.1590/S0100-879X2011007500107; Gerdes MJ, 2004, PROSTATE, V58, P299, DOI 10.1002/pros.10327; Giovannucci E, 2003, HORM METAB RES, V35, P694, DOI 10.1055/s-2004-814147; Gorden P, 2012, ENDOCR PRACT, V18, P763, DOI 10.4158/EP12139.RA; GROSS SA, 1987, J SUBMICR CYTOL PATH, V19, P77; Grossmann M, 2013, BEST PRACT RES CL EN, V27, P603, DOI 10.1016/j.beem.2013.05.001; Hautanen A, 2000, INT J OBESITY, V24, pS64, DOI 10.1038/sj.ijo.0801281; Hodson L, 2001, EUR J CLIN NUTR, V55, P908, DOI 10.1038/sj.ejcn.1601234; Hsing AW, 2007, AM J CLIN NUTR, V86, p843S, DOI 10.1093/ajcn/86.3.843S; Issa MM, 2007, AM J MANAG CARE, V13, pS4; Kapoor D, 2005, CLIN ENDOCRINOL, V63, P239, DOI 10.1111/j.1365-2265.2005.02299.x; LIANG TM, 1992, BIOCHEM J, V285, P557, DOI 10.1042/bj2850557; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; Montoya MT, 2002, AM J CLIN NUTR, V75, P484, DOI 10.1093/ajcn/75.3.484; Morgan DA, 2001, BRAZILIAN J UROLOGY, V27, P26; Morgan DA, 1993, AM J PHYSIOL, V264, P423, DOI 0165-1838(95)00108-5; Nandeesha H, 2006, CLIN CHIM ACTA, V370, P89, DOI 10.1016/j.cca.2006.01.019; Rahman NU, 2007, BJU INT, V100, P658, DOI 10.1111/j.1464-410X.2007.07069.x; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ribeiro DL, 2012, J ANDROL, V33, P854, DOI 10.2164/jandrol.111.016089; Rokling-Andersen MH, 2009, BRIT J NUTR, V102, P995, DOI 10.1017/S0007114509353210; SANDA MG, 1994, J UROLOGY, V152, P115, DOI 10.1016/S0022-5347(17)32831-8; Souza-Mello V, 2007, BRIT J NUTR, V98, P1159, DOI 10.1017/S0007114507771878; Suzuki S, 2002, AM J CLIN NUTR, V75, P689, DOI 10.1093/ajcn/75.4.689; van Kuilenburg J, 2011, J CLIN LIPIDOL, V5, P273, DOI 10.1016/j.jacl.2011.05.003; Vikram A, 2010, PROSTATE, V70, P79, DOI 10.1002/pros.21041; Vikram A, 2010, EUR J PHARMACOL, V641, P75, DOI 10.1016/j.ejphar.2010.05.042; Zhou J, 2012, SCI WORLD J IN PRESS	29	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102876	10.1371/journal.pone.0102876	http://dx.doi.org/10.1371/journal.pone.0102876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029463	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600102
J	Hamasaki, T; Nakamichi, N; Teruya, K; Shirahata, S				Hamasaki, Takeki; Nakamichi, Noboru; Teruya, Kiichiro; Shirahata, Sanetaka			Removal Efficiency of Radioactive Cesium and Iodine Ions by a Flow-Type Apparatus Designed for Electrochemically Reduced Water Production	PLOS ONE			English	Article							NUCLEAR-POWER-PLANT; AQUEOUS-SOLUTIONS; PLATINUM NANOPARTICLES; CAENORHABDITIS-ELEGANS; SAFETY REGULATIONS; DNA-DAMAGE; LIFE-SPAN; FUKUSHIMA; RADIATION; HYDROGEN	The Fukushima Daiichi Nuclear Power Plant accident on March 11, 2011 attracted people's attention, with anxiety over possible radiation hazards. Immediate and long-term concerns are around protection from external and internal exposure by the liberated radionuclides. In particular, residents living in the affected regions are most concerned about ingesting contaminated foodstuffs, including drinking water. Efficient removal of radionuclides from rainwater and drinking water has been reported using several pot-type filtration devices. A currently used flow-type test apparatus is expected to simultaneously provide radionuclide elimination prior to ingestion and protection from internal exposure by accidental ingestion of radionuclides through the use of a micro-carbon carboxymethyl cartridge unit and an electrochemically reduced water production unit, respectively. However, the removability of radionuclides from contaminated tap water has not been tested to date. Thus, the current research was undertaken to assess the capability of the apparatus to remove radionuclides from artificially contaminated tap water. The results presented here demonstrate that the apparatus can reduce radioactivity levels to below the detection limit in applied tap water containing either 300 Bq/kg of Cs-137 or 150 Bq/kg of I-125. The apparatus had a removal efficiency of over 90% for all concentration ranges of radio-cesium and -iodine tested. The results showing efficient radionuclide removability, together with previous studies on molecular hydrogen and platinum nanoparticles as reactive oxygen species scavengers, strongly suggest that the test apparatus has the potential to offer maximum safety against radionuclide-contaminated foodstuffs, including drinking water.	[Hamasaki, Takeki; Nakamichi, Noboru; Teruya, Kiichiro; Shirahata, Sanetaka] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka 812, Japan	Kyushu University	Shirahata, S (corresponding author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka 812, Japan.	sirahata@grt.kyushu-u.ac.jp	Takeki, Tomikawa/AAC-8060-2019		Grants-in-Aid for Scientific Research [26450161] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Akpolat M, 2009, ARCH TOXICOL, V83, P609, DOI 10.1007/s00204-008-0352-4; Amano H, 2012, J ENVIRON RADIOACTIV, V111, P42, DOI 10.1016/j.jenvrad.2011.10.019; Awual MR, 2014, CHEM ENG J, V242, P127, DOI 10.1016/j.cej.2013.12.072; Borai EH, 2009, J HAZARD MATER, V172, P416, DOI 10.1016/j.jhazmat.2009.07.033; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; Christodouleas JP, 2011, NEW ENGL J MED, V364, P2334, DOI 10.1056/NEJMra1103676; Chuai YH, 2012, BIOCHEM J, V442, P49, DOI 10.1042/BJ20111786; Dahiya S, 2008, J HAZARD MATER, V150, P376, DOI 10.1016/j.jhazmat.2007.04.134; Ding DH, 2014, J HAZARD MATER, V270, P187, DOI 10.1016/j.jhazmat.2014.01.056; El-Kamash AM, 2008, J HAZARD MATER, V151, P432, DOI 10.1016/j.jhazmat.2007.06.009; EWING D, 1987, ARCH BIOCHEM BIOPHYS, V254, P53, DOI 10.1016/0003-9861(87)90080-4; Fukuda S, 2014, J PLANT RES, V127, P79, DOI 10.1007/s10265-013-0596-9; Gobbel GT, 1998, J NEUROSCI, V18, P147; GOOSSENS R, 1989, WATER RES, V23, P693, DOI 10.1016/0043-1354(89)90201-7; Hamada N, 2012, J RADIAT RES, V53, P641, DOI 10.1093/jrr/rrs032; Hamada N, 2012, J ENVIRON RADIOACTIV, V111, P83, DOI 10.1016/j.jenvrad.2011.08.008; Hamasaki T, 2008, LANGMUIR, V24, P7354, DOI 10.1021/la704046f; Higaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037184; Hu BY, 2012, J HAZARD MATER, V217, P85, DOI 10.1016/j.jhazmat.2012.02.071; Jagetia GC, 2005, LIFE SCI, V77, P780, DOI 10.1016/j.lfs.2005.01.015; Kamei D, 2012, THER APHER DIAL, V16, P87, DOI 10.1111/j.1744-9987.2011.01029.x; KAMETANI K, 1992, BUNSEKI KAGAKU, V41, P337; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Kim MJ, 2006, LIFE SCI, V79, P2288, DOI 10.1016/j.lfs.2006.07.027; Kinjo T, 2012, CYTOTECHNOLOGY, V64, P357, DOI 10.1007/s10616-012-9469-7; Koizumi A, 2013, ENVIRON SCI TECHNOL, V47, P9612, DOI 10.1021/es401422g; Kosaka K, 2012, WATER RES, V46, P4397, DOI 10.1016/j.watres.2012.05.055; Li YP, 2002, CYTOTECHNOLOGY, V40, P139, DOI 10.1023/A:1023936421448; Li YP, 2011, CYTOTECHNOLOGY, V63, P119, DOI 10.1007/s10616-010-9317-6; Liu X, 2014, BIORESOUR TECHNOL; Ministry of Health Labour and Welfare Japan, MEAS RES RAD FOODST; Ministry of Health Labour and Welfare Japan, INF GREAT E JAP EART; Mizuno T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01742; Momoshima N, 2012, J ENVIRON RADIOACTIV, V111, P28, DOI 10.1016/j.jenvrad.2011.09.001; Murakami M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03599; Nakanishi H, 2013, NANO BIOMED ENG, V5, P76, DOI [10.5101/nbe.v5i2.p76-85, DOI 10.5101/NBE.V5I2.P76-85]; Nakanishi T, 2014, J ENVIRON RADIOACTIV, V128, P9, DOI 10.1016/j.jenvrad.2013.10.019; Nuclear Regulation Authority (NRA), 2013, MON INF ENV RAD LEV; Nunomura A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/200682323; Ohno K, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/353152; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta T, 2012, J ENVIRON RADIOACTIV, V111, P38, DOI 10.1016/j.jenvrad.2011.11.017; Osmanlioglu AE, 2007, APPL RADIAT ISOTOPES, V65, P17, DOI 10.1016/j.apradiso.2006.08.012; Pangeni B, 2014, CHEM ENG J, V242, P109, DOI 10.1016/j.cej.2013.12.042; Parajuli D, 2013, ENVIRON SCI TECHNOL, V47, P3800, DOI 10.1021/es303467n; Qian LR, 2010, J RADIAT RES, V51, P741, DOI 10.1269/jrr.10093; Qian LR, 2010, FREE RADICAL RES, V44, P275, DOI 10.3109/10715760903468758; Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010; Rana D, 2013, DESALINATION, V321, P77, DOI 10.1016/j.desal.2012.11.007; Sato I, 2011, J TOXICOL SCI, V36, P829, DOI 10.2131/jts.36.829; Sengupta P, 2014, J HAZARD MATER, V266, P94, DOI 10.1016/j.jhazmat.2013.12.010; Shakir K, 2007, SEP PURIF TECHNOL, V54, P373, DOI 10.1016/j.seppur.2006.10.006; Shimura H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044200; Shirahata S, 2012, TRENDS FOOD SCI TECH, V23, P124, DOI 10.1016/j.tifs.2011.10.009; Song KC, 1997, SEP PURIF TECHNOL, V12, P215, DOI 10.1016/S1383-5866(97)00045-2; Spulber S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042078; Spyropoulos BG, 2011, DIGEST DIS SCI, V56, P285, DOI 10.1007/s10620-010-1307-1; Szabo J, 2014, ENV INT; Tagami K, 2011, CHEMOSPHERE, V84, P1282, DOI 10.1016/j.chemosphere.2011.05.050; Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104; Terasaki Y, 2011, AM J PHYSIOL-LUNG C, V301, pL415, DOI 10.1152/ajplung.00008.2011; Teruya K, 2013, BIOL PHARM BULL, V36, P352, DOI 10.1248/bpb.b12-00709; Thakur P, 2013, SCI TOTAL ENVIRON, V458, P577, DOI 10.1016/j.scitotenv.2013.03.105; Thammawong C, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1689-z; Valsala TP, 2009, J HAZARD MATER, V166, P1148, DOI 10.1016/j.jhazmat.2008.12.019; Vijayalaxmi, 2004, INT J RADIAT ONCOL, V59, P639, DOI 10.1016/j.ijrobp.2004.02.006; Vipin AK, 2013, J HAZARD MATER, V258, P93, DOI 10.1016/j.jhazmat.2013.04.024; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; WATARI K, 1988, J NUCL SCI TECHNOL, V25, P495, DOI 10.3327/jnst.25.495; Yan Hanxu, 2011, BMC Proc, V5 Suppl 8, pP69, DOI 10.1186/1753-6561-5-S8-P69; Yan HX, 2011, BIOSCI BIOTECH BIOCH, V75, P1295, DOI 10.1271/bbb.110072; Yan HX, 2010, BIOSCI BIOTECH BIOCH, V74, P2011, DOI 10.1271/bbb.100250; Ye J, 2008, BIOL PHARM BULL, V31, P19, DOI 10.1248/bpb.31.19; Yoshihisa Y, 2011, FREE RADICAL RES, V45, P326, DOI 10.3109/10715762.2010.532494; Yoshihisa Y, 2010, EXP DERMATOL, V19, P1000, DOI 10.1111/j.1600-0625.2010.01128.x; Yoshinobu H, 2012, Patent application number, Patent No. [US 20120132578, 20120132578]; Zhu YG, 2000, J EXP BOT, V51, P1635, DOI 10.1093/jexbot/51.351.1635	77	18	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102218	10.1371/journal.pone.0102218	http://dx.doi.org/10.1371/journal.pone.0102218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029447	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600046
J	Tajuddin, N; Moon, KH; Marshall, SA; Nixon, K; Neafsey, EJ; Kim, HY; Collins, MA				Tajuddin, Nuzhath; Moon, Kwan-Hoon; Marshall, S. Alex; Nixon, Kimberly; Neafsey, Edward J.; Kim, Hee-Yong; Collins, Michael A.			Neuroinflammation and Neurodegeneration in Adult Rat Brain from Binge Ethanol Exposure: Abrogation by Docosahexaenoic Acid	PLOS ONE			English	Article							ALCOHOL-INDUCED NEURODEGENERATION; CYTOSOLIC PHOSPHOLIPASE A(2); SLICE CULTURES; AQUAPORIN-4 EXPRESSION; NEURONAL DEGENERATION; COGNITIVE IMPAIRMENT; ACTIVATION; DAMAGE; EDEMA; INTOXICATION	Evidence that brain edema and aquaporin-4 (AQP4) water channels have roles in experimental binge ethanol-induced neurodegeneration has stimulated interest in swelling/edema-linked neuroinflammatory pathways leading to oxidative stress. We report here that neurotoxic binge ethanol exposure produces comparable significant effects in vivo and in vitro on adult rat brain levels of AQP4 as well as neuroinflammation-linked enzymes: key phospholipase A2 (PLA2) family members and poly (ADP-ribose) polymerase-1 (PARP-1). In adult male rats, repetitive ethanol intoxication (3 gavages/d for 4 d, similar to 9 g/kg/d, achieving blood ethanol levels similar to 375 mg/dl; "Majchrowicz" model) significantly increased AQP4, Ca+2-dependent PLA2 GIVA (cPLA2), phospho-cPLA2 GIVA (p-cPLA2), secretory PLA2 GIIA (sPLA2) and PARP-1 in regions incurring extensive neurodegeneration in this model-hippocampus, entorhinal cortex, and olfactory bulb-but not in two regions typically lacking neurodamage, frontal cortex and cerebellum. Also, ethanol reduced hippocampal Ca+2-independent PLA2 GVIA (iPLA2) levels and increased brain "oxidative stress footprints" (4-hydroxynonenal-adducted proteins). For in vitro studies, organotypic cultures of rat hippocampal-entorhinocortical slices of adult age (similar to 60 d) were ethanol-binged (100 mM or,450 mg/dl) for 4 d, which augments AQP4 and causes neurodegeneration (Collins et al. 2013). Reproducing the in vivo results, cPLA2, p-cPLA2, sPLA2 and PARP-1 were significantly elevated while iPLA2 was decreased. Furthermore, supplementation with docosahexaenoic acid (DHA; 22:6n-3), known to quell AQP4 and neurodegeneration in ethanol-treated slices, blocked PARP-1 and PLA2 changes while counteracting endogenous DHA reduction and increases in oxidative stress footprints (3-nitrotyrosinated proteins). Notably, the PARP-1 inhibitor PJ-34 suppressed binge ethanol-dependent neurodegeneration, indicating PARP upstream involvement. The results with corresponding models support involvement of AQP4- and PLA2-associated neuroinflammatory pro-oxidative pathways in the neurodamage, with potential regulation by PARP-1 as well. Furthermore, DHA emerges as an effective inhibitor of these binge ethanol-dependent neuroinflammatory pathways as well as associated neurodegeneration in adult-age brain.	[Tajuddin, Nuzhath; Moon, Kwan-Hoon; Neafsey, Edward J.; Collins, Michael A.] Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60660 USA; [Marshall, S. Alex; Nixon, Kimberly] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY USA; [Kim, Hee-Yong] NIAAA, Lab Mol Signaling, NIH, Bethesda, MD USA	Loyola University Chicago; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Collins, MA (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60660 USA.	mcollin@luc.edu	Nixon, Kimberly/A-1217-2015; Neafsey, Edward J./ABG-3419-2021; Nixon, Kimberly/Y-9270-2019	Nixon, Kimberly/0000-0002-3466-9912	NIH [U01 AA018279, R01 AA0016959, T32 DA016176]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016959, ZIAAA000284, U01AA018279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA016176] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by NIH U01 AA018279 (MAC), R01 AA0016959 (KN), and T32 DA016176 (SAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI J, 1991, J STUD ALCOHOL, V52, P448, DOI 10.15288/jsa.1991.52.448; Adermark L, 2011, ADDICT BIOL, V16, P43, DOI 10.1111/j.1369-1600.2010.00206.x; Akbar M, 2006, J NEUROSCI RES, V83, P432, DOI 10.1002/jnr.20744; Alexander LD, 2004, KIDNEY INT, V65, P551, DOI 10.1111/j.1523-1755.2004.00405.x; Aschner M, 2001, BRAIN RES, V900, P219, DOI 10.1016/S0006-8993(01)02314-9; Barron S, 2008, ALCOHOL CLIN EXP RES, V32, P929, DOI 10.1111/j.1530-0277.2008.00649.x; Basavappa S, 1998, J NEUROPHYSIOL, V79, P1441, DOI 10.1152/jn.1998.79.3.1441; Bazan NG, 2013, PROSTAG LEUKOTR ESS, V88, P127, DOI 10.1016/j.plefa.2012.08.008; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Berry JN, 2012, NEUROSCIENCE, V222, P147, DOI 10.1016/j.neuroscience.2012.07.033; Blanco AM, 2007, FRONT BIOSCI-LANDMRK, V12, P2616, DOI 10.2741/2259; Brown J, 2009, NEUROCHEM RES, V34, P260, DOI 10.1007/s11064-008-9765-y; Cao DH, 2005, LIFE SCI, V78, P74, DOI 10.1016/j.lfs.2005.04.083; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Cieslik M, 2013, NEUROCHEM INT, V62, P626, DOI 10.1016/j.neuint.2013.02.016; Cippitelli A, 2014, ADDICT BIOL, V19, P27, DOI 10.1111/j.1369-1600.2012.00451.x; Cippitelli A, 2010, BIOL PSYCHIAT, V67, P823, DOI 10.1016/j.biopsych.2009.12.018; Collins MA, 1996, ALCOHOL CLIN EXP RES, V20, P284, DOI 10.1111/j.1530-0277.1996.tb01641.x; Collins MA, 1998, FASEB J, V12, P221, DOI 10.1096/fasebj.12.2.221; Collins MA, 2013, NEUROTOX RES, V23, P105, DOI 10.1007/s12640-012-9360-5; Collins Michael A, 2012, Front Biosci (Elite Ed), V4, P1358; Corso TD, 1998, ALCOHOL CLIN EXP RES, V22, P217, DOI 10.1111/j.1530-0277.1998.tb03641.x; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Crews F, 2006, ALCOHOL CLIN EXP RES, V30, P1938, DOI 10.1111/j.1530-0277.2006.00239.x; Czapski GA, 2013, NEUROCHEM INT, V62, P664, DOI 10.1016/j.neuint.2013.01.020; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Eckert GP, 2013, PROSTAG LEUKOTR ESS, V88, P105, DOI 10.1016/j.plefa.2012.05.006; Esposito G, 2008, HUM MOL GENET, V17, P440, DOI 10.1093/hmg/ddm322; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Furuya H, 2000, Environ Health Prev Med, V5, P103, DOI 10.1265/ehpm.2000.103; Galluzzi L, 2014, MOL MECH REGULATED N; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gotz ME, 2001, ALCOHOL CLIN EXP RES, V25, P717, DOI 10.1111/j.1530-0277.2001.tb02272.x; Green JT, 2008, J LIPID RES, V49, P939, DOI 10.1194/jlr.R700017-JLR200; Gunnarson E, 2008, GLIA, V56, P587, DOI 10.1002/glia.20627; Hamelink C, 2005, J PHARMACOL EXP THER, V314, P780, DOI 10.1124/jpet.105.085779; Haussinger D, 2005, METAB BRAIN DIS, V20, P285, DOI 10.1007/s11011-005-7908-2; Hayes DM, 2013, ALCOHOL CLIN EXP RES, V37, P425, DOI 10.1111/j.1530-0277.2012.01955.x; Hoda MN, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-21; HUDSPITH M, 1985, ALCOHOL, V2, P133, DOI 10.1016/0741-8329(85)90030-8; HUNT WA, 1993, ALCOHOL, V10, P559, DOI 10.1016/0741-8329(93)90083-Z; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Jones AW, 1999, J STUD ALCOHOL, V60, P400, DOI 10.15288/jsa.1999.60.400; Katada R, 2012, AM J PATHOL, V180, P17, DOI 10.1016/j.ajpath.2011.09.011; Kauppinen TM, 2009, J CEREBR BLOOD F MET, V29, P820, DOI 10.1038/jcbfm.2009.9; Kim HY, 2008, CHEM PHYS LIPIDS, V153, P34, DOI 10.1016/j.chemphyslip.2008.02.014; Kim HY, 2011, PROSTAG OTH LIPID M, V96, P114, DOI 10.1016/j.prostaglandins.2011.07.002; Kim HY, 2010, PROSTAG LEUKOTR ESS, V82, P165, DOI 10.1016/j.plefa.2010.02.025; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Lambert IH, 2006, ACTA PHYSIOL, V187, P75, DOI 10.1111/j.1748-1716.2006.01557.x; Langelier B, 2005, LIPIDS, V40, P719, DOI 10.1007/s11745-005-1435-8; Lee Y, 2013, NAT NEUROSCI, V16, P1392, DOI 10.1038/nn.3500; LEHTONEN JYA, 1995, BIOPHYS J, V68, P1888, DOI 10.1016/S0006-3495(95)80366-8; Li LH, 2011, FASEB J, V25, P1556, DOI 10.1096/fj.10-177279; Lin TN, 2004, J NEUROCHEM, V90, P637, DOI 10.1111/j.1471-4159.2004.02540.x; MAJCHROWICZ E, 1975, PSYCHOPHARMACOLOGIA, V43, P245, DOI 10.1007/BF00429258; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; Marshall SA, 2013, NEUROBIOL DIS; Mayurasakorn K, 2011, CURR OPIN CLIN NUTR, V14, P158, DOI 10.1097/MCO.0b013e328342cba5; Moon KH, 2006, HEPATOLOGY, V44, P1218, DOI 10.1002/hep.21372; Morishima T, 2008, NEUROSCI RES, V61, P18, DOI 10.1016/j.neures.2008.01.005; Moses GSD, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-28; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Ong WY, 2010, CURR MED CHEM, V17, P2746, DOI 10.2174/092986710791859289; Orr SK, 2013, J NEUROCHEM, V127, P378, DOI 10.1111/jnc.12392; Orr SK, 2013, PROSTAG LEUKOTR ESS, V88, P97, DOI 10.1016/j.plefa.2012.05.008; Oyama LM, 2000, ALCOHOL, V21, P201, DOI 10.1016/S0741-8329(00)00074-4; Patten AR, 2013, NEUROSCI LETT, V551, P7, DOI 10.1016/j.neulet.2013.05.051; Patten AR, 2013, J NUTR BIOCHEM, V24, P760, DOI 10.1016/j.jnutbio.2012.04.003; Rao JS, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-101; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Rashid MA, 2013, J NEUROCHEM, V125, P869, DOI 10.1111/jnc.12255; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Riahi Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE879, DOI 10.1152/ajpendo.00508.2010; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Serhan CN, 2004, LIPIDS, V39, P1125, DOI 10.1007/s11745-004-1339-7; Shield KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051923; Sripathirathan K, 2009, J NEUROTRAUM, V26, P261, DOI 10.1089/neu.2008.0682; Strokin M, 2006, NEUROSCIENCE, V140, P547, DOI 10.1016/j.neuroscience.2006.02.026; Sun GY, 2012, MOL NEUROBIOL, V46, P85, DOI 10.1007/s12035-012-8261-1; Sun GY, 2010, NEUROMOL MED, V12, P133, DOI 10.1007/s12017-009-8092-z; SWITZER RC, 1982, ANAT REC, V202, pA186; Tajuddin NF, 2013, ALCOHOL, V47, P39, DOI 10.1016/j.alcohol.2012.09.003; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Umhau JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075333; Virta JJ, 2010, J ALZHEIMERS DIS, V22, P939, DOI 10.3233/JAD-2010-100870; Wang ML, 2006, BIOCHEM BIOPH RES CO, V350, P399, DOI 10.1016/j.bbrc.2006.09.057; Wen ZM, 2007, J NEUROSCI RES, V85, P1568, DOI 10.1002/jnr.21263; Wen ZM, 2004, J NEUROCHEM, V89, P1368, DOI 10.1111/j.1471-4159.2004.02433.x; Xu DZ, 2001, EXP BIOL MED, V226, P927, DOI 10.1177/153537020122601008; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yang H, 2013, NEUROCHEM RES, V38, P753, DOI 10.1007/s11064-013-0974-7; Zhao YN, 2013, BEHAV BRAIN RES, V236, P270, DOI 10.1016/j.bbr.2012.08.052; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014; Zou JY, 1996, ALCOHOL CLIN EXP RES, V20, P1406, DOI 10.1111/j.1530-0277.1996.tb01141.x	99	53	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101223	10.1371/journal.pone.0101223	http://dx.doi.org/10.1371/journal.pone.0101223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029343	Green Submitted, Green Published, gold			2022-12-25	WOS:000341306600012
J	Franchini, DM; Chan, CF; Morgan, H; Incorvaia, E; Rangam, G; Dean, W; Santos, F; Reik, W; Petersen-Mahrt, SK				Franchini, Don-Marc; Chan, Chun-Fung; Morgan, Hugh; Incorvaia, Elisabetta; Rangam, Gopinath; Dean, Wendy; Santos, Fatima; Reik, Wolf; Petersen-Mahrt, Svend K.			Processive DNA Demethylation via DNA Deaminase-Induced Lesion Resolution	PLOS ONE			English	Article							BASE EXCISION-REPAIR; CLASS SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; SOMATIC HYPERMUTATION; MISMATCH-REPAIR; EPIGENETIC MEMORY; MAMMALIAN-CELLS; AID DEFICIENCY; IN-VITRO; 5-METHYLCYTOSINE	Base modifications of cytosine are an important aspect of chromatin biology, as they can directly regulate gene expression, while DNA repair ensures that those modifications retain genome integrity. Here we characterize how cytosine DNA deaminase AID can initiate DNA demethylation. In vitro, AID initiated targeted DNA demethylation of methyl CpGs when in combination with DNA repair competent extracts. Mechanistically, this is achieved by inducing base alterations at or near methyl-cytosine, with the lesion being resolved either via single base substitution or a more efficient processive polymerase dependent repair. The biochemical findings are recapitulated in an in vivo transgenic targeting assay, and provide the genetic support of the molecular insight into DNA demethylation. This targeting approach supports the hypothesis that mCpG DNA demethylation can proceed via various pathways and mCpGs do not have to be targeted to be demethylated.	[Franchini, Don-Marc; Incorvaia, Elisabetta; Rangam, Gopinath; Petersen-Mahrt, Svend K.] IFOM Fdn Inst FIRC Oncol Mol, DNA Editing Immun & Epigenet, Milan, Italy; [Franchini, Don-Marc; Rangam, Gopinath; Petersen-Mahrt, Svend K.] London Res Inst, Clare Hall Labs, DNA Editing Lab, S Mimms, Herts, England; [Chan, Chun-Fung; Morgan, Hugh; Dean, Wendy; Santos, Fatima; Reik, Wolf] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge, England; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England	IFOM - FIRC Institute of Molecular Oncology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Petersen-Mahrt, SK (corresponding author), IFOM Fdn Inst FIRC Oncol Mol, DNA Editing Immun & Epigenet, Milan, Italy.	svend.petersen-mahrt@ifom.eu	Rangam, Gopinath/J-8832-2019; Franchini, Don Marc/A-5203-2015; Reik, Wolf/I-6794-2012; Dean, Wendy/GSE-3948-2022	Rangam, Gopinath/0000-0001-5081-5804; Franchini, Don Marc/0000-0002-2562-5643; Dean, Wendy/0000-0001-9441-5044; Reik, Wolf/0000-0003-0216-9881; Santos, Fatima/0000-0002-3854-4084	Biotechnology and Biological Sciences Research Council, UK; MRC - Medical Research Council, UK; Network of Excellence - The Epigenome, EU; Cell Centric, UK; CJ Martin Fellowship; NHMRC Early Career Fellowships, Australia; London Research Institute - Cancer Research UK postdoctoral fellowships, UK; IFOM - Fondazione Istituto FIRC di Oncologia Molecolare, Italy; London Research Institute - Cancer Research UK core funding, UK; IFOM - Fondazione Istituto FIRC di Oncologia Molecolare core funding, Italy; DIVA - Discover Validation of Anticancer drugs, Lombardi, Italy; AIRC - Italian Association for Cancer research [13149]; BBSRC [BBS/E/B/000C0403] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0403] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC - Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Network of Excellence - The Epigenome, EU; Cell Centric, UK; CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Early Career Fellowships, Australia(National Health and Medical Research Council (NHMRC) of Australia); London Research Institute - Cancer Research UK postdoctoral fellowships, UK; IFOM - Fondazione Istituto FIRC di Oncologia Molecolare, Italy; London Research Institute - Cancer Research UK core funding, UK; IFOM - Fondazione Istituto FIRC di Oncologia Molecolare core funding, Italy; DIVA - Discover Validation of Anticancer drugs, Lombardi, Italy; AIRC - Italian Association for Cancer research(Fondazione AIRC per la ricerca sul cancro); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	W.R. was supported by Biotechnology and Biological Sciences Research Council, UK, MRC - Medical Research Council, UK, Network of Excellence - The Epigenome, EU, and Cell Centric, UK. H. M. was supported by a CJ Martin Fellowship, NHMRC Early Career Fellowships, Australia. G. R. was supported by London Research Institute - Cancer Research UK postdoctoral fellowships, UK. D. M. F. was supported by London Research Institute - Cancer Research UK postdoctoral fellowships, UK, and IFOM - Fondazione Istituto FIRC di Oncologia Molecolare fellowships, Italy. E. I. was supported by an IFOM - Fondazione Istituto FIRC di Oncologia Molecolare, Italy. S. K. P. M. was supported by London Research Institute - Cancer Research UK core funding, UK, IFOM - Fondazione Istituto FIRC di Oncologia Molecolare core funding, Italy, DIVA - Discover Validation of Anticancer drugs, Lombardi, Italy, and AIRC - Italian Association for Cancer research - 13149. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Chow JC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000604; Coker HA, 2006, METHOD ENZYMOL, V408, P156, DOI 10.1016/S0076-6879(06)08010-4; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Fraenkel S, 2007, NAT IMMUNOL, V8, P715, DOI 10.1038/ni1476; Franchini DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082097; Franchini DM, 2012, ANNU REV GENET, V46, P419, DOI 10.1146/annurev-genet-110711-155451; Fritz EL, 2013, NAT IMMUNOL, V14, P749, DOI 10.1038/ni.2616; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; He Y-F, 2011, SCIENCE; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Jolly CJ, 2001, IMMUNOL CELL BIOL, V79, P18, DOI 10.1046/j.1440-1711.2001.00968.x; KARRAN P, 1981, BIOCHEMISTRY-US, V20, P6092, DOI 10.1021/bi00524a027; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kumar R, 2013, NATURE, V500, P89, DOI 10.1038/nature12299; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Munoz DP, 2013, P NATL ACAD SCI USA, V110, pE2977, DOI 10.1073/pnas.1301021110; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; NYCE J, 1986, NUCLEIC ACIDS RES, V14, P4353, DOI 10.1093/nar/14.10.4353; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Pena-Diaz J, 2012, MOL CELL, V47, P669, DOI 10.1016/j.molcel.2012.07.006; Petersen-Mahrt S, 2005, IMMUNOL REV, V203, P80, DOI 10.1111/j.0105-2896.2005.00232.x; Pham P, 2008, J BIOL CHEM, V283, P31754, DOI 10.1074/jbc.M805524200; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rangam G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043279; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Santos F, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-39; Schanz S, 2009, P NATL ACAD SCI USA, V106, P5593, DOI 10.1073/pnas.0901726106; Schmitz KM, 2012, SEMIN IMMUNOL, V24, P241, DOI 10.1016/j.smim.2012.07.001; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Willmann KL, 2012, J EXP MED, V209, P2099, DOI 10.1084/jem.20112145; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	55	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e97754	10.1371/journal.pone.0097754	http://dx.doi.org/10.1371/journal.pone.0097754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025377	gold, Green Submitted, Green Published			2022-12-25	WOS:000339992400001
J	Li, S; Flisikowska, T; Kurome, M; Zakhartchenko, V; Kessler, B; Saur, D; Kind, A; Wolf, E; Flisikowski, K; Schnieke, A				Li, Shun; Flisikowska, Tatiana; Kurome, Mayuko; Zakhartchenko, Valeri; Kessler, Barbara; Saur, Dieter; Kind, Alexander; Wolf, Eckhard; Flisikowski, Krzysztof; Schnieke, Angelika			Dual Fluorescent Reporter Pig for Cre Recombination: Transgene Placement at the ROSA26 Locus	PLOS ONE			English	Article							IN-VIVO; EXPRESSION; MOUSE; CELLS; IDENTIFICATION; TRANSDUCTION; MODELS; STRAIN; MICE	We are extending the Cre/loxP site-specific recombination system to pigs, focussing on conditional and tissue-specific expression of oncogenic mutations to model human cancers. Identifying the location, pattern and extent of Cre recombination in vivo is an important aspect of this technology. Here we report pigs with a dual fluorochrome cassette under the control of the strong CAG promoter that switches expression after Cre-recombination, from membrane-targeted tandem dimer Tomato to membrane-targeted green fluorescent protein. The reporter cassette was placed at the porcine ROSA26 locus by conventional gene targeting using primary mesenchymal stem cells, and animals generated by nuclear transfer. Gene targeting efficiency was high, and analysis of foetal organs and primary cells indicated that the reporter is highly expressed and functional. Cre reporter pigs will provide a multipurpose indicator of Cre recombinase activity, an important new tool for the rapidly expanding field of porcine genetic modification.	[Li, Shun; Flisikowska, Tatiana; Kind, Alexander; Flisikowski, Krzysztof; Schnieke, Angelika] Tech Univ Munich, Chair Livestock Biotechnol, Freising Weihenstephan, Germany; [Kurome, Mayuko; Zakhartchenko, Valeri; Kessler, Barbara; Wolf, Eckhard] Univ Munich, Oberschleissheim, Germany; [Saur, Dieter] Tech Univ Munich, Klinikum Rechts Isar 2, D-80290 Munich, Germany	Technical University of Munich; University of Munich; Technical University of Munich	Schnieke, A (corresponding author), Tech Univ Munich, Chair Livestock Biotechnol, Freising Weihenstephan, Germany.	schnieke@wzw.tum.de	Flisikowska, Tatiana/I-9043-2014; Saur, Dieter/O-8355-2015	Flisikowska, Tatiana/0000-0003-0481-117X; Saur, Dieter/0000-0001-5874-0210; Wolf, Eckhard/0000-0002-0430-9510; Schnieke, Angelika/0000-0002-5761-9635; Zakhartchenko, Valeri/0000-0002-5974-9759	Deutsche Forschungsgemeinschaft (German Research Foundation) [SCHN971/3-1, WO 685/16-1]; China Scholarship Council [2011699005]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council)	This work was supported financially by the Deutsche Forschungsgemeinschaft (German Research Foundation) through grant number SCHN971/3-1, WO 685/16-1. Shun Li would like to thank the China Scholarship Council for financial support for his PhD study (No. 2011699005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besenfelder U, 1997, THERIOGENOLOGY, V47, P1051, DOI 10.1016/S0093-691X(97)00062-9; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Flisikowska T, 2013, TRANSGENIC RES, V22, P673, DOI 10.1007/s11248-013-9720-9; FLOTTE TR, 1995, GENE THER, V2, P29; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Iverson SV, 2011, HEPATOLOGY, V54, P655, DOI 10.1002/hep.24398; Kobayashi T, 2012, STEM CELLS DEV, V21, P2981, DOI 10.1089/scd.2012.0065; Kurome M, 2006, TRANSGENIC RES, V15, P229, DOI 10.1007/s11248-006-0004-5; Leuchs S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043323; Li L, 2009, BIOCHEM BIOPH RES CO, V382, P232, DOI 10.1016/j.bbrc.2009.02.146; Li XP, 2014, CELL RES, V24, P501, DOI 10.1038/cr.2014.15; Munst Bernhard, 2009, J Vis Exp, DOI 10.3791/1627; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Prather RS, 2013, ANNU REV ANIM BIOSCI, V1, P203, DOI 10.1146/annurev-animal-031412-103715; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Suvorova ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006158; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Yin XJ, 2002, BIOL REPROD, V67, P442, DOI 10.1095/biolreprod67.2.442; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	23	27	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102455	10.1371/journal.pone.0102455	http://dx.doi.org/10.1371/journal.pone.0102455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025770	gold, Green Submitted, Green Published			2022-12-25	WOS:000339992400075
J	Chou, AM; Sem, KP; Wright, GD; Sudhaharan, T; Ahmed, S				Chou, Ai Mei; Sem, Kai Ping; Wright, Graham Daniel; Sudhaharan, Thankiah; Ahmed, Sohail			Dynamin1 Is a Novel Target for IRSp53 Protein and Works with Mammalian Enabled (Mena) Protein and Eps8 to Regulate Filopodial Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Biology; Cell Migration; Fluorescence Resonance Energy Transfer (FRET); Imaging; IRSp53; TIRF; Dynamin; Filopodia	ACTIN CYTOSKELETON; N-WASP; NEURITE OUTGROWTH; ARP2/3 COMPLEX; BAR DOMAINS; CELL-SHAPE; CDC42; GROWTH; RAC; REORGANIZATION	Background: IRSp53 generates filopodia by coupling membrane protrusion with actin dynamics through SH3 domain binding partners. Results: Dynamin1 interacts with IRSp53, and its GTPase and actin binding domains are required for filopodial formation. Conclusion: Dynamin1 plays a role in filopodial initiation and assembly. Significance: A novel role for dynamin1 in filopodial dynamics has implications for cell migration and wound healing. Filopodia are dynamic actin-based structures that play roles in processes such as cell migration, wound healing, and axonal guidance. Cdc42 induces filopodial formation through IRSp53, an Inverse-Bin-Amphiphysins-Rvs (I-BAR) domain protein. Previous work from a number of laboratories has shown that IRSp53 generates filopodia by coupling membrane protrusion with actin dynamics through its Src homology 3 domain binding partners. Here, we show that dynamin1 (Dyn1), the large guanosine triphosphatase, is an interacting partner of IRSp53 through pulldown and Forster resonance energy transfer analysis, and we explore its role in filopodial formation. In neuroblastoma cells, Dyn1 localizes to filopodia, associated tip complexes, and the leading edge just behind the anti-capping protein mammalian enabled (Mena). Dyn1 knockdown reduces filopodial formation, which can be rescued by overexpressing wild-type Dyn1 but not the GTPase mutant Dyn1-K44A and the loss-of-function actin binding domain mutant Dyn1-K/E. Interestingly, dynasore, an inhibitor of Dyn GTPase, also reduced filopodial number and increased their lifetime. Using rapid time-lapse total internal reflection fluorescence microscopy, we show that Dyn1 and Mena localize to filopodia only during initiation and assembly. Dyn1 actin binding domain mutant inhibits filopodial formation, suggesting a role in actin elongation. In contrast, Eps8, an actin capping protein, is seen most strongly at filopodial tips during disassembly. Taken together, the results suggest IRSp53 partners with Dyn1, Mena, and Eps8 to regulate filopodial dynamics.	[Chou, Ai Mei; Sem, Kai Ping; Wright, Graham Daniel; Sudhaharan, Thankiah; Ahmed, Sohail] Immunos, Inst Med Biol, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Ahmed, S (corresponding author), Immunos, Inst Med Biol, 06-06,8A Biomed Grove, Singapore 138648, Singapore.	sohail.ahmed@imb.a-star.edu.sg		Chou, Amy/0000-0002-6831-0799; Wright, Graham/0000-0003-2362-1312	A-STAR	A-STAR(Agency for Science Technology & Research (A*STAR))	This work was supported by A-STAR.	Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Disanza A, 2013, EMBO J, V32, P2735, DOI 10.1038/emboj.2013.208; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fierro-Gonzalez JC, 2013, NAT CELL BIOL, V15, P1424, DOI 10.1038/ncb2875; Fujiwara T, 2000, BIOCHEM BIOPH RES CO, V271, P626, DOI 10.1006/bbrc.2000.2671; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Goh WI, 2012, J BIOL CHEM, V287, P4702, DOI 10.1074/jbc.M111.305102; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Gupton Stephanie L, 2007, Sci STKE, V2007, pre5, DOI 10.1126/stke.4002007re5; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Jovceva E, 2007, J CELL SCI, V120, P1888, DOI 10.1242/jcs.004366; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; McMahon AP, 2013, DEV CELL, V25, P328, DOI 10.1016/j.devcel.2013.05.008; McNiven MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1944, DOI 10.2741/1348; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Menna E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000138; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Millard TH, 2008, DEVELOPMENT, V135, P621, DOI 10.1242/dev.014001; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Mundigl O, 1998, J NEUROSCI, V18, P93; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pykalainen A, 2011, NAT STRUCT MOL BIOL, V18, P902, DOI 10.1038/nsmb.2079; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Watanabe TM, 2010, J BIOL CHEM, V285, P19605, DOI 10.1074/jbc.M109.093864; Yamada H, 2013, J NEUROSCI, V33, P4514, DOI 10.1523/JNEUROSCI.2762-12.2013; Zhao HX, 2011, CURR OPIN CELL BIOL, V23, P14, DOI 10.1016/j.ceb.2010.10.005	53	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24383	24396		10.1074/jbc.M114.553883	http://dx.doi.org/10.1074/jbc.M114.553883			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25031323	Green Published, hybrid			2022-12-25	WOS:000341505600033
J	Tafesse, FG; Guimaraes, CP; Maruyama, T; Carette, JE; Lory, S; Brummelkamp, TR; Ploegh, HL				Tafesse, Fikadu G.; Guimaraes, Carla P.; Maruyama, Takeshi; Carette, Jan E.; Lory, Stephen; Brummelkamp, Thijn R.; Ploegh, Hidde L.			GPR107, a G-protein-coupled Receptor Essential for Intoxication by Pseudomonas aeruginosa Exotoxin A, Localizes to the Golgi and Is Cleaved by Furin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Toxin; Furin; G-protein-coupled Receptor (GPCR); Intracellular Trafficking; Sortase A; GPR107; KBM7; Pseudomonas aeruginosa Exotoxin A; Haploid Genetic Screen	ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; DNA-SEQUENCE; HUMAN-CELLS; MEMBRANE; TOXIN; GENE; ACTIVATION; REVEALS; COMPLEX	Background: Bacterial toxins, including P. aeruginosa exotoxin A (PE), are valuable tools to dissect biological processes. Results: A genome-wide genetic screen identifies several novel host factors used by PE, including GPR107. Conclusion: Bacterial toxins can help identify novel host components involved in key intracellular trafficking steps. Significance: GPR107 may be a receptor that associates with G-proteins at the Golgi to regulate membrane transport. A number of toxins, including exotoxin A (PE) of Pseudomonas aeruginosa, kill cells by inhibiting protein synthesis. PE kills by ADP-ribosylation of the translation elongation factor 2, but many of the host factors required for entry, membrane translocation, and intracellular transport remain to be elucidated. A genome-wide genetic screen in human KBM7 cells was performed to uncover host factors used by PE, several of which were confirmed by CRISPR/Cas9-gene editing in a different cell type. Several proteins not previously implicated in the PE intoxication pathway were identified, including GPR107, an orphan G-protein-coupled receptor. GPR107 localizes to the trans-Golgi network and is essential for retrograde transport. It is cleaved by the endoprotease furin, and a disulfide bond connects the two cleaved fragments. Compromising this association affects the function of GPR107. The N-terminal region of GPR107 is critical for its biological function. GPR107 might be one of the long-sought receptors that associates with G-proteins to regulate intracellular vesicular transport.	[Tafesse, Fikadu G.; Guimaraes, Carla P.; Maruyama, Takeshi; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tafesse, Fikadu G.; Guimaraes, Carla P.; Maruyama, Takeshi; Ploegh, Hidde L.] MIT, Cambridge, MA 02142 USA; [Carette, Jan E.] Stanford Sch Med, Stanford, CA 94305 USA; [Lory, Stephen] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Brummelkamp, Thijn R.] Netherlands Canc Inst, NL-1006 BE Amsterdam, Netherlands	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Stanford University; Harvard University; Harvard Medical School; Netherlands Cancer Institute	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	Maruyama, Takeshi/T-7568-2019	Maruyama, Takeshi/0000-0003-0331-4702; Carette, Jan/0000-0002-5187-8070; Tafesse, Fikadu/0000-0002-8575-4164	National Institutes of Health [AI087879]; Netherlands Organization for Scientific Research; New England Regional Center of Excellence Harvard Medical School; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); New England Regional Center of Excellence Harvard Medical School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI087879 (to H. L. P.). This work was also supported by the Netherlands Organization for Scientific Research (to F. G. T.) and New England Regional Center of Excellence Harvard Medical School (to C. P. G.).	Abi-Habib RJ, 2004, BLOOD, V104, P2143, DOI 10.1182/blood-2004-01-0339; Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; Arac D, 2005, J MOL BIOL, V346, P589, DOI 10.1016/j.jmb.2004.12.004; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Bonifacino JS, 2011, TRENDS CELL BIOL, V21, P159, DOI 10.1016/j.tcb.2010.11.003; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Campelo F, 2012, ANNU REV BIOCHEM, V81, P407, DOI 10.1146/annurev-biochem-051710-094912; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; DEALMEIDA JB, 1993, J CELL SCI, V106, P1239; Edgar AJ, 2007, DNA SEQUENCE, V18, P235, DOI 10.1080/10425170701207182; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Gorbushin AM, 2009, EXP PARASITOL, V123, P24, DOI 10.1016/j.exppara.2009.05.004; GRAY GL, 1984, P NATL ACAD SCI-BIOL, V81, P2645, DOI 10.1073/pnas.81.9.2645; Gu ML, 1996, INFECT IMMUN, V64, P524, DOI 10.1128/IAI.64.2.524-527.1996; Guimaraes CP, 2013, NAT PROTOC, V8, P1787, DOI 10.1038/nprot.2013.101; Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Humphray SJ, 2004, NATURE, V429, P369, DOI 10.1038/nature02465; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Jackson ME, 1999, J CELL SCI, V112, P467; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Pastrana DV, 2005, BBA-MOL BASIS DIS, V1741, P234, DOI 10.1016/j.bbadis.2005.06.007; Popp Maximilian Wei-Lin, 2009, Curr Protoc Protein Sci, VChapter 15, DOI 10.1002/0471140864.ps1503s56; Rosmarin DM, 2012, P NATL ACAD SCI USA, V109, P10059, DOI 10.1073/pnas.1120244109; Sandvig K, 2013, HISTOCHEM CELL BIOL, V140, P317, DOI 10.1007/s00418-013-1111-z; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Su XY, 2013, CRIT REV BIOCHEM MOL, V48, P515, DOI 10.3109/10409238.2013.831023; Tafesse FG, 2013, P NATL ACAD SCI USA, V110, P6406, DOI 10.1073/pnas.1219909110; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wedekind JE, 2001, J MOL BIOL, V314, P823, DOI 10.1006/jmbi.2001.5195; Weldon JE, 2011, FEBS J, V278, P4683, DOI 10.1111/j.1742-4658.2011.08182.x; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Williams AL, 2004, MOL BIOL CELL, V15, P162, DOI 10.1091/mbc.E03-07-0535; Yosten GLC, 2012, AM J PHYSIOL-REG I, V303, pR941, DOI 10.1152/ajpregu.00336.2012	62	35	38	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24005	24018		10.1074/jbc.M114.589275	http://dx.doi.org/10.1074/jbc.M114.589275			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25031321	hybrid, Green Published			2022-12-25	WOS:000341505600001
J	Zhang, P; Yi, S; Li, X; Liu, R; Jiang, H; Huang, Z; Liu, Y; Wu, J; Huang, Y				Zhang, Peng; Yi, Shuhong; Li, Xi; Liu, Ruilei; Jiang, Hua; Huang, Zenan; Liu, Yu; Wu, Juekun; Huang, Yong			Preparation of Triple-Negative Breast Cancer Vaccine through Electrofusion with Day-3 Dendritic Cells	PLOS ONE			English	Article							HUMAN MONOCYTES; T-CELLS; CLASS-I; DIFFERENTIATION; GENERATION; STRATEGY; FUTURE	Dendritic cells (DCs) are professional antigen-presenting cells (APCs) in human immune system. DC-based tumor vaccine has met with some success in specific malignancies, inclusive of breast cancer. In this study, we electrofused MDA-MB-231 breast cancer cell line with day-3 DCs derived from peripheral blood monocytes, and explored the biological characteristics of fusion vaccine and its anti-tumor effects in vitro. Day-3 mature DCs were generated from day-2 immature DCs by adding cocktails composed of TNF-alpha, IL-1 beta, IL-6 and PEG(2). Day-3 mature DCs were identified and electofused with breast cancer cells to generate fusion vaccine. Phenotype of fusion cells were identified by fluorescence microscope and flow cytometer. The fusion vaccine was evaluated for T cell proliferation, secretion of IL-12 and IFN-gamma, and induction of tumor-specific CTL response. Despite differences in morphology, day-3 and day-7 DC expressed similar surface markers. The secretion of IL-12 and IFN-gamma in fusion vaccine group was much higher than that in the control group. Compared with control group, DC-tumor fusion vaccine could better stimulate the proliferation of allogeneic T lymphocytes and kill more breast cancer cells (MDA-MB-231) in vitro. Day-3 DCs had the same function as the day-7 DCs, but with a shorter culture period. Our findings suggested that day-3 DCs fused with whole apoptotic breast cancer cells could elicit effective specific antitumor T cell responses in vitro and may be developed into a prospective candidate for adoptivet immunotherapy.	[Zhang, Peng; Li, Xi; Liu, Ruilei; Jiang, Hua; Huang, Zenan; Liu, Yu; Wu, Juekun; Huang, Yong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Thyroid & Breast Surg, Guangzhou 510275, Guangdong, Peoples R China; [Yi, Shuhong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hepat Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Huang, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Thyroid & Breast Surg, Guangzhou 510275, Guangdong, Peoples R China.	dryonghuang@189.cn			Fundamental Research Funds for the Central Universities - Ministry of Education of China [09ykpy15]	Fundamental Research Funds for the Central Universities - Ministry of Education of China	This study was supported by the Fundamental Research Funds for the Central Universities (grant number 09ykpy15), funded by the Ministry of Education of China. http://www.moe.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2005, J CLIN IMMUNOL, V25, P87, DOI 10.1007/s10875-005-2814-2; Avigan D, 2004, CLIN CANCER RES, V10, P4699, DOI 10.1158/1078-0432.CCR-04-0347; Avigan DE, 2007, J IMMUNOTHER, V30, P749, DOI 10.1097/CJI.0b013e3180de4ce8; Benencia F, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/425476; Bohnenkamp HR, 2004, CELL IMMUNOL, V231, P112, DOI 10.1016/j.cellimm.2004.12.007; Bonehill A, 2004, J IMMUNOL, V172, P6649, DOI 10.4049/jimmunol.172.11.6649; Burdek M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-90; Campbell-Anson Ryan E, 2008, J Immune Based Ther Vaccines, V6, P1, DOI 10.1186/1476-8518-6-1; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Curigliano G, 2007, EXPERT REV ANTICANC, V7, P1225, DOI 10.1586/14737140.7.9.1225; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; Dauer M, 2005, J IMMUNOL METHODS, V302, P145, DOI 10.1016/j.jim.2005.05.010; Delirezh N, 2009, CELL IMMUNOL, V257, P23, DOI 10.1016/j.cellimm.2009.02.002; Fong L, 2000, ANNU REV IMMUNOL, V18, P245, DOI 10.1146/annurev.immunol.18.1.245; Jarnjak-Jankovic S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-119; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Ma WX, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-34; Mittenclorf EA, 2007, CANCER-AM CANCER SOC, V110, P1677, DOI 10.1002/cncr.22978; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Trefzer U, 2005, VACCINE, V23, P2367, DOI 10.1016/j.vaccine.2005.01.081; Trinchieri G, 1998, Int Rev Immunol, V16, P365, DOI 10.3109/08830189809043002; Tuyaerts S, 2007, CANCER IMMUNOL IMMUN, V56, P1513, DOI 10.1007/s00262-007-0334-z; Zhang YF, 2007, BREAST CANCER RES TR, V105, P277, DOI 10.1007/s10549-006-9457-8	25	23	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102197	10.1371/journal.pone.0102197	http://dx.doi.org/10.1371/journal.pone.0102197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036145	gold, Green Submitted, Green Published			2022-12-25	WOS:000339615200040
J	Baron, JL; Vikram, A; Duda, S; Stout, JE; Bibby, K				Baron, Julianne L.; Vikram, Amit; Duda, Scott; Stout, Janet E.; Bibby, Kyle			Shift in the Microbial Ecology of a Hospital Hot Water System following the Introduction of an On-Site Monochloramine Disinfection System	PLOS ONE			English	Article							DRINKING-WATER; OPPORTUNISTIC PATHOGENS; PSEUDOMONAS-AERUGINOSA; BACTERIAL-POPULATIONS; COMMUNITY STRUCTURE; CHLORAMINE DECAY; SURFACE-WATER; BIOFILMS; CONTAMINATION; RESISTANCE	Drinking water distribution systems, including premise plumbing, contain a diverse microbiological community that may include opportunistic pathogens. On-site supplemental disinfection systems have been proposed as a control method for opportunistic pathogens in premise plumbing. The majority of on-site disinfection systems to date have been installed in hospitals due to the high concentration of opportunistic pathogen susceptible occupants. The installation of on-site supplemental disinfection systems in hospitals allows for evaluation of the impact of on-site disinfection systems on drinking water system microbial ecology prior to widespread application. This study evaluated the impact of supplemental monochloramine on the microbial ecology of a hospital's hot water system. Samples were taken three months and immediately prior to monochloramine treatment and monthly for the first six months of treatment, and all samples were subjected to high throughput Illumina 16S rRNA region sequencing. The microbial community composition of monochloramine treated samples was dramatically different than the baseline months. There was an immediate shift towards decreased relative abundance of Betaproteobacteria, and increased relative abundance of Firmicutes, Alphaproteobacteria, Gammaproteobacteria, Cyanobacteria and Actinobacteria. Following treatment, microbial populations grouped by sampling location rather than sampling time. Over the course of treatment the relative abundance of certain genera containing opportunistic pathogens and genera containing denitrifying bacteria increased. The results demonstrate the driving influence of supplemental disinfection on premise plumbing microbial ecology and suggest the value of further investigation into the overall effects of premise plumbing disinfection strategies on microbial ecology and not solely specific target microorganisms.	[Baron, Julianne L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Baron, Julianne L.; Duda, Scott; Stout, Janet E.] Special Pathogens Lab, Pittsburgh, PA USA; [Vikram, Amit; Stout, Janet E.; Bibby, Kyle] Univ Pittsburgh, Swanson Sch Engn, Dept Civil & Environm Engn, Pittsburgh, PA 15260 USA; [Bibby, Kyle] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bibby, K (corresponding author), Univ Pittsburgh, Swanson Sch Engn, Dept Civil & Environm Engn, Pittsburgh, PA 15260 USA.	BibbyKJ@pitt.edu	Vikram, Amit/G-5816-2010; Bibby, Kyle J/C-6189-2018	Vikram, Amit/0000-0002-1207-9292; Bibby, Kyle J/0000-0003-3142-6090	Alfred P. Sloan Foundation [B2013-12]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This project was funded by a grant from the Alfred P. Sloan Foundation (grant B2013-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007; Berry D, 2010, APPL ENVIRON MICROB, V76, P6685, DOI 10.1128/AEM.00644-10; BSR/ASHRAE, 2011, PREV LEG ASS BUILD W; Buse HY, 2011, LETT APPL MICROBIOL, V53, P217, DOI 10.1111/j.1472-765X.2011.03094.x; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chiao TH, 2014, ENVIRON SCI TECHNOL, V48, P4038, DOI 10.1021/es4055725; Douterelo I, 2013, WATER RES, V47, P503, DOI 10.1016/j.watres.2012.09.053; Duda S, 2014, EVALUATION NEW UNPUB; Duda S, 2013, 8 INT C LEG; Edgar RC, 2010, BIOINFORMATICS; Emtiazi F, 2004, WATER RES, V38, P1197, DOI 10.1016/j.watres.2003.10.056; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Flannery B, 2006, EMERG INFECT DIS, V12, P588; Gomez-Alvarez V, 2012, APPL ENVIRON MICROB, V78, P6095, DOI 10.1128/AEM.01018-12; Henne K, 2012, APPL ENVIRON MICROB, V78, P3530, DOI 10.1128/AEM.06373-11; Hicks Lauri A., 2011, Morbidity and Mortality Weekly Report, V60, P1083; Hoefel D, 2005, APPL ENVIRON MICROB, V71, P6479, DOI 10.1128/AEM.71.11.6479-6488.2005; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Jensen N, 2003, LETT APPL MICROBIOL, V36, P9, DOI 10.1046/j.1472-765X.2003.01251.x; Kandiah S, 2012, ASS PROF INF CONTR E; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P2492, DOI 10.1128/AEM.54.10.2492-2499.1988; Lin YE, 2011, INFECT CONT HOSP EP, V32, P166, DOI 10.1086/657934; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marchesi I, 2012, AM J INFECT CONTROL, V40, P279, DOI 10.1016/j.ajic.2011.03.008; Martiny AC, 2003, APPL ENVIRON MICROB, V69, P6899, DOI 10.1128/AEM.69.11.6899-6907.2003; Mathieu L, 2009, WATER RES, V43, P3375, DOI 10.1016/j.watres.2009.05.005; Mondello Placido, 2006, Infez Med, V14, P235; Morisita M, 1959, MEMOIRS FS E, V2; National Research Council (NRC), 2006, DRINK WAT DISTR SYST; Nguyen C, 2012, WATER RES, V46, P611, DOI 10.1016/j.watres.2011.11.006; Perola O, 2002, J HOSP INFECT, V50, P196, DOI 10.1053/jhin.2001.1163; Pryor M, 2004, WATER SCI TECHNOL, V50, P83, DOI 10.2166/wst.2004.0025; Regan JM, 2002, APPL ENVIRON MICROB, V68, P73, DOI 10.1128/AEM.68.1.73-81.2002; Revetta RP, 2010, WATER RES, V44, P1353, DOI 10.1016/j.watres.2009.11.008; Revetta RP, 2013, FEMS MICROBIOL ECOL; Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x; Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046; Squier, 2000, Curr Infect Dis Rep, V2, P490, DOI 10.1007/s11908-000-0049-1; Stout J. E., 2011, HOSP EPIDEMIOLOGY IN; Stout J.E., 2012, ASS WAT TECHN ANN CO; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Sydnor ERM, 2012, INFECT CONT HOSP EP, V33, P235, DOI 10.1086/664047; van der Wielen PWJJ, 2013, APPL ENVIRON MICROB, V79, P825, DOI 10.1128/AEM.02748-12; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang H, 2014, ENVIRON SCI TECHNOL, V48, P1426, DOI 10.1021/es402636u; Wang H, 2013, ENVIRON SCI TECHNOL, V47, P10117, DOI 10.1021/es402455r; Wang H, 2012, APPL ENVIRON MICROB, V78, P6285, DOI 10.1128/AEM.01492-12; White C, 2011, APPL ENVIRON MICROB, V77, P5557, DOI 10.1128/AEM.02446-10; Williams MM, 2013, BIOFOULING, V29, P147, DOI 10.1080/08927014.2012.757308; Williams MM, 2003, APPL ENVIRON MICROB, V69, P5463, DOI 10.1128/AEM.69.9.5463-5471.2003; Yapicioglu H, 2012, J PAEDIATR CHILD H, V48, P430, DOI 10.1111/j.1440-1754.2011.02248.x; Zhang Y, 2008, J ENVIRON ENG, V134, P521, DOI 10.1061/(ASCE)0733-9372(2008)134:7(521); Zhang Y, 2009, J AM WATER WORKS ASS, V101, P51; Zhang Y, 2009, ENVIRON SCI TECHNOL, V43, P1890, DOI 10.1021/es802482s	56	53	53	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102679	10.1371/journal.pone.0102679	http://dx.doi.org/10.1371/journal.pone.0102679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033448	Green Accepted, Green Published, gold			2022-12-25	WOS:000339418300078
J	Haque, S; Nawrot, DA; Alakurtti, S; Ghemtio, L; Yli-Kauhaluoma, J; Tammela, P				Haque, Shafiul; Nawrot, Dorota A.; Alakurtti, Sami; Ghemtio, Leo; Yli-Kauhaluoma, Jari; Tammela, Paivi			Screening and Characterisation of Antimicrobial Properties of Semisynthetic Betulin Derivatives	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; CRYSTAL-STRUCTURE; ANTIBACTERIAL ACTIVITY; ANTIMALARIAL ACTIVITY; BIOLOGICAL-ACTIVITY; ACID-BINDING; OUTER BARK; PREDICTION; TRITERPENOIDS; STABILITY	Betulin (lup-20(29)-ene-3 beta, 28-diol) is a naturally occurring triterpene, which is found in substantial amounts from the outer bark of birch trees. A library of 51 structurally diverse semisynthetic betulin derivatives was screened against five bacterial strains, Enterobacter aerogenes, Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, Staphylococcus aureus and a fungal strain Candida albicans, using broth microdilution assays. Primary antimicrobial screening at 50 mu M concentration led to the identification of five compounds showing antimicrobial properties (inhibition of growth by >70% against one or more microbial strains). According to the dose-response results, 28-O-(N-acetylanthraniloyl) betulin (compound 5) was the most active, showing MIC90 of 6.25 mu M against two Gram-positive bacteria, E. faecalis and S. aureus. However, the activity of this compound was affected by albumin binding, which was demonstrated by the loss of activity in a host-pathogen co-culture assay as well as in the antibacterial assay in the presence of increased concentration of albumin. Furthermore, the effects on mammalian cells were evaluated by cytotoxicity assessment on hepatocyte cell culture after 24 h exposure to the compounds. Betulinic aldehyde (18), betulin-28-oxime (31) and hetero cycloadduct with acetoxy groups at carbon atoms 3 and 28 and ethyl substituent at the triazolo ring (43) displayed cytotoxicity towards hepatocytes, with IC50 values of 47, 25 and 16 mu M, respectively. The IC50 value for 28-O-(N-acetylanthraniloyl) betulin (5) was 56 mu M. The current study presents an insight into using betulin scaffold for developing derivatives with antibacterial potential, and furthermore the necessity of in-depth analysis of found actives through selectivity profiling and follow-up studies including in silico ADMET predictions.	[Haque, Shafiul; Nawrot, Dorota A.; Ghemtio, Leo; Tammela, Paivi] Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland; [Alakurtti, Sami; Yli-Kauhaluoma, Jari] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, Helsinki, Finland; [Alakurtti, Sami] VTT Tech Res Ctr Finland, Espoo, Finland	University of Helsinki; University of Helsinki; VTT Technical Research Center Finland	Tammela, P (corresponding author), Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland.	paivi.tammela@helsinki.fi	HAQUE, SHAFIUL/AAN-2946-2020; Tammela, Päivi/A-4670-2010	HAQUE, SHAFIUL/0000-0002-2989-121X; Tammela, Päivi/0000-0003-4697-8066; Yli-Kauhaluoma, Jari/0000-0003-0370-7653; ghemtio, leo/0000-0003-3591-5676	European Union [227239]; Academy of Finland [252308]; Biocenter Finland (Drug Discovery and Chemical Biology Network)	European Union(European Commission); Academy of Finland(Academy of Finland); Biocenter Finland (Drug Discovery and Chemical Biology Network)	The research leading to these results has received funding from the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement no. 227239 [ForestSpeCs], Academy of Finland (Grant 252308) and Biocenter Finland (Drug Discovery and Chemical Biology Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Alakurtti S, 2010, BIOORGAN MED CHEM, V18, P1573, DOI 10.1016/j.bmc.2010.01.003; Magina MDA, 2012, QUIM NOVA, V35, P1184, DOI 10.1590/S0100-40422012000600022; [Anonymous], TOP 10 CAUSES OF DEA; Beauchemin R, 2007, BIOMACROMOLECULES, V8, P3177, DOI 10.1021/bm700697a; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Boryczka S, 2012, J PHARM SCI-US, V101, P4458, DOI 10.1002/jps.23321; Bringmann G, 1997, PLANTA MED, V63, P255, DOI 10.1055/s-2006-957666; Chandramu C, 2003, PHYTOTHER RES, V17, P129, DOI 10.1002/ptr.1088; Cheng A, 2003, J COMPUT AID MOL DES, V17, P811, DOI 10.1023/B:JCAM.0000021834.50768.c6; Cheng AL, 2003, J MED CHEM, V46, P3572, DOI 10.1021/jm020266b; Chung PY, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-25; Cichewicz RH, 2004, MED RES REV, V24, P90, DOI 10.1002/med.10053; Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Dehelean CA, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-137; Egan WJ, 2000, J MED CHEM, V43, P3867, DOI 10.1021/jm000292e; Egan WJ, 2002, ADV DRUG DELIVER REV, V54, P273, DOI 10.1016/S0169-409X(02)00004-2; EKMAN R, 1983, HOLZFORSCHUNG, V37, P205, DOI 10.1515/hfsg.1983.37.4.205; Fears R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002556; Fontanay S, 2008, J ETHNOPHARMACOL, V120, P272, DOI 10.1016/j.jep.2008.09.001; FUJIOKA T, 1994, J NAT PROD, V57, P243, DOI 10.1021/np50104a008; Fulda S, 1999, INT J CANCER, V82, P435, DOI 10.1002/(SICI)1097-0215(19990730)82:3<435::AID-IJC18>3.0.CO;2-1; Fulda S, 1997, CANCER RES, V57, P4956; Fulda S, 1998, J BIOL CHEM, V273, P33942, DOI 10.1074/jbc.273.51.33942; Gehrke ITS, 2013, J ETHNOPHARMACOL, V148, P486, DOI 10.1016/j.jep.2013.04.043; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; HESS SC, 1995, J ETHNOPHARMACOL, V47, P97, DOI 10.1016/0378-8741(95)01260-K; Jager S, 2008, MOLECULES, V13, P3224, DOI 10.3390/molecules13123224; Kanakis CD, 2007, J AGR FOOD CHEM, V55, P970, DOI 10.1021/jf062638l; Kazakova OB, 2011, CHEM NAT COMPD+, V47, P752, DOI 10.1007/s10600-011-0050-y; Kazakova OB, 2010, RUSS J BIOORG CHEM+, V36, P383, DOI 10.1134/S1068162010030155; Kim DSHL, 1998, BIOORG MED CHEM LETT, V8, P1707, DOI 10.1016/S0960-894X(98)00295-9; Kleymann G, 2004, J BIOMOL SCREEN, V9, P578, DOI 10.1177/1087057104265291; Krasutsky PA, 2002, WO patent, Patent No. [2002/26761, 200226761]; Kvasnica M, 2005, BIOORGAN MED CHEM, V13, P3447, DOI 10.1016/j.bmc.2005.03.006; Loonen H, 1999, ENVIRON TOXICOL CHEM, V18, P1763, DOI 10.1002/etc.5620180822; Moghaddam M. G., 2012, Pharmacology and Pharmacy, V3, P119, DOI 10.4236/pp.2012.32018; Monaghan RL, 2006, BIOCHEM PHARMACOL, V71, P901, DOI 10.1016/j.bcp.2005.11.023; N'soukpoe-Kossi CN, 2007, INT J BIOL MACROMOL, V40, P484, DOI 10.1016/j.ijbiomac.2006.11.005; NCCLS- NATIONAL COMITE CLINICAL LABORATORY STANDARDS, 2003, NCCLS DOCUMENT M7 A6; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; NICK A, 1995, PHYTOCHEMISTRY, V40, P1691, DOI 10.1016/0031-9422(95)00491-O; Patocka J, 2003, J APPL BIOMED, V1, P7, DOI [DOI 10.32725/JAB.2003.002, https://doi.org/10.32725/jab.2003.002, DOI 10.32725/jab.2003.002]; Petitpas I, 2001, J MOL BIOL, V314, P955, DOI 10.1006/jmbi.2000.5208; Piddock LJV, 2012, LANCET INFECT DIS, V12, P249, DOI 10.1016/S1473-3099(11)70316-4; Pohjala L, 2009, J NAT PROD, V72, P1917, DOI 10.1021/np9003245; Prachayasittikul S, 2010, EXCLI J, V9, P1; Roychoudhury S, 2003, J BIOMOL SCREEN, V8, P555, DOI 10.1177/1087057103256917; Salin O, 2010, BIOCHEM PHARMACOL, V80, P1141, DOI 10.1016/j.bcp.2010.06.051; Sathya Bama S, 2012, INT J PHARM PHARM SC, V4, P557; Selzer E, 2000, J INVEST DERMATOL, V114, P935, DOI 10.1046/j.1523-1747.2000.00972.x; Sinha B. N., 2009, Journal of Natural Remedies, V9, P99; Subramanyam R, 2009, J PHOTOCH PHOTOBIO B, V94, P8, DOI 10.1016/j.jphotobiol.2008.09.002; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Susnow RG, 2003, J CHEM INF COMP SCI, V43, P1308, DOI 10.1021/ci030283p; Tene M, 2009, INT J BIOL CHEM SCI, V3, P538; Tolstikov GA, 2005, CHEM SUSTAIN DEV, V13, P1; Xia XY, 2004, J MED CHEM, V47, P4463, DOI 10.1021/jm0303195; YLI-KAUHALUOMA J, 2007, WO Patent application, Patent No. [2007/141389, 2007141389, 141389]; Yogeeswari P, 2005, CURR MED CHEM, V12, P657, DOI 10.2174/0929867053202214; Zenger K, 2013, J PHARM PHARMACOL, V65, P1765, DOI 10.1111/jphp.12070	63	42	44	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102696	10.1371/journal.pone.0102696	http://dx.doi.org/10.1371/journal.pone.0102696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032708	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300079
J	Jiao, ZH; Li, M; Feng, YX; Shi, JC; Zhang, J; Shao, B				Jiao, Zhi-Hao; Li, Ming; Feng, Yi-Xing; Shi, Jia-Chen; Zhang, Jing; Shao, Bing			Hormesis Effects of Silver Nanoparticles at Non-Cytotoxic Doses to Human Hepatoma Cells	PLOS ONE			English	Article							SPRAGUE-DAWLEY RATS; P38 MAPK ACTIVATION; IN-VITRO TOXICITY; OXIDATIVE STRESS; DEPENDENT TOXICITY; MAMMALIAN-CELLS; PARTICLE-SIZE; DNA-DAMAGE; PROLIFERATION; CYTOTOXICITY	Silver nanoparticles (AgNPs) have attracted considerable attentions due to their unique properties and diverse applications. Although it has been reported that AgNPs have acute toxic effects on a variety of cultured mammalian cells and animal models, few studies have been conducted to evaluate the associated risk of AgNPs to human health at non-cytotoxic doses. In this paper, HepG2 cells were exposed to 10 nm and 100 nm AgNPs under non-cytotoxic conditions, and cell viability was assessed. At low doses, AgNPs displayed "hormesis'' effects by accelerating cell proliferation. Further studies indicated that the activation states of MAPKs were differentially regulated in this process. Specifically, by increasing the expression of downstream genes, p38 MAPK played a central role in non-cytotoxic AgNP-induced hormesis. Moreover, the treatment of HepG2 cells with silver ions (Ag+) at the same dose levels induced distinct biological effects, suggesting that different intrinsic properties exist for AgNPs and Ag+.	[Jiao, Zhi-Hao; Li, Ming; Feng, Yi-Xing; Shi, Jia-Chen; Zhang, Jing; Shao, Bing] Beijing Ctr Dis Control & Prevent, Beijing Key Lab Diagnost & Traceabil Technol Food, Beijing, Peoples R China		Shao, B (corresponding author), Beijing Ctr Dis Control & Prevent, Beijing Key Lab Diagnost & Traceabil Technol Food, Beijing, Peoples R China.	shaobingch@sina.com	shao, bing/L-8793-2019		Capital Health Research and Development of Special [2011-1014-01]; Beijing Municipal Senior Technical Training Plan in Health System [2011-2-29]	Capital Health Research and Development of Special; Beijing Municipal Senior Technical Training Plan in Health System	This work was supported by the Capital Health Research and Development of Special (2011-1014-01, http://www.bjhb.gov.cn/) and the Beijing Municipal Senior Technical Training Plan in Health System (2011-2-29, http://www.bjhb.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016; Ahamed M, 2010, TOXICOL APPL PHARM, V242, P263, DOI 10.1016/j.taap.2009.10.016; Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009; Arora S, 2009, TOXICOL APPL PHARM, V236, P310, DOI 10.1016/j.taap.2009.02.020; Bar-Ilan O, 2009, SMALL, V5, P1897, DOI 10.1002/smll.200801716; Benn T, 2010, J ENVIRON QUAL, V39, P1875, DOI 10.2134/jeq2009.0363; Benn TM, 2008, ENVIRON SCI TECHNOL, V42, P4133, DOI 10.1021/es7032718; Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Cha K, 2008, BIOTECHNOL LETT, V30, P1893, DOI 10.1007/s10529-008-9786-2; Chairuangkitti P, 2013, TOXICOL IN VITRO, V27, P330, DOI 10.1016/j.tiv.2012.08.021; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dubas ST, 2008, MATER LETT, V62, P2661, DOI 10.1016/j.matlet.2008.01.033; Duffin R, 2007, INHAL TOXICOL, V19, P849, DOI 10.1080/08958370701479323; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; Eom HJ, 2010, ENVIRON SCI TECHNOL, V44, P8337, DOI 10.1021/es1020668; Evanoff DD, 2005, CHEMPHYSCHEM, V6, P1221, DOI 10.1002/cphc.200500113; Foldbjerg R, 2009, TOXICOL LETT, V190, P156, DOI 10.1016/j.toxlet.2009.07.009; Gerber C, 2006, NAT NANOTECHNOL, V1, P3, DOI 10.1038/nnano.2006.70; Gopinath P, 2010, COLLOID SURFACE B, V77, P240, DOI 10.1016/j.colsurfb.2010.01.033; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Iavicoli I, 2010, DOSE-RESPONSE, V8, P501, DOI 10.2203/dose-response.10-016.Iavicoli; Kaur J, 2013, FOOD CHEM TOXICOL, V51, P1, DOI 10.1016/j.fct.2012.08.044; Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001; Kim YS, 2008, INHAL TOXICOL, V20, P575, DOI 10.1080/08958370701874663 ; Lankoff A, 2012, TOXICOL LETT, V208, P197, DOI 10.1016/j.toxlet.2011.11.006; Lee HY, 2010, J NANOPART RES, V12, P1567, DOI 10.1007/s11051-009-9666-2; Lim D, 2012, ENVIRON TOXICOL CHEM, V31, P585, DOI 10.1002/etc.1706; Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubick N, 2008, ENVIRON SCI TECHNOL, V42, P8617, DOI 10.1021/es8026314; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001; Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Rashidi L, 2011, CRIT REV FOOD SCI, V51, P723, DOI 10.1080/10408391003785417; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Samberg ME, 2010, ENVIRON HEALTH PERSP, V118, P407, DOI 10.1289/ehp.0901398; Scown TM, 2010, TOXICOL SCI, V115, P521, DOI 10.1093/toxsci/kfq076; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shin SH, 2007, INT IMMUNOPHARMACOL, V7, P1813, DOI 10.1016/j.intimp.2007.08.025; STEBBING ARD, 1982, SCI TOTAL ENVIRON, V22, P213, DOI 10.1016/0048-9697(82)90066-3; Sung JH, 2008, INHAL TOXICOL, V20, P567, DOI 10.1080/08958370701874671 ; Takenaka S, 2001, ENVIRON HEALTH PERSP, V109, P547, DOI 10.2307/3454667; Tang JL, 2009, J NANOSCI NANOTECHNO, V9, P4924, DOI 10.1166/jnn.2009.1269; Veronesi B, 2014, ACS SUSTAINABLE CHEM; Vigneshwaran N, 2007, J NANOSCI NANOTECHNO, V7, P1893, DOI 10.1166/jnn.2007.737; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Yu SJ, 2013, ENVIRON SCI TECHNOL, V47, P3268, DOI 10.1021/es304346p; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	61	74	74	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102564	10.1371/journal.pone.0102564	http://dx.doi.org/10.1371/journal.pone.0102564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033410	Green Submitted, gold, Green Published			2022-12-25	WOS:000339418300061
J	Schneider, A; Wubken, M; Linde, K; Buhner, M				Schneider, Antonius; Wuebken, Magdalena; Linde, Klaus; Buehner, Markus			Communicating and Dealing with Uncertainty in General Practice: The Association with Neuroticism	PLOS ONE			English	Article							MEDICALLY UNEXPLAINED SYMPTOMS; DECISION-MAKING; PRIMARY-CARE; PHYSICIANS REACTIONS; PERSONALITY; VALIDATION; SCALES; PRACTITIONERS; PERSPECTIVE; HEURISTICS	Background: Diagnostic reasoning in primary care setting where presented problems and patients are mostly unselected appears as a complex process. The aim was to develop a questionnaire to describe how general practitioners (GPs) deal with uncertainty to gain more insight into the decisional process. The association of personality traits with medical decision making was investigated additionally. Methods: Raw items were identified by literature research and focus group. Items were improved by interviewing ten GPs with thinking-aloud-method. A personal case vignette related to a complex and uncertainty situation was introduced. The final questionnaire was administered to 228 GPs in Germany. Factorial validity was calculated with explorative and confirmatory factor analysis. The results of the Communicating and Dealing with Uncertainty (CoDU) - questionnaire were compared with the scales of the 'Physician Reaction to Uncertainty' (PRU) questionnaire and with the personality traits which were determined with the Big Five Inventory (BFI-K). Results: The items could be assigned to four scales with varying internal consistency, namely 'communicating uncertainty' (Cronbach alpha 0.79), 'diagnostic action' (0.60), 'intuition' (0.39) and 'extended social anamnesis' (0.69). Neuroticism was positively associated with all PRU scales 'anxiety due to uncertainty' (Pearson correlation 0.487), 'concerns about bad outcomes' (0.488), 'reluctance to disclose uncertainty to patients' (0.287), 'reluctance to disclose mistakes to physicians' (0.212) and negatively associated with the CoDU scale 'communicating uncertainty' (-0.242) (p<0.01 for all). 'Extraversion' (0.146; p<0.05), 'agreeableness' (0.145, p<0.05), 'conscientiousness' (0.168, p<0.05) and 'openness to experience' (0.186, p<0.01) were significantly positively associated with 'communicating uncertainty'. 'Extraversion' (0.162), 'consciousness' (0.158) and 'openness to experience' (0.155) were associated with 'extended social anamnesis' (p<0.05). Conclusion: The questionnaire allowed describing the diagnostic decision making process of general practitioners in complex situations. Personality traits are associated with diagnostic reasoning and communication with patients, which might be important for medical education and quality improvement purposes.	[Schneider, Antonius; Wuebken, Magdalena; Linde, Klaus] Tech Univ Munich, Klinikum Rechts Isar, Inst Gen Practice, D-80290 Munich, Germany; [Buehner, Markus] Univ Munich, Dept Psychol, Munich, Germany	Technical University of Munich; University of Munich	Schneider, A (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Gen Practice, D-80290 Munich, Germany.	antonius.schneider@tum.de		Linde, Klaus/0000-0002-2902-970X				Allison JJ, 1998, MED DECIS MAKING, V18, P320, DOI 10.1177/0272989X9801800310; Andre M, 2003, FAM PRACT, V20, P514, DOI 10.1093/fampra/cmg503; Baliatsas C, 2014, J PSYCHOSOM RES, V76, P405, DOI 10.1016/j.jpsychores.2014.02.008; Borges NJ, 2002, J CAREER ASSESSMENT, V10, P362, DOI 10.1177/10672702010003006; Chamorro-Premuzic T, 2012, PERSONALITY INDIVIDU, V41, P419; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Elstein AS, 1999, ACAD MED, V74, P791, DOI 10.1097/00001888-199907000-00012; Gask L, 2011, J PSYCHOSOM RES, V71, P325, DOI 10.1016/j.jpsychores.2011.05.008; GERRITY MS, 1992, AM J SOCIOL, V97, P1022, DOI 10.1086/229860; Gerrity MS, 1995, MOTIV EMOTION, V19, P175, DOI 10.1007/BF02250510; Ghosh AK, 2005, J LAB CLIN MED, V145, P171, DOI 10.1016/j.lab.2005.02.006; Graham EK, 2012, J GERONTOL B-PSYCHOL, V67, P545, DOI 10.1093/geronb/gbr149; Green LA, 2001, NEW ENGL J MED, V344, P2021, DOI 10.1056/NEJM200106283442611; Hall KH, 2002, MED EDUC, V36, P216, DOI 10.1046/j.1365-2923.2002.01140.x; Heine SJ, 2009, ANNU REV PSYCHOL, V60, P369, DOI 10.1146/annurev.psych.60.110707.163655; Hewson MG, 1996, J GEN INTERN MED, V11, P481, DOI 10.1007/BF02599044; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D, 2009, AM PSYCHOL, V64, P515, DOI 10.1037/a0016755; KNOTTNERUS JA, 1991, FAM PRACT, V8, P305, DOI 10.1093/fampra/8.4.305; LEDLEY RS, 1959, SCIENCE, V130, P9, DOI 10.1126/science.130.3366.9; Lievens F, 2009, J APPL PSYCHOL, V94, P1514, DOI 10.1037/a0016137; Marewski Julian N, 2012, Dialogues Clin Neurosci, V14, P77; Murdock KW, 2013, J INDIVID DIFFER, V34, P97, DOI 10.1027/1614-0001/a000104; O'Riordan Margaret, 2011, Qual Prim Care, V19, P175; Hartman TCO, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-68; Rammstedt B, 2005, DIAGNOSTICA, V51, P195, DOI 10.1026/0012-1924.51.4.195; RAVETZ JR, 1987, KNOWLEDGE, V9, P87, DOI 10.1177/107554708700900104; Schneider A, 2013, DTSCH ARZTEBL INT, V110, P653, DOI 10.3238/arztebl.2013.0653; Schneider A, 2010, J EVAL CLIN PRACT, V16, P431, DOI 10.1111/j.1365-2753.2010.01464.x; Schneider A, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-81; SHROUT PE, 1989, J CLIN EPIDEMIOL, V42, P69, DOI 10.1016/0895-4356(89)90027-9; Stolper CF, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-1; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wheling P, 2013, WISSEN GRENZE UMGANG, P43; WILLIS GB, 1991, APPL COGNITIVE PSYCH, V5, P251, DOI 10.1002/acp.2350050307; WONCA, 2013, EUR DEF GEN PRACT FA	37	8	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102780	10.1371/journal.pone.0102780	http://dx.doi.org/10.1371/journal.pone.0102780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25029276	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600100
J	Shimizu, M; Goto, M; Kawai, T; Yamashita, A; Kusakabe, Y				Shimizu, Madoka; Goto, Masao; Kawai, Takayuki; Yamashita, Atsuko; Kusakabe, Yuko			Distinct Human and Mouse Membrane Trafficking Systems for Sweet Taste Receptors T1r2 and T1r3	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GABA(B) RECEPTORS; SUBTYPE 1; DOMAIN; IDENTIFICATION; EXPRESSION; RESPONSES; REGION; GENE; GUSTDUCIN	The sweet taste receptors T1r2 and T1r3 are included in the T1r taste receptor family that belongs to class C of the G protein-coupled receptors. Heterodimerization of T1r2 and T1r3 is required for the perception of sweet substances, but little is known about the mechanisms underlying this heterodimerization, including membrane trafficking. We developed tagged mouse T1r2 and T1r3, and human T1R2 and T1R3 and evaluated membrane trafficking in human embryonic kidney 293 (HEK293) cells. We found that human T1R3 surface expression was only observed when human T1R3 was coexpressed with human T1R2, whereas mouse T1r3 was expressed without mouse T1r2 expression. A domain-swapped chimera and truncated human T1R3 mutant showed that the Venus flytrap module and cysteine-rich domain (CRD) of human T1R3 contain a region related to the inhibition of human T1R3 membrane trafficking and coordinated regulation of human T1R3 membrane trafficking. We also found that the Venus flytrap module of both human T1R2 and T1R3 are needed for membrane trafficking, suggesting that the coexpression of human T1R2 and T1R3 is required for this event. These results suggest that the Venus flytrap module and CRD receive taste substances and play roles in membrane trafficking of human T1R2 and T1R3. These features are different from those of mouse receptors, indicating that human T1R2 and T1R3 are likely to have a novel membrane trafficking system.	[Shimizu, Madoka; Goto, Masao; Kawai, Takayuki; Kusakabe, Yuko] NARO, Natl Food Res Inst, Tsukuba, Ibaraki, Japan; [Yamashita, Atsuko] RIKEN SPring 8 Ctr, Sayo, Hyogo, Japan; [Yamashita, Atsuko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; RIKEN; Okayama University	Kusakabe, Y (corresponding author), NARO, Natl Food Res Inst, Tsukuba, Ibaraki, Japan.	ykusa@affrc.go.jp	Yamashita, Atsuko/H-5566-2017; Kusakabe, Yuko/AAA-1944-2019	Yamashita, Atsuko/0000-0002-8001-4642; 	Research for the Utilization and Industrialization of Agricultural Biotechnology from the Ministry of Agriculture, Forestry and Fisheries; Targeted Proteins Research Program from MEXT; JSPS KAKENHI [25450194]	Research for the Utilization and Industrialization of Agricultural Biotechnology from the Ministry of Agriculture, Forestry and Fisheries; Targeted Proteins Research Program from MEXT; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant of the Research for the Utilization and Industrialization of Agricultural Biotechnology from the Ministry of Agriculture, Forestry and Fisheries, the Targeted Proteins Research Program from MEXT, and JSPS KAKENHI Grant Number 25450194. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmanov AA, 2001, CHEM SENSES, V26, P905, DOI 10.1093/chemse/26.7.905; Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; BARTOSHUK LM, 1975, J COMP PHYSIOL PSYCH, V89, P971, DOI 10.1037/h0077172; BEAUCHAMP GK, 1977, J COMP PHYSIOL PSYCH, V91, P1118, DOI 10.1037/h0077380; Bhattacharya A, 2010, J NEUROCHEM, V112, P723, DOI 10.1111/j.1471-4159.2009.06493.x; Danilova V, 2004, J NEUROPHYSIOL, V92, P1067, DOI 10.1152/jn.01183.2003; Danilova V, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-5; Danilova V, 1998, J NEUROPHYSIOL, V80, P2102, DOI 10.1152/jn.1998.80.4.2102; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Guo YZ, 2006, AMINO ACIDS, V30, P397, DOI 10.1007/s00726-006-0332-z; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Hu JX, 2000, J BIOL CHEM, V275, P16382, DOI 10.1074/jbc.M000277200; Ishimaru Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045426; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kim MR, 2003, BIOCHEM BIOPH RES CO, V312, P500, DOI 10.1016/j.bbrc.2003.10.137; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Knollman PE, 2005, J BIOL CHEM, V280, P24506, DOI 10.1074/jbc.M501978200; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; Kusakabe Y, 2002, CHEM SENSES, V27, P445, DOI 10.1093/chemse/27.5.445; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Martin SC, 1999, MOL CELL NEUROSCI, V13, P180, DOI 10.1006/mcne.1999.0741; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; Pagano A, 2001, J NEUROSCI, V21, P1189; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; Ueda T, 2003, J NEUROSCI, V23, P7376; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106	31	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e100425	10.1371/journal.pone.0100425	http://dx.doi.org/10.1371/journal.pone.0100425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029362	gold, Green Published, Green Submitted			2022-12-25	WOS:000341306600005
J	Chen, L; Keitany, GJ; Peng, XH; Gibson, C; Mohar, I; Vignali, M; Crispe, IN; Huang, FS; Wang, RB				Chen, Lin; Keitany, Gladys J.; Peng, Xiaohong; Gibson, Claire; Mohar, Isaac; Vignali, Marissa; Crispe, Ian N.; Huang, Fusheng; Wang, Ruobing			Identification of Pre-Erythrocytic Malaria Antigens That Target Hepatocytes for Killing In Vivo and Contribute to Protection Elicited by Whole-Parasite Vaccination	PLOS ONE			English	Article							YOELII CIRCUMSPOROZOITE PROTEIN; T-CELL IMMUNITY; PHASE 2A TRIAL; PLASMODIUM-BERGHEI; NAIVE ADULTS; LIVER-STAGES; IMMUNIZATION; FALCIPARUM; RESPONSES; SPOROZOITES	Pre-erythrocytic malaria vaccines, including those based on whole-parasite approaches, have shown protective efficacy in animal and human studies. However few pre-erythocytic antigens other than the immunodominant circumsporozoite protein (CSP) have been studied in depth with the goal of developing potent subunit malaria vaccines that are suited for use in endemic areas. Here we describe a novel technique to identify pre-erythrocytic malaria antigens that contribute to protection elicited by whole-parasite vaccination in the mouse model. Our approach combines immunization with genetically attenuated parasites and challenge with DNA plasmids encoding for potential protective pre-erythrocytic malaria antigens as luciferase fusions by hydrodynamic tail vein injection. After optimizing the technique, we first showed that immunization with Pyfabb/f(-), a P. yoelii genetically attenuated parasite, induces killing of CSP-presenting hepatocytes. Depletion of CD8(+) but not CD4(+) T cells diminished the killing of CSP-expressing hepatocytes, indicating that killing is CD8(+) T cell-dependent. Finally we showed that the use of heterologous prime/boost immunization strategies that use genetically attenuated parasites and DNA vaccines enabled the characterization of a novel pre-erythrocytic antigen, Tmp21, as a contributor to Pyfabb/f(-) induced protection. This technique will be valuable for identification of potentially protective liver stage antigens and has the potential to contribute to the understanding of immunity elicited by whole parasite vaccination, as well as the development of effective subunit malaria vaccines.	[Chen, Lin; Peng, Xiaohong; Huang, Fusheng] Third Mil Med Univ, Dept Pathogen Biol, Chongqing, Peoples R China; [Chen, Lin; Keitany, Gladys J.; Peng, Xiaohong; Gibson, Claire; Vignali, Marissa; Wang, Ruobing] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Mohar, Isaac; Crispe, Ian N.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Crispe, Ian N.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Wang, Ruobing] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Army Medical University; Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Huang, FS (corresponding author), Third Mil Med Univ, Dept Pathogen Biol, Chongqing, Peoples R China.	fushenghster@gmail.com; ruobing.wang@seattlebiomed.org		Vignali, Marissa/0000-0002-7319-3371	National Institutes of Health [R01AI076498]; Bill and Melinda Gates Foundation [OPP1016829]; National Natural Science Foundation of China [30972570]; Seattle BioMed; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Seattle BioMed; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grant R01AI076498 to R. W., Bill and Melinda Gates Foundation grant OPP1016829 to R. W., National Natural Science Foundation of China #30972570 to F. H., and by Seattle BioMed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MAL VACC TECHN ROADM; Barbosa A, 2009, INFECT IMMUN, V77, P4502, DOI 10.1128/IAI.00442-09; Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471; Bijker EM, 2013, P NATL ACAD SCI USA, V110, P7862, DOI 10.1073/pnas.1220360110; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Butler NS, 2010, J IMMUNOL, V184, P2528, DOI 10.4049/jimmunol.0903529; Cabrera M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070842; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; Cockburn IA, 2014, INFECT IMMUN, V82, P1460, DOI 10.1128/IAI.01500-13; Cockburn IA, 2013, P NATL ACAD SCI USA, V110, P9090, DOI 10.1073/pnas.1303858110; Cooney LA, 2013, INFECT IMMUN, V81, P4171, DOI 10.1128/IAI.00871-13; Duffy PE, 2012, EXPERT REV VACCINES, V11, P1261, DOI [10.1586/ERV.12.92, 10.1586/erv.12.92]; Epstein JE, 2013, CURR OPIN INFECT DIS, V26, P420, DOI 10.1097/QCO.0000000000000002; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Franke ED, 1997, J IMMUNOL, V159, P3424; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Hafalla JCR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003303; Herweijer H, 2007, GENE THER, V14, P99, DOI 10.1038/sj.gt.3302891; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Krzych U, 2005, CURR TOP MICROBIOL, V297, P1; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Mauduit M, 2010, INFECT IMMUN, V78, P2182, DOI 10.1128/IAI.01415-09; Mauduit M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007717; Miller JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060820; Mishra S, 2011, VACCINE, V29, P7335, DOI 10.1016/j.vaccine.2011.07.081; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Murphy SC, 2013, P NATL ACAD SCI USA, V110, P6055, DOI 10.1073/pnas.1303834110; Nganou-Makamdop K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036508; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Obeng-Adjei N, CANC GENE THER, V20, P652; Rai U, 2012, BIOMOLECULES, V2, P23, DOI 10.3390/biom2010023; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Sebestyen MG, 2006, J GENE MED, V8, P852, DOI 10.1002/jgm.921; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Trimnell A, 2009, J IMMUNOL, V183, P5870, DOI 10.4049/jimmunol.0900302; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; Vaughan AM, 2010, HUM VACCINES, V6, P107, DOI 10.4161/hv.6.1.9654; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Wang RB, 2005, EUR J IMMUNOL, V35, P1859, DOI 10.1002/eji.200425807; Wang RB, 1998, INFECT IMMUN, V66, P4193; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	50	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102225	10.1371/journal.pone.0102225	http://dx.doi.org/10.1371/journal.pone.0102225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025375	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992400052
J	Galanter, WL; Bryson, ML; Falck, S; Rosenfield, R; Laragh, M; Shrestha, N; Schiff, GD; Lambert, BL				Galanter, William L.; Bryson, Michelle L.; Falck, Suzanne; Rosenfield, Rachel; Laragh, Marci; Shrestha, Neeha; Schiff, Gordon D.; Lambert, Bruce L.			Indication Alerts Intercept Drug Name Confusion Errors during Computerized Entry of Medication Orders	PLOS ONE			English	Article							VISUAL-PERCEPTION; TRIAL	Background: Confusion between similar drug names is a common cause of potentially harmful medication errors. Interventions to prevent these errors at the point of prescribing have had limited success. The purpose of this study is to measure whether indication alerts at the time of computerized physician order entry (CPOE) can intercept drug name confusion errors. Methods and Findings: A retrospective observational study of alerts provided to prescribers in a public, tertiary hospital and ambulatory practice with medication orders placed using CPOE. Consecutive patients seen from April 2006 through February 2012 were eligible if a clinician received an indication alert during ordering. A total of 54,499 unique patients were included. The computerized decision support system prompted prescribers to enter indications when certain medications were ordered without a coded indication in the electronic problem list. Alerts required prescribers either to ignore them by clicking OK, to place a problem in the problem list, or to cancel the order. Main outcome was the proportion of indication alerts resulting in the interception of drug name confusion errors. Error interception was determined using an algorithm to identify instances in which an alert triggered, the initial medication order was not completed, and the same prescriber ordered a similar-sounding medication on the same patient within 5 minutes. Similarity was defined using standard text similarity measures. Two clinicians performed chart review of all cases to determine whether the first, non-completed medication order had a documented or non-documented, plausible indication for use. If either reviewer found a plausible indication, the case was not considered an error. We analyzed 127,458 alerts and identified 176 intercepted drug name confusion errors, an interception rate of 0.14+/-6.01%. Conclusions: Indication alerts intercepted 1.4 drug name confusion errors per 1000 alerts. Institutions with CPOE should consider using indication prompts to intercept drug name confusion errors.	[Galanter, William L.; Falck, Suzanne; Laragh, Marci] UIC, Dept Med, Chicago, IL 60607 USA; [Galanter, William L.; Bryson, Michelle L.] UIC, Dept Pharm Practice, Chicago, IL USA; [Rosenfield, Rachel] Univ Illinois, Coll Med, Chicago, IL USA; [Shrestha, Neeha] UIC, Dept Pharm Adm, Chicago, IL USA; [Schiff, Gordon D.] Harvard Univ, Dept Med, Boston, MA 02115 USA; [Lambert, Bruce L.] Northwestern Univ, Dept Commun Studies, Chicago, IL 60611 USA; [Lambert, Bruce L.] Northwestern Univ, Ctr Commun & Hlth, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; Harvard University; Northwestern University; Northwestern University	Galanter, WL (corresponding author), UIC, Dept Med, Chicago, IL 60607 USA.	BillG@uic.edu		Galanter, William/0000-0001-7811-5391	Agency for Healthcare Research and Quality [U19HS021093]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021093] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was supported by grant number U19HS021093 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspden P, 2007, PREVENTING MED ERROR; Barker KN, 2002, ARCH INTERN MED, V162, P1897, DOI 10.1001/archinte.162.16.1897; Cina JL, 2006, JT COMM J QUAL PATIE, V32, P73, DOI 10.1016/S1553-7250(06)32010-7; Cohen M.R., 2007, MED ERRORS; Darker IT, 2011, ERGONOMICS, V54, P21, DOI 10.1080/00140139.2010.535022; Falck S, INT J MED I IN PRESS; Filik R, 2010, DRUG SAFETY, V33, P677, DOI 10.2165/11532360-000000000-00000; Flynn Elizabeth Allan, 2003, J Am Pharm Assoc (Wash), V43, P191; Galanter W, 2013, J AM MED INFORM ASSN, V20, P477, DOI 10.1136/amiajnl-2012-001555; Galanter WL, 2010, INT J MED INFORM, V79, P332, DOI 10.1016/j.ijmedinf.2008.05.005; Galanter WL, 2005, J AM MED INFORM ASSN, V12, P269, DOI 10.1197/jamia.M1727; HICKS RW, 2008, MEDMARX DATA REPORT; Institute for Safe Medication Practices (ISMP), 2010, ISMPS LIST CONF DRUG; Irwin A, 2013, HUM FACTORS, V55, P253, DOI 10.1177/0018720812457565; Kondrak G, 2006, ARTIF INTELL MED, V36, P29, DOI 10.1016/j.artmed.2005.07.005; Lambert BL, 2005, DRUG SAFETY, V28, P495, DOI 10.2165/00002018-200528060-00003; Lambert BL, 1999, MED CARE, V37, P1214, DOI 10.1097/00005650-199912000-00005; Lambert BL, 2008, MEDMARX DATA REPORT, P10; Poon EG, 2010, NEW ENGL J MED, V362, P1698, DOI 10.1056/NEJMsa0907115; Raschke RA, 1998, JAMA-J AM MED ASSOC, V280, P1317, DOI 10.1001/jama.280.15.1317; US FDA, 2014, GUID IND BEST PRACT; Walton SM, 2011, APPL CLIN INFORM, V2, P94, DOI 10.4338/ACI-2010-11-RA-0072	22	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101977	10.1371/journal.pone.0101977	http://dx.doi.org/10.1371/journal.pone.0101977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025346	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400032
J	Li, BS; Zuo, QF; Zhao, YL; Xiao, B; Zhuang, Y; Mao, XH; Wu, C; Yang, SM; Zeng, H; Zou, QM; Guo, G				Li, B-S; Zuo, Q-F; Zhao, Y-L; Xiao, B.; Zhuang, Y.; Mao, X-H; Wu, C.; Yang, S-M; Zeng, H.; Zou, Q-M; Guo, G.			MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival	ONCOGENE			English	Article							CELL-PROLIFERATION; TUMOR-SUPPRESSOR; TOB; EXPRESSION; APOPTOSIS; PROTEIN; MIR-25; CONTRIBUTES; NODE	Gastric cancer (GC) is one of the most common tumors and the molecular mechanism underlying its metastasis is still largely unclear. Here, we show that miR-25 was overexpressed in plasma and primary tumor tissues of GC patients with tumor node metastasis stage (III or IV) or lymph node metastasis. MiR-25 inhibition significantly decreased the metastasis, invasion and proliferation of GC cells in vitro, and reduced their capacity to develop distal pulmonary metastases and peritoneal dissemination in vivo. Furthermore, miR-25 repressed transducer of ERBB2, 1 (TOB1) expression by directly binding to TOB1-3'-UTR, and the inverse correlation was observed between the expressions of miR-25 and TOB1 mRNA in primary GC tissues. Moreover, the loss of TOB1 increased the metastasis, invasion and proliferation of GC cells, and the restoration of TOB1 led to suppressed metastasis, invasion and proliferation. The receiver operating characteristics analysis yielded an area under the curve value of 0.7325 in distinguishing the GC patients with death from those with survival. The analysis of optimal cutoff value revealed poor survival in GC patients with high plasma concentrations of miR-25 (40.2333 amol/mu l). Taken together, miR-25 promotes GC progression by directly downregulating TOB1 expression, and may be a noninvasive biomarker for the prognosis of GC patients.	[Li, B-S; Zuo, Q-F; Xiao, B.; Zhuang, Y.; Mao, X-H; Wu, C.; Zeng, H.; Zou, Q-M; Guo, G.] Third Mil Med Univ, Coll Pharm, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Chongqing 400038, Peoples R China; [Zhao, Y-L] Third Mil Med Univ, Southwest Hosp, Gen Surg, Chongqing 400038, Peoples R China; [Zhao, Y-L] Third Mil Med Univ, Southwest Hosp, Ctr Minimally Invas Gastrointestinal Surg, Chongqing 400038, Peoples R China; [Yang, S-M] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Zou, QM (corresponding author), Third Mil Med Univ, Coll Pharm, Dept Microbiol & Biochem Pharm, 30 Gao Tan Yan Rd, Chongqing 400038, Peoples R China.	Qmzou2007@163.com; guogang7001@163.com			National Science Foundation of China (NSFC) [81301729, 81202310]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	We thank the staff at National Engineering Research Center of Immunological Products. This work was supported by grants from the National Science Foundation of China (NSFC): grant no. 81301729 (to LBS) and 81202310 (to XB).	AKAGI T, 1976, ACTA MED OKAYAMA, V30, P215; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Esposito F, 2012, J CLIN ENDOCR METAB, V97, pE710, DOI 10.1210/jc.2011-3068; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Gao P, 2013, ONCOGENE, V32, P491, DOI 10.1038/onc.2012.61; Helms MW, 2009, CANCER RES, V69, P5049, DOI 10.1158/0008-5472.CAN-08-4154; Iwanaga K, 2003, CANCER LETT, V202, P71, DOI 10.1016/j.canlet.2003.08.019; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiao Y, 2012, ACTA PHARMACOL SIN, V33, P250, DOI 10.1038/aps.2011.163; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kim BH, 2013, J SURG ONCOL, V107, P505, DOI 10.1002/jso.23271; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kundu J, 2012, INT J ONCOL, V41, P839, DOI 10.3892/ijo.2012.1517; Kurashige J, 2012, ANN SURG ONCOL, V19, pS656, DOI 10.1245/s10434-012-2217-6; Leite KRM, 2013, UROL ONCOL-SEMIN ORI, V31, P796, DOI 10.1016/j.urolonc.2011.07.002; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Li Q, 2013, CANCER LETT, V335, P168, DOI 10.1016/j.canlet.2013.02.029; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Matsuda S, 1996, ONCOGENE, V12, P705; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Razumilava N, 2012, HEPATOLOGY, V55, P465, DOI 10.1002/hep.24698; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Swarbrick A, 2010, NAT MED, V16, P1134, DOI 10.1038/nm.2227; Ushijima T, 2004, CANCER CELL, V5, P121, DOI 10.1016/S1535-6108(04)00033-9; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Xu XH, 2012, BIOCHEM BIOPH RES CO, V421, P640, DOI 10.1016/j.bbrc.2012.03.048; Yao QY, 2013, CANCER LETT, V335, P219, DOI 10.1016/j.canlet.2013.02.031; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Yoshida Y, 2003, MECH DEVELOP, V120, P629, DOI 10.1016/S0925-4773(03)00020-0; Yu JC, 2011, MOL CELLS, V32, P47, DOI 10.1007/s10059-011-2316-4; Zhang CX, 2009, CURR OPIN MOL THER, V11, P641; Zhao HY, 2014, MOL CELL BIOCHEM, V385, P207, DOI 10.1007/s11010-013-1829-x; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156; Zheng B, 2012, ONCOGENE, V31, P4509, DOI 10.1038/onc.2011.581	39	100	107	0	28	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2015	34	20					2556	2565		10.1038/onc.2014.214	http://dx.doi.org/10.1038/onc.2014.214			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI1YN	25043310				2022-12-25	WOS:000354541300002
J	Kosek, D; Kylarova, S; Psenakova, K; Rezabkova, L; Herman, P; Vecer, J; Obsilova, V; Obsil, T				Kosek, Dalibor; Kylarova, Salome; Psenakova, Katarina; Rezabkova, Lenka; Herman, Petr; Vecer, Jaroslav; Obsilova, Veronika; Obsil, Tomas			Biophysical and Structural Characterization of the Thioredoxin-binding Domain of Protein Kinase ASK1 and Its Interaction with Reduced Thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Ultracentrifugation; Circular Dichroism (CD); Fluorescence; Small-angle X-ray Scattering (SAXS); Thioredoxin; Apoptosis Signal-regulating Kinase 1 (ASK1)	SECONDARY STRUCTURE; STRUCTURE PREDICTION; CIRCULAR-DICHROISM; ESCHERICHIA-COLI; CELL-DEATH; BIOLOGICAL MACROMOLECULES; ASK1-MEDIATED APOPTOSIS; SOLUTION SCATTERING; INDEPENDENT MANNER; FAMILY PROTEINS	Background: Thioredoxin is a physiological inhibitor of ASK1. Results: The catalytic motif of thioredoxin is essential for its binding to ASK1 and the interaction does not involve intermolecular disulfide bonds. Conclusion: Thioredoxin-binding domain of ASK1 is a rigid domain that interacts with reduced thioredoxin through a large binding interface. Significance: Structural basis of the interaction between ASK1 and reduced thioredoxin. Apoptosis signal-regulating kinase 1 (ASK1), a mitogen-activated protein kinase kinase kinase, plays a key role in the pathogenesis of multiple diseases. Its activity is regulated by thioredoxin (TRX1) but the precise mechanism of this regulation is unclear due to the lack of structural data. Here, we performed biophysical and structural characterization of the TRX1-binding domain of ASK1 (ASK1-TBD) and its complex with reduced TRX1. ASK1-TBD is a monomeric and rigid domain that forms a stable complex with reduced TRX1 with 1:1 molar stoichiometry. The binding interaction does not involve the formation of intermolecular disulfide bonds. Residues from the catalytic WCGPC motif of TRX1 are essential for complex stability with Trp(31) being directly involved in the binding interaction as suggested by time-resolved fluorescence. Small-angle x-ray scattering data reveal a compact and slightly asymmetric shape of ASK1-TBD and suggest reduced TRX1 interacts with this domain through the large binding interface without inducing any dramatic conformational change.	[Kosek, Dalibor; Kylarova, Salome; Psenakova, Katarina; Rezabkova, Lenka; Obsil, Tomas] Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic; [Kosek, Dalibor; Kylarova, Salome; Psenakova, Katarina; Obsilova, Veronika; Obsil, Tomas] Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague, Czech Republic; [Herman, Petr; Vecer, Jaroslav] Charles Univ Prague, Inst Phys, Fac Math & Phys, CR-12116 Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague	Obsil, T (corresponding author), Charles Univ Prague, Fac Sci, Hlavova 8, Prague 12843, Czech Republic.	obsil@natur.cuni.cz	Kylarova, Salome/M-3414-2017; Herman, Petr/A-2626-2008; Obsilova, Veronika/B-7116-2012; Obsil, Tomas/B-7142-2012; Psenakova, Katarina/AAG-1857-2021; Košek, Dalibor/AAD-4715-2021; Rezabkova, Lenka/O-8229-2017	Kylarova, Salome/0000-0001-5584-8242; Herman, Petr/0000-0001-6918-2576; Obsilova, Veronika/0000-0003-4887-0323; Obsil, Tomas/0000-0003-4602-1272; Psenakova, Katarina/0000-0001-8877-6599; Rezabkova, Lenka/0000-0002-7274-8080	Czech Science Foundation [14-10061S]; Grant Agency of Charles University [568912]; Academy of Sciences of the Czech Republic Research Project of the Institute of Physiology [RVO:67985823]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University; Academy of Sciences of the Czech Republic Research Project of the Institute of Physiology	This work was supported by Czech Science Foundation Project 14-10061S, Grant Agency of Charles University Project 568912, and Academy of Sciences of the Czech Republic Research Project RVO:67985823 of the Institute of Physiology.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; FORMANKAY JD, 1992, J BIOMOL NMR, V2, P431, DOI 10.1007/BF02192807; Fujino G, 2007, MOL CELL BIOL, V27, P8152, DOI 10.1128/MCB.00227-07; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; HOLMGREN A, 1975, P NATL ACAD SCI USA, V72, P2305, DOI 10.1073/pnas.72.6.2305; HUBER HE, 1986, J BIOL CHEM, V261, P5006; Hwang CY, 2004, ONCOGENE, V23, P8868, DOI 10.1038/sj.onc.1208116; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kawarazaki Y, 2014, EXPERT OPIN THER TAR, V18, P651, DOI 10.1517/14728222.2014.896903; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Nadeau PJ, 2009, MOL BIOL CELL, V20, P3628, DOI 10.1091/mbc.E09-03-0211; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; OBLONG JE, 1994, J BIOL CHEM, V269, P11714; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; QIN J, 1994, STRUCTURE, V2, P503, DOI 10.1016/S0969-2126(00)00051-4; Rezabkova L, 2012, BIOPHYS J, V103, P1960, DOI 10.1016/j.bpj.2012.09.021; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SCHAUERTE JA, 1989, BIOCHEMISTRY-US, V28, P3948, DOI 10.1021/bi00435a048; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takeda K, 2004, EMBO REP, V5, P161, DOI 10.1038/sj.embor.7400072; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Vecer J, 2011, J FLUORESC, V21, P873, DOI 10.1007/s10895-009-0589-1; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	45	27	30	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24463	24474		10.1074/jbc.M114.583807	http://dx.doi.org/10.1074/jbc.M114.583807			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25037217	Green Published, hybrid			2022-12-25	WOS:000341505600039
J	Thorfve, A; Bergstrand, A; Ekstrom, K; Lindahl, A; Thomsen, P; Larsson, A; Tengvall, P				Thorfve, Anna; Bergstrand, Anna; Ekstrom, Karin; Lindahl, Anders; Thomsen, Peter; Larsson, Anette; Tengvall, Pentti			Gene Expression Profiling of Peri-Implant Healing of PLGA-Li+ Implants Suggests an Activated Wnt Signaling Pathway In Vivo	PLOS ONE			English	Article							BONE-FORMATION; BETA-CATENIN; OSTEOGENIC DIFFERENTIATION; CALCIUM-PHOSPHATE; OSSEOINTEGRATION; CELL; LITHIUM; MACROPHAGE; SCLEROSTIN; MEDIATION	Bone development and regeneration is associated with the Wnt signaling pathway that, according to literature, can be modulated by lithium ions (Li+). The aim of this study was to evaluate the gene expression profile during peri-implant healing of poly(lactic-co-glycolic acid) (PLGA) implants with incorporated Li+, while PLGA without Li+ was used as control, and a special attention was then paid to the Wnt signaling pathway. The implants were inserted in rat tibia for 7 or 28 days and the gene expression profile was investigated using a genome-wide microarray analysis. The results were verified by qPCR and immunohistochemistry. Histomorphometry was used to evaluate the possible effect of Li+ on bone regeneration. The microarray analysis revealed a large number of significantly differentially regulated genes over time within the two implant groups. The Wnt signaling pathway was significantly affected by Li+, with approximately 34% of all Wnt-related markers regulated over time, compared to 22% for non-Li+ containing (control; Ctrl) implants. Functional cluster analysis indicated skeletal system morphogenesis, cartilage development and condensation as related to Li+. The downstream Wnt target gene, FOSL1, and the extracellular protein-encoding gene, ASPN, were significantly upregulated by Li+ compared with Ctrl. The presence of beta-catenin, FOSL1 and ASPN positive cells was confirmed around implants of both groups. Interestingly, a significantly reduced bone area was observed over time around both implant groups. The presence of periostin and calcitonin receptor-positive cells was observed at both time points. This study is to the best of the authors' knowledge the first report evaluating the effect of a local release of Li+ from PLGA at the fracture site. The present study shows that during the current time frame and with the present dose of Li+ in PLGA implants, Li+ is not an enhancer of early bone growth, although it affects the Wnt signaling pathway.	[Thorfve, Anna; Ekstrom, Karin; Thomsen, Peter; Tengvall, Pentti] Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Inst Clin Sci, Gothenburg, Sweden; [Thorfve, Anna; Ekstrom, Karin; Lindahl, Anders; Thomsen, Peter; Tengvall, Pentti] BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden; [Bergstrand, Anna; Larsson, Anette] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Bergstrand, Anna; Larsson, Anette] SuMo BIOMAT VINN Excellence Ctr, Gothenburg, Sweden; [Bergstrand, Anna] Stiftelsen Chalmers Ind Tekn, Gothenburg, Sweden; [Lindahl, Anders] Univ Gothenburg, Dept Clin Chem & Transfus Med, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; Chalmers University of Technology; University of Gothenburg	Thorfve, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Inst Clin Sci, Gothenburg, Sweden.	anna.thorfve@biomaterials.gu.se	Lindahl, Anders/H-9550-2014; Larsson, Anette/D-1954-2013; Ekström, Karin/M-7501-2013	Lindahl, Anders/0000-0003-2871-5166; Ekström, Karin/0000-0001-7808-4572; Thomsen, Peter/0000-0003-3910-6665; Larsson, Anette/0000-0002-6119-8423	Swedish Research Council (VR) [K2009-52X-09495-22-3, 621-2011-6037]; BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy; SuMo Biomaterials VINN Excellence Center; Handlanden Hjalmar Svensson Research Foundation	Swedish Research Council (VR)(Swedish Research Council); BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy; SuMo Biomaterials VINN Excellence Center; Handlanden Hjalmar Svensson Research Foundation	The support of the Swedish Research Council (VR grants K2009-52X-09495-22-3 and 621-2011-6037), the BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy, the SuMo Biomaterials VINN Excellence Center and the Handlanden Hjalmar Svensson Research Foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers J, 2011, J CELL BIOL, V192, P1057, DOI 10.1083/jcb.201008012; Alblowi J, 2013, BONE, V53, P294, DOI 10.1016/j.bone.2012.12.006; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592; Bakiri L, 2007, BONE, V40, P867, DOI 10.1016/j.bone.2006.11.005; Battiston KG, 2012, BIOMATERIALS, V33, P8316, DOI 10.1016/j.biomaterials.2012.08.014; Bonucci EE, 2011, FRONT BIOSCI ELITE E, V17, P100; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Corr M, 2008, NAT CLIN PRACT RHEUM, V4, P550, DOI 10.1038/ncprheum0904; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Devarajan-Ketha H, 2012, BIOCHEM BIOPH RES CO, V417, P830, DOI 10.1016/j.bbrc.2011.12.048; Donos N, 2011, CLIN ORAL IMPLAN RES, V22, P365, DOI 10.1111/j.1600-0501.2010.02113.x; Dreifke MB, 2013, J BIOMED MATER RES A, V101, P2436, DOI 10.1002/jbm.a.34521; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Ertugrul AS, 2013, AUST DENT J, V58, P170, DOI 10.1111/adj.12022; Galli C, 2013, CLIN ORAL IMPLAN RES, V24, P921, DOI 10.1111/j.1600-0501.2012.02488.x; Gimble JM, 2012, CLIN BIOCHEM, V45, P874, DOI 10.1016/j.clinbiochem.2012.03.006; Gould TD, 2002, NEUROSCIENTIST, V8, P497, DOI 10.1177/107385802237176; Han PP, 2012, BIOMATERIALS, V33, P6370, DOI 10.1016/j.biomaterials.2012.05.061; Heilmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084232; Heo JS, 2010, MOL CELLS, V30, P449, DOI 10.1007/s10059-010-0139-3; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikegawa S, 2008, CURR MED CHEM, V15, P724, DOI 10.2174/092986708783885237; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivanovski S, 2011, CLIN ORAL IMPLAN RES, V22, P373, DOI 10.1111/j.1600-0501.2010.02112.x; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kerachian MA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3062; Khangs G, 2006, ENCY MED DEVICES INS, P366; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Kojima N, 2008, CLIN ORAL IMPLAN RES, V19, P173, DOI 10.1111/j.1600-0501.2007.01432.x; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lanao RPF, 2013, J BIOMED MATER RES A, V101, P3123, DOI 10.1002/jbm.a.34623; Lanao RPF, 2013, TISSUE ENG PART B-RE, V19, P380, DOI [10.1089/ten.teb.2012.0443, 10.1089/ten.TEB.2012.0443]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lories RJ, 2013, NAT REV RHEUMATOL, V9, P328, DOI 10.1038/nrrheum.2013.25; Malhi GS, 2012, AUST NZ J PSYCHIAT, V46, P192, DOI 10.1177/0004867412437346; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Meyer F, 2012, J ORTHOP RES, V30, P864, DOI 10.1002/jor.22019; Miclea RL, 2011, OSTEOARTHR CARTILAGE, V19, P1363, DOI 10.1016/j.joca.2011.07.014; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058622; Olivares-Navarrete R, 2011, BIOMATERIALS, V32, P6399, DOI 10.1016/j.biomaterials.2011.05.036; Rauner M, 2007, INT ARCH ALLERGY IMM, V143, P31, DOI 10.1159/000098223; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Shinohara K, 2011, J ORTHOP RES, V29, P1064, DOI 10.1002/jor.21374; Son JS, 2013, J BIOMED MATER RES B, V101B, P247, DOI 10.1002/jbm.b.32834; Takeda S, 2008, J NEUROENDOCRINOL, V20, P802, DOI 10.1111/j.1365-2826.2008.01732.x; TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208; Thalji G, 2013, BONE, V52, P444, DOI 10.1016/j.bone.2012.07.026; Thorfve A, 2012, CARTILAGE, V3, P43, DOI 10.1177/1947603511414178; Tiainen J, 2004, J BIOMED MATER RES B, V70B, P49, DOI 10.1002/jbm.b.30013; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Vestergaard P, 2005, CALCIFIED TISSUE INT, V77, P1, DOI 10.1007/s00223-004-0258-y; von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9; Wang F, 2010, EUR J PHARMACOL, V640, P226, DOI 10.1016/j.ejphar.2010.04.024; Wang JW, 2009, DENT MATER, V25, P353, DOI 10.1016/j.dental.2008.07.013; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wise JK, 2010, PLOS ONE, V5, DOI [10.1371/journal.-pone.0012987, DOI 10.1371/JOURNAL.-PONE.0012987]; Yoon SJ, 2008, TISSUE ENG PT A, V14, P539, DOI 10.1089/tea.2007.0129; Zupan J, 2013, BIOCHEM MEDICA, V23, P43, DOI 10.11613/BM.2013.007	71	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102597	10.1371/journal.pone.0102597	http://dx.doi.org/10.1371/journal.pone.0102597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047349	gold, Green Published			2022-12-25	WOS:000339558100050
J	Huang, JD; Amaral, J; Lee, JW; Rodriguez, IR				Huang, Jiahn-Dar; Amaral, Juan; Lee, Jung Wha; Rodriguez, Ignacio R.			7-Ketocholesterol-Induced Inflammation Signals Mostly through the TLR4 Receptor Both In Vitro and In Vivo	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; BIOLOGICAL-ACTIVITY; CYTOKINE PRODUCTION; WNT PATHWAY; INHIBITOR; OXYSTEROLS; CELLS; MECHANISMS; OXIDATION	The cholesterol oxide 7-ketocholesterol (7KCh) has been implicated in numerous age-related diseases such as atherosclerosis, Alzheimer's disease, Parkinson's disease, cancer and age-related macular degeneration. It is formed by the autooxidation of cholesterol and especially cholesterol-fatty acid esters found in lipoprotein deposits. This molecule causes complex and potent inflammatory responses in vitro and in vivo. It is suspected of causing chronic inflammation in tissues exposed to oxidized lipoprotein deposits. In this study we have examined the inflammatory pathways activated by 7KCh both in cultured ARPE19 cells and in vivo using 7KCh-containing implants inserted into the anterior chamber of the rat eye. Our results indicate that 7KCh-induced inflammation is mediated mostly though the TLR4 receptor with some cross-activation of EGFR-related pathways. The majority of the cytokine inductions seem to signal via the TRIF/TRAM side of the TLR4 receptor. The MyD88/TIRAP side only significantly effects IL-1 beta inductions. The 7KCh-induced inflammation also seems to involve a robust ER stress response. However, this response does not seem to involve a calcium efflux-mediated UPR. Instead the ER stress response seems to be mediated by yet identified kinases activated through the TLR4 receptor. Some of the kinases identified are the RSKs which seem to mediate the cytokine inductions and the cell death pathway but do not seem to be involved in the ER stress response.	[Huang, Jiahn-Dar; Amaral, Juan; Lee, Jung Wha; Rodriguez, Ignacio R.] NEI, Retinal Cell & Mol Biol Lab, Mech Retinal Dis Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Rodriguez, IR (corresponding author), NEI, Retinal Cell & Mol Biol Lab, Mech Retinal Dis Sect, NIH, Bethesda, MD 20892 USA.	rodriguezi@nei.nih.gov		Amaral, Juan/0000-0001-8755-9170	National Eye Institute Intramural Research Program; NATIONAL EYE INSTITUTE [ZIAEY000307] Funding Source: NIH RePORTER	National Eye Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the National Eye Institute Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056099; Aye ILMH, 2012, MOL HUM REPROD, V18, P341, DOI 10.1093/molehr/gas001; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chiang EY, 2011, J IMMUNOL, V186, P1279, DOI 10.4049/jimmunol.1002821; Cornell TT, 2010, INFECT IMMUN, V78, P2868, DOI 10.1128/IAI.00018-10; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; den Dekker WK, 2010, ATHEROSCLEROSIS, V209, P314, DOI 10.1016/j.atherosclerosis.2009.09.075; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Dzeletovic S, 1995, CHEM PHYS LIPIDS, V78, P119, DOI 10.1016/0009-3084(95)02489-6; Erridge C, 2007, FREE RADICAL RES, V41, P260, DOI 10.1080/10715760601070091; Fagotto F, 2013, EMBO REP, V14, P422, DOI 10.1038/embor.2013.45; Garcia-Cruset S, 2001, FREE RADICAL RES, V35, P31, DOI 10.1080/10715760100300571; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Han YC, 1996, CANCER RES, V56, P3859; Haneklaus M, 2013, CURR OPIN IMMUNOL, V25, P40, DOI 10.1016/j.coi.2012.12.004; Hirsch DD, 1997, J BIOL CHEM, V272, P4568, DOI 10.1074/jbc.272.7.4568; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Huang JD, 2012, BBA-MOL CELL BIOL L, V1821, P637, DOI 10.1016/j.bbalip.2012.01.013; Inagaki-Ohara Kyoko, 2013, JAKSTAT, V2, pe24053, DOI 10.4161/jkst.24053; Lara R, 2013, CANCER RES, V73, P5301, DOI 10.1158/0008-5472.CAN-12-4448; Larrayoz IM, 2010, INVEST OPHTH VIS SCI, V51, P4942, DOI 10.1167/iovs.09-4854; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee WH, 2009, Z NATURFORSCH C, V64, P307; Liao PL, 2010, TOXICOL LETT, V197, P88, DOI 10.1016/j.toxlet.2010.05.002; Linossi EM, 2013, CYTOKINE GROWTH F R, V24, P241, DOI 10.1016/j.cytogfr.2013.03.005; Liu J, 2009, ARCH BIOCHEM BIOPHYS, V487, P54, DOI 10.1016/j.abb.2009.05.004; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Lordan S, 2009, J NUTR BIOCHEM, V20, P321, DOI 10.1016/j.jnutbio.2009.01.001; Lyons MA, 2001, BBA-MOL CELL BIOL L, V1530, P209, DOI 10.1016/S1388-1981(01)00083-X; Lyons MA, 1999, J LIPID RES, V40, P1846; Markman B, 2013, CURR PHARM DESIGN, V19, P895, DOI 10.2174/138161213804547213; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Miller YI, 2012, BRIT J PHARMACOL, V167, P990, DOI 10.1111/j.1476-5381.2012.02097.x; Moreira EF, 2009, INVEST OPHTH VIS SCI, V50, P523, DOI 10.1167/iovs.08-2373; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ohtsuka M, 2006, J ATHEROSCLER THROMB, V13, P256, DOI 10.5551/jat.13.256; Poli G, 2013, REDOX BIOL, V1, P125, DOI 10.1016/j.redox.2012.12.001; Rabuffetti M, 2000, J NEUROSCI, V20, P4398, DOI 10.1523/JNEUROSCI.20-12-04398.2000; Ratti M, 2014, ANTI-CANCER DRUG, V25, P127, DOI 10.1097/CAD.0000000000000035; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Rodriguez IR, 2010, J LIPID RES, V51, P2847, DOI 10.1194/jlr.R004820; Rodriguez IR, 2004, INVEST OPHTH VIS SCI, V45, P2830, DOI 10.1167/iovs.04-0075; Ruiz-Nunez B, 2013, J NUTR BIOCHEM, V24, P1183, DOI 10.1016/j.jnutbio.2013.02.009; SANCHEZMARGALET V, 1994, BIOCHEM BIOPH RES CO, V204, P446, DOI 10.1006/bbrc.1994.2480; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Savva A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00387; Shi G, 2013, IOVS 2013, V2013, P150; Smith JA, 2005, CANCER RES, V65, P1027; STANDAERT ML, 1995, BIOCHEM BIOPH RES CO, V209, P1082, DOI 10.1006/bbrc.1995.1608; Su XQ, 2006, EUR J IMMUNOL, V36, P199, DOI 10.1002/eji.200535415; Tolloczko B, 2004, J PHARMACOL EXP THER, V311, P787, DOI 10.1124/jpet.104.069013; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; van Reyk DM, 2006, REDOX REP, V11, P255, DOI 10.1179/135100006X155003; Vejux A, 2008, BRAZ J MED BIOL RES, V41, P545, DOI 10.1590/S0100-879X2008000700001; Vejux A, 2009, MOL ASPECTS MED, V30, P153, DOI 10.1016/j.mam.2009.02.006; Wang SF, 2013, BIOCHEM PHARMACOL, V86, P548, DOI 10.1016/j.bcp.2013.06.006; Yamada M, 2005, J MED CHEM, V48, P7457, DOI 10.1021/jm050623t; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107; Zhang CY, 2013, CELL MOL IMMUNOL, V10, P84, DOI 10.1038/cmi.2012.57; Zhao W, 2012, FEBS LETT, V586, P705, DOI 10.1016/j.febslet.2012.01.016; Zhou MX, 2003, ONCOGENE, V22, P8137, DOI 10.1038/sj.onc.1206911	69	30	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e100985	10.1371/journal.pone.0100985	http://dx.doi.org/10.1371/journal.pone.0100985			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036103	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200011
J	Jung, H; Lee, JA; Choi, S; Lee, H; Ahn, B				Jung, Hana; Lee, Jin A.; Choi, Seoyoon; Lee, Hyunwoo; Ahn, Byungchan			Characterization of the Caenorhabditis elegans HIM-6/BLM Helicase: Unwinding Recombination Intermediates	PLOS ONE			English	Article							BLOOMS-SYNDROME HELICASE; STRAND BREAK REPAIR; TOPOISOMERASE-III-ALPHA; SYNDROME GENE-PRODUCT; SACCHAROMYCES-CEREVISIAE; FLAP ENDONUCLEASE-1; REPLICATION FORKS; GENOME STABILITY; BIOCHEMICAL-CHARACTERIZATION; HOMOLOGOUS RECOMBINATION	Mutations in three human RecQ genes are implicated in heritable human syndromes. Mutations in BLM, a RecQ gene, cause Bloom syndrome (BS), which is characterized by short stature, cancer predisposition, and sensitivity to sunlight. BLM is a RecQ DNA helicase that, with interacting proteins, is able to dissolve various DNA structures including double Holliday junctions. A BLM ortholog, him-6, has been identified in Caenorhabditis elegans, but little is known about its enzymatic activities or its in vivo roles. By purifying recombinant HIM-6 and performing biochemical assays, we determined that the HIM-6 has DNA-dependent ATPase activity HIM-6 and helicase activity that proceeds in the 3'-5' direction and needs at least five 3' overhanging nucleotides. HIM-6 is also able to unwind DNA structures including D-loops and Holliday junctions. Worms with him-6 mutations were defective in recovering the cell cycle arrest after HU treatment. These activities strongly support in vivo roles for HIM-6 in processing recombination intermediates.	[Jung, Hana; Lee, Jin A.; Choi, Seoyoon; Lee, Hyunwoo; Ahn, Byungchan] Univ Ulsan, Dept Life Sci, Ulsan 680749, South Korea	University of Ulsan	Ahn, B (corresponding author), Univ Ulsan, Dept Life Sci, Ulsan 680749, South Korea.	bbccahn@mail.ulsan.ac.kr		Lee, Jin-A/0000-0002-8390-2311	Basic Research Promotion Fund through the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2011-0364, NRF-2013-0343]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Basic Research Promotion Fund through the National Research Foundation of Korea - Ministry of Education, Science and Technology; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported the Basic Research Promotion Fund through the National Research Foundation of Korea (NRF-2011-0364, NRF-2013-0343) funded by the Ministry of Education, Science and Technology. http://ernd.nrf.re.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Agostinho A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003591; Bennett RJ, 1998, J BIOL CHEM, V273, P9644, DOI 10.1074/jbc.273.16.9644; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2001, EMBO J, V20, P5791; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Choi DH, 2013, J MICROBIOL, V51, P105, DOI 10.1007/s12275-013-3048-2; Cobb JA, 2006, NUCLEIC ACIDS RES, V34, P4106, DOI 10.1093/nar/gkl557; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; ELLIS NA, 1995, AM J HUM GENET, V57, P1019; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Grabowski MM, 2005, MECH AGEING DEV, V126, P1314, DOI 10.1016/j.mad.2005.08.005; Groocock LM, 2012, MOL CELL BIOL, V32, P276, DOI 10.1128/MCB.06184-11; Hyun M, 2008, BIOCHEMISTRY-US, V47, P7583, DOI 10.1021/bi800197m; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; Kim YC, 2002, GENES CELLS, V7, P19, DOI 10.1046/j.1356-9597.2001.00496.x; Kim YM, 2005, MOL CELLS, V20, P228; Kusano K, 1999, GENETICS, V151, P1027; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Manthei KA, 2013, CELL MOL LIFE SCI, V70, P4067, DOI 10.1007/s00018-013-1325-1; McVey M, 2004, P NATL ACAD SCI USA, V101, P15694, DOI 10.1073/pnas.0406157101; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; NAKAYAMA H, 1984, MOL GEN GENET, V195, P474, DOI 10.1007/BF00341449; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; O'Neil NJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003582; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Saito TT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003586; Sebesta M, 2011, DNA REPAIR, V10, P567, DOI 10.1016/j.dnarep.2011.03.003; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Sidorova JM, 2013, DNA REPAIR, V12, P128, DOI 10.1016/j.dnarep.2012.11.005; Srivastava V, 2009, J CELL SCI, V122, P3093, DOI 10.1242/jcs.051813; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Traverso G, 2003, CANCER RES, V63, P8578; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; Wang WS, 2005, J BIOL CHEM, V280, P5391, DOI 10.1074/jbc.M412359200; Watt PM, 1996, GENETICS, V144, P935; Wicky C, 2004, MOL CELL BIOL, V24, P5016, DOI 10.1128/MCB.24.11.5016-5027.2004; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	51	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102402	10.1371/journal.pone.0102402	http://dx.doi.org/10.1371/journal.pone.0102402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036527	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200056
J	Lee, WK; Su, YA; Song, TJ; Chiu, YC; Lin, CH				Lee, We-Kang; Su, Yi-An; Song, Tzu-Jiun; Chiu, Yao-Chu; Lin, Ching-Hung			Are Normal Decision-Makers Sensitive to Changes in Value Contrast under Uncertainty? Evidence from the Iowa Gambling Task	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; SEX-DIFFERENCES; PERFORMANCE; DAMAGE; DECKS; GAIN	The Iowa Gambling Task (IGT) developed by Bechara et al. in 1994 is used to diagnose patients with Ventromedial Medial Prefrontal Cortex (VMPFC) lesions, and it has become a landmark in research on decision making. According to Bechara et al., the manipulation of progressive increments of monetary value can normalize the performance of patients with VMPFC lesions; thus, they developed a computerized version of the IGT. However, the empirical results showed that patients' performances did not improve as a result of this manipulation, which suggested that patients with VMPFC lesions performed myopically for future consequences. Using the original version of the IGT, some IGT studies have demonstrated that increments of monetary value significantly influence the performance of normal subjects in the IGT. However, other research has resulted in inconsistent findings. In this study, we used the computerized IGT (1X-IGT) and manipulated the value contrast of progressive increments (i.e., by designing the 10X-IGT, which contained 10 times of progressive increment) to investigate the influence of value contrast on the performance of normal subjects. The resulting empirical observations indicated that the value contrast (1X-vs. 10X-IGT) of the progressive increment had no effect on the performance of normal subjects. This study also provides a discussion of the issue of value in IGT-related studies. Moreover, we found the "prominent deck B phenomenon" in both versions of the IGT, which indicated that the normal subjects were guided mostly by the gain-loss frequency, rather than by the monetary value contrast. In sum, the behavioral performance of normal subjects demonstrated a low correlation with changes in monetary value, even in the 10X-IGT.	[Lee, We-Kang; Su, Yi-An; Song, Tzu-Jiun; Chiu, Yao-Chu] Soochow Univ, Dept Psychol, Taipei, Taiwan; [Lee, We-Kang] Natl Chengchi Univ, Dept Psychol, Taipei 11623, Taiwan; [Lin, Ching-Hung] China Med Univ Hosp, Biomed Engn R&D Ctr, Taipei, Taiwan; [Lin, Ching-Hung] Natl Chiao Tung Univ, Biomed Elect Translat Res Ctr, Hsinchu, Taiwan; [Lin, Ching-Hung] Kaohsiung Med Univ, Dept Psychol, Kaohsiung, Taiwan	Soochow University; National Chengchi University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; Kaohsiung Medical University	Chiu, YC (corresponding author), Soochow Univ, Dept Psychol, Taipei, Taiwan.	yaochu@mail2000.com.tw; eandy924@gmail.com		Lin, Ching-Hung/0000-0003-3618-0579	National Science Council of Taiwan [NSC 99-2410-H-031-025]; National Chiao Tung University; Ministry of Education, Taiwan [MOE-100W960]; Kaohsiung Medical University [KMU-Q103022]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Chiao Tung University; Ministry of Education, Taiwan(Ministry of Education, Taiwan); Kaohsiung Medical University	The authors would like to thank the National Science Council of Taiwan for financially supporting this study under Contract No. NSC 99-2410-H-031-025. The fifth author was also supported in part by the "Aim for the Top University Plan" of National Chiao Tung University and the Ministry of Education, Taiwan (MOE-100W960) and by Kaohsiung Medical University (KMU-Q103022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bechara A., 2007, IOWA GAMBLING TASK P; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Chiu Y.C., 2012, PSYCHOL RES PROGR PS, P93; Chiu YC, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-37; Chiu YC, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-13; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Damasio A, 1994, DESCARTES ERROR EMOT; Fernie G, 2006, BRAIN COGNITION, V60, P94, DOI 10.1016/j.bandc.2005.09.011; Fum D, 2008, SOMATIC MARKERS FREQ; Horstmann A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00061; Li XL, 2009, MODERN BUSINESS TRAD, V12; Lin CH, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-16; Lin CH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00220; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047202; Lin CH, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-45; Lin CH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-72; Overman WH, 2004, BRAIN COGNITION, V55, P134, DOI 10.1016/s0278-2626(03)00279-3; Overman WH, 2004, NEUROPSYCHOLOGIA, V42, P1838, DOI 10.1016/j.neuropsychologia.2004.03.014; Penolazzi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058946; Steingroever H, 2013, PSYCHOL ASSESSMENT, V25, P180, DOI 10.1037/a0029929; Takano Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009368; Tomb I, 2002, NAT NEUROSCI, V5, P1103, DOI 10.1038/nn1102-1103; Upton DJ, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00034; van den Bos R, 2006, BIOL PSYCHOL, V71, P155, DOI 10.1016/j.biopsycho.2005.05.003; van den Bos R, 2013, BEHAV BRAIN RES, V238, P95, DOI 10.1016/j.bbr.2012.10.002; Wilder KE, 1998, SCHIZOPHR RES, V30, P169, DOI 10.1016/S0920-9964(97)00135-7	31	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101878	10.1371/journal.pone.0101878	http://dx.doi.org/10.1371/journal.pone.0101878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036094	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200025
J	Robbins, RM; Gbur, SC; Beitel, GJ				Robbins, Renee M.; Gbur, Samantha C.; Beitel, Greg J.			Non-Canonical Roles for Yorkie and Drosophila Inhibitor of Apoptosis 1 in Epithelial Tube Size Control	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; SEPTATE JUNCTIONS; TUMOR-SUPPRESSOR; ORGAN SIZE; CASPASE INHIBITION; TRACHEAL SYSTEM; GENETIC-CONTROL; CELL POLARITY; PROTEIN; MORPHOGENESIS	Precise control of epithelial tube size is critical for organ function, yet the molecular mechanisms remain poorly understood. Here, we examine the roles of cell growth and a highly conserved organ growth regulatory pathway in controlling the dimensions of the Drosophila tracheal (airway) system, a well-characterized system for investigating epithelial tube morphogenesis. We find that tracheal tube-size is regulated in unexpected ways by the transcription factor Yorkie (Yki, homolog of mammalian YAP and TAZ) and the Salvador/Warts/Hippo (SWH) kinase pathway. Yki activity typically promotes cell division, inhibits apoptosis, and can promote cell growth. However, reducing Yki activity in developing embryos increases rather than decreases the length of the major tracheal tubes, the dorsal trunks (DTs). Similarly, reduction of Hippo pathway activity, which antagonizes Yki, shortens tracheal DTs. yki mutations do not alter DT cell volume or cell number, indicating that Yki and the Hippo pathway regulate cell shape and apical surface area, but not volume. Yki does not appear to act through known tracheal pathways of apical extracellular matrix, septate junctions (SJs), basolateral or tubular polarity. Instead, the Hippo pathway and Yki appear to act downstream or in parallel to SJs because a double mutant combination of an upstream Hippo pathway activator, kibra, and the SJ component sinu have the short tracheal phenotype of a kibra mutant. We demonstrate that the critical target of Yki in tube size control is Drosophila Inhibitor of Apoptosis 1 (DIAP1), which in turn antagonizes the Drosophila effector caspase, Ice. Strikingly, there is no change in tracheal cell number in DIAP1 or Ice mutants, thus epithelial tube size regulation defines new non-apoptotic roles for Yki, DIAP1 and Ice.	[Robbins, Renee M.; Gbur, Samantha C.; Beitel, Greg J.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Robbins, Renee M.; Gbur, Samantha C.; Beitel, Greg J.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Beitel, GJ (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	beitel@northwestern.edu			US National Institutes of Health [R01GM108964]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108964] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by the US National Institutes of Health (www.nih.gov) grant R01GM108964 to GJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Arias A.M., 1993, DEV DROSOPHILA, P609; Baer MM, 2010, MECH DEVELOP, V127, P28, DOI 10.1016/j.mod.2009.11.003; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Chen HJ, 2011, DEV BIOL, V357, P370, DOI 10.1016/j.ydbio.2011.07.003; Chou TB, 1996, GENETICS, V144, P1673; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Enomoto M, 2013, EMBO REP, V14, P65, DOI 10.1038/embor.2012.185; FEHON RG, 1994, DEVELOPMENT, V120, P545; Forster D, 2012, NAT CELL BIOL, V14, P526, DOI 10.1038/ncb2456; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Ghabrial AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002087; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Harvey KF, 2012, COLD SPRING HARBOR P, V4; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Iruela-Arispe ML, 2013, DEVELOPMENT, V140, P2851, DOI 10.1242/dev.070680; Kumar Sharad, 2004, Sci STKE, V2004, ppe49, DOI 10.1126/stke.2542004pe49; Kuranaga E, 2012, GENES CELLS, V17, P83, DOI 10.1111/j.1365-2443.2011.01579.x; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Laprise P, 2010, CURR BIOL, V20, P55, DOI 10.1016/j.cub.2009.11.017; Laprise P, 2009, NATURE, V459, P1141, DOI 10.1038/nature08067; Le T, 2007, BIOTECHNIQUES, V42, P162, DOI 10.2144/000112386; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Lisi S, 2000, GENETICS, V154, P669; Liu YR, 2013, MELANOMA RES, V23, P243, DOI 10.1097/CMR.0b013e3283625498; Lucas EP, 2013, J CELL BIOL, V201, P875, DOI 10.1083/jcb.201210073; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Moussian B, 2005, J MORPHOL, V264, P117, DOI 10.1002/jmor.10324; Nelson KS, 2012, NAT CELL BIOL, V14, P518, DOI 10.1038/ncb2467; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Schwerk C, 2003, BIOCHEM PHARMACOL, V66, P1453, DOI 10.1016/S0006-2952(03)00497-0; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Shrestha A, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00078; Spradling AC, 1999, GENETICS, V153, P135; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Swanson LE, 2006, CURR BIOL, V16, pR51, DOI 10.1016/j.cub.2006.01.008; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tumaneng K, 2012, CURR BIOL, V22, pR368, DOI 10.1016/j.cub.2012.03.003; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wei X, 2007, EMBO J, V26, P1772, DOI 10.1038/sj.emboj.7601630; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; Wilson PD, 2007, ANNU REV PATHOL-MECH, V2, P341, DOI 10.1146/annurev.pathol.2.010506.091850; Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008; Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134; Xu DB, 2009, FLY, V3, P78, DOI 10.4161/fly.3.1.7800; Yarbrough WM, 2010, J CARDIOVASC PHARM, V55, P408, DOI 10.1097/FJC.0b013e3181d4ca66; Yokokura T, 2004, J BIOL CHEM, V279, P52603, DOI 10.1074/jbc.M409691200; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	74	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101609	10.1371/journal.pone.0101609	http://dx.doi.org/10.1371/journal.pone.0101609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036253	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200019
J	Wu, J; Wang, J; Pan, CT; Guan, XY; Wang, Y; Liu, SY; He, YJ; Chen, JL; Chen, LF; Lu, G				Wu, Jian; Wang, Jie; Pan, Changtian; Guan, Xiaoyan; Wang, Yan; Liu, Songyu; He, Yanjun; Chen, Jingli; Chen, Lifei; Lu, Gang			Genome-Wide Identification of MAPKK and MAPKKK Gene Families in Tomato and Transcriptional Profiling Analysis during Development and Stress Response	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RAF-LIKE MAPKKK; ARABIDOPSIS-THALIANA; CELL-DEATH; SOLANUM-LYCOPERSICON; SIGNAL-TRANSDUCTION; POSITIVE REGULATOR; PLANT IMMUNITY; RICE; EXPRESSION	Mitogen-activated protein kinase (MAPK) cascades have important functions in plant growth, development, and response to various stresses. The MAPKK and MAPKKK gene families in tomato have never been systematically analyzed. In this study, we performed a genome-wide analysis of the MAPKK and MAPKKK gene families in tomato and identified 5 MAPKK genes and 89 MAPKKK genes. Phylogenetic analyses of the MAPKK and MAPKKK gene families showed that all the MAPKK genes formed four groups (groups A, B, C, and D), whereas all the MAPKKK genes were classified into three subfamilies, namely, MEKK, RAF, and ZIK. Evolutionary analysis showed that whole genome or chromosomal segment duplications were the main factors responsible for the expansion of the MAPKK and MAPKKK gene families in tomato. Quantitative real-time RT-PCR analysis showed that the majority of MAPKK and MAPKKK genes were expressed in all tested organs with considerable differences in transcript levels indicating that they might be constitutively expressed. However, the expression level of most of these genes changed significantly under heat, cold, drought, salt, and Pseudomonas syringae treatment. Furthermore, their expression levels exhibited significant changes in response to salicylic acid and indole-3-acetic acid treatment, implying that these genes might have important roles in the plant hormone network. Our comparative analysis of the MAPKK and MAPKKK families would improve our understanding of the evolution and functional characterization of MAPK cascades in tomato.	[Wu, Jian; Wang, Jie; Pan, Changtian; Guan, Xiaoyan; Wang, Yan; Liu, Songyu; He, Yanjun; Chen, Jingli; Chen, Lifei; Lu, Gang] Zhejiang Univ, Dept Hort, Key Lab Hort Plant Growth Dev & Biotechnol, Agr Minist China, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Lu, G (corresponding author), Zhejiang Univ, Dept Hort, Key Lab Hort Plant Growth Dev & Biotechnol, Agr Minist China, Hangzhou, Zhejiang, Peoples R China.	glu@zju.edu.cn	Pan, Changtian/AAG-8526-2019	Pan, Changtian/0000-0002-5852-059X	Nation Natural Science Foundation of China [31071337, 31271633]; Natural Science Foundation of Zhejiang province, China [R3110209]	Nation Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang province, China(Natural Science Foundation of Zhejiang Province)	This work was supported by the Grants from the Nation Natural Science Foundation of China [Grant numbers 31071337, 31271633] and the Natural Science Foundation of Zhejiang province, China (R3110209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Beck M, 2011, NEW PHYTOL, V189, P1069, DOI 10.1111/j.1469-8137.2010.03565.x; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Champion A, 2004, TRENDS PLANT SCI, V9, P123, DOI 10.1016/j.tplants.2004.01.005; Cheong YH, 2003, PLANT PHYSIOL, V132, P1961, DOI 10.1104/pp.103.023176; Cristina M, 2010, Annual Review of Plant Biology, V61, P621; Dai Y, 2006, PLANT CELL, V18, P308, DOI 10.1105/tpc.105.037846; Daisuke S, 2011, PLANT BIOTECHNOL, V28, P463; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Frye CA, 1998, PLANT CELL, V10, P947, DOI 10.1105/tpc.10.6.947; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Hashimoto M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-103; Hong WF, 2007, J INTEGR PLANT BIOL, V49, P843, DOI 10.1111/j.1744-7909.2007.00505.x; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Kong FL, 2012, GENE, V499, P108, DOI 10.1016/j.gene.2012.01.048; Kong XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057714; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Krysan PJ, 2002, PLANT CELL, V14, P1109, DOI 10.1105/tpc.001164; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Liu YK, 2013, PLANT MOL BIOL REP, V31, P1446, DOI 10.1007/s11105-013-0623-y; Liu ZN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-594; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Melech-Bonfil S, 2011, PLANT SIGNAL BEHAV, V6, P154, DOI 10.4161/psb.6.1.14311; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Melikant B, 2004, FEBS LETT, V576, P5, DOI 10.1016/j.febslet.2004.08.051; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Mitsumune MG, 2006, J EXP BOT, V57, P4171; MIZOGUCHI T, 1994, PLANT J, V5, P111, DOI 10.1046/j.1365-313X.1994.5010111.x; Mockaitis K, 2000, PLANT J, V24, P785, DOI 10.1046/j.1365-313x.2000.00921.x; Nakagami H, 2006, J BIOL CHEM, V281, P38697, DOI 10.1074/jbc.M605293200; Neupane A, 2013, EVOL BIOINFORM, V9, P363, DOI 10.4137/EBO.S12526; Ning J, 2011, PLANT CELL, V23, P4334, DOI 10.1105/tpc.111.093419; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; Oh CS, 2011, J BIOL CHEM, V286, P14129, DOI 10.1074/jbc.M111.225086; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pedley KF, 2004, J BIOL CHEM, V279, P49229, DOI 10.1074/jbc.M410323200; Qiu JL, 2008, PLANT PHYSIOL, V148, P212, DOI 10.1104/pp.108.120006; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samuel MA, 2002, PLANT CELL, V14, P2059, DOI 10.1105/tpc.002337; Samuel MA, 2005, J EXP BOT, V56, P2195, DOI 10.1093/jxb/eri219; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schauser L, 2005, J MOL EVOL, V60, P229, DOI 10.1007/s00239-004-0144-2; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Takahashi F, 2007, PLANT CELL, V19, P805, DOI 10.1105/tpc.106.046581; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wu J, 2011, PLANT CELL REP, V30, P2059, DOI 10.1007/s00299-011-1113-z; Wu T, 2011, MOL BIOL REP, V38, P3967, DOI 10.1007/s11033-010-0514-3; Xing Y, 2007, J EXP BOT, V58, P2969, DOI 10.1093/jxb/erm144; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604	58	70	77	17	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e103032	10.1371/journal.pone.0103032	http://dx.doi.org/10.1371/journal.pone.0103032			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036993	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200107
J	Butler, T; Dick, C; Carlson, ML; Whittall, JB				Butler, Timothy; Dick, Cynthia; Carlson, Matthew L.; Whittall, Justen B.			Transcriptome Analysis of a Petal Anthocyanin Polymorphism in the Arctic Mustard, Parrya nudicaulis	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; GENE-EXPRESSION; FLOWER COLOR; GENOME SIZE; NEIGHBORING GENES; ARABIDOPSIS; EVOLUTION; SEQUENCE; COEXPRESSION; RNA	Angiosperms are renown for their diversity of flower colors. Often considered adaptations to pollinators, the most common underlying pigments, anthocyanins, are also involved in plants' stress response. Although the anthocyanin biosynthetic pathway is well characterized across many angiosperms and is composed of a few candidate genes, the consequences of blocking this pathway and producing white flowers has not been investigated at the transcriptome scale. We take a transcriptome-wide approach to compare expression differences between purple and white petal buds in the arctic mustard, Parrya nudicaulis, to determine which genes' expression are consistently correlated with flower color. Using mRNA-Seq and de novo transcriptome assembly, we assembled an average of 722 bp per gene (49.81% coding sequence based on the A. thaliana homolog) for 12,795 genes from the petal buds of a pair of purple and white samples. Our results correlate strongly with qRT-PCR analysis of nine candidate genes in the anthocyanin biosynthetic pathway where chalcone synthase has the greatest difference in expression between color morphs (P/W = similar to 7x). Among the most consistently differentially expressed genes between purple and white samples, we found 3 x more genes with higher expression in white petals than in purple petals. These include four unknown genes, two drought-response genes (CDSP32, ERD5), a cold-response gene (GR-RBP2), and a pathogen defense gene (DND1). Gene ontology analysis of the top 2% of genes with greater expression in white relative to purple petals revealed enrichment in genes associated with stress responses including cold, drought and pathogen defense. Unlike the uniform downregulation of chalcone synthase that may be directly involved in the loss of petal anthocyanins, the variable expression of several genes with greater expression in white petals suggest that the physiological and ecological consequences of having white petals may be microenvironment-dependent.	[Butler, Timothy; Dick, Cynthia; Whittall, Justen B.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA; [Carlson, Matthew L.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK USA	Santa Clara University; University of Alaska System; University of Alaska Anchorage	Whittall, JB (corresponding author), Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA.	jwhittall@scu.edu		Butler, Timothy/0000-0001-5803-1035	NSF IPY; SCU Undergraduate Research Initiative Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	NSF IPY(National Science Foundation (NSF)); SCU Undergraduate Research Initiative Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funds were provided by NSF IPY to JBW & MLC and an SCU Undergraduate Research Initiative Award to TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Bennett M., 2005, PLANT DNA C VALUES D; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Chen WH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-178; Cooley AM, 2011, CURR BIOL, V21, P700, DOI 10.1016/j.cub.2011.03.028; Dick CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018230; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fulkerson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032790; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gilad Y, 2009, TRENDS GENET, V25, P463, DOI 10.1016/j.tig.2009.09.003; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Jeukens J, 2010, MOL ECOL, V19, P5389, DOI 10.1111/j.1365-294X.2010.04934.x; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Kohn MH, 2008, GENES GENET SYST, V83, P265, DOI 10.1266/ggs.83.265; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; LEE NH, 1995, P NATL ACAD SCI USA, V92, P8303, DOI 10.1073/pnas.92.18.8303; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lysak MA, 2009, MOL BIOL EVOL, V26, P85, DOI 10.1093/molbev/msn223; Manfield IW, 2006, NUCLEIC ACIDS RES, V34, pW504, DOI 10.1093/nar/gkl204; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; Melendez-Ackerman E, 1998, EVOLUTION, V52, P1293, DOI 10.1111/j.1558-5646.1998.tb02011.x; Mizuno H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-683; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MOSQUIN T, 1966, EVOLUTION CANADAS FL, P41; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pielou E.C., 1994, NATURALISTS GUIDE AR; Preston J, 2004, PLANT J, V40, P979, DOI 10.1111/j.1365-313X.2004.02280.x; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ramos-Onsins SE, 2008, MOL ECOL, V17, P1211, DOI 10.1111/j.1365-294X.2007.03633.x; Rausher MD, 2008, INT J PLANT SCI, V169, P7, DOI 10.1086/523358; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Rokas A, 2009, TRENDS ECOL EVOL, V24, P192, DOI 10.1016/j.tree.2008.11.004; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Streisfeld MA, 2005, EVOLUTION, V59, P2548, DOI 10.1111/j.0014-3820.2005.tb00968.x; Streisfeld MA, 2011, EVOLUTION, V65, P629, DOI 10.1111/j.1558-5646.2010.01165.x; Streisfeld MA, 2009, MOL BIOL EVOL, V26, P433, DOI 10.1093/molbev/msn268; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; von Wettberg EJ, 2010, EVOL ECOL RES, V12, P457; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Warwick SI, 2006, PLANT SYST EVOL, V259, P237, DOI 10.1007/s00606-006-0421-1; Whittall J, 2009, NEW PHYTOL, V182, P5, DOI 10.1111/j.1469-8137.2009.02796.x; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2010, CURRENT PROTOCOLS BI, V31	60	12	12	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101338	10.1371/journal.pone.0101338	http://dx.doi.org/10.1371/journal.pone.0101338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033465	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300014
J	Chennupati, R; Meens, MJPMT; Marion, V; Janssen, BJ; Lamers, WH; De Mey, JGR; Kohler, SE				Chennupati, Ramesh; Meens, Merlijn J. P. M. T.; Marion, Vincent; Janssen, Ben J.; Lamers, Wouter H.; De Mey, Jo G. R.; Kohler, S. Eleonore			Endothelial Arginine Resynthesis Contributes to the Maintenance of Vasomotor Function in Male Diabetic Mice	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; DEPENDENT HYPERPOLARIZATION; ARGININOSUCCINATE SYNTHASE; GAP-JUNCTIONS; ARGINASE; INHIBITION; EXPRESSION; ARTERIES; INSULIN; DYSFUNCTION	Aim: Argininosuccinate synthetase (ASS) is essential for recycling L-citrulline, the by-product of NO synthase (NOS), to the NOS substrate L-arginine. Here, we assessed whether disturbed arginine resynthesis modulates endothelium-dependent vasodilatation in normal and diabetic male mice. Methods and Results: Endothelium-selective Ass-deficient mice (Ass(fl/fl) /Tie2Cre(tg/-) = Ass-KOTie2) were generated by crossing Ass(fl/fl) mice (= control) with Tie2Cre mice. Gene ablation in endothelial cells was confirmed by immunohistochemistry. Blood pressure (MAP) was recorded in 34-week-old male mice. Vasomotor responses were studied in isolated saphenous arteries of 12-and 34-week-old Ass-KOTie2 and control animals. At the age of 10 weeks, diabetes was induced in control and AssKO(Tie2) mice by streptozotocin injections. Vasomotor responses of diabetic animals were studied 10 weeks later. MAP was similar in control and Ass-KOTie2 mice. Depletion of circulating L-arginine by arginase 1 infusion or inhibition of NOS activity with L-NAME resulted in an increased MAP (10 and 30 mmHg, respectively) in control and Ass-KOTie2 mice. Optimal arterial diameter, contractile responses to phenylephrine, and relaxing responses to acetylcholine and sodium nitroprusside were similar in healthy control and Ass-KOTie2 mice. However, in diabetic Ass-KOTie2 mice, relaxation responses to acetylcholine and endothelium-derived NO (EDNO) were significantly reduced when compared to diabetic control mice. Conclusions: Absence of endothelial citrulline recycling to arginine did not affect blood pressure and systemic arterial vasomotor responses in healthy mice. EDNO-mediated vasodilatation was significantly more impaired in diabetic Ass-KOTie2 than in control mice demonstrating that endothelial arginine recycling becomes a limiting endothelial function in diabetes.	[Chennupati, Ramesh; Marion, Vincent; Lamers, Wouter H.; Kohler, S. Eleonore] Maastricht Univ, Dept Anat & Embryol, Maastricht, Netherlands; [Chennupati, Ramesh; Meens, Merlijn J. P. M. T.; Janssen, Ben J.; De Mey, Jo G. R.] Maastricht Univ, Dept Pharmacol, Maastricht, Netherlands; [Chennupati, Ramesh; Janssen, Ben J.; De Mey, Jo G. R.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Chennupati, Ramesh; Marion, Vincent; Lamers, Wouter H.; Kohler, S. Eleonore] Maastricht Univ, Nutr Metab & Toxicol NUTRIM, Maastricht, Netherlands; [Meens, Merlijn J. P. M. T.; Marion, Vincent] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [De Mey, Jo G. R.] Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense, Denmark; [De Mey, Jo G. R.] Odense Univ Hosp, Dept Cardiovasc & Thorac Surg, DK-5000 Odense, Denmark	Maastricht University; Maastricht University; Maastricht University; Maastricht University; University of Geneva; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Kohler, SE (corresponding author), Maastricht Univ, Dept Anat & Embryol, Maastricht, Netherlands.	leo.koehler@maastrichtuniversity.nl	Lamers, Wouter H./D-2965-2012; Marion, Vincent/H-9730-2016; Köhler, Eleonore/D-2915-2012	Köhler, Eleonore/0000-0003-1977-9977; De Mey, Jo G. R./0000-0001-6274-8071; Chennupati, Ramesh/0000-0002-3994-5285; Marion, Vincent/0000-0002-8271-7376	Grant Netherlands Heart Foundation NHF [2008B107]	Grant Netherlands Heart Foundation NHF	Grant Netherlands Heart Foundation NHF (Nederlands hartstichting; project 2008B107). The website is: https://www.hartstichting.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso F, 2010, AM J PHYSIOL-HEART C, V299, pH1365, DOI 10.1152/ajpheart.00029.2010; BAYDOUN AR, 1990, BIOCHEM BIOPH RES CO, V173, P940, DOI 10.1016/S0006-291X(05)80876-9; Bobbie MW, 2010, INVEST OPHTH VIS SCI, V51, P3758, DOI 10.1167/iovs.09-4489; Burnham MP, 2006, BRIT J PHARMACOL, V148, P434, DOI 10.1038/sj.bjp.0706748; Chen F, 2014, CELL PHYSIOL BIOCHEM, V33, P1058, DOI 10.1159/000358676; Chennupati R, 2013, BRIT J PHARMACOL, V169, P1486, DOI 10.1111/bph.12175; Chicoine LG, 2004, AM J PHYSIOL-LUNG C, V287, pL60, DOI 10.1152/ajplung.00194.2003; Dahl G, 2007, CELL COMMUN ADHES, V14, P259, DOI 10.1080/15419060801891018; Elkayam U, 2002, J CARD FAIL, V8, P15, DOI 10.1054/jcaf.2002.31910; Feron O, 1999, J CLIN INVEST, V103, P897, DOI 10.1172/JCI4829; Fukao M, 1997, BRIT J PHARMACOL, V121, P1383, DOI 10.1038/sj.bjp.0701258; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; GOLD ME, 1989, BIOCHEM BIOPH RES CO, V164, P714, DOI 10.1016/0006-291X(89)91518-0; Goodwin BL, 2004, J BIOL CHEM, V279, P18353, DOI 10.1074/jbc.M308160200; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Haines RJ, 2012, BIOCHEM BIOPH RES CO, V421, P9, DOI 10.1016/j.bbrc.2012.03.074; Hilgers RHP, 2010, J PHARMACOL EXP THER, V333, P210, DOI 10.1124/jpet.109.161448; HOGG N, 1993, FEBS LETT, V334, P170, DOI 10.1016/0014-5793(93)81706-6; Hou CJY, 2008, J HISTOCHEM CYTOCHEM, V56, P745, DOI 10.1369/jhc.2008.950816; Karbach S, 2011, J MOL CELL CARDIOL, V51, P855, DOI 10.1016/j.yjmcc.2011.07.024; Kurz S, 1997, J CLIN INVEST, V99, P369, DOI 10.1172/JCI119166; Lerman A, 1998, CIRCULATION, V97, P2123, DOI 10.1161/01.CIR.97.21.2123; Levin-Iaina N, 2007, RENAL FAILURE, V29, P1031, DOI 10.1080/08860220701641744; Li HG, 2009, CURR PHARM DESIGN, V15, P3133, DOI 10.2174/138161209789058002; Marion V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067021; Matchkov VV, 2004, BRIT J PHARMACOL, V142, P961, DOI 10.1038/sj.bjp.0705870; NUSSLER AK, 1994, J BIOL CHEM, V269, P1257; Persson P, 2014, HYPERTENSION, V64, P323, DOI 10.1161/HYPERTENSIONAHA.114.03519; Pfenniger A, 2010, ARTERIOSCL THROM VAS, V30, P827, DOI 10.1161/ATVBAHA.109.200816; Queisser MA, 2010, DIABETES, V59, P670, DOI 10.2337/db08-1565; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Sandow SL, 2004, J PHYSIOL-LONDON, V556, P875, DOI 10.1113/jphysiol.2003.058669; Shin W, 2012, EXP MOL MED, V44, P594, DOI 10.3858/emm.2012.44.10.068; Storkebaum E, 2010, CIRCULATION, V122, P273, DOI 10.1161/CIRCULATIONAHA.109.929364; Taddei S, 1996, CIRCULATION, V94, P1298, DOI 10.1161/01.CIR.94.6.1298; Takabe W, 2004, ARTERIOSCL THROM VAS, V24, P1640, DOI 10.1161/01.ATV.0000134377.17680.26; Tang YF, 2010, GENESIS, V48, P563, DOI 10.1002/dvg.20654; Toque HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072277; Tsihlis ND, 2011, CELL BIOCHEM BIOPHYS, V60, P89, DOI 10.1007/s12013-011-9179-3; VANEIJK HMH, 1993, J CHROMATOGR-BIOMED, V620, P143, DOI 10.1016/0378-4347(93)80062-9; Vukosavljevic N, 2006, MICROVASC RES, V71, P48, DOI 10.1016/j.mvr.2005.10.006; Wang GR, 1998, P NATL ACAD SCI USA, V95, P4888, DOI 10.1073/pnas.95.9.4888; Wijnands KAP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037439; Wu GY, 2009, BIOFACTORS, V35, P21, DOI 10.1002/biof.3; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029649; Zhang CH, 2001, FASEB J, V15, P1264, DOI 10.1096/fj.00-0681fje	48	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102264	10.1371/journal.pone.0102264	http://dx.doi.org/10.1371/journal.pone.0102264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033204	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300043
J	Dietert, K; Reppe, K; Mundhenk, L; Witzenrath, M; Gruber, AD				Dietert, Kristina; Reppe, Katrin; Mundhenk, Lars; Witzenrath, Martin; Gruber, Achim D.			mCLCA3 Modulates IL-17 and CXCL-1 Induction and Leukocyte Recruitment in Murine Staphylococcus aureus Pneumonia	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; ACUTE LUNG INJURY; AIRWAY EPITHELIUM; CYSTIC-FIBROSIS; MUCUS OVERPRODUCTION; EXPRESSION; INFLAMMATION; DISEASE; ASTHMA; MODEL	The human hCLCA1 and its murine ortholog mCLCA3 (calcium-activated chloride channel regulators) are exclusively expressed in mucus cells and linked to inflammatory airway diseases with increased mucus production, such as asthma, cystic fibrosis and chronic obstructive pulmonary disease. Both proteins have a known impact on the mucus cell metaplasia trait in these diseases. However, growing evidence points towards an additional role in innate immune responses. In the current study, we analyzed Staphylococcus aureus pneumonia, an established model to study pulmonary innate immunity, in mCLCA3-deficient and wild-type mice, focusing on the cellular and cytokine-driven innate inflammatory response. We compared clinical signs, bacterial clearance, leukocyte immigration and cytokine responses in the bronchoalveolar compartment, as well as pulmonary vascular permeability, histopathology, mucus cell number and mRNA expression levels of selected genes (mClca1 to 7, Muc5ac, Muc5b, Muc2, Cxcl-1, Cxcl-2, Il-17). Deficiency of mCLCA3 resulted in decreased neutrophilic infiltration into the bronchoalveolar space during bacterial infection. Only the cytokines IL-17 and the murine CXCL-8 homolog CXCL-1 were decreased on mRNA and protein levels during bacterial infection in mCLCA3-deficient mice compared to wild-type controls. However, no differences in clinical outcome, histopathology or mucus cell metaplasia were observed. We did not find evidence for regulation of any other CLCA homolog that would putatively compensate for the lack of mCLCA3. In conclusion, mCLCA3 appears to modulate leukocyte response via IL-17 and murine CXCL-8 homologs in acute Staphylococcus aureus pneumonia which is well in line with the proposed function of hCLCA1 as a signaling molecule acting on alveolar macrophages.	[Dietert, Kristina; Mundhenk, Lars; Gruber, Achim D.] Free Univ Berlin, Dept Vet Pathol, Berlin, Germany; [Reppe, Katrin; Witzenrath, Martin] Charite, Dept Infect Dis & Pulm Med, D-13353 Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gruber, AD (corresponding author), Free Univ Berlin, Dept Vet Pathol, Berlin, Germany.	achim.gruber@fu-berlin.de	Gruber, Achim D./ABA-4514-2021	Dietert, Kristina/0000-0002-5667-6750	German Research Foundation (DFG) [SFB-TR 84 C3, SFB-TR 84 C6]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) SFB-TR 84 C3, C6 (to M.W.) and Z1b (to A.D.G.). http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevy YG, 2012, J CLIN INVEST, V122, P4555, DOI 10.1172/JCI64896; Banerjee A, 2010, INFECT IMMUN, V78, P1353, DOI 10.1128/IAI.00969-09; BECKER S, 1994, AM J PHYSIOL, V266, pL278, DOI 10.1152/ajplung.1994.266.3.L278; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Bragonzi A, 2010, INT J MED MICROBIOL, V300, P584, DOI 10.1016/j.ijmm.2010.08.012; Braun J, 2010, J CYST FIBROS, V9, P351, DOI 10.1016/j.jcf.2010.06.003; Braun J, 2010, HISTOCHEM CELL BIOL, V133, P285, DOI 10.1007/s00418-009-0667-0; Brouillard F, 2005, MOL CELL PROTEOMICS, V4, P1762, DOI 10.1074/mcp.M500098-MCP200; Ching JCH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083130; CRUZORIVE LM, 1987, J MICROSC-OXFORD, V145, P121; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gillet Y, 2001, ARCH PEDIATRIE, V8, p742S, DOI 10.1016/S0929-693X(01)80190-1; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Hasnain SZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001856; Hauber HP, 2007, J ENDOTOXIN RES, V13, P109, DOI 10.1177/0968051907079168; Hauber HP, 2010, J CYST FIBROS, V9, P277, DOI 10.1016/j.jcf.2010.05.002; Hegab AE, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012484; HUANG S, 1992, AM J PATHOL, V141, P981; Jensen HE, 2010, IN VIVO, V24, P257; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Kamada F, 2004, GENES IMMUN, V5, P540, DOI 10.1038/sj.gene.6364124; Kapetanovic R, 2010, MICROBES INFECT, V12, P759, DOI 10.1016/j.micinf.2010.05.003; Klopfleisch R, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-123; Kohler J, 2011, MICROBES INFECT, V13, P914, DOI 10.1016/j.micinf.2011.05.004; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Laan M, 1999, J IMMUNOL, V162, P2347; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; Long AJ, 2006, AM J RESP CELL MOL, V35, P357, DOI 10.1165/rcmb.2005-0451OC; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Mundhenk L, 2012, AM J RESP CELL MOL, V47, P87, DOI 10.1165/rcmb.2010-0508OC; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Norris MD, 2000, MED PEDIATR ONCOL, V35, P585, DOI 10.1002/1096-911X(20001201)35:6<585::AID-MPO20>3.3.CO;2-G; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; Patel AC, 2006, PHYSIOL GENOMICS, V25, P502, DOI 10.1152/physiolgenomics.00321.2005; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Reppe K, 2009, AM J RESP CELL MOL, V40, P474, DOI 10.1165/rcmb.2008-0071OC; Robichaud A, 2005, AM J RESP CELL MOL, V33, P303, DOI 10.1165/rcmb.2004-0372OC; Schneider JP, 2012, METHOD CELL BIOL, V113, P257, DOI 10.1016/B978-0-12-407239-8.00012-4; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Song LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082367; Thai P, 2005, AM J RESP CELL MOL, V33, P523, DOI 10.1165/rcmb.2004-0220RC; Ulrich M, 1998, AM J RESP CELL MOL, V19, P83, DOI 10.1165/ajrcmb.19.1.3137; Witzenrath M, 2006, CRIT CARE MED, V34, P1947, DOI 10.1097/01.CCM.0000220496.48295.A9; Wolter DJ, 2013, CLIN INFECT DIS, V57, P384, DOI 10.1093/cid/cit270; Wong JK, 2013, PEDIAT PULMONOL; Zhang HL, 2010, CHINESE MED J-PEKING, V123, P1603, DOI 10.3760/cma.j.issn.0366-6999.2010.12.022; Zhou YH, 2001, AM J RESP CELL MOL, V25, P486, DOI 10.1165/ajrcmb.25.4.4578	53	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102606	10.1371/journal.pone.0102606	http://dx.doi.org/10.1371/journal.pone.0102606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033194	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300067
J	Hassan, SED; Bell, TH; Stefani, FOP; Denis, D; Hijri, M; St-Arnaud, M				Hassan, Saad El-Din; Bell, Terrence H.; Stefani, Franck O. P.; Denis, David; Hijri, Mohamed; St-Arnaud, Marc			Contrasting the Community Structure of Arbuscular Mycorrhizal Fungi from Hydrocarbon-Contaminated and Uncontaminated Soils following Willow (Salix spp. L.) Planting	PLOS ONE			English	Article							METAL-POLLUTED SOILS; MOLECULAR DIVERSITY; AGRICULTURAL SOILS; SPORE GERMINATION; HEAVY-METALS; AM FUNGI; GROWTH; ROOTS; RHIZOSPHERE; BACTERIAL	Phytoremediation is a potentially inexpensive alternative to chemical treatment of hydrocarbon-contaminated soils, but its success depends heavily on identifying factors that govern the success of root-associated microorganisms involved in hydrocarbon degradation and plant growth stimulation. Arbuscular mycorrhizal fungi (AMF) form symbioses with many terrestrial plants, and are known to stimulate plant growth, although both species identity and the environment influence this relationship. Although AMF are suspected to play a role in plant adaptation to hydrocarbon contamination, their distribution in hydrocarbon-contaminated soils is not well known. In this study, we examined how AMF communities were structured within the rhizosphere of 11 introduced willow cultivars as well as unplanted controls across uncontaminated and hydrocarbon-contaminated soils at the site of a former petrochemical plant. We obtained 69 282 AMF-specific 18S rDNA sequences using 454-pyrosequencing, representing 27 OTUs. Contaminant concentration was the major influence on AMF community structure, with different AMF families dominating at each contaminant level. The most abundant operational taxonomic unit in each sample represented a large proportion of the total community, and this proportion was positively associated with increasing contamination, and seemingly, by planting as well. The most contaminated soils were dominated by three phylotypes closely related to Rhizophagus irregularis, while these OTUs represented only a small proportion of sequences in uncontaminated and moderately contaminated soils. These results suggest that in situ inoculation of AMF strains could be an important component of phytoremediation treatments, but that strains should be selected from the narrow group that is both adapted to contaminant toxicity and able to compete with indigenous AMF species.	[Hassan, Saad El-Din] Al Azhar Univ, Fac Sci, Dept Bot & Microbiol, Cairo, Egypt; [Bell, Terrence H.; Stefani, Franck O. P.; Denis, David; Hijri, Mohamed; St-Arnaud, Marc] Univ Montreal, Inst Rech Biol Vegetale, Biodivers Ctr, Montreal, PQ H1X 2B2, Canada; [Bell, Terrence H.; Stefani, Franck O. P.; Denis, David; Hijri, Mohamed; St-Arnaud, Marc] Jardin Bot Montreal, Montreal, PQ, Canada	Egyptian Knowledge Bank (EKB); Al Azhar University; Universite de Montreal	St-Arnaud, M (corresponding author), Univ Montreal, Inst Rech Biol Vegetale, Biodivers Ctr, Montreal, PQ H1X 2B2, Canada.	marc.st-arnaud@umontreal.ca	Hijri, Mohamed/AAL-5737-2021; Hijri, Mohamed/ABC-5969-2021; Hassan, Saad El-Din/AAV-6138-2021; St-Arnaud, Marc/D-1184-2017	Hijri, Mohamed/0000-0001-6112-8372; Hassan, Saad El-Din/0000-0002-8443-1275; St-Arnaud, Marc/0000-0002-7181-9895; Bell, Terrence/0000-0003-3603-7270	Genome Canada - GenoRem Project; Fonds quebecois de la recherche sur la nature et les technologies; Genome Quebec	Genome Canada - GenoRem Project; Fonds quebecois de la recherche sur la nature et les technologies(FQRNT); Genome Quebec	This work was supported by the Genome Quebec and Genome Canada funded GenoRem Project. T.H. Bell was supported by a postdoctoral grant from the Fonds quebecois de la recherche sur la nature et les technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argus George W., 2007, Harvard Papers in Botany, V12, P335, DOI 10.3100/1043-4534(2007)12[335:SSDMAA]2.0.CO;2; Audet P, 2007, ENVIRON POLLUT, V147, P609, DOI 10.1016/j.envpol.2006.10.006; Beauchamp VB, 2006, NEW PHYTOL, V170, P369, DOI 10.1111/j.1469-8137.2006.01668.x; Bedini S, 2010, SOIL BIOL BIOCHEM, V42, P758, DOI 10.1016/j.soilbio.2010.01.010; Bell TH, 2014, ISME J, V8, P331, DOI 10.1038/ismej.2013.149; Bell TH, 2013, ISME J, V7, P1200, DOI 10.1038/ismej.2013.1; Bell TH, 2014, TRENDS BIOT IN PRESS, DOI [10.1016/j.tibtech.2014.1002.1008, DOI 10.1016/J.TIBTECH.2014.1002.1008]; Bunn R, 2009, ECOLOGY, V90, P1378, DOI 10.1890/07-2080.1; Cabello MN, 1997, FEMS MICROBIOL ECOL, V22, P233, DOI 10.1016/S0168-6496(96)00094-3; Calonne M, 2014, BOTANY, V92, P173, DOI 10.1139/cjb-2013-0094; Chagnon PL, 2013, TRENDS PLANT SCI, V18, P484, DOI 10.1016/j.tplants.2013.05.001; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; Chen JH, 2014, FEMS MICROBIOL ECOL, V87, P164, DOI 10.1111/1574-6941.12212; Dai ML, 2012, CAN J MICROBIOL, V58, P81, DOI [10.1139/W11-111, 10.1139/w11-111]; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davison J, 2011, FEMS MICROBIOL ECOL, V78, P103, DOI 10.1111/j.1574-6941.2011.01103.x; de la Providencia IE, MOL ANAL PETRO UNPUB; Debiane D, 2008, ENVIRON EXP BOT, V64, P120, DOI 10.1016/j.envexpbot.2008.04.003; Debiane D, 2011, FUNGAL BIOL-UK, V115, P782, DOI 10.1016/j.funbio.2011.06.003; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Dumbrell AJ, 2010, J ECOL, V98, P419, DOI 10.1111/j.1365-2745.2009.01622.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellouze W, 2012, APPL SOIL ECOL, V60, P98, DOI 10.1016/j.apsoil.2012.02.004; Fester T, 2013, MICROB BIOTECHNOL, V6, P80, DOI 10.1111/j.1751-7915.2012.00357.x; Franco-Ramirez A, 2007, J BASIC MICROB, V47, P378, DOI 10.1002/jobm.200610293; Gaur A, 2004, CURR SCI INDIA, V86, P528; Glassman SI, 2012, ECOLOGY, V93, P1550, DOI 10.1890/10-2135.1; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Hassan SE, 2013, BIOL FERT SOILS, V49, P1109, DOI 10.1007/s00374-013-0813-7; Hassan SED, 2011, MOL ECOL, V20, P3469, DOI 10.1111/j.1365-294X.2011.05142.x; Hassan SE, 2013, NEW BIOTECHNOL, V30, P780, DOI 10.1016/j.nbt.2013.07.002; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Huang YZ, 2014, CHEM ECOL, V30, P118, DOI 10.1080/02757540.2013.841892; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Joner EJ, 2003, ENVIRON SCI TECHNOL, V37, P2371, DOI 10.1021/es020196y; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Jumpponen A, 2007, MICROB ECOL, V53, P233, DOI 10.1007/s00248-004-0006-x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Koch AM, 2006, ECOL LETT, V9, P103, DOI 10.1111/j.1461-0248.2005.00853.x; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Lekberg Y, 2013, ISME J, V7, P1424, DOI 10.1038/ismej.2013.41; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Lioussanne L, 2010, SOIL BIOL BIOCHEM, V42, P473, DOI 10.1016/j.soilbio.2009.11.034; Liu AiGuo, 2009, International Journal of Phytoremediation, V11, P39, DOI 10.1080/15226510802363444; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Marmiroli M, 2011, TREE PHYSIOL, V31, P1319, DOI 10.1093/treephys/tpr090; Marschner P, 1997, PLANT SOIL, V189, P11, DOI 10.1023/A:1004266907442; Mummey DL, 2008, FEMS MICROBIOL ECOL, V64, P260, DOI 10.1111/j.1574-6941.2008.00475.x; NELSEN CE, 1982, PLANTA, V154, P407, DOI 10.1007/BF01267807; Nuccio EE, 2013, ENVIRON MICROBIOL, V15, P1870, DOI 10.1111/1462-2920.12081; Oehl F, 2009, AGR ECOSYST ENVIRON, V134, P257, DOI 10.1016/j.agee.2009.07.008; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Paradi I, 2006, FOREST ECOL MANAG, V237, P366, DOI 10.1016/j.foreco.2006.09.059; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santos-Gonzalez JC, 2007, APPL ENVIRON MICROB, V73, P5613, DOI 10.1128/AEM.00262-07; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Sikes BA, 2012, OIKOS, V121, P1791, DOI 10.1111/j.1600-0706.2012.20160.x; Sipila TP, 2008, ISME J, V2, P968, DOI 10.1038/ismej.2008.50; Staffa A, 2013, EXPLOITING FLX CHEM; Vallino M, 2006, ENVIRON MICROBIOL, V8, P971, DOI 10.1111/j.1462-2920.2006.00980.x; Van der Heijden EW, 2001, PLANT SOIL, V228, P275, DOI 10.1023/A:1004850423794; van der Heijden EW, 2001, MYCORRHIZA, V10, P185, DOI 10.1007/s005720000077; van der Heijden EW, 1999, CAN J BOT, V77, P1821, DOI 10.1139/cjb-77-12-1821; Verbruggen E, 2013, NEW PHYTOL, V197, P1104, DOI 10.1111/j.1469-8137.2012.04348.x; Verbruggen E, 2012, MOL ECOL, V21, P2341, DOI 10.1111/j.1365-294X.2012.05534.x; Verdin A, 2006, MYCORRHIZA, V16, P397, DOI 10.1007/s00572-006-0055-8; Vierheilig H, 2000, SOIL BIOL BIOCHEM, V32, P589, DOI 10.1016/S0038-0717(99)00155-8; Volante A, 2005, MYCORRHIZA, V16, P43, DOI 10.1007/s00572-005-0012-y; WEISSENHORN I, 1993, PLANT SOIL, V157, P247, DOI 10.1007/BF00011053; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wu QS, 2008, EUR J SOIL BIOL, V44, P122, DOI 10.1016/j.ejsobi.2007.10.001; Yergeau E, 2014, ISME J, V8, P344, DOI 10.1038/ismej.2013.163; Zarei M, 2010, ENVIRON POLLUT, V158, P2757, DOI 10.1016/j.envpol.2010.04.017	77	35	35	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102838	10.1371/journal.pone.0102838	http://dx.doi.org/10.1371/journal.pone.0102838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032685	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300103
J	Kang, M; Ryu, J; Lee, D; Lee, MS; Kim, HJ; Nam, SH; Song, HE; Choi, J; Lee, GH; Kim, TY; Lee, H; Kim, SJ; Ye, SK; Kim, S; Lee, JW				Kang, Minkyung; Ryu, Jihye; Lee, Doohyung; Lee, Mi-Sook; Kim, Hye-Jin; Nam, Seo Hee; Song, Haeng Eun; Choi, Jungeun; Lee, Gyu-Ho; Kim, Tai Young; Lee, Hansoo; Kim, Sang Jick; Ye, Sang-Kyu; Kim, Semi; Lee, Jung Weon			Correlations between Transmembrane 4 L6 Family Member 5 (TM4SF5), CD151, and CD63 in Liver Fibrotic Phenotypes and Hepatic Migration and Invasive Capacities	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-CELL MOTILITY; SIGNALING PATHWAYS; CROSS-TALK; C-SRC; CANCER; EXPRESSION; ADHESION; MICRODOMAINS; SUPERFAMILY	Transmembrane 4 L6 family member 5 (TM4SF5) is overexpressed during CCl4-mediated murine liver fibrosis and in human hepatocellular carcinomas. The tetraspanins form tetraspanin-enriched microdomains (TEMs) consisting of large membrane protein complexes on the cell surface. Thus, TM4SF5 may be involved in the signal coordination that controls liver malignancy. We investigated the relationship between TM4SF5-positive TEMs with liver fibrosis and tumorigenesis, using normal Chang hepatocytes that lack TM4SF5 expression and chronically TGF beta 1-treated Chang cells that express TM4SF5. TM4SF5 expression is positively correlated with tumorigenic CD151 expression, but is negatively correlated with tumor-suppressive CD63 expression in mouse fibrotic and human hepatic carcinoma tissues, indicating cooperative roles of the tetraspanins in liver malignancies. Although CD151 did not control the expression of TM4SF5, TM4SF5 appeared to control the expression levels of CD151 and CD63. TM4SF5 interacted with CD151, and caused the internalization of CD63 from the cell surface into late lysosomal membranes, presumably leading to terminating the tumor-suppressive functions of CD63. TM4SF5 could overcome the tumorigenic effects of CD151, especially cell migration and extracellular matrix (ECM)-degradation. Taken together, TM4SF5 appears to play a role in liver malignancy by controlling the levels of tetraspanins on the cell surface, and could provide a promising therapeutic target for the treatment of liver malignancies.	[Kang, Minkyung; Ye, Sang-Kyu] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kang, Minkyung; Ryu, Jihye; Lee, Doohyung; Lee, Mi-Sook; Kim, Hye-Jin; Song, Haeng Eun; Lee, Gyu-Ho; Kim, Tai Young; Lee, Jung Weon] Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Med Bioconvergence Res Ctr, Dept Pharm,Res Inst Pharmaceut Sci, Seoul, South Korea; [Nam, Seo Hee; Choi, Jungeun; Lee, Jung Weon] Seoul Natl Univ, Interdisciplinary Program Genet Engn, Seoul, South Korea; [Lee, Hansoo; Kim, Semi] Kangwon Natl Univ, Dept Biol Sci, Chunchon, Kangwon Do, South Korea; [Kim, Sang Jick] Korea Res Inst Biosci & Biotechnol, Therapeut Antibody Res Ctr, Taejon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, JW (corresponding author), Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Med Bioconvergence Res Ctr, Dept Pharm,Res Inst Pharmaceut Sci, Seoul, South Korea.	jwl@snu.ac.kr	Lee, Jung Weon/AAC-1146-2020; Lee, Jung Weon/F-9149-2012	Lee, Jung Weon/0000-0003-2722-8200; KIM, TAI YOUNG/0000-0001-8086-2476	National Research Foundation of Korea (NRF) for the Tumor Microenvironment Global Core Research Center (GCRC) - Korea government (Ministry of Science, ICT & Future Planning) [2011-0030001]; Medicinal Bioconvergence Research Center [NRF-2012M3A6A4054271];  [2012-0005606/2013-035235]	National Research Foundation of Korea (NRF) for the Tumor Microenvironment Global Core Research Center (GCRC) - Korea government (Ministry of Science, ICT & Future Planning); Medicinal Bioconvergence Research Center; 	This work was supported by the National Research Foundation of Korea (NRF) grant for the Tumor Microenvironment Global Core Research Center (GCRC) funded by the Korea government (Ministry of Science, ICT & Future Planning) (2011-0030001), for senior researchers program (Leap research, 2012-0005606/2013-035235), and for Medicinal Bioconvergence Research Center (NRF-2012M3A6A4054271) to JWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi S, 2009, BLOOD, V113, P1845, DOI 10.1182/blood-2008-05-160671; DETCHOKUL S, 2013, BR J PHARM; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; Hong IK, 2012, J BIOL CHEM, V287, P32027, DOI 10.1074/jbc.M111.314443; Jung O, 2013, BBA-MOL CELL RES, V1833, P629, DOI 10.1016/j.bbamcr.2012.11.026; Jung O, 2012, J CELL SCI, V125, P5960, DOI 10.1242/jcs.100586; Kang M, 2012, BIOCHEM J, V443, P691, DOI 10.1042/BJ20111584; Kim HP, 2005, BBA-MOL CELL RES, V1743, P151, DOI 10.1016/j.bbamcr.2004.09.014; Kim SM, 2012, Korean Patent, Patent No. [10- 2012- 0085437., 10201200085437]; Kim SM, 2012, Korean Patent, Patent No. [10- 2012- 0085436, 1020120085436]; Lee MS, 2012, BBA-MOL CELL RES, V1823, P514, DOI 10.1016/j.bbamcr.2011.11.017; Lee SA, 2008, J CLIN INVEST, V118, P1354, DOI 10.1172/JCI33768; Lee SA, 2011, FRONT BIOSCI-LANDMRK, V16, P1752, DOI 10.2741/3818; Lee SA, 2010, J CELL BIOCHEM, V111, P59, DOI 10.1002/jcb.22662; Lee SY, 2006, EXP CELL RES, V312, P2983, DOI 10.1016/j.yexcr.2006.06.001; Lekishvili T, 2008, J CELL SCI, V121, P685, DOI 10.1242/jcs.020347; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Radford KJ, 1997, J IMMUNOL, V158, P3353; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Sala-Valdes M, 2012, EXPERT OPIN THER TAR, V16, P985, DOI 10.1517/14728222.2012.712688; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; Severi T, 2010, ACTA PHARMACOL SIN, V31, P1409, DOI 10.1038/aps.2010.142; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Testa JE, 1999, CANCER RES, V59, P3812; Wright MD, 2000, PROTEIN SCI, V9, P1594, DOI 10.1110/ps.9.8.1594; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang XWH, 2010, CANCER RES, V70, P2256, DOI 10.1158/0008-5472.CAN-09-4032; Zhong W, 2009, HEPATOLOGY, V50, P1524, DOI 10.1002/hep.23189	31	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102817	10.1371/journal.pone.0102817	http://dx.doi.org/10.1371/journal.pone.0102817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033048	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300098
J	Zhao, TF; Zhang, QY; Long, HL; Xu, L				Zhao, Tanfeng; Zhang, Qingyou; Long, Hailin; Xu, Lu			Graph Theoretical Representation of Atomic Asymmetry and Molecular Chirality of Benzenoids in Two-Dimensional Space	PLOS ONE			English	Article							CONTINUOUS SYMMETRY MEASURES; POLYHEX HYDROCARBONS; SHAPE; ENUMERATION; SIMILARITY	In order to explore atomic asymmetry and molecular chirality in 2D space, benzenoids composed of 3 to 11 hexagons in 2D space were enumerated in our laboratory. These benzenoids are regarded as planar connected polyhexes and have no internal holes; that is, their internal regions are filled with hexagons. The produced dataset was composed of 357,968 benzenoids, including more than 14 million atoms. Rather than simply labeling the huge number of atoms as being either symmetric or asymmetric, this investigation aims at exploring a quantitative graph theoretical descriptor of atomic asymmetry. Based on the particular characteristics in the 2D plane, we suggested the weighted atomic sum as the descriptor of atomic asymmetry. This descriptor is measured by circulating around the molecule going in opposite directions. The investigation demonstrates that the weighted atomic sums are superior to the previously reported quantitative descriptor, atomic sums. The investigation of quantitative descriptors also reveals that the most asymmetric atom is in a structure with a spiral ring with the convex shape going in clockwise direction and concave shape going in anticlockwise direction from the atom. Based on weighted atomic sums, a weighted F index is introduced to quantitatively represent molecular chirality in the plane, rather than merely regarding benzenoids as being either chiral or achiral. By validating with enumerated benzenoids, the results indicate that the weighted F indexes were in accordance with their chiral classification (achiral or chiral) over the whole benzenoids dataset. Furthermore, weighted F indexes were superior to previously available descriptors. Benzenoids possess a variety of shapes and can be extended to practically represent any shape in 2D space-our proposed descriptor has thus the potential to be a general method to represent 2D molecular chirality based on the difference between clockwise and anticlockwise sums around a molecule.	[Zhao, Tanfeng; Zhang, Qingyou; Long, Hailin; Xu, Lu] Henan Univ, Coll Chem & Chem Engn, Inst Environm & Analyt Sci, Kaifeng, Peoples R China; [Xu, Lu] Chinese Acad Sci, Changchun Inst Appl Chem, Changchun 130022, Peoples R China	Henan University; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS	Zhang, QY (corresponding author), Henan Univ, Coll Chem & Chem Engn, Inst Environm & Analyt Sci, Kaifeng, Peoples R China.	zhqingyou@aliyun.com		Zhao, Tanfeng/0000-0002-6654-3679; Zhang, Qingyou/0000-0002-8923-0843	National Natural Science Foundation of China [20875022]; International Science and Technology Cooperation of Henan Province [114300510009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation of Henan Province	This work was supported from 2009-2011 by the National Natural Science Foundation of China (No. 20875022, http://www.nsfc.gov.cn/). From 2011-2014, this work was funded by the International Science and Technology Cooperation of Henan Province (No. 114300510009) and our collaborators in the research group of Prof. Joao Aires-de-Sousa (Universidade Nova de Lisboa, Portugal), http://www.hnkjt.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MS, 2010, J COMPUT AID MOL DES, V24, P789, DOI 10.1007/s10822-010-9374-0; Buda A. B., 1991, ELEM MATH, V46, P65; Caporossi G, 1998, J CHEM INF COMP SCI, V38, P610, DOI 10.1021/ci970116n; Dryzun C, 2009, PHYS CHEM CHEM PHYS, V11, P9653, DOI 10.1039/b911179d; Fennell CJ, 2010, J AM CHEM SOC, V132, P234, DOI 10.1021/ja906399e; Huang PY, 2012, NANO LETT, V12, P1081, DOI 10.1021/nl204423x; Kelvin WTB, 1904, BALTIMORE LECTURES M, P439; MEYER AY, 1991, J COMPUT AID MOL DES, V5, P427, DOI 10.1007/BF00125663; MEZEY PG, 1995, J MATH CHEM, V17, P185, DOI 10.1007/BF01164847; Nicholls A, 2010, J MED CHEM, V53, P3862, DOI 10.1021/jm900818s; Randic M, 1996, J CHEM INF COMP SCI, V36, P429, DOI 10.1021/ci950091x; Randic M, 1996, J CHEM INF COMP SCI, V36, P1183, DOI 10.1021/ci960014h; Randic M, 2001, J CHEM INF COMP SCI, V41, P639, DOI 10.1021/ci000115m; RANDIC M, 1995, J CHEM INF COMP SCI, V35, P594, DOI 10.1021/ci00025a031; TOSIC R, 1995, J CHEM INF COMP SCI, V35, P181, DOI 10.1021/ci00024a002; Voge M, 2002, J CHEM INF COMP SCI, V42, P456, DOI 10.1021/ci010098g; Yan X, 2013, J CHEM INF MODEL, V53, P1967, DOI 10.1021/ci300601q; ZABRODSKY H, 1992, J AM CHEM SOC, V114, P7843, DOI 10.1021/ja00046a033; ZABRODSKY H, 1995, J AM CHEM SOC, V117, P462, DOI 10.1021/ja00106a053; ZABRODSKY H, 1993, J AM CHEM SOC, V115, P8278, DOI 10.1021/ja00071a042; Zauhar RJ, 2008, United States Patent Application, Patent No. 20080294404; Zhang QY, 2010, CHEM J CHINESE U, V31, P1620; Zhang QY, 2011, ACTA CHIM SINICA, V69, P311	23	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102043	10.1371/journal.pone.0102043	http://dx.doi.org/10.1371/journal.pone.0102043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032832	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300032
J	Ammenwerth, W; Wurps, H; Klemens, MA; Crolow, C; Schulz-Menger, J; Schonfeld, N; Bittner, RC; Bauer, TT				Ammenwerth, Wilhelm; Wurps, Henrik; Klemens, Mark A.; Crolow, Catharina; Schulz-Menger, Jeanette; Schoenfeld, Nicolas; Bittner, Roland C.; Bauer, Torsten T.			Reduced Oxygen Uptake Efficiency Slope in Patients with Cardiac Sarcoidosis	PLOS ONE			English	Article							CARDIORESPIRATORY FUNCTIONAL RESERVE; CHRONIC HEART-FAILURE; MAGNETIC-RESONANCE; ENHANCED MRI; INVOLVEMENT; EXERCISE; STANDARDIZATION; PERFORMANCE; MYOCARDITIS; MANAGEMENT	Background: The non-invasive diagnosis of cardiac sarcoidosis (CS) is difficult. Cardiovascular magnetic resonance (CMR) has become a very valuable diagnostic tool in patients with suspected CS, but usually a combination of different tests is used. Oxygen uptake efficiency slope (OUES) is a parameter of cardiopulmonary exercise testing (CPET), which is used as an indicator for cardiovascular impairment. We investigated the predictive value of OUES for the diagnosis of myocardial involvement in sarcoid patients. Methods: Retrospectively 37 consecutive patients (44.9 +/- 13.8 years) with histologically confirmed sarcoidosis and clinical suspicion of heart involvement underwent noninvasive diagnostic testing including CMR. CS was diagnosed according to the guidelines from the Japanese Society of Sarcoidosis and other Granulomatous Disorders with additional consideration of CMR findings. Furthermore, CPET with calculation of predicted OUES according to equations by Hollenberg et al. was carried out. Results: Patients with CS (11/37; 30%) had a worse cardiovascular response to exercise. OUES was significantly lower in CS-group compared to non-CS-group (59.3 +/- 19.1 vs 88.0 +/- 15.4% pred., p < 0.0001). ROC curve method identified 70% pred. as the OUES cut-off point, which maximized sensitivity and specificity for detection of CS (96% sensitivity, 82% specificity, 89% overall accuracy). OUES <70% pred. was the single best predictor of CS (Odds ratio: 100.43, 95% CI: 1.99 to 5064, p < 0.001) even in multivariate analyses. Conclusion: OUES assessed in CPET may be helpful in identifying patient with cardiac involvement of sarcoidosis. Patient selection for CMR may be assisted by CPET findings in patients with sarcoidosis.	[Ammenwerth, Wilhelm; Wurps, Henrik; Crolow, Catharina; Schoenfeld, Nicolas; Bauer, Torsten T.] HELIOS Klinikum Emil von Behring, Lungenklin Heckeshorn, Dept Pneumol, Berlin, Germany; [Klemens, Mark A.; Bittner, Roland C.] HELIOS Klinikum Emil von Behring, Inst Radiol & Nucl Med, Berlin, Germany; [Schulz-Menger, Jeanette] WG Cardiac MRI ECRC, Berlin, Germany; [Schulz-Menger, Jeanette] HELIOS Klinikum Berlin Buch, Dept Cardiol & Nephrol, Berlin, Germany	Helios Kliniken; Helios Kliniken; Helios Kliniken	Bauer, TT (corresponding author), HELIOS Klinikum Emil von Behring, Lungenklin Heckeshorn, Dept Pneumol, Berlin, Germany.	torsten.bauer@helios-kliniken.de		Schulz-Menger, Jeanette/0000-0003-3100-1092	Oskar-Helene-Heim Foundation, Berlin, Germany; HELIOS Research Center, Berlin, Germany	Oskar-Helene-Heim Foundation, Berlin, Germany; HELIOS Research Center, Berlin, Germany	The study was supported by the Oskar-Helene-Heim Foundation, Berlin, Germany and HELIOS Research Center, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreacci JL, 2002, J SPORT SCI, V20, P345, DOI 10.1080/026404102753576125; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Baba R, 1996, J AM COLL CARDIOL, V28, P1567, DOI 10.1016/S0735-1097(96)00412-3; Baba R, 1999, EUR J APPL PHYSIOL O, V80, P397, DOI 10.1007/s004210050610; Baba Y, 2012, INT HEART J, V53, P287, DOI 10.1536/ihj.53.287; Codreanu A, 2007, J MAGN RESON IMAGING, V25, P957, DOI 10.1002/jmri.20897; Cooper C.B., 2001, EXERCISE TESTING INT; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Davies LC, 2006, EUR HEART J, V27, P684, DOI 10.1093/eurheartj/ehi672; Dubrey SW, 2010, PROG CARDIOVASC DIS, V52, P336, DOI 10.1016/j.pcad.2009.11.010; Fahy GJ, 1996, CHEST, V109, P62, DOI 10.1378/chest.109.1.62; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Gademan MGJ, 2008, EUR J CARDIOV PREV R, V15, P140, DOI 10.1097/HJR.0b013e3282ef19986; Handa T, 2010, SARCOIDOSIS VASC DIF, V27, P27; Hiraga HYK., 1993, GUIDELINES DIAGNOSIS, P23; Hollenberg M, 2000, J AM COLL CARDIOL, V36, P194, DOI 10.1016/S0735-1097(00)00691-4; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Ishimaru S, 2005, EUR HEART J, V26, P1538, DOI 10.1093/eurheartj/ehi180; IWAI K, 1994, SARCOIDOSIS, V11, P26; Kim JS, 2009, AM HEART J, V157, P9, DOI 10.1016/j.ahj.2008.09.009; Laszlo G, 2006, THORAX, V61, P744, DOI 10.1136/thx.2006.061648; Magri D, 2013, EUR J INTERN MED, V24, P278, DOI 10.1016/j.ejim.2012.12.010; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; ROBERTS WC, 1977, AM J MED, V63, P86, DOI 10.1016/0002-9343(77)90121-8; Schulz-Menger J, 2006, HEART, V92, P399, DOI 10.1136/hrt.2004.058016; Shimada T, 2001, AM J MED, V110, P520, DOI 10.1016/S0002-9343(01)00677-5; SILVERMAN KJ, 1978, CIRCULATION, V58, P1204, DOI 10.1161/01.CIR.58.6.1204; Smedema JP, 2005, CHEST, V128, P1629, DOI 10.1378/chest.128.3.1629; Smedema JP, 2005, CHEST, V128, P30, DOI 10.1378/chest.128.1.30; Soejima K, 2009, J CARDIOVASC ELECTR, V20, P578, DOI 10.1111/j.1540-8167.2008.01417.x; Tadamura E, 2005, AM J ROENTGENOL, V185, P110, DOI 10.2214/ajr.185.1.01850110; TELLIER P, 1988, AM J MED, V85, P189; Van Laethem C, 2005, AM HEART J, V149, P175, DOI 10.1016/j.ahj.2004.07.004; Van Laethem C, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.04.032; Vignaux O, 2002, CHEST, V122, P1895, DOI 10.1378/chest.122.6.1895; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005	38	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102333	10.1371/journal.pone.0102333	http://dx.doi.org/10.1371/journal.pone.0102333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029031	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000341306600066
J	Cambou, MC; Perez-Brumer, AG; Segura, ER; Salvatierra, HJ; Lama, JR; Sanchez, J; Clark, JL				Cambou, Mary C.; Perez-Brumer, Amaya G.; Segura, Eddy R.; Javier Salvatierra, H.; Lama, Javier R.; Sanchez, Jorge; Clark, Jesse L.			The Risk of Stable Partnerships: Associations between Partnership Characteristics and Unprotected Anal Intercourse among Men Who Have Sex with Men and Transgender Women Recently Diagnosed with HIV and/or STI in Lima, Peru	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; CONDOM USE; NEGOTIATED SAFETY; GAY MEN; BEHAVIOR; TRANSMISSION; EPIDEMIC; PATTERNS; SAMPLE	Background: Partnership type is an important factor associated with unprotected anal intercourse (UAI) and subsequent risk for HIV and sexually transmitted infections (STI). We examined the association of partnership type with UAI among men who have sex with men (MSM) and male-to-female transgender women (TGW) in Lima, Peru, recently diagnosed with HIV and/or STI. Methods: We report data from a cross-sectional analysis of MSM and TGW recently diagnosed with HIV and/or STI in Lima, Peru between 2011 and 2012. We surveyed participants regarding UAI with up to their three most recent sexual partners according to partner type. Multivariable Generalized Estimate Equating (GEE) models with Poisson distribution were used to estimate prevalence ratios (PR) for UAI according to partner type. Results: Among 339 MSM and TGW recently diagnosed with HIV and/or STI (mean age: 30.6 years, SD 9.0), 65.5% self-identified as homosexual/gay, 16.0% as bisexual, 15.2% as male-to-female transgender, and 3.3% as heterosexual. Participants provided information on 893 recent male or TGW partners with whom they had engaged in insertive or receptive anal intercourse: 28.9% stable partners, 56.4% non-stable/non-transactional partners (i.e. casual or anonymous), and 14.7% transactional partners (i.e. transactional sex client or sex worker). Unprotected anal intercourse was reported with 41.3% of all partners. In multivariable analysis, factors associated with UAI included partnership type (non-stable/non-transactional partner APR 0.73, [95% CI 0.59-0.91], transactional partner APR 0.53 [0.36-0.78], p<0.05) and the number of previous sexual encounters with the partner (>10 encounters APR 1.43 [1.06-1.92], p<0.05). Conclusion: UAI was more commonly reported for stable partners and in partnerships with >10 sexual encounters, suggesting UAI is more prevalent in partnerships with a greater degree of interpersonal commitment. Further research assessing partner-level factors and behavior is critical for improving HIV and/or STI prevention efforts among Peruvian MSM and TGW.	[Cambou, Mary C.; Perez-Brumer, Amaya G.; Segura, Eddy R.; Clark, Jesse L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Cambou, Mary C.; Perez-Brumer, Amaya G.; Segura, Eddy R.; Clark, Jesse L.] Program Global Hlth, Los Angeles, CA USA; [Perez-Brumer, Amaya G.] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA; [Javier Salvatierra, H.; Lama, Javier R.; Sanchez, Jorge] Asociac Civil Impacta Salud & Educ, Lima, Peru	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University	Clark, JL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA.	JLClark@mednet.ucla.edu	Oliveira, Claudia DL/G-8618-2011	Clark, Jesse/0000-0001-5862-6530; Segura, Eddy R/0000-0003-3580-7712; Perez-Brumer, Amaya/0000-0003-2441-4358	National Institutes of Health [R25 MH087222, K23 MH084611]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107, R25MH087222, K23MH084611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support was provided by the National Institutes of Health (http://grants.nih.gov/grants/oer.htm) R25 MH087222 "South American Program in HIV Prevention Research (SAPHIR)'' (Recipient: MCC); and K23 MH084611 "Partner Notification Strategies for HIV/STI Control in Urban Peru'' (PI: JLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Behrens T, 2004, METHOD INFORM MED, V43, P505; BOSGA MB, 1995, AIDS EDUC PREV, V7, P103; Carballo-Dieguez A, 1997, AIDS BEHAV, V1, P9, DOI DOI 10.1023/A:1026257620055; Chemnasiri T, 2010, AIDS EDUC PREV, V22, P100, DOI 10.1521/aeap.2010.22.2.100; Clark JL, 2008, SEX TRANSM INFECT, V84, P449, DOI 10.1136/sti.2008.031310; Clark J, 2013, AIDS BEHAV, V17, P1313, DOI 10.1007/s10461-012-0210-5; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Coutinho Leticia M S, 2008, Rev. Saúde Pública, V42, P992, DOI 10.1590/S0034-89102008000600003; Davidovich U, 2000, AIDS, V14, P701, DOI 10.1097/00002030-200004140-00009; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Gorbach PM, 2003, J URBAN HEALTH, V80, P15; Guzman R, 2005, JAIDS-J ACQ IMM DEF, V38, P82, DOI 10.1097/00126334-200501010-00015; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hart GJ, 2010, CURR OPIN INFECT DIS, V23, P39, DOI 10.1097/QCO.0b013e328334feb1; Hoff CC, 1997, J ACQ IMMUN DEF SYND, V14, P72, DOI 10.1097/00042560-199701010-00012; Jacobson JO, 2014, AIDS BEHAV, V18, P88, DOI 10.1007/s10461-013-0478-0; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; KIPPAX S, 1993, AIDS, V7, P257, DOI 10.1097/00002030-199302000-00015; Knox J, 2010, PSYCHOL HEALTH MED, V15, P660, DOI 10.1080/13548506.2010.507772; Lattimore S, 2011, SEX TRANSM DIS, V38, P221, DOI 10.1097/OLQ.0b013e3181f2ebe1; Macaluso M, 2000, AIDS, V14, P537, DOI 10.1097/00002030-200003310-00009; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McLean J., 1994, AIDS Care, V6, P331, DOI 10.1080/09540129408258645; Merson M, 2008, LANCET, V372, P1805, DOI 10.1016/S0140-6736(08)61752-3; Moreau-Gruet F, 2001, AIDS, V15, P1025, DOI 10.1097/00002030-200105250-00011; Nagaraj S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-181; Perez-Brumer AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059072; Rocha GM, 2013, AIDS BEHAV, V17, P1288, DOI 10.1007/s10461-012-0398-4; Sanchez J, 2007, JAIDS-J ACQ IMM DEF, V44, P578, DOI 10.1097/QAI.0b013e318033ff82; Sanchez J, 2009, JAIDS-J ACQ IMM DEF, V51, pS47, DOI 10.1097/QAI.0b013e3181a2671d; Siegler AJ, 2013, JAIDS-J ACQ IMM DEF, V64, P307, DOI 10.1097/QAI.0b013e3182a0e880; Silva-Santisteban A, 2012, AIDS BEHAV, V16, P872, DOI 10.1007/s10461-011-0053-5; Soto RJ, 2007, JAIDS-J ACQ IMM DEF, V46, P101; Truong HHM, 2006, SEX TRANSM INFECT, V82, P461, DOI 10.1136/sti.2006.019950; van Kesteren NMC, 2007, PATIENT EDUC COUNS, V65, P5, DOI 10.1016/j.pec.2006.09.003; Villaran MV, 2012, AM J MENS HEALTH, V6, P266, DOI 10.1177/1557988311431628; Wagner GJ, 1998, AIDS EDUC PREV, V10, P245	39	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102894	10.1371/journal.pone.0102894	http://dx.doi.org/10.1371/journal.pone.0102894			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25029514	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600103
J	Deng, G; Zhong, XY; Zhang, N; Lao, CY; Wang, B; Peng, DX; Liu, LJ				Deng Gang; Zhong Xinyue; Zhang Na; Lao Chengying; Wang Bo; Peng Dingxiang; Liu Lijun			A Proteomics Sample Preparation Method for Mature, Recalcitrant Leaves of Perennial Plants	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; PROTEIN EXTRACTION; ALEURONE LAYER; TISSUES; SEED; SOLUBILIZATION; TECHNOLOGY; EXPRESSION; STORAGE; WHEAT	Sample preparation is key to the success of proteomics studies. In the present study, two sample preparation methods were tested for their suitability on the mature, recalcitrant leaves of six representative perennial plants (grape, plum, pear, peach, orange, and ramie). An improved sample preparation method was obtained: Tris and Triton X-100 were added together instead of CHAPS to the lysis buffer, and a 20% TCA-water solution and 100% precooled acetone were added after the protein extraction for the further purification of protein. This method effectively eliminates nonprotein impurities and obtains a clear two-dimensional gel electrophoresis array. The method facilitates the separation of high-molecular-weight proteins and increases the resolution of low-abundance proteins. This method provides a widely applicable and economically feasible technology for the proteomic study of the mature, recalcitrant leaves of perennial plants.	[Deng Gang; Zhong Xinyue; Lao Chengying; Wang Bo; Peng Dingxiang; Liu Lijun] Huazhong Agr Univ, Coll Plant Sci & Technol, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Wuhan, Hubei, Peoples R China; [Deng Gang] Yunnan Univ, Sch Agr Sci, Kunming, Yunnan, Peoples R China; [Zhang Na] Wuhan Agr & Sci Inst, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Yunnan University	Liu, LJ (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Wuhan, Hubei, Peoples R China.	liulijun@mail.hzau.edu.cn	Deng, Gang/ABB-3072-2021	Deng, Gang/0000-0002-0136-2535	National science and technology support [2010BAD02B01]; National Natural Science Foundation of China [31000731]; China Agriculture Research System [CARS-19-E12]	National science and technology support; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This research was supported by a grant from National science and technology support (2010BAD02B01), the National Natural Science Foundation of China (31000731) and China Agriculture Research System (CARS-19-E12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS R, 1993, OIKOS, V66, P144, DOI 10.2307/3545208; Bancel E, 2010, J PROTEOME RES, V9, P3299, DOI 10.1021/pr9010525; Bodzon-Kulakowska A, 2007, J CHROMATOGR B, V849, P1, DOI 10.1016/j.jchromb.2006.10.040; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dai S, 2006, PROTEOMICS, V6, P2504, DOI 10.1002/pmic.200401351; Deng G, 2013, INT J AGRIC BIOL, V15, P570; Freeman WM, 2004, NEUROCHEM RES, V29, P1065, DOI 10.1023/B:NERE.0000023594.21352.17; GELFI C, 1983, J BIOCHEM BIOPH METH, V8, P157, DOI 10.1016/0165-022X(83)90041-6; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; Islam N, 2004, PROTEOMICS, V4, P1903, DOI 10.1002/pmic.200300816; Kottapalli KR, 2008, PLANT SCI, V175, P321, DOI 10.1016/j.plantsci.2008.05.005; Leimgruber RM, 2002, PROTEOMICS, V2, P135, DOI 10.1002/1615-9861(200202)2:2<135::AID-PROT135>3.0.CO;2-1; Magni C, 2007, PHYTOCHEMISTRY, V68, P997, DOI 10.1016/j.phytochem.2007.01.003; Meziani S, 2012, J CEREAL SCI, V55, P323, DOI 10.1016/j.jcs.2012.01.010; Molloy MP, 1998, ELECTROPHORESIS, V19, P837, DOI 10.1002/elps.1150190539; Noir S, 2005, BIOCHEM BIOPH RES CO, V337, P1257, DOI 10.1016/j.bbrc.2005.09.185; Rashid A, 2013, PLANT MOL BIOL REP, V31, P464, DOI 10.1007/s11105-012-0498-3; Rose JKC, 2004, PLANT J, V39, P715, DOI 10.1111/j.1365-313X.2004.02182.x; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; SAS Institute Inc, 1989, SAS STAT US GUID VER; Taulavuori E, 2010, PROTOPLASMA, V241, P19, DOI 10.1007/s00709-009-0096-x; Valcu CM, 2006, PROTEOMICS, V6, P1599, DOI 10.1002/pmic.200500314; Wang W, 2003, ELECTROPHORESIS, V24, P2369, DOI 10.1002/elps.200305500; Wang W, 2008, J SEP SCI, V31, P2032, DOI 10.1002/jssc.200800087; WASINGER VC, 1995, ELECTROPHORESIS, V16, P1090, DOI 10.1002/elps.11501601185; Wong M, 2006, LANDSCAPE, V50, P15; Wu QF, 2011, ACTA PHYSIOL PLANT, V33, P2387, DOI 10.1007/s11738-011-0779-8; Zellner M, 2005, ELECTROPHORESIS, V26, P2481, DOI 10.1002/elps.200410262; Zhu Y, 2011, ACTA PHYSIOL PLANT, V33, P1467, DOI 10.1007/s11738-010-0683-7	30	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102175	10.1371/journal.pone.0102175	http://dx.doi.org/10.1371/journal.pone.0102175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028960	Green Submitted, Green Published, gold			2022-12-25	WOS:000341306600041
J	Gremse, F; Krone, O; Thamm, M; Kiessling, F; Tolba, RH; Rieger, S; Gremse, C				Gremse, Felix; Krone, Oliver; Thamm, Mirko; Kiessling, Fabian; Tolba, Rene Hany; Rieger, Siegfried; Gremse, Carl			Performance of Lead-Free versus Lead-Based Hunting Ammunition in Ballistic Soap	PLOS ONE			English	Article							RIFLE BULLETS; BLOOD LEAD; COMPUTED-TOMOGRAPHY; WILDLIFE MANAGEMENT; CALIFORNIA CONDORS; POTENTIAL TOXICITY; DIETARY EXPOSURE; HEALTH-RISKS; COPPER; DEER	Background: Lead-free hunting bullets are an alternative to lead-containing bullets which cause health risks for humans and endangered scavenging raptors through lead ingestion. However, doubts concerning the effectiveness of lead-free hunting bullets hinder the wide-spread acceptance in the hunting and wildlife management community. Methods: We performed terminal ballistic experiments under standardized conditions with ballistic soap as surrogate for game animal tissue to characterize dimensionally stable, partially fragmenting, and deforming lead-free bullets and one commonly used lead-containing bullet. The permanent cavities created in soap blocks are used as a measure for the potential wound damage. The soap blocks were imaged using computed tomography to assess the volume and shape of the cavity and the number of fragments. Shots were performed at different impact speeds, covering a realistic shooting range. Using 3D image segmentation, cavity volume, metal fragment count, deflection angle, and depth of maximum damage were determined. Shots were repeated to investigate the reproducibility of ballistic soap experiments. Results: All bullets showed an increasing cavity volume with increasing deposited energy. The dimensionally stable and fragmenting lead-free bullets achieved a constant conversion ratio while the deforming copper and lead-containing bullets showed a ratio, which increases linearly with the total deposited energy. The lead-containing bullet created hundreds of fragments and significantly more fragments than the lead-free bullets. The deflection angle was significantly higher for the dimensionally stable bullet due to its tumbling behavior and was similarly low for the other bullets. The deforming bullets achieved higher reproducibility than the fragmenting and dimensionally stable bullets. Conclusion: The deforming lead-free bullet closely resembled the deforming lead-containing bullet in terms of energy conversion, deflection angle, cavity shape, and reproducibility, showing that similar terminal ballistic behavior can be achieved. Furthermore, the volumetric image processing allowed superior analysis compared to methods that involve cutting of the soap blocks.	[Gremse, Felix; Thamm, Mirko; Kiessling, Fabian] Rhein Westfal TH Aachen, Univ Hosp, Aachen, Germany; [Krone, Oliver] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Tolba, Rene Hany] Rhein Westfal TH Aachen, Univ Hosp, Aachen, Germany; [Rieger, Siegfried; Gremse, Carl] HNE Eberswalde, Eberswalde, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Leibniz Institut fur Zoo und Wildtierforschung; RWTH Aachen University; RWTH Aachen University Hospital	Gremse, C (corresponding author), HNE Eberswalde, Eberswalde, Germany.	carl.gremse@hnee.de	Kiessling, Fabian/Y-2417-2019	Kiessling, Fabian/0000-0002-7341-0399; Gremse, Carl/0000-0002-9936-4255	Mecklenburg West Pomerania Ministry for Agriculture, Environment and Consumer Protection; German Federal Ministry of Food and Agriculture [09HS023]; Philips Research, Aachen, Germany	Mecklenburg West Pomerania Ministry for Agriculture, Environment and Consumer Protection; German Federal Ministry of Food and Agriculture; Philips Research, Aachen, Germany	The authors kindly acknowledge funding by the Mecklenburg West Pomerania Ministry for Agriculture, Environment and Consumer Protection, the German Federal Ministry of Food and Agriculture (grant number 09HS023), as well as funding by Philips Research, Aachen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery D, 2009, INGESTION LEAD SPENT, P161, DOI DOI 10.4080/ILSA.2009.0115; Baatz M, 2009, COMB CHEM HIGH T SCR, V12, P908, DOI 10.2174/138620709789383196; Bedrosian B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051978; Bellinger DC, 2013, ENVIRON HEALTH PERSP, V121, pA178, DOI 10.1289/ehp.1306945; Bellinger DC, 2013, MICROBIOL ENV TOXICO; Bierkens J, 2012, SCI TOTAL ENVIRON, V414, P90, DOI 10.1016/j.scitotenv.2011.10.048; Bolliger SA, 2010, INT J LEGAL MED, V124, P613, DOI 10.1007/s00414-010-0503-z; Bundesinstitut fur Risikobewertung, 2011, GES UMW BEI VERW BLE; Bundesinstitut fur Risikobewertung, 2013, BFR S FORSCH ZUM THE; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Caudell JN, 2013, WILDLIFE SOC B, V37, P824, DOI 10.1002/wsb.311; Caudell Joe N., 2012, Human-Wildlife Interactions, V6, P105; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; Church ME, 2006, ENVIRON SCI TECHNOL, V40, P6143, DOI 10.1021/es060765s; Cornatzer WE., 2009, INGESTION LEAD SPENT, P154; EFSA Panel on Contaminants in the Food Chain (CONTAM), 2010, SCI OP LEAD FOOD; Ehling J, 2014, AM J PATHOL, V184, P431, DOI 10.1016/j.ajpath.2013.10.014; Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Franson JC, 2012, ARCH ENVIRON CON TOX, V62, P145, DOI 10.1007/s00244-011-9671-1; Green RE, 2012, FOOD CHEM TOXICOL, V50, P4180, DOI 10.1016/j.fct.2012.08.032; Green RE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004022; Gremse C, 2014, ERWEITERTER BERICHT; Gremse F, 2011, RADIOLOGY, V260, P709, DOI 10.1148/radiol.11110069; Gremse F, 2011, SMALL ANIMAL IMAGING: BASICS AND PRACTICAL GUIDE, P363, DOI 10.1007/978-3-642-12945-2_25; Grund Marrett D., 2010, Human-Wildlife Interactions, V4, P257; Hauser R, 2008, ENVIRON HEALTH PERSP, V116, P976, DOI 10.1289/ehp.10516; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Iqbal S, 2009, ENVIRON RES, V109, P952, DOI 10.1016/j.envres.2009.08.007; Irschik I, 2013, EUR J WILDLIFE RES, V59, P129, DOI 10.1007/s10344-012-0656-9; JANZON B, 1982, ACTA CHIR SCAND, P79; Jeffery AJ, 2008, CLIN RADIOL, V63, P1160, DOI 10.1016/j.crad.2008.03.003; Johansen P, 2006, ENVIRON POLLUT, V142, P93, DOI 10.1016/j.envpol.2005.09.015; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017656; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015350; Kneubuehl B, 2013, GESCHOSSE BALLISTIK; Kneubuehl BP, 2011, WOUND BALLISTICS: BASICS AND APPLICATIONS, P1, DOI 10.1007/978-3-642-20356-5; Knott J, 2010, SCI TOTAL ENVIRON, V409, P95, DOI 10.1016/j.scitotenv.2010.08.053; Knott Jeff, 2009, Conservation Evidence, V6, P71; Krone Oliver, 2009, P289, DOI 10.4080/ilsa.2009.0207; Lambertucci SA, 2010, ENVIRON SCI TECHNOL, V44, P7759, DOI 10.1021/es102667c; Lindboe M, 2012, FOOD ADDIT CONTAM A, V29, P1052, DOI 10.1080/19440049.2012.680201; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; Nawaratne S, 1997, J COMPUT ASSIST TOMO, V21, P481, DOI 10.1097/00004728-199705000-00027; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Pain DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010315; Perdekamp MG, 2008, INT J LEGAL MED, V122, P81, DOI 10.1007/s00414-007-0161-y; Perdekamp MG, 2013, INT J LEGAL MED, V127, P791, DOI 10.1007/s00414-012-0808-1; Rutty GN, 2008, INT J LEGAL MED, V122, P1, DOI 10.1007/s00414-006-0145-3; Schyma C, 2012, FORENSIC SCI INT, V214, P82, DOI 10.1016/j.forsciint.2011.07.021; Spicher V, 2008, BLEIVERGIFTUNGEN BEI, P81; Stroud Richard K., 2009, P119; Thomas VG, 2008, SCI TOTAL ENVIRON, V394, P283, DOI 10.1016/j.scitotenv.2008.01.049; Thomas VG, 2007, SCI TOTAL ENVIRON, V374, P71, DOI 10.1016/j.scitotenv.2006.10.004; Thomas VG, 2013, AMBIO, V42, P737, DOI 10.1007/s13280-012-0361-7; Trinogga A, 2013, SCI TOTAL ENVIRON, V443, P226, DOI 10.1016/j.scitotenv.2012.10.084; Wright JP, 2008, PLOS MED, V5, P732, DOI 10.1371/journal.pmed.0050101	57	32	32	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102015	10.1371/journal.pone.0102015	http://dx.doi.org/10.1371/journal.pone.0102015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029572	Green Published, gold			2022-12-25	WOS:000341306600031
J	Ribeiro, MBN; Jerozolimski, A; de Robert, P; Salles, NV; Kayapo, B; Pimentel, TP; Magnusson, WE				Ribeiro, Maria Beatriz N.; Jerozolimski, Adriano; de Robert, Pascale; Salles, Nilson V.; Kayapo, Biribiri; Pimentel, Tania P.; Magnusson, William E.			Anthropogenic Landscape in Southeastern Amazonia: Contemporary Impacts of Low-Intensity Harvesting and Dispersal of Brazil Nuts by the Kayapo Indigenous People	PLOS ONE			English	Article							TREE BERTHOLLETIA-EXCELSA; POPULATION-STRUCTURE; SEED DISPERSAL; EXTRACTIVE RESERVES; DASYPROCTA-LEPORINA; PRISTINE MYTH; FOREST; LECYTHIDACEAE; CONSERVATION; PREDATION	Brazil nut, the Bertholletia excelsa seed, is one of the most important non-timber forest products in the Amazon Forest and the livelihoods of thousands of traditional Amazonian families depend on its commercialization. B. excelsa has been frequently cited as an indicator of anthropogenic forests and there is strong evidence that past human management has significantly contributed to its present distribution across the Amazon, suggesting that low levels of harvesting may play a positive role in B. excelsa recruitment. Here, we evaluate the effects of Brazil nut harvesting by the Kayapo Indigenous people of southeastern Amazonia on seedling recruitment in 20 B. excelsa groves subjected to different harvesting intensities, and investigated if management by harvesters influences patterns of B. excelsa distribution. The number of years of low-intensity Brazil nut harvesting by the Kayapo over the past two decades was positively related to B. excelsa seedling density in groves. One of the mechanisms behind the higher seedling density in harvested sites seems to be seed dispersal by harvesters along trails. The Kayapo also intentionally plant B. excelsa seeds and seedlings across their territories. Our results show not only that low-intensity Brazil nut harvesting by the Kayapo people does not reduce recruitment of seedlings, but that harvesting and/or associated activities conducted by traditional harvesters may benefit B. excelsa beyond grove borders. Our study supports the hypothesis that B. excelsa dispersal throughout the Amazon was, at least in part, influenced by indigenous groups, and strongly suggests that current human management contributes to the maintenance and formation of B. excelsa groves. We suggest that changes in Brazil nut management practices by traditional people to prevent harvesting impacts may be unnecessary and even counterproductive in many areas, and should be carefully evaluated before implementation.	[Ribeiro, Maria Beatriz N.] INPA, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Jerozolimski, Adriano; Salles, Nilson V.; Kayapo, Biribiri] AFP, Tucuma, Para, Brazil; [de Robert, Pascale] IRD, UMR PALOC, Paris, France; [de Robert, Pascale] Museu Paraense Emilio Goeldi, Belem, Para, Brazil; [Pimentel, Tania P.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Dinam Ambiental CDAM, Manaus, Amazonas, Brazil; [Magnusson, William E.] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Institut de Recherche pour le Developpement (IRD); Museu Paraense Emilio Goeldi; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Ribeiro, MBN (corresponding author), INPA, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.	ribeiro.mbn@gmail.com			Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [141697/2007-5]; Conservacao Internacional do Brasil - CI-Brasil [CPFY 08/022]; Instituto Internacional de Educacao do Brasil - IEB/Gordon and Betty Moore Foundation [B/2007/02/BDP/04]; Institut de Recherche Pour le Developpement - IRD; International Conservation Fund of Canada - ICFC; CNPq through the National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM); Program for Biodiversity Research (PPBio); INCT-CENBAM	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conservacao Internacional do Brasil - CI-Brasil; Instituto Internacional de Educacao do Brasil - IEB/Gordon and Betty Moore Foundation; Institut de Recherche Pour le Developpement - IRD; International Conservation Fund of Canada - ICFC; CNPq through the National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM); Program for Biodiversity Research (PPBio); INCT-CENBAM	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (http://www.cnpq.br) (grant number 141697/2007-5); Conservacao Internacional do Brasil - CI-Brasil (http://www.conservation.org.br)(grant number CPFY 08/022); Instituto Internacional de Educacao do Brasil - IEB/Gordon and Betty Moore Foundation (http://www.iieb.org.br) (grant number B/2007/02/BDP/04); Institut de Recherche Pour le Developpement - IRD (http://www.ird.org); and International Conservation Fund of Canada - ICFC (http://icfcanada.org). MBNR was supported by a CNPq scholarship through the National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM) during manuscript preparation. WEM is supported by the Program for Biodiversity Research (PPBio) and the INCT-CENBAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], 2005, FIELD METHOD, DOI [10.1177/1525822X05277460, DOI 10.1177/1525822X05277460]; Arnaud E, 1987, INDIO EXPANSAO NACL, P427; AUGSPURGER CK, 1984, ECOLOGY, V65, P1705, DOI 10.2307/1937766; BAIDER C, 2000, THESIS U SAO PAULO S; Balee W., 1989, Advances in Economic Botany, V7, P1; Brockington D, 2006, CONSERV BIOL, V20, P250, DOI 10.1111/j.1523-1739.2006.00335.x; Buckland S.T., 2001, pi; BUCKLEY DP, 1988, THEOR APPL GENET, V76, P923, DOI 10.1007/BF00273682; CLAY J.W., 1997, HARVESTING WILD SPEC, P246; Clement CR, 2010, BIOTROPICA, V42, P534, DOI 10.1111/j.1744-7429.2010.00674.x; Clement CR, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P159, DOI 10.1007/1-4020-2597-1_9; Connell J.H., 1971, DYNAMICS POPULATIONS, P298; Cotta JN, 2008, FOREST ECOL MANAG, V256, P28, DOI 10.1016/j.foreco.2008.03.026; Denevan WM, 2011, GEOGR REV, V101, P576, DOI 10.1111/j.1931-0846.2011.00118.x; Dirzo R, 2007, BIOTROPICA, V39, P355, DOI 10.1111/j.1744-7429.2007.00274.x; Embrapa, 1997, MAN MET AN SOL; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Heckenberger MJ, 2003, SCIENCE, V301, P1710, DOI 10.1126/science.1086112; Hemming J, 2003, DIE YOU MUST BRAZILI, P110; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Jansen PA, 2012, P NATL ACAD SCI USA, V109, P12610, DOI 10.1073/pnas.1205184109; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnston K., 2001, USING ARCGIS GEOSTAT; Jorge MSP, 2005, BIOTROPICA, V37, P317, DOI 10.1111/j.1744-7429.2005.00041.x; Kainer KA, 1998, ECOL APPL, V8, P397, DOI 10.1890/1051-0761(1998)008[0397:BNSEAA]2.0.CO;2; Kainer KA, 2007, FOREST ECOL MANAG, V250, P244, DOI 10.1016/j.foreco.2007.05.024; Kanashiro M, 1997, SILVAE GENET, V46, P219; Levis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048559; Mori S. A., 1990, Advances in Economic Botany, V8, P130; MORSELLO C, 2002, THESIS U E ANGLIA NO; Motta Maues M., 2002, POLLINATING BEES THE, P245; Myers GP, 2000, FOREST ECOL MANAG, V127, P119, DOI 10.1016/S0378-1127(99)00124-3; ORTIZ E. G., 2002, TAPPING GREEN MARKET, P61; Paiva PM, 2011, FOREST ECOL MANAG, V261, P508, DOI 10.1016/j.foreco.2010.11.001; Pereira HS, 1994, REV UNIVERSIDADE AMA, V3, P11; Peres CA, 1997, J TROP ECOL, V13, P69, DOI 10.1017/S0266467400010269; Peres CA, 1997, J TROP ECOL, V13, P595, DOI 10.1017/S0266467400010749; Peres CA, 2001, CONSERV BIOL, V15, P793, DOI 10.1046/j.1523-1739.2001.015003793.x; Peres CA, 2003, SCIENCE, V302, P2112, DOI 10.1126/science.1091698; Peres CA, 2006, BIODIVERS CONSERV, V15, P2627, DOI 10.1007/s10531-005-5406-9; Posey D. A., 1985, Agroforestry Systems, V3, P139, DOI 10.1007/BF00122640; Posey DA, 2004, KAYAPO ETHNOECOLOGY; Ribeiro MBN, 2014, FOREST ECOL MANAG, V319, P67, DOI 10.1016/j.foreco.2014.02.005; Robert P, 2009, ANUARIO AMERICANISTA, V6-7, P563; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; Schwartzman S, 2000, CONSERV BIOL, V14, P1351, DOI 10.1046/j.1523-1739.2000.99329.x; Schwartzman S, 2005, CONSERV BIOL, V19, P721, DOI 10.1111/j.1523-1739.2005.00695.x; Schwartzman S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0164; Scoles R., 2011, Boletim do Museu Paraense Emilio Goeldi, Ciencias Naturais, V6, P273; Scoles R, 2012, FOREST ECOL MANAG, V265, P71, DOI 10.1016/j.foreco.2011.10.027; Scoles R, 2011, HUM ECOL, V39, P455, DOI 10.1007/s10745-011-9412-0; Shanley P, 2002, TAPPING GREEN MARKET; Shepard GH, 2011, ECON BOT, V65, P44, DOI 10.1007/s12231-011-9151-6; Silvius KM, 2003, BIOTROPICA, V35, P74, DOI 10.1111/j.1744-7429.2003.tb00264.x; Smith J. Jerome, 1993, CULTURAL ANTHR METHO, V5, P1, DOI DOI 10.1177/1525822X9300500301; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; Ticktin T, 2004, J APPL ECOL, V41, P11, DOI 10.1111/j.1365-2664.2004.00859.x; Haugaasen JMT, 2010, J TROP ECOL, V26, P251, DOI 10.1017/S0266467410000027; TURNER Terence, 1992, HIST INDIOS BRASIL, P311; Vieira S, 2005, P NATL ACAD SCI USA, V102, P18502, DOI 10.1073/pnas.0505966102; VIVEIROS DE CASTRO Eduardo, 1986, ARAWETE OS DEUSES CA; Wadt LHO, 2008, BIOL CONSERV, V141, P332, DOI 10.1016/j.biocon.2007.10.007; Wadt LHO, 2005, FOREST ECOL MANAG, V211, P371, DOI 10.1016/j.foreco.2005.02.061; Wright SJ, 2000, CONSERV BIOL, V14, P227, DOI 10.1046/j.1523-1739.2000.98333.x; Zuidema PA, 2002, J TROP ECOL, V18, P1, DOI 10.1017/S0266467402002018	66	39	44	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102187	10.1371/journal.pone.0102187	http://dx.doi.org/10.1371/journal.pone.0102187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029191	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600043
J	Wang, WL; Chen, KX; Liu, Q; Johnston, N; Ma, ZH; Zhang, FC; Zheng, XF				Wang, Weilan; Chen, Kaixu; Liu, Qing; Johnston, Nathan; Ma, Zhenghai; Zhang, Fuchun; Zheng, Xiufen			Suppression of Tumor Growth by Pleurotus ferulae Ethanol Extract through Induction of Cell Apoptosis, and Inhibition of Cell Proliferation and Migration	PLOS ONE			English	Article							GANODERMA-LUCIDUM; IN-VITRO; CANCER-CELLS; CYCLE ARREST; ANTICANCER; MUSHROOMS; PROTEINS; MELANOMA; MAITAKE; VIVO	Cancer is the second leading cause of death worldwide. Edible medicinal mushrooms have been used in traditional medicine as regimes for cancer patients. Recently anti-cancer bioactive components from some mushrooms have been isolated and their anti-cancer effects have been tested. Pleurotus ferulae, a typical edible medicinal mushroom in Xinjiang China, has also been used to treat cancer patients in folk medicine. However, little studies have been reported on the anticancer components of Pleurotus ferulae. This study aims to extract bioactive components from Pleurotus ferulae and to investigate the anti-cancer effects of the extracts. We used ethanol to extract anti-cancer bioactive components enriched with terpenoids from Pleurotus ferulae. We tested the anti-tumour effects of ethanol extracts on the melanoma cell line B16F10, the human gastric cancer cell line BGC 823 and the immortalized human gastric epithelial mucosa cell line GES-1 in vitro and a murine melanoma model in vivo. Cell toxicity and cell proliferation were measured by MTT assays. Cell cycle progression, apoptosis, caspase 3 activity, mitochondrial membrane potential (MMP), migration and gene expression were studied in vitro. PFEC suppressed tumor cell growth, inhibited cell proliferation, arrested cells at G0/G1 phases and was not toxic to non-cancer cells. PFEC also induced cell apoptosis and necrosis, increased caspase 3 activity, reduced the MMP, prevented cell invasion and changed the expression of genes associated with apoptosis and the cell cycle. PFEC delayed tumor formation and reduced tumor growth in vivo. In conclusion, ethanol extracted components from Pleurotus ferulae exert anti-cancer effects through direct suppression of tumor cell growth and invasion, demonstrating its therapeutic potential in cancer treatment.	[Wang, Weilan; Chen, Kaixu; Ma, Zhenghai; Zhang, Fuchun; Zheng, Xiufen] Xinjiang Univ, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Peoples R China; [Liu, Qing] Jilin Univ, Norman Bethune Coll Med, Changchun 130023, Peoples R China; [Johnston, Nathan; Zheng, Xiufen] Univ Western Ontario, Dept Pathol, London, ON, Canada; [Zheng, Xiufen] Lawson Hlth Res Inst, London, ON, Canada	Xinjiang University; Jilin University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Zhang, FC (corresponding author), Xinjiang Univ, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Peoples R China.	zfcxj@sina.com; xzheng26@uwo.ca		Ma, Zhenghai/0000-0002-0930-7696	National Natural Science Foundation of China [31260267]; Xinjiang University, Heart and Stroke Foundation of Canada; Lawson Health Research Institute	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xinjiang University, Heart and Stroke Foundation of Canada; Lawson Health Research Institute	The study was supported by grants from National Natural Science Foundation of China (31260267), Xinjiang University, Heart and Stroke Foundation of Canada and Lawson Health Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2011, BBA-GEN SUBJECTS, V1810, P519, DOI 10.1016/j.bbagen.2011.02.010; Alam N, 2012, SAUDI J BIOL SCI, V19, P111, DOI 10.1016/j.sjbs.2011.11.004; Albeituni SH, 2013, ANTI-CANCER AGENT ME, V13, P689, DOI 10.2174/1871520611313050003; Ansor NM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-256; Arpha K, 2012, J AGR FOOD CHEM, V60, P9834, DOI 10.1021/jf302433r; Boh B, 2013, RECENT PAT ANTI-CANC, V8, P255, DOI 10.2174/1574891X113089990036; Ding ZY, 2014, ANN MICROBIOL, V64, P121, DOI 10.1007/s13213-013-0640-y; Fong ZV, 2014, BRIT J DERMATOL, V170, P20, DOI 10.1111/bjd.12687; Gan Yong, 2001, Mycosystema, V20, P228; Gong YN, 2008, J GANSU LIANHE U NAT, V02, P64; Hsiao YC, 2007, J BIOMED SCI, V14, P107, DOI 10.1007/s11373-006-9117-3; Kim KH, 2013, J NAT PROD, V76, P845, DOI 10.1021/np300801x; Kim SP, 2013, J AGR FOOD CHEM, V61, P4898, DOI 10.1021/jf400916c; Kobayashi Y, 2012, J BIOL CHEM, V287, P33973, DOI 10.1074/jbc.M111.327692; Lee YS, 2010, J ETHNOPHARMACOL, V131, P56, DOI 10.1016/j.jep.2010.05.064; Lemieszek MK, 2013, FOOD FUNCT, V4, P575, DOI 10.1039/c2fo30324h; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Liu J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00905; Montoya S, 2012, WORLD J MICROB BIOT, V28, P1533, DOI 10.1007/s11274-011-0957-2; Alonso EN, 2013, J MED FOOD, V16, P602, DOI 10.1089/jmf.2012.0222; Rains JL, 2011, MOL CELL BIOCHEM, V349, P77, DOI 10.1007/s11010-010-0662-8; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; Soares AA, 2013, MOLECULES, V18, P7609, DOI 10.3390/molecules18077609; Spagnolo F, 2012, ARCH DERMATOL RES, V304, P177, DOI 10.1007/s00403-012-1223-7; Sun XH, 2002, ACTA NUTRIMENTA SINI, V24, P139; Trajkovic LMH, 2009, NUTR CANCER, V61, P696, DOI 10.1080/01635580902898743; Urbanelli S, 2003, HEREDITY, V90, P253, DOI 10.1038/sj.hdy.6800239; Wang CY, 2013, CARBOHYD POLYM, V94, P479, DOI 10.1016/j.carbpol.2013.01.034; Wasser SP, 2011, APPL MICROBIOL BIOT, V89, P1323, DOI 10.1007/s00253-010-3067-4; Weidmann V, 2013, BEILSTEIN J ORG CHEM, V9, P2233, DOI 10.3762/bjoc.9.262; Wu GS, 2012, FITOTERAPIA, V83, P408, DOI 10.1016/j.fitote.2011.12.004; Yang L, 2010, PROGR MODERN BIOMEDI, V20, P3957; [杨琳 Yang Lin], 2011, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V22, P2114; Yin X, 2013, J NAT PROD, V76, P1365, DOI 10.1021/np400359y	34	26	30	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102673	10.1371/journal.pone.0102673	http://dx.doi.org/10.1371/journal.pone.0102673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029345	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600092
J	Ferraz-Nogueira, JP; Diez-Guerra, FJ; Llopis, J				Ferraz-Nogueira, Jose P.; Javier Diez-Guerra, F.; Llopis, Juan			Visualization of Phosphatidic Acid Fluctuations in the Plasma Membrane of Living Cells	PLOS ONE			English	Article							PHOSPHOLIPASE-D ISOFORM; DYNAMIC-RANGE; MYOSIN-II; PROTEIN; HETEROGENEITY; LOCALIZATION; LAMELLIPODIA; EXPRESSION; FILOPODIA; BINDING	We developed genetically-encoded fluorescent sensors based on Forster Resonance Energy Transfer to monitor phosphatidic acid (PA) fluctuations in the plasma membrane using Spo20 as PA-binding motif. Basal PA levels and phospholipase D activity varied in different cell types. In addition, stimuli that activate PA phosphatases, leading to lower PA levels, increased lamellipodia and filopodia formation. Lower PA levels were observed in the leading edge than in the trailing edge of migrating HeLa cells. In MSC80 and OLN93 cells, which are stable cell lines derived from Schwann cells and oligodendrocytes, respectively, a higher ratio of diacylglycerol to PA levels was demonstrated in the membrane processes involved in myelination, compared to the cell body. We propose that the PA sensors reported here are valuable tools to unveil the role of PA in a variety of intracellular signaling pathways.	[Ferraz-Nogueira, Jose P.; Llopis, Juan] Univ Castilla La Mancha, Ctr Reg Invest Biomed, Albacete, Spain; [Ferraz-Nogueira, Jose P.; Llopis, Juan] Univ Castilla La Mancha, Fac Med Albacete, Albacete, Spain; [Javier Diez-Guerra, F.] Univ Autonoma Madrid, Fac Ciencias, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Javier Diez-Guerra, F.] Univ Autonoma Madrid, Fac Ciencias, Dept Biol Mol, E-28049 Madrid, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Llopis, J (corresponding author), Univ Castilla La Mancha, Ctr Reg Invest Biomed, Albacete, Spain.	juan.llopis@uclm.es	Llopis, Juan/I-2622-2012; Diez-Guerra, Fco. Javier/K-9063-2014	Llopis, Juan/0000-0002-9460-0642; Diez-Guerra, Fco. Javier/0000-0003-1707-4519; Ferraz Nogueira, Jose Pedro/0000-0002-9839-2043	Spanish Ministry of Economy and Competitiveness; European Regional Development Fund (ERDF) [BFU2012-39548]; Junta de Comunidades de Castilla-La Mancha/ERDF [PPII10-0270-6889]; Spanish Ministry of Science and Innovation [BFU2010-18297]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (ERDF)(European Commission); Junta de Comunidades de Castilla-La Mancha/ERDF(Junta de Comunidades de Castilla-La Mancha); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness and European Regional Development Fund (ERDF) (grant BFU2012-39548 to J.L.), Junta de Comunidades de Castilla-La Mancha/ERDF (grant PPII10-0270-6889 to J.L.), and the Spanish Ministry of Science and Innovation (grant BFU2010-18297 to F.J.D-G). Institutional support from Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bohdanowicz M, 2013, MOL BIOL CELL, V24, P1700, DOI 10.1091/mbc.E12-11-0789; BOUTRY JM, 1992, J NEUROSCI RES, V32, P15, DOI 10.1002/jnr.490320103; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Bruce Charlotte C., 2007, P427, DOI 10.1007/978-0-387-70830-0_19; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Czarny M, 1999, J BIOL CHEM, V274, P2717, DOI 10.1074/jbc.274.5.2717; Domingo B, 2010, CELL MOL LIFE SCI, V67, P3345, DOI 10.1007/s00018-010-0386-7; Dominguez-Gonzalez I, 2007, BIOCHEM J, V404, P31, DOI 10.1042/BJ20061483; Du GW, 2009, MOL BIOL CELL, V20, P200, DOI 10.1091/mbc.E08-06-0555; Fiucci G, 2000, INT J CANCER, V85, P882, DOI 10.1002/(SICI)1097-0215(20000315)85:6<882::AID-IJC24>3.0.CO;2-E; Foster DA, 2003, MOL CANCER RES, V1, P789; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Gomez-Cambronero J, 2013, ADV BIOL REGUL; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Hermansson M, 2011, PROG LIPID RES, V50, P240, DOI 10.1016/j.plipres.2011.02.004; Huang CM, 2011, BIOMATERIALS, V32, P214, DOI 10.1016/j.biomaterials.2010.08.076; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kollins KM, 2009, DEV NEUROBIOL, V69, P279, DOI 10.1002/dneu.20704; Kotera I, 2010, ACS CHEM BIOL, V5, P215, DOI 10.1021/cb900263z; Kraft CA, 2008, J BIOL CHEM, V283, P36636, DOI 10.1074/jbc.M804633200; Krager KJ, 2012, J LIPID RES, V53, P2214, DOI 10.1194/jlr.D026468; Kunida K, 2012, J CELL SCI, V125, P2381, DOI 10.1242/jcs.096859; LISCOVITCH M, 1989, J BIOL CHEM, V264, P1450; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Morris AJ, 1997, ANAL BIOCHEM, V252, P1, DOI 10.1006/abio.1997.2299; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nishioka T, 2008, MOL BIOL CELL, V19, P4213, DOI 10.1091/mbc.E08-03-0315; Nishioka T, 2010, J BIOL CHEM, V285, P35979, DOI 10.1074/jbc.M110.153007; Palm GJ, 1997, NAT STRUCT BIOL, V4, P361, DOI 10.1038/nsb0597-361; Picazo F, 2011, BIOSENS BIOELECTRON, V26, P2147, DOI 10.1016/j.bios.2010.09.024; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Rainteau D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041985; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Sato M, 2003, NAT CELL BIOL, V5, P1016, DOI 10.1038/ncb1054; Sato M, 2006, NAT METHODS, V3, P797, DOI 10.1038/nmeth930; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Tavare JM, 2001, J ENDOCRINOL, V170, P297, DOI 10.1677/joe.0.1700297; von Kleist S, 1975, J Natl Cancer Inst, V55, P555; Wang HB, 2012, J NEUROSCI RES, V90, P1547, DOI 10.1002/jnr.23036; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13	52	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102526	10.1371/journal.pone.0102526	http://dx.doi.org/10.1371/journal.pone.0102526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025521	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400083
J	Liu, ZY; Szarecka, A; Yonkunas, M; Speranskiy, K; Kurnikova, M; Cascio, M				Liu, Zhenyu; Szarecka, Agnieszka; Yonkunas, Michael; Speranskiy, Kirill; Kurnikova, Maria; Cascio, Michael			Crosslinking Constraints and Computational Models as Complementary Tools in Modeling the Extracellular Domain of the Glycine Receptor	PLOS ONE			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTORS; 3-DIMENSIONAL PROTEIN STRUCTURES; MOLECULAR-DYNAMICS SIMULATIONS; LIGAND-BINDING DOMAIN; X-RAY-STRUCTURE; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; M2 SEGMENT; RESOLUTION	The glycine receptor (GlyR), a member of the pentameric ligand-gated ion channel superfamily, is the major inhibitory neurotransmitter-gated receptor in the spinal cord and brainstem. In these receptors, the extracellular domain binds agonists, antagonists and various other modulatory ligands that act allosterically to modulate receptor function. The structures of homologous receptors and binding proteins provide templates for modeling of the ligand-binding domain of GlyR, but limitations in sequence homology and structure resolution impact on modeling studies. The determination of distance constraints via chemical crosslinking studies coupled with mass spectrometry can provide additional structural information to aid in model refinement, however it is critical to be able to distinguish between intra-and inter-subunit constraints. In this report we model the structure of GlyBP, a structural and functional homolog of the extracellular domain of human homomeric alpha 1 GlyR. We then show that intra-and intersubunit Lys-Lys crosslinks in trypsinized samples of purified monomeric and oligomeric protein bands from SDS-polyacrylamide gels may be identified and differentiated by MALDI-TOF MS studies of limited resolution. Thus, broadly available MS platforms are capable of providing distance constraints that may be utilized in characterizing large complexes that may be less amenable to NMR and crystallographic studies. Systematic studies of state-dependent chemical crosslinking and mass spectrometric identification of crosslinked sites has the potential to complement computational modeling efforts by providing constraints that can validate and refine allosteric models.	[Liu, Zhenyu; Cascio, Michael] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Szarecka, Agnieszka; Yonkunas, Michael; Speranskiy, Kirill; Kurnikova, Maria] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [Szarecka, Agnieszka] Grand Valley State Univ, Dept Cell & Mol Biol, Allendale, MI 49401 USA; [Cascio, Michael] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Grand Valley State University; Duquesne University	Cascio, M (corresponding author), Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA.	casciom@duq.edu	Yonkunas, Michael/P-8397-2019; Kurnikova, maria G/H-4510-2017	Yonkunas, Michael/0000-0002-4570-279X; Kurnikova, maria G/0000-0002-8010-8374	NIH grant [R01 NS053788]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053788] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant R01 NS053788. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach A, 2013, J MOL BIOL, V425, P1461, DOI 10.1016/j.jmb.2013.01.027; Back JW, 2003, J MOL BIOL, V331, P303, DOI 10.1016/S0022-2836(03)00721-6; BAUER PI, 1990, BIOCHEM J, V270, P17, DOI 10.1042/bj2700017; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chiara DC, 2009, BIOCHEMISTRY-US, V48, P10066, DOI 10.1021/bi901271w; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dihazi GH, 2003, RAPID COMMUN MASS SP, V17, P2005, DOI 10.1002/rcm.1144; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; Dutertre S, 2012, J BIOL CHEM, V287, P40216, DOI 10.1074/jbc.R112.408229; Forne I, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012088; Grutter T, 2005, CR BIOL, V328, P223, DOI 10.1016/j.crvi.2004.11.004; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2006, J MOL NEUROSCI, V30, P101, DOI 10.1385/JMN:30:1:101; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, CURR OPIN STRUC BIOL, V19, P418, DOI 10.1016/j.sbi.2009.07.006; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horenstein J, 2005, J BIOL CHEM, V280, P1573, DOI 10.1074/jbc.M410881200; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobsen RB, 2006, PROTEIN SCI, V15, P1303, DOI 10.1110/ps.052040406; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Kannan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065610; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Lasker K, 2010, MOL CELL PROTEOMICS, V9, P1689, DOI 10.1074/mcp.R110.000067; Leite JF, 2000, J BIOL CHEM, V275, P13683, DOI 10.1074/jbc.275.18.13683; Leite JF, 2002, BIOCHEMISTRY-US, V41, P6140, DOI 10.1021/bi015895m; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Liu Z, 2008, BIOCHEMISTRY-US, V47, P9803, DOI 10.1021/bi800659x; Lobo IA, 2004, J NEUROCHEM, V90, P962, DOI 10.1111/j.1471-4159.2004.02561.x; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; McCracken LM, 2010, ACS CHEM NEUROSCI, V1, P482, DOI 10.1021/cn100019g; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mouradov Dmitri, 2008, V426, P459, DOI 10.1007/978-1-60327-058-8_31; Nury H, 2010, J MOL BIOL, V395, P1114, DOI 10.1016/j.jmb.2009.11.024; Paramelle D, 2013, PROTEOMICS, V13, P438, DOI 10.1002/pmic.201200305; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pottiez G, 2012, ANAL BIOCHEM, V421, P712, DOI 10.1016/j.ab.2011.12.012; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Rosen A, 2007, BIOPHYS J, V92, P3130, DOI 10.1529/biophysj.106.094490; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Showalter SA, 2007, J CHEM THEORY COMPUT, V3, P961, DOI 10.1021/ct7000045; Sine SM, 2002, J BIOL CHEM, V41, P10472; Sinz A, 2003, J MASS SPECTROM, V38, P1225, DOI 10.1002/JMS.559; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Smit AB, 2003, ANN NY ACAD SCI, V998, P81, DOI 10.1196/annals.1254.010; Smit AB, 2006, J MOL NEUROSCI, V30, P9, DOI 10.1385/JMN:30:1:9; Speranskiy K, 2007, PROTEINS, V67, P950, DOI 10.1002/prot.21251; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trakselis MA, 2005, BIOCONJUGATE CHEM, V16, P741, DOI 10.1021/bc050043a; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WANG D, 1977, BIOCHEMISTRY-US, V16, P2937, DOI 10.1021/bi00632a021; Yamodo IH, 2010, BIOCHEMISTRY-US, V49, P156, DOI 10.1021/bi901550p; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097; Zheng WJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001046	68	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102571	10.1371/journal.pone.0102571	http://dx.doi.org/10.1371/journal.pone.0102571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025226	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000339992400089
J	Sampson, VB; David, JM; Puig, I; Patil, PU; de Herreros, AG; Thomas, GV; Rajasekaran, AK				Sampson, Valerie B.; David, Justin M.; Puig, Isabel; Patil, Pratima U.; Garcia de Herreros, Antonio; Thomas, George V.; Rajasekaran, Ayyappan K.			Wilms' Tumor Protein Induces an Epithelial-Mesenchymal Hybrid Differentiation State in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; SUPPRESSOR GENE; CANCER; WT1; TRANSITIONS; VHL; METASTASIS; NETWORKS; ADHESION	The Wilms' tumor transcription factor (WT1) was originally classified as a tumor suppressor, but it is now known to also be associated with cancer progression and poor prognosis in several malignancies. WT1 plays an essential role in orchestrating a developmental process known as mesenchymal-to-epithelial transition (MET) during kidney development, but also induces the reverse process, epithelial-to-mesenchymal transition (EMT) during heart development. WT1 is not expressed in the adult kidney, but shows elevated expression in clear cell renal cell carcinoma (ccRCC). However, the role of WT1 in this disease has not been characterized. In this study, we demonstrate that WT1 is upregulated in ccRCC cells that are deficient in the expression of the von Hippel-Lindau tumor suppressor protein (VHL). We found that WT1 transcriptionally activated Snail, a master transcriptional repressor that is known to induce EMT. Although Snail represses E-cadherin and induces mesenchymal characteristics, we found partial maintenance of E-cadherin and associated epithelial characteristics in kidney cells and ccRCC cells that express WT1, since WT1 upregulates E-cadherin expression and competes with Snail repression. These findings support a novel paradigm in which WT1 induces an epithelial-mesenchymal hybrid transition (EMHT), characterized by Snail up-regulation with E-cadherin maintenance, a tumor cell differentiation state in which cancer cells keep both EMT and MET characteristics which may promote tumor cell plasticity and tumor progression.	[Sampson, Valerie B.; David, Justin M.; Patil, Pratima U.; Rajasekaran, Ayyappan K.] Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, Wilmington, DE 19803 USA; [David, Justin M.; Patil, Pratima U.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Puig, Isabel; Garcia de Herreros, Antonio] IMIM Inst Hosp Mar Invest Med, Barcelona, Spain; [Thomas, George V.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA	Nemours Alfred I. duPont Hospital for Children; University of Delaware; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Oregon Health & Science University	Rajasekaran, AK (corresponding author), Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, Wilmington, DE 19803 USA.	arakaran687@gmail.com	Sampson, Valerie/AAP-8773-2021; de Herreros, A Garcia/H-3104-2014	de Herreros, A Garcia/0000-0001-5270-0808; David, Justin/0000-0003-2151-605X; Puig Borreil, Isabel/0000-0001-5614-4298; Thomas, George V/0000-0001-7416-8840	NIH [P20GM103464, DK56216]; Nemours Foundation [SAF2010-16089]; NATIONAL CANCER INSTITUTE [R01CA169172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nemours Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grants P20GM103464 (Dr. Thomas Shaffer), DK56216 and the Nemours Foundation (A.K. Rajasekaran), SAF2010-16089 (A.G. de Herreros). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Brett A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-3; Campbell CE, 1998, INT J CANCER, V78, P182, DOI 10.1002/(SICI)1097-0215(19981005)78:2<182::AID-IJC11>3.3.CO;2-D; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Dutton JR, 2006, CELL PROLIFERAT, V39, P519, DOI 10.1111/j.1365-2184.2006.00409.x; Espineda CE, 2004, MOL BIOL CELL, V15, P1364, DOI 10.1091/mbc.E03-09-0646; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Hosono S, 2000, J BIOL CHEM, V275, P10943, DOI 10.1074/jbc.275.15.10943; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; KESSLER PM, 1995, MOL MED, V1, P457, DOI 10.1007/BF03401583; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Linehan WM, 2009, INT J BIOCHEM CELL B, V41, P753, DOI 10.1016/j.biocel.2008.09.024; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Moore AW, 1999, DEVELOPMENT, V126, P1845; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2; Scharnhorst V, 2001, GENE, V273, P141, DOI 10.1016/S0378-1119(01)00593-5; Scholz H, 2005, PHYSIOLOGY, V20, P54, DOI 10.1152/physiol.00048.2004; Scholz H, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00004; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Thiery JP, 2009, B ACAD NAT MED PARIS, V193, P1969, DOI 10.1016/S0001-4079(19)32372-6; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Wagner KD, 2003, FASEB J, V17, P1364, DOI 10.1096/fj.02-1065fje	36	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102041	10.1371/journal.pone.0102041	http://dx.doi.org/10.1371/journal.pone.0102041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025131	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400037
J	Chen, HH; Yu, HI; Cho, WC; Tarn, WY				Chen, H-H; Yu, H-I; Cho, W-C; Tarn, W-Y			DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway	ONCOGENE			English	Article							RNA HELICASE DDX3; PROTEIN; BETA; TRANSLATION; REQUIREMENT; REVEALS; TARGET; GROWTH; YEAST; RAC1	The DEAD-box RNA helicase DDX3 is a versatile protein involved in multiple steps of gene expression and various cellular signaling pathways. DDX3 mutations have been implicated in the wingless (Wnt) type of medulloblastoma. We show here that small interfering RNA-mediated DDX3 knockdown in various cell lines increased cell-cell adhesion but decreased cell-extracellular matrix adhesion. Moreover, DDX3 depletion suppressed cell motility and impaired directional migration in the wound-healing assay. Accordingly, DDX3-depleted cells exhibited reduced invasive capacities in vitro as well as reduced metastatic potential in mice. We also examined the mechanism underlying DDX3-regulated cell migration. DDX3 knockdown reduced the levels of both Rac1 and beta-catenin proteins, and consequentially downregulated the expression of several beta-catenin target genes. Moreover, we demonstrated that DDX3-regulated Rac1 mRNA translation, possibly through an interaction with its 5'-untranslated region, and affected beta-catenin protein stability in an Rac1-dependent manner. Taken together, our results indicate the DDX3-Rac1-beta-catenin regulatory axis in modulating the expression of Wnt/beta-catenin target genes. Therefore, this report provides a mechanistic context for the role of DDX3 in Wnt-type tumors.	[Chen, H-H; Yu, H-I; Cho, W-C; Tarn, W-Y] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	Academia Sinica - Taiwan	Tarn, WY (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	wtarn@ibms.sinica.edu.tw	Tarn, Woan-Yuh/N-8464-2018		National Health Research Institutes of Taiwan [NHRI-EX101-10046NI]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan)	We thank Dr Yi-Shing Shieh for the TOPflash and FOPflash vectors, and Cho-Ying Chiang for technical assistance. This work was supported by a grant (NHRI-EX101-10046NI to WYT) from the National Health Research Institutes of Taiwan.	Akhtar N, 2001, MOL BIOL CELL, V12, P847, DOI 10.1091/mbc.12.4.847; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Chen BD, 2011, CELL MOL NEUROBIOL, V31, P251, DOI 10.1007/s10571-010-9615-8; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Fukumura J, 2003, J BIOCHEM, V134, P71, DOI 10.1093/jb/mvg126; Grallert B, 2000, J CELL SCI, V113, P1447; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Huang JS, 2004, BIOCHEM BIOPH RES CO, V315, P950, DOI 10.1016/j.bbrc.2004.01.151; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kang DW, 2010, CANCER RES, V70, P4233, DOI 10.1158/0008-5472.CAN-09-3470; Koshio J, 2013, CANCER IMMUNOL IMMUN, V62, P1619, DOI 10.1007/s00262-013-1467-x; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; Lai MC, 2010, MOL CELL BIOL, V30, P5444, DOI 10.1128/MCB.00560-10; Lee CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-64; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Marsden S, 2006, J MOL BIOL, V361, P327, DOI 10.1016/j.jmb.2006.06.016; Miao XY, 2013, INT J CLIN EXP PATHO, V6, P179; Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Soto-Rifo R, 2013, NUCLEIC ACIDS RES, V41, P6286, DOI 10.1093/nar/gkt306; Soto-Rifo R, 2012, EMBO J, V31, P3745, DOI 10.1038/emboj.2012.220; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Sun MN, 2011, BBA-MOL CELL RES, V1813, P438, DOI 10.1016/j.bbamcr.2011.01.003; Tarn WY, 2009, RNA BIOL, V6, P17, DOI 10.4161/rna.6.1.7440; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Wu DW, 2014, ONCOGENE, V33, P1515, DOI 10.1038/onc.2013.107; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zavarella S, 2009, J NEUROSURG-PEDIATR, V4, P97, DOI 10.3171/2009.4.PEDS08322; Zhu G, 2012, ONCOGENE, V31, P1001, DOI 10.1038/onc.2011.294	37	85	89	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2015	34	21					2790	2800		10.1038/onc.2014.190	http://dx.doi.org/10.1038/onc.2014.190			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI7XN	25043297				2022-12-25	WOS:000354979500011
J	Ng, KY; Yin, T; Machida, K; Wu, YI; Mayer, BJ				Ng, K. Y.; Yin, T.; Machida, K.; Wu, Y. I.; Mayer, B. J.			Phosphorylation of Dok1 by Abl family kinases inhibits CrkI transforming activity	ONCOGENE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; FACTOR-INDUCED ACTIVATION; PROTEIN-TYROSINE KINASE; PROLINE-RICH SEQUENCES; V-CRK; ADAPTER PROTEIN; CELL-MIGRATION; NEGATIVE REGULATION; MOLECULAR RESPONSE; DOCKING PROTEIN	The Crk SH2/SH3 adaptor and the Abl nonreceptor tyrosine kinase were first identified as oncoproteins, and both can induce tumorigenesis when overexpressed or mutationally activated. We previously reported the surprising finding that inhibition or knockdown of Abl family kinases enhanced transformation of mouse fibroblasts by CrkI. Abl family inhibitors are currently used or are being tested for treatment of human malignancies, and our finding raised concerns that such inhibitors might actually promote the growth of tumors overexpressing CrkI. Here, we identify the Dok1 adaptor as the key effector for the enhancement of CrkI transformation by Abl inhibition. We show that phosphorylation of tyrosines 295 and 361 of Dok1 by Abl family kinases suppresses CrkI transforming activity, and that upon phosphorylation these tyrosines bind the SH2 domains of the Ras inhibitor p120 RasGAP. Knockdown of RasGAP resulted in a similar enhancement of CrkI transformation, consistent with a critical role for Ras activity. Imaging studies using a FRET sensor of Ras activation revealed alterations in the localization of activated Ras in CrkI-transformed cells. Our results support a model in which Dok1 phosphorylation normally suppresses localized Ras pathway activity in Crk-transformed cells via recruitment and/or activation of RasGAP, and that preventing this negative feedback mechanism by inhibiting Abl family kinases leads to enhanced transformation by Crk.	[Ng, K. Y.; Machida, K.; Mayer, B. J.] Univ Connecticut, Ctr Hlth, Raymond & Beverly Sackler Lab Genet & Mol Med, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Yin, T.; Wu, Y. I.; Mayer, B. J.] Univ Connecticut, Ctr Hlth, Richard D Berlin Ctr Cell Anal & Modeling, Dept Genet & Dev Biol, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Mayer, BJ (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	bmayer@uchc.edu			National Institutes of Health [CA82258, NS071216]; NATIONAL CANCER INSTITUTE [R01CA082258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Sofya Borinskaya for technical help in soft agar colony counting, Mari Ogiue-Ikeda for the preparation of the SH2 probes and Joshua Jadwin for critically reading this manuscript. In addition, we greatly appreciate Pier Paolo Pandolfi from Harvard Medical School for generously providing the human Dok1 cDNA. This study was supported by grants CA82258 (to BJM) and NS071216 (to YIW) from the National Institutes of Health.	ABELSON HT, 1970, CANCER RES, V30, P2213; Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; Akin C, 2004, BLOOD, V103, P3222, DOI 10.1182/blood-2003-11-3816; Allington TM, 2009, FASEB J, V23, P4231, DOI 10.1096/fj.09-138412; Apperley JF, 2002, NEW ENGL J MED, V347, P481, DOI 10.1056/NEJMoa020150; Ashman LK, 2013, EXPERT OPIN INV DRUG, V22, P103, DOI 10.1517/13543784.2013.740010; Bell Emily S, 2012, Genes Cancer, V3, P341, DOI 10.1177/1947601912459951; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Berger AH, 2010, NAT GENET, V42, P216, DOI 10.1038/ng.527; BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; deJong R, 1997, ONCOGENE, V14, P507, DOI 10.1038/sj.onc.1200885; Downey C, 2008, CELL MOL LIFE SCI, V65, P1446, DOI 10.1007/s00018-008-8038-x; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Gil-Henn H, 2013, ONCOGENE, V32, P2622, DOI 10.1038/onc.2012.284; Greulich H, 1996, CELL GROWTH DIFFER, V7, P1443; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Hodgson L., 2010, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb1411s46, DOI 10.1002/0471143030.CB1411S46]; Hughes TP, 2014, BLOOD, V123, P1353, DOI 10.1182/blood-2013-06-510396; Kain KH, 2003, ONCOGENE, V22, P6071, DOI 10.1038/sj.onc.1206930; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Lambert MP, 2011, J HEPATOL, V54, P705, DOI 10.1016/j.jhep.2010.07.027; Lee S, 2004, ONCOGENE, V23, P2287, DOI 10.1038/sj.onc.1207385; Linghu H, 2006, ONCOGENE, V25, P3547, DOI 10.1038/sj.onc.1209398; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; Mashima R, 2010, LAB INVEST, V90, P1357, DOI 10.1038/labinvest.2010.121; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; MATSUDA M, 1994, MOL CELL BIOL, V14, P5495, DOI 10.1128/MCB.14.8.5495; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; MAYER BJ, 1990, J VIROL, V64, P3581, DOI 10.1128/JVI.64.8.3581-3589.1990; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Mihrshahi R, 2009, J IMMUNOL, V183, P4879, DOI 10.4049/jimmunol.0901531; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nelms K, 1998, GENOMICS, V53, P243, DOI 10.1006/geno.1998.5514; Neuzillet C, 2014, PHARMACOL THERAPEUT, V141, P160, DOI 10.1016/j.pharmthera.2013.10.001; Niki M, 2004, J EXP MED, V200, P1689, DOI 10.1084/jem.20041306; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Reichardt P, 2011, CURR CANCER DRUG TAR, V11, P688, DOI 10.2174/156800911796191042; REICHMAN CT, 1992, CELL GROWTH DIFFER, V3, P451; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; Rodrigues SP, 2005, MOL CANCER RES, V3, P183; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Saulnier A, 2012, INT J CANCER, V130, P2484, DOI 10.1002/ijc.26299; Scheffzek K, 2001, STRUCTURE, V9, P1043, DOI 10.1016/S0969-2126(01)00674-8; Senechal K, 1998, MOL CELL BIOL, V18, P5082, DOI 10.1128/MCB.18.9.5082; Shinohara H, 2004, GENES CELLS, V9, P601, DOI 10.1111/j.1356-9597.2004.00748.x; Songyang Z, 2001, J BIOL CHEM, V276, P2459, DOI 10.1074/jbc.M005504200; Sriram Ganapathy, 2010, Genes Cancer, V1, P1132, DOI 10.1177/1947601910397188; Takino T, 2003, CANCER RES, V63, P2335; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; TENHOEVE J, 1993, ONCOGENE, V8, P2469; Wagner MJ, 2013, COLD SPRING HARB PER, V5; Wang BL, 1996, ONCOGENE, V13, P1379; Watanabe T, 2009, CELL RES, V19, P638, DOI 10.1038/cr.2009.40; White D, 2005, BLOOD, V106, P2520, DOI 10.1182/blood-2005-03-1103; Yamanashi Y, 2000, GENE DEV, V14, P11; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yasuda T, 2004, J EXP MED, V200, P1681, DOI 10.1084/jem.20041247; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015; Yip SC, 2007, J CELL SCI, V120, P3138, DOI 10.1242/jcs.005298; Zheng J, 2010, ONCOGENE, V29, P6378, DOI 10.1038/onc.2010.369; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	68	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2015	34	20					2650	2659		10.1038/onc.2014.210	http://dx.doi.org/10.1038/onc.2014.210			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI1YN	25043303	Green Accepted			2022-12-25	WOS:000354541300011
J	Emptage, RP; Tonthat, NK; York, JD; Schumacher, MA; Zhou, P				Emptage, Ryan P.; Tonthat, Nam K.; York, John D.; Schumacher, Maria A.; Zhou, Pei			Structural Basis of Lipid Binding for the Membrane-embedded Tetraacyldisaccharide-1-phosphate 4 '-Kinase LpxK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme; Lipid A; Lipid-binding Protein; Lipopolysaccharide (LPS); Membrane Protein; Antibiotic; Lipid Kinase	ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; SUBSTRATE RECOGNITION; LIPOPOLYSACCHARIDE; ENDOTOXIN; KINASE; CLASSIFICATION; BIOSYNTHESIS; PRECURSOR; PROTEINS	Background: LpxK is an essential membrane-bound kinase in the lipid A biosynthetic pathway. Results: Structural and kinetic studies reveal the molecular basis of lipid binding. Conclusion: The LpxK active site recognizes the lipid's glucosamine/phosphate headgroups and only accommodates disaccharides. Significance: These studies provide a structural template for designing novel antibiotics and a glimpse of catalysis at the membrane interface. The membrane-bound tetraacyldisaccharide-1-phosphate 4-kinase, LpxK, catalyzes the sixth step of the lipid A (Raetz) biosynthetic pathway and is a viable antibiotic target against emerging Gram-negative pathogens. We report the crystal structure of lipid IVA, the LpxK product, bound to the enzyme, providing a rare glimpse into interfacial catalysis and the surface scanning strategy by which many poorly understood lipid modification enzymes operate. Unlike the few previously structurally characterized proteins that bind lipid A or its precursors, LpxK binds almost exclusively to the glucosamine/phosphate moieties of the lipid molecule. Steady-state kinetic analysis of multiple point mutants of the lipid-binding pocket pinpoints critical residues involved in substrate binding, and characterization of N-terminal helix truncation mutants uncovers the role of this substructure as a hydrophobic membrane anchor. These studies make critical contributions to the limited knowledge surrounding membrane-bound enzymes that act upon lipid substrates and provide a structural template for designing small molecule inhibitors targeting this essential kinase.	[Emptage, Ryan P.; Tonthat, Nam K.; Schumacher, Maria A.; Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [York, John D.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37205 USA	Duke University; Vanderbilt University	Zhou, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, POB 3711, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416	National Institutes of Health Grant [GM-51310, AI-055588]; United States Department of Energy, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280, R01GM051310] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-51310 (to C. R. H. R. and P. Z.) and AI-055588 (to P. Z.). Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, and the Office of Basic Energy Sciences under Contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chung HS, 2010, BIOCHEMISTRY-US, V49, P4126, DOI 10.1021/bi100343e; Emptage RP, 2013, BIOCHEMISTRY-US, V52, P2280, DOI 10.1021/bi400097z; Emptage RP, 2012, P NATL ACAD SCI USA, V109, P12956, DOI 10.1073/pnas.1206072109; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Garrett TA, 1998, J BIOL CHEM, V273, P12457, DOI 10.1074/jbc.273.20.12457; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; Huang CY, 2012, P NATL ACAD SCI USA, V109, P6496, DOI 10.1073/pnas.1203900109; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Lavogina D, 2010, CHEMMEDCHEM, V5, P23, DOI 10.1002/cmdc.200900252; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; Mamat U, 2009, J BIOL CHEM, V284, P22248, DOI 10.1074/jbc.M109.033308; Metzger LE, 2012, NAT STRUCT MOL BIOL, V19, P1132, DOI 10.1038/nsmb.2393; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Plotz BM, 2000, J BIOL CHEM, V275, P11222, DOI 10.1074/jbc.275.15.11222; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAY BL, 1987, J BIOL CHEM, V262, P1122; Sambrook J., 2001, MOL CLONING LAB MANU; Stahelin RV, 2009, J LIPID RES, V50, pS299, DOI 10.1194/jlr.R800078-JLR200; Tresaugues L, 2014, STRUCTURE, V22, P744, DOI 10.1016/j.str.2014.01.013; Wang Z, 2013, STRUCTURE, V21, P798, DOI 10.1016/j.str.2013.02.025; Yoon SI, 2010, P NATL ACAD SCI USA, V107, P10990, DOI 10.1073/pnas.1004153107	37	8	8	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24059	24068		10.1074/jbc.M114.589986	http://dx.doi.org/10.1074/jbc.M114.589986			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023290	Green Published, hybrid			2022-12-25	WOS:000341505600006
J	Kaya, AI; Lokits, AD; Gilbert, JA; Iverson, TM; Meiler, J; Hamm, HE				Kaya, Ali I.; Lokits, Alyssa D.; Gilbert, James A.; Iverson, Tina M.; Meiler, Jens; Hamm, Heidi E.			A Conserved Phenylalanine as a Relay between the alpha 5 Helix and the GDP Binding Region of Heterotrimeric G(i) Protein alpha Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; G Protein-coupled Receptor (GPCR); Heterotrimeric G Protein; Protein Conformation; Rhodopsin; Signal Transduction; GDP Release	CRYSTAL-STRUCTURE; BETA-GAMMA; NUCLEOTIDE EXCHANGE; RECEPTOR; ACTIVATION; G(I-ALPHA-1); TRANSDUCIN; RHODOPSIN; MODEL; GTP	Background: GPCRs regulate heterotrimeric G protein activation. However, the intermediate steps regulating GDP release are still unknown. Results: Energy analysis pinpoints information flow through G-receptor interaction and GDP release. Conclusion: Hydrophobic interactions around 5 helix, 2-3 strands, and 1 helix are key for GDP stability. Significance: G protein activation defines regulation of high affinity receptor interactions and plays a role defining different cellular responses. G protein activation by G protein-coupled receptors is one of the critical steps for many cellular signal transduction pathways. Previously, we and other groups reported that the 5 helix in the G protein subunit plays a major role during this activation process. However, the precise signaling pathway between the 5 helix and the guanosine diphosphate (GDP) binding pocket remains elusive. Here, using structural, biochemical, and computational techniques, we probed different residues around the 5 helix for their role in signaling. Our data showed that perturbing the Phe-336 residue disturbs hydrophobic interactions with the 2-3 strands and 1 helix, leading to high basal nucleotide exchange. However, mutations in strands 5 and 6 do not perturb G protein activation. We have highlighted critical residues that leverage Phe-336 as a relay. Conformational changes are transmitted starting from Phe-336 via 2-3/1 to Switch I and the phosphate binding loop, decreasing the stability of the GDP binding pocket and triggering nucleotide release. When the 1 and 5 helices were cross-linked, inhibiting the receptor-mediated displacement of the C-terminal 5 helix, mutation of Phe-336 still leads to high basal exchange rates. This suggests that unlike receptor-mediated activation, helix 5 rotation and translocation are not necessary for GDP release from the subunit. Rather, destabilization of the backdoor region of the G subunit is sufficient for triggering the activation process.	[Kaya, Ali I.; Gilbert, James A.; Iverson, Tina M.; Meiler, Jens; Hamm, Heidi E.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Lokits, Alyssa D.] Vanderbilt Univ, Med Ctr, Dept Neurosci, Nashville, TN 37232 USA; [Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Meiler, Jens] Vanderbilt Univ, Med Ctr, Dept Chem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Hamm, HE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 442 Robinson Res Bldg, Nashville, TN 37232 USA.	Heidi.hamm@vanderbilt.edu	Hamm, Heidi E/G-2374-2014	Meiler, Jens/0000-0001-8945-193X	National Institutes of Health [EY006062, GM095633, GM080403, MH090192, GM099842, DK097376, S10 RR026915]; National Institutes of Science [BIO Career 0742762, CHE 1305874]; U.S. Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026915] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099842, R01GM080403, R01GM095633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090192] Funding Source: NIH RePORTER; Division Of Chemistry [1305874] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY006062 (to H. E. H.); GM095633 (to T. M. I.); GM080403, MH090192, GM099842, and DK097376 (to J. M.); and S10 RR026915 (to Vanderbilt Robotic Crystallization Facility). This work was also supported by National Institutes of Science Grants BIO Career 0742762 and CHE 1305874 (to J. M.), U.S. Department of Energy Contract DE-AC02-06CH11357, funds from the Michigan Economic Development Corporation, and Michigan Technology Tri-Corridor Grant 085P1000817.	Abdulaev NG, 2005, J BIOL CHEM, V280, P38071, DOI 10.1074/jbc.M505259200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexander NS, 2014, NAT STRUCT MOL BIOL, V21, P56, DOI 10.1038/nsmb.2705; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Ceruso MA, 2004, J MOL BIOL, V338, P469, DOI 10.1016/j.jmb.2004.02.064; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; Coleman DE, 1998, BIOCHEMISTRY-US, V37, P14376, DOI 10.1021/bi9810306; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst OP, 2000, METHOD ENZYMOL, V315, P471; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; Johnston CA, 2008, PLANT SIGNAL BEHAV, V3, P1067, DOI 10.4161/psb.3.12.7184; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Louet M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002595; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; Marin EP, 2001, J BIOL CHEM, V276, P23873, DOI 10.1074/jbc.M101197200; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; Medkova M, 2002, BIOCHEMISTRY-US, V41, P9962, DOI 10.1021/bi0255726; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Oldham WM, 2007, ADV PROTEIN CHEM, V74, P67, DOI 10.1016/S0065-3233(07)74002-0; Oldham WM, 2007, P NATL ACAD SCI USA, V104, P7927, DOI 10.1073/pnas.0702623104; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Preininger AM, 2009, BIOCHEMISTRY-US, V48, P2630, DOI 10.1021/bi801853a; QUILLIAM LA, 1995, P NATL ACAD SCI USA, V92, P1272, DOI 10.1073/pnas.92.5.1272; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rondard P, 2001, P NATL ACAD SCI USA, V98, P6150, DOI 10.1073/pnas.101136198; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHMIDT CJ, 1992, J BIOL CHEM, V267, P13807; Schubbert S, 2007, MOL CELL BIOL, V27, P7765, DOI 10.1128/MCB.00965-07; Sovik O, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049361; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Thaker TM, 2012, METHODS MOL BIOL, V796, P133, DOI 10.1007/978-1-61779-334-9_8; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	53	33	35	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24475	24487		10.1074/jbc.M114.572875	http://dx.doi.org/10.1074/jbc.M114.572875			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25037222	Green Published, hybrid			2022-12-25	WOS:000341505600040
J	Lin, A; Man, HY				Lin, Amy; Man, Heng-Ye			Endocytic Adaptor Epidermal Growth Factor Receptor Substrate 15 (Eps15) Is Involved in the Trafficking of Ubiquitinated alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Protein; -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor (AMPA receptor; AMPAR); Receptor Internalization; Trafficking; Ubiquitylation (Ubiquitination); EPS15; Nedd4	ACTIVITY-DEPENDENT UBIQUITINATION; HOMEOSTATIC REGULATION; GLUTAMATE RECEPTORS; TERMINAL DOMAIN; AMPA RECEPTORS; DEGRADATION; DETERMINANTS; ABUNDANCE; PATHWAYS; BINDING	Background: AMPAR trafficking plays an important role in synaptic plasticity, but how ubiquitinated AMPARs internalize remains largely unknown. Results: The endocytic adaptor EPS15 interacts with ubiquitinated AMPARs and facilitates receptor internalization. Conclusion: EPS15 is required for the internalization of ubiquitinated AMPARs. Significance: Selective targeting of a distinct pool of surface AMPARs for internalization provides novel insights into the mechanisms of synaptic regulation. AMPA-type glutamate receptors (AMPARs) play a critical role in mediating fast excitatory synaptic transmission in the brain. Alterations in receptor expression, distribution, and trafficking have been shown to underlie synaptic plasticity and higher brain functions, including learning and memory, as well as brain dysfunctions such as drug addiction and psychological disorders. Therefore, it is essential to elucidate the molecular mechanisms that regulate AMPAR dynamics. We have shown previously that mammalian AMPARs are subject to posttranslational modification by ubiquitin, with AMPAR ubiquitination enhancing receptor internalization and reducing AMPAR cell surface expression. Here we report a crucial role for epidermal growth factor receptor substrate 15 (Eps15), an endocytic adaptor, in ubiquitination-dependent AMPAR internalization. We find that suppression or overexpression of Eps15 results in changes in AMPAR surface expression. Eps15 interacts with AMPARs, which requires Nedd4-mediated GluA1 ubiquitination and the ubiquitin-interacting motif of Eps15. Importantly, we find that Eps15 plays an important role in AMPAR internalization. Knockdown of Eps15 suppresses the internalization of GluA1 but not the mutant GluA1 that lacks ubiquitination sites, indicating a role of Eps15 for the internalization of ubiquitinated AMPARs. These results reveal a novel molecular mechanism employed specifically for the trafficking of the ubiquitin-modified AMPARs.	[Lin, Amy; Man, Heng-Ye] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Man, HY (corresponding author), Dept Biol, 5 Cummington Mall, Boston, MA 02115 USA.	hman@bu.edu			National Institutes of Health [MH 079407]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH 079407 (to H. Y.M.).	Aguilar RC, 2005, P NATL ACAD SCI USA, V102, P2679, DOI 10.1073/pnas.0500213102; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 1995, J CELL BIOL, V131, P1831, DOI 10.1083/jcb.131.6.1831; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Bingol B, 2004, NEUROPHARMACOLOGY, V47, P755, DOI 10.1016/j.neuropharm.2004.07.028; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chi S, 2008, MOL BIOL CELL, V19, P3564, DOI 10.1091/mbc.E07-10-0997; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; Henegouwen PMPVE, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-24; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Hou QM, 2011, NEURON, V72, P806, DOI 10.1016/j.neuron.2011.10.011; Jarzylo LA, 2012, J NEUROSCI, V32, P2552, DOI 10.1523/JNEUROSCI.3237-11.2012; Kastning K, 2007, P NATL ACAD SCI USA, V104, P2991, DOI 10.1073/pnas.0611170104; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kowalski JR, 2011, J NEUROSCI, V31, P1341, DOI 10.1523/JNEUROSCI.4765-10.2011; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lin A, 2011, J NEUROCHEM, V119, P27, DOI 10.1111/j.1471-4159.2011.07221.x; Lussier MP, 2011, J NEUROSCI, V31, P3077, DOI 10.1523/JNEUROSCI.5944-10.2011; Madshus IH, 2006, TRAFFIC, V7, P258, DOI 10.1111/j.1600-0854.2006.00393.x; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Schwarz LA, 2010, J NEUROSCI, V30, P16718, DOI 10.1523/JNEUROSCI.3686-10.2010; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang G, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/825364	42	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24652	24664		10.1074/jbc.M114.582114	http://dx.doi.org/10.1074/jbc.M114.582114			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023288	hybrid, Green Published			2022-12-25	WOS:000341505600055
J	Yuyama, K; Sun, H; Sakai, S; Mitsutake, S; Okada, M; Tahara, H; Furukawa, J; Fujitani, N; Shinohara, Y; Igarashi, Y				Yuyama, Kohei; Sun, Hui; Sakai, Shota; Mitsutake, Susumu; Okada, Megumi; Tahara, Hidetoshi; Furukawa, Jun-ichi; Fujitani, Naoki; Shinohara, Yasuro; Igarashi, Yasuyuki			Decreased Amyloid-beta Pathologies by Intracerebral Loading of Glycosphingolipid-enriched Exosomes in Alzheimer Model Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid- (AB); Exosome; Glycolipid; Microglia	CELLULAR GLYCOMICS; ALPHA-SYNUCLEIN; GM1 GANGLIOSIDE; MOUSE MODEL; IN-VIVO; PROTEIN; DISEASE; BRAIN; ACCUMULATION; CELLS	Background: Exosome, a type of extracellular vesicles, can associate with A in vitro. Results: Intracerebrally injected exosomes trapped A on surface glycosphingolipids and transported it into microglia in AD mouse brains, resulting in reductions in A pathology. Conclusion: Exogenous exosomes act as potent scavengers for A in mouse brains. Significance: The findings provide a novel therapeutic approach for AD. Elevated levels of amyloid- peptide (A) in the human brain are linked to the pathogenesis of Alzheimer disease. Recent in vitro studies have demonstrated that extracellular A can bind to exosomes, which are cell-secreted nanovesicles with lipid membranes that are known to transport their cargos intercellularly. Such findings suggest that the exosomes are involved in A metabolism in brain. Here, we found that neuroblastoma-derived exosomes exogenously injected into mouse brains trapped A and with the associated A were internalized into brain-resident phagocyte microglia. Accordingly, continuous intracerebral administration of the exosomes into amyloid- precursor protein transgenic mice resulted in marked reductions in A levels, amyloid depositions, and A-mediated synaptotoxicity in the hippocampus. In addition, we determined that glycosphingolipids (GSLs), a group of membrane glycolipids, are highly abundant in the exosomes, and the enriched glycans of the GSLs are essential for A binding and assembly on the exosomes both in vitro and in vivo. Our data demonstrate that intracerebrally administered exosomes can act as potent scavengers for A by carrying it on the exosome surface GSLs and suggest a role of exosomes in A clearance in the central nervous system. Improving A clearance by exosome administration would provide a novel therapeutic intervention for Alzheimer disease.	[Yuyama, Kohei; Sun, Hui; Sakai, Shota; Mitsutake, Susumu; Igarashi, Yasuyuki] Hokkaido Univ, Grad Sch Adv Life Sci, Lab Biomembrane & Biofunct Chem, Sapporo, Hokkaido 0010021, Japan; [Yuyama, Kohei; Sun, Hui; Sakai, Shota; Mitsutake, Susumu; Furukawa, Jun-ichi; Fujitani, Naoki; Shinohara, Yasuro; Igarashi, Yasuyuki] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido 0010021, Japan; [Mitsutake, Susumu] Saga Univ, Dept Appl Biochem & Food Sci, Fac Agr, Saga 8408502, Japan; [Okada, Megumi; Tahara, Hidetoshi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cellular & Mol Biol, Hiroshima 7348553, Japan; [Furukawa, Jun-ichi; Fujitani, Naoki; Shinohara, Yasuro] Hokkaido Univ, Grad Sch Adv Life Sci, Lab Med & Funct Glyc, Sapporo, Hokkaido 0010021, Japan	Hokkaido University; Hokkaido University; Saga University; Hiroshima University; Hokkaido University	Igarashi, Y (corresponding author), Hokkaido Univ, Grad Sch Adv Life Sci, Lab Biomembrane & Biofunct Chem, Kita21 Nishi11, Sapporo, Hokkaido 000021, Japan.	yigarash@pharm.hokudai.ac.jp	Tahara, Hidetoshi/G-7697-2019; Mitsutake, Susumu/A-4082-2012	Fujitani, Naoki/0000-0002-4035-7317	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [221S0001, 26440041] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Part of this work was conducted at Hokkaido University, supported by "Nanotechnology Platform" Program of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110; Fujitani N, 2011, J BIOL CHEM, V286, P41669, DOI 10.1074/jbc.M111.301796; Grapp M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3123; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Keilani S, 2012, J NEUROSCI, V32, P5223, DOI 10.1523/JNEUROSCI.4860-11.2012; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Sanghera N, 2011, CHEM BIOL, V18, P1422, DOI 10.1016/j.chembiol.2011.08.016; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Takata K, 2007, EUR J NEUROSCI, V26, P2458, DOI 10.1111/j.1460-9568.2007.05852.x; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Utsumi M, 2009, GLYCOCONJUGATE J, V26, P999, DOI 10.1007/s10719-008-9216-7; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Xu YH, 2010, J LIPID RES, V51, P1643, DOI 10.1194/jlr.R003996; Yanagisawa K, 2002, ANN NY ACAD SCI, V977, P384, DOI 10.1111/j.1749-6632.2002.tb04841.x; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Yuyama K, 2010, NEUROSCI LETT, V481, P168, DOI 10.1016/j.neulet.2010.06.080; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164	42	200	205	4	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24488	24498		10.1074/jbc.M114.577213	http://dx.doi.org/10.1074/jbc.M114.577213			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25037226	hybrid, Green Published			2022-12-25	WOS:000341505600041
J	Brown, PA; Lemaitre, E; Briand, FX; Courtillon, C; Guionie, O; Allee, C; Toquin, D; Bayon-Auboyer, MH; Jestin, V; Eterradossi, N				Brown, Paul A.; Lemaitre, Evelyne; Briand, Francois-Xavier; Courtillon, Celine; Guionie, Olivier; Allee, Chantal; Toquin, Didier; Bayon-Auboyer, Marie-Helene; Jestin, Veronique; Eterradossi, Nicolas			Molecular Comparisons of Full Length Metapneumovirus (MPV) Genomes, Including Newly Determined French AMPV-C and -D Isolates, Further Supports Possible Subclassification within the MPV Genus	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; TURKEY RHINOTRACHEITIS VIRUS; SMALL HYDROPHOBIC PROTEIN; AVIAN-METAPNEUMOVIRUS; FUSION PROTEIN; SUBGROUP-C; SUBTYPE-C; GLYCOPROTEIN GENE; IN-VITRO; ATTACHMENT GLYCOPROTEIN	Four avian metapneumovirus (AMPV) subgroups (A-D) have been reported previously based on genetic and antigenic differences. However, until now full length sequences of the only known isolates of European subgroup C and subgroup D viruses (duck and turkey origin, respectively) have been unavailable. These full length sequences were determined and compared with other full length AMPV and human metapneumoviruses (HMPV) sequences reported previously, using phylogenetics, comparisons of nucleic and amino acid sequences and study of codon usage bias. Results confirmed that subgroup C viruses were more closely related to HMPV than they were to the other AMPV subgroups in the study. This was consistent with previous findings using partial genome sequences. Closer relationships between AMPV-A, B and D were also evident throughout the majority of results. Three metapneumovirus "clusters'' HMPV, AMPV-C and AMPV-A, B and D were further supported by codon bias and phylogenetics. The data presented here together with those of previous studies describing antigenic relationships also between AMPV-A, B and D and between AMPV-C and HMPV may call for a subclassification of metapneumoviruses similar to that used for avian paramyxoviruses, grouping AMPV-A, B and D as type I metapneumoviruses and AMPV-C and HMPV as type II.	[Brown, Paul A.; Lemaitre, Evelyne; Briand, Francois-Xavier; Courtillon, Celine; Guionie, Olivier; Allee, Chantal; Toquin, Didier; Bayon-Auboyer, Marie-Helene; Jestin, Veronique; Eterradossi, Nicolas] Univ Europeenne Bretagne, French Agcy Food Environm & Occupat Hlth Safety A, Avian & Rabbit Virol Immunol & Parasitol Unit VIP, Ploufragan Plouzane Lab, Ploufragan, France	Universite de Bretagne Occidentale	Brown, PA (corresponding author), Univ Europeenne Bretagne, French Agcy Food Environm & Occupat Hlth Safety A, Avian & Rabbit Virol Immunol & Parasitol Unit VIP, Ploufragan Plouzane Lab, Ploufragan, France.	Paul.brown@anses.fr		Courtillon, Celine/0000-0002-3006-764X; BRIAND, Francois-Xavier/0000-0002-8094-9368	Regional Council of Brittany (Region Bretagne) SAD METABE 7160 programme; Departement des Cotes d'Armor	Regional Council of Brittany (Region Bretagne) SAD METABE 7160 programme(Region Bretagne); Departement des Cotes d'Armor(Region Bretagne)	Regional Council of Brittany (Region Bretagne) SAD METABE 7160 programme and of Departement des Cotes d'Armor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez R, 2004, VIRUS RES, V105, P67, DOI 10.1016/j.virusres.2004.04.019; Bao XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062568; Bao XY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000077; Bayon-Auboyer MH, 2000, J GEN VIROL, V81, P2723, DOI 10.1099/0022-1317-81-11-2723; Bayon-Auboyer MH, 1999, ARCH VIROL, V144, P1091, DOI 10.1007/s007050050572; Bennett RS, 2005, J VIROL, V79, P14834, DOI 10.1128/JVI.79.23.14834-14842.2005; Bennett RS, 2004, AVIAN DIS, V48, P902, DOI 10.1637/7208-051804R; Biacchesi S, 2005, J VIROL, V79, P12608, DOI 10.1128/JVI.79.19.12608-12613.2005; Boere G., 2006, FLYWAY CONCEPT WHAT; Brown PA, 2013, J VIROL METHODS, V193, P121, DOI 10.1016/j.jviromet.2013.05.007; Brown PA, 2009, VIRUS RES, V146, P13, DOI 10.1016/j.virusres.2009.08.009; Buys S.B., 1980, TURKEYS, P36; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Catelli E, 2006, VACCINE, V24, P6476, DOI 10.1016/j.vaccine.2006.06.076; Chockalingam AK, 2010, AVIAN DIS, V54, P915, DOI 10.1637/9016-081909-RESNOTE.1; Clubbe J, 2011, VACCINE, V29, P9493, DOI 10.1016/j.vaccine.2011.10.024; Collins P., 2001, RESP SYNCYTIAL VIRUS; Cook JKA, 2000, VET J, V160, P118, DOI 10.1053/tvjl.2000.0486; Cook JKA, 1999, AVIAN PATHOL, V28, P607, DOI 10.1080/03079459994407; Cox RG, 2012, J VIROL, V86, P12148, DOI 10.1128/JVI.01133-12; Crowe James E Jr, 2004, Pediatr Infect Dis J, V23, pS215, DOI 10.1097/01.inf.0000144668.81573.6d; de Almeida RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076413; de Graaf M, 2009, J GEN VIROL; de Graaf M, 2008, J GEN VIROL, V89, P2933, DOI 10.1099/vir.0.2008/006957-0; de Graaf M, 2008, J GEN VIROL, V89, P975, DOI 10.1099/vir.0.83537-0; de Graaf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058572; Deng QJ, 2011, VIRUS RES, V160, P102, DOI 10.1016/j.virusres.2011.05.020; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Dolganiuc V, 2003, J VIROL, V77, P12968, DOI 10.1128/JVI.77.24.12968-12979.2003; Easton AJ, 2004, CLIN MICROBIOL REV, V17, P390, DOI 10.1128/CMR.17.2.390-412.2004; Easton AJ, 1997, VIRUS RES, V48, P27, DOI 10.1016/S0168-1702(96)01430-X; Esperante SA, 2013, BIOCHEMISTRY-US, V52, P6779, DOI 10.1021/bi401029q; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; GIRAUD P, 1986, VET REC, V119, P606; Govindarajan D, 2005, VIRUS GENES, V30, P331, DOI 10.1007/s11262-005-6775-6; Govindarajan D, 2004, J GEN VIROL, V85, P3671, DOI 10.1099/vir.0.80400-0; Govindarajan D, 2004, VIRUS RES, V105, P59, DOI 10.1016/j.virusres.2004.04.014; Govindarajan D, 2006, J VIROL, V80, P5790, DOI 10.1128/JVI.00138-06; Herfst S, 2008, J VIROL, V82, P8891, DOI 10.1128/JVI.00472-08; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Kolli D, 2011, J IMMUNOL, V187, P47, DOI 10.4049/jimmunol.1002589; Kong BW, 2008, VIRUS RES, V132, P114, DOI 10.1016/j.virusres.2007.11.006; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; Lee EH, 2007, VIRUS RES, V128, P18, DOI 10.1016/j.virusres.2007.03.029; Leyrat C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080371; Li J, 1996, VIRUS RES, V41, P185, DOI 10.1016/0168-1702(96)01288-9; LING R, 1992, J GEN VIROL, V73, P1709, DOI 10.1099/0022-1317-73-7-1709; LING R, 1995, VIRUS RES, V36, P247, DOI 10.1016/0168-1702(95)00008-E; Ling R, 2008, J GEN VIROL, V89, P525, DOI 10.1099/vir.0.83309-0; Loo LH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-294; LOUNSBACH GR, 1993, J GEN VIROL, V74, P2559, DOI 10.1099/0022-1317-74-12-2559; Lupini C, 2011, AVIAN PATHOL, V40, P525, DOI 10.1080/03079457.2011.607428; Lwamba HCM, 2005, VIRUS RES, V107, P83, DOI 10.1016/j.virusres.2004.07.002; Mas V, 2011, J VIROL, V85, P12650, DOI 10.1128/JVI.05485-11; MCDOUGALL JS, 1986, VET REC, V118, P206, DOI 10.1136/vr.118.8.206; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Naylor CJ, 2004, J GEN VIROL, V85, P3219, DOI 10.1099/vir.0.80229-0; Naylor CJ, 1998, J GEN VIROL, V79, P1393, DOI 10.1099/0022-1317-79-6-1393; Naylor CJ, 2010, VACCINE, V28, P6800, DOI 10.1016/j.vaccine.2010.07.015; Pham QN, 2005, J VIROL, V79, P15114, DOI 10.1128/JVI.79.24.15114-15122.2005; POCH O, 1990, J GEN VIROL, V71, P1153, DOI 10.1099/0022-1317-71-5-1153; Pringle C R, 1998, Arch Virol, V143, P1449, DOI 10.1007/s007050050389; Randhawa JS, 1997, J VIROL, V71, P9849, DOI 10.1128/JVI.71.12.9849-9854.1997; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ren JP, 2012, J VIROL, V86, P13049, DOI 10.1128/JVI.01248-12; Schlender J, 2003, J VIROL, V77, P4609, DOI 10.1128/JVI.77.8.4609-4616.2003; Shin HJ, 2000, J CLIN MICROBIOL, V38, P4282, DOI 10.1128/JCM.38.11.4282-4284.2000; Sugiyama M, 2010, VIRUS GENES, V41, P389, DOI 10.1007/s11262-010-0518-z; Svenda M, 1997, VIRUS RES, V48, P57, DOI 10.1016/S0168-1702(96)01426-8; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanner SJ, 2014, P NATL ACAD SCI USA, V111, P1580, DOI 10.1073/pnas.1317262111; Toquin D, 1999, Vet Rec, V145, P680; Toquin D, 2006, VIRUS GENES, V32, P97, DOI 10.1007/s11262-005-5850-3; Toquin D, 2003, J GEN VIROL, V84, P2169, DOI 10.1099/vir.0.19043-0; Toquin D, 2000, AVIAN DIS, V44, P977, DOI 10.2307/1593075; Toquin D, 2006, COMP SUCEPTIBILITY S, P70; Toquin D, 1999, VET REC, V23, P145; Turpin EA, 2008, AVIAN PATHOL, V37, P343, DOI 10.1080/03079450802068566; Ulbrandt ND, 2008, J GEN VIROL, V89, P3113, DOI 10.1099/vir.0.2008/005199-0; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Velayudhan BT, 2008, VIRUS GENES, V37, P266, DOI 10.1007/s11262-008-0220-6; Wei L, 2013, EMERG INFECT DIS, V19, P1092, DOI 10.3201/eid1907.121126; Wei Y, 2014, J VIROL; Werle B, 1998, VACCINE, V16, P1127, DOI 10.1016/S0264-410X(98)80109-6; WILDING GP, 1986, VET REC, V118, P735, DOI 10.1136/vr.118.26.735-b; Williams JV, 2006, J INFECT DIS, V193, P387, DOI 10.1086/499274; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; WYETH PJ, 1986, VET REC, V119, P139, DOI 10.1136/vr.119.6.139-a; YU Q, 1992, VIROLOGY, V186, P426, DOI 10.1016/0042-6822(92)90007-C; YU Q, 1992, J GEN VIROL, V73, P1355, DOI 10.1099/0022-1317-73-6-1355; Yunus AS, 2003, VIRUS RES, V93, P91, DOI 10.1016/S0168-1702(03)00074-1; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]; Zhong Q, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/460837	96	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102740	10.1371/journal.pone.0102740	http://dx.doi.org/10.1371/journal.pone.0102740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036224	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200082
J	Mo, F; Wyatt, AW; Sun, Y; Brahmbhatt, S; McConeghy, BJ; Wu, CX; Wang, YZ; Gleave, ME; Volik, SV; Collins, CC				Mo, Fan; Wyatt, Alexander W.; Sun, Yue; Brahmbhatt, Sonal; McConeghy, Brian J.; Wu, Chunxiao; Wang, Yuzhuo; Gleave, Martin E.; Volik, Stanislav V.; Collins, Colin C.			Systematic Identification and Characterization of RNA Editing in Prostate Tumors	PLOS ONE			English	Article							DNA-SEQUENCING DATA; HUMAN TRANSCRIPTOME; NONCODING RNAS; ACCURATE IDENTIFICATION; MOLECULAR-CLONING; SEQ DATA; CANCER; DISCOVERY; ALIGNMENT; GENOME	RNA editing modifies the sequence of primary transcripts, potentially resulting in profound effects to RNA structure and protein-coding sequence. Recent analyses of RNA sequence data are beginning to provide insights into the distribution of RNA editing across the entire transcriptome, but there are few published matched whole genome and transcriptome sequence datasets, and designing accurate bioinformatics methodology has proven highly challenging. To further characterize the RNA editome, we analyzed 16 paired DNA-RNA sequence libraries from prostate tumor specimens, employing a comprehensive strategy to rescue low coverage sites and minimize false positives. We identified over a hundred thousand putative RNA editing events, a third of which were recurrent in two or more samples, and systematically characterized their type and distribution across the genome. Within genes the majority of events affect non-coding regions such as introns and untranslated regions (UTRs), but 546 genes had RNA editing events predicted to result in deleterious amino acid alterations. Finally, we report a potential association between RNA editing of microRNA binding sites within 39 UTRs and increased transcript expression. These results provide a systematic characterization of the landscape of RNA editing in low coverage sequence data from prostate tumor specimens. We demonstrate further evidence for RNA editing as an important regulatory mechanism and suggest that the RNA editome should be further studied in cancer.	[Mo, Fan; Wyatt, Alexander W.; Sun, Yue; Brahmbhatt, Sonal; McConeghy, Brian J.; Wu, Chunxiao; Wang, Yuzhuo; Gleave, Martin E.; Volik, Stanislav V.; Collins, Colin C.] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Mo, Fan; Wyatt, Alexander W.; Sun, Yue; Brahmbhatt, Sonal; McConeghy, Brian J.; Wu, Chunxiao; Wang, Yuzhuo; Gleave, Martin E.; Volik, Stanislav V.; Collins, Colin C.] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Wang, Yuzhuo] BC Canc Agcy, Dept Expt Therapeut, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; British Columbia Cancer Agency	Collins, CC (corresponding author), Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada.	ccollins@prostatecentre.com		Gleave, Martin/0000-0003-4235-0167; Wang, Yuzhuo/0000-0002-9749-8591	Prostate Cancer Canada; Prostate Cancer Foundation; Canadian Institutes of Health Research; Canadian Prostate Cancer Genome Network; Canadian Cancer Society Research Institute; Coalition to Cure Prostate Cancer Young Investigator Award; Prostate Cancer Foundation BC; National Natural Science Foundation of China [60171009]	Prostate Cancer Canada; Prostate Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Prostate Cancer Genome Network; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Coalition to Cure Prostate Cancer Young Investigator Award; Prostate Cancer Foundation BC; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Prostate Cancer Canada (CC, YW), Prostate Cancer Foundation (CC, YW), Canadian Institutes of Health Research (YW), The Canadian Prostate Cancer Genome Network (CC), Canadian Cancer Society Research Institute (CC), Coalition to Cure Prostate Cancer Young Investigator Award (AW), Prostate Cancer Foundation BC (AW), and National Natural Science Foundation of China, No. 60171009 (CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen L, 2013, NAT MED; Deng L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.9; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Galeano F, 2012, SEMIN CELL DEV BIOL, V23, P244, DOI 10.1016/j.semcdb.2011.09.003; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gu TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033720; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Jiang QF, 2013, P NATL ACAD SCI USA, V110, P1041, DOI 10.1073/pnas.1213021110; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Lagana A, 2012, BIOINFORMATICS, V28, P3166, DOI 10.1093/bioinformatics/bts589; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lapuk AV, 2012, J PATHOL, V227, P286, DOI 10.1002/path.4047; Lasek AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022636; Lee JH, 2013, RNA; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin D, 2013, CANC RES CANRES, V2921; Liu W, 2013, CANCER; Louro R, 2008, GENOMICS, V92, P18, DOI 10.1016/j.ygeno.2008.03.013; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mo F, 2012, J CLIN MICROBIOL, V50, P536, DOI 10.1128/JCM.06170-11; Moor CH, 2005, MECH TRANSLATIONAL C, VElsevier, P49; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Piskol R, 2013, NAT BIOTECHNOL, V31, P19, DOI 10.1038/nbt.2472; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Schlumbrecht MP, 2011, MODERN PATHOL, V24, P453, DOI 10.1038/modpathol.2010.211; Schoft VK, 2007, NUCLEIC ACIDS RES, V35, P3723, DOI 10.1093/nar/gkm314; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Walter BA, 2013, J CANCER, V4, P350, DOI 10.7150/jca.6394; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Wu CX, 2012, GENE CHROMOSOME CANC, V51, P1144, DOI 10.1002/gcc.21999; Wu CX, 2012, J PATHOL, V227, P53, DOI 10.1002/path.3987; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yamashita T, 2013, BRAIN RES; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zinshteyn B, 2009, WIRES SYST BIOL MED, V1, P202, DOI 10.1002/wsbm.10	67	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101431	10.1371/journal.pone.0101431	http://dx.doi.org/10.1371/journal.pone.0101431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036877	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200016
J	Zaspel, JM; Weller, SJ; Wardwell, CT; Zahiri, R; Wahlberg, N				Zaspel, Jennifer M.; Weller, Susan J.; Wardwell, Charles T.; Zahiri, Reza; Wahlberg, Niklas			Phylogeny and Evolution of Pharmacophagy in Tiger Moths (Lepidoptera: Erebidae: Arctiinae)	PLOS ONE			English	Article							PYRROLIZIDINE ALKALOIDS; DEFENSE-MECHANISMS; PLANTS; SYSTEMS; CHOICE; CATERPILLAR; ARTHROPODS; INFERENCE; SELECTION; TAXA	The focus of this study was to reconstruct a phylogenetic hypothesis for the moth subfamily Arctiinae (tiger moths, woolly bears) to investigate the evolution of larval and adult pharmacophagy of pyrrolizidine alkaloids (PAs) and the pathway to PA chemical specialization in Arctiinae. Pharmacophagy, collection of chemicals for non-nutritive purposes, is well documented in many species, including the model species Utetheisa ornatrix L. A total of 86 exemplar ingroup species representing tiger moth tribes and subtribes (68 genera) and nine outgroup species were selected. Ingroup species included the most species-rich generic groups to represent the diversity of host-plant associations and pharmacophagous behaviors found throughout Arctiinae. Up to nine genetic markers were sequenced: one mitochondrial (COI barcode region), one nuclear rRNA (D2 region, 28S rRNA), and seven nuclear protein-coding gene fragments: elongation factor 1-alpha protein, wingless, ribosomal protein subunit S5, carbamoylphosphate synthase domain regions, glyceraldehyde-3-phosphate dehydrogenase, isocitrate dehydrogenase and cytosolic malate dehydrogenase. A total of 6984 bp was obtained for most species. These data were analyzed using model-based phylogenetic methods: maximum likelihood (ML) and Bayesian inference (BI). Ancestral pharmacophagous behaviors and obligate PA associations were reconstructed using the resulting Bayes topology and Reconstructing Ancestral States in Phylogenies (RASP) software. Our results corroborate earlier studies on the evolution of adult pharmacophagous behaviors, suggesting that this behavior arose multiple times and is concentrated in the phaegopterine-euchromiine-ctenuchine clade (PEC). Our results suggest that PA specialization may have arisen early in the phylogeny of the subfamily and that facultative larval pharmacophagous behaviors are the derived condition.	[Zaspel, Jennifer M.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Weller, Susan J.; Wardwell, Charles T.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Zahiri, Reza] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Wahlberg, Niklas] Univ Turku, Dept Biol, Genet Lab, SF-20500 Turku, Finland; [Weller, Susan J.] Univ Minnesota, Bell Museum Nat Hist, Minneapolis, MN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Minnesota System; University of Minnesota Twin Cities; University of Guelph; University of Turku; University of Minnesota System; University of Minnesota Twin Cities	Zaspel, JM (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	jzaspel@purdue.edu	Zahiri, Reza/G-5797-2018; Wahlberg, Niklas/B-7765-2008	Zahiri, Reza/0000-0001-6274-6973; Wahlberg, Niklas/0000-0002-1259-3363	NSF-DEB [0919185]; UMN Agricultural Experiment Station; Purdue University; CIMO; Finnish Cultural Foundation; Alfred Kordelin Foundation	NSF-DEB(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); UMN Agricultural Experiment Station; Purdue University; CIMO; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Alfred Kordelin Foundation	Funding for the study was provided by NSF-DEB 0919185 to S. Weller and J. Zaspel. Additional funds were provided by UMN Agricultural Experiment Station and Purdue University. The following Finnish foundations also provided support for this research: CIMO, Finnish Cultural Foundation and the Alfred Kordelin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendib A, 1998, CR ACAD SCI III-VIE, V321, P1007, DOI 10.1016/S0764-4469(99)80056-0; BENN M, 1979, EXPERIENTIA, V35, P731, DOI 10.1007/BF01968208; Bernays EA, 2005, NATURE, V436, P476, DOI 10.1038/436476a; Bernays EA, 2002, J COMP PHYSIOL A, V188, P715, DOI 10.1007/s00359-002-0345-3; Bernays EA, 2001, J INSECT PHYSIOL, V47, P1029, DOI 10.1016/S0022-1910(01)00079-8; Boada R, 1997, THESIS WAKE FOREST U; BOPPRE M, 1985, J COMP PHYSIOL A, V157, P569, DOI 10.1007/BF01351351; BOPPRE M, 1990, J CHEM ECOL, V16, P165, DOI 10.1007/BF01021277; BOPPRE M, 1981, ECOL ENTOMOL, V6, P449, DOI 10.1111/j.1365-2311.1981.tb00637.x; Bowers M. Deane, 2009, P83; Brehm G, 2007, ANN MO BOT GARD, V94, P463, DOI 10.3417/0026-6493(2007)94[463:PAAPLV]2.0.CO;2; CAPINERA JL, 1978, J ECON ENTOMOL, V71, P661, DOI 10.1093/jee/71.4.661; Capinera JL., 2001, HDB VEGETABLE PESTS; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Conner W., 2009, TIGER MOTHS WOOLLY B; CONNER WE, 1980, BEHAV ECOL SOCIOBIOL, V7, P55, DOI 10.1007/BF00302519; Conner WE, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P248, DOI 10.1017/CBO9780511542664.008; Conner WE, 2000, P NATL ACAD SCI USA, V97, P14406, DOI 10.1073/pnas.260503797; Conner William E., 2009, P155; Conner William E., 2009, P177; Corcoran AJ, 2009, SCIENCE, V325, P325, DOI 10.1126/science.1174096; DaCosta M, 2007, THESIS U MINNESOTA S; Dacosta MA, 2005, ZOOTAXA, P1; Davidson Robert B., 1997, Journal of the Lepidopterists' Society, V51, P288; Dubatolov Vladimir V., 2009, Atalanta (Marktleuthen), V40, P285; DUSSOURD DE, 1991, P NATL ACAD SCI USA, V88, P9224, DOI 10.1073/pnas.88.20.9224; DUSSOURD DE, 1988, P NATL ACAD SCI USA, V85, P5992, DOI 10.1073/pnas.85.16.5992; FERGUSON D C, 1985, Entomography, V3, P181; FORBES WTM, 1960, LEPIDOPTERA NEW YO 4; GOSS GJ, 1979, ENVIRON ENTOMOL, V8, P487, DOI 10.1093/ee/8.3.487; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hartmann T, 2005, INSECT BIOCHEM MOLEC, V35, P391, DOI 10.1016/j.ibmb.2004.12.010; Hartmann T., 1995, CHEM BIOL PERSPECT, V9, P155; Hartmann Thomas, 2009, P55; Hauser CL, 1997, SYST ENTOMOL, V22, P1, DOI 10.1046/j.1365-3113.1997.d01-21.x; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Holloway J.D., 1988, MOTHS BORNEO FAMILY; Hwang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045523; Iyengar VK, 1999, P NATL ACAD SCI USA, V96, P15013, DOI 10.1073/pnas.96.26.15013; Iyengar VK, 2002, NATURE, V419, P830, DOI 10.1038/nature01027; Iyengar VK, 1999, P NATL ACAD SCI USA, V96, P9169, DOI 10.1073/pnas.96.16.9169; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kiriakoff S. G., 1950, Biologisch Jaarboek Antwerpen, V17, P66; Kitching I.J., 1998, HDB ZOOLOGY ARTHROPO, P355, DOI DOI 10.1515/9783110804744.355; KRASNOFF SB, 1990, ZOOL J LINN SOC-LOND, V99, P319, DOI 10.1111/j.1096-3642.1990.tb00558.x; KRASNOFF SB, 1989, J CHEM ECOL, V15, P47, DOI 10.1007/BF02027773; Lafontaine JD, 2010, ZOOKEYS, P6, DOI 10.3897/zookeys.40.414; LAMUNYON CW, 1993, P NATL ACAD SCI USA, V90, P4689, DOI 10.1073/pnas.90.10.4689; LaMunyon CW, 1997, ECOL ENTOMOL, V22, P69, DOI 10.1046/j.1365-2311.1997.00033.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lee S, 2008, SYST ENTOMOL, V33, P595, DOI 10.1111/j.1365-3113.2008.00430.x; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Pena C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039071; PLISKE TE, 1975, ENVIRON ENTOMOL, V4, P474, DOI 10.1093/ee/4.3.474; PLISKE TE, 1975, ENVIRON ENTOMOL, V4, P455, DOI 10.1093/ee/4.3.455; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; ROTHSCHILD M, 1979, BIOL J LINN SOC, V12, P305, DOI 10.1111/j.1095-8312.1979.tb00062.x; Schmidt BC, 2008, ZOOTAXA, P1; Schulz Stefan, 2009, P145; Scott CH, 2014, SYST ENTOMOL, V39, P286, DOI 10.1111/syen.12047; Simmons RB, 2002, P ROY SOC B-BIOL SCI, V269, P983, DOI 10.1098/rspb.2002.1970; Simmons RB, 2012, ANN ENTOMOL SOC AM, V105, P804, DOI 10.1603/AN11166; Singer Michael S., 2009, P103; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Singer MS, 2002, ANIM BEHAV, V64, P629, DOI 10.1006/anbe.2002.3082; Singer MS, 2004, AM NAT, V164, P423, DOI 10.1086/423152; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; WAGNER DL, 2005, CATERPILLARS E N AM, DOI DOI 10.1515/9781400838295, Patent No. [2203.04766, 220304766]; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Warren LO, 1970, ARKANSAS AGR EXPT ST, V759; Watson A., 1986, Occasional Papers on Systematic Entomology, P1; Weller, 2002, CLADISTIC STUDY ARCT; Weller SJ, 1999, BIOL J LINN SOC, V68, P557, DOI 10.1111/j.1095-8312.1999.tb01188.x; Weller Susan, 2009, P11; Yu Y., 2011, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zahiri R, 2012, SYST ENTOMOL, V37, P102, DOI 10.1111/j.1365-3113.2011.00607.x; Zahiri R, 2011, ZOOL SCR, V40, P158, DOI 10.1111/j.1463-6409.2010.00459.x; Zaspel JM, 2013, ZOOL ANZ, V253, P6, DOI 10.1016/j.jcz.2013.06.001; Zaspel JM, 2012, MOL PHYLOGENET EVOL, V65, P786, DOI 10.1016/j.ympev.2012.06.029; Zaspel JM, 2006, ZOOTAXA, P1; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; [No title captured]	85	48	51	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101975	10.1371/journal.pone.0101975	http://dx.doi.org/10.1371/journal.pone.0101975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036028	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200031
J	Sommansson, A; Saudi, WSW; Nylander, O; Sjoblom, M				Sommansson, Anna; Saudi, Wan Salman Wan; Nylander, Olof; Sjoblom, Markus			The Ethanol-Induced Stimulation of Rat Duodenal Mucosal Bicarbonate Secretion In Vivo Is Critically Dependent on Luminal Cl-	PLOS ONE			English	Article							APICAL CL-/HCO3-EXCHANGER; HCO3-SECRETION; ALKALINE SECRETION; ACID; PERMEABILITY; CFTR; TRANSPORT; CAMP; IDENTIFICATION; INHIBITION	Alcohol may induce metabolic and functional changes in gastrointestinal epithelial cells, contributing to impaired mucosal barrier function. Duodenal mucosal bicarbonate secretion (DBS) is a primary epithelial defense against gastric acid and also has an important function in maintaining the homeostasis of the juxtamucosal microenvironment. The aim in this study was to investigate the effects of the luminal perfusion of moderate concentrations of ethanol in vivo on epithelial DBS, fluid secretion and paracellular permeability. Under thiobarbiturate anesthesia, a similar to 30-mm segment of the proximal duodenum with an intact blood supply was perfused in situ in rats. The effects on DBS, duodenal transepithelial net fluid flux and the blood-to-lumen clearance of Cr-51-EDTA were investigated. Perfusing the duodenum with isotonic solutions of 10% or 15% ethanol-by-volume for 30 min increased DBS in a concentration-dependent manner, while the net fluid flux did not change. Pre-treatment with the CFTR inhibitor CFTRinh172 (i.p. or i.v.) did not change the secretory response to ethanol, while removing Cl- from the luminal perfusate abolished the ethanol-induced increase in DBS. The administration of hexamethonium (i.v.) but not capsazepine significantly reduced the basal net fluid flux and the ethanol-induced increase in DBS. Perfusing the duodenum with a combination of 1.0 mM HCl and 15% ethanol induced significantly greater increases in DBS than 15% ethanol or 1.0 mM HCl alone but did not influence fluid flux. Our data demonstrate that ethanol induces increases in DBS through a mechanism that is critically dependent on luminal Cl- and partly dependent on enteric neural pathways involving nicotinic receptors. Ethanol and HCl appears to stimulate DBS via the activation of different bicarbonate transporting mechanisms.	[Sommansson, Anna; Saudi, Wan Salman Wan; Nylander, Olof; Sjoblom, Markus] Uppsala Univ, Dept Neurosci, Div Gastrointestinal Physiol, Uppsala, Sweden	Uppsala University	Sjoblom, M (corresponding author), Uppsala Univ, Dept Neurosci, Div Gastrointestinal Physiol, Uppsala, Sweden.	Markus.Sjoblom@neuro.uu.se	Saudi, Wan Salman Wan/I-5866-2016	Saudi, Wan Salman Wan/0000-0001-6424-2066	Emil and Ragna Borjesson Foundation; Lars Hiertas Foundation	Emil and Ragna Borjesson Foundation; Lars Hiertas Foundation	We thank Gunilla Jedstedt and Marie Heidenvall for their excellent technical assistance. Support was given by the Emil and Ragna Borjesson Foundation and the Lars Hiertas Foundation.	Akiba Y, 1999, AM J PHYSIOL-GASTR L, V277, pG268, DOI 10.1152/ajpgi.1999.277.2.G268; Akiba Y, 2005, AM J PHYSIOL-GASTR L, V289, pG753, DOI 10.1152/ajpgi.00130.2005; ALLEN A, 1993, PHYSIOL REV, V73, P823, DOI 10.1152/physrev.1993.73.4.823; [Anonymous], 2012, PHYSL GASTROINTESTIN; Clarke LL, 1998, AM J PHYSIOL-GASTR L, V274, pG718, DOI 10.1152/ajpgi.1998.274.4.G718; DRAPER LR, 1983, GUT, V24, P399, DOI 10.1136/gut.24.5.399; Flemstrom G, 2001, NEWS PHYSIOL SCI, V16, P23; FLEMSTROM G, 1987, PHYSL GASTROINTESTIN, P1011; Hogan DL, 1997, GASTROENTEROLOGY, V113, P533, DOI 10.1053/gast.1997.v113.pm9247473; Hogan DL, 1997, AM J PHYSIOL-GASTR L, V272, pG872, DOI 10.1152/ajpgi.1997.272.4.G872; Hong JH, 2013, P NATL ACAD SCI USA, V110, P4105, DOI 10.1073/pnas.1221410110; ISENBERG JI, 1993, AM J PHYSIOL, V265, pG677, DOI 10.1152/ajpgi.1993.265.4.G677; Jacob P, 2002, GASTROENTEROLOGY, V122, P709, DOI 10.1053/gast.2002.31875; Jakab RL, 2011, AM J PHYSIOL-GASTR L, V300, pG82, DOI 10.1152/ajpgi.00245.2010; Juric M, 2013, INFLAMM BOWEL DIS, V19, P904, DOI 10.1097/MIB.0b013e3182813322; Kagawa S, 2003, DIGEST DIS SCI, V48, P1850, DOI 10.1023/A:1025480003388; Ko SBH, 2002, AM J PHYSIOL-CELL PH, V283, pC1206, DOI 10.1152/ajpcell.00512.2001; KRISHNAMRA N, 1986, J NUTR SCI VITAMINOL, V32, P229, DOI 10.3177/jnsv.32.229; LACY ER, 1986, DIGEST DIS SCI, V31, pS101, DOI 10.1007/BF01309332; Levitt MD, 1997, AM J PHYSIOL-GASTR L, V273, pG951, DOI 10.1152/ajpgi.1997.273.4.G951; Myers CP, 1998, GASTROENTEROLOGY, V114, P527, DOI 10.1016/S0016-5085(98)70536-0; NYLANDER O, 1989, AM J PHYSIOL, V257, pG653; Nylander O, 2001, AM J PHYSIOL-GASTR L, V281, pG1169, DOI 10.1152/ajpgi.2001.281.5.G1169; Pihl L, 2008, ACTA PHYSIOL, V193, P67, DOI 10.1111/j.1748-1716.2007.01777.x; Pihl L, 2010, ACTA PHYSIOL, V200, P181, DOI 10.1111/j.1748-1716.2010.02112.x; Seidler U, 1997, J PHYSIOL-LONDON, V505, P411, DOI 10.1111/j.1469-7793.1997.411bb.x; Seidler U, 2009, EXP PHYSIOL, V94, P175, DOI 10.1113/expphysiol.2008.043018; Singh AK, 2008, ACTA PHYSIOL, V193, P357, DOI 10.1111/j.1748-1716.2008.01854.x; Singh AK, 2013, J PHYSIOL-LONDON, V591, P5377, DOI 10.1113/jphysiol.2013.254854; Sommansson A, 2013, AM J PHYSIOL-GASTR L, V305, pG95, DOI 10.1152/ajpgi.00074.2013; Sommansson A, 2013, J PINEAL RES, V54, P282, DOI 10.1111/jpi.12013; Trevisani M, 2002, NAT NEUROSCI, V5, P546, DOI 10.1038/nn852; TSAI JH, 1991, TOHOKU J EXP MED, V164, P81, DOI 10.1620/tjem.164.81; Tuo BG, 2006, GASTROENTEROLOGY, V130, P349, DOI 10.1053/j.gastro.2005.10.017; Vaquera J, 2002, HISTOL HISTOPATHOL, V17, P199, DOI 10.14670/HH-17.199; VATTAY P, 1989, ACTA PHYSIOL HUNG, V73, P251; Wang ZH, 2002, AM J PHYSIOL-GASTR L, V282, pG573, DOI 10.1152/ajpgi.00338.2001; World Health Organization, 2011, GLOB STAT REP ALC HL; Xu J, 2003, AM J PHYSIOL-GASTR L, V285, pG1225, DOI 10.1152/ajpgi.00236.2003; Yang DK, 2011, J CLIN INVEST, V121, P956, DOI 10.1172/JCI43475	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102654	10.1371/journal.pone.0102654	http://dx.doi.org/10.1371/journal.pone.0102654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033198	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300075
J	Wang, LS; Jiao, Y; Cao, YH; Liu, GF; Wang, YJ; Gu, WK				Wang, Lishi; Jiao, Yan; Cao, Yanhong; Liu, Gaifen; Wang, Yongjun; Gu, Weikuan			Limitation Positive Loci in QTL Mapping Using Recombinant Inbred Strains	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PANEL	While the identification of causal genes of quantitative trait loci (QTL) remains a difficult problem in the post-genome era, the number of QTL continues to accumulate, mainly identified using the recombinant inbred (RI) strains. Over the last decade, hundreds of publications have reported nearly a thousand QTL identified from RI strains. We hypothesized that the inaccuracy of most of these QTL makes it difficult to identify causal genes. Using data from RI strains derived from C57BL/6J (B6) X DBA/2J (D2), we tested the possibility of detection of reliable QTL with different numbers of strains in the same trait in five different traits. Our results indicated that studies using RI strains of less than 30 in general have a higher probability of failing to detect reliable QTL. Errors in many studies could include false positive loci, switches between QTL with small and major effects, and missing the real major loci. The similar data was obtained from a RI strain population derived from a different pair of parents and a RI strain population of rat. Thus, thousands of reported QTL from studies of RI strains may need to be double-checked for accuracy before proceeding to causal gene identification.	[Wang, Lishi; Jiao, Yan; Cao, Yanhong; Gu, Weikuan] Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg, Memphis, TN 38152 USA; [Wang, Lishi; Jiao, Yan; Cao, Yanhong; Gu, Weikuan] Univ Tennessee, Hlth Sci Ctr, Campbell Clin, BME, Memphis, TN USA; [Jiao, Yan] Mudanjiang Med Coll, Mudanjiang, Peoples R China; [Cao, Yanhong] Harbin Med Univ, Chinese Ctr Dis Control & Prevent, Ctr Endem Dis Control, Inst Kaschin Beck Dis, Harbin, Peoples R China; [Cao, Yanhong] Educ Bur Heilongjiang Prov, Harbin, Peoples R China; [Cao, Yanhong] Minist Hlth 23618104, Harbin, Peoples R China; [Liu, Gaifen; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Lishi] Inner Mongolia Med Univ, Dept Basic Med Res, Hohhot, Inner Mongolia, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Mudanjiang Medical University; Chinese Center for Disease Control & Prevention; Harbin Medical University; Capital Medical University; Inner Mongolia Medical University	Gu, WK (corresponding author), Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg, Memphis, TN 38152 USA.	wgu@uthsc.edu			National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health [1R01AA016342]; Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, TN; National Natural Science Foundation of China [81171679]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016342] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, TN; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was partially supported by grants from the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health (1R01AA016342 to WG), Genediscovery Core at UTHSC, the Veterans Administration Medical Center in Memphis, TN, and National Natural Science Foundation of China (Project 81171679 to YHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Bennett B, 2002, ALCOHOL CLIN EXP RES, V26, P1615, DOI 10.1097/01.ALC.0000037136.49550.B3; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Buresova M, 2006, PHYSIOL GENOMICS, V26, P226, DOI 10.1152/physiolgenomics.00056.2006; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chesler EJ, 2001, SCIENCE, V294; Gaglani SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-44; Goodman S, 2007, PLOS MED, V4, P773, DOI 10.1371/journal.pmed.0040168; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; Huang Y, 2013, GENET MOL RES, V12, P3662, DOI 10.4238/2013.September.18.1; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Logan RW, 2013, GENES BRAIN BEHAV, V12, P424, DOI 10.1111/gbb.12029; Manenti G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000331; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; Philip VM, 2011, GENOME RES, V21, P1223, DOI 10.1101/gr.113886.110; Porcu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018405; RYAN J, 1987, J NATL CANCER I, V79, P1351; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299	19	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102307	10.1371/journal.pone.0102307	http://dx.doi.org/10.1371/journal.pone.0102307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032693	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300047
J	Klein, BA; Stiegler, M; Klein, A; Tautz, J				Klein, Barrett Anthony; Stiegler, Martin; Klein, Arno; Tautz, Juergen			Mapping Sleeping Bees within Their Nest: Spatial and Temporal Analysis of Worker Honey Bee Sleep	PLOS ONE			English	Article							AGE POLYETHISM; COLONY; HIVE; THERMOREGULATION; DEPRIVATION; DYNAMICS; COMB; REST	Patterns of behavior within societies have long been visualized and interpreted using maps. Mapping the occurrence of sleep across individuals within a society could offer clues as to functional aspects of sleep. In spite of this, a detailed spatial analysis of sleep has never been conducted on an invertebrate society. We introduce the concept of mapping sleep across an insect society, and provide an empirical example, mapping sleep patterns within colonies of European honey bees (Apis mellifera L.). Honey bees face variables such as temperature and position of resources within their colony's nest that may impact their sleep. We mapped sleep behavior and temperature of worker bees and produced maps of their nest's comb contents as the colony grew and contents changed. By following marked bees, we discovered that individuals slept in many locations, but bees of different worker castes slept in different areas of the nest relative to position of the brood and surrounding temperature. Older worker bees generally slept outside cells, closer to the perimeter of the nest, in colder regions, and away from uncapped brood. Younger worker bees generally slept inside cells and closer to the center of the nest, and spent more time asleep than awake when surrounded by uncapped brood. The average surface temperature of sleeping foragers was lower than the surface temperature of their surroundings, offering a possible indicator of sleep for this caste. We propose mechanisms that could generate caste-dependent sleep patterns and discuss functional significance of these patterns.	[Klein, Barrett Anthony] Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA; [Stiegler, Martin; Tautz, Juergen] Univ Wurzburg, BEEgrp, Biozentrum, D-97070 Wurzburg, Germany; [Klein, Arno] Sage Bionetworks, Seattle, WA USA	University of Wisconsin System; University of Wurzburg	Klein, BA (corresponding author), Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA.	barrett@pupating.org	Klein, Arno/Z-4901-2019	Klein, Arno/0000-0002-0707-2889	National Science Foundation [0710142]; Deutscher Akademischer Austausch Dienst [A0670415]; Environmental Science Institute, The University of Texas at Austin; Bienenforschung Wurzburg e.V.	National Science Foundation(National Science Foundation (NSF)); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Environmental Science Institute, The University of Texas at Austin; Bienenforschung Wurzburg e.V.	BAK received the following funding: Doctoral Dissertation Improvement Grant #0710142, National Science Foundation (http://www.nsf.gov). Deutscher Akademischer Austausch Dienst #A0670415 (https://www.daad.org). Environmental Science Institute, The University of Texas at Austin (no number; http://www.esi.utexas.edu). Bienenforschung Wurzburg e.V. (no number; http://www.bienenforschung.biozentrum.uni-wuerzburg.de/bienenforschung_wuerzburg_ev/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ES, 1995, OECOLOGIA, V102, P156, DOI 10.1007/BF00333246; Anderson JR, 1998, AM J PRIMATOL, V46, P63, DOI 10.1002/(SICI)1098-2345(1998)46:1<63::AID-AJP5>3.0.CO;2-T; Anderson JR, 2000, SLEEP MED REV, V4, P355, DOI 10.1053/smrv.2000.0105; Baracchi D, 2010, ETHOLOGY, V116, P579, DOI 10.1111/j.1439-0310.2010.01770.x; Bates D, 2006, LME4 PACKAGE; Bujok B, 2002, NATURWISSENSCHAFTEN, V89, P299, DOI 10.1007/s00114-002-0338-7; CAMAZINE S, 1991, BEHAV ECOL SOCIOBIOL, V28, P61, DOI 10.1007/BF00172140; CARTWRIGHT BA, 1987, BIOL CYBERN, V57, P85, DOI 10.1007/BF00318718; CLARK DL, 1990, ANIM BEHAV, V39, P1138, DOI 10.1016/S0003-3472(05)80786-9; Dustmann JH, 2000, BIENEN KONNEN FARBEN; Eban-Rothschild AD, 2008, J EXP BIOL, V211, P2408, DOI 10.1242/jeb.016915; FAHRENHOLZ L, 1989, J COMP PHYSIOL B, V159, P551, DOI 10.1007/BF00694379; FLANIGAN WF, 1973, ELECTROEN CLIN NEURO, V34, P521, DOI 10.1016/0013-4694(73)90069-2; FRANKS NR, 1992, BEHAV ECOL SOCIOBIOL, V30, P109; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; HESS W. R., 1926, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V4, P465, DOI 10.1007/BF00340746; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Humphrey JAC, 2008, J THEOR BIOL, V250, P194, DOI 10.1016/j.jtbi.2007.09.026; Jandt JM, 2009, ANIM BEHAV, V77, P641, DOI 10.1016/j.anbehav.2008.11.019; Johnson BR, 2008, BEHAV ECOL SOCIOBIOL, V62, P777, DOI 10.1007/s00265-007-0503-2; Kaiser W., 2002, Journal of Sleep Research, V11, P115; KAISER W, 1988, J COMP PHYSIOL A, V163, P565, DOI 10.1007/BF00603841; Klein BA, 2008, J EXP BIOL, V211, P3028, DOI 10.1242/jeb.017426; Klein BA, 2011, ANIM BEHAV, V82, P77, DOI 10.1016/j.anbehav.2011.03.026; Klein BA, 2010, P NATL ACAD SCI USA, V107, P22705, DOI 10.1073/pnas.1009439108; Kleinhenz M, 2003, J EXP BIOL, V206, P4217, DOI 10.1242/jeb.00680; Kovac H, 2007, J INSECT PHYSIOL, V53, P1250, DOI 10.1016/j.jinsphys.2007.06.019; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Moore D, 2001, J INSECT PHYSIOL, V47, P843, DOI 10.1016/S0022-1910(01)00057-9; Moore D, 1998, BEHAV ECOL SOCIOBIOL, V43, P147, DOI 10.1007/s002650050476; Noser R, 2010, ANIM COGN, V13, P145, DOI 10.1007/s10071-009-0254-8; Pieron H, 1913, PROBLEME PHYSL SOMME; Pinheiro J, 2002, MIXED EFFECTS MODELS, P83; R Development Core Team, 2005, R LANG ENV STAT COMP; Rattenborg NC, 1999, NATURE, V397, P397, DOI 10.1038/17037; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; SAKAGAMI SHOICHI F., 1953, JAPANESE JOUR ZOOL, V11, P117; Sauer S, 2004, J SLEEP RES, V13, P145, DOI 10.1111/j.1365-2869.2004.00393.x; Sauer S, 2003, J COMP PHYSIOL A, V189, P599, DOI 10.1007/s00359-003-0436-9; Sauer S, 1999, P 1 GOTT C GERM NEUR, VII, P241; Sauer S, 1998, APIDOLOGIE, V29, P445; Schmolz E, 2002, THERMOCHIM ACTA, V382, P221, DOI 10.1016/S0040-6031(01)00740-7; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1991, ETHOLOGY, V87, P284; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Seeley TD, 1985, HONEYBEE ECOLOGY STU; Stabentheiner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008967; SZABO TI, 1985, J APICULT RES, V24, P27, DOI 10.1080/00218839.1985.11100645; Tobler I., 1985, ENDOGENOUS SLEEP SUB, P57; Vega L, 2011, J THERM ANAL CALORIM, V104, P233, DOI 10.1007/s10973-011-1373-4; von Frisch K., 1967, DANCE LANGUAGE ORIEN; von Frisch K, 1977, PUBLICATION LINDAUER, V23; Witteveen BH, 2009, MAR ECOL PROG SER, V393, P173, DOI 10.3354/meps08231	54	15	15	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102316	10.1371/journal.pone.0102316	http://dx.doi.org/10.1371/journal.pone.0102316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029445	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600061
J	Passos, C; Tassino, B; Reyes, F; Rosenthal, GG				Passos, Carlos; Tassino, Bettina; Reyes, Federico; Rosenthal, Gil G.			Seasonal Variation in Female Mate Choice and Operational Sex Ratio in Wild Populations of an Annual Fish, Austrolebias reicherti	PLOS ONE			English	Article							MATING PREFERENCES; COLOR POLYMORPHISM; BODY-SIZE; SELECTION; CYPRINODONTIFORMES; PLASTICITY; EVOLUTION; DENSITY; QUALITY; ROLES	The intensity of mating competition and the potential benefits for female of mating with certain males can be influenced by several extrinsic factors, such that behavioral decisions can be highly context-dependent. Short-lived species with a single reproductive season are a unique model to study context-sensitive mating decisions. Through exhaustive sampling in the field and simultaneous choice tests in the laboratory, we evaluated operational sex ratio (OSR) and female mate choice at the beginning and end of the reproductive season in the annual killifish Austrolebias reicherti. We found seasonal change in both OSR and female mate choice. At the start of the reproductive season the OSR did not deviate from parity, and females preferred larger males. Later in the reproductive season, while the proportion of males in the ponds decreased, females became unselective with respect to male size. The particular biological cycle of annual killifish, where both life expectancy and mating opportunities decline sharply over a short timescale, could account for the seasonal change in female choice. Reduction in choosiness could arise from diminished reproductive prospects due to a decline in male availability. Moreover, as the end of the season approaches, any benefits of choosiness are presumably reduced: a female's fitness will be higher if she mates with any male than if she forgoes reproduction and dies. Future work will disentangle the mechanisms underlying seasonal changes in mating preferences, notably direct responses to demographic factors, environmental cues, or intrinsic changes during development.	[Passos, Carlos; Tassino, Bettina; Reyes, Federico] Univ Republica, Fac Ciencias, Secc Etol, Montevideo, Uruguay; [Rosenthal, Gil G.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Rosenthal, Gil G.] Ctr Invest Cient Huastecas Aguazarca, Calnali, Hidalgo, Mexico	Universidad de la Republica, Uruguay; Texas A&M University System; Texas A&M University College Station	Passos, C (corresponding author), Univ Republica, Fac Ciencias, Secc Etol, Montevideo, Uruguay.	cpassos@fcien.edu.uy	; Rosenthal, Gil/E-6924-2015	Reyes, Federico/0000-0002-6993-2784; Rosenthal, Gil/0000-0003-0342-9024	Programa para el Desarrollo de las Ciencias Basicas; Agencia Nacional de Investigacion e Innovacion [FCE 2201117025]; Agencia Nacional de Investigacion e Innovacion	Programa para el Desarrollo de las Ciencias Basicas; Agencia Nacional de Investigacion e Innovacion; Agencia Nacional de Investigacion e Innovacion	This work was supported by the Programa para el Desarrollo de las Ciencias Basicas, and the Agencia Nacional de Investigacion e Innovacion (FCE 2201117025). The Agencia Nacional de Investigacion e Innovacion provided a Ph.D. research fellowship to CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Aronsen T, 2013, EVOLUTION, V67, P3243, DOI 10.1111/evo.12201; BalshineEarn S, 1996, BEHAV ECOL SOCIOBIOL, V39, P107, DOI 10.1007/s002650050272; Basolo AL, 2004, ANIM BEHAV, V68, P75, DOI 10.1016/j.anbehav.2003.07.019; BERGLUND A, 1994, BEHAV ECOL, V5, P254, DOI 10.1093/beheco/5.3.254; BERGLUND A, 1993, BEHAV ECOL SOCIOBIOL, V32, P331; Berois N, 2012, WIRES DEV BIOL, V1, P595, DOI 10.1002/wdev.39; Borg AA, 2006, ANIM BEHAV, V72, P763, DOI 10.1016/j.anbehav.2005.11.025; Chapman BB, 2010, P ROY SOC B-BIOL SCI, V277, P1395, DOI 10.1098/rspb.2009.2055; Costa WJEM, 2006, ZOOTAXA, P1; CROWLEY PH, 1991, AM NAT, V137, P567, DOI 10.1086/285184; Darwin G., 1871, P423; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Forsgren E, 2004, NATURE, V429, P551, DOI 10.1038/nature02562; Garcia CM, 1998, J FISH BIOL, V53, P104, DOI 10.1111/j.1095-8649.1998.tb01021.x; Garcia D, 2008, NEOTROP ICHTHYOL, V6, P243, DOI 10.1590/S1679-62252008000200012; Gibson RM, 1996, TRENDS ECOL EVOL, V11, P468, DOI 10.1016/0169-5347(96)10050-1; HAAS R, 1976, EVOLUTION, V30, P614, DOI 10.1111/j.1558-5646.1976.tb00938.x; Heuschele J, 2009, BEHAV ECOL, V20, P1223, DOI 10.1093/beheco/arp123; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jirotkul M, 1999, ANIM BEHAV, V58, P287, DOI 10.1006/anbe.1999.1149; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Jones AG, 2005, INTEGR COMP BIOL, V45, P874, DOI 10.1093/icb/45.5.874; Kingston JJ, 2003, ANIM BEHAV, V65, P735, DOI 10.1006/anbe.2003.2110; Kokko H, 2005, EVOLUTION, V59, P1876; Kokko H, 2002, PHILOS T R SOC B, V357, P319, DOI 10.1098/rstb.2001.0926; Kvarnemo C, 1999, BEHAV ECOL SOCIOBIOL, V45, P245, DOI 10.1007/s002650050559; Lehtonen TK, 2008, ANIM BEHAV, V75, P55, DOI 10.1016/j.anbehav.2007.04.011; Lindstrom K, 2001, AM NAT, V158, P64, DOI 10.1086/320867; Loureiro M, 2008, ZOOTAXA, P1; MacLaren RD, 2006, ETHOLOGY, V112, P678, DOI 10.1111/j.1439-0310.2006.01213.x; Passos C, 2013, ETHOLOGY, V119, P891, DOI 10.1111/eth.12129; Passos C, 2013, BEHAV PROCESS, V96, P20, DOI 10.1016/j.beproc.2013.01.008; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; Qvarnstrom A, 2001, TRENDS ECOL EVOL, V16, P5, DOI 10.1016/S0169-5347(00)02030-9; REAL L, 1990, AM NAT, V136, P376, DOI 10.1086/285103; Reaney LT, 2007, BEHAV ECOL SOCIOBIOL, V61, P1515, DOI 10.1007/s00265-007-0383-5; Reichard M, 2009, J FISH BIOL, V74, P198, DOI 10.1111/j.1095-8649.2008.02129.x; Rosenthal GG, 1998, P NATL ACAD SCI USA, V95, P4431, DOI 10.1073/pnas.95.8.4431; Rosenthal GG, 2011, BIOL LETTERS, V7, P525, DOI 10.1098/rsbl.2011.0027; RYAN MJ, 1987, SCIENCE, V236, P595, DOI 10.1126/science.236.4801.595; Simpson B.R.C., 1979, Symposia of the Zoological Society of London, P243; Vaz-Ferreira R, 1964, APARTADOS ARCH SOC B, V26, P44; Walling CA, 2010, BEHAV ECOL SOCIOBIOL, V64, P541, DOI 10.1007/s00265-009-0869-4; Wong BBM, 2004, ANIM BEHAV, V67, P583, DOI 10.1016/j.anbehav.2003.08.015; WOURMS JP, 1972, J EXP ZOOL, V182, P389, DOI 10.1002/jez.1401820310; Zuk Marlene, 1994, P354	49	43	43	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101649	10.1371/journal.pone.0101649	http://dx.doi.org/10.1371/journal.pone.0101649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029019	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600018
J	Sakthivel, P; Gereke, M; Breithaupt, A; Fuchs, D; Gigliotti, L; Gruber, AD; Dianzani, U; Bruder, D				Sakthivel, Priya; Gereke, Marcus; Breithaupt, Angele; Fuchs, Dietmar; Gigliotti, Luca; Gruber, Achim D.; Dianzani, Umberto; Bruder, Dunja			Attenuation of Immune-Mediated Influenza Pneumonia by Targeting the Inducible Co-Stimulator (ICOS) Molecule on T Cells	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; REGULATORY-CELLS; IL-10 PRODUCTION; CO-STIMULATION; CUTTING EDGE; VIRUS; RESPONSES; ACTIVATION; CD4(+); LIGAND	Inducible Co-stimulator (ICOS) plays a critical role in mediating T cell differentiation and function and is considered a key player in balancing T effector and T regulatory (T-reg) cell responses. Here we show that activation of the ICOS signalling pathway during acute influenza A virus (IAV) infection by application of an agonistic ICOS antibody reduced the frequency of CD8(+) T cells in the respiratory tract of IAV infected animals and delayed pathogen elimination. In line with this, immune-mediated influenza pneumonia was significantly ameliorated in mice that received ICOS agonist as indicated by significantly reduced alveolar infiltrations and bronchointerstitial pneumonia, while at the same time virus-related pathology remained unaffected. Importantly, ICOS agonist treatment resulted in expansion of CD4(+)Foxp3(+) T-regs in IAV infected mice, which was associated with elevated levels of the immunosuppressive cytokine IL-10 in the alveolar space. Together, our findings suggest a prominent role of ICOS signaling during acute IAV infection by increasing the T-reg/CD8(+) T cell ratio with beneficial outcome on immune-mediated pneumonia and underline the suitability of ICOS as potential therapeutic target for immune intervention in those infectious conditions characterized by strong immunopathology rather than virus-mediated cytopathic effects.	[Sakthivel, Priya; Gereke, Marcus; Bruder, Dunja] Helmholtz Ctr Infect Res, Immune Regulat Grp, Braunschweig, Germany; [Gereke, Marcus; Bruder, Dunja] Otto Von Guericke Univ, Inst Med Microbiol Infect Control & Prevent, Infect Immunol Grp, Magdeburg, Germany; [Breithaupt, Angele; Gruber, Achim D.] Free Univ Berlin, Inst Vet Pathol, Dept Vet Med, Berlin, Germany; [Fuchs, Dietmar] Med Univ Innsbruck, Div Biol Chem, A-6020 Innsbruck, Austria; [Gigliotti, Luca; Dianzani, Umberto] A Avogadro Univ Eastern Piedmont, Dept Hlth Sci, Novara, Italy; [Gigliotti, Luca; Dianzani, Umberto] A Avogadro Univ Eastern Piedmont, Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy	Helmholtz Association; Helmholtz-Center for Infection Research; Otto von Guericke University; Free University of Berlin; Medical University of Innsbruck; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Bruder, D (corresponding author), Helmholtz Ctr Infect Res, Immune Regulat Grp, Braunschweig, Germany.	dunja.bruder@med.ovgu.de	Dianzani, Umberto/K-1952-2016; Breithaupt, Angele/GON-7227-2022; Gruber, Achim D./ABA-4514-2021; Breithaupt, Angele/B-6155-2013; Fuchs, Dietmar/AAL-8011-2021; Gigliotti, Casimiro Luca/H-8809-2016	Breithaupt, Angele/0000-0002-6373-5923; Fuchs, Dietmar/0000-0003-1627-9563; Gigliotti, Casimiro Luca/0000-0002-3127-5686; DIANZANI, Umberto/0000-0001-6723-3931	Alexander-von-Humboldt Foundation; President's Initiative and Networking Fund of the Helmholtz Association of German Research Centers (HGF) [W2/W3-029]; Centre of Dynamic Systems (CDS), Magdeburg; Associazione Italiana Ricerca sul Cancro (Milano); Fondazione Amici di Jean (Torino)	Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); President's Initiative and Networking Fund of the Helmholtz Association of German Research Centers (HGF); Centre of Dynamic Systems (CDS), Magdeburg; Associazione Italiana Ricerca sul Cancro (Milano)(Fondazione AIRC per la ricerca sul cancro); Fondazione Amici di Jean (Torino)	This study was funded by the Alexander-von-Humboldt Foundation providing a postdoctoral fellowship to Priya Sakthivel. Dunja Bruder received financial support from the President's Initiative and Networking Fund of the Helmholtz Association of German Research Centers (HGF) under contract number W2/W3-029 and from the Centre of Dynamic Systems (CDS), Magdeburg. Umberto Dianzani and Luca Gigliotti received financial support from the Associazione Italiana Ricerca sul Cancro (Milano) and Fondazione Amici di Jean (Torino). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Bertram EM, 2004, SEMIN IMMUNOL, V16, P185, DOI 10.1016/j.smim.2004.02.006; Bertram EM, 2002, EUR J IMMUNOL, V32, P3376, DOI 10.1002/1521-4141(200212)32:12<3376::AID-IMMU3376>3.0.CO;2-Y; Betts RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027849; Busse M, 2012, J IMMUNOL, V189, P1975, DOI 10.4049/jimmunol.1103581; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Fox JM, 2013, J GEN VIROL, V94, P1451, DOI 10.1099/vir.0.053124-0; Fu TH, 2011, CANCER RES, V71, P5445, DOI 10.1158/0008-5472.CAN-11-1138; FUCHS D, 1990, J ACQ IMMUN DEF SYND, V3, P873; Gao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052657; Gereke M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-47; Gotsman I, 2006, CIRCULATION, V114, P2047, DOI 10.1161/CIRCULATIONAHA.106.633263; Greenwald RJ, 2002, J IMMUNOL, V168, P991, DOI 10.4049/jimmunol.168.3.991; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Honkanen J, 2008, DIABETES-METAB RES, V24, P635, DOI 10.1002/dmrr.904; Humphreys IR, 2006, EUR J IMMUNOL, V36, P2928, DOI 10.1002/eji.200636155; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Khayyamian S, 2002, P NATL ACAD SCI USA, V99, P6198, DOI 10.1073/pnas.092576699; Klingenberg R, 2005, EUR J IMMUNOL, V35, P1712, DOI 10.1002/eji.200425727; Kohyama M, 2004, P NATL ACAD SCI USA, V101, P4192, DOI 10.1073/pnas.0400214101; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; Kornete M, 2012, J IMMUNOL, V188, P1064, DOI 10.4049/jimmunol.1101303; Laich A, 2002, CLIN CHEM, V48, P579; Liu XS, 2006, J IMMUNOL, V177, P2873, DOI 10.4049/jimmunol.177.5.2873; Liu XL, 2001, J EXP MED, V194, P1339, DOI 10.1084/jem.194.9.1339; Liu XS, 2003, J IMMUNOL, V171, P4765, DOI 10.4049/jimmunol.171.9.4765; Marks E, 2007, INFECT IMMUN, V75, P4638, DOI 10.1128/IAI.00465-07; Mcgee HS, 2010, AM J RESP CELL MOL, V42, P331, DOI 10.1165/rcmb.2008-0397OC; Mesturini R, 2013, CYTOKINE, V64, P322, DOI 10.1016/j.cyto.2013.05.021; Mittrucker HW, 2002, J IMMUNOL, V169, P5813, DOI 10.4049/jimmunol.169.10.5813; Nouailles G, 2011, EUR J IMMUNOL, V41, P981, DOI 10.1002/eji.201040608; Nurieva RI, 2003, J CLIN INVEST, V111, P701, DOI 10.1172/JCI200317321; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Paulos CM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000448; Pfaff AW, 2008, INT J PARASITOL, V38, P249, DOI 10.1016/j.ijpara.2007.07.007; Quiroga MF, 2006, J IMMUNOL, V176, P5965, DOI 10.4049/jimmunol.176.10.5965; Redoglia V, 1996, EUR J IMMUNOL, V26, P2781, DOI 10.1002/eji.1830261134; Redpath SA, 2013, EUR J IMMUNOL, V43, P705, DOI 10.1002/eji.201242794; Scott BG, 2004, J NEUROIMMUNOL, V153, P16, DOI 10.1016/j.jneuroim.2004.04.019; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Telieps T, 2013, EUR J IMMUNOL, V43, P1499, DOI 10.1002/eji.201242819; Turner DL, 2013, J VIROL, V87, P4496, DOI 10.1128/JVI.03413-12; Vidric M, 2006, INFECT IMMUN, V74, P1050, DOI 10.1128/IAI.74.2.1050-1061.2006; Wallin JJ, 2001, J IMMUNOL, V167, P132, DOI 10.4049/jimmunol.167.1.132; Wang SD, 2000, BLOOD, V96, P2808; Wilson EH, 2006, J IMMUNOL, V177, P2365, DOI 10.4049/jimmunol.177.4.2365; Wong SC, 2003, BLOOD, V102, P1381, DOI 10.1182/blood-2002-08-2416; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Yu XZ, 2006, J IMMUNOL, V176, P7394, DOI 10.4049/jimmunol.176.12.7394	53	10	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e100970	10.1371/journal.pone.0100970	http://dx.doi.org/10.1371/journal.pone.0100970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029240	gold, Green Submitted, Green Published			2022-12-25	WOS:000341306600011
J	Almlof, JC; Lundmark, P; Lundmark, A; Ge, B; Pastinen, T; Goodall, AH; Cambien, F; Deloukas, P; Ouwehand, WH; Syvanen, AC				Almlof, Jonas Carlsson; Lundmark, Per; Lundmark, Anders; Ge, Bing; Pastinen, Tomi; Goodall, Alison H.; Cambien, Francois; Deloukas, Panos; Ouwehand, Willem H.; Syvanen, Ann-Christine		Cardiogenics Consortium	Single Nucleotide Polymorphisms with Cis-Regulatory Effects on Long Non-Coding Transcripts in Human Primary Monocytes	PLOS ONE			English	Article							ALLELE-SPECIFIC EXPRESSION; X-INACTIVATION CENTER; HUMAN GENOME; HUMAN-CELLS; RNAS; GENE; ENHANCERS; LOCI; BIAS; MAP	We applied genome-wide allele-specific expression analysis of monocytes from 188 samples. Monocytes were purified from white blood cells of healthy blood donors to detect cis-acting genetic variation that regulates the expression of long non-coding RNAs. We analysed 8929 regions harboring genes for potential long non-coding RNA that were retrieved from data from the ENCODE project. Of these regions, 60% were annotated as intergenic, which implies that they do not overlap with protein-coding genes. Focusing on the intergenic regions, and using stringent analysis of the allele-specific expression data, we detected robust cis-regulatory SNPs in 258 out of 489 informative intergenic regions included in the analysis. The cis-regulatory SNPs that were significantly associated with allele-specific expression of long non-coding RNAs were enriched to enhancer regions marked for active or bivalent, poised chromatin by histone modifications. Out of the IncRNA regions regulated by cis-acting regulatory SNPs, 20% (n = 52) were co-regulated with the closest protein coding gene. We compared the identified cis-regulatory SNPs with those in the catalog of SNPs identified by genome-wide association studies of human diseases and traits. This comparison identified 32 SNPs in loci from genome-wide association studies that displayed a strong association signal with allele-specific expression of non-coding RNAs in monocytes, with p-values ranging from 6.7x10(-7) to 9.5x10(-89). The identified cis-regulatory SNPs are associated with diseases of the immune system, like multiple sclerosis and rheumatoid arthritis.	[Almlof, Jonas Carlsson; Lundmark, Per; Lundmark, Anders; Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden; [Ge, Bing; Pastinen, Tomi] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Goodall, Alison H.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Goodall, Alison H.] Glenfield Gen Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Cambien, Francois] Univ Paris 06, INSERM, UMRS 937, Paris, France; [Cambien, Francois] Sch Med, Paris, France; [Deloukas, Panos] Queen Mary Univ London, Ctr Heart, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Deloukas, Panos; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge, England; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21413, Saudi Arabia; [Ouwehand, Willem H.] Cambridge Ctr, Natl Hlth Serv Blood & Transplant, Cambridge, England	Uppsala University; McGill University; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; University of London; Queen Mary University London; Wellcome Trust Sanger Institute; King Abdulaziz University; NHS Blood & Transplant (NHSBT)	Syvanen, AC (corresponding author), Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden.	Ann-Christine.Syvanen@medsci.uu.se	Cambien, Francois/AAP-9751-2020; Deloukas, Panos/B-2922-2013; Erdmann, Jeanette/P-7513-2014; Almlöf, Jonas/E-1608-2017	Deloukas, Panos/0000-0001-9251-070X; Erdmann, Jeanette/0000-0002-4486-6231; Almlöf, Jonas/0000-0002-1211-9821; Maouche, Seraya/0000-0001-8186-1635; Rendon, Augusto/0000-0001-8994-0039; Wallace, Chris/0000-0001-9755-1703; Matvienko-Sikar, Karen/0000-0003-2777-6581; Ouwehand, Willem/0000-0002-7744-1790	EU [LSHM-CT-2006-037593]; European Union [262055]; European Sequencing and Genotyping Infrastructure (ESGI); Swedish Research Council [A028001, C0524801]; Knut and Alice Wallenberg Foundation [KAW 2011.0073];  [282510 BLUEPRINT]; British Heart Foundation [RG/09/012/28096] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10214, RP-PG-0310-1002, NF-SI-0513-10151] Funding Source: researchfish	EU(European Commission); European Union(European Commission); European Sequencing and Genotyping Infrastructure (ESGI); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); ; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was performed as part of WP5 of the Cardiogenics EU FP6 project (grant number LSHM-CT-2006-037593). The work leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreements no 262055, European Sequencing and Genotyping Infrastructure (ESGI) and 282510 BLUEPRINT. A full list of the investigators in the Blueprint consortium who contributed to the generation of the data is available from www.blueprint-epigenome.eu. The study received funding from the Swedish Research Council (grants no A028001 and C0524801 to A-CS) and the Knut and Alice Wallenberg Foundation (KAW 2011.0073 to A-CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2011, NATURE, V477, P518, DOI 10.1038/477518a; Almlof JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052260; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garnier S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003240; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lerner-Ellis JP, 2009, HUM MUTAT, V30, P1072, DOI 10.1002/humu.21001; Li Xiaoyan, 2002, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V16, P412; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Satya RV, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks425; Stevenson KR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-536; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018	34	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102612	10.1371/journal.pone.0102612	http://dx.doi.org/10.1371/journal.pone.0102612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025429	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400093
J	Toma, MI; Erdmann, K; Diezel, M; Meinhardt, M; Zastrow, S; Fuessel, S; Wirth, MP; Baretton, GB				Toma, Marieta I.; Erdmann, Kati; Diezel, Michael; Meinhardt, Matthias; Zastrow, Stefan; Fuessel, Susanne; Wirth, Manfred P.; Baretton, Gustavo B.			Lack of Ephrin Receptor A1 Is a Favorable Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							TYROSINE KINASE; EPHA2 OVEREXPRESSION; DOWN-REGULATION; GROWTH-FACTOR; EXPRESSION; ANGIOGENESIS; METASTASIS; INVASION; LIGAND	The EPH receptor tyrosine kinases and their cell-bound ligands, the ephrins, have been shown to be associated with cancer development and progression. In this study, mRNA and protein expression of the receptors EPHA1 and EPHA2 as well as of their ligand EFNA1 and their prognostic relevance in clear cell renal cell carcinoma was evaluated. Gene expression was measured in 75 cryo-preserved primary tumors and matched non-malignant renal specimens by quantitative PCR. Protein expression was analyzed by immunohistochemistry on tissue microarrays comprising non-malignant, primary tumors and metastatic renal tissues of 241 patients. Gene and protein expression of all three factors was altered in tumor specimens with EPHA1 and EPHA2 being generally diminished in tumors compared to normal renal tissue, whereas EFNA1 was commonly elevated. A positive EPHA1 and EPHA2 protein staining as well as a low EFNA1 protein level were significantly linked to more aggressive tumor features, but only a positive EPHA1 immunoreactivity was significantly associated with poor survival. In subgroup analyses, EPHA1 and EPHA2 protein levels were significantly higher in metastatic than in primary lesions. Patients with EPHA1/EPHA2-positive tumors or with tumors with positive EPHA1 and low EFNA1 immunoreactivity had the shortest survival rates compared to the respective other combinations. In a multivariate model, EPHA1 was an independent prognostic marker for different survival endpoints. In conclusion, an impaired EPH-ephrin signaling could contribute to the pathogenesis and progression of clear cell renal cell carcinoma.	[Toma, Marieta I.; Diezel, Michael; Meinhardt, Matthias; Baretton, Gustavo B.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Inst Pathol, Dresden, Germany; [Erdmann, Kati; Zastrow, Stefan; Fuessel, Susanne; Wirth, Manfred P.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Urol, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Toma, MI (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Inst Pathol, Dresden, Germany.	marieta.toma@uniklinikum-dresden.de	Zastrow, Stefan/ABF-3692-2021; Toma, Marieta/AAI-8022-2021		MedDrive grant program of the Technical University Dresden [60.207]	MedDrive grant program of the Technical University Dresden	This study was funded by the MedDrive grant program of the Technical University Dresden. Grant Nr 60.207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athar U, 2008, CAN J UROL, V15, P3954; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen G, 2010, ONCOL REP, V23, P563, DOI 10.3892/or_00000670; Cheng N, 2002, MOL CANCER RES, V1, P2; Cui XD, 2010, INT J CANCER, V126, P940, DOI 10.1002/ijc.24798; Dong YC, 2009, MODERN PATHOL, V22, P151, DOI 10.1038/modpathol.2008.188; Eichelberg C, 2009, EUR UROL, V55, P851, DOI 10.1016/j.eururo.2009.01.003; Flanigan Robert C, 2003, Curr Treat Options Oncol, V4, P385, DOI 10.1007/s11864-003-0039-2; Giaginis C, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-8; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Herrem CJ, 2005, CLIN CANCER RES, V11, P226; Holm R, 2007, J CLIN PATHOL, V60, P1086, DOI 10.1136/jcp.2006.041194; Holm Ruth, 2008, Int J Med Sci, V5, P121; Ishikawa M, 2012, LUNG CANCER, V76, P431, DOI 10.1016/j.lungcan.2011.12.004; Kamat AA, 2009, CANCER-AM CANCER SOC, V115, P2684, DOI 10.1002/cncr.24335; Kinch MS, 2003, CLIN CANCER RES, V9, P613; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Li X, 2010, TUMOR BIOL, V31, P477, DOI 10.1007/s13277-010-0060-6; Liu Y, 2012, J CANCER RES CLIN, V138, P195, DOI 10.1007/s00432-011-1087-9; Liu Y, 2011, J CANCER RES CLIN, V137, P761, DOI 10.1007/s00432-010-0936-2; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Merritt WM, 2010, CANCER BIOL THER, V10, P1306, DOI 10.4161/cbt.10.12.13582; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Noblitt LW, 2004, CANCER GENE THER, V11, P757, DOI 10.1038/sj.cgt.7700761; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Patel NS, 2009, TUMOR BIOL, V30, P292, DOI 10.1159/000260241; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Shahzad MMK, 2009, CANCER BIOL THER, V8, P1027, DOI 10.4161/cbt.8.11.8523; Taddei ML, 2011, MOL CANCER RES, V9, P149, DOI 10.1158/1541-7786.MCR-10-0298; Tatsumi T, 2003, CANCER RES, V63, P4481; Toma MI, 2008, NEOPLASIA, V10, P634, DOI 10.1593/neo.08160; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wang JD, 2013, APMIS, V121, P30, DOI 10.1111/j.1600-0463.2012.02941.x; Wu D, 2004, GYNECOL ONCOL, V94, P312, DOI 10.1016/j.ygyno.2004.05.019; Yuan WJ, 2009, DIGEST DIS SCI, V54, P2410, DOI 10.1007/s10620-008-0649-4	35	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102262	10.1371/journal.pone.0102262	http://dx.doi.org/10.1371/journal.pone.0102262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025847	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400056
J	Wang, WT; Catto, JWF; Meuth, M				Wang, W-T; Catto, J. W. F.; Meuth, M.			Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors	ONCOGENE			English	Article							REPLICATION FORK PROGRESSION; DNA-DAMAGE CHECKPOINT; PHOSPHORYLATION; KINASE; ACTIVATION; APOPTOSIS; RPA; PROMOTES; INACTIVATION; EXPRESSION	While DNA damage response pathways are well characterized in cancer cells, much less is known about their status in normal cells. These pathways protect tumour cells from DNA damage and replication stress and consequently present potential therapeutic targets. Here we characterize the response of human telomerase reverse transcriptase (hTERT)-immortalized normal human urothelial (NHU) and bladder cancer cell lines to agents that disrupt the DNA damage response. Effects of replication and DNA damage response inhibitors on cell cycle progression, checkpoint induction and apoptosis were analysed in hTERT-NHU and bladder cancer cell lines. The primary signalling cascade responding to replication stress in malignant cells (ataxia telangiectasia-mutated (ATM) and Rad3-related-checkpoint kinase 1 (ATR-CHK1)) is not activated in hTERT-NHU cells after treatment with a replication inhibitor and these cells do not depend upon CHK1 for protection from apoptosis during replication stress. Instead, ATM signalling is rapidly activated under these conditions. Intriguingly, an ATM inhibitor suppressed S-phase checkpoint activation after exposure to replication inhibitors and stopped entry of cells into S-phase indicating G1 checkpoint activation. Consistent with this, hTERT-NHU cells treated with the ATM inhibitor showed increased levels of cyclin-dependent kinase inhibitor p19(INK4D), reduced levels of cyclin D1 and CDK4, and reduced phosphorylation of the retinoblastoma protein. In contrast, a bladder cancer cell line cotreated with ATM and replication inhibitors progressed more slowly through S phase and showed a marked increase in apoptosis. Taken together, our findings suggest that ATM and CHK1 signalling cascades have different roles in tumour and normal epithelial cells, confirming these as promising therapeutic targets.	[Wang, W-T; Catto, J. W. F.; Meuth, M.] Univ Sheffield, Sch Med, YCR CRUK Sheffield Canc Res Ctr, Mol Oncol Unit,Dept Oncol, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield	Meuth, M (corresponding author), Univ Sheffield, Sch Med, YCR CRUK Sheffield Canc Res Ctr, Mol Oncol Unit,Dept Oncol, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	m.meuth@sheffield.ac.uk		catto, james/0000-0003-2787-8828	Yorkshire Cancer Research [S305PA]; P. A. Banner Trust	Yorkshire Cancer Research; P. A. Banner Trust	This work was supported in part by a programme grant from Yorkshire Cancer Research (S305PA) and the P. A. Banner Trust. We are grateful to Helen Bryant for her comments on the manuscript.	Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bennett CN, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3230; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Blackwood E, 2013, MOL CANCER THER, V12, P1968, DOI 10.1158/1535-7163.MCT-12-1218; Bolderson E, 2004, HUM MOL GENET, V13, P2937, DOI 10.1093/hmg/ddh316; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Carrassa L, 2011, CELL CYCLE, V10, P2121, DOI 10.4161/cc.10.13.16398; Ceruti JM, 2005, ONCOGENE, V24, P4065, DOI 10.1038/sj.onc.1208570; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Cho SH, 2005, CELL CYCLE, V4, P131, DOI 10.4161/cc.4.1.1299; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clarke CAL, 2005, BIOCHEM J, V388, P705, DOI 10.1042/BJ20041966; Cole KA, 2011, P NATL ACAD SCI USA, V108, P3336, DOI 10.1073/pnas.1012351108; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Di Fiore R, 2013, J CELL PHYSIOL, V228, P1676, DOI 10.1002/jcp.24329; Gagou ME, 2010, MOL BIOL CELL, V21, P739, DOI 10.1091/mbc.E09-07-0618; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kaneko Y, 1999, ONCOGENE, V18, P3673, DOI 10.1038/sj.onc.1202706; Liu QH, 2000, GENE DEV, V14, P1448; Liu SQ, 2012, NUCLEIC ACIDS RES, V40, P10780, DOI 10.1093/nar/gks849; Lukas C, 2001, CANCER RES, V61, P4990; Meuth M, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-21; Myers K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000324; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Rodriguez R, 2008, CELL DEATH DIFFER, V15, P889, DOI 10.1038/cdd.2008.4; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takai H, 2000, GENE DEV, V14, P1439; Tavera-Mendoza L, 2006, EMBO REP, V7, P180, DOI 10.1038/sj.embor.7400594; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Walker M, 2009, ONCOGENE, V28, P2314, DOI 10.1038/onc.2009.102; Wang JL, 2002, CELL CYCLE, V1, P267, DOI 10.4161/cc.1.4.137; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	54	7	8	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2015	34	22					2887	2896		10.1038/onc.2014.221	http://dx.doi.org/10.1038/onc.2014.221			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CJ2OM	25043304	Green Submitted			2022-12-25	WOS:000355324300008
J	Shin, J; Carr, A; Corner, GA; Togel, L; Davaos-Salas, M; Tran, H; Chueh, AC; Al-Obaidi, S; Chionh, F; Ahmed, N; Buchanan, DD; Young, JP; Malo, MS; Hodin, RA; Arango, D; Sieber, OM; Augenlicht, LH; Dhillon, AS; Weber, TK; Mariadason, JM				Shin, Joongho; Carr, Azadeh; Corner, Georgia A.; Toegel, Lars; Davaos-Salas, Mercedes; Hoanh Tran; Chueh, Anderly C.; Al-Obaidi, Sheren; Chionh, Fiona; Ahmed, Naseem; Buchanan, Daniel D. y; Young, Joanne P.; Malo, Madhu S.; Hodin, Richard A.; Arango, Diego; Sieber, Oliver M.; Augenlicht, Leonard H.; Dhillon, Amardeep S.; Weber, Thomas K.; Mariadason, John M.			The Intestinal Epithelial Cell Differentiation Marker Intestinal Alkaline Phosphatase (ALPi) Is Selectively Induced by Histone Deacetylase Inhibitors (HDACi) in Colon Cancer Cells in a Kruppel-like Factor 5 (KLF5)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLAND METHYLATOR PHENOTYPE; CHAIN FATTY-ACIDS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CPG ISLAND; COLORECTAL-CANCER; MYELOID-LEUKEMIA; DNA METHYLATION; CARCINOMA-CELLS; BUTYRATE	The histone deacetylase inhibitor (HDACi) sodium butyrate promotes differentiation of colon cancer cells as evidenced by induced expression and enzyme activity of the differentiation marker intestinal alkaline phosphatase (ALPi). Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity. This differential sensitivity was similarly evident following treatment with the structurally distinct HDACi, MS-275. Resistant cell lines were significantly enriched for those harboring the CpG island methylator phenotype (p = 0.036, Chi square test), and resistant cell lines harbored methylation of the ALPi promoter, particularly of a CpG site within a critical KLF/Sp regulatory element required for butyrate induction of ALPi promoter activity. However, butyrate induction of an exogenous ALPi promoter-reporter paralleled up-regulation of endogenous ALPi expression across the cell lines, suggesting the presence or absence of a key transcriptional regulator is the major determinant of ALPi induction. Through microarray profiling of sensitive and resistant cell lines, we identified KLF5 to be both basally more highly expressed as well as preferentially induced by butyrate in sensitive cell lines. KLF5 overexpression induced ALPi promoter-reporter activity in resistant cell lines, KLF5 knockdown attenuated butyrate induction of ALPi expression in sensitive lines, and butyrate selectively enhanced KLF5 binding to the ALPi promoter in sensitive cells. These findings demonstrate that butyrate induction of the cell differentiation marker ALPi is mediated through KLF5 and identifies subsets of colon cancer cell lines responsive and refractory to this effect.	[Shin, Joongho; Carr, Azadeh; Ahmed, Naseem; Augenlicht, Leonard H.; Mariadason, John M.] Albert Einstein Coll Med, Dept Oncol, Montefiore Med Ctr, Bronx, NY 10461 USA; [Corner, Georgia A.; Toegel, Lars; Davaos-Salas, Mercedes; Hoanh Tran; Chueh, Anderly C.; Al-Obaidi, Sheren; Chionh, Fiona; Mariadason, John M.] Austin Hlth, Ludwig Inst Canc Res, Melbourne, Vic 3084, Australia; [Buchanan, Daniel D. y; Young, Joanne P.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Malo, Madhu S.; Hodin, Richard A.] Harvard Univ, Sch Med, Dept Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Arango, Diego] Univ Autonoma Barcelona, Ctr Invest Bioquim & Biol Mol Nanomed, Vall dHebron Univ Hosp, Grp Mol Oncol,Res Inst, Barcelona 08035, Spain; [Arango, Diego] Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Barcelona, Spain; [Sieber, Oliver M.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Dhillon, Amardeep S.] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Weber, Thomas K.] Vet Affairs New York Harbor Hlth Care Syst, Brooklyn, NY 11209 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ludwig Institute for Cancer Research; QIMR Berghofer Medical Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Walter & Eliza Hall Institute; Peter Maccallum Cancer Center	Mariadason, JM (corresponding author), Austin Hlth, Ludwig Inst Canc Res, Level Olivia Newton John Canc & Wellness Ctr 5, 145-163 Studley Rd, Heidelberg, Vic 3084, Australia.	john.mariadason@ludwig.edu.au	Chueh, Anderly/AAF-9375-2022; Sieber, Oliver/ABA-9211-2021; Sieber, Oliver/M-9473-2015; Chueh, Anderly C./D-8615-2015; Arango, Diego/AFW-0125-2022; Arango, Diego/M-5667-2016; Chüeh, Anderly C/AFC-2076-2022	Sieber, Oliver/0000-0001-9480-0786; Sieber, Oliver/0000-0001-9480-0786; Chueh, Anderly C./0000-0003-1140-5516; Arango, Diego/0000-0003-2953-3284; Arango, Diego/0000-0003-2953-3284; Chüeh, Anderly C/0000-0003-1140-5516; Al-Obaidi, Sheren/0000-0002-4390-7564; Young, Joanne/0000-0002-1514-1522; Buchanan, Daniel/0000-0003-2225-6675; Mariadason, John/0000-0001-9123-7684; Dhillon, Amardeep/0000-0002-6065-663X	Operational Infrastructure Support Program (Victorian government, Australia); Spanish Ministry for Economy and Competitiveness [CP05/00256, TRA2009-0093, SAF2008-00789, PI12/03112, PI12/01095]; Association for International Cancer Research Grant [AICR13-0245]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR 157]; Australian Research Council [FT0992234]; National Health and Medical Research Council [1046092]; CONACyT Mexico [186310]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Operational Infrastructure Support Program (Victorian government, Australia); Spanish Ministry for Economy and Competitiveness(Spanish Government); Association for International Cancer Research Grant; Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); CONACyT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Operational Infrastructure Support Program (Victorian government, Australia), Spanish Ministry for Economy and Competitiveness Grants CP05/00256, TRA2009-0093, SAF2008-00789, PI12/03112, and PI12/01095, the Association for International Cancer Research Grant AICR13-0245, Agencia de Gestio d'Ajuts Universitaris i de Recerca SGR 157 (to D. A.), and Australian Research Council Future Fellowship FT0992234 and National Health and Medical Research Council Senior Research Fellowship 1046092 (to J. M. M.).; Supported by a fellowship from CONACyT Mexico (186310).	Alkhoury F, 2005, AM J PHYSIOL-GASTR L, V289, pG285, DOI 10.1152/ajpgi.00037.2005; Bell SM, 2013, DEV BIOL, V375, P128, DOI 10.1016/j.ydbio.2012.12.010; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Boumber YA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000162; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Chen CS, 2004, GENE, V330, P133, DOI 10.1016/j.gene.2004.01.014; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Diakiw SM, 2012, LEUKEMIA RES, V36, P110, DOI 10.1016/j.leukres.2011.09.013; Gebhard C, 2006, CANCER RES, V66, P6118, DOI 10.1158/0008-5472.CAN-06-0376; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Ghaleb AM, 2008, CURR COLORECT CANC R, V4, P59, DOI 10.1007/s11888-008-0011-4; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Hinnebusch BF, 2004, AM J PHYSIOL-GASTR L, V286, pG23, DOI 10.1152/ajpgi.00203.2003; Hodin RA, 1996, CELL GROWTH DIFFER, V7, P647; ITO F, 1984, J BIOL CHEM, V259, P2526; Kim JH, 1999, AM J PHYSIOL-GASTR L, V276, pG800, DOI 10.1152/ajpgi.1999.276.4.G800; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Mahmood A, 2003, AM J PHYSIOL-GASTR L, V285, pG433, DOI 10.1152/ajpgi.00466.2002; Malo MS, 2006, AM J PHYSIOL-GASTR L, V290, pG737, DOI 10.1152/ajpgi.00394.2005; Mariadason JM, 2003, CANCER RES, V63, P8791; Mariadason JM, 1997, AM J PHYSIOL-GASTR L, V272, pG705, DOI 10.1152/ajpgi.1997.272.4.G705; Mariadason JM, 2000, J CELL PHYSIOL, V183, P347, DOI 10.1002/(SICI)1097-4652(200006)183:3<347::AID-JCP7>3.0.CO;2-W; McComb R. B., 1979, ALKALINE PHOSPHATASE, P865; McConnell BB, 2011, GASTROENTEROLOGY, V141, P1302, DOI 10.1053/j.gastro.2011.06.086; Meng S, 1999, SURGERY, V126, P293, DOI 10.1067/msy.1999.98927; Nakaya T, 2014, CANCER RES, V74, P2882, DOI 10.1158/0008-5472.CAN-13-2574; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; Nguyen HTT, 2006, BIOCHEM BIOPH RES CO, V342, P236, DOI 10.1016/j.bbrc.2006.01.141; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Pettersson F, 2011, Cell Death Differ, V18, P1231, DOI 10.1038/cdd.2010.173; Potapova A, 2010, EUR J HAEMATOL, V84, P298, DOI 10.1111/j.1600-0609.2009.01389.x; SILKE J, 1995, FEBS LETT, V370, P170, DOI 10.1016/0014-5793(95)00830-3; Teodoridis JM, 2008, CANCER LETT, V268, P177, DOI 10.1016/j.canlet.2008.03.022; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wilson AJ, 2008, MOL BIOL CELL, V19, P4062, DOI 10.1091/mbc.E08-02-0139; Yardley DA, 2013, J CLIN ONCOL, V31, P2128, DOI 10.1200/JCO.2012.43.7251; YOUNG GP, 1984, AM J PHYSIOL, V247, pG419, DOI 10.1152/ajpgi.1984.247.4.G419	41	45	46	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25306	25316		10.1074/jbc.M114.557546	http://dx.doi.org/10.1074/jbc.M114.557546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25037223	Green Published, hybrid			2022-12-25	WOS:000341985300049
J	Platholi, J; Federman, A; Detert, JA; Heerdt, P; Hemmings, HC				Platholi, Jimcy; Federman, Anna; Detert, Julia A.; Heerdt, Paul; Hemmings, Hugh C., Jr.			Regulation of Protein Phosphatase 1(I) by Cdc25C-associated Kinase 1 (C-TAK1) and PFTAIRE Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Enzyme; Enzyme Mechanism; Ischemia; Protein Phosphorylation; Inhibitor 2	RABBIT SKELETAL-MUSCLE; PHOSPHORYLATES HUMAN CDC25C; PHOSPHOPROTEIN PHOSPHATASE; SYNERGISTIC PHOSPHORYLATION; MODULATOR SUBUNIT; BOVINE HEART; INHIBITOR-2; IDENTIFICATION; ACTIVATION; BRAIN	Background: Protein phosphatases exist as multisubunit complexes. Results: Two protein kinases in endogenous brain protein phosphatase 1(I) were found to regulate its activation in opposing directions through inhibitor 2 phosphorylation. Conclusion: These kinases support a signaling cascade that regulates protein phosphatase 1(I) activation in global cerebral ischemia. Significance: Understanding the signaling pathways regulating the activity of protein phosphatases is critical to elucidating their physiological and pathological roles. Protein phosphatase 1(I) (PP-1(I)) is a major endogenous form of protein phosphatase 1 (PP-1) that consists of the core catalytic subunit PP-1c and the regulatory subunit inhibitor 2 (I-2). Phosphorylation of the Thr-72 residue of I-2 is required for activation of PP-1(I). We studied the effects of two protein kinases identified previously in purified brain PP-1(I) by mass spectrometry, Cdc25C-associated kinase 1 (C-TAK1) and PFTAIRE (PFTK1) kinase, for their ability to regulate PP-1(I). Purified C-TAK1 phosphorylated I-2 in reconstituted PP-1(I) (PP-1cI-2) on Ser-71, which resulted in partial inhibition of its ATP-dependent phosphatase activity and inhibited subsequent phosphorylation of Thr-72 by the exogenous activating kinase GSK-3. In contrast, purified PFTK1 phosphorylated I-2 at Ser-86, a site known to potentiate Thr-72 phosphorylation and activation of PP-1(I) phosphatase activity by GSK-3. These findings indicate that brain PP-1(I) associates with and is regulated by the associated protein kinases C-TAK1 and PFTK1. Multisite phosphorylation of the I-2 regulatory subunit of PP-1(I) leads to activation or inactivation of PP-1(I) through bidirectional modulation of Thr-72 phosphorylation, the critical activating residue of I-2.	[Platholi, Jimcy; Federman, Anna; Detert, Julia A.; Heerdt, Paul; Hemmings, Hugh C., Jr.] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY 10065 USA; [Platholi, Jimcy; Federman, Anna; Heerdt, Paul; Hemmings, Hugh C., Jr.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA	Cornell University; Cornell University	Hemmings, HC (corresponding author), Weill Cornell Med Coll, Dept Anesthesiol, 1300 York Ave, New York, NY 10065 USA.	hchemmi@med.cornell.edu			National Institutes of Health [NS 56315]; Weill Cornell Medical College Department of Anesthesiology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell Medical College Department of Anesthesiology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS 56315. This work was also supported by the Weill Cornell Medical College Department of Anesthesiology.	AGOSTINIS P, 1992, FEBS LETT, V305, P121, DOI 10.1016/0014-5793(92)80877-J; Ayllon V, 2002, EUR J IMMUNOL, V32, P1847, DOI 10.1002/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7; Ayllon V, 2000, EMBO J, V19, P2237, DOI 10.1093/emboj/19.10.2237; BALLOU LM, 1986, CONTROL PHOSPHORYLAT, P331; Berggren K, 2000, ELECTROPHORESIS, V21, P2509, DOI 10.1002/1522-2683(20000701)21:12<2509::AID-ELPS2509>3.3.CO;2-0; Besset V, 1998, MOL REPROD DEV, V50, P18, DOI 10.1002/(SICI)1098-2795(199805)50:1&lt;18::AID-MRD3&gt;3.0.CO;2-#; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cohen PTW, 2002, J CELL SCI, V115, P241; DEPAOLIROACH AA, 1984, J BIOL CHEM, V259, P2144; Hedou GF, 2008, J NEUROSCI, V28, P154, DOI 10.1523/JNEUROSCI.4109-07.2008; HEMMINGS BA, 1982, FEBS LETT, V150, P319, DOI 10.1016/0014-5793(82)80760-6; HOLMES CFB, 1987, BIOCHIM BIOPHYS ACTA, V929, P208, DOI 10.1016/0167-4889(87)90178-9; HOLMES CFB, 1986, BIOCHIM BIOPHYS ACTA, V870, P408, DOI 10.1016/0167-4838(86)90248-7; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; JURGENSEN S, 1984, J BIOL CHEM, V259, P5864; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE JC, 1988, BIOCHEM BIOPH RES CO, V150, P197, DOI 10.1016/0006-291X(88)90505-0; Lazzaro MA, 1997, J NEUROCHEM, V69, P348, DOI 10.1046/j.1471-4159.1997.69010348.x; Leach C, 2003, J BIOL CHEM, V278, P26015, DOI 10.1074/jbc.M300782200; LI HC, 1985, J BIOL CHEM, V260, P6416; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Muller J, 2003, EMBO J, V22, P4431, DOI 10.1093/emboj/cdg426; Munton RP, 2004, FEBS LETT, V567, P121, DOI 10.1016/j.febslet.2004.03.121; OGG S, 1994, J BIOL CHEM, V269, P30461; ORGAD S, 1987, EUR J BIOCHEM, V164, P31, DOI 10.1111/j.1432-1033.1987.tb10988.x; PARK IK, 1994, J BIOL CHEM, V269, P944; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Platholi J, 2008, J NEUROCHEM, V105, P2029, DOI 10.1111/j.1471-4159.2008.05300.x; PONDAVEN P, 1987, EUR J BIOCHEM, V167, P135, DOI 10.1111/j.1432-1033.1987.tb13314.x; PRICE DJ, 1985, BIOCHEM BIOPH RES CO, V128, P1203, DOI 10.1016/0006-291X(85)91068-X; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; RESINK TJ, 1983, EUR J BIOCHEM, V133, P455, DOI 10.1111/j.1432-1033.1983.tb07485.x; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Tanimukai H, 2004, MOL BRAIN RES, V126, P146, DOI 10.1016/j.molbrainres.2004.04.003; TUNG HYL, 1984, EUR J BIOCHEM, V145, P57, DOI 10.1111/j.1432-1033.1984.tb08521.x; VANDENHEEDE JR, 1985, J BIOL CHEM, V260, P512; VILLAMORUZZI E, 1984, J BIOL CHEM, V259, P5857; WANG QM, 1995, J BIOL CHEM, V270, P18352, DOI 10.1074/jbc.270.31.18352; Wang RH, 2001, ONCOGENE, V20, P6111, DOI 10.1038/sj.onc.1204829; YANG SD, 1986, J BIOL CHEM, V261, P1786; YANG SD, 1985, J BIOL CHEM, V260, P3464	47	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23893	23900		10.1074/jbc.M114.557744	http://dx.doi.org/10.1074/jbc.M114.557744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25028520	hybrid, Green Published			2022-12-25	WOS:000341505000055
J	Jain, M; Zhang, L; Boufraqech, M; Liu-Chittenden, Y; Bussey, K; Demeure, MJ; Wu, XL; Su, L; Pacak, K; Stratakis, CA; Kebebew, E				Jain, Meenu; Zhang, Lisa; Boufraqech, Myriem; Liu-Chittenden, Yi; Bussey, Kimberly; Demeure, Michael J.; Wu, Xiaolin; Su, Ling; Pacak, Karel; Stratakis, Constantine A.; Kebebew, Electron			ZNF367 Inhibits Cancer Progression and Is Targeted by miR-195	PLOS ONE			English	Article							GROWTH; GENE; IDENTIFICATION; TUMOR; ASSOCIATION; RESISTANCE; MUTATIONS; MICRORNAS; INVASION; PROTEIN	Background: Several members of the zinc finger protein family have been recently shown to have a role in cancer initiation and progression. Zinc finger protein 367 (ZNF367) is a member of the zinc finger protein family and is expressed in embryonic or fetal erythroid tissue but is absent in normal adult tissue. Methodology/Principal Findings: We show that ZNF367 is overexpressed in adrenocortical carcinoma, malignant pheochromocytoma/paraganglioma and thyroid cancer as compared to normal tissue and benign tumors. Using both functional knockdown and ectopic overexpression in multiple cell lines, we show that ZNF367 inhibits cellular proliferation, invasion, migration, and adhesion to extracellular proteins in vitro and in vivo. Integrated gene and microRNA expression analyses showed an inverse correlation between ZNF367 and miR-195 expression. Luciferase assays demonstrated that miR-195 directly regulates ZNF367 expression and that miR-195 regulates cellular invasion. Moreover, integrin alpha 3 (ITGA3) expression was regulated by ZNF367. Conclusions/Significance: Our findings taken together suggest that ZNF367 regulates cancer progression.	[Jain, Meenu; Zhang, Lisa; Boufraqech, Myriem; Liu-Chittenden, Yi; Kebebew, Electron] NCI, Endocrine Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Bussey, Kimberly; Demeure, Michael J.] Translat Genom Res Inst, Phoenix, AZ USA; [Wu, Xiaolin; Su, Ling] SAIC Frederick Inc, Lab Mol Technol, Frederick Natl Lab Canc Res, Frederick, MD USA; [Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth, Sect Med Neuroendocrinol, NIH, Bethesda, MD USA; [Stratakis, Constantine A.] Eunice Kennedy Shriver Natl Inst Child Hlth, Sect Endocrinol & Genet, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Translational Genomics Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kebebew, E (corresponding author), NCI, Endocrine Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	kebebewe@mail.nih.gov	Bussey, Kimberly J./D-2567-2011; Boufraqech, Myriem/E-4823-2016; Stratakis, Constantine/AAP-4745-2020	Bussey, Kimberly/0000-0003-1001-8207; Liu, Yi/0000-0001-6357-5360	Center for Cancer Research, National Cancer Institute, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC011275] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the intramural research program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama T, 2012, MOL ENDOCRINOL, V26, P493, DOI 10.1210/me.2011-1004; AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Asano H, 2004, BIOCHEM J, V384, P647, DOI 10.1042/BJ20040394; Bai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038875; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Duan ZF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006967; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Furuta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060155; Gerdin A., 2010, ACTA OPHTHALMOLOGICA, V88; Gilligan P, 2002, GENE, V294, P35, DOI 10.1016/S0378-1119(02)00793-X; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kuramoto K, 2000, CANCER RES, V60, P425; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Mao JH, 2012, ONCOL LETT, V4, P1125, DOI 10.3892/ol.2012.863; Ozata DM, 2011, ENDOCR-RELAT CANCER, V18, P643, DOI 10.1530/ERC-11-0082; Pasini B, 2009, J INTERN MED, V266, P19, DOI 10.1111/j.1365-2796.2009.02111.x; Rink L, 2009, MOL CANCER THER, V8, P2172, DOI 10.1158/1535-7163.MCT-09-0193; Rossi M, 2004, CANCER LETT, V215, P229, DOI 10.1016/j.canlet.2004.05.014; Sachs N, 2012, P NATL ACAD SCI USA, V109, P21468, DOI 10.1073/pnas.1204614110; Seyhan AA, 2012, MOL BIOSYST, V8, P1553, DOI 10.1039/c2mb05512k; Slaby O, 2012, GENE CHROMOSOME CANC, V51, P707, DOI 10.1002/gcc.21957; Soon PSH, 2009, CLIN CANCER RES, V15, P7684, DOI 10.1158/1078-0432.CCR-09-1587; Wang T, 2012, J CELL MOL MED, V16, P1134, DOI 10.1111/j.1582-4934.2011.01388.x; Wang XQ, 2012, MED ONCOL, V29, P919, DOI 10.1007/s12032-011-9880-5; Xekouki P, 2012, J CLIN ENDOCR METAB, V97, pE357, DOI 10.1210/jc.2011-1179; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Zhang QQ, 2012, NEURO-ONCOLOGY, V14, P278, DOI 10.1093/neuonc/nor216	27	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101423	10.1371/journal.pone.0101423	http://dx.doi.org/10.1371/journal.pone.0101423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047265	Green Submitted, Green Published, gold			2022-12-25	WOS:000339558100009
J	Kalle, M; Papareddy, P; Kasetty, G; van der Plas, MJA; Morgelin, M; Malmsten, M; Schmidtchen, A				Kalle, Martina; Papareddy, Praveen; Kasetty, Gopinath; van der Plas, Mariena J. A.; Morgelin, Matthias; Malmsten, Martin; Schmidtchen, Artur			A Peptide of Heparin Cofactor II Inhibits Endotoxin-Mediated Shock and Invasive Pseudomonas aeruginosa Infection	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; HOST-DEFENSE PEPTIDES; SEVERE SEPSIS; ANTIMICROBIAL PEPTIDES; INFLAMMATORY RESPONSE; BACTERIAL-INFECTIONS; ACTIVATION; TIFACOGIN; EFFICACY; SYSTEM	Sepsis and septic shock remain important medical problems with high mortality rates. Today's treatment is based mainly on using antibiotics to target the bacteria, without addressing the systemic inflammatory response, which is a major contributor to mortality in sepsis. Therefore, novel treatment options are urgently needed to counteract these complex sepsis pathologies. Heparin cofactor II (HCII) has recently been shown to be protective against Gram-negative infections. The antimicrobial effects were mapped to helices A and D of the molecule. Here we show that KYE28, a 28 amino acid long peptide representing helix D of HCII, is antimicrobial against the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa, the Gram-positive Bacillus subtilis and Staphylococcus aureus, as well as the fungus Candida albicans. Moreover, KYE28 binds to LPS and thereby reduces LPS-induced pro-inflammatory responses by decreasing NF-kappa B/AP-1 activation in vitro. In mouse models of LPS-induced shock, KYE28 significantly enhanced survival by dampening the pro-inflammatory cytokine response. Finally, in an invasive Pseudomonas infection model, the peptide inhibited bacterial growth and reduced the pro-inflammatory response, which lead to a significant reduction of mortality. In summary, the peptide KYE28, by simultaneously targeting bacteria and LPS-induced pro-inflammatory responses represents a novel therapeutic candidate for invasive infections.	[Kalle, Martina; Papareddy, Praveen; Kasetty, Gopinath; van der Plas, Mariena J. A.; Schmidtchen, Artur] Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Biomed Ctr, Lund, Sweden; [Morgelin, Matthias] Lund Univ, Div Infect Med, Dept Clin Sci, Biomed Ctr, Lund, Sweden; [Malmsten, Martin] Uppsala Univ, Dept Pharm, Uppsala, Sweden; [Schmidtchen, Artur] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore	Lund University; Lund University; Uppsala University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kalle, M (corresponding author), Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Biomed Ctr, Lund, Sweden.	martina.kalle@gmail.com	Schmidtchen, Artur/F-9507-2015; van der Plas, Mariena/GYV-3702-2022	van der Plas, Mariena/0000-0002-3233-2881; Papareddy, Praveen/0000-0002-3872-478X; Malmsten, Martin/0000-0003-0046-5599	Swedish Research Council [2012-1883, 1842]; Welander-Finsen Foundation; Knut and Alice Wallenberg Foundation; Crafoord Foundation; Osterlund Foundation; Kock Foundation; Swedish Government Funds for Clinical Research (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Welander-Finsen Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Crafoord Foundation; Osterlund Foundation; Kock Foundation; Swedish Government Funds for Clinical Research (ALF)	This work was supported by grants from the Swedish Research Council (project 2012-1883 and 1842), the Welander-Finsen, Knut and Alice Wallenberg, Crafoord, Osterlund, Kock Foundations, and The Swedish Government Funds for Clinical Research (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2001, CRIT CARE MED, V29, P2081, DOI 10.1097/00003246-200111000-00007; Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Albiger B, 2007, J INTERN MED, V261, P511, DOI 10.1111/j.1365-2796.2007.01821.x; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; de Jong HK, 2010, J INNATE IMMUN, V2, P422, DOI 10.1159/000316286; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dhainaut JF, 2005, CRIT CARE MED, V33, P341, DOI 10.1097/01.CCM.0000153520.31562.48; Faix JD, 2013, CRIT REV CL LAB SCI, V50, P23, DOI 10.3109/10408363.2013.764490; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; French GL, 2010, INT J ANTIMICROB AG, V36, pS3, DOI 10.1016/S0924-8579(10)70003-0; Fritsche TR, 2008, J ANTIMICROB CHEMOTH, V61, P1092, DOI 10.1093/jac/dkn074; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harder J, 2007, J ENDOTOXIN RES, V13, P317, DOI 10.1177/0968051907088275; Herwald H, 1998, NAT MED, V4, P298, DOI 10.1038/nm0398-298; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Kalle M, 2013, J IMMUNOL, V190, P6303, DOI 10.4049/jimmunol.1203030; Kalle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051313; Kasetty G, 2011, J INNATE IMMUN, V3, P471, DOI 10.1159/000327016; Kasetty G, 2011, ANTIMICROB AGENTS CH, V55, P2880, DOI 10.1128/AAC.01515-10; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Laterre PF, 2009, CRIT CARE, V13, DOI 10.1186/cc7747; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Levi M, 1999, THROMB HAEMOSTASIS, V82, P695; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; Marti-Carvajal AJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004388.pub5; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Oehmcke S, 2010, J MOL MED, V88, P121, DOI 10.1007/s00109-009-0564-y; Papareddy P, 2014, BBA-BIOMEMBRANES, V1838, P1225, DOI 10.1016/j.bbamem.2014.01.026; Papareddy P, 2010, J BIOL CHEM, V285, P28387, DOI 10.1074/jbc.M110.127019; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; Pasupuleti M, 2008, BIOCHEMISTRY-US, V47, P9057, DOI 10.1021/bi800991e; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; PATEL RT, 1994, BRIT J SURG, V81, P1306, DOI 10.1002/bjs.1800810914; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P2, DOI 10.1111/j.1469-0691.2008.02126.x; Schuerholz T, 2012, CRIT CARE, V16, DOI 10.1186/cc11220; Sha T, 2007, EUR J PHARMACOL, V571, P231, DOI 10.1016/j.ejphar.2007.06.027; Singh S, 2013, BBA-BIOMEMBRANES, V1828, P2709, DOI 10.1016/j.bbamem.2013.06.015; Sonesson A, 2011, EXP DERMATOL, V20, P1004, DOI 10.1111/j.1600-0625.2011.01391.x; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tossi A, 2000, BIOPOLYMERS, V55, P4; van den Boogaard FE, 2011, J THROMB HAEMOST, V9, P122, DOI 10.1111/j.1538-7836.2010.04089.x; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wiedermann CJ, 2006, CRIT CARE MED, V34, P285, DOI 10.1097/01.CCM.0000194731.08896.99; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	53	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102577	10.1371/journal.pone.0102577	http://dx.doi.org/10.1371/journal.pone.0102577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047075	Green Published, gold			2022-12-25	WOS:000339558100047
J	Mostocotto, C; Carbone, M; Battistelli, C; Ciotti, A; Amati, P; Maione, R				Mostocotto, Cassandra; Carbone, Mariarosaria; Battistelli, Cecilia; Ciotti, Agnese; Amati, Paolo; Maione, Rossella			Poly(ADP-Ribosyl)ation Is Required to Modulate Chromatin Changes at c-MYC Promoter during Emergence from Quiescence	PLOS ONE			English	Article							MAP KINASE; HISTONE ACETYLATION; TRANSCRIPTIONAL REGULATION; GENE ACTIVATION; PARP-1; CELLS; PHOSPHOACETYLATION; DIFFERENTIATION; POLYMERASE-1; CASCADES	Poly(ADP-ribosyl)ation is a post-translational modification of various proteins and participates in the regulation of chromatin structure and transcription through complex mechanisms not completely understood. We have previously shown that PARP-1, the major family member of poly(ADP-ribose)polymerases, plays an important role in the cell cycle reactivation of resting cells by regulating the expression of Immediate Early Response Genes, such as c-MYC, c-FOS, JUNB and EGR-1. In the present work we have investigated the molecular mechanisms by which the enzyme induces c-MYC transcription upon serum stimulation of quiescent cells. We show that PARP-1 is constitutively associated in vivo to a c-MYC promoter region recognized as biologically relevant for the transcriptional regulation of the gene. Moreover, we report that serum stimulation causes the prompt accumulation of ADP-ribose polymers on the same region and that this modification is required for chromatin decondensation and for the exchange of negative for positive transcriptional regulators. Finally we provide evidence that the inhibition of PARP activity along with serum stimulation impairs c-MYC induction by preventing the proper accumulation of histone H3 phosphoacetylation, a specific chromatin mark for the activation of Immediate Early Response Genes. These findings not only suggest a novel strategy by which PARP-1 regulates the transcriptional activity of promoters but also provide new information about the complex regulation of c-MYC expression, a critical determinant of the transition from quiescence to proliferation.	[Mostocotto, Cassandra; Carbone, Mariarosaria; Battistelli, Cecilia; Ciotti, Agnese; Amati, Paolo; Maione, Rossella] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy; [Mostocotto, Cassandra; Carbone, Mariarosaria; Battistelli, Cecilia; Ciotti, Agnese; Amati, Paolo; Maione, Rossella] Pasteur Inst Fdn Cenci Bolognetti, Rome, Italy	Sapienza University Rome	Maione, R (corresponding author), Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy.	maione@bce.uniroma1.it	Battistelli, Cecilia/AFD-8694-2022	Battistelli, Cecilia/0000-0002-5611-7377	Italian Ministry of University and Research - Basic research investment fund (MIUR/FIRB) - collaboration Istituto Pasteur-Fondazione Cenci Bolognetti/Institut Pasteur Paris; Tavola Valdese - fondi OPM by way of "Associazione per lo Sviluppo delle Scienze Pasteuriane"; Fondazione Adriano Buzzati-Traverso'; Consorzio Interuniversitario Biotecnologie'	Italian Ministry of University and Research - Basic research investment fund (MIUR/FIRB) - collaboration Istituto Pasteur-Fondazione Cenci Bolognetti/Institut Pasteur Paris; Tavola Valdese - fondi OPM by way of "Associazione per lo Sviluppo delle Scienze Pasteuriane"; Fondazione Adriano Buzzati-Traverso'; Consorzio Interuniversitario Biotecnologie'	This work was supported by grants from Italian Ministry of University and Research - Basic research investment fund (MIUR/FIRB) - collaboration Istituto Pasteur-Fondazione Cenci Bolognetti/Institut Pasteur Paris and from Tavola Valdese - fondi OPM by way of "Associazione per lo Sviluppo delle Scienze Pasteuriane''. CM and MC were supported by fellowships from "Fondazione Adriano Buzzati-Traverso'' and "Consorzio Interuniversitario Biotecnologie'' respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert T, 2001, J BIOL CHEM, V276, P20482, DOI 10.1074/jbc.M100265200; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Carbone M, 2008, ONCOGENE, V27, P6083, DOI 10.1038/onc.2008.221; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Davie JR, 2010, ADV ENZYME REGUL, V50, P135, DOI 10.1016/j.advenzreg.2009.10.008; Fekete A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042690; Figliola R, 2008, J MOL BIOL, V380, P265, DOI 10.1016/j.jmb.2008.05.004; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fimia GM, 1998, MOL BIOL CELL, V9, P1449, DOI 10.1091/mbc.9.6.1449; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Hottiger MO, 2011, FEBS LETT, V585, P1595, DOI 10.1016/j.febslet.2011.03.031; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kameoka M, 2004, J VIROL, V78, P8931, DOI 10.1128/JVI.78.16.8931-8934.2004; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraus WL, MOL ASPECTS MED; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Li QJ, 2003, EMBO J, V22, P281, DOI 10.1093/emboj/cdg028; Liu JH, 2006, EMBO J, V25, P2119, DOI 10.1038/sj.emboj.7601101; MAJELLO B, 1995, ONCOGENE, V10, P1841; O'Donnell A, 2008, MOL CELL, V29, P780, DOI 10.1016/j.molcel.2008.01.019; O'Donnell A, 2013, EMBO REP, V14, P1084, DOI 10.1038/embor.2013.164; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Pullner A, 1996, J BIOL CHEM, V271, P31452, DOI 10.1074/jbc.271.49.31452; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Soldatenkov VA, 2008, ACS CHEM BIOL, V3, P214, DOI 10.1021/cb700234f; Thomas C, 2013, MOL ASPECTS MED, V34, P1124, DOI 10.1016/j.mam.2013.04.001; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082872; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96	44	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102575	10.1371/journal.pone.0102575	http://dx.doi.org/10.1371/journal.pone.0102575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047032	Green Published, Green Submitted, gold			2022-12-25	WOS:000339558100046
J	Bustillo-Zabalbeitia, I; Montessuit, S; Raemy, E; Basanez, G; Terrones, O; Martinou, JC				Bustillo-Zabalbeitia, Itsasne; Montessuit, Sylvie; Raemy, Etienne; Basanez, Gorka; Terrones, Oihana; Martinou, Jean-Claude			Specific Interaction with Cardiolipin Triggers Functional Activation of Dynamin-Related Protein 1	PLOS ONE			English	Article							DOMINANT OPTIC ATROPHY; MITOCHONDRIAL FISSION; OXIDATIVE-PHOSPHORYLATION; CONFORMATIONAL-CHANGES; MEMBRANE-BINDING; MAMMALIAN-CELLS; DRP1; GTPASE; FUSION; DOMAIN	Dynamin-Related Protein 1 (Drp1), a large GTPase of the dynamin superfamily, is required for mitochondrial fission in healthy and apoptotic cells. Drp1 activation is a complex process that involves translocation from the cytosol to the mitochondrial outer membrane (MOM) and assembly into rings/spirals at the MOM, leading to membrane constriction/division. Similar to dynamins, Drp1 contains GTPase (G), bundle signaling element (BSE) and stalk domains. However, instead of the lipid-interacting Pleckstrin Homology (PH) domain present in the dynamins, Drp1 contains the so-called B insert or variable domain that has been suggested to play an important role in Drp1 regulation. Different proteins have been implicated in Drp1 recruitment to the MOM, although how MOM-localized Drp1 acquires its fully functional status remains poorly understood. We found that Drp1 can interact with pure lipid bilayers enriched in the mitochondrion-specific phospholipid cardiolipin (CL). Building on our previous study, we now explore the specificity and functional consequences of this interaction. We show that a four lysine module located within the B insert of Drp1 interacts preferentially with CL over other anionic lipids. This interaction dramatically enhances Drp1 oligomerization and assembly-stimulated GTP hydrolysis. Our results add significantly to a growing body of evidence indicating that CL is an important regulator of many essential mitochondrial functions.	[Bustillo-Zabalbeitia, Itsasne; Basanez, Gorka; Terrones, Oihana] Univ Basque Country UPV EHU, Biophys Unit CSIC UPV EHU, Bilbao, Spain; [Bustillo-Zabalbeitia, Itsasne; Basanez, Gorka; Terrones, Oihana] Univ Basque Country UPV EHU, Dept Biochem & Mol Biol, Bilbao, Spain; [Montessuit, Sylvie; Raemy, Etienne; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, Geneva, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; University of Geneva	Terrones, O (corresponding author), Univ Basque Country UPV EHU, Biophys Unit CSIC UPV EHU, Bilbao, Spain.	oihana.terrones@ehu.es; Jean-Claude.Martinou@unige.ch	Terrones, Oihana/AAA-8903-2019; Basanez, Gorka/L-9509-2014; Terrones, Oihana/I-4023-2015	Basanez, Gorka/0000-0002-7475-7861; martinou, Jean-claude/0000-0002-9847-2051; Terrones, Oihana/0000-0001-7421-6486	Swiss National Science Foundation [31993A-141068/1]; IGE3; State of Geneva; Spanish Ministerio de Ciencia e Innovacion [BFU2011-28566]; Basque Government [IT838-13]; FEBS Short-Term fellowship; Basque Government	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); IGE3; State of Geneva; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Basque Government(Basque Government); FEBS Short-Term fellowship; Basque Government(Basque Government)	This work was funded by the Swiss National Science Foundation (31993A-141068/1), IGE3 and the State of Geneva (J.-C.M.), the Spanish Ministerio de Ciencia e Innovacion grant BFU2011-28566 and the Basque Government grant IT838-13 (G.B., O.T.). O.T. was supported by a postdoctoral Juan de la Cierva fellow, Spanish Government, and by a FEBS Short-Term fellowship. I.B.-Z. was supported by a predoctoral fellowship from the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; Bui HT, 2012, J CELL BIOL, V199, P613, DOI 10.1083/jcb.201207079; Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Cocklin S, 2006, J MOL RECOGNIT, V19, P354, DOI 10.1002/jmr.784; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J; Gawlowski T, 2012, J BIOL CHEM, V287, P30024, DOI 10.1074/jbc.M112.390682; Gonzalvez F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009342; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Guo C, 2013, EMBO J; Herzig S, 2008, CURR MOL MED, V8, P131, DOI 10.2174/156652408783769625; Heymann JAW, 2009, J CELL SCI, V122, P3427, DOI 10.1242/jcs.051714; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; Landeta O, 2011, J BIOL CHEM, V286, P8213, DOI 10.1074/jbc.M110.165852; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Liu JH, 2008, BIOCHEMISTRY-US, V47, P4518, DOI 10.1021/bi701962c; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Mears JA, 2008, METHOD CELL BIOL, V88, P237, DOI 10.1016/S0091-679X(08)00413-5; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Onoue K, 2012, J CELL SCI; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rujiviphat J, 2009, J BIOL CHEM, V284, P28682, DOI 10.1074/jbc.M109.044933; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sinibaldi F, 2013, BIOCHEMISTRY; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; von der Malsburg A, 2011, J BIOL CHEM, V286, P37858, DOI 10.1074/jbc.M111.249037; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335	72	107	107	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102738	10.1371/journal.pone.0102738	http://dx.doi.org/10.1371/journal.pone.0102738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036098	gold, Green Published			2022-12-25	WOS:000339615200081
J	Mubarqui, RL; Perez, RC; Kladt, RA; Lopez, JLZ; Parker, A; Seck, MT; Sall, B; Bouyer, J				Mubarqui, Ruben Leal; Perez, Rene Cano; Kladt, Roberto Angulo; Lopez, Jose Luis Zavala; Parker, Andrew; Seck, Momar Talla; Sall, Baba; Bouyer, Jeremy			The Smart Aerial Release Machine, a Universal System for Applying the Sterile Insect Technique	PLOS ONE			English	Article							TSETSE-FLIES; PALPALIS-GAMBIENSIS; MATING PERFORMANCE; DIPTERA; GLOSSINIDAE; ZANZIBAR; SENEGAL; MODELS; UNGUJA; ISLAND	Background: Beyond insecticides, alternative methods to control insect pests for agriculture and vectors of diseases are needed. Management strategies involving the mass-release of living control agents have been developed, including genetic control with sterile insects and biological control with parasitoids, for which aerial release of insects is often required. Aerial release in genetic control programmes often involves the use of chilled sterile insects, which can improve dispersal, survival and competitiveness of sterile males. Currently available means of aerially releasing chilled fruit flies are however insufficiently precise to ensure homogeneous distribution at low release rates and no device is available for tsetse. Methodology/Principal Findings: Here we present the smart aerial release machine, a new design by the Mubarqui Company, based on the use of vibrating conveyors. The machine is controlled through Bluetooth by a tablet with Android Operating System including a completely automatic guidance and navigation system (MaxNav software). The tablet is also connected to an online relational database facilitating the preparation of flight schedules and automatic storage of flight reports. The new machine was compared with a conveyor release machine in Mexico using two fruit flies species (Anastrepha ludens and Ceratitis capitata) and we obtained better dispersal homogeneity (% of positive traps, p<0.001) for both species and better recapture rates for Anastrepha ludens (p<0.001), especially at low release densities (<1500 per ha). We also demonstrated that the machine can replace paper boxes for aerial release of tsetse in Senegal. Conclusions/Significance: This technology limits damages to insects and allows a large range of release rates from 10 flies/km(2) for tsetse flies up to 600 000 flies/km(2) for fruit flies. The potential of this machine to release other species like mosquitoes is discussed. Plans and operating of the machine are provided to allow its use worldwide.	[Mubarqui, Ruben Leal; Perez, Rene Cano; Kladt, Roberto Angulo] Serv Aereos Biol & Forest Mubarqui, Cuidad Victoria, Mexico; [Lopez, Jose Luis Zavala] Programa Moscamed, Tapachula, Mexico; [Parker, Andrew] Int Atom Energy Agcy FAO IAEA, Joint Food & Agr Org, Insect Pest Control Lab, Programme Nucl Tech Food & Agr, Vienna, Austria; [Seck, Momar Talla; Bouyer, Jeremy] Inst Senegalais Rech Agricoles, Lab Natl Elevage & Rech Vet, Dakar, Hann, Senegal; [Sall, Baba] Direct Serv Vet, Dakar, Senegal; [Bouyer, Jeremy] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Montpellier, France; [Bouyer, Jeremy] INRA, Unite Mixte Rech 1309, Montpellier, France	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; CIRAD; INRAE	Bouyer, J (corresponding author), Inst Senegalais Rech Agricoles, Lab Natl Elevage & Rech Vet, Dakar, Hann, Senegal.	bouyer@cirad.fr	Bouyer, Jérémy/AAK-7370-2020	Bouyer, Jérémy/0000-0002-1913-416X; Parker, Andrew Gordon/0000-0001-8187-1278	Mubarqui Company; International Atomic Energy Agency	Mubarqui Company; International Atomic Energy Agency(International Atomic Energy Agency)	The work was funded by the Mubarqui Company and the International Atomic Energy Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredondo J, 2013, EFECTO TIEMPO HIPOXI; Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9; Bates D., 2011, LME4 LINEAR MIXED EE; BAUER B, 1984, REV ELEVAGE MED VET, V37, P9; Bjelis M, 2011, J APPL ENTOMOL, V137, P154; Bouyer J, 2008, MED VET ENTOMOL, V22, P140, DOI 10.1111/j.1365-2915.2008.00727.x; Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002; Bouyer J, 2010, J MED ENTOMOL, V47, P543, DOI 10.1603/ME09149; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CHALLIER A, 1973, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V11, P251; Day MF, 2012, INSECT PATHOLOGY ADV, V1, P29; Dicko AH, 2014, P NATL ACAD IN PRESS; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Enkerlin W., 2007, GUIDANCE PACKING SHI; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Gutierrez Ruelas JM, 2012, SITUACION ACTUAL MOS; HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Leal Mubarqui R, 2005, MANUAL OPERACION MET; Liedo P, 2007, FLA ENTOMOL, V90, P33, DOI 10.1653/0015-4040(2007)90[33:IMPOMS]2.0.CO;2; McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968; Mutika GN, 2013, ENTOMOL EXP APPL, V146, P177, DOI 10.1111/j.1570-7458.2012.01305.x; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; R Core Team, 2014, R LANG ENV STAT COMP; Rayaisse JB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001491; RULL J, 1996, FRUIT FLY PESTS WORL, P561; SCHWARZ AJ, 1985, FLA ENTOMOL, V68, P467, DOI 10.2307/3495135; Tan LT, 2011, J APPL ENTOMOL, P126; Tween G., 2007, P229, DOI 10.1007/978-1-4020-6059-5_21; Villasenor A, 2000, CURRENT PROGR MEDFLY, P361; Vreysen M. J. B., 2007, AREA WIDE CONTROL IN; Vreysen MJB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002857; Vreysen MJB, 2013, J INVERTEBR PATHOL, V112, pS15, DOI 10.1016/j.jip.2012.07.026; Vreysen MJB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000907; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Zavala JL, 2014, 9 INT S FRUIT FLIES	37	30	30	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e103077	10.1371/journal.pone.0103077	http://dx.doi.org/10.1371/journal.pone.0103077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036274	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200110
J	Roe, K; Orillo, B; Verma, S				Roe, Kelsey; Orillo, Beverly; Verma, Saguna			West Nile Virus-Induced Cell Adhesion Molecules on Human Brain Microvascular Endothelial Cells Regulate Leukocyte Adhesion and Modulate Permeability of the In Vitro Blood-Brain Barrier Model	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; T-CELLS; INFECTION; EXPRESSION; MIGRATION; ICAM-1; TRANSMIGRATION; MONOCYTES; VCAM-1; ENTRY	Characterizing the mechanisms by which West Nile virus (WNV) causes blood-brain barrier (BBB) disruption, leukocyte infiltration into the brain and neuroinflammation is important to understand the pathogenesis of WNV encephalitis. Here, we examined the role of endothelial cell adhesion molecules (CAMs) in mediating the adhesion and transendothelial migration of leukocytes across human brain microvascular endothelial cells (HBMVE). Infection with WNV (NY99 strain) significantly induced ICAM-1, VCAM-1, and E-selectin in human endothelial cells and infected mice brain, although the levels of their ligands on leukocytes (VLA-4, LFA-1 and MAC-1) did not alter. The permeability of the in vitro BBB model increased dramatically following the transmigration of monocytes and lymphocytes across the models infected with WNV, which was reversed in the presence of a cocktail of blocking antibodies against ICAM-1, VCAM-1, and E-selectin. Further, WNV infection of HBMVE significantly increased leukocyte adhesion to the HBMVE monolayer and transmigration across the infected BBB model. The blockade of these CAMs reduced the adhesion and transmigration of leukocytes across the infected BBB model. Further, comparison of infection with highly neuroinvasive NY99 and non-lethal (Eg101) strain of WNV demonstrated similar level of virus replication and fold-increase of CAMs in HBMVE cells suggesting that the non-neuropathogenic response of Eg101 is not because of its inability to infect HBMVE cells. Collectively, these results suggest that increased expression of specific CAMs is a pathological event associated with WNV infection and may contribute to leukocyte infiltration and BBB disruption in vivo. Our data further implicate that strategies to block CAMs to reduce BBB disruption may limit neuroinflammation and virus-CNS entry via 'Trojan horse' route, and improve WNV disease outcome.	[Roe, Kelsey; Orillo, Beverly; Verma, Saguna] Univ Hawaii, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA	University of Hawaii System	Verma, S (corresponding author), Univ Hawaii, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.	saguna@hawaii.edu			Centers of Biomedical Research Excellence [P20RR018727]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018727] Funding Source: NIH RePORTER	Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was partially supported by grants from the Centers of Biomedical Research Excellence (P20RR018727) and institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2005, CELL MOL NEUROBIOL, V25, P5, DOI 10.1007/s10571-004-1374-y; Arjona A, 2007, J CLIN INVEST, V117, P3059, DOI 10.1172/JCI32218; Avolio C, 2003, BRAIN RES BULL, V61, P357, DOI 10.1016/S0361-9230(03)00098-4; Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; Dai JF, 2008, J VIROL, V82, P4164, DOI 10.1128/JVI.02621-07; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Diamond MS, 2009, ANTIVIR RES, V83, P214, DOI 10.1016/j.antiviral.2009.05.006; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; Dobbie MS, 1999, BRAIN RES, V830, P330, DOI 10.1016/S0006-8993(99)01436-5; Eugenin EA, 2006, J LEUKOCYTE BIOL, V79, P444, DOI 10.1189/jlb.0405215; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Getts DR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-246; Giri R, 2002, AM J PHYSIOL-CELL PH, V283, pC895, DOI 10.1152/ajpcell.00293.2001; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; Hasebe R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-165; Hussmann KL, 2013, J VIROL, V87, P2814, DOI 10.1128/JVI.02577-12; Hussmann KL, 2014, J GEN VIROL; Kanmogne Georgette D, 2007, J Cereb Blood Flow Metab, V27, P123, DOI 10.1038/sj.jcbfm.9600330; Kanwar JR, 2000, IMMUNOL CELL BIOL, V78, P641, DOI 10.1046/j.1440-1711.2000.00947.x; Kim YC, 2000, J DERMATOL SCI, V24, P38, DOI 10.1016/S0923-1811(00)00080-3; King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012; Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12; Lachenmaier SM, 2011, J NEUROIMMUNOL, V232, P119, DOI 10.1016/j.jneuroim.2010.10.029; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003; Mestre L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-102; Nottet HSLM, 1996, J IMMUNOL, V156, P1284; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0; Schafer A, 2011, J VIROL, V85, P10682, DOI 10.1128/JVI.05032-11; Scherbik SV, 2007, J VIROL, V81, P12005, DOI 10.1128/JVI.01359-07; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Shen J, 1997, J VIROL, V71, P9323, DOI 10.1128/JVI.71.12.9323-9332.1997; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Shrestha B, 2008, J VIROL, V82, P8956, DOI 10.1128/JVI.01118-08; Stanimirovic D, 2000, BRAIN PATHOL, V10, P113; Steiner O, 2010, J IMMUNOL, V185, P4846, DOI 10.4049/jimmunol.0903732; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; van Marle G, 2007, J VIROL, V81, P10933, DOI 10.1128/JVI.02422-06; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036; Verma S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-66; Wang SH, 2008, J IMMUNOL, V181, P2084, DOI 10.4049/jimmunol.181.3.2084; Wang T, 2013, VIRUSES-BASEL, V5, P2298, DOI 10.3390/v5092298; Wong D, 2007, J NEUROIMMUNOL, V184, P136, DOI 10.1016/j.jneuroim.2006.12.003; Wu DT, 2000, J NEUROVIROL, V6, pS82	49	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102598	10.1371/journal.pone.0102598	http://dx.doi.org/10.1371/journal.pone.0102598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036379	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200076
J	Singh, VK; Barman, C; Tandon, R				Singh, Vineet Kumar; Barman, Chandan; Tandon, Rajesh			Nectar Robbing Positively Influences the Reproductive Success of Tecomella undulata (Bignoniaceae)	PLOS ONE			English	Article							PLANT REPRODUCTION; POLLEN LIMITATION; POLLINATION; ROBBERS; BIOLOGY; FRUIT; CONSEQUENCES; BEHAVIOR; CHEATERS; FLOWERS	The net consequence of nectar robbing on reproductive success of plants is usually negative and the positive effect is rarely produced. We evaluated the influence of nectar robbing on the behaviour of pollinators and the reproductive success of Tecomella undulata (Bignoniaceae) in a natural population. Experimental pollinations showed that the trees were strictly self-incompatible. The three types of floral colour morphs of the tree viz. red, orange and yellow, lacked compatibility barriers. The pollinators (Pycnonotus cafer and Pycnonotus leucotis) and the robber (Nectarinia asiatica) showed equal preference for all the morphs, as they visited each morph with nearly equal frequency and flower-handling time. The sunbirds caused up to 60% nectar robbing, mostly (99%) by piercing through the corolla tube. Although nectar is replenished at regular intervals, insufficient amount of nectar compelled the pollinators to visit additional trees in bloom. Data of manual nectar robbing from the entire tree showed that the pollinators covered lower number of flowers per tree (5 flowers/tree) and more trees per bout (7 trees/bout) than the unrobbed ones (19 flowers/tree and 2 trees bout). The robbed trees set a significantly greater amount of fruits than the unrobbed trees. However, the number of seeds in a fruit did not differ significantly. The study shows that plant-pollinator-robber interaction may benefit the self-incompatible plant species under conditions that increases the visits of pollinators among the compatible conspecifics in a population.	[Singh, Vineet Kumar; Barman, Chandan; Tandon, Rajesh] Univ Delhi, Dept Bot, Delhi 110007, India	University of Delhi	Tandon, R (corresponding author), Univ Delhi, Dept Bot, Delhi 110007, India.	rjtnd@rediffmail.com	SINGH, VINEET KUMAR/AAT-9481-2021	Tandon, Rajesh/0000-0003-3318-5956	Ministry of Environment & Forests, Government of India [22/9/2010-RE]	Ministry of Environment & Forests, Government of India	The work was supported by the Ministry of Environment & Forests, Government of India [22/9/2010-RE]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizmendi MC, 1996, FUNCT ECOL, V10, P119, DOI 10.2307/2390270; Bittencourt NS, 2011, FLORA, V206, P872, DOI 10.1016/j.flora.2011.05.004; Bittencourt NS, 2004, PLANT SYST EVOL, V247, P241, DOI 10.1007/s00606-004-0142-2; Bittencourt NS, 2003, ANN BOT-LONDON, V91, P827, DOI 10.1093/aob/mcg088; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Burkle LA, 2007, AM J BOT, V94, P1935, DOI 10.3732/ajb.94.12.1935; Castellanos MC, 2002, AM J BOT, V89, P111, DOI 10.3732/ajb.89.1.111; Castro S, 2008, PLANT ECOL, V199, P201, DOI 10.1007/s11258-008-9424-z; Dafni A, 2005, PRACTICAL POLLINATIO, P503; Darwin C., 1872, EFFECTS CROSS SELF F; DEJONG TJ, 1992, OECOLOGIA, V89, P310, DOI 10.1007/BF00317407; Faegri K., 1979, PRINCIPLES POLLINATI; Fumero-Caban JJ, 2013, PLANT SPEC BIOL, V28, P224, DOI 10.1111/j.1442-1984.2012.00388.x; GALEN C, 1983, OIKOS, V41, P245, DOI 10.2307/3544271; Genini J, 2010, BIOL LETTERS, V6, P494, DOI 10.1098/rsbl.2009.1021; Gibbs PE, 1999, ANN BOT-LONDON, V84, P449, DOI 10.1006/anbo.1999.0933; HEINRICH B, 1972, SCIENCE, V176, P597, DOI 10.1126/science.176.4035.597; HERNANDEZ HM, 1979, ANN MO BOT GARD, V66, P512, DOI 10.2307/2398843; HODGES CM, 1985, ECOLOGY, V66, P179, DOI 10.2307/1941318; HODGES SA, 1995, AM J BOT, V82, P197, DOI 10.2307/2445527; INOUYE DW, 1980, ECOLOGY, V61, P1251, DOI 10.2307/1936841; Irwin RE, 2002, OECOLOGIA, V133, P525, DOI 10.1007/s00442-002-1060-z; Irwin RE, 1998, OECOLOGIA, V116, P519, DOI 10.1007/s004420050617; Irwin RE, 2001, OECOLOGIA, V129, P161, DOI 10.1007/s004420100739; Irwin RE, 2000, OIKOS, V91, P499, DOI 10.1034/j.1600-0706.2000.910311.x; Irwin RE, 2010, ANNU REV ECOL EVOL S, V41, P271, DOI 10.1146/annurev.ecolsys.110308.120330; KLINKHAMER PGL, 1993, OIKOS, V66, P180, DOI 10.2307/3545212; KNOX RB, 1989, AUST J BOT, V37, P103, DOI 10.1071/BT9890103; Leonard AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055914; Maloof JE, 2001, AM J BOT, V88, P1960, DOI 10.2307/3558423; Maloof JE, 2000, ECOLOGY, V81, P2651, DOI 10.1890/0012-9658(2000)081[2651:ANRCOM]2.0.CO;2; Milet-Pinheiro P, 2009, PLANT BIOLOGY, V11, P131, DOI 10.1111/j.1438-8677.2008.00118.x; Miller TE, 1996, ECOLOGY, V77, P1329, DOI 10.2307/2265530; Morris WF, 1996, ECOLOGY, V77, P1451, DOI 10.2307/2265542; Morris WF, 2010, ECOLOGY, V91, P1276, DOI 10.1890/08-2278.1; Navarro L, 2000, AM J BOT, V87, P980, DOI 10.2307/2656997; Pandey RP, 1983, ASSESSMENT THREATENE, P55; PYKE GH, 1991, NATURE, V350, P58, DOI 10.1038/350058a0; Richardson SC, 2004, OECOLOGIA, V139, P246, DOI 10.1007/s00442-004-1504-8; ROUBIK DW, 1982, ECOLOGY, V63, P354, DOI 10.2307/1938953; SCHEMSKE DW, 1984, SCIENCE, V225, P519, DOI 10.1126/science.225.4661.519; Sharma KC, 2011, INDIAN J FUNDAM APPL, V1, P50; SUGDEN EA, 1986, AM J BOT, V73, P919, DOI 10.2307/2444305; Tandon R, 2003, ANN BOT-LONDON, V92, P715, DOI 10.1093/aob/mcg193; Traveset A, 1998, FUNCT ECOL, V12, P459, DOI 10.1046/j.1365-2435.1998.00212.x; Utelli AB, 2001, OECOLOGIA, V127, P266, DOI 10.1007/s004420000580; Vikas, 2009, J TROP ECOL, V25, P93, DOI 10.1017/S0266467408005634; Wang YS, 2013, J MATH BIOL, V66, P1155, DOI 10.1007/s00285-012-0527-8; Zhu XF, 2010, BIOL LETTERS, V6, P785, DOI 10.1098/rsbl.2010.0345	49	25	26	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102607	10.1371/journal.pone.0102607	http://dx.doi.org/10.1371/journal.pone.0102607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036554	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200077
J	Rietdijk, WJR; Franken, IHA; Thurik, AR				Rietdijk, Wim J. R.; Franken, Ingmar H. A.; Thurik, A. Roy			Internal Consistency of Event-Related Potentials Associated with Cognitive Control: N2/P3 and ERN/Pe	PLOS ONE			English	Article							BRAIN ACTIVITY; RESPONSE-INHIBITION; ERP COMPONENTS; FUNCTIONAL-SIGNIFICANCE; ERROR; RELIABILITY; TASKS; STABILITY; VALIDITY; N2	Recent studies in psychophysiology show an increased attention for examining the reliability of Event-Related Potentials (ERPs), which are measures of cognitive control (e.g., Go/No-Go tasks). An important index of reliability is the internal consistency (e.g., Cronbach's alpha) of a measure. In this study, we examine the internal consistency of the N2 and P3 in a Go/No-Go task. Furthermore, we attempt to replicate the previously found internal consistency of the Error-Related Negativity (ERN) and Positive-Error (Pe) in an Eriksen Flanker task. Healthy participants performed a Go/No-Go task and an Eriksen Flanker task, whereby the amplitudes of the correct No-Go N2/P3, and error trials for ERN/Pe were the variables of interest. This study provides evidence that the N2 and P3 in a Go/No-Go task are internally consistent after 20 and 14 trials are included in the average, respectively. Moreover, the ERN and Pe become internally consistent after approximately 8 trials are included in the average. In addition guidelines and suggestions for future research are discussed.	[Rietdijk, Wim J. R.; Thurik, A. Roy] Erasmus Univ, Erasmus Sch Econ, Dept Appl Econ, Rotterdam, Netherlands; [Franken, Ingmar H. A.] Erasmus Univ, Inst Psychol, Rotterdam, Netherlands; [Thurik, A. Roy] Panteia, Zoetermeer, Netherlands; [Thurik, A. Roy] GSCM Montpellier Business Sch, Montpellier, France	Erasmus University Rotterdam; Erasmus University Rotterdam	Rietdijk, WJR (corresponding author), Erasmus Univ, Erasmus Sch Econ, Dept Appl Econ, Rotterdam, Netherlands.	rietdijk@ese.eur.nl	Franken, Ingmar/AAB-7562-2019; Franken, Ingmar/C-2382-2008; Thurik, Roy/A-9386-2012	Franken, Ingmar/0000-0002-7853-2694; Franken, Ingmar/0000-0002-7853-2694; Thurik, Roy/0000-0002-0242-6908	Erasmus University	Erasmus University	Funding (4x100 euro) was obtained from the host university of the corresponding author (Erasmus University) to pay the winning participant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasi A., 1997, PSYCHOL TESTING; BERNSTEIN PS, 1995, J EXP PSYCHOL HUMAN, V21, P1312, DOI 10.1037/0096-1523.21.6.1312; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P1209, DOI 10.1111/psyp.12138; Cohen J, 1997, INT J PSYCHOPHYSIOL, V25, P249, DOI 10.1016/S0167-8760(96)00743-X; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Franken IHA, 2000, ADDICT BEHAV, V25, P99, DOI 10.1016/S0306-4603(98)00112-9; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G, 2012, CURR DIR PSYCHOL SCI, V21, P101, DOI 10.1177/0963721412436809; Kiang M, 2013, CLIN NEUROPHYSIOL, V124, P667, DOI 10.1016/j.clinph.2012.09.029; Littel M, 2012, ADDICT BIOL, V17, P934, DOI 10.1111/j.1369-1600.2012.00467.x; Luijten M, 2013, J PSYCH NEUROSCI, V38; Luijten M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018898; Maguire MJ, 2011, BRAIN COGNITION, V76, P77, DOI 10.1016/j.bandc.2011.02.015; Maguire MJ, 2009, BRAIN COGNITION, V71, P196, DOI 10.1016/j.bandc.2009.08.018; Marhe R, 2013, BIOL PSYCHIAT, V73, P782, DOI 10.1016/j.biopsych.2012.12.016; Meyer A, 2014, PSYCHOPHYSI IN PRESS; Meyer A, 2013, PSYCHOPHYSIOLOGY, V50, P1220, DOI 10.1111/psyp.12132; Olvet DM, 2009, PSYCHOPHYSIOLOGY, V46, P957, DOI 10.1111/j.1469-8986.2009.00848.x; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Pontifex MB, 2010, PSYCHOPHYSIOLOGY, V47, P767, DOI 10.1111/j.1469-8986.2010.00974.x; Riesel A, 2013, BIOL PSYCHOL, V93, P377, DOI 10.1016/j.biopsycho.2013.04.007; Wostmann NM, 2013, BRAIN COGNITION, V81, P82, DOI 10.1016/j.bandc.2012.09.010; Yudkowsky R., 2019, ASSESSMENT HLTH PROF	31	76	76	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102672	10.1371/journal.pone.0102672	http://dx.doi.org/10.1371/journal.pone.0102672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033272	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300076
J	Christianson, D; Creel, S				Christianson, David; Creel, Scott			Ecosystem Scale Declines in Elk Recruitment and Population Growth with Wolf Colonization: A Before-After-Control-Impact Approach	PLOS ONE			English	Article							NORTHERN YELLOWSTONE ELK; ROCKY-MOUNTAIN ELK; ADULT FEMALE ELK; DENSITY-DEPENDENCE; PREDATION RISK; ANTIPREDATOR RESPONSE; TEMPORAL VARIATION; CERVUS-ELAPHUS; GRIZZLY BEARS; NATIONAL-PARK	The reintroduction of wolves (Canis lupus) to Yellowstone provided the unusual opportunity for a quasi-experimental test of the effects of wolf predation on their primary prey (elk - Cervus elaphus) in a system where top-down, bottom-up, and abiotic forces on prey population dynamics were closely and consistently monitored before and after reintroduction. Here, we examined data from 33 years for 12 elk population segments spread across southwestern Montana and northwestern Wyoming in a large scale before-after-control-impact analysis of the effects of wolves on elk recruitment and population dynamics. Recruitment, as measured by the midwinter juvenile: female ratio, was a strong determinant of elk dynamics, and declined by 35% in elk herds colonized by wolves as annual population growth shifted from increasing to decreasing. Negative effects of population density and winter severity on recruitment, long recognized as important for elk dynamics, were detected in uncolonized elk herds and in wolf-colonized elk herds prior to wolf colonization, but not after wolf colonization. Growing season precipitation and harvest had no detectable effect on recruitment in either wolf treatment or colonization period, although harvest rates of juveniles: females declined by 37% in wolf-colonized herds. Even if it is assumed that mortality due to predation is completely additive, liberal estimates of wolf predation rates on juvenile elk could explain no more than 52% of the total decline in juvenile: female ratios in wolf-colonized herds, after accounting for the effects of other limiting factors. Collectively, these long-term, large-scale patterns align well with prior studies that have reported substantial decrease in elk numbers immediately after wolf recolonization, relatively weak additive effects of direct wolf predation on elk survival, and decreased reproduction and recruitment with exposure to predation risk from wolves.	[Christianson, David] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Creel, Scott] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA	University of Arizona; Montana State University System; Montana State University Bozeman	Christianson, D (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	dchristianson@email.arizona.edu			National Science Foundation (DEB 610) [1067129]; Division Of Environmental Biology [1067129] Funding Source: National Science Foundation	National Science Foundation (DEB 610); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation (DEB 610 #1067129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; Barber-Meyer SM, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-004; Becker MS, 2009, TERR ECOL SER, V3, P339, DOI 10.1016/S1936-7961(08)00217-0; Bonenfant C, 2005, J APPL ECOL, V42, P361, DOI 10.1111/j.1365-2664.2005.01008.x; BRAZDA AR, 1953, J WILDLIFE MANAGE, V17, P9, DOI 10.2307/3796798; Brodie J, 2013, J APPL ECOL, V50, P295, DOI 10.1111/1365-2664.12044; Christianson D, 2008, BEHAV ECOL, V19, P1258, DOI 10.1093/beheco/arn079; Christianson D, 2010, ECOLOGY, V91, P1184, DOI 10.1890/09-0221.1; Citta JJ, 2014, MAR MAMMAL SCI, V30, P20, DOI 10.1111/mms.12013; Coughenour MB, 1996, ECOL APPL, V6, P573, DOI 10.2307/2269393; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2008, ANIM BEHAV, V76, P1139, DOI 10.1016/j.anbehav.2008.07.006; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Creel S, 2013, ECOL EVOL, V3, P5189, DOI 10.1002/ece3.896; Creel S, 2011, ECOL APPL, V21, P2847, DOI 10.1890/11-0768.1; Creel S, 2011, ECOLOGY, V92, P2190, DOI 10.1890/11-0327.1; Creel S, 2009, J ANIM ECOL, V78, P1291, DOI 10.1111/j.1365-2656.2009.01581.x; Cunningham JA, 2009, J WILDLIFE MANAGE, V73, P639, DOI 10.2193/2008-010; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Doak DF, 2014, CONSERV LETT, V7, P312, DOI 10.1111/conl.12048; Eberhardt LL, 2007, J WILDLIFE MANAGE, V71, P594, DOI 10.2193/2005-770; Eberhardt LL, 1998, J WILDLIFE MANAGE, V62, P1046, DOI 10.2307/3802557; Evans SB, 2006, J WILDLIFE MANAGE, V70, P1372, DOI 10.2193/0022-541X(2006)70[1372:SOAFEI]2.0.CO;2; Fortin JK, 2013, J WILDLIFE MANAGE, V77, P270, DOI 10.1002/jwmg.483; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Garrott RA, 2009, TERR ECOL SER, V3, P1; Garrott RA, 2009, TERR ECOL SER, V3, P191, DOI 10.1016/S1936-7961(08)00211-X; Garrott RA, 2009, TERR ECOL SER, V3, P489, DOI 10.1016/S1936-7961(08)00223-6; GREER KENNETH R., 1964, TRANS N AMER WILDLIFE NATUR RESOURCES CONF, V29, P237; Griffin KA, 2011, J ANIM ECOL, V80, P1246, DOI 10.1111/j.1365-2656.2011.01856.x; GUNTHER KA, 1990, INT C BEAR, V8, P329; Hamlin KL, 2009, TERR ECOL SER, V3, P541, DOI 10.1016/S1936-7961(08)00225-X; Haroldson MA, 2000, ANN REPORT INTERAGEN, P36; Haroldson MA, 2011, YELLOWSTONE GRIZZLY, P10; Harris NC, 2008, J WILDLIFE MANAGE, V72, P1143, DOI 10.2193/2007-277; Hopcraft JGC, 2010, TRENDS ECOL EVOL, V25, P119, DOI 10.1016/j.tree.2009.08.001; Houston D. B., 1982, NO YELLOWSTONE ELK; Johnson BK, 2013, J WILDLIFE MANAGE, V77, P102, DOI 10.1002/jwmg.427; Kay CE, 1997, J RANGE MANAGE, V50, P139, DOI 10.2307/4002370; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lime DW, 1993, ECOLOGICAL ISSUES RE, P306; MCLAREN BE, 1994, SCIENCE, V266, P1555, DOI 10.1126/science.266.5190.1555; Metz MC, 2012, J ANIM ECOL, V81, P553, DOI 10.1111/j.1365-2656.2011.01945.x; Middleton AD, 2013, ECOL LETT, V16, P1023, DOI 10.1111/ele.12133; Middleton AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0870; Murtaugh PA, 2007, ECOLOGY, V88, P56, DOI 10.1890/0012-9658(2007)88[56:SACIED]2.0.CO;2; Peacor SD, 2008, NONCONSUMPTIVE EFFEC; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; PECKARSKY BL, 1993, ECOLOGY, V74, P1836, DOI 10.2307/1939941; PEEK JM, 1967, J WILDLIFE MANAGE, V31, P304, DOI 10.2307/3798321; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Raithel JD, 2007, J WILDLIFE MANAGE, V71, P795, DOI 10.2193/2005-608; Rosenheim JA, 1998, ANNU REV ENTOMOL, V43, P421, DOI 10.1146/annurev.ento.43.1.421; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Schwartz CC, 2006, WILDLIFE MONOGR, P1; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; Singer FJ, 1997, J WILDLIFE MANAGE, V61, P12, DOI 10.2307/3802410; Smith BL, 2006, NEONATAL MORTALITY E; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Stephenson S, 2010, WYOMING WILDL, V11, P2; Taper ML, 2002, J WILDLIFE MANAGE, V66, P106, DOI 10.2307/3802877; Vucetich JA, 2005, OIKOS, V111, P259, DOI 10.1111/j.0030-1299.2005.14180.x; Vucetich JA, 2011, J ANIM ECOL, V80, P1236, DOI 10.1111/j.1365-2656.2011.01855.x; White PJ, 2011, ECOL APPL, V21, P3, DOI 10.1890/09-2123.1; White PJ, 2005, WILDLIFE SOC B, V33, P942, DOI 10.2193/0091-7648(2005)33[942:NYEAWR]2.0.CO;2; White PJ, 2005, BIOL CONSERV, V125, P141, DOI 10.1016/j.biocon.2005.01.048; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Wright GJ, 2006, J WILDLIFE MANAGE, V70, P1070, DOI 10.2193/0022-541X(2006)70[1070:SONYEB]2.0.CO;2	69	31	32	3	188	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102330	10.1371/journal.pone.0102330	http://dx.doi.org/10.1371/journal.pone.0102330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028933	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600064
J	Hertel, A; Kaminski, J; Tomasello, M				Hertel, Anne; Kaminski, Juliane; Tomasello, Michael			Generalize or Personalize - Do Dogs Transfer an Acquired Rule to Novel Situations and Persons?	PLOS ONE			English	Article							CANIS-FAMILIARIS; ASSOCIATION	Recent studies have raised the question of whether dogs, like human infants, comprehend an established rule as generalizable, normative knowledge or rather as episodic information, existing only in the immediate situation. In the current study we tested whether dogs disobeyed a prohibition to take a treat (i) in the presence of the communicator of the ban, (ii) after a temporary absence of the communicator, and (iii) in the presence of a novel person. Dogs disobeyed the rule significantly more often when the communicator left the room for a moment or when they were faced with a new person, than when she stayed present in the room. These results indicate that dogs "forget" a rule as soon as the immediate human context becomes disrupted.	[Hertel, Anne; Kaminski, Juliane; Tomasello, Michael] Max Planck Inst Evolutionare Anthropol, Dept Dev & Comparat Psychol, D-04103 Leipzig, Germany; [Hertel, Anne] Univ Bremen, Inst Ecol, D-28359 Bremen, Germany; [Kaminski, Juliane] Univ Portsmouth, Portsmouth, Hants, England	Max Planck Society; University of Bremen; University of Portsmouth	Hertel, A (corresponding author), Max Planck Inst Evolutionare Anthropol, Dept Dev & Comparat Psychol, D-04103 Leipzig, Germany.	anne.hertel@hotmail.com		Kaminski, Juliane/0000-0002-3437-3484; Hertel, Anne/0000-0001-7952-8243	Volkswagenstiftung	Volkswagenstiftung(Volkswagen)	Juliane Kaminski was funded by a grant from the Volkswagenstiftung (http://www.volkswagen-stiftung.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Ashton RL, 2011, J COMP PSYCHOL, V125, P194, DOI 10.1037/a0022584; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bates D. M., 2010, LME4 MIXED EFFECTS M; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Carpenter M., 1998, MONOGR SOC RES CHILD, V63; Csibra G, 2006, ATTENTION PERFORM, P249; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; Dumas C, 1998, BEHAV PROCESS, V42, P101, DOI 10.1016/S0376-6357(97)00071-5; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 1999, J COMP PSYCHOL, V113, P173, DOI 10.1037/0735-7036.113.2.173; HOLM S, 1979, SCAND J STAT, V6, P65; Hothorn T., 2011, EXACTRANKTESTS EXACT; MARSHALLPESCINI S, 2012, PLOS ONE, V7; Piaget J., 1954, CONSTRUCTION REALITY; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rakoczy H, 2008, DEV PSYCHOL, V44, P875, DOI 10.1037/0012-1649.44.3.875; Rakoczy H, 2013, CHILD DEV PERSPECT, V7, P17, DOI 10.1111/cdep.12010; Rakoczy H, 2009, BRIT J DEV PSYCHOL, V27, P445, DOI 10.1348/026151008X337752; Rakoczy H, 2009, COGNITIVE DEV, V24, P61, DOI 10.1016/j.cogdev.2008.07.004; Schwab C, 2006, J COMP PSYCHOL, V120, P169, DOI 10.1037/0735-7036.120.3.169; Tomasello M, 2009, SCIENCE, V325, P1213, DOI 10.1126/science.1179670; Topal J, 2008, SCIENCE, V321, P1831, DOI 10.1126/science.1161437; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Watson JS, 2001, J COMP PSYCHOL, V115, P219, DOI 10.1037//0735-7036.115.3.219; Zuur Alain F., 2009, P1	28	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102666	10.1371/journal.pone.0102666	http://dx.doi.org/10.1371/journal.pone.0102666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029253	Green Submitted, Green Published, gold			2022-12-25	WOS:000341306600091
J	Kumar, A; Harrelson, T; Lewis, NE; Gallagher, EJ; LeRoith, D; Shiloach, J; Betenbaugh, MJ				Kumar, Amit; Harrelson, Thomas; Lewis, Nathan E.; Gallagher, Emily J.; LeRoith, Derek; Shiloach, Joseph; Betenbaugh, Michael J.			Multi-Tissue Computational Modeling Analyzes Pathophysiology of Type 2 Diabetes in MKR Mice	PLOS ONE			English	Article							PROTEIN REFERENCE DATABASE; SUBUNIT-RELATED PROTEIN; HUMAN SKELETAL-MUSCLE; HUMAN METABOLIC NETWORK; FATTY-ACID-METABOLISM; INSULIN-RESISTANCE; MOLECULAR-CLONING; MENDELIAN-INHERITANCE; PANCREATIC-ISLET; SYSTEMS BIOLOGY	Computational models using metabolic reconstructions for in silico simulation of metabolic disorders such as type 2 diabetes mellitus (T2DM) can provide a better understanding of disease pathophysiology and avoid high experimentation costs. There is a limited amount of computational work, using metabolic reconstructions, performed in this field for the better understanding of T2DM. In this study, a new algorithm for generating tissue-specific metabolic models is presented, along with the resulting multi-confidence level (MCL) multi-tissue model. The effect of T2DM on liver, muscle, and fat in MKR mice was first studied by microarray analysis and subsequently the changes in gene expression of frank T2DM MKR mice versus healthy mice were applied to the multi-tissue model to test the effect. Using the first multi-tissue genome-scale model of all metabolic pathways in T2DM, we found out that branched-chain amino acids' degradation and fatty acids oxidation pathway is downregulated in T2DM MKR mice. Microarray data showed low expression of genes in MKR mice versus healthy mice in the degradation of branched-chain amino acids and fatty-acid oxidation pathways. In addition, the flux balance analysis using the MCL multi-tissue model showed that the degradation pathways of branched-chain amino acid and fatty acid oxidation were significantly downregulated in MKR mice versus healthy mice. Validation of the model was performed using data derived from the literature regarding T2DM. Microarray data was used in conjunction with the model to predict fluxes of various other metabolic pathways in the T2DM mouse model and alterations in a number of pathways were detected. The Type 2 Diabetes MCL multi-tissue model may explain the high level of branched-chain amino acids and free fatty acids in plasma of Type 2 Diabetic subjects from a metabolic fluxes perspective.	[Kumar, Amit; Harrelson, Thomas; Betenbaugh, Michael J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Kumar, Amit; Shiloach, Joseph] NIDDK, Biotechnol Core Lab, Biotechnol Core Lab, Bethesda, MD 20892 USA; [Lewis, Nathan E.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Gallagher, Emily J.; LeRoith, Derek] Icahn Sch Med Mt Sinai, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA; [Gallagher, Emily J.; LeRoith, Derek] Icahn Sch Med Mt Sinai, Metab Inst, New York, NY 10029 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Brigham Young University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Betenbaugh, MJ (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	beten@jhu.edu	Lewis, Nathan/ABE-7290-2020	Lewis, Nathan/0000-0001-7700-3654; Harrelson, Thomas/0000-0002-8689-4273; Kumar, Amit/0000-0003-2140-5130	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075080, P30DK079637] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for the study was provided by the Intramural program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2007, MOL CELL PROTEOMICS, V6, P1257, DOI 10.1074/mcp.M600476-MCP200; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Arden SD, 1999, DIABETES, V48, P531, DOI 10.2337/diabetes.48.3.531; Barbosa M, 2012, CLIN GENET, V81, P47, DOI 10.1111/j.1399-0004.2011.01638.x; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Bliksrud YT, 2005, J MOL MED-JMM, V83, P406, DOI 10.1007/s00109-005-0648-2; Boden G, 1999, P ASSOC AM PHYSICIAN, V111, P241, DOI 10.1046/j.1525-1381.1999.99220.x; Bordbar A, 2012, J INTERN MED, V271, P131, DOI 10.1111/j.1365-2796.2011.02494.x; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-180; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-110; Bordbar A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.68; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; Brisson D, 2001, BIOESSAYS, V23, P534, DOI 10.1002/bies.1073; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd961; Cha BS, 2005, AM J PHYSIOL-ENDOC M, V289, pE151, DOI 10.1152/ajpendo.00141.2004; Champe PC., 2005, BIOCHEMISTRY-US; Chuang D. T., 2001, METABOLIC MOL BASES; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Deng YF, 2002, DNA SEQUENCE, V13, P301, DOI 10.1080/1042517021000011636; Devlin T. M., 2002, TXB BIOCH CLIN CORRE; Dianzani I, 1998, HUM MUTAT, V12, P267, DOI 10.1002/(SICI)1098-1004(1998)12:4<267::AID-HUMU8>3.3.CO;2-0; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; ETO K, 1994, BIOCHEM BIOPH RES CO, V198, P990, DOI 10.1006/bbrc.1994.1141; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Ferrer J, 1996, DIABETES, V45, P262, DOI 10.2337/diabetes.45.2.262; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Gille C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.62; Halvatsiotis PG, 2002, DIABETES NUTR METAB, V15, P136; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hamosh A, 2001, METABOLIC MOL BASES; Han D, 2011, J PROTEOME RES, V10, P564, DOI 10.1021/pr100759a; Harvey JW, 2005, VET CLIN PATH, V34, P248, DOI 10.1111/j.1939-165X.2005.tb00049.x; Higai K, 2003, CLIN CHIM ACTA, V329, P117, DOI 10.1016/S0009-8981(02)00427-8; Hilton JE, 2003, HUM MUTAT, V22, P67, DOI 10.1002/humu.10236; Hojlund K, 2008, MOL CELL PROTEOMICS, V7, P257, DOI 10.1074/mcp.M700304-MCP200; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; ISHIKAWA M, 1987, Acta Paediatrica Japonica, V29, P224; Itoh N, 2007, AM J PHYSIOL-ENDOC M, V293, pE1069, DOI 10.1152/ajpendo.00182.2007; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Jones JG, 1998, AM J PHYSIOL-ENDOC M, V275, pE843, DOI 10.1152/ajpendo.1998.275.5.E843; Keating SM, 2006, BIOINFORMATICS, V22, P1275, DOI 10.1093/bioinformatics/btl111; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kim H, 2006, AM J PHYSIOL-ENDOC M, V290, pE1227, DOI 10.1152/ajpendo.00344.2005; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; LEDLEY FD, 1990, BIOESSAYS, V12, P335, DOI 10.1002/bies.950120706; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Li XR, 2004, BIOCHEM BIOPH RES CO, V320, P625, DOI 10.1016/j.bbrc.2004.05.205; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Mardinoglu A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.5; Marks DB, 1996, BASIC MED BIOCH CLIN; Martin CC, 2002, J MOL ENDOCRINOL, V29, P205, DOI 10.1677/jme.0.0290205; Martin CC, 2001, J BIOL CHEM, V276, P25197, DOI 10.1074/jbc.M101549200; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Menge BA, 2010, REGUL PEPTIDES, V160, P75, DOI 10.1016/j.regpep.2009.08.001; MILLAN JL, 1987, P NATL ACAD SCI USA, V84, P5311, DOI 10.1073/pnas.84.15.5311; Mingrone G, 2004, ANN NY ACAD SCI, V1033, P99, DOI 10.1196/annals.1320.009; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Modaressi S, 1996, BIOCHEM J, V315, P807, DOI 10.1042/bj3150807; Mudd SH, 2003, J INHERIT METAB DIS, V26, P443, DOI 10.1023/A:1025121326959; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nordlie RC, 1985, ENZYMES BIOL MEMBRAN; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Ohgami M, 2003, BIOCHEM PHARMACOL, V65, P989, DOI 10.1016/S0006-2952(02)01656-8; Orten JM, 1975, HUMAN BIOCH; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Pfeiffer T, 1999, BIOINFORMATICS, V15, P251, DOI 10.1093/bioinformatics/15.3.251; Phang J. M., 2001, METABOLIC MOL BASES; PISTERS PWT, 1991, METABOLISM, V40, P59, DOI 10.1016/0026-0495(91)90193-Z; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qiu LH, 2005, MOL CELL PROTEOMICS, V4, P1311, DOI 10.1074/mcp.M500016-MCP200; Ramchandani VA, 2001, PATHOL BIOL, V49, P676, DOI 10.1016/S0369-8114(01)00232-2; REISH O, 1995, AM J HUM GENET, V57, P127; Saltiel AR, 2000, J CLIN INVEST, V106, P163, DOI 10.1172/JCI10533; Salway J.G., 2017, METABOLISM GLANCE; Sanchez JC, 2002, MOL CELL PROTEOMICS, V1, P509, DOI 10.1074/mcp.M200033-MCP200; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; SCHOLTE HR, 1971, BIOCHIM BIOPHYS ACTA, V231, P479, DOI 10.1016/0005-2760(71)90115-9; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; SHELLY LL, 1993, J BIOL CHEM, V268, P21482; Shieh JJ, 2003, J BIOL CHEM, V278, P47098, DOI 10.1074/jbc.M309472200; Shlomi T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.22; Skovbro M, 2008, DIABETOLOGIA, V51, P1253, DOI 10.1007/s00125-008-1014-z; Sladek NE, 2003, J BIOCHEM MOL TOXIC, V17, P7, DOI 10.1002/jbt.10057; Stancakova A, 2012, DIABETES, V61, P1895, DOI 10.2337/db11-1378; Thyfault JP, 2004, AM J PHYSIOL-ENDOC M, V287, pE1076, DOI 10.1152/ajpendo.00177.2004; Tillmann H, 1998, GENE, V212, P295, DOI 10.1016/S0378-1119(98)00181-4; Tomoeda K, 2000, MOL GENET METAB, V71, P506, DOI 10.1006/mgme.2000.3085; Vilboux T, 2009, HUM MUTAT, V30, P1611, DOI 10.1002/humu.21120; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang YL, 2012, BMC SYST BIOL, V6, DOI [10.1186/1752-0509-6-153, 10.1186/1752-0509-6-S3-S21]; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; Yu Y, 2001, BIOCHEM PHARMACOL, V62, P81, DOI 10.1016/S0006-2952(01)00636-0; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	111	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102319	10.1371/journal.pone.0102319	http://dx.doi.org/10.1371/journal.pone.0102319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029527	gold, Green Published, Green Submitted			2022-12-25	WOS:000341306600062
J	Larsson, AI; Jarnegren, J; Stromberg, SM; Dahl, MP; Lundalv, T; Brooke, S				Larsson, Ann I.; Jarnegren, Johanna; Stromberg, Susanna M.; Dahl, Mikael P.; Lundalv, Tomas; Brooke, Sandra			Embryogenesis and Larval Biology of the Cold-Water Coral Lophelia pertusa	PLOS ONE			English	Article							BROADCAST-SPAWNING CORALS; NON-MENDELIAN INHERITANCE; FOOD-SUPPLY MECHANISMS; DEEP-SEA CORAL; SCLERACTINIAN CORAL; GENETIC-STRUCTURE; ENVIRONMENTAL CONTROLS; MICROSATELLITE LOCI; MARINE POPULATIONS; ASEXUAL PRODUCTION	Cold-water coral reefs form spectacular and highly diverse ecosystems in the deep sea but little is known about reproduction, and virtually nothing about the larval biology in these corals. This study is based on data from two locations of the North East Atlantic and documents the first observations of embryogenesis and larval development in Lophelia pertusa, the most common framework-building cold-water scleractinian. Embryos developed in a more or less organized radial cleavage pattern from similar to 160 mu m large neutral or negatively buoyant eggs, to 120-270 mu m long ciliated planulae. Embryogenesis was slow with cleavage occurring at intervals of 6-8 hours up to the 64-cell stage. Genetically characterized larvae were sexually derived, with maternal and paternal alleles present. Larvae were active swimmers (0.5 mm s(-1)) initially residing in the upper part of the water column, with bottom probing behavior starting 3-5 weeks after fertilization. Nematocysts had developed by day 30, coinciding with peak bottom-probing behavior, and possibly an indication that larvae are fully competent to settle at this time. Planulae survived for eight weeks under laboratory conditions, and preliminary results indicate that these planulae are planktotrophic. The late onset of competency and larval longevity suggests a high dispersal potential. Understanding larval biology and behavior is of paramount importance for biophysical modeling of larval dispersal, which forms the basis for predictions of connectivity among populations.	[Larsson, Ann I.; Stromberg, Susanna M.; Dahl, Mikael P.] Univ Gothenburg, Dept Biol & Environm Sci, Tjarno, Sweden; [Jarnegren, Johanna] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Lundalv, Tomas] Univ Gothenburg, Sven Loven Ctr Marine Sci, Tjarno, Sweden; [Brooke, Sandra] Florida State Univ, Coastal & Marine Lab, St Teresa, FL USA	University of Gothenburg; Norwegian Institute Nature Research; University of Gothenburg; State University System of Florida; Florida State University	Jarnegren, J (corresponding author), Univ Tromsoe, Dept Med Biol, Tromso, Norway.	Johanna.Jarnegren@nina.no	Lundälv, Tomas/O-7121-2019; Larsson, Ann/I-1807-2013		Statoil through the CORAMM (Coral Risk Assessment, Monitoring and Modelling) project; VISTA project [6153]; Research Council of Norway [204025 DIACORA]; FORMAS [2010-1604]; Oscar and Lili Lamm foundation; EC FP 7 project HERMIONE [226354]	Statoil through the CORAMM (Coral Risk Assessment, Monitoring and Modelling) project; VISTA project; Research Council of Norway(Research Council of Norway); FORMAS(Swedish Research Council Formas); Oscar and Lili Lamm foundation; EC FP 7 project HERMIONE	This work was funded by Statoil through the CORAMM (Coral Risk Assessment, Monitoring and Modelling) project, by VISTA project No. 6153 and by the Research Council of Norway through project No. 204025 DIACORA. Additional support was provided by FORMAS (contract No. 2010-1604; http://www.formas.se), by Oscar and Lili Lamm foundation (http://www.stiftelsenlamm.a.se), and by EC FP 7 project HERMIONE, grant agreement No. 226354 (http://www.eu-hermione.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abr`amoff M.D., 2004, IMAGE PROCESSING IMA; Altieri AH, 2003, BIOL BULL-US, V204, P241, DOI 10.2307/1543595; Ayre DJ, 1997, MAR ECOL PROG SER, V159, P175, DOI 10.3354/meps159175; AYRE DJ, 1986, MAR BIOL, V90, P187, DOI 10.1007/BF00569126; Baird AH, 2004, MAR FRESHWATER RES, V55, P469, DOI 10.1071/MF03121; Ball EE, 2002, INT J DEV BIOL, V46, P671; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Bell N, 1999, NATURE, V402, P601, DOI 10.1038/45127; Birrell CL, 2008, MAR ECOL PROG SER, V362, P129, DOI 10.3354/meps07524; Brooke S, 2005, MAR BIOL, V146, P665, DOI 10.1007/s00227-004-1481-9; Brooke S, 2003, CONT SHELF RES, V23, P847, DOI 10.1016/S0278-4343(03)00080-3; Brooke S, DEEPWATER P IN PRESS; Brooke S, 2013, MAR BIOL, V160, P139, DOI 10.1007/s00227-012-2071-x; Brusca RC, 2003, INVERTEBRATES; CHIA FS, 1979, J MORPHOL, V160, P275, DOI 10.1002/jmor.1051600303; CHIA FS, 1973, MAR BIOL, V23, P73, DOI 10.1007/BF00394113; Chinga-Carrasco, 2002, MICROSCOPY SCI TECH, P2182; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Cordes EE, 2008, DEEP-SEA RES PT I, V55, P777, DOI 10.1016/j.dsr.2008.03.005; Corell H, 2012, MAR ECOL PROG SER, V467, P29, DOI 10.3354/meps09963; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dahl MP, 2012, CORAL REEFS, V31, P1135, DOI 10.1007/s00338-012-0937-5; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Davies AJ, 2009, LIMNOL OCEANOGR, V54, P620, DOI 10.4319/lo.2009.54.2.0620; Dobrowolski MP, 2002, FUNGAL GENET BIOL, V35, P197, DOI 10.1006/fgbi.2001.1319; Dullo WC, 2008, MAR ECOL PROG SER, V371, P165, DOI 10.3354/meps07623; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Fadlallah Y.H., 1983, Coral Reefs, V2, P129, DOI 10.1007/BF00336720; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; Gass SE, 2006, MAR POLLUT BULL, V52, P549, DOI 10.1016/j.marpolbul.2005.10.002; Gleason DF, 2009, CORAL REEFS, V28, P549, DOI 10.1007/s00338-009-0480-1; Gleason DF, 2011, J EXP MAR BIOL ECOL, V408, P42, DOI 10.1016/j.jembe.2011.07.025; Harii S, 2002, MAR TECHNOL SOC J, V36, P76, DOI 10.4031/002533202787914188; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hayashibara T., 1997, P 8 INT COR REEF S, V2, P1231; Hayward DC, 2004, DEV GENES EVOL, V214, P257, DOI 10.1007/s00427-004-0398-0; Hellberg ME, 2002, MAR BIOL, V141, P629, DOI 10.1007/s00227-002-0861-2; Henry LA, 2007, DEEP-SEA RES PT I, V54, P654, DOI 10.1016/j.dsr.2007.01.005; Heyward AJ, 2012, SCIENCE, V335, P1064, DOI 10.1126/science.1216055; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; JACKSON JBC, 1986, B MAR SCI, V39, P588; JOHNSON MS, 1982, MAR BIOL, V70, P157, DOI 10.1007/BF00397680; KERR AM, 2010, P ROY SOC LOND B BIO, V278, P75; Larsson AI, 2006, ECOLOGY, V87, P1960, DOI 10.1890/0012-9658(2006)87[1960:BLASFE]2.0.CO;2; Larsson AI, 2013, MAR ECOL PROG SER, V483, P169, DOI 10.3354/meps10284; Lavaleye M, 2009, OCEANOGRAPHY, V22, P76, DOI 10.5670/oceanog.2009.08; Lavaleye MSS, 2001, CORAL RECRUITMENT EX, V20; Le Goff-Vitry MC, 2004, MOL ECOL, V13, P537, DOI 10.1046/j.1365-294X.2004.2079.x; Levin Lisa A., 1995, P1; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Mangubhai S, 2009, MAR ECOL PROG SER, V374, P305, DOI 10.3354/meps07910; Martin Vicki J., 2002, P51; Martindale MQ, 2005, NAT REV GENET, V6, P917, DOI 10.1038/nrg1725; Mercier A, 2011, MAR BIOL, V158, P371, DOI 10.1007/s00227-010-1565-7; Morrison CL, 2008, MOL ECOL RESOUR, V8, P1037, DOI 10.1111/j.1755-0998.2008.02147.x; Morrison CL, 2011, CONSERV GENET, V12, P713, DOI 10.1007/s10592-010-0178-5; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Mullineaux LS, 1997, DEEP-SEA RES PT I, V44, P745, DOI 10.1016/S0967-0637(96)00130-6; Neulinger SC, 2008, APPL ENVIRON MICROB, V74, P7272, DOI 10.1128/AEM.01777-08; OLIVER J, 1992, BIOL BULL, V183, P409, DOI 10.2307/1542017; Raimondi PT, 2000, ECOLOGY, V81, P3193, DOI 10.1890/0012-9658(2000)081[3193:TCOCLB]2.0.CO;2; REED JK, 1980, B MAR SCI, V30, P667; Rentzsch F, 2008, DEVELOPMENT, V135, P1761, DOI 10.1242/dev.020784; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Roark EB, 2009, P NATL ACAD SCI USA, V106, P5204, DOI 10.1073/pnas.0810875106; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts JM, 2002, UNDERWATER TECHNOL, V25, P83, DOI 10.3723/175605402783219163; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; ROSEN BR, 1969, SCIENCE, V166, P119, DOI 10.1126/science.166.3901.119; SAMMARCO PW, 1982, MAR ECOL PROG SER, V10, P57, DOI 10.3354/meps010057; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Smith KL, 2000, AM J PRIMATOL, V51, P219; Sponaugle S, 2002, B MAR SCI, V70, P341; Stake JL, 2003, J EXP MAR BIOL ECOL, V288, P181, DOI 10.1016/S0022-0981(03)00018-2; STODDART JA, 1983, MAR BIOL, V76, P279, DOI 10.1007/BF00393029; STODDART JA, 1988, MAR BIOL, V99, P489, DOI 10.1007/BF00392556; Strathmann M.F., 1987, P83; SZMANTFROELICH A, 1980, BIOL BULL, V158, P257, DOI 10.2307/1540935; Thiem O, 2006, J MARINE SYST, V60, P207, DOI 10.1016/j.jmarsys.2005.12.004; TRANTER PRG, 1982, J MAR BIOL ASSOC UK, V62, P845, DOI 10.1017/S0025315400070387; Valentine JW, 1997, P NATL ACAD SCI USA, V94, P8001, DOI 10.1073/pnas.94.15.8001; Wagner H, 2011, J MARINE SYST, V85, P19, DOI 10.1016/j.jmarsys.2010.11.003; Waller RG, 2005, ERLANGEN EARTH C SER, P691, DOI 10.1007/3-540-27673-4_35; Waller RG, 2005, CORAL REEFS, V24, P514, DOI 10.1007/s00338-005-0501-7; Waller RG, 2008, DEEP-SEA RES PT II, V55, P2527, DOI 10.1016/j.dsr2.2008.07.001; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Williams B, 2006, GEOLOGY, V34, P773, DOI 10.1130/G22685.1; Wisshak M, 2005, ERLANGEN EARTH C SER, P979, DOI 10.1007/3-540-27673-4_49; Yamashita K, 2003, BIOL BULL-US, V204, P256, DOI 10.2307/1543597; Yeoh SR, 2010, MAR BIOL, V157, P351, DOI 10.1007/s00227-009-1322-y	97	48	48	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102222	10.1371/journal.pone.0102222	http://dx.doi.org/10.1371/journal.pone.0102222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028936	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600048
J	Neshati, Z; Liu, J; Zhou, GQ; Schalij, MJ; de Vries, AAF				Neshati, Zeinab; Liu, Jia; Zhou, Guangqian; Schalij, Martin J.; de Vries, Antoine A. F.			Development of a Lentivirus Vector-Based Assay for Non-Destructive Monitoring of Cell Fusion Activity	PLOS ONE			English	Article							GENE-EXPRESSION; LUCIFERASE REPORTER; DIFFERENTIATION; CARDIOMYOCYTES; EFFICIENCY; CULTURE; CODON	Cell-to-cell fusion can be quantified by endowing acceptor and donor cells with latent reporter genes/proteins and activators of these genes/proteins, respectively. One way to accomplish this goal is by using a bipartite lentivirus vector (LV)-based cell fusion assay system in which the cellular fusion partners are transduced with a flippase-activatable Photinus pyralis luciferase (PpLuc) expression unit (acceptor cells) or with a recombinant gene encoding FLPe(NLS+), a nuclear-targeted and molecularly evolved version of flippase (donor cells). Fusion of both cell populations will lead to the FLPe-dependent generation of a functional PpLuc gene. PpLuc activity is typically measured in cell lysates, precluding consecutive analysis of one cell culture. Therefore, in this study the PpLuc-coding sequence was replaced by that of Gaussia princeps luciferase (GpLuc), a secretory protein allowing repeated analysis of the same cell culture. In myotubes the spread of FLPe(NLS+) may be limited due to its nuclear localization signal (NLS) causing low signal outputs. To test this hypothesis, myoblasts were transduced with LVs encoding either FLPe(NLS+) or an NLS-less version of FLPe (FLPe(NLS+)) and subsequently co-cultured in different ratios with myoblasts containing the FLPe-activatable GpLuc expression cassette. At different times after induction of cell-to-cell fusion the GpLuc activity in the culture medium was determined. FLPe(NLS+) and FLPe(NLS+) both activated the latent GpLuc gene but when the percentage of FLPe-expressing myoblasts was limiting, FLPe(NLS+) generally yielded slightly higher signals than FLPe(NLS+) while at low acceptor-to-donor cell ratios FLPe(NLS+) was usually superior. The ability of FLPe(NLS+) to spread through myofibers and to induce reporter gene expression is thus not limited by its NLS. However, at high FLPe concentrations the presence of the NLS negatively affected reporter gene expression. In summary, a rapid and simple chemiluminescence assay for quantifying cell-to-cell fusion progression based on GpLuc has been developed.	[Neshati, Zeinab; Liu, Jia; Schalij, Martin J.; de Vries, Antoine A. F.] Leiden Univ, Med Ctr, Heart Ctr Leiden, Leiden, Netherlands; [Liu, Jia; Zhou, Guangqian] Shenzhen Univ, Sch Med, Shenzhen, Peoples R China	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Shenzhen University	de Vries, AAF (corresponding author), Leiden Univ, Med Ctr, Heart Ctr Leiden, Leiden, Netherlands.	a.a.f.de_vries@lumc.nl	Neshati, Zeinab/O-5856-2017; de Vries, Antoine/ABG-5787-2021	Neshati, Zeinab/0000-0003-2644-6679; 	Dutch Duchenne Parent Project (DPP); Iranian Ministry of Science, Research and Technology	Dutch Duchenne Parent Project (DPP); Iranian Ministry of Science, Research and Technology	This work was supported by research grants from the Dutch Duchenne Parent Project (DPP) and the Iranian Ministry of Science, Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cudre-Mauroux C, 2003, HUM GENE THER, V14, P1525, DOI 10.1089/104303403322495034; Feng T, 2002, BIOTECHNIQUES, V32, P992, DOI 10.2144/02325bm03; Goncalves MAFV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010954; GONDA DK, 1989, J BIOL CHEM, V264, P16700; GRZESCHIK KH, 1986, EXPERIENTIA, V42, P1128, DOI 10.1007/BF01941287; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Holkers M, 2006, BIOTECHNIQUES, V41, P711, DOI 10.2144/000112307; Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lu X, 2009, CANCER RES, V69, P8536, DOI 10.1158/0008-5472.CAN-09-2159; Maguire CA, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.25; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; Mohler WA, 1996, P NATL ACAD SCI USA, V93, P12423, DOI 10.1073/pnas.93.22.12423; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Ramkisoensing AA, 2012, STEM CELLS, V30, P2830, DOI 10.1002/stem.1236; Ramkisoensing AA, 2012, STEM CELLS, V30, P1236, DOI 10.1002/stem.1086; Sambrook J, 2001, MOL CLONING LAB MANU; Sanges D, 2011, ADV EXP MED BIOL, V713, P137, DOI 10.1007/978-94-007-0763-4_9; Serov OL, 2011, INT REV CEL MOL BIO, V291, P155, DOI 10.1016/B978-0-12-386035-4.00005-7; Shinn-Thomas JH, 2011, INT REV CEL MOL BIO, V289, P149, DOI 10.1016/B978-0-12-386039-2.00005-5; Shinn-Thomas Jessica H., 2008, V475, P347, DOI 10.1007/978-1-59745-250-2_20; Sinkovics JG, 2011, ADV EXP MED BIOL, V714, P5, DOI 10.1007/978-94-007-0782-5_2; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Turan S, 2011, FASEB J, V25, P4088, DOI 10.1096/fj.11-186940; Uil TG, 2009, J GENE MED, V11, P990, DOI 10.1002/jgm.1395; van Nierop GP, 2009, NUCLEIC ACIDS RES, V37, P5725, DOI 10.1093/nar/gkp643	29	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102433	10.1371/journal.pone.0102433	http://dx.doi.org/10.1371/journal.pone.0102433			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028973	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600073
J	Warlich, E; Schambach, A; Lock, D; Wedekind, D; Glage, S; Eckardt, D; Bosio, A; Knobel, S				Warlich, Eva; Schambach, Axel; Lock, Dominik; Wedekind, Dirk; Glage, Silke; Eckardt, Dominik; Bosio, Andreas; Knoebel, Sebastian			FAS-Based Cell Depletion Facilitates the Selective Isolation of Mouse Induced Pluripotent Stem Cells	PLOS ONE			English	Article							SURFACE-MARKERS; SOMATIC-CELLS; IPS CELLS; IN-VITRO; EXPRESSION; TRANSPLANTATION; GENERATION; FIBROBLASTS; DIFFERENTIATION; MAINTENANCE	Cellular reprogramming of somatic cells into induced pluripotent stem cells (iPSC) opens up new avenues for basic research and regenerative medicine. However, the low efficiency of the procedure remains a major limitation. To identify iPSC, many studies to date relied on the activation of pluripotency-associated transcription factors. Such strategies are either retrospective or depend on genetically modified reporter cells. We aimed at identifying naturally occurring surface proteins in a systematic approach, focusing on antibody-targeted markers to enable live-cell identification and selective isolation. We tested 170 antibodies for differential expression between mouse embryonic fibroblasts (MEF) and mouse pluripotent stem cells (PSC). Differentially expressed markers were evaluated for their ability to identify and isolate iPSC in reprogramming cultures. Epithelial cell adhesion molecule (EPCAM) and stage-specific embryonic antigen 1 (SSEA1) were upregulated early during reprogramming and enabled enrichment of OCT4 expressing cells by magnetic cell sorting. Downregulation of somatic marker FAS was equally suitable to enrich OCT4 expressing cells, which has not been described so far. Furthermore, FAS downregulation correlated with viral transgene silencing. Finally, using the marker SSEA-1 we exemplified that magnetic separation enables the establishment of bona fide iPSC and propose strategies to enrich iPSC from a variety of human source tissues.	[Warlich, Eva; Lock, Dominik; Eckardt, Dominik; Bosio, Andreas; Knoebel, Sebastian] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; [Warlich, Eva; Schambach, Axel] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Warlich, Eva; Schambach, Axel; Glage, Silke] REBIRTH Cluster Excellence, Hannover, Germany; [Schambach, Axel] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Wedekind, Dirk; Glage, Silke] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany	Miltenyi Biotec; Hannover Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Hannover Medical School	Knobel, S (corresponding author), Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.	sebastiank@miltenyibiotec.de	Schambach, Axel/C-5491-2011	Lock, Dominik/0000-0002-3056-4582; Bosio, Andreas/0000-0001-9776-2535	Deutsche Forschungsgemeinschaft [SFB738]; DAAD; German Federal Ministry of Education and Research (BMBF); European Union	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by grants of the Deutsche Forschungsgemeinschaft (SFB738, Cluster of Excellence REBIRTH), the DAAD, the German Federal Ministry of Education and Research (BMBF) and the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujarour R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01179; Barral S, 2013, STEM CELL RES, V10, P133, DOI 10.1016/j.scr.2012.10.005; Beelen DW, 2000, BONE MARROW TRANSPL, V26, P823, DOI 10.1038/sj.bmt.1702635; Bitan M, 2005, EXP HEMATOL, V33, P713, DOI 10.1016/j.exphem.2005.03.004; Boiani M, 2005, STEM CELLS, V23, P1089, DOI 10.1634/stemcells.2004-0352; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Brunlid G, 2007, STEM CELLS, V25, P2551, DOI 10.1634/stemcells.2006-0745; Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen HF, 2011, STEM CELL REV REP, V7, P722, DOI 10.1007/s12015-011-9233-y; Despres D, 2000, J HEMATOTH STEM CELL, V9, P557; Dick E, 2011, STEM CELL RES, V6, P158, DOI 10.1016/j.scr.2010.10.002; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Gundry RL, 2012, MOL CELL PROTEOMICS, V11, P303, DOI 10.1074/mcp.M112.018135; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Handgretinger R, 1998, BONE MARROW TRANSPL, V21, P987, DOI 10.1038/sj.bmt.1701228; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; Hau A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049636; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Hirano K, 2013, BIOCHEM BIOPH RES CO, V430, P1175, DOI 10.1016/j.bbrc.2012.12.005; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Kahler DJ, PLOS ONE, V8; Kim JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007166; Lang P, 1999, BONE MARROW TRANSPL, V24, P583, DOI 10.1038/sj.bmt.1701961; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li WL, 2009, STEM CELLS, V27, P2992, DOI 10.1002/stem.240; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schambach A, 2006, MOL THER, V13, P391, DOI 10.1016/j.ymthe.2005.08.012; Sheard MA, 2003, CANCER RES, V63, P7176; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Sundberg M, 2009, STEM CELL RES, V2, P113, DOI 10.1016/j.scr.2008.08.001; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanabe K, 2013, P NATL ACAD SCI USA, V110, P12172, DOI 10.1073/pnas.1310291110; Valamehr B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00213; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zweigerdt R, 2003, CYTOTHERAPY, V5, P399, DOI 10.1080/14653240310003062	61	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102171	10.1371/journal.pone.0102171	http://dx.doi.org/10.1371/journal.pone.0102171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029550	Green Submitted, Green Published, gold			2022-12-25	WOS:000341306600039
J	Cukras, S; Morffy, N; Ohn, T; Kee, Y				Cukras, Scott; Morffy, Nicholas; Ohn, Takbum; Kee, Younghoon			Inactivating UBE2M Impacts the DNA Damage Response and Genome Integrity Involving Multiple Cullin Ligases	PLOS ONE			English	Article							FANCONI-ANEMIA PATHWAY; UBIQUITIN LIGASE; BETA-TRCP; S-PHASE; MEDIATED DEGRADATION; NEDD8 CONJUGATION; CDK INHIBITOR; CELL-CYCLE; REPLICATION; NEDDYLATION	Protein neddylation is involved in a wide variety of cellular processes. Here we show that the DNA damage response is perturbed in cells inactivated with an E2 Nedd8 conjugating enzyme UBE2M, measured by RAD51 foci formation kinetics and cell based DNA repair assays. UBE2M knockdown increases DNA breakages and cellular sensitivity to DNA damaging agents, further suggesting heightened genomic instability and defective DNA repair activity. Investigating the downstream Cullin targets of UBE2M revealed that silencing of Cullin 1, 2, and 4 ligases incurred significant DNA damage. In particular, UBE2M knockdown, or defective neddylation of Cullin 2, leads to a blockade in the G1 to S progression and is associated with delayed S-phase dependent DNA damage response. Cullin 4 inactivation leads to an aberrantly high DNA damage response that is associated with increased DNA breakages and sensitivity of cells to DNA damaging agents, suggesting a DNA repair defect is associated. siRNA interrogation of key Cullin substrates show that CDT1, p21, and Claspin are involved in elevated DNA damage in the UBE2M knockdown cells. Therefore, UBE2M is required to maintain genome integrity by activating multiple Cullin ligases throughout the cell cycle.	[Cukras, Scott; Morffy, Nicholas; Kee, Younghoon] Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33606 USA; [Ohn, Takbum] Chosun Univ, Coll Med, Dept Cellular & Mol Med, Kwangju, South Korea	State University System of Florida; University of South Florida; Chosun University	Kee, Y (corresponding author), Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33606 USA.	Ykee@usf.edu	Kee, Younghoon/J-4107-2019	Morffy, Nicholas/0000-0003-3170-2032	University of South Florida Research & Innovation Internal Awards Program [0088622]; USF Proposal Enhancement Grant	University of South Florida Research & Innovation Internal Awards Program; USF Proposal Enhancement Grant	This work was supported, in part, by the University of South Florida Research & Innovation Internal Awards Program under Grant No. 0088622, and USF Proposal Enhancement Grant to Y.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Bacquin A, 2013, NUCLEIC ACIDS RES, V41, P6501, DOI 10.1093/nar/gkt397; Bai J, 2011, HUM PATHOL, V42, P375, DOI 10.1016/j.humpath.2010.09.003; Bo Hideki, 2004, Journal of Nippon Medical School, V71, P172, DOI 10.1272/jnms.71.172; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chen LC, 1998, CANCER RES, V58, P3677; Cron KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073710; Deshaies RJ, 2010, SUBCELL BIOCHEM, V54, P41, DOI 10.1007/978-1-4419-6676-6_4; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Dutta P, 2013, MOL ONCOL, V7, P647, DOI 10.1016/j.molonc.2013.02.008; Garcia K, 2014, MOL CANC THER; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jazaeri AA, 2013, MOL CANCER THER, V12, P1958, DOI 10.1158/1535-7163.MCT-12-1028; Jia LJ, 2011, NEOPLASIA, V13, P561, DOI 10.1593/neo.11420; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Johnson N, 2011, NAT MED, V17, P875, DOI 10.1038/nm.2377; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kee Y, 2012, MOL CANCER RES, V10, P369, DOI 10.1158/1541-7786.MCR-11-0497; Kee Y, 2009, GENE DEV, V23, P555, DOI 10.1101/gad.1761309; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Li JM, 2012, FRONT ONCOL, V2, P1, DOI [10.3389/fonc.2012.00079, 10.3389/fonc.2012.00029]; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Ma T, 2013, MOL CELL, V49, P897, DOI 10.1016/j.molcel.2013.01.006; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Moss J, 2010, GENE DEV, V24, P2705, DOI 10.1101/gad.1970810; Murakawa Y, 2007, CANCER RES, V67, P8536, DOI 10.1158/0008-5472.CAN-07-1166; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Nawrocki ST, 2013, CLIN CANCER RES, V19, P3577, DOI 10.1158/1078-0432.CCR-12-3212; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Salon C, 2007, J PATHOL, V213, P303, DOI 10.1002/path.2223; Silverman JS, 2012, TRENDS BIOCHEM SCI, V37, P66, DOI 10.1016/j.tibs.2011.10.004; Sorensen CS, 2004, CELL CYCLE, V3, P941; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Starostina NG, 2010, DEV CELL, V19, P753, DOI 10.1016/j.devcel.2010.10.013; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Wada H, 2000, J BIOL CHEM, V275, P17008, DOI 10.1074/jbc.275.22.17008; Wada H, 1999, BIOCHEM BIOPH RES CO, V257, P100, DOI 10.1006/bbrc.1999.0339; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wang ZW, 2012, ONCOTARGET, V3, P1026; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034079; Yarde DN, 2009, CANCER RES, V69, P9367, DOI 10.1158/0008-5472.CAN-09-2616; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; Zhao Y, 2014, ANTIOXID REDOX SIGNA	60	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101844	10.1371/journal.pone.0101844	http://dx.doi.org/10.1371/journal.pone.0101844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025768	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400025
J	Yeh, YC; Liu, CJ; Kuo, RN; Lai, CL; Shau, WY; Chen, PJ; Lai, MS				Yeh, Yi-Chun; Liu, Chun-Jen; Kuo, Raymond Nienchen; Lai, Chiu-Ling; Shau, Wen-Yi; Chen, Pei-Jer; Lai, Mei-Shu			Association of Adjuvant Antiviral Therapy with Risk of Cancer Progression and Deaths in Patients with Hepatitis-B-Virus-Related Hepatocellular Carcinoma following Curative Treatment: A Nationwide Cohort Study	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; INTERFERON THERAPY; LIVER RESECTION; RECURRENCE; LAMIVUDINE; ALPHA; PREVENTION; SURVIVAL; EFFICACY; HCC	Background: Limited information about tumor status and the time at which antiviral therapy was initiated may have influenced effect estimation in previous research. The aim of this study was to investigate the effect of antiviral therapies on HBV-related HCC progression and deaths in patients receiving curative treatment based on clear clinical-pathological cancer status and the association of start time of adjuvant antiviral therapy initiation and outcomes. Methodology: A nationwide inception cohort study of newly diagnosed HCC patients who suffered from viral hepatitis B and received curative HCC therapy as the first course of treatment were identified from the Taiwan Cancer Registry between January 1, 2004, and December 31, 2009. Matched Cox proportional hazards models based on propensity score matching and incorporated time-varying exposure were used to estimate adjusted hazard ratios and 95% confidence intervals (CIs). Findings: Among 3,855 HCC patients with HBV, antiviral therapy was administered to 490 (12.7%) following curative treatment. Antiviral-treated patients had a higher percentage of young age, early stage, and smaller tumor size of HCC compared with untreated patients. After propensity score matching, treated patients demonstrated a higher risk of HCC progression (hazard ratio, 1.42; 95% CI, 1.20-1.69) and death from all causes (1.45; 1.15-1.82) than untreated patients. Similar results were also obtained in sub-cohort of patients who were alive with cancer-free status at least one year after receiving curative treatment and the sub-cohort of patients with liver resection. The interval length between initiation of antiviral therapy and first-line curative treatment did not show a significant association with all-cause mortality. Conclusions: This study found that adjuvant antiviral therapy did not reduce the risk of HCC progression or mortality in HBV-related HCC patients after cancer status adjusting.	[Yeh, Yi-Chun; Lai, Mei-Shu] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan; [Yeh, Yi-Chun; Lai, Mei-Shu] Natl Taiwan Univ Hosp, Ctr Comparat Effectiveness Res, Natl Ctr Excellence Clin Trial & Res, Taipei, Taiwan; [Liu, Chun-Jen; Chen, Pei-Jer] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Liu, Chun-Jen; Chen, Pei-Jer] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan; [Liu, Chun-Jen; Shau, Wen-Yi; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Kuo, Raymond Nienchen] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei 10764, Taiwan; [Lai, Chiu-Ling] Kainan Univ, Dept Hlth Ind Management, Sch Healthcare Management, Taoyuan, Taiwan; [Shau, Wen-Yi] Pfizer Ltd, Med Affairs Div, New Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Nan Kai University Technology; Pfizer	Chen, PJ (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	peijerchen@ntu.edu.tw; mslai@ntu.edu.tw	Kuo, Raymond N./N-2558-2018	Kuo, Raymond N./0000-0003-4980-853X; Lai, Mei-shu/0000-0001-6130-3468; Chen, Pei-Jer/0000-0001-8316-3785; LIU, CHUN-JEN/0000-0002-6202-0993	Science and Technology Unit, Ministry of Health and Welfare in Taiwan [DOH99-TD-B-111-001, DOH100-TD-B-111-001, DOH101-TD-B-111-001]	Science and Technology Unit, Ministry of Health and Welfare in Taiwan	This study was supported by a grant from the Science and Technology Unit, Ministry of Health and Welfare (formerly the Department of Health) in Taiwan (DOH99-TD-B-111-001, DOH100-TD-B-111-001, DOH101-TD-B-111-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bureau of National Health Insurance Department of Health Executive Yuan, 2011, NAT HLTH INS TAIW 20; Chan ACY, 2011, ARCH SURG-CHICAGO, V146, P675, DOI 10.1001/archsurg.2011.125; Chen LT, 2012, ANN SURG, V255, P8, DOI 10.1097/SLA.0b013e3182363ff9; Germani G, 2010, J HEPATOL, V52, P380, DOI 10.1016/j.jhep.2009.12.004; Greene FL, 2002, AJCC CANC STAGING MA, P131; Hsu CS, 2013, JAMA-J AM MED ASSOC, V309, P765, DOI 10.1001/jama.2013.568; Hung IFN, 2008, AM J GASTROENTEROL, V103, P1663, DOI 10.1111/j.1572-0241.2008.01872.x; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kubo S, 2007, HEPATOL RES, V37, P94, DOI 10.1111/j.1872-034X.2007.00013.x; Kuzuya T, 2007, J GASTROEN HEPATOL, V22, P1929, DOI 10.1111/j.1440-1746.2006.04707.x; Li N, 2010, ANN SURG ONCOL, V17, P179, DOI 10.1245/s10434-009-0694-z; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lin SM, 2004, CANCER-AM CANCER SOC, V100, P376, DOI 10.1002/cncr.20004; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lo CM, 2007, ANN SURG, V245, P831, DOI 10.1097/01.sla.0000245829.00977.45; Mazzaferro V, 2006, HEPATOLOGY, V44, P1543, DOI 10.1002/hep.21415; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Piao CY, 2005, ACTA MED OKAYAMA, V59, P217; Poon RTP, 2009, ANN SURG ONCOL, V16, P792, DOI 10.1245/s10434-009-0330-y; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Shen YC, 2010, J HEPATOL, V52, P889, DOI 10.1016/j.jhep.2009.12.041; Someya T, 2006, J GASTROENTEROL, V41, P1206, DOI 10.1007/s00535-006-1912-0; Sun HC, 2006, J CANCER RES CLIN, V132, P458, DOI 10.1007/s00432-006-0091-y; Taiwan Cancer Registry, 2010, TAIW CANC REG DAT 20; Wu C-Y, 2013, JAMA-J AM MED ASSOC, V309, P765; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009; Yoshida H, 2008, HEPATOL INT, V2, P89, DOI 10.1007/s12072-007-9020-7; Yuen MF, 2007, ANTIVIR THER, V12, P1295	32	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102051	10.1371/journal.pone.0102051	http://dx.doi.org/10.1371/journal.pone.0102051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025231	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400039
J	Lobato, L; Bouzhir-Sima, L; Yamashita, T; Wilson, MT; Vos, MH; Liebl, U				Lobato, Laura; Bouzhir-Sima, Latifa; Yamashita, Taku; Wilson, Michael T.; Vos, Marten H.; Liebl, Ursula			Dynamics of the Heme-binding Bacterial Gas-sensing Dissimilative Nitrate Respiration Regulator (DNR) and Activation Barriers for Ligand Binding and Escape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYMETHYL CYTOCHROME-C; SOLUBLE GUANYLATE-CYCLASE; TRANSCRIPTION FACTOR COOA; NITRIC-OXIDE DYNAMICS; ESCHERICHIA-COLI; CARBON-MONOXIDE; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA; SENSOR PROTEINS; YEAST ISO-1-CYTOCHROME-C	DNR (dissimilative nitrate respiration regulator) is a heme-binding transcription factor that is involved in the regulation of denitrification in Pseudomonas aeruginosa. In the ferrous deoxy state, the heme is 6-coordinate; external NO and CO can replace an internal ligand. Using fluorescence anisotropy, we show that high-affinity sequence-specific DNA binding occurs only when the heme is nitrosylated, consistent with the proposed function of DNR as NO sensor and transcriptional activator. This role is moreover supported by the NO "trapping" properties revealed by ultrafast spectroscopy that are similar to those of other heme-based NO sensor proteins. Dissociated CO-heme pairs rebind in an essentially barrierless way. This process competes with migration out of the heme pocket. The latter process is thermally activated (E-a similar to 7 kJ/mol). This result is compared with other heme proteins, including the homologous CO sensor/transcription factor CooA, variants of the 5-coordinate mycobacterial sensor DosT and the electron transfer protein cytochrome c. This comparison indicates that thermal activation of ligand escape from the heme pocket is specific for systems where an external ligand replaces an internal one. The origin of this finding and possible implications are discussed.	[Lobato, Laura; Bouzhir-Sima, Latifa; Vos, Marten H.; Liebl, Ursula] Ecole Polytech, CNRS, Lab Opt & Biosci, F-91128 Palaiseau, France; [Lobato, Laura; Bouzhir-Sima, Latifa; Vos, Marten H.; Liebl, Ursula] INSERM, U696, F-91128 Palaiseau, France; [Yamashita, Taku] Osaka Univ, Grad Sch Pharmaceut Sci, Analyt Chem Lab, Suita, Osaka 5650871, Japan; [Wilson, Michael T.] Univ Essex, Sch Biol Sci, Colchester C04 3SQ, Essex, England	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Osaka University; University of Essex	Vos, MH (corresponding author), Ecole Polytech, CNRS, Lab Opt & Biosci, F-91128 Palaiseau, France.	marten.vos@polytechnique.edu; ursula.liebl@polytechnique.edu		LIEBL, Ursula/0000-0003-0869-4388; Vos, Marten/0000-0003-0493-4831	Agence National de la Recherche [ANR-09-PIRI-0019]; "La Caixa," Spain	Agence National de la Recherche(French National Research Agency (ANR)); "La Caixa," Spain(La Caixa Foundation)	This work was supported by Agence National de la Recherche Grant ANR-09-PIRI-0019 (to M. H. V. and U. L.).; Recipient of a two-year fellowship from "La Caixa," Spain.	Aono S, 2012, ANTIOXID REDOX SIGN, V16, P678, DOI 10.1089/ars.2011.4248; ARAI H, 1995, FEBS LETT, V371, P73, DOI 10.1016/0014-5793(95)00885-D; Benabbas A, 2012, J BIOL CHEM, V287, P21729, DOI 10.1074/jbc.M112.345090; Bisht NK, 2011, BBA-PROTEINS PROTEOM, V1814, P1042, DOI 10.1016/j.bbapap.2010.09.016; Borjigin M, 2007, ACTA CRYSTALLOGR D, V63, P282, DOI 10.1107/S0907444906051638; BREN KL, 1993, J AM CHEM SOC, V115, P10382, DOI 10.1021/ja00075a073; Bruno S, 2007, J AM CHEM SOC, V129, P2880, DOI 10.1021/ja066638d; Brzezinski P, 1997, P NATL ACAD SCI USA, V94, P6176, DOI 10.1073/pnas.94.12.6176; Castiglione N, 2009, MICROBIOL-SGM, V155, P2838, DOI 10.1099/mic.0.028027-0; Creze C, 2012, J BIOL CHEM, V287, P15648, DOI 10.1074/jbc.M112.346361; Flynn PF, 2001, BIOCHEMISTRY-US, V40, P6559, DOI 10.1021/bi0102252; Gabba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049770; Germani F, 2013, ADV MICROB PHYSIOL, V63, P1, DOI 10.1016/B978-0-12-407693-8.00001-7; Giardina G, 2008, J MOL BIOL, V378, P1002, DOI 10.1016/j.jmb.2008.03.013; Giardina G, 2009, PROTEINS, V77, P174, DOI 10.1002/prot.22428; Girvan HM, 2013, J BIOL CHEM, V288, P13194, DOI 10.1074/jbc.R112.422642; Gonzalez G, 2002, BIOCHEMISTRY-US, V41, P8414, DOI 10.1021/bi025845x; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Kakar S, 2010, BIOPHYS CHEM, V152, P1, DOI 10.1016/j.bpc.2010.08.008; Kapetanaki SM, 2009, BIOCHEMISTRY-US, V48, P1613, DOI 10.1021/bi801817v; Kim J, 2009, J PHYS CHEM B, V113, P260, DOI 10.1021/jp804656t; Kruglik SG, 2007, J BIOL CHEM, V282, P5053, DOI 10.1074/jbc.M604327200; Kumazaki S, 2000, J BIOL CHEM, V275, P38378, DOI 10.1074/jbc.M005533200; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Larsen RW, 2003, BBA-GEN SUBJECTS, V1619, P15, DOI 10.1016/S0304-4165(02)00436-1; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; Liebl U, 2003, BIOCHEMISTRY-US, V42, P6527, DOI 10.1021/bi027359f; Liebl U, 2002, P NATL ACAD SCI USA, V99, P12771, DOI 10.1073/pnas.192311699; Liebl U, 2013, BBA-PROTEINS PROTEOM, V1834, P1684, DOI 10.1016/j.bbapap.2013.02.025; LOUIE GV, 1990, J MOL BIOL, V214, P527, DOI 10.1016/0022-2836(90)90197-T; Lukacs A, 2006, J PHYS CHEM B, V110, P15654, DOI 10.1021/jp063686b; Martin E, 2012, BIOCHEMISTRY-US, V51, P2737, DOI 10.1021/bi300105s; MORRIS RJ, 1980, J BIOL CHEM, V255, P8050; Negrerie M, 2001, J BIOL CHEM, V276, P46815, DOI 10.1074/jbc.M102224200; Nienhaus K, 2004, J BIOL CHEM, V279, P22944, DOI 10.1074/jbc.M401561200; PETRICH JW, 1988, BIOCHEMISTRY-US, V27, P4049, DOI 10.1021/bi00411a022; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Puranik M, 2004, J BIOL CHEM, V279, P21096, DOI 10.1074/jbc.M400613200; Rinaldo S, 2012, ANTIOXID REDOX SIGN, V17, P1178, DOI 10.1089/ars.2011.4226; Roberts GP, 2005, J INORG BIOCHEM, V99, P280, DOI 10.1016/j.jinorgbio.2004.10.032; Rubtsov IV, 2001, J AM CHEM SOC, V123, P10056, DOI 10.1021/ja011023w; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; Silkstone G, 2005, DALTON T, P3489, DOI 10.1039/b508183c; Silkstone G, 2002, BIOPHYS CHEM, V98, P65, DOI 10.1016/S0301-4622(02)00085-6; Silkstone G, 2007, J BIOL CHEM, V282, P1638, DOI 10.1074/jbc.M605760200; Silkstone G, 2010, J BIOL CHEM, V285, P19785, DOI 10.1074/jbc.M109.067736; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Thorsteinsson MV, 2000, J BIOL CHEM, V275, P39332, DOI 10.1074/jbc.M007691200; Vos MH, 2008, BBA-BIOENERGETICS, V1777, P15, DOI 10.1016/j.bbabio.2007.10.004; Vos MH, 2012, BIOCHEMISTRY-US, V51, P159, DOI 10.1021/bi201467c; WILSON MT, 1973, J BIOL CHEM, V248, P8162; Yamashita T, 2004, J BIOL CHEM, V279, P21394, DOI 10.1074/jbc.M400512200; Yamashita T, 2008, J BIOL CHEM, V283, P2344, DOI 10.1074/jbc.M708123200; Yoo BK, 2012, J BIOL CHEM, V287, P6851, DOI 10.1074/jbc.M111.299297	56	23	23	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26514	26524		10.1074/jbc.M114.571398	http://dx.doi.org/10.1074/jbc.M114.571398			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25037216	hybrid, Green Published			2022-12-25	WOS:000342128800042
J	Zi, M; Maqsood, A; Prehar, S; Mohamed, TMA; Abou-Leisa, R; Robertson, A; Cartwright, EJ; Ray, SG; Oh, S; Lim, DS; Neyses, L; Oceandy, D				Zi, Min; Maqsood, Arfa; Prehar, Sukhpal; Mohamed, Tamer M. A.; Abou-Leisa, Riham; Robertson, Abigail; Cartwright, Elizabeth J.; Ray, Simon G.; Oh, Sangphil; Lim, Dae-Sik; Neyses, Ludwig; Oceandy, Delvac			The Mammalian Ste20-like Kinase 2 (Mst2) Modulates Stress-induced Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiac Hypertrophy; Cardiovascular Disease; Genetic Polymorphism; Signal Transduction; Transgenic Mice	CARDIOMYOCYTE PROLIFERATION; PROTEIN-KINASE; HEART SIZE; PUMP 4B; APOPTOSIS; GROWTH; RAF-1; SUPPRESSION; INHIBITION; REGULATOR	Background: The role of components of the Hippo signaling pathway in mediating pathological cardiac hypertrophy is incompletely understood. Results: Genetic ablation of Mst2 reduces pathological cardiac hypertrophic response in adult mice. Conclusion: Mst2 regulates stress-induced cardiac hypertrophy by modulating the Raf1-ERK1/2 pathway. Significance: Mst2 might become a novel therapeutic target to reduce pathological hypertrophy. The Hippo signaling pathway has recently moved to center stage in cardiac research because of its key role in cardiomyocyte proliferation and regeneration of the embryonic and newborn heart. However, its role in the adult heart is incompletely understood. We investigate here the role of mammalian Ste20-like kinase 2 (Mst2), one of the central regulators of this pathway. Mst2(-/-) mice showed no alteration in cardiomyocyte proliferation. However, Mst2(-/-) mice exhibited a significant reduction of hypertrophy and fibrosis in response to pressure overload. Consistently, overexpression of MST2 in neonatal rat cardiomyocytes significantly enhanced phenylephrine-induced cellular hypertrophy. Mechanistically, Mst2 positively modulated the prohypertrophic Raf1-ERK1/2 pathway. However, activation of the downstream effectors of the Hippo pathway (Yes-associated protein) was not affected by Mst2 ablation. An initial genetic study in mitral valve prolapse patients revealed an association between a polymorphism in the human MST2 gene and adverse cardiac remodeling. These results reveal a novel role of Mst2 in stress-dependent cardiac hypertrophy and remodeling in the adult mouse and likely human heart.	[Zi, Min; Maqsood, Arfa; Prehar, Sukhpal; Mohamed, Tamer M. A.; Abou-Leisa, Riham; Robertson, Abigail; Cartwright, Elizabeth J.; Neyses, Ludwig; Oceandy, Delvac] Univ Manchester, Inst Cardiovasc Sci, Manchester M13 9PT, Lancs, England; [Zi, Min; Maqsood, Arfa; Prehar, Sukhpal; Mohamed, Tamer M. A.; Abou-Leisa, Riham; Robertson, Abigail; Cartwright, Elizabeth J.; Neyses, Ludwig; Oceandy, Delvac] Manchester Acad Hlth Sci Ctr, Manchester M13 9PT, Lancs, England; [Ray, Simon G.] Univ S Manchester Hosp, Dept Cardiol, Manchester M23 9LT, Lancs, England; [Ray, Simon G.] Manchester Acad Hlth Sci Ctr, Manchester M23 9LT, Lancs, England; [Oh, Sangphil; Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Dept Biol Sci, Natl Creat Res Initiat Ctr, Taejon 305701, South Korea	University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Korea Advanced Institute of Science & Technology (KAIST)	Oceandy, D (corresponding author), Univ Manchester, Inst Cardiovasc Sci, 5-002 AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	delvac.oceandy@manchester.ac.uk	Neyses, Ludwig/AGY-7446-2022; Oceandy, Delvac/G-9911-2015; Lim, Dae-Sik/C-1599-2011; Robertson, Abigail/G-7715-2015	Oceandy, Delvac/0000-0002-6242-6491; Lim, Dae-Sik/0000-0003-2356-7555; Robertson, Abigail/0000-0002-2592-8898; Prehar, Sukhpal/0000-0002-4334-7931; Cartwright, Elizabeth/0000-0002-6836-7795	British Heart Foundation Intermediate Fellowship Grant [FS/09/046/28043]; British Heart Foundation Project Grants [PG/11/23/28801, PG/13/12/30017]; British Heart Foundation Intermediate Basic Science Research Fellowship; British Heart Foundation [PG/13/12/30017, PG/11/23/28801, FS/09/046/28043] Funding Source: researchfish	British Heart Foundation Intermediate Fellowship Grant; British Heart Foundation Project Grants; British Heart Foundation Intermediate Basic Science Research Fellowship; British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Intermediate Fellowship Grant FS/09/046/28043 and British Heart Foundation Project Grants PG/11/23/28801 and PG/13/12/30017 (to D. O.).; A recipient of a British Heart Foundation Intermediate Basic Science Research Fellowship.	Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; Glennon PE, 1996, CIRC RES, V78, P954, DOI 10.1161/01.RES.78.6.954; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Kilili GK, 2010, J BIOL CHEM, V285, P15076, DOI 10.1074/jbc.M109.078915; Maejima Y, 2013, NAT MED, V19, P1478, DOI 10.1038/nm.3322; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Oceandy D, 2007, CIRCULATION, V115, P483, DOI 10.1161/CIRCULATIONAHA.106.643791; Oceandy D, 2009, CIRCULATION, V120, P607, DOI 10.1161/CIRCULATIONAHA.109.868554; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; ROKEY R, 1986, J AM COLL CARDIOL, V7, P1273, DOI 10.1016/S0735-1097(86)80146-2; Romano D, 2010, CANCER RES, V70, P1195, DOI 10.1158/0008-5472.CAN-09-3147; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	30	23	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24275	24288		10.1074/jbc.M114.562405	http://dx.doi.org/10.1074/jbc.M114.562405			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25035424	Green Published, hybrid			2022-12-25	WOS:000341505600024
J	Lind, M; Kallman, T; Chen, J; Ma, XF; Bousquet, J; Morgante, M; Zaina, G; Karlsson, B; Elfstrand, M; Lascoux, M; Stenlid, J				Lind, Marten; Kallman, Thomas; Chen, Jun; Ma, Xiao-Fei; Bousquet, Jean; Morgante, Michele; Zaina, Giusi; Karlsson, Bo; Elfstrand, Malin; Lascoux, Martin; Stenlid, Jan			A Picea abies Linkage Map Based on SNP Markers Identifies QTLs for Four Aspects of Resistance to Heterobasidion parviporum Infection	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; COASTAL DOUGLAS-FIR; CONTROLLING ADAPTIVE TRAITS; SHIKIMATE HYDROXYCINNAMOYLTRANSFERASE; LEAF RUST; GENE MAP; EVOLUTION; CONIFER; GROWTH; ROT	A consensus linkage map of Picea abies, an economically important conifer, was constructed based on the segregation of 686 SNP markers in a F-1 progeny population consisting of 247 individuals. The total length of 1889.2 cM covered 96.5% of the estimated genome length and comprised 12 large linkage groups, corresponding to the number of haploid P. abies chromosomes. The sizes of the groups (from 5.9 to 9.9% of the total map length) correlated well with previous estimates of chromosome sizes (from 5.8 to 10.8% of total genome size). Any locus in the genome has a 97% probability to be within 10 cM from a mapped marker, which makes the map suited for QTL mapping. Infecting the progeny trees with the root rot pathogen Heterobasidion parviporum allowed for mapping of four different resistance traits: lesion length at the inoculation site, fungal spread within the sapwood, exclusion of the pathogen from the host after initial infection, and ability to prevent the infection from establishing at all. These four traits were associated with two, four, four and three QTL regions respectively of which none overlapped between the traits. Each QTL explained between 4.6 and 10.1% of the respective traits phenotypic variation. Although the QTL regions contain many more genes than the ones represented by the SNP markers, at least four markers within the confidence intervals originated from genes with known function in conifer defence; a leucoanthocyanidine reductase, which has previously been shown to upregulate during H. parviporum infection, and three intermediates of the lignification process; a hydroxycinnamoyl CoA shikimate/quinate hydroxycinnamoyltransferase, a 4-coumarate CoA ligase, and a R2R3-MYB transcription factor.	[Lind, Marten; Elfstrand, Malin; Stenlid, Jan] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden; [Kallman, Thomas; Chen, Jun; Ma, Xiao-Fei; Lascoux, Martin] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden; [Bousquet, Jean] Univ Laval, Inst Syst & Integrat Biol, Quebec City, PQ, Canada; [Morgante, Michele; Zaina, Giusi] Univ Udine, Dipartimento Sci Agr & Ambientali, I-33100 Udine, Italy; [Karlsson, Bo] Skogforsk, Svalov, Sweden	Swedish University of Agricultural Sciences; Uppsala University; Laval University; University of Udine; Skogforsk	Lind, M (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden.	marten.lind@slu.se	Stenlid, Jan/K-5909-2019; Ma, Xiaofei/ABB-5302-2022	Ma, Xiaofei/0000-0001-9456-0065; Lind, Marten/0000-0002-3817-2823; Kallman, Thomas/0000-0003-0498-2665; Lascoux, Martin/0000-0003-1699-9042; Stenlid, Jan/0000-0002-5344-2094; MORGANTE, Michele/0000-0003-2591-2156; Elfstrand, Malin/0000-0002-0214-5284	European Community; Seventh Framework Programme (FP7/2007-2013) [211868]; Swedish Research Council FORMAS [dnr 217-2007-433]; Biodiversa projects Linktree; TipTree [ANR-12-EBID-0003]; Swedish Foundation for Strategic Research (SSF) [R8b08-0011]	European Community(European Commission); Seventh Framework Programme (FP7/2007-2013); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Biodiversa projects Linktree; TipTree; Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research)	Financial support was received from the European Community's Sixth Framework Programme, under the Network of Excellence Evoltree (www.evoltree.eu/), by the Seventh Framework Programme (FP7/2007-2013) under the grant agreement no 211868 (Project Noveltree, www.noveltree.eu/), and by the Swedish Research Council FORMAS grant dnr 217-2007-433 (www.formas.se/en). Support also came from the Biodiversa projects Linktree (www.igv.fi.cnr.it/linktree/) and TipTree, grant ANR-12-EBID-0003 (www.agence-nationale-recherche.fr/en/anr-funded-project/?tx_lwmsuivibilan_pi2[CODE] = ANR-12-EBID-0003), and from the Swedish Foundation for Strategic Research (SSF), grant number R8b08-0011 (www.stratresearch.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achere V, 2004, THEOR APPL GENET, V108, P1602, DOI [10.1007/s00122-004-1587-y, 10.1007/s00122-004-1595-y]; Alves AA, 2012, EUPHYTICA, V183, P27, DOI 10.1007/s10681-011-0455-5; Arnerup J, 2010, SCAND J FOREST RES, V25, P106, DOI 10.1080/02827581003730799; Arnerup J, 2011, INDUCED DEFENCE REPO; Asiegbu FO, 2005, MOL PLANT PATHOL, V6, P395, DOI 10.1111/J.1364-3703.2005.00295.X; Beavis WD, 1998, MOL DISSECTION COMPL; Bedon F, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-17; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Broman KW, 2003, GENETICS, V163, P1169; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Chancerel E, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-50; Chancerel E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-368; Chen J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-589; Chen J, 2012, GENETICS, V191, P865, DOI 10.1534/genetics.112.140749; Danielsson M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-154; Devey ME, 2004, THEOR APPL GENET, V108, P516, DOI 10.1007/s00122-003-1471-1; Echt CS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-17; Eckert AJ, 2009, GENETICS, V182, P1289, DOI 10.1534/genetics.109.102350; Eckert AJ, 2009, TREE GENET GENOMES, V5, P225, DOI 10.1007/s11295-008-0183-8; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Farjon A, 1990, PINACEAE DRAWINGS DE; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Freeman JS, 2008, GENETICS, V178, P563, DOI 10.1534/genetics.107.081414; Gaut BS, 2007, NAT REV GENET, V8, P77, DOI 10.1038/nrg1970; GROSS GG, 1974, EUR J BIOCHEM, V42, P453, DOI 10.1111/j.1432-1033.1974.tb03359.x; Hammerbacher A, 2011, BIOSYNTHESIS POLYPHE; Jermstad KD, 2003, GENETICS, V165, P1489; Jermstad KD, 2001, THEOR APPL GENET, V102, P1142, DOI 10.1007/s001220000505; Karlsson B, 2006, SCAND J FOREST RES, V21, P108, DOI 10.1080/02827580500529969; Kim BG, 2011, J KOREAN SOC APPL BI, V54, P817, DOI 10.3839/jksabc.2011.125; KUBISIAK TL, 1995, THEOR APPL GENET, V90, P1119, DOI 10.1007/BF00222931; LANDER ES, 1989, GENETICS, V121, P185; Lange K, 1982, AM J HUMAN GENETICS, V34; Larsson H, 2013, G3-GENES GENOM GENET, V3, P795, DOI 10.1534/g3.112.005462; Liu X, 2011, J AGR SCI, V3; Loman J, 2007, STAT YB FORESTRY OFF; Lubaretz O, 1996, THEOR APPL GENET, V92, P411, DOI 10.1007/BF00223687; Martinez-Garcia PJ, 2013, TREE GENET GENOMES, V9, P1529, DOI 10.1007/s11295-013-0646-4; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Moriguchi Y, 2012, BMC GENOMICS, V13; Moritsuka E, 2012, GENETICS, V190, P1145, DOI 10.1534/genetics.111.136697; Neves LG, 2014, G3-GENES GENOM GENET, V4, P29, DOI 10.1534/g3.113.008714; Nystedt B, 2013, NATURE; Pavy N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-21; Pavy N, 2013, MOL ECOL RESOUR, V13, P324, DOI 10.1111/1755-0998.12062; Pavy N, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-84; Pelgas B, 2005, THEOR APPL GENET, V111, P1466, DOI 10.1007/s00122-005-0068-2; Pelgas B, 2006, THEOR APPL GENET, V113, P1371, DOI 10.1007/s00122-006-0354-7; Pelgas B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-145; Plough LV, 2011, GENETICS, V189, P1473, DOI 10.1534/genetics.111.131854; Prunier J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-368; Raherison E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-434; Raj M, 2005, SILVAE GENET, V54, P126, DOI 10.1515/sg-2005-0020; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Samils B, 2011, TREE GENET GENOMES, V7, P1219, DOI 10.1007/s11295-011-0408-0; SAX KARL, 1933, JOUR ARNOLD ARBORETUM, V14, P356; Schnable PS, 1998, CURR OPIN PLANT BIOL, V1, P123, DOI 10.1016/S1369-5266(98)80013-7; Siljak-Yakovlev S, 2002, THEOR APPL GENET, V104, P505, DOI 10.1007/s001220100755; Stenlid J, 1986, SCAND J FOREST RES, V1, P303, DOI 10.1080/02827588609382421; Thor M, 2005, SCAND J FOREST RES, V20, P165, DOI 10.1080/02827580510008347; Ukrainetz NK, 2008, TREE GENET GENOMES, V4, P159, DOI 10.1007/s11295-007-0097-x; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; van Ooijen JW, 2002, MAPQTL 4 0 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wagner A, 2007, P NATL ACAD SCI USA, V104, P11856, DOI 10.1073/pnas.0701428104; Williams CG, 2009, CONIFER REPRODUCTIVE BIOLOGY, P39; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Woodward S, 1998, BIOL ECOLOGY IMPACT; Xu SZ, 2003, GENETICS, V165, P2259; Yin TM, 2003, THEOR APPL GENET, V106, P1075, DOI 10.1007/s00122-003-1194-3	72	37	39	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101049	10.1371/journal.pone.0101049	http://dx.doi.org/10.1371/journal.pone.0101049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036209	gold, Green Published, Green Submitted			2022-12-25	WOS:000339615200012
J	Mori, K; Kitazawa, R; Kondo, T; Mori, M; Hamada, Y; Nishida, M; Minami, Y; Haraguchi, R; Takahashi, Y; Kitazawa, S				Mori, Kiyoshi; Kitazawa, Riko; Kondo, Takeshi; Mori, Michiko; Hamada, Yasuhiro; Nishida, Michiru; Minami, Yasuhiro; Haraguchi, Ryuma; Takahashi, Yutaka; Kitazawa, Sohei			Diabetic Osteopenia by Decreased beta-Catenin Signaling Is Partly Induced by Epigenetic Derepression of sFRP-4 Gene	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; INDUCED OXIDATIVE STRESS; GLYCATION END-PRODUCTS; HIGH-BONE-MASS; TRANSCRIPTIONAL REGULATION; METHYLATION STATUS; HYDROGEN-PEROXIDE; PROMOTER REGION; LRP5 GENE; MICE	In diabetics, methylglyoxal (MG), a glucose-derived metabolite, plays a noxious role by inducing oxidative stress, which causes and exacerbates a series of complications including low-turnover osteoporosis. In the present study, while MG treatment of mouse bone marrow stroma-derived ST2 cells rapidly suppressed the expression of osteotrophic Wnt-targeted genes, including that of osteoprotegerin (OPG, a decoy receptor of the receptor activator of NF-kappaB ligand (RANKL)), it significantly enhanced that of secreted Frizzled-related protein 4 (sFRP-4, a soluble inhibitor of Wnts). On the assumption that upregulated sFRP-4 is a trigger that downregulates Wnt-related genes, we sought out the molecular mechanism whereby oxidative stress enhanced the sFRP-4 gene. Sodium bisulfite sequencing revealed that the sFRP-4 gene was highly methylated around the sFRP-4 gene basic promoter region, but was not altered by MG treatment. Electrophoretic gel motility shift assay showed that two continuous CpG loci located five bases upstream of the TATA-box were, when methylated, a target of methyl CpG binding protein 2 (MeCP2) that was sequestered upon induction of 8-hydroxy-2-deoxyguanosine, a biomarker of oxidative damage to DNA. These in vitro data suggest that MG-derived oxidative stress (not CpG demethylation) epigenetically and rapidly derepress sFRP-4 gene expression. We speculate that under persistent oxidative stress, as in diabetes and during aging, osteopenia and ultimately low-turnover osteoporosis become evident partly due to osteoblastic inactivation by suppressed Wnt signaling of mainly canonical pathways through the derepression of sFRP-4 gene expression.	[Mori, Kiyoshi; Kitazawa, Riko; Kondo, Takeshi; Mori, Michiko; Kitazawa, Sohei] Kobe Univ, Grad Sch Med, Dept Pathol, Div Diagnost Mol Pathol, Kobe, Hyogo 657, Japan; [Mori, Kiyoshi] Osaka Natl Hosp, Natl Hosp Org, Dept Pathol, Osaka, Japan; [Kitazawa, Riko; Kitazawa, Sohei] Ehime Univ, Grad Sch Med, Dept Mol Pathol, Toon City, Ehime, Japan; [Kitazawa, Riko; Haraguchi, Ryuma; Kitazawa, Sohei] Ehime Univ Hosp, Dept Diagnost Pathol, Toon City, Ehime, Japan; [Kondo, Takeshi] Kobe Univ, Grad Sch Med, Dept Legal Med, Kobe, Hyogo 657, Japan; [Hamada, Yasuhiro] Univ Tokushima, Inst Hlth Biosci, Dept Therapeut Nutr, Tokushima 770, Japan; [Nishida, Michiru; Minami, Yasuhiro] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Kobe, Hyogo 657, Japan; [Takahashi, Yutaka] Kobe Univ, Grad Sch Med, Dept Internal Med, Kobe, Hyogo 657, Japan	Kobe University; Osaka National Hospital; Ehime University; Ehime University; Kobe University; Tokushima University; Kobe University; Kobe University	Kitazawa, S (corresponding author), Kobe Univ, Grad Sch Med, Dept Pathol, Div Diagnost Mol Pathol, Kobe, Hyogo 657, Japan.	kitazawa@m.ehime-u.ac.jp	Kitazawa, Sohei/E-5602-2010	Kitazawa, Sohei/0000-0002-7466-7356	Ministry of Education, Culture, Sports, Science and Technology, Japan [21790351, 16590278, 19390100, 19659086, 20790283, 25860143, 18590372, 21590419, 24590461]; Grants-in-Aid for Scientific Research [22590333, 24790640, 26670176] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (21790351 to K. M., 16590278, 19390100 and 19659086 to S. K., 20790283 to T. K., 25860143 to R. H., 18590372, 21590419 and 24590461 to R. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalou S, 2003, BIOCHEM SOC T, V31, P1394; Akhand AA, 2001, FREE RADICAL BIO MED, V31, P1228, DOI 10.1016/S0891-5849(01)00702-X; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bocker MT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1826; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chen JR, 2010, J BONE MINER RES, V25, P1117, DOI 10.1002/jbmr.7; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Fatokun AA, 2006, BONE, V39, P542, DOI 10.1016/j.bone.2006.02.062; Fujii H, 2008, BONE, V42, P372, DOI 10.1016/j.bone.2007.10.007; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grassi F, 2007, P NATL ACAD SCI USA, V104, P15087, DOI 10.1073/pnas.0703610104; Hamada Y, 2007, BONE, V40, P1408, DOI 10.1016/j.bone.2006.12.057; Hamada Y, 2009, BONE, V44, P936, DOI 10.1016/j.bone.2008.12.011; Han Y, 2007, MOL CELL BIOCHEM, V305, P123, DOI 10.1007/s11010-007-9535-1; Hazra TK, 2001, NUCLEIC ACIDS RES, V29, P1967, DOI 10.1093/nar/29.9.1967; Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kitazawa R, 2007, MOL ENDOCRINOL, V21, P148, DOI 10.1210/me.2006-0205; Kitazawa S, 1999, J BIOL CHEM, V274, P28787, DOI 10.1074/jbc.274.40.28787; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Marsit CJ, 2006, INT J CANCER, V119, P1761, DOI 10.1002/ijc.22051; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; Nishimura R, 2008, J BONE MINER METAB, V26, P203, DOI 10.1007/s00774-007-0824-2; Qi J, 2006, WORLD J GASTROENTERO, V12, P7113, DOI 10.3748/wjg.v12.i44.7113; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Takagi H, 2008, J GASTROENTEROL, V43, P378, DOI 10.1007/s00535-008-2170-0; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Wong VKW, 2003, BIOL CHEM, V384, P1147, DOI 10.1515/BC.2003.127; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393	41	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102797	10.1371/journal.pone.0102797	http://dx.doi.org/10.1371/journal.pone.0102797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036934	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200086
J	Liang, Q; Han, Q; Huang, W; Nan, G; Xu, BQ; Jiang, JL; Chen, ZN				Liang, Qiang; Han, Qing; Huang, Wan; Nan, Gang; Xu, Bao-Qing; Jiang, Jian-Li; Chen, Zhi-Nan			HAb18G/CD147 Regulates Vinculin-Mediated Focal Adhesion and Cytoskeleton Organization in Cultured Human Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							HUMAN HEPATOMA-CELLS; PROMOTES INVASION; LIVING CELLS; IN-VITRO; METASTASIS; PHOSPHORYLATION; RECRUITMENT; DYNAMICS; PAXILLIN; MOTILITY	Focal adhesions (FAs), integrin-mediated macromolecular complexes located at the cell membrane extracellular interface, have been shown to regulate cell adhesion and migration. Our previous studies have indicated that HAb18G/CD147 (CD147) is involved in cytoskeleton reorganization and FA formation in human hepatocellular carcinoma (HCC) cells. However, the precise mechanisms underlying these processes remain unclear. In the current study, we determined that CD147 was involved in vinculin-mediated FA focal adhesion formation in HCC cells. We also found that deletion of CD147 led to reduced vinculin-mediated FA areas (P<0.0001), length/width ratios (P<0.0001), and mean intensities (P<0.0001). CD147 promoted lamellipodia formation by localizing Arp2/3 to the leading edge of the cell. Deletion of CD147 significantly reduced the fluorescence (t(1/2)) recovery times (22.7 +/- 63.3 s) of vinculin-mediated focal adhesions (P<0.0001). In cell-spreading assays, CD147 was found to be essential for dynamic focal adhesion enlargement and disassembly. Furthermore, the current data showed that CD147 reduced tyrosine phosphorylation in vinculin-mediated focal adhesions, and enhanced the accumulation of the acidic phospholipid phosphatidylinositol-4, 5-bisphosphate (PIP2). Together, these results revealed that CD147 is involved in vinculin-mediated focal adhesion formation, which subsequently promotes cytoskeleton reorganization to facilitate invasion and migration of human HCC cells.	[Liang, Qiang; Huang, Wan; Nan, Gang; Xu, Bao-Qing; Jiang, Jian-Li; Chen, Zhi-Nan] Fourth Mil Med Univ, Cell Engn Res Ctr, Xian 710032, Shaanxi, Peoples R China; [Liang, Qiang; Huang, Wan; Nan, Gang; Xu, Bao-Qing; Jiang, Jian-Li; Chen, Zhi-Nan] Fourth Mil Med Univ, Dept Cell Biol, State Key Discipline Cell Biol, Xian 710032, Shaanxi, Peoples R China; [Han, Qing] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Immunol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Jiang, JL (corresponding author), Fourth Mil Med Univ, Cell Engn Res Ctr, Xian 710032, Shaanxi, Peoples R China.	jiangjl@fmmu.edu.cn; znchen@fmmu.edu.cn		Chen, Zhi-Nan/0000-0001-5512-4623	National ST Major Project [2011ZX09102-001-21, 2012ZX10002017-002, 2013ZX09301301]; National Natural Science Foundation of China [31101005, 31371405]; National High Technology Research and Development program of China [2012AA020302]	National ST Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the National S&T Major Project (2011ZX09102-001-21, 2012ZX10002017-002, 2013ZX09301301), the National Natural Science Foundation of China (31101005, 31371405), the National High Technology Research and Development program of China (2012AA020302). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Craig SW, 2003, CURR BIOL, V13, pR236, DOI 10.1016/S0960-9822(03)00160-X; Dai JY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-337; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Dumbauld DW, 2010, BIOL CELL, V102, P203, DOI 10.1042/BC20090104; Erickson MG, 2003, BIOPHYS J, V85, P599, DOI 10.1016/S0006-3495(03)74504-4; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Huang W, 2013, BIOCHEM J, V449, P437, DOI 10.1042/BJ20120343; Jia L, 2006, IUBMB LIFE, V58, P209, DOI 10.1080/15216540600719580; Jiang JL, 2004, CELL MOL LIFE SCI, V61, P2083, DOI 10.1007/s00018-004-4146-4; Jiang JL, 2001, J BIOL CHEM, V276, P46870, DOI 10.1074/jbc.M108291200; Li Y, 2009, HISTOPATHOLOGY, V54, P677, DOI 10.1111/j.1365-2559.2009.03280.x; Liao CG, 2011, MOL CELL BIOL, V31, P2591, DOI 10.1128/MCB.05160-11; McGrath JL, 2007, CURR BIOL, V17, pR357, DOI 10.1016/j.cub.2007.03.057; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mohl CC, 2009, CELL MOTIL CYTOSKEL, V66, P350, DOI 10.1002/cm.20375; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Shyu YJ, 2008, P NATL ACAD SCI USA, V105, P151, DOI 10.1073/pnas.0705181105; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Wen KK, 2009, J BIOL CHEM, V284, P30463, DOI 10.1074/jbc.M109.021295; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Xu J, 2007, MOL CANCER RES, V5, P605, DOI 10.1158/1541-7786.MCR-06-0286; Xu WM, 1998, DEVELOPMENT, V125, P327; Xu WM, 1998, J CELL SCI, V111, P1535; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang ZY, 2004, MOL BIOL CELL, V15, P4234, DOI 10.1091/mbc.E04-03-0264; Zhao P, 2011, HEPATOLOGY, V54, P2012, DOI 10.1002/hep.24592; Zhao P, 2010, CANCER SCI, V101, P387, DOI 10.1111/j.1349-7006.2009.01420.x	39	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102496	10.1371/journal.pone.0102496	http://dx.doi.org/10.1371/journal.pone.0102496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033086	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300058
J	de Andrade, RCLP; Sayao, JM				Lima Pedroso de Andrade, Rafael Cesar; Sayao, Juliana Manso			Paleohistology and Lifestyle Inferences of a Dyrosaurid (Archosauria: Crocodylomorpha) from Paraiba Basin (Northeastern Brazil)	PLOS ONE			English	Article							BONE-HISTOLOGY; DETERMINATE GROWTH; AGE; REPTILIA; PALEOCENE; EVOLUTION	Among the few vertebrates that survived the mass extinction event documented at the Cretaceous-Paleocene boundary are dyrosaurid crocodylomorphs. Surprisingly, there is little information regarding the bone histology of dyrosaurids, despite their relatively common occurrence in the fossil record, and the potential to gain insight about their biology and lifestyle. We provide the first description of the long bone histology of the dyrosaurids. Specimens were collected from the Maria Farinha Formation, in the Paraiba Basin of northeast Brazil. Thin sections of a right femur and left tibia were made. In the left tibia, the cortex consists of lamellar-zonal bone with five lines of arrested growth (LAGs), spaced similar to 300 mu m apart. The tibia contains a small to medium-sized organized vascular network of both simple vascular canals and primary osteons that decrease in density periostially. The femur exhibits a similar histological pattern overall but has double-LAGs, and an EFS layer (the latter is rare in living crocodylians). Secondary osteons occur in the deep cortex near and inside the spongiosa as a result of remodeling in both bones. This tissue pattern is fairly common among slow-growing animals. These specimens were a sub-adult and a senescent. Patterns in the distribution of bone consistent with osteosclerosis suggest that these animals probably hada fast-swimming ecology. Although these results are consistent with the histology in anatomically convergent taxa, it will be necessary to make additional sections from the mid-diaphysis in order to assign their ecology.	[Lima Pedroso de Andrade, Rafael Cesar] Univ Fed Pernambuco, Grad Student Programa Posgrad CTG, Recife, PE, Brazil; [Sayao, Juliana Manso] Univ Fed Pernambuco, Ctr Acad Vitoria, Vitoria De Santo Antao, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	de Andrade, RCLP (corresponding author), Univ Fed Pernambuco, Grad Student Programa Posgrad CTG, Recife, PE, Brazil.	rafael-clpa1@hotmail.com	Sayao, Juliana M/H-5652-2013		Conselho Nacional Pq [401787/2010-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES fellowship)	Conselho Nacional Pq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES fellowship)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research is supported by Conselho Nacional Pq (Proc. N. 401787/2010-9 grant to J.M.S.) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES fellowship to R.C.L.P.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGOLLO J, 1987, GEOBIOS-LYON, V20, P123, DOI 10.1016/S0016-6995(87)80061-X; Barbosa JA, 2008, P ROY SOC B-BIOL SCI, V275, P1385, DOI 10.1098/rspb.2008.0110; Bardet N, 2008, B SOC GEOL FR, V179, P605, DOI 10.2113/gssgfbull.179.6.605; BARTELS WS, 1984, J PALEONTOL, V58, P1347; Beurlen K., 1967, Boletim da Sociedade Brasileira de Geologia, V16, P73; Beurlen K., 1967, B SOC BRASILEIRA GEO, V16, P43; Bona P, 2007, AMEGHINIANA, V44, P435; Brochu CA, 2002, J PALEONTOL, V76, P1060, DOI 10.1666/0022-3360(2002)076<1060:ADCBFM>2.0.CO;2; BUFFETAUT E, 1990, TECTONOPHYSICS, V171, P337, DOI 10.1016/0040-1951(90)90108-K; Buffetaut E., 1982, ANN PALEONTOLOGIE, V68, P327; Buffetaut Eric, 1991, Revista Tecnica de Yacimientos Petroliferos Fiscales Bolivianos, V12, P541; Caetano M. H., 1993, Amphibia-Reptilia, V14, P117, DOI 10.1163/156853893X00291; Castanet JFJ, 1977, B BIOL FR BELG, V3, P183; CHINSAMY A, 1994, NATURE, V368, P196, DOI 10.1038/368196a0; Chinsamy A., 1992, Palaeontologia Africana, V29, P39; Chinsamy A, 2009, ANAT REC, V292, P1462, DOI 10.1002/ar.20990; Cope ED, 1886, P AM PHILOS SOC, V23, P1; Cox, 1976, MORPHOLOGY BIOL REPT, P123; CURRIE P J, 1982, Annals of the South African Museum, V86, P247; de Buffrenil V., 1980, ARCHIVES DE ZOOLOGIE EXPERIMENTALE ET GENERALE, V121, P63; de Ricqles A., 1975, Colloques Internationaux du Centre National de la Recherche Scientifique, P351; de Ricqles Armand, 2001, P289; DEBUFFRENIL V, 1988, J MORPHOL, V198, P149, DOI 10.1002/jmor.1051980203; DEBUFFRENIL V, 1990, PALEOBIOLOGY, V16, P435, DOI 10.1017/S0094837300010174; Denton Robert K. Jr, 1997, P375, DOI 10.1016/B978-012155210-7/50020-X; Dumont M, 2013, J MORPHOL, V274, P570, DOI 10.1002/jmor.20122; Enlow D. H., 1957, Texas Journal of Science, V9, P186; FRANCILLONVIEILLOT H, 1990, J HERPETOL, V24, P13, DOI 10.2307/1564284; Gayet Mireille, 1991, Revista Tecnica de Yacimientos Petroliferos Fiscales Bolivianos, V12, P393; GROSS WALTER, 1934, ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V103, P731, DOI 10.1007/BF02118752; Hastings A, 2007, J VERTEBR PALEONTOL, V27, p87A; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Houssaye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095637; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Hua S, 1996, J VERTEBR PALEONTOL, V16, P703, DOI 10.1080/02724634.1996.10011359; HUTTON JM, 1986, COPEIA, P332, DOI 10.2307/1444994; Kaiser HE, 1969, ACTA BIOTHEOR S9; Kellner AWA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081386; Lamm ET, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P55; Lee AH, 2013, J VERTEBR PALEONTOL, V33, P865, DOI 10.1080/02724634.2013.743898; Montefeltro FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021916; Nascimento-Silva M, 2011, J S AM EARTH SCI, P1; Owen R, 1849, Q J GEOL SOC LONDON, V5, P380, DOI DOI 10.1144/GSL.JGS.1849.005.01-02.43; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Pinheiro AEP, 2012, HIST BIOL, P1, DOI [10.1080/08912963.2012.705838, DOI 10.1080/08912963.2012.705838)]; Pol D, 2012, J VERTEBR PALEONTOL, V32, P328, DOI 10.1080/02724634.2012.646833; Ricqles A. de, 1998, J VERT PALEONT, V18, p72A; Rieppel Olivier, 1995, Palaeontologische Zeitschrift, V69, P289; Salgado L, 2007, AMEGHINIANA, V44, P1; Sayao Juliana M., 2003, Geological Society Special Publication, V217, P335, DOI 10.1144/GSL.SP.2003.217.01.21; Schwarz D, 2006, PALAEONTOLOGY, V49, P695, DOI 10.1111/j.1475-4983.2006.00563.x; Silva MC, 2007, ESTUD GEOL, V17, P85, DOI DOI 10.18190/1980-8208/ESTUD0SGE0L0GIC0S.V17N2P85-95; Stefano G, 1903, B SOC GEOL ITAL, V22, P51; Stein K., 2009, METHODS FOSSIL PREPA, P69; STORRS GW, 1993, AM J SCI, V293A, P63, DOI 10.2475/ajs.293.A.63; Wiffen J, 1995, GEOBIOS-LYON, V28, P625, DOI 10.1016/S0016-6995(95)80216-9; Woodward HN, 2011, J HERPETOL, V45, P339	57	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102189	10.1371/journal.pone.0102189	http://dx.doi.org/10.1371/journal.pone.0102189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032965	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300041
J	Aberhan, M; Kiessling, W				Aberhan, Martin; Kiessling, Wolfgang			Rebuilding Biodiversity of Patagonian Marine Molluscs after the End-Cretaceous Mass Extinction	PLOS ONE			English	Article							WEST-CENTRAL ARGENTINA; NEUQUEN BASIN; NORTHERN PATAGONIA; PALEOGENE BOUNDARY; FOSSIL RECORD; RECOVERY; DIVERSITY; BIVALVES; ABUNDANCE; DYNAMICS	We analysed field-collected quantitative data of benthic marine molluscs across the Cretaceous-Palaeogene boundary in Patagonia to identify patterns and processes of biodiversity reconstruction after the end-Cretaceous mass extinction. We contrast diversity dynamics from nearshore environments with those from offshore environments. In both settings, Early Palaeogene (Danian) assemblages are strongly dominated by surviving lineages, many of which changed their relative abundance from being rare before the extinction event to becoming the new dominant forms. Only a few of the species in the Danian assemblages were newly evolved. In offshore environments, however, two newly evolved Danian bivalve species attained ecological dominance by replacing two ecologically equivalent species that disappeared at the end of the Cretaceous. In both settings, the total number of Danian genera at a locality remained below the total number of late Cretaceous (Maastrichtian) genera at that locality. We suggest that biotic interactions, in particular incumbency effects, suppressed post-extinction diversity and prevented the compensation of diversity loss by originating and invading taxa. Contrary to the total number of genera at localities, diversity at the level of individual fossiliferous horizons before and after the boundary is indistinguishable in offshore environments. This indicates an evolutionary rapid rebound to pre-extinction values within less than ca 0.5 million years. In nearshore environments, by contrast, diversity of fossiliferous horizons was reduced in the Danian, and this lowered diversity lasted for the entire studied post-extinction interval. In this heterogeneous environment, low connectivity among populations may have retarded the recolonisation of nearshore habitats by survivors.	[Aberhan, Martin; Kiessling, Wolfgang] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Berlin, Germany; [Kiessling, Wolfgang] Univ Erlangen Nurnberg, GeoZentrum Nordbayern, D-91054 Erlangen, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Erlangen Nuremberg	Aberhan, M (corresponding author), Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Berlin, Germany.	martin.aberhan@mfn-berlin.de	Kiessling, Wolfgang/E-2259-2015	Kiessling, Wolfgang/0000-0002-1088-2014	Deutsche Forschungsgemeinschaft [Ab 109/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (grant number: Ab 109/8-1; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberhan M, 2007, GEOLOGY, V35, P227, DOI 10.1130/G23197A.1; AGUIRREURRETA MB, 1989, PALAEONTOLOGY, V32, P499; Algar AC, 2013, GLOBAL ECOL BIOGEOGR, V22, P391, DOI 10.1111/geb.12003; Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; Alroy J, 2010, PALEONTOLOGICAL SOC, V16, P55, DOI [10.1017/S1089332600001819, DOI 10.1017/S1089332600001819]; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; Barreda VD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052455; Berggren WA, 1995, GEOCHRONOLOGY TIME S, V54, P129, DOI DOI 10.2110/PEC.95.04.0129; BRYAN JR, 1989, PALAEOGEOGR PALAEOCL, V69, P279, DOI 10.1016/0031-0182(89)90170-3; Casadio S, 2005, CRETACEOUS RES, V26, P507, DOI 10.1016/j.cretres.2005.01.009; Casadio S, 2009, AMEGHINIANA, V46, P27; Chavan A., 1946, Bull Mus Hist nat Paris (2), V18, P345; CHIESA JO, 1995, ACAD NACL CIENCIAS E, V11, P17; Chiesa Jorge O., 2001, Revista Espanola de Paleontologia, V16, P299; Coxall HK, 2006, GEOLOGY, V34, P297, DOI 10.1130/G21702.1; Darragh Thomas A., 1997, Proceedings of the Royal Society of Victoria, V109, P57; del Rio CJ, 2004, J PALEONTOL, V78, P1097, DOI 10.1666/0022-3360(2004)078<1097:TMMAOE>2.0.CO;2; del Rio CJ, 2002, GEOLOGIA RECURSOS NA, V2, P1; del Rio CJ, 2008, NEUES JAHRB GEOL P-A, V249, P281, DOI 10.1127/0077-7749/2008/0249-0281; Del Rio CJ, 2007, ALCHERINGA, V31, P241, DOI 10.1080/03115510701484713; del Rio CJ, 2011, NEUES JAHRB GEOL P-A, V259, P129, DOI 10.1127/0077-7749/2011/0103; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; Erwin Douglas H., 2007, Palaeoworld, V16, P9, DOI 10.1016/j.palwor.2007.05.013; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; GRIFFIN M, 1994, J PALEONTOL, V68, P257, DOI 10.1017/S002233600002285X; Hallam A., 1990, P249; HANSEN T, 1987, Cretaceous Research, V8, P229, DOI 10.1016/0195-6671(87)90023-1; Hansen TA, 2004, PALAEOGEOGR PALAEOCL, V214, P233, DOI 10.1016/j.palaeo.2004.06.017; HANSEN TA, 1993, PALEOBIOLOGY, V19, P251, DOI 10.1017/S0094837300015906; Harries P.J., 1996, BIOTIC RECOVERY MASS, V102, P41; Harrington HJ, 1958, NZ GEOLOGICAL SURVEY, V59, P1; Heinberg C, 1999, PALAEOGEOGR PALAEOCL, V154, P87, DOI 10.1016/S0031-0182(99)00088-7; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P389, DOI 10.1016/j.tree.2013.05.019; Hull PM, 2011, NAT GEOSCI, V4, P856, DOI 10.1038/NGEO1302; Hull PM, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002082; Jablonski D, 2005, J EXP ZOOL PART B, V304B, P504, DOI 10.1002/jez.b.21075; Jablonski D, 1998, SCIENCE, V279, P1327, DOI 10.1126/science.279.5355.1327; Jablonski D, 2002, P NATL ACAD SCI USA, V99, P8139, DOI 10.1073/pnas.102163299; Jiang SJ, 2010, NAT GEOSCI, V3, P280, DOI 10.1038/NGEO775; Kafanov Alexander I., 2004, Science Reports of the Institute of Geoscience University of Tsukuba Section B Geological Sciences, V25, P9; Kauffman EG, 2004, J PALEONTOL, V78, P1187, DOI 10.1666/0022-3360(2004)078<1187:ARNGOM>2.0.CO;2; Keller G, 2007, CRETACEOUS RES, V28, P939, DOI 10.1016/j.cretres.2007.01.006; Kiessling W, 2007, PALEOBIOLOGY, V33, P414, DOI 10.1666/06069.1; Kowalewski M, 2006, PALEOBIOLOGY, V32, P533, DOI 10.1666/05074.1; Lazo DG, 2007, GEOL J, V42, P127, DOI 10.1002/gj.1080; Lazo DG, 2011, J PALEONTOL, V85, P719, DOI 10.1666/10-098.1; Lazo DG, 2003, CRETACEOUS RES, V24, P765, DOI 10.1016/j.cretres.2003.09.001; Lockwood R, 2003, P NATL ACAD SCI USA, V100, P2478, DOI 10.1073/pnas.0535132100; Lyons KG, 2005, CONSERV BIOL, V19, P1019, DOI 10.1111/j.1523-1739.2005.00106.x; McElwain JC, 2007, TRENDS ECOL EVOL, V22, P548, DOI 10.1016/j.tree.2007.09.003; McElwain JC, 2007, PALEOBIOLOGY, V33, P547, DOI 10.1666/06026.1; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Patzkowsky ME, 2007, PALEOBIOLOGY, V33, P295, DOI 10.1666/06078.1; Roopnarine PD, 2006, PALEOBIOLOGY, V32, P1; Scasso RA, 2012, CRETACEOUS RES, V36, P37, DOI 10.1016/j.cretres.2012.02.002; Scasso RA, 2005, CRETACEOUS RES, V26, P283, DOI 10.1016/j.cretres.2004.12.003; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Sessa JA, 2012, PALEOBIOLOGY, V38, P218, DOI 10.1666/10042.1; Sheehan PM, 2008, LETHAIA, V41, P147, DOI 10.1111/j.1502-3931.2008.00116.x; Simpson C, 2009, PALEOBIOLOGY, V35, P631, DOI 10.1666/0094-8373-35.4.631; Sole RV, 2010, J THEOR BIOL, V267, P193, DOI 10.1016/j.jtbi.2010.08.015; SQUIRES RL, 1994, VELIGER, V37, P253; Stilwell JD, 2003, ALCHERINGA, V27, P245, DOI 10.1080/03115510308619107; Stilwell JD, 2003, PALAEOGEOGR PALAEOCL, V195, P319, DOI 10.1016/S0031-0182(03)00364-X; Stilwell Jeffrey D., 2004, Bulletins of American Paleontology, V367, P1; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Vermeij GJ, 2013, PALEOBIOLOGY, V39, P560, DOI 10.1666/13009; WALLER TR, 1992, J PALEONTOL, V66, P215, DOI 10.1017/S0022336000033746; Woods H., 1917, NZ GEOLOGICAL SURVEY, V4, P1; ZINSMEISTER WJ, 1995, J PALEONTOL, V69, P692, DOI 10.1017/S0022336000035216	74	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102629	10.1371/journal.pone.0102629	http://dx.doi.org/10.1371/journal.pone.0102629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028930	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600088
J	Carroll, AL; Sillett, SC; Kramer, RD				Carroll, Allyson L.; Sillett, Stephen C.; Kramer, Russell D.			Millennium-Scale Crossdating and Inter-Annual Climate Sensitivities of Standing California Redwoods	PLOS ONE			English	Article							COAST REDWOOD; FIRE HISTORY; GIANT SEQUOIA; TEMPERATURE PATTERNS; DOUGLAS-FIR; DROUGHT; FORESTS; FOG; DENDROCLIMATOLOGY; RECONSTRUCTIONS	Extremely decay-resistant wood and fire-resistant bark allow California's redwoods to accumulate millennia of annual growth rings that can be useful in biological research. Whereas tree rings of Sequoiadendron giganteum (SEGI) helped formalize the study of dendrochronology and the principle of crossdating, those of Sequoia sempervirens (SESE) have proven much more difficult to decipher, greatly limiting dendroclimatic and other investigations of this species. We overcame these problems by climbing standing trees and coring trunks at multiple heights in 14 old-growth forest locations across California. Overall, we sampled 1,466 series with 483,712 annual rings from 120 trees and were able to crossdate 83% of SESE compared to 99% of SEGI rings. Standard and residual tree-ring chronologies spanning up to 1,685 years for SESE and 1,538 years for SEGI were created for each location to evaluate crossdating and to examine correlations between annual growth and climate. We used monthly values of temperature, precipitation, and drought severity as well as summer cloudiness to quantify potential drivers of inter-annual growth variation over century-long time series at each location. SESE chronologies exhibited a latitudinal gradient of climate sensitivities, contrasting cooler northern rainforests and warmer, drier southern forests. Radial growth increased with decreasing summer cloudiness in northern rainforests and a central SESE location. The strongest dendroclimatic relationship occurred in our southernmost SESE location, where radial growth correlated negatively with dry summer conditions and exhibited responses to historic fires. SEGI chronologies showed negative correlations with June temperature and positive correlations with previous October precipitation. More work is needed to understand quantitative relationships between SEGI radial growth and moisture availability, particularly snowmelt. Tree-ring chronologies developed here for both redwood species have numerous scientific applications, including determination of tree ages, accurate dating of fire-return intervals, archaeology, analyses of stable isotopes, long-term climate reconstructions, and quantifying rates of carbon sequestration.	[Carroll, Allyson L.; Sillett, Stephen C.; Kramer, Russell D.] Humboldt State Univ, Dept Forestry & Wildland Resources, Arcata, CA 95521 USA	California State University System; California State Polytechnic University, Humboldt	Carroll, AL (corresponding author), Humboldt State Univ, Dept Forestry & Wildland Resources, Arcata, CA 95521 USA.	allyson.carroll@gmail.com		Kramer, Russell/0000-0001-5723-771X	Save-the-Redwoods League's Redwoods; Climate Change Initiative (RCCI); National Science Foundation [IOB-0445277]	Save-the-Redwoods League's Redwoods; Climate Change Initiative (RCCI); National Science Foundation(National Science Foundation (NSF))	This research was funded by the Save-the-Redwoods League's Redwoods and Climate Change Initiative (RCCI) and the endowment creating the Kenneth L. Fisher Chair in Redwood Forest Ecology at Humboldt State University. Earlier work in Humboldt Redwoods State Park was funded by the National Science Foundation (IOB-0445277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzoglou JT, 2013, INT J CLIMATOL, V33, P121, DOI 10.1002/joc.3413; Ambrose AR, 2009, PLANT CELL ENVIRON, V32, P743, DOI 10.1111/j.1365-3040.2009.01950.x; Antevs E, 1925, MONTHLY WEATHER REV, V53, P449; Averill J. L, 1924, J FOREST, V22, P31; Biondi F, 1997, AM MIDL NAT, V138, P237, DOI 10.2307/2426817; Briffa KR, 1995, ANALYSIS OF CLIMATE VARIABILITY, P77; BRIFFA KR, 1992, J CLIMATE, V5, P735, DOI 10.1175/1520-0442(1992)005<0735:TRDROS>2.0.CO;2; Brown P. M., 1992, Tree-Ring Bulletin, V52, P1; Brown PM, 2003, NORTHWEST SCI, V77, P147; BROWN PM, 1994, CAN J FOREST RES, V24, P21, DOI 10.1139/x94-004; Brown PM, 1999, NORTHWEST SCI, V73, P205; Burgess SSO, 2004, PLANT CELL ENVIRON, V27, P1023, DOI 10.1111/j.1365-3040.2004.01207.x; Carroll A. L., 2005, Madrono, V52, P114, DOI 10.3120/0024-9637(2005)52[114:CAOAYC]2.0.CO;2; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Cook E.R, 1985, TIME SERIES ANAL APP; Cook ER, 2007, EARTH-SCI REV, V81, P93, DOI 10.1016/j.earscirev.2006.12.002; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; Douglass A. E., 1945, TREE RING BULL, V11, P26; Douglass AE, 1933, CARNEGIE I WASHINGTO, V32; Douglass AE, 1928, CARNEGIE I WASHINGTO, VII; Douglass AE, 1919, CARNEGIE I WASHINGTO, VI; Drake F, 1628, WORLD ENCOMPAS UNPUB; Dunning D, 1925, TIMBERMAN, V26, P200; Dyer T.G.J., 2006, TREE RINGS CLIMATE, DOI 10.2307/2402947; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; FRITTS HC, 1974, ECOL MONOGR, V44, P411, DOI 10.2307/1942448; FRITZ EMANUEL, 1940, TREE RING BULL, V6, P19; Gedalof Z, 2001, CAN J FOREST RES, V31, P322, DOI 10.1139/cjfr-31-2-322; GRAUMLICH LJ, 1987, ANN ASSOC AM GEOGR, V77, P19, DOI 10.1111/j.1467-8306.1987.tb00142.x; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Hughes MK, 1992, CLIM DYNAM, V6, P161, DOI 10.1007/BF00193528; Hughes MK, 1996, TREE RINGS, ENVIRONMENT AND HUMANITY, P225; Hughes MK, 1990, P 6 ANN PAC CLIM PAC, P111; Johnstone JA, 2013, J GEOPHYS RES-BIOGEO, V118, P1438, DOI 10.1002/jgrg.20111; Johnstone JA, 2010, P NATL ACAD SCI USA, V107, P4533, DOI 10.1073/pnas.0915062107; Kapnick S, 2009, CEC5002009016F PIER; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; KELLY KA, 1985, J GEOPHYS RES-OCEANS, V90, P1783, DOI 10.1029/JC090iC06p11783; Knapp PA, 2004, J CLIMATE, V17, P140, DOI 10.1175/1520-0442(2004)017&lt;0140:OOSDIT&gt;2.0.CO;2; Kramer RD, 2014, TREE PHYSIOL, V34, P314, DOI 10.1093/treephys/tpu011; Larjavaara M, 2014, NEW PHYTOL, V202, P344, DOI 10.1111/nph.12656; Mastrandrea MD, 2012, CLIMATIC CHANGE, V111, P5, DOI 10.1007/s10584-011-0240-4; MEKO D, 1993, J CLIMATE, V6, P1773, DOI [10.1175/1520-0442(1993)006<1773:SPOTGA>2.0.CO;2, 10.1175/1520-0442(1993)006&lt;1773:SPOTGA&gt;2.0.CO;2]; Meko DM, 2001, J AM WATER RESOUR AS, V37, P1029, DOI 10.1111/j.1752-1688.2001.tb05530.x; Meko DM, 2001, INT J CLIMATOL, V21, P697, DOI 10.1002/joc.646; Mote PW, 2010, CLIMATIC CHANGE, V102, P29, DOI 10.1007/s10584-010-9848-z; Osborn T. J., 1997, Dendrochronologia, V15, P89; Palmer W.C., 1965, 45 US DEP COMM WEATH, V30; R Core Team, 2014, R LANG ENV STAT COMP; Regent Instruments Canada Inc, 2009, WINDENDRO TREE RING; RIENECKER MM, 1986, J GEOPHYS RES-OCEANS, V91, P6597, DOI 10.1029/JC091iC05p06597; Roden JS, 2009, HOLOCENE, V19, P189, DOI 10.1177/0959683608098959; RUNDEL PW, 1972, AM MIDL NAT, V87, P81, DOI 10.2307/2423883; Sawyer J. O., 2000, REDWOOD FOREST, P39; SCHULMAN EDMUND, 1940, TREE RING BULL, V6, P22; Sillett SC, 2007, ECOL MONOGR, V77, P335, DOI 10.1890/06-0994.1; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Speer JH, 2010, FUNDAMENTALS TREE RI; Spickler JC, 2006, HERPETOL CONSERV BIO, V1, P16; Stahle DW, 2013, EARTH INTERACT, V17, DOI 10.1175/2013EI000518.1; Stahle DW., 2000, EOS, V81, P121, DOI [10.1029/00EO00076, DOI 10.1029/00EO00076]; Stecker R.E., 1980, GIANT SEQUOIA ECOLOG; Stephens SL, 2005, FIRE ECOL, V1, P2, DOI DOI 10.4996/FIREECOLOGY.0101002; Stephenson Nathan L., 2000, Madrono, V47, P61; SWETNAM TW, 1993, SCIENCE, V262, P885, DOI 10.1126/science.262.5135.885; Swetnam TW, 1987, FIRE HIST DENDROCLIM; Timell T. E, 1986, COMPRESSION WOOD GYM; Van Pelt R., 2001, FOREST GIANTS PACIFI; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Waring KM, 2006, CAN J FOREST RES, V36, P2216, DOI 10.1139/X06-127; WARING RH, 1979, SCIENCE, V204, P1380, DOI 10.1126/science.204.4400.1380; Watson E, 2002, CAN J FOREST RES, V32, P1858, DOI 10.1139/X02-096; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Willard D, 2000, GUIDE SEQUOIA GROVES; Williams AP, 2008, OECOLOGIA, V156, P601, DOI 10.1007/s00442-008-1025-y; YAMAGUCHI DK, 1991, CAN J FOREST RES, V21, P414, DOI 10.1139/x91-053; Zang C, 2013, DENDROCHRONOLOGIA, V31, P68, DOI 10.1016/j.dendro.2012.08.001	83	41	42	3	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102545	10.1371/journal.pone.0102545	http://dx.doi.org/10.1371/journal.pone.0102545			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029026	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600082
J	Edwards, T; Cox, EC; Buzzard, V; Wiese, C; Hillard, LS; Murphy, RW				Edwards, Taylor; Cox, Elizabeth Canty; Buzzard, Vanessa; Wiese, Christiane; Hillard, L. Scott; Murphy, Robert W.			Genetic Assessments and Parentage Analysis of Captive Bolson Tortoises (Gopherus flavomarginatus) Inform Their "Rewilding'' in New Mexico	PLOS ONE			English	Article							ALLELE FREQUENCY DATA; COMPUTER-PROGRAM; DESERT TORTOISE; MICROSATELLITE LOCI; CONSERVATION GENETICS; PAIRWISE RELATEDNESS; POPULATION-STRUCTURE; BREEDING PROGRAMS; MOLECULAR MARKERS; AGASSIZII	The Bolson tortoise (Gopherus flavomarginatus) is the first species of extirpated megafauna to be repatriated into the United States. In September 2006, 30 individuals were translocated from Arizona to New Mexico with the long-term objective of restoring wild populations via captive propagation. We evaluated mtDNA sequences and allelic diversity among 11 microsatellite loci from the captive population and archived samples collected from wild individuals in Durango, Mexico (n = 28). Both populations exhibited very low genetic diversity and the captive population captured roughly 97.5% of the total wild diversity, making it a promising founder population. Genetic screening of other captive animals (n = 26) potentially suitable for reintroduction uncovered multiple hybrid G. flavomarginatusxG. polyphemus, which were ineligible for repatriation; only three of these individuals were verified as purebred G. flavomarginatus. We used these genetic data to inform mate pairing, reduce the potential for inbreeding and to monitor the maintenance of genetic diversity in the captive population. After six years of successful propagation, we analyzed the parentage of 241 hatchlings to assess the maintenance of genetic diversity. Not all adults contributed equally to successive generations. Most yearly cohorts of hatchlings failed to capture the diversity of the parental population. However, overlapping generations of tortoises helped to alleviate genetic loss because the entire six-year cohort of hatchlings contained the allelic diversity of the parental population. Polyandry and sperm storage occurred in the captives and future management strategies must consider such events.	[Edwards, Taylor; Cox, Elizabeth Canty] Univ Arizona, Univ Arizona Genet Core, Tucson, AZ 85721 USA; [Buzzard, Vanessa] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Wiese, Christiane; Hillard, L. Scott] Ladder Ranch, Turner Endangered Species Fund, Caballo, NM USA; [Hillard, L. Scott] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada	University of Arizona; University of Arizona; University of California System; University of California Los Angeles; Royal Ontario Museum	Edwards, T (corresponding author), Univ Arizona, Univ Arizona Genet Core, Tucson, AZ 85721 USA.	taylore@email.arizona.edu		Edwards, Taylor/0000-0002-7235-6175	Natural Sciences and Engineering Research Council (Canada) [3148]; Sundance Biology, Inc.; Tucson Herpetological Society; Arizona Research Laboratories	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sundance Biology, Inc.; Tucson Herpetological Society; Arizona Research Laboratories	This research was supported, in part, by the Natural Sciences and Engineering Research Council (Canada) Discovery Grant 3148. Additional funding was provided by Sundance Biology, Inc. biologists, M. Vaughn, the Tucson Herpetological Society and Arizona Research Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre Gustavo, 1997, P333; Urena-Aranda CA, 2012, AMPHIBIA-REPTILIA, V33, P45, DOI 10.1163/156853811X621508; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Banks MA, 2000, J HERED, V91, P87, DOI 10.1093/jhered/91.1.87; Britten HB, 1997, COPEIA, P523; Cornuet JM, 1996, GENETICS, V144, P2001; Davy CM, 2011, CONSERV GENET, V12, P1313, DOI 10.1007/s10592-011-0232-y; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Edwards T, 2004, CONSERV GENET, V5, P485, DOI 10.1023/B:COGE.0000041031.58192.7c; Edwards T, 2003, MOL ECOL NOTES, V3, P589, DOI 10.1046/j.1471-8286.2003.00521.x; Edwards T, 2011, CONSERV GENET RESOUR, V3, P365, DOI 10.1007/s12686-010-9363-6; Edwards T, 2003, THESIS U ARIZONA TUC; Edwards T, 2013, CONSERV GENET, V14, P649, DOI 10.1007/s10592-013-0458-y; Engstrom Tag N., 2007, Chelonian Research Monographs, V4, P124; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FITZSIMMONS NN, 1995, MOL BIOL EVOL, V12, P432; Frankham R., 2002, INTRO CONSERVATION G; Fujii A, 2010, CHELONIAN CONSERV BI, V9, P61, DOI 10.2744/CCB-0786.1; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hansen DM, 2010, ECOGRAPHY, V33, P272, DOI 10.1111/j.1600-0587.2010.06305.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hauswaldt JS, 2005, MOL ECOL, V14, P723, DOI 10.1111/j.1365-294X.2005.02451.x; Ivy JA, 2009, J HERED, V100, P441, DOI 10.1093/jhered/esp019; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; LI CC, 1993, HUM HERED, V43, P45, DOI 10.1159/000154113; Lynch M, 1999, GENETICS, V152, P1753; MORAFKA DJ, 1994, CAN J ZOOL, V72, P1665, DOI 10.1139/z94-222; Morafka DJ, 1981, ECOLOGY CHIHUAHUAN D, P35; Morafka DJ, 1988, ANN CARNEGIE MUS, P47; Murphy RW, 2007, CHELONIAN CONSERV BI, V6, P229, DOI 10.2744/1071-8443(2007)6[229:AGAOTR]2.0.CO;2; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; de Cara MAR, 2013, MOL ECOL, V22, P6091, DOI 10.1111/mec.12560; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Schwartz TS, 2003, MOL ECOL NOTES, V3, P283, DOI 10.1046/j.1471-8286.2003.00428.x; TAJIMA F, 1983, GENETICS, V105, P437; Truett Joe, 2009, Ecological Restoration, V27, P144, DOI 10.3368/er.27.2.144; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; van Dijk PP, 2007, IUCN 2013 IUCN RED L; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wang JL, 2002, GENETICS, V160, P1203; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Williams DA, 2007, CHELONIAN CONSERV BI, V6, P302, DOI 10.2744/1071-8443(2007)6[302:GCFTCB]2.0.CO;2; Witzenberger KA, 2011, BIODIVERS CONSERV, V20, P1843, DOI 10.1007/s10531-011-0074-4	46	11	11	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102787	10.1371/journal.pone.0102787	http://dx.doi.org/10.1371/journal.pone.0102787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029369	Green Published, gold			2022-12-25	WOS:000341306600101
J	Song, HS; Hora, B; Bhattacharya, T; Goonetilleke, N; Liu, MKP; Wiehe, K; Li, H; Iyer, SS; McMichael, AJ; Perelson, AS; Gao, F				Song, Hongshuo; Hora, Bhavna; Bhattacharya, Tanmoy; Goonetilleke, Nilu; Liu, Michael K. P.; Wiehe, Kevin; Li, Hui; Iyer, Shilpa S.; McMichael, Andrew J.; Perelson, Alan S.; Gao, Feng			Reversion and T Cell Escape Mutations Compensate the Fitness Loss of a CD8(+) T Cell Escape Mutant in Their Cognate Transmitted/Founder Virus	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL REPLICATION CAPACITY; SUBTYPE C INFECTION; HIV-1 INFECTION; IN-VIVO; ELITE CONTROLLERS; TYPE-1 INFECTION; P24 GAG; EVOLUTION; HLA	Immune escape mutations that revert back to the consensus sequence frequently occur in newly HIV-1-infected individuals and have been thought to render the viruses more fit. However, their impact on viral fitness and their interaction with other immune escape mutations have not been evaluated in the background of their cognate transmitted/founder (T/F) viral genomes. To precisely determine the role of reversion mutations, we introduced reversion mutations alone or together with CD8(+) T cell escape mutations in their unmodified cognate T/F viral genome and determined their impact on viral fitness in primary CD4(+) T cells. Two reversion mutations, V247I and I64T, were identified in Gag and Tat, respectively, but neither had measurable effect on the fitness of their cognate T/F virus. The V247I and G248A mutations that were detected before and concurrently with the potent T cell escape mutation T242N, respectively, were selected by early T cell responses. The V247I or the G248A mutation alone partially restored the fitness loss caused by the T242N mutation. Together they could fully restore the fitness of the T242N mutant to the T/F level. These results demonstrate that the fitness loss caused by a T cell escape mutation could be compensated by preexisting or concurrent reversion and other T cell escape mutations. Our findings indicate that the overall viral fitness is modulated by the complex interplay among T cell escape, compensatory and reversion mutations to maintain the balance between immune escape and viral replication capacity.	[Song, Hongshuo; Hora, Bhavna; Wiehe, Kevin; Gao, Feng] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27708 USA; [Bhattacharya, Tanmoy; Perelson, Alan S.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Bhattacharya, Tanmoy] Santa Fe Inst, Santa Fe, NM 87501 USA; [Goonetilleke, Nilu; Liu, Michael K. P.; McMichael, Andrew J.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Li, Hui; Iyer, Shilpa S.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Li, Hui; Iyer, Shilpa S.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	Duke University; United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; University of Oxford; University of Pennsylvania; University of Pennsylvania	Gao, F (corresponding author), Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27708 USA.	fgao@duke.edu	Perelson, Alan S/Z-1959-2019; Bhattacharya, Tanmoy/J-8956-2013	Perelson, Alan S/0000-0002-2455-0002; Bhattacharya, Tanmoy/0000-0002-1060-652X	Center for HIV/AIDS Vaccine Immunology [AI067854]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery [AI100645]; Duke Centers for AIDS Research from the National Institutes of Health (NIH) [AI064518]; United States Department of Energy [DE-AC52-06NA25396]; NIH [AI028433]; National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) [OD011095]; MRC [MR/K012037/1] Funding Source: UKRI; Medical Research Council [MR/K012037/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, U19AI067854, P30AI064518, UM1AI100645, R01AI028433, R37AI028433] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011095] Funding Source: NIH RePORTER	Center for HIV/AIDS Vaccine Immunology; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; Duke Centers for AIDS Research from the National Institutes of Health (NIH); United States Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Center for HIV/AIDS Vaccine Immunology (AI067854) and the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (AI100645) and the Duke Centers for AIDS Research (AI064518) from the National Institutes of Health (NIH). Portions of this work were done under the auspices of the United States Department of Energy under contract DE-AC52-06NA25396 and ASP was also supported by NIH grants AI028433 and the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) through grant OD011095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Bailey JR, 2007, J INFECT DIS, V196, P50, DOI 10.1086/518515; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Boutwell CL, 2013, J VIROL, V87, P3952, DOI 10.1128/JVI.03233-12; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Chopera DR, 2012, J VIROL, V86, P13423, DOI 10.1128/JVI.02171-12; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Du SC, 2011, J MOL BIOL, V406, P371, DOI 10.1016/j.jmb.2010.11.027; Duda A, 2009, J VIROL, V83, P1228, DOI 10.1128/JVI.01545-08; Ferguson AL, 2013, IMMUNITY, V38, P606, DOI 10.1016/j.immuni.2012.11.022; Ferrari G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001273; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Gao F, 2014, CELL IN PRESS; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Huang KHG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019018; Jiang CL, 2011, J VIROL, V85, P10669, DOI 10.1128/JVI.05249-11; King AA, 2008, SUBPLEX SUBPLEX OPTI; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Navis M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002422; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; Nielsen HB, 2012, UCMINF GEN PURPOSE U; Novitsky V, 2010, VIROLOGY, V403, P37, DOI 10.1016/j.virol.2010.04.001; Novitsky V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007727; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rolland M, 2013, J VIROL, V87, P5461, DOI 10.1128/JVI.03033-12; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Song HS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-89; Thobakgale CF, 2009, J VIROL, V83, P10234, DOI 10.1128/JVI.00921-09; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	49	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102734	10.1371/journal.pone.0102734	http://dx.doi.org/10.1371/journal.pone.0102734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028937	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600096
J	Lutz, SZ; Franck, O; Bohm, A; Machann, J; Schick, F; Machicao, F; Fritsche, A; Haring, HU; Staiger, H				Lutz, Stefan Z.; Franck, Olga; Boehm, Anja; Machann, Juergen; Schick, Fritz; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald			Common Genetic Variation in the Human CTF1 Locus, Encoding Cardiotrophin-1, Determines Insulin Sensitivity	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; ADIPOSE-TISSUE; RESISTANCE; OBESITY; HOMEOSTASIS; METABOLISM; CYTOKINE; INDEXES; CELLS; LIVER	Aims/Hypothesis: Recently, cardiotrophin-1, a member of the interleukin-6 family of cytokines was described to protect beta-cells from apoptosis, to improve glucose-stimulated insulin secretion and insulin resistance, and to prevent streptozotocin-induced diabetes in mice. Here, we studied whether common single nucleotide polymorphisms (SNPs) in the CTF1 locus, encoding cardiotrophin-1, influence insulin secretion and insulin sensitivity in humans. Methods: We genotyped 1,771 German subjects for three CTF1 tagging SNPs (rs1046276, rs1458201, and rs8046707). The subjects were metabolically characterized by an oral glucose tolerance test. Subgroups underwent magnetic resonance (MR) imaging/spectroscopy and hyperinsulinaemic-euglycaemic clamps. Results: After appropriate adjustment, the minor allele of CTF1 SNP rs8046707 was significantly associated with decreased in vivo measures of insulin sensitivity. The other tested SNPs were not associated with OGTT-derived sensitivity parameters, nor did the three tested SNPs show any association with OGTT-derived parameters of insulin release. In the MR subgroup, SNP rs8046707 was nominally associated with lower visceral adipose tissue. Furthermore, the SNP rs1458201 showed a nominal association with increased VLDL levels. Conclusions: In conclusion, this study, even though preliminary and awaiting further confirmation by independent replication, provides first evidence that common genetic variation in CTF1 could contribute to insulin sensitivity in humans. Our SNP data indicate an insulin-desensitizing effect of cardiotrophin-1 and underline that cardiotrophin-1 represents an interesting target to influence insulin sensitivity.	[Lutz, Stefan Z.; Franck, Olga; Boehm, Anja; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Tubingen, Germany; [Lutz, Stefan Z.; Boehm, Anja; Machann, Juergen; Schick, Fritz; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen, Inst Diabet Res & Metab Dis, Helmholtz Ctr Munich, Tubingen, Germany; [Lutz, Stefan Z.; Boehm, Anja; Machann, Juergen; Schick, Fritz; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] German Ctr Diabet Res DZD, Tubingen, Germany; [Machann, Juergen; Schick, Fritz] Univ Tubingen, Sect Expt Radiol, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Fritsche, Andreas] Univ Tubingen, Dept Internal Med, Div Nutr & Prevent Med, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Haring, HU (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014	Schick, Fritz/0000-0002-4231-3406; Staiger, Harald/0000-0002-9507-5333; Moller, Anja/0000-0002-5344-8533	German Federal Ministry of Education and Research (BMBF) [01GI0925]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of the University of Tubingen	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of the University of Tubingen	The study was supported in part by a grant (01GI0925) from the German Federal Ministry of Education and Research (BMBF) to the German Centre for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Furthermore, we acknowledge the support by the Deutsche Forschungsgemeinschaft and the Open Access Publishing Fund of the University of Tubingen.	Asrih M, 2013, J MOL CELL CARDIOL, V56, P106, DOI 10.1016/j.yjmcc.2012.12.015; Bustos M, 2003, GASTROENTEROLOGY, V125, P192, DOI 10.1016/S0016-5085(03)00698-X; Castano D, 2014, J HEPATOL, V60, P1017, DOI 10.1016/j.jhep.2013.12.012; Chopra I, 2012, DIABETOLOGIA, V55, P783, DOI 10.1007/s00125-011-2407-y; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Febbraio MA, 2007, J CLIN INVEST, V117, P841, DOI 10.1172/JCI30453; Herzberg-Schafer SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014194; Hung HC, 2013, INT J CARDIOL, V169, pE33, DOI 10.1016/j.ijcard.2013.08.112; Jimenez-Gonzalez M, 2013, DIABETOLOGIA, V56, P838, DOI 10.1007/s00125-012-2822-8; Machann J, 2006, MAGN RESON MED, V55, P913, DOI 10.1002/mrm.20825; Machann J, 2005, J MAGN RESON IMAGING, V21, P455, DOI 10.1002/jmri.20292; Malavazos AE, 2008, HYPERTENSION, V51, pE8, DOI 10.1161/HYPERTENSIONAHA.107.105346; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mitsumoto H, 2001, MUSCLE NERVE, V24, P769, DOI 10.1002/mus.1068; Moreno-Aliaga MJ, 2012, ADIPOCYTE, V1, P112, DOI 10.4161/adip.19696; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Natal C, 2008, AM J PHYSIOL-ENDOC M, V294, pE52, DOI 10.1152/ajpendo.00506.2007; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Weigert C, 2005, AM J PHYSIOL-ENDOC M, V289, pE251, DOI 10.1152/ajpendo.00448.2004; Zvonic S, 2004, J BIOL CHEM, V279, P47572, DOI 10.1074/jbc.M403998200	25	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e100391	10.1371/journal.pone.0100391	http://dx.doi.org/10.1371/journal.pone.0100391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025664	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400003
J	Pal, S; Dey, SK; Saha, C				Pal, Sandip; Dey, Subrata Kumar; Saha, Chabita			Inhibition of Catalase by Tea Catechins in Free and Cellular State: A Biophysical Approach	PLOS ONE			English	Article							ISOTHERMAL TITRATION CALORIMETRY; POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; CANCER PREVENTION; OXIDATIVE DAMAGE; IN-VIVO; BINDING; GREEN; DNA; ANTIOXIDANT; APOPTOSIS	Tea flavonoids bind to variety of enzymes and inhibit their activities. In the present study, binding and inhibition of catalase activity by catechins with respect to their structure-affinity relationship has been elucidated. Fluorimetrically determined binding constants for (-)-epigallocatechin gallate (EGCG) and (-)-epicatechin gallate (ECG) with catalase were observed to be 2.27x10(6) M-1 and 1.66x10(6) M-1, respectively. Thermodynamic parameters evidence exothermic and spontaneous interaction between catechins and catalase. Major forces of interaction are suggested to be through hydrogen bonding along with electrostatic contributions and conformational changes. Distinct loss of a-helical structure of catalase by interaction with EGCG was captured in circular dichroism (CD) spectra. Gallated catechins demonstrated higher binding constants and inhibition efficacy than non-gallated catechins. EGCG exhibited maximum inhibition of pure catalase. It also inhibited cellular catalase in K562 cancer cells with significant increase in cellular ROS and suppression of cell viability (IC50 54.5 mu M). These results decipher the molecular mechanism by which tea catechins interact with catalase and highlight the potential of gallated catechin like EGCG as an anticancer drug. EGCG may have other non-specific targets in the cell, but its anticancer property is mainly defined by ROS accumulation due to catalase inhibition.	[Pal, Sandip; Dey, Subrata Kumar; Saha, Chabita] West Bengal Univ Technol, Dept Biotechnol, Kolkata, W Bengal, India	Maulana Abul Kalam Azad University of Technology	Saha, C (corresponding author), West Bengal Univ Technol, Dept Biotechnol, Kolkata, W Bengal, India.	k.chabita@gmail.com	Saha, chabita/AAW-5020-2021		Indian Council of Medical Research (ICMR); Department of Science and Technology (DST), Govt. of India	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Department of Science and Technology (DST), Govt. of India(Department of Science & Technology (India))	Mr. Sandip Pal is financially supported by Senior Research Fellowship (SRF) Grant of Indian Council of Medical Research (ICMR). Dr. Chabita Saha is thankful to Department of Science and Technology (DST), Govt. of India for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; ALSHAKHSHIR R, 1994, VACCINE, V12, P472, DOI 10.1016/0264-410X(94)90127-9; Ashoka S, 2006, J LUMIN, V121, P179, DOI 10.1016/j.jlumin.2005.12.001; Attar F, 2009, ANN NY ACAD SCI, V1171, P292, DOI 10.1111/j.1749-6632.2009.04683.x; Bechtel W, 2009, ANTICANCER RES, V29, P4541; Bourassa P, 2013, J PHOTOCH PHOTOBIO B, V128, P43, DOI 10.1016/j.jphotobiol.2013.07.021; Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793; Crespy V, 2004, J NUTR, V134, p3431S, DOI 10.1093/jn/134.12.3431S; DEISSEROTH A, 1970, PHYSIOL REV, V50, P319, DOI 10.1152/physrev.1970.50.3.319; Dong ZG, 1997, CANCER RES, V57, P4414; Dubeau S, 2010, FOOD CHEM, V122, P539, DOI 10.1016/j.foodchem.2010.03.005; Elbling L, 2005, FASEB J, V19, P807, DOI 10.1096/fj.04-2915fje; Ermakova S, 2005, J BIOL CHEM, V280, P16882, DOI 10.1074/jbc.M414185200; Fang MZ, 2003, CANCER RES, V63, P7563; Ghosh D, 2012, J ENVIRON PATHOL TOX, V31, P1; Gohlke Holger, 2002, Angew Chem Int Ed Engl, V41, P2644, DOI 10.1002/1521-3773(20020802)41:15<2644::AID-ANIE2644>3.0.CO;2-O; HALLIWELL B, 1995, CRIT REV FOOD SCI, V35, P7, DOI 10.1080/10408399509527682; Halliwell B, 2008, ARCH BIOCHEM BIOPHYS, V476, P107, DOI 10.1016/j.abb.2008.01.028; Hasni I, 2011, FOOD CHEM, V126, P630, DOI 10.1016/j.foodchem.2010.11.087; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hossain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018333; Hu YD, 2014, SPECTROCHIM ACTA A, V121, P230, DOI 10.1016/j.saa.2013.09.078; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Ishii T, 2009, CHEM RES TOXICOL, V22, P1689, DOI 10.1021/tx900148k; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jha NS, 2009, THERMOCHIM ACTA, V482, P21, DOI 10.1016/j.tca.2008.10.012; Kanakis CD, 2011, FOOD CHEM, V127, P1046, DOI 10.1016/j.foodchem.2011.01.079; Khan MA, 2002, INT J BIOL MACROMOL, V30, P243, DOI 10.1016/S0141-8130(02)00038-7; LENEHAN PF, 1995, CANCER CHEMOTH PHARM, V35, P377, DOI 10.1007/s002800050250; Leone M, 2003, CANCER RES, V63, P8118; Liang YC, 1999, J CELL BIOCHEM, V75, P1; Liu JQ, 2004, J PHARMACEUT BIOMED, V35, P671, DOI 10.1016/j.jpba.2004.02.010; Liu WB, 2010, NEUROCHEM INT, V57, P206, DOI 10.1016/j.neuint.2010.05.011; Lyn-Cook BD, 1999, NUTR CANCER, V35, P80, DOI 10.1207/S1532791480-86; Nair CKK, 2008, MUTAT RES-GEN TOX EN, V650, P48, DOI 10.1016/j.mrgentox.2007.10.001; Nelson DL, 2004, LEHNINGER PRINCIPLES, P190; Oikawa S, 2003, FREE RADICAL RES, V37, P881, DOI 10.1080/1071576031000150751; Pal S, 2013, RADIAT ENVIRON BIOPH, V52, P269, DOI 10.1007/s00411-013-0463-z; Pal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043321; PERCY ME, 1984, CAN J BIOCHEM CELL B, V62, P1006, DOI 10.1139/o84-129; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Prochazkova D, 2011, FITOTERAPIA, V82, P513, DOI 10.1016/j.fitote.2011.01.018; Putnam CD, 2000, J MOL BIOL, V296, P295, DOI 10.1006/jmbi.1999.3458; Richi B, 2012, MUTAT RES-GEN TOX EN, V747, P62, DOI 10.1016/j.mrgentox.2012.04.002; Sadik CD, 2003, BIOCHEM PHARMACOL, V65, P773, DOI 10.1016/S0006-2952(02)01621-0; Sanchez-Del-Campo L, 2009, INT J MOL SCI, V10, P5398, DOI 10.3390/ijms10125398; Sazuka M, 1996, BIOSCI BIOTECH BIOCH, V60, P1317, DOI 10.1271/bbb.60.1317; Shim JH, 2010, CANCER PREV RES, V3, P670, DOI 10.1158/1940-6207.CAPR-09-0185; Siddiqui IA, 2006, MOL NUTR FOOD RES, V50, P130, DOI 10.1002/mnfr.200500113; Stern KG, 1936, J BIOL CHEM, V112, P661; SUND H, 1967, EUR J BIOCHEM, V1, P400, DOI 10.1111/j.1432-1033.1967.tb00088.x; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Trevisanato SI, 2000, NUTR REV, V58, P1, DOI 10.1111/j.1753-4887.2000.tb01818.x; Wang X, 2003, BIOCHEM PHARMACOL, V66, P2039, DOI 10.1016/S0006-2952(03)00585-9; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yamashita N, 1998, CHEM RES TOXICOL, V11, P855, DOI 10.1021/tx970129v; Yamashita N, 2000, FREE RADICAL RES, V33, P623, DOI 10.1080/10715760000301141; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang GY, 1998, CARCINOGENESIS, V19, P611, DOI 10.1093/carcin/19.4.611; Yang L, 2011, CANCER SCI, V102, P870, DOI 10.1111/j.1349-7006.2011.01874.x	60	33	34	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102460	10.1371/journal.pone.0102460	http://dx.doi.org/10.1371/journal.pone.0102460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025898	gold, Green Submitted, Green Published			2022-12-25	WOS:000339992400076
J	Xu, Z; Huo, XY; Ye, H; Tang, CN; Nandakumar, V; Lou, F; Zhang, DD; Dong, HC; Sun, H; Jiang, SW; Zhang, GC; Liu, ZY; Dong, ZS; Guo, BS; He, Y; Yan, CW; Wang, L; Su, ZY; Li, YY; Gu, DY; Zhang, XJ; Wu, XM; Wei, XW; Hong, LZ; Zhang, YM; Yang, JS; Gong, YL; Tang, CJ; Jones, L; Huang, XF; Chen, SY; Chen, JF				Xu, Zhi; Huo, Xinying; Ye, Hua; Tang, Chuanning; Nandakumar, Vijayalakshmi; Lou, Feng; Zhang, Dandan; Dong, Haichao; Sun, Hong; Jiang, Shouwen; Zhang, Guangchun; Liu, Zhiyuan; Dong, Zhishou; Guo, Baishuai; He, Yan; Yan, Chaowei; Wang, Lu; Su, Ziyi; Li, Yangyang; Gu, Dongying; Zhang, Xiaojing; Wu, Xiaomin; Wei, Xiaowei; Hong, Lingzhi; Zhang, Yangmei; Yang, Jinsong; Gong, Yonglin; Tang, Cuiju; Jones, Lindsey; Huang, Xue F.; Chen, Si-Yi; Chen, Jinfei			Genetic Mutation Analysis of Human Gastric Adenocarcinomas Using Ion Torrent Sequencing Platform	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; IDENTIFIES FREQUENT MUTATION; MULTICENTER PHASE-II; ADVANCED ESOPHAGEAL; SOMATIC MUTATIONS; STOMACH-CANCER; CARCINOMA; EXPRESSION; REVEALS; PROTEIN	Gastric cancer is the one of the major causes of cancer-related death, especially in Asia. Gastric adenocarcinoma, the most common type of gastric cancer, is heterogeneous and its incidence and cause varies widely with geographical regions, gender, ethnicity, and diet. Since unique mutations have been observed in individual human cancer samples, identification and characterization of the molecular alterations underlying individual gastric adenocarcinomas is a critical step for developing more effective, personalized therapies. Until recently, identifying genetic mutations on an individual basis by DNA sequencing remained a daunting task. Recent advances in new next-generation DNA sequencing technologies, such as the semiconductor-based Ion Torrent sequencing platform, makes DNA sequencing cheaper, faster, and more reliable. In this study, we aim to identify genetic mutations in the genes which are targeted by drugs in clinical use or are under development in individual human gastric adenocarcinoma samples using Ion Torrent sequencing. We sequenced 737 loci from 45 cancer-related genes in 238 human gastric adenocarcinoma samples using the Ion Torrent Ampliseq Cancer Panel. The sequencing analysis revealed a high occurrence of mutations along the TP53 locus (9.7%) in our sample set. Thus, this study indicates the utility of a cost and time efficient tool such as Ion Torrent sequencing to screen cancer mutations for the development of personalized cancer therapy.	[Xu, Zhi; Huo, Xinying; Gu, Dongying; Zhang, Xiaojing; Wu, Xiaomin; Wei, Xiaowei; Hong, Lingzhi; Zhang, Yangmei; Yang, Jinsong; Gong, Yonglin; Tang, Cuiju; Chen, Jinfei] Nanjing Med Univ, Dept Oncol, Affiliated Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China; [Ye, Hua; Tang, Chuanning; Lou, Feng; Zhang, Dandan; Dong, Haichao; Sun, Hong; Jiang, Shouwen; Zhang, Guangchun; Liu, Zhiyuan; Dong, Zhishou; Guo, Baishuai; He, Yan; Yan, Chaowei; Wang, Lu; Su, Ziyi; Li, Yangyang] San Valley Biotechnol Inc, Beijing, Peoples R China; [Nandakumar, Vijayalakshmi; Jones, Lindsey; Huang, Xue F.; Chen, Si-Yi] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	Nanjing Medical University; University of Southern California	Chen, JF (corresponding author), Nanjing Med Univ, Dept Oncol, Affiliated Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China.	siyichen@usc.edu; jinfeichen@sohu.com	Hong, Lingzhi/GNO-9746-2022		National Natural Science Foundation of China [81272469, 81000880]; Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project; Wu Jieping Foundation; National Institutes of Health [R01 CA90427, R01 AI084811]; NATIONAL CANCER INSTITUTE [R01CA090427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084811] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project; Wu Jieping Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by grants from National Natural Science Foundation of China to Dr. Jinfei Chen (Grant No. 81272469) and Dr. Zhi Xu (Grant No. 81000880); a grant from Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project to Dr. Jinfei Chen; and the grants from the Wu Jieping Foundation and the National Institutes of Health (R01 CA90427 and R01 AI084811 to Si-Yi Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Batran SE, 2012, INT J CANCER, V130, P491, DOI 10.1002/ijc.26396; [Anonymous], EX VAR SERV NHLBI GO; [Anonymous], 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Arkenau HT, 2009, J CANCER RES CLIN, V135, P855, DOI 10.1007/s00432-009-0583-7; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bang Y-J, LANCET, V376, P687; Borch K, 2000, BRIT J SURG, V87, P618, DOI 10.1046/j.1365-2168.2000.01425.x; Catenacci DVT, 2011, CANCER DISCOV, V1, P573, DOI 10.1158/2159-8290.CD-11-0175; Chan JA, 2011, ANN ONCOL, V22, P1367, DOI 10.1093/annonc/mdq604; Chen CT, 2012, MOL CANCER THER, V11, P660, DOI 10.1158/1535-7163.MCT-11-0754; Chen J, 2011, J CANCER RES CLIN, V137, P1799, DOI 10.1007/s00432-011-1057-2; Corso G, 2011, EUR J CANCER, V47, P443, DOI 10.1016/j.ejca.2010.09.008; Davis PA, 2001, CRIT REV ONCOL HEMAT, V40, P77, DOI 10.1016/S1040-8428(00)00131-1; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Doi T, 2010, J CLIN ONCOL, V28, P1904, DOI 10.1200/JCO.2009.26.2923; Ferry DR, 2007, CLIN CANCER RES, V13, P5869, DOI 10.1158/1078-0432.CCR-06-1970; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Hartgrink HH, 2002, BRIT J SURG, V89, P1438, DOI 10.1046/j.1365-2168.2002.02220.x; Hattori Y, 1996, CLIN CANCER RES, V2, P1373; Holbrook JD, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-119; Ilson DH, 2011, CANCER-AM CANCER SOC, V117, P1409, DOI 10.1002/cncr.25602; Jackson JR, 2000, CANCER RES, V60, P566; Janmaat ML, 2006, J CLIN ONCOL, V24, P1612, DOI 10.1200/JCO.2005.03.4900; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Shahi PK, 2007, CLIN TRANSL ONCOL, V9, P438, DOI 10.1007/s12094-007-0082-8; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Machado AMD, 2010, BBA-REV CANCER, V1806, P58, DOI 10.1016/j.bbcan.2010.01.007; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nagarajan N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r115; Okines AFC, 2010, EUR J CANCER, V46, P1949, DOI 10.1016/j.ejca.2010.05.003; ORY K, 1994, EMBO J, V13, P3496, DOI 10.1002/j.1460-2075.1994.tb06656.x; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peart MJ, 2006, CANCER CELL, V10, P173, DOI 10.1016/j.ccr.2006.08.014; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2; Pourmand N, 2006, P NATL ACAD SCI USA, V103, P6466, DOI 10.1073/pnas.0601184103; Sigal A, 2000, CANCER RES, V60, P6788; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vidal O, 2009, BRIT J SURG, V96, P1443, DOI 10.1002/bjs.6780; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yoon DH, 2012, BRIT J CANCER, V106, P1039, DOI 10.1038/bjc.2012.47	44	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e100442	10.1371/journal.pone.0100442	http://dx.doi.org/10.1371/journal.pone.0100442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025766	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400004
J	Saqcena, M; Mukhopadhyay, S; Hosny, C; Alhamed, A; Chatterjee, A; Foster, DA				Saqcena, M.; Mukhopadhyay, S.; Hosny, C.; Alhamed, A.; Chatterjee, A.; Foster, D. A.			Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs	ONCOGENE			English	Article							PANCREATIC-CANCER; TRANSFORMED-CELLS; METABOLISM; GROWTH; MYC; P53; GLYCOLYSIS; ACTIVATION; HALLMARK; BIOLOGY	Cancer cells undergo a metabolic transformation that allows for increased anabolic demands, wherein glycolytic and tricarboxylic acid (TCA) cycle intermediates are shunted away for the synthesis of biological molecules required for cell growth and division. One of the key shunts is the exit of citrate from the mitochondria and the TCA cycle for the generation of cytosolic acetyl-coenzyme A that can be used for fatty acid and cholesterol biosynthesis. With the loss of mitochondrial citrate, cancer cells rely on the 'conditionally essential' amino acid glutamine (Q) as an anaplerotic carbon source for TCA cycle intermediates. Although Q deprivation causes G1 cell cycle arrest in non-transformed cells, its impact on the cancer cell cycle is not well characterized. We report here a correlation between bypass of the Q-dependent G1 checkpoint and cancer cells harboring K-Ras mutations. Instead of arresting in G1 in response to Q-deprivation, K-Ras-driven cancer cells arrest in either S-or G2/M-phase. Inhibition of K-Ras effector pathways was able to revert cells to G1 arrest upon Q deprivation. Blocking anaplerotic utilization of Q mimicked Q deprivation-causing S-and G2/M-phase arrest in K-Ras mutant cancer cells. Significantly, Q deprivation or suppression of anaplerotic Q utilization created synthetic lethality to the cell cycle phase-specific cytotoxic drugs, capecitabine and paclitaxel. These data suggest that disabling of the G1 Q checkpoint could represent a novel vulnerability of cancer cells harboring K-Ras and possibly other mutations that disable the Q-dependent checkpoint.	[Saqcena, M.; Mukhopadhyay, S.; Hosny, C.; Alhamed, A.; Chatterjee, A.; Foster, D. A.] CUNY, Hunter Coll, Dept Biol Sci, New York, NY 10065 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Foster, DA (corresponding author), CUNY, Hunter Coll, Dept Biol Sci, 695 Pk Ave,Room 927, New York, NY 10065 USA.	foster@genectr.hunter.cuny.edu	Mukhopadhyay, Suman/N-3556-2017; Saqcena, Mahesh/U-5973-2017; damiani, chiara/R-4256-2016	Mukhopadhyay, Suman/0000-0002-4658-1942; Saqcena, Mahesh/0000-0002-2210-3444; 	National Institute of Health [R01-CA046677]; National Center for Research Resources of the National Institute of Health [RP-03037]; Research Centers in Minority Institutions; NATIONAL CANCER INSTITUTE [R01CA179542, R01CA046677] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources of the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by the National Institute of Health grant R01-CA046677 and a pilot project award from the Research Centers in Minority Institutions award RP-03037 from the National Center for Research Resources of the National Institute of Health.	Baker NM, 2013, NATURE, V497, P577, DOI 10.1038/nature12248; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BOS JL, 1989, CANCER RES, V49, P4682; Chen YH, 2005, ONCOGENE, V24, P672, DOI 10.1038/sj.onc.1208099; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DOTTO GP, 1985, NATURE, V318, P472; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Gaglio D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004715; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Salloum D, 2014, MOL CANCER THER, V13, P733, DOI 10.1158/1535-7163.MCT-13-0762; Saqcena M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074157; Schneider G, 2005, GASTROENTEROLOGY, V128, P1606, DOI 10.1053/j.gastro.2005.04.001; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Thornburg JM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2154; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; Walko CM, 2005, CLIN THER, V27, P23, DOI 10.1016/j.clinthera.2005.01.005; Wang XS, 2011, CANCER DISCOV, V1, P35, DOI 10.1158/2159-8274.CD-10-0022; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099	41	34	36	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2015	34	20					2672	2680		10.1038/onc.2014.207	http://dx.doi.org/10.1038/onc.2014.207			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI1YN	25023699	Green Accepted			2022-12-25	WOS:000354541300013
J	Zeldich, E; Chen, CD; Colvin, TA; Bove-Fenderson, EA; Liang, J; Zhou, TBT; Harris, DA; Abraham, CR				Zeldich, Ella; Chen, Ci-Di; Colvin, Teresa A.; Bove-Fenderson, Erin A.; Liang, Jennifer; Zhou, Tracey B. Tucker; Harris, David A.; Abraham, Carmela R.			The Neuroprotective Effect of Klotho is Mediated via Regulation of Members of the Redox System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Glutamate; Neuroprotection; Oxidative Stress	PROTEIN-KINASE-B; OXIDATIVE STRESS; A-BETA; MICROGLIAL ACTIVATION; MEMBRANE ASYMMETRY; GENE-EXPRESSION; CELL-DEATH; GLUTAMATE; PEROXIREDOXIN; BRAIN	Background: Klotho is an age suppressor protein whose brain function is unknown. Results: Klotho protects hippocampal neurons from glutamate and amyloid -induced oxidative damage through the induction of the thioredoxin/peroxiredoxin system. Conclusion: Klotho is neuroprotective via the regulation of the redox system. Significance: Understanding the mechanism underlying Klotho-induced neuroprotection may lead to the development of novel therapeutic approaches against neurodegeneration. Generation of reactive oxygen species (ROS), leading to oxidative damage and neuronal cell death, plays an important role in the pathogenesis of neurodegenerative disorders, including Alzheimer disease. The present study aimed to examine the mechanism by which the anti-aging protein Klotho exerts neuroprotective effects against neuronal damage associated with neurodegeneration and oxidative stress. Pretreatment of rat primary hippocampal neurons and mouse hippocampal neuronal cell line HT22 with recombinant Klotho protected these cells from glutamate and oligomeric amyloid (oA)-induced cytotoxicity. In addition, primary hippocampal neurons obtained from Klotho-overexpressing mouse embryos were more resistant to both cytotoxic insults, glutamate and oA, compared with neurons from wild-type littermates. An antioxidative stress array analysis of neurons treated with Klotho revealed that Klotho significantly enhances the expression of the thioredoxin/peroxiredoxin (Trx/Prx) system with the greatest effect on the induction of Prx-2, an antioxidant enzyme, whose increase was confirmed at the mRNA and protein levels. Klotho-induced phosphorylation of the PI3K/Akt pathway, a pathway important in apoptosis and longevity, was associated with sustained inhibitory phosphorylation of the transcription factor forkhead box O3a (FoxO3a) and was essential for the induction of Prx-2. Down-regulation of Prx-2 expression using a lentivirus harboring shRNA almost completely abolished the ability of Klotho to rescue neurons from glutamate-induced death and significantly, but not completely, inhibited cell death mediated by oA, suggesting that Prx-2 is a key modulator of neuroprotection. Thus, our results demonstrate, for the first time, the neuroprotective role of Klotho and reveal a novel mechanism underlying this effect.	[Zeldich, Ella; Chen, Ci-Di; Bove-Fenderson, Erin A.; Liang, Jennifer; Harris, David A.; Abraham, Carmela R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Colvin, Teresa A.; Abraham, Carmela R.] Boston Univ, Sch Med, Program Mol Med, Boston, MA 02118 USA; [Zhou, Tracey B. Tucker; Abraham, Carmela R.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Abraham, CR (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio O Conte Bldg K304, Boston, MA 02118 USA.	cabraham@bu.edu	Zeldich, Ella/K-7702-2013	Zeldich, Ella/0000-0002-9946-4512; Harris, David/0000-0002-6985-5790	Alzheimer's Drug Discovery Foundation	Alzheimer's Drug Discovery Foundation	This work was supported by a grant from the Alzheimer's Drug Discovery Foundation (to C. R. A.).	Abraham CR, 2012, FUTURE MED CHEM, V4, P1671, DOI [10.4155/fmc.12.134, 10.4155/FMC.12.134]; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Armstrong JS, 2010, FASEB J, V24, P2152, DOI 10.1096/fj.09-143222; Arner E S, 2001, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0704s05; Banerjee S, 2013, CELL PHYSIOL BIOCHEM, V31, P659, DOI 10.1159/000350085; Baranzini SE, 2010, BRAIN, V133, P2603, DOI 10.1093/brain/awq192; Behl C, 1997, ENDOCRINOLOGY, V138, P101, DOI 10.1210/en.138.1.101; Bell KFS, 2011, ANTIOXID REDOX SIGN, V14, P1467, DOI 10.1089/ars.2010.3567; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chateau MT, 2010, AGING-US, V2, P567, DOI 10.18632/aging.100195; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen CD, 2013, J NEUROSCI, V33, P1927, DOI 10.1523/JNEUROSCI.2080-12.2013; Chen W, 2003, INT J DEV NEUROSCI, V21, P209, DOI 10.1016/S0736-5748(03)00037-6; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Chong ZZ, 2004, J CEREBR BLOOD F MET, V24, P728, DOI 10.1097/01.WCB.0000122746.72175.0E; Chonga ZZ, 2004, EXP CELL RES, V296, P196, DOI 10.1016/j.yexcr.2004.01.021; Cimini A, 2013, J CELL BIOCHEM, V114, P708, DOI 10.1002/jcb.24412; Clinton SM, 2013, BRAIN RES, V1527, P1, DOI 10.1016/j.brainres.2013.06.044; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Cumming RC, 2007, J BIOL CHEM, V282, P30523, DOI 10.1074/jbc.M700869200; Das A, 2010, NEUROCHEM RES, V35, P2175, DOI 10.1007/s11064-010-0321-1; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076; Duce JA, 2008, GLIA, V56, P106, DOI 10.1002/glia.20593; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Fukui M, 2010, FREE RADICAL BIO MED, V49, P800, DOI 10.1016/j.freeradbiomed.2010.06.002; Fukui M, 2010, MOL CARCINOGEN, V49, P750, DOI 10.1002/mc.20650; Gan Y, 2012, ANTIOXID REDOX SIGN, V17, P719, DOI 10.1089/ars.2011.4298; German DC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.018; HANAOKA K, 1991, DIFFERENTIATION, V48, P183, DOI 10.1111/j.1432-0436.1991.tb00256.x; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Hwang IK, 2010, FREE RADICAL BIO MED, V48, P1242, DOI 10.1016/j.freeradbiomed.2010.02.007; Ikushima M, 2006, BIOCHEM BIOPH RES CO, V339, P827, DOI 10.1016/j.bbrc.2005.11.094; Izbeki F, 2010, J PHYSIOL-LONDON, V588, P3101, DOI 10.1113/jphysiol.2010.191023; Jin YN, 2010, J BIOENERG BIOMEMBR, V42, P199, DOI 10.1007/s10863-010-9286-7; Kang JQ, 2003, J NEUROSCI RES, V74, P37, DOI 10.1002/jnr.10740; Kang JQ, 2003, MOL PHARMACOL, V64, P557, DOI 10.1124/mol.64.3.557; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Kim SU, 2011, NEUROBIOL AGING, V32, P1054, DOI 10.1016/j.neurobiolaging.2009.05.017; King GD, 2012, AGE, V34, P1405, DOI 10.1007/s11357-011-9315-4; King GD, 2012, BIOCHEM J, V441, P453, DOI 10.1042/BJ20101909; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; Kuang X, 2014, NEUROBIOL AGING, V35, P169, DOI 10.1016/j.neurobiolaging.2013.07.019; Kudo W, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.43; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039382; Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kwon KJ, 2010, J CLIN NEUROL, V6, P127, DOI 10.3988/jcn.2010.6.3.127; Lee Young Ju, 2011, Lab Anim Res, V27, P293, DOI 10.5625/lar.2011.27.4.293; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Lopert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050683; Luo H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.3; Uranga RM, 2013, J BIOL CHEM, V288, P19773, DOI 10.1074/jbc.M113.457622; Masuda H, 2005, MECH AGEING DEV, V126, P1274, DOI 10.1016/j.mad.2005.07.007; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Medina MG, 2005, EMBO J, V24, P1706, DOI 10.1038/sj.emboj.7600650; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Melo A, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/467180; Mishra S, 2011, NEUROREPORT, V22, P23, DOI 10.1097/WNR.0b013e328341e141; Murakami S, 2006, EXP GERONTOL, V41, P1014, DOI 10.1016/j.exger.2006.06.061; Nagai Taku, 2003, FASEB Journal, V17, P50; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Patenaude A, 2005, CELL MOL LIFE SCI, V62, P1063, DOI 10.1007/s00018-005-4541-5; Pei JJ, 2003, ACTA NEUROPATHOL, V105, P381, DOI 10.1007/s00401-002-0657-y; Reddy PH, 2009, CNS SPECTRUMS, V14, P8, DOI 10.1017/S1092852900024901; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sanphui P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.148; Semba RD, 2014, NEUROSCI LETT, V558, P37, DOI 10.1016/j.neulet.2013.10.058; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shi QL, 2007, ALZ DIS ASSOC DIS, V21, P276, DOI 10.1097/WAD.0b013e31815721c3; Shiozaki M, 2008, NEUROSCIENCE, V152, P924, DOI 10.1016/j.neuroscience.2008.01.032; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Teocchi MA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-53; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; UETSUKI T, 1989, J BIOL CHEM, V264, P5791; Wang CJ, 2010, N-S ARCH PHARMACOL, V381, P73, DOI 10.1007/s00210-009-0470-4; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wang YA, 2006, CANCER BIOL THER, V5, P20, DOI 10.4161/cbt.5.1.2430; Wohrle S, 2011, J BONE MINER RES, V26, P2486, DOI 10.1002/jbmr.478; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Zeldich E, 2007, J CELL PHYSIOL, V213, P750, DOI 10.1002/jcp.21142; Zhong DS, 2008, CANCER RES, V68, P7270, DOI 10.1158/0008-5472.CAN-08-1484; Zhu H, 2012, EXP BIOL MED, V237, P143, DOI 10.1258/ebm.2011.011152	91	133	141	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24700	24715		10.1074/jbc.M114.567321	http://dx.doi.org/10.1074/jbc.M114.567321			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25037225	Green Published, hybrid			2022-12-25	WOS:000341505600059
J	Cavallari, M; Ceccarelli, A; Wang, GY; Moscufo, N; Hannoun, S; Matulis, CR; Jackson, JS; Glanz, BI; Bakshi, R; Neema, M; Guttmann, CRG				Cavallari, Michele; Ceccarelli, Antonia; Wang, Guang-Yi; Moscufo, Nicola; Hannoun, Salem; Matulis, Christina R.; Jackson, Jonathan S.; Glanz, Bonnie I.; Bakshi, Rohit; Neema, Mohit; Guttmann, Charles R. G.			Microstructural Changes in the Striatum and Their Impact on Motor and Neuropsychological Performance in Patients with Multiple Sclerosis	PLOS ONE			English	Article							GRAY-MATTER ATROPHY; DIFFUSION TENSOR; COGNITIVE IMPAIRMENT; T2 HYPOINTENSITY; MRI; MS; DEGENERATION; REGISTRATION; INVOLVEMENT; VOLUMETRY	Grey matter (GM) damage is a clinically relevant feature of multiple sclerosis (MS) that has been previously assessed with diffusion tensor imaging (DTI). Fractional anisotropy (FA) of the basal ganglia and thalamus might be increased in MS patients, and correlates with disability scores. Despite the established role of the striatum and thalamus in motor control, mood and cognition, the impact of DTI changes within these structures on motor and neuropsychological performance has not yet been specifically addressed in MS. We investigated DTI metrics of deep GM nuclei and their potential association with mobility and neuropsychological function. DTI metrics from 3T MRI were assessed in the caudate, putamen, and thalamus of 30 MS patients and 10 controls. Sixteen of the patients underwent neuropsychological testing. FA of the caudate and putamen was higher in MS patients compared to controls. Caudate FA correlated with Expanded Disability Status Scale score, Ambulation Index, and severity of depressive symptomatology. Putamen and thalamus FA correlated with deficits in memory tests. In contrast, cerebral white matter (WM) lesion burden showed no significant correlation with any of the disability, mobility and psychometric parameters. Our findings support evidence of FA changes in the basal ganglia in MS patients, as well as deep GM involvement in disabling features of MS, including mobility and cognitive impairment. Deep GM FA appears to be a more sensitive correlate of disability than WM lesion burden.	[Cavallari, Michele; Wang, Guang-Yi; Moscufo, Nicola; Guttmann, Charles R. G.] Harvard Univ, Sch Med, Dept Radiol, Brigham & Womens Hosp,Ctr Neurol Imaging, Boston, MA 02115 USA; [Cavallari, Michele] Univ Roma La Sapienza, Dipartimento Neurosci Salute Mentale & Organi Sen, Rome, Italy; [Ceccarelli, Antonia; Matulis, Christina R.; Jackson, Jonathan S.; Glanz, Bonnie I.; Bakshi, Rohit; Neema, Mohit] Harvard Univ, Sch Med, Dept Neurol,Lab Neuroimaging Res, Brigham & Womens Hosp,Partners Multiple Sclerosis, Boston, MA 02115 USA; [Wang, Guang-Yi] Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Hannoun, Salem] Univ Lyon 1, Ctr Rech Acquisit Traitement Image Sante CREATIS, CNRS, Unites Mixtes Rech UMR 5220, F-69365 Lyon, France; [Hannoun, Salem] Univ Lyon 1, INSERM, U1044, F-69365 Lyon, France; [Hannoun, Salem] Univ Lyon, Observ Francais Sclerose Plaques OFSEP, Lyon, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Sapienza University Rome; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Guttmann, CRG (corresponding author), Harvard Univ, Sch Med, Dept Radiol, Brigham & Womens Hosp,Ctr Neurol Imaging, Boston, MA 02115 USA.	guttmann@bwh.harvard.edu	ceccarelli, antonia/N-9563-2019; Guttmann, Charles RG/J-3093-2018; Hannoun, Salem/I-2761-2016	ceccarelli, antonia/0000-0002-1628-5667; Hannoun, Salem/0000-0002-5982-3242; Guttmann, Charles/0000-0002-7006-9762	National Institute on Aging [NIH 2R01AG22092-06A]; NATIONAL INSTITUTE ON AGING [R01AG022092] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Michele Cavallari, Nicola Moscufo, and Charles RG Guttmann acknowledge support from the National Institute on Aging (NIH 2R01AG22092-06A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnato F, 2006, AM J NEURORADIOL, V27, P2161; Bakshi R, 2002, ARCH NEUROL-CHICAGO, V59, P62, DOI 10.1001/archneur.59.1.62; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859; Bergsland N, 2012, AM J NEURORADIOL, V33, P1573, DOI 10.3174/ajnr.A3086; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Bozzali M, 2002, AM J NEURORADIOL, V23, P985; Brass SD, 2006, MULT SCLER J, V12, P437, DOI 10.1191/135248506ms1301oa; Catalaa I, 1999, AM J NEURORADIOL, V20, P1613; Ceccarelli A, 2012, AM J NEURORADIOL, V33, P1579, DOI 10.3174/ajnr.A3083; Ceccarelli A, 2012, CURR OPIN NEUROL, V25, P402, DOI 10.1097/WCO.0b013e328354f63f; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926; Cohen JA, 2001, ARCH NEUROL-CHICAGO, V58, P961, DOI 10.1001/archneur.58.6.961; Dawson JW, 1916, EDINBURGH MED J, V17, DOI [10.1007/978-3-319-02735-7, DOI 10.1007/978-3-319-02735-7]; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Geurts JJG, 2005, AM J NEURORADIOL, V26, P572; Hannoun S, 2012, AM J NEURORADIOL, V33, P1363, DOI 10.3174/ajnr.A2983; Hasan KM, 2012, J NEUROL SCI, V313, P99, DOI 10.1016/j.jns.2011.09.015; Hasan KM, 2011, J NEUROSCI, V31, P16826, DOI 10.1523/JNEUROSCI.4184-11.2011; Hasan KM, 2009, J MAGN RESON IMAGING, V29, P70, DOI 10.1002/jmri.21648; HAUSER SL, 1983, NEW ENGL J MED, V308, P173, DOI 10.1056/NEJM198301273080401; Horakova D, 2008, J NEUROL NEUROSUR PS, V79, P407, DOI 10.1136/jnnp.2007.120378; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Mike A, 2011, AM J NEURORADIOL, V32, P515, DOI 10.3174/ajnr.A2340; Nakamura K, 2009, NEUROIMAGE, V44, P769, DOI 10.1016/j.neuroimage.2008.09.059; Neema M, 2009, AM J NEURORADIOL, V30, P911, DOI 10.3174/ajnr.A1514; Pal D, 2011, J CLIN NEUROSCI, V18, P193, DOI 10.1016/j.jocn.2010.05.033; Pirko I, 2007, NEUROLOGY, V68, P634, DOI 10.1212/01.wnl.0000250267.85698.7a; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popescu BFG, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-11; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sander DM, 1898, MSCHR PSYCHIAT NEURO, V4, P427; Sastre-Garriga J, 2009, J NEUROL SCI, V282, P120, DOI 10.1016/j.jns.2008.12.019; Schmahmann JD, 2008, CORTEX, V44, P1037, DOI 10.1016/j.cortex.2008.04.004; Stankiewicz JM, 2011, J NEUROIMAGING, V21, pe50, DOI 10.1111/j.1552-6569.2009.00449.x; Vrenken H, 2006, J MAGN RESON IMAGING, V23, P628, DOI 10.1002/jmri.20564; Yu B, 2008, 2008 CONFERENCE ON LASERS AND ELECTRO-OPTICS & QUANTUM ELECTRONICS AND LASER SCIENCE CONFERENCE, VOLS 1-9, P947, DOI 10.1109/ISBI.2008.4541154	39	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101199	10.1371/journal.pone.0101199	http://dx.doi.org/10.1371/journal.pone.0101199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047083	Green Published, gold, Green Submitted			2022-12-25	WOS:000339558100007
J	Halupka, K				Halupka, Konrad			Spreading Information in a Network of Interacting Neighbours	PLOS ONE			English	Article							SONG; EVOLUTION; BIRDS; SYNCHRONIZATION; DISCRIMINATION; BEHAVIOR; NOISE	Dispersed individuals can coordinate the onset of life history events, like reproduction or migration, on a large (population) spatial scale. However, the mechanism of this synchronisation has not yet been identified. In many species signals produced by one individual stimulate signalling activity of immediate neighbours. I propose that such local focuses of signalling could transform into waves propagating in space. This hypothesis predicts that signalling self-organizes into bursts, because neighbours tend to enter activity and refractory periods together. Temporal characteristics of such pulses should be more similar in locations proximate to one another than in distant ones. Finally, denser populations should produce relatively more complex wave patterns, since the number of propagating waves is proportional to the number of individuals. These predictions were tested in an analysis of time series of numbers of territorial songs in chaffinches, Fringilla coelebs, and the results supported the hypothesis. Time series of singing activity had memory of their past states: they were autoregressive processes with spectra in which low frequency oscillations predominated. The degree of similarity in two synchronously sampled time series, measured as a Euclidean distance between their spectra, decreased with the increasing physical distance of sampling spots and the number of signalling males. It is concluded that networks of interacting neighbours may integrate populations synchronising life cycles of dispersed individuals.	Univ Wroclaw, Dept Behav Ecol, PL-50138 Wroclaw, Poland	University of Wroclaw	Halupka, K (corresponding author), Univ Wroclaw, Dept Behav Ecol, PL-50138 Wroclaw, Poland.	konrad.halupka@uni.wroc.pl	Halupka, Konrad/E-2534-2018	Halupka, Konrad/0000-0001-5139-1134	University of Wroclaw [1069/S/KBEE/2012-2013]	University of Wroclaw	Research was funded by the University of Wroclaw (1069/S/KBEE/2012-2013). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW RJ, 1962, ANN NY ACAD SCI, V102, P296, DOI 10.1111/j.1749-6632.1962.tb13648.x; Backwell P, 2006, ACTA ETHOL, V9, P22, DOI 10.1007/s10211-005-0009-8; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Beauchamp G, 2011, ETHOLOGY, V117, P326, DOI 10.1111/j.1439-0310.2011.01875.x; Brooke PN, 2000, BEHAV ECOL SOCIOBIOL, V49, P79, DOI 10.1007/s002650000256; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Brumm H, 2009, ANIM BEHAV, V77, P37, DOI 10.1016/j.anbehav.2008.09.009; Calabrese JM, 2004, AM NAT, V164, P25, DOI 10.1086/421443; Caro SP, 2007, BEHAV PROCESS, V75, P1, DOI 10.1016/j.beproc.2007.02.011; Catchpole CK, 1979, VOCAL COMMUNICATION; Chang C.-I., 2013, HYPERSPECTRAL DATA P, DOI [10.1002/9781118269787, DOI 10.1002/9781118269787]; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Cramp S.E., 1994, HDB BIRDS EUROPE MID; Darling F.F., 1938, BIRD FLOCKS BREEDING; Evans LE, 2009, ANIM BEHAV, V78, P671, DOI 10.1016/j.anbehav.2009.05.031; Feng AS, 2009, ETHOLOGY, V115, P851, DOI 10.1111/j.1439-0310.2009.01666.x; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; GREENFIELD MD, 1994, ANNU REV ECOL SYST, V25, P97, DOI 10.1146/annurev.es.25.110194.000525; Halley JM, 1999, THEOR POPUL BIOL, V56, P215, DOI 10.1006/tpbi.1999.1424; Hare JF, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2153; Hau M, 2008, ORNITOL NEOTROP, V19, P39; Helm B, 2006, ANIM BEHAV, V72, P245, DOI 10.1016/j.anbehav.2005.12.007; Henson SM, 2010, AUK, V127, P571, DOI 10.1525/auk.2010.09202; HUTCHINSON JMC, 1993, ANIM BEHAV, V45, P1153, DOI 10.1006/anbe.1993.1139; IMS RA, 1990, TRENDS ECOL EVOL, V5, P135, DOI 10.1016/0169-5347(90)90218-3; Jovani R, 2008, P ROY SOC B-BIOL SCI, V275, P1557, DOI 10.1098/rspb.2008.0125; Kastberger G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036736; Araujo SBL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057362; Lohr B, 2003, ANIM BEHAV, V65, P763, DOI 10.1006/anbe.2003.2093; Mathevon N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001580; McGregor PK, 2005, ANIMAL COMMUNICATION; Naguib M, 2000, ANIM BEHAV, V59, P715, DOI 10.1006/anbe.1999.1354; Naguib M, 2006, BEHAV ECOL SOCIOBIOL, V59, P419, DOI 10.1007/s00265-005-0066-z; Naguib Marc, 2005, P300, DOI 10.1017/CBO9780511610363.018; Porter TA, 2001, J ZOOL, V253, P383, DOI 10.1017/S0952836901000358; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SMITH DG, 1979, BEHAVIOUR, V68, P193, DOI 10.1163/156853979X00313; Trainor BC, 2006, GEN COMP ENDOCR, V148, P252, DOI 10.1016/j.ygcen.2006.03.006; Ward L. M., 2007, SCHOLARPEDIA, V2, P1537, DOI [DOI 10.4249/SCH0LARPEDIA.1537, 10.4249/scholarpedia.1537, DOI 10.4249/SCHOLARPEDIA.1537]; Wolf M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2777; YOMTOV Y, 1975, AUK, V92, P778, DOI 10.2307/4084788; Ziegler TE, 2013, AM J PRIMATOL, V75, P202, DOI 10.1002/ajp.22061	42	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102801	10.1371/journal.pone.0102801	http://dx.doi.org/10.1371/journal.pone.0102801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036106	gold, Green Submitted, Green Published			2022-12-25	WOS:000339615200088
J	Schuck, S; Weinhold, A; Luu, VT; Baldwin, IT				Schuck, Stefan; Weinhold, Arne; Van Thi Luu; Baldwin, Ian T.			Isolating Fungal Pathogens from a Dynamic Disease Outbreak in a Native Plant Population to Establish Plant-Pathogen Bioassays for the Ecological Model Plant Nicotiana attenuata	PLOS ONE			English	Article							PHYTOPHTHORA-INFESTANS; HERBIVORE INTERACTIONS; JASMONIC ACID; 1ST REPORT; RESISTANCE; SPECIFICITY; GENE; TIME; IDENTIFICATION; FLUCTUATIONS	The wild tobacco species Nicotiana attenuata has been intensively used as a model plant to study its interaction with insect herbivores and pollinators in nature, however very little is known about its native pathogen community. We describe a fungal disease outbreak in a native N. attenuata population comprising 873 plants growing in an area of about 1500 m(2). The population was divided into 14 subpopulations and disease symptom development in the subpopulations was monitored for 16 days, revealing a waxing and waning of visible disease symptoms with some diseased plants recovering fully. Native fungal N. attenuata pathogens were isolated from diseased plants, characterized genetically, chemotaxonomically and morphologically, revealing several isolates of the ascomycete genera Fusarium and Alternaria, that differed in the type and strength of the disease symptoms they caused in bioassays on either detached leaves or intact soil-grown plants. These isolates and the bioassays will empower the study of N. attenuata-pathogen interactions in a realistic ecological context.	[Schuck, Stefan; Weinhold, Arne; Van Thi Luu; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Max Planck Society	Baldwin, IT (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.	baldwin@ice.mpg.de	Baldwin, Ian T/K-1809-2013; Weinhold, Arne/R-1739-2016; Schepler-Luu, Van/ABG-1804-2021	Weinhold, Arne/0000-0001-9999-7450; Schepler-Luu, Van/0000-0002-0709-2783; Baldwin, Ian/0000-0001-5371-2974; Schuck, Stefan/0000-0002-3959-4884	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahmooli IH, 2013, PLANT DIS, V97, P687, DOI 10.1094/PDIS-09-12-0828-PDN; Allen C, 2009, PLANT PHYSIOL, V150, P1631, DOI 10.1104/pp.109.140004; Andersen B, 2005, PHYTOPATHOLOGY, V95, P1021, DOI 10.1094/PHYTO-95-1021; Andersen B, 2004, J AGR FOOD CHEM, V52, P7507, DOI 10.1021/jf048727k; Andrew M, 2009, MYCOLOGIA, V101, P95, DOI 10.3852/08-135; Bahulikar Rahul A., 2004, BMC Ecology, V4, P12, DOI 10.1186/1472-6785-4-12; Baldwin IT, 2001, PLANT PHYSIOL, V127, P1449, DOI 10.1104/pp.010762; Barrett LG, 2009, NEW PHYTOL, V183, P513, DOI 10.1111/j.1469-8137.2009.02927.x; Belisario A, 2004, PLANT DIS, V88, P426, DOI 10.1094/PDIS.2004.88.4.426A; Belisario A, 2002, PLANT DIS, V86, P599, DOI [10.1094/PDIS.2002.86.6.599, 10.1094/PDIS.2002.86.1.74A]; Bernasconi G, 2009, HEREDITY, V103, P5, DOI 10.1038/hdy.2009.34; Bhattacharya S, 2012, PLANT J, V71, P587, DOI 10.1111/j.1365-313X.2012.05011.x; Bilgrami K S, 1994, Mycotoxin Res, V10, P56, DOI 10.1007/BF03192251; Bonaventure G, 2011, PLANT CELL ENVIRON, V34, P1507, DOI 10.1111/j.1365-3040.2011.02348.x; Bosshard PP, 2003, J CLIN MICROBIOL, V41, P4134, DOI 10.1128/JCM.41.9.4134-4140.2003; Bubner B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-14; BURDON JJ, 1991, EVOLUTION, V45, P205, DOI [10.2307/2409494, 10.1111/j.1558-5646.1991.tb05278.x]; BURDON JJ, 1982, ANNU REV PHYTOPATHOL, V20, P143, DOI 10.1146/annurev.py.20.090182.001043; Carlsson-Graner U, 2002, OIKOS, V97, P97, DOI 10.1034/j.1600-0706.2002.970110.x; De Hoog G. S., 2000, ATLAS CLIN FUNGI; DINOOR A, 1984, ANNU REV PHYTOPATHOL, V22, P443; Fourie P, 2013, PHYTOPATHOLOGY, V103, P281, DOI 10.1094/PHYTO-07-11-0194; Gaquerel E, 2010, J AGR FOOD CHEM, V58, P9418, DOI 10.1021/jf1017737; GARDES M, 1991, CAN J BOT, V69, P180, DOI 10.1139/b91-026; Giller PS, 1996, BIODIVERS CONSERV, V5, P135, DOI 10.1007/BF00055827; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hadwiger LA, 2008, PHYTOPATHOLOGY, V98, P372, DOI 10.1094/PHYTO-98-4-0372; Hettenhausen C, 2012, PLANT PHYSIOL, V158, P759, DOI 10.1104/pp.111.190074; Kessler D, 2012, PLANT J, V71, P529, DOI 10.1111/j.1365-313X.2012.05008.x; Khan J, 2009, PHYTOPATHOLOGY, V99, P796, DOI 10.1094/PHYTO-99-7-0796; Kriss AB, 2010, PHYTOPATHOLOGY, V100, P784, DOI 10.1094/PHYTO-100-8-0784; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Laine AL, 2005, J EVOLUTION BIOL, V18, P930, DOI 10.1111/j.1420-9101.2005.00933.x; Lebeda A, 2008, EUR J PLANT PATHOL, V122, P127, DOI 10.1007/s10658-008-9291-4; LENNE JM, 1991, ANNU REV PHYTOPATHOL, V29, P35, DOI 10.1146/annurev.py.29.090191.000343; LEONARDSSCHIPPERS C, 1992, MOL GEN GENET, V233, P278, DOI 10.1007/BF00587589; Mehrabi R, 2011, FEMS MICROBIOL REV, V35, P542, DOI 10.1111/j.1574-6976.2010.00263.x; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Morel JB, 1997, CELL DEATH DIFFER, V4, P671, DOI 10.1038/sj.cdd.4400309; Nemri A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041366; Nielsen KF, 2003, J CHROMATOGR A, V1002, P111, DOI 10.1016/S0021-9673(03)00490-4; Ostry V, 2008, WORLD MYCOTOXIN J, V1, P175, DOI 10.3920/WMJ2008.x013; Pham GH, 2004, PLANT SURFACE MICROBIOLOGY, P237; Pulimood TB, 2007, J ALLERGY CLIN IMMUN, V120, P610, DOI 10.1016/j.jaci.2007.04.045; Rayapuram C, 2007, PLANT J, V52, P700, DOI 10.1111/j.1365-313X.2007.03267.x; Rep M, 2010, CURR OPIN PLANT BIOL, V13, P420, DOI 10.1016/j.pbi.2010.04.004; Schmidt SM, 2011, CURR OPIN PLANT BIOL, V14, P392, DOI 10.1016/j.pbi.2011.03.006; Schuman MC, 2009, NEW PHYTOL, V183, P1134, DOI 10.1111/j.1469-8137.2009.02894.x; Shibata Y, 2010, MOL PLANT MICROBE IN, V23, P1130, DOI 10.1094/MPMI-23-9-1130; Simmons EG, 1999, HOST SPECIFIC TOXIN; Soubeyrand S, 2009, AM NAT, V174, P308, DOI 10.1086/603624; Steppuhn A, 2008, MOL ECOL, V17, P3717, DOI 10.1111/j.1365-294X.2008.03862.x; Sun Y, 2012, MYCOL PROG, V11, P781, DOI 10.1007/s11557-011-0790-x; Tack AJM, 2012, J EVOLUTION BIOL, V25, P1918, DOI 10.1111/j.1420-9101.2012.02588.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Tsuge T, 2013, FEMS MICROBIOL REV, V37, P44, DOI 10.1111/j.1574-6976.2012.00350.x; van der Does HC, 2007, MOL PLANT MICROBE IN, V20, P1175, DOI 10.1094/MPMI-20-10-1175; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; Wang L, 2013, J GENET GENOMICS, V40, P597, DOI 10.1016/j.jgg.2013.10.001; Weber RW, 2003, IMMUNOL ALLERGY CLIN, V23, P411, DOI 10.1016/S0889-8561(03)00062-6; Weidenborner M, 2001, CAN J MICROBIOL, V47, P460, DOI 10.1139/cjm-47-5-460; White T., 1990, PCR PROTOCOLS GUIDE, P315; WILLS RT, 1993, AUST J ECOL, V18, P145, DOI 10.1111/j.1442-9993.1993.tb00439.x; Wu JQ, 2008, PLANT PHYSIOL, V146, P927, DOI 10.1104/pp.107.114785; Xue AG, 2003, PHYTOPATHOLOGY, V93, P329, DOI 10.1094/PHYTO.2003.93.3.329	66	22	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102915	10.1371/journal.pone.0102915	http://dx.doi.org/10.1371/journal.pone.0102915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036191	Green Published, gold			2022-12-25	WOS:000339615200096
J	Datta, S; Roychoudhury, S; Ghosh, A; Dasgupta, D; Ghosh, A; Chakraborty, B; Roy, S; Gupta, S; Santra, AK; Datta, S; Das, K; Dhali, GK; Chowdhury, A; Banerjee, S				Datta, Somenath; Roychoudhury, Shrabasti; Ghosh, Alip; Dasgupta, Debanjali; Ghosh, Amit; Chakraborty, Bidhan; Roy, Sukanta; Gupta, Subash; Santra, Amal Kumar; Datta, Simanti; Das, Kausik; Dhali, Gopal Krishna; Chowdhury, Abhijit; Banerjee, Soma			Distinct Distribution Pattern of Hepatitis B Virus Genotype C and D in Liver Tissue and Serum of Dual Genotype Infected Liver Cirrhosis and Hepatocellular Carcinoma Patients	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; DISEASE PATIENTS; HBV GENOTYPES; DNA; INTEGRATION; RECOMBINATION; SUBGENOTYPES; MIXTURES	Aims: The impact of co-infection of several hepatitis B virus (HBV) genotypes on the clinical outcome remains controversial. This study has for the first time investigated the distribution of HBV genotypes in the serum and in the intrahepatic tissue of liver cirrhotic (LC) and hepatocellular carcinoma (HCC) patients from India. In addition, the genotype-genotype interplay and plausible mechanism of development of HCC has also been explored. Methods: The assessment of HBV genotypes was performed by nested PCR using either surface or HBx specific primers from both the circulating virus in the serum and replicative virus that includes covalently closed circular DNA (cccDNA) and relaxed circular DNA (rcDNA) of HBV from the intrahepatic tissue. The integrated virus within the host chromosome was genotyped by Alu-PCR method. Each PCR products were cloned and sequences of five randomly selected clones were subsequently analysed. Results: HBV/genotype D was detected in the serum of all LC and HCC patients whereas the sequences of the replicative HBV DNA (cccDNA and rcDNA) from the intrahepatic tissue of the same patients revealed the presence of both HBV/ genotype C and D. The sequences of the integrated viruses exhibited the solo presence of HBV/genotype C in the majority of LC and HCC tissues while both HBV/genotype C and D clones were found in few patients in which HBV/genotype C was predominated. Moreover, compared to HBV/genotype D, genotype C had higher propensity to generate double strand breaks, ER stress and reactive oxygen species and it had also showed higher cellular homologous-recombination efficiency that engendered more chromosomal rearrangements, which ultimately led to development of HCC. Conclusions: Our study highlights the necessity of routine analysis of HBV genotype from the liver tissue of each chronic HBV infected patient in clinical practice to understand the disease prognosis and also to select therapeutic strategy.	[Datta, Somenath; Roychoudhury, Shrabasti; Ghosh, Alip; Dasgupta, Debanjali; Ghosh, Amit; Chakraborty, Bidhan; Santra, Amal Kumar; Datta, Simanti; Banerjee, Soma] Postgrad Inst Med Educ & Res, Sch Digest & Liver Dis, Liver Res Ctr, Kolkata, India; [Roy, Sukanta] Postgrad Inst Med Educ & Res, Sch Digest & Liver Dis, Dept Gastrointestinal Surg, Kolkata, India; [Gupta, Subash] Indraprastha Apollo Hosp, Ctr Liver & Biliary Surg, New Delhi, India; [Das, Kausik; Chowdhury, Abhijit] Postgrad Inst Med Educ & Res, Sch Digest & Liver Dis, Dept Hepatol, Kolkata, India; [Dhali, Gopal Krishna] Postgrad Inst Med Educ & Res, Sch Digest & Liver Dis, Dept Gastroenterol, Kolkata, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Banerjee, S (corresponding author), Postgrad Inst Med Educ & Res, Sch Digest & Liver Dis, Liver Res Ctr, Kolkata, India.	somabanerjee70@gmail.com	Dasgupta, Debanjali/AGT-9408-2022; Dhali, Gopal Krishna/AAE-5331-2022; Ghosh, Amit/AAB-3140-2019; Datta, Somenath/AAD-7752-2021	Dasgupta, Debanjali/0000-0001-8307-9719; Dhali, Gopal Krishna/0000-0002-6759-5067; Das, Kausik/0000-0001-6602-5516	West-Bengal State DST [75/ST/P/ST/9G-21/2012]	West-Bengal State DST	West-Bengal State DST has funded this study through the project no: 75/ST/P/S&T/9G-21/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2005, J ANTIMICROB CHEMOTH, V55, P139, DOI 10.1093/jac/dkh533; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; Biswas A, 2009, HEPATOL RES, V39, P53, DOI 10.1111/j.1872-034X.2008.00403.x; Borkakoty BJ, 2008, INDIAN J MED RES, V127, P65; Cao GW, 2009, WORLD J GASTROENTERO, V15, P5761, DOI 10.3748/wjg.15.5761; Chan HLY, 2005, J INFECT DIS, V191, P2022, DOI 10.1086/430324; Chattopadhyay S, 2006, WORLD J GASTROENTERO, V12, P6702, DOI 10.3748/wjg.v12.i41.6702; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; COUROUCE AM, 1983, DEV BIOL STAND, V54, P527; Datta S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-156; Ding D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003065; Fang ZL, 2004, WORLD J GASTROENTERO, V10, P3264, DOI 10.3748/wjg.v10.i22.3264; Fung SK, 2004, HEPATOLOGY, V40, P790, DOI 10.1002/hep.20455; Gerner PR, 1998, VIROLOGY, V245, P163, DOI 10.1006/viro.1998.9126; Ghosh S, 2012, CLIN MICROBIOL INFEC, V18, pE412, DOI 10.1111/j.1469-0691.2012.03975.x; Guerrero RB, 2005, J HEPATOL, V42, P760, DOI 10.1016/j.jhep.2005.02.005; Hannoun C, 2002, J INFECT DIS, V186, P752, DOI 10.1086/342599; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Henderson G, 1997, MOL CELL BIOL, V17, P3779, DOI 10.1128/MCB.17.7.3779; Hu XW, 2010, J HUAZHONG U SCI-MED, V30, P265, DOI 10.1007/s11596-010-0341-8; Ismail AM, 2014, INT J INFECT DIS, V20, P1, DOI 10.1016/j.ijid.2013.12.007; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Kao JH, 2002, J CLIN MICROBIOL, V40, P22, DOI 10.1128/JCM.40.1.22-25.2002; Kao JH, 2003, INTERVIROLOGY, V46, P400, DOI 10.1159/000074999; Kao JH, 2003, GASTROENTEROLOGY, V125, P1916, DOI 10.1053/j.gastro.2003.05.014; Kidd-Ljunggren K, 2002, J GEN VIROL, V83, P1267, DOI 10.1099/0022-1317-83-6-1267; Kumar Kailash, 2011, Asian J Transfus Sci, V5, P144, DOI 10.4103/0973-6247.83240; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Liu CJ, 2005, J INFECT DIS, V192, P1308, DOI 10.1086/444470; Loft S, 1996, J MOL MED, V74, P297, DOI 10.1007/BF00207507; Ma JC, 2007, HEPATOB PANCREAT DIS, V6, P166; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mason WS, 2010, J VIROL, V84, P8308, DOI 10.1128/JVI.00833-10; MINAMI M, 1995, GENOMICS, V29, P403, DOI 10.1006/geno.1995.9004; Murakami Y, 2005, GUT, V54, P1162, DOI 10.1136/gut.2004.054452; Nishikawa M, 2001, CANCER RES, V61, P1843; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Saigo K, 2008, HUM MUTAT, V29, P703, DOI 10.1002/humu.20701; Srisuttee R, 2011, INT J MOL MED, V28, P255, DOI 10.3892/ijmm.2011.699; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Thakur V, 2002, J GASTROEN HEPATOL, V17, P165, DOI 10.1046/j.1440-1746.2002.02605.x; Toan NL, 2006, HEPATOLOGY, V43, P1375, DOI 10.1002/hep.21188; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Wang ZH, 2007, HEPATOL RES, V37, pS36, DOI 10.1111/j.1872-034X.2007.00102.x; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Yin JH, 2008, CARCINOGENESIS, V29, P1685, DOI 10.1093/carcin/bgm301	47	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102573	10.1371/journal.pone.0102573	http://dx.doi.org/10.1371/journal.pone.0102573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032957	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300065
J	Ling, BH; Piatak, M; Rogers, L; Johnson, AM; Russell-Lodrigue, K; Hazuda, DJ; Lifson, JD; Veazey, RS				Ling, Binhua; Piatak, Michael, Jr.; Rogers, Linda; Johnson, Ann-Marie; Russell-Lodrigue, Kasi; Hazuda, Daria J.; Lifson, Jeffrey D.; Veazey, Ronald S.			Effects of Treatment with Suppressive Combination Antiretroviral Drug Therapy and the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid; (SAHA) on SIV-Infected Chinese Rhesus Macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; RALTEGRAVIR INTENSIFICATION; IMMUNE ACTIVATION; HIV-1 INFECTION; VALPROIC ACID; IN-VIVO; RESERVOIR; PATHOGENESIS; INDIVIDUALS; REPLICATION	Objectives: Viral reservoirs-persistent residual virus despite combination antiretroviral therapy (cART)-remain an obstacle to cure of HIV-1 infection. Difficulty studying reservoirs in patients underscores the need for animal models that mimics HIV infected humans on cART. We studied SIV-infected Chinese-origin rhesus macaques (Ch-RM) treated with intensive combination antiretroviral therapy (cART) and 3 weeks of treatment with the histone deacetyalse inhibitor, suberoylanilide hydroxamic acid (SAHA). Methods: SIVmac251 infected Ch-RM received reverse transcriptase inhibitors PMPA and FTC and integrase inhibitor L-870812 beginning 7 weeks post infection. Integrase inhibitor L-900564 and boosted protease inhibitor treatment with Darunavir and Ritonavir were added later. cART was continued for 45 weeks, with daily SAHA administered for the last 3 weeks, followed by euthanasia/necropsy. Plasma viral RNA and cell/tissue-associated SIV gag RNA and DNA were quantified by qRT-PCR/qPCR, with flow cytometry monitoring changes in immune cell populations. Results: Upon cART initiation, plasma viremia declined, remaining <30 SIV RNA copy Eq/ml during cART, with occasional blips. Decreased viral replication was associated with decreased immune activation and partial restoration of intestinal CD4+ T cells. SAHA was well tolerated but did not result in demonstrable treatment-associated changes in plasma or cell associated viral parameters. Conclusions: The ability to achieve and sustain virological suppression makes cART-suppressed, SIV-infected Ch-RM a potentially useful model to evaluate interventions targeting residual virus. However, despite intensive cART over one year, persistent viral DNA and RNA remained in tissues of all three animals. While well tolerated, three weeks of SAHA treatment did not demonstrably impact viral RNA levels in plasma or tissues; perhaps reflecting dosing, sampling and assay limitations.	[Ling, Binhua; Rogers, Linda; Johnson, Ann-Marie; Russell-Lodrigue, Kasi; Veazey, Ronald S.] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; [Ling, Binhua] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD USA; [Hazuda, Daria J.] Merck Res Labs, West Point, PA USA; [Veazey, Ronald S.] Tulane Univ, Sch Med, Dept Pathol & Lab Med, New Orleans, LA 70112 USA	Tulane University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Merck & Company; Tulane University	Ling, BH (corresponding author), Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.	bling@tulane.edu; rveazey@tulane.edu	Russell-Lodrigue, Kasi E/G-7084-2016	Russell-Lodrigue, Kasi E/0000-0003-3719-0779	NIAID [R01 AI093307-01A1]; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health [OD011104-51]; CI/NIH [HHSN261200800001E]; National Center for Research Resources;  [R01 AI084793]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093307, R01AI084793] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health; CI/NIH; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by R01 AI084793 (RSV), NIAID R01 AI093307-01A1 (BL) and the National Center for Research Resources, and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through grant no. OD011104-51, and in part with federal funds from CI/NIH Contract HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2014, J INFECT DIS; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Cline AN, 2005, J MED PRIMATOL, V34, P303; Cory TJ, 2013, CURR OPIN HIV AIDS; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Del Prete GQ, 2013, CURR OPIN HIV AIDS, V8, P262, DOI 10.1097/COH.0b013e328361cf40; Duvic M, 2007, BIOL-TARGETS THER, V1, P377; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hatano H, 2011, J INFECT DIS, V203, P960, DOI 10.1093/infdis/jiq138; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Lewin SR, 2011, AIDS, V25, P885, DOI 10.1097/QAD.0b013e3283467041; Ling BH, 2002, AIDS, V16, P1489, DOI 10.1097/00002030-200207260-00005; Ling BH, 2013, AIDS RES HUM RETROV, V29, P1465, DOI [10.1089/aid.2012.0378, 10.1089/AID.2012.0378]; Ling BH, 2010, J INFECT DIS, V202, P1846, DOI 10.1086/657413; Margolis DM, 2011, CURR OPIN HIV AIDS, V6, P25, DOI 10.1097/COH.0b013e328341242d; Marthas ML, 2001, AIDS RES HUM RETROV, V17, P1455, DOI 10.1089/088922201753197123; Plaeger SF, 2012, AIDS RES HUM RETROV, V28, P469, DOI [10.1089/aid.2011.0213, 10.1089/AID.2011.0213]; Poles MA, 2006, JAIDS-J ACQ IMM DEF, V43, P65, DOI 10.1097/01.qai.0000230524.71717.14; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Sungkanuparph S, 2005, CLIN INFECT DIS, V41, P1326, DOI 10.1086/496985; Van Rompay KKA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-57; Venneti S, 2008, AM J PATHOL, V172, P1603, DOI 10.2353/ajpath.2008.070967; Wightman F, 2012, IMMUNOL CELL BIOL, V90, P47, DOI 10.1038/icb.2011.95; Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb; Zink MC, 2010, J INFECT DIS, V202, P161, DOI 10.1086/653213	32	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102795	10.1371/journal.pone.0102795	http://dx.doi.org/10.1371/journal.pone.0102795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033210	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300091
J	Mao, XG; Egli, R; Petersen, N; Hanzlik, M; Liu, XM				Mao, Xuegang; Egli, Ramon; Petersen, Nikolai; Hanzlik, Marianne; Liu, Xiuming			Magneto-Chemotaxis in Sediment: First Insights	PLOS ONE			English	Article							BACTERIA; CULTIVATION; PROKARYOTES; HEMISPHERE	Magnetotactic bacteria (MTB) use passive alignment with the Earth magnetic field as a mean to increase their navigation efficiency in horizontally stratified environments through what is known as magneto-aerotaxis (M-A). Current M-A models have been derived from MTB observations in aqueous environments, where a >80% alignment with inclined magnetic field lines produces a one-dimensional search for optimal living conditions. However, the mean magnetic alignment of MTB in their most widespread living environment, i.e. sediment, has been recently found to be <1%, greatly reducing or even eliminating the magnetotactic advantage deduced for the case of MTB in water. In order to understand the role of magnetotaxis for MTB populations living in sediment, we performed first M-A observations with lake sediment microcosms. Microcosm experiments were based on different combinations of (1) MTB position with respect to their preferred living depth (i.e. above, at, and below), and (2) magnetic field configurations (i.e. correctly and incorrectly polarized vertical fields, horizontal fields, and zero fields). Results suggest that polar magnetotaxis is more complex than implied by previous experiments, and revealed unexpected differences between two types of MTB living in the same sediment. Our main findings are: (1) all investigated MTB benefit of a clear magnetotactic advantage when they need to migrate over macroscopic distances for reaching their optimal living depth, (2) magnetotaxis is not used by all MTB under stationary, undisturbed conditions, (3) some MTB can rely only on chemotaxis for macroscopic vertical displacements in sediment while other cannot, and (4) some MTB use a fixed polar M-A mechanisms, while other can switch their M-A polarity, performing what can be considered as a mixed polar-axial M-A. These observations demonstrate that sedimentary M-A is controlled by complex mechanical, chemical, and temporal factors that are poorly reproduced in aqueous environments.	[Mao, Xuegang; Liu, Xiuming] Fujian Normal Univ, Coll Geog Sci, Fuzhou, Peoples R China; [Egli, Ramon] Cent Inst Meteorol & Geodynam, Vienna, Austria; [Mao, Xuegang; Petersen, Nikolai] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Hanzlik, Marianne] Tech Univ Munich, Dept Chem, D-80290 Munich, Germany; [Liu, Xiuming] Macquarie Univ, Dept Geog & Environm, Sydney, NSW 2109, Australia	Fujian Normal University; University of Munich; Technical University of Munich; University of Munich; Macquarie University	Egli, R (corresponding author), Cent Inst Meteorol & Geodynam, Vienna, Austria.	ramon.egli@zamg.ac.at	Egli, Ramon/AAQ-3767-2020	Egli, Ramon/0000-0001-6825-4742	German Research Foundation [EG 294/1-1, EG 294/2-1]; China Scholarship Council; Natural Science Foundation of China (NSF) [41210002]	German Research Foundation(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council); Natural Science Foundation of China (NSF)(National Natural Science Foundation of China (NSFC))	EG 294/1-1 and EG 294/2-1, German Research Foundation (http://www.dfg.de/en/); XM was funded by the China Scholarship Council (en.csc.edu.cn/). Natural Science Foundation of China (NSF grant 41210002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; BLAKEMORE RP, 1982, ANNU REV MICROBIOL, V36, P217, DOI 10.1146/annurev.mi.36.100182.001245; BLAKEMORE RP, 1980, NATURE, V286, P384, DOI 10.1038/286384a0; Chen CF, 2011, APPL MICROBIOL BIOT, V90, P269, DOI 10.1007/s00253-010-3017-1; Cox BL, 2002, GEOMICROBIOL J, V19, P387, DOI 10.1080/01490450290098504; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Flies CB, 2005, FEMS MICROBIOL ECOL, V52, P185, DOI 10.1016/j.femsec.2004.11.006; Frankel RB, 1997, BIOPHYS J, V73, P994, DOI 10.1016/S0006-3495(97)78132-3; Hanzlik M, 1996, EARTH PLANET SC LETT, V145, P125, DOI 10.1016/S0012-821X(96)00191-4; Jogler C, 2010, ENVIRON MICROBIOL, V12, P2466, DOI 10.1111/j.1462-2920.2010.02220.x; KIRSCHVINK JL, 1980, J EXP BIOL, V86, P345; Lin W, 2009, INT MICROBIOL, V12, P237, DOI 10.2436/20.1501.01.103; Mao XG, 2014, GEOCHEM GEOPHY GEOSY, V15, P255, DOI 10.1002/2013GC005034; Pan YX, 2005, EARTH PLANET SC LETT, V232, P109, DOI 10.1016/j.epsl.2005.01.006; PETERMANN H, 1993, EARTH PLANET SC LETT, V117, P223, DOI 10.1016/0012-821X(93)90128-V; Petersen N, 1989, GEOMAGNETISM PALEOMA, P231, DOI DOI 10.1007/978-94-009-0905-2_17; Shapiro OH, 2011, ENV MICROBIOL REP, V3, P233, DOI 10.1111/j.1758-2229.2010.00215.x; Simmons SL, 2006, SCIENCE, V311, P371, DOI 10.1126/science.1122843; Smith MJ, 2006, BIOPHYS J, V91, P1098, DOI 10.1529/biophysj.106.085167; SPORMANN AM, 1984, FEMS MICROBIOL LETT, V22, P171; SPRING S, 1993, APPL ENVIRON MICROB, V59, P2397, DOI 10.1128/AEM.59.8.2397-2403.1993; Spring S, 2000, FEMS MICROBIOL REV, V24, P573, DOI 10.1016/S0168-6445(00)00046-2; STEINBERGER B, 1994, J FLUID MECH, V273, P189, DOI 10.1017/S0022112094001904; Taktikos J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081936; Zhang WJ, 2010, ENV MICROBIOL REP, V2, P646, DOI 10.1111/j.1758-2229.2010.00150.x	27	21	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102810	10.1371/journal.pone.0102810	http://dx.doi.org/10.1371/journal.pone.0102810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032699	Green Submitted, Green Published, gold			2022-12-25	WOS:000339418300095
J	Ong, JJ; Read, TRH; Vodstrcil, LA; Walker, S; Chen, M; Bradshaw, CS; Garland, SM; Tabrizi, SN; Cornall, A; Grulich, A; Hocking, J; Fairley, CK				Ong, Jason J.; Read, Tim R. H.; Vodstrcil, Lenka A.; Walker, Sandra; Chen, Marcus; Bradshaw, Catriona S.; Garland, Suzanne M.; Tabrizi, Sepehr N.; Cornall, Alyssa; Grulich, Andrew; Hocking, Jane; Fairley, Christopher K.			Detection of Oral Human Papillomavirus in HIV-Positive Men Who Have Sex with Men 3 Years after Baseline: A Follow Up Cross-Sectional Study	PLOS ONE			English	Article							HPV INFECTION; PREVALENCE; AMPLIFICATION; CANCERS; MUCOSAL; HEAD	Background: Human papillomavirus (HPV) is a causative agent in oropharyngeal squamous cell carcinoma. The natural history of oral HPV in HIV-positive men who have sex with men (MSM) is unclear. Methods: Detection of oral human papillomavirus in 173 HIV-positive MSM using oral rinse samples 3 years apart was investigated. HPV DNA was detected by polymerase chain reaction, and genotyped by Roche Linear Array. Results: Of 173 men tested in 2010, 30 had at least one HPV genotype (17%, 95% CI: 12-23), 15 at least one hr-HPV (9%, 95% CI: 5-14) and 8 had HPV 16 (5%, 95% CI: 2-9) detected. In 2013, 33 had at least one HPV genotype (19%, 95% CI: 14-26), 20 had at least one hr-HPV (12%, 95% CI: 7-17) and 7 had HPV 16 (4%, 95% CI: 2-8) detected. Of 30 men at baseline (2010) with any HPV detected, 14 (47%, 95% CI: 28-66) had at least one persistent genotype. Of the 15 men in 2010 with high risk (hr-) HPV, 6 men (40%, 95% CI: 16-68) had at least one persistent hr-HPV genotype. The incidence rate of detection of at least one new HPV genotype was 4.8 per 100 person years (95% CI: 3.1-7.0), of at least one hr-HPV genotype was 3.2 per 100 person years (95% CI: 1.8-5.1) and of HPV 16 was 0.8 per 100 person years (95% CI: 0.2-2.0). The clearance rate was 14.9 per 100 person years (95% CI: 8.2-24.2) for any HPV, 18.2 per 100 person years (95% CI: 8.2-32.7) for hr-HPV and 17.4 per 100 person years (95% CI: 5.0-38.8) for HPV-16. Persistent HPV detection was associated with duration of HIV (OR 1.13 (per additional year), 95% CI: 1.00-1.26) and tonsillectomy (OR 8.17, 95% CI: 1.30-51.40). Conclusion: The same oral HPV genotype was detected again after 3 years in nearly half of HIV-positive men who have sex with men.	[Ong, Jason J.; Vodstrcil, Lenka A.; Hocking, Jane] Univ Melbourne Parkville, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Read, Tim R. H.; Vodstrcil, Lenka A.; Walker, Sandra; Chen, Marcus; Bradshaw, Catriona S.; Fairley, Christopher K.] Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia; [Read, Tim R. H.; Chen, Marcus; Bradshaw, Catriona S.; Fairley, Christopher K.] Monash Univ, Cent Clin Sch, Clayton, Vic, Australia; [Garland, Suzanne M.; Tabrizi, Sepehr N.] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia; [Garland, Suzanne M.; Tabrizi, Sepehr N.; Cornall, Alyssa] Royal Womens Hosp, Dept Microbiol & Infect Dis, Reg HPV Lab, Net Reference Lab, Parkville, Vic, Australia; [Garland, Suzanne M.; Tabrizi, Sepehr N.; Cornall, Alyssa] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Grulich, Andrew] Univ New S Wales, Kirby Inst, Darlinghurst, NSW, Australia	University of Melbourne; Monash University; University of Melbourne; Murdoch Children's Research Institute; University of New South Wales Sydney; Kirby Institute	Ong, JJ (corresponding author), Univ Melbourne Parkville, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.	j.ong@unimelb.edu.au	Hocking, Jane/AAD-5203-2021; Ong, Jason/AAB-3086-2019; Vodstrcil, Lenka/AAF-8722-2020; Vodstrcil, Lenka/AAC-1896-2019	Hocking, Jane/0000-0001-9329-8501; Ong, Jason/0000-0001-5784-7403; Vodstrcil, Lenka/0000-0003-3679-9195; bradshaw, catriona/0000-0002-6643-5678; Christopher, Fairley/0000-0001-9081-1664	National Health and Research Medical Council [568971]	National Health and Research Medical Council	National Health and Research Medical Council Program grant (568971) (https://www.nhmrc.gov.au/). CK received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beachler DC, 2013, CURR OPIN ONCOL, V25, P503, DOI 10.1097/CCO.0b013e32836242b4; Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734; Bzhalava D, 2013, VIROLOGY, V445, P224, DOI 10.1016/j.virol.2013.07.015; Chung CH, 2009, CLIN CANCER RES, V15, P6758, DOI 10.1158/1078-0432.CCR-09-0784; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hocking JS, 2011, BRIT J CANCER, V104, P886, DOI 10.1038/sj.bjc.6606091; Kreimer AR, 2013, LANCET, V382, P877, DOI 10.1016/S0140-6736(13)60809-0; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; LaytonHenry J, 1996, INT J GYNECOL CANCER, V6, P193, DOI 10.1046/j.1525-1438.1996.06030193.x; Nasrin M, 2012, Bangladesh Med Res Counc Bull, V38, P59; Read TRH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049324; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Tabrizi SN, 2005, AM J CLIN PATHOL, V123, P896, DOI 10.1309/MPERNJ0G62RECHCQ; Tugizov SM, 2013, VIROLOGY, V446, P378, DOI 10.1016/j.virol.2013.08.018; Videla S, 2013, SEX TRANSM DIS, V40, P3, DOI 10.1097/OLQ.0b013e31827e87bd; Walline Heather M, 2013, JAMA Otolaryngol Head Neck Surg, V139, P1320, DOI 10.1001/jamaoto.2013.5460	19	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102138	10.1371/journal.pone.0102138	http://dx.doi.org/10.1371/journal.pone.0102138			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033212	Green Published, gold			2022-12-25	WOS:000339418300035
J	Bainbridge, TW; DeAlmeida, VI; Izrael-Tomasevic, A; Chalouni, C; Pan, B; Goldsmith, J; Schoen, AP; Quinones, GA; Kelly, R; Lill, JR; Sandoval, W; Costa, M; Polakis, P; Arnott, D; Rubinfeld, B; Ernst, JA				Bainbridge, Travis W.; DeAlmeida, Venita I.; Izrael-Tomasevic, Anita; Chalouni, Cecile; Pan, Borlan; Goldsmith, Joshua; Schoen, Alia P.; Quinones, Gabriel A.; Kelly, Ryan; Lill, Jennie R.; Sandoval, Wendy; Costa, Mike; Polakis, Paul; Arnott, David; Rubinfeld, Bonnee; Ernst, James A.			Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and ROR2 Kinase Domains	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-ASSOCIATED ANTIGEN; TOXOPLASMA-GONDII; CELL-MIGRATION; CRD DOMAIN; ACTIVATION; BINDING; GROWTH; COMPLEX	Receptor tyrosine kinase-like orphan receptors (ROR) 1 and 2 are atypical members of the receptor tyrosine kinase (RTK) family and have been associated with several human diseases. The vertebrate RORs contain an ATP binding domain that deviates from the consensus amino acid sequence, although the impact of this deviation on catalytic activity is not known and the kinase function of these receptors remains controversial. Recently, ROR2 was shown to signal through a Wnt responsive, beta-catenin independent pathway and suppress a canonical Wnt/beta-catenin signal. In this work we demonstrate that both ROR1 and ROR2 kinase domains are catalytically deficient while CAM-1, the C. elegans homolog of ROR, has an active tyrosine kinase domain, suggesting a divergence in the signaling processes of the ROR family during evolution. In addition, we show that substitution of the non-consensus residues from ROR1 or ROR2 into CAM-1 and MuSK markedly reduce kinase activity, while restoration of the consensus residues in ROR does not restore robust kinase function. We further demonstrate that the membrane-bound extracellular domain alone of either ROR1 or ROR2 is sufficient for suppression of canonical Wnt3a signaling, and that this domain can also enhance Wnt5a suppression of Wnt3a signaling. Based on these data, we conclude that human ROR1 and ROR2 are RTK-like pseudokinases.	[Bainbridge, Travis W.; Izrael-Tomasevic, Anita; Schoen, Alia P.; Quinones, Gabriel A.; Kelly, Ryan; Lill, Jennie R.; Sandoval, Wendy; Arnott, David; Ernst, James A.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [DeAlmeida, Venita I.; Goldsmith, Joshua; Costa, Mike; Polakis, Paul; Rubinfeld, Bonnee] Genentech Inc, Dept Canc Targets, San Francisco, CA 94080 USA; [Chalouni, Cecile] Genentech Inc, Ctr Adv Light Microscopy, San Francisco, CA 94080 USA; [Pan, Borlan] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ernst, JA (corresponding author), Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA.	ernst.james@gene.com		Kelly, Ryan/0000-0001-5003-9104; Rubinfeld, Bonnee/0000-0001-9861-6775				Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Akbarzadeh S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001873; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; CASNELLIE JE, 1991, METHOD ENZYMOL, V200, P115; Castellana NE, 2011, PROTEOMICS, V11, P395, DOI 10.1002/pmic.201000487; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Henriquez JP, 2012, ACTA PHYSIOL, V204, P128, DOI 10.1111/j.1748-1716.2011.02295.x; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Kim C, 2003, DEV BIOL, V264, P376, DOI 10.1016/j.ydbio.2003.09.007; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Labesse G, 2009, STRUCTURE, V17, P139, DOI 10.1016/j.str.2008.11.005; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Munshi S, 2003, ACTA CRYSTALLOGR D, V59, P1725, DOI 10.1107/S0907444903015415; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Qiu W, 2009, EMBO J, V28, P969, DOI 10.1038/emboj.2009.24; Rajakulendran T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3111pe8; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Shabani M, 2007, TUMOR BIOL, V28, P318, DOI 10.1159/000121405; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Tice DA, 2002, J BIOL CHEM, V277, P6118, DOI 10.1074/jbc.M111255200; Till JH, 2002, STRUCTURE, V10, P1187, DOI 10.1016/S0969-2126(02)00814-6; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Vendel AC, 2009, J IMMUNOL, V182, P1509, DOI 10.4049/jimmunol.182.3.1509; WHITE MF, 1984, J BIOL CHEM, V259, P255; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Zhang XH, 2007, BBA-GEN SUBJECTS, V1770, P1490, DOI 10.1016/j.bbagen.2007.06.017	52	26	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102695	10.1371/journal.pone.0102695	http://dx.doi.org/10.1371/journal.pone.0102695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029443	Green Submitted, Green Published, gold			2022-12-25	WOS:000341306600093
J	Braulik, GT; Arshad, M; Noureen, U; Northridge, SP				Braulik, Gill T.; Arshad, Masood; Noureen, Uzma; Northridge, Simon P.			Habitat Fragmentation and Species Extirpation in Freshwater Ecosystems; Causes of Range Decline of the Indus River Dolphin (Platanista gangetica minor)	PLOS ONE			English	Article							EXTINCTION; BIODIVERSITY; DYNAMICS; FUTURE; FLOW	Habitat fragmentation of freshwater ecosystems is increasing rapidly, however the understanding of extinction debt and species decline in riverine habitat fragments lags behind that in other ecosystems. The mighty rivers that drain the Himalaya - the Ganges, Brahmaputra, Indus, Mekong and Yangtze - are amongst the world's most biodiverse freshwater ecosystems. Many hundreds of dams have been constructed, are under construction, or are planned on these rivers and large hydrological changes and losses of biodiversity have occurred and are expected to continue. This study examines the causes of range decline of the Indus dolphin, which inhabits one of the world's most modified rivers, to demonstrate how we may expect other vertebrate populations to respond as planned dams and water developments come into operation. The historical range of the Indus dolphin has been fragmented into 17 river sections by diversion dams; dolphin sighting and interview surveys show that river dolphins have been extirpated from ten river sections, they persist in 6, and are of unknown status in one section. Seven potential factors influencing the temporal and spatial pattern of decline were considered in three regression model sets. Low dry-season river discharge, due to water abstraction at irrigation barrages, was the principal factor that explained the dolphin's range decline, influencing 1) the spatial pattern of persistence, 2) the temporal pattern of subpopulation extirpation, and 3) the speed of extirpation after habitat fragmentation. Dolphins were more likely to persist in the core of the former range because water diversions are concentrated near the range periphery. Habitat fragmentation and degradation of the habitat were inextricably intertwined and in combination caused the catastrophic decline of the Indus dolphin.	[Braulik, Gill T.; Northridge, Simon P.] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Braulik, Gill T.; Arshad, Masood; Noureen, Uzma] World Wildlife Fund Pakistan, Lahore, Pakistan; [Braulik, Gill T.] Wildlife Conservat Soc, Zanzibar, Tanzania	University of St Andrews	Braulik, GT (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	gillbraulik@downstream.vg	Braulik, Gill/X-9184-2019	Braulik, Gill/0000-0001-8919-4187; Northridge, Simon/0000-0002-7402-3462	World Wildlife Fund-Pakistan; Pakistan Wetlands Project; US Marine Mammal Commission [E4047595]; Natural Environment Research Council [smru10001] Funding Source: researchfish	World Wildlife Fund-Pakistan; Pakistan Wetlands Project; US Marine Mammal Commission; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	World Wildlife Fund-Pakistan -(http://www.wwfpak.org/) funded the interview surveys with support through the Pakistan Wetlands Project. The US Marine Mammal Commission (www.mmc.gov) provided funding to GB for reporting and analysis in grant number E4047595. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J., 1879, ANATOMICAL ZOOLOGICA; Baruah Debojit, 2012, Environmentalist, V32, P85, DOI 10.1007/s10669-011-9375-0; Bashir T, 2010, CURR SCI INDIA, V98, P287; Behera Sandeep K., 2008, Journal of the Bombay Natural History Society, V105, P90; Braulik GT, 2012, AQUAT CONSERV, V22, P533, DOI 10.1002/aqc.2246; Braulik GT, 2006, BIOL CONSERV, V129, P579, DOI 10.1016/j.biocon.2005.11.026; Braulik Gillian T., 2012, Endangered Species Research, V17, P201, DOI 10.3354/esr00425; Braulik GT, 2012, CONSERVATION ECOLOGY; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butchart S. H. M., 2006, Bulletin of the British Ornithologists' Club, V126, P7; Channell R, 2000, J BIOGEOGR, V27, P169, DOI 10.1046/j.1365-2699.2000.00382.x; Collen B, 2010, DIVERS DISTRIB, V16, P755, DOI 10.1111/j.1472-4642.2010.00689.x; Crawley MJ., 2007, R BOOK; Dharmadhikary S., 2008, MOUNTAINS CONCRETE D; Directorate of Land Reclamation Punjab, 2007, SURF WAT QUAL MON PL; Dudgeon D, 2000, BIOSCIENCE, V50, P793, DOI 10.1641/0006-3568(2000)050[0793:LSHCIT]2.0.CO;2; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dutta AP, 2010, EARTH           0501, P32; FAO, 2012, FAO WAT REP, V38; Fox J, 2008, APPL REGRESSION ANAL; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; Gilpin M., 1990, LIVING PATCHY ENV, P177; IUCN, 2013, IUCN RED LIST THREAT; IUCN, 2011, PAK WAT GAT GAT WAT; Johnson PTJ, 2011, CONSERV BIOL, V25, P556, DOI 10.1111/j.1523-1739.2010.01645.x; Kelkar N, 2010, CONSERV BIOL, V24, P1130, DOI 10.1111/j.1523-1739.2010.01467.x; Khan H., 1947, J BOMBAY NAT HIST SO, V46, P529; LOMOLINO MV, 1995, J MAMMAL, V76, P335, DOI 10.2307/1382345; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Pilleri G., 1972, P23; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; R Development Core Team, 2012, R LANG ENV STAT COMP; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Reeves R. R., 1991, NATURA UTRECHT, V5, P3; REEVES RR, 1991, ENVIRON CONSERV, V18, P341, DOI 10.1017/S0376892900022591; REEVES RR, 1994, AMBIO, V23, P172; Ryan GE, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00171.1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Simberloff D., 1986, Life Sciences Research Report, P259; Sinha R. K., 2000, BIOL CONSERVATION FR, V23, P54; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Turvey ST, 2010, P ROY SOC B-BIOL SCI, V277, P3139, DOI 10.1098/rspb.2010.0584; Verma S, 2009, PHYS CHEM EARTH, V34, P261, DOI 10.1016/j.pce.2008.05.002; World Water Assessment Programme, 2012, 4 UNESCO WORLD WAT A; Xenopoulos MA, 2006, ECOLOGY, V87, P1907, DOI 10.1890/0012-9658(2006)87[1907:GWTFUS]2.0.CO;2; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	48	38	40	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101657	10.1371/journal.pone.0101657	http://dx.doi.org/10.1371/journal.pone.0101657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029270	Green Submitted, Green Published, gold			2022-12-25	WOS:000341306600020
J	McCracken, CB; Kiss, ZHT				McCracken, Clinton B.; Kiss, Zelma H. T.			Time and Frequency-Dependent Modulation of Local Field Potential Synchronization by Deep Brain Stimulation	PLOS ONE			English	Article							GLOBUS-PALLIDUS INTERNUS; SUBTHALAMIC NUCLEUS OSCILLATIONS; 20 HZ SLOWS; PARKINSONS-DISEASE; NEURONAL-ACTIVITY; ENTOPEDUNCULAR NUCLEUS; BETA-OSCILLATIONS; GAMMA-ACTIVITY; POSTSYNAPTIC POTENTIALS; ELECTRICAL-STIMULATION	High-frequency electrical stimulation of specific brain structures, known as deep brain stimulation (DBS), is an effective treatment for movement disorders, but mechanisms of action remain unclear. We examined the time-dependent effects of DBS applied to the entopeduncular nucleus (EP), the rat homolog of the internal globus pallidus, a target used for treatment of both dystonia and Parkinson's disease (PD). We performed simultaneous multi-site local field potential (LFP) recordings in urethane-anesthetized rats to assess the effects of high-frequency (HF, 130 Hz; clinically effective), low-frequency (LF, 15 Hz; ineffective) and sham DBS delivered to EP. LFP activity was recorded from dorsal striatum (STR), ventroanterior thalamus (VA), primary motor cortex (M1), and the stimulation site in EP. Spontaneous and acute stimulation-induced LFP oscillation power and functional connectivity were assessed at baseline, and after 30, 60, and 90 minutes of stimulation. HF EP DBS produced widespread alterations in spontaneous and stimulus-induced LFP oscillations, with some effects similar across regions and others occurring in a region-and frequency band-specific manner. Many of these changes evolved over time. HF EP DBS produced an initial transient reduction in power in the low beta band in M1 and STR; however, phase synchronization between these regions in the low beta band was markedly suppressed at all time points. DBS also enhanced low gamma synchronization throughout the circuit. With sustained stimulation, there were significant reductions in low beta synchronization between M1-VA and STR-VA, and increases in power within regions in the faster frequency bands. HF DBS also suppressed the ability of acute EP stimulation to induce beta oscillations in all regions along the circuit. This dynamic pattern of synchronizing and desynchronizing effects of EP DBS suggests a complex modulation of activity along cortico-BG-thalamic circuits underlying the therapeutic effects of GPi DBS for conditions such as PD and dystonia.	[Kiss, Zelma H. T.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Kiss, ZHT (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.	zkiss@ucalgary.ca	Kiss, Zelma/D-2342-2016	Kiss, Zelma/0000-0002-8656-2690	Canadian Institutes of Health Research; Parkinson Society Canada; Hotchkiss Brain Institute; Alberta Innovates [201200847] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Parkinson Society Canada; Hotchkiss Brain Institute; Alberta Innovates	This work was supported by a grant from the Canadian Institutes of Health Research. Dr. Kiss is a Clinical Scholar of the Alberta Heritage Foundation for Medical Research. Dr. McCracken received fellowship support from Parkinson Society Canada and Hotchkiss Brain Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Anderson ME, 2003, J NEUROPHYSIOL, V89, P1150, DOI 10.1152/jn.00475.2002; Anderson TR, 2006, J NEUROSCI, V26, P841, DOI 10.1523/JNEUROSCI.3523-05.2006; Bar-Gad I, 2004, J NEUROSCI, V24, P7410, DOI 10.1523/JNEUROSCI.1691-04.2004; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344; Benazzouz A, 2000, NEUROSCIENCE, V99, P289, DOI 10.1016/S0306-4522(00)00199-8; Beurrier C, 2001, J NEUROPHYSIOL, V85, P1351, DOI 10.1152/jn.2001.85.4.1351; Bittar RG, 2005, J CLIN NEUROSCI, V12, P12, DOI 10.1016/j.jocn.2004.03.025; Boraud T, 1996, NEUROSCI LETT, V215, P17, DOI 10.1016/S0304-3940(96)12943-8; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Brown P, 2004, EXP NEUROL, V188, P480, DOI 10.1016/j.expneurol.2004.05.009; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Brucke C, 2012, J NEUROSCI, V32, P1008, DOI 10.1523/JNEUROSCI.3860-11.2012; CARTER DA, 1978, J COMP NEUROL, V177, P113, DOI 10.1002/cne.901770108; Cassidy M, 2002, BRAIN, V125, P1235, DOI 10.1093/brain/awf135; Chen CC, 2006, NEUROLOGY, V66, P418, DOI 10.1212/01.wnl.0000196470.00165.7d; Chen CC, 2007, EXP NEUROL, V205, P214, DOI 10.1016/j.expneurol.2007.01.027; Chen CC, 2006, EXP NEUROL, V202, P480, DOI 10.1016/j.expneurol.2006.07.011; Chen CC, 2011, EXP NEUROL, V231, P91, DOI 10.1016/j.expneurol.2011.05.018; Chiken S, 2013, J NEUROSCI, V33, P2268, DOI 10.1523/JNEUROSCI.4144-11.2013; Cleary DR, 2013, J NEUROPHYSIOL, V109, P978, DOI 10.1152/jn.00420.2012; Coubes P, 2004, J NEUROSURG, V101, P189, DOI 10.3171/jns.2004.101.2.0189; Courtemanche R, 2003, J NEUROSCI, V23, P11741; Creed M, 2011, EUR NEUROPSYCHOPHARM, V21, P393, DOI 10.1016/j.euroneuro.2010.06.012; Creed MC, 2012, J NEUROSCI, V32, P9574, DOI 10.1523/JNEUROSCI.1196-12.2012; Creed MC, 2012, EUR NEUROPSYCHOPHARM, V22, P506, DOI 10.1016/j.euroneuro.2011.11.004; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Crowell AL, 2012, BRAIN, V135, P615, DOI 10.1093/brain/awr332; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Eusebio A, 2011, J NEUROL NEUROSUR PS, V82, P569, DOI 10.1136/jnnp.2010.217489; Eusebio A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00047; Fakhar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058665; Florin E, 2008, CLIN NEUROPHYSIOL, V119, P2098, DOI 10.1016/j.clinph.2008.05.026; Foffani G, 2005, J PHYSIOL-LONDON, V568, P699, DOI 10.1113/jphysiol.2005.089722; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Hoffer ZS, 2001, J COMP NEUROL, V439, P87, DOI 10.1002/cne.1337; Hristova A, 2000, CLIN NEUROPHARMACOL, V23, P208, DOI 10.1097/00002826-200007000-00007; Johnson MD, 2009, EXP NEUROL, V219, P359, DOI 10.1016/j.expneurol.2009.04.022; Kempf F, 2007, EUR J NEUROSCI, V25, P3137, DOI 10.1111/j.1460-9568.2007.05536.x; Kempf F, 2009, EUR J NEUROSCI, V29, P943, DOI 10.1111/j.1460-9568.2009.06655.x; Kha HT, 2000, J COMP NEUROL, V426, P366; Kiss ZHT, 2007, BRAIN, V130, P2879, DOI 10.1093/brain/awm229; Kita H, 2001, NEUROSCIENCE, V105, P871, DOI 10.1016/S0306-4522(01)00231-7; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Kuhn AA, 2006, EUR J NEUROSCI, V23, P1956, DOI 10.1111/j.1460-9568.2006.04717.x; Kuncel AM, 2004, CLIN NEUROPHYSIOL, V115, P2431, DOI 10.1016/j.clinph.2004.05.031; Kupsch A, 2003, J NEUROL, V250, P1201, DOI 10.1007/s00415-003-0179-0; Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618; Lai HY, 2014, NEUROIMAGE, V84, P11, DOI 10.1016/j.neuroimage.2013.08.026; Leblois A, 2007, EUR J NEUROSCI, V26, P1701, DOI 10.1111/j.1460-9568.2007.05777.x; Levy R, 2002, BRAIN, V125, P1196, DOI 10.1093/brain/awf128; Li Q, 2012, NEURON, V76, P1030, DOI 10.1016/j.neuron.2012.09.032; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Liu XG, 2002, MOVEMENT DISORD, V17, P346, DOI 10.1002/mds.10038; Liu XG, 2008, BRAIN, V131, P1562, DOI 10.1093/brain/awn083; Lopez-Azcarate J, 2010, J NEUROSCI, V30, P6667, DOI 10.1523/JNEUROSCI.5459-09.2010; Magarinos-Ascone CM, 2008, NEUROSCIENCE, V152, P558, DOI 10.1016/j.neuroscience.2008.01.001; MAGGI CA, 1986, EXPERIENTIA, V42, P109, DOI 10.1007/BF01952426; Mallet N, 2008, J NEUROSCI, V28, P4795, DOI 10.1523/JNEUROSCI.0123-08.2008; Mallet N, 2008, J NEUROSCI, V28, P14245, DOI 10.1523/JNEUROSCI.4199-08.2008; Marceglia S, 2006, J PHYSIOL-LONDON, V571, P579, DOI 10.1113/jphysiol.2005.100271; McCairn KW, 2012, NEUROREPORT, V23, P206, DOI 10.1097/WNR.0b013e32834fab9d; McCairn KW, 2009, J NEUROPHYSIOL, V101, P1941, DOI 10.1152/jn.91092.2008; McCracken CB, 2007, J NEUROSCI, V27, P12601, DOI 10.1523/JNEUROSCI.3750-07.2007; McCracken CB, 2009, J NEUROSCI, V29, P5354, DOI 10.1523/JNEUROSCI.0131-09.2009; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Meissner W, 2005, BRAIN, V128, P2372, DOI 10.1093/brain/awh616; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Min HK, 2012, NEUROIMAGE, V63, P1408, DOI 10.1016/j.neuroimage.2012.08.006; Montgomery EB, 2006, CLIN NEUROPHYSIOL, V117, P2691, DOI 10.1016/j.clinph.2006.08.011; Moro E, 2002, NEUROLOGY, V59, P706, DOI 10.1212/WNL.59.5.706; NAGY JI, 1978, BRAIN RES, V158, P15, DOI 10.1016/0006-8993(78)90003-3; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pogosyan A, 2006, EXP NEUROL, V202, P271, DOI 10.1016/j.expneurol.2006.06.014; Priori A, 2004, EXP NEUROL, V189, P369, DOI 10.1016/j.expneurol.2004.06.001; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Ruge D, 2011, MOVEMENT DISORD, V26, P1913, DOI 10.1002/mds.23731; Sani S, 2009, EXP NEUROL, V216, P295, DOI 10.1016/j.expneurol.2008.12.006; Sharott A, 2005, EUR J NEUROSCI, V21, P1413, DOI 10.1111/j.1460-9568.2005.03973.x; Sharott A, 2008, BRAIN, V131, P473, DOI 10.1093/brain/awm324; Shin DS, 2007, NEUROSCIENCE, V149, P68, DOI 10.1016/j.neuroscience.2007.06.055; Silberstein P, 2005, BRAIN, V128, P1277, DOI 10.1093/brain/awh480; Silberstein P, 2003, BRAIN, V126, P2597, DOI 10.1093/brain/awg267; Tang JKH, 2007, J NEUROPHYSIOL, V98, P720, DOI 10.1152/jn.01107.2006; Tang JKH, 2007, EXP NEUROL, V204, P845, DOI 10.1016/j.expneurol.2007.01.010; Timmermann L, 2004, MOVEMENT DISORD, V19, P1328, DOI 10.1002/mds.20198; van der Meer MAA, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00300; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Vitek JL, 2002, MOVEMENT DISORD, V17, pS69, DOI 10.1002/mds.10144; Weinberger M, 2012, CLIN NEUROPHYSIOL, V123, P358, DOI 10.1016/j.clinph.2011.07.029; Weinberger M, 2009, EXP NEUROL, V219, P58, DOI 10.1016/j.expneurol.2009.05.014; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156; WILSON CJ, 1986, BRAIN RES, V367, P201, DOI 10.1016/0006-8993(86)91593-3; Wingeier B, 2006, EXP NEUROL, V197, P244, DOI 10.1016/j.expneurol.2005.09.016; Wu YR, 2001, MOVEMENT DISORD, V16, P208, DOI 10.1002/mds.1046	98	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102576	10.1371/journal.pone.0102576	http://dx.doi.org/10.1371/journal.pone.0102576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029468	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600086
J	De Paolo, S; Salvemini, M; Gaudio, L; Aceto, S				De Paolo, Sofia; Salvemini, Marco; Gaudio, Luciano; Aceto, Serena			De Novo Transcriptome Assembly from Inflorescence of Orchis italica: Analysis of Coding and Non-Coding Transcripts	PLOS ONE			English	Article							MADS-BOX GENES; PI/GLO-LIKE LOCUS; RNA-SEQ DATA; IDENTIFICATION; EVOLUTIONARY; EXPRESSION; ROLES; ANNOTATION; PROTEINS; GENOME	The floral transcriptome of Orchis italica, a wild orchid species, was obtained using Illumina RNA-seq technology and specific de novo assembly and analysis tools. More than 100 million raw reads were processed resulting in 132,565 assembled transcripts and 86,079 unigenes with an average length of 606 bp and N50 of 956 bp. Functional annotation assigned 38,984 of the unigenes to records present in the NCBI non-redundant protein database, 32,161 of them to Gene Ontology terms, 15,775 of them to Eukaryotic Orthologous Groups (KOG) and 7,143 of them to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The in silico expression analysis based on the Fragments Per Kilobase of transcript per Million mapped reads (FPKM) was confirmed by real-time RT-PCR experiments on 10 selected unigenes, which showed high and statistically significant positive correlation with the RNA-seq based expression data. The prediction of putative long non-coding RNAs was assessed using two different software packages, CPC and Portrait, resulting in 7,779 unannotated unigenes that matched the threshold values for both of the analyses. Among the predicted long non-coding RNAs, one is the homologue of TAS3, a long non-coding RNA precursor of trans-acting small interfering RNAs (ta-siRNAs). The differential expression pattern observed for the selected putative long non-coding RNAs suggests their possible functional role in different floral tissues.	[De Paolo, Sofia; Salvemini, Marco; Gaudio, Luciano; Aceto, Serena] Univ Naples Federico II, Dept Biol, Naples, Italy	University of Naples Federico II	Aceto, S (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	serena.aceto@unina.it	Aceto, Serena/E-5350-2010; Gaudio, Luciano/AAF-4322-2020; Salvemini, Marco/AAJ-5560-2021	Gaudio, Luciano/0000-0002-0172-2190; Aceto, Serena/0000-0003-3906-4872; SALVEMINI, Marco/0000-0003-2297-9267	Regione Campania Grant [L.R. N5/2002]	Regione Campania Grant(Regione Campania)	This work was supported by 2009 Regione Campania Grant L.R. N5/2002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto S, 2007, GENE, V392, P299, DOI 10.1016/j.gene.2007.01.005; Aceto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097839; Aceto S, 2011, CURR GENOMICS, V12, P342, DOI 10.2174/138920211796429754; Aceto S, 2010, J HERED, V101, P124, DOI 10.1093/jhered/esp082; Acri-Nunes-Miranda R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00076; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Arrial RT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-239; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; BIANCO P, 1991, PLANT SYST EVOL, V178, P235; Cantone C, 2009, GENE, V434, P9, DOI 10.1016/j.gene.2008.12.015; Cantone C, 2011, GENE, V481, P48, DOI 10.1016/j.gene.2011.04.004; Causier B, 2010, SEMIN CELL DEV BIOL, V21, P73, DOI 10.1016/j.semcdb.2009.10.005; Chang YY, 2011, PLANT CELL PHYSIOL, V52, P1532, DOI 10.1093/pcp/pcr101; Chang YY, 2010, PLANT PHYSIOL, V152, P837, DOI 10.1104/pp.109.147116; Chao YT, 2014, PLANT MOL BIOL, V84, P529, DOI 10.1007/s11103-013-0150-0; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; Chou ML, 2013, PLANTA, V237, P1425, DOI 10.1007/s00425-013-1850-z; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Hsu HF, 2002, PLANT CELL PHYSIOL, V43, P1198, DOI 10.1093/pcp/pcf143; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanno A, 2007, THESCIENTIFICWORLDJO, V7, P268, DOI 10.1100/tsw.2007.86; Kim ED, 2012, TRENDS PLANT SCI, V17, P16, DOI 10.1016/j.tplants.2011.10.008; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leitch IJ, 2009, ANN BOT-LONDON, V104, P469, DOI 10.1093/aob/mcp003; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085480; Lin CS, 2013, PLANT MOL BIOL, V82, P193, DOI 10.1007/s11103-013-0055-y; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Mondragon-Palomino M, 2011, PLANT J, V66, P1008, DOI 10.1111/j.1365-313X.2011.04560.x; Mondragon-Palomino M, 2009, ANN BOT-LONDON, V104, P583, DOI 10.1093/aob/mcn258; Mondragon-Palomino M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-81; Montieri S, 2004, GENE, V333, P101, DOI 10.1016/j.gene.2004.02.015; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Qi X, 2013, PLANT MOL BIOL, V83, P459, DOI 10.1007/s11103-013-0104-6; Quintero Andres, 2013, Genomics Proteomics & Bioinformatics, V11, P172, DOI 10.1016/j.gpb.2013.03.001; Rudall PJ, 2002, BIOL REV, V77, P403, DOI 10.1017/S1464793102005936; Salemme M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077454; Salemme M, 2013, MOL BIOL REP, V40, P3523, DOI 10.1007/s11033-012-2426-x; Salemme M, 2011, DEV GENES EVOL, V221, P241, DOI 10.1007/s00427-011-0372-6; Sedeek KEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064621; Skipper M, 2006, GENE, V366, P266, DOI 10.1016/j.gene.2005.08.014; Song IJ, 2006, DEV GENES EVOL, V216, P301, DOI 10.1007/s00427-005-0057-0; Su CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080462; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tremblay RL, 2005, BIOL J LINN SOC, V84, P1, DOI 10.1111/j.1095-8312.2004.00400.x; Tsai WC, 2004, PLANT CELL PHYSIOL, V45, P831, DOI 10.1093/pcp/pch095; Tsai WC, 2008, PLANT CELL PHYSIOL, V49, P814, DOI 10.1093/pcp/pcn059; Wang SY, 2011, PLANT CELL PHYSIOL, V52, P563, DOI 10.1093/pcp/pcr015; Wu G, 2013, J GENET GENOMICS, V40, P217, DOI 10.1016/j.jgg.2013.04.002; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Xu YF, 2006, PLANT J, V46, P54, DOI 10.1111/j.1365-313X.2006.02669.x; Yamaguchi A, 2012, J PLANT RES, V125, P693, DOI 10.1007/s10265-012-0513-7; Zhang CQ, 2013, INT J MOL SCI, V14, P14689, DOI 10.3390/ijms140714689; Zhang CQ, 2012, BIOINFORMATICS, V28, P2561, DOI 10.1093/bioinformatics/bts500; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhang JH, 2013, PLANTA, V237, P89, DOI 10.1007/s00425-012-1753-4; ZHANG XS, 1993, PLANT CELL, V5, P403, DOI 10.1105/tpc.5.4.403; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	75	21	21	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102155	10.1371/journal.pone.0102155	http://dx.doi.org/10.1371/journal.pone.0102155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025767	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400045
J	Mucciarelli, M; Ferrazzini, D; Belletti, P				Mucciarelli, Marco; Ferrazzini, Diana; Belletti, Piero			Genetic Variability and Population Divergence in the Rare Fritillaria tubiformis subsp moggridgei Rix (Liliaceae) as Revealed by RAPD Analysis	PLOS ONE			English	Article							NARCISSUS-LONGISPATHUS; HABITAT FRAGMENTATION; DNA MARKERS; DIVERSITY; PLANT; DIFFERENTIATION; ISSR	Fritillaria tubiformis subsp. moggridgei Rix. is a rare alpine geophyte with shiny yellow flowers. This plant is sporadically distributed across the southwestern Alps where it is biogeographically close to F. tubiformis var. burnatii Planch. The latter has dark purple flowers and ranges in the majority of the Western and Central Alps. In order to develop appropriate strategies of conservation, a RAPD based analysis was conducted to study the genetic status of these taxa and the distribution of genetic variability of the subspecies by sampling seven populations distributed across the subspecies' range. Four populations of var. burnatii were chosen within this range and included in the genetic analysis. Some 264 individuals were analysed and 201 polymorphic loci were scored. Genetic diversity scored in the subspecies was in line with expectations for endemic species (H-e = 0.194). F. tubiformis var. burnatii showed lower intraspecific diversity (H-e = 0.173), notwithstanding a wider range than the subspecies. Most of the total phenotypic variation (about 83%) was allocated within populations, and significant lower proportions between taxa (6.45%) and between populations of the same taxon (10.64%). Moreover, PCoA analysis and Bayesian clustering separated populations into two genetically differentiated groups corresponding with the subspecific taxa. However, three populations ascribed to the subsp. moggridgei repeatedly showed genetic admixture with var. burnatii populations. Our findings suggest that: i) although the different flower colour, the two taxa are genetically very similar and share a consistent part of their gene pool, ii) the majority of genetic variability is allocated within populations rather than among them, iii) a representative amount of genetic diversity can be preserved by sampling from a restricted number of populations. The efficacy of RAPD markers in analysing genetic variation, and the contribution of the results to the preservation of biodiversity of the species, are discussed.	[Mucciarelli, Marco] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Ferrazzini, Diana; Belletti, Piero] Univ Turin, Dept Agr Forest & Food Sci, Turin, Italy	University of Turin; University of Turin	Mucciarelli, M (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	marco.mucciarelli@unito.it	Mucciarelli, Marco/D-6054-2011					Badfar-Chaleshtori S, 2012, BIOCHEM SYST ECOL, V42, P35, DOI 10.1016/j.bse.2011.12.027; Barrett SCH, 2004, HEREDITY, V92, P459, DOI 10.1038/sj.hdy.6800441; Bartolucci F, 2012, CANDOLLEA, V67, P23, DOI 10.15553/c2012v671a2; Bekessy SA, 2003, BIOL CONSERV, V110, P267, DOI 10.1016/S0006-3207(02)00225-2; Casazza G, 2013, BOT J LINN SOC, V173, P637, DOI 10.1111/boj.12110; Conti F., 2005, ANNOTATED CHECKLIST, V4, P227; del Hoyo A, 2012, PLANT ECOL DIVERS, V5, P501, DOI 10.1080/17550874.2012.735270; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Escudero A, 2003, BIOL CONSERV, V113, P351, DOI 10.1016/S0006-3207(03)00122-8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Jump AS, 2006, P NATL ACAD SCI USA, V103, P8096, DOI 10.1073/pnas.0510127103; Kramer AT, 2009, TRENDS PLANT SCI, V14, P599, DOI 10.1016/j.tplants.2009.08.005; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Lewontin R.C., 1972, EVOLUTIONARY BIOL, V14, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; Li XJ, 2008, BELG J BOT, V141, P95; Liu JF, 2013, INT J MOL SCI, V14, P14860, DOI 10.3390/ijms140714860; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; MACPHERSON JM, 1993, MOL CELL PROBE, V7, P293, DOI 10.1006/mcpr.1993.1043; Medrano M, 2008, ANN BOT-LONDON, V102, P183, DOI 10.1093/aob/mcn086; Mucciarelli M, 2013, PHYTOTAXA, V91, P1, DOI 10.11646/phytotaxa.91.1.1; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1987, MOL EVOLUTIONARY GEN; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; Pautasso M, 2009, PERSPECT PLANT ECOL, V11, P157, DOI 10.1016/j.ppees.2009.01.003; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; Rohlf, 2001, NTSYS PC NUMERAL TAX; Rustaiee AR, 2010, HORTIC ENVIRON BIOTE, V51, P335; Schneider S., 2000, ARLEQUIN VER 2 000 S; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Sozen E, 2010, EKOLOJI, V19, P1, DOI 10.5053/ekoloji.2010.771; Vali U, 2008, MOL ECOL, V17, P3808, DOI 10.1111/j.1365-294X.2008.03876.x; Wang BY, 2011, GENET MOL RES, V10, P114, DOI 10.4238/vol10-1gmr995; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WOLF PG, 1993, SYST BOT, V18, P652, DOI 10.2307/2419539; Yamagishi M, 2010, LANDSC ECOL ENG, V6, P75, DOI 10.1007/s11355-009-0084-5; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zych M, 2012, PLANT BIOLOGY, V14, P285, DOI 10.1111/j.1438-8677.2011.00510.x	46	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101967	10.1371/journal.pone.0101967	http://dx.doi.org/10.1371/journal.pone.0101967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025317	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400031
J	Stoop, JN; Liu, BS; Shi, J; Jansen, DTSL; Hegen, M; Huizinga, TWJ; Trouw, LA; Toes, REM				Stoop, Jeroen N.; Liu, Bi-Sheng; Shi, Jing; Jansen, Diahann T. S. L.; Hegen, Martin; Huizinga, Tom W. J.; Trouw, Leendert A.; Toes, Rene E. M.			Antibodies Specific for Carbamylated Proteins Precede the Onset of Clinical Symptoms in Mice with Collagen Induced Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; CITRULLINATED PROTEINS; T-CELLS; AUTOIMMUNE ARTHRITIS; ANIMAL-MODELS; II COLLAGEN; AUTOANTIBODIES; PREDICT	Objective: The immune response to post-translationally modified antigens is a key characteristic of rheumatoid arthritis. Carbamylation is such a posttranslational modification. Recently, we demonstrated that autoantibodies recognizing carbamylated proteins are present in sera of rheumatoid arthritis. The molecular mechanisms underlying the break of tolerance and hence the induction of anti-CarP antibody responses are unknown as well as their appearance in mouse models for systemic arthritis. Therefore we analyzed their appearance in the mouse collagen-induced arthritis model. Methods: collagen induced arthritis was induced by immunization with type II collagen in complete Freund's adjuvant. Arthritis severity was monitored by clinical scoring and anti-CarP antibody levels were determined by ELISA. Results: Anti-CarP antibodies were detectable in mice with collagen induced arthritis. We did not detect ACPA in mice with collagen induced arthritis. The specificity of the antibodies for carbamylated proteins was confirmed by inhibition assays and immunoblotting. Injection with complete Freund's adjuvant without type II collagen could also induce anti-CarP antibodies, however, in mice with arthritis, the anti-CarP antibody response was stronger and developed more rapidly. The onset of collagen induced arthritis was preceded by an increase of anti-CarP IgG2a levels in the serum. Conclusion: In mice with collagen induced arthritis we did not observe an immune response against citrullinated antigens, but we did observe an immune response against carbamylated antigens. This anti-CarP response already appeared before disease onset, indicating that collagen induced arthritis can be used as an in vivo model to study anti-CarP antibodies. Our data also indicate that the tolerance to carbamylated proteins, in contrast to the response to citrullinated proteins, is easily broken and that arthritis boosts the immune response against these proteins. The anti-CarP response in mice with CIA can be used as a model for immune responses to post-translationally modified proteins.	[Stoop, Jeroen N.; Liu, Bi-Sheng; Shi, Jing; Jansen, Diahann T. S. L.; Huizinga, Tom W. J.; Trouw, Leendert A.; Toes, Rene E. M.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Hegen, Martin] Pfizer Worldwide Res & Dev, Immunosci Res Unit, Cambridge, MA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pfizer	Stoop, JN (corresponding author), Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands.	J.N.Stoop@lumc.nl	Trouw, Leendert/AGK-5202-2022	Trouw, Leendert/0000-0001-5186-2290; Jansen, Diahann/0000-0003-4535-9167; Toes, Rene/0000-0002-9618-6414	IMI JU [115142-2]; Dutch Arthritis Foundation; Netherlands Organization for Scientific Research; Pfizer; Janssen biologics BV; ReumaFonds [13-3-401] Funding Source: researchfish	IMI JU; Dutch Arthritis Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Pfizer(Pfizer); Janssen biologics BV; ReumaFonds	This work was supported by the IMI JU funded project BeTheCure, contract no 115142-2, the Dutch Arthritis Foundation, The Netherlands Organization for Scientific Research and Pfizer. Leendert Trouw receives a fellowship from Janssen biologics BV. Martin Hegen (who is an employee of Pfizer) has been involved in the design of the study and in the preparation of the manuscript in a scientific collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Backlund J, 2013, ANN RHEUM DIS, V72, P1225, DOI 10.1136/annrheumdis-2012-202055; Bevaart L, 2010, ARTHRITIS RHEUM-US, V62, P2192, DOI 10.1002/art.27503; Burkhardt H, 2002, ARTHRITIS RHEUM, V46, P2339, DOI 10.1002/art.10472; Cantaert T, 2013, ARTHRITIS RHEUM-US, V65, P939, DOI 10.1002/art.37839; Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Kollias G, 2011, ANN RHEUM DIS, V70, P1357, DOI 10.1136/ard.2010.148551; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Mydel P, 2010, J IMMUNOL, V184, P6882, DOI 10.4049/jimmunol.1000075; Shi J, 2013, ANN RHEUM DIS; Shi J, 2014, AUTOIMMUN REV, V13, P225, DOI 10.1016/j.autrev.2013.10.008; Shi J, 2013, ARTHRITIS RHEUM-US, V65, P911, DOI 10.1002/art.37830; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Sirpal S, 2009, CLIN SCI, V116, P681, DOI 10.1042/CS20080322; TERATO K, 1985, J EXP MED, V162, P637, DOI 10.1084/jem.162.2.637; Trouw LA, 2009, ARTHRITIS RHEUM-US, V60, P1923, DOI 10.1002/art.24622; Uysal H, 2009, J EXP MED, V206, P449, DOI 10.1084/jem.20081862; van Duivenvoorde LM, 2007, J IMMUNOL, V179, P1506, DOI 10.4049/jimmunol.179.3.1506; Vossenaar ER, 2003, ARTHRITIS RHEUM-US, V48, P2489, DOI 10.1002/art.11229; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Weinstein JS, 2012, IMMUNOL REV, V247, P160, DOI 10.1111/j.1600-065X.2012.01122.x	24	37	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102163	10.1371/journal.pone.0102163	http://dx.doi.org/10.1371/journal.pone.0102163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025869	gold, Green Submitted, Green Published			2022-12-25	WOS:000339992400046
J	Yamanaka, S; Yokote, S; Yamada, A; Katsuoka, Y; Izuhara, L; Shimada, Y; Omura, N; Okano, HJ; Ohki, T; Yokoo, T				Yamanaka, Shuichiro; Yokote, Shinya; Yamada, Akifumi; Katsuoka, Yuichi; Izuhara, Luna; Shimada, Yohta; Omura, Nobuo; Okano, Hirotaka James; Ohki, Takao; Yokoo, Takashi			Adipose Tissue-Derived Mesenchymal Stem Cells in Long-Term Dialysis Patients Display Downregulation of PCAF Expression and Poor Angiogenesis Activation	PLOS ONE			English	Article							GENE-EXPRESSION; STROMAL CELLS; HYPOXIA; GROWTH; FIBROBLASTS; RESPONSES; RB	We previously demonstrated that mesenchymal stem cells (MSCs) differentiate into functional kidney cells capable of urine and erythropoietin production, indicating that they may be used for kidney regeneration. However, the viability of MSCs from dialysis patients may be affected under uremic conditions. In this study, we isolated MSCs from the adipose tissues of end-stage kidney disease (ESKD) patients undergoing long-term dialysis (KD-MSCs; mean: 72.3 months) and from healthy controls (HC-MSCs) to compare their viability. KD-MSCs and HC-MSCs were assessed for their proliferation potential, senescence, and differentiation capacities into adipocytes, osteoblasts, and chondrocytes. Gene expression of stem cell-specific transcription factors was analyzed by PCR array and confirmed by western blot analysis at the protein level. No significant differences of proliferation potential, senescence, or differentiation capacity were observed between KD-MSCs and HC-MSCs. However, gene and protein expression of p300/CBP-associated factor (PCAF) was significantly suppressed in KD-MSCs. Because PCAF is a histone acetyltransferase that mediates regulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha), we examined the hypoxic response in MSCs. HC-MSCs but not KD-MSCs showed upregulation of PCAF protein expression under hypoxia. Similarly, HIF-1 alpha and vascular endothelial growth factor (VEGF) expression did not increase under hypoxia in KD-MSCs but did so in HC-MSCs. Additionally, a directed in vivo angiogenesis assay revealed a decrease in angiogenesis activation of KD-MSCs. In conclusion, long-term uremia leads to persistent and systematic downregulation of PCAF gene and protein expression and poor angiogenesis activation of MSCs from patients with ESKD. Furthermore, PCAF, HIF-1 alpha, and VEGF expression were not upregulated by hypoxic stimulation of KD-MSCs. These results suggest that the hypoxic response may be blunted in MSCs from ESKD patients.	[Yamanaka, Shuichiro; Katsuoka, Yuichi; Izuhara, Luna; Okano, Hirotaka James] Jikei Univ, Sch Med, Dept Internal Med, Div Regenerat Med, Tokyo, Japan; [Yamanaka, Shuichiro; Yokote, Shinya; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan; [Yamada, Akifumi] Jikei Univ, Dept Pediat, Sch Med, Tokyo, Japan; [Shimada, Yohta] Jikei Univ, Dept Gene Therapy, Inst DNA Med, Sch Med, Tokyo, Japan; [Omura, Nobuo; Ohki, Takao] Jikei Univ, Dept Surg, Sch Med, Tokyo, Japan	Jikei University; Jikei University; Jikei University; Jikei University; Jikei University	Yokoo, T (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan.	tyokoo@jikei.ac.jp		Shimada, Yohta/0000-0003-2003-1552; Okano, Hirotaka James/0000-0003-4611-7098	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology and Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Basile JR, 2007, J BIOL CHEM, V282, P6899, DOI 10.1074/jbc.M609570200; Bastiaansen AJNM, 2013, ARTERIOSCL THROM VAS, V33, P1902, DOI 10.1161/ATVBAHA.113.301579; Bechtel-Walz W, 2014, CELL TISSUE RES, V356, P601, DOI 10.1007/s00441-014-1884-y; Berger A, 2009, AM J MANAG CARE, V15, P509; Bernhardt WM, 2006, KIDNEY INT, V69, P114, DOI 10.1038/sj.ki.5000062; Chen SW, 2011, J BIOL CHEM, V286, P32775, DOI 10.1074/jbc.M111.248278; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Drewa T, 2008, TRANSPL P, V40, P1668, DOI 10.1016/j.transproceed.2008.03.141; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Gonzalez-Cruz RD, 2012, P NATL ACAD SCI USA, V109, pE1523, DOI 10.1073/pnas.1120349109; Guedez L, 2003, AM J PATHOL, V162, P1431, DOI 10.1016/S0002-9440(10)64276-9; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Japanese Society of Nephrology, 2012, JPN J NEPHROL, V54, P1031; Jin YT, 2002, J BIOL CHEM, V277, P30838, DOI 10.1074/jbc.M204078200; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nekanti U, 2010, INT J BIOL SCI, V6, P499; Noh H, 2012, NEPHROL DIAL TRANSPL, V27, P218, DOI 10.1093/ndt/gfr267; Okuyama H, 2006, J BIOL CHEM, V281, P15554, DOI 10.1074/jbc.M602003200; Pillai S, 2010, CANCER RES, V70, P4931, DOI 10.1158/0008-5472.CAN-10-0501; Ravnskjaer K, 2013, J CLIN INVEST, V123, P4318, DOI 10.1172/JCI69035; Roemeling-van Rhijn M, 2012, KIDNEY INT, V82, P748, DOI 10.1038/ki.2012.187; SAHAGUN G, 1989, AM J PATHOL, V134, P1227; Shakib K, 2005, PROTEOMICS, V5, P2819, DOI 10.1002/pmic.200401108; Shimada Y, 2011, BIOCHEM BIOPH RES CO, V415, P274, DOI 10.1016/j.bbrc.2011.10.038; Sonoda T, 2003, TRANSPLANTATION, V75, P199, DOI 10.1097/01.TP.0000040867.67360.9F; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; Xinaris C, 2012, J AM SOC NEPHROL, V23, P1857, DOI 10.1681/ASN.2012050505; Yamada A, 2014, HUM CELL, V27, P59, DOI 10.1007/s13577-013-0082-7; Yokoo T, 2005, P NATL ACAD SCI USA, V102, P3296, DOI 10.1073/pnas.0406878102; Yokoo T, 2008, TRANSPLANTATION, V85, P1654, DOI 10.1097/TP.0b013e318173a35d; Yokoo T, 2006, J AM SOC NEPHROL, V17, P1026, DOI 10.1681/ASN.2005101043; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	42	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102311	10.1371/journal.pone.0102311	http://dx.doi.org/10.1371/journal.pone.0102311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025381	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400063
J	Ouyang, C; Nie, L; Gu, MD; Wu, AL; Han, X; Wang, XJ; Shao, JZ; Xia, ZP				Ouyang, Chuan; Nie, Li; Gu, Meidi; Wu, Ailing; Han, Xu; Wang, Xiaojian; Shao, Jianzhong; Xia, Zongping			Transforming Growth Factor (TGF)-beta-activated Kinase 1 (TAK1) Activation Requires Phosphorylation of Serine 412 by Protein Kinase A Catalytic Subunit alpha (PKAC alpha) and X-linked Protein Kinase (PRKX)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Innate Immunity; Mitogen-activated Protein Kinase (MAPK); NF-kappaB; Protein Kinase A (PKA); Serine; Threonine Protein Kinase; Toll-like Receptor (TLR); Tumor Necrosis Factor (TNF); IL-1R; TAK1	NF-KAPPA-B; AMP-INDEPENDENT ACTIVATION; SIGNALING PATHWAYS; POLYUBIQUITIN CHAINS; ADAPTER PROTEIN; IN-VIVO; TAB2; ZEBRAFISH; INNATE; EVOLUTION	Background: Understanding of molecular mechanism of TAK1 activation is incomplete. Results: PKAC and PRKX phosphorylate TAK1 at serine 412 to regulate TAK1 activation in the IL-1 receptor (IL-1R) and Toll-like receptor (TLR) signaling pathways. Conclusion: TAK1 activation requires phosphorylation by PKAC and PRKX. Significance: This study advanced our understanding of the molecular mechanism of TAK1 activation. TGF--activated kinase 1 (TAK1) is a key kinase in mediating Toll-like receptors (TLRs) and interleukin-1 receptor (IL-1R) signaling. Although TAK1 activation involves the phosphorylation of Thr-184 and Thr-187 residues at the activation loop, the molecular mechanism underlying the complete activation of TAK1 remains elusive. In this work, we show that the Thr-187 phosphorylation of TAK1 is regulated by its C-terminal coiled-coil domain-mediated dimerization in an autophosphorylation manner. Importantly, we find that TAK1 activation in mediating downstream signaling requires an additional phosphorylation at Ser-412, which is critical for TAK1 response to proinflammatory stimuli, such as TNF-, LPS, and IL-1. In vitro kinase and shRNA-based knockdown assays reveal that TAK1 Ser-412 phosphorylation is regulated by cAMP-dependent protein kinase catalytic subunit (PKAC) and X-linked protein kinase (PRKX), which is essential for proper signaling and proinflammatory cytokine induction by TLR/IL-1R activation. Morpholino-based in vivo knockdown and rescue studies show that the corresponding site Ser-391 in zebrafish TAK1 plays a conserved role in NF-B activation. Collectively, our data unravel a previously unknown mechanism involving TAK1 phosphorylation mediated by PKAC and PRKX that contributes to innate immune signaling.	[Ouyang, Chuan; Wu, Ailing; Han, Xu; Xia, Zongping] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Ouyang, Chuan; Wu, Ailing; Han, Xu; Xia, Zongping] Zhejiang Univ, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Ouyang, Chuan; Wu, Ailing; Han, Xu; Xia, Zongping] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Nie, Li; Shao, Jianzhong] Zhejiang Univ, Sch Med, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Gu, Meidi; Wang, Xiaojian] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Wang, XJ (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China.	wangxiaojian@cad.zju.edu.cn; shaojz@zju.edu.cn; xia2010@zju.edu.cn		Ouyang, Chuan/0000-0003-1667-191X	National Basic Research Program of China (973) Grants [2013CB945004, 2011CB910800]; National Natural Science Foundation of China Grant [31071242]; Natural Science Foundation of Zhejiang Province Grant [R2110588]	National Basic Research Program of China (973) Grants(National Basic Research Program of China); National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province Grant(Natural Science Foundation of Zhejiang Province)	This work was supported by National Basic Research Program of China (973) Grants 2013CB945004 and 2011CB910800, National Natural Science Foundation of China Grant 31071242, and Natural Science Foundation of Zhejiang Province Grant R2110588.	Ajibade AA, 2013, TRENDS IMMUNOL, V34, P307, DOI 10.1016/j.it.2013.03.007; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Dulin NO, 2001, J BIOL CHEM, V276, P20827, DOI 10.1074/jbc.C100195200; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Gu MD, 2014, J IMMUNOL, V192, P2846, DOI 10.4049/jimmunol.1302537; Inagaki M, 2008, J BIOL CHEM, V283, P33080, DOI 10.1074/jbc.M807574200; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kobayashi Y, 2005, J BIOL CHEM, V280, P11395, DOI 10.1074/jbc.M411189200; Kwak JH, 2008, J BIOL CHEM, V283, P19816, DOI 10.1074/jbc.M802285200; Mosenden R, 2011, CELL SIGNAL, V23, P1009, DOI 10.1016/j.cellsig.2010.11.018; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Prickett TD, 2008, J BIOL CHEM, V283, P19245, DOI 10.1074/jbc.M800943200; Sakurai H, 2002, BIOCHEM BIOPH RES CO, V297, P1277, DOI 10.1016/S0006-291X(02)02379-3; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; van der Vaart Michiel, 2012, Adv Hematol, V2012, P159807, DOI 10.1155/2012/159807; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xiong R, 2012, J IMMUNOL, V188, P2653, DOI 10.4049/jimmunol.1100959; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zieger M, 2001, BIOCHEM BIOPH RES CO, V282, P952, DOI 10.1006/bbrc.2001.4683	35	33	34	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24226	24237		10.1074/jbc.M114.559963	http://dx.doi.org/10.1074/jbc.M114.559963			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25028512	Green Published, hybrid			2022-12-25	WOS:000341505600020
J	Wilson, KE; Li, YW; Yang, N; Shen, H; Orillion, AR; Zhang, JM				Wilson, Kayla E.; Li, Ying-Wei; Yang, Nuo; Shen, He; Orillion, Ashley R.; Zhang, Jianmin			PTPN14 Forms a Complex with Kibra and LATS1 Proteins and Negatively Regulates the YAP Oncogenic Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cell Migration; Epithelial-Mesenchymal Transition (EMT); Protein Phosphatase; Protein-Protein Interaction	HIPPO SIGNALING PATHWAY; TYROSINE-PHOSPHATASE PEZ; TUMOR-SUPPRESSOR LATS1; COLORECTAL CANCERS; CELL-PROLIFERATION; SIZE CONTROL; DROSOPHILA; KINASE; BETA; INDUCTION	Background: Transcriptional co-activators YAP/TAZ are pivotal effectors of the Hippo pathway and their dysfunction promote epithelial-to-mesenchymal transition (EMT) and malignant transformation. Results: PTPN14 interacts with Kibra and activates LATS1 (upstream negative regulator of YAP). Conclusion: PTPN14 and Kibra activate LATS1 and negatively regulate the YAP oncogenic function. Significance: Study of the YAP regulatory mechanism is crucial for understanding its role in the physiological and pathological processes. The Hippo signaling pathway regulates cellular proliferation and survival, thus exerting profound effects on normal cell fate and tumorigenesis. Pivotal effectors of this pathway are YAP/TAZ, transcriptional co-activators whose dysfunction contributes to epithelial-to-mesenchymal transition and malignant transformation. Therefore, it is of great importance to decipher the mechanisms underlying the regulations of YAP/TAZ at various levels. Here we report that non-receptor tyrosine phosphatase 14 (PTPN14) interacts with the Kibra protein. The interaction between PTPN14 and Kibra is through the PPXY domain of PTPN14 and WW domain of Kibra. PTPN14 and Kibra can induce the LATS1 activation independently and cooperatively. Interestingly, activation of LATS1 by PTPN14 is dependent on the C terminus of PTPN14 and independent of the upstream mammalian STE20-like kinase (MST) proteins. Furthermore, we demonstrate that PTPN14 increases the LAST1 protein stability. Last, overexpression of Kibra rescues the increased cell migration and aberrant three-dimensional morphogenesis induced by knockdown of PTPN14, and this rescue is mediated through the activation of the upstream LATS1 kinase and subsequent cytoplasmic sequestration of YAP. In summary, our results indicate a potential regulatory role of PTPN14 in the Hippo pathway and demonstrate another layer of regulation in the YAP oncogenic function.	[Wilson, Kayla E.; Li, Ying-Wei; Yang, Nuo; Shen, He; Zhang, Jianmin] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Orillion, Ashley R.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Zhang, JM (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Elm & Carlton St, Buffalo, NY 14263 USA.	jianmin.zhang@roswellpark.org	Zhang, Jianmin/AAN-2931-2020		American Cancer Society Institutional Grant (ACS-IRG); Roswell Park Alliance Grant; National Institutes of Health through the NCI [P30 CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	American Cancer Society Institutional Grant (ACS-IRG)(American Cancer Society); Roswell Park Alliance Grant; National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an American Cancer Society Institutional Grant (ACS-IRG) to Roswell Park Cancer Institute (RPCI), a Roswell Park Alliance Grant, and National Institutes of Health Grant P30 CA016056 through the NCI (to J. Z.).	Bates TC, 2009, NEUROSCI LETT, V458, P140, DOI 10.1016/j.neulet.2009.04.050; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Huang JM, 2013, ONCOGENE, V32, P2220, DOI 10.1038/onc.2012.231; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Lin JI, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003813; Liu X, 2013, ONCOGENE, V32, P1266, DOI 10.1038/onc.2012.147; Michaloglou C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061916; Moleirinho S, 2013, ONCOGENE, V32, P1821, DOI 10.1038/onc.2012.196; Niedergethmann M, 2007, BRIT J CANCER, V97, P1432, DOI 10.1038/sj.bjc.6604031; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Poernbacher I, 2012, CURR BIOL, V22, P389, DOI 10.1016/j.cub.2012.01.019; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; SMITH AL, 1995, BIOCHEM BIOPH RES CO, V209, P959, DOI 10.1006/bbrc.1995.1591; Varelas X, 2012, TRENDS CELL BIOL, V22, P88, DOI 10.1016/j.tcb.2011.10.002; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; Wadham C, 2000, J CELL SCI, V113, P3117; Wang WQ, 2014, MOL CELL PROTEOMICS, V13, P119, DOI 10.1074/mcp.M113.030049; Wang WQ, 2012, GENE DEV, V26, P1959, DOI 10.1101/gad.192955.112; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; XU TA, 1995, DEVELOPMENT, V121, P1053; Yang N, 2012, CELL CYCLE, V11, P2922, DOI 10.4161/cc.21386; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	40	58	62	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23693	23700		10.1074/jbc.M113.534701	http://dx.doi.org/10.1074/jbc.M113.534701			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25023289	Green Published, hybrid			2022-12-25	WOS:000341505000037
J	Brenes, JC; Schwarting, RKW				Brenes, Juan C.; Schwarting, Rainer K. W.			Attribution and Expression of Incentive Salience Are Differentially Signaled by Ultrasonic Vocalizations in Rats	PLOS ONE			English	Article							FOOD-SEEKING; REWARD; REINFORCEMENT; COCAINE; BEHAVIOR; DEPRIVATION; AGGRESSION; EXTINCTION; MOTIVATION; AROUSAL	During Pavlovian incentive learning, the affective properties of rewards are thought to be transferred to their predicting cues. However, how rewards are represented emotionally in animals is widely unknown. This study sought to determine whether 50-kHz ultrasonic vocalizations (USVs) in rats may signal such a state of incentive motivation to natural, nutritional rewards. To this end, rats learned to anticipate food rewards and, across experiments, the current physiological state (deprived vs. sated), the type of learning mechanism recruited (Pavlovian vs. instrumental), the hedonic properties of UCS (low vs. high palatable food), and the availability of food reward (continued vs. discontinued) were manipulated. Overall, we found that reward-cues elicited 50-kHz calls as they were signaling a putative affective state indicative of incentive motivation in the rat. Attribution and expression of incentive salience, however, seemed not to be an unified process, and could be teased apart in two different ways: 1) under high motivational state (i.e., hunger), the attribution of incentive salience to cues occurred without being expressed at the USVs level, if reward expectations were higher than the outcome; 2) in all experiments when food rewards were devalued by satiation, reward cues were still able to elicit USVs and conditioned anticipatory activity although reward seeking and consumption were drastically weakened. Our results suggest that rats are capable of representing rewards emotionally beyond apparent, immediate physiological demands. These findings may have translational potential in uncovering mechanisms underlying aberrant and persistent motivation as observed in drug addiction, gambling, and eating disorders.	[Brenes, Juan C.] Univ Costa Rica, Inst Psychol Res, San Pedro, Costa Rica; [Brenes, Juan C.] Univ Costa Rica, Neurosci Res Ctr, San Pedro, Costa Rica; [Brenes, Juan C.; Schwarting, Rainer K. W.] Univ Marburg, Marburg, Germany	Universidad Costa Rica; Universidad Costa Rica; Philipps University Marburg	Brenes, JC (corresponding author), Univ Costa Rica, Inst Psychol Res, Rodrigo Facio Campus, San Pedro, Costa Rica.	brenesaenz@gmail.com	Schwarting, RAINER/AAJ-1516-2021	Schwarting, Rainer/0000-0002-4686-3974	Deutsche Forschungsgemeinschaft [Schw 559/10-1]; Deutscher Akademischer Austauschdienst (DAAD, Germany); University of Costa Rica	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst (DAAD, Germany)(Deutscher Akademischer Austausch Dienst (DAAD)); University of Costa Rica	This work was supported by the grant Schw 559/10-1 from the Deutsche Forschungsgemeinschaft. JCB was funded by the Deutscher Akademischer Austauschdienst (DAAD, Germany), and the University of Costa Rica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL A, 1958, PSYCHOL BULL, V55, P102, DOI 10.1037/h0043125; AMSEL A, 1977, SCIENCE, V197, P786, DOI 10.1126/science.560717; AZRIN NH, 1966, J EXP ANAL BEHAV, V9, P191, DOI 10.1901/jeab.1966.9-191; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Baron A, 2005, BEHAV ANALYST, V28, P85, DOI 10.1007/BF03392107; Berridge KC, 2001, PSYCHOL LEARN MOTIV, V40, P223, DOI 10.1016/s0079-7421(00)80022-5; Berridge KC, 2012, EUR J NEUROSCI, V35, P1124, DOI 10.1111/j.1460-9568.2012.07990.x; BINDRA D, 1978, BEHAV BRAIN SCI, V1, P41, DOI 10.1017/S0140525X00059380; Bolles RC, 1975, THEORY MOTIVATION, P330; Brandon SE, 2003, BEHAV PROCESS, V62, P5, DOI 10.1016/S0376-6357(03)00016-0; Browning JR, 2011, NEUROPHARMACOLOGY, V61, P268, DOI 10.1016/j.neuropharm.2011.04.012; Burgdorf J, 2000, BEHAV NEUROSCI, V114, P320, DOI 10.1037//0735-7044.114.2.320; Burgdorf J, 2001, BEHAV NEUROSCI, V115, P940, DOI 10.1037/0735-7044.115.4.940; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Burgdorf J, 2007, BEHAV BRAIN RES, V182, P274, DOI 10.1016/j.bbr.2007.03.010; Coffey KR, 2013, BEHAV BRAIN RES, V237, P256, DOI 10.1016/j.bbr.2012.09.041; CORNELL CE, 1989, PHYSIOL BEHAV, V45, P695, DOI 10.1016/0031-9384(89)90281-3; Covington HE, 2003, EUR J PHARMACOL, V467, P1, DOI 10.1016/S0014-2999(03)01558-9; Crespi LP, 1942, AM J PSYCHOL, V55, P467, DOI 10.2307/1417120; Daly H.B., 1974, PSYCHOL LEARNING MOT, P187, DOI [10.1016/S0079-7421(08)60455-7, DOI 10.1016/S0079-7421(08)60455-7]; DANDREA T, 1971, J EXP ANAL BEHAV, V15, P319, DOI 10.1901/jeab.1971.15-319; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; Flagel SB, 2009, NEUROPHARMACOLOGY, V56, P139, DOI 10.1016/j.neuropharm.2008.06.027; FLAHERTY CF, 1985, ANIM LEARN BEHAV, V13, P309, DOI 10.3758/BF03200025; Hull C, 1952, BEHAV SYSTEM INTRO B, P151; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; Konorski J, 1967, INTEGRATIVE ACTIVITY, P29; Meyer PJ, 2012, PSYCHOPHARMACOLOGY, V219, P999, DOI 10.1007/s00213-011-2429-7; Mowrer OH, 1960, LEARNING THEORY BEHA, DOI DOI 10.1037/10802-000; Nair SG, 2009, PROG NEUROBIOL, V89, P18, DOI 10.1016/j.pneurobio.2009.05.003; Natusch C, 2010, PHARMACOL BIOCHEM BE, V96, P251, DOI 10.1016/j.pbb.2010.05.013; PANKSEPP J, 1992, PSYCHOL REV, V99, P554, DOI 10.1037/0033-295X.99.3.554; Papini M.R., 1997, REV GEN PSYCHOL, V1, P175, DOI [10.1037/1089-2680.1.2.175, DOI 10.1037/1089-2680.1.2.175]; Pecoraro NC, 1999, J EXP PSYCHOL ANIM B, V25, P153, DOI 10.1037/0097-7403.25.2.153; Petrovich GD, 2007, PHYSIOL BEHAV, V90, P362, DOI 10.1016/j.physbeh.2006.09.031; RESCORLA RA, 1967, PSYCHOL REV, V74, P151, DOI 10.1037/h0024475; Robinson MJF, 2013, CURR BIOL, V23, P282, DOI 10.1016/j.cub.2013.01.016; SCHACHTER S, 1968, SCIENCE, V161, P751, DOI 10.1126/science.161.3843.751; Schwarting RKW, 2007, BEHAV BRAIN RES, V182, P208, DOI 10.1016/j.bbr.2007.01.029; Timberlake W, 2001, HANDBOOK OF CONTEMPORARY LEARNING THEORIES, P155; Toates FM, 1986, MOTIVATIONAL SYSTEMS, P121; Volkow ND, 2013, BIOL PSYCHIAT, V73, P811, DOI 10.1016/j.biopsych.2012.12.020; WEINGARTEN HP, 1983, SCIENCE, V220, P431, DOI 10.1126/science.6836286; Willey AR, 2013, BEHAV BRAIN RES, V245, P107, DOI 10.1016/j.bbr.2013.02.020; Williams SN, 2010, J PHARMACOL EXP THER, V332, P463, DOI 10.1124/jpet.109.158535; Wohr M, 2008, PHYSIOL BEHAV, V93, P766, DOI 10.1016/j.physbeh.2007.11.031; Wohr M, 2013, CELL TISSUE RES, V354, P81, DOI 10.1007/s00441-013-1607-9; WONG PTP, 1979, ANIM LEARN BEHAV, V7, P111, DOI 10.3758/BF03209667	48	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102414	10.1371/journal.pone.0102414	http://dx.doi.org/10.1371/journal.pone.0102414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047234	Green Published, gold, Green Submitted			2022-12-25	WOS:000339558100029
J	Kim, JH; Jeon, M; Song, JS; Lee, JH; Choi, BJ; Jung, HS; Moon, SJ; DenBesten, PK; Kim, SO				Kim, Ji-Hee; Jeon, Mijeong; Song, Je-Seon; Lee, Jae-Ho; Choi, Byung-Jai; Jung, Han-Sung; Moon, Seok Jun; DenBesten, Pamela K.; Kim, Seong-Oh			Distinctive Genetic Activity Pattern of the Human Dental Pulp between Deciduous and Permanent Teeth	PLOS ONE			English	Article							EPITHELIAL STEM-CELLS; BONE SIALOPROTEIN; CDNA MICROARRAY; BINDING PROTEIN; MESSENGER-RNA; EXPRESSION; OSTEONECTIN; ODONTOBLASTS; TISSUE; PROGNOSIS	Human deciduous and permanent teeth exhibit different developmental processes, morphologies, histological characteristics and life cycles. In addition, their pulp tissues react differently to external stimuli, such as the pulp sensitivity test, dental trauma and pulp therapy materials. These suggest differences in gene expression and regulation, and in this study we compared gene-expression profiles of the human dental pulp from deciduous and permanent teeth. Pulp tissues from permanent premolars and deciduous molars aged 11-14 years were extirpated and mRNA was isolated for cDNA microarray analysis, and quantitative real-time PCR (qPCR). Other teeth were used for immunohistochemical analysis (IHC). Microarray analysis identified 263 genes with a twofold or greater difference in expression level between the two types of pulp tissue, 43 and 220 of which were more abundant in deciduous and permanent pulp tissues, respectively. qPCR analysis was conducted for eight randomly selected genes, and the findings were consistent with the cDNA microarray results. IHC confirmed that insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) was broadly expressed in deciduous dental pulp tissue, but minimally expressed in permanent dental pulp tissue. Immunohistochemical analysis showed that calbindin 1 (CALB1), leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5), and gamma-aminobutyric acid A receptor beta 1 (GABRB1) were abundantly expressed in permanent predentin/odontoblasts, but only minimally expressed in deciduous dental pulp tissue. These results show that deciduous and permanent pulp tissues have different characteristics and gene expression, suggesting that they may have different functions and responses to therapies focused on pulp or dentin regeneration.	[Kim, Ji-Hee; Jeon, Mijeong; Song, Je-Seon; Lee, Jae-Ho; Choi, Byung-Jai; Kim, Seong-Oh] Yonsei Univ, Dept Pediat Dent, Coll Dent, Oral Sci Res Ctr, Seoul 120749, South Korea; [Jung, Han-Sung] Yonsei Univ, Dept Oral Biol, Coll Dent, Div Histol, Seoul 120749, South Korea; [Moon, Seok Jun] Yonsei Univ, Dept Oral Biol, Coll Dent, Div Pharmacol, Seoul 120749, South Korea; [DenBesten, Pamela K.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of California System; University of California San Francisco	Kim, SO (corresponding author), Yonsei Univ, Dept Pediat Dent, Coll Dent, Oral Sci Res Ctr, Seoul 120749, South Korea.	ksodds@yuhs.ac	Jung, Han-Sung/I-3848-2012	Moon, Seok Jun/0000-0001-7282-2888; Jung, Han-Sung/0000-0003-2795-531X; Kim, Seong Oh/0000-0002-8620-1377; Song, Je Seon/0000-0001-8620-5629; lee, jaeho/0000-0002-1556-3485	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2041910, 2011-0022160]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2041910, 2011-0022160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Borum MK, 1998, ENDOD DENT TRAUMATOL, V14, P31; BYERS MR, 1982, PAIN, V13, P221, DOI 10.1016/0304-3959(82)90012-4; CHEN JK, 1993, ARCH ORAL BIOL, V38, P241, DOI 10.1016/0003-9969(93)90034-J; Egan C A, 1999, Int J Paediatr Dent, V9, P57, DOI 10.1046/j.1365-263x.1999.00096.x; Fuks A B, 2000, Dent Clin North Am, V44, P571; Fuks AB, 2000, DENT CLIN N AM, V44, pvii; Garcia JMQ, 2003, INT ENDOD J, V36, P404, DOI 10.1046/j.1365-2591.2003.00669.x; Gu LJ, 2004, INT J ONCOL, V24, P671; Hamshere ML, 2009, BRIT J PSYCHIAT, V195, P23, DOI 10.1192/bjp.bp.108.061424; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Huysseune A, 2004, BIOESSAYS, V26, P665, DOI 10.1002/bies.20039; Itota T, 2001, ARCH ORAL BIOL, V46, P829, DOI 10.1016/S0003-9969(01)00041-3; JACOBSEN I, 1978, ACTA ODONTOL SCAND, V36, P199, DOI 10.3109/00016357809004668; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; McLachlan JL, 2005, BBA-MOL BASIS DIS, V1741, P271, DOI 10.1016/j.bbadis.2005.03.007; Nakamura S, 2009, J ENDODONT, V35, P1536, DOI 10.1016/j.joen.2009.07.024; Paakkonen V, 2008, INT ENDOD J, V41, P117; Paakkonen V, 2005, EUR J ORAL SCI, V113, P369, DOI 10.1111/j.1600-0722.2005.00237.x; Paakkonen V, 2007, CYTOKINE, V40, P44, DOI 10.1016/j.cyto.2007.08.003; Pillas D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000856; RAPP R, 1967, ANAT REC, V159, P89, DOI 10.1002/ar.1091590113; REICHERT T, 1992, CALCIFIED TISSUE INT, V50, P468, DOI 10.1007/BF00296779; Robertson A, 1996, J ENDODONT, V22, P557, DOI 10.1016/S0099-2399(96)80018-5; Shi S, 2001, BONE, V29, P532, DOI 10.1016/S8756-3282(01)00612-3; Shiba H, 2001, J DENT RES, V80, P1653, DOI 10.1177/00220345010800071101; Smith MM, 2009, J EXP ZOOL PART B, V312B, P260, DOI 10.1002/jez.b.21272; Staquet MJ, 2008, J DENT RES, V87, P256, DOI 10.1177/154405910808700304; Suomalainen M, 2010, DEV DYNAM, V239, P364, DOI 10.1002/dvdy.22106; Takeda T, 2008, J DENT RES, V87, P676, DOI 10.1177/154405910808700716; WASSERMA.RH, 1966, SCIENCE, V152, P791, DOI 10.1126/science.152.3723.791; Wells MA, 2006, BIOCHEM J, V400, P501, DOI 10.1042/BJ20060721	32	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102893	10.1371/journal.pone.0102893	http://dx.doi.org/10.1371/journal.pone.0102893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047033	Green Published, Green Submitted, gold			2022-12-25	WOS:000339558100086
J	Berke, SK; Jablonski, D; Krug, AZ; Valentine, JW				Berke, Sarah K.; Jablonski, David; Krug, Andrew Z.; Valentine, James W.			Origination and Immigration Drive Latitudinal Gradients in Marine Functional Diversity	PLOS ONE			English	Article							BODY-SIZE; PATTERNS; EVOLUTIONARY; DYNAMICS; EXTINCTION; FIDELITY; TROPICS; IMPACT; RECORD	Global patterns in the functional attributes of organisms are critical to understanding biodiversity trends and predicting biotic responses to environmental change. In the first global marine analysis, we find a strong decrease in functional richness, but a strong increase in functional evenness, with increasing latitude using intertidal-to-outer-shelf bivalves as a model system (N = 5571 species). These patterns appear to be driven by the interplay between variation in origination rates among functional groups, and latitudinal patterns in origination and range expansion, as documented by the rich fossil record of the group. The data suggest that (i) accumulation of taxa in spatial bins and functional categories has not impeded continued diversification in the tropics, and (ii) extinctions will influence ecosystem function differentially across latitudes.	[Berke, Sarah K.] Siena Coll, Dept Biol, New York, NY 12211 USA; [Berke, Sarah K.; Jablonski, David; Krug, Andrew Z.] Siena Coll, Dept Biol, New York, NY 12211 USA; [Krug, Andrew Z.] Flint Hill Sch, Oakton, VA USA; [Valentine, James W.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berke, SK (corresponding author), Siena Coll, Dept Biol, New York, NY 12211 USA.	skberke@gmail.com			National Science Foundation [EAR-0922156, DEB-0919451]; NASA Exobiology Program [EXOB08-0089]	National Science Foundation(National Science Foundation (NSF)); NASA Exobiology Program(National Aeronautics & Space Administration (NASA))	Funding provided by National Science Foundation EAR-0922156, DEB-0919451, nsf.gov and NASA Exobiology Program, EXOB08-0089, astrobiology.nasa.gov/exobiology/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Duffy JE, 2012, MARINE BIODIVERSITY AND ECOSYSTEM FUNCTIONING: FRAMEWORKS, METHODOLOGIES, AND INTEGRATION, P164; Foote M, 2001, PALEOBIOLOGY, V27, P602, DOI 10.1666/0094-8373(2001)027<0602:ITPOPO>2.0.CO;2; Freestone AL, 2011, ECOLOGY, V92, P208, DOI 10.1890/09-1841.1; Harper EM, 1998, ADEQUACY OF THE FOSSIL RECORD, P243; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; Huber M., 2010, COMPENDIUM BIVALVES; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jablonski D, 2013, P NATL ACAD SCI USA, V110, P10487, DOI 10.1073/pnas.1308997110; Kidwell SM, 2005, SCIENCE, V307, P914, DOI 10.1126/science.1106654; Kosnik MA, 2006, PALAIOS, V21, P588, DOI 10.2110/palo.2006.p06-012r; Krug AZ, 2007, P NATL ACAD SCI USA, V104, P18129, DOI 10.1073/pnas.0709202104; Krug AZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015362; Krug AZ, 2009, SCIENCE, V323, P767, DOI 10.1126/science.1164905; Laliberte E., 2011, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Markert A, 2010, BIOL INVASIONS, V12, P15, DOI 10.1007/s10530-009-9425-4; Mason NWH, 2013, J VEG SCI, V24, P777, DOI 10.1111/jvs.12097; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mouillot D, 2005, OECOLOGIA, V142, P353, DOI 10.1007/s00442-004-1744-7; Ohnishi S, 2006, FISHERIES SCI, V72, P787, DOI 10.1111/j.1444-2906.2006.01219.x; Pianka E. R., 1999, EVOLUTIONARY ECOLOGY; Rivadeneira MM, 2010, PALAIOS, V25, P40, DOI 10.2110/palo.2009.p09-035r; Roy K, 2000, P NATL ACAD SCI USA, V97, P13150, DOI 10.1073/pnas.97.24.13150; Steneck Robert S., 2001, P121; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Stevens RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056853; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Swenson NG, 2012, GLOBAL ECOL BIOGEOGR, V21, P798, DOI 10.1111/j.1466-8238.2011.00727.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Todd JA, 2012, NEOGENE MARINE BIOTA; Valentine James W., 2009, P3; Valentine JW, 2006, P NATL ACAD SCI USA, V103, P6599, DOI 10.1073/pnas.0601264103; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Volkenborn N, 2012, J MAR RES, V70, P794, DOI 10.1357/002224012806770955; Wilson B, 1998, MOLLUSCA SO SYNTHESI, V5, P827; Woodin SA, 2010, INTEGR COMP BIOL, V50, P176, DOI 10.1093/icb/icq031	42	20	20	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101494	10.1371/journal.pone.0101494	http://dx.doi.org/10.1371/journal.pone.0101494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036112	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200018
J	Carr, DE; Roulston, TH; Hart, H				Carr, David E.; Roulston, T'ai H.; Hart, Haley			Inbreeding in Mimulus guttatus Reduces Visitation by Bumble Bee Pollinators	PLOS ONE			English	Article							FLORAL DISPLAY SIZE; ARTIFICIAL FLOWERS; SELF-FERTILIZATION; POTENTIAL MALE; 5 GENERATIONS; PLANT; DEPRESSION; POLLEN; EVOLUTION; HERBIVORY	Inbreeding in plants typically reduces individual fitness but may also alter ecological interactions. This study examined the effect of inbreeding in the mixed-mating annual Mimulus guttatus on visitation by pollinators (Bombus impatiens) in greenhouse experiments. Previous studies of M. guttatus have shown that inbreeding reduced corolla size, flower number, and pollen quantity and quality. Using controlled crosses, we produced inbred and outbred families from three different M. guttatus populations. We recorded the plant genotypes that bees visited and the number of flowers probed per visit. In our first experiment, bees were 31% more likely to visit outbred plants than those selfed for one generation and 43% more likely to visit outbred plants than those selfed for two generations. Inbreeding had only a small effect on the number of flowers probed once bees arrived at a genotype. These differences were explained partially by differences in mean floral display and mean flower size, but even when these variables were controlled statistically, the effect of inbreeding remained large and significant. In a second experiment we quantified pollen viability from inbred and self plants. Bees were 37-54% more likely to visit outbred plants, depending on the population, even when controlling for floral display size. Pollen viability proved to be as important as floral display in predicting pollinator visitation in one population, but the overall explanatory power of a multiple regression model was weak. Our data suggested that bees use cues in addition to display size, flower size, and pollen reward quality in their discrimination of inbred plants. Discrimination against inbred plants could have effects on plant fitness and thereby reinforce selection for outcrossing. Inbreeding in plant populations could also reduce resource quality for pollinators, potentially resulting in negative effects on pollinator populations.	[Carr, David E.; Roulston, T'ai H.] Univ Virginia, Blandy Expt Farm, Boyce, VA 22620 USA; [Hart, Haley] Southeastern High Sch, Detroit, MI USA	University of Virginia	Carr, DE (corresponding author), Univ Virginia, Blandy Expt Farm, Boyce, VA 22620 USA.	david.carr@virginia.edu	Roulston, Tai/AAI-4974-2020	Roulston, Tai/0000-0002-1220-1315	National Science Foundation [DEB-0614395, DBI-0453465]	National Science Foundation(National Science Foundation (NSF))	D.E.C. received funding from DEB-0614395, National Science Foundation, http://www.nsf.gov/. T.H.R. received funding from DBI-0453465, National Science Foundation, http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonovics J., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P426; Arathi HS, 2004, INT J PLANT SCI, V165, P1039, DOI 10.1086/423876; Arathi HS, 2002, INT J PLANT SCI, V163, P567, DOI 10.1086/340444; Ashman TL, 2005, ECOLOGY, V86, P2099, DOI 10.1890/04-1161; Bangert RK, 2005, CONSERV BIOL, V19, P379, DOI 10.1111/j.1523-1739.2005.00450.x; Beardsley PM, 2002, AM J BOT, V89, P1093, DOI 10.3732/ajb.89.7.1093; Bello-Bedoy R, 2011, J EVOLUTION BIOL, V24, P518, DOI 10.1111/j.1420-9101.2010.02185.x; Byers DL, 1999, ANNU REV ECOL SYST, V30, P479, DOI 10.1146/annurev.ecolsys.30.1.479; Byers KJRP, 2014, J EXP BIOL, V217, P614, DOI 10.1242/jeb.092213; Campbell SA, 2013, ECOL LETT, V16, P252, DOI 10.1111/ele.12036; Carr DE, 2014, ANNU REV ENTOMOL, V59, P185, DOI 10.1146/annurev-ento-011613-162049; Carr DE, 2002, EVOLUTION, V56, P22, DOI 10.1111/j.0014-3820.2002.tb00846.x; CARR DE, 1995, HEREDITY, V75, P437, DOI 10.1038/hdy.1995.159; Carr DE, 1997, EVOLUTION, V51, P1797, DOI 10.1111/j.1558-5646.1997.tb05103.x; Carr DE, 2003, EVOL ECOL, V17, P85, DOI 10.1023/A:1022439432213; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Chittka L, 2002, ENTOMOL GEN, V26, P85; Church D, 2001, GREAT LAKES ENTOMOL, V34, P85; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Darwin C, 1878, EFFECTS CROSS SELF F; Dobson HEM, 2000, PLANT SYST EVOL, V222, P63, DOI 10.1007/BF00984096; DOLE JA, 1992, AM J BOT, V79, P650, DOI 10.2307/2444881; Dudash MR, 1997, EVOLUTION, V51, P54, DOI [10.2307/2410960, 10.1111/j.1558-5646.1997.tb02388.x]; DUDASH MR, 1991, AM J BOT, V78, P1746, DOI 10.2307/2444854; Fenster CB, 1997, J EVOLUTION BIOL, V10, P641, DOI 10.1007/s000360050046; Frankham R., 2002, INTRO CONSERVATION G; Galloway LF, 2002, INT J PLANT SCI, V163, P133, DOI 10.1086/324556; Gegear RJ, 2004, CAN J ZOOL, V82, P587, DOI 10.1139/Z04-029; Hayes CN, 2004, OECOLOGIA, V140, P601, DOI 10.1007/s00442-004-1623-2; Herlihy CR, 2004, EVOLUTION, V58, P2693, DOI 10.1111/j.0014-3820.2004.tb01622.x; Hull-Sanders HM, 2005, ECOLOGY, V86, P897, DOI 10.1890/04-0935; Ivey CT, 2005, AM J BOT, V92, P1641, DOI 10.3732/ajb.92.10.1641; Ivey CT, 2004, ECOLOGY, V85, P567, DOI 10.1890/02-0730; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Kariyat RR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0020; Kariyat RR, 2012, ECOL LETT, V15, P301, DOI 10.1111/j.1461-0248.2011.01738.x; Karron JD, 2004, HEREDITY, V92, P242, DOI 10.1038/sj.hdy.6800402; Kearns C. A., 1993, TECHNIQUES POLLINATI; Kelly JK, 2005, NEW PHYTOL, V165, P55, DOI 10.1111/j.1469-8137.2004.01184.x; Kelly JK, 2003, HEREDITY, V90, P77, DOI 10.1038/sj.hdy.6800181; KIANG YT, 1972, EVOLUTION, V26, P308, DOI [10.2307/2407041, 10.1111/j.1558-5646.1972.tb00197.x]; KLINKHAMER PGL, 1989, OIKOS, V54, P201, DOI 10.2307/3565267; Leimu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042326; Levin DA, 2013, ANN BOT, V109, P613; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; MACNAIR MR, 1989, NEW PHYTOL, V112, P269, DOI 10.1111/j.1469-8137.1989.tb02383.x; Mitchell RJ, 2004, FUNCT ECOL, V18, P116, DOI 10.1111/j.1365-2435.2004.00812.x; Ouborg NJ, 2000, ECOLOGY, V81, P520, DOI 10.2307/177445; Pernal SF, 2002, ANIM BEHAV, V63, P369, DOI 10.1006/anbe.2001.1904; Plowright CMS, 1999, BEHAVIOUR, V136, P951, DOI 10.1163/156853999501667; Rae JM, 2013, PLANT SPEC BIOL, V28, P177, DOI 10.1111/j.1442-1984.2012.00375.x; RITLAND C, 1989, AM J BOT, V76, P1731, DOI 10.2307/2444472; RITLAND K, 1990, EVOLUTION, V44, P1230, DOI [10.2307/2409284, 10.1111/j.1558-5646.1990.tb05227.x]; ROBERTSON AW, 1995, OIKOS, V72, P106, DOI 10.2307/3546044; Robertson AW, 1999, ECOLOGY, V80, P2594, DOI 10.1890/0012-9658(1999)080[2594:BBSOMG]2.0.CO;2; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Simonds V, 2004, ANIM BEHAV, V67, P379, DOI 10.1016/j.anbehav.2003.03.020; Stephenson AG, 2004, ECOLOGY, V85, P3023, DOI 10.1890/04-0005; Uyenoyama M.K., 1993, OXFORD SURVEYS EVOLU, V9, P327, DOI [DOI 10.1016/0040-5809(91)90046-I, 10.1016/0040-5809(91)90046-I]; Vickery RK, 1999, GREAT BASIN NAT, V59, P112; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Wiegmann DD, 2003, PHYSIOL BEHAV, V79, P561, DOI 10.1016/S0031-9384(03)00122-7; Willis JH, 1999, HEREDITY, V83, P337, DOI 10.1038/sj.hdy.6885790; WILLIS JH, 1993, HEREDITY, V71, P145, DOI 10.1038/hdy.1993.118; WILLSON MF, 1977, EVOLUTION, V31, P495, DOI 10.1111/j.1558-5646.1977.tb01040.x; Wise MJ, 2011, INT J PLANT SCI, V172, P199, DOI 10.1086/657677; Yeamans RL, 2011, THESIS U VIRGINIA	67	16	16	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101463	10.1371/journal.pone.0101463	http://dx.doi.org/10.1371/journal.pone.0101463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036035	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200017
J	Ji, ZW; Su, J; Liu, CL; Wang, HY; Huang, DS; Zhou, XB				Ji, Zhiwei; Su, Jing; Liu, Chenglin; Wang, Hongyan; Huang, Deshuang; Zhou, Xiaobo			Integrating Genomics and Proteomics Data to Predict Drug Effects Using Binary Linear Programming	PLOS ONE			English	Article							CANCER-CELLS; P38 MAPK; APOPTOSIS; EXPRESSION; P53; PHOSPHORYLATION; GENERATION; INDUCTION; CARCINOMA; PATHWAY	The Library of Integrated Network-Based Cellular Signatures (LINCS) project aims to create a network-based understanding of biology by cataloging changes in gene expression and signal transduction that occur when cells are exposed to a variety of perturbations. It is helpful for understanding cell pathways and facilitating drug discovery. Here, we developed a novel approach to infer cell-specific pathways and identify a compound's effects using gene expression and phosphoproteomics data under treatments with different compounds. Gene expression data were employed to infer potential targets of compounds and create a generic pathway map. Binary linear programming (BLP) was then developed to optimize the generic pathway topology based on the mid-stage signaling response of phosphorylation. To demonstrate effectiveness of this approach, we built a generic pathway map for the MCF7 breast cancer cell line and inferred the cell-specific pathways by BLP. The first group of 11 compounds was utilized to optimize the generic pathways, and then 4 compounds were used to identify effects based on the inferred cell-specific pathways. Cross-validation indicated that the cell-specific pathways reliably predicted a compound's effects. Finally, we applied BLP to re-optimize the cell-specific pathways to predict the effects of 4 compounds (trichostatin A, MS-275, staurosporine, and digoxigenin) according to compound-induced topological alterations. Trichostatin A and MS-275 (both HDAC inhibitors) inhibited the downstream pathway of HDAC1 and caused cell growth arrest via activation of p53 and p21; the effects of digoxigenin were totally opposite. Staurosporine blocked the cell cycle via p53 and p21, but also promoted cell growth via activated HDAC1 and its downstream pathway. Our approach was also applied to the PC3 prostate cancer cell line, and the cross-validation analysis showed very good accuracy in predicting effects of 4 compounds. In summary, our computational model can be used to elucidate potential mechanisms of a compound's efficacy.	[Ji, Zhiwei; Su, Jing; Liu, Chenglin; Wang, Hongyan; Zhou, Xiaobo] Ctr Bioinformat & Syst Biol, Wake Forest Sch Med, Div Radiol Sci, Winston Salem, NC 27103 USA; [Ji, Zhiwei; Huang, Deshuang] Tongji Univ, Sch Elect & Informat Engn, Shanghai, Peoples R China	Wake Forest University; Tongji University	Zhou, XB (corresponding author), Ctr Bioinformat & Syst Biol, Wake Forest Sch Med, Div Radiol Sci, Med Ctr Blvd, Winston Salem, NC 27103 USA.	xizhou@wakehealth.edu	shi, zhensheng/GXN-3967-2022	Su, Jing/0000-0003-4917-6173	NIH [U01HL111560-04, U01CA166886-03]; NSFC [61373105]; NATIONAL CANCER INSTITUTE [U01CA166886] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL111560] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project is funded by NIH U01HL111560-04 (Zhou) and NIH U01CA166886-03 (Zhou). This work was also partially supported by NSFC No. 61373105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Arikuma T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S11; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Chang J, 2012, BRIT J CANCER, V106, P116, DOI 10.1038/bjc.2011.532; Chen SC, 2006, HYPERTENSION, V47, P252, DOI 10.1161/01.HYP.0000198424.93598.6b; Chen XP, 2013, J CELL BIOCHEM, V114, P1145, DOI 10.1002/jcb.24457; Coulonval K, 2003, J BIOL CHEM, V278, P52052, DOI 10.1074/jbc.M307012200; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Dimitrova ES, 2010, J COMPUT BIOL, V17, P853, DOI 10.1089/cmb.2008.0023; Gasparian AV, 2002, J CELL SCI, V115, P141; Giacinti L, 2012, J CELL PHYSIOL, V227, P3426, DOI 10.1002/jcp.24043; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Gregg Jennifer, 2011, Genes Cancer, V2, P900, DOI 10.1177/1947601911431885; Gu J, 2012, MOL BIOSYST, V8, P2041, DOI 10.1039/c2mb25065a; Hopfensitz M, 2012, IEEE ACM T COMPUT BI, V9, P487, DOI 10.1109/TCBB.2011.62; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Kachhap SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011208; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kim H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-37; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Mather W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.068105; Mitsos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000591; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Ogata H, 1998, BIOSYSTEMS, V47, P119, DOI 10.1016/S0303-2647(98)00017-3; Opiteck GJ, 2004, EXPERT REV PROTEOMIC, V1, P57, DOI 10.1586/14789450.1.1.57; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; Rodriguez-Berriguete G, 2012, PROSTATE, V72, P40, DOI 10.1002/pros.21404; Rosato RR, 2003, CANCER RES, V63, P3637; Rubin E, 2001, ONCOGENE, V20, P3776, DOI 10.1038/sj.onc.1204518; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Su JS, 2012, NMR BIOMED, V25, P379, DOI 10.1002/nbm.1764; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200; Xue LY, 2003, EXP CELL RES, V283, P135, DOI 10.1016/S0014-4827(02)00032-0; Zhang BH, 2013, EUR REV MED PHARMACO, V17, P758; Zhao Guo-qin, 2013, Yingyong Shengtai Xuebao, V24, P2122	39	17	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102798	10.1371/journal.pone.0102798	http://dx.doi.org/10.1371/journal.pone.0102798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036040	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200087
J	Liu, Q; Hou, JF; Chen, XG; Liu, GT; Zhang, D; Sun, H; Zhang, JL				Liu, Qian; Hou, Jinfeng; Chen, Xiaoguang; Liu, Gengtao; Zhang, Dan; Sun, Hua; Zhang, Jinlan			P-Glycoprotein Mediated Efflux Limits the Transport of the Novel Anti-Parkinson's Disease Candidate Drug FLZ across the Physiological and PD Pathological In Vitro BBB Models	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MICROVASCULAR ENDOTHELIAL-CELLS; RAT-BRAIN; PRIMARY CULTURES; SH-SY5Y CELLS; PROTECTS; PERMEABILITY; ASTROCYTES; EXPRESSION; INDUCTION	FLZ, a novel anti-Parkinson's disease (PD) candidate drug, has shown poor blood-brain barrier (BBB) penetration based on the pharmacokinetic study using rat brain. P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) are two important transporters obstructing substrates entry into the CNS as well as in relation to PD neuropathology. However, it is unclear whether P-gp and BCRP are involved in low BBB permeability of FLZ and what the differences of FLZ brain penetration are between normal and Parkinson's conditions. For this purpose, in vitro BBB models mimicking physiological and PD pathological-related BBB properties were constructed by C6 astroglial cells co-cultured with primary normal or PD rat cerebral microvessel endothelial cells (rCMECs) and in vitro permeability experiments of FLZ were carried out. High transepithelial electrical resistance (TEER) and low permeability for sodium fluorescein (NaF) confirmed the BBB functionality of the two models. Significantly greater expressions of P-gp and BCRP were detected in PD rCMECs associated with the lower in vitro BBB permeability of FLZ in pathological BBB model compared with physiological model. In transport studies only P-gp blocker effectively inhibited the efflux of FLZ, which was consistent with the in vivo permeability data. This result was also confirmed by ATPase assays, suggesting FLZ is a substrate for P-gp but not BCRP. The present study first established in vitro BBB models reproducing PD-related changes of BBB functions in vivo and demonstrated that poor brain penetration of FLZ and low BBB permeability were due to the P-gp transport.	[Liu, Qian; Hou, Jinfeng; Chen, Xiaoguang; Liu, Gengtao; Zhang, Dan; Sun, Hua; Zhang, Jinlan] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Substance & Funct Nat Med, Beijing, Peoples R China; [Liu, Qian; Hou, Jinfeng; Chen, Xiaoguang; Liu, Gengtao; Zhang, Dan; Sun, Hua; Zhang, Jinlan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Qian] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Neurosurgical Institute; Capital Medical University	Sun, H (corresponding author), Chinese Acad Med Sci, Inst Mat Med, Dept Pharmacol, Beijing 100730, Peoples R China.	sunhua@imm.ac.cn; zhjl@imm.ac.cn			Beijing Municipal Natural Science Foundation [7122113]; China National Natural Science Foundation [81072697]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Beijing Municipal Natural Science Foundation (No. 7122113) as well as China National Natural Science Foundation (No. 81072697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Bao XQ, 2012, NEUROSCIENCE, V202, P396, DOI 10.1016/j.neuroscience.2011.11.036; Calabria AR, 2006, J NEUROCHEM, V97, P922, DOI 10.1111/j.1471-4159.2006.03793.x; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Carvey PM, 2005, EUR J NEUROSCI, V22, P1158, DOI 10.1111/j.1460-9568.2005.04281.x; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Colgan OC, 2008, BRAIN RES, V1193, P84, DOI 10.1016/j.brainres.2007.11.072; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Deracinois B, 2013, PROTEOMICS; ElAli A, 2011, NEUROSCIENTIST, V17, P423, DOI 10.1177/1073858410391270; Feng WH, 2005, MOL NEUROBIOL, V31, P295, DOI 10.1385/MN:31:1-3:295; GORDON EL, 1991, IN VITRO CELL DEV B, V27, P312; GRABB PA, 1995, J NEUROSURG, V82, P1053, DOI 10.3171/jns.1995.82.6.1053; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; Hou JF, 2012, J PHARMACEUT BIOMED, V66, P232, DOI 10.1016/j.jpba.2012.03.001; Kong XC, 2011, BRAIN RES, V1383, P99, DOI 10.1016/j.brainres.2011.01.093; Nagpal K, 2013, EXPERT OPIN DRUG DEL; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Ogunshola OO, 2011, CURR PHARM DESIGN, V17, P2755; PANULA P, 1978, EXPERIENTIA, V34, P95, DOI 10.1007/BF01921925; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Poller B, 2011, MOL PHARMACEUT, V8, P571, DOI 10.1021/mp1003898; Prabhakarpandian B, 2013, LAB CHIP, V13, P1093, DOI 10.1039/c2lc41208j; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Tan KH, 2001, NEUROREPORT, V12, P1329, DOI 10.1097/00001756-200105250-00008; Veszelka S, 2007, NEUROCHEM INT, V50, P219, DOI 10.1016/j.neuint.2006.08.006; Weiss J, 2007, J ANTIMICROB CHEMOTH, V59, P238, DOI 10.1093/jac/dkl474; Xue Q, 2013, INT J BIOL SCI, V9, P174, DOI 10.7150/ijbs.5115; Zhang D, 2007, EUR J PHARMACOL, V561, P1, DOI 10.1016/j.ejphar.2006.11.015; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	33	27	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102442	10.1371/journal.pone.0102442	http://dx.doi.org/10.1371/journal.pone.0102442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036090	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200060
J	Pedley, AM; Lill, MA; Davisson, VJ				Pedley, Anthony M.; Lill, Markus A.; Davisson, V. Jo			Flexibility of PCNA-Protein Interface Accommodates Differential Binding Partners	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; PHOSPHOINOSITIDE 3-KINASE BETA; SMALL-MOLECULE INHIBITORS; DOUBLE-STRAND BREAK; DNA-REPLICATION; FLAP ENDONUCLEASE-1; DRUG DISCOVERY; FLUORESCENCE POLARIZATION; REPAIR; DYNAMICS	The expanding roles of PCNA in functional assembly of DNA replication and repair complexes motivated investigation of the structural and dynamic properties guiding specificity of PCNA-protein interactions. A series of biochemical and computational analyses were combined to evaluate the PIP Box recognition features impacting complex formation. The results indicate subtle differences in topological and molecular descriptors distinguishing both affinity and stoichiometry of binding among PCNA-peptide complexes through cooperative effects. These features were validated using peptide mimics of p85 alpha and Akt, two previously unreported PCNA binding partners. This study characterizes for the first time a reverse PIP Box interaction with PCNA. Small molecule ligand binding at the PIP Box interaction site confirmed the adaptive nature of the protein in dictating overall shape and implicates allosterism in transmitting biological effects.	[Pedley, Anthony M.; Lill, Markus A.; Davisson, V. Jo] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Davisson, VJ (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	davisson@purdue.edu	Lill, Markus A/E-5118-2017	Lill, Markus A/0000-0003-3023-5188; Pedley, Anthony/0000-0003-1034-5072	Office of the Assistant Secretary of Defense for Health Affairs through the Breast Cancer Research Program [W81XWH-10-1-0105, W81XWH-11-1-0050]; Purdue Center for Cancer Research	Office of the Assistant Secretary of Defense for Health Affairs through the Breast Cancer Research Program; Purdue Center for Cancer Research	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Breast Cancer Research Program under Award No. W81XWH-10-1-0105 (VJD) and No. W81XWH-11-1-0050 (AMP). The cost of publication was covered by the Purdue Center for Cancer Research. The opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis M, 2013, BIOORGAN MED CHEM, V21, P1972, DOI 10.1016/j.bmc.2013.01.022; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bohm HJ, 1996, ANGEW CHEM INT EDIT, V35, P2589; Bowers K.J., 2006, P 2006 ACM IEEE C SU, DOI [10.1109/SC.2006.54, DOI 10.1109/SC.2006.54]; Bozza WP, 2012, ANAL BIOCHEM, V427, P69, DOI 10.1016/j.ab.2012.04.018; Brath U, 2009, J MOL BIOL, V387, P233, DOI 10.1016/j.jmb.2009.01.047; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Case DA, 2012, AMBER 12; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cozzini P, 2008, J MED CHEM, V51, P6237, DOI 10.1021/jm800562d; De Biasio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048390; Doruker P, 2000, PROTEINS, V40, P512, DOI 10.1002/1097-0134(20000815)40:3<512::AID-PROT180>3.3.CO;2-D; Fenwick RB, 2009, BIOCHEMISTRY-US, V48, P2192, DOI 10.1021/bi802129d; Fridman Y, 2013, PROTEINS, V81, P341, DOI 10.1002/prot.24190; Fridman Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000507; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Guo ZG, 2008, J MOL BIOL, V377, P679, DOI 10.1016/j.jmb.2007.10.074; He X, 2009, APOPTOSIS, V14, P268, DOI 10.1007/s10495-009-0313-2; Hlinkova V, 2008, ACTA CRYSTALLOGR D, V64, P941, DOI 10.1107/S0907444908021665; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inoue A, 2014, J BIOL CHEM, V289, P7109, DOI 10.1074/jbc.M113.520429; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; Kumar A, 2010, P NATL ACAD SCI USA, V107, P7491, DOI 10.1073/pnas.0914242107; Lea WA, 2011, EXPERT OPIN DRUG DIS, V6, P17, DOI 10.1517/17460441.2011.537322; Lu ZL, 2007, J BIOL CHEM, V282, P17921, DOI 10.1074/jbc.M610413200; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Marques M, 2009, P NATL ACAD SCI USA, V106, P7525, DOI 10.1073/pnas.0812000106; Meireles LMC, 2010, NUCLEIC ACIDS RES, V38, pW407, DOI 10.1093/nar/gkq502; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Prinz Heino, 2010, J Chem Biol, V3, P37, DOI 10.1007/s12154-009-0029-3; Punchihewa C, 2012, J BIOL CHEM, V287, P14289, DOI 10.1074/jbc.M112.353201; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Robertson AD, 2002, TRENDS BIOCHEM SCI, V27, P521, DOI 10.1016/S0968-0004(02)02184-9; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Schrodinger L., PYMOL MOL GRAPHICS S; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Talavera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021053; Warbrick E, 1997, ONCOGENE, V14, P2313, DOI 10.1038/sj.onc.1201072; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Xia LQ, 2005, J MOL BIOL, V346, P1259, DOI 10.1016/j.jmb.2005.01.014; Xu H, 2001, BIOCHEMISTRY-US, V40, P4512, DOI 10.1021/bi010103+; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; ZHANG P, 1995, BIOCHEMISTRY-US, V34, P10703, DOI 10.1021/bi00034a002; Zheleva DI, 2000, BIOCHEMISTRY-US, V39, P7388, DOI 10.1021/bi992498r	60	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102481	10.1371/journal.pone.0102481	http://dx.doi.org/10.1371/journal.pone.0102481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036435	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200063
J	Sakkiah, S; Senese, S; Yang, QF; Lee, KW; Torres, JZ				Sakkiah, Sugunadevi; Senese, Silvia; Yang, Qianfan; Lee, Keun Woo; Torres, Jorge Z.			Dynamic and Multi-Pharmacophore Modeling for Designing Polo-Box Domain Inhibitors	PLOS ONE			English	Article							MOLECULAR-BASIS; KINASE 1; PLK1; POLO-LIKE-KINASE-1; LOCALIZATION; BINDING; PERMEABILITY; LIGANDS; DOCKING; MITOSIS	The polo-like kinase 1 (Plk1) is a critical regulator of cell division that is overexpressed in many types of tumors. Thus, a strategy in the treatment of cancer has been to target the kinase activity (ATPase domain) or substrate-binding domain (Polo-box Domain, PBD) of Plk1. However, only few synthetic small molecules have been identified that target the Plk1-PBD. Here, we have applied an integrative approach that combines pharmacophore modeling, molecular docking, virtual screening, and in vitro testing to discover novel Plk1-PBD inhibitors. Nine Plk1-PBD crystal structures were used to generate structure-based hypotheses. A common pharmacophore model (Hypo1) composed of five chemical features was selected from the 9 structure-based hypotheses and used for virtual screening of a drug-like database consisting of 159,757 compounds to identify novel Plk1-PBD inhibitors. The virtual screening technique revealed 9,327 compounds with a maximum fit value of 3 or greater, which were selected and subjected to molecular docking analyses. This approach yielded 93 compounds that made good interactions with critical residues within the Plk1-PBD active site. The testing of these 93 compounds in vitro for their ability to inhibit the Plk1-PBD, showed that many of these compounds had Plk1-PBD inhibitory activity and that compound Chemistry_28272 was the most potent Plk1-PBD inhibitor. Thus Chemistry_28272 and the other top compounds are novel Plk1-PBD inhibitors and could be used for the development of cancer therapeutics.	[Sakkiah, Sugunadevi; Senese, Silvia; Yang, Qianfan; Torres, Jorge Z.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Lee, Keun Woo] GNU, RINS, PMBBRC, SSAC,Div Appl Life Sci,Program BK21, Jinju, South Korea; [Torres, Jorge Z.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Torres, Jorge Z.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Torres, JZ (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	torres@chem.ucla.edu		Sakkiah, Suguna Devi/0000-0002-8337-9348; Torres, Jorge/0000-0002-2158-889X	National Science Foundation [NSF-MCB1243645]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Science Foundation Grant NSF-MCB1243645 to J.Z.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bayliss R, 2012, OPEN BIOL, V2; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Egan WJ, 2002, ADV DRUG DELIVER REV, V54, P273, DOI 10.1016/S0169-409X(02)00004-2; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Garcia-Alvarez B, 2007, P NATL ACAD SCI USA, V104, P3107, DOI 10.1073/pnas.0609131104; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Komlodi-Pasztor E, 2012, CLIN CANCER RES, V18, P51, DOI 10.1158/1078-0432.CCR-11-0999; Laufer S, 2012, CHEMBIOCHEM, V13, P2146; ledz P. S, 2011, ANGEW CHEM INT EDIT, V50, P4003; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Murugan RN, 2013, BIOORGAN MED CHEM, V21, P2623, DOI 10.1016/j.bmc.2013.02.020; Murugan RN, 2011, MOL CELLS, V32, P209, DOI 10.1007/s10059-011-0126-3; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240; Reindl WG, 2008, CHEM BIOL, V15, P459, DOI 10.1016/j.chembiol.2008.03.013; Sakkiah S, 2011, EUR J MED CHEM, V46, P2937, DOI 10.1016/j.ejmech.2011.04.018; Sledz P, 2012, ANGEW CHEM INT EDIT, V51, P7680, DOI 10.1002/anie.201202660; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Yun SM, 2009, NAT STRUCT MOL BIOL, V16, P876, DOI 10.1038/nsmb.1628	27	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101405	10.1371/journal.pone.0101405	http://dx.doi.org/10.1371/journal.pone.0101405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036740	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200015
J	Wang, YY; Li, YD; Liu, JB; Ran, XX; Guo, YY; Ren, NN; Chen, X; Jiang, H; Li, YQ				Wang, Yue-Yue; Li, Yu-Dong; Liu, Jian-Bo; Ran, Xin-Xin; Guo, Yuan-Yang; Ren, Ni-Ni; Chen, Xin; Jiang, Hui; Li, Yong-Quan			Characterization and Evolutionary Implications of the Triad Asp-Xxx-Glu in Group II Phosphopantetheinyl Transferases	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; POLYKETIDE SYNTHASE; 4'-PHOSPHOPANTETHEINYL TRANSFERASE; POSTTRANSLATIONAL MODIFICATION; NATAMYCIN PRODUCTION; MUTATIONAL ANALYSIS; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; FATTY-ACID; PROTEIN	Phosphopantetheinyl transferases (PPTases), which play an essential role in both primary and secondary metabolism, are magnesium binding enzymes. In this study, we characterized the magnesium binding residues of all known group II PPTases by biochemical and evolutionary analysis. Our results suggested that group II PPTases could be classified into two subgroups, two-magnesium-binding-residue-PPTases containing the triad Asp-Xxx-Glu and three-magnesium-binding-residue-PPTases containing the triad Asp-Glu-Glu. Mutations of two three-magnesium-binding-residue-PPTases and one two-magnesium-binding-residue-PPTase indicate that the first and the third residues in the triads are essential to activities; the second residues in the triads are non-essential. Although variations of the second residues in the triad Asp-Xxx-Glu exist throughout the whole phylogenetic tree, the second residues are conserved in animals, plants, algae, and most prokaryotes, respectively. Evolutionary analysis suggests that: the animal group II PPTases may originate from one common ancestor; the plant two-magnesium-binding-residue-PPTases may originate from one common ancestor; the plant three-magnesium-binding-residue-PPTases may derive from horizontal gene transfer from prokaryotes.	[Wang, Yue-Yue; Liu, Jian-Bo; Ran, Xin-Xin; Guo, Yuan-Yang; Ren, Ni-Ni; Chen, Xin; Jiang, Hui; Li, Yong-Quan] Zhejiang Univ, Coll Sci, Zhengzhou, Peoples R China; [Li, Yu-Dong] Zhejiang Gongshang Univ, Dept Bioengn, Hangzhou, Zhejiang, Peoples R China; [Jiang, Hui; Li, Yong-Quan] Key Lab Microbial Biochem & Metab Engn Zhejiang P, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Gongshang University	Jiang, H (corresponding author), Zhejiang Univ, Coll Sci, Zhengzhou, Peoples R China.	jianghuisioc@zju.edu.cn; lyq@zju.edu.cn	Li, Yudong/GSN-4036-2022; li, Yu/HCI-9086-2022; li, yu/HGL-9518-2022		National Basic Research Program of China (973 Program) [2012CB721005]; Zhejiang Provincial Natural Science Foundation of China [LZ12C01001]; National Natural Science Foundation of China [31200600]; National High Technology Research & Development Program of China (863 Program) [2012AA02A706]; National Key Technologies R & D Program of China [2011BAD23B05-2]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research & Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Key Technologies R & D Program of China(National Key Technology R&D Program)	This work was supported by National Basic Research Program of China (973 Program) 2012CB721005, Zhejiang Provincial Natural Science Foundation of China LZ12C01001, National Natural Science Foundation of China 31200600, National High Technology Research & Development Program of China (863 Program) 2012AA02A706, National Key Technologies R & D Program of China 2011BAD23B05-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beld J, 2014, NAT PROD REP, V31, P61, DOI 10.1039/c3np70054b; Bunkoczi G, 2007, CHEM BIOL, V14, P1243, DOI 10.1016/j.chembiol.2007.10.013; Chirgadze NY, 2000, EMBO J, V19, P5281, DOI 10.1093/emboj/19.20.5281; Copp JN, 2007, J BACTERIOL, V189, P3133, DOI 10.1128/JB.01850-06; Copp JN, 2006, APPL ENVIRON MICROB, V72, P2298, DOI 10.1128/AEM.72.4.2298-2305.2006; Dall'Aglio P, 2011, BIOCHEMISTRY-US, V50, P5704, DOI 10.1021/bi2003668; De Lay NR, 2006, MOL MICROBIOL, V61, P232, DOI 10.1111/j.1365-2958.2006.05222.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Du YL, 2011, APPL ENVIRON MICROB, V77, P8415, DOI 10.1128/AEM.05898-11; Du YL, 2011, MICROBIOL-SGM, V157, P1300, DOI 10.1099/mic.0.046607-0; Du YL, 2009, J MICROBIOL, V47, P506, DOI 10.1007/s12275-009-0014-0; Finking R, 2002, J BIOL CHEM, V277, P50293, DOI 10.1074/jbc.M205042200; Guo SJ, 2003, FEMS MICROBIOL LETT, V224, P261, DOI 10.1016/S0378-1097(03)00455-5; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Huang Y, 2006, J BIOL CHEM, V281, P29660, DOI 10.1074/jbc.M604895200; Jiang H, 2013, APPL ENVIRON MICROB, V79, P3346, DOI 10.1128/AEM.00099-13; Joshi AK, 2003, J BIOL CHEM, V278, P33142, DOI 10.1074/jbc.M305459200; Kieser T., 2000, PRACTICAL STREPTOMYC, DOI DOI 10.2436/im.v3i4.9291; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lombo F, 2004, CHEMBIOCHEM, V5, P1181, DOI 10.1002/cbic.200400073; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Lu YW, 2008, J BACTERIOL, V190, P6903, DOI 10.1128/JB.00865-08; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Meiser P, 2008, CHEMBIOCHEM, V9, P1549, DOI 10.1002/cbic.200800077; Mofid MR, 2004, BIOCHEMISTRY-US, V43, P4128, DOI 10.1021/bi036013h; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Murugan E, 2008, FEBS LETT, V582, P1097, DOI 10.1016/j.febslet.2008.02.061; Praphanphoj V, 2001, MOL GENET METAB, V72, P336, DOI 10.1006/mgme.2000.3138; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Reuter K, 1999, EMBO J, V18, P6823, DOI 10.1093/emboj/18.23.6823; Roberts AA, 2009, CHEMBIOCHEM, V10, P1869, DOI 10.1002/cbic.200900095; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Stanley AE, 2006, CHEM COMMUN, P3981, DOI 10.1039/b609556a; Sun JH, 1999, MICROBIOL-UK, V145, P2221, DOI 10.1099/00221287-145-9-2221; Sunbul M, 2009, METHOD ENZYMOL, V458, P255, DOI 10.1016/S0076-6879(09)04810-1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; Weissman KJ, 2004, CHEMBIOCHEM, V5, P116, DOI 10.1002/cbic.200300775; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang J, 2008, P NATL ACAD SCI USA, V105, P1460, DOI 10.1073/pnas.0711625105; Zhou Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S8; Zhou Z, 2011, CURR GENOMICS, V12, P404, DOI 10.2174/138920211797248556	44	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e103031	10.1371/journal.pone.0103031	http://dx.doi.org/10.1371/journal.pone.0103031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036863	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200106
J	Zhao, W; Zou, K; Farasyn, T; Ho, WT; Zhao, ZZJ				Zhao, Wanke; Zou, Kang; Farasyn, Taleah; Ho, Wanting Tina; Zhao, Zhizhuang Joe			Generation and Characterization of a JAK2V617F-Containing Erythroleukemia Cell Line	PLOS ONE			English	Article							TYROSINE KINASE JAK2; HEMATOPOIETIC STEM; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE DISORDERS; MUTATION; EXPRESSION; JAK2V617F; JAK2(V617F); ERYTHROPOIETIN; MYELOFIBROSIS	The JAK2V617F mutation is found in the majority of patients with myeloproliferative neoplasms (MPNs). Transgenic expression of the mutant gene causes MPN-like phenotypes in mice. We have produced JAK2V617F mice with p53 null background. Some of these mice developed acute erythroleukemia. From one of these mice, we derived a cell line designated J53Z1. J53Z1 cells were stained positive for surface markers CD71 and CD117 but negative for Sca-1, TER-119, CD11b, Gr-1, F4/80, CD11c, CD317, CD4, CD8a, CD3e, B220, CD19, CD41, CD42d, NK-1.1, and FceR1. Real time PCR analyses demonstrated expressions of erythropoietin receptor EpoR, GATA1, and GATA2 in these cells. J53Z1 cells grew rapidly in suspension culture containing fetal bovine serum with a doubling time of similar to 18 hours. When transplanted into C57Bl/6 mice, J53Z1 cells induced acute erythroleukemia with massive infiltration of tumor cells in the spleen and liver. J53Z1 cells were responsive to stimulation with erythropoietin and stem cell factor and were selectively inhibited by JAK2 inhibitors which induced apoptosis of the cells. Together, J53Z1 cells belong to the erythroid lineage, and they may be useful for studying the role of JAK2V617F in proliferation and differentiation of erythroid cells and for identifying potential therapeutic drugs targeting JAK2.	[Zhao, Wanke; Farasyn, Taleah; Ho, Wanting Tina; Zhao, Zhizhuang Joe] Univ Oklahoma Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Zou, Kang] Oklahoma Sch Sci & Math, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhao, ZZJ (corresponding author), Univ Oklahoma Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA.				Stephenson Cancer Center of University of Oklahoma	Stephenson Cancer Center of University of Oklahoma	This work was supported by a pilot grant from the Stephenson Cancer Center of University of Oklahoma. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Ferbeyre G, 2002, NATURE, V415, P26, DOI 10.1038/415026a; Guo Y, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-72; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jin X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084340; Kaneko H, 2010, CURR OPIN HEMATOL, V17, P163, DOI 10.1097/MOH.0b013e32833800b8; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; LaFave LM, 2012, TRENDS PHARMACOL SCI, V33, P574, DOI 10.1016/j.tips.2012.08.005; LAW JC, 1993, LEUKEMIA RES, V17, P1045, DOI 10.1016/0145-2126(93)90161-D; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Li Z, 2007, J BIOL CHEM, V282, P3428, DOI 10.1074/jbc.C600277200; Liu Y, 2009, CELL CYCLE, V8, P3120, DOI 10.4161/cc.8.19.9627; Marty C, 2010, BLOOD, V116, P783, DOI 10.1182/blood-2009-12-257063; Mesa RA, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-79; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Prasher JM, 2001, ONCOGENE, V20, P2946, DOI 10.1038/sj.onc.1204395; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; RUSCETTI SK, 1990, J VIROL, V64, P1057, DOI 10.1128/JVI.64.3.1057-1062.1990; Shi KY, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-25; Shide K, 2008, LEUKEMIA, V22, P87, DOI 10.1038/sj.leu.2405043; Sui XW, 1998, BLOOD, V92, P1142, DOI 10.1182/blood.V92.4.1142.416k42_1142_1149; Tefferi A, 2008, LEUKEMIA, V22, P3, DOI 10.1038/sj.leu.2404946; Tian CX, 2003, BLOOD, V101, P2235, DOI 10.1182/blood-2002-04-1217; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579; Zhao AH, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-40; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200; Zhao WK, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-15; Zhao WM, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-4	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e99017	10.1371/journal.pone.0099017	http://dx.doi.org/10.1371/journal.pone.0099017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036984	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200002
J	Bogler, C; Mehnert, J; Steinbrink, J; Haynes, JD				Bogler, Carsten; Mehnert, Jan; Steinbrink, Jens; Haynes, John-Dylan			Decoding Vigilance with NIRS	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; BRAIN-COMPUTER-INTERFACE; DIFFUSE OPTICAL TOMOGRAPHY; CEREBRAL-BLOOD; SUSTAINED ATTENTION; PERFORMANCE; TALAIRACH; CORTEX; TASK; FMRI	Sustained, long-term cognitive workload is associated with variations and decrements in performance. Such fluctuations in vigilance can be a risk factor especially during dangerous attention demanding activities. Functional MRI studies have shown that attentional performance is correlated with BOLD-signals, especially in parietal and prefrontal cortical regions. An interesting question is whether these BOLD-signals could be measured in real-world scenarios, say to warn in a dangerous workplace whenever a subjects' vigilance is low. Because fMRI lacks the mobility needed for such applications, we tested whether the monitoring of vigilance might be possible using Near-Infrared Spectroscopy (NIRS). NIRS is a highly mobile technique that measures hemodynamics in the surface of the brain. We demonstrate that non-invasive NIRS signals correlate with vigilance. These signals carry enough information to decode subjects' reaction times at a single trial level.	[Bogler, Carsten; Haynes, John-Dylan] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany; [Bogler, Carsten; Haynes, John-Dylan] Charite, D-13353 Berlin, Germany; [Bogler, Carsten; Mehnert, Jan; Haynes, John-Dylan] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Bogler, Carsten; Haynes, John-Dylan] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany; [Mehnert, Jan; Steinbrink, Jens] Charite, Berlin NeuroImaging Ctr, D-13353 Berlin, Germany; [Steinbrink, Jens] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Steinbrink, Jens] Berlin Inst Technol, Bernstein Focus Neurotechnol Berlin, Berlin, Germany; [Mehnert, Jan] Inst Technol, Dept Machine Learning, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Berlin	Bogler, C (corresponding author), Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany.	carsten.bogler@bccn-berlin.de; haynes@bccn-berlin.de	Mehnert, Jan/AAX-8791-2020; Haynes, John-Dylan/Q-1148-2016	Mehnert, Jan/0000-0001-7088-740X; Haynes, John-Dylan/0000-0003-1786-6954; Bogler, Carsten/0000-0003-0162-6016	German Ministry for Research (BMBF) [01GQ1001C]; Bernstein Focus Neurotechnology Berlin [01GQ0850]; NIH [R42NS050007, R44NS049734]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R44NS049734, R42NS050007] Funding Source: NIH RePORTER	German Ministry for Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Bernstein Focus Neurotechnology Berlin; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by German Ministry for Research (BMBF 01GQ1001C), Bernstein Focus Neurotechnology Berlin (01GQ0850) and in part by NIH Grant nos. R42NS050007 and R44NS049734. The authors would like to thank the Max-Planck Institute for Human Cognitive and Brain Sciences (Leipzig, Germany) for providing the infrastructure and NIRx Medizintechnik GmbH (Berlin, Germany) for their support and technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelnour AF, 2009, NEUROIMAGE, V46, P133, DOI 10.1016/j.neuroimage.2009.01.033; Ayaz H, 2012, NEUROIMAGE, V59, P36, DOI 10.1016/j.neuroimage.2011.06.023; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Blankertz B, 2007, NEUROIMAGE, V37, P539, DOI 10.1016/j.neuroimage.2007.01.051; Buttfield A, 2006, IEEE T NEUR SYS REH, V14, P164, DOI 10.1109/TNSRE.2006.875555; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coste CP, 2011, CEREB CORTEX, V21, P2612, DOI 10.1093/cercor/bhr050; Davies DR, 1982, PSYCHOL VIGILANCE; De Joux N, 2013, BRAIN COGNITION, V81, P370, DOI 10.1016/j.bandc.2012.12.003; Derosiere G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00583; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Friston K., 1997, HUMAN BRAIN FUNCTION, P141; Gregg Nicholas M, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00014; Habermehl C, 2012, NEUROIMAGE, V59, P3201, DOI 10.1016/j.neuroimage.2011.11.062; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; Haufe S, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056001; Helton WS, 2013, EXP BRAIN RES, V226, P357, DOI 10.1007/s00221-013-3441-4; Helton WS, 2010, NEUROPSYCHOLOGIA, V48, P1683, DOI 10.1016/j.neuropsychologia.2010.02.014; Kleinschmidt A, 1996, J CEREBR BLOOD F MET, V16, P817, DOI 10.1097/00004647-199609000-00006; Koch Stefan P, 2010, Front Neuroenergetics, V2, P12, DOI 10.3389/fnene.2010.00012; Laird AR, 2010, NEUROIMAGE, V51, P677, DOI 10.1016/j.neuroimage.2010.02.048; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lee JH, 2009, NEUROSCI LETT, V450, P1, DOI 10.1016/j.neulet.2008.11.024; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Luck S.J., 2005, INTRO EVENT RELATED; Mackworth NH, 1948, Q J EXP PSYCHOL, V1, P6, DOI 10.1080/17470214808416738; MANGUN GRR, 1987, HUM FACTORS, V29, P195, DOI 10.1177/001872088702900207; Mouao-Miranda J, 2007, NEUROIMAGE, V36, P88, DOI 10.1016/j.neuroimage.2007.02.020; Nelson JT, 2014, NEUROIMAGE, V85, P909, DOI 10.1016/j.neuroimage.2012.11.061; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Ossowski U, 2011, CONSCIOUS COGN, V20, P1649, DOI 10.1016/j.concog.2011.08.015; Parra L, 2002, NEUROIMAGE, V17, P223, DOI 10.1006/nimg.2002.1212; Piper SK, 2014, NEUROIMAGE, V85, P64, DOI 10.1016/j.neuroimage.2013.06.062; Shaw TH, 2013, BRAIN COGNITION, V82, P265, DOI 10.1016/j.bandc.2013.05.003; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Sorger B, 2009, PROG BRAIN RES, V177, P275, DOI 10.1016/S0079-6123(09)17719-1; Stevenson H, 2011, BRAIN COGNITION, V77, P215, DOI 10.1016/j.bandc.2011.08.007; Tsubone T, 2007, P ANN INT IEEE EMBS, P5342, DOI 10.1109/IEMBS.2007.4353548; Warm J. S., 1984, SUSTAINED ATTENTION; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152; Weiskopf N, 2003, NEUROIMAGE, V19, P577, DOI 10.1016/S1053-8119(03)00145-9; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yoo SS, 2004, NEUROREPORT, V15, P1591, DOI 10.1097/01.wnr.0000133296.39160.fe; Zeff BW, 2007, P NATL ACAD SCI USA, V104, P12169, DOI 10.1073/pnas.0611266104; Zhang Y, 2008, J COGNITIVE NEUROSCI, V20, P1915, DOI 10.1162/jocn.2008.20132	52	30	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101729	10.1371/journal.pone.0101729	http://dx.doi.org/10.1371/journal.pone.0101729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032963	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300025
J	Chiu, CY; Huang, YL; Tsai, MH; Tu, YL; Hua, MC; Yao, TC; Yeh, KW; Huang, JL				Chiu, Chih-Yung; Huang, Yu-Lin; Tsai, Ming-Han; Tu, Yu-Ling; Hua, Man-Chin; Yao, Tsung-Chieh; Yeh, Kuo-Wei; Huang, Jing-Long			Sensitization to Food and Inhalant Allergens in Relation to Atopic Diseases in Early Childhood: A Birth Cohort Study	PLOS ONE			English	Article							SERUM IGE LEVELS; ASTHMA; ASSOCIATION; PREVALENCE; DISORDERS; EXPOSURE; INFANT; RISK; SKIN	Objectives: A correct interpretation of sensitization to common allergens is critical in determining susceptibility to allergic diseases. The aim of this study was to investigate the patterns of sensitization to food and inhalant allergens, and their relation to the development of atopic diseases in early childhood. Methods: Children aged 0 through 4 years from a birth cohort in the Prediction of Allergies in Taiwanese Children (PATCH) study were enrolled. Specific IgE antibody against food and inhalant allergens were measured and their association between total serum IgE levels and atopic diseases were assessed. Results: A total of 182 children were regular followed up at clinics for a four-year follow-up period. The prevalence of food allergen sensitization increased markedly after 6 months of age, reaching up to 47% at 1.5 years of age and then declined significantly to 10% in parallel with a considerable increase in the prevalence of sensitization to inhalant allergens up to 25% at age 4. Food allergen sensitization appeared to be mainly associated with the elevation of serum total IgE levels before age 2. A combined sensitization to food and inhalant allergens had an additive effect on serum IgE levels after age 2, and was significantly associated with the risk of developing atopic diseases at age 4. Conclusions: Sensitization to food occurs early in life, in parallel with the rising prevalence of sensitization to inhalant allergens at older age. A combined sensitization to food and inhalant allergens not only has an additive increase in serum IgE antibody production but also increases the risk of developing allergic respiratory diseases in early childhood.	[Chiu, Chih-Yung; Tsai, Ming-Han; Hua, Man-Chin] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan; [Chiu, Chih-Yung; Huang, Yu-Lin; Tsai, Ming-Han; Tu, Yu-Ling; Hua, Man-Chin; Yao, Tsung-Chieh; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Chiu, Chih-Yung] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Div Pediat Pulmonol, Taoyuan, Taiwan; [Huang, Yu-Lin; Tu, Yu-Ling; Yao, Tsung-Chieh; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan; [Huang, Yu-Lin; Tu, Yu-Ling; Yao, Tsung-Chieh; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Yeh, KW (corresponding author), Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan.	kwyeh@adm.cgmh.org.tw; long@adm.cgmh.org.tw	Yeh, Kuo-Wei/V-3725-2019; Chiu, CY/Q-4238-2019	Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753	Chang Gung Medical foundation, Chang Gung University, Taiwan [CMRPG2B0050-52]	Chang Gung Medical foundation, Chang Gung University, Taiwan	This work was supported by CMRPG2B0050-52 from the Chang Gung Medical foundation, Chang Gung University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Ballardini N, 2006, ALLERGY, V61, P337, DOI 10.1111/j.1398-9995.2005.00936.x; Borish L, 2005, ANN ALLERG ASTHMA IM, V95, P247, DOI 10.1016/S1081-1206(10)61221-5; Bousquet J, 2002, ALLERGY, V57, P661, DOI 10.1034/j.1398-9995.2002.02002.x; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Busse W, 2005, CHEST, V127, P1312, DOI 10.1378/chest.127.4.1312; de Jong AB, 2011, PEDIAT ALLERG IMM-UK, V22, P166, DOI 10.1111/j.1399-3038.2010.00993.x; Downs SH, 2001, ARCH DIS CHILD, V84, P20, DOI 10.1136/adc.84.1.20; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Halvorsen R, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/460737; Hattevig G, 1993, Pediatr Allergy Immunol, V4, P182, DOI 10.1111/j.1399-3038.1993.tb00089.x; Hill DJ, 2008, CLIN EXP ALLERGY, V38, P161, DOI 10.1111/j.1365-2222.2007.02861.x; Host A, 2003, ALLERGY, V58, P559, DOI 10.1034/j.1398-9995.2003.00238.x; Kulig M, 1998, PEDIAT ALLERG IMM-UK, V9, P61, DOI 10.1111/j.1399-3038.1998.tb00305.x; Kulig M, 1999, J ALLERGY CLIN IMMUN, V103, P1173, DOI 10.1016/S0091-6749(99)70195-8; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Law M, 2005, BRIT MED J, V330, P1187, DOI 10.1136/bmj.38435.582975.AE; Lee AJ, 2013, ASIA PAC ALLERGY, V3, P3, DOI 10.5415/apallergy.2013.3.1.3; Leung R, 1997, J ALLERGY CLIN IMMUN, V99, P594, DOI 10.1016/S0091-6749(97)70018-6; Martinez FD, 2002, PEDIATRICS, V109, P362; Martorell Aragones A, 2001, Allergol Immunopathol (Madr), V29, P72; Moore MM, 2004, PEDIATRICS, V113, P468, DOI 10.1542/peds.113.3.468; Satwani Hema, 2009, JPMA Journal of the Pakistan Medical Association, V59, P698; SEYMOUR JL, 1987, J AM ACAD DERMATOL, V17, P988, DOI 10.1016/S0190-9622(87)70288-6; Sun BQ, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-2; Sunyer J, 1996, EUR RESPIR J, V9, P1880, DOI 10.1183/09031936.96.09091880; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979; Togias Alkis G., 2000, Journal of Allergy and Clinical Immunology, V106, pS247; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433; Vance GHS, 2005, CLIN EXP ALLERGY, V35, P1318, DOI 10.1111/j.1365-2222.2005.02346.x; Worth A, 2010, CURR OPIN ALLERGY CL, V10, P226, DOI 10.1097/ACI.0b013e3283387fae; Yong SB, 2013, J MICROBIOL IMMUNOL, V46, P295, DOI 10.1016/j.jmii.2012.07.002; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888	33	42	43	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102809	10.1371/journal.pone.0102809	http://dx.doi.org/10.1371/journal.pone.0102809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033453	Green Submitted, Green Published, gold			2022-12-25	WOS:000339418300094
J	Qie, LF; Jia, GQ; Zhang, WY; Schnable, J; Shang, ZL; Li, W; Liu, BH; Li, MZ; Chai, Y; Zhi, H; Diao, XM				Qie, Lufeng; Jia, Guanqing; Zhang, Wenying; Schnable, James; Shang, Zhonglin; Li, Wei; Liu, Binhui; Li, Mingzhe; Chai, Yang; Zhi, Hui; Diao, Xianmin			Mapping of Quantitative Trait Locus (QTLs) that Contribute to Germination and Early Seedling Drought Tolerance in the Interspecific Cross Setaria italicaxSetaria viridis	PLOS ONE			English	Article							FOXTAIL MILLET; COLEOPTILE LENGTH; TRANSGRESSIVE SEGREGATION; GENETIC-ANALYSIS; GRAIN-YIELD; ITALICA; STRESS; SEQUENCE; RESISTANCE; MARKERS	Drought tolerance is an important breeding target for enhancing the yields of grain crop species in arid and semi-arid regions of the world. Two species of Setaria, domesticated foxtail millet (S. italica) and its wild ancestor green foxtail (S. viridis) are becoming widely adopted as models for functional genomics studies in the Panicoid grasses. In this study, the genomic regions controlling germination and early seedling drought tolerance in Setaria were identified using 190 F-7 lines derived from a cross between Yugu1, a S. italica cultivar developed in China, and a wild S. viridis genotype collected from Uzbekistan. Quantitative trait loci were identified which contribute to a number of traits including promptness index, radical root length, coleoptile length and lateral root number at germinating stage and seedling survival rate was characterized by the ability of desiccated seedlings to revive after rehydration. A genetic map with 128 SSR markers which spans 1293.9 cM with an average of 14 markers per linkage group of the 9 linkage groups was constructed. A total of eighteen QTLs were detected which included nine that explained over 10% of the phenotypic variance for a given trait. Both the wild green foxtail genotype and the foxtail millet cultivar contributed the favorite alleles for traits detected in this trial, indicating that wild Setaria viridis populations may serve as a reservoir for novel stress tolerance alleles which could be employed in foxtail millet breeding.	[Qie, Lufeng; Jia, Guanqing; Schnable, James; Chai, Yang; Zhi, Hui; Diao, Xianmin] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Li, Wei; Diao, Xianmin] Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Shijiazhuang, Peoples R China; [Zhang, Wenying; Liu, Binhui; Li, Mingzhe] Hebei Acad Agr & Forestry Sci, Inst Dry Land Agr, Hengshui, Peoples R China; [Qie, Lufeng; Shang, Zhonglin; Diao, Xianmin] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Hebei Academy of Agricultural & Forestry Sciences; Hebei Academy of Agricultural & Forestry Sciences; Hebei Normal University	Zhi, H (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China.	diaoxianmin@caas.cn; zhihui@caas.cn		Schnable, James/0000-0001-6739-5527	Beijing Natural Science Foundation [6142019]; Fundamental Research Funds of ICS-CAAS [2013007]; Science and Technology Innovation Project of CAAS; National High Technology Research and Development Program of China (863 Program) [2013AA102603]; National Natural Science Foundation of China [31171560, 31301328, 31200910]; China Agricultural Research System [CARS07-12.5-A02]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fundamental Research Funds of ICS-CAAS; Science and Technology Innovation Project of CAAS; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agricultural Research System	This work was supported by Beijing Natural Science Foundation (6142019), Fundamental Research Funds of ICS-CAAS (Grant to Guanqing Jia, 2013007), Science and Technology Innovation Project of CAAS, National High Technology Research and Development Program of China (863 Program) (2013AA102603), the National Natural Science Foundation of China (31171560, 31301328, 31200910), and China Agricultural Research System (CARS07-12.5-A02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluko G, 2004, THEOR APPL GENET, V109, P630, DOI 10.1007/s00122-004-1668-y; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bell MA, 2005, TRENDS ECOL EVOL, V20, P358, DOI 10.1016/j.tree.2005.04.021; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bidinger FR, 2007, CROP SCI, V47, P969, DOI 10.2135/cropsci2006.07.0465; BLUM A, 1980, EUPHYTICA, V29, P727, DOI 10.1007/BF00023219; BOUSLAMA M, 1984, CROP SCI, V24, P933, DOI 10.2135/cropsci1984.0011183X002400050026x; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Chen GX, 2010, GENET RESOUR CROP EV, V57, P85, DOI 10.1007/s10722-009-9453-z; DEVICENTE MC, 1993, GENETICS, V134, P585; Devos KM, 1998, THEOR APPL GENET, V96, P63, DOI 10.1007/s001220050709; Dhanda SS, 2004, J AGRON CROP SCI, V190, P6, DOI 10.1111/j.1439-037X.2004.00592.x; Dias PMB, 2011, THEOR APPL GENET, V122, P429, DOI 10.1007/s00122-010-1458-7; Doust AN, 2004, P NATL ACAD SCI USA, V101, P9045, DOI 10.1073/pnas.0402892101; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Fleury D, 2010, J EXP BOT, V61, P3211, DOI 10.1093/jxb/erq152; Foolad MR, 2003, GENOME, V46, P536, DOI [10.1139/g03-035, 10.1139/G03-035]; Grando S, 1995, EUPHYTICA, V86, P73, DOI 10.1007/BF00035941; Gu S., 1987, FOXTAIL MILLET CULTI, P63; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Hu SP, 2007, RICE SCI, V14, P13, DOI 10.1016/S1672-6308(07)60003-1; Jia XP, 2009, THEOR APPL GENET, V118, P821, DOI 10.1007/s00122-008-0942-9; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Li YM, 1997, FOXTAIL MILLET BREED, P421; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Mauro-Herrera M, 2013, G3-GENES GENOM GENET, V3, P283, DOI 10.1534/g3.112.005207; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; Mir RR, 2012, THEOR APPL GENET, V125, P625, DOI 10.1007/s00122-012-1904-9; Monteros MJ, 2006, 11 BIENN C MOL CELL; Qi X, 2013, PLANT MOL BIOL, V83, P459, DOI 10.1007/s11103-013-0104-6; Rebetzke GJ, 2007, FIELD CROP RES, V100, P10, DOI 10.1016/j.fcr.2006.05.001; RICHARDS RA, 1979, EUPHYTICA, V28, P755, DOI 10.1007/BF00038945; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Salekdeh GH, 2009, TRENDS PLANT SCI, V14, P488, DOI 10.1016/j.tplants.2009.07.007; Sanchez AC, 2002, PLANT MOL BIOL, V48, P713, DOI 10.1023/A:1014894130270; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Venuprasad R, 2009, THEOR APPL GENET, V120, P177, DOI 10.1007/s00122-009-1168-1; Wang JK, 2009, THEOR APPL GENET, V119, P65, DOI 10.1007/s00122-009-1017-2; Wang S, 2012, WINDOWS QTL CARTOGRA; Wang ZM, 1998, THEOR APPL GENET, V96, P31, DOI 10.1007/s001220050705; Xiong LM, 2006, PLANT PHYSIOL, V142, P1065, DOI 10.1104/pp.106.084632; Xu Y, 1997, MOL GEN GENET, V253, P535, DOI 10.1007/s004380050355; Yi F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-212; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang JP, 2007, GENOMICS, V90, P121, DOI 10.1016/j.ygeno.2007.03.016; Zhang S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-78; [朱学海 ZHU Xuehai], 2008, [植物遗传资源学报, Journal of Plant Genetic Resources], V9, P62	56	38	44	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101868	10.1371/journal.pone.0101868	http://dx.doi.org/10.1371/journal.pone.0101868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033201	gold, Green Submitted, Green Published			2022-12-25	WOS:000339418300027
J	Talebpour, A; Maaskant, R; Khine, AA; Alavie, T				Talebpour, Abdossamad; Maaskant, Robert; Khine, Aye Aye; Alavie, Tino			Use of Surface Enhanced Blocking (SEB) Electrodes for Microbial Cell Lysis in Flow-Through Devices	PLOS ONE			English	Article							ESCHERICHIA-COLI; ELECTRICAL LYSIS; INACTIVATION	By simultaneously subjecting microbial cells to high amplitude pulsed electric fields and flash heating of the cell suspension fluid, effective release of intracellular contents was achieved. The synergistic effect of the applied electric field and elevated temperature on cell lysis in a flow-through device was demonstrated for Gram-negative and Gram-positive bacteria, and Mycobacterium species. The resulting lysate is suitable for downstream nucleic acid amplification and detection without requiring further preparation. The lysis chamber employs surface enhanced blocking electrodes which possess an etched micro-structured surface and a thin layer of dielectric metal oxide which provides a large effective area and blocks transmission of electrical current. The surface enhanced blocking electrodes enable simultaneous suppression of the rapid onset of electric field screening in the bulk of the cell suspension medium and avoidance of undesired electrochemical processes at the electrode-electrolyte interface. In addition the blocking layer ensures the robustness of the cell lysis device in applications involving prolonged flow-through processing of the microbial cells.	[Talebpour, Abdossamad; Maaskant, Robert; Khine, Aye Aye; Alavie, Tino] Qvella Inc, Richmond Hill, ON, Canada		Talebpour, A (corresponding author), Qvella Inc, Richmond Hill, ON, Canada.	samadt@qvella.com						Aronsson K, 2005, INT J FOOD MICROBIOL, V99, P19, DOI 10.1016/j.ijfoodmicro.2004.07.012; Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII; Bazant MZ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.021506; Beunis F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011502; Borukhov I, 1997, PHYS REV LETT, V79, P435, DOI 10.1103/PhysRevLett.79.435; Chazalviel JN, 1999, COULOMB SCREENING MO, P72; Cheng J, 1998, NAT BIOTECHNOL, V16, P541, DOI 10.1038/nbt0698-541; de la Rosa C, 2008, IEEE T BIO-MED ENG, V55, P2426, DOI 10.1109/TBME.2008.923148; DYER CK, 1978, ELECTROCHIM ACTA, V23, P347, DOI 10.1016/0013-4686(78)80073-5; Elias E, 2007, HEAT MASS TRANSFER, V43, P957, DOI 10.1007/s00231-006-0167-x; Geng T, 2013, LAB CHIP, V13, P3803, DOI 10.1039/c3lc50566a; Han ZJ, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3077605; HULSHEGER H, 1983, RADIAT ENVIRON BIOPH, V22, P149, DOI 10.1007/BF01338893; Kanzaki N, 1981, U.S. Patent, Patent No. [4,276,129, 4276129]; Kilic MS, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021502; Lee SW, 1999, SENSOR ACTUAT A-PHYS, V73, P74, DOI 10.1016/S0924-4247(98)00257-X; McCleskey RB, 2011, J CHEM ENG DATA, V56, P317, DOI 10.1021/je101012n; Mitchell GJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0892; Morshed Bashir I., 2013, Critical Reviews in Biomedical Engineering, V41, P37; Packard MM, 2013, DIAGNOSTICS, V3, P105, DOI 10.3390/diagnostics3010105; Pavlin M, 2010, ADV PLANAR LIPID BIL, V6, P165; Persat A, 2009, LAB CHIP, V9, P2454, DOI 10.1039/b906468k; Sakaguchi H, 2010, PHYS REV E, V75; SARANG PG, 1986, J PHYS E SCI INSTRUM, V19, P1063, DOI 10.1088/0022-3735/19/12/018; Wang HY, 2006, BIOSENS BIOELECTRON, V22, P582, DOI 10.1016/j.bios.2006.01.032; Wu J, 2008, IET NANOBIOTECHNOL, V2, P14, DOI 10.1049/iet-nbt:20070023; ZEKOVIC LD, 1983, THIN SOLID FILMS, V109, P217, DOI 10.1016/0040-6090(83)90111-6; Zhong K, 2005, J FOOD PROCESS ENG, V28, P595, DOI 10.1111/j.1745-4530.2005.00041.x	28	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102707	10.1371/journal.pone.0102707	http://dx.doi.org/10.1371/journal.pone.0102707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033080	gold, Green Submitted, Green Published			2022-12-25	WOS:000339418300082
J	Ziegler, YS; Moresco, JJ; Tu, PG; Yates, JR; Nardulli, AM				Ziegler, Yvonne S.; Moresco, James J.; Tu, Patricia G.; Yates, John R., III; Nardulli, Ann M.			Plasma Membrane Proteomics of Human Breast Cancer Cell Lines Identifies Potential Targets for Breast Cancer Diagnosis and Treatment	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BETA-TUBULIN EXPRESSION; GENE-EXPRESSION; PROSTATE-CANCER; ADHESION MOLECULE; POOR-PROGNOSIS; OVARIAN-CANCER; TUMOR-CELLS; MYOSIN-II; RECEPTOR	The use of broad spectrum chemotherapeutic agents to treat breast cancer results in substantial and debilitating side effects, necessitating the development of targeted therapies to limit tumor proliferation and prevent metastasis. In recent years, the list of approved targeted therapies has expanded, and it includes both monoclonal antibodies and small molecule inhibitors that interfere with key proteins involved in the uncontrolled growth and migration of cancer cells. The targeting of plasma membrane proteins has been most successful to date, and this is reflected in the large representation of these proteins as targets of newer therapies. In view of these facts, experiments were designed to investigate the plasma membrane proteome of a variety of human breast cancer cell lines representing hormone-responsive, ErbB2 over-expressing and triple negative cell types, as well as a benign control. Plasma membranes were isolated by using an aqueous two-phase system, and the resulting proteins were subjected to mass spectrometry analysis. Overall, each of the cell lines expressed some unique proteins, and a number of proteins were expressed in multiple cell lines, but in patterns that did not always follow traditional clinical definitions of breast cancer type. From our data, it can be deduced that most cancer cells possess multiple strategies to promote uncontrolled growth, reflected in aberrant expression of tyrosine kinases, cellular adhesion molecules, and structural proteins. Our data set provides a very rich and complex picture of plasma membrane proteins present on breast cancer cells, and the sorting and categorizing of this data provides interesting insights into the biology, classification, and potential treatment of this prevalent and debilitating disease.	[Ziegler, Yvonne S.; Nardulli, Ann M.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Moresco, James J.; Tu, Patricia G.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of Illinois System; University of Illinois Urbana-Champaign; Scripps Research Institute	Nardulli, AM (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	anardull@life.illinois.edu		Moresco, James/0000-0003-1178-1642	National Institutes of Health [R01 DK053884]; National Institute of General Medical Sciences [8 P41 GM103533]; National Institute on Aging [R01AG027463]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	YSZ and AMN were supported by the National Institutes of Health (R01 DK053884 to AMN, www.nih.gov). PGT, JJM, and JRY were supported by the National Institute of General Medical Sciences (8 P41 GM103533 to JRY, www.nigms.nih.gov). JJM and JRY were supported by the National Institute on Aging (R01AG027463 to JRY, www.nia.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2013, J NUCL MED, V54, P913, DOI 10.2967/jnumed.112.111534; Alshareeda AT, 2013, BREAST CANCER RES TR, V139, P23, DOI 10.1007/s10549-013-2518-x; Aptsiauri N, 2013, SPRINGER BRIEFS CANC, V6, P13; Arjonen A, 2014, J CLIN INVE IN PRESS; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Boichuk S, 2014, CANCER RES, V74, P1200, DOI 10.1158/0008-5472.CAN-13-1955; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Carvalho PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-316; Carvalho PC, 2010, ANONYMOUS CURRENT PR; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Chettouh H, 2013, CANCER RES, V73, P3974, DOI 10.1158/0008-5472.CAN-12-3824; Cho SH, 2012, INT J ONCOL, V41, P211, DOI 10.3892/ijo.2012.1453; Christiansen DH, 2005, LEUKEMIA, V19, P2232, DOI 10.1038/sj.leu.2404009; Clucas J, 2014, J CELL SCI, V127, P267, DOI 10.1242/jcs.133108; Cooper ZA, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24320; Daaka Y., 2004, SCI STKE, V2004, pre2, DOI [10.1126/stke.2162004re2, DOI 10.1126/STKE.2162004RE2]; de Groote ML, 2014, INT J CANCER, V134, P280, DOI 10.1002/ijc.28375; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Drews-Elger K, 2014, BREAST CANCER RES TR, V144, P503, DOI 10.1007/s10549-014-2887-9; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Fujihara Tomofumi, 1999, Gastric Cancer, V2, P221, DOI 10.1007/s101200050067; Giarnieri E, 2005, ANTICANCER RES, V25, P3237; Gonzalez L, 2012, ANN DIAGN PATHOL, V16, P260, DOI 10.1016/j.anndiagpath.2011.11.004; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; Haeuw JF, 2011, BIOCHEM SOC T, V39, P553, DOI 10.1042/BST0390553; Hai J, 2012, CLIN CANCER RES, V18, P1914, DOI 10.1158/1078-0432.CCR-11-2893; Heideman MR, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3564; Hsu KS, 2013, VITAM HORM, V93, P323, DOI 10.1016/B978-0-12-416673-8.00005-8; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Hwang JR, 2012, CARCINOGENESIS, V33, P77, DOI 10.1093/carcin/bgr257; Imbert AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043752; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Jensen M, 2007, CANCER LETT, V258, P9, DOI 10.1016/j.canlet.2007.09.004; Kaneko K, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-454; Kischel P, 2012, ANTICANCER RES, V32, P5211; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Kohmo S, 2010, CANCER RES, V70, P8025, DOI 10.1158/0008-5472.CAN-10-0996; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lennartsson J, 2006, CURR CANCER DRUG TAR, V6, P65, DOI 10.2174/156800906775471725; Levallet G, 2012, MOL CANCER THER, V11, P1203, DOI 10.1158/1535-7163.MCT-11-0899; Li DQ, 2006, PROTEOMICS, V6, P3352, DOI 10.1002/pmic.200500617; Li R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039766; Lili LN, 2014, PANCREAS, V43, P198, DOI 10.1097/MPA.0000000000000020; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039989; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu ZF, 2008, DRUG DEVELOP RES, V69, P329, DOI 10.1002/ddr.20265; Liu Z, 2014, INT J MOL MED, V33, P589, DOI 10.3892/ijmm.2013.1598; Malaguarnera Roberta, 2011, Front Endocrinol (Lausanne), V2, P93, DOI 10.3389/fendo.2011.00093; Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Meyer AS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004155; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Morre DM, 2000, J CHROMATOGR B, V743, P377, DOI 10.1016/S0378-4347(00)00058-X; Muller-Tidow C, 2005, CANCER RES, V65, P1778, DOI 10.1158/0008-5472.CAN-04-3388; Murayama Y, 2008, J CELL PHYSIOL, V216, P135, DOI 10.1002/jcp.21384; Nakopoulou L, 2002, HISTOPATHOLOGY, V40, P536, DOI 10.1046/j.1365-2559.2002.01392.x; Nallapalli RK, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-50; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Ou YQ, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.06.017; Park SJ, 2013, CELL SIGNAL, V25, P2147, DOI 10.1016/j.cellsig.2013.07.001; Pillai SKK, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-18; Rangel LBA, 2004, CANCER BIOL THER, V3, P1021, DOI 10.4161/cbt.3.10.1142; Raymond JR, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-6; Roland CL, 2007, SURGERY, V141, P705, DOI 10.1016/j.surg.2007.01.016; Ross DT, 2001, DIS MARKERS, V17, P99, DOI 10.1155/2001/850531; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; Saifo MS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-310; Samuel J, 2014, NEW ENGL J MED, V370, P286, DOI 10.1056/NEJMc1310849; Sandberg R, 2005, P NATL ACAD SCI USA, V102, P2052, DOI 10.1073/pnas.0408105102; Schindler J, 2006, MOL CELL PROTEOMICS, V5, P390, DOI 10.1074/mcp.T500017-MCP200; Schneider SA, 2013, MOD PATHOL IN PRESS; Schroder C, 2011, J CANCER RES CLIN, V137, P1193, DOI 10.1007/s00432-011-0984-2; Schulz WA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-505; Seve P, 2005, MOL CANCER THER, V4, P2001, DOI 10.1158/1535-7163.MCT-05-0244; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siu IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078895; Smith DC, 2013, J CLIN ONCOL, V31, P412, DOI 10.1200/JCO.2012.45.0494; Stevenson RP, 2012, J CELL SCI, V125, P1073, DOI 10.1242/jcs.093799; Suizu F, 2000, J BIOCHEM-TOKYO, V128, P435, DOI 10.1093/oxfordjournals.jbchem.a022771; Tsang Stella W Y, 2003, Methods Mol Biol, V227, P351, DOI 10.1385/1-59259-387-9:351; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Veitonmaki N, 2013, CANCER CELL, V23, P502, DOI 10.1016/j.ccr.2013.02.026; Volakis LI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086110; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; Ward Y, 2013, ONCOGENE, V32, P2726, DOI 10.1038/onc.2012.301; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wazir U, 2013, CANCER GENOM PROTEOM, V10, P69; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wobus M, 2006, MOL CARCINOGEN, V45, P881, DOI 10.1002/mc.20262; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Woolner S, 2009, TRENDS CELL BIOL, V19, P245, DOI 10.1016/j.tcb.2009.03.003; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065463; Yao Jian, 2012, Cancer Biology Medicine, V9, P234, DOI 10.7497/j.issn.2095-3941.2012.04.003; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711; Yu JW, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/210205; Yue JY, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-7; Zabouo G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2215; Zeimet AG, 2013, JNCI-J NATL CANCER I, V105, P1142, DOI 10.1093/jnci/djt144	110	32	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102341	10.1371/journal.pone.0102341	http://dx.doi.org/10.1371/journal.pone.0102341			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029196	Green Submitted, Green Published, gold			2022-12-25	WOS:000341306600067
J	Ilgen, P; Stoldt, S; Conradi, LC; Wurm, CA; Ruschoff, J; Ghadimi, BM; Liersch, T; Jakobs, S				Ilgen, Peter; Stoldt, Stefan; Conradi, Lena-Christin; Wurm, Christian Andreas; Rueschoff, Josef; Ghadimi, B. Michael; Liersch, Torsten; Jakobs, Stefan			STED Super-Resolution Microscopy of Clinical Paraffin-Embedded Human Rectal Cancer Tissue	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; STIMULATED-EMISSION; BRAIN-SLICES; RESOLUTION; NANOSCOPY; IMMUNOFLUORESCENCE; SYNAPSES; REVEALS	Formalin fixed and paraffin-embedded human tissue resected during cancer surgery is indispensable for diagnostic and therapeutic purposes and represents a vast and largely unexploited resource for research. Optical microscopy of such specimen is curtailed by the diffraction-limited resolution of conventional optical microscopy. To overcome this limitation, we used STED super-resolution microscopy enabling optical resolution well below the diffraction barrier. We visualized nanoscale protein distributions in sections of well-annotated paraffin-embedded human rectal cancer tissue stored in a clinical repository. Using antisera against several mitochondrial proteins, STED microscopy revealed distinct sub-mitochondrial protein distributions, suggesting a high level of structural preservation. Analysis of human tissues stored for up to 17 years demonstrated that these samples were still amenable for super-resolution microscopy. STED microscopy of sections of HER2 positive rectal adenocarcinoma revealed details in the surface and intracellular HER2 distribution that were blurred in the corresponding conventional images, demonstrating the potential of super-resolution microscopy to explore the thus far largely untapped nanoscale regime in tissues stored in biorepositories.	[Ilgen, Peter; Stoldt, Stefan; Wurm, Christian Andreas; Jakobs, Stefan] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Conradi, Lena-Christin; Ghadimi, B. Michael; Liersch, Torsten] Univ Med Ctr Gottingen, Dept Gen Visceral & Pediat Surg, Gottingen, Germany; [Rueschoff, Josef] Inst Pathol Nordhessen, Kassel, Germany; [Rueschoff, Josef] Univ Med Ctr Gottingen, Dept Pathol, Gottingen, Germany; [Jakobs, Stefan] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Jakobs, Stefan] Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen	Liersch, T (corresponding author), Univ Med Ctr Gottingen, Dept Gen Visceral & Pediat Surg, Gottingen, Germany.	tliersc@gwdg.de; sjakobs@gwdg.de	Jakobs, Stefan/F-4898-2012	Jakobs, Stefan/0000-0002-8028-3121	Deutsche Forschungsgemeinschaft through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain"; EU project IMAGINT [Health-F5-2011-259881];  [KFO179]	Deutsche Forschungsgemeinschaft through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain"; EU project IMAGINT; 	Part of the work was supported by the Deutsche Forschungsgemeinschaft through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain" and the EU project IMAGINT (Health-F5-2011-259881) (both to SJ) as well as through the KFO179 "Biological Basis of Individual Tumor Response in Patients with Rectal Cancer." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2012, NATURE, V486, P141, DOI 10.1038/486141a; Berning S, 2012, SCIENCE, V335, P551, DOI 10.1126/science.1215369; Chmyrov A, 2013, NAT METHODS, V10, P737, DOI 10.1038/nmeth.2556; Conradi LC, 2013, AM J SURG PATHOL, V37, P522, DOI 10.1097/PAS.0b013e318272ff4d; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; Eiseman E., 1999, HDB HUMAN TISSUE SOU; Glynne-Jones R, 2013, J GASTROINTEST ONCOL, V4, P264, DOI 10.3978/j.issn.2078-6891.2013.037; Harke B, 2008, OPT EXPRESS, V16, P4154, DOI 10.1364/OE.16.004154; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hewitt RE, 2011, CURR OPIN ONCOL, V23, P112, DOI 10.1097/CCO.0b013e32834161b8; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Jakobs S, 2014, CURR OPIN CHEM BIOL, V20, P9, DOI 10.1016/j.cbpa.2014.03.019; Jans DC, 2013, P NATL ACAD SCI USA, V110, P8936, DOI 10.1073/pnas.1301820110; Kempf C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062893; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Kolmakov K, 2010, CHEM-EUR J, V16, P158, DOI 10.1002/chem.200902309; Nanguneri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038098; Punge A, 2008, MICROSC RES TECHNIQ, V71, P644, DOI 10.1002/jemt.20602; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Rodel C, 2012, LANCET ONCOL, V13, P679, DOI 10.1016/S1470-2045(12)70187-0; Rodel C, 2012, CURR OPIN ONCOL, V24, P441, DOI 10.1097/CCO.0b013e328352ea02; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Sergina NV, 2007, TRENDS MOL MED, V13, P527, DOI 10.1016/j.molmed.2007.10.002; Shi SR, 2011, J HISTOCHEM CYTOCHEM, V59, P13, DOI 10.1369/jhc.2010.957191; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Toomre D, 2010, ANNU REV CELL DEV BI, V26, P285, DOI 10.1146/annurev-cellbio-100109-104048; Urban NT, 2011, BIOPHYS J, V101, P1277, DOI 10.1016/j.bpj.2011.07.027; Viegas MS, 2007, EUR J HISTOCHEM, V51, P59; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; Wurm CA, 2011, P NATL ACAD SCI USA, V108, P13546, DOI 10.1073/pnas.1107553108; Yang B., 2013, ARXIV13073833PHYSICS	34	23	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101563	10.1371/journal.pone.0101563	http://dx.doi.org/10.1371/journal.pone.0101563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025184	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400018
J	Poirier, AC; Schmitt, P; Rosa, RD; Vanhove, AS; Kieffer-Jaquinod, S; Rubio, TP; Charriere, GM; Destoumieux-Garzon, D				Poirier, Aurore C.; Schmitt, Paulina; Rosa, Rafael D.; Vanhove, Audrey S.; Kieffer-Jaquinod, Sylvie; Rubio, Tristan P.; Charriere, Guillaume M.; Destoumieux-Garzon, Delphine			Antimicrobial Histones and DNA Traps in Invertebrate Immunity EVIDENCES IN CRASSOSTREA GIGAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; INNATE IMMUNITY; PACIFIC OYSTER; INFECTION; HEMOCYTES; DEFENSE; BACTERIA; CAPTURE; SHRIMP; NETS	Although antimicrobial histones have been isolated from multiple metazoan species, their role in host defense has long remained unanswered. We found here that the hemocytes of the oyster Crassostrea gigas release antimicrobial H1-like and H5-like histones in response to tissue damage and infection. These antimicrobial histones were shown to be associated with extracellular DNA networks released by hemocytes, the circulating immune cells of invertebrates, in response to immune challenge. The hemocyte-released DNA was found to surround and entangle vibrios. This defense mechanism is reminiscent of the neutrophil extracellular traps (ETs) recently described in vertebrates. Importantly, oyster ETs were evidenced in vivo in hemocyte-infiltrated interstitial tissues surrounding wounds, whereas they were absent from tissues of unchallenged oysters. Consistently, antimicrobial histones were found to accumulate in oyster tissues following injury or infection with vibrios. Finally, oyster ET formation was highly dependent on the production of reactive oxygen species by hemocytes. This shows that ET formation relies on common cellular and molecular mechanisms from vertebrates to invertebrates. Altogether, our data reveal that ET formation is a defense mechanism triggered by infection and tissue damage, which is shared by relatively distant species suggesting either evolutionary conservation or convergent evolution within Bilateria.	[Rubio, Tristan P.; Charriere, Guillaume M.; Destoumieux-Garzon, Delphine] Univ Montpellier I, Univ Montpellier 2, IFREMER, Lab Ecol Coastal Marine Syst,CNRS UMR 5119, F-34095 Montpellier, France; [Rubio, Tristan P.; Charriere, Guillaume M.; Destoumieux-Garzon, Delphine] IRD, F-34095 Montpellier, France; [Schmitt, Paulina] Pontificia Univ Catolica Valparaiso, Inst Biol, Lab Genet & Inmunol Mol, Valparaiso 2373223, Chile; [Kieffer-Jaquinod, Sylvie] Univ Grenoble 1, CEA, INSERM, U1038,Etud Dynam Proteomes,Lab Biol Grande Echell, F-38054 Grenoble 9, France	Ifremer; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Pontificia Universidad Catolica de Valparaiso; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Charriere, GM (corresponding author), Univ Montpellier 2, Lab ECOSYM, Equipe Reponse Immunitaire Macroorganismes Marins, CC80,Pl Eugene Bataillon, F-34095 Montpellier, France.	guillaume.charriere@univ-montp2.fr	Destoumieux-Garzón, Delphine/O-3328-2014; Rosa, Rafael Diego/L-6944-2019; Poirier, Aurore C./AAB-6795-2019; Charriere, Guillaume/Z-1574-2019; Rubio, Tristan/O-6022-2014; Charriere, Guillaume M/O-8317-2014	Destoumieux-Garzón, Delphine/0000-0002-8793-9138; Rosa, Rafael Diego/0000-0002-4076-3163; Poirier, Aurore C./0000-0002-9041-7605; Charriere, Guillaume/0000-0002-4796-1488; Charriere, Guillaume M/0000-0002-4796-1488; Rubio, Tristan/0000-0002-9751-6913; Vanhove, Audrey/0000-0003-2203-8512; kieffer-jaquinod, Sylvie/0000-0003-1281-758X	Agence Nationale de la Recherche (ANR) (Vibriogen project) [Blanc SVSE7 2011]; Languedoc-Roussillon region (REVARESP project, Chercheur(se) d'avenir); Ministry of Higher Education and Research; Ifremer	Agence Nationale de la Recherche (ANR) (Vibriogen project)(French National Research Agency (ANR)); Languedoc-Roussillon region (REVARESP project, Chercheur(se) d'avenir)(Region Occitanie); Ministry of Higher Education and Research(Ministry of Higher Education & Scientific Research (MHESR)); Ifremer	This work was supported by grants from the Agence Nationale de la Recherche (ANR) (Vibriogen project, Blanc SVSE7 2011) and the Languedoc-Roussillon region (REVARESP project, Chercheur(se) d'avenir 2009).; Supported by a fellowship from the Ministry of Higher Education and Research.; Supported by a fellowship from Ifremer.	Altincicek B, 2008, J IMMUNOL, V181, P2705, DOI 10.4049/jimmunol.181.4.2705; Bachere E, 2004, IMMUNOL REV, V198, P149, DOI 10.1111/j.0105-2896.2004.00115.x; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Brinkmann V, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00413; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; De Zoysa M, 2009, FISH SHELLFISH IMMUN, V27, P639, DOI 10.1016/j.fsi.2009.08.007; Donaghy L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046594; Dorrington T, 2011, FISH SHELLFISH IMMUN, V30, P94, DOI 10.1016/j.fsi.2010.09.006; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gay M, 2004, DIS AQUAT ORGAN, V62, P65, DOI 10.3354/dao062065; Guimaraes-Costa Anderson B, 2012, J Parasitol Res, V2012, P929743, DOI 10.1155/2012/929743; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; Kawasaki H., 2008, Infectious Disorders - Drug Targets, V8, P195; Li CH, 2007, FISH SHELLFISH IMMUN, V22, P663, DOI 10.1016/j.fsi.2006.08.013; Li J, 2013, FISH SHELLFISH IMMUN, V35, P63, DOI 10.1016/j.fsi.2013.04.001; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Miller BF, 1942, SCIENCE, V96, P428, DOI 10.1126/science.96.2497.428; Palic D, 2007, DEV COMP IMMUNOL, V31, P805, DOI 10.1016/j.dci.2006.11.010; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Parseghian MH, 2006, BIOCHEM CELL BIOL, V84, P589, DOI 10.1139/O06-082; Patat SA, 2004, EUR J BIOCHEM, V271, P4825, DOI 10.1111/j.1432-1033.2004.04448.x; Ramos-Kichik V, 2009, TUBERCULOSIS, V89, P29, DOI 10.1016/j.tube.2008.09.009; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Sawabe T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00414; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmitt P, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00160; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Seo JK, 2011, COMP BIOCHEM PHYS B, V158, P223, DOI 10.1016/j.cbpb.2010.11.011; Tadie JM, 2013, AM J PHYSIOL-LUNG C, V304, pL342, DOI 10.1152/ajplung.00151.2012; Ng TH, 2013, DEV COMP IMMUNOL, V41, P644, DOI 10.1016/j.dci.2013.06.014; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847	37	66	68	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24821	24831		10.1074/jbc.M114.576546	http://dx.doi.org/10.1074/jbc.M114.576546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25037219	Green Published, hybrid			2022-12-25	WOS:000341985300009
J	Allison, SE; Tuinema, BR; Everson, ES; Sugiman-Marangos, S; Zhang, K; Junop, MS; Coombes, BK				Allison, Sarah E.; Tuinema, Brian R.; Everson, Ellen S.; Sugiman-Marangos, Seiji; Zhang, Kun; Junop, Murray S.; Coombes, Brian K.			Identification of the Docking Site between a Type III Secretion System ATPase and a Chaperone for Effector Cargo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; Chaperone; Crystal Structure; Microbiology; Type III Secretion System (T3SS)	SALMONELLA PATHOGENICITY ISLAND-2; ENTERICA SEROVAR TYPHIMURIUM; PROTON MOTIVE FORCE; PROTEIN TRANSLOCASE; VIRULENCE GENES; FLII ATPASE; HOST; APPARATUS; SSEA; ACTIVATION	Background: Chaperones engage type III secretion system (T3SS) ATPases to facilitate effector secretion. Results: The molecular basis of the chaperone-T3SS ATPase interaction interface was elucidated. Conclusion: The C-terminal region of T3SS ATPases mediates binding with multiple contact points along the chaperone. Significance: The chaperone-T3SS ATPase interaction is important for Salmonella pathogenesis and may be a target for anti-virulence drugs. A number of Gram-negative pathogens utilize type III secretion systems (T3SSs) to inject bacterial effector proteins into the host. An important component of T3SSs is a conserved ATPase that captures chaperone-effector complexes and energizes their dissociation to facilitate effector translocation. To date, there has been limited work characterizing the chaperone-T3SS ATPase interaction despite it being a fundamental aspect of T3SS function. In this study, we present the 2.1 resolution crystal structure of the Salmonella enterica SPI-2-encoded ATPase, SsaN. Our structure revealed a local and functionally important novel feature in helix 10 that we used to define the interaction domain relevant to chaperone binding. We modeled the interaction between the multicargo chaperone, SrcA, and SsaN and validated this model using mutagenesis to identify the residues on both the chaperone and ATPase that mediate the interaction. Finally, we quantified the benefit of this molecular interaction on bacterial fitness in vivo using chromosomal exchange of wild-type ssaN with mutants that retain ATPase activity but no longer capture the chaperone. Our findings provide insight into chaperone recognition by T3SS ATPases and demonstrate the importance of the chaperone-T3SS ATPase interaction for the pathogenesis of Salmonella.	[Allison, Sarah E.; Tuinema, Brian R.; Everson, Ellen S.; Sugiman-Marangos, Seiji; Zhang, Kun; Junop, Murray S.; Coombes, Brian K.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Allison, Sarah E.; Tuinema, Brian R.; Everson, Ellen S.; Sugiman-Marangos, Seiji; Zhang, Kun; Junop, Murray S.; Coombes, Brian K.] Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada	McMaster University; McMaster University	Coombes, BK (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1280 Main St W,Hlth Sci Ctr Rm 4H17, Hamilton, ON L8S 4K1, Canada.	coombes@mcmaster.ca	Junop, Murray S/E-4160-2015	Junop, Murray S/0000-0001-6676-5717; Coombes, Brian/0000-0001-9883-1010; Sugiman-Marangos, Seiji/0000-0002-8475-5456	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research Grant [MOP 82704]; Canada Foundation for Innovation; Canada Research Chair; Canada Graduate Scholarship from the Canadian Institutes of Health Research; Ontario Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canada Graduate Scholarship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research Grant MOP 82704, the Canada Foundation for Innovation, and a Canada Research Chair (to B. K. C.).; Recipient of a Canada Graduate Scholarship from the Canadian Institutes of Health Research.; Recipient of an Ontario Graduate Scholarship.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Auvray F, 2002, J MOL BIOL, V318, P941, DOI 10.1016/S0022-2836(02)00172-9; Baison-Olmo F, 2012, BIOCHEM BIOPH RES CO, V423, P240, DOI 10.1016/j.bbrc.2012.05.095; Bozue J, 2012, FEMS MICROBIOL LETT, V332, P113, DOI 10.1111/j.1574-6968.2012.02583.x; Chen L, 2013, MANAGE COMMUN Q, V27, P3, DOI 10.1177/0893318913475485; Claret L, 2003, MOL MICROBIOL, V48, P1349, DOI 10.1046/j.1365-2958.2003.03506.x; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Coombes BK, 2003, MICROBES INFECT, V5, P561, DOI 10.1016/S1286-4579(03)00094-7; Cooper CA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-221; Cooper CA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000751; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dai SP, 2004, J BACTERIOL, V186, P5078, DOI 10.1128/jb.186.15.5078-5086.2004; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Darwin KH, 2001, J BACTERIOL, V183, P1452, DOI 10.1128/JB.183.4.1452-1454.2001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galan JE, 1996, MOL MICROBIOL, V20, P263, DOI 10.1111/j.1365-2958.1996.tb02615.x; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Ibuki T, 2011, NAT STRUCT MOL BIOL, V18, P277, DOI 10.1038/nsmb.1977; Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Miki T, 2009, J BACTERIOL, V191, P6843, DOI 10.1128/JB.00863-09; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011; Muller SA, 2006, MOL MICROBIOL, V61, P119, DOI 10.1111/j.1365-2958.2006.05219.x; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200; Ruiz-Albert J, 2003, MICROBIOL-SGM, V149, P1103, DOI 10.1099/mic.0.26190-0; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Stone CB, 2008, J BACTERIOL, V190, P6580, DOI 10.1128/JB.00761-08; Stone CB, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00021; Swietnicki W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019716; Thomas NA, 2005, MOL MICROBIOL, V57, P1762, DOI 10.1111/j.1365-2958.2005.04802.x; Tucker SC, 2000, J BACTERIOL, V182, P2262, DOI 10.1128/JB.182.8.2262-2268.2000; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994; Yoshida Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094347; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196; Zurawski DV, 2003, MOL MICROBIOL, V47, P1341, DOI 10.1046/j.1365-2958.2003.03373.x	54	27	27	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23734	23744		10.1074/jbc.M114.578476	http://dx.doi.org/10.1074/jbc.M114.578476			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25035427	Green Published, hybrid			2022-12-25	WOS:000341505000041
J	Kwon, YD; Yoon, SS; Chang, H				Kwon, Young Dae; Yoon, Sung Sang; Chang, Hyejung			High Total Hospitalization Cost but Low Cost of Imaging Studies in Recurrent Acute Ischemic Stroke Patients	PLOS ONE			English	Article							CEREBRAL INFARCTION; COMMUNITY; EPIDEMIOLOGY; PREDICTORS; LENGTH; STAY; RISK	Background: Due to the high risk and severity of recurrence after stroke attack, recurrence is a major reason contributing to the disease burden. This study aims to determine whether recurrence is a significant contributor of hospitalization cost in items for ischemic stroke patients. Methods: This study assessed acute ischemic stroke patients admitted to an academic medical center in 2003 through 2009. The t-test and Chi-square tests were used to compare first-ever and recurrent ischemic stroke groups in terms of total and categorized hospitalization cost, and multiple regression was performed to assess the influence of stroke recurrence. Results: Recurrent ischemic strokes were associated with higher total cost, but examination cost showed no difference between the two groups. The recurrent stroke group showed higher laboratory but lower imaging cost. Of imaging studies, there was no significant difference in computed tomography scan cost while the first-ever stroke group spent more on magnetic resonance imaging and sonography. Controlling for other influential factors, recurrence was discovered to be a significant factor in lowering examination cost. Conclusions: The findings of stroke recurrence in lowering examination cost could be explained from two perspectives, different clinical patterns of healthcare utilization and patients' economic status in recurrent stroke.	[Kwon, Young Dae] Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea; [Yoon, Sung Sang] Kyung Hee Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Chang, Hyejung] Kyung Hee Univ, Sch Management, Dept Hlth Serv Management, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Kyung Hee University; Kyung Hee University	Chang, H (corresponding author), Kyung Hee Univ, Sch Management, Dept Hlth Serv Management, Seoul, South Korea.	hjchang@khu.ac.kr	Kwon, Young Dae/T-1591-2017; Chang, Hyejung/K-5764-2013	Kwon, Young Dae/0000-0002-8781-6832; 	Kyung Hee University [KHU-2009554]	Kyung Hee University	This study was supported by a Faculty Research Grant from the Kyung Hee University in 2009 (KHU-2009554). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; BURN J, 1994, STROKE, V25, P333, DOI 10.1161/01.STR.25.2.333; Chang Hyejung, 2011, [Journal of the Korean Neurological Association, 대한신경과학회지], V29, P9; Chang KC, 2002, STROKE, V33, P2670, DOI 10.1161/01.STR.0000034396.68980.39; Fine MJ, 2000, AM J MED, V109, P378, DOI 10.1016/S0002-9343(00)00500-3; Gumbinger C, 2013, NEUROEPIDEMIOLOGY, V41, P161, DOI 10.1159/000354356; Hacke W, 2000, EUR J NEUROL, V7, P607, DOI 10.1046/j.1468-1331.2000.00137.x; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Jorgensen HS, 1997, NEUROLOGY, V48, P891; Keerthi MM, 2011, STROKE, V42, P1489; Leoo T, 2008, CEREBROVASC DIS, V25, P254, DOI 10.1159/000113864; Modrego PJ, 2000, NEUROL SCI, V21, P355, DOI 10.1007/s100720070050; Mohr JP, 2004, STROKE PATHOPHYSIOLO, P42; Neumann PJ, 2010, HEALTH AFFAIR, V29, P196, DOI 10.1377/hlthaff.2009.0077; Paul AT, 2000, J AM COLL SURGEONS, V191, P123; Peltola M, 2013, CEREBROVASC DIS, V35, P113, DOI 10.1159/000346092; Ryglewicz D, 1997, NEUROL RES, V19, P377, DOI 10.1080/01616412.1997.11740828; SACCO RL, 1994, NEUROLOGY, V44, P626, DOI 10.1212/WNL.44.4.626; Samsa GP, 1999, STROKE, V30, P338, DOI 10.1161/01.STR.30.2.338; Schmidt EV, 1988, STROKE, V19, P942; Spieler JF, 2003, EUR J NEUROL, V10, P621, DOI 10.1046/j.1468-1331.2003.00665.x; YASAKA M, 1993, STROKE, V24, P1681, DOI 10.1161/01.STR.24.11.1681	22	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101360	10.1371/journal.pone.0101360	http://dx.doi.org/10.1371/journal.pone.0101360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047140	Green Published, gold, Green Submitted			2022-12-25	WOS:000339558100008
J	Faller, EM; McVey, MJ; MacPherson, PA				Faller, Elliott M.; McVey, Mark J.; MacPherson, Paul A.			IL-7 Receptor Recovery on CD8 T-Cells Isolated from HIV plus Patients Is Inhibited by the HIV Tat Protein	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN PERIPHERAL-BLOOD; INTERLEUKIN-7 RECEPTOR; HIV-1-INFECTED INDIVIDUALS; ANTIRETROVIRAL THERAPY; CYNOMOLGUS MONKEYS; CD127 EXPRESSION; GROWTH-FACTOR; SELECTIVE EXPRESSION; DISEASE PROGRESSION	Expression of the IL-7 receptor alpha-chain (CD127) is decreased on CD8 T-cells in HIV infected patients and partially recovers in those receiving antiretroviral therapy with sustained viral suppression. We have shown that soluble HIV Tat protein down regulates CD127 expression on CD8 T-cells isolated from healthy HIV-negative individuals. Tat is taken up by CD8 T-cells via endocytosis, exits the endosome and then translocates to the inner leaflet of the cell membrane where it binds to the cytoplasmic tail of CD127 inducing receptor internalization and degradation by the proteasome. This down regulation of CD127 by Tat results in impaired CD8 T-cell function. Interestingly, suppression of CD127 by Tat is reversible and requires the continual presence of Tat in the culture media. We thus questioned whether the low IL-7 receptor expression evident on CD8 T-cells in HIV+ patients was similarly reversible and if suppression of the receptor could be maintained ex vivo by Tat protein alone. We show here that when CD8 T-cells isolated from HIV+ patients are incubated alone in fresh medium, low CD127 expression on the cell surface recovers to normal levels. This recovery of CD127, however, is completely inhibited by the addition of HIV Tat protein to the culture media. This study then provides evidence that soluble factor(s) are responsible for low CD127 expression on circulating CD8 T-cells in HIV+ individuals and further implicates Tat in suppressing this receptor essential to CD8 T-cell proliferation and function.	[Faller, Elliott M.; McVey, Mark J.; MacPherson, Paul A.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [MacPherson, Paul A.] Div Infect Dis, Ottawa, ON, Canada; [Faller, Elliott M.; MacPherson, Paul A.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	MacPherson, PA (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.	pmacpherson@ottawahospital.on.ca		McVey, Mark/0000-0002-0918-7030	CIHR [200510lDB-162377-159103, 200509CNI-161294-HPA-ADYP-39720]; OHTN [ROGA240]	CIHR(Canadian Institutes of Health Research (CIHR)); OHTN	Elliott Faller was supported by a Doctoral research grant (200510lDB-162377-159103) from CIHR. P. MacPherson was supported by a New Investigator Award (200509CNI-161294-HPA-ADYP-39720) from CIHR (http://www.cihr-irsc.gc.ca). This Project was performed with grant funding from OHTN, grant number ROGA240 (www.ohtn.on.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON MR, 1990, J EXP MED, V172, P577, DOI 10.1084/jem.172.2.577; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; ARMITAGE RJ, 1990, J IMMUNOL, V144, P938; Benito JM, 2008, J INFECT DIS, V198, P1466, DOI 10.1086/592716; BETTENS F, 1991, AIDS RES HUM RETROV, V7, P773, DOI 10.1089/aid.1991.7.773; Borsetti A, 2008, ARCH VIROL, V153, P463, DOI 10.1007/s00705-007-0009-2; Borsetti A, 2009, VIRAL IMMUNOL, V22, P117, DOI 10.1089/vim.2008.0082; Boutboul F, 2005, AIDS, V19, P1981, DOI 10.1097/01.aids.0000191919.24185.46; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; Cafaro A, 2000, J MED PRIMATOL, V29, P193, DOI 10.1034/j.1600-0684.2000.290313.x; CARINI C, 1994, AIDS RES HUM RETROV, V10, P121, DOI 10.1089/aid.1994.10.121; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; CHIRMULE N, 1995, J VIROL, V69, P492, DOI 10.1128/JVI.69.1.492-498.1995; Cohen SS, 1999, P NATL ACAD SCI USA, V96, P10842, DOI 10.1073/pnas.96.19.10842; Colle JH, 2006, CLIN EXP IMMUNOL, V143, P398, DOI 10.1111/j.1365-2249.2006.03022.x; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Ensoli B, 2009, VACCINE, V28, P371, DOI 10.1016/j.vaccine.2009.10.038; Faller E, 2009, INT IMMUNOL, V21, P203, DOI 10.1093/intimm/dxn140; Faller EM, 2006, JAIDS-J ACQ IMM DEF, V43, P257, DOI 10.1097/01.qai.0000230319.78288.f4; Faller EM, 2010, J IMMUNOL, V185, P2854, DOI 10.4049/jimmunol.0902207; Ferrantelli F, 2011, VACCINE, V29, P2918, DOI 10.1016/j.vaccine.2011.02.006; FERRARI G, 1995, CLIN EXP IMMUNOL, V101, P239; Finke S, 1998, GENE THER, V5, P31, DOI 10.1038/sj.gt.3300560; Fittipaldi A, 2005, ADV DRUG DELIVER REV, V57, P597, DOI 10.1016/j.addr.2004.10.011; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Fry TJ, 2001, TRENDS IMMUNOL, V22, P564, DOI 10.1016/S1471-4906(01)02028-2; Fry TJ, 2002, J HEMATOTH STEM CELL, V11, P803, DOI 10.1089/152581602760404603; Fry TJ, 2003, BLOOD, V101, P2294, DOI 10.1182/blood-2002-07-2297; FURLINI MCRG, 1995, J ACQ IMMUN DEF SYND, V10, P408, DOI 10.1097/00042560-199512000-00003; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; GERSTOFT J, 1985, SCAND J IMMUNOL, V22, P463, DOI 10.1111/j.1365-3083.1985.tb01904.x; Ghazawi FM, 2013, IMMUNOL CELL BIOL, V91, P149, DOI 10.1038/icb.2012.69; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Heintel T, 2002, AIDS, V16, P1497, DOI 10.1097/00002030-200207260-00006; HELLAND DE, 1991, J VIROL, V65, P4547, DOI 10.1128/JVI.65.8.4547-4549.1991; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; JICHA DL, 1991, J EXP MED, V174, P1511, DOI 10.1084/jem.174.6.1511; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Koesters SA, 2006, EUR J IMMUNOL, V36, P336, DOI 10.1002/eji.200535111; KOS FJ, 1992, EUR J IMMUNOL, V22, P3183, DOI 10.1002/eji.1830221224; Lee SH, 1996, ONCOGENE, V13, P2131; Lenz DC, 2004, P NATL ACAD SCI USA, V101, P9357, DOI 10.1073/pnas.0400640101; Liu SJ, 2007, INT IMMUNOL, V19, P1213, DOI 10.1093/intimm/dxm093; LOTZE MT, 1981, CANCER RES, V41, P4420; MacPherson PA, 2001, J ACQ IMMUN DEF SYND, V28, P454, DOI 10.1097/00042560-200112150-00008; MIEDEMA F, 1988, J CLIN INVEST, V82, P1908, DOI 10.1172/JCI113809; Migueles SA, 2001, IMMUNOL LETT, V79, P141, DOI 10.1016/S0165-2478(01)00276-0; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Poggi A, 2004, BLOOD, V103, P2205, DOI 10.1182/blood-2003-08-2928; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Re MC, 2001, J CLIN VIROL, V21, P81, DOI 10.1016/S1386-6532(00)00189-X; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Rezza G, 2005, J INFECT DIS, V191, P1321, DOI 10.1086/428909; Rowshani AT, 2004, EUR J IMMUNOL, V34, P882, DOI 10.1002/eji.200324821; Sasson SC, 2006, CURR DRUG TARGETS, V7, P1571, DOI 10.2174/138945006779025365; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shanker P, 2000, BLOOD, V96, P3094, DOI 10.1182/blood.V96.9.3094.h8003094_3094_3101; SHARMA B, 1985, CLIN EXP IMMUNOL, V62, P296; SMYTH MJ, 1991, CELL IMMUNOL, V138, P390, DOI 10.1016/0008-8749(91)90163-6; Soares MVD, 1998, J IMMUNOL, V161, P5909; Spiegel HML, 2000, J VIROL, V74, P1018, DOI 10.1128/JVI.74.2.1018-1022.2000; Swainson L, 2006, J IMMUNOL, V176, P6702, DOI 10.4049/jimmunol.176.11.6702; Talayev VY, 2005, CLIN EXP IMMUNOL, V141, P440, DOI 10.1111/j.1365-2249.2005.02863.x; van Baarle D, 2001, BLOOD, V98, P146, DOI 10.1182/blood.V98.1.146; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Vingerhoets J, 1998, IMMUNOL LETT, V61, P53, DOI 10.1016/S0165-2478(97)00162-4; VISCIDI RP, 1989, SCIENCE, V246, P1606, DOI 10.1126/science.2556795; WELCH PA, 1989, J IMMUNOL, V143, P3562; Westermann J, 1998, GENE THER, V5, P264, DOI 10.1038/sj.gt.3300568; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yang OO, 2005, VIROLOGY, V332, P16, DOI 10.1016/j.virol.2004.11.028; Yezid H, 2009, J BIOL CHEM, V284, P22736, DOI 10.1074/jbc.M109.023705; Zagury D, 1998, P NATL ACAD SCI USA, V95, P3851, DOI 10.1073/pnas.95.7.3851; Zagury J F, 1998, J Hum Virol, V1, P282	84	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102677	10.1371/journal.pone.0102677	http://dx.doi.org/10.1371/journal.pone.0102677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033393	gold, Green Published			2022-12-25	WOS:000339418300077
J	Mohammed, YH; Yamada, M; Lin, LL; Grice, JE; Roberts, MS; Raphael, AP; Benson, HAE; Prow, TW				Mohammed, Yousuf H.; Yamada, Miko; Lin, Lynlee L.; Grice, Jeffrey E.; Roberts, Michael S.; Raphael, Anthony P.; Benson, Heather A. E.; Prow, Tarl W.			Microneedle Enhanced Delivery of Cosmeceutically Relevant Peptides in Human Skin	PLOS ONE			English	Article							IN-VIVO; TRANSDERMAL DELIVERY; DRUG-DELIVERY; PROTEINS	Peptides and proteins play an important role in skin health and well-being. They are also found to contribute to skin aging and melanogenesis. Microneedles have been shown to substantially enhance skin penetration and may offer an effective means of peptide delivery enhancement. The aim of this investigation was to assess the influence of microneedles on the skin penetration of peptides using fluorescence imaging to determine skin distribution. In particular the effect of peptide chain length (3, 4, 5 amino acid chain length) on passive and MN facilitated skin penetration was investigated. Confocal laser scanning microscopy was used to image fluorescence intensity and the area of penetration of fluorescently tagged peptides. Penetration studies were conducted on excised full thickness human skin in Franz type diffusion cells for 1 and 24 hours. A 2 to 22 fold signal improvement in microneedle enhanced delivery of melanostatin, rigin and pal-KTTKS was observed. To our knowledge this is the first description of microneedle enhanced skin permeation studies on these peptides.	[Mohammed, Yousuf H.; Yamada, Miko; Lin, Lynlee L.; Raphael, Anthony P.; Prow, Tarl W.] Univ Queensland, Sch Med, Translat Res Inst, Dermatol Res Ctr, Brisbane, Qld, Australia; [Mohammed, Yousuf H.; Benson, Heather A. E.] Curtin Univ, CHIRI Biosci, Sch Pharm, Perth, WA 6845, Australia; [Mohammed, Yousuf H.; Grice, Jeffrey E.; Roberts, Michael S.] Univ Queensland, Sch Med, Princess Alexandra Hosp, Therapeut Res Ctr, Brisbane, Qld, Australia	University of Queensland; Curtin University; University of Queensland	Prow, TW (corresponding author), Univ Queensland, Sch Med, Translat Res Inst, Dermatol Res Ctr, Brisbane, Qld, Australia.	t.prow@uq.edu.au	Grice, Jeffrey/F-6257-2010; Yamada, Miko/AAW-6136-2020; Roberts, Michael S/C-5247-2014; Prow, Tarl/AAB-8359-2019; Lin, Li/H-2348-2013; Prow, Tarl W/A-4764-2010; Raphael, Anthony/A-7173-2012	Grice, Jeffrey/0000-0002-8862-4461; Yamada, Miko/0000-0001-8795-4461; Roberts, Michael S/0000-0003-3894-5301; Prow, Tarl/0000-0003-2892-6238; Lin, Li/0000-0003-3100-9668; Prow, Tarl W/0000-0003-2892-6238; Raphael, Anthony/0000-0002-5870-9528; FCCN, Bogus/0000-0001-6282-8004; Mohammed, Yousuf/0000-0002-7825-7557; FCCN, Bogus/0000-0003-1034-3552	Australian National Health and Medical Research Council; University of Queensland; Australian Postgraduate	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland); Australian Postgraduate	This project was funded by Australian National Health and Medical Research Council. APR acknowledges The University of Queensland Post-Doctoral Fellowship and Early Career Research Award for funding. YM acknowledges the Australian Postgraduate Award for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bal SM, 2010, J CONTROL RELEASE, V147, P218, DOI 10.1016/j.jconrel.2010.07.104; Banks SL, 2011, PHARM RES-DORDR, V28, P1211, DOI 10.1007/s11095-011-0372-2; Banks SL, 2010, J PHARM SCI-US, V99, P3072, DOI 10.1002/jps.22083; Benson HAE, 2008, J PHARM SCI-US, V97, P3591, DOI 10.1002/jps.21277; Donald JE, 2009, NUCLEIC ACIDS RES, V37, pD191, DOI 10.1093/nar/gkn716; Gill HS, 2008, J PHYS CHEM SOLIDS, V69, P1537, DOI 10.1016/j.jpcs.2007.10.059; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Lintner K, 2000, USE PEPTIDES COSMETI; Martanto W, 2006, J CONTROL RELEASE, V112, P357, DOI 10.1016/j.jconrel.2006.02.017; Prausnitz MR, 2006, NAT BIOTECHNOL, V24, P416, DOI 10.1038/nbt0406-416; Sachdeva V, 2013, CURR PHARM BIOTECHNO, V14, P180; Sauermann K, 2002, SKIN RES TECHNOL, V8, P141, DOI 10.1034/j.1600-0846.2002.20345.x; Zhang LJ, 2009, CLIN DERMATOL, V27, P485, DOI 10.1016/j.clindermatol.2009.05.013; Zhang XD, 2009, BIOL PHARM BULL, V32, P86, DOI 10.1248/bpb.32.86	14	54	56	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101956	10.1371/journal.pone.0101956	http://dx.doi.org/10.1371/journal.pone.0101956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033398	Green Published, gold, Green Accepted			2022-12-25	WOS:000339418300029
J	Tavares, A; Nielsen, JB; Boye, K; Rohde, S; Paulo, AC; Westh, H; Schonning, K; de Lencastre, H; Miragaia, M				Tavares, Ana; Nielsen, Jesper B.; Boye, Kit; Rohde, Susanne; Paulo, Ana C.; Westh, Henrik; Schonning, Kristian; de Lencastre, Herminia; Miragaia, Maria			Insights into Alpha-Hemolysin (Hla) Evolution and Expression among Staphylococcus aureus Clones with Hospital and Community Origin	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; GENETIC BACKGROUNDS; METHICILLIN; VIRULENCE; TOXIN; INFECTION; EPIDEMIC; PORE; RESISTANCE; PORTUGAL	Background: Alpha-hemolysin (Hla) is a major virulence factor in the pathogenesis of Staphylococcus aureus infection, being active against a wide range of host cells. Although hla is ubiquitous in S. aureus, its genetic diversity and variation in expression in different genetic backgrounds is not known. We evaluated nucleotide sequence variation and gene expression profiles of hla among representatives of hospital (HA) and community-associated (CA) S. aureus clones. Methods: 51 methicillin-resistant S. aureus and 22 methicillin-susceptible S. aureus were characterized by PFGE, spa typing, MLST and SCCmec typing. The internal regions of hla and the hla promoter were sequenced and gene expression was assessed by RT-PCR. Results: Alpha-hemolysin encoding- and promoter sequences were diverse, with 12 and 23 different alleles, respectively. Based on phylogenetic analysis, we suggest that hla may have evolved together with the S. aureus genetic background, except for ST22, ST121, ST59 and ST93. Conversely, the promoter region showed lack of co-evolution with the genetic backgrounds. Four non-synonymous amino acid changes were identified close to important regions of hla activity. Amino acid changes in the RNAIII binding site were not associated to hla expression. Although expression rates of hla were in general strain-specific, we observed CA clones showed significantly higher hla expression (p = 0.003) when compared with HA clones. Conclusion: We propose that the hla gene has evolved together with the genetic background. Overall, CA genetic backgrounds showed higher levels of hla expression than HA, and a high strain-to-strain variation of gene expression was detected in closely related strains.	[Tavares, Ana; de Lencastre, Herminia; Miragaia, Maria] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Nielsen, Jesper B.; Boye, Kit; Rohde, Susanne; Westh, Henrik; Schonning, Kristian] Copenhagen Univ Hosp, Dept Clin Microbiol 445, Hvidovre, Denmark; [Paulo, Ana C.] Inst Tecnol Quim & Biol, Oeiras, Portugal; [Westh, Henrik; Schonning, Kristian] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [de Lencastre, Herminia] Rockefeller Univ, Lab Microbiol & Infect Dis, New York, NY 10021 USA; [Miragaia, Maria] Inst Tecnol Quim & Biol, Lab Bacterial Evolut & Mol Epidemiol, Oeiras, Portugal	Universidade Nova de Lisboa; University of Copenhagen; University of Copenhagen; Rockefeller University	Miragaia, M (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal.	miragaia@itqb.unl.pt	Miragaia, Maria/J-2704-2015	Miragaia, Maria/0000-0002-1323-7184; /0000-0001-6816-8932; Westh, Henrik/0000-0001-5681-647X; Tavares, Ana/0000-0002-2221-4785; PAULO, Ana Cristina/0000-0002-9249-2609	Fundacao Calouste Gulbenkian [P-99911]; Fundacao para a Ciencia e Tecnologia [PTDC/BIA-MIC/3195/2012, PTDC/BIA-EVF/117507/2010]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [Pest-OE/EQB/LAO004/2011]; FCT [SFRH/BD/44220/2008]	Fundacao Calouste Gulbenkian(European Commission); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by project Ref. P-99911 from Fundacao Calouste Gulbenkian (http://www.gulbenkian.pt/Institucional/pt/Homepage) and Project PTDC/BIA-MIC/3195/2012 from Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/) awarded to HdL; Project PTDC/BIA-EVF/117507/2010 from Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/) awarded to MM; and through grant Ref. Pest-OE/EQB/LAO004/2011 from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. A. Tavares was supported by grant SFRH/BD/44220/2008 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Amorim ML, 2002, MICROB DRUG RESIST, V8, P301, DOI 10.1089/10766290260469561; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Ballal A, 2009, J BACTERIOL, V191, P1656, DOI 10.1128/JB.01555-08; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Castillo-Ramirez S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002129; Conceicao T, 2010, EUR J CLIN MICROBIOL, V29, P543, DOI 10.1007/s10096-010-0892-4; Crisostomo MI, 2001, P NATL ACAD SCI USA, V98, P9865, DOI 10.1073/pnas.161272898; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; De Lencastre H, 2000, MICROB DRUG RESIST, V6, P1, DOI 10.1089/mdr.2000.6.1; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; Deurenberg RH, 2009, CURR MOL MED, V9, P100, DOI 10.2174/156652409787581637; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Faria NA, 2005, J CLIN MICROBIOL, V43, P1836, DOI 10.1128/JCM.43.4.1836-1842.2005; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Kobayashi SD, 2005, ARCH IMMUNOL THER EX, V53, P505; Kuhn G, 2006, J BACTERIOL, V188, P169, DOI 10.1128/JB.188.1.169-178.2006; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Liang XD, 2005, J BACTERIOL, V187, P5486, DOI 10.1128/JB.187.15.5486-5492.2005; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Liang XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018428; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Montoya M, 2003, BBA-BIOMEMBRANES, V1609, P19, DOI 10.1016/S0005-2736(02)00663-6; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Oliveira DC, 2006, J ANTIMICROB CHEMOTH, V58, P23, DOI 10.1093/jac/dkl208; Otto M., 2013, INT J MED MICROBIOL; RICHARDSON JF, 1993, J HOSP INFECT, V25, P45, DOI 10.1016/0195-6701(93)90007-M; Roberts RB, 1998, J INFECT DIS, V178, P164, DOI 10.1086/515610; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Sa-Leao R, 1999, J CLIN MICROBIOL, V37, P1913; SANCHES IS, 1995, J CLIN MICROBIOL, V33, P1243, DOI 10.1128/JCM.33.5.1243-1246.1995; Schmidt KA, 2001, INFECT IMMUN, V69, P4749, DOI 10.1128/IAI.69.8.4749-4758.2001; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tavares A, 2013, EUR J CLIN MICROBIOL, V32, P1269, DOI 10.1007/s10096-013-1872-2; Thoendel M, 2011, CHEM REV, V111, P117, DOI 10.1021/cr100370n; Valeva A, 1997, BIOCHEMISTRY-US, V36, P13298, DOI 10.1021/bi971075r; VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Wilson GJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002271; Zielinska AK, 2011, J BACTERIOL, V193, P2948, DOI 10.1128/JB.01517-10	50	27	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e98634	10.1371/journal.pone.0098634	http://dx.doi.org/10.1371/journal.pone.0098634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033196	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300003
J	Wetter, A; Nensa, F; Schenck, M; Heusch, P; Poppel, T; Bockisch, A; Forsting, M; Schlosser, TW; Lauenstein, TC; Nagarajah, J				Wetter, Axel; Nensa, Felix; Schenck, Marcus; Heusch, Philipp; Poeppel, Thorsten; Bockisch, Andreas; Forsting, Michael; Schlosser, Thomas W.; Lauenstein, Thomas C.; Nagarajah, James			Combined PET Imaging and Diffusion-Weighted Imaging of Intermediate and High-Risk Primary Prostate Carcinomas with Simultaneous [F-18] Choline PET/MRI	PLOS ONE			English	Article							WHOLE-BODY; RESPONSE ASSESSMENT; THERAPY RESPONSE; CANCER; MRI; COEFFICIENT; RADIOTHERAPY; BIOPSY; KINASE; HEAD	Purpose: To characterize intermediate and high-risk prostate carcinomas with measurements of standardized uptake values (SUVs) and apparent diffusion coefficient (ADC) values by means of simultaneous [F-18] choline PET/MRI. Materials and Methods: 35 patients with primary prostate cancer underwent simultaneous [F-18] choline PET/MRI. From these, 21 patients with an intermediate and high risk constellation who were not under ongoing hormonal therapy were included. Altogether 32 tumor lesions with a focal uptake of [F-18] choline could be identified. Average ADC values (ADC(aver)) minimum ADC values (ADC(min)) as well as maximum and mean SUVs (SUVmax, SUVmean) of tumor lesions were assessed with volume-of-interest (VOI) and Region-of-interest (ROI) measurements. As a reference, also ADC(aver), ADC(min) and SUVmax and SUVmean of non-tumorous prostate tissue were measured. Statistical analysis comprised calculation of descriptive parameters and calculation of Pearson's product moment correlations between ADC values and SUVs of tumor lesions. Results: Mean ADC(aver) and ADC(min) of tumor lesions were 0.94 +/- 0.22 x 10(-3) mm(2)/s and 0.65 +/- 0.21 x 10(-3) mm(2)/s, respectively. Mean SUVmax and SUVmean of tumor lesions were 6.3 +/- 2.3 and 2.6 +/- 0.8, respectively. These values were in each case significantly different from the reference values (p<0.001). There was no significant correlation between the measured SUVs and ADC values (SUVmax vs. ADC(aver): R = -0.24, p = 0.179; SUVmax vs. ADC(min): R = -0.03, p = 0.877; SUVmean vs. ADC(aver): R = -0.27, p = 0.136; SUVmean vs. ADC(min): R = -0.08, p = 0.679). Conclusion: Both SUVs and ADC values differ significantly between tumor lesions and healthy tissue. However, there is no significant correlation between these two parameters. This might be explained by the fact that SUVs and ADC values characterize different parts of tumor biology.	[Wetter, Axel; Nensa, Felix; Forsting, Michael; Schlosser, Thomas W.; Lauenstein, Thomas C.] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Schenck, Marcus] Univ Hosp Essen, Dept Urol & Paediat Urol, Essen, Germany; [Heusch, Philipp] Univ Dusseldorf, Fac Med, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany; [Poeppel, Thorsten; Bockisch, Andreas; Nagarajah, James] Univ Hosp Essen, Dept Nucl Med, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; Heinrich Heine University Dusseldorf; University of Duisburg Essen	Wetter, A (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	axel.wetter@uk-essen.de	Nagarajah, James/H-1472-2012; Nagarajah, James/X-5804-2019	Nagarajah, James/0000-0002-3555-0809; Nagarajah, James/0000-0002-3555-0809; Nensa, Felix/0000-0002-5811-7100				Bae H, 2014, INT UROL NEPHROL, V46, P555, DOI 10.1007/s11255-013-0557-1; Bains LJ, 2012, CANCER IMAGING, V12, P395, DOI 10.1102/1470-7330.2012.9047; Bauman G, 2012, PROSTATE CANCER P D, V15, P45, DOI 10.1038/pcan.2011.35; Beheshti M, 2010, RADIOLOGY, V254, P925, DOI 10.1148/radiol.09090413; Bonekamp S, 2012, J MAGN RESON IMAGING, V35, P257, DOI 10.1002/jmri.22786; Borren A, 2013, ACTA ONCOL, V52, P1629, DOI 10.3109/0284186X.2013.787164; Challapalli A, 2014, NUCL MED COMMUN, V35, P20, DOI 10.1097/MNM.0000000000000014; Choi SH, 2011, J NUCL MED, V52, P1056, DOI 10.2967/jnumed.111.089334; Contractor K, 2011, CLIN CANCER RES, V17, P7673, DOI 10.1158/1078-0432.CCR-11-2048; D'Amico AV, 2001, J UROLOGY, V166, P2185, DOI 10.1016/S0022-5347(05)65531-0; De Waele A, 2010, CLIN NUCL MED, V35, P701, DOI 10.1097/RLU.0b013e3181e9faf5; Giannarini G, 2012, EUR UROL, V61, P326, DOI 10.1016/j.eururo.2011.09.019; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Heijmen L, 2013, EUR RADIOL, V23, P748, DOI 10.1007/s00330-012-2654-4; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kitajima K, 2013, EUR J RADIOL, V82, P1219, DOI 10.1016/j.ejrad.2013.02.021; Martinez-Moller A, 2009, J NUCL MED, V50, P520, DOI 10.2967/jnumed.108.054726; Murphy G, 2013, AM J ROENTGENOL, V201, P1229, DOI 10.2214/AJR.12.10178; Nagel KNA, 2013, RADIOLOGY, V267, P164, DOI 10.1148/radiol.12111683; Nakajo M, 2012, CLIN NUCL MED, V37, P475, DOI 10.1097/RLU.0b013e318248524a; Rakheja R, 2013, AM J ROENTGENOL, V201, P1115, DOI 10.2214/AJR.13.11304; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Roe K, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-65; Scher B, 2007, EUR J NUCL MED MOL I, V34, P45, DOI 10.1007/s00259-006-0190-7; Schwarzenbock S, 2013, NUKLEARMED-NUCL MED, V52, P141, DOI 10.3413/Nukmed-0521-12-07; Song I, 2010, AM J ROENTGENOL, V195, P534; Song I, 2010, AM J ROENTGENOL, V194, pW477, DOI 10.2214/AJR.09.3557; Souvatzoglou M, 2013, EUR J NUCL MED MOL I, V40, P1486, DOI 10.1007/s00259-013-2467-y; Thoeny HC, 2010, J MAGN RESON IMAGING, V32, P2, DOI 10.1002/jmri.22167; Varoquaux A, 2013, EUR J NUCL MED MOL I, V40, P842, DOI 10.1007/s00259-013-2351-9; Wetter A, 2014, EUR J NUCL MED MOL I, V41, P79, DOI 10.1007/s00259-013-2560-2; Wetter A, 2013, INVEST RADIOL, V48, P256, DOI 10.1097/RLI.0b013e318282c654; Wu LM, 2012, ACAD RADIOL, V19, P1215, DOI 10.1016/j.acra.2012.05.016; Zhang J, 2013, ACAD RADIOL, V20, P1535, DOI 10.1016/j.acra.2013.09.007	34	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101571	10.1371/journal.pone.0101571	http://dx.doi.org/10.1371/journal.pone.0101571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033396	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300021
J	Mendez, JC; Perez, O; Prado, L; Merchant, H				Carlos Mendez, Juan; Perez, Oswaldo; Prado, Luis; Merchant, Hugo			Linking Perception, Cognition, and Action: Psychophysical Observations and Neural Network Modelling	PLOS ONE			English	Article							DECISION-MAKING; MOVEMENT PREPARATION; PREMOTOR CORTEX; WORKING-MEMORY; RESPONSE COMPETITION; REACHING MOVEMENTS; PREFRONTAL CORTEX; PARIETAL CORTEX; MEASURING TIME; ARM MOVEMENTS	It has been argued that perception, decision making, and movement planning are in reality tightly interwoven brain processes. However, how they are implemented in neural circuits is still a matter of debate. We tested human subjects in a temporal categorization task in which intervals had to be categorized as short or long. Subjects communicated their decision by moving a cursor into one of two possible targets, which appeared separated by different angles from trial to trial. Even though there was a 1 second-long delay between interval presentation and decision communication, categorization difficulty affected subjects' performance, reaction (RT) and movement time (MT). In addition, reaction and movement times were also influenced by the distance between the targets. This implies that not only perceptual, but also movement-related considerations were incorporated into the decision process. Therefore, we searched for a model that could use categorization difficulty and target separation to describe subjects' performance, RT, and MT. We developed a network consisting of two mutually inhibiting neural populations, each tuned to one of the possible categories and composed of an accumulation and a memory node. This network sequentially acquired interval information, maintained it in working memory and was then attracted to one of two possible states, corresponding to a categorical decision. It faithfully replicated subjects' RT and MT as a function of categorization difficulty and target distance; it also replicated performance as a function of categorization difficulty. Furthermore, this model was used to make new predictions about the effect of untested durations, target distances and delay durations. To our knowledge, this is the first biologically plausible model that has been proposed to account for decision making and communication by integrating both sensory and motor planning information.	[Carlos Mendez, Juan; Perez, Oswaldo; Prado, Luis; Merchant, Hugo] UNAM, Dept Neurobiol Conductual & Cognit, Inst Neurobiol, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Merchant, H (corresponding author), UNAM, Dept Neurobiol Conductual & Cognit, Inst Neurobiol, Campus Juriquilla, Queretaro, Mexico.	hugomerchant@unam.mx	Merchant, Hugo/E-8703-2019	Merchant, Hugo/0000-0002-3488-9501; Perez, Oswaldo/0000-0002-1888-7434; Mendez Nunez, Juan Carlos/0000-0002-7251-0750	Consejo Nacional de Ciencia y Tecnologia [151223]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN201214-25]; Consejo Nacional de Ciencia y Tecnologia scholarship [244466]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Consejo Nacional de Ciencia y Tecnologia scholarship	Supported by Consejo Nacional de Ciencia y Tecnologia (151223) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (IN201214-25) grants to H. M., and Consejo Nacional de Ciencia y Tecnologia scholarship 244466 to J.C.M. This work is part of the Doctoral Thesis of Juan Carlos Mendez - Programa de Doctorado en Ciencias Biomedicas - Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrouillet P, 2011, J EXP PSYCHOL LEARN, V37, P1302, DOI 10.1037/a0022933; Bartolo R, 2014, J NEUROSCI, V34, P3910, DOI 10.1523/JNEUROSCI.2679-13.2014; Bastian A, 2003, EUR J NEUROSCI, V18, P2047, DOI 10.1046/j.1460-9568.2003.02906.x; Bock O, 2000, BEHAV BRAIN RES, V108, P85, DOI 10.1016/S0166-4328(99)00134-5; BOCK O, 1992, EXP BRAIN RES, V90, P209; Bongers RM, 2010, NEUROSCI LETT, V469, P189, DOI 10.1016/j.neulet.2009.11.072; Buonomano DV, 2010, TRENDS COGN SCI, V14, P520, DOI 10.1016/j.tics.2010.09.002; Mendez JC, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00050; Chang SWC, 2004, J GEN PSYCHOL, V131, P328; Chapman CS, 2010, COGNITION, V116, P168, DOI 10.1016/j.cognition.2010.04.008; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Cisek P, 2007, PROG BRAIN RES, V165, P475, DOI 10.1016/S0079-6123(06)65030-9; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Grent-'t-Jong T, 2014, J NEUROPHYSIOL; Haggard P, 1996, J EXP PSYCHOL HUMAN, V22, P42, DOI 10.1037/0096-1523.22.1.42; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; Keri S, 2003, BRAIN RES REV, V43, P85, DOI 10.1016/S0165-0173(03)00204-2; Keulen RF, 2002, J EXP PSYCHOL HUMAN, V28, P515, DOI 10.1037/0096-1523.28.3.515; Lebedev MA, 2008, J NEUROPHYSIOL, V99, P166, DOI 10.1152/jn.00734.2007; Lemus L, 2007, P NATL ACAD SCI USA, V104, P17174, DOI 10.1073/pnas.0707961104; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Martinez-Garcia M, 2011, P NATL ACAD SCI USA, V108, P11626, DOI 10.1073/pnas.1108137108; McDowell K, 2002, EXP BRAIN RES, V144, P303, DOI 10.1007/s00221-002-1046-4; Merchant H, 1997, J NEUROPHYSIOL, V77, P1132, DOI 10.1152/jn.1997.77.3.1132; Merchant H, 2008, J NEUROPHYSIOL, V99, P939, DOI 10.1152/jn.01225.2007; Merchant H, 2014, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00274; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Merchant H, 2013, J NEUROSCI, V33, P9082, DOI 10.1523/JNEUROSCI.5513-12.2013; Merchant H, 2011, P NATL ACAD SCI USA, V108, P19784, DOI 10.1073/pnas.1112933108; MIALL RC, 1995, EXP BRAIN RES, V103, P421; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; Naselaris T, 2006, J NEUROPHYSIOL, V96, P3231, DOI 10.1152/jn.00487.2006; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pastor-Bernier A, 2011, J NEUROSCI, V31, P7083, DOI 10.1523/JNEUROSCI.5681-10.2011; Pellizzer G, 2003, EXP BRAIN RES, V150, P276, DOI 10.1007/s00221-003-1453-1; Perez O, 2013, J NEUROSCI METH, V212, P203, DOI 10.1016/j.jneumeth.2012.10.019; Ponce-Alvarez A, 2012, J NEUROSCI, V32, P11956, DOI 10.1523/JNEUROSCI.6176-11.2012; Portrat S, 2008, J EXP PSYCHOL LEARN, V34, P1561, DOI 10.1037/a0013356; Praamstra P, 2009, J NEUROPHYSIOL, V102, P2084, DOI 10.1152/jn.00413.2009; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rao SM, 1997, J NEUROSCI, V17, P5528; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; ROMO R, 1993, J NEUROPHYSIOL, V70, P2690, DOI 10.1152/jn.1993.70.6.2690; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Romo R, 1996, NEUROREPORT, V7, P1273, DOI 10.1097/00001756-199605170-00011; Schneider BA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001413; Smyrnis N, 2000, EXP BRAIN RES, V134, P21, DOI 10.1007/s002210000416; Song JH, 2009, TRENDS COGN SCI, V13, P360, DOI 10.1016/j.tics.2009.04.009; Tzagarakis C, 2010, J NEUROSCI, V30, P11270, DOI 10.1523/JNEUROSCI.6026-09.2010; Van Thiel E, 1998, Motor Control, V2, P331; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Welsh TN, 1999, EXP BRAIN RES, V127, P207, DOI 10.1007/s002210050790; WOLPERT DM, 1994, EXP BRAIN RES, V98, P153; WOLPERT DM, 1995, EXP BRAIN RES, V103, P460	60	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102553	10.1371/journal.pone.0102553	http://dx.doi.org/10.1371/journal.pone.0102553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029193	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600083
J	Gohler, A; Hetzer, A; Holtfreter, B; Geisel, MH; Schmidt, CO; Steinmetz, I; Kocher, T				Goehler, Andre; Hetzer, Adrian; Holtfreter, Birte; Geisel, Marie Henrike; Schmidt, Carsten Oliver; Steinmetz, Ivo; Kocher, Thomas			Quantitative Molecular Detection of Putative Periodontal Pathogens in Clinically Healthy and Periodontally Diseased Subjects	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; RIBOSOMAL-RNA GENES; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PORPHYROMONAS-GINGIVALIS; METHANOGENIC ARCHAEA; BACTERIAL PATHOGENS; INFECTIONS; MICROBIOTA; POPULATION	Periodontitis is a multi-microbial oral infection with high prevalence among adults. Putative oral pathogens are commonly found in periodontally diseased individuals. However, these organisms can be also detected in the oral cavity of healthy subjects. This leads to the hypothesis, that alterations in the proportion of these organisms relative to the total amount of oral microorganisms, namely their abundance, rather than their simple presence might be important in the transition from health to disease. Therefore, we developed a quantitative molecular method to determine the abundance of various oral microorganisms and the portion of bacterial and archaeal nucleic acid relative to the total nucleic acid extracted from individual samples. We applied quantitative real-time PCRs targeting single-copy genes of periodontal bacteria and 16S-rRNA genes of Bacteria and Archaea. Testing tongue scrapings of 88 matched pairs of periodontally diseased and healthy subjects revealed a significantly higher abundance of P. gingivalis and a higher total bacterial abundance in diseased subjects. In fully adjusted models the risk of being periodontally diseased was significantly higher in subjects with high P. gingivalis and total bacterial abundance. Interestingly, we found that moderate abundances of A. actinomycetemcomitans were associated with reduced risk for periodontal disease compared to subjects with low abundances, whereas for high abundances, this protective effect leveled off. Moderate archaeal abundances were health associated compared to subjects with low abundances. In conclusion, our methodological approach unraveled associations of the oral flora with periodontal disease, which would have gone undetected if only qualitative data had been determined.	[Goehler, Andre; Hetzer, Adrian; Steinmetz, Ivo] Ernst Moritz Arndt Univ Greifswald, Friedrich Loeffler Inst Med Microbiol, Greifswald, Germany; [Holtfreter, Birte; Geisel, Marie Henrike; Kocher, Thomas] Ernst Moritz Arndt Univ Greifswald, Univ Med, Sch Dent, Unit Periodontol, Greifswald, Germany; [Geisel, Marie Henrike] Univ Duisburg Essen, Univ Hosp Essen, IMIBE, Essen, Germany; [Schmidt, Carsten Oliver] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Sect Methods Community Med, Univ Med Greifswald, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Friedrich Loeffler Institute; Ernst Moritz Arndt Universitat Greifswald; University of Duisburg Essen; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School	Steinmetz, I (corresponding author), Ernst Moritz Arndt Univ Greifswald, Friedrich Loeffler Inst Med Microbiol, Greifswald, Germany.	steinmetz.ivo@uni-greifswald.de; kocher@uni-greifswald.de	Goehler, André/AAZ-7067-2020; Schmidt, Carsten Oliver/AAH-2778-2019	Goehler, André/0000-0002-4006-3511; Schmidt, Carsten Oliver/0000-0001-5266-9396; Steinmetz, Ivo/0000-0003-0510-7336	Federal Ministry of Education and Research [ZZ9603, 01ZZ0103, 01ZZ0701, 0313801O]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; GABA International, Switzerland	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; GABA International, Switzerland	SHIP is part of the Community Medicine Research net (CMR) of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grant no. ZZ9603, 01ZZ0103, 01ZZ0701) and the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania (http://www.community-medicine.de). Microbial analysis, A. H. and A. G were supported by grant no 0313801O (Federal Ministry of Education and Research) to T. K. and I. S. B. H. was supported by an unlimited educational grant by GABA International, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ammann TW, 2012, J PERIODONTAL RES; Ardila Carlos M, 2012, J Indian Soc Periodontol, V16, P65, DOI [10.4103/0972-124x.94607, 10.4103/0972-124X.94607]; Asikainen Sirkka, 2008, P1; Bandhaya P, 2012, J CLIN PERIODONTOL, V39, P519, DOI 10.1111/j.1600-051X.2012.01871.x; Beck JD, 1999, AM HEART J, V138, pS528, DOI 10.1016/S0002-8703(99)70293-0; Beikler T, 2004, J CLIN PERIODONTOL, V31, P777, DOI 10.1111/j.1600-051X.2004.00557.x; Beikler T, 2006, J PERIODONTOL, V77, P1323, DOI 10.1902/jop.2006.050204; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Conrads G, 2002, INT J SYST EVOL MICR, V52, P493, DOI 10.1099/00207713-52-2-493; D'Ercole S, 2008, CRIT REV MICROBIOL, V34, P33, DOI [10.1080/10408410701693317, 10.1080/10408410701693317 ]; Do Nascimento C, 2008, Minerva Stomatol, V57, P561; Dridi B, 2011, ANAEROBE, V17, P56, DOI 10.1016/j.anaerobe.2011.03.001; Eick S, 2013, CLIN ORAL INVEST, V17, P79, DOI 10.1007/s00784-012-0696-2; Gmur R, 1999, EUR J ORAL SCI, V107, P225, DOI 10.1046/j.0909-8836...x; Greenland S, 2000, AM J EPIDEMIOL, V151, P531; Hujoel P, 2013, EUR J ORAL SCI, V121, P2, DOI 10.1111/eos.12011; Hyvarinen K, 2009, INNATE IMMUN-LONDON, V15, P195, DOI 10.1177/1753425908101920; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; KEIL U, 1988, ACTA MED SCAND, P119; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kilian M, 2006, PERIODONTOL 2000, V42, P158, DOI 10.1111/j.1600-0757.2006.00159.x; Kingman A, 2008, J CLIN PERIODONTOL, V35, P659, DOI 10.1111/j.1600-051X.2008.01243.x; Kuboniwa M, 2004, ORAL MICROBIOL IMMUN, V19, P168, DOI 10.1111/j.0902-0055.2004.00135.x; Lee HJ, 2012, CURR MICROBIOL; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; LOESCHE WJ, 1992, J CLIN MICROBIOL, V30, P427, DOI 10.1128/JCM.30.2.427-433.1992; Mager DL, 2003, J CLIN PERIODONTOL, V30, P1031, DOI 10.1046/j.0303-6979.2003.00418.x; Matarazzo F, 2012, CLIN MICROBIOL INFEC, V18, P834, DOI 10.1111/j.1469-0691.2012.03958.x; Matarazzo F, 2011, J CLIN PERIODONTOL, V38, P621, DOI 10.1111/j.1600-051X.2011.01734.x; Morikawa M, 2008, J PERIODONTAL RES, V43, P268, DOI 10.1111/j.1600-0765.2007.01025.x; Morillo JM, 2004, J CLIN PERIODONTOL, V31, P1054, DOI [10.1111/j.1600-051x.2004.00608.x, 10.1111/j.1600-051X.2004.00608.x]; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; POULSEN K, 1994, MICROBIOL-UK, V140, P2049, DOI 10.1099/13500872-140-8-2049; Quirynen M, 2001, J CLIN PERIODONTOL, V28, P499, DOI 10.1034/j.1600-051x.2001.028006499.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rylev M, 2008, J CLIN PERIODONTOL, V35, P346, DOI 10.1111/j.1600-051X.2008.01280.x; Sanz M, 2004, J CLIN PERIODONTOL, V31, P1034, DOI 10.1111/j.1600-051X.2004.00609.x; Savage A, 2009, J CLIN PERIODONTOL, V36, P458, DOI 10.1111/j.1600-051X.2009.01408.x; Slots J, 1999, PERIODONTOL 2000, V20, P82, DOI 10.1111/j.1600-0757.1999.tb00159.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stingu CS, 2012, QUINTESSENCE INT, V43, pE23; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Suzuki N, 2004, J CLIN MICROBIOL, V42, P3827, DOI 10.1128/JCM.42.8.3827-3830.2004; Suzuki N, 2005, CLIN MED RES, V3, P176, DOI 10.3121/cmr.3.3.176; Tanner ACR, 2006, J DENT RES, V85, P318, DOI 10.1177/154405910608500407; Torrungruang K, 2009, J PERIODONTOL, V80, P122, DOI [10.1902/jop.2009.080248, 10.1902/jop.2009.080248 ]; Vianna ME, 2008, J BACTERIOL, V190, P3779, DOI 10.1128/JB.01861-07; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Yang S, 2002, J CLIN MICROBIOL, V40, P3449, DOI 10.1128/JCM.40.9.3449-3454.2002; Yoshida A, 2003, J CLIN MICROBIOL, V41, P863, DOI 10.1128/JCM.41.2.863-866.2003; Yoshida Y, 2003, ORAL MICROBIOL IMMUN, V18, P135, DOI 10.1034/j.1399-302X.2003.00034.x; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	57	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e99244	10.1371/journal.pone.0099244	http://dx.doi.org/10.1371/journal.pone.0099244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029268	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600004
J	Roscher, C; Schumacher, J; Gerighausen, U; Schmid, B				Roscher, Christiane; Schumacher, Jens; Gerighausen, Uta; Schmid, Bernhard			Different Assembly Processes Drive Shifts in Species and Functional Composition in Experimental Grasslands Varying in Sown Diversity and Community History	PLOS ONE			English	Article							TRAIT CONVERGENCE; PLANT-COMMUNITIES; DIVERGENCE; BIODIVERSITY; MECHANISMS; RICHNESS; INVASION; SIMILARITY; FRAMEWORK; PATTERNS	Background: The prevalence of different biotic processes (limiting similarity, weaker competitor exclusion) and historical contingency due to priority effects are in the focus of ongoing discussions about community assembly and non-random functional trait distributions. Methodology/Principal Findings: We experimentally manipulated assembly history in a grassland biodiversity experiment (Jena Experiment) by applying two factorially crossed split-plot treatments to all communities: (i) duration of weeding (never weeded since sowing or cessation of weeding after 3 or 6 years); (ii) seed addition (control vs. seed addition 4 years after sowing). Spontaneous colonization of new species in the control treatment without seed addition increased realized species richness and functional richness (FRic), indicating continuously denser packing of niches. Seed addition resulted in forced colonization and increased realized species richness, FRic, functional evenness (FEve) and functional divergence (FDiv), i. e. higher abundances of species with extreme trait values. Furthermore, the colonization of new species led to a decline in FEve through time, suggesting that weaker competitors were reduced in abundance or excluded. Communities with higher initial species richness or with longer time since cessation of weeding were more restricted in the entry of new species and showed smaller increases in FRic after seed addition than other communities. The two assembly-history treatments caused a divergence of species compositions within communities originally established with the same species. Communities originally established with different species converged in species richness and functional trait composition over time, but remained more distinct in species composition. Conclusions/Significance: Contrasting biotic processes (limiting similarity, weaker competitor exclusion) increase functional convergence between communities initially established with different species. Historical contingency with regard to realized species compositions could not be eradicated by cessation of weeding or forced colonization and was still detectable 5 years after application of these treatments, providing evidence for the role of priority effects in community assembly.	[Roscher, Christiane] UFZ, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Schumacher, Jens] Univ Jena, Inst Stochast, Jena, Germany; [Gerighausen, Uta] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Schmid, Bernhard] Univ Zurich, Zurich Basel Plant Sci Ctr, Zurich, Switzerland	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Friedrich Schiller University of Jena; Max Planck Society; University of Zurich; University of Zurich	Roscher, C (corresponding author), UFZ, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany.	christiane.roscher@ufz.de	Schmid, Bernhard/C-8625-2009	Schmid, Bernhard/0000-0002-8430-3214	German Science Foundation [FOR 456, RO2397/3]; Max Planck Society; Friedrich Schiller University of Jena; Swiss National Science Foundation [310030E-131193]	German Science Foundation(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Friedrich Schiller University of Jena; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the German Science Foundation (FOR 456 and RO2397/3) with additional support from the Max Planck Society and the Friedrich Schiller University of Jena. BS was additionally supported by the Swiss National Science Foundation (310030E-131193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2013, ECOLOGY, V94, P465, DOI 10.1890/11-2279.1; Bernard-Verdier M, 2012, J ECOL, V100, P1422, DOI 10.1111/1365-2745.12003; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Cadotte MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019363; CAILLIEZ F, 1983, PSYCHOMETRIKA, V48, P305, DOI 10.1007/BF02294026; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; de Bello F, 2009, J VEG SCI, V20, P475, DOI 10.1111/j.1654-1103.2009.01042.x; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; DRAKE JA, 1991, AM NAT, V137, P1, DOI 10.1086/285143; Ellenberg H., 1988, VEGETATION ECOLOGY C; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gerhold P, 2013, J VEG SCI, V24, P843, DOI 10.1111/jvs.12052; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hubbell Stephen P., 2001, V32, pi; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Klotz S, 2003, SCHRREIHE VEGKD, V38, P1; Kluge G, 2000, BER DTSCH WETTERDIEN, V213, P1; Laliberte E, 2010, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; LONDO G, 1976, VEGETATIO, V33, P61, DOI 10.1007/BF00055300; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Mason NWH, 2011, J ECOL, V99, P788, DOI 10.1111/j.1365-2745.2011.01801.x; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; MCCUNE B., 1997, PC ORD MULTIVARIATE; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Myers JA, 2009, ECOL LETT, V12, P1250, DOI 10.1111/j.1461-0248.2009.01373.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petermann JS, 2010, ECOLOGY, V91, P408, DOI 10.1890/08-2304.1; Pfisterer AB, 2004, BASIC APPL ECOL, V5, P5, DOI 10.1078/1439-1791-00215; Pinheiro J., 2019, NLME LINEAR NONLINEA; Price JN, 2014, FUNCT ECOL, V28, P509, DOI 10.1111/1365-2435.12186; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2009, OIKOS, V118, P1425; Roscher C, 2009, J ECOL, V97, P32, DOI 10.1111/j.1365-2745.2008.01451.x; Roscher C, 2013, BASIC APPL ECOL, V14, P187, DOI 10.1016/j.baae.2013.01.003; Rothmaler R, 2005, EXKURSIONSFLORA DEUT, V4; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Van der Putten WH, 2000, OECOLOGIA, V124, P91, DOI 10.1007/s004420050028; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Weiher E, 1998, OIKOS, V81, P309, DOI 10.2307/3547051	52	19	19	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101928	10.1371/journal.pone.0101928	http://dx.doi.org/10.1371/journal.pone.0101928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029105	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600026
J	Chen, CH; Huang, CC; Liao, DL				Chen, Chia-Hsiang; Huang, Chia-Chun; Liao, Ding-Lieh			Association Analysis of GABRB3 Promoter Variants with Heroin Dependence	PLOS ONE			English	Article							CHILDHOOD ABSENCE EPILEPSY; RECEPTOR BETA-3 SUBUNIT; D-2 DOPAMINE-RECEPTOR; GABA(A) RECEPTORS; DRUG-ABUSE; GENES; ADDICTION; NEURONS; RELAPSE; SEEKING	GABRB3 encoding the beta 3 subunit of GABAA receptor has been implicated in multiple neuropsychiatric disorders, including substance abuse. Previous studies reported that SNPs at the 5' regulatory region of GABRB3 could regulate GABRB3 gene expression and associated with childhood absence epilepsy (CAE). The study aimed to investigate whether SNPs at the 5' regulatory region of GABRB3 were associated with heroin dependence in our population. We first re-sequenced 1.5 kb of the 5' regulatory region of GABRB3 gene to examine the SNP profile in the genomic DNA of 365 control subjects. Then, we conducted a case-control association analysis between 576 subjects with heroin dependence (549 males, 27 females) and 886 controls (472 males, 414 females) by genotyping the rs4906902 as a tag SNP. We also conducted a reporter gene assay to assess the promoter activity of two major haplotypes derived from SNPs at this region. We detected 3 common SNPs (rs4906902, rs8179184 and rs20317) at this region that had strong pair-wise linkage disequilibrium. The C allele of rs4906902 was found to be associated with increased risk of heroin dependence (odds ratio: 1.27, p = 0.002). Two major haplotypes (C-A-G and T-G-C) derived from these 3 SNPs accounted for 99% of this sample, and reporter gene activity assay showed that haplotype C-A-G that contained the C allele of the tag SNP rs4906902 had higher activity than haplotype T-G-C. Our data suggest that GABRB3 might be associated with heroin dependence, and increased expression of GABRB3 might contribute to the pathogenesis of heroin dependence.	[Chen, Chia-Hsiang] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan; [Chen, Chia-Hsiang] Chang Gung Univ, Dept & Grad Inst Biomed Sci, Taoyuan, Taiwan; [Huang, Chia-Chun] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Liao, Ding-Lieh] Bali Psychiat Ctr, Dept Hlth, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Tzu Chi University	Chen, CH (corresponding author), Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan.	cchen3801@gmail.com		Chen, Chia-Hsiang/0000-0002-8232-2403	National Health Research Institutes, Taiwan; National Science Council, Taiwan	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by an intramural grant from the National Health Research Institutes, Taiwan, and a grant from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Conner BT, 2010, J SUBST ABUSE TREAT, V38, P178, DOI 10.1016/j.jsat.2009.07.004; Gurba KN, 2012, J BIOL CHEM, V287, P12083, DOI 10.1074/jbc.M111.332528; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Janssen MJ, 2009, J NEUROSCI, V29, P5116, DOI 10.1523/JNEUROSCI.4737-08.2009; Lachance-Touchette P, 2010, EPILEPSIA, V51, P1894, DOI 10.1111/j.1528-1167.2010.02642.x; Levran O, 2009, GENES BRAIN BEHAV, V8, P531, DOI 10.1111/j.1601-183X.2009.00501.x; Liao HM, 2012, SCHIZOPHR RES, V139, P229, DOI 10.1016/j.schres.2012.05.015; Loh EW, 2007, AM J MED GENET B, V144B, P439, DOI 10.1002/ajmg.b.30429; Maria SS, 2007, NEUROPHARMACOLOGY, V52, P1555, DOI 10.1016/j.neuropharm.2007.02.012; Mark TL, 2001, DRUG ALCOHOL DEPEN, V61, P195, DOI 10.1016/S0376-8716(00)00162-9; Noble EP, 1998, PSYCHIAT RES, V81, P133, DOI 10.1016/S0165-1781(98)00084-5; Parker JG, 2011, J NEUROSCI, V31, P17103, DOI 10.1523/JNEUROSCI.1715-11.2011; Rogers JL, 2008, NEUROSCIENCE, V151, P579, DOI 10.1016/j.neuroscience.2007.10.012; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Simon EW, 2010, AM J MED GENET B, V153B, P463, DOI 10.1002/ajmg.b.31000; Smith KR, 2012, J NEUROSCI, V32, P2485, DOI 10.1523/JNEUROSCI.1622-11.2011; Song JZ, 2003, AM J MED GENET B, V117B, P39, DOI 10.1002/ajmg.b.10022; Sutcliffe JS, 2003, J AM ACAD CHILD PSY, V42, P253, DOI 10.1097/00004583-200302000-00021; Tanaka M, 2008, AM J HUM GENET, V82, P1249, DOI 10.1016/j.ajhg.2008.04.020; Tanaka M, 2012, EPILEPSIA, V53, P1450, DOI 10.1111/j.1528-1167.2012.03572.x; Tsuang MT, 1996, AM J MED GENET, V67, P473, DOI 10.1002/(SICI)1096-8628(19960920)67:5<473::AID-AJMG6>3.3.CO;2-D; Urak L, 2006, HUM MOL GENET, V15, P2533, DOI 10.1093/hmg/ddl174; Van den Oever MC, 2010, NEUROPSYCHOPHARMACOL, V35, P2120, DOI 10.1038/npp.2010.90; Vlachou S, 2010, ADV PHARMACOL, V58, P315, DOI 10.1016/S1054-3589(10)58013-X; Vogels A, 2002, GENET COUNSEL, V13, P385; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Wu W, 2012, BIOCHEM BIOPH RES CO, V422, P91, DOI 10.1016/j.bbrc.2012.04.112; Young RMD, 2004, PSYCHIAT RES, V127, P171, DOI 10.1016/j.psychres.2003.11.004	30	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102227	10.1371/journal.pone.0102227	http://dx.doi.org/10.1371/journal.pone.0102227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025424	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400053
J	Jin, HK; Xie, XX; Wang, H; Hu, J; Liu, F; Liu, ZG; Zhou, JM; Zhang, YY; Xi, XP; Hu, BQ; Liao, YP; Tang, JT				Jin, Hekun; Xie, Xiaoxue; Wang, Hui; Hu, Jun; Liu, Feng; Liu, Zhigang; Zhou, Jumei; Zhang, Yingying; Xi, Xuping; Hu, Bingqiang; Liao, Yuping; Tang, Jingtian			ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma	PLOS ONE			English	Article							REPAIR GENE POLYMORPHISMS; CELL LUNG-CANCER; CISPLATIN-BASED CHEMOTHERAPY; PLATINUM-BASED CHEMOTHERAPY; IONIZING-RADIATION SENSITIVITY; ACID SUBSTITUTION VARIANTS; DNA-REPAIR; CHROMOSOMAL-ABERRATIONS; PROGNOSTIC-SIGNIFICANCE; PROTEIN EXPRESSION	Background: Single nucleotide polymorphisms (SNPs) in DNA repair genes can alter gene expression and activity and affect response to cancer treatment and, correspondingly, survival. The present study was designed to evaluate the utility of the XRCC1 Arg399Gln and ERCC1 Cys8092Ala SNPs, measured in pretreatment biopsy samples, as predictors of response to radiotherapy in patients with non-metastatic nasopharyngeal carcinoma (NPC). Materials and methods: The study included 75 consecutive patients with stage II-IVA-B NPC. XRCC1 Arg399Glu and ERCC1 Cys8092Ala SNPs were identified from paraffin-embedded biopsy specimens via Sanger sequencing. Expression of p53 and pAkt protein was analyzed by immunohistochemical staining. Potential relationships between genetic polymorphisms and progression-free survival (PFS) were analyzed by using a Cox proportional hazards model, the Kaplan-Meier method, and the log-rank test. Results: Multivariate analysis showed that carriers of the ERCC1 8092 Ala/Ala genotype [hazard ratio (HR) 1.882; 95% confidence interval (CI) 1.031-3.438; P = 0.039] and heavy smokers (>= 20 pack-years) carrying the XRCC1 Arg/Arg genotype (HR 2.019; 95% CI 1.010-4.036; P = 0.047) had significantly lower PFS rates. Moreover, combined positive expression of p53 and pAkt led to significantly increased PFS in subgroups carrying the XRCC1 Gln allele (HR 7.057; 95% CI 2.073-24.021; P = 0.002) or the ERCC1 Cys allele (HR 2.568; 95% CI 1.056-6.248; P = 0.038). Conclusions: The ERCC1 Cys8092Ala polymorphism is an independent predictor of response to radiotherapy for NPC, and the XRCC1 Arg399Glu mutation combined with smoking status seems to predict PFS as well. Our results further suggest a possible correlation between these genetic polymorphisms and p53 protein status on survival.	[Jin, Hekun; Zhang, Yingying; Liao, Yuping] Cent S Univ, Xiangya Hosp, Dept Radiat Oncol, Changsha, Hunan, Peoples R China; [Xie, Xiaoxue; Wang, Hui; Liu, Feng; Liu, Zhigang; Zhou, Jumei; Xi, Xuping; Hu, Bingqiang] Cent S Univ, Dept Radiat Oncol, Hunan Prov Tumor Hosp, Changsha, Hunan, Peoples R China; [Xie, Xiaoxue; Wang, Hui; Hu, Jun; Liu, Feng; Liu, Zhigang; Zhou, Jumei; Xi, Xuping; Hu, Bingqiang] Cent S Univ, Affiliated Tumor Hosp, Xiangya Med Sch, Changsha, Hunan, Peoples R China; [Hu, Jun] Cent S Univ, Dept Pathol, Hunan Prov Tumor Hosp, Changsha, Hunan, Peoples R China; [Tang, Jingtian] Tsinghua Univ, Dept Engn Phys, Inst Med Phys & Engn, Key Lab Particle & Radiat Imaging,Minist Educ, Beijing 100084, Peoples R China	Central South University; Central South University; Central South University; Central South University; Tsinghua University	Tang, JT (corresponding author), Tsinghua Univ, Dept Engn Phys, Inst Med Phys & Engn, Key Lab Particle & Radiat Imaging,Minist Educ, Beijing 100084, Peoples R China.	tangjt@mail.tsinghua.edu.cn	tang, jing/HHR-9815-2022		National Natural Science Foundation of China [81301942]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (Grant No.:81301942). (URLs: http://www.nsfc.gov.cn/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman SZ, 2000, CANCER LETT, V159, P63, DOI 10.1016/S0304-3835(00)00532-2; Angelini S, 2005, MUTAT RES-FUND MOL M, V570, P105, DOI 10.1016/j.mrfmmm.2004.10.007; Chen C, 2013, CANCER CHEMOTH PHARM, V72, P315, DOI 10.1007/s00280-013-2196-8; Chen PC, 2000, CANCER EPIDEM BIOMAR, V9, P843; Erculj N, 2012, ANN ONCOL, V23, P961, DOI 10.1093/annonc/mdr324; Hara A, 2004, ACTA NEUROPATHOL, V108, P43, DOI 10.1007/s00401-004-0860-0; Hu JJ, 2001, CARCINOGENESIS, V22, P917, DOI 10.1093/carcin/22.6.917; Hu JJ, 2002, ENVIRON MOL MUTAGEN, V39, P208, DOI 10.1002/em.10058; Ito H, 2004, CARCINOGENESIS, V25, P1395, DOI 10.1093/carcin/bgh153; Kalikaki A, 2009, CLIN LUNG CANCER, V10, P118, DOI 10.3816/CLC.2009.n.015; Khrunin AV, 2010, PHARMACOGENOMICS J, V10, P54, DOI 10.1038/tpj.2009.45; Kiuru A, 2005, ENVIRON MOL MUTAGEN, V46, P198, DOI 10.1002/em.20155; Lei YC, 2002, MUTAT RES-GEN TOX EN, V519, P93, DOI 10.1016/S1383-5718(02)00127-4; LEVINE AJ, 1992, CANCER SURV, V12, P59; Lunn RM, 1999, CANCER RES, V59, P2557; Ma BBT, 2003, HEAD NECK-J SCI SPEC, V25, P864, DOI 10.1002/hed.10307; Maity A, 1997, INT J RADIAT ONCOL, V37, P639, DOI 10.1016/S0360-3016(96)00598-6; Marintchev A, 2000, NUCLEIC ACIDS RES, V28, P2049, DOI 10.1093/nar/28.10.2049; Masuda M, 1998, HEAD NECK-J SCI SPEC, V20, P640, DOI 10.1002/(SICI)1097-0347(199810)20:7<640::AID-HED11>3.0.CO;2-K; McGurk CJ, 2006, J CELL BIOCHEM, V97, P1121, DOI 10.1002/jcb.20711; McMillan TJ, 2002, BASIC CLIN RADIOBIOL, P71; Monaco R, 2007, PROTEIN J, V26, P541, DOI 10.1007/s10930-007-9095-y; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Okuda K, 2011, J SURG RES, V168, P206, DOI 10.1016/j.jss.2009.09.006; Park SY, 2006, MED ONCOL, V23, P489, DOI 10.1385/MO:23:4:489; Pastorelli R, 2002, INT J CANCER, V100, P9, DOI 10.1002/ijc.10463; Quintela-Fandino M, 2006, J CLIN ONCOL, V24, P4333, DOI 10.1200/JCO.2006.05.8768; Salles B, 1999, FOOD CHEM TOXICOL, V37, P1009, DOI 10.1016/S0278-6915(99)00094-0; Shen MR, 1998, CANCER RES, V58, P604; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Takenaka T, 2010, LUNG CANCER, V67, P101, DOI 10.1016/j.lungcan.2009.03.007; Tuimala J, 2004, MUTAT RES-FUND MOL M, V554, P319, DOI 10.1016/j.mrfmmm.2004.05.009; Wang LF, 2006, ACTA OTO-LARYNGOL, V126, P769, DOI 10.1080/00016480500469545; Wang Y, 2011, ONCOL REP, V25, P1047, DOI 10.3892/or.2011.1170; Wei QY, 2000, J NATL CANCER I, V92, P1764; Wei QY, 1998, CANCER EPIDEM BIOMAR, V7, P309; Wilson MD, 2001, ENVIRON MOL MUTAGEN, V38, P209, DOI 10.1002/em.1073; Wu XF, 2008, PHARMACOGENET GENOM, V18, P955, DOI 10.1097/FPC.0b013e32830efdd4; Yang M, 2006, EUR J CANCER PREV, V15, P269, DOI 10.1097/01.cej.0000195709.79696.0c; Yang ZH, 2009, MOL CARCINOGEN, V48, P196, DOI 10.1002/mc.20468; Yin M, 2011, LUNG CANCER, V72, P370, DOI 10.1016/j.lungcan.2010.10.011; Yip WK, 2008, ONCOL REP, V19, P319; Zhou W, 2004, CLIN CANCER RES, V10, P4939, DOI 10.1158/1078-0432.CCR-04-0247; Zhou W, 2003, CANCER EPIDEM BIOMAR, V12, P359; Zipprich Jennifer, 2010, J Carcinog, V9, P4, DOI 10.4103/1477-3163.62535	46	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101256	10.1371/journal.pone.0101256	http://dx.doi.org/10.1371/journal.pone.0101256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025378	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400012
J	Liu, Z; Zhang, GW; Li, J; Liu, JB; Lv, PF				Liu, Zheng; Zhang, Guangwu; Li, Jian; Liu, Jiabang; Lv, Pengfeng			The Tumor-Suppressive MicroRNA-135b Targets c-Myc in Osteoscarcoma	PLOS ONE			English	Article							HUMAN OSTEOSARCOMA; GASTRIC-CANCER; PROSTATE-CANCER; PROTEIN EXPRESSION; BREAST-CANCER; METASTASIS; CELLS; PROGRESSION; PROGNOSIS; PATHWAY	Osteosarcoma is the most common primary tumor of the bone. It leads to many deaths because of its rapid proliferation and metastasis. Recent studies have shown that microRNAs are important gene regulators that are involved in various cancer-related processes. In this study, we found that miR-135b was down-regulated in both osteoscarcoma patient tumor tissues and osteoscarcoma cell lines in comparison to paired adjacent non-tumor bone tissue. We observed that a lower level of miR-135b was associated with metastasis. The ectopic expression of miR-135b markedly suppressed osteoscarcoma cell proliferation, migration, and invasion. Conversely, the inhibition of miR-135b expression dramatically accelerated cell proliferation, migration, and invasion. The forced expression of miR-135b in osteosarcoma cells resulted in a significant reduction in the protein level of c-Myc and repressed the activity of a luciferase reporter that contained the 39-untranslated region of the c-Myc mRNA. These effects were abolished by the mutation of the predicted miR-135b-binding site, which indicates that c-Myc may be a miR-135b target gene. Moreover, the ectopic expression of c-Myc partially reversed the inhibition of cell proliferation and invasion that was caused by miR-135b. These data therefore suggest that miR-135b may function as a tumor suppressor to regulate osteosarcoma cell proliferation and invasion through a mechanism that targets the c-Myc oncogene. These findings indicate that miR-135b may play a role in the pathogenesis of osteosarcoma.	[Liu, Zheng; Zhang, Guangwu; Li, Jian; Liu, Jiabang; Lv, Pengfeng] Peking Univ, Dept Orthoped Surg, Shougang Hosp, Beijing 100871, Peoples R China	Peking University	Liu, Z (corresponding author), Peking Univ, Dept Orthoped Surg, Shougang Hosp, Beijing 100871, Peoples R China.	lz301198@aliyun.com						Akinyeke T, 2013, CARCINOGENESIS, V34, P2823, DOI 10.1093/carcin/bgt307; Arigoni M, 2013, AM J PATHOL, V182, P2058, DOI 10.1016/j.ajpath.2013.02.046; Dueck AC, 2013, CLIN CANCER RES, V19, P5798, DOI 10.1158/1078-0432.CCR-13-0558; Gamberi G, 1998, ONCOLOGY-BASEL, V55, P556, DOI 10.1159/000011912; Halappanavar S, 2013, J IMMUNOL, V190, P3679, DOI 10.4049/jimmunol.1202456; Huang J, 2009, SCI CHINA SER C, V52, P31, DOI 10.1007/s11427-009-0014-7; Khatri R, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00268; Li K, 2013, CHINESE MED J-PEKING, V126, P82, DOI 10.3760/cma.j.issn.0366-6999.20122477; Li YF, 2013, CELL TISSUE RES, V354, P533, DOI 10.1007/s00441-013-1715-6; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Liu ZJ, 2013, J MOL CELL BIOL, V5, P280, DOI 10.1093/jmcb/mjt020; Miao J, 2013, TUMOUR BIOL; Nair R, 2013, ONCOGENE; Osaki M, 2011, MOL THER, V19, P1123, DOI 10.1038/mt.2011.53; Pello OM, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22984; Schaap-Oziemlak AM, 2010, STEM CELLS DEV, V19, P877, DOI 10.1089/scd.2009.0112; Scionti I, 2008, ANN ONCOL, V19, P1500, DOI 10.1093/annonc/mdn148; Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312; Thayanithy V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043720; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Wu WY, 2011, WORLD J GASTROENTERO, V17, P3645, DOI 10.3748/wjg.v17.i31.3645; Wu X, 2012, CANCER EPIDEMIOL, V36, P212, DOI 10.1016/j.canep.2011.08.002; Wu XY, 2013, INT J MED SCI, V10, P676, DOI 10.7150/ijms.5528; Xu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079752; Xu Y, 2012, ONCOGENE, V31, P1398, DOI 10.1038/onc.2011.340; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Yang JL, 2013, CURR OPIN ONCOL, V25, P398, DOI 10.1097/CCO.0b013e3283622c1b; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Zhang H, 2008, INT J CANCER, V123, P810, DOI 10.1002/ijc.23638; Zhao HE, 2012, INT J MOL MED, V30, P1013, DOI 10.3892/ijmm.2012.1111; Zhao LY, 2012, INT J BIOCHEM CELL B, V44, P2051, DOI 10.1016/j.biocel.2012.08.005; Zheng YY, 2011, CANCER BIOMARK, V10, P71, DOI 10.3233/CBM-2011-0231; Zhou GX, 2013, J INT MED RES, V41, P1, DOI 10.1177/0300060513475959	33	36	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102621	10.1371/journal.pone.0102621	http://dx.doi.org/10.1371/journal.pone.0102621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025684	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400094
J	Melendez, L; Laiolo, P; Mironov, S; Garcia, M; Magana, O; Jovani, R				Melendez, Leandro; Laiolo, Paola; Mironov, Sergey; Garcia, Monica; Magana, Oscar; Jovani, Roger			Climate-Driven Variation in the Intensity of a Host-Symbiont Animal Interaction along a Broad Elevation Gradient	PLOS ONE			English	Article							FEATHER MITE ABUNDANCE; COMMUNITY RESPONSES; HIGH-ALTITUDE; BIRDS; DIVERSITY; IMPACT; ACARI; TITS; PROCTOPHYLLODIDAE; PARASITISM	Gradients of environmental stress may affect biotic interactions in unpredictable ways responding to climate variation, depending on the abiotic stress tolerance of interacting partners. Here, we study the effect of local climate on the intensity of feather mites in six mountain passerines along a 1400 m elevational gradient characterized by shifting temperature and rainfall. Although obligatory symbionts of warm-blooded organisms are assumed to live in mild and homeothermic environments, those inhabiting external, non-blood-irrigated body portions of the host organism, such as feather mites, are expected to endure exposure to the direct influence of a fluctuating climate. As expected, feather mite intensity declined with elevation in all bird species, a pattern that was also found in cold-adapted passerines that have typical alpine habits. The elevation cline was mainly explained by a positive effect of the average temperature upon mite intensity in five of the six species studied. Precipitation explained less variance in mite intensity than average temperature, and showed a negative correlation in half of the studied species. We found no climate-driven migration of mites along the wings of birds, no replacement of mite species along elevation gradients and no association with available food resources for mites (estimated by the size of the uropygial gland). This study suggests that ectosymbionts of warm-blooded animals may be highly sensitive to climatic variation and become less abundant under stressful environmental conditions, providing empirical evidence of the decline of specialized biotic interactions among animal species at high elevations.	[Melendez, Leandro; Laiolo, Paola; Garcia, Monica; Magana, Oscar] Univ Oviedo, Res Unit Biodivers UO, CSIC, PA, Mieres, Spain; [Jovani, Roger] Estn Biol Donana CSIC, Dept Evolutionary Ecol, Seville, Spain; [Mironov, Sergey] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia	Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences	Jovani, R (corresponding author), Estn Biol Donana CSIC, Dept Evolutionary Ecol, Amer Vespucio S-N, Seville, Spain.	jovani@ebd.csic.es	Laiolo, Paola/Q-3747-2019; Laiolo, Paola/B-6566-2014; Jovani, Roger/C-7080-2013	Laiolo, Paola/0000-0002-2009-6797; Laiolo, Paola/0000-0002-2009-6797; Jovani, Roger/0000-0002-8693-9742	Spanish Ministries of Science and Innovation (Ramon y Cajal research contract) [RYC-2009-03967, CGL2008-02749, CGL2011-28177]; Fundacion Biodiversidad	Spanish Ministries of Science and Innovation (Ramon y Cajal research contract); Fundacion Biodiversidad(European Commission)	Funding was provided by the Spanish Ministries of Science and Innovation (Ramon y Cajal research contract RYC-2009-03967 to RJ; CGL2008-02749 and CGL2011-28177 to PL) and Fundacion Biodiversidad (to PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Antoniazzi LR, 2011, J ZOOL, V283, P126, DOI 10.1111/j.1469-7998.2010.00753.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Atyeo W. T., 1966, Bulletin of the University of Nebraska State Museum, V5, P1; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Blanco G, 1997, J AVIAN BIOL, V28, P197, DOI 10.2307/3676970; Blanco G, 2001, J AVIAN BIOL, V32, P271, DOI 10.1111/j.0908-8857.2001.320310.x; Brown CR, 2006, CAN J ZOOL, V84, P1307, DOI 10.1139/Z06-110; CERNY V, 1982, Angewandte Parasitologie, V23, P158; Dabert J, 1999, EXP APPL ACAROL, V23, P437, DOI 10.1023/A:1006180705101; Dubinin V. B., 1951, Fauna USSR Moscow, V6, P1; Fabina NS, 2013, GLOBAL CHANGE BIOL, V19, P3306, DOI 10.1111/gcb.12320; Figuerola J, 2003, ANIM BEHAV, V65, P551, DOI 10.1006/anbe.2003.2072; GAEDE K, 1987, EXP APPL ACAROL, V3, P45, DOI 10.1007/BF01200412; Galvan I, 2008, J EVOLUTION BIOL, V21, P133, DOI 10.1111/j.1420-9101.2007.01459.x; Galvan I, 2006, IBIS, V148, P687, DOI 10.1111/j.1474-919X.2006.00576.x; Galvan I, 2012, J AVIAN BIOL, V43, P273, DOI 10.1111/j.1600-048X.2012.05686.x; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Gaud J., 1996, ANN MUS R AFR CENTR, V277, P1; Giauque H, 2013, AM J BOT, V100, P1435, DOI 10.3732/ajb.1200568; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Haribal M, 2011, INT J ACAROL, V37, P75, DOI 10.1080/01647954.2010.495952; Harper DGC, 1999, ANIM BEHAV, V58, P553, DOI 10.1006/anbe.1999.1154; HERR DG, 1986, AM STAT, V40, P265, DOI 10.2307/2684597; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Inouye DW, 2003, TASK VEG SC, V39, P195; Jovani R, 2006, CAN J ZOOL, V84, P729, DOI 10.1139/Z06-042; Jovani R, 2001, ANIM BEHAV, V62, P723, DOI 10.1006/anbe.2001.1814; Jovani R, 2000, ECOSCIENCE, V7, P428, DOI 10.1080/11956860.2000.11682613; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Krantz G., 2009, MANUAL ACAROLOGY; Laiolo P, 2004, J APPL ECOL, V41, P294, DOI 10.1111/j.0021-8901.2004.00893.x; Laiolo P, 2013, J EVOLUTION BIOL, V26, P2171, DOI 10.1111/jeb.12213; Laiolo P, 2013, OECOLOGIA, V171, P207, DOI 10.1007/s00442-012-2392-y; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Melendez L, 2014, IBIS, V156, P276, DOI 10.1111/ibi.12127; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Merrill RM, 2008, J ANIM ECOL, V77, P145, DOI 10.1111/j.1365-2656.2007.01303.x; Mironov S.V., 2002, Parazitologiya (St. Petersburg), V36, P356; Moya-Larano J, 2012, ADV ECOL RES, V47, P1, DOI 10.1016/B978-0-12-398315-2.00001-6; Moyer BR, 2002, OIKOS, V97, P223, DOI 10.1034/j.1600-0706.2002.970208.x; Newton I, 2010, MIGRATION ECOLOGY BI; Ninyerola M, 2005, ATLAS CLIMATICO DIGI; Perez-Tris J, 2002, BIOL J LINN SOC, V76, P481, DOI 10.1046/j.1095-8312.2002.00083.x; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Proctor H, 2000, TRENDS ECOL EVOL, V15, P358, DOI 10.1016/S0169-5347(00)01924-8; Proctor HC, 2003, ANNU REV ENTOMOL, V48, P185, DOI 10.1146/annurev.ento.48.091801.112725; Pugnaire FI, 2001, OIKOS, V93, P42, DOI 10.1034/j.1600-0706.2001.930104.x; R Core Team, 2012, R LANG ENV STAT COMP; Roe AD, 2011, MICROB ECOL, V62, P347, DOI 10.1007/s00248-011-9841-8; Rozsa L, 1997, CAN J ZOOL, V75, P1535, DOI 10.1139/z97-778; Ruotsalainen AL, 2004, OECOLOGIA, V140, P226, DOI 10.1007/s00442-004-1586-3; Sandilands V, 2004, COMP BIOCHEM PHYS A, V137, P217, DOI 10.1016/j.cbpb.2003.10.004; SPIEKSMA FT, 1971, BMJ-BRIT MED J, V1, P82, DOI 10.1136/bmj.1.5740.82; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Thompson CW, 1997, AM NAT, V149, P270, DOI 10.1086/285990; Wiles PR, 2000, CAN J ZOOL, V78, P1397, DOI 10.1139/cjz-78-8-1397	59	25	26	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101942	10.1371/journal.pone.0101942	http://dx.doi.org/10.1371/journal.pone.0101942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025873	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400026
J	Shekar, S; Yeo, ZX; Wong, JCL; Chan, MKL; Ong, DCT; Tongyoo, P; Wong, SY; Lee, ASG				Shekar, Sandhya; Yeo, Zhen Xuan; Wong, Joshua C. L.; Chan, Maurice K. L.; Ong, Danny C. T.; Tongyoo, Pumipat; Wong, Sin-Yew; Lee, Ann S. G.			Detecting Novel Genetic Variants Associated with Isoniazid-Resistant Mycobacterium tuberculosis	PLOS ONE			English	Article							DRUG-RESISTANCE; DNA FINGERPRINTS; SEQUENCING DATA; SOUTH-AFRICA; MUTATIONS; DIVERSITY; SELECTION; SYNTHASE; COMPLEX; TARGETS	Background: Isoniazid (INH) is a highly effective antibiotic central for the treatment of Mycobacterium tuberculosis (MTB). INH-resistant MTB clinical isolates are frequently mutated in the katG gene and the inhA promoter region, but 10 to 37% of INH-resistant clinical isolates have no detectable alterations in currently known gene targets associated with INH-resistance. We aimed to identify novel genes associated with INH-resistance in these latter isolates. Methodology/Principal Findings: INH-resistant clinical isolates of MTB were pre-screened for mutations in the katG, inhA, kasA and ndh genes and the regulatory regions of inhA and ahpC. Twelve INH-resistant isolates with no mutations, and 17 INH-susceptible MTB isolates were subjected to whole genome sequencing. Phylogenetically related variants and synonymous mutations were excluded and further analysis revealed mutations in 60 genes and 4 intergenic regions associated with INH-resistance. Sanger sequencing verification of 45 genes confirmed that mutations in 40 genes were observed only in INH-resistant isolates and not in INH-susceptible isolates. The ratios of non-synonymous to synonymous mutations (dN/dS ratio) for the INH-resistance associated mutations identified in this study were 1.234 for INH-resistant and 0.654 for INH-susceptible isolates, strongly suggesting that these mutations are indeed associated with INH-resistance. Conclusion: The discovery of novel targets associated with INH-resistance described in this study may potentially be important for the development of improved molecular detection strategies.	[Shekar, Sandhya; Yeo, Zhen Xuan; Wong, Joshua C. L.; Chan, Maurice K. L.; Ong, Danny C. T.; Tongyoo, Pumipat; Lee, Ann S. G.] Natl Canc Ctr, Div Med Sci, Singapore, Singapore; [Wong, Sin-Yew] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore; [Lee, Ann S. G.] Duke NUS Grad Med Sch, Off Clin & Acad Fac Affairs, Singapore, Singapore; [Lee, Ann S. G.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore	National Cancer Centre Singapore (NCCS); Singapore General Hospital; National University of Singapore; National University of Singapore	Lee, ASG (corresponding author), Natl Canc Ctr, Div Med Sci, Singapore, Singapore.	dmslsg@nccs.com.sg		Tongyoo, Pumipat/0000-0002-3274-5475	Biomedical Research Council (BMRC) of Singapore [BMRC 08/1/31/19/584]	Biomedical Research Council (BMRC) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a grant from the Biomedical Research Council (BMRC) of Singapore (BMRC 08/1/31/19/584). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cardoso RF, 2004, ANTIMICROB AGENTS CH, V48, P3373, DOI 10.1128/AAC.48.9.3373-3381.2004; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Chopra T, 2009, METHOD ENZYMOL, V459, P259, DOI 10.1016/S0076-6879(09)04612-6; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Gladki A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-36; Goyal M, 1997, J CLIN MICROBIOL, V35, P647, DOI 10.1128/JCM.35.3.647-651.1997; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Ioerger TR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-670; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Lee ASG, 1999, ANTIMICROB AGENTS CH, V43, P2087, DOI 10.1128/AAC.43.8.2087; Lee ASG, 2002, J CLIN MICROBIOL, V40, P657, DOI 10.1128/JCM.40.2.657-659.2002; Lee ASG, 2001, ANTIMICROB AGENTS CH, V45, P2157, DOI 10.1128/AAC.45.7.2157-2159.2001; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Miesel L, 1998, J BACTERIOL, V180, P2459, DOI 10.1128/JB.180.9.2459-2467.1998; Motiwala AS, 2010, J INFECT DIS, V201, P881, DOI 10.1086/650999; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Ong DCT, 2010, J CLIN MICROBIOL, V48, P1047, DOI 10.1128/JCM.02036-09; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Rousseau C, 2003, MICROBIOL-SGM, V149, P1837, DOI 10.1099/mic.0.26278-0; Safi H, 2010, ANTIMICROB AGENTS CH, V54, P103, DOI 10.1128/AAC.01288-09; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Torok ME, 2013, J CLIN MICROBIOL, V51, P611, DOI 10.1128/JCM.02279-12; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wilson TM, 1996, MOL MICROBIOL, V19, P1025, DOI 10.1046/j.1365-2958.1996.449980.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang CJ, 2013, BIOINFORMATICS, V29, P645, DOI 10.1093/bioinformatics/btt009; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; Zhang M, 2005, J CLIN MICROBIOL, V43, P5477, DOI 10.1128/JCM.43.11.5477-5482.2005; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	39	20	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102383	10.1371/journal.pone.0102383	http://dx.doi.org/10.1371/journal.pone.0102383			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025225	Green Submitted, gold, Green Published			2022-12-25	WOS:000339992400069
J	Voce, DJ; Schmitt, AM; Uppal, A; McNerney, ME; Bernal, GM; Cahill, KE; Wahlstrom, JS; Nassiri, A; Yu, X; Crawley, CD; White, KP; Onel, K; Weichselbaum, RR; Yamini, B				Voce, D. J.; Schmitt, A. M.; Uppal, A.; McNerney, M. E.; Bernal, G. M.; Cahill, K. E.; Wahlstrom, J. S.; Nassiri, A.; Yu, X.; Crawley, C. D.; White, K. P.; Onel, K.; Weichselbaum, R. R.; Yamini, B.			Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor	ONCOGENE			English	Article							NF-KAPPA-B; CHRONIC LYMPHOCYTIC-LEUKEMIA; MYELOID-LEUKEMIA; CELL LYMPHOMA; P50 SUBUNIT; EXPRESSION; GENE; TEMOZOLOMIDE; MICROARRAY; MICE	NF-kappa B proteins play a central and subunit-specific role in the response to DNA damage. Previous work identified p50/NF-kappa B1 as being necessary for cytotoxicity in response to DNA alkylation damage. Given the importance of damage-induced cell death for the maintenance of genomic stability, we examined whether Nfkb1 acts as a tumor suppressor in the setting of alkylation damage. Hprt mutation analysis demonstrates that Nfkb1(-/-) cells accumulate more alkylator-induced, but not ionizing radiation (IR)-induced, mutations than similarly treated wild-type cells. Subsequent in vivo tumor induction studies reveal that following alkylator treatment, but not IR, Nfkb1(-/-) mice develop more lymphomas than similarly treated Nfkb1(+/+) animals. Heterozygous mice develop lymphomas at an intermediate rate and retain functional p50 in their tumors, indicating that Nfkb1 acts in a haploinsufficient manner. Analysis of human cancers, including therapy-related myeloid neoplasms, demonstrates that NFKB1 mRNA expression is downregulated compared with control samples in multiple hematological malignancies. These data indicate that Nfkb1 is a haploinsufficient, pathway-specific tumor suppressor that prevents the development of hematologic malignancy in the setting of alkylation damage.	[Voce, D. J.; Schmitt, A. M.; Bernal, G. M.; Cahill, K. E.; Wahlstrom, J. S.; Nassiri, A.; Yu, X.; Crawley, C. D.; Yamini, B.] Univ Chicago, Neurosurg Sect, Chicago, IL 60637 USA; [Uppal, A.] Univ Chicago, Dept Surg, Sect Gen Surg, Chicago, IL 60637 USA; [McNerney, M. E.] Univ Chicago, Dept Pathol, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [White, K. P.] Univ Chicago, Dept Human Genet, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Onel, K.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Weichselbaum, R. R.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Weichselbaum, R. R.] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Yamini, B (corresponding author), Univ Chicago, Neurosurg Sect, MC3026,5841S Maryland Ave, Chicago, IL 60637 USA.	byamini@surgery.bsd.uchicago.edu		McNerney, Megan/0000-0002-8260-3598	NIH [1R01CA136937]; Ludwig Center for Metastasis Research; Leukemia & Lymphoma Society; Chicago Cancer Genomes Project; NATIONAL CANCER INSTITUTE [R01CA136937, K08CA181254] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center for Metastasis Research; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Chicago Cancer Genomes Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to RF de Pooter and B Kee for helpful contributions. This work was supported by NIH grant 1R01CA136937 (to BY), The Ludwig Center for Metastasis Research; Leukemia & Lymphoma Society Fellow award (M.E.M) and the Chicago Cancer Genomes Project.	Allan JM, 2005, NAT REV CANCER, V5, P943, DOI 10.1038/nrc1749; Andersson A, 2007, LEUKEMIA, V21, P1198, DOI 10.1038/sj.leu.2404688; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Chang PY, 2006, CANCER RES, V66, P6008, DOI 10.1158/0008-5472.CAN-06-0194; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; DUMENCO LL, 1993, SCIENCE, V259, P219, DOI 10.1126/science.8421782; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Glauert HP, 2006, TOXICOL SCI, V90, P331, DOI 10.1093/toxsci/kfj116; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; JOSHI VV, 1970, J NATL CANCER I, V45, P335; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Keller U, 2005, ONCOGENE, V24, P6231, DOI 10.1038/sj.onc.1208779; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Li ZP, 2005, J IMMUNOL, V174, P205, DOI 10.4049/jimmunol.174.1.205; Margison GP, 2002, MUTAGENESIS, V17, P483, DOI 10.1093/mutage/17.6.483; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; McNerney ME, 2013, BLOOD, V121, P975, DOI 10.1182/blood-2012-04-426965; Newlands ES, 1997, CANCER TREAT REV, V23, P35, DOI 10.1016/S0305-7372(97)90019-0; Neyns B, 2008, J CLIN ONCOL, V26, P4518, DOI 10.1200/JCO.2008.18.8177; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Schmitt AM, 2011, MOL CELL, V44, P785, DOI 10.1016/j.molcel.2011.09.026; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Smith SM, 2003, BLOOD, V102, P43, DOI 10.1182/blood-2002-11-3343; Wolff B, 1999, ONCOGENE, V18, P2663, DOI 10.1038/sj.onc.1202617; Wood ME, 2012, J CLIN ONCOL, V30, P3734, DOI 10.1200/JCO.2012.41.8681; Yamini B, 2007, CANCER RES, V67, P6889, DOI 10.1158/0008-5472.CAN-06-4496	38	17	18	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2015	34	21					2807	2813		10.1038/onc.2014.211	http://dx.doi.org/10.1038/onc.2014.211			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI7XN	25043302	Green Accepted			2022-12-25	WOS:000354979500013
J	Mokvist, F; Mamedov, F; Styring, S				Mokvist, Fredrik; Mamedov, Fikret; Styring, Stenbjorn			Defining the Far-red Limit of Photosystem I THE PRIMARY CHARGE SEPARATION IS FUNCTIONAL TO 840 nm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyanobacteria; Electron Paramagnetic Resonance (EPR); Electron Transport; Photosynthesis; Photosynthetic Pigment; Plant; Photosystem I; Far-red Light; Charge Separation	LIGHT-HARVESTING COMPLEX; PRIMARY ELECTRON-DONOR; CHARGE-TRANSFER STATES; LONG-WAVELENGTH LIMIT; RESONANCE SIGNAL II; ENERGY-TRANSFER; PHYSIOLOGICAL DONOR; THYLAKOID MEMBRANES; REACTION CENTERS; EXCITATION	Background: It is generally accepted that Photosystem I is functional under illumination up to 760 nm. Results: We show that Photosystem I photochemistry is induced by far-red photons up to 840 nm. Conclusion: The limit of Photosystem I is 80 nm more red-shifted than previously thought. Significance: Charge transfer bands associated with P-700 could be responsible for this effect. The far-red limit of photosystem I (PS I) photochemistry was studied by EPR spectroscopy using laser flashes between 730 and 850 nm. In manganese-depleted spinach thylakoid membranes, the primary donor in PS I, P-700, was oxidized simultaneously with tyrosine Z, the secondary donor in PS II. It was found that at 295 K PS I photochemistry, observed as P-700(+) formation, was functional up to 840 nm. This is 30 nm further to the red region than was reported for PS II photochemistry (Thapper, A., Mamedov, F., Mokvist, F., Hammarstrom, L., and Styring, S. (2009) Plant Cell 21, 2391-2401). The same far-red limit for the P-700(+) formation was observed in a PS I reaction center core preparation from Nostoc punctiforme. The reduction of the acceptor side of PS I, observed as reduction of the iron-sulfur centers F-A and F-B by low temperature EPR measurements, was also functional at 15 K with light up to >830 nm. Taken together, these results, obtained from both plants and cyanobacteria, most likely rule out involvement of the red-absorbing antenna chlorophylls in this reaction. Instead we propose the existence of weak charge transfer bands absorbing in the far-red region in the ensemble of excitonically coupled chlorophyll a molecules around P-700 similar to what has been found in the reaction center of PS II. These charge transfer bands could be responsible for the far-red light absorption leading to PS I photochemistry at wavelengths up to 840 nm.	[Mokvist, Fredrik; Mamedov, Fikret; Styring, Stenbjorn] Uppsala Univ, Angstrom Lab, Dept Chem Angstrom, S-75120 Uppsala, Sweden	Uppsala University	Mamedov, F (corresponding author), Uppsala Univ, Angstrom Lab, Dept Chem Angstrom, POB 523, S-75120 Uppsala, Sweden.	Fikret.Mamedov@kemi.uu.se; Stenbjorn.Styring@kemi.uu.se	Styring, Stenbjörn/L-8414-2016; Mamedov, Fikret/A-1761-2016	Styring, Stenbjörn/0000-0002-2803-9244; Mamedov, Fikret/0000-0002-6218-3039	Swedish Research Council; Swedish Energy Agency; Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council, Swedish Energy Agency, and Knut and Alice Wallenberg Foundation.	BABCOCK GT, 1975, BIOCHIM BIOPHYS ACTA, V376, P315, DOI 10.1016/0005-2728(75)90024-9; BABCOCK GT, 1975, BIOCHIM BIOPHYS ACTA, V376, P329, DOI 10.1016/0005-2728(75)90025-0; Bald D, 1996, PHOTOSYNTH RES, V49, P103, DOI 10.1007/BF00117661; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Blankenship R. E., 2008, MOL MECH PHOTOSYNTHE; Brettel K, 2001, BBA-BIOENERGETICS, V1507, P100, DOI 10.1016/S0005-2728(01)00202-X; Busch A, 2011, BBA-BIOENERGETICS, V1807, P864, DOI 10.1016/j.bbabio.2010.09.009; Byrdin M, 2002, BIOPHYS J, V83, P433, DOI 10.1016/S0006-3495(02)75181-3; Campbell EL, 2008, J BACTERIOL, V190, P7382, DOI 10.1128/JB.00990-08; Campbell EL, 2007, J BACTERIOL, V189, P5247, DOI 10.1128/JB.00360-07; Carbonera D, 2005, BIOCHEMISTRY-US, V44, P8337, DOI 10.1021/bi050260z; Cardona T, 2007, PHYSIOL PLANTARUM, V131, P622, DOI 10.1111/j.1399-3054.2007.00982.x; Cardona T, 2012, BBA-BIOENERGETICS, V1817, P26, DOI 10.1016/j.bbabio.2011.07.012; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; COMMONER B, 1956, P NATL ACAD SCI USA, V42, P710, DOI 10.1073/pnas.42.10.710; Croce R, 2007, BIOPHYS J, V93, P2418, DOI 10.1529/biophysj.107.106955; Danielsson R, 2004, BBA-BIOENERGETICS, V1608, P53, DOI 10.1016/j.bbabio.2003.10.005; de Weerd FL, 2003, J PHYS CHEM B, V107, P6214, DOI 10.1021/jp027737q; DURRANT JR, 1995, P NATL ACAD SCI USA, V92, P4798, DOI 10.1073/pnas.92.11.4798; Emerson R, 1943, AM J BOT, V30, P165, DOI 10.2307/2437236; EMERSON R, 1957, P NATL ACAD SCI USA, V43, P133, DOI 10.1073/pnas.43.1.133; Frese RN, 2002, BBA-BIOENERGETICS, V1554, P180, DOI 10.1016/S0005-2728(02)00242-6; Fromme R., 2008, PRIMARY PROCESSES 2, P111; Gadjieva R, 1999, BIOCHEMISTRY-US, V38, P10578, DOI 10.1021/bi9904656; GILLIE JK, 1989, PHOTOSYNTH RES, V22, P233, DOI 10.1007/BF00048302; GLAZER AN, 1984, BIOCHIM BIOPHYS ACTA, V768, P29, DOI 10.1016/0304-4173(84)90006-5; Gobets B, 2001, BBA-BIOENERGETICS, V1507, P80, DOI 10.1016/S0005-2728(01)00203-1; Golbeck JH, 2006, PHOTOSYSTEM; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Hippler Michael, 2006, V24, P499; Hughes JL, 2006, BBA-BIOENERGETICS, V1757, P841, DOI 10.1016/j.bbabio.2006.05.035; Jensen PE, 2007, BBA-BIOENERGETICS, V1767, P335, DOI 10.1016/j.bbabio.2007.03.004; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Karapetyan NV, 1999, FEBS LETT, V460, P395, DOI 10.1016/S0014-5793(99)01352-6; KOK B, 1962, BIOCHEM BIOPH RES CO, V9, P349, DOI 10.1016/0006-291X(62)90053-0; KRAWCZYK S, 1991, FEBS LETT, V286, P110, DOI 10.1016/0014-5793(91)80952-Y; MIDDENDORF TR, 1993, BIOCHIM BIOPHYS ACTA, V1143, P223, DOI 10.1016/0005-2728(93)90147-8; Mokvist F., 2013, 16 INT C PHOT ST LOU; Mokvist F, 2014, BIOCHEMISTRY-US, V53, P4228, DOI 10.1021/bi5006392; Muller MG, 2010, P NATL ACAD SCI USA, V107, P4123, DOI 10.1073/pnas.0905407107; Novoderezhkin VI, 2007, BIOPHYS J, V93, P1293, DOI 10.1529/biophysj.106.096867; Palsson LO, 1998, BIOPHYS J, V74, P2611, DOI 10.1016/S0006-3495(98)77967-6; Pettai H, 2005, FEBS LETT, V579, P4017, DOI 10.1016/j.febslet.2005.04.088; Pettai H, 2005, BBA-BIOENERGETICS, V1708, P311, DOI 10.1016/j.bbabio.2005.05.005; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rivadossi A, 1999, PHOTOSYNTH RES, V60, P209, DOI 10.1023/A:1006236829711; Romero E, 2012, BIOPHYS J, V103, P185, DOI 10.1016/j.bpj.2012.06.026; Romero E, 2009, BIOPHYS J, V96, pL35, DOI 10.1016/j.bpj.2008.11.043; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Schlodder E, 1998, BIOCHEMISTRY-US, V37, P9466, DOI 10.1021/bi973182r; Schlodder E, 2014, J AM CHEM SOC, V136, P3904, DOI 10.1021/ja412375j; Schmid VHR, 1997, P NATL ACAD SCI USA, V94, P7667, DOI 10.1073/pnas.94.14.7667; Setif P., 2008, PRIMARY PROCESSES 2, P147; Setif Pierre, 2006, V24, P439; Srinivasan N, 2009, BBA-BIOENERGETICS, V1787, P1057, DOI 10.1016/j.bbabio.2009.04.010; STEFANSSON H, 1995, BBA-BIOENERGETICS, V1231, P323, DOI 10.1016/0005-2728(95)00103-P; Thapper A, 2009, PLANT CELL, V21, P2391, DOI 10.1105/tpc.108.064154; TRISSL HW, 1993, PHOTOSYNTH RES, V35, P247, DOI 10.1007/BF00016556; Vassiliev IR, 2001, BBA-BIOENERGETICS, V1507, P139, DOI 10.1016/S0005-2728(01)00197-9; WARDEN JT, 1976, BIOCHIM BIOPHYS ACTA, V423, P462, DOI 10.1016/0005-2728(76)90201-2; Wientjes E, 2012, BBA-BIOENERGETICS, V1817, P711, DOI 10.1016/j.bbabio.2012.02.030; Wientjes E, 2011, BIOPHYS J, V101, P745, DOI 10.1016/j.bpj.2011.06.045; Xu W, 2001, BBA-BIOENERGETICS, V1507, P32, DOI 10.1016/S0005-2728(01)00208-0	63	10	10	2	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24630	24639		10.1074/jbc.M114.555649	http://dx.doi.org/10.1074/jbc.M114.555649			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023284	Green Published, hybrid			2022-12-25	WOS:000341505600053
J	Angel, N; Li, L; Dosdall, DJ				Angel, Nathan; Li, Li; Dosdall, Derek J.			His Bundle Activates Faster than Ventricular Myocardium during Prolonged Ventricular Fibrillation	PLOS ONE			English	Article							SUBENDOCARDIAL PURKINJE-FIBERS; SUDDEN CARDIAC DEATH; CONDUCTING SYSTEM; CANINE HEART; ARRHYTHMIAS; DOGS; PROPAGATION; PATTERNS; MODEL; ELECTROGRAMS	Background: The Purkinje fiber system has recently been implicated as an important driver of the rapid activation rate during long duration ventricular fibrillation (VF>2 minutes). The goal of this study is to determine whether this activity propagates to or occurs in the proximal specialized conduction system during VF as well. Methods and Results: An 8X8 array with 300 mm spaced electrodes was placed over the His bundles of isolated, perfused rabbit hearts (n = 12). Ventricular myocardial (VM) and His activations were differentiated by calculating Laplacian recordings from unipolar signals. Activation rates of the VM and His bundle were compared and the His bundle conduction velocity was measured during perfused VF followed by 8 minutes of unperfused VF. During perfused VF the average VM activation rate of 11.04 activations/sec was significantly higher than the His bundle activation rate of 6.88 activations/sec (p<0.05). However from 3-8 minutes of unperfused VF the His system activation rate (6.16, 5.53, 5.14, 5.22, 6.00, and 4.62 activations/sec significantly faster than the rate of the VM (4.67, 3.63, 2.94, 2.24, 3.45, and 2.31 activations/sec) (p<0.05). The conduction velocity of the His system immediately decreased to 94% of the sinus rate during perfused VF then gradually decreased to 67% of sinus rhythm conduction at 8 minutes of unperfused VF. Conclusion: During prolonged VF the activation rate of the His bundle is faster than that of the VM. This suggests that the proximal conduction system, like the distal Purkinje system, may be an important driver during long duration VF and may be a target for interventional therapy.	[Angel, Nathan; Li, Li] Univ Utah, Comprehens Arrhythmia Res & Management Ctr, Div Cardiovasc Med, Salt Lake City, UT 84112 USA; [Angel, Nathan; Dosdall, Derek J.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Dosdall, Derek J.] Univ Utah, Ctr Engn Innovat, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Dosdall, DJ (corresponding author), Univ Utah, Comprehens Arrhythmia Res & Management Ctr, Div Cardiovasc Med, Salt Lake City, UT 84112 USA.	derek.dosdall@utah.edu			National Heart, Lung, and Blood Institute of the National Institutes of Health [R00HL091138]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL091138] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under the Award Number: R00HL091138. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHTAR M, 1975, CIRCULATION, V52, P766, DOI 10.1161/01.CIR.52.5.766; BAGDONAS AA, 1961, AM HEART J, V61, P206, DOI 10.1016/0002-8703(61)90577-4; Behradfar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088000; BENHAIM SA, 1993, AM J PHYSIOL, V265, pH1588; Berenfeld O, 1998, CIRC RES, V82, P1063, DOI 10.1161/01.RES.82.10.1063; Bogun F, 2006, J AM COLL CARDIOL, V48, P2500, DOI 10.1016/j.jacc.2006.07.062; Camargo AFD, 2005, J ELECTROCARDIOL, V38, P226, DOI 10.1016/j.jelectrocard.2004.12.002; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUID CAR US LAB AN, VEighth; Coronel R, 2000, J CARDIOVASC ELECTR, V11, P1119, DOI 10.1111/j.1540-8167.2000.tb01758.x; Decker KF, 2009, AM J PHYSIOL-HEART C, V296, pH1017, DOI 10.1152/ajpheart.01216.2008; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; Dosdall DJ, 2008, AM J PHYSIOL-HEART C, V295, pH883, DOI 10.1152/ajpheart.00466.2008; Dun W, 2008, J MOL CELL CARDIOL, V45, P617, DOI 10.1016/j.yjmcc.2008.08.001; Efimov I, 2006, HEART RHYTHM, V3, P1100, DOI 10.1016/j.hrthm.2006.03.005; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; FRIEDMAN PL, 1973, CIRC RES, V33, P612, DOI 10.1161/01.RES.33.5.612; FRIEDMAN PL, 1973, CIRC RES, V33, P597, DOI 10.1161/01.RES.33.5.597; Haissaguerre M, 2002, LANCET, V359, P677, DOI 10.1016/S0140-6736(02)07807-8; Huang J, 2014, IMPORTANCE PURKINIE; Huelsing DJ, 1999, AM J PHYSIOL-HEART C, V276, pH572, DOI 10.1152/ajpheart.1999.276.2.H572; Huselsing D, 1999, J BIOL SYST, V7, P491; JOYNER RW, 1986, BIOPHYS J, V50, P1157, DOI 10.1016/S0006-3495(86)83559-7; MENDEZ C, 1970, CIRC RES, V26, P135, DOI 10.1161/01.RES.26.2.135; MYERBURG RJ, 1972, CIRC RES, V30, P217, DOI 10.1161/01.RES.30.2.217; Odening KE, 2010, ELECTROPHYSIOLOGICAL, P643; Oriente V, 2009, RESUSCITATION, V80, P1417, DOI 10.1016/j.resuscitation.2009.08.017; Punske BB, 2003, ANN BIOMED ENG, V31, P781, DOI 10.1114/1.1581877; Robichaux RP, 2010, J CARDIOVASC ELECTR, V21, P1266, DOI 10.1111/j.1540-8167.2010.01803.x; Scheinman MM, 2009, HEART RHYTHM, V6, P1050, DOI 10.1016/j.hrthm.2009.03.011; STEINHAUS BM, 1989, CIRC RES, V64, P449, DOI 10.1161/01.RES.64.3.449; Tabereaux PB, 2007, CIRCULATION, V116, P1113, DOI 10.1161/CIRCULATIONAHA.107.699264; Tovar OH, 2000, CIRCULATION, V102, P2886; Turakhia M, 2007, CURR PROB CARDIOLOGY, V32, P501, DOI 10.1016/j.cpcardiol.2007.05.002; van Rees JB, 2011, J AM COLL CARDIOL, V57, P556, DOI 10.1016/j.jacc.2010.06.059; Weiss JN, 2005, CIRCULATION, V112, P1232, DOI 10.1161/CIRCULATIONAHA.104.529545; Weiss JN, 1999, CIRCULATION, V99, P2819, DOI 10.1161/01.CIR.99.21.2819; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334; Zipes DP, 1999, J CARDIOVASC ELECTR, V10, P267, DOI 10.1111/j.1540-8167.1999.tb00672.x	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101666	10.1371/journal.pone.0101666	http://dx.doi.org/10.1371/journal.pone.0101666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036418	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200020
J	Granjeiro, EM; Marroni, SS; Martins Dias, DP; Heck Bonagamba, LG; Costa, KM; dos Santos, JC; Cortes Oliveira, JA; Machado, BH; Garcia-Cairasco, N				Granjeiro, Erica Maria; Marroni, Simone Saldanha; Martins Dias, Daniel Penteado; Heck Bonagamba, Leni Gomes; Costa, Kaue Machado; dos Santos, Jessica Cristina; Cortes Oliveira, Jose Antonio; Machado, Benedito H.; Garcia-Cairasco, Norberto			Behavioral and Cardiorespiratory Responses to Bilateral Microinjections of Oxytocin into the Central Nucleus of Amygdala of Wistar Rats, an Experimental Model of Compulsion	PLOS ONE			English	Article							DORSAL MOTOR NUCLEUS; BLOOD-PRESSURE; SPECTRAL-ANALYSIS; SOLITARY TRACT; BRAIN-STEM; HEART-RATE; CARDIOVASCULAR REGULATION; CONSCIOUS RATS; VAGUS NERVE; ADH RELEASE	Introduction: The central nucleus of amygdala plays an important role mediating fear and anxiety responses. It is known that oxytocin microinjections into the central nucleus of amygdala induce hypergrooming, an experimental model of compulsive behavior. We evaluated the behavioral and cardiorespiratory responses of conscious rats microinjected with oxytocin into the central nucleus of amygdala. Methods: Male Wistar rats were implanted with guide cannulae into the central nucleus of amygdala and microinjected with oxytocin (0.5 mu g, 1 mu g) or saline. After 24 h, rats had a catheter implanted into the femoral artery for pulsatile arterial pressure measurement. The pulsatile arterial pressure was recorded at baseline conditions and data used for cardiovascular variability and baroreflex sensitivity analysis. Respiratory and behavioral parameters were assessed during this data collection session. Results: Microinjections of oxytocin (0.5 mu g) into the central nucleus of amygdala produced hypergrooming behavior but did not change cardiorespiratory parameters. However, hypergrooming evoked by microinjections of oxytocin (1 mu g) into the central nucleus of amygdala was accompanied by increase in arterial pressure, heart rate and ventilation and augmented the power of low and high (respiratory-related) frequency bands of the systolic arterial pressure spectrum. No changes were observed in power of the low and high frequency bands of the pulse interval spectrum. Baroreflex sensitivity was found lower after oxytocin microinjections, demonstrating that the oxytocin-induced pressor response may involve an inhibition of baroreflex pathways and a consequent facilitation of sympathetic outflow to the cardiovascular system. Conclusions: The microinjection of oxytocin (1 mu g) into the central nucleus of amygdala not only induces hypergrooming but also changes cardiorespiratory parameters. Moreover, specific oxytocin receptor antagonism attenuated hypergrooming but did not affect pressor, tachycardic and ventilatory responses to oxytocin, suggesting the involvement of distinct neural pathways.	[Granjeiro, Erica Maria; Marroni, Simone Saldanha; Martins Dias, Daniel Penteado; Heck Bonagamba, Leni Gomes; Costa, Kaue Machado; dos Santos, Jessica Cristina; Cortes Oliveira, Jose Antonio; Machado, Benedito H.; Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Physiol, BR-14049 Ribeirao Preto, SP, Brazil; [Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Neurosci & Behav Sci, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Garcia-Cairasco, N (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Physiol, BR-14049 Ribeirao Preto, SP, Brazil.	ngcairas@fmrp.usp.br	Costa, Kauê M/H-5574-2012; Dias, Daniel Penteado Martins/J-1783-2014; Machado, Benedito Honorio/B-5139-2013; Cairasco, Norberto Garcia/E-3250-2015	Costa, Kauê M/0000-0002-5562-6495; Cairasco, Norberto Garcia/0000-0001-8857-3775; dos Santos, Jessica Cristina/0000-0002-9671-7123	Fundacao de Amparo A Pesquisa do Estado de Sao Paulo [06/60768-6, 2007/50261-4, 05/56447-7, FAPESP-Cinapce 2005/56447-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil) [02417/09-0]	Fundacao de Amparo A Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Fundacao de Amparo A Pesquisa do Estado de Sao Paulo Grants (06/60768-6; 2007/50261-4; 05/56447-7; FAPESP-Cinapce 2005/56447-7) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil; Grant (02417/09-0). BHM and NGC are established investigators by CNPq-Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala APL, 2009, RESP PHYSIOL NEUROBI, V168, P19, DOI 10.1016/j.resp.2009.06.011; BARTLETT D, 1970, RESP PHYSIOL, V10, P384, DOI 10.1016/0034-5687(70)90056-3; BERNTSON GG, 1988, ANN NY ACAD SCI, V525, P350, DOI 10.1111/j.1749-6632.1988.tb38619.x; BERRIDGE KC, 1989, BEHAV BRAIN RES, V33, P241, DOI 10.1016/S0166-4328(89)80119-6; Braga DC, 2000, AM J PHYSIOL-REG I, V278, pR1474, DOI 10.1152/ajpregu.2000.278.6.R1474; Busnelli M, 2012, J BIOL CHEM, V287, P3617, DOI 10.1074/jbc.M111.277178; CERUTTI C, 1991, ARCH MAL COEUR VAISS, V84, P1235; CHARPAK S, 1984, BRAIN RES, V300, P83, DOI 10.1016/0006-8993(84)91342-8; Coelho BEA, 2008, BRAZ J PROBAB STAT, V22, P183; DANIELSEN EH, 1989, BRAIN RES BULL, V22, P705, DOI 10.1016/0361-9230(89)90090-7; DRAGO F, 1981, BEHAV NEURAL BIOL, V33, P117, DOI 10.1016/S0163-1047(81)92293-7; Draper N.R., 1998, APPL REGRESSION ANAL, P79; FEUERSTEIN G, 1984, J PHARMACOL EXP THER, V228, P348; GALENO TM, 1983, AM J PHYSIOL, V245, pR281, DOI 10.1152/ajpregu.1983.245.2.R281; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; GISPEN WH, 1975, LIFE SCI, V17, P645, DOI 10.1016/0024-3205(75)90103-4; Granjeiro EM, 2009, AUTON NEUROSCI-BASIC, V151, P117, DOI 10.1016/j.autneu.2009.07.022; Granjeiro EM, 2009, RESP PHYSIOL NEUROBI, V166, P32, DOI 10.1016/j.resp.2009.01.003; Grippo AJ, 2009, PSYCHONEUROENDOCRINO, V34, P1542, DOI 10.1016/j.psyneuen.2009.05.017; HILTON SM, 1963, J PHYSIOL-LONDON, V165, P160, DOI 10.1113/jphysiol.1963.sp007049; HOPKINS DA, 1978, EXP BRAIN RES, V32, P529; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; INOUE K, 1991, AM J PHYSIOL, V260, pH842, DOI 10.1152/ajpheart.1991.260.3.H842; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Kuo TBJ, 2005, J CARDIOVASC ELECTR, V16, P864, DOI 10.1111/j.1540-8167.2005.40656.x; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V272, pH485, DOI 10.1152/ajpheart.1997.272.1.H485; Labuschagne I, 2010, NEUROPSYCHOPHARMACOL, V35, P2403, DOI 10.1038/npp.2010.123; Larsen BA, 2009, CARDIOVASCULAR PSYCH, V2009, DOI [10.1155/2009/791017, DOI 10.1155/2009/791017]; Mack SO, 2007, J APPL PHYSIOL, V102, P189, DOI 10.1152/japplphysiol.00522.2006; Marroni SS, 2007, MOL PSYCHIATR, V12, P1103, DOI 10.1038/sj.mp.4002015; Michelini LC, 2001, ANN NY ACAD SCI, V940, P206; MIYAMOTO M, 1977, EUR J PHARMACOL, V44, P143, DOI 10.1016/0014-2999(77)90100-5; MOOS FC, 1995, BRAIN RES, V669, P309, DOI 10.1016/0006-8993(94)01296-T; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Nie L, 1992, Sheng Li Xue Bao, V44, P303; Nosaka S, 1996, JPN J PHYSIOL, V46, P271, DOI 10.2170/jjphysiol.46.271; Oliva WM, 2010, AUTON NEUROSCI-BASIC, V155, P73, DOI 10.1016/j.autneu.2010.01.013; Petersson M, 2007, PSYCHONEUROENDOCRINO, V32, P959, DOI 10.1016/j.psyneuen.2007.06.015; Pittig A, 2013, INT J PSYCHOPHYSIOL, V87, P19, DOI 10.1016/j.ijpsycho.2012.10.012; RICHARD P, 1991, PHYSIOL REV, V71, P331, DOI 10.1152/physrev.1991.71.2.331; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; SACHS BD, 1988, ANN NY ACAD SCI, V525, P1, DOI 10.1111/j.1749-6632.1988.tb38591.x; Saha S, 2005, CLIN EXP PHARMACOL P, V32, P450, DOI 10.1111/j.1440-1681.2005.04210.x; Saha S, 2000, NEUROSCIENCE, V99, P613, DOI 10.1016/S0306-4522(00)00240-2; SCHWABER JS, 1982, J NEUROSCI, V2, P1424, DOI 10.1523/jneurosci.02-10-01424.1982; SHARE L, 1976, CARDIOLOGY, V61, P51, DOI 10.1159/000169792; SHARE L, 1988, PHYSIOL REV, V68, P1248, DOI 10.1152/physrev.1988.68.4.1248; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; STOCK G, 1978, PFLUG ARCH EUR J PHY, V376, P177, DOI 10.1007/BF00581581; SVED AF, 1985, HYPERTENSION, V7, P262, DOI 10.1161/01.HYP.7.2.262; Terenzi MG, 2005, NEUROSCIENCE, V134, P345, DOI 10.1016/j.neuroscience.2005.04.004; THAMES MD, 1979, AM J PHYSIOL, V237, pH299, DOI 10.1152/ajpheart.1979.237.3.H299; Tokita K, 2010, NEUROSCIENCE, V171, P351, DOI 10.1016/j.neuroscience.2010.08.026; TRAN LD, 1982, BRIT J PHARMACOL, V77, P69, DOI 10.1111/j.1476-5381.1982.tb09270.x; VANDERKOOY D, 1984, J COMP NEUROL, V224, P1, DOI 10.1002/cne.902240102; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; WALLACE DM, 1992, BRAIN RES BULL, V28, P447, DOI 10.1016/0361-9230(92)90046-Z; Wsol A, 2014, STRESS, V17, P117, DOI 10.3109/10253890.2013.872620; Wsol A, 2008, J PHYSIOL PHARMACOL, V59, P123; YAMASHITA H, 1979, BRAIN RES, V170, P259, DOI 10.1016/0006-8993(79)90106-9; Yang CCH, 1996, AM J PHYSIOL-HEART C, V270, pH575, DOI 10.1152/ajpheart.1996.270.2.H575; YOSHIMURA R, 1993, ENDOCRINOLOGY, V133, P1239, DOI 10.1210/en.133.3.1239; ZHANG JX, 1986, BRAIN RES, V386, P136, DOI 10.1016/0006-8993(86)90150-2; Zoccal DB, 2010, RESP PHYSIOL NEUROBI, V174, P98, DOI 10.1016/j.resp.2010.08.011; Zoccal DB, 2009, CLIN EXP PHARMACOL P, V36, P1188, DOI 10.1111/j.1440-1681.2009.05202.x	66	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e99284	10.1371/journal.pone.0099284	http://dx.doi.org/10.1371/journal.pone.0099284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036025	Green Published, gold, Green Submitted			2022-12-25	WOS:000339615200003
J	Le, MH; Cao, YR; Zhang, XC; Stacey, G				Le, Mi Ha; Cao, Yangrong; Zhang, Xue-Cheng; Stacey, Gary			LIK1, A CERK1-Interacting Kinase, Regulates Plant Immune Responses in Arabidopsis	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; INNATE IMMUNITY; CHITIN; DEFENSE; GENES; CERK1; EXPRESSION; THALIANA; COMPLEX; PROTEIN	Chitin, an integral component of the fungal cell wall, is one of the best-studied microbe-associated molecular patterns. Previous work identified a LysM receptor-like kinase (LysM-RLK1/CERK1) as the primary chitin receptor in Arabidopsis. In order to identify proteins that interact with CERK1, we conducted a yeast two-hybrid screen using the intracellular kinase domain of CERK1 as the bait. This screen identified 54 putative CERK1-interactors. Screening mutants defective in 43 of these interacting proteins identified only two, a calmodulin like protein (At3g10190) and a leucine-rich repeat receptor like kinase (At3g14840), which differed in their response to pathogen challenge. In the present work, we focused on characterizing the LRR-RLK gene where mutations altered responses to chitin elicitation. This LRR-RLK was named LysM RLK1-interacting kinase 1 (LIK1). The interaction between CERK1 and LIK1 was confirmed by co-immunoprecipitation using protoplasts and transgenic plants. In vitro experiments showed that LIK1 was directly phosphorylated by CERK1. In vivo phosphorylation assays showed that Col-0 wild-type plants have more phosphorylated LIK1 than cerk1 mutant plants, suggesting that LIK1 may be directly phosphorylated by CERK1. Lik1 mutant plants showed an enhanced response to both chitin and flagellin elicitors. In comparison to the wild-type plants, lik1 mutant plants were more resistant to the hemibiotrophic pathogen Pseudomonas syringae, but more susceptible to the necrotrophic pathogen Sclerotinia sclerotiorum. Consistent with the enhanced susceptibility to necrotrophs, lik1 mutants showed reduced expression of genes involved in jasmonic acid and ethylene signaling pathways. These data suggest that LIK1 directly interacts with CERK1 and regulates MAMP-triggered innate immunity.	[Le, Mi Ha; Cao, Yangrong; Zhang, Xue-Cheng; Stacey, Gary] Univ Missouri, C S Bond Life Sci Ctr, Natl Ctr Soybean Biotechnol, Div Plant Sci & Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Stacey, G (corresponding author), Univ Missouri, C S Bond Life Sci Ctr, Natl Ctr Soybean Biotechnol, Div Plant Sci & Biochem, Columbia, MO 65211 USA.	staceyg@missouri.edu	poinssot, benoit/B-2569-2009	poinssot, benoit/0000-0001-5890-4318	Vietnam Education Foundation; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-08ER15309]	Vietnam Education Foundation; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE))	This research was supported by a fellowship awarded to Mi Ha Le by the Vietnam Education Foundation and by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through Grant DE-FG02-08ER15309, to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DICKMAN MB, 1992, PHYSIOL MOL PLANT P, V41, P255, DOI 10.1016/0885-5765(92)90025-Q; Fan J, 2008, PLANT J, V53, P393, DOI 10.1111/j.1365-313X.2007.03303.x; Faulkner C, 2013, P NATL ACAD SCI USA, V110, P9166, DOI 10.1073/pnas.1203458110; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hamel LP, 2010, PLANTA, V232, P787, DOI 10.1007/s00425-010-1215-9; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Liu TT, 2012, SCIENCE, V336, P1160, DOI 10.1126/science.1218867; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Narusaka Y, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25345; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x; Shinya T, 2012, PLANT CELL PHYSIOL, V53, P1696, DOI 10.1093/pcp/pcs113; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Sun WX, 2012, PLANT CELL, V24, P1096, DOI 10.1105/tpc.112.095919; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Takahashi H, 2004, PLANT CELL PHYSIOL, V45, P803, DOI 10.1093/pcp/pch085; Tanaka K, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22598; Wan J, 2010, BIOL PLANTE MICROBE; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wan JR, 2012, PLANT PHYSIOL, V160, P396, DOI 10.1104/pp.112.201699; Wan JR, 2008, PLANT SIGNAL BEHAV, V3, P831, DOI 10.4161/psb.3.10.5916; Wan JR, 2004, MOL PLANT PATHOL, V5, P125, DOI [10.1111/j.1364-3703.2004.00215.x, 10.1111/J.1364-3703.2004.00215.X]; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; Willmann R, 2011, P NATL ACAD SCI USA, V108, P19824, DOI 10.1073/pnas.1112862108; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zeng LR, 2012, PLANT J, V69, P92, DOI 10.1111/j.1365-313X.2011.04773.x; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zhang XC, 2007, PLANT PHYSIOL, V144, P623, DOI 10.1104/pp.107.097097; Zhang XC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-183	48	45	46	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102245	10.1371/journal.pone.0102245	http://dx.doi.org/10.1371/journal.pone.0102245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036661	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200043
J	Legrand, N; Araud, T; Conne, B; Kuijpers, O; Jaquier-Gubler, P; Curran, J				Legrand, Noemie; Araud, Tanguy; Conne, Beatrice; Kuijpers, Odin; Jaquier-Gubler, Pascale; Curran, Joseph			An AUG Codon Conserved for Protein Function Rather than Translational Initiation: The Story of the Protein sElk1	PLOS ONE			English	Article							CONTROL REPORTER SYSTEM; ELK-1; EXPRESSION; COMPLEX; BRAIN; RNA	Elk1 belongs to the ternary complex (TCF) subfamily of the ETS-domain transcription factors. Several studies have implicated an important function for Elk1 in the CNS including synaptic plasticity and cell differentiation. Whilst studying ELK1 gene expression in rat brain a 54 aa N-terminally truncated isoform lacking the DBD was observed on immunoblots. A similar protein was also detected in NGF differentiated PC12 cells. It was proposed that this protein, referred to as sElk1, arose due to a de-novo initiation event at the second AUG codon on the Elk1 ORF. Transient over-expression of sElk1 potentiated neurite growth in the PC12 model and induced differentiation in the absence of NGF, leading to the proposition that it may have a specific function in the CNS. Here we report on the translational expression from the mouse and rat transcript and compare it with our earlier published work on human. Results demonstrate that the previously observed sElk1 protein is a non-specific band arising from the antibody employed. The tight conservation of the internal AUG reported to drive sElk1 expression is in fact coupled to Elk1 protein function, a result consistent with the Elk1-SRE crystal structure. It is also supported by the observed conservation of this methionine in the DBD of all ETS transcription factors independent of the N- or C-terminal positioning of this domain. Reporter assays demonstrate that elements both within the 5'UTR and downstream of the AUG(Elk1) serve to limit 40S access to the AUG(sElk1) codon.	[Legrand, Noemie; Araud, Tanguy; Conne, Beatrice; Kuijpers, Odin; Jaquier-Gubler, Pascale; Curran, Joseph] Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Conne, Beatrice] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Curran, Joseph] Univ Geneva, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Curran, J (corresponding author), Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland.	Joseph.Curran@unige.ch			Swiss National Science Foundation [31003A_143772]; La Ligue Genevoise contre le Cancer	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); La Ligue Genevoise contre le Cancer	This study was supported by the Swiss National Science Foundation (Grant #31003A_143772) and La Ligue Genevoise contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araud T, 2007, NUCLEIC ACIDS RES, V35, P4649, DOI 10.1093/nar/gkm482; Barrett LE, 2006, P NATL ACAD SCI USA, V103, P5155, DOI 10.1073/pnas.0510477103; Figueroa C, 2003, ONCOGENE, V22, P5554, DOI 10.1038/sj.onc.1206496; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Lavaur J, 2007, J NEUROSCI, V27, P14448, DOI 10.1523/JNEUROSCI.2279-07.2007; Lin H, 2007, TOXICOL SCI, V96, P83, DOI 10.1093/toxsci/kfl172; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Rahim G, 2012, MOL CELL BIOL, V32, P1745, DOI 10.1128/MCB.06751-11; Sgambato V, 1998, J NEUROSCI, V18, P214; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Somers J, 2013, INT J BIOCHEM CELL B, V45, P1690, DOI 10.1016/j.biocel.2013.04.020; Szatmari EM, 2013, J NEUROSCI, V33, P5367, DOI 10.1523/JNEUROSCI.2641-12.2013; Vanhoutte P, 2001, J BIOL CHEM, V276, P5189, DOI 10.1074/jbc.M006678200; VANHOUTTE P, 2002, HAND CHEM N, V19, P287; Wang XQ, 2004, NUCLEIC ACIDS RES, V32, P1382, DOI 10.1093/nar/gkh305; Wiesenthal V, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj029; Wiesenthal V, 2006, NAT PROTOC, V1, P1531, DOI 10.1038/nprot.2006.274	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102890	10.1371/journal.pone.0102890	http://dx.doi.org/10.1371/journal.pone.0102890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036748	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200092
J	Chakraborty, S; Nunez, D; Hu, SY; Domingo, MP; Pardo, J; Karmenyan, A; Galvez, EM; Chiou, A				Chakraborty, Sandeep; Nunez, David; Hu, Shih-Yang; Domingo, Maria Pilar; Pardo, Julian; Karmenyan, Artashes; Galvez, Eva Ma; Chiou, Arthur			FRET Based Quantification and Screening Technology Platform for the Interactions of Leukocyte Function-Associated Antigen-1 (LFA-1) with InterCellular Adhesion Molecule-1 (ICAM-1)	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; I-DOMAIN; PROTEIN INTERACTIONS; INTEGRIN REGULATION; CRYSTAL-STRUCTURE; COUNTER-RECEPTOR; STRUCTURAL BASIS; BINDING; SPECTROSCOPY; AFFINITY	The interaction between leukocyte function-associated antigen-1(LFA-1) and intercellular adhesion molecule-1 (ICAM-1) plays a pivotal role in cellular adhesion including the extravasation and inflammatory response of leukocytes, and also in the formation of immunological synapse. However, irregular expressions of LFA-1 or ICAM-1 or both may lead to autoimmune diseases, metastasis cancer, etc. Thus, the LFA-1/ICAM-1 interaction may serve as a potential therapeutic target for the treatment of these diseases. Here, we developed one simple 'in solution' steady state fluorescence resonance energy transfer (FRET) technique to obtain the dissociation constant (K-d) of the interaction between LFA-1 and ICAM-1. Moreover, we developed the assay into a screening platform to identify peptides and small molecules that inhibit the LFA-1/ICAM-1 interaction. For the FRET pair, we used Alexa Fluor 488-LFA-1 conjugate as donor and Alexa Fluor 555-human recombinant ICAM-1 (D1-D2-Fc) as acceptor. From our quantitative FRET analysis, the K-d between LFA-1 and D1-D2-Fc was determined to be 17.93 +/- 1.34 nM. Both the K-d determination and screening assay were performed in a 96-well plate platform, providing the opportunity to develop it into a high-throughput assay. This is the first reported work which applies FRET based technique to determine K-d as well as classifying inhibitors of the LFA-1/ICAM-1 interaction.	[Chakraborty, Sandeep; Hu, Shih-Yang; Chiou, Arthur] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Nunez, David; Domingo, Maria Pilar; Galvez, Eva Ma] CSIC, Inst Carboquim, Zaragoza, Spain; [Nunez, David; Domingo, Maria Pilar; Pardo, Julian; Galvez, Eva Ma] Biomed Res Ctr Aragon, Aragon Hlth Res Inst, Immune Effector Cells Grp, Zaragoza, Spain; [Pardo, Julian] Univ Zaragoza, Fac Ciencias, Dept Biochem & Mol & Cell Biol, E-50009 Zaragoza, Spain; [Pardo, Julian] Govt Aragon, Aragon I D Fdn, Zaragoza, Spain; [Pardo, Julian] Univ Zaragoza, Nanosci Inst Aragon, Aragon I D Fdn, Zaragoza, Spain; [Karmenyan, Artashes; Chiou, Arthur] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Carboquimica (ICB); University of Zaragoza; University of Zaragoza; National Yang Ming Chiao Tung University	Karmenyan, A (corresponding author), Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan.	artashes@ym.edu.tw; eva@icb.csic.es; aechiou@ym.edu.tw	Domingo, Pilar/D-6325-2014; Galvez, Eva M./K-6751-2014; Karmenyan, Artashes/U-3697-2019; Pardo, Julián/K-6764-2014	Domingo, Pilar/0000-0002-6829-8769; Galvez, Eva M./0000-0001-6928-5516; Pardo, Julián/0000-0003-0154-0730; Nunez Jurado, David/0000-0002-0360-5625	National Science Council, Taiwan, ROC (Spain-Taiwan Collaborative Research Project) [NSC99-2923- E-010-001-MY3]; Taiwan Ministry of Education - Spanish National Science Council (CSIC) [2009tw0034]; Spanish Ministry of Economy and Competitiveness [SAF2011-25390]	National Science Council, Taiwan, ROC (Spain-Taiwan Collaborative Research Project); Taiwan Ministry of Education - Spanish National Science Council (CSIC); Spanish Ministry of Economy and Competitiveness(Spanish Government)	SC SH AK AC were jointly supported by the National Science Council, Taiwan, ROC (Spain-Taiwan Collaborative Research Project, Project No. NSC99-2923- E-010-001-MY3), the Top University Project from Taiwan Ministry of Education while DN MPD JP EG were supported by the Spanish National Science Council (CSIC) (2009tw0034), SAF2011-25390 from Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2003, PEPTIDES, V24, P487, DOI 10.1016/S0196-9781(03)00083-4; Barbeau B, 1998, J VIROL, V72, P7125, DOI 10.1128/JVI.72.9.7125-7136.1998; Bernabeu M, 2012, CELL MICROBIOL, V14, P386, DOI 10.1111/j.1462-5822.2011.01726.x; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Bojarski P, 2011, J PHYS CHEM B, V115, P10120, DOI 10.1021/jp202152m; Bossis G, 2005, METHOD ENZYMOL, V398, P20, DOI 10.1016/S0076-6879(05)98003-8; Chen HM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2799171; Ciubotaru M, 2007, MOL CELL BIOL, V27, P4745, DOI 10.1128/MCB.00177-07; CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Estecha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033313; Fairclough R H, 1978, Methods Enzymol, V48, P347; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; Fuchs R, 2010, REV MED VIROL, V20, P281, DOI 10.1002/rmv.654; Giguere JF, 2004, J VIROL, V78, P12062, DOI 10.1128/JVI.78.21.12062-12065.2004; Gottlieb AB, 2002, ARCH DERMATOL, V138, P591, DOI 10.1001/archderm.138.5.591; Grunwald D, 2005, CURR PHARM BIOTECHNO, V6, P381, DOI 10.2174/138920105774370616; Hieb AR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1045; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; HUANG CC, 1995, J BIOL CHEM, V270, P19008, DOI 10.1074/jbc.270.32.19008; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ihanus E, 2003, EUR J BIOCHEM, V270, P1710, DOI 10.1046/j.1432-1033.2003.03528.x; ISOBE M, 1992, SCIENCE, V255, P1125, DOI 10.1126/science.1347662; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; KAVANAUGH AF, 1994, ARTHRITIS RHEUM, V37, P992, DOI 10.1002/art.1780370703; Kinashi T, 2007, ADV IMMUNOL, V93, P185, DOI 10.1016/S0065-2776(06)93005-3; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lichlyter DJ, 2003, BIOSENS BIOELECTRON, V19, P219, DOI 10.1016/S0956-5663(03)00215-X; Liu L, 2008, BIOCONJUGATE CHEM, V19, P574, DOI 10.1021/bc700369q; Long EO, 2011, J IMMUNOL, V186, P5021, DOI 10.4049/jimmunol.1100646; Lou JN, 1997, NEUROREPORT, V8, P629, DOI 10.1097/00001756-199702100-00010; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma XY, 2006, PROTEIN PEPTIDE LETT, V13, P397, DOI 10.2174/092986606775974429; Maliwal BP, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.011006; Martin SF, 2008, PROTEIN SCI, V17, P777, DOI 10.1110/ps.073369608; Medintz IL, 2003, NAT MATER, V2, P630, DOI 10.1038/nmat961; Nunez D, 2013, PROCESS BIOCHEM, V48, P708, DOI 10.1016/j.procbio.2013.03.006; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Song Y, 2012, BIOTECHNOL BIOENG, V109, P2875, DOI 10.1002/bit.24564; Song Y, 2011, ANN BIOMED ENG, V39, P1224, DOI 10.1007/s10439-010-0225-x; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stankovic-Valentin Nicolas, 2009, V497, P241, DOI 10.1007/978-1-59745-566-4_16; Steinman L, 1996, P NATL ACAD SCI USA, V93, P2253, DOI 10.1073/pnas.93.6.2253; Sun YS, 2013, CYTOM PART A, V83, P780, DOI 10.1002/cyto.a.22321; Tibbetts SA, 2000, PEPTIDES, V21, P1161, DOI 10.1016/S0196-9781(00)00255-2; Tominaga Y, 1998, J IMMUNOL, V161, P4016; Tsuganezawa K, 2013, J BIOMOL SCREEN, V18, P1103, DOI 10.1177/1087057113492200; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; Wu SH, 2014, BIOSENS BIOELECTRON, V56, P159, DOI 10.1016/j.bios.2014.01.008; Xiao CA, 2005, STRUCTURE, V13, P1019, DOI 10.1016/j.str.2005.04.011; Yang HP, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/368938; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001; Zheng Y, 2013, LEUKEMIA, V27, P702, DOI 10.1038/leu.2012.272; Zhou CL, 2011, PEPTIDES, V32, P408, DOI 10.1016/j.peptides.2010.10.019; Zhu XW, 2013, ASIAN PAC J CANCER P, V14, P1579, DOI 10.7314/APJCP.2013.14.3.1579	64	8	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102572	10.1371/journal.pone.0102572	http://dx.doi.org/10.1371/journal.pone.0102572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032811	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300064
J	Li, C; Xu, XF; Wang, XJ; Pan, YJ				Li, Chang; Xu, Xiaofei; Wang, Xiu Jun; Pan, Yuanjiang			Imine Resveratrol Analogues: Molecular Design, Nrf2 Activation and SAR Analysis	PLOS ONE			English	Article							CANCER PREVENTION; EPITHELIAL-CELLS; HEME OXYGENASE-1; PATHWAY; INDUCTION; PHYTOCHEMICALS; DERIVATIVES; EXPRESSION; PROTECT; ENZYMES	Resveratrol is a natural phenol with protective effects against cancer and inflammation-related diseases. Its mechanism of action involves the activation of nuclear factor E2 p45-related factor 2 (Nrf2), which plays a key role in regulation of genes driven by antioxidant response element (ARE). Inspired by the effect of resveratrol, here we synthesized a series of imine resveratrol analogs (IRAs), evaluated their abilities to activate Nrf2 by using cell based ARE-reporter assay. After the first-round screening, preliminary and quantitative structure-activity relationship (SAR) was analyzed, and the structural features determining Nrf2 activation ability were proposed. Two novel IRAs were designed and subsequently synthesized, namely 2-methoxyl-3,6-dihydroxyl-IRA and 2,3,6-trihydroxyl-IRA. They were proved to be the most potent Nrf2 activators among the IRAs.	[Li, Chang; Xu, Xiaofei; Pan, Yuanjiang] Zhejiang Univ, Dept Chem, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Xiu Jun] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wang, XJ (corresponding author), Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310003, Zhejiang, Peoples R China.	xjwang@zju.edu.cn; panyuanjiang@zju.edu.cn	Li, Chang/AAP-7203-2020	Li, Chang/0000-0003-4681-0191	Joint Sino-German Research Project [GZ689]; Ministry of Commerce; PRC (Research and Development of Natural Herbal Medicine Phase II, a Technology Aid Project to Republic of Indonesia); Science and Technology Department of Zhejiang Province, China [2010C33156]; National Natural Science Foundation of China [81172230]; Zhejiang Natural Science Foundation [LZ12H16001]	Joint Sino-German Research Project; Ministry of Commerce; PRC (Research and Development of Natural Herbal Medicine Phase II, a Technology Aid Project to Republic of Indonesia); Science and Technology Department of Zhejiang Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was financially supported from Joint Sino-German Research Project (GZ689), Ministry of Commerce, PRC (Research and Development of Natural Herbal Medicine Phase II, a Technology Aid Project to Republic of Indonesia), Science and Technology Department of Zhejiang Province, China (2010C33156), the National Natural Science Foundation of China (81172230) and the Zhejiang Natural Science Foundation (LZ12H16001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko Y, 2013, CHEM RES TOXICOLOGY; Ahn YH, 2010, P NATL ACAD SCI USA, V107, P9590, DOI 10.1073/pnas.1004104107; Akiyama T, 2008, ADV SYNTH CATAL, V350, P399, DOI 10.1002/adsc.200700521; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bishayee A, 2010, CANCER PREV RES, V3, P753, DOI 10.1158/1940-6207.CAPR-09-0171; Cheung KL, 2011, CHEM RES TOXICOL, V24, P670, DOI 10.1021/tx1004369; Dinikova-Kostova AT, 2004, METHOD ENZYMOL, V382, P423; Dinkova-Kostova AT, 2010, J BIOL CHEM, V285, P33747, DOI 10.1074/jbc.M110.163485; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Farombi EO, 2008, FOOD CHEM TOXICOL, V46, P1279, DOI 10.1016/j.fct.2007.09.095; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Hsieh Tze-chen, 2006, Med Chem, V2, P275, DOI 10.2174/157340606776930709; Hu CQ, 2011, CHEM RES TOXICOL, V24, P515, DOI 10.1021/tx100389r; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jiang LY, 2010, J AGR FOOD CHEM, V58, P9020, DOI 10.1021/jf102005z; Juan Andres R, 2008, EUROPEAN J PHARM, V591, P66; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kumar V, 2011, J MED CHEM, V54, P4147, DOI 10.1021/jm2002348; Lee CY, 2010, EUR J MED CHEM, V45, P2957, DOI 10.1016/j.ejmech.2010.03.023; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Lu J, 2012, BIOORG MED CHEM LETT, V22, P5744, DOI 10.1016/j.bmcl.2012.06.026; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003; Nair S, 2006, PHARM RES-DORDR, V23, P2621, DOI 10.1007/s11095-006-9099-x; Talalay P, 2001, J NUTR, V131, p3027S, DOI 10.1093/jn/131.11.3027S; Tanaka K, 2000, GREEN CHEM, V2, P272, DOI 10.1039/b006424f; Tang XW, 2011, FREE RADICAL BIO MED, V50, P1599, DOI 10.1016/j.freeradbiomed.2011.03.008; Umar A, 2012, NAT REV CANCER, V12, P835, DOI 10.1038/nrc3397; Vrba J, 2013, J MED CHEM, V56, P856, DOI 10.1021/jm3013344; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Xi MY, 2013, EUR J MED CHEM, V66, P364, DOI 10.1016/j.ejmech.2013.06.007; Yamanaka M, 2007, J AM CHEM SOC, V129, P6756, DOI 10.1021/ja0684803	33	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101455	10.1371/journal.pone.0101455	http://dx.doi.org/10.1371/journal.pone.0101455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25028928	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600016
J	Zargarian, L; Tisne, C; Barraud, P; Xu, XQ; Morellet, N; Rene, B; Mely, Y; Fosse, P; Mauffret, O				Zargarian, Loussine; Tisne, Carine; Barraud, Pierre; Xu, Xiaoqian; Morellet, Nelly; Rene, Brigitte; Mely, Yves; Fosse, Philippe; Mauffret, Olivier			Dynamics of Linker Residues Modulate the Nucleic Acid Binding Properties of the HIV-1 Nucleocapsid Protein Zinc Fingers	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; BACKBONE DYNAMICS; NMR RELAXATION; CHAPERONE ACTIVITY; STRAND TRANSFER; CTAR DNA; STRUCTURAL DETERMINANTS; REVERSE TRANSCRIPTION	The HIV-1 nucleocapsid protein (NC) is a small basic protein containing two zinc fingers (ZF) separated by a short linker. It is involved in several steps of the replication cycle and acts as a nucleic acid chaperone protein in facilitating nucleic acid strand transfers occurring during reverse transcription. Recent analysis of three-dimensional structures of NC-nucleic acids complexes established a new property: the unpaired guanines targeted by NC are more often inserted in the C-terminal zinc finger (ZF2) than in the N-terminal zinc finger (ZF1). Although previous NMR dynamic studies were performed with NC, the dynamic behavior of the linker residues connecting the two ZF domains remains unclear. This prompted us to investigate the dynamic behavior of the linker residues. Here, we collected N-15 NMR relaxation data and used for the first time data at several fields to probe the protein dynamics. The analysis at two fields allows us to detect a slow motion occurring between the two domains around a hinge located in the linker at the G35 position. However, the amplitude of motion appears limited in our conditions. In addition, we showed that the neighboring linker residues R29, A30, P31, R32, K33 displayed restricted motion and numerous contacts with residues of ZF1. Our results are fully consistent with a model in which the ZF1-linker contacts prevent the ZF1 domain to interact with unpaired guanines, whereas the ZF2 domain is more accessible and competent to interact with unpaired guanines. In contrast, ZF1 with its large hydrophobic plateau is able to destabilize the double-stranded regions adjacent to the guanines bound by ZF2. The linker residues and the internal dynamics of NC regulate therefore the different functions of the two zinc fingers that are required for an optimal chaperone activity.	[Zargarian, Loussine; Xu, Xiaoqian; Rene, Brigitte; Fosse, Philippe; Mauffret, Olivier] CNRS, Unite Mixte Rech 8113, Ecole Normale Super Cachan, Lab Biol & Pharmacol Appl, Cachan, France; [Tisne, Carine; Barraud, Pierre] Univ Paris 05, Unite Mixte Rech 8015, CNRS, Lab Cristallog & RMN Biol, Paris, France; [Xu, Xiaoqian] E China Normal Univ, Dept Life Sci, Shanghai 200062, Peoples R China; [Morellet, Nelly] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, Gif Sur Yvette, France; [Mely, Yves] Univ Strasbourg, Fac Pharm, CNRS, Lab Biophoton & Pharmacol,Unite Mixte Rech 7213, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; East China Normal University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mauffret, O (corresponding author), CNRS, Unite Mixte Rech 8113, Ecole Normale Super Cachan, Lab Biol & Pharmacol Appl, Cachan, France.	olivier.mauffret@lbpa.ens-cachan.fr	Barraud, Pierre/AAT-9884-2020	Barraud, Pierre/0000-0003-4460-8360; morellet, nelly/0000-0001-5076-8884; Tisne, Carine/0000-0001-5534-4650	ANRS; CNRS; TGIR-RMN-THC [Fr3050 CNRS]	ANRS(ANRSFrench National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); TGIR-RMN-THC	ANRS and CNRS supported the work. Financial support from the TGIR-RMN-THC Fr3050 CNRS for conducting the research is gratefully acknowledged. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Aduri R, 2013, NUCLEIC ACIDS RES, V41, P2565, DOI 10.1093/nar/gks1350; Akke M, 1997, RNA, V3, P702; Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; Avilov SV, 2008, NUCLEIC ACIDS RES, V36, P885, DOI 10.1093/nar/gkm1109; Avilov SV, 2009, BIOCHEMISTRY-US, V48, P2422, DOI 10.1021/bi8022366; Baber JL, 2001, J AM CHEM SOC, V123, P3953, DOI 10.1021/ja0041876; Barraud P, 2007, BIOCHIMIE, V89, P1204, DOI 10.1016/j.biochi.2007.01.016; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Bazzi A, 2011, NUCLEIC ACIDS RES, V39, P3903, DOI 10.1093/nar/gkq1290; Beltz H, 2005, J MOL BIOL, V348, P1113, DOI 10.1016/j.jmb.2005.02.042; Beltz H, 2004, J MOL BIOL, V338, P711, DOI 10.1016/j.jmb.2004.03.019; Bourbigot S, 2008, J MOL BIOL, V383, P1112, DOI 10.1016/j.jmb.2008.08.046; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Cristofari G, 2002, PROG NUCLEIC ACID RE, V72, P223, DOI 10.1016/S0079-6603(02)72071-0; Cruceanu M, 2006, J MOL BIOL, V363, P867, DOI 10.1016/j.jmb.2006.08.070; DAMASCHUN G, 1993, BIOCHEMISTRY-US, V32, P7739, DOI 10.1021/bi00081a019; Darlix JL, 2007, ADV PHARMACOL, V55, P299, DOI 10.1016/S1054-3589(07)55009-X; Darlix JL, 2011, J MOL BIOL, V410, P565, DOI 10.1016/j.jmb.2011.03.037; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fisher RJ, 2006, NUCLEIC ACIDS RES, V34, P472, DOI 10.1093/nar/gkj442; Fisher RJ, 1998, J VIROL, V72, P1902, DOI 10.1128/JVI.72.3.1902-1909.1998; Godet J, 2013, NUCLEIC ACIDS RES, V41, P5036, DOI 10.1093/nar/gkt164; Godet J, 2011, NUCLEIC ACIDS RES, V39, P6633, DOI 10.1093/nar/gkr274; Godet J, 2010, RNA BIOL, V7, P687, DOI 10.4161/rna.7.6.13616; GORELICK RJ, 1993, J VIROL, V67, P4027, DOI 10.1128/JVI.67.7.4027-4036.1993; Guo JH, 2000, J VIROL, V74, P8980, DOI 10.1128/JVI.74.19.8980-8988.2000; Guo JH, 2002, J VIROL, V76, P4370, DOI 10.1128/JVI.76.9.4370-4378.2002; Heath MJ, 2003, J BIOL CHEM, V278, P30755, DOI 10.1074/jbc.M303819200; Hyre DE, 1998, J MOL BIOL, V279, P929, DOI 10.1006/jmbi.1998.1811; Johnson PE, 2000, BIOCHEMISTRY-US, V39, P9084, DOI 10.1021/bi000841i; Kafaie J, 2008, VIROLOGY, V375, P592, DOI 10.1016/j.virol.2008.02.001; Kay LE, 2005, J MAGN RESON, V173, P193, DOI 10.1016/j.jmr.2004.11.021; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Korzhnev DM, 1997, J MAGN RESON, V127, P184, DOI 10.1006/jmre.1997.1190; Korzhnev DM, 2000, J BIOMOL NMR, V17, P231, DOI 10.1023/A:1008348827208; Lee BM, 1998, J MOL BIOL, V279, P633, DOI 10.1006/jmbi.1998.1766; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; Lienin SF, 1998, J AM CHEM SOC, V120, P9870, DOI 10.1021/ja9810179; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Luginbuhl P, 2002, PROG NUCL MAG RES SP, V40, P199, DOI 10.1016/S0079-6565(01)00043-7; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MELY Y, 1994, BIOCHEMISTRY-US, V33, P12085, DOI 10.1021/bi00206a011; MELY Y, 1993, BIOPHYS J, V65, P1513, DOI 10.1016/S0006-3495(93)81222-0; Mirambeau G, 2006, J MOL BIOL, V364, P496, DOI 10.1016/j.jmb.2006.08.065; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; MORELLET N, 1994, J MOL BIOL, V235, P287, DOI 10.1016/S0022-2836(05)80033-6; Morellet N, 1998, J MOL BIOL, V283, P419, DOI 10.1006/jmbi.1998.2098; Musier-Forsyth K, 2010, RNA BIOL, V7, P632, DOI 10.4161/rna.7.6.14467; Oberstrass FC, 2008, J AM CHEM SOC, V130, P12007, DOI 10.1021/ja8023115; Ochsenbein F, 2001, J BIOMOL NMR, V19, P3, DOI 10.1023/A:1008390606077; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; OTTMANN M, 1995, J VIROL, V69, P1778, DOI 10.1128/JVI.69.3.1778-1784.1995; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; PENG JW, 1991, J MAGN RESON, V95, P421, DOI 10.1016/0022-2364(91)90233-J; Ramalanjaona N, 2007, J MOL BIOL, V374, P1041, DOI 10.1016/j.jmb.2007.10.001; Ramboarina S, 2002, J MOL BIOL, V316, P611, DOI 10.1006/jmbi.2001.5379; Ravindranathan S, 2010, J MOL BIOL, V396, P732, DOI 10.1016/j.jmb.2009.12.004; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shajani Z, 2005, J MOL BIOL, V349, P699, DOI 10.1016/j.jmb.2005.04.012; Sleiman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064700; Spriggs S, 2008, BIOCHEMISTRY-US, V47, P13064, DOI 10.1021/bi8014373; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; Tisne C, 2005, CURR HIV RES, V3, P147, DOI 10.2174/1570162053506919; Tisne C, 2003, BIOCHIMIE, V85, P557, DOI 10.1016/S0300-9084(03)00034-8; Tisne C, 2001, J MOL BIOL, V306, P443, DOI 10.1006/jmbi.2000.4391; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Urbaneja MA, 1999, J MOL BIOL, V287, P59, DOI 10.1006/jmbi.1998.2521; Vuilleumier C, 1999, BIOCHEMISTRY-US, V38, P16816, DOI 10.1021/bi991145p; Webb JA, 2013, RNA, V19, P1078, DOI 10.1261/rna.038869.113; Williams MC, 2002, P NATL ACAD SCI USA, V99, P8614, DOI 10.1073/pnas.132128999; Williams MC, 2001, P NATL ACAD SCI USA, V98, P6121, DOI 10.1073/pnas.101033198; Wu H, 2013, VIRUS RES, V42, P2525; Yip GNB, 2004, J MAGN RESON, V171, P25, DOI 10.1016/j.jmr.2004.06.021	84	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102150	10.1371/journal.pone.0102150	http://dx.doi.org/10.1371/journal.pone.0102150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029439	Green Published, gold			2022-12-25	WOS:000341306600037
J	Cho, BJ; Heo, JW; Shin, JP; Ahn, J; Kim, TW; Chung, H				Cho, Bum-Joo; Heo, Jang Won; Shin, Jae Pil; Ahn, Jeeyun; Kim, Tae Wan; Chung, Hum			Association between Reproductive Factors and Age-Related Macular Degeneration in Postmenopausal Women: The Korea National Health and Nutrition Examination Survey 2010-2012	PLOS ONE			English	Article							RISK-FACTORS; HORMONE REPLACEMENT; VISUAL IMPAIRMENT; MACULOPATHY; LACTATION; PREVALENCE; ESTROGEN; THERAPY; EYE; POPULATION	Purpose: To examine the association between female reproductive factors and age-related macular degeneration (AMD) in postmenopausal women. Design: Nationwide population-based cross-sectional study. Methods: A nationally representative dataset acquired from the 2010-2012 Korea National Health and Nutrition Examination Survey was analyzed. The dataset involved information for 4,377 postmenopausal women aged >= 50 years with a fundus photograph evaluable for AMD in either eye. All participants were interviewed using standardized questionnaires to determine reproductive factors including menstruation, pregnancy, parity, lactation, and hormonal use. The association between reproductive factors and each type of AMD was investigated. Results: The mean age of the study participants was 63.1 +/- 0.2 years. Mean ages at menarche and menopause were 16.1 +/- 0.0 and 49.2 +/- 0.1 years, respectively. The overall prevalence rates of early and late AMD were 11.2% (95% confidence interval [CI], 10.1-12.5) and 0.8% (95% CI, 0.5-1.2), respectively. When adjusted for age, neither smoking nor alcohol use was associated with the presence of any AMD or late AMD. Multivariate logistic regression analysis revealed age (OR, 1.12 per 1 year), duration of lactation (OR, 0.91 per 6 months), and duration of use of oral contraceptive pills (OCP) (OR, 1.10 per 6 months) as associated factors for late AMD. The other variables did not yield a significant correlation with the risk of any AMD or late AMD. Conclusion: After controlling for confounders, a longer duration of lactation appeared to protect against the development of late AMD. A longer duration of OCP use was associated with a higher risk of late AMD.	[Cho, Bum-Joo; Heo, Jang Won; Ahn, Jeeyun; Kim, Tae Wan; Chung, Hum] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Cho, Bum-Joo; Heo, Jang Won; Chung, Hum] Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul 110744, South Korea; [Shin, Jae Pil] Kyungpook Natl Univ, Sch Med, Dept Ophthalmol, Taegu, South Korea; [Ahn, Jeeyun; Kim, Tae Wan] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Ophthalmol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Kyungpook National University; Seoul National University (SNU); Seoul National University Hospital	Heo, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	jangwonheo@gmail.com		Ahn, Jeeyun/0000-0001-9017-1652; Cho, Bum-Joo/0000-0002-0244-388X				Abramov Y, 2004, MENOPAUSE, V11, P62, DOI 10.1097/01.GME.0000074701.19603.11; [Anonymous], 2013, AM J OPHTHALMOL; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Cheung CMG, 2013, AM J OPHTHALMOL, V155, P764, DOI 10.1016/j.ajo.2012.10.013; Cho BJ, 2014, INVEST OPHTH VIS SCI, V55, P1101, DOI 10.1167/iovs.13-13096; Christin-Maitre S, 2013, BEST PRACT RES CL EN, V27, P3, DOI 10.1016/j.beem.2012.11.004; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Connell PP, 2009, J OPHTHALMOL, V2009, DOI 10.1155/2009/360764; Edwards DRV, 2010, INVEST OPHTH VIS SCI, V51, P1873, DOI 10.1167/iovs.09-4000; Erke MG, 2013, BRIT J OPHTHALMOL, V97, P1036, DOI 10.1136/bjophthalmol-2012-302461; Fagerhaug TN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1070; Feskanich D, 2008, ARCH OPHTHALMOL-CHIC, V126, P519, DOI 10.1001/archopht.126.4.519; Fraser-Bell S, 2006, AM J OPHTHALMOL, V141, P79, DOI 10.1016/j.ajo.2005.08.024; Gemmy Cheung CM, 2013, AM J OPHTHALMOL, V155, pe761; Haan MN, 2006, ARCH OPHTHALMOL-CHIC, V124, P988, DOI 10.1001/archopht.124.7.988; KJOS SL, 1993, OBSTET GYNECOL, V82, P451; Klein BEK, 2000, AM J OPHTHALMOL, V130, P322, DOI 10.1016/S0002-9394(00)00474-8; Klein R, 2003, OPHTHALMOLOGY, V110, P636, DOI 10.1016/S0161-6420(02)01448-3; La Corte AIC, 2008, J RENIN-ANGIO-ALDO S, V9, P221, DOI 10.1177/1470320308096405; McClure CK, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.030; Nirmalan PK, 2004, INVEST OPHTH VIS SCI, V45, P4273, DOI 10.1167/iovs.04-0285; Pascolini D, 2004, OPHTHAL EPIDEMIOL, V11, P67, DOI 10.1076/opep.11.2.67.28158; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P1740, DOI 10.1167/iovs.02-0775; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Schwarz EB, 2009, OBSTET GYNECOL, V113, P974, DOI 10.1097/01.AOG.0000346884.67796.ca; Sitruk-Ware R, 2013, BEST PRACT RES CL EN, V27, P13, DOI 10.1016/j.beem.2012.09.004; Smith W, 1997, AUST NZ J OPHTHALMOL, V25, pS13; Snow KK, 2002, AM J OPHTHALMOL, V134, P842, DOI 10.1016/S0002-9394(02)01755-5; Stuebe AM, 2005, JAMA-J AM MED ASSOC, V294, P2601, DOI 10.1001/jama.294.20.2601; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; Urrutia RP, 2013, OBSTET GYNECOL, V122, P380, DOI 10.1097/AOG.0b013e3182994c43; van Leeuwen R, 2003, INVEST OPHTH VIS SCI, V44, P3771, DOI 10.1167/iovs.03-0121; Wiegratz I, 2004, CONTRACEPTION, V70, P97, DOI 10.1016/j.contraception.2004.03.004; Williams MJA, 2006, J EPIDEMIOL COMMUN H, V60, P146, DOI 10.1136/jech.2005.039222; YANNUZZI LA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1701; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421	36	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102816	10.1371/journal.pone.0102816	http://dx.doi.org/10.1371/journal.pone.0102816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025761	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400105
J	Lassen, LM; Nielsen, AZ; Olsen, CE; Bialek, W; Jensen, K; Moller, BL; Jensen, PE				Lassen, Laerke Munter; Nielsen, Agnieszka Zygadlo; Olsen, Carl Erik; Bialek, Wojciech; Jensen, Kenneth; Moller, Birger Lindberg; Jensen, Poul Erik			Anchoring a Plant Cytochrome P450 via PsaM to the Thylakoids in Synechococcus sp PCC 7002: Evidence for Light-Driven Biosynthesis	PLOS ONE			English	Article							PHOTOSYSTEM-I; CYANOBACTERIA; INACTIVATION; COMPLEX; P450	Plants produce an immense variety of specialized metabolites, many of which are of high value as their bioactive properties make them useful as for instance pharmaceuticals. The compounds are often produced at low levels in the plant, and due to their complex structures, chemical synthesis may not be feasible. Here, we take advantage of the reducing equivalents generated in photosynthesis in developing an approach for producing plant bioactive natural compounds in a photosynthetic microorganism by functionally coupling a biosynthetic enzyme to photosystem I. This enables driving of the enzymatic reactions with electrons extracted from the photosynthetic electron transport chain. As a proof of concept, we have genetically fused the soluble catalytic domain of the cytochrome P450 CYP79A1, originating from the endoplasmic reticulum membranes of Sorghum bicolor, to a photosystem I subunit in the cyanobacterium Synechococcus sp. PCC 7002, thereby targeting it to the thylakoids. The engineered enzyme showed light-driven activity both in vivo and in vitro, demonstrating the possibility to achieve light-driven biosynthesis of high-value plant specialized metabolites in cyanobacteria.	[Lassen, Laerke Munter; Nielsen, Agnieszka Zygadlo; Olsen, Carl Erik; Jensen, Kenneth; Moller, Birger Lindberg; Jensen, Poul Erik] Univ Copenhagen, Ctr Synthet Biol BioSYNergy, VILLUM Res Ctr Plant Plast, Copenhagen Plant Sci Ctr,Dept Plant & Environm Sc, Copenhagen, Denmark; [Bialek, Wojciech] Univ Wroclaw, Dept Biophys, Fac Biotechnol, PL-50138 Wroclaw, Poland	University of Copenhagen; University of Wroclaw	Jensen, PE (corresponding author), Univ Copenhagen, Ctr Synthet Biol BioSYNergy, VILLUM Res Ctr Plant Plast, Copenhagen Plant Sci Ctr,Dept Plant & Environm Sc, Copenhagen, Denmark.	peje@plen.ku.dk	Møller, Birger Lindberg/H-2657-2014; Møller, Birger Lindberg/GQI-1792-2022; Bialek, Wojciech/R-6858-2019; Jensen, Poul Erik/A-4862-2014; Olsen, Carl E/H-3031-2014; Jensen, Kenneth/G-3638-2011; Bialek, Wojciech/GMX-2583-2022; Zygadlo Nielsen, Agnieszka/J-4850-2016	Møller, Birger Lindberg/0000-0002-3252-3119; Møller, Birger Lindberg/0000-0002-3252-3119; Bialek, Wojciech/0000-0002-3390-5450; Jensen, Poul Erik/0000-0001-6524-7723; Olsen, Carl E/0000-0002-2275-0596; Jensen, Kenneth/0000-0001-6286-5577; Zygadlo Nielsen, Agnieszka/0000-0002-7948-8912	VILLUM Center of Excellence "Plant Plasticity"; Center of Synthetic Biology "bioSYNergy" - UCPH Excellence Program for Interdisciplinary Research; "Plant Power: Light-driven synthesis of complex terpenoids using cytochrome P450s" - Danish Council for Strategic Research, Programme Commission on Strategic Growth Technologies [12-131834]; ERC Advanced Research Grant [323034]; Villum Fonden [00007523] Funding Source: researchfish	VILLUM Center of Excellence "Plant Plasticity"; Center of Synthetic Biology "bioSYNergy" - UCPH Excellence Program for Interdisciplinary Research; "Plant Power: Light-driven synthesis of complex terpenoids using cytochrome P450s" - Danish Council for Strategic Research, Programme Commission on Strategic Growth Technologies; ERC Advanced Research Grant; Villum Fonden(Villum Fonden)	The authors gratefully acknowledge financial support from 1) the VILLUM Center of Excellence "Plant Plasticity", 2) Center of Synthetic Biology "bioSYNergy" funded by the UCPH Excellence Program for Interdisciplinary Research, 3) "Plant Power: Light-driven synthesis of complex terpenoids using cytochrome P450s" (12-131834) funded by the Danish Council for Strategic Research, Programme Commission on Strategic Growth Technologies and 4) ERC Advanced Research Grant No. 323034 "Light driven P450s". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts A, 2008, PLANT PHYSIOL BIOCH, V46, P228, DOI 10.1016/j.plaphy.2007.12.013; Amunts A, 2009, STRUCTURE, V17, P637, DOI 10.1016/j.str.2009.03.006; Bak S, 1998, PLANT MOL BIOL, V36, P393, DOI 10.1023/A:1005915507497; BALANDRIN MF, 1985, SCIENCE, V228, P1154, DOI 10.1126/science.3890182; Bentley FK, 2013, BIOENERG RES, V6, P917, DOI 10.1007/s12155-013-9325-4; Bickley J, 1995, Methods Mol Biol, V46, P141; Chemler JA, 2008, CURR OPIN BIOTECH, V19, P597, DOI 10.1016/j.copbio.2008.10.011; CHITNIS VP, 1993, FEBS LETT, V336, P330, DOI 10.1016/0014-5793(93)80831-E; Covello PS, 2007, PHYTOCHEMISTRY, V68, P1864, DOI 10.1016/j.phytochem.2007.02.016; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Frigaard NU, 2004, METH MOL B, V274, P325; Grimme RA, 2008, J AM CHEM SOC, V130, P6308, DOI 10.1021/ja800923y; Hamdane D, 2008, PHOTOSYNTH RES, V98, P657, DOI 10.1007/s11120-008-9322-1; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Helman Y, 2003, CURR BIOL, V13, P230, DOI 10.1016/S0960-9822(03)00046-0; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Ihara M, 2006, PHOTOCHEM PHOTOBIOL, V82, P676, DOI 10.1562/2006-01-16-RA-778; Jacobsen JH, 2011, PHOTOSYNTH RES, V107, P215, DOI 10.1007/s11120-010-9613-1; Jensen K, 2012, TRENDS PLANT SCI, V17, P60, DOI 10.1016/j.tplants.2011.12.008; Jensen K, 2012, BIOTECHNOL LETT, V34, P239, DOI 10.1007/s10529-011-0768-4; Jensen K, 2011, ACS CHEM BIOL, V6, P533, DOI 10.1021/cb100393j; Jensen PE, 2007, BBA-BIOENERGETICS, V1767, P335, DOI 10.1016/j.bbabio.2007.03.004; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; Krassen H, 2009, ACS NANO, V3, P4055, DOI 10.1021/nn900748j; Lamb DC, 2007, CURR OPIN BIOTECH, V18, P504, DOI 10.1016/j.copbio.2007.09.010; Lassen LM, 2014, ACS SYNTH BIOL, V3, P1, DOI 10.1021/sb400136f; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lubner CE, 2010, BIOCHEMISTRY-US, V49, P10264, DOI 10.1021/bi1016167; Marienhagen J, 2013, J BIOTECHNOL, V163, P166, DOI 10.1016/j.jbiotec.2012.06.001; Moal G, 2012, BBA-BIOENERGETICS, V1817, P1635, DOI 10.1016/j.bbabio.2012.05.015; Naithani S, 2000, PHOTOSYNTH RES, V63, P225, DOI 10.1023/A:1006463932538; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nielsen AZ, 2013, ACS SYNTH BIOL, V2, P308, DOI 10.1021/sb300128r; Nielsen KA, 2008, PHYTOCHEMISTRY, V69, P88, DOI 10.1016/j.phytochem.2007.06.033; Oliver JWK, 2014, METAB ENG, V22, P76, DOI 10.1016/j.ymben.2014.01.001; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Parmar A, 2011, BIORESOURCE TECHNOL, V102, P10163, DOI 10.1016/j.biortech.2011.08.030; Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0; Rao SR, 2002, BIOTECHNOL ADV, V20, P101, DOI 10.1016/S0734-9750(02)00007-1; Rosgaard L, 2012, J BIOTECHNOL, V162, P134, DOI 10.1016/j.jbiotec.2012.05.006; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Schottkowski M, 2009, J BIOL CHEM, V284, P1813, DOI 10.1074/jbc.M806116200; Setif P, 2002, BBA-BIOENERGETICS, V1555, P204, DOI 10.1016/S0005-2728(02)00279-7; STEVENS SE, 1973, J PHYCOL, V9, P427, DOI 10.1111/j.1529-8817.1973.tb04116.x; Utschig LM, 2011, J PHYS CHEM LETT, V2, P236, DOI 10.1021/jz101728v; van Beilen JB, 2003, TRENDS BIOTECHNOL, V21, P170, DOI 10.1016/S0167-7799(03)00032-5; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Xu W, 2001, BBA-BIOENERGETICS, V1507, P32, DOI 10.1016/S0005-2728(01)00208-0; Xue Yusheng, 2013, J APPL PHYCOL, P1	51	32	33	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102184	10.1371/journal.pone.0102184	http://dx.doi.org/10.1371/journal.pone.0102184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025215	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400049
J	Okajima, I; Nakajima, S; Ochi, M; Inoue, Y				Okajima, Isa; Nakajima, Shun; Ochi, Moeko; Inoue, Yuichi			Reducing Dysfunctional Beliefs about Sleep Does Not Significantly Improve Insomnia in Cognitive Behavioral Therapy	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; VALIDATION; SCALE; DISTURBANCES; METAANALYSIS; DEPRESSION; ATTITUDES; CRITERIA; VERSION; ADULTS	The present study examined to examine whether improvement of insomnia is mediated by a reduction in sleep-related dysfunctional beliefs through cognitive behavioral therapy for insomnia. In total, 64 patients with chronic insomnia received cognitive behavioral therapy for insomnia consisting of 6 biweekly individual treatment sessions of 50 minutes in length. Participants were asked to complete the Athens Insomnia Scale and the Dysfunctional Beliefs and Attitudes about Sleep scale both at the baseline and at the end of treatment. The results showed that although cognitive behavioral therapy for insomnia greatly reduced individuals' scores on both scales, the decrease in dysfunctional beliefs and attitudes about sleep with treatment did not seem to mediate improvement in insomnia. The findings suggest that sleep-related dysfunctional beliefs endorsed by patients with chronic insomnia may be attenuated by cognitive behavioral therapy for insomnia, but changes in such beliefs are not likely to play a crucial role in reducing the severity of insomnia.	[Okajima, Isa; Nakajima, Shun; Ochi, Moeko; Inoue, Yuichi] Neuropsychiat Res Inst, Japan Somnol Ctr, Tokyo, Japan; [Okajima, Isa; Nakajima, Shun; Ochi, Moeko; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Tokyo 1608402, Japan; [Okajima, Isa; Nakajima, Shun; Ochi, Moeko; Inoue, Yuichi] Yoyogi Sleep Disorder Ctr, Tokyo, Japan	Tokyo Medical University	Okajima, I (corresponding author), Neuropsychiat Res Inst, Japan Somnol Ctr, Tokyo, Japan.	okajima@somnology.com			(KAKENHI) - Japan Society for the Promotion of Science (JSPS) [25780439]; Grants-in-Aid for Scientific Research [25780439] Funding Source: KAKEN	(KAKENHI) - Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Young Scientists (B) (KAKENHI) awarded by the Japan Society for the Promotion of Science (JSPS, Grant Number 25780439). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASSIFICATION S, Vxviii, P297; American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR, Vxii, P370; Ancoli-Israel S, 1999, SLEEP, V22, pS347; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bastien CH, 2004, J CONSULT CLIN PSYCH, V72, P653, DOI 10.1037/0022-006X.72.4.653; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; Carney CE, 2010, J PSYCHOSOM RES, V68, P57, DOI 10.1016/j.jpsychores.2009.08.007; Cohen J., 1988, STAT POWER ANAL BEHA, Vxxi, P567; Edinger JD, 2008, BEHAV THER, V39, P406, DOI 10.1016/j.beth.2007.12.001; Edinger JD, 2000, J CONSULT CLIN PSYCH, V68, P586, DOI 10.1037/0022-006X.68.4.586; Edinger JD, 2001, SLEEP, V24, P591, DOI 10.1093/sleep/24.5.591; Edinger JD, 2001, JAMA-J AM MED ASSOC, V285, P1856, DOI 10.1001/jama.285.14.1856; Espie CA, 2001, J CONSULT CLIN PSYCH, V69, P58, DOI 10.1037//0022-006X.69.1.58; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Jansson-Froejmark Markus, 2008, Cognitive Behaviour Therapy, V37, P5, DOI 10.1080/16506070801907013; Kim K, 2000, SLEEP, V23, P41; Lichstein KL, 2003, BEHAV RES THER, V41, P427, DOI 10.1016/S0005-7967(02)00023-2; Morin CM, 2007, SLEEP, V30, P1547, DOI 10.1093/sleep/30.11.1547; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Morin CM, 2002, BEHAV RES THER, V40, P741, DOI 10.1016/S0005-7967(01)00055-9; Morin CM, 1999, SLEEP, V22, P1134, DOI 10.1093/sleep/22.8.1134; Munezawa T., 2009, JPN J SLEEP MED, V3, P396; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Okajima I, 2013, PSYCHIAT RES, V210, P515, DOI 10.1016/j.psychres.2013.06.028; Okajima I, 2013, PSYCHIAT CLIN NEUROS, V67, P420, DOI 10.1111/pcn.12073; Okajima I, 2012, J CLIN PSYCHIAT, V73, P377, DOI 10.4088/JCP.10m06286; Okajima I, 2011, SLEEP BIOL RHYTHMS, V9, P24, DOI 10.1111/j.1479-8425.2010.00481.x; Schwartz DR, 2012, CLIN PSYCHOL REV, V32, P664, DOI 10.1016/j.cpr.2012.06.006; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Soldatos CR, 2003, J PSYCHOSOM RES, V55, P263, DOI 10.1016/S0022-3999(02)00604-9; van Straten A, 2009, SLEEP MED REV, V13, P61, DOI 10.1016/j.smrv.2008.04.006; World Health Organization, 1992, ICD 10 CLASS MENT BE, Vxii, P362; Wu RG, 2006, PSYCHOTHER PSYCHOSOM, V75, P220, DOI 10.1159/000092892	34	20	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102565	10.1371/journal.pone.0102565	http://dx.doi.org/10.1371/journal.pone.0102565			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6RN	25025164	Green Submitted, gold, Green Published			2022-12-25	WOS:000339992400088
J	Patel, A; Burton, DGA; Halvorsen, K; Balkan, W; Reiner, T; Perez-Stable, C; Cohen, A; Munoz, A; Giribaldi, MG; Singh, S; Robbins, DJ; Nguyen, DM; Rai, P				Patel, A.; Burton, D. G. A.; Halvorsen, K.; Balkan, W.; Reiner, T.; Perez-Stable, C.; Cohen, A.; Munoz, A.; Giribaldi, M. G.; Singh, S.; Robbins, D. J.; Nguyen, D. M.; Rai, P.			MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways	ONCOGENE			English	Article							ONCOGENIC RAS; CANCER-CELLS; TUMOR-CELLS; DNA; SENESCENCE; P53; INHIBITION; APOPTOSIS; PROTEIN; GROWTH	Oncogenic RAS promotes production of reactive oxygen species (ROS), which mediate pro-malignant signaling but can also trigger DNA damage-induced tumor suppression. Thus RAS-driven tumor cells require redox-protective mechanisms to mitigate the damaging aspects of ROS. Here, we show that MutT Homolog 1 (MTH1), the mammalian 8-oxodGTPase that sanitizes oxidative damage in the nucleotide pool, is important for maintaining several KRAS-driven pro-malignant traits in a nonsmall cell lung carcinoma (NSCLC) model. MTH1 suppression in KRAS-mutant NSCLC cells impairs proliferation and xenograft tumor formation. Furthermore, MTH1 levels modulate KRAS-induced transformation of immortalized lung epithelial cells. MTH1 expression is upregulated by oncogenic KRAS and correlates positively with high KRAS levels in NSCLC human tumors. At a molecular level, in p53-competent KRAS-mutant cells, MTH1 loss provokes DNA damage and induction of oncogene-induced senescence. In p53-nonfunctional KRAS-mutant cells, MTH1 suppression does not produce DNA damage but reduces proliferation and leads to an adaptive decrease in KRAS expression levels. Thus, MTH1 not only enables evasion of oxidative DNA damage and its consequences, but can also function as a molecular rheostat for maintaining oncogene expression at optimal levels. Accordingly, our results indicate MTH1 is a novel and critical component of oncogenic KRAS-associated malignancy and its inhibition is likely to yield significant tumor-suppressive outcomes in KRAS-driven tumors.	[Patel, A.; Burton, D. G. A.; Halvorsen, K.; Perez-Stable, C.; Cohen, A.; Munoz, A.; Giribaldi, M. G.; Rai, P.] Univ Miami, Leonard M Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Reiner, T.; Perez-Stable, C.] Bruce W Carter Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Miami, FL USA; [Perez-Stable, C.; Robbins, D. J.; Nguyen, D. M.; Rai, P.] Univ Miami, Leonard M Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Cohen, A.] Univ Miami, Leonard M Miller Sch Med, David & Sheila Fuente Grad Program Canc Biol, Miami, FL 33136 USA; [Singh, S.; Robbins, D. J.; Nguyen, D. M.] Univ Miami, Leonard M Miller Sch Med, Dept Surg, Miami, FL 33136 USA	University of Miami; Geriatric Research Education & Clinical Center; University of Miami; University of Miami; University of Miami	Rai, P (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Med, RMSB 7094,D-503,1600 North West 10th Ave, Miami, FL 33136 USA.	prai@med.miami.edu	Singh, Samer/H-8468-2013	Singh, Samer/0000-0002-0921-1686; Rai, Priyamvada/0000-0001-7822-7553	James and Esther King Florida Biomedical New Investigator Research grant, a University of Miami Dean's Bridge Fund award; NIH/NCI grant [R01CA175086]; NATIONAL CANCER INSTITUTE [R01CA175086] Funding Source: NIH RePORTER	James and Esther King Florida Biomedical New Investigator Research grant, a University of Miami Dean's Bridge Fund award; NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Ramiro Verdun for helpful discussions, and Karen Alvarez Delfin for technical assistance. This work was supported by a James and Esther King Florida Biomedical New Investigator Research grant, a University of Miami Dean's Bridge Fund award and an NIH/NCI grant (R01CA175086) to PR.	Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Burton DGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068003; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Chen CY, 1998, CELL DEATH DIFFER, V5, P984, DOI 10.1038/sj.cdd.4400448; Cho WCS, 2011, RNA BIOL, V8, P125, DOI 10.4161/rna.8.1.14259; Clark DW, 2012, FREE RADICAL BIO MED, V53, P51, DOI 10.1016/j.freeradbiomed.2012.04.024; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dobbs TA, 2008, DNA REPAIR, V7, P1372, DOI 10.1016/j.dnarep.2008.05.001; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; FAN SJ, 1994, CANCER RES, V54, P5824; Fei DL, 2010, CANCER RES, V70, P1981, DOI 10.1158/0008-5472.CAN-09-2898; Finkel T, 2006, ANTIOXID REDOX SIGN, V8, P1857, DOI 10.1089/ars.2006.8.1857; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Ghosh A, 2009, J BIOL CHEM, V284, P31074, DOI 10.1074/jbc.M109.027532; Hommura F, 2000, CLIN CANCER RES, V6, P4073; Hu CM, 2012, CANCER CELL, V22, P36, DOI 10.1016/j.ccr.2012.04.038; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Janik J, 2011, MUTAT RES-FUND MOL M, V709-10, P21, DOI 10.1016/j.mrfmmm.2011.02.009; Kennedy CH, 2003, FREE RADICAL BIO MED, V34, P1447, DOI 10.1016/S0891-5849(03)00176-X; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; LEE JM, 1993, P NATL ACAD SCI USA, V90, P5742, DOI 10.1073/pnas.90.12.5742; Liou JS, 2000, J BIOL CHEM, V275, P39001, DOI 10.1074/jbc.M007154200; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08; MUKHOPADHYAY T, 1991, CANCER RES, V51, P1744; Nakabeppu Y, 2001, MUTAT RES-FUND MOL M, V477, P59, DOI 10.1016/S0027-5107(01)00096-3; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Patel A, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-3; Rai P, 2011, ONCOGENE, V30, P1489, DOI 10.1038/onc.2010.520; Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Reiner T, 2006, PROSTATE, V66, P1487, DOI 10.1002/pros.20478; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Speina E, 2005, JNCI-J NATL CANCER I, V97, P384, DOI 10.1093/jnci/dji058; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Szalai VA, 2002, J AM CHEM SOC, V124, P1625, DOI 10.1021/ja0119651; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wikman H, 2000, INT J CANCER, V88, P932, DOI 10.1002/1097-0215(20001215)88:6<932::AID-IJC15>3.0.CO;2-P; Zhou JM, 2001, EMBO J, V20, P914, DOI 10.1093/emboj/20.4.914	53	66	68	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2015	34	20					2586	2596		10.1038/onc.2014.195	http://dx.doi.org/10.1038/onc.2014.195			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI1YN	25023700	Green Accepted			2022-12-25	WOS:000354541300005
J	Ariza, A; Kaartvedt, S; Rostad, A; Garijo, JC; Aristegui, J; Fraile-Nuez, E; Hernandez-Leon, S				Ariza, Alejandro; Kaartvedt, Stein; Rostad, Anders; Carlos Garijo, Juan; Aristegui, Javier; Fraile-Nuez, Eugenio; Hernandez-Leon, Santiago			The Submarine Volcano Eruption off El Hierro Island: Effects on the Scattering Migrant Biota and the Evolution of the Pelagic Communities	PLOS ONE			English	Article							DIEL VERTICAL MIGRATIONS; CANARY-ISLANDS; ZOOPLANKTON BIOMASS; OXYGEN-CONSUMPTION; MIDWATER FISHES; CARBON; ZONE; MESOZOOPLANKTON; MYCTOPHIDAE; MICRONEKTON	The submarine volcano eruption off El Hierro Island (Canary Islands) on 10 October 2011 promoted dramatic perturbation of the water column leading to changes in the distribution of pelagic fauna. To study the response of the scattering biota, we combined acoustic data with hydrographic profiles and concurrent sea surface turbidity indexes from satellite imagery. We also monitored changes in the plankton and nekton communities through the eruptive and post-eruptive phases. Decrease of oxygen, acidification, rising temperature and deposition of chemicals in shallow waters resulted in a reduction of epipelagic stocks and a disruption of diel vertical migration (nocturnal ascent) of mesopelagic organisms. Furthermore, decreased light levels at depth caused by extinction in the volcanic plume resulted in a significant shallowing of the deep acoustic scattering layer. Once the eruption ceased, the distribution and abundances of the pelagic biota returned to baseline levels. There was no evidence of a volcano-induced bloom in the plankton community.	[Ariza, Alejandro; Carlos Garijo, Juan; Aristegui, Javier; Hernandez-Leon, Santiago] Univ Las Palmas Gran Canaria, Inst Oceanog & Cambio Global, Las Palmas Gran Canaria, Canary Islands, Spain; [Kaartvedt, Stein; Rostad, Anders] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Makkah, Saudi Arabia; [Fraile-Nuez, Eugenio] Ctr Oceanog Canarias, Inst Espanol Oceanog, Santa Cruz De Tenerife, Canary Islands, Spain	Universidad de Las Palmas de Gran Canaria; King Abdullah University of Science & Technology; Spanish Institute of Oceanography	Ariza, A (corresponding author), Univ Las Palmas Gran Canaria, Inst Oceanog & Cambio Global, Las Palmas Gran Canaria, Canary Islands, Spain.	avariza@ulpgc.es	Nuez, Eugenio Fraile/R-2258-2019; Fraile-Nuez, Eugenio/D-1521-2010; Ariza, Alejandro/O-6180-2016; Arístegui, Javier/D-5833-2013; Hernández-León, Santiago/M-2563-2014	Nuez, Eugenio Fraile/0000-0003-4250-4445; Fraile-Nuez, Eugenio/0000-0003-4250-4445; Arístegui, Javier/0000-0002-7526-7741; Ariza, Alejandro/0000-0001-7864-4381; Rostad, Anders/0000-0002-2512-9033; Hernandez-Leon, Santiago/0000-0002-3085-4969	Instituto de Oceanografia y Cambio Global (IOCAG); Instituto Espanol de Oceanografia (IEO); MAFIA [CTM2012-39587]; CETOBAPH [CGL2009-13112)]; Spanish Ministry of Science and Innovation [BES2009-028908]	Instituto de Oceanografia y Cambio Global (IOCAG); Instituto Espanol de Oceanografia (IEO); MAFIA; CETOBAPH; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was suported by the Instituto de Oceanografia y Cambio Global (IOCAG) and the Instituto Espanol de Oceanografia (IEO). This work was also funded by projects MAFIA (CTM2012-39587) and CETOBAPH (CGL2009-13112). A. Ariza was supported by a postgraduate grant from the Spanish Ministry of Science and Innovation (BES2009-028908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel MV, 2000, HYDROBIOLOGIA, V440, P161, DOI 10.1023/A:1004115010030; Aristegui J, 1997, DEEP-SEA RES PT I, V44, P71, DOI 10.1016/S0967-0637(96)00093-3; Aristegui J, 2001, SCI MAR, V65, P51, DOI 10.3989/scimar.2001.65s151; Arranz P, 2007, THESIS U LAS PALMAS; Arranz P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028353; BALINO BM, 1993, MAR ECOL PROG SER, V102, P35, DOI 10.3354/meps102035; BARHAM EG, 1966, SCIENCE, V151, P1399, DOI 10.1126/science.151.3716.1399; Barton ED, 1998, PROG OCEANOGR, V41, P455, DOI 10.1016/S0079-6611(98)00023-8; Bianchi D, 2013, NAT GEOSCI, V6, P545, DOI 10.1038/NGEO1837; Boden BP, 1967, S ZOOL SOC LOND, V19; Bordes F., 2009, CATALOGO ESPECIES ME; CLARK CW, 1988, AM NAT, V131, P271, DOI 10.1086/284789; CLARKE GL, 1956, DEEP-SEA RES, V4, P1; Claustre H, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014056; Davenport R, 2002, DEEP-SEA RES PT II, V49, P3481, DOI 10.1016/S0967-0645(02)00095-4; Davison PC, 2013, PROG OCEANOGR, V116, P14, DOI 10.1016/j.pocean.2013.05.013; DIETZ RS, 1948, J MAR RES, V7, P430; DONNELLY J, 1988, MAR BIOL, V97, P483, DOI 10.1007/BF00391044; DOTY M. S., 1956, JOUR CONSEIL PERM INTERNATL EXPLOR MER, V22, P33; Doxaran D, 2009, ESTUAR COAST SHELF S, V81, P321, DOI 10.1016/j.ecss.2008.11.013; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Foote K, 1987, 144 ICES; Fraile-Nuez E, 2012, SCI REPORTS, V2; Grosjean P, 2007, ZOO PHYTOIMAGE VERSI; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hamme RC, 2010, GEOPHYS RES LETT, V37; Hernandez-Leon S, 2004, MAR BIOL, V145, P1191, DOI 10.1007/s00227-004-1396-5; Hernandez-Leon S, 2007, PROG OCEANOGR, V74, P397, DOI 10.1016/j.pocean.2007.04.010; HERNANDEZLEON S, 1988, J PLANKTON RES, V10, P1141, DOI 10.1093/plankt/10.6.1141; Hidaka K, 2001, DEEP-SEA RES PT I, V48, P1923, DOI 10.1016/S0967-0637(01)00003-6; Irigoien X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4271; Kaartvedt S, 1996, MAR ECOL PROG SER, V136, P51, DOI 10.3354/meps136051; Kaartvedt S, 2012, MAR ECOL PROG SER, V452, P1, DOI 10.3354/meps09688; Korneliussen RJ, 2000, ICES J MAR SCI, V57, P1204, DOI 10.1006/jmsc.2000.0806; Korneliussen RJ, 2009, ICES J MAR SCI, V66, P1111, DOI 10.1093/icesjms/fsp119; Lehette P, 2009, LIMNOL OCEANOGR-METH, V7, P304, DOI 10.4319/lom.2009.7.304; Lin II, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2009GB003758; Lopes AR, 2013, DEEP SEA RES 1; Love RH, 2004, DEEP-SEA RES PT I, V51, P1, DOI 10.1016/j.dsr.2003.09.004; MacLennan D.N., 1992, SPRINGER SCI BUS MED; Mantas VM, 2011, REMOTE SENS ENVIRON, V115, P1341, DOI 10.1016/j.rse.2011.01.014; Nechad B, 2010, REMOTE SENS ENVIRON, V114, P854, DOI 10.1016/j.rse.2009.11.022; NEILSON JD, 1990, ADV MAR BIOL, V26, P115, DOI 10.1016/S0065-2881(08)60200-X; Olgun N, 2013, MAR ECOL PROG SER, V488, P81, DOI 10.3354/meps10403; Pearre S, 2003, BIOL REV, V78, P1, DOI 10.1017/S146479310200595X; Rivera J, 2013, GEOLOGY, V41, P355, DOI 10.1130/G33863.1; Robinson C, 2010, DEEP-SEA RES PT II, V57, P1504, DOI 10.1016/j.dsr2.2010.02.018; ROE HSJ, 1974, MAR BIOL, V28, P99, DOI 10.1007/BF00396301; ROE HSJ, 1983, MAR BIOL, V77, P287, DOI 10.1007/BF00395818; Santana-Casiano JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01140; Sassa C, 2010, MAR ECOL PROG SER, V407, P227, DOI 10.3354/meps08526; Schukat A, 2013, DEEP-SEA RES PT I, V75, P146, DOI 10.1016/j.dsr.2013.02.003; Simmonds J., 2005, FISHERIES ACOUSTICS; Staby A, 2011, MAR ECOL PROG SER, V422, P265, DOI 10.3354/meps08938; Stanton TK, 2000, ICES J MAR SCI, V57, P793, DOI 10.1006/jmsc.1999.0517; TORRES JJ, 1979, DEEP-SEA RES, V26, P185, DOI 10.1016/0198-0149(79)90075-X; Troupin C, 2012, OCEAN MODEL, V52-53, P90, DOI 10.1016/j.ocemod.2012.05.002; TUCKER GH, 1951, J MAR RES, V10, P215; Tuya F, 2006, CIENCIAS MARINAS, V32; UNESCO, 1994, TECHNICAL REPORT; Watanabe H, 1999, FISH OCEANOGR, V8, P115, DOI 10.1046/j.1365-2419.1999.00103.x; Wienerroither R, 2009, MAR BIOL RES, V5, P328, DOI 10.1080/17451000802478055	63	12	12	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102354	10.1371/journal.pone.0102354	http://dx.doi.org/10.1371/journal.pone.0102354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047077	Green Submitted, Green Published, gold			2022-12-25	WOS:000339558100027
J	Van Hemelrijck, M; Feller, A; Garmo, H; Valeri, F; Korol, D; Dehler, S; Rohrmann, S				Van Hemelrijck, Mieke; Feller, Anita; Garmo, Hans; Valeri, Fabio; Korol, Dimitri; Dehler, Silvia; Rohrmann, Sabine			Incidence of Second Malignancies for Prostate Cancer	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; RADICAL PROSTATECTOMY; RADIATION-THERAPY; PRIMARY TUMORS; RISK; BRACHYTHERAPY; ADENOCARCINOMA; DEATH	Introduction: There is a need to assess risk of second primary cancers in prostate cancer (PCa) patients, especially since PCa treatment may be associated with increased risk of second primary tumours. Methods: We calculated standardized incidence ratios (SIRs) for second primary tumours comparing men diagnosed with PCa between 1980 and 2010 in the Canton of Zurich, Switzerland (n = 20,559), and the general male population in the Canton. Results: A total of 1,718 men developed a second primary tumour after PCa diagnosis, with lung and colon cancer being the most common (15 and 13% respectively). The SIR for overall second primary cancer was 1.11 (95% CI: 1.06-1.17). Site-specific SIRs varied from 1.19 (1.05-1.34) to 2.89 (2.62-4.77) for lung and thyroid cancer, respectively. When stratified by treatment, the highest SIR was observed for thyroid cancer (3.57 (1.30-7.76)) when undergoing surgery, whereas liver cancer was common when treated with radiotherapy (3.21 (1.54-5.90)) and kidney bladder was most prevalent for those on hormonal treatment (3.15 (1.93-4.87)). Stratification by time since PCa diagnosis showed a lower risk of cancer for men with PCa compared to the general population for the first four years, but then a steep increase in risk was observed. Conclusion: In the Canton of Zurich, there was an increased risk of second primary cancers among men with PCa compared to the general population. Increased diagnostic activity after PCa diagnosis may partly explain increased risks within the first years of diagnosis, but time-stratified analyses indicated that increased risks remained and even increased over time.	[Van Hemelrijck, Mieke; Garmo, Hans] Kings Coll London, Sch Med, Canc Epidemiol Unit, Div Canc Studies, London WC2R 2LS, England; [Feller, Anita] Fdn Natl Inst Canc Epidemiol & Registrat NICER, Zurich, Switzerland; [Feller, Anita] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Valeri, Fabio; Korol, Dimitri; Dehler, Silvia] Canc Registry Zurich & Zug, Zurich, Switzerland; [Rohrmann, Sabine] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland	University of London; King's College London; University of Bern; University of Zurich	Van Hemelrijck, M (corresponding author), Kings Coll London, Sch Med, Canc Epidemiol Unit, Div Canc Studies, London WC2R 2LS, England.	mieke.vanhemelrijck@kcl.ac.uk	Rohrmann, Sabine/D-2113-2012	Rohrmann, Sabine/0000-0002-2215-1200; Feller, Anita/0000-0002-3837-8477; Van Hemelrijck, Mieke/0000-0002-7317-0858				American Cancer Society, 2013, PROSTATE CANC; Braisch U, 2012, EUR J CANCER PREV, V21, P552, DOI 10.1097/CEJ.0b013e328351c748; Breslow NE., 1987, STAT METHODS CANC RE, P81; Dehler S, 2012, KREBSREGISTER KANTON; Eifler JB, 2012, J UROLOGY, V188, P798, DOI 10.1016/j.juro.2012.04.109; European Commission Eurostat, 2013, EUR SHORTL CAUS DEAT; Foundation National Institue for Cancer Epidemiology and Registrationm, 2014, CANC INC MORT SWITZ; Herrmann C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-287; Hinnen KA, 2011, J CLIN ONCOL, V29, P4510, DOI 10.1200/JCO.2011.35.0991; Levi F, 1999, CANCER, V86, P1567, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1567::AID-CNCR25>3.0.CO;2-Z; Margel D, 2011, ANN SURG, V254, P947, DOI 10.1097/SLA.0b013e3182382fd5; Moon K, 2006, CANCER-AM CANCER SOC, V107, P991, DOI 10.1002/cncr.22083; Murray L, 2014, RADIOTHER ONCOL; Nash GF, 2012, ANN ROY COLL SURG, V94, P456, DOI 10.1308/003588412X13373405384611; Pawlish KS, 1997, PROSTATE, V33, P75; Rapiti E, 2008, INT J CANCER, V123, P1141, DOI 10.1002/ijc.23601; Smith GD, 2000, BMJ-BRIT MED J, V321, P847, DOI 10.1136/bmj.321.7265.847; Van Hemelrijck M, 2012, CANCER-AM CANCER SOC, V118, P6207, DOI 10.1002/cncr.27672; Wallner LP, 2013, CANCER EPIDEM BIOMAR, V22, P313, DOI 10.1158/1055-9965.EPI-12-1137; Wu XF, 2004, CLIN CANCER RES, V10, P3988, DOI 10.1158/1078-0432.CCR-03-0762; Zar N, 2008, EUR J CANCER, V44, P718, DOI 10.1016/j.ejca.2007.12.003; Zelefsky MJ, 2012, BJU INT, V110, P1696, DOI 10.1111/j.1464-410X.2012.11385.x; Zelefsky MJ, 2012, INT J RADIAT ONCOL, V83, P953, DOI 10.1016/j.ijrobp.2011.08.034	23	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102596	10.1371/journal.pone.0102596	http://dx.doi.org/10.1371/journal.pone.0102596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047238	gold, Green Published, Green Accepted			2022-12-25	WOS:000339558100049
J	Alvarez, GG; VanDyk, DD; Aaron, SD; Cameron, DW; Davies, N; Stephen, N; Mallick, R; Momoli, F; Moreau, K; Obed, N; Baikie, M; Osborne, G				Alvarez, Gonzalo G.; VanDyk, Deborah D.; Aaron, Shawn D.; Cameron, D. William; Davies, Naomi; Stephen, Natasha; Mallick, Ranjeeta; Momoli, Franco; Moreau, Katherine; Obed, Natan; Baikie, Maureen; Osborne, Geraldine			TAIMA (Stop) TB: The Impact of a Multifaceted TB Awareness and Door-to-Door Campaign in Residential Areas of High Risk for TB in Iqaluit, Nunavut	PLOS ONE			English	Article							TUBERCULOSIS TRANSMISSION; METAANALYSIS; COMMUNITIES; MARIJUANA; SMOKING	Background: The incidence rate of active tuberculosis (TB) disease in the Canadian Territory of Nunavut has shown a rising trend over the past 10 years. In 2010 it was 60 times greater than the national incidence rate. The objective of the Taima (translates to "stop'' in Inuktitut) TB study was to implement and evaluate a public health campaign to enhance existing TB prevention efforts in Nunavut. Methods: A TB awareness campaign followed by a door-to-door screening campaign was carried out in Iqaluit, Nunavut. The aim of the campaign was to raise awareness about TB, and to provide in-home screening and treatment for people living in residential areas at high risk for TB. Screening was based on geographic location rather than on individual risk factors. Results: During the general awareness campaign an increase in the number of people who requested TB testing at the local public health clinic was observed. However, this increase was not sustained following cessation of the awareness campaign. Targeted TB screening in high risk residential areas in Iqaluit resulted in 224 individuals having TSTs read, and detection of 42 previously unidentified cases of latent TB, (overall yield of 18.8% or number needed to screen = 5.3). These cases of latent TB infection (LTBI) were extra cases that had not been picked up by traditional screening practices (34% relative increase within the community). This resulted in a 33% relative increase in the completion of LTBI treatment within the community. The program directly and indirectly identified 5/17 new cases of active TB disease in Iqaluit during the study period (29.5% of all incident cases). Conclusions: While contact tracing investigations remain a cornerstone of TB prevention, additional awareness, screening, and treatment programs like Taima TB may contribute to the successful control of TB in Aboriginal communities.	[Alvarez, Gonzalo G.; VanDyk, Deborah D.; Aaron, Shawn D.; Cameron, D. William; Mallick, Ranjeeta; Momoli, Franco] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Alvarez, Gonzalo G.; Aaron, Shawn D.; Cameron, D. William; Mallick, Ranjeeta; Momoli, Franco; Moreau, Katherine] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Alvarez, Gonzalo G.; Aaron, Shawn D.; Cameron, D. William] Ottawa Hosp, Dept Med, Div Respirol, Ottawa, ON, Canada; [Alvarez, Gonzalo G.; Aaron, Shawn D.; Cameron, D. William] Ottawa Hosp, Dept Med, Div Infect Dis, Ottawa, ON, Canada; [Momoli, Franco; Moreau, Katherine] Childrens Hosp Eastern Ontario, Res Inst, Ctr Practice Changing Res, Ottawa, ON K1H 8L1, Canada; [Obed, Natan] Nunavut Tunngavik Inc, Dept Social & Cultural Dev, Iqaluit, NU, Canada; [Davies, Naomi; Stephen, Natasha; Baikie, Maureen; Osborne, Geraldine] Govt Nunavut, Dept Hlth, Iqaluit, NU, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario	Alvarez, GG (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	galvarez@ohri.ca	Cameron, Bill/E-9180-2010	Cameron, Bill/0000-0002-0090-3539; Aaron, Shawn/0000-0002-4762-3542; Alvarez, Gonzalo G/0000-0003-1562-5305	Public Health Agency of Canada; National Lung Health Framework	Public Health Agency of Canada; National Lung Health Framework	Funding was provided by the Public Health Agency of Canada, and the National Lung Health Framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Boffa J, 2011, SOC SCI MED, V72, P733, DOI 10.1016/j.socscimed.2010.10.033; Boulanger RF, 2013, LANCET INFECT DIS, V13, P540, DOI 10.1016/S1473-3099(13)70042-2; Cain KP, 2012, AM J RESP CRIT CARE, V186, P273, DOI 10.1164/rccm.201111-2076OC; Cegielski JP, 2014, AM J PUBLIC HEALTH, V104, pS225, DOI [10.2105/AJPH.2012.300781, 10.2105/AJPH.2012.300781r]; COMSTOCK GW, 1967, AM REV RESPIR DIS, V95, P935; Cook VJ, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18643; Egeland GM, 2011, CAN MED ASSOC J, V183, P1022, DOI 10.1503/cmaj.101801; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Godoy P, 2013, INT J TUBERC LUNG D, V17, P771, DOI 10.5588/ijtld.12.0696; GRZYBOWSKI S, 1976, Bulletin of the International Union Against Tuberculosis, V51, P181; Halverson J EE, 2013, CANADIAN RESP J, V20, p3A; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Menzies D, 2013, CANADIAN RESP J, V20; Moonan PK, 2006, AM J RESP CRIT CARE, V174, P599, DOI 10.1164/rccm.200512-1977OC; Oeltmann JE, 2006, EMERG INFECT DIS, V12, P1156, DOI 10.3201/eid1207.051436; Public Health Agency of Canada, 2012, TUB CAN 2010 PRER; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; Soborg B, 2010, EUR RESPIR J, V36, P878, DOI 10.1183/09031936.00015510; Statistics Canada, 2010, AN HOUS NEEDS NUN NU; Tait H, 2006, IN HLTH SOC COND; Tan WC, 2009, CAN MED ASSOC J, V180, P814, DOI 10.1503/cmaj.081040; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; Wen CP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-156	25	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100975	10.1371/journal.pone.0100975	http://dx.doi.org/10.1371/journal.pone.0100975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033320	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300012
J	Del Pino, F; Jara, C; Pino, L; Godoy-Herrera, R				Del Pino, Francisco; Jara, Claudia; Pino, Luis; Godoy-Herrera, Raul			The Neuro-Ecology of Drosophila Pupation Behavior	PLOS ONE			English	Article							LARVA; GENE	Many species of Drosophila form conspecific pupa aggregations across the breeding sites. These aggregations could result from species-specific larval odor recognition. To test this hypothesis we used larval odors of D. melanogaster and D. pavani, two species that coexist in the nature. When stimulated by those odors, wild type and vestigial (vg) third-instar larvae of D. melanogaster pupated on conspecific larval odors, but individuals deficient in the expression of the odor co-receptor Orco randomly pupated across the substrate, indicating that in this species, olfaction plays a role in pupation site selection. Larvae are unable to learn but can smell, the Syn(97CS) and rut strains of D. melanogaster, did not respond to conspecific odors or D. pavani larval cues, and they randomly pupated across the substrate, suggesting that larval odor-based learning could influence the pupation site selection. Thus, Orco, Syn(97CS) and rut loci participated in the pupation site selection. When stimulated by conspecific and D. melanogaster larval cues, D. pavani larvae also pupated on conspecific odors. The larvae of D. gaucha, a sibling species of D. pavani, did not respond to D. melanogaster larval cues, pupating randomly across the substrate. In nature, D. gaucha is isolated from D. melanogaster. Interspecific hybrids, which result from crossing pavani female with gaucha males clumped their pupae similarly to D. pavani, but the behavior of gaucha female x pavani male hybrids was similar to D. gaucha parent. The two sibling species show substantial evolutionary divergence in organization and functioning of larval nervous system. D. melanogaster and D. pavani larvae extracted information about odor identities and the spatial location of congener and alien larvae to select pupation sites. We hypothesize that larval recognition contributes to the cohabitation of species with similar ecologies, thus aiding the organization and persistence of Drosophila species guilds in the wild.	[Del Pino, Francisco; Jara, Claudia; Pino, Luis; Godoy-Herrera, Raul] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Genet Humana, Santiago 7, Chile	Universidad de Chile	Godoy-Herrera, R (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Genet Humana, Santiago 7, Chile.	raulgodoy.herrera@gmail.com	Corrêa, Marcio N Nunes/D-1034-2019	Corrêa, Marcio N Nunes/0000-0003-0855-2750	Fondo Nacional de Investigacion Cientifica y Tecnologica (FONDECYT) [1100110]	Fondo Nacional de Investigacion Cientifica y Tecnologica (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The work was supported by Fondo Nacional de Investigacion Cientifica y Tecnologica (FONDECYT) No 1100110. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Ashburner M, 2004, DROSOPHILA LAB HDB, P934; BARKER JSF, 1981, AUST J BIOL SCI, V34, P613, DOI 10.1071/BI9810613; Beltrami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039393; Beltrami M, 2010, EVOL ECOL, V24, P347, DOI 10.1007/s10682-009-9310-8; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Borenstein E, 2008, EVOLUTION, V62, P586, DOI 10.1111/j.1558-5646.2007.00313.x; BRNCIC D, 1957, EVOLUTION, V11, P300, DOI 10.2307/2405794; Brncic D, 1957, ESPECIES CHILENAS DR; BRNCIC D, 1970, ESSAYS EVOLUTION GEN, P401; Burdick A. B., 1954, DROSOPH INF SERV, V28, P170; Carson H.L., 1971, LYON ARBORETUM LECT, V2; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Dukas R, 1999, BEHAV ECOL SOCIOBIOL, V45, P195, DOI 10.1007/s002650050553; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; FOGLEMAN JC, 1981, P NATL ACAD SCI-BIOL, V78, P4435, DOI 10.1073/pnas.78.7.4435; FOSTER JLM, 1993, APPL ENVIRON MICROB, V59, P1; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Godoy-Herrera R, 2005, GENETICA, V124, P33, DOI 10.1007/s10709-004-5913-8; GODOYHERRERA R, 1994, BEHAV GENET, V24, P427, DOI 10.1007/BF01076178; Hoare DJ, 2008, J NEUROSCI, V28, P9710, DOI 10.1523/JNEUROSCI.1955-08.2008; Imai T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001776; Iyengar A, 2010, P NATL ACAD SCI USA, V107, P9855, DOI 10.1073/pnas.1003856107; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Labeur C, 2002, GENETICA, V114, P269, DOI 10.1023/A:1016223000650; Laland KN, 2000, BEHAV BRAIN SCI, V23, P131, DOI 10.1017/S0140525X00002417; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; Markow Therese A., 2006, P235, DOI 10.1016/B978-012473052-6/50011-1; Masuda-Nakagawa LM, 2009, P NATL ACAD SCI USA, V106, P10314, DOI 10.1073/pnas.0900178106; Medina-Munoz MC, 2005, BEHAV ECOL, V16, P316, DOI 10.1093/beheco/arh125; Michels B, 2005, LEARN MEMORY, V12, P224, DOI 10.1101/lm.92805; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; Powell J. R., 1997, PROGR PROSPECTS EVOL; RodriguezGirones MA, 1997, THEOR POPUL BIOL, V52, P32, DOI 10.1006/tpbi.1997.1317; Saumweber T, 2011, CHEM SENSES, V36, P223, DOI 10.1093/chemse/bjq128; Wang YL, 2001, NEURON, V29, P267, DOI 10.1016/S0896-6273(01)00196-9	38	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102159	10.1371/journal.pone.0102159	http://dx.doi.org/10.1371/journal.pone.0102159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033294	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300036
J	Ferrer, MF; Scharrig, E; Alberdi, L; Cedola, M; Pretre, G; Drut, R; Song, WC; Gomez, RM				Ferrer, Maria F.; Scharrig, Emilia; Alberdi, Lucrecia; Cedola, Maia; Pretre, Gabriela; Drut, Ricardo; Song, Wen-Chao; Gomez, Ricardo M.			Decay-Accelerating Factor 1 Deficiency Exacerbates Leptospiral-Induced Murine Chronic Nephritis and Renal Fibrosis	PLOS ONE			English	Article							T-CELL IMMUNITY; CHRONIC KIDNEY-DISEASE; NITRIC-OXIDE SYNTHASE; AUTOIMMUNE-DISEASE; MEMBRANE-PROTEINS; GENE-EXPRESSION; IN-VIVO; MICE; COMPLEMENT; INTERROGANS	Leptospirosis is a global zoonosis caused by pathogenic Leptospira, which can colonize the proximal renal tubules and persist for long periods in the kidneys of infected hosts. Here, we characterized the infection of C57BL/6J wild-type and Daf1(-/-) mice, which have an enhanced host response, with a virulent Leptospira interrogans strain at 14 days post-infection, its persistence in the kidney, and its link to kidney fibrosis at 90 days post-infection. We found that Leptospira interrogans can induce acute moderate nephritis in wild-type mice and is able to persist in some animals, inducing fibrosis in the absence of mortality. In contrast, Daf1(-/-) mice showed acute mortality, with a higher bacterial burden. At the chronic stage, Daf1(-/-) mice showed greater inflammation and fibrosis than at 14 days post-infection and higher levels at all times than the wild-type counterpart. Compared with uninfected mice, infected wild-type mice showed higher levels of IL-4, IL-10 and IL-13, with similar levels of alpha-smooth muscle actin, galectin-3, TGF-beta 1, IL-17, IFN-gamma, and lower IL-12 levels at 90 days post-infection. In contrast, fibrosis in Daf1(-/-) mice was accompanied by high expression of a-smooth muscle actin, galectin-3, IL10, IL-13, and IFN-gamma, similar levels of TGF-beta 1, IL-12, and IL-17 and lower IL-4 levels. This study demonstrates the link between Leptospira-induced murine chronic nephritis with renal fibrosis and shows a protective role of Daf1.	[Ferrer, Maria F.; Scharrig, Emilia; Alberdi, Lucrecia; Cedola, Maia; Pretre, Gabriela; Gomez, Ricardo M.] CONICET UNLP, Inst Biotecnol & Biol Mol, La Plata, Buenos Aires, Argentina; [Drut, Ricardo] UNLP, Fac Med, Catedra Patol A, La Plata, Buenos Aires, Argentina; [Song, Wen-Chao] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University of Pennsylvania; Pennsylvania Medicine	Gomez, RM (corresponding author), CONICET UNLP, Inst Biotecnol & Biol Mol, La Plata, Buenos Aires, Argentina.	rmg1426@gmail.com	Gomez, Ricardo M/AAG-9555-2019; alberdi, maria lucrecia/P-5916-2016	Gomez, Ricardo M/0000-0002-4001-519X; alberdi, maria lucrecia/0000-0001-9421-3311; PRETRE, GABRIELA/0000-0002-0428-1570; Scharrig, Emilia/0000-0003-2599-5297; Ferrer, Maria F/0000-0003-2171-2990	Universidad Nacional de La Plata [X592]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 07-00642, 07-00028, 12-0434]	Universidad Nacional de La Plata(National University of La Plata); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This work was supported by grants from Universidad Nacional de La Plata (X592), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) PICT 07-00642, 07-00028 and 12-0434 (RMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER B, 1976, INFECT IMMUN, V14, P703, DOI 10.1128/IAI.14.3.703-708.1976; An FQ, 2009, INVEST OPHTH VIS SCI, V50, P3778, DOI 10.1167/iovs.08-3264; Atasoyu EM, 2005, NEPHROL DIAL TRANSPL, V20, P2290, DOI 10.1093/ndt/gfi014; Athanazio DA, 2008, ACTA TROP, V105, P95, DOI 10.1016/j.actatropica.2007.09.004; Bandeira M, 2011, INFECT IMMUN, V79, P2936, DOI 10.1128/IAI.05099-11; Bani-Ahmad M, 2011, CLIN EXP IMMUNOL, V163, P199, DOI 10.1111/j.1365-2249.2010.04284.x; Bao LH, 2009, J CLIN INVEST, V119, P1264, DOI 10.1172/JCI36000; Cauvi DM, 2012, IMMUNOLOGY, V135, P333, DOI 10.1111/j.1365-2567.2011.03545.x; Chassin C, 2009, J IMMUNOL, V183, P2669, DOI 10.4049/jimmunol.0900506; Conway B, 2012, QJM-INT J MED, V105, P611, DOI 10.1093/qjmed/hcr235; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; d'Andon MF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002664; Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fang CY, 2007, J IMMUNOL, V179, P3178, DOI 10.4049/jimmunol.179.5.3178; Fang CY, 2009, BLOOD, V114, P1005, DOI 10.1182/blood-2009-01-198283; Ganoza CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000612; GOMEZ RM, 1992, INT J EXP PATHOL, V73, P643; GOMEZ RM, 1991, J MED VIROL, V35, P71, DOI 10.1002/jmv.1890350202; Heeger PS, 2005, J EXP MED, V201, P1523, DOI 10.1084/jem.20041967; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hung CC, 2006, NEPHROL DIAL TRANSPL, V21, P898, DOI 10.1093/ndt/gfi316; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Kyriakidis I, 2011, CYTOKINE, V54, P117, DOI 10.1016/j.cyto.2011.01.014; Lalli PN, 2007, J IMMUNOL, V179, P5793, DOI 10.4049/jimmunol.179.9.5793; Lesher AM, 2010, NEPHROLOGY, V15, P663, DOI 10.1111/j.1440-1797.2010.01373.x; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; LIU FT, 1995, AM J PATHOL, V147, P1016; Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Ma LJ, 2003, AM J PATHOL, V163, P1261, DOI 10.1016/S0002-9440(10)63486-4; Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154; Matsui M, 2011, INFECT IMMUN, V79, P4480, DOI 10.1128/IAI.05727-11; Miwa T, 2002, AM J PATHOL, V161, P1077, DOI 10.1016/S0002-9440(10)64268-X; Miwa T, 2007, AM J PATHOL, V170, P1258, DOI 10.2353/ajpath.2007.060601; Monahan AM, 2009, VET PATHOL, V46, P792, DOI 10.1354/vp.08-VP-0265-N-REV; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; Noguchi H, 1918, J EXP MED, V28, P561, DOI 10.1084/jem.28.5.561; PENNA D, 1963, AM J TROP MED HYG, V12, P896, DOI 10.4269/ajtmh.1963.12.896; Pereira MM, 1998, EXP TOXICOL PATHOL, V50, P191, DOI 10.1016/S0940-2993(98)80083-3; Plank R, 2000, MICROBES INFECT, V2, P1265, DOI 10.1016/S1286-4579(00)01280-6; Pretre G, 2013, MICROB PATHOGENESIS, V56, P21, DOI 10.1016/j.micpath.2012.10.002; Pretre G, 2011, MICROB PATHOGENESIS, V51, P203, DOI 10.1016/j.micpath.2011.03.011; Rana T, 2014, J INFECT DIS, V209, P1066, DOI 10.1093/infdis/jit619; Randall R, 1944, SCIENCE, V100, P133, DOI 10.1126/science.100.2589.133; Santos CS, 2010, J MED MICROBIOL, V59, P1101, DOI 10.1099/jmm.0.021089-0; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Sendler M, 2013, GUT, V62, P430, DOI 10.1136/gutjnl-2011-300771; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Solana ME, 2012, MUSCLE NERVE, V46, P582, DOI 10.1002/mus.23347; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39; Tian YC, 2006, J AM SOC NEPHROL, V17, P2792, DOI 10.1681/ASN.2006020159; Veninga H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024431; Vernel-Pauillac F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000582; Yang CW, 2007, KIDNEY INT, V72, P918, DOI 10.1038/sj.ki.5002393; Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119; Yang CW, 2001, NEPHROL DIAL TRANSPL, V16, P73, DOI 10.1093/ndt/16.suppl_5.73; Zhang XH, 2007, BLOOD, V110, P228, DOI 10.1182/blood-2006-12-063636	64	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102860	10.1371/journal.pone.0102860	http://dx.doi.org/10.1371/journal.pone.0102860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032961	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300105
J	Jordan, TR; Sheen, M; Abedipour, L; Paterson, KB				Jordan, Timothy R.; Sheen, Mercedes; Abedipour, Lily; Paterson, Kevin B.			Visual Speech Perception in Foveal and Extrafoveal Vision: Further Implications for Divisions in Hemispheric Projections	PLOS ONE			English	Article							LATERALIZED WORD RECOGNITION; SPLIT-FOVEA; INTERHEMISPHERIC COMMUNICATION; RETINAL ECCENTRICITY; NASOTEMPORAL OVERLAP; CEREBRAL ASYMMETRY; MOUTH ASYMMETRY; FIELD ADVANTAGE; MOVING FACES; REPRESENTATION	When observing a talking face, it has often been argued that visual speech to the left and right of fixation may produce differences in performance due to divided projections to the two cerebral hemispheres. However, while it seems likely that such a division in hemispheric projections exists for areas away from fixation, the nature and existence of a functional division in visual speech perception at the foveal midline remains to be determined. We investigated this issue by presenting visual speech in matched hemiface displays to the left and right of a central fixation point, either exactly abutting the foveal midline or else located away from the midline in extrafoveal vision. The location of displays relative to the foveal midline was controlled precisely using an automated, gaze-contingent eye-tracking procedure. Visual speech perception showed a clear right hemifield advantage when presented in extrafoveal locations but no hemifield advantage (left or right) when presented abutting the foveal midline. Thus, while visual speech observed in extrafoveal vision appears to benefit from unilateral projections to left-hemisphere processes, no evidence was obtained to indicate that a functional division exists when visual speech is observed around the point of fixation. Implications of these findings for understanding visual speech perception and the nature of functional divisions in hemispheric projection are discussed.	[Jordan, Timothy R.; Sheen, Mercedes] Zayed Univ, Dept Psychol, Dubai, U Arab Emirates; [Abedipour, Lily; Paterson, Kevin B.] Univ Leicester, Dept Psychol, Leicester LE1 7RH, Leics, England	Zayed University; University of Leicester	Jordan, TR (corresponding author), Zayed Univ, Dept Psychol, Dubai, U Arab Emirates.	Timothy.Jordan@zu.ac.ae		Paterson, Kevin/0000-0002-8150-8628	Ulverscroft Foundation; BA Mid-Career Fellowship; ERF Professorial Fellowship	Ulverscroft Foundation; BA Mid-Career Fellowship; ERF Professorial Fellowship	This research was funded by the Ulverscroft Foundation, an ERF Professorial Fellowship to Tim Jordan, and a BA Mid-Career Fellowship to Kevin Paterson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almabruk AAA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018131; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; BENNETT HL, 1987, NEUROPSYCHOLOGIA, V25, P681, DOI 10.1016/0028-3932(87)90059-5; Bourne VJ, 2006, LATERALITY, V11, P373, DOI 10.1080/13576500600633982; Brandt T, 2000, NEUROREPORT, V11, P2803, DOI 10.1097/00001756-200008210-00039; BRYSBAERT M, 1994, BEHAV BRAIN RES, V64, P151, DOI 10.1016/0166-4328(94)90127-9; Brysbaert M, 1996, NEUROPSYCHOLOGY, V10, P385, DOI 10.1037/0894-4105.10.3.385; BUNT AH, 1977, J COMP NEUROL, V171, P619, DOI 10.1002/cne.901710412; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; CAMPBELL R, 1986, BRAIN COGNITION, V5, P1, DOI 10.1016/0278-2626(86)90059-X; CAMPBELL R, 1982, BRIT J PSYCHOL, V73, P95, DOI 10.1111/j.2044-8295.1982.tb01794.x; Carbary TJ, 1999, BRAIN COGNITION, V40, P71; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; DRASDO N, 1977, NATURE, V266, P554, DOI 10.1038/266554a0; Ellis AW, 2010, NEUROPSYCHOLOGIA, V48, P353, DOI 10.1016/j.neuropsychologia.2009.08.021; ERBER NP, 1969, J SPEECH HEAR RES, V12, P423, DOI 10.1044/jshr.1202.423; Fendrich R, 1996, NEUROPSYCHOLOGIA, V34, P637, DOI 10.1016/0028-3932(95)00155-7; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; GILBERT C, 1973, NEUROPSYCHOLOGIA, V11, P355, DOI 10.1016/0028-3932(73)90049-3; GRAVES R, 1983, NEUROPSYCHOLOGIA, V21, P641, DOI 10.1016/0028-3932(83)90062-3; GRAVES R, 1982, NEUROPSYCHOLOGIA, V20, P371, DOI 10.1016/0028-3932(82)90037-9; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hunter ZR, 2007, J COGNITIVE NEUROSCI, V19, P1373, DOI 10.1162/jocn.2007.19.8.1373; Jordan TR, 2008, NEUROPSYCHOLOGY, V22, P738, DOI 10.1037/a0013140; Jordan TR, 2007, NEUROPSYCHOLOGY, V21, P721, DOI 10.1037/0894-4105.21.6.721; Jordan TR, 2011, ATTEN PERCEPT PSYCHO, V73, P2270, DOI 10.3758/s13414-011-0152-4; Jordan TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023957; Jordan TR, 2011, CORTEX, V47, P992, DOI 10.1016/j.cortex.2011.02.012; Jordan TR, 2010, NEUROPSYCHOLOGIA, V48, P2782, DOI 10.1016/j.neuropsychologia.2010.04.029; Jordan TR, 2010, CORTEX, V46, P298, DOI 10.1016/j.cortex.2009.01.008; Jordan TR, 2010, CORTEX, V46, P100, DOI 10.1016/j.cortex.2008.10.008; Jordan TR, 2009, NEUROPSYCHOLOGIA, V47, P2341, DOI 10.1016/j.neuropsychologia.2008.07.020; Jordan TR, 2009, NEUROPSYCHOLOGIA, V47, P2004, DOI 10.1016/j.neuropsychologia.2008.12.014; Jordan TR, 2009, CORTEX, V45, P495, DOI 10.1016/j.cortex.2007.07.007; Jordan TR, 2009, COGN AFFECT BEHAV NE, V9, P113, DOI 10.3758/CABN.9.1.113; Jordan TR, 2000, LANG SPEECH, V43, P107, DOI 10.1177/00238309000430010401; Jordan TR, 2000, PERCEPT PSYCHOPHYS, V62, P1394, DOI 10.3758/BF03212141; Jordan TR, 1998, Q J EXP PSYCHOL-A, V51, P371, DOI 10.1080/713755764; Jordan TR, 2006, NEUROPSYCHOLOGIA, V44, P686, DOI 10.1016/j.neuropsychologia.2005.08.008; Jordan TR, 2003, COGN NEUROPSYCHOL, V20, P81, DOI 10.1080/02643290244000202; Jordan TR, 2003, COGN NEUROPSYCHOL, V20, P49, DOI 10.1080/02643290244000185; Jordan TR, 2001, J EXP PSYCHOL HUMAN, V27, P1386, DOI 10.1037//0096-1523.27.6.1386; Jordan TR, 2000, J EXP PSYCHOL HUMAN, V26, P1192, DOI 10.1037/0096-1523.26.3.1192; Jordan TR, 1998, HEARING EYE 2, P155; Lavidor M, 2004, NAT REV NEUROSCI, V5, P729, DOI 10.1038/nrn1498; Lavidor M, 2001, COGNITIVE BRAIN RES, V12, P265, DOI 10.1016/S0926-6410(01)00056-8; LEVENTHAL AG, 1988, SCIENCE, V240, P66, DOI 10.1126/science.3353708; Lindell AK, 2003, CORTEX, V39, P111, DOI 10.1016/S0010-9452(08)70079-0; Lindzey G., 1952, J PERSONALTIY, V21, P687; MACLEOD A, 1987, British Journal of Audiology, V21, P131, DOI 10.3109/03005368709077786; MACLEOD A, 1990, British Journal of Audiology, V24, P29, DOI 10.3109/03005369009077840; MacSweeney M, 2001, P ROY SOC B-BIOL SCI, V268, P451, DOI 10.1098/rspb.2000.0393; MacSweeney M, 2000, NEUROREPORT, V11, P1729, DOI 10.1097/00001756-200006050-00026; MCCURDY HG, 1949, J ABNORM SOC PSYCH, V44, P553, DOI 10.1037/h0062519; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MIDDELWEERD MJ, 1987, J ACOUST SOC AM, V82, P2145, DOI 10.1121/1.395659; MISHKIN M, 1952, J EXP PSYCHOL, V43, P43, DOI 10.1037/h0061361; Monteiro A, 2004, BEHAV RES METH INS C, V36, P107, DOI 10.3758/BF03195556; Nicholls MER, 2006, BRAIN LANG, V97, P322, DOI 10.1016/j.bandl.2005.11.007; Nicholls MER, 2004, PSYCHOL SCI, V15, P138, DOI 10.1111/j.0963-7214.2004.01502011.x; Patching GR, 1998, BEHAV RES METH INS C, V30, P643, DOI 10.3758/BF03209482; Reinhard J, 2003, INVEST OPHTH VIS SCI, V44, P1568, DOI 10.1167/iovs.02-0313; Reisberg D., 1987, HEARING EYE PSYCHOL, P97; Seinen M, 1969, Ned Tijdschr Psychol, V24, P551; STONE J, 1973, J COMP NEUROL, V150, P333, DOI 10.1002/cne.901500306; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Thomas SM, 2004, J EXP PSYCHOL HUMAN, V30, P873, DOI 10.1037/0096-1523.30.5.873; Thomas SM, 2002, PERCEPT PSYCHOPHYS, V64, P932, DOI 10.3758/BF03196797; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Trauzettel-Klosinski S, 1998, INVEST OPHTH VIS SCI, V39, P2177; WOLF ME, 1987, NEUROPSYCHOLOGIA, V25, P375, DOI 10.1016/0028-3932(87)90026-1; Wolff W, 1933, CHARACT PERSON, V2, P168	74	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e98273	10.1371/journal.pone.0098273	http://dx.doi.org/10.1371/journal.pone.0098273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8VR	25032950	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300001
J	Rachlis, B; Cole, DC; van Lettow, M; Escobar, M; Muula, AS; Ahmad, F; Orbinski, J; Chan, AK				Rachlis, Beth; Cole, Donald C.; van Lettow, Monique; Escobar, Michael; Muula, Adamson S.; Ahmad, Farah; Orbinski, James; Chan, Adrienne K.			Follow-Up Visit Patterns in an Antiretroviral Therapy (ART) Programme in Zomba, Malawi	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SUB-SAHARAN AFRICA; SOUTH-AFRICA; PATIENTS LOST; ADULT PATIENTS; PATIENT RETENTION; DRUG-RESISTANCE; UNITED-STATES; HIV/AIDS CARE; 1ST YEAR	Background: Identifying follow-up (FU) visit patterns, and exploring which factors influence them are likely to be useful in determining which patients on antiretroviral therapy (ART) may become Lost to Follow-Up (LTFU). Using an operation and implementation research approach, we sought 1) to describe the timing of FU visits amongst patients who have been on ART for shorter and longer periods of time; and 2) to determine the median time to late visits, and 3) to identify specific factors that may be associated with these patterns in Zomba, Malawi. Methods and Findings: Using routinely collected programme monitoring data from Zomba District, we performed descriptive analyses on all ART visits among patients who initiated ART between Jan. 1, 2007-June 30, 2010. Based on an expected FU date, each FU visit was classified as early (>= 4 day before an expected FU date), on time (3 days before an expected FU date/up to 6 days after an expected FU date), or late (>= 7 days after an expected FU date). In total, 7,815 patients with 76417 FU visits were included. Ninety-two percent of patients had >= 2 FU visits. At the majority of visits, patients were either on time or late. The median time to a first late visit among those with 2 or more visits was 216 days (IQR: 128-359). Various patient-and visit-level factors differed significantly across Early, On Time, and Late visit groups including ART adherence and frequency of, and type of side effects. Discussion: The majority of patients do not demonstrate consistent FU visit patterns. Individuals were generally on ART for at least 6 months before experiencing their first late visit. Our findings have implications for the development of effective interventions that meet patient needs when they present early and can reduce patient losses to follow-up when they are late. In particular, time-varying visit characteristics need further research.	[Rachlis, Beth; Cole, Donald C.; van Lettow, Monique; Escobar, Michael; Chan, Adrienne K.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [van Lettow, Monique; Chan, Adrienne K.] Dignitas Int, Zomba, Malawi; [Muula, Adamson S.] Univ Malawi, Coll Med, Blantyre, Malawi; [Ahmad, Farah] York Univ, Sch Hlth Policy & Management, Toronto, ON M3J 2R7, Canada; [Orbinski, James] Ctr Int Governance Innovat, Waterloo, ON, Canada; [Chan, Adrienne K.] Sunnybrook Hlth Sci Ctr, Div Infect Dis, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Malawi; York University - Canada; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Rachlis, B (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	beth.rachlis@utoronto.ca	Ahmad, Farah/B-4261-2008; Muula, Adamson/AAF-1153-2020	Ahmad, Farah/0000-0001-9747-1148; Escobar, Michael/0000-0001-9055-4709	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Alamo ST, 2012, JAIDS-J ACQ IMM DEF, V60, pE36, DOI 10.1097/FTD.0b013e3182526e6a; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; [Anonymous], 2012, GLOB REP UNAIDS REP; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Bastard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049091; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Birbeck GL, 2009, AM J TROP MED HYG, V80, P669, DOI 10.4269/ajtmh.2009.80.669; Bisson GP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000174; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Braitstein P, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-7; Brennan AT, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-49; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brugha R, 2003, BRIT MED J, V326, P1382, DOI 10.1136/bmj.326.7403.1382; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Chalker John, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P193, DOI 10.1177/1545109708320687; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Dahab M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-63; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Daniel O. J., 2008, African Journal of Biomedical Research, V11, P221; Davies MA, 2009, CLIN INFECT DIS, V49, P973, DOI 10.1086/605501; Eholie SP, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17334; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fatti G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012888; Ford N, 2010, AIDS, V24, P2645, DOI 10.1097/QAD.0b013e32833ec5b2; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, TROP MED INT HEALTH, V15, P63, DOI 10.1111/j.1365-3156.2010.02507.x; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Gilbert L, 2010, HEALTH SOC CARE COMM, V18, P139, DOI 10.1111/j.1365-2524.2009.00881.x; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; Horberg MA, 2013, AIDS PATIENT CARE ST, V27, P442, DOI 10.1089/apc.2013.0073; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2008, GLOB REP UNAIDS REP; Joint United Nations Programme on HIV/AIDS Website (UNAIDS), 2012, REP GLOB AIDS PAND; Kalichman SC, 1999, J GEN INTERN MED, V14, P267, DOI 10.1046/j.1525-1497.1999.00334.x; Kunutsor S, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/872396; Malawi Ministry of Health, 2008, TREATM AIDS GUID US; Malawi National Statistical Office and MEASURE DHS, 2010, MAL DEM HLTH SURV 20; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; McGuire M, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02504.x; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Ministry of Health Government of Malawi, 2012, INT HIV PROGR REP JU; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Mukora R, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-205; Murray LK, 2009, AIDS CARE, V21, P78, DOI 10.1080/09540120802032643; Mutevedzi PC, 2013, TROP MED INT HEALTH, V18, P934, DOI 10.1111/tmi.12135; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Norman A, 2007, AM J PUBLIC HEALTH, V97, P1775, DOI 10.2105/AJPH.2005.082511; O'Connor C, 2011, JAIDS-J ACQ IMM DEF, V58, P429, DOI 10.1097/QAI.0b013e318230d507; Ochieng-Ooko V, 2010, B WORLD HEALTH ORGAN, V88, P681, DOI 10.2471/BLT.09.064329; Peters DH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6753; Pinto AD, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18055; Rachlis BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018948; Ramadhani HO, 2007, CLIN INFECT DIS, V45, P1492, DOI 10.1086/522991; Remien RH, 2003, ADHERENCE MEDICATION; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rougemont Mathieu, 2009, AIDS Res Ther, V6, P21, DOI 10.1186/1742-6405-6-21; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Schouten Erik J, 2011, J Int AIDS Soc, V14 Suppl 1, pS4, DOI 10.1186/1758-2652-14-S1-S4; Skiest DJ, 2007, J INFECT DIS, V195, P1426, DOI 10.1086/512681; Torpey KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002204; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; Uzochukwu BSC, 2009, HEALTH POLICY PLANN, V24, P189, DOI 10.1093/heapol/czp006; van Oosterhout JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042029; Watt MH, 2009, SOC SCI MED, V68, P1793, DOI 10.1016/j.socscimed.2009.02.037; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; World Health Organization Website, 2009, PRIOR INT HIV AIDS P; Yiannoustos CT, 2008, PLOS ONE, V3, pe38	75	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101875	10.1371/journal.pone.0101875	http://dx.doi.org/10.1371/journal.pone.0101875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8VR	25033285	Green Submitted, Green Published, gold			2022-12-25	WOS:000339418300028
J	Sede, MM; Moretti, FA; Laufer, NL; Jones, LR; Quarleri, JF				Sede, Mariano M.; Moretti, Franco A.; Laufer, Natalia L.; Jones, Leandro R.; Quarleri, Jorge F.			HIV-1 Tropism Dynamics and Phylogenetic Analysis from Longitudinal Ultra-Deep Sequencing Data of CCR5-and CXCR4-Using Variants	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4 CELL COUNT; CORECEPTOR USAGE; MAXIMUM-LIKELIHOOD; ANTIRETROVIRAL TREATMENT; INFECTED PATIENTS; IMPACT; PREDICTION; MUTATIONS; TREE	Objective: Coreceptor switch from CCR5 to CXCR4 is associated with HIV disease progression. The molecular and evolutionary mechanisms underlying the CCR5 to CXCR4 switch are the focus of intense recent research. We studied the HIV-1 tropism dynamics in relation to coreceptor usage, the nature of quasispecies from ultra deep sequencing (UDPS) data and their phylogenetic relationships. Methods: Here, we characterized C2-V3-C3 sequences of HIV obtained from 19 patients followed up for 54 to 114 months using UDPS, with further genotyping and phylogenetic analysis for coreceptor usage. HIV quasispecies diversity and variability as well as HIV plasma viral load were measured longitudinally and their relationship with the HIV coreceptor usage was analyzed. The longitudinal UDPS data were submitted to phylogenetic analysis and sampling times and coreceptor usage were mapped onto the trees obtained. Results: Although a temporal viral genetic structuring was evident, the persistence of several viral lineages evolving independently along the infection was statistically supported, indicating a complex scenario for the evolution of viral quasispecies. HIV X4-using variants were present in most of our patients, exhibiting a dissimilar inter- and intra-patient predominance as the component of quasispecies even on antiretroviral therapy. The viral populations from some of the patients studied displayed evidences of the evolution of X4 variants through fitness valleys, whereas for other patients the data favored a gradual mode of emergence. Conclusions: CXCR4 usage can emerge independently, in multiple lineages, along the course of HIV infection. The mode of emergence, i.e. gradual or through fitness valleys seems to depend on both virus and patient factors. Furthermore, our analyses suggest that, besides becoming dominant after population-level switches, minor proportions of X4 viruses might exist along the infection, perhaps even at early stages of it. The fate of these minor variants might depend on both viral and host factors.	[Sede, Mariano M.; Moretti, Franco A.; Laufer, Natalia L.; Quarleri, Jorge F.] Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & Sida INBIRS, Buenos Aires, DF, Argentina; [Sede, Mariano M.; Moretti, Franco A.; Laufer, Natalia L.; Jones, Leandro R.; Quarleri, Jorge F.] Consejo Nacl Invest Cient & Tecn, Consejo Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Jones, Leandro R.] Univ Nacl Patagonia San Juan Bosco, Fac Ciencias Nat, Lab Virol & Genet Mol, Chubut, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de la Patagonia San Juan Bosco	Quarleri, JF (corresponding author), Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & Sida INBIRS, Buenos Aires, DF, Argentina.	quarleri@fmed.uba.ar	Laufer, Natalia/AAB-7472-2022; Quarleri, Jorge/AFR-0308-2022	Laufer, Natalia/0000-0002-5690-9454; Quarleri, Jorge/0000-0001-5110-8773; Jones, Leandro/0000-0002-5877-4194	National Agency of Scientific and Technological Promotion(ANPCYT) [0422]	National Agency of Scientific and Technological Promotion(ANPCYT)(ANPCyT)	This study has been funded by National Agency of Scientific and Technological Promotion(ANPCYT) grant 0422 [http://www.agencia.mincyt.gob.ar/ frontend/agencia/convocatoria/105]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2011, CLIN MICROBIOL INFEC, V17, P725, DOI 10.1111/j.1469-0691.2010.03350.x; ALBERT J, 1990, J CLIN MICROBIOL, V28, P1560, DOI 10.1128/JCM.28.7.1560-1564.1990; Archer J, 2009, AIDS, V23, P1209, DOI 10.1097/QAD.0b013e32832b4399; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; Briz V, 2008, J ANTIMICROB CHEMOTH, V61, P405, DOI 10.1093/jac/dkm469; Bunnik EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002106; Bushman FD, 2008, AIDS, V22, P1411, DOI 10.1097/QAD.0b013e3282fc972e; Chor B, 2006, J ACM, V53, P722, DOI 10.1145/1183907.1183909; Daumer M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-30; Delgado E, 2012, J ANTIMICROB CHEMOTH, V67, P25, DOI 10.1093/jac/dkr438; Delwart EL, 1997, J VIROL, V71, P7498, DOI 10.1128/JVI.71.10.7498-7508.1997; Dimonte S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-33; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Duran A, 2012, LATE DIAGNOSIS HIV I; Dybowski JN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000743; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; GRAHAM RL, 1982, MATH BIOSCI, V60, P133, DOI 10.1016/0025-5564(82)90125-0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huang W, 2008, J VIROL, V82, P5584, DOI 10.1128/JVI.02676-07; Hunt PW, 2006, J INFECT DIS, V194, P926, DOI 10.1086/507312; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Jones LR, 2010, CLADISTICS, V26, P213; Jones LR, 2007, DARWINIANA, V45, P30; Kagan RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046334; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2007, BIOINFORMATICS, V23, P372, DOI 10.1093/bioinformatics/btl592; Kijak GH, 2002, J VIROL, V76, P7000, DOI 10.1128/JVI.76.14.7000-7009.2002; Kumar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061437; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Monno L, 2011, ANTIMICROB AGENTS CH, V55, P5078, DOI 10.1128/AAC.00743-11; Ogert RA, 2001, J VIROL, V75, P5998, DOI 10.1128/JVI.75.13.5998-6006.2001; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; Poon AFY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002753; Pou C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067085; Poveda E, 2007, J MED VIROL, V79, P1040, DOI 10.1002/jmv.20900; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Foundation for Statistical Computing, 2012, R LANG ENV STAT COMP; Raymond S, 2014, J ANTIMICROB CHEMOTH; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Sanchez V, 2010, J CLIN MICROBIOL, V48, P4135, DOI 10.1128/JCM.01204-10; Saracino A, 2009, J MED VIROL, V81, P2036, DOI 10.1002/jmv.21598; Savkovic B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038755; Seclen E, 2011, J CLIN MICROBIOL, V49, P3380, DOI 10.1128/JCM.00908-11; Seclen E, 2011, J INFECT DIS, V204, P139, DOI 10.1093/infdis/jir218; Shannon CE, 1997, M D COMPUT, V14, P306; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Skrabal K, 2003, AIDS, V17, P809, DOI 10.1097/00002030-200304110-00005; Skums P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S6; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Svicher V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053603; Swenson LC, 2012, CURR OPIN HIV AIDS; Thielen A, 2012, INTERVIROLOGY, V55, P113, DOI 10.1159/000332002; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06	60	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102857	10.1371/journal.pone.0102857	http://dx.doi.org/10.1371/journal.pone.0102857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032817	Green Submitted, gold, Green Published			2022-12-25	WOS:000339418300104
J	Teruel-Montoya, R; Kong, XG; Abraham, S; Ma, L; Kunapuli, SP; Holinstat, M; Shaw, CA; McKenzie, SE; Edelstein, LC; Bray, PF				Teruel-Montoya, Raul; Kong, Xianguo; Abraham, Shaji; Ma, Lin; Kunapuli, Satya P.; Holinstat, Michael; Shaw, Chad A.; McKenzie, Steven E.; Edelstein, Leonard C.; Bray, Paul F.			MicroRNA Expression Differences in Human Hematopoietic Cell Lineages Enable Regulated Transgene Expression	PLOS ONE			English	Article							MESSENGER-RNA; CIRCULATING MICRORNAS; GENE-TRANSFER; STEM-CELL; FACTOR-IX; T-CELLS; PLATELETS; CANCER; IDENTIFICATION; DISEASES	Blood microRNA (miRNA) levels have been associated with and shown to participate in disease pathophysiology. However, the hematopoietic cell of origin of blood miRNAs and the individual blood cell miRNA profiles are poorly understood. We report the miRNA content of highly purified normal hematopoietic cells from the same individuals. Although T-cells, B-cells and granulocytes had the highest miRNA content per cell, erythrocytes contributed more cellular miRNA to the blood, followed by granulocytes and platelets. miRNA profiling revealed different patterns and different expression levels of miRNA specific for each lineage. miR-30c-5p was determined to be an appropriate reference normalizer for cross-cell qRT-PCR comparisons. miRNA profiling of 5 hematopoietic cell lines revealed differential expression of miR-125a-5p. We demonstrated endogenous levels of miR-125a-5p regulate reporter gene expression in Meg-01 and Jurkat cells by (1) constructs containing binding sites for miR-125a-5p or (2) over-expressing or inhibiting miR-125a-5p. This quantitative analysis of the miRNA profiles of peripheral blood cells identifies the circulating hematopoietic cellular miRNAs, supports the use of miRNA profiles for distinguishing different hematopoietic lineages and suggests that endogenously expressed miRNAs can be exploited to regulate transgene expression in a cell-specific manner.	[Teruel-Montoya, Raul; Kong, Xianguo; Abraham, Shaji; Ma, Lin; Holinstat, Michael; McKenzie, Steven E.; Edelstein, Leonard C.; Bray, Paul F.] Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA; [Teruel-Montoya, Raul; Kong, Xianguo; Abraham, Shaji; Ma, Lin; Holinstat, Michael; McKenzie, Steven E.; Edelstein, Leonard C.; Bray, Paul F.] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; [Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19122 USA; [Kunapuli, Satya P.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA; [Shaw, Chad A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shaw, Chad A.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Shaw, Chad A.] Rice Univ, Dept Stat, Houston, TX 77251 USA	Jefferson University; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Baylor College of Medicine; Baylor College of Medicine; Rice University	Bray, PF (corresponding author), Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA.	paul.bray@jefferson.edu	Teruel-Montoya, Raúl/H-9012-2017	Teruel-Montoya, Raúl/0000-0002-6741-9725; McKenzie, Steven/0000-0003-2654-8560; Edelstein, Leonard/0000-0002-8976-6410	National Heart, Lung and Blood Institute [R01HL102482, R01MD007880]; National Institute on Minority Health and Health Disparities of the National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102482, R01HL116713] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007880] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was funded by R01HL102482 and R01MD007880 from the National Heart, Lung and Blood Institute and National Institute on Minority Health and Health Disparities of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; Bisset LR, 2004, EUR J HAEMATOL, V72, P203, DOI 10.1046/j.0902-4441.2003.00199.x; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Boon RA, 2013, ARTERIOSCL THROM VAS, V33, P186, DOI 10.1161/ATVBAHA.112.300139; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Chen SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002360; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Diehl P, CARDIOVASCULAR RES, V93, P633; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Edelstein LC, 2013, J THROMB HAEMOST, V11, P340, DOI 10.1111/jth.12214; Edelstein LC, NAT MED; Edelstein LC, 2013, NAT MED; Eikmans M, 2013, BLOOD, V121, pE81, DOI 10.1182/blood-2012-06-438887; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Ferrajoli A, 2013, BLOOD, V122, P1891, DOI 10.1182/blood-2013-01-478222; Follenzi A, 2004, BLOOD, V103, P3700, DOI 10.1182/blood-2003-09-3217; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; GEORGE JN, 1982, BLOOD, V60, P834; Girardot M, 2010, BLOOD, V116, P437, DOI 10.1182/blood-2008-06-165985; Guo G, CELL STEM CELL, V13, P492; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Khetawat G, 2000, BLOOD, V95, P2289, DOI 10.1182/blood.V95.7.2289.007k03_2289_2296; Klusmann JH, 2010, GENE DEV, V24, P478, DOI 10.1101/gad.1856210; Kumar MS, 2011, BLOOD, V118, P4666, DOI 10.1182/blood-2010-12-324715; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mingozzi F, 2003, J CLIN INVEST, V111, P1347, DOI 10.1172/JCI200316887; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Ricicova M, 2003, FEMS YEAST RES, V4, P119, DOI 10.1016/S1567-1356(03)00145-4; Risitano A, 2012, BLOOD, V119, P6288, DOI 10.1182/blood-2011-12-396440; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Simon LM, 2014, BLOOD, V123, pE37, DOI 10.1182/blood-2013-12-544692; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Stratz C, 2012, THROMB HAEMOSTASIS, V107, P634, DOI 10.1160/TH11-10-0742; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Ward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015810; Weiland M, 2012, RNA BIOL, V9, P850, DOI 10.4161/rna.20378; WICKI AN, 1989, THROMB HAEMOSTASIS, V61, P448; Willeit P, 2013, CIRCULATION RES; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xu X, 2012, BLOOD, V120, P3575, DOI 10.1182/blood-2012-02-411264; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zhang QZ, 2013, CURR OPIN HEMATOL, V20, P265, DOI 10.1097/MOH.0b013e3283612628	64	57	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102259	10.1371/journal.pone.0102259	http://dx.doi.org/10.1371/journal.pone.0102259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029370	Green Published, gold, Green Submitted			2022-12-25	WOS:000341306600053
J	Zwart, MC; Baker, A; McGowan, PJK; Whittingham, MJ				Zwart, Mieke C.; Baker, Andrew; McGowan, Philip J. K.; Whittingham, Mark J.			The Use of Automated Bioacoustic Recorders to Replace Human Wildlife Surveys: An Example Using Nightjars	PLOS ONE			English	Article							RECORDINGS; BIRDS	To be able to monitor and protect endangered species, we need accurate information on their numbers and where they live. Survey methods using automated bioacoustic recorders offer significant promise, especially for species whose behaviour or ecology reduces their detectability during traditional surveys, such as the European nightjar. In this study we examined the utility of automated bioacoustic recorders and the associated classification software as a way to survey for wildlife, using the nightjar as an example. We compared traditional human surveys with results obtained from bioacoustic recorders. When we compared these two methods using the recordings made at the same time as the human surveys, we found that recorders were better at detecting nightjars. However, in practice fieldworkers are likely to deploy recorders for extended periods to make best use of them. Our comparison of this practical approach with human surveys revealed that recorders were significantly better at detecting nightjars than human surveyors: recorders detected nightjars during 19 of 22 survey periods, while surveyors detected nightjars on only six of these occasions. In addition, there was no correlation between the amount of vocalisation captured by the acoustic recorders and the abundance of nightjars as recorded by human surveyors. The data obtained from the recorders revealed that nightjars were most active just before dawn and just after dusk, and least active during the middle of the night. As a result, we found that recording at both dusk and dawn or only at dawn would give reasonably high levels of detection while significantly reducing recording time, preserving battery life. Our analyses suggest that automated bioacoustic recorders could increase the detection of other species, particularly those that are known to be difficult to detect using traditional survey methods. The accuracy of detection is especially important when the data are used to inform conservation.	[Zwart, Mieke C.; McGowan, Philip J. K.; Whittingham, Mark J.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Baker, Andrew] Baker Consultants Ltd, Matlock, Derby, England	Newcastle University - UK	Whittingham, MJ (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	mark.whittingham@newcastle.ac.uk			Wildlife Acoustics Inc.; World Pheasant Association	Wildlife Acoustics Inc.; World Pheasant Association	Funding for this project was provided by Wildlife Acoustics Inc. (http://www.wildlifeacoustics.com/) and World Pheasant Association (http://www.pheasant.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, OFF J EUR UNION L, V20, P7; Bates D., 2015, LINEAR MIXED EFFECTS, V67, P1, DOI 10.18637/jss.v067.i01; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; Brandes TS, 2008, BIRD CONSERV INT, V18, pS163, DOI 10.1017/S0959270908000415; CADBURY CJ, 1981, BIRD STUDY, V28, P1, DOI 10.1080/00063658109476692; Campbell M, 2012, J FIELD ORNITHOL, V83, P391, DOI 10.1111/j.1557-9263.2012.00389.x; Celis-Murillo A, 2012, J FIELD ORNITHOL, V83, P166, DOI 10.1111/j.1557-9263.2012.00366.x; GILBERT G, 1994, J FIELD ORNITHOL, V65, P335; Gilbert G., 1998, BIRD MONITORING METH; Hobson KA, 2002, WILDLIFE SOC B, V30, P709; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Peake T. M., 2001, Animal Biodiversity and Conservation, V24, P81; R Core Team, 2021, R LANG ENV STAT COMP; Rempel RS, 2005, J FIELD ORNITHOL, V76, P1, DOI 10.1648/0273-8570-76.1.1; Southwood TRE, 2000, ECOLOGICAL METHODS; Sutherland W. J., 2004, BIRD ECOLOGY CONSERV; Swiston KA, 2009, J FIELD ORNITHOL, V80, P42, DOI 10.1111/j.1557-9263.2009.00204.x; Trifa VM, 2008, J ACOUST SOC AM, V123, P2424, DOI 10.1121/1.2839017	19	72	75	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102770	10.1371/journal.pone.0102770	http://dx.doi.org/10.1371/journal.pone.0102770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029035	Green Submitted, Green Published, gold			2022-12-25	WOS:000341306600098
J	Cordek, DG; Croom-Perez, TJ; Hwang, J; Hargittai, MRS; Subba-Reddy, CV; Han, QX; Lodeiro, MF; Ning, G; McCrory, TS; Arnold, JJ; Koc, H; Lindenbach, BD; Showalter, SA; Cameron, CE				Cordek, Daniel G.; Croom-Perez, Tayler J.; Hwang, Jungwook; Hargittai, Michele R. S.; Subba-Reddy, Chennareddy V.; Han, Qingxia; Lodeiro, Maria Fernanda; Ning, Gang; McCrory, Thomas S.; Arnold, Jamie J.; Koc, Hasan; Lindenbach, Brett D.; Showalter, Scott A.; Cameron, Craig E.			Expanding the Proteome of an RNA Virus by Phosphorylation of an Intrinsically Disordered Viral Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hepatitis C Virus (HCV); Intrinsically Disordered Protein; Phosphorylation; RNA Virus; Viral Replication; NMR; Non-structural Protein 5A	HEPATITIS-C VIRUS; NONSTRUCTURAL PROTEIN; NS5A PROTEIN; POTENT INHIBITORS; KINASE-C; REPLICATION; BINDING; DOMAIN; 5A; IDENTIFICATION	Background: How can HCV require only 10 proteins for decades-long evasion of the immune system? Results: Phosphorylation of the intrinsically disordered domain (IDD) of NS5A changes its dynamics, inducing unique structure and function. Conclusion: IDD phosphorylation expands the HCV proteome. Significance: Post-translational modification of a viral IDD represents a strategy to expand a viral proteome when coding capacity is limited. The human proteome contains myriad intrinsically disordered proteins. Within intrinsically disordered proteins, polyproline-II motifs are often located near sites of phosphorylation. We have used an unconventional experimental paradigm to discover that phosphorylation by protein kinase A (PKA) occurs in the intrinsically disordered domain of hepatitis C virus non-structural protein 5A (NS5A) on Thr-2332 near one of its polyproline-II motifs. Phosphorylation shifts the conformational ensemble of the NS5A intrinsically disordered domain to a state that permits detection of the polyproline motif by using N-15-, C-13-based multidimensional NMR spectroscopy. PKA-dependent proline resonances were lost in the presence of the Src homology 3 domain of c-Src, consistent with formation of a complex. Changing Thr-2332 to alanine in hepatitis C virus genotype 1b reduced the steady-state level of RNA by 10-fold; this change was lethal for genotype 2a. The lethal phenotype could be rescued by changing Thr-2332 to glutamic acid, a phosphomimetic substitution. Immunofluorescence and transmission electron microscopy showed that the inability to produce Thr(P)-2332-NS5A caused loss of integrity of the virus-induced membranous web/replication organelle. An even more extreme phenotype was observed in the presence of small molecule inhibitors of PKA. We conclude that the PKA-phosphorylated form of NS5A exhibits unique structure and function relative to the unphosphorylated protein. We suggest that post-translational modification of viral proteins containing intrinsic disorder may be a general mechanism to expand the viral proteome without a corresponding expansion of the genome.	[Cordek, Daniel G.; Croom-Perez, Tayler J.; Han, Qingxia; Lodeiro, Maria Fernanda; McCrory, Thomas S.; Arnold, Jamie J.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Ning, Gang] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Showalter, Scott A.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Hwang, Jungwook] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Hargittai, Michele R. S.] St Francis Univ, Dept Chem, Loretto, PA 15940 USA; [Subba-Reddy, Chennareddy V.; Lindenbach, Brett D.] Yale Univ, Dept Microbial Pathogenesis, Sch Med, New Haven, CT 06536 USA; [Koc, Hasan] Marshall Univ, Dept Pharmaceut Sci & Res, Sch Pharm, Huntington, WV 25755 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Hanyang University; Yale University; Marshall University	Cameron, CE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 201, University Pk, PA 16802 USA.	cec9@psu.edu	Showalter, Scott A/A-1655-2012; han, qingxia/G-6260-2015; Hwang, Jungwook/P-1614-2015	Showalter, Scott A/0000-0001-5179-032X; Hwang, Jungwook/0000-0002-2290-1649; Croom-Perez, Tayler/0000-0002-7096-1515	National Institutes of Health, NIGMS [R01GM0089001]; National Institutes of Health, NIAID [R21 AI100590]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI100590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089001] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant R01GM0089001 (to Kevin D. Raney and C. E. C.) and National Institutes of Health, NIAID, Grant R21 AI100590 (to C. E. C.).	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Backes P, 2010, J VIROL, V84, P5775, DOI 10.1128/JVI.02343-09; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bukh J, 2002, P NATL ACAD SCI USA, V99, P14416, DOI 10.1073/pnas.212532699; Burckstummer T, 2006, FEBS LETT, V580, P575, DOI 10.1016/j.febslet.2005.12.071; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Cordek DC, 2011, DRUG FUTURE, V36, P691, DOI 10.1358/dof.2011.036.09.1641618; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Elam WA, 2013, PROTEIN SCI, V22, P405, DOI 10.1002/pro.2217; Feuerstein S, 2012, J MOL BIOL, V420, P310, DOI 10.1016/j.jmb.2012.04.023; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gilliver AN, 2010, J GEN VIROL, V91, P2428, DOI 10.1099/vir.0.023614-0; GLASS DB, 1989, J BIOL CHEM, V264, P8802; Goddard T. D., 2006, SPARKY VERSION 3 113; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Grieco D, 1996, SCIENCE, V271, P1718, DOI 10.1126/science.271.5256.1718; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Huang LY, 2004, PROTEIN EXPRES PURIF, V37, P144, DOI 10.1016/j.pep.2004.05.005; Hughes M, 2009, J VIROL, V83, P10788, DOI 10.1128/JVI.02406-08; Hwang J, 2010, J VIROL, V84, P12480, DOI 10.1128/JVI.01319-10; Ide Y, 1997, GENE, V201, P151, DOI 10.1016/S0378-1119(97)00440-X; Ide Y, 1996, GENE, V182, P203, DOI 10.1016/S0378-1119(96)00555-0; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Katze MG, 2000, VIROLOGY, V278, P501, DOI 10.1006/viro.2000.0662; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Lemay KL, 2013, J VIROL, V87, P1255, DOI 10.1128/JVI.02154-12; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Liang Y, 2006, MOL CELLS, V22, P13; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Macdonald A, 2005, J GEN VIROL, V86, P1035, DOI 10.1099/vir.0.80734-0; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; Martin-Garcia JM, 2012, ACTA CRYSTALLOGR D, V68, P1030, DOI 10.1107/S0907444912019798; Moriishi K, 2007, REV MED VIROL, V17, P343, DOI 10.1002/rmv.542; Neddermann P, 2004, J VIROL, V78, P13306, DOI 10.1128/JVI.78.23.13306-13314.2004; Pfannkuche A, 2011, HEPATOLOGY, V53, P1127, DOI 10.1002/hep.24214; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Quintavalle M, 2006, J VIROL, V80, P11305, DOI 10.1128/JVI.01465-06; Reed KE, 1999, J BIOL CHEM, V274, P28011, DOI 10.1074/jbc.274.39.28011; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; Sahu D, 2014, ANAL BIOCHEM, V449, P17, DOI 10.1016/j.ab.2013.12.005; Saxena V, 2012, J VIROL, V86, P4139, DOI 10.1128/JVI.06327-11; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamma G, 2008, PFLUG ARCH EUR J PHY, V456, P729, DOI 10.1007/s00424-008-0453-1; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533; Targett-Adams P, 2011, J VIROL, V85, P6353, DOI 10.1128/JVI.00215-11; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Wang QX, 2010, NUCLEIC ACIDS RES, V38, P1312, DOI 10.1093/nar/gkp1118; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yi M, 2014, J VIROL, V88, P3678, DOI 10.1128/JVI.03540-13; Zhong WD, 2000, J VIROL, V74, P9134, DOI 10.1128/JVI.74.19.9134-9143.2000	61	16	16	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24397	24416		10.1074/jbc.M114.589911	http://dx.doi.org/10.1074/jbc.M114.589911			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25031324	hybrid, Green Published			2022-12-25	WOS:000341505600034
J	Groveman, BR; Dolan, MA; Taubner, LM; Kraus, A; Wickner, RB; Caughey, B				Groveman, Bradley R.; Dolan, Michael A.; Taubner, Lara M.; Kraus, Allison; Wickner, Reed B.; Caughey, Byron			Parallel In-register Intermolecular beta-Sheet Architectures for Prion-seeded Prion Protein (PrP) Amyloids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Molecular Dynamics; Nuclear Magnetic Resonance (NMR); Prion; Protein Structure	SOLID-STATE NMR; SCRAPIE; CONVERSION; FIBRILS; STRAIN; CONFORMATION; ORGANIZATION; RESIDUES; HELICES; DOMAIN	Background: The structures of infectious mammalian prions remain unclear. Results: Based in part on NMR data, we developed models with single PrP molecules spanning the entire cross-section of prion fibrils. Conclusion: These models are consistent with many empirical features of prion amyloids. Significance: We provide a new basis for conceptualizing and experimentally evaluating the structures and propagation of infectious prions. Structures of the infectious form of prion protein (e.g. PrPSc or PrP-Scrapie) remain poorly defined. The prevalent structural models of PrPSc retain most of the native -helices of the normal, noninfectious prion protein, cellular prion protein (PrPC), but evidence is accumulating that these helices are absent in PrPSc amyloid. Moreover, recombinant PrPC can form amyloid fibrils in vitro that have parallel in-register intermolecular -sheet architectures in the domains originally occupied by helices 2 and 3. Here, we provide solid-state NMR evidence that the latter is also true of initially prion-seeded recombinant PrP amyloids formed in the absence of denaturants. These results, in the context of a primarily -sheet structure, led us to build detailed models of PrP amyloid based on parallel in-register architectures, fibrillar shapes and dimensions, and other available experimentally derived conformational constraints. Molecular dynamics simulations of PrP(90-231) octameric segments suggested that such linear fibrils, which are consistent with many features of PrPSc fibrils, can have stable parallel in-register -sheet cores. These simulations revealed that the C-terminal residues approximate to 124-227 more readily adopt stable tightly packed structures than the N-terminal residues approximate to 90-123 in the absence of cofactors. Variations in the placement of turns and loops that link the -sheets could give rise to distinct prion strains capable of faithful template-driven propagation. Moreover, our modeling suggests that single PrP monomers can comprise the entire cross-section of fibrils that have previously been assumed to be pairs of laterally associated protofilaments. Together, these insights provide a new basis for deciphering mammalian prion structures.	[Groveman, Bradley R.; Taubner, Lara M.; Kraus, Allison; Caughey, Byron] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Dolan, Michael A.] NIAID, Computat Biol Sect, Bioinformat & Computat Biosci Branch, Bethesda, MD 20892 USA; [Wickner, Reed B.] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Caughey, B (corresponding author), NIAID, Rocky Mt Labs, 903 S 4th St, Hamilton, MT 59840 USA.	bcaughey@nih.gov			National Institutes of Health Intramural Program of the NIAID; National Institutes of Health Intramural Program of the NIDDK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024950] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program of the NIAID; National Institutes of Health Intramural Program of the NIDDK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Programs of the NIAID and the NIDDK.	Adrover M, 2010, J BIOL CHEM, V285, P21004, DOI 10.1074/jbc.M110.111815; Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baron GS, 2011, BIOCHEMISTRY-US, V50, P4479, DOI 10.1021/bi2003907; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; GABIZON R, 1988, J BIOL CHEM, V263, P4950; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Helmus JJ, 2011, J AM CHEM SOC, V133, P13934, DOI 10.1021/ja206469q; Herrmann LM, 1998, NEUROREPORT, V9, P2457, DOI 10.1097/00001756-199808030-00006; HOPE J, 1988, EUR J BIOCHEM, V172, P271, DOI 10.1111/j.1432-1033.1988.tb13883.x; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; Jones EM, 2011, J BIOL CHEM, V286, P42777, DOI 10.1074/jbc.M111.302539; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; Kocisko DA, 1996, BIOCHEMISTRY-US, V35, P13434, DOI 10.1021/bi9610562; Kraus A, 2013, ANNU REV MICROBIOL, V67, P543, DOI 10.1146/annurev-micro-092412-155735; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MCKINLEY MP, 1991, LAB INVEST, V65, P622; MERZ PA, 1981, ACTA NEUROPATHOL, V54, P63, DOI 10.1007/BF00691333; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Onisko B, 2005, BIOCHEMISTRY-US, V44, P10100, DOI 10.1021/bi0501582; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Petkova AT, 2002, J MAGN RESON, V155, P293, DOI 10.1006/jmre.2002.2519; Piro JR, 2011, BIOCHEMISTRY-US, V50, P7111, DOI 10.1021/bi200786p; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Sajnani G, 2008, J MOL BIOL, V382, P88, DOI 10.1016/j.jmb.2008.06.070; Shewmaker F, 2008, BIOCHEMISTRY-US, V47, P4000, DOI 10.1021/bi7024589; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sim VL, 2009, NEUROBIOL AGING, V30, P2031, DOI 10.1016/j.neurobiolaging.2008.02.016; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Tycko R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2437194; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Vazquez-Fernandez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050111; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Welker E, 2002, J BIOL CHEM, V277, P33477, DOI 10.1074/jbc.M204273200; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; Wickner RB, 2013, BIOCHEMISTRY-US, V52, P1514, DOI 10.1021/bi301686a; Wickner RB, 2010, FEMS YEAST RES, V10, P980, DOI 10.1111/j.1567-1364.2010.00666.x; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55	68	118	118	0	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24129	24142		10.1074/jbc.M114.578344	http://dx.doi.org/10.1074/jbc.M114.578344			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25028516	Green Published, hybrid			2022-12-25	WOS:000341505600012
J	Ishida, K; Taguchi, K; Matsumoto, T; Kobayashi, T				Ishida, Keiko; Taguchi, Kumiko; Matsumoto, Takayuki; Kobayashi, Tsuneo			Activated Platelets from Diabetic Rats Cause Endothelial Dysfunction by Decreasing Akt/Endothelial NO Synthase Signaling Pathway	PLOS ONE			English	Article							TREATMENT-INDUCED IMPROVEMENT; CORONARY-ARTERY-DISEASE; OXIDATIVE STRESS; DEPENDENT RELAXATION; VASCULAR-DISEASE; HEART-FAILURE; MECHANISMS; COMPLICATIONS; INVOLVEMENT; BLOCKADE	Diabetes is associated with endothelial dysfunction and platelet activation, both of which may contribute to increased cardiovascular risk. The purpose of this study was to characterize circulating platelets in diabetes and clarify their effects on endothelial function. Male Wistar rats were injected with streptozotocin (STZ) to induce diabetes. Each experiment was performed by incubating carotid arterial rings with platelets (1.65x10(7) cells/mL; 30 min) isolated from STZ or control rats. Thereafter, the vascular function was characterized in isolated carotid arterial rings in organ bath chambers, and each expression and activation of enzymes involved in nitric oxide and oxidative stress levels were analyzed. Endothelium-dependent relaxation induced by acetylcholine was significantly attenuated in carotid arteries treated with platelets isolated from STZ rats. Similarly, treatment with platelets isolated from STZ rats significantly reduced ACh-induced Akt/endothelial NO synthase signaling/NO production and enhanced TXB2 (metabolite of TXA(2)), while CD61 (platelet marker) and CD62P (activated platelet marker) were increased in carotid arteries treated with platelets isolated from STZ rats. Furthermore, the platelets isolated from STZ rats decreased total eNOS protein and eNOS dimerization, and increased oxidative stress. These data provide direct evidence that circulating platelets isolated from diabetic rats cause dysfunction of the endothelium by decreasing NO production (via Akt/endothelial NO synthase signaling pathway) and increasing TXA(2). Moreover, activated platelets disrupt the carotid artery by increasing oxidative stress.	[Ishida, Keiko; Taguchi, Kumiko; Matsumoto, Takayuki; Kobayashi, Tsuneo] Hoshi Univ, Inst Med Chem, Dept Physiol & Morphol, Shinagawa Ku, Tokyo 142, Japan	Hoshi University	Kobayashi, T (corresponding author), Hoshi Univ, Inst Med Chem, Dept Physiol & Morphol, Shinagawa Ku, Ebara 2-4-41, Tokyo 142, Japan.	tkoba@hoshi.ac.jp		Ishida, Keiko/0000-0002-0344-6193; Matsumoto, Takayuki/0000-0001-9177-8384	Ministry of Education, Culture, Sports, Science and Technology, Japan [25870258, 24590127]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Ministry of Education, Culture, Sports, Science and Technology, Japan (25870258 and 24590127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colas R, 2011, DIABETOLOGIA, V54, P2931, DOI 10.1007/s00125-011-2272-8; Colwell JA, 2003, DIABETES CARE, V26, P2181, DOI 10.2337/diacare.26.7.2181; Feletou M, 2010, PFLUG ARCH EUR J PHY, V459, P941, DOI 10.1007/s00424-010-0812-6; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Guerci B, 2001, DIABETES METAB, V27, P436; Hadas K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074401; Heeschen C, 2003, NEW ENGL J MED, V348, P1104, DOI 10.1056/NEJMoa022600; Heistad DD, 2006, ARTERIOSCL THROM VAS, V26, P689, DOI 10.1161/01.ATV.0000203525.62147.28; Heitzer T, 2003, CIRCULATION, V108, P536, DOI 10.1161/01.cir.0000081774.31064.62; Jay D, 2006, FREE RADICAL BIO MED, V40, P183, DOI 10.1016/j.freeradbiomed.2005.06.018; Kamata K, 2000, N-S ARCH PHARMACOL, V362, P52, DOI 10.1007/s002100000248; Kobayashi T, 2000, BRIT J PHARMACOL, V131, P231, DOI 10.1038/sj.bjp.0703572; Kobayashi T, 2012, CLIN SCI, V123, P375, DOI 10.1042/CS20110621; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; Littleton-Kearney MT, 2005, BIOL RES NURS, V7, P135, DOI 10.1177/1099800405276832; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Matsumoto T, 2007, FREE RADICAL BIO MED, V42, P993, DOI 10.1016/j.freeradbiomed.2006.12.028; Matsumoto T, 2014, PFLUG ARCH EUR J PHY, V466, P331, DOI 10.1007/s00424-013-1330-0; Matsumoto T, 2009, ATHEROSCLEROSIS, V205, P87, DOI 10.1016/j.atherosclerosis.2008.11.015; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; Natarajan A, 2008, DIABETES VASC DIS RE, V5, P138, DOI 10.3132/dvdr.2008.023; NIMPF J, 1986, BASIC RES CARDIOL, V81, P437, DOI 10.1007/BF01907750; Resnick HE, 2000, DIABETES CARE, V23, P176, DOI 10.2337/diacare.23.2.176; Romano MR, 2009, EUR J PHARMACOL, V608, P48, DOI 10.1016/j.ejphar.2009.02.034; Schafer A, 2004, THROMB HAEMOSTASIS, V92, P97, DOI 10.1160/th04-02-0118; Schafer A, 2003, THROMB HAEMOSTASIS, V89, P1024, DOI 10.1055/s-0037-1613404; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; Schwarz M, 2006, CIRC RES, V99, P25, DOI 10.1161/01.RES.0000232317.84122.0c; Sowers JR, 2013, HYPERTENSION, V61, P943, DOI 10.1161/HYPERTENSIONAHA.111.00612; Sudhahar V, 2013, DIABETES, V62, P3839, DOI 10.2337/db12-1228; Taguchi K, 2012, DIABETES, V61, P1978, DOI 10.2337/db11-1729; Tschoepe D, 1997, DIABETOLOGIA, V40, P573, DOI 10.1007/s001250050717; Tual-Chalot S, 2010, AM J RESP CRIT CARE, V182, P261, DOI 10.1164/rccm.200909-1347OC; Vaidya D, 2009, METAB SYNDR RELAT D, V7, P289, DOI 10.1089/met.2008.0083; Vericel E, 2004, DIABETES, V53, P1046, DOI 10.2337/diabetes.53.4.1046; Vinik AI, 2001, DIABETES CARE, V24, P1476, DOI 10.2337/diacare.24.8.1476; Wang XW, 2012, CIRCULATION, V125, P3117, DOI 10.1161/CIRCULATIONAHA.111.030312; Zhang X, 2013, J THROMB TH IN PRESS	40	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102310	10.1371/journal.pone.0102310	http://dx.doi.org/10.1371/journal.pone.0102310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047034	Green Published, Green Submitted, gold			2022-12-25	WOS:000339558100026
J	Vriens, B; Ammann, AA; Hagendorfer, H; Lenz, M; Berg, M; Winkel, LHE				Vriens, Bas; Ammann, Adrian A.; Hagendorfer, Harald; Lenz, Markus; Berg, Michael; Winkel, Lenny H. E.			Quantification of Methylated Selenium, Sulfur, and Arsenic in the Environment	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; GAS-CHROMATOGRAPHY; SPECIATION ANALYSIS; VOLATILE SELENIUM; NATURAL-WATERS; ICP-MS; SPECTROMETRY; SE; GROUNDWATER; ELEMENTS	Biomethylation and volatilization of trace elements may contribute to their redistribution in the environment. However, quantification of volatile, methylated species in the environment is complicated by a lack of straightforward and field-deployable air sampling methods that preserve element speciation. This paper presents a robust and versatile gas trapping method for the simultaneous preconcentration of volatile selenium (Se), sulfur (S), and arsenic (As) species. Using HPLC-HR-ICP- MS and ESI-MS/MS analyses, we demonstrate that volatile Se and S species efficiently transform into specific non-volatile compounds during trapping, which enables the deduction of the original gaseous speciation. With minor adaptations, the presented HPLC-HR-ICP-MS method also allows for the quantification of 13 non-volatile methylated species and oxyanions of Se, S, and As in natural waters. Application of these methods in a peatland indicated that, at the selected sites, fluxes varied between 190-210 ng Se.m(-2).d(-1), 90-270 ng As.m(-2).d(-1), and 4-14 mu g S.m(-2).d(-1), and contained at least 70% methylated Se and S species. In the surface water, methylated species were particularly abundant for As (> 50% of total As). Our results indicate that methylation plays a significant role in the biogeochemical cycles of these elements.	[Vriens, Bas; Berg, Michael; Winkel, Lenny H. E.] Swiss Fed Inst Aquat Sci & Technol, Dept Water Resources & Drinking Water, Dubendorf, Switzerland; [Vriens, Bas; Winkel, Lenny H. E.] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Ammann, Adrian A.] Swiss Fed Inst Aquat Sci & Technol, Dept Environm Toxicol, Dubendorf, Switzerland; [Hagendorfer, Harald] Swiss Fed Inst Mat Sci & Technol, Dept Thin Films & Photovolta, Dubendorf, Switzerland; [Lenz, Markus] Univ Appl Sci & Arts Northwestern Switzerland, Inst Ecopreneurship, Sch Life Sci, Muttenz, Switzerland; [Lenz, Markus] Wageningen Univ, Dept Environm Technol, NL-6700 AP Wageningen, Netherlands	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); FHNW University of Applied Sciences & Arts Northwestern Switzerland; Wageningen University & Research	Winkel, LHE (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Dept Water Resources & Drinking Water, Dubendorf, Switzerland.	lenny.winkel@eawag.ch	Berg, Michael/C-3738-2012; Lenz, Markus/AAN-7142-2020	Berg, Michael/0000-0002-7342-4061; Lenz, Markus/0000-0001-6832-3218; Vriens, Bas/0000-0001-8444-3383; Winkel, Lenny/0000-0001-7586-7256	Swiss National Science Foundation [SNF PP00P2_133619, 200020_138210]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the Swiss National Science Foundation (http://www.snf.ch) (SNF PP00P2_133619 and 200020_138210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann AA., 2011, AM J ANAL CHEM, V2, P27, DOI DOI 10.4236/AJAC.2011.21004; Ammann AA, 2010, J CHROMATOGR A, V1217, P2111, DOI 10.1016/j.chroma.2010.01.086; Amouroux D, 2001, EARTH PLANET SC LETT, V189, P277, DOI 10.1016/S0012-821X(01)00370-3; Amouroux D, 1998, ANAL CHIM ACTA, V377, P241, DOI 10.1016/S0003-2670(98)00425-5; ANDERSON LCD, 1991, ENVIRON SCI TECHNOL, V25, P420, DOI 10.1021/es00015a007; B'Hymer C, 2006, J CHROMATOGR A, V1114, P1, DOI 10.1016/j.chroma.2006.02.063; Bednar AJ, 2004, WATER RES, V38, P355, DOI 10.1016/j.watres.2003.09.034; Bentley R, 2004, CHEMOSPHERE, V55, P291, DOI 10.1016/j.chemosphere.2003.12.017; Bentley R, 2002, MICROBIOL MOL BIOL R, V66, P250, DOI 10.1128/MMBR.66.2.250-271.2002; Cai Y, 2000, TRAC-TREND ANAL CHEM, V19, P62, DOI 10.1016/S0165-9936(99)00180-6; Chasteen TG, 2003, CHEM REV, V103, P1, DOI 10.1021/cr010210+; Chen BB, 2013, J ANAL ATOM SPECTROM, V28, P334, DOI 10.1039/c2ja30280b; Chen YW, 2010, ANAL CHIM ACTA, V671, P9, DOI 10.1016/j.aca.2010.05.011; D'Ulivo A, 2007, ANAL CHEM, V79, P3008, DOI 10.1021/ac061962c; Fernandez-Martinez Alejandro, 2009, Reviews in Environmental Science and Bio/Technology, V8, P81, DOI 10.1007/s11157-009-9145-3; Francesconi KA, 2002, BOOK SOIL P, P51; Latorre CH, 2013, ANAL CHIM ACTA, V804, P37, DOI 10.1016/j.aca.2013.09.054; Jain CK, 2000, WATER RES, V34, P4304, DOI 10.1016/S0043-1354(00)00182-2; JIANG S, 1983, ATMOS ENVIRON, V17, P111, DOI 10.1016/0004-6981(83)90014-8; Juresa D, 2006, ANAL CHEM, V78, P8569, DOI 10.1021/ac061496r; Langner P, 2012, NAT GEOSCI, V5, P66, DOI [10.1038/NGEO1329, 10.1038/ngeo1329]; Lenz M, 2012, ENVIRON SCI TECHNOL, V46, P11988, DOI 10.1021/es302550b; Li KC, 2004, INT J ENVIRON AN CH, V84, P749, DOI 10.1080/03067310410001729619; Lomans BP, 2002, CELL MOL LIFE SCI, V59, P575, DOI 10.1007/s00018-002-8450-6; Martinez-Bravo Y, 2001, J CHROMATOGR A, V926, P265, DOI 10.1016/S0021-9673(01)01062-7; Meija J, 2002, ANAL CHEM, V74, P5837, DOI 10.1021/ac020285t; Mestrot A, 2011, ENVIRON SCI TECHNOL, V45, P1798, DOI 10.1021/es103463d; Mestrot A, 2009, ENVIRON SCI TECHNOL, V43, P8270, DOI 10.1021/es9018755; MESZAROS E, 1978, ATMOS ENVIRON, V12, P699, DOI 10.1016/0004-6981(78)90250-0; Niedzielski P, 2005, ANAL CHIM ACTA, V551, P199, DOI 10.1016/j.aca.2005.06.073; Pandey SK, 2009, ENVIRON SCI TECHNOL, V43, P3020, DOI 10.1021/es803272f; Pantsar-Kallio M, 2000, ANAL CHIM ACTA, V410, P65, DOI 10.1016/S0003-2670(99)00892-2; Pecheyran C, 1998, ANAL CHEM, V70, P2639, DOI 10.1021/ac9709615; Pecheyran C, 1998, J ANAL ATOM SPECTROM, V13, P615, DOI 10.1039/a802246a; Planer-Friedrich B, 2002, ANAL BIOANAL CHEM, V374, P1191, DOI 10.1007/s00216-002-1636-9; Planer-Friedrich B, 2007, ENVIRON SCI TECHNOL, V41, P5245, DOI 10.1021/es070273v; Plant JA, 2005, TREATISE ON GEOCHEMISTRY, VOL 9: ENVIRONMENTAL GEOCHEMISTRY, P17; Pyrzynska K, 2002, MICROCHIM ACTA, V140, P55, DOI 10.1007/s00604-001-0899-8; Thayer JS, 2002, APPL ORGANOMET CHEM, V16, P677, DOI 10.1002/aoc.375; Tonietto GB, 2010, ANAL BIOANAL CHEM, V397, P1755, DOI 10.1007/s00216-010-3764-y; Vriens B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4035; Wardencki W, 1998, J CHROMATOGR A, V793, P1, DOI 10.1016/S0021-9673(97)00997-7; Wen HJ, 2007, ATMOS ENVIRON, V41, P7151, DOI 10.1016/j.atmosenv.2007.07.035; Winkel L, 2008, NAT GEOSCI, V1, P536, DOI 10.1038/ngeo254; Winkel L, 2010, ENVIRON SCI TECHNOL, V44, P382, DOI 10.1021/es902345m; Winkel LHE, 2012, ENVIRON SCI TECHNOL, V46, P571, DOI 10.1021/es203434d; Winkel LHE, 2011, P NATL ACAD SCI USA, V108, P1246, DOI 10.1073/pnas.1011915108; Yang GS, 2012, CHEMOSPHERE, V87, P845, DOI 10.1016/j.chemosphere.2012.01.023	49	22	22	7	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102906	10.1371/journal.pone.0102906	http://dx.doi.org/10.1371/journal.pone.0102906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047128	Green Published, Green Submitted, gold			2022-12-25	WOS:000339558100088
J	Huang, JL; Lin, YJ; Hung, YW; Hsieh, YC; Cheng, CM; Wang, KY				Huang, Jin-Long; Lin, Yenn-Jiang; Hung, Yi-Wen; Hsieh, Yu-Cheng; Cheng, Chien-Ming; Wang, Kuo-Yang			Preventing Phrenic Nerve Stimulation by a Patch Insulation in an Intact Swine Heart Model	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; VENTRICULAR PACING THRESHOLDS; LEAD; MANAGEMENT; OVERCOME	Introduction: Phrenic nerve stimulation (PNS) could be prevented by a silastic patch over the epicardial lead. We studied the effects in preventing PNS by placing a silastic patch directly over an epicardial lead or placing a graft around the phrenic nerve (PN). Methods and Results: Fourteen Lanyu swine were enrolled. A bipolar lead was placed epicardially on the left ventricle (LV) inferior to the PN. An implantable cardioverter-defibrillator (ICD) lead was placed into the right ventricle (RV). The maximal influential distance (MID) was measured under 3 pacing configurations to express the influential electrical field on the PN. The threshold of the LV and PN were evaluated epicardially. Then, PTFE patches of different sizes (10x10 mm, 20x20 mm and 30x30 mm) were placed between the LV lead and PN to study the rise in PN threshold in 7 swine. On the other hand, the PN were surrounded by a PTFE graft of different lengths (10 mm, 20 mm, and 30 mm) in the remaining 7 swine. LV-bipolar pacing showed the shortest MID when compared to the other 2 unipolar pacing configurations at pacing voltage of 10 V. The patch was most effective in preventing PNS during LV-bipolar pacing. PNS was prevented under all circumstances with a larger PTFE patch (30x30 mm) or long graft (30 mm). Conclusions: PNS was avoided by placing a PTFE patch over the LV lead or a graft around the PN despite pacing configurations. Hence if PNS persisted during CRT implantation, a PTFE patch on the LV lead or a graft around the PN could be considered.	[Huang, Jin-Long; Hsieh, Yu-Cheng; Wang, Kuo-Yang] Taichung Vet Gen Hosp, Ctr Cardiovasc, Taichung, Taiwan; [Huang, Jin-Long; Lin, Yenn-Jiang; Hsieh, Yu-Cheng] Natl Yang Ming Univ, Sch Med, Dept Med, Inst Clin Med, Taipei 112, Taiwan; [Huang, Jin-Long; Lin, Yenn-Jiang; Hsieh, Yu-Cheng] Natl Yang Ming Univ, Sch Med, Dept Med, Cardiovasc Res Inst, Taipei 112, Taiwan; [Huang, Jin-Long; Wang, Kuo-Yang] Chung Shan Med Univ, Sch Med, Dept Med, Taichung, Taiwan; [Lin, Yenn-Jiang] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Hung, Yi-Wen] Natl Chung Hsing Univ, Coll Vet Med, Dept Vet Med, Taichung Vet Gen Hosp,Dept Educ & Res, Taichung 40227, Taiwan; [Cheng, Chien-Ming] Minist Hlth & Welf, Feng Yuan Hosp, Dept Med, Div Cardiol, Taichung, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chung Shan Medical University; Taipei Veterans General Hospital; National Chung Hsing University; Taichung Veterans General Hospital	Huang, JL (corresponding author), Taichung Vet Gen Hosp, Ctr Cardiovasc, Taichung, Taiwan.	golden@vghtc.gov.tw			National Science Council [NSC 100-2314-B-075A-005-MY3]; Taichung Veterans General Hospital [1003105C, 1013105C, 1023105C]	National Science Council(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital	Supported in part by grants from the National Science Council (NSC 100-2314-B-075A-005-MY3); Taichung Veterans General Hospital (1003105C, 1013105C, and 1023105C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Sham'a R, 2011, EUROPACE, V13, P997, DOI 10.1093/europace/eur076; Anderson SE, 2010, J ELECTROCARDIOL, V43, P136, DOI 10.1016/j.jelectrocard.2009.08.002; Biffi M, 2012, CIRC-ARRHYTHMIA ELEC, V5, P815, DOI 10.1161/CIRCEP.112.971317; Biffi M, 2011, CURR OPIN CARDIOL, V26, P12, DOI 10.1097/HCO.0b013e3283413838; Biffi M, 2009, CIRC-ARRHYTHMIA ELEC, V2, P402, DOI 10.1161/CIRCEP.108.836254; Champagne J, 2011, EUROPACE, V13, P409, DOI 10.1093/europace/euq499; Dendy Khalin F, 2011, Indian Pacing Electrophysiol J, V11, P64; Gurevitz O, 2005, PACE, V28, P1255, DOI 10.1111/j.1540-8159.2005.00265.x; James DS, 1963, CIRCULATION, V28, P114; Kirubakaran S, 2012, EUROPACE, V14, P608, DOI 10.1093/europace/eur355; Mediratta N, 2012, EUROPACE, V14, P1049, DOI 10.1093/europace/eur396; Oh S, 2011, HEART RHYTHM, V8, P1637, DOI 10.1016/j.hrthm.2011.05.002; Rickard J, 2011, AM J CARDIOL, V108, P1576, DOI 10.1016/j.amjcard.2011.07.017; Rickard J, 2011, J INTERV CARD ELECTR, V31, P61, DOI 10.1007/s10840-011-9555-3; Selvaraj Raja, 2011, Indian Pacing Electrophysiol J, V11, P61; Thibault B, 2010, EUROPACE, V12, P751, DOI 10.1093/europace/eup435; van Steenberghe M, 2011, INT J CARDIOL, V147, P328, DOI 10.1016/j.ijcard.2010.12.087; Wells WJ, 2003, ANN THORAC SURG, V76, P1757, DOI 10.1016/S0003-4975(03)00557-5	18	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102608	10.1371/journal.pone.0102608	http://dx.doi.org/10.1371/journal.pone.0102608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033271	Green Submitted, Green Published, gold			2022-12-25	WOS:000339418300068
J	van de Kamp, T; Rolo, TD; Vagovic, P; Baumbach, T; Riedel, A				van de Kamp, Thomas; Rolo, Tomy dos Santos; Vagovic, Patrik; Baumbach, Tilo; Riedel, Alexander			Three-Dimensional Reconstructions Come to Life - Interactive 3D PDF Animations in Functional Morphology	PLOS ONE			English	Article							HAWKMOTH MANDUCA-SEXTA; NEW-GUINEA; MECHANICS; CURCULIONIDAE; COLEOPTERA; SPECIMENS; SCIENCE; INSECT; MODELS; FLIGHT	Digital surface mesh models based on segmented datasets have become an integral part of studies on animal anatomy and functional morphology; usually, they are published as static images, movies or as interactive PDF files. We demonstrate the use of animated 3D models embedded in PDF documents, which combine the advantages of both movie and interactivity, based on the example of preserved Trigonopterus weevils. The method is particularly suitable to simulate joints with largely deterministic movements due to precise form closure. We illustrate the function of an individual screw-and-nut type hip joint and proceed to the complex movements of the entire insect attaining a defence position. This posture is achieved by a specific cascade of movements: Head and legs interlock mutually and with specific features of thorax and the first abdominal ventrite, presumably to increase the mechanical stability of the beetle and to maintain the defence position with minimal muscle activity. The deterministic interaction of accurately fitting body parts follows a defined sequence, which resembles a piece of engineering.	[van de Kamp, Thomas; Rolo, Tomy dos Santos; Vagovic, Patrik; Baumbach, Tilo] KIT, ANKA Inst Photon Sci & Synchrotron Radiat, Eggenstein Leopoldshafen, Germany; [van de Kamp, Thomas; Riedel, Alexander] State Museum Nat Hist SMNK, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	van de Kamp, T (corresponding author), KIT, ANKA Inst Photon Sci & Synchrotron Radiat, Eggenstein Leopoldshafen, Germany.	thomas.vandekamp@kit.edu	Baumbach, Tilo Gerd/K-5355-2013; dos Santos Rolo, Tomy/F-5511-2016; Riedel, Alexander/V-2608-2019; van de Kamp, Thomas/G-1440-2016	dos Santos Rolo, Tomy/0000-0002-9771-3511; Riedel, Alexander/0000-0002-8291-4425; van de Kamp, Thomas/0000-0001-7390-1318	Deutsche Forschungsgemeinschaft, DFG [RI 1817/3-1, RI 1817/3-3]; German Federal Ministry of Education and Research [05K10CKB, 05K12CK2]; Deutsche Forschungsgemeinschaft; Karlsruhe Institute of Technology	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association)	This work was partly funded by Deutsche Forschungsgemeinschaft, DFG (www.dfg.de; RI 1817/3-1, 3-3) and the German Federal Ministry of Education and Research (www.bmbf.de; grants 05K10CKB and 05K12CK2). The authors' acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeumler N, 2008, ZOOSYMPOSIA, V1, P101, DOI 10.11646/zoosymposia.1.1.9; Baier DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063982; Betz O, 2007, J MICROSC-OXFORD, V227, P51, DOI 10.1111/j.1365-2818.2007.01785.x; BLEICH OTTO ERNST, 1928, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPHOL U OKOL TIERE, V10, P1, DOI 10.1007/BF00419278; Bogelsack G, 2000, THEOR BIOSCI, V119, P104, DOI 10.1078/1431-7613-00008; Brainerd EL, 2010, J EXP ZOOL PART A, V313A, P262, DOI 10.1002/jez.589; Corfield JR, 2008, NAT PROTOC, V3, P597, DOI 10.1038/nprot.2008.17; FULL RJ, 1991, J EXP BIOL, V156, P215; Gatesy SM, 2010, J EXP ZOOL PART A, V313A, P244, DOI 10.1002/jez.588; Handschuh S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-44; HOMBERGER DG, 1988, AM ZOOL, V28, P217; Lauridsen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017879; Murienne J, 2008, NATURE, V453, P450, DOI 10.1038/453450d; Riedel A, 2010, ZOOTAXA, P59; Riedel A, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.280.3906; Riedel A, 2010, ZOOL SCR, V39, P63, DOI 10.1111/j.1463-6409.2009.00404.x; Rolo TD, 2014, P NATL ACAD SCI USA, V111, P3921, DOI 10.1073/pnas.1308650111; Ruthensteiner B, 2008, MICROSC RES TECHNIQ, V71, P778, DOI 10.1002/jemt.20618; Sahara W, 2006, J ORTHOP RES, V24, P1823, DOI 10.1002/jor.20208; Spence AJ, 2010, J EXP BIOL, V213, P1907, DOI 10.1242/jeb.042515; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; van de Kamp T, 2011, SCIENCE, V333, P52, DOI 10.1126/science.1204245; Weide D, 2014, ACTA ZOOL-STOCKHOLM, V95, P84, DOI 10.1111/azo.12011; Weitkamp T, 2011, J SYNCHROTRON RADIAT, V18, P617, DOI 10.1107/S0909049511002895; Westneat MW, 2008, ANNU REV PHYSIOL, V70, P119, DOI 10.1146/annurev.physiol.70.113006.100434; Willmott AP, 1997, J EXP BIOL, V200, P2705; Willmott AP, 1997, J EXP BIOL, V200, P2723; Witmer LM, 2008, ANAT REC, V291, P1362, DOI 10.1002/ar.20794; Ziegler A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-45; Zill S, 2000, MICROSC RES TECHNIQ, V48, P367, DOI 10.1002/(SICI)1097-0029(20000315)48:6<367::AID-JEMT7>3.3.CO;2-P	30	47	48	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102355	10.1371/journal.pone.0102355	http://dx.doi.org/10.1371/journal.pone.0102355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029366	Green Published, Green Submitted, gold			2022-12-25	WOS:000341306600069
J	Chen, J; Hu, WJ; Wang, C; Liu, TW; Chalifour, A; Chen, J; Shen, ZJ; Liu, X; Wang, WH; Zheng, HL				Chen, Juan; Hu, Wen-Jun; Wang, Chao; Liu, Ting-Wu; Chalifour, Annie; Chen, Juan; Shen, Zhi-Jun; Liu, Xiang; Wang, Wen-Hua; Zheng, Hai-Lei			Proteomic Analysis Reveals Differences in Tolerance to Acid Rain in Two Broad-Leaf Tree Species, Liquidambar formosana and Schima superba	PLOS ONE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; SALT STRESS; RESPONSIVE PROTEINS; DROUGHT TOLERANCE; SEEDLING GROWTH; PHYTOCHROME B; EXPRESSION; BIOSYNTHESIS; GERMINATION	Acid rain (AR) is a serious environmental issue inducing harmful impacts on plant growth and development. It has been reported that Liquidambar formosana, considered as an AR-sensitive tree species, was largely injured by AR, compared with Schima superba, an AR-tolerant tree species. To clarify the different responses of these two species to AR, a comparative proteomic analysis was conducted in this study. More than 1000 protein spots were reproducibly detected on two-dimensional electrophoresis gels. Among them, 74 protein spots from L. formosana gels and 34 protein spots from S. superba gels showed significant changes in their abundances under AR stress. In both L. formosana and S. superba, the majority proteins with more than 2 fold changes were involved in photosynthesis and energy production, followed by material metabolism, stress and defense, transcription, post-translational and modification, and signal transduction. In contrast with L. formosana, no hormone response-related protein was found in S. superba. Moreover, the changes of proteins involved in photosynthesis, starch synthesis, and translation were distinctly different between L. formosana and S. superba. Protein expression analysis of three proteins (ribulose-1,5-bisphosphate carboxylase/oxygenase large subunit, ascorbate peroxidase and glutathione-S-transferase) by Western blot was well correlated with the results of proteomics. In conclusion, our study provides new insights into AR stress responses in woody plants and clarifies the differences in strategies to cope with AR between L. formosana and S. superba.	[Chen, Juan; Hu, Wen-Jun; Liu, Ting-Wu; Chen, Juan; Shen, Zhi-Jun; Liu, Xiang; Wang, Wen-Hua; Zheng, Hai-Lei] Xiamen Univ, Key Lab Coastal & Wetland Ecosyst, Minist Educ, Coll Environm & Ecol, Xiamen, Fujian, Peoples R China; [Wang, Chao] Chinese Acad Sci, Inst Urban & Environm, Xiamen, Peoples R China; [Liu, Ting-Wu] Huaiyin Normal Univ, Dept Biol, Huaian, Jiangsu, Peoples R China; [Chalifour, Annie] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China	Xiamen University; Chinese Academy of Sciences; Institute of Urban Environment, CAS; Huaiyin Normal University; City University of Hong Kong	Zheng, HL (corresponding author), Xiamen Univ, Key Lab Coastal & Wetland Ecosyst, Minist Educ, Coll Environm & Ecol, Xiamen, Fujian, Peoples R China.	zhenghl@xmu.edu.cn	Zheng, Hai-Lei/G-3432-2010	Zheng, Hai-Lei/0000-0001-8588-1529; Chalifour, Annie/0000-0003-2266-3094	Natural Science Foundation of China (NSFC) [31300505, 30930076, 31260057, 30770192, 30670317]; China Postdoctoral Science Foundation [2012M521278]; Foundation of the Chinese Ministry of Education [20070384033, 209084]; Program for New Century Excellent Talents in Xiamen University [NCETXMU X07115]; Scholarship Award for Excellent Doctoral Student - Chinese Ministry of Education	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Foundation of the Chinese Ministry of Education(Ministry of Education, China); Program for New Century Excellent Talents in Xiamen University(Program for New Century Excellent Talents in University (NCET)); Scholarship Award for Excellent Doctoral Student - Chinese Ministry of Education(Ministry of Education, China)	This study was financially supported by the Natural Science Foundation of China (NSFC) (31300505, 30930076, 31260057, 30770192, 30670317), China Postdoctoral Science Foundation (2012M521278), the Foundation of the Chinese Ministry of Education (20070384033, 209084), the Program for New Century Excellent Talents in Xiamen University (NCETXMU X07115), and the Scholarship Award for Excellent Doctoral Student granted by the Chinese Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bai XG, 2011, J PROTEOME RES, V10, P4349, DOI 10.1021/pr200333f; Beato VM, 2011, PLANT PHYSIOL BIOCH, V49, P1350, DOI 10.1016/j.plaphy.2011.06.001; Carvalho RF, 2011, J INTEGR PLANT BIOL, V53, P920, DOI 10.1111/j.1744-7909.2011.01081.x; Chen J, 2013, PLANT PHYSIOL BIOCH, V64, P41, DOI 10.1016/j.plaphy.2012.12.012; Chen J, 2012, ENVIRON POLLUT, V160, P192, DOI 10.1016/j.envpol.2011.09.007; Cheng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054154; Cheng J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030088, 10.1371/journal.pone.0042436]; Dai Z, 2012, ENVIRON SCI POLLUT R, V20, P4216; DeHayes DH, 1999, BIOSCIENCE, V49, P789, DOI 10.2307/1313570; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Fan HB, 2000, FOREST ECOL MANAG, V126, P321, DOI 10.1016/S0378-1127(99)00103-6; Feng ZW, 2002, J ENVIRON SCI-CHINA, V14, P227; Firon N, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls024; Flagella Z, 2006, FUNCT PLANT BIOL, V33, P357, DOI 10.1071/FP05244; Foo E, 2006, PLANT J, V46, P911, DOI 10.1111/j.1365-313X.2006.02754.x; Fu JM, 2010, PLANT MOL BIOL, V73, P339, DOI 10.1007/s11103-010-9622-7; Ho SL, 2013, PLANT MOL BIOL, V81, P347, DOI 10.1007/s11103-012-0006-z; Hossain Z, 2013, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00310; Hu WJ, 2014, PLANT SOIL, V380, P285, DOI 10.1007/s11104-014-2086-9; Hu WJ, 2014, INT J MOL SCI, V15, P4333, DOI 10.3390/ijms15034333; Hu WJ, 2014, NITRIC OXIDE-BIOL CH, V36, P19, DOI 10.1016/j.niox.2013.10.008; Huang SS, 2011, PHYSIOL PLANTARUM, V144, P73; Ji XL, 2009, PROTEOMICS, V9, P5328, DOI 10.1002/pmic.200900012; Jiang H, 2013, CHEMOSPHERE, V91, P1213, DOI 10.1016/j.chemosphere.2013.01.041; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Kim DW, 2005, ELECTROPHORESIS, V26, P4521, DOI 10.1002/elps.200500334; Kovacik J, 2014, PLANT PHYSIOL BIOCH, V80, P33, DOI 10.1016/j.plaphy.2014.03.015; Kovacik J, 2014, J HAZARD MATER, V273, P110, DOI 10.1016/j.jhazmat.2014.03.040; Kovacik J, 2012, J HAZARD MATER, V239, P175, DOI 10.1016/j.jhazmat.2012.08.062; Kovacik J, 2011, ECOTOXICOLOGY, V20, P348, DOI 10.1007/s10646-010-0585-x; Kurepa J, 2008, BIOCHIMIE, V90, P324, DOI 10.1016/j.biochi.2007.07.019; Kwon Y, 2007, PLANT J, V49, P184, DOI 10.1111/j.1365-313X.2006.02950.x; Larssen T, 2006, ENVIRON SCI TECHNOL, V40, P418, DOI 10.1021/es0626133; Liu J, 2012, PLANT MOL BIOL, V78, P289, DOI 10.1007/s11103-011-9860-3; Liu JX, 2007, ACTA PHYSIOL PLANT, V29, P33, DOI 10.1007/s11738-006-0005-2; Liu TW, 2013, GENOME, V56, P49, DOI 10.1139/gen-2012-0090; Liu TW, 2011, TREE PHYSIOL, V31, P402, DOI 10.1093/treephys/tpr019; Liu TW, 2011, J PROTEOME RES, V10, P2579, DOI 10.1021/pr200056a; Liu TW, 2011, PROTEOMICS, V11, P2079, DOI 10.1002/pmic.201000307; Montillet JL, 2005, PLANT PHYSIOL, V138, P1516, DOI 10.1104/pp.105.059907; Neves NR, 2009, SCI TOTAL ENVIRON, V407, P3740, DOI 10.1016/j.scitotenv.2009.02.035; Pandey A, 2008, MOL CELL PROTEOMICS, V7, P88, DOI 10.1074/mcp.M700314-MCP200; Pang QY, 2010, J PROTEOME RES, V9, P2584, DOI 10.1021/pr100034f; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Rapaport D, 2002, TRENDS BIOCHEM SCI, V27, P191, DOI 10.1016/S0968-0004(02)02065-0; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Sanchez-Aguayo I, 2004, PLANTA, V220, P278, DOI 10.1007/s00425-004-1350-2; Sehrawat A, 2013, PROTEOMICS, V13, P1816, DOI 10.1002/pmic.201200445; Sun ZG, 2012, ECOTOX ENVIRON SAFE, V79, P62, DOI 10.1016/j.ecoenv.2011.12.004; Symons GM, 2008, PLANTA, V227, P1115, DOI 10.1007/s00425-007-0685-x; Sysoeva MI, 2013, RUSS J PLANT PHYSL+, V60, P383, DOI 10.1134/S1021443713020180; Tang RH, 2007, SCIENCE, V315, P1423, DOI 10.1126/science.1134457; Tapia G, 2011, PLANT BIOLOGY, V13, P69, DOI 10.1111/j.1438-8677.2009.00311.x; Villeth GR, 2009, FEMS MICROBIOL LETT, V298, P260, DOI 10.1111/j.1574-6968.2009.01728.x; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang LX, 2013, J PROTEOME RES, V12, P5124, DOI 10.1021/pr4006469; Wang SJ, 2006, BIOL PLANTARUM, V50, P537, DOI 10.1007/s10535-006-0085-2; Wyrwicka A, 2006, ENVIRON EXP BOT, V56, P198, DOI 10.1016/j.envexpbot.2005.02.003; Yamasato A, 2005, PLANT CELL, V17, P1585, DOI 10.1105/tpc.105.031518; Yang QS, 2007, PROTEOMICS, V7, P737, DOI 10.1002/pmic.200600703; Zorb C, 2010, PROTEOMICS, V10, P4441, DOI 10.1002/pmic.201000231	63	6	7	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102532	10.1371/journal.pone.0102532	http://dx.doi.org/10.1371/journal.pone.0102532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025692	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400084
J	Russell, JR; Hedley, PE; Cardle, L; Dancey, S; Morris, J; Booth, A; Odee, D; Mwaura, L; Omondi, W; Angaine, P; Machua, J; Muchugi, A; Milne, I; Kindt, R; Jamnadass, R; Dawson, IK				Russell, Joanne R.; Hedley, Peter E.; Cardle, Linda; Dancey, Siobhan; Morris, Jenny; Booth, Allan; Odee, David; Mwaura, Lucy; Omondi, William; Angaine, Peter; Machua, Joseph; Muchugi, Alice; Milne, Iain; Kindt, Roeland; Jamnadass, Ramni; Dawson, Ian K.			tropiTree: An NGS-Based EST-SSR Resource for 24 Tropical Tree Species	PLOS ONE			English	Article							PRUNUS-AFRICANA; GENETIC DIVERSITY; MICROSATELLITE DEVELOPMENT; AGROFORESTRY; GENOME; PHYLOGEOGRAPHY; DOMESTICATION; ANNOTATION; MANAGEMENT; HIGHLANDS	The development of genetic tools for non-model organisms has been hampered by cost, but advances in next-generation sequencing (NGS) have created new opportunities. In ecological research, this raises the prospect for developing molecular markers to simultaneously study important genetic processes such as gene flow in multiple non-model plant species within complex natural and anthropogenic landscapes. Here, we report the use of bar-coded multiplexed paired-end Illumina NGS for the de novo development of expressed sequence tag-derived simple sequence repeat (EST-SSR) markers at low cost for a range of 24 tree species. Each chosen tree species is important in complex tropical agroforestry systems where little is currently known about many genetic processes. An average of more than 5,000 EST-SSRs was identified for each of the 24 sequenced species, whereas prior to analysis 20 of the species had fewer than 100 nucleotide sequence citations. To make results available to potential users in a suitable format, we have developed an open-access, interactive online database, tropiTree (http://bioinf.hutton.ac.uk/tropiTree), which has a range of visualisation and search facilities, and which is a model for the efficient presentation and application of NGS data.	[Russell, Joanne R.; Hedley, Peter E.; Cardle, Linda; Dancey, Siobhan; Morris, Jenny; Booth, Allan; Milne, Iain; Dawson, Ian K.] James Hutton Inst, Invergowrie, Scotland; [Dancey, Siobhan] Univ Dundee, Coll Life Sci, Dundee, Scotland; [Odee, David; Omondi, William; Angaine, Peter; Machua, Joseph] Kenya Forestry Res Inst, Headquarters, Nairobi, Kenya; [Odee, David] Ctr Ecol & Hydrol, Ctr Ecol & Hydrol Edinburgh, Penicuik, Midlothian, Scotland; [Mwaura, Lucy; Muchugi, Alice; Kindt, Roeland; Jamnadass, Ramni; Dawson, Ian K.] World Agroforestry Ctr, Headquarters, Nairobi, Kenya	James Hutton Institute; University of Dundee; UK Centre for Ecology & Hydrology (UKCEH); CGIAR; World Agroforestry (ICRAF)	Dawson, IK (corresponding author), James Hutton Inst, Invergowrie, Scotland.	iankdawson@aol.com	Hedley, Peter/F-1149-2011; Angaine, Peter Murithi/AAV-6572-2020	Hedley, Peter/0000-0003-0866-324X; Angaine, Peter M./0000-0002-6477-8802; Dawson, Ian/0000-0003-4245-6973; Milne, Iain/0000-0002-4126-0859; Dawson, Ian/0000-0003-1345-3642; Machua, Joseph/0000-0002-0442-5407; Milne, Linda/0000-0002-1798-8022	Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barnes R.D., 2003, TROPICAL FORESTRY PA; Bayala J, 2011, CONSERVATION AGR TRE; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Garcia-Lopez MC, 2014, TREE GENET GENOMES, V10, P585, DOI 10.1007/s11295-014-0706-4; Carsan S, 2014, CURR OPIN ENV SUST, V6, P35, DOI 10.1016/j.cosust.2013.10.007; CLC bio, 2012, CLC ASS CELL 4 0; CLC bio, 2014, US MAN CLC ASS CELL; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dangasuk G.O., 2006, AFRICAN CROP SCI, V14, P263; Dawson IK, 2013, BIODIVERS CONSERV, V22, P301, DOI 10.1007/s10531-012-0429-5; Dawson IK, 2009, BIODIVERS CONSERV, V18, P969, DOI 10.1007/s10531-008-9516-z; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Fernandez-Silva I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055990; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Garrity DP, 2004, AGROFOREST SYST, V61-2, P5, DOI 10.1023/B:AGFO.0000028986.37502.7c; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hall JB, 2000, PRUNUS AFRICANA MONO, P3; Harris SA, 1997, PLANT SYST EVOL, V207, P119, DOI 10.1007/BF00985213; Joy N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056694; Kadu CAC, 2011, MOL ECOL, V20, P165, DOI 10.1111/j.1365-294X.2010.04931.x; Kadu CAC, 2013, ANN BOT-LONDON, V111, P47, DOI 10.1093/aob/mcs235; Kadu CAC, 2012, PHYTOCHEMISTRY, V83, P70, DOI 10.1016/j.phytochem.2012.06.001; Kehlenbeck K, 2011, AGROFOREST SYST, V83, P133, DOI 10.1007/s10457-011-9413-4; Kumar V, 2014, TREE GENET GENOMES, V10, P449, DOI 10.1007/s11295-013-0690-0; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; Lilleso JBL, 2011, AGROFOREST SYST, V83, P347, DOI 10.1007/s10457-011-9412-5; Liu ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083549; Mayer C, 2010, PHOBOS TANDEM REPEAT; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Muchugi A, 2006, S AFR J BOT, V72, P498, DOI 10.1016/j.sajb.2006.01.003; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Rico C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03376; Russell JR, 2009, TREE GENET GENOMES, V5, P517, DOI 10.1007/s11295-009-0205-1; Schoebel CN, 2013, J EVOLUTION BIOL, V26, P600, DOI 10.1111/jeb.12077; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van der Merwe M, 2014, MOL ECOL RESOUR, V14, P199, DOI 10.1111/1755-0998.12176; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang SJ, 2014, TREE GENET GENOMES, V10, P573, DOI 10.1007/s11295-014-0705-5; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394	44	9	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102502	10.1371/journal.pone.0102502	http://dx.doi.org/10.1371/journal.pone.0102502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025376	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000339992400081
J	Su, HX; Zhou, HH; Wang, MY; Cheng, J; Zhang, SC; Hui, F; Chen, XZ; Liu, SH; Liu, QJ; Zhu, ZJ; Hu, QR; Wu, Y; Ji, SR				Su, Hai-Xiang; Zhou, Hai-Hong; Wang, Ming-Yu; Cheng, Jin; Zhang, Shi-Chao; Hui, Feng; Chen, Xue-Zhong; Liu, Shan-Hui; Liu, Qin-Jiang; Zhu, Zi-Jiang; Hu, Qing-Rong; Wu, Yi; Ji, Shang-Rong			Mutations of C-Reactive Protein (CRP)-286 SNP, APC and p53 in Colorectal Cancer: Implication for a CRP-Wnt Crosstalk	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; COMPLEMENT ACTIVATION; TUMORICIDAL ACTIVITY; ENDOTHELIAL-CELLS; GENE PROMOTER; INFLAMMATION; PLATELETS; BINDS; LIPOPOLYSACCHARIDE; ATHEROSCLEROSIS	C-reactive protein (CRP) is an established marker of inflammation with pattern-recognition receptor-like activities. Despite the close association of the serum level of CRP with the risk and prognosis of several types of cancer, it remains elusive whether CRP contributes directly to tumorigenesis or just represents a bystander marker. We have recently identified recurrent mutations at the SNP position -286 (rs3091244) in the promoter of CRP gene in several tumor types, instead suggesting that locally produced CRP is a potential driver of tumorigenesis. However, it is unknown whether the -286 site is the sole SNP position of CRP gene targeted for mutation and whether there is any association between CRP SNP mutations and other frequently mutated genes in tumors. Herein, we have examined the genotypes of three common CRP non-coding SNPs (rs7553007, rs1205, rs3093077) in tumor/normal sample pairs of 5 cancer types (n = 141). No recurrent somatic mutations are found at these SNP positions, indicating that the -286 SNP mutations are preferentially selected during the development of cancer. Further analysis reveals that the -286 SNP mutations of CRP tend to co-occur with mutated APC particularly in rectal cancer (p = 0.04; n = 67). By contrast, mutations of CRP and p53 or K-ras appear to be unrelated. There results thus underscore the functional importance of the -286 mutation of CRP in tumorigenesis and imply an interaction between CRP and Wnt signaling pathway.	[Su, Hai-Xiang; Zhou, Hai-Hong; Chen, Xue-Zhong; Liu, Qin-Jiang; Zhu, Zi-Jiang; Hu, Qing-Rong] Gansu Prov Acad Inst Med Res, Lanzhou, Peoples R China; [Su, Hai-Xiang; Zhou, Hai-Hong; Chen, Xue-Zhong; Liu, Qin-Jiang; Zhu, Zi-Jiang; Hu, Qing-Rong] Gansu Prov Tumor Hosp, Lanzhou, Peoples R China; [Wang, Ming-Yu; Cheng, Jin; Zhang, Shi-Chao; Hui, Feng; Liu, Shan-Hui; Wu, Yi; Ji, Shang-Rong] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 730000, Peoples R China; [Wu, Yi] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Wu, Y (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 730000, Peoples R China.	wuy@lzu.edu.cn; jsr@lzu.edu.cn		Ji, Shang-Rong/0000-0001-8595-3756; Wu, Yi/0000-0003-0365-5590	Ministry of Science and Technology of China [2011CB910500]; National Natural Science Foundation of China [30930024, 31222015, 31270813, 31170696]; Ministry of Education of China [PCSIRT: IRT1137, 121108]; Gansu Province [1011FKCA089]; Lanzhou University [lzujbky-2013-bt05, lzujbky-2014-86]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Gansu Province; Lanzhou University(Lanzhou University)	This work was supported by grants from the Ministry of Science and Technology of China [grant number 2011CB910500]; the National Natural Science Foundation of China [grant numbers 30930024, 31222015, 31270813, 31170696]; the Ministry of Education of China [grant numbers PCSIRT: IRT1137, 121108]; Gansu Province [grant number: 1011FKCA089]; and Lanzhou University [grant numbers: lzujbky-2013-bt05, lzujbky-2014-86]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; Allin KH, 2010, JNCI-J NATL CANCER I, V102, P202, DOI 10.1093/jnci/djp459; Armaghany Tannaz, 2012, Gastrointest Cancer Res, V5, P19; BARNA BP, 1984, CANCER RES, V44, P305; BARNA BP, 1987, CANCER RES, V47, P3959; Bisoendial RJ, 2005, CIRC RES, V96, P714, DOI 10.1161/01.RES.0000163015.67711.AB; Boncler M, 2011, PHARMACOL REP, V63, P464, DOI 10.1016/S1734-1140(11)70513-8; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Carlucci F, 2010, ARTHRITIS RHEUM-US, V62, P245, DOI 10.1002/art.27232; Choi YS, 2007, NUCLEIC ACIDS RES, V35, P5511, DOI 10.1093/nar/gkm547; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DEODHAR SD, 1982, CANCER RES, V42, P5084; Du Clos Terry W, 2013, ISRN Inflamm, V2013, P379040, DOI 10.1155/2013/379040; Eisenhardt SU, 2009, TRENDS CARDIOVAS MED, V19, P232, DOI 10.1016/j.tcm.2010.02.002; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Filep JG, 2009, CIRC RES, V105, P109, DOI 10.1161/CIRCRESAHA.109.202010; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; Goel A, 2010, CURR OPIN GASTROEN, V26, P47, DOI 10.1097/MOG.0b013e328332b850; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirschfield GM, 2005, P NATL ACAD SCI USA, V102, P8309, DOI 10.1073/pnas.0503202102; Hirschfield GM, 2003, J IMMUNOL, V171, P6046, DOI 10.4049/jimmunol.171.11.6046; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2009, FASEB J, V23, P1806, DOI 10.1096/fj.08-116962; Ji SR, 2006, ARTERIOSCL THROM VAS, V26, P935, DOI 10.1161/01.ATV.0000206211.21895.73; Ji SR, 2006, INT J BIOCHEM CELL B, V38, P648, DOI 10.1016/j.biocel.2005.11.004; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Khreiss T, 2005, CIRC RES, V97, P690, DOI 10.1161/01.RES.0000183881.11739.CB; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; Kim EE, 2013, CURR MED IMAGING REV, V9, P1; Koike T, 2009, CIRCULATION, V120, P2088, DOI 10.1161/CIRCULATIONAHA.109.872796; Kovacs A, 2007, P NATL ACAD SCI USA, V104, P13768, DOI 10.1073/pnas.0706027104; Lane T, 2014, CIRC RES, V114, P672, DOI 10.1161/CIRCRESAHA.114.302770; Li HY, 2014, J BIOL CHEM, V289, P14283, DOI 10.1074/jbc.M114.555318; Ma X, 2013, CHINESE SCI BULL, V58, P1642, DOI 10.1007/s11434-012-5591-3; Mihlan M, 2011, FASEB J, V25, P4198, DOI 10.1096/fj.11-186460; Mold C, 1999, IMMUNOPHARMACOLOGY, V42, P23, DOI 10.1016/S0162-3109(99)00007-7; Mold C, 2002, J IMMUNOL, V169, P7019, DOI 10.4049/jimmunol.169.12.7019; Molins B, 2008, ARTERIOSCL THROM VAS, V28, P2239, DOI 10.1161/ATVBAHA.108.174359; Molins B, 2011, CARDIOVASC RES, V92, P328, DOI 10.1093/cvr/cvr226; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Paul A, 2004, CIRCULATION, V109, P647, DOI 10.1161/01.CIR.0000114526.50618.24; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Rodriguez W, 2005, ARTHRITIS RHEUM-US, V52, P642, DOI 10.1002/art.20846; Schwedler SB, 2006, AM J KIDNEY DIS, V47, P212, DOI 10.1053/j.ajkd.2005.10.028; Singh SK, 2008, ANN MED, V40, P110, DOI 10.1080/07853890701749225; Skoglund C, 2008, IMMUNOL CELL BIOL, V86, P466, DOI 10.1038/icb.2008.9; Slevin M, 2010, BRAIN PATHOL, V20, P151, DOI 10.1111/j.1750-3639.2008.00256.x; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Teupser D, 2011, J BIOL CHEM, V286, P6272, DOI 10.1074/jbc.M110.161414; Turu MM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-47; Wang MY, 2014, CELL RES, V24, P505, DOI 10.1038/cr.2014.7; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Xu PC, 2014, INNATE IMMUN-LONDON, V20, P440, DOI 10.1177/1753425913508164; Yang J, 2007, CANCER CELL, V12, P252, DOI 10.1016/j.ccr.2007.08.008; Yang XW, 2012, HUM IMMUNOL, V73, P156, DOI 10.1016/j.humimm.2011.12.007; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	63	18	19	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102418	10.1371/journal.pone.0102418	http://dx.doi.org/10.1371/journal.pone.0102418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025473	Green Submitted, gold, Green Published			2022-12-25	WOS:000339992400073
J	Zhu, GL; Ju, WM; Chen, JM; Liu, YB				Zhu, Gaolong; Ju, Weimin; Chen, J. M.; Liu, Yibo			A Novel Moisture Adjusted Vegetation Index (MAVI) to Reduce Background Reflectance and Topographical Effects on LAI Retrieval	PLOS ONE			English	Article							LEAF-AREA INDEX; FOREST; NDVI; SENSITIVITY; BANDS	A new moisture adjusted vegetation index (MAVI) is proposed using the red, near infrared, and shortwave infrared (SWIR) reflectance in band-ratio form in this paper. The effectiveness of MAVI in retrieving leaf area index (LAI) is investigated using Landsat-5 data and field LAI measurements in two forest and two grassland areas. The ability of MAVI to retrieve forest LAI under different background conditions is further evaluated using canopy reflectance of Jack Pine and Black Spruce forests simulated by the 4-Scale model. Compared with several commonly used two-band vegetation index, such as normalized difference vegetation index, soil adjusted vegetation index, modified soil adjusted vegetation index, optimized soil adjusted vegetation index, MAVI is a better predictor of LAI, on average, which can explain 70% of variations of LAI in the four study areas. Similar to other SWIR-related three-band vegetation index, such as modified normalized difference vegetation index (MNDVI) and reduced simple ratio (RSR), MAVI is able to reduce the background reflectance effects on forest canopy LAI retrieval. MAVI is more suitable for retrieving LAI than RSR and MNDVI, because it avoids the difficulty in properly determining the maximum and minimum SWIR values required in RSR and MNDVI, which improves the robustness of MAVI in retrieving LAI of different land cover types. Moreover, MAVI is expressed as ratios between different spectral bands, greatly reducing the noise caused by topographical variations, which makes it more suitable for applications in mountainous area.	[Zhu, Gaolong] Minjiang Univ, Dept Geog, Fuzhou, Peoples R China; [Zhu, Gaolong; Ju, Weimin; Chen, J. M.] Nanjing Univ, Int Inst Earth Syst Sci, Nanjing 210008, Jiangsu, Peoples R China; [Ju, Weimin] Nanjing Univ, Inst Climate & Global Change Res, Nanjing 210008, Jiangsu, Peoples R China; [Chen, J. M.] Univ Toronto, Dept Geog, Toronto, ON M5S 1A1, Canada; [Liu, Yibo] Nanjing Univ Informat Sci & Technol, Jiangsu Key Lab Agr Meteorol, Coll Appl Meteorol, Nanjing, Jiangsu, Peoples R China	Minjiang University; Nanjing University; Nanjing University; University of Toronto; Nanjing University of Information Science & Technology	Ju, WM (corresponding author), Nanjing Univ, Int Inst Earth Syst Sci, Nanjing 210008, Jiangsu, Peoples R China.	juweimin@nju.edu.cn	liu, yibo/H-8936-2012; Chen, Jing/AAD-4768-2020	liu, yibo/0000-0002-4345-0138; Chen, Jing/0000-0002-8682-1293	National Natural Science Foundation of China [41271354]; National Basic Research Program of China [2010CB950702]; Program for New Century Excellent Talents in Fujian Province University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in Fujian Province University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (Grant No. 41271354), the National Basic Research Program of China (Grant No. 2010CB950702), and the Program for New Century Excellent Talents in Fujian Province University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASRAR G, 1984, AGRON J, V76, P300, DOI 10.2134/agronj1984.00021962007600020029x; Bannari A., 1995, REM SENS REV, V13, P95, DOI [10.1080/02757259509532298, DOI 10.1080/02757259509532298]; BARET F, 1991, REMOTE SENS ENVIRON, V35, P161, DOI 10.1016/0034-4257(91)90009-U; BARET F, 1988, REMOTE SENS ENVIRON, V26, P213, DOI 10.1016/0034-4257(88)90078-8; Baret F., 1993, REMOTE SENS REV, V7, P65, DOI [10.1080/02757259309532166, DOI 10.1080/02757259309532166]; Brown L, 2000, REMOTE SENS ENVIRON, V71, P16, DOI 10.1016/S0034-4257(99)00035-8; Burgess DW, 1995, REMOTE SENS ENVIRON, V54, P223, DOI 10.1016/0034-4257(95)00155-7; BUTERA MK, 1986, IEEE T GEOSCI REMOTE, V24, P122, DOI 10.1109/TGRS.1986.289693; Chen J.M., 1996, CAN J REMOTE SENS, V22, P229, DOI [10.1080/07038992.1996.10855178, DOI 10.1080/07038992.1996.10855178]; Chen JM, 1997, IEEE T GEOSCI REMOTE, V35, P1316, DOI 10.1109/36.628798; Chen JM, 1996, REMOTE SENS ENVIRON, V55, P153, DOI 10.1016/0034-4257(95)00195-6; CLEVERS JGPW, 1989, REMOTE SENS ENVIRON, V29, P25, DOI 10.1016/0034-4257(89)90076-X; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; Gilabert MA, 2002, REMOTE SENS ENVIRON, V82, P303, DOI 10.1016/S0034-4257(02)00048-2; Gilabert MA, 1998, PROC SPIE, V3499, P396, DOI 10.1117/12.332774; Gong P, 2003, IEEE T GEOSCI REMOTE, V41, P1355, DOI 10.1109/TGRS.2003.812910; Huang JJ, 2007, FOREST ECOL MANAG, V239, P150, DOI 10.1016/j.foreco.2006.11.019; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; Kusaka T, 1997, INT GEOSCI REMOTE SE, P972, DOI 10.1109/IGARSS.1997.615314; LePrieur D, 1994, REMOTE SENSING REV, V10, P265, DOI DOI 10.1080/02757259409532250; Li Jin, 2010, Acta Prataculturae Sinica, V19, P243; LIU HQ, 1995, IEEE T GEOSCI REMOTE, V33, P457, DOI 10.1109/36.377946; Lymburner L, 2000, PHOTOGRAMM ENG REM S, V66, P183; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Matsushita B, 2007, SENSORS-BASEL, V7, P2636, DOI 10.3390/s7112636; MYNENI RB, 1994, REMOTE SENS ENVIRON, V49, P200, DOI 10.1016/0034-4257(94)90016-7; NEMANI R, 1993, INT J REMOTE SENS, V14, P2519, DOI 10.1080/01431169308904290; Ning Bo, 2009, Journal of Northeast Forestry University, V37, P56; Pan QingMin, 2004, Acta Phytoecologica Sinica, V28, P665; PANIGRAHY S, 1992, INT J REMOTE SENS, V13, P2943, DOI 10.1080/01431169208904092; Pisek J, 2010, IEEE T GEOSCI REMOTE, V48, P499, DOI 10.1109/TGRS.2009.2024756; PROY C, 1989, REMOTE SENS ENVIRON, V30, P21, DOI 10.1016/0034-4257(89)90044-8; QI J, 1994, REMOTE SENS ENVIRON, V48, P119, DOI 10.1016/0034-4257(94)90134-1; RICHARDSON AJ, 1977, PHOTOGRAMM ENG REM S, V43, P1541; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Rouse J.W., 1973, 3 EARTH RESOURCES TE, DOI DOI 10.1002/MRM.26868; Vermote EF, 1997, IEEE T GEOSCI REMOTE, V35, P675, DOI 10.1109/36.581987; Vescovo L, 2008, ADV SPACE RES, V41, P1764, DOI 10.1016/j.asr.2007.07.043; Wu JD, 2007, FIELD CROP RES, V102, P33, DOI 10.1016/j.fcr.2007.01.003	41	11	12	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102560	10.1371/journal.pone.0102560	http://dx.doi.org/10.1371/journal.pone.0102560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025128	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400087
J	Geillon, F; Gondcaille, C; Charbonnier, S; Van Roermund, CW; Lopez, TE; Dias, AMM; de Barros, JPP; Arnould, C; Wanders, RJ; Trompier, D; Savary, S				Geillon, Flore; Gondcaille, Catherine; Charbonnier, Soeli; Van Roermund, Carlo W.; Lopez, Tatiana E.; Dias, Alexandre M. M.; de Barros, Jean-Paul Pais; Arnould, Christine; Wanders, Ronald J.; Trompier, Doriane; Savary, Stephane			Structure-Function Analysis of Peroxisomal ATP-binding Cassette Transporters Using Chimeric Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Fatty Acid; Peroxisome; Protein Chimera; Protein-Protein Interaction	X-LINKED ADRENOLEUKODYSTROPHY; CHAIN FATTY-ACID; ABC-TRANSPORTER; MEMBRANE-PROTEIN; PMP70 ABCD3; EXPRESSION; METABOLISM; MOUSE; ALDP; COA	Background: Peroxisomal ABC transporters are predicted to function as homodimers in mammals. Results: ABCD1 interacts with ABCD2. Chimeric proteins mimicking full-length dimers represent novel tools for functional study. Artificial homodimers and heterodimers are functional. Conclusion: Interchangeability between ABCD1 and ABCD2 is confirmed, but PUFA transport depends on ABCD2. Significance: For the first time, heterodimers in mammals are proven to be functional. ABCD1 and ABCD2 are two closely related ATP-binding cassette half-transporters predicted to homodimerize and form peroxisomal importers for fatty acyl-CoAs. Available evidence has shown that ABCD1 and ABCD2 display a distinct but overlapping substrate specificity, although much remains to be learned in this respect as well as in their capability to form functional heterodimers. Using a cell model expressing an ABCD2-EGFP fusion protein, we first demonstrated by proximity ligation assay and co-immunoprecipitation assay that ABCD1 interacts with ABCD2. Next, we tested in the pxa1/pxa2 yeast mutant the functionality of ABCD1/ABCD2 dimers by expressing chimeric proteins mimicking homo- or heterodimers. For further structure-function analysis of ABCD1/ABCD2 dimers, we expressed chimeric dimers fused to enhanced GFP in human skin fibroblasts of X-linked adrenoleukodystrophy patients. These cells are devoid of ABCD1 and accumulate very long-chain fatty acids (C26:0 and C26:1). We checked that the chimeric proteins were correctly expressed and targeted to the peroxisomes. Very long-chain fatty acid levels were partially restored in transfected X-linked adrenoleukodystrophy fibroblasts regardless of the chimeric construct used, thus demonstrating functionality of both homo- and heterodimers. Interestingly, the level of C24:6 n-3, the immediate precursor of docosahexaenoic acid, was decreased in cells expressing chimeric proteins containing at least one ABCD2 moiety. Our data demonstrate for the first time that both homo- and heterodimers of ABCD1 and ABCD2 are functionally active. Interestingly, the role of ABCD2 (in homo- and heterodimeric forms) in the metabolism of polyunsaturated fatty acids is clearly evidenced, and the chimeric dimers provide a novel tool to study substrate specificity of peroxisomal ATP-binding cassette transporters.	[Geillon, Flore; Gondcaille, Catherine; Charbonnier, Soeli; Lopez, Tatiana E.; Dias, Alexandre M. M.; Trompier, Doriane; Savary, Stephane] Univ Bourgogne, Lab BioperoxIL, EA7270, F-21000 Dijon, France; [Van Roermund, Carlo W.; Wanders, Ronald J.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [de Barros, Jean-Paul Pais] Univ Bourgogne, Lipid Analyt Platform INSERM U866, F-21079 Dijon, France; [Arnould, Christine] Univ Bourgogne, INRA, ERL CNRS6300, Ctr Microscopie,Agroecol UMR1347, F-21000 Dijon, France	Universite de Bourgogne; University of Amsterdam; Academic Medical Center Amsterdam; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Savary, S (corresponding author), Univ Bourgogne, Lab BioperoxIL, EA7270, 6 Bd Gabriel, F-21000 Dijon, France.	stsavary@u-bourgogne.fr	TROMPIER, Doriane/D-5862-2017; Savary, Stephane/C-8137-2011; Charbonnier, Soëli/H-7003-2017	Savary, Stephane/0000-0002-9237-1727; Charbonnier, Soëli/0000-0002-3185-635X; Trompier, Doriane/0000-0002-0746-1753; Lopez, Tatiana/0000-0002-3658-682X; PAIS DE BARROS, Jean-Paul/0000-0002-5124-2283	regional council of Burgundy	regional council of Burgundy(Region Bourgogne-Franche-Comte)	This work was supported by grants from the regional council of Burgundy.	Baarine M, 2012, NEUROSCIENCE, V213, P1, DOI 10.1016/j.neuroscience.2012.03.058; Berger J, 1999, EUR J BIOCHEM, V265, P719, DOI 10.1046/j.1432-1327.1999.00772.x; Bhatia A, 2005, BIOCHEMISTRY-US, V44, P10893, DOI 10.1021/bi0503807; Bons JAP, 2008, CLIN CHIM ACTA, V387, P59, DOI 10.1016/j.cca.2007.09.002; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; EWART GD, 1994, J BIOL CHEM, V269, P10370; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Flavigny E, 1999, FEBS LETT, V448, P261, DOI 10.1016/S0014-5793(99)00379-8; Footitt S, 2002, EMBO J, V21, P2912, DOI 10.1093/emboj/cdf300; Fouquet F, 1997, NEUROBIOL DIS, V3, P271, DOI 10.1006/nbdi.1997.0127; Fourcade S, 2009, AM J PHYSIOL-ENDOC M, V296, pE211, DOI 10.1152/ajpendo.90736.2008; Genin EC, 2011, J BIOL CHEM, V286, P8075, DOI 10.1074/jbc.M110.211912; Gueugnon F, 2006, BIOCHEM BIOPH RES CO, V341, P150, DOI 10.1016/j.bbrc.2005.12.152; Guimaraes CP, 2005, J HUM GENET, V50, P99, DOI 10.1007/s10038-004-0226-4; Guimaraes CP, 2004, BBA-MOL BASIS DIS, V1689, P235, DOI 10.1016/j.bbadis.2004.04.001; HASHIMOTO T, 1986, J BIOCHEM-TOKYO, V100, P301, DOI 10.1093/oxfordjournals.jbchem.a121716; Hillebrand M, 2007, J BIOL CHEM, V282, P26997, DOI 10.1074/jbc.M702122200; Jimenez-Sanchez G, 1999, PEDIATR RES, V45, p139A, DOI 10.1203/00006450-199904020-00824; Jimenez-Sanchez G., 2000, J INHERIT METAB DIS, V23, P256; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kashiwayama Y, 2005, BBA-MOL CELL RES, V1746, P116, DOI 10.1016/j.bbamcr.2005.10.006; Landgraf P, 2003, EUR J CELL BIOL, V82, P401, DOI 10.1078/0171-9335-00331; Leclercq S, 2008, BIOCHIMIE, V90, P1602, DOI 10.1016/j.biochi.2008.05.022; Liu JJ, 2012, J LIPID RES, V53, P1071, DOI 10.1194/jlr.M022160; Liu J, 2010, J LIPID RES, V51, P162, DOI 10.1194/jlr.M900237-JLR200; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; Lousa CD, 2013, P NATL ACAD SCI USA, V110, P1279, DOI 10.1073/pnas.1218034110; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Nyathi Y, 2012, FEBS LETT, V586, P2280, DOI 10.1016/j.febslet.2012.05.065; Nyathi Y, 2010, J BIOL CHEM, V285, P29892, DOI 10.1074/jbc.M110.151225; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Pujol A, 2004, HUM MOL GENET, V13, P2997, DOI 10.1093/hmg/ddh323; Rosenberg MF, 2001, J BIOL CHEM, V276, P16076, DOI 10.1074/jbc.M100176200; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; Smith KD, 1999, NEUROCHEM RES, V24, P521, DOI 10.1023/A:1022535930009; Tanaka AR, 2002, J BIOL CHEM, V277, P40142, DOI 10.1074/jbc.M205079200; Troffer-Charlier N, 1998, EUR J CELL BIOL, V75, P254, DOI 10.1016/S0171-9335(98)80121-0; Trompier D., 2013, X LINKED ADRENOLEUKO, V2, P1; Trompier D, 2014, BIOCHEM BIOPH RES CO, V446, P651, DOI 10.1016/j.bbrc.2014.01.025; van Roermund CWT, 2014, BBA-MOL CELL BIOL L, V1841, P563, DOI 10.1016/j.bbalip.2013.12.001; van Roermund CWT, 2011, BBA-MOL CELL BIOL L, V1811, P148, DOI 10.1016/j.bbalip.2010.11.010; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Weber FD, 2014, HUM MOL GENET, V23, P2542, DOI 10.1093/hmg/ddt645; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Zhang XB, 2011, BIOCHEM J, V436, P547, DOI 10.1042/BJ20110249; Zoghbi ME, 2014, BIOCHEM BIOPH RES CO, V443, P97, DOI 10.1016/j.bbrc.2013.11.050	51	19	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24511	24520		10.1074/jbc.M114.575506	http://dx.doi.org/10.1074/jbc.M114.575506			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25043761	Green Published, hybrid			2022-12-25	WOS:000341505600043
J	Bao, T; Zhang, X; Rao, ZM; Zhao, XJ; Zhang, RZ; Yang, TW; Xu, ZH; Yang, ST				Bao, Teng; Zhang, Xian; Rao, Zhiming; Zhao, Xiaojing; Zhang, Rongzhen; Yang, Taowei; Xu, Zhenghong; Yang, Shangtian			Efficient Whole-Cell Biocatalyst for Acetoin Production with NAD(+) Regeneration System through Homologous Co-Expression of 2,3-Butanediol Dehydrogenase and NADH Oxidase in Engineered Bacillus subtilis	PLOS ONE			English	Article							SERRATIA-MARCESCENS H32; SACCHAROMYCES-CEREVISIAE; STATISTICAL OPTIMIZATION; MODERATE-EXPRESSION; MEDIUM COMPONENTS; ESCHERICHIA-COLI; REDUCTASE GENE; GLUCOSE; FERMENTATION; PURIFICATION	Acetoin (3-hydroxy-2-butanone), an extensively-used food spice and bio-based platform chemical, is usually produced by chemical synthesis methods. With increasingly requirement of food security and environmental protection, bio-fermentation of acetoin by microorganisms has a great promising market. However, through metabolic engineering strategies, the mixed acid-butanediol fermentation metabolizes a certain portion of substrate to the by-products of organic acids such as lactic acid and acetic acid, which causes energy cost and increases the difficulty of product purification in downstream processes. In this work, due to the high efficiency of enzymatic reaction and excellent selectivity, a strategy for efficiently converting 2,3-butandiol to acetoin using whole-cell biocatalyst by engineered Bacillus subtilis is proposed. In this process, NAD(+) plays a significant role on 2,3-butanediol and acetoin distribution, so the NADH oxidase and 2,3-butanediol dehydrogenase both from B. subtilis are co-expressed in B. subtilis 168 to construct an NAD(+) regeneration system, which forces dramatic decrease of the intracellular NADH concentration (1.6 fold) and NADH/NAD(+) ratio (2.2 fold). By optimization of the enzymatic reaction and applying repeated batch conversion, the whole-cell biocatalyst efficiently produced 91.8 g/L acetoin with a productivity of 2.30 g/(L.h), which was the highest record ever reported by biocatalysis. This work indicated that manipulation of the intracellular cofactor levels was more effective than the strategy of enhancing enzyme activity, and the bioprocess for NAD(+) regeneration may also be a useful way for improving the productivity of NAD(+)-dependent chemistry-based products.	[Bao, Teng; Zhang, Xian; Rao, Zhiming; Zhao, Xiaojing; Yang, Taowei] Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Zhang, Rongzhen] Jiangnan Univ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China; [Xu, Zhenghong] Jiangnan Univ, Sch Med & Pharmaceut, Wuxi, Jiangsu, Peoples R China; [Yang, Shangtian] Ohio State Univ, Dept Chem Engn, Columbus, OH 43210 USA	Jiangnan University; Jiangnan University; Jiangnan University; University System of Ohio; Ohio State University	Rao, ZM (corresponding author), Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China.	raozhm@jiangnan.edu.cn	Yang, Shang-Tian/A-7892-2009		Program for New Century Excellent Talents in University [NCET-10-0459]; National Basic Research Program of China (973 Program) [2012CB725202]; National Natural Science Foundation of China [21276110]; Chinese Ministry of Education [113033A]; Fundamental Research Funds for the Central Universities [JUSRP51306A, JUSRP21121]; 111 Project [111-2-06]; Priority Academic Program Development of Jiangsu Higher Education Institution	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Project(Ministry of Education, China - 111 Project); Priority Academic Program Development of Jiangsu Higher Education Institution	This work was supported by the Program for New Century Excellent Talents in University (NCET-10-0459), the National Basic Research Program of China (973 Program) (2012CB725202), the National Natural Science Foundation of China (21276110), the Research Project of Chinese Ministry of Education. (No. 113033A), the Fundamental Research Funds for the Central Universities (JUSRP51306A and JUSRP21121), the 111 Project (111-2-06) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrios-Rivera SJ, 2002, METAB ENG, V4, P217, DOI 10.1006/mben.2002.0227; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen T, 2013, J BIOTECHNOL, V168, P499, DOI 10.1016/j.jbiotec.2013.09.020; Cho S, 2013, APPL BIOCHEM BIOTECH, V170, P1922, DOI 10.1007/s12010-013-0291-2; CROW VL, 1990, APPL ENVIRON MICROB, V56, P1656, DOI 10.1128/AEM.56.6.1656-1665.1990; DARTOIS V, 1994, APPL ENVIRON MICROB, V60, P1670, DOI 10.1128/AEM.60.5.1670-1673.1994; de Felipe FL, 2001, INT DAIRY J, V11, P37, DOI 10.1016/S0958-6946(01)00031-0; Gao C, 2013, BIORESOURCE TECHNOL, V137, P111, DOI 10.1016/j.biortech.2013.02.115; Gao J, 2013, LETT APPL MICROBIOL, V57, P274, DOI 10.1111/lam.12107; Geueke B, 2003, ENZYME MICROB TECH, V32, P205, DOI 10.1016/S0141-0229(02)00290-9; Gong Y, 2004, DESALINATION, V161, P169, DOI 10.1016/S0011-9164(04)90052-5; Gonzalez E, 2001, CHEM-BIOL INTERACT, V130, P425, DOI 10.1016/S0009-2797(00)00282-9; Gonzalez E, 2000, J BIOL CHEM, V275, P35876, DOI 10.1074/jbc.M003035200; HEIDLAS J, 1990, ARCH MICROBIOL, V154, P267, DOI 10.1007/BF00248966; Heux S, 2006, METAB ENG, V8, P303, DOI 10.1016/j.ymben.2005.12.003; HOHNBENTZ H, 1978, ARCH MICROBIOL, V116, P197, DOI 10.1007/BF00406037; Ji XJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-7; Ji XJ, 2011, BIOTECHNOL ADV, V29, P351, DOI 10.1016/j.biotechadv.2011.01.007; KANEKO T, 1990, APPL ENVIRON MICROB, V56, P2644, DOI 10.1128/AEM.56.9.2644-2649.1990; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li LX, 2012, BIORESOURCE TECHNOL, V115, P111, DOI 10.1016/j.biortech.2011.08.097; Liu YF, 2011, PROCESS BIOCHEM, V46, P390, DOI 10.1016/j.procbio.2010.07.024; Liu Z, 2011, BIORESOURCE TECHNOL, V102, P10741, DOI 10.1016/j.biortech.2011.08.110; Machielsen R, 2006, APPL ENVIRON MICROB, V72, P233, DOI 10.1128/AEM.72.1.233-238.2006; O'Donnell JM, 2004, AM J PHYSIOL-HEART C, V286, pH2237, DOI 10.1152/ajpheart.01113.2003; Perkins JB, 1999, J IND MICROBIOL BIOT, V22, P8, DOI 10.1038/sj.jim.2900587; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Sun JA, 2012, BIORESOURCE TECHNOL, V119, P94, DOI 10.1016/j.biortech.2012.05.108; Sun JN, 2012, BIOTECHNOL BIOPROC E, V17, P598, DOI 10.1007/s12257-011-0587-4; TODA F, 1989, J CHEM SOC PERK T 1, P1555, DOI 10.1039/p19890001555; Wang M, 2012, BIOTECHNOL LETT, V34, P1877, DOI 10.1007/s10529-012-0981-9; Wang XQ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-155; Wang Z, 2013, APPL MICROBIOL BIOTE; Xiao ZJ, 2007, APPL MICROBIOL BIOT, V74, P61, DOI 10.1007/s00253-006-0646-5; Xiao ZJ, 2007, CRIT REV MICROBIOL, V33, P127, DOI 10.1080/10408410701364604; Xiao ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008860; Zhang LY, 2012, J CHEM TECHNOL BIOT, V87, P1551, DOI 10.1002/jctb.3791; Zhang X, 2014, METAB ENG, V23, P34, DOI 10.1016/j.ymben.2014.02.002; Zhang X, 2013, WORLD J MICROB BIOT, V29, P1783, DOI 10.1007/s11274-013-1339-8; Zhang X, 2013, J IND MICROBIOL BIOT, V40, P1067, DOI 10.1007/s10295-013-1303-5; Zhang X, 2011, WORLD J MICROB BIOT, V27, P2785, DOI 10.1007/s11274-011-0754-y; Zhang XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087788; Zhang YJ, 2013, BIORESOURCE TECHNOL, V130, P256, DOI 10.1016/j.biortech.2012.10.036; Zhou YJJ, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-103	44	34	36	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102951	10.1371/journal.pone.0102951	http://dx.doi.org/10.1371/journal.pone.0102951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036158	gold, Green Published, Green Submitted			2022-12-25	WOS:000339615200102
J	Du, JK; Li, L; Dou, YH; Li, PP; Chen, R; Liu, HL				Du, Jikun; Li, Li; Dou, Yuhong; Li, Peipei; Chen, Rui; Liu, Helu			Diagnostic Utility of Neutrophil CD64 as a Marker for Early-Onset Sepsis in Preterm Neonates	PLOS ONE			English	Article							BACTERIAL-INFECTION; EXPRESSION; PROCALCITONIN; BIOMARKER; ACCURACY; INDEXES; TERM	Introduction: Neutrophil CD64 has been proposed as an early marker of sepsis. This study aims to evaluate the diagnostic utility of neutrophil CD64 for identification of early-onset sepsis in preterm neonates. Methods: The prospective study was conducted in a neonatal intensive care unit between November 2010 and June 2011. Preterm neonates in whom infection was suspected when they were <12 hours of age were enrolled. Complete blood count with differential, blood culture, neutrophil CD11b and CD64 measurement were performed. Receiver operating characteristic curve analysis was performed to evaluate the performance of neutrophil CD64 as biomarker of sepsis. Results: A total of 158 preterm neonates was enrolled, 88 of whom were suspected infection. The suspected sepsis group was of lesser gestational age (P<0.001) and lower birth weight (P<0.001), compared with controls. The hematologic profiles of the suspected sepsis group were characterized by higher white blood cell count, neutrophil counts and C-reactive protein. The suspected sepsis neonates had significantly higher neutrophil CD64 expression compared with controls. Neutrophil CD64 had an area value under the curve of 0.869 with an optimal cutoff values of 1010 phycoerythrin molecules bound/cell and it had a high sensitivity (81.82%) and negative predictive value (77.4%). The level of neutrophil CD64 was independent of antibiotic therapy within 24 hours after the onset of sepsis in preterm neonates. Conclusions: Neutrophil CD64 is a highly sensitive marker for suspected early-onset sepsis in preterm neonates. Our study suggests that neutrophil CD64 may be incorporated as a valuable marker to diagnose infection.	[Du, Jikun; Dou, Yuhong; Li, Peipei; Liu, Helu] Guangzhou Med Univ, Shenzhen Shajing Hosp, Dept Clin Lab, Shenzhen, Peoples R China; [Li, Li] Guangdong Med Coll, Dept Pharmacol, Dongguan, Peoples R China; [Chen, Rui] Shenzhen Baoan Maternal & Child Hlth Hosp, Shenzhen, Peoples R China	Guangzhou Medical University; Guangdong Medical University	Chen, R (corresponding author), Shenzhen Baoan Maternal & Child Hlth Hosp, Shenzhen, Peoples R China.	110665707@qq.com; liuhelu@21cn.com	du, jikun/G-3990-2013		Baoan Key Medical Subject Construction Program	Baoan Key Medical Subject Construction Program	This work was supported by the Baoan Key Medical Subject Construction Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari V, 2008, PEDIATRICS, V121, P129, DOI 10.1542/peds.2007-1308; Bizzarro MJ, 2005, PEDIATRICS, V116, P595, DOI 10.1542/peds.2005-0552; Buhimschi CS, 2007, PEDIATR RES, V61, P318, DOI 10.1203/01.pdr.0000252439.48564.37; Chirico G, 2011, PEDIATRIC REP, V3, P1, DOI 10.4081/pr.2011.e1; Clark RH, 2006, PEDIATRICS, V117, P1979, DOI 10.1542/peds.2005-1707; DASILVA O, 1995, PEDIATR INFECT DIS J, V14, P362; Fjaertoft G, 2005, ACTA PAEDIATR, V94, P295, DOI 10.1111/j.1651-2227.2005.tb03072.x; Fjaertoft G, 1999, PEDIATR RES, V45, P871, DOI 10.1203/00006450-199906000-00016; Ganatra HA, 2010, CLIN PERINATOL, V37, P501, DOI 10.1016/j.clp.2010.02.004; GERDES JS, 1991, CLIN PERINATOL, V18, P361, DOI 10.1016/S0095-5108(18)30528-1; Gonzalez BE, 2003, J PERINAT MED, V31, P60, DOI 10.1515/JPM.2003.009; Gros A, 2012, INTENS CARE MED, V38, P445, DOI 10.1007/s00134-012-2483-6; Icardi M, 2009, J CLIN MICROBIOL, V47, P3914, DOI 10.1128/JCM.00628-09; Kayange N, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-39; Layseca-Espinosa E, 2002, PEDIAT ALLERG IMM-UK, V13, P319, DOI 10.1034/j.1399-3038.2002.01064.x; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; MESSARITAKIS J, 1990, ARCH DIS CHILD-FETAL, V65, P380, DOI 10.1136/adc.65.4_Spec_No.380; Ng PC, 2006, CURR OPIN PEDIATR, V18, P125, DOI 10.1097/01.mop.0000193293.87022.4c; Ng PC, 2004, PEDIATR RES, V56, P796, DOI 10.1203/01.PDR.0000142586.47798.5E; Ng PC, 2004, ARCH DIS CHILD-FETAL, V89, pF229, DOI 10.1136/adc.2002.023838; Ng PC, 2002, PEDIATR RES, V51, P296, DOI 10.1203/00006450-200203000-00006; Nuutila J, 2007, J IMMUNOL METHODS, V328, P189, DOI 10.1016/j.jim.2007.09.002; Onal EE, 1999, LANCET, V353, P239, DOI 10.1016/S0140-6736(05)77250-0; OZDEMIR A, 1994, AM J PERINAT, V11, P282, DOI 10.1055/s-2007-994592; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; RODWELL RL, 1988, J PEDIATR-US, V112, P761, DOI 10.1016/S0022-3476(88)80699-1; Romagnoli C, 2001, EUR J PEDIATR, V160, P345, DOI 10.1007/PL00008445; Roussel M, 2012, AM J RESP CRIT CARE, V186, P1058, DOI 10.1164/ajrccm.186.10.1058; Soni S, 2013, PEDIATR INFECT DIS J, V32, pE33, DOI 10.1097/INF.0b013e31826faede; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Streimish I, 2012, PEDIATR INFECT DIS J, V31, P777, DOI 10.1097/INF.0b013e318256fb07; Streimish I, 2014, AM J PERINAT, V31, P21, DOI 10.1055/s-0033-1334453; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Umlauf VN, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/763191; van der Meer W, 2007, J ENDOTOXIN RES, V13, P94, DOI 10.1177/0968051907079101; Weinschenk NP, 2000, J PEDIATR-US, V137, P345, DOI 10.1067/mpd.2000.107846; Weirich E, 1998, J PEDIATR-US, V132, P445, DOI 10.1016/S0022-3476(98)70018-6; Zeitoun AAH, 2010, SCAND J INFECT DIS, V42, P299, DOI 10.3109/00365540903449832	38	28	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102647	10.1371/journal.pone.0102647	http://dx.doi.org/10.1371/journal.pone.0102647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033045	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300074
J	Hurt, RA; Robeson, MS; Shakya, M; Moberly, JG; Vishnivetskaya, TA; Gu, BH; Elias, DA				Hurt, Richard A., Jr.; Robeson, Michael S., II; Shakya, Migun; Moberly, James G.; Vishnivetskaya, Tatiana A.; Gu, Baohua; Elias, Dwayne A.			Improved Yield of High Molecular Weight DNA Coincides with Increased Microbial Diversity Access from Iron Oxide Cemented Sub-Surface Clay Environments	PLOS ONE			English	Article							MEDIATED FENTON REACTIONS; ORGANIC-MATTER; COMPETITIVE ADSORPTION; MINERAL PARTICLES; HUMIC ACIDS; RNA; SOILS; EXTRACTION; RECOVERY; SEQUENCES	Despite over three decades of progress, extraction of high molecular weight (HMW) DNA from high clay soils or iron oxide cemented clay has remained challenging. HMW DNA is desirable for next generation sequencing as it yields the most comprehensive coverage. Several DNA extraction procedures were compared from samples that exhibit strong nucleic acid adsorption. pH manipulation or use of alternative ion solutions offered no improvement in nucleic acid recovery. Lysis by liquid N-2 grinding in concentrated guanidine followed by concentrated sodium phosphate extraction supported HMW DNA recovery from clays high in iron oxides. DNA recovered using 1 M sodium phosphate buffer (PB) as a competitive desorptive wash was 15.22 +/- 2.33 mu g DNA/g clay, with most DNA consisting of >20 Kb fragments, compared to 2.46 +/- 0.25 mu g DNA/g clay with the Powerlyzer system (MoBio). Increasing PB concentration in the lysis reagent coincided with increasing DNA fragment length during initial extraction. Rarefaction plots of 16S rRNA (V1-V3 region) pyrosequencing from A-horizon and clay soils showed an similar to 80% and similar to 400% larger accessed diversity compared to the Powerlyzer soil DNA system, respectively. The observed diversity from the Firmicutes showed the strongest increase with >3-fold more operational taxonomic units (OTU) recovered.	[Hurt, Richard A., Jr.; Robeson, Michael S., II; Moberly, James G.; Elias, Dwayne A.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA; [Shakya, Migun; Vishnivetskaya, Tatiana A.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Gu, Baohua] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory	Elias, DA (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA.	eliasda@ornl.gov	Elias, Dwayne/GZL-8202-2022; Gu, Baohua/B-9511-2012; Vishnivetskaya, Tatiana/A-4488-2008; Robeson, Michael Scott/J-5211-2019	Gu, Baohua/0000-0002-7299-2956; Vishnivetskaya, Tatiana/0000-0002-0660-023X; Robeson, Michael Scott/0000-0001-7119-6301; , ENIGMA/0000-0002-0894-2831; Shakya, Migun/0000-0003-3876-691X; Moberly, James/0000-0003-0950-0952	U.S. Department of Energy, Office of Science, Biological and Environmental Research [DE-AC05-00OR22725, DE-AC02-05CH11231]; U.S. Department of Energy [DEAC05-00OR22725]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was conducted by the Oak Ridge National Laboratory Mercury Subsurface Science Focus Area and ENIGMA-Ecosystems and Networks Integrated with Genes and Molecular Assemblies (http://enigma.lbl.gov), a Scientific Focus Area Program at Lawrence Berkeley National Laboratory. Support was provided by the U.S. Department of Energy, Office of Science, Biological and Environmental Research under Contract No. DE-AC05-00OR22725 for ORNL and DE-AC02-05CH11231 for LBNL. ORNL is managed by UT-Battelle LLC for the U.S. Department of Energy under contract DEAC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm E, 1996, MOL MICROBIAL ECOLOG; Andeer P, 2012, APPL ENVIRON MICROB, V78, P163, DOI 10.1128/AEM.05973-11; Attene-Ramos MS, 2007, MOL CANCER RES, V5, P455, DOI 10.1158/1541-7786.MCR-06-0439; Avena MJ, 1998, ENVIRON SCI TECHNOL, V32, P2572, DOI 10.1021/es980112e; Bertrand H, 2005, J MICROBIOL METH, V62, P1, DOI 10.1016/j.mimet.2005.01.003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cleaves HJ, 2011, CHEMOSPHERE, V83, P1560, DOI 10.1016/j.chemosphere.2011.01.023; Cohn CA, 2006, GEOCHEM T, V7, DOI 10.1186/1467-4866-7-3; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cullen DW, 1998, SOIL BIOL BIOCHEM, V30, P983, DOI 10.1016/S0038-0717(98)00001-7; DeAngelis KM, 2011, APPL ENVIRON MICROB, V77, P6313, DOI 10.1128/AEM.05262-11; Diaz PI, 2012, MOL ORAL MICROBIOL, V27, P182, DOI 10.1111/j.2041-1014.2012.00642.x; Direito SOL, 2012, FEMS MICROBIOL ECOL, V81, P111, DOI 10.1111/j.1574-6941.2012.01325.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Frostegard A, 1999, APPL ENVIRON MICROB, V65, P5409; GREAVES M. P., 1969, Soil Biology and Biochemistry, V1, P317, DOI 10.1016/0038-0717(69)90014-5; Gu BH, 1996, GEOCHIM COSMOCHIM AC, V60, P2977, DOI 10.1016/0016-7037(96)00157-3; Gu BH, 1996, GEOCHIM COSMOCHIM AC, V60, P1943, DOI 10.1016/0016-7037(96)00059-2; GU BH, 1994, ENVIRON SCI TECHNOL, V28, P38, DOI 10.1021/es00050a007; Hazen TC, 2013, CURR OPIN BIOTECH, V24, P526, DOI 10.1016/j.copbio.2012.10.020; Hurt RA, 2001, APPL ENVIRON MICROB, V67, P4495, DOI 10.1128/AEM.67.10.4495-4503.2001; Hwang C, 2006, APPL MICROBIOL BIOT, V71, P748, DOI 10.1007/s00253-005-0189-1; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; Liles MR, 2008, APPL ENVIRON MICROB, V74, P3302, DOI 10.1128/AEM.02630-07; Liu AG, 1999, J COLLOID INTERF SCI, V218, P225, DOI 10.1006/jcis.1999.6419; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Luo WS, 2011, ENVIRON SCI TECHNOL, V45, P2994, DOI 10.1021/es103073u; Luo YZ, 1996, J BIOL CHEM, V271, P21167, DOI 10.1074/jbc.271.35.21167; LUO YZ, 1994, P NATL ACAD SCI USA, V91, P12438, DOI 10.1073/pnas.91.26.12438; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; OGRAM A, 1988, ENVIRON SCI TECHNOL, V22, P982, DOI 10.1021/es00173a020; OGRAM AV, 1994, APPL ENVIRON MICROB, V60, P393, DOI 10.1128/AEM.60.2.393-396.1994; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Raskin L, 1997, ECOLOGY PHYSL GASTRO, V2; Robertson RM, 2006, P NATL ACAD SCI USA, V103, P7310, DOI 10.1073/pnas.0601903103; Sanchez-Martin MJ, 2008, J HAZARD MATER, V150, P115, DOI 10.1016/j.jhazmat.2007.04.093; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shakya M, 2013, ENVIRON MICROBIOL, V15, P1882, DOI 10.1111/1462-2920.12086; Tanaka T, 2009, LANGMUIR, V25, P2956, DOI 10.1021/la8032397; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; VARADACHARI C, 1994, SOIL BIOL BIOCHEM, V26, P1145, DOI 10.1016/0038-0717(94)90136-8; Vermeer AWP, 1998, LANGMUIR, V14, P4210, DOI 10.1021/la970836o; Vermeer AWP, 1998, LANGMUIR, V14, P2810, DOI 10.1021/la970624r; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wong D, 2004, MICROB ECOL, V47, P80, DOI 10.1007/s00248-003-1021-z; Yankson KK, 2009, APPL ENV MICROBIOL, V75; Zhou J, 2011, ISME J          0224, V24, P1; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	55	18	19	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102826	10.1371/journal.pone.0102826	http://dx.doi.org/10.1371/journal.pone.0102826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033199	gold, Green Submitted, Green Published			2022-12-25	WOS:000339418300099
J	Kenney, LA; Eagles-Smith, CA; Ackerman, JT; von Hippel, FA				Kenney, Leah A.; Eagles-Smith, Collin A.; Ackerman, Joshua T.; von Hippel, Frank A.			Temporal Variation in Fish Mercury Concentrations within Lakes from the Western Aleutian Archipelago, Alaska	PLOS ONE			English	Article							ORGANOCHLORINE CONTAMINANTS; ENVIRONMENTAL CONTAMINANTS; DIETARY METHYLMERCURY; SEABIRDS; ISLANDS; SEA; CALIFORNIA; DERIVATION; EMISSIONS; PATTERNS	We assessed temporal variation in mercury (Hg) concentrations of threespine stickleback (Gasterosteus aculeatus) from Agattu Island, Aleutian Archipelago, Alaska. Total Hg concentrations in whole-bodied stickleback were measured at two-week intervals from two sites in each of two lakes from June 1 to August 10, 2011 during the time period when lakes were ice-free. Across all sites and sampling events, stickleback Hg concentrations ranged from 0.37-1.07 mu g/g dry weight (dw), with a mean (+/- SE) of 0.55 +/- 0.01 mu g/g dw. Mean fish Hg concentrations declined by 9% during the study period, from 0.57 +/- 0.01 mu g/g dw in early June to 0.52 +/- 0.01 mu g/g dw in mid-August. Mean fish Hg concentrations were 6% higher in Loon Lake (0.56 +/- 0.01 mu g/g dw) than in Lake 696 (0.53 +/- 0.01 mu g/g dw), and 4% higher in males (0.56 +/- 0.01 mu g/g dw) than in females (0.54 +/- 0.01 mu g/g dw). Loon Lake was distinguished from Lake 696 by the presence of piscivorous waterbirds during the breeding season. Mercury concentrations in stickleback from Agattu Island were higher than would be expected for an area without known point sources of Hg pollution, and high enough to be of concern to the health of piscivorous wildlife.	[Kenney, Leah A.; von Hippel, Frank A.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK 99508 USA; [Eagles-Smith, Collin A.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA; [Ackerman, Joshua T.] US Geol Survey, Western Ecol Res Ctr, Dixon, CA USA	University of Alaska System; University of Alaska Anchorage; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Kenney, LA (corresponding author), Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK 99508 USA.	leahkenney@gmail.com	Ackerman, Joshua T./AAF-9503-2019; Eagles-Smith, Collin/AAH-3811-2019; Eagles-Smith, Collin/T-8580-2019	Eagles-Smith, Collin/0000-0003-1329-5285; Ackerman, Josh/0000-0002-3074-8322	USGS Forest and Rangeland Ecosystem Science Center; USGS Western Ecological Research Center; USGS Environmental Health Mission Area Contaminant Biology Program	USGS Forest and Rangeland Ecosystem Science Center(United States Geological Survey); USGS Western Ecological Research Center; USGS Environmental Health Mission Area Contaminant Biology Program	This work was partially funded by USGS Forest and Rangeland Ecosystem Science Center, USGS Western Ecological Research Center, and the USGS Environmental Health Mission Area Contaminant Biology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAP, 2002, ARCT POLL 2002 PERS; Anthony RG, 1999, ENVIRON TOXICOL CHEM, V18, P2054, DOI 10.1002/etc.5620180925; Anthony RG, 2007, ENVIRON TOXICOL CHEM, V26, P1843, DOI 10.1897/06-334R.1; Bacon CE, 1999, ENVIRON TOXICOL CHEM, V18, P452, DOI [10.1002/etc.5620180313, 10.1897/1551-5028(1999)018&lt;0452:COOCAS&gt;2.3.CO;2]; Bell M.A., 1994, EVOLUTIONARY BIOL TH; Blais JM, 2005, SCIENCE, V309, P445, DOI 10.1126/science.1112658; BLOOM NS, 1992, CAN J FISH AQUAT SCI, V49, P1010, DOI 10.1139/f92-113; Boszke L, 2003, POL J ENVIRON STUD, V12, P275; Burger J, 2007, SCI TOTAL ENVIRON, V387, P175, DOI 10.1016/j.scitotenv.2007.07.049; Byrd GV, 2005, FISH OCEANOGR, V14, P139; Choy ES, 2010, SCI TOTAL ENVIRON, V408, P1858, DOI 10.1016/j.scitotenv.2010.01.014; Depew DC, 2012, ENVIRON TOXICOL CHEM, V31, P2399, DOI 10.1002/etc.1971; Depew DC, 2012, ENVIRON TOXICOL CHEM, V31, P1536, DOI 10.1002/etc.1859; Driscoll CT, 2013, ENVIRON SCI TECHNOL, V47, P4967, DOI 10.1021/es305071v; Eagles-Smith CA, 2009, ENVIRON SCI TECHNOL, V43, P8658, DOI 10.1021/es901400c; EPA, 2000, 7473 EPA; Evers DC, 2008, ECOTOXICOLOGY, V17, P69, DOI 10.1007/s10646-007-0168-7; FALANDYSZ J, 1993, B ENVIRON CONTAM TOX, V51, P710; Heinz GH, 2009, ARCH ENVIRON CON TOX, V56, P129, DOI 10.1007/s00244-008-9160-3; Kaler RSA, 2014, MAR POLLUT BULL, V82, P189, DOI 10.1016/j.marpolbul.2014.02.034; Kenney LA, 2011, THESIS U ALASKA ANCH; Kenney LA, 2012, ENVIRON TOXICOL CHEM, V31, P2647, DOI 10.1002/etc.1990; Miles AK, 2009, ENVIRON TOXICOL CHEM, V28, P1643, DOI 10.1897/08-498.1; PACYNA JM, 1995, WATER AIR SOIL POLL, V80, P621, DOI 10.1007/BF01189714; Pirrone N, 2010, ATMOS CHEM PHYS, V10, P5951, DOI 10.5194/acp-10-5951-2010; Rea LD, 2013, SCI TOTAL ENVIRON, V454, P277, DOI 10.1016/j.scitotenv.2013.02.095; Reese SL, 2012, CHEMOSPHERE, V88, P873, DOI 10.1016/j.chemosphere.2012.03.096; Ricca MA, 2008, SCI TOTAL ENVIRON, V406, P308, DOI 10.1016/j.scitotenv.2008.06.030; Rocque DA, 2004, ENVIRON TOXICOL CHEM, V23, P759, DOI 10.1897/03-182; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; Shedd K, 2013, THESIS U ALASKA ANCH; SLOTTON DG, 1995, WATER AIR SOIL POLL, V80, P841, DOI 10.1007/BF01189735; Streets DG, 2009, ENVIRON SCI TECHNOL, V43, P2983, DOI 10.1021/es802474j; Us Epa 0 0 0 A, 2013, MERC AIR TOX STAND M; USF&WS, 2008, BIRDS CONS 2008; Ward DM, 2010, T AM FISH SOC, V139, P1, DOI 10.1577/T09-032.1; Ward Scott M., 1999, North American Journal of Fisheries Management, V19, P89, DOI 10.1577/1548-8675(1999)019<0089:SVICOM>2.0.CO;2; Watras CJ, 1998, SCI TOTAL ENVIRON, V219, P183, DOI 10.1016/S0048-9697(98)00228-9; Wiener James G., 2007, P87, DOI 10.1201/9780849388897.ch4; Willacker JJ, 2013, ENVIRON TOXICOL CHEM, V32, P1623, DOI 10.1002/etc.2213; Zhang L, 2012, ENVIRON POLLUT, V161, P178, DOI 10.1016/j.envpol.2011.10.023	41	8	9	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102244	10.1371/journal.pone.0102244	http://dx.doi.org/10.1371/journal.pone.0102244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029042	gold, Green Submitted, Green Published			2022-12-25	WOS:000341306600050
J	Abdulhadi, MA; Perno, JR; Melhem, ER; Nucifora, PGP				Abdulhadi, Mike A.; Perno, Joseph R.; Melhem, Elias R.; Nucifora, Paolo G. P.			Characteristics of Spondylotic Myelopathy on 3D Driven-Equilibrium Fast Spin Echo and 2D Fast Spin Echo Magnetic Resonance Imaging: A Retrospective Cross-Sectional Study	PLOS ONE			English	Article							CERVICAL COMPRESSION MYELOPATHY; INCREASED SIGNAL INTENSITY; PREDICT PROGNOSIS; CORD; MRI; SURGERY; SEQUENCES; IMAGES; STENOSIS; RECOVERY	In patients with spinal stenosis, magnetic resonance imaging of the cervical spine can be improved by using 3D driven-equilibrium fast spin echo sequences to provide a high-resolution assessment of osseous and ligamentous structures. However, it is not yet clear whether 3D driven-equilibrium fast spin echo sequences adequately evaluate the spinal cord itself. As a result, they are generally supplemented by additional 2D fast spin echo sequences, adding time to the examination and potential discomfort to the patient. Here we investigate the hypothesis that in patients with spinal stenosis and spondylotic myelopathy, 3D driven-equilibrium fast spin echo sequences can characterize cord lesions equally well as 2D fast spin echo sequences. We performed a retrospective analysis of 30 adult patients with spondylotic myelopathy who had been examined with both 3D driven-equilibrium fast spin echo sequences and 2D fast spin echo sequences at the same scanning session. The two sequences were inspected separately for each patient, and visible cord lesions were manually traced. We found no significant differences between 3D driven-equilibrium fast spin echo and 2D fast spin echo sequences in the mean number, mean area, or mean transverse dimensions of spondylotic cord lesions. Nevertheless, the mean contrast-to-noise ratio of cord lesions was decreased on 3D driven-equilibrium fast spin echo sequences compared to 2D fast spin echo sequences. These findings suggest that 3D driven-equilibrium fast spin echo sequences do not need supplemental 2D fast spin echo sequences for the diagnosis of spondylotic myelopathy, but they may be less well suited for quantitative signal measurements in the spinal cord.	[Abdulhadi, Mike A.] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA; [Perno, Joseph R.; Nucifora, Paolo G. P.] Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA; [Melhem, Elias R.] Univ Maryland, Baltimore, MD 21201 USA; [Nucifora, Paolo G. P.] Univ Penn, Philadelphia, PA 19104 USA	Children's Hospitals & Clinics of Minnesota; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; University System of Maryland; University of Maryland Baltimore; University of Pennsylvania	Nucifora, PGP (corresponding author), Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA.	paolo.nucifora@uphs.upenn.edu						Ahn JS, 2010, CLIN ORTHOP SURG, V2, P98, DOI 10.4055/cios.2010.2.2.98; Arvin B, 2011, NEUROSURGERY, V69, P362, DOI 10.1227/NEU.0b013e31821a418c; Avadhani A, 2010, SPINE J, V10, P475, DOI 10.1016/j.spinee.2010.03.024; Chatley A, 2009, J NEUROSURG-SPINE, V11, P562, DOI 10.3171/2009.6.SPINE091; Chiewvit Pipat, 2011, Journal of the Medical Association of Thailand, V94, P346; Cho YE, 2011, EUR SPINE J, V20, P2267, DOI 10.1007/s00586-011-1878-3; Eck JC, 2010, SPINE, V35, pE1306, DOI 10.1097/BRS.0b013e3181e23e62; Freund PAB, 2010, J MAGN RESON IMAGING, V32, P1242, DOI 10.1002/jmri.22340; GEORGY BA, 1994, AM J ROENTGENOL, V162, P923, DOI 10.2214/ajr.162.4.8141019; Harrop JS, 2010, SPINE, V35, P620, DOI 10.1097/BRS.0b013e3181b723af; Kang Y, 2011, AM J ROENTGENOL, V197, pW134, DOI 10.2214/AJR.10.5560; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Kohno K, 1997, SURG NEUROL, V48, P237, DOI 10.1016/S0090-3019(97)00166-3; Kwon JW, 2012, CLIN RADIOL, V67, P106, DOI 10.1016/j.crad.2011.06.011; Maldjian C, 1999, ACAD RADIOL, V6, P84, DOI 10.1016/S1076-6332(99)80486-3; Markl M, 2012, J MAGN RESON IMAGING, V35, P1274, DOI 10.1002/jmri.23638; MATSUDA Y, 1991, J NEUROSURG, V74, P887, DOI 10.3171/jns.1991.74.6.0887; Matsumoto M, 2000, SPINE, V25, P677, DOI 10.1097/00007632-200003150-00005; Maus TP, 2012, RADIOL CLIN N AM, V50, P651, DOI 10.1016/j.rcl.2012.04.007; MEHALIC TF, 1990, NEUROSURGERY, V26, P217, DOI 10.1227/00006123-199002000-00006; Meindl T, 2009, EUR RADIOL, V19, P713, DOI 10.1007/s00330-008-1175-7; Melhem E R, 2000, Magn Reson Imaging Clin N Am, V8, P435; Melhem ER, 2001, RADIOLOGY, V218, P283, DOI 10.1148/radiology.218.1.r01ja38283; MORIO Y, 1994, ARCH ORTHOP TRAUM SU, V113, P254, DOI 10.1007/BF00443813; Morio Y, 2001, SPINE, V26, P1238, DOI 10.1097/00007632-200106010-00012; Naraghi A, 2012, AM J ROENTGENOL, V199, pW283, DOI 10.2214/AJR.12.9099; OHSHIO I, 1993, SPINE, V18, P1140, DOI 10.1097/00007632-199307000-00005; OKADA Y, 1993, SPINE, V18, P2024, DOI 10.1097/00007632-199310001-00016; RAMANAUSKAS WL, 1989, J COMPUT ASSIST TOMO, V13, P399, DOI 10.1097/00004728-198905000-00005; Shin JJ, 2010, ACTA NEUROCHIR, V152, P1687, DOI 10.1007/s00701-010-0692-8; Suri Ashish, 2003, Spine J, V3, P33, DOI 10.1016/S1529-9430(02)00448-5; TAKAHASHI M, 1987, NEURORADIOLOGY, V29, P550, DOI 10.1007/BF00350439; Tracy JA, 2010, NEUROLOGIST, V16, P176, DOI 10.1097/NRL.0b013e3181da3a29; TSURUDA JS, 1991, AM J NEURORADIOL, V12, P237; TSURUDA JS, 1990, AM J ROENTGENOL, V154, P375, DOI 10.2214/ajr.154.2.2153331; VANUIJEN CMJ, 1984, MAGNET RESON MED, V1, P502, DOI 10.1002/mrm.1910010409; Vedantam A, 2011, J NEUROSURG-SPINE, V15, P660, DOI 10.3171/2011.8.SPINE11452; WADA E, 1995, SPINE, V20, P2226, DOI 10.1097/00007632-199510001-00009; Yukawa Y, 2007, SPINE, V32, P1675, DOI 10.1097/BRS.0b013e318074d62e; Zhang YZ, 2010, SPINE, V35, pE396, DOI 10.1097/BRS.0b013e3181c6dbc4	40	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e100964	10.1371/journal.pone.0100964	http://dx.doi.org/10.1371/journal.pone.0100964			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025170	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992400008
J	Deressa, T; Stoecklinger, A; Wallner, M; Himly, M; Kofler, S; Hainz, K; Brandstetter, H; Thalhamer, J; Hammerl, P				Deressa, Tekalign; Stoecklinger, Angelika; Wallner, Michael; Himly, Martin; Kofler, Stefan; Hainz, Katrina; Brandstetter, Hans; Thalhamer, Josef; Hammerl, Peter			Structural Integrity of the Antigen Is a Determinant for the Induction of T-Helper Type-1 Immunity in Mice by Gene Gun Vaccines against E.coli Beta-Galactosidase	PLOS ONE			English	Article							DERMAL DENDRITIC CELLS; EPIDERMAL LANGERHANS CELLS; CAT ALLERGEN FEL-D-1; DNA VACCINES; INFECTIOUS-DISEASES; MEDIATED-IMMUNITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; INTERFERON-GAMMA; CPG MOTIFS	The type of immune response is critical for successful protection and typically determined by pathogen-associated danger molecules. In contrast, protein antigens are usually regarded as passive target structures. Here, we provide evidence that the structure of the antigen can profoundly influence the type of response that is elicited under else identical conditions. In mice, gene gun vaccines induce predominantly Th2-biased immune reactions against most antigens. One exception is E. coli beta-galactosidase (beta Gal) that induces a balanced Th1/Th2 response. Because both, the delivered material (plasmid DNA-coated gold particles) as well as the procedure (biolistic delivery to the skin surface) is the same as for other antigens we hypothesized that Th1 induction could be a function of beta Gal protein expressed in transfected cells. To test this we examined gene gun vaccines encoding structural or functional variants of the antigen. Employing a series of gene gun vaccines encoding individual structural domains of beta Gal, we found that neither of them induced IgG2a antibodies. Even disruption of the homo-tetramer association of the native protein by deletion of a few N-terminal amino acids was sufficient to abrogate IgG2a production. However, enzymatically inactive beta Gal with only one point mutation in the catalytic center retained the ability to induce Th1 reactions. Thus, structural but not functional integrity of the antigen must be retained for Th1 induction. beta Gal is not a Th1 adjuvant in the classical sense because neither were beta Gal-transgenic ROSA26 mice particularly Th1-biased nor did co-administration of a beta Gal-encoding plasmid induce IgG2a against other antigens. Despite this, gene gun vaccines elicited Th1 reactions to antigens fused to the open reading frame of beta Gal. We interpret these findings as evidence that different skin-borne antigens may be differentially handled by the immune system and that the three-dimensional structure of an antigen is an important determinant for this.	[Deressa, Tekalign; Stoecklinger, Angelika; Wallner, Michael; Himly, Martin; Kofler, Stefan; Hainz, Katrina; Brandstetter, Hans; Thalhamer, Josef; Hammerl, Peter] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Salzburg University	Hammerl, P (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	peter.hammerl@sbg.ac.at	Brandstetter, Hans/E-6754-2011; Thalhamer, Josef/E-5787-2011; Stoecklinger, Angelika/C-7616-2016; Wallner, Michael/L-5437-2015; Himly, Martin/D-1568-2015	Brandstetter, Hans/0000-0002-6089-3045; Thalhamer, Josef/0000-0003-2285-6400; Stoecklinger, Angelika/0000-0002-0351-8142; Wallner, Michael/0000-0001-6568-7892; Himly, Martin/0000-0001-5416-085X	Austrian Research Fund, FWF [W1213, P25243-B22]; Christian Doppler Laboratory for Allergy Diagnosis Therapy	Austrian Research Fund, FWF(Austrian Science Fund (FWF)); Christian Doppler Laboratory for Allergy Diagnosis Therapy	This work was supported by the Austrian Research Fund, FWF, grants W1213 and P25243-B22, and the Christian Doppler Laboratory for Allergy Diagnosis & Therapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Alvarez D, 2005, J IMMUNOL, V174, P1664, DOI 10.4049/jimmunol.174.3.1664; ANSEL J, 1990, J INVEST DERMATOL, V94, pS101, DOI 10.1111/1523-1747.ep12876053; Brtko J, 1999, MOL CELL ENDOCRINOL, V152, P85, DOI 10.1016/S0303-7207(99)00054-4; Collins AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00235; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; De Vooght V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012581; Fomsgaard A, 1998, SCAND J IMMUNOL, V47, P289, DOI 10.1046/j.1365-3083.1998.00323.x; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Fuller DH, 2007, VIROLOGY, V364, P245, DOI 10.1016/j.virol.2007.02.024; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gronlund H, 2003, J BIOL CHEM, V278, P40144, DOI 10.1074/jbc.M301416200; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Kaiser L, 2003, J BIOL CHEM, V278, P37730, DOI 10.1074/jbc.M304740200; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kent SJ, 1998, J VIROL, V72, P10180, DOI 10.1128/JVI.72.12.10180-10188.1998; Klinman DM, 1999, VACCINE, V17, P19, DOI 10.1016/S0264-410X(98)00151-0; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Kwok SC, 2003, J BIOL CHEM, V278, P35248, DOI 10.1074/jbc.M305306200; Laddy DJ, 2006, INT REV IMMUNOL, V25, P99, DOI 10.1080/08830180600785827; LANGLEY KE, 1976, BIOCHEMISTRY-US, V15, P4866, DOI 10.1021/bi00667a018; Larsen L, 2011, J DERMATOL SCI, V64, P85, DOI 10.1016/j.jdermsci.2011.07.008; Leitner WW, 1997, J IMMUNOL, V159, P6112; Locksley RM, 1999, J INFECT DIS, V179, pS305, DOI 10.1086/513843; Ludwig-Portugall I, 2004, J ALLERGY CLIN IMMUN, V114, P951, DOI 10.1016/j.jaci.2004.06.013; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Miller LS, 2007, J INVEST DERMATOL, V127, P262, DOI 10.1038/sj.jid.5700559; Mougneau E, 2011, IMMUNOL REV, V240, P286, DOI 10.1111/j.1600-065X.2010.00983.x; Mueller GA, 1998, BIOCHEMISTRY-US, V37, P12707, DOI 10.1021/bi980578+; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; NobenTrauth N, 1996, TRANSGENIC RES, V5, P487, DOI 10.1007/BF01980214; Ohkuri T, 2010, J IMMUNOL, V185, P4199, DOI 10.4049/jimmunol.0902249; Okamoto M, 2009, NAT IMMUNOL, V10, P872, DOI 10.1038/ni.1747; Oran AE, 2003, J IMMUNOL, V171, P1999, DOI 10.4049/jimmunol.171.4.1999; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Roy MJ, 2000, VACCINE, V19, P764, DOI 10.1016/S0264-410X(00)00302-9; Sato Y, 1996, SCIENCE, V273, P352, DOI 10.1126/science.273.5273.352; Scheiblhofer S, 2007, MOL IMMUNOL, V44, P1879, DOI 10.1016/j.molimm.2006.09.023; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Schulte S, 2008, AM J PATHOL, V172, P1500, DOI 10.2353/ajpath.2008.070776; Sen D, 2010, P NATL ACAD SCI USA, V107, P8334, DOI 10.1073/pnas.0912817107; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Spies B, 2003, J IMMUNOL, V171, P5908, DOI 10.4049/jimmunol.171.11.5908; STEIN PE, 1991, J MOL BIOL, V221, P941, DOI 10.1016/0022-2836(91)80185-W; Stetson DB, 2002, IMMUNITY, V17, P191, DOI 10.1016/S1074-7613(02)00363-1; Stoecklinger A, 2007, J IMMUNOL, V179, P886, DOI 10.4049/jimmunol.179.2.886; Stoecklinger A, 2011, J IMMUNOL, V186, P1377, DOI 10.4049/jimmunol.1002557; TABE L, 1984, J MOL BIOL, V180, P645, DOI 10.1016/0022-2836(84)90031-7; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thomas JC, 2013, HUM VACC IMMUNOTHER, V9, P744, DOI 10.4161/hv.22998; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tuzun Y, 2007, DERMATOL CLIN, V25, P467, DOI 10.1016/dct.2007.06.003; Turner MS, 2014, DIABETOLOGIA, V57, P1428, DOI 10.1007/s00125-014-3233-9; Vrtala S, 1999, J IMMUNOL, V163, P5489; Wang JY, 2013, ALLERGY ASTHMA IMMUN, V5, P68, DOI 10.4168/aair.2013.5.2.68; Weiss R, 2002, VACCINE, V20, P3148, DOI 10.1016/S0264-410X(02)00250-5; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582	64	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102280	10.1371/journal.pone.0102280	http://dx.doi.org/10.1371/journal.pone.0102280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025197	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400059
J	Parmar, C; Velazquez, ER; Leijenaar, R; Jermoumi, M; Carvalho, S; Mak, RH; Mitra, S; Shankar, BU; Kikinis, R; Haibe-Kains, B; Lambin, P; Aerts, HJWL				Parmar, Chintan; Velazquez, Emmanuel Rios; Leijenaar, Ralph; Jermoumi, Mohammed; Carvalho, Sara; Mak, Raymond H.; Mitra, Sushmita; Shankar, B. Uma; Kikinis, Ron; Haibe-Kains, Benjamin; Lambin, Philippe; Aerts, Hugo J. W. L.			Robust Radiomics Feature Quantification Using Semiautomatic Volumetric Segmentation	PLOS ONE			English	Article							CELL LUNG-CANCER; INTEROBSERVER VARIABILITY; TEXTURAL FEATURES; PET IMAGES; TUMOR; REPRODUCIBILITY; HETEROGENEITY	Due to advances in the acquisition and analysis of medical imaging, it is currently possible to quantify the tumor phenotype. The emerging field of Radiomics addresses this issue by converting medical images into minable data by extracting a large number of quantitative imaging features. One of the main challenges of Radiomics is tumor segmentation. Where manual delineation is time consuming and prone to inter-observer variability, it has been shown that semi-automated approaches are fast and reduce inter-observer variability. In this study, a semiautomatic region growing volumetric segmentation algorithm, implemented in the free and publicly available 3D-Slicer platform, was investigated in terms of its robustness for quantitative imaging feature extraction. Fifty-six 3D-radiomic features, quantifying phenotypic differences based on tumor intensity, shape and texture, were extracted from the computed tomography images of twenty lung cancer patients. These radiomic features were derived from the 3D-tumor volumes defined by three independent observers twice using 3D-Slicer, and compared to manual slice-by-slice delineations of five independent physicians in terms of intra-class correlation coefficient (ICC) and feature range. Radiomic features extracted from 3D-Slicer segmentations had significantly higher reproducibility (ICC = 0.85+/-0.15, p = 0.0009) compared to the features extracted from the manual segmentations (ICC = 0.77+/-0.17). Furthermore, we found that features extracted from 3D-Slicer segmentations were more robust, as the range was significantly smaller across observers (p = 3.819e-07), and overlapping with the feature ranges extracted from manual contouring (boundary lower: p = 0.007, higher: p = 5.863e-06). Our results show that 3D-Slicer segmented tumor volumes provide a better alternative to the manual delineation for feature quantification, as they yield more reproducible imaging descriptors. Therefore, 3D-Slicer can be employed for quantitative image feature extraction and image data mining research in large patient cohorts.	[Parmar, Chintan; Velazquez, Emmanuel Rios; Jermoumi, Mohammed; Mak, Raymond H.; Lambin, Philippe; Aerts, Hugo J. W. L.] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol,Med Sch, Boston, MA 02115 USA; [Parmar, Chintan; Velazquez, Emmanuel Rios; Leijenaar, Ralph; Carvalho, Sara; Aerts, Hugo J. W. L.] Maastricht Univ, Dept Radiat Oncol MAASTRO, Maastricht, Netherlands; [Parmar, Chintan; Mitra, Sushmita; Shankar, B. Uma] Indian Stat Inst, Machine Intelligence Unit, Kolkata, India; [Jermoumi, Mohammed] Univ Massachusetts, Lowell, MA USA; [Kikinis, Ron; Aerts, Hugo J. W. L.] Harvard Univ, Brigham & Womens Hosp, Dept Radiol, Sch Med, Boston, MA 02115 USA; [Haibe-Kains, Benjamin] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Haibe-Kains, Benjamin] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Maastricht University; Indian Statistical Institute; Indian Statistical Institute Kolkata; University of Massachusetts System; University of Massachusetts Lowell; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Parmar, C (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol,Med Sch, Boston, MA 02115 USA.	Chintan_Parmar@dfci.harvard.edu; Hugo_Aerts@dfci.harvard.edu	parmar, chintan/J-2977-2019; Aerts, Hugo/ABF-2821-2020; Aerts, Hugo/P-6350-2015; Haibe-Kains, Benjamin/D-3702-2011	parmar, chintan/0000-0002-2140-814X; Aerts, Hugo/0000-0002-2122-2003; Aerts, Hugo/0000-0002-2122-2003; Haibe-Kains, Benjamin/0000-0002-7684-0079; Lambin, Philippe/0000-0001-7961-0191; SHANKAR, B. UMA/0000-0003-0332-2294; Mitra, Sushmita/0000-0001-9285-1117; Mak, Raymond/0000-0002-8754-0565	National Institutes of Health [NIH-USA U01 CA 143062-01]; National Institutes of Health (NIH HHS/United States) [U54-EB005149, P41-EB015902]; CTMM framework (AIRFORCE project) [030-103]; EU; euroCAT (IVA Interreg); Kankeronderzoekfonds Limburg from the Health Foundation Limburg; Dutch Cancer Society [KWF UM 2011-5020, KWF UM 2009-4454]; QuIC-ConCePT project [115151]; NATIONAL CANCER INSTITUTE [U01CA143062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015902, U54EB005149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH HHS/United States)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTMM framework (AIRFORCE project); EU(European Commission); euroCAT (IVA Interreg); Kankeronderzoekfonds Limburg from the Health Foundation Limburg; Dutch Cancer Society(KWF Kankerbestrijding); QuIC-ConCePT project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors acknowledge financial support from the National Institutes of Health (NIH-USA U01 CA 143062-01, Radiomics of NSCLC, and NIH HHS/United States U54-EB005149, P41-EB015902), the CTMM framework (AIRFORCE project, grant 030-103), EU 6th and 7th framework program (METOXIA, EURECA, ARTFORCE), euroCAT (IVA Interreg - www.eurocat.info), Kankeronderzoekfonds Limburg from the Health Foundation Limburg and the Dutch Cancer Society (KWF UM 2011-5020, KWF UM 2009-4454). The authors also acknowledge financial support from the QuIC-ConCePT project (Grant Agreement No. 115151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts H. J., 2014, NATURE COMMUNICATION; Buckler AJ, 2011, RADIOLOGY, V258, P906, DOI 10.1148/radiol.10100799; Buckler AJ, 2011, RADIOLOGY, V259, P875, DOI 10.1148/radiol.10100800; Deasy JO, 2003, MED PHYS, V30, P979, DOI 10.1118/1.1568978; Egger J, 2013, SCI REPORTS, V3; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Galavis PE, 2010, ACTA ONCOL, V49, P1012, DOI 10.3109/0284186X.2010.498437; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Gamer M, 2013, R PACKAGE VERSION 0; Ganeshan B, 2013, RADIOLOGY, V266, P326, DOI 10.1148/radiol.12112428; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; Ganeshan B, 2010, CANCER IMAGING, V10, P137, DOI 10.1102/1470-7330.2010.0021; Gu Y, 2012, PATTERN RECOGN, V46, P692; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Heye T, 2013, RADIOLOGY, V266, P812, DOI 10.1148/radiol.12120255; Hunter LA, 2013, MED PHYS, V40, DOI 10.1118/1.4829514; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Leijenaar RTH, 2013, ACTA ONCOL, V52, P1391, DOI 10.3109/0284186X.2013.812798; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Tixier F, 2012, J NUCL MED, V53, P693, DOI 10.2967/jnumed.111.099127; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; Van Baardwijk A, 2007, INT J RADIAT ONCOL, V68, P771, DOI 10.1016/j.ijrobp.2006.12.067; van Baardwijk A, 2010, J CLIN ONCOL, V28, P1380, DOI 10.1200/JCO.2009.24.7221; Velazquez ER, 2013, SCI REP-UK, V3, DOI 10.1038/srep03529; Velazquez ER, 2012, RADIOTHER ONCOL, V105, P167, DOI 10.1016/j.radonc.2012.09.023; Zinn PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041522; Zinn PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025451	31	370	388	8	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102107	10.1371/journal.pone.0102107	http://dx.doi.org/10.1371/journal.pone.0102107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025374	gold, Green Submitted, Green Published			2022-12-25	WOS:000339992400042
J	Pereira, AM; Tudor, C; Pouille, PA; Shekhar, S; Kanger, JS; Subramaniam, V; Martin-Blanco, E				Pereira, Andrea M.; Tudor, Cicerone; Pouille, Philippe-Alexandre; Shekhar, Shashank; Kanger, Johannes S.; Subramaniam, Vinod; Martin-Blanco, Enrique			Plasticity of the MAPK Signaling Network in Response to Mechanical Stress	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; REGULATING JNK ACTIVITY; N-TERMINAL KINASE; GENE-EXPRESSION; DORSAL CLOSURE; CELL-SURVIVAL; GROWTH-FACTOR; CROSS-TALK; DROSOPHILA; PHOSPHORYLATION	Cells display versatile responses to mechanical inputs and recent studies have identified the mitogen-activated protein kinase (MAPK) cascades mediating the biological effects observed upon mechanical stimulation. Although, MAPK pathways can act insulated from each other, several mechanisms facilitate the crosstalk between the components of these cascades. Yet, the combinatorial complexity of potential molecular interactions between these elements have prevented the understanding of their concerted functions. To analyze the plasticity of the MAPK signaling network in response to mechanical stress we performed a non-saturating epistatic screen in resting and stretched conditions employing as readout a JNK responsive dJun-FRET biosensor. By knocking down MAPKs, and JNK pathway regulators, singly or in pairs in Drosophila S2R+ cells, we have uncovered unexpected regulatory links between JNK cascade kinases, Rho GTPases, MAPKs and the JNK phosphatase Puc. These relationships have been integrated in a system network model at equilibrium accounting for all experimentally validated interactions. This model allows predicting the global reaction of the network to its modulation in response to mechanical stress. It also highlights its context-dependent sensitivity.	[Pereira, Andrea M.; Pouille, Philippe-Alexandre; Martin-Blanco, Enrique] Inst Biol Mol Barcelona CSIC, Barcelona, Spain; [Tudor, Cicerone; Shekhar, Shashank; Kanger, Johannes S.; Subramaniam, Vinod] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Tudor, Cicerone; Shekhar, Shashank; Kanger, Johannes S.; Subramaniam, Vinod] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Twente; University of Twente	Subramaniam, V (corresponding author), Univ Twente, MESA Inst Nanotechnol, POB 217, NL-7500 AE Enschede, Netherlands.	v.subramaniam@utwente.nl; embbmc@ibmb.csic.es	Subramaniam, Vinod/B-4197-2010; Pereira, Andrea/AAL-2973-2020; Shekhar, Shashank/B-3068-2013; Martin-Blanco, Enrique/ABH-1280-2020	Subramaniam, Vinod/0000-0001-6712-7266; Martin-Blanco, Enrique/0000-0002-6926-910X; Shekhar, Shashank/0000-0003-1494-0151	Spanish FPU; Marie Curie Research Training Network IMMUNANOMAP; Ministry of Economy and Competitivity (DGI); Ministry of Economy and Competitivity (Consolider); "Stitching voor Fundamenteel Onderzoek der Materie" (FOM); Nederlandse Organisatie voor Wetenschappelik Onderzoek (N.W.O.); European Union	Spanish FPU(Spanish Government); Marie Curie Research Training Network IMMUNANOMAP; Ministry of Economy and Competitivity (DGI); Ministry of Economy and Competitivity (Consolider); "Stitching voor Fundamenteel Onderzoek der Materie" (FOM)(FOM (The Netherlands)); Nederlandse Organisatie voor Wetenschappelik Onderzoek (N.W.O.)(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission)	A.M.P held a Spanish FPU PhD studentship, and C.T. was supported by the Marie Curie Research Training Network IMMUNANOMAP. Research in the E.M.-B. laboratory is funded by grants of the Ministry of Economy and Competitivity (DGI and Consolider). Research in the V.S. laboratory is supported by "Stitching voor Fundamenteel Onderzoek der Materie" (FOM), the Nederlandse Organisatie voor Wetenschappelik Onderzoek (N.W.O.), and the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Canela-Xandri O, 2008, BIOPHYS J, V95, P5111, DOI 10.1529/biophysj.108.133306; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fey D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00355; GIRARD PR, 1995, J CELL PHYSIOL, V163, P179, DOI 10.1002/jcp.1041630121; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Jeschke M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003357; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Komuro I, 1996, FASEB J, V10, P631, DOI 10.1096/fasebj.10.5.8621062; Kreeger PK, 2009, CANCER RES, V69, P8191, DOI 10.1158/0008-5472.CAN-09-1921; Li SP, 2003, CANCER RES, V63, P3473; LIU M, 1992, AM J PHYSIOL, V263, pL376; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Martin-Blanco E, 1998, INT J DEV BIOL, V42, P363; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Pereira AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026182; Poh YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007886; Ren KW, 2012, CELL PHYSIOL BIOCHEM, V30, P827, DOI 10.1159/000341461; Renshaw MW, 1996, J BIOL CHEM, V271, P21691, DOI 10.1074/jbc.271.36.21691; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Shvartsman SY, 2009, FLY, V3, P62, DOI 10.4161/fly.3.1.7776; Sonna LA, 2003, PHYSIOL GENOMICS, V12, P195, DOI 10.1152/physiolgenomics.00104.2002; Stronach B, 2002, GENE DEV, V16, P377, DOI 10.1101/gad.953002; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; WILSON E, 1993, J CELL BIOL, V123, P741, DOI 10.1083/jcb.123.3.741; Xiao YQ, 2002, J BIOL CHEM, V277, P14884, DOI 10.1074/jbc.M111718200	36	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101963	10.1371/journal.pone.0101963	http://dx.doi.org/10.1371/journal.pone.0101963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025279	Green Published, Green Submitted, gold			2022-12-25	WOS:000339992400030
J	Zhu, JJ; Liu, SS; Ye, FQ; Shen, Y; Tie, Y; Zhu, J; Jin, YH; Zheng, XF; Wu, YG; Fu, HJ				Zhu, Juanjuan; Liu, Shanshan; Ye, Fuqiang; Shen, Yuan; Tie, Yi; Zhu, Jie; Jin, Yinghua; Zheng, Xiaofei; Wu, Yongge; Fu, Hanjiang			The Long Noncoding RNA Expression Profile of Hepatocellular Carcinoma Identified by Microarray Analysis	PLOS ONE			English	Article							GENE; ENHANCER; CANCER; EPIDEMIOLOGY; PROGNOSIS; DISEASE	Background: Thousands of long noncoding RNAs (lncRNAs) have been reported in mammalian genomes. These RNAs represent an important subset of pervasive genes involved in a broad range of biological functions. Aberrant expression of lncRNAs is associated with many types of cancers. Here, in order to explore the potential lncRNAs involved in hepatocellular carcinoma (HCC) oncogenesis, we performed lncRNA gene expression profile analysis in 3 pairs of human HCC and adjacent non-tumor (NT) tissues by microarray. Methodology: Differentially expressed lncRNAs and mRNAs were detected by human lncRNA microarray containing 33,045 lncRNAs and 30,215 coding transcripts. Bioinformatic analyses (gene ontology, pathway and network analysis) were applied for further study of these differentially expressed mRNAs. By qRT-PCR analysis in nineteen pairs of HCC and adjacent normal tissues, we found that eight lncRNAs were aberrantly expressed in HCC compared with adjacent NT tissues, which is consistent with microarray data. Conclusions: We identified 214 lncRNAs and 338 mRNAs abnormally expressed in all three HCC tissues (Fold Change >= 2.0, P < 0.05 and FDR < 0.05) with the genome-wide lncRNAs and mRNAs expression profile analysis. The lncRNA-mRNA co-expression network was constructed, which may be used for predicting target genes of lncRNAs. Furthermore, we demonstrated for the first time that BC017743, ENST00000395084, NR_026591, NR_015378 and NR_024284 were up-regulated, whereas NR_027151, AK056988 and uc003yqb. 1 were down-regulated in nineteen pairs of HCC samples compared with adjacent NT samples. Expression of seven lncRNAs was significantly correlated to their nearby coding genes. In conclusion, our results indicated that the lncRNA expression profile in HCC was significantly changed, and we identified a series of new hepatocarcinoma associated lncRNAs. These results provide important insights about the lncRNAs in HCC pathogenesis.	[Zhu, Juanjuan; Liu, Shanshan; Jin, Yinghua; Wu, Yongge] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Zhu, Juanjuan; Liu, Shanshan; Ye, Fuqiang; Shen, Yuan; Tie, Yi; Zhu, Jie; Zheng, Xiaofei; Fu, Hanjiang] Beijing Inst Radiat Med, Beijing, Peoples R China	Jilin University; Academy of Military Medical Sciences - China	Wu, YG (corresponding author), Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China.	ygwu@jlu.edu.cn; fuhj75@126.com		Fu, Hanjiang/0000-0002-4352-1178	Chinese State Key Projects for Basic Research [2010CB912801, 2013CB910801]; Chinese National Natural Science Foundation [31070702, 81072021, 31170713]	Chinese State Key Projects for Basic Research; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported partially by Chinese State Key Projects for Basic Research (2010CB912801, 2013CB910801), Chinese National Natural Science Foundation projects (31070702, 81072021, 31170713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Braconi C, 2011, P NATL ACAD SCI USA, V108, P786, DOI 10.1073/pnas.1011098108; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hao K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-389; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Johnson R, 2012, NEUROBIOL DIS, V46, P245, DOI 10.1016/j.nbd.2011.12.006; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kowalczyk MS, 2012, NATURE, V482, P310, DOI 10.1038/482310a; Lai MC, 2012, MED ONCOL, V29, P1810, DOI 10.1007/s12032-011-0004-z; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pan YF, 2011, CHINESE MED J-PEKING, V124, P2378, DOI 10.3760/cma.j.issn.0366-6999.2011.15.023; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Puszyk WM, 2013, LAB INVEST, V93, P983, DOI 10.1038/labinvest.2013.94; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Smith Robert J, 2013, Hepatobiliary Surg Nutr, V2, P89, DOI 10.3978/j.issn.2304-3881.2012.11.02; Song K, 2013, HEPATOLOGY, V58, P1681, DOI 10.1002/hep.26514; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042377; Yuan SX, 2012, HEPATOLOGY, V56, P2231, DOI 10.1002/hep.25895; Zhang LS, 2013, HEPATOLOGY, V57, P1919, DOI 10.1002/hep.26162	41	55	56	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101707	10.1371/journal.pone.0101707	http://dx.doi.org/10.1371/journal.pone.0101707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025236	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400020
J	De Mei, C; Ercolani, L; Parodi, C; Veronesi, M; Lo Vecchio, C; Bottegoni, G; Torrente, E; Scarpelli, R; Marotta, R; Ruffili, R; Mattioli, M; Reggiani, A; Wade, M; Grimaldi, B				De Mei, C.; Ercolani, L.; Parodi, C.; Veronesi, M.; Lo Vecchio, C.; Bottegoni, G.; Torrente, E.; Scarpelli, R.; Marotta, R.; Ruffili, R.; Mattioli, M.; Reggiani, A.; Wade, M.; Grimaldi, B.			Dual inhibition of REV-ERB beta and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells	ONCOGENE			English	Article							CIRCADIAN CLOCK; ALPHA; METABOLISM; TIME; IDENTIFICATION; SIGNATURE; BEHAVIOR; DESIGN; LIGAND	REV-ERB alpha and REV-ERB beta nuclear receptors regulate several physiological processes, including circadian rhythm and metabolism. A previous study reported the REV-ERB alpha gene to be co-overexpressed with ERBB2 in breast cancer cell lines. Surprisingly, we found that several tumor types, including a number of breast cancer cell lines, predominantly express the REV-ERB beta variant. This pattern was independent of ERBB2 and ER status, and opposite to that of non-cancer mammary epithelial HMEC cells, in which REV-ERB alpha was the major variant. Consistent with this molecular profile, REV-ERB target genes in both circadian and metabolic pathways were derepressed upon silencing of REV-ERB beta, but not REV-ERB alpha. Strikingly, we found that REV-ERB beta is a determinant of sensitivity to chloroquine, a clinically relevant lysosomotropic agent that suppresses autophagy. The cytoprotective function of REV-ERB beta appears to operate downstream of autophagy blockade. Through compound screening, we identified ARN5187, a novel lysosomotropic REV-ERB beta ligand with a dual inhibitory activity toward REV-ERB-mediated transcriptional regulation and autophagy. Remarkably, although ARN5187 and chloroquine share similar lysosomotropic potency and have a similar effect on autophagy inhibition, ARN5187 is significantly more cytotoxic. Collectively, our results reveal that dual inhibition of REV-ERB beta and autophagy is an effective strategy for eliciting cytotoxicity in cancer cells. Furthermore, our discovery of a novel inhibitor compound of both REV-ERB and autophagy may provide a scaffold for the discovery of new multifunctional anticancer agents.	[De Mei, C.; Ercolani, L.; Parodi, C.; Veronesi, M.; Lo Vecchio, C.; Bottegoni, G.; Torrente, E.; Scarpelli, R.; Reggiani, A.; Grimaldi, B.] Ist Italiano Tecnol, Dept Drug Discovery & Dev, I-16136 Genoa, Italy; [Marotta, R.; Ruffili, R.] Ist Italiano Tecnol, EM Lab, Dept Nanochem, I-16136 Genoa, Italy; [Mattioli, M.; Wade, M.] Ist Italiano Tecnol, Ctr Genom Sci IIT SEMM, Milan, Italy	Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT	Grimaldi, B (corresponding author), Ist Italiano Tecnol, Dept Drug Discovery & Dev, Via Morego 30, I-16136 Genoa, Italy.	benedetto.grimaldi@iit.it	Scarpelli, Rita/O-9422-2015; Wade, Mark/B-6719-2009; Marotta, Roberto/HGV-1599-2022; Marotta, Roberto/B-5382-2014; Mattioli, Michela/K-3951-2013; VERONESI, MARINA/A-2749-2012	Wade, Mark/0000-0002-2688-5965; Mattioli, Michela/0000-0002-1692-9178; Ercolani, Luisa/0000-0002-0418-3460; VERONESI, MARINA/0000-0001-8491-8844; Grimaldi, Benedetto/0000-0002-2589-9302; Bottegoni, Giovanni/0000-0003-1251-583X	Istituto Italiano di Tecnologia (IIT)	Istituto Italiano di Tecnologia (IIT)	We thank Professor Daniele Piomelli for helpful discussions and for revising the manuscript. We thank Dr Gennaro Colella for MCF-7, HEP-G2 and HCT-116 cell lines, and Dr Natalia Realini for providing cDNA from H-1299, HEP-G2, A-375, A-431 and HCT-116 cells. We also thank Professor Mariapia Abbracchio, Dr Ana Guijarro, Dr Andrea Contestabile and Dr Francesco Niola for discussions. Dr L Ercolani is supported by an interdepartmental post-doctoral fellowship from the Istituto Italiano di Tecnologia (IIT).	Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bertucci F, 2004, ONCOGENE, V23, P2564, DOI 10.1038/sj.onc.1207361; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Carew Jennifer S, 2012, Cancer Manag Res, V4, P357, DOI 10.2147/CMAR.S26133; Carew JS, 2011, J BIOL CHEM, V286, P6602, DOI 10.1074/jbc.M110.151324; Checinska A, 2011, PIGM CELL MELANOMA R, V24, P1116, DOI 10.1111/j.1755-148X.2011.00927.x; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Dalvit C, 2002, COMB CHEM HIGH T SCR, V5, P605, DOI 10.2174/1386207023329923; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Engelen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056623; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Grimaldi B, 2009, INT J BIOCHEM CELL B, V41, P81, DOI 10.1016/j.biocel.2008.08.035; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Hastak K, 2010, CANCER RES, V70, P7970, DOI 10.1158/0008-5472.CAN-09-4521; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hu C, 2008, BIOORGAN MED CHEM, V16, P7888, DOI 10.1016/j.bmc.2008.07.076; Kelleher FC, 2014, CANCER LETT, V342, P9, DOI 10.1016/j.canlet.2013.09.040; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Konigshoff M, 2003, CLIN CHEM, V49, P219, DOI 10.1373/49.2.219; Kourtidis A, 2010, CANCER RES, V70, P1783, DOI 10.1158/0008-5472.CAN-09-1550; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Marotta R, 2013, METHODS MOL BIOL, V1025, P179, DOI 10.1007/978-1-62703-462-3_14; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Nadanaciva S, 2011, TOXICOL IN VITRO, V25, P715, DOI 10.1016/j.tiv.2010.12.010; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Nishimura Masuhiro, 2004, Drug Metab Pharmacokinet, V19, P135, DOI 10.2133/dmpk.19.135; Ozturk N, 2009, P NATL ACAD SCI USA, V106, P2841, DOI 10.1073/pnas.0813028106; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rossetti S, 2012, CELL CYCLE, V11, P350, DOI 10.4161/cc.11.2.18792; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Savvidis C, 2012, MOL MED, V18, P1249, DOI 10.2119/molmed.2012.00077; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Tagad HD, 2011, BIOORGAN MED CHEM, V19, P5238, DOI 10.1016/j.bmc.2011.07.002; Teboul M, 2009, J APPL PHYSIOL, V107, P1965, DOI 10.1152/japplphysiol.00515.2009; Tormo D, 2009, CANCER CELL, V16, P103, DOI 10.1016/j.ccr.2009.07.004; Totrov M, 2008, CHEM BIOL DRUG DES, V71, P15, DOI 10.1111/j.1747-0285.2007.00605.x; Trump RP, 2013, J MED CHEM, V56, P4729, DOI 10.1021/jm400458q; Vulpetti A, 2012, DRUG DISCOV TODAY, V17, P890, DOI 10.1016/j.drudis.2012.03.014; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284	44	74	79	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2015	34	20					2597	2608		10.1038/onc.2014.203	http://dx.doi.org/10.1038/onc.2014.203			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI1YN	25023698	hybrid, Green Published			2022-12-25	WOS:000354541300006
J	Stiban, J; Farnum, GA; Hovde, SL; Kaguni, LS				Stiban, Johnny; Farnum, Gregory A.; Hovde, Stacy L.; Kaguni, Laurie S.			The N-terminal Domain of the Drosophila Mitochondrial Replicative DNA Helicase Contains an Iron-Sulfur Cluster and Binds DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; DNA Helicase; DNA Replication; Drosophila; Iron-Sulfur Protein; Mitochondria; Mitochondrial DNA (mtDNA)	SECONDARY STRUCTURE ANALYSES; 4FE-4S CLUSTER; PROTEIN; TWINKLE; PRIMASE; MUTATIONS; SEQUENCE; FNR; DEFECTS; REGION	Background: Despite high evolutionary conservation, the function of the N-terminal domain (NTD) of mtDNA helicase remains elusive. Results:Drosophila NTD contains an iron-sulfur cluster and binds DNA. Conclusion: The iron-sulfur cluster in mtDNA helicase enhances protein stability, and may regulate its biological functions. Significance: Discovery of an Fe-S cluster in insect mtDNA helicase presents a novel opportunity to explore species-specific relationships in the replisome. The metazoan mitochondrial DNA helicase is an integral part of the minimal mitochondrial replisome. It exhibits strong sequence homology with the bacteriophage T7 gene 4 protein primase-helicase (T7 gp4). Both proteins contain distinct N- and C-terminal domains separated by a flexible linker. The C-terminal domain catalyzes its characteristic DNA-dependent NTPase activity, and can unwind duplex DNA substrates independently of the N-terminal domain. Whereas the N-terminal domain in T7 gp4 contains a DNA primase activity, this function is lost in metazoan mtDNA helicase. Thus, although the functions of the C-terminal domain and the linker are partially understood, the role of the N-terminal region in the metazoan replicative mtDNA helicase remains elusive. Here, we show that the N-terminal domain of Drosophila melanogaster mtDNA helicase coordinates iron in a 2Fe-2S cluster that enhances protein stability in vitro. The N-terminal domain binds the cluster through conserved cysteine residues (Cys(68), Cys(71), Cys(102), and Cys(105)) that are responsible for coordinating zinc in T7 gp4. Moreover, we show that the N-terminal domain binds both single- and double-stranded DNA oligomers, with an apparent K-d of approximate to 120 nm. These findings suggest a possible role for the N-terminal domain of metazoan mtDNA helicase in recruiting and binding DNA at the replication fork.	[Stiban, Johnny; Farnum, Gregory A.; Hovde, Stacy L.; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Stiban, Johnny; Farnum, Gregory A.; Hovde, Stacy L.; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA; [Stiban, Johnny] Birzeit Univ, Dept Biol & Biochem, IL-627 West Bank, Israel	Michigan State University; Michigan State University; Birzeit University	Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	lskaguni@msu.edu	Stiban, Johnny/AAB-3468-2019; Stiban, Johnny/AAC-1515-2019	Stiban, Johnny/0000-0002-3748-9976; Farnum, Gregory/0000-0002-0192-8252	National Institutes of Health [GM45295]; office of the Vice President for academic affairs at Birzeit University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); office of the Vice President for academic affairs at Birzeit University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM45295 (to L. S. K.).; Recipient of a career development award from the office of the Vice President for academic affairs at Birzeit University.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463; Bird LE, 1997, NUCLEIC ACIDS RES, V25, P2620, DOI 10.1093/nar/25.13.2620; Chen DW, 2001, BIOCHEMISTRY-US, V40, P596, DOI 10.1021/bi002265w; Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; Ding HG, 1998, BIOCHEMISTRY-US, V37, P17280, DOI 10.1021/bi980532g; El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; Ferrer M, 2007, NATURE, V445, P91, DOI 10.1038/nature05362; Frick DN, 1999, J BIOL CHEM, V274, P35889, DOI 10.1074/jbc.274.50.35889; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; GASTEIGER EHC, 2005, PROTEOMICS PROTOCOLS, P38; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009; Huang QQ, 2008, FEBS LETT, V582, P1431, DOI 10.1016/j.febslet.2008.03.028; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; Jervis AJ, 2009, P NATL ACAD SCI USA, V106, P4659, DOI 10.1073/pnas.0804943106; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KHOROSHILOVA N, 1995, P NATL ACAD SCI USA, V92, P2499, DOI 10.1073/pnas.92.7.2499; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Kusakabe T, 1999, P NATL ACAD SCI USA, V96, P4295, DOI 10.1073/pnas.96.8.4295; Lane MD, 2004, ENCY BIOL CHEM, P482; Lee SJ, 2010, NUCLEIC ACIDS RES, V38, P4372, DOI 10.1093/nar/gkq205; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795; Makowska-Grzyska MM, 2010, METHODS, V51, P411, DOI 10.1016/j.ymeth.2010.03.005; Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200; Matsushima Y, 2009, BBA-BIOENERGETICS, V1787, P290, DOI 10.1016/j.bbabio.2008.11.005; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Rabinowitz J C, 1978, Methods Enzymol, V53, P275; Reents H, 2006, MOL MICROBIOL, V60, P1432, DOI 10.1111/j.1365-2958.2006.05198.x; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Sanchez-Martinez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043954; Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Suhasini AN, 2013, MUTAT RES-REV MUTAT, V752, P138, DOI 10.1016/j.mrrev.2012.12.004; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015; White MF, 2012, CURR OPIN STRUC BIOL, V22, P94, DOI 10.1016/j.sbi.2011.11.004; White MF, 2009, BIOCHEM SOC T, V37, P547, DOI 10.1042/BST0370547; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079; Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663	52	12	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24032	24042		10.1074/jbc.M114.587774	http://dx.doi.org/10.1074/jbc.M114.587774			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023283	hybrid, Green Published			2022-12-25	WOS:000341505600004
J	Cachay, ER; Hill, L; Wyles, D; Colwell, B; Ballard, C; Torriani, F; Mathews, WC				Cachay, Edward R.; Hill, Lucas; Wyles, David; Colwell, Bradford; Ballard, Craig; Torriani, Francesca; Mathews, William C.			The Hepatitis C Cascade of Care among HIV Infected Patients: A Call to Address Ongoing Barriers to Care	PLOS ONE			English	Article							VIRUS HCV; USE DRUGS; PEOPLE; COINFECTION; OUTPATIENT; MANAGEMENT; UPDATE	Background: The aims were to investigate the hepatitis C (HCV) cascade of care among HIV-infected patients and to identify reasons for not referring for and not initiating HCV therapy after completion of HCV treatment staging. Design and Methods: Retrospective cohort analysis of HIV-infected patients under care at the University of California, San Diego (UCSD). We identified patients screened for and diagnosed with active HCV infection. Logistic regression analyses were used to identify factors associated with lack of referral for HCV therapy. Electronic medical records were reviewed to ascertain reasons for not initiating HCV therapy. Results: Between 2008 and 2012, 4725 HIV-infected patients received care at the UCSD Owen clinic. Most patients [4534 (96%)] were screened for HCV, 748 (16%) patients had reactive serum HCV antibodies but only 542 patients had active HCV infection. Lack of engagement in care was the most important predictor of non-referral for HCV therapy [odds ratio (OR): 5.08, 95% confidence interval 3.24-6.97, p<0.00001]. Other significant predictors included unstable housing (OR: 2.26), AIDS (OR: 1.83), having a detectable HIV viral load (OR: 1.98) and being non-white (OR: 1.67). The most common reason (40%) for not initiating or deferring HCV therapy was the presence of ongoing barriers to care. Conclusions: Screening for HCV in HIV-infected patients linked to care is high but almost half of patients diagnosed with HCV are not referred for HCV therapy. Despite improvements in HCV therapy the benefits will not be realized unless effective measures for dealing with barriers to care are implemented.	[Cachay, Edward R.; Wyles, David; Torriani, Francesca; Mathews, William C.] Univ Calif San Diego, Dept Med, Owen Clin, San Diego, CA 92103 USA; [Cachay, Edward R.; Wyles, David; Torriani, Francesca] Univ Calif San Diego, Dept Med, Div Infect Dis, San Diego, CA 92103 USA; [Hill, Lucas; Colwell, Bradford; Ballard, Craig] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Cachay, ER (corresponding author), Univ Calif San Diego, Dept Med, Owen Clin, San Diego, CA 92103 USA.	ecachay@ucsd.edu	Trajman, Anete/C-7679-2016; Mathews, William C/E-4451-2010; Torriani, Francesca/HGE-5175-2022	Trajman, Anete/0000-0002-4000-4984; Mathews, William C/0000-0002-2352-0725; 	Clinical Investigation Core of the University of California San Diego Center for AIDS Research [AI036214]; CFAR Network of Integrated Clinical Systems (CNICS) [R24 AI067039-01A1]; Pacific AIDS Education and Training Center (PAETC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, R24AI067039] Funding Source: NIH RePORTER	Clinical Investigation Core of the University of California San Diego Center for AIDS Research; CFAR Network of Integrated Clinical Systems (CNICS); Pacific AIDS Education and Training Center (PAETC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Clinical Investigation Core of the University of California San Diego Center for AIDS Research [AI036214], the CFAR Network of Integrated Clinical Systems (CNICS) [R24 AI067039-01A1], and the Pacific AIDS Education and Training Center (PAETC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Adeyemi OM ES, 2014, 21 C RETR OPP INF BO; Astell-Burt T, 2012, SOC SCI MED, V75, P240, DOI 10.1016/j.socscimed.2012.02.046; Barreiro P, 2014, ANTIVIR RES, V105, P1, DOI 10.1016/j.antiviral.2014.02.004; Brener L, 2013, SEX HEALTH, V10, P268, DOI 10.1071/SH12179; Cachay ER, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-9; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Freimman JM, 2014, CLIN INFEC IN PRESS; Grebely J, 2013, J INFECT DIS, V207, pS19, DOI 10.1093/infdis/jis928; Grint D, 2013, HIV MED, V14, P614, DOI 10.1111/hiv.12068; Haubitz S SV, 2014, 21 C RETR OPP INF BO; Higgs P, 2011, HEPAT MON, V11, P513; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Kresina TF, 2005, CLIN INFECT DIS, V41, pS83, DOI 10.1086/429502; Lekas HM, 2012, QUAL HEALTH RES, V22, P54, DOI 10.1177/1049732311418248; Meyer JP, 2013, CLIN INFECT DIS, V57, P1309, DOI 10.1093/cid/cit427; Meyer PA, 2013, MMWR-MORBID MORTAL W, V62, P184; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Norton BL, 2012, AIDS PATIENT CARE ST, V26, P541, DOI 10.1089/apc.2012.0170; Olsen Y, 2014, JAMA-J AM MED ASSOC, V311, P1393, DOI 10.1001/jama.2014.2147; Osborn CY, 2007, AM J PREV MED, V33, P374, DOI 10.1016/j.amepre.2007.07.022; Scott JD, 2009, AIDS PATIENT CARE ST, V23, P925, DOI 10.1089/apc.2009.0099; Soriano V, 2013, CURR HIV-AIDS REP, V10, P226, DOI 10.1007/s11904-013-0169-5; Stepanova M, 2011, HEPATOLOGY, V53, P737, DOI 10.1002/hep.24131; Taylor LE, 2013, CLIN INFECT DIS, V57, pS118, DOI 10.1093/cid/cit326; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; Vellozzi C, 2011, J VIRAL HEPATITIS, V18, P316, DOI 10.1111/j.1365-2893.2010.01299.x; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918	28	50	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102883	10.1371/journal.pone.0102883	http://dx.doi.org/10.1371/journal.pone.0102883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036553	Green Published, gold			2022-12-25	WOS:000339615200091
J	Gao, YH; Guan, WJ; Xu, G; Lin, ZY; Tang, Y; Lin, ZM; Li, HM; Gao, Y; Luo, Q; Zhong, NS; Chen, RC				Gao, Yonghua; Guan, Weijie; Xu, Gang; Lin, Zhiya; Tang, Yan; Lin, Zhimin; Li, Huimin; Gao, Yang; Luo, Qun; Zhong, Nanshan; Chen, Rongchang			Sleep Disturbances and Health-Related Quality of Life in Adults with Steady-State Bronchiectasis	PLOS ONE			English	Article							CHINESE VERSION; RESPIRATORY QUESTIONNAIRE; DAYTIME SLEEPINESS; HOSPITAL ANXIETY; VALIDATION; DEPRESSION; COMPLAINTS; SYMPTOMS; COUGH; INDEX	Background: Sleep disturbances are common in patients with chronic lung diseases, but little is known about the prevalence in patients with bronchiectasis. A cross sectional study was conducted to investigate the prevalence and determinants associated with sleep disturbances, and the correlation between sleep disturbances and quality of life (QoL) in adults with steady-state bronchiectasis. Methods: One hundred and forty-four bronchiectasis patients and eighty healthy subjects were enrolled. Sleep disturbances, daytime sleepiness, and QoL were measured by utilizing the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS) and St. George Respiratory Questionnaire (SGRQ), respectively. Demographic, clinical indices, radiology, spirometry, bacteriology, anxiety and depression were also assessed. Results: Adults with steady-state bronchiectasis had a higher prevalence of sleep disturbances (PSQI>5) (57% vs. 29%, P<0.001), but not daytime sleepiness (ESS >= 10) (32% vs. 30%, P = 0.76), compared with healthy subjects. In the multivariate model, determinants associated with sleep disturbances in bronchiectasis patients included depression (OR, 10.09; 95% CI, 3.46-29.37; P<0.001), nocturnal cough (OR, 1.89; 95% CI, 1.13-3.18; P = 0.016), aging (OR, 1.04; 95% CI, 1.01-1.07; P = 0.009) and increased 24-hour sputum volume (OR, 2.01; 95% CI, 1.22-3.33; P = 0.006). Patients with sleep disturbances had more significantly impaired QoL affecting all domains than those without. Only 6.2% of patients reported using a sleep medication at least weekly. Conclusions: In adults with steady-state bronchiectasis, sleep disturbances are more common than in healthy subjects and are related to poorer QoL. Determinants associated with sleep disturbances include depression, aging, nighttime cough and increased sputum volume. Assessment and intervention of sleep disturbances are warranted and may improve QoL.	[Gao, Yonghua; Guan, Weijie; Xu, Gang; Lin, Zhiya; Tang, Yan; Lin, Zhimin; Li, Huimin; Gao, Yang; Luo, Qun; Zhong, Nanshan; Chen, Rongchang] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Chen, RC (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	ChenRC@vip.163.com	Guan, Wei-jie/K-8257-2019		Changjiang Scholars and Innovative Research Team in University [ITR0961]	Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The work was supported by Changjiang Scholars and Innovative Research Team in University ITR0961 (Dr. N. Zhong and R. Chen), which was endowed by the Ministry of Health, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER AF, 1988, AM REV RESPIR DIS, V137, P969, DOI 10.1164/ajrccm/137.4.969; Batal O, 2011, LUNG, V189, P141, DOI 10.1007/s00408-010-9277-9; Bouka A, 2012, RESP MED, V106, P1244, DOI 10.1016/j.rmed.2012.06.010; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chan KKY, 2010, EUR RESPIR J, V35, P368, DOI 10.1183/09031936.00110409; Chan SL, 2002, CHEST, V122, P2030, DOI 10.1378/chest.122.6.2030; Chen NH, 2002, QUAL LIFE RES, V11, P817, DOI 10.1023/A:1020818417949; Da Costa D, 2005, ARTHRIT RHEUM-ARTHR, V53, P272, DOI 10.1002/art.21069; De Soyza A, 2013, THORAX, V68, P695, DOI 10.1136/thoraxjnl-2012-202893; Erdem E, 2011, PEDIATR PULM, V46, P919, DOI 10.1002/ppul.21454; Fokkens W, 2007, RHINOLOGY, V45, P97; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Havlikova E, 2011, J NEUROL, V258, P2222, DOI 10.1007/s00415-011-6098-6; HSU JY, 1994, EUR RESPIR J, V7, P1246, DOI 10.1183/09031936.94.07071246; Jankelowitz L, 2005, CHEST, V127, P1593, DOI 10.1378/chest.127.5.1593; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; King PT, 2006, RESP MED, V100, P2183, DOI 10.1016/j.rmed.2006.03.012; KLINK ME, 1994, CHEST, V105, P151, DOI 10.1378/chest.105.1.151; Krishnan V, 2008, CHEST, V134, P693, DOI 10.1378/chest.08-0173; Leung CM, 1999, ACTA PSYCHIAT SCAND, V100, P456, DOI 10.1111/j.1600-0447.1999.tb10897.x; Lindberg E, 1997, SLEEP, V20, P381, DOI 10.1093/sleep/20.6.381; Maggi S, 1998, J AM GERIATR SOC, V46, P161, DOI 10.1111/j.1532-5415.1998.tb02533.x; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Martinez-Garcia MA, 2005, CHEST, V128, P739, DOI 10.1378/chest.128.2.739; Milross Maree A, 2002, Sleep Med, V3, P205, DOI 10.1016/S1389-9457(01)00157-5; Nunes DM, 2009, LUNG, V187, P159, DOI 10.1007/s00408-009-9147-5; O'Leary CJ, 2002, RESP MED, V96, P686, DOI 10.1053/rmed.2002.1330; Olveira C, 2013, QUAL LIFE RES, V22, P597, DOI 10.1007/s11136-012-0188-5; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Scharf SM, 2011, INT J CHRONIC OBSTR, V6, P1, DOI 10.2147/COPD.S15666; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Tsang KW, 2009, RESPIROLOGY, V14, P637, DOI 10.1111/j.1440-1843.2009.01569.x; Wilson CB, 1997, AM J RESP CRIT CARE, V156, P536, DOI 10.1164/ajrccm.156.2.9607083; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102970	10.1371/journal.pone.0102970	http://dx.doi.org/10.1371/journal.pone.0102970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036723	gold, Green Published, Green Submitted			2022-12-25	WOS:000339615200105
J	Ibrahim, OMA; Dogru, M; Matsumoto, Y; Igarashi, A; Kojima, T; Wakamatsu, TH; Inaba, T; Shimizu, T; Shimazaki, J; Tsubota, K				Ibrahim, Osama M. A.; Dogru, Murat; Matsumoto, Yukihiro; Igarashi, Ayako; Kojima, Takashi; Wakamatsu, Tais Hitomi; Inaba, Takaaki; Shimizu, Takahiko; Shimazaki, Jun; Tsubota, Kazuo			Oxidative Stress Induced Age Dependent Meibomian Gland Dysfunction in Cu, Zn-Superoxide Dismutase-1 (Sod1) Knockout Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DRY EYE DISEASE; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; SJOGRENS-SYNDROME; LACRIMAL GLAND; MUSCLE ATROPHY; CYTOCHROME-C; MITOCHONDRIAL; DAMAGE	Purpose: The purpose of our study was to investigate alterations in the meibomian gland (MG) in Cu, Zn-Superoxide Dismutase-1 knockout (Sod1(-/-)) mouse. Methods: Tear function tests [Break up time (BUT) and cotton thread] and ocular vital staining test were performed on Sod1(-/-) male mice (n = 24) aged 10 and 50 weeks, and age and sex matched wild-type (+/+) mice (n = 25). Tear and serum samples were collected at sacrifice for inflammatory cytokine assays. MG specimens underwent Hematoxylin and Eosin staining, Mallory staining for fibrosis, Oil Red O lipid staining, TUNEL staining, immunohistochemistry stainings for 4HNE, 8-OHdG and CD45. Transmission electron microscopic examination (TEM) was also performed. Results: Corneal vital staining scores in the Sod1(-/-) mice were significantly higher compared with the wild type mice throughout the follow-up. Tear and serum IL-6 and TNF-alpha levels also showed significant elevations in the 10 to 50 week Sod1(-/-) mice. Oil Red O staining showed an accumulation of large lipid droplets in the Sod1(-/-) mice at 50 weeks. Immunohistochemistry revealed both increased TUNEL and oxidative stress marker stainings of the MG acinar epithelium in the Sod1(-/-) mice compared to the wild type mice. Immunohistochemistry staining for CD45 showed increasing inflammatory cell infiltrates from 10 to 50 weeks in the Sod1(-/-) mice compared to the wild type mice. TEM revealed prominent mitochondrial changes in 50 week Sod1(-/-) mice. Conclusions: Our results suggest that reactive oxygen species might play a vital role in the pathogensis of meibomian gland dysfunction. The Sod1(-/-) mouse appears to be a promising model for the study of reactive oxygen species associated MG alterations.	[Ibrahim, Osama M. A.; Dogru, Murat; Matsumoto, Yukihiro; Kojima, Takashi; Wakamatsu, Tais Hitomi; Inaba, Takaaki; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Dogru, Murat; Igarashi, Ayako; Shimizu, Takahiko] Tokyo Dent Coll, Dept Ophthalmol, Chiba, Japan; [Shimizu, Takahiko] Chiba Univ, Grad Sch Med, Dept Adv Aging Med, Chiba, Japan	Keio University; Tokyo Dental College; Chiba University	Dogru, M (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	muratodooru2012@yahoo.com	Wakamatsu, Tais/E-9300-2012; Jun, Shimazaki/K-5976-2019		Japan Society for the Promotion of Science [22791694]; Johnson and Johnson Vision Care Company	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Johnson and Johnson Vision Care Company	This work was supported by funds from Japan Society for the Promotion of Science (Grant No. 22791694) (http://www.jsps.go.jp/english/e-grants/) and Johnson and Johnson Vision Care Company (http://www.jnj.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIO JL, 1995, CORNEA, V14, P175; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395; BHUYAN KC, 1986, LIFE SCI, V38, P1463, DOI 10.1016/0024-3205(86)90559-X; Bruunsgaard H, 2003, CLIN EXP IMMUNOL, V132, P24, DOI 10.1046/j.1365-2249.2003.02137.x; Bruunsgaard H, 2004, J AM GERIATR SOC, V52, P1361, DOI 10.1111/j.1532-5415.2004.52369.x; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Chong ZZ, 2010, OXID MED CELL LONGEV, V3, P153, DOI 10.4161/oxim.3.2.11758; Chwa M, 2006, INVEST OPHTH VIS SCI, V47, P1902, DOI 10.1167/iovs.05-0828; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; Dahl M, 2007, J CLIN INVEST, V117, P757, DOI 10.1172/JCI29968; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Den S, 2006, CORNEA, V25, P651, DOI 10.1097/01.ico.0000227889.11500.6f; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Dotti G, 2001, EXP HEMATOL, V29, P952, DOI 10.1016/S0301-472X(01)00668-3; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FOX RI, 1994, J IMMUNOL, V152, P5532; Fubini B, 2003, FREE RADICAL BIO MED, V34, P1507, DOI 10.1016/S0891-5849(03)00149-7; Fujimura M, 2000, J NEUROSCI, V20, P2817; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; GRITZ DC, 1991, CURR EYE RES, V10, P927, DOI 10.3109/02713689109020328; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; HOM MM, 1990, OPTOMETRY VISION SCI, V67, P710, DOI 10.1097/00006324-199009000-00010; HYKIN PG, 1992, CORNEA, V11, P334, DOI 10.1097/00003226-199207000-00012; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Jenny NS, 2002, ARTERIOSCL THROM VAS, V22, P2066, DOI 10.1161/01.ATV.0000040224.49362.60; JESTER JV, 1989, INVEST OPHTH VIS SCI, V30, P927; Kim GW, 2003, J NEUROSCI, V23, P8733; Kojima T, 2012, AM J PATHOL, V180, P1879, DOI 10.1016/j.ajpath.2012.01.019; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kuwahara H, 2010, FREE RADICAL BIO MED, V48, P1252, DOI 10.1016/j.freeradbiomed.2010.02.011; Li Q, 2009, MOL CELL BIOCHEM, V322, P151, DOI 10.1007/s11010-008-9952-9; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Murakami K, 2009, BIOCHEM BIOPH RES CO, V382, P457, DOI 10.1016/j.bbrc.2009.03.053; Narayanan S, 2006, INVEST OPHTH VIS SCI, V47, P2445, DOI 10.1167/iovs.05-1364; Nava F, 2001, NEUROSCI LETT, V307, P57, DOI 10.1016/S0304-3940(01)01930-9; Nien CJ, 2011, ARCH OPHTHALMOL-CHIC, V129, P462, DOI 10.1001/archophthalmol.2011.69; Nien CJ, 2009, EXP EYE RES, V89, P1021, DOI 10.1016/j.exer.2009.08.013; Noda Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092999; Nojiri H, 2006, J BIOL CHEM, V281, P33789, DOI 10.1074/jbc.M602118200; Nojiri H, 2011, J BONE MINER RES, V26, P2682, DOI 10.1002/jbmr.489; Nunomura A, 1999, J NEUROSCI, V19, P1959; Obata H, 2002, CORNEA, V21, pS70, DOI 10.1097/01.ico.0000263122.45898.09; OHNISHI Y, 1979, INVEST OPHTH VIS SCI, V18, P981; Pavlides S, 2010, CELL CYCLE, V9, P3485, DOI 10.4161/cc.9.17.12721; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; PULIDO R, 1988, J IMMUNOL, V140, P3851; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rodriguez-Iturbe B, 2003, HYPERTENSION, V41, P341, DOI 10.1161/01.HYP.0000052833.20759.64; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Stern Michael E, 2004, Ocul Surf, V2, P124; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Sullivan BD, 2006, ARCH OPHTHALMOL-CHIC, V124, P1286, DOI 10.1001/archopht.124.9.1286; Tishler M, 1998, OPHTHALMOLOGY, V105, P2327, DOI 10.1016/S0161-6420(98)91236-2; TOYOKUNI S, 1995, FEBS LETT, V359, P189, DOI 10.1016/0014-5793(95)00033-6; Toyokuni S, 1997, LAB INVEST, V76, P365; Tsubota K, 2010, OPHTHALMIC RES, V44, P146, DOI 10.1159/000316594; Uchino M, 2006, OPTOMETRY VISION SCI, V83, P797, DOI 10.1097/01.opx.0000232814.39651.fa; Uchiyama S, 2006, J BIOL CHEM, V281, P31713, DOI 10.1074/jbc.M603422200; WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Ying W, 2010, CURR MED CHEM, V17, P2152, DOI 10.2174/092986710791299911; Zoukhri D, 2006, EXP EYE RES, V82, P885, DOI 10.1016/j.exer.2005.10.018	71	46	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e99328	10.1371/journal.pone.0099328	http://dx.doi.org/10.1371/journal.pone.0099328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036096	Green Submitted, Green Published, gold			2022-12-25	WOS:000339615200004
J	Kant, R; Rintahaka, J; Yu, X; Sigvart-Mattila, P; Paulin, L; Mecklin, JP; Saarela, M; Palva, A; von Ossowski, I				Kant, Ravi; Rintahaka, Johanna; Yu, Xia; Sigvart-Mattila, Pia; Paulin, Lars; Mecklin, Jukka-Pekka; Saarela, Maria; Palva, Airi; von Ossowski, Ingemar			A Comparative Pan-Genome Perspective of Niche-Adaptable Cell-Surface Protein Phenotypes in Lactobacillus rhamnosus	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; FUNCTIONAL-ANALYSIS; GASTROINTESTINAL-TRACT; ADHESION PROPERTIES; PROBIOTIC BACTERIA; SOLUBLE-PROTEIN; GG; CASEI; STRAINS; HEALTH	Lactobacillus rhamnosus is a ubiquitously adaptable Gram-positive bacterium and as a typical commensal can be recovered from various microbe-accessible bodily orifices and cavities. Then again, other isolates are food-borne, with some of these having been long associated with naturally fermented cheeses and yogurts. Additionally, because of perceived health benefits to humans and animals, numerous L. rhamnosus strains have been selected for use as so-called probiotics and are often taken in the form of dietary supplements and functional foods. At the genome level, it is anticipated that certain genetic variances will have provided the niche-related phenotypes that augment the flexible adaptiveness of this species, thus enabling its strains to grow and survive in their respective host environments. For this present study, we considered it functionally informative to examine and catalogue the genotype-phenotype variation existing at the cell surface between different L. rhamnosus strains, with the presumption that this might be relatable to habitat preferences and ecological adaptability. Here, we conducted a pan-genomic study involving 13 genomes from L. rhamnosus isolates with various origins. In using a benchmark strain (gut-adapted L. rhamnosus GG) for our pan-genome comparison, we had focused our efforts on a detailed examination and description of gene products for certain functionally relevant surface-exposed proteins, each of which in effect might also play a part in niche adaptability among the other strains. Perhaps most significantly of the surface protein loci we had analyzed, it would appear that the spaCBA operon (known to encode SpaCBA-called pili having a mucoadhesive phenotype) is a genomic rarity and an uncommon occurrence in L. rhamnosus. However, for any of the so-piliated L. rhamnosus strains, they will likely possess an increased niche-specific fitness, which functionally might presumably be manifested by a protracted transient colonization of the gut mucosa or some similar microhabitat.	[Kant, Ravi; Rintahaka, Johanna; Yu, Xia; Palva, Airi; von Ossowski, Ingemar] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland; [Sigvart-Mattila, Pia] MTT Agrifood Res Finland, Jokioinen, Finland; [Paulin, Lars] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Mecklin, Jukka-Pekka] Univ Eastern Finland, Jyvaskyla Cent Hosp, Dept Surg, Jyvaskyla, Finland; [Mecklin, Jukka-Pekka] Univ Eastern Finland, Inst Clin Med, Jyvaskyla, Finland; [Saarela, Maria] VTT Tech Res Ctr Finland, Espoo, Finland	University of Helsinki; Natural Resources Institute Finland (Luke); University of Helsinki; Central Finland Central Hospital; University of Eastern Finland; University of Eastern Finland; VTT Technical Research Center Finland	Palva, A (corresponding author), Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland.	airi.palva@helsinki.fi; ingemar.von.ossowski@helsinki.fi	Mecklin, Jukka-Pekka/AAB-5378-2020; Mecklin, Jukka-Pekka/AAC-9650-2019; Kant, Ravi/AAF-8495-2021; Saarela, Maria/AAY-5918-2020	Mecklin, Jukka-Pekka/0000-0003-4895-2249; Kant, Ravi/0000-0003-3878-9775; Saarela, Maria/0000-0001-8842-7292; von Ossowski, Ingemar Eric/0000-0002-9899-671X	Academy of Finland-funded Center of Excellence in Microbial Food Safety (CoE-MiFoSa) research program [141140]; University of Helsinki Applied Bioscience (ABS) Graduate School	Academy of Finland-funded Center of Excellence in Microbial Food Safety (CoE-MiFoSa) research program; University of Helsinki Applied Bioscience (ABS) Graduate School	Financial support for this study was through the Academy of Finland-funded Center of Excellence in Microbial Food Safety (CoE-MiFoSa) research program (Grant No. 141140) (http://www.aka.fi). The University of Helsinki Applied Bioscience (ABS) Graduate School (http://www.vetmed.helsinki.fi/abs/index.htm) provided additional salary funding to Ravi Kant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne S, 2005, MICROBES INFECT, V7, P1256, DOI 10.1016/j.micinf.2005.04.011; Alander M, 1999, APPL ENVIRON MICROB, V65, P351; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bauerl C, 2010, J MOL MICROB BIOTECH, V19, P231, DOI 10.1159/000322233; Bernardeau M, 2008, INT J FOOD MICROBIOL, V126, P278, DOI 10.1016/j.ijfoodmicro.2007.08.015; Black BF, 1998, SCI BREASTFEEDING, V3; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Bron PA, 2013, CURR OPIN MICROBIOL, V16, P262, DOI 10.1016/j.mib.2013.06.001; Chen ZL, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00073-12; Claes IJJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-161; Claes IJJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031588; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dicks LMT, 2010, BENEF MICROBES, V1, P11, DOI 10.3920/BM2009.0012; Douillard FP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003683; Douillard FP, 2013, APPL ENVIRON MICROB, V79, P1923, DOI 10.1128/AEM.03467-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gorbach SL, 2000, AM J GASTROENTEROL, V95, pS2, DOI 10.1016/S0002-9270(99)00806-0; Haakensen M, 2009, INT J FOOD MICROBIOL, V130, P56, DOI 10.1016/j.ijfoodmicro.2009.01.001; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kant R, 2011, MICROB BIOTECHNOL, V4, P323, DOI 10.1111/j.1751-7915.2010.00215.x; Kontula P, 1999, J DAIRY SCI, V82, P249, DOI 10.3168/jds.S0022-0302(99)75230-6; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lebeer S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-15; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Lebeer S, 2011, MICROB BIOTECHNOL, V4, P368, DOI 10.1111/j.1751-7915.2010.00199.x; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Manganelli R, 1999, INFECT IMMUN, V67, P50, DOI 10.1128/IAI.67.1.50-56.1999; Martin R, 2007, J APPL MICROBIOL, V103, P2638, DOI 10.1111/j.1365-2672.2007.03497.x; Morita H, 2009, J BACTERIOL, V191, P7630, DOI 10.1128/JB.01287-09; Munoz-Provencio D, 2010, J APPL MICROBIOL, V108, P1050, DOI 10.1111/j.1365-2672.2009.04508.x; Nava GM, 2011, GUT MICROBES, V2, P99, DOI 10.4161/gmic.2.2.15416; Newburg DS, 2013, BIOCHEMISTRY-MOSCOW+, V78, P771, DOI 10.1134/S0006297913070092; Ouwehand AC, 2001, INT J FOOD MICROBIOL, V64, P119, DOI 10.1016/S0168-1605(00)00440-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pittet V, 2012, J BACTERIOL, V194, P726, DOI 10.1128/JB.06430-11; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Saarela M, 2002, INT J FOOD MICROBIOL, V78, P99, DOI 10.1016/S0168-1605(02)00235-0; Saarela M, 2000, J BIOTECHNOL, V84, P197, DOI 10.1016/S0168-1656(00)00375-8; Salminen S, 2010, CURR OPIN BIOTECH, V21, P157, DOI 10.1016/j.copbio.2010.03.016; Sengupta R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/237921; Smokvina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068731; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P3189, DOI 10.1128/AEM.70.6.3189-3194.2004; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Toh HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075073, 10.1371/journal.pone.0064989]; Tompkins TA, 2012, J BACTERIOL, V194, P902, DOI 10.1128/JB.06584-11; Tripathi P, 2013, ACS NANO, V7, P3685, DOI 10.1021/nn400705u; Tuomola EM, 2000, INT J FOOD MICROBIOL, V60, P75, DOI 10.1016/S0168-1605(00)00319-6; Vancanneyt M, 2006, APPL ENVIRON MICROB, V72, P5376, DOI 10.1128/AEM.00091-06; Velez MP, 2010, FEMS IMMUNOL MED MIC, V59, P386, DOI 10.1111/j.1574-695X.2010.00680.x; von Ossowski I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064416; von Ossowski I, 2011, APPL ENVIRON MICROB, V77, P4465, DOI 10.1128/AEM.02497-10; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; Walter J, 2005, PROBIOTICS AND PREBIOTICS: SCIENTIFIC ASPECTS, P51; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Yan F, 2002, J BIOL CHEM, V277, P50959, DOI 10.1074/jbc.M207050200; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2013, J BIOL CHEM, V288, P30742, DOI 10.1074/jbc.M113.492397; Yan F, 2012, GUT MICROBES, V3, P25, DOI 10.4161/gmic.19245; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004	70	38	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102762	10.1371/journal.pone.0102762	http://dx.doi.org/10.1371/journal.pone.0102762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032833	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300088
J	Pittet, F; Houdelier, C; Le Bot, O; Leterrier, C; Lumineau, S				Pittet, Florent; Houdelier, Cecilia; Le Bot, Oceane; Leterrier, Christine; Lumineau, Sophie			Fearfulness Affects Quail Maternal Care and Subsequent Offspring Development	PLOS ONE			English	Article							COTURNIX-COTURNIX-JAPONICA; SOCIAL REINSTATEMENT BEHAVIOR; JAPANESE-QUAIL; TONIC IMMOBILITY; EMOTIONAL REACTIVITY; INDIVIDUAL-DIFFERENCES; PRECOCIAL BIRD; GENE-EXPRESSION; RHESUS MACAQUES; DOMESTIC QUAIL	Our study investigated relationships between a precocial bird's fearfulness and maternal care, and the implication of maternal care as a vector for non-genomic transmission of fearfulness to chicks. We compared care given to chicks between two sets of female Japanese quail selected to present either high (LTI) or low fearfulness (STI). Chicks, from a broiler line, were adopted by these females following a sensitization procedure. Chicks' fearfulness after separation from their mother was assessed by well-established procedures. LTIs took longer to present maternal responses, pecked chicks more during the first days post-hatch, presented impaired maternal vocal behaviour and were globally less active than STI females. Chicks mothered by LTIs presented more fearful reactions than did chicks mothered by STIs, supporting the hypothesis of a non-genetic maternal transmission of fearfulness. We suggest that the longer latencies required by LTIs to become maternal are a consequence of their greater fear of chicks, and that their lower general and vocal activity could be components of a heightened antipredatory strategy. We discuss the transmission of maternal fearfulness to fostered chicks, taking into account the possible implication of several well-known mechanisms underlying maternal effects.	[Pittet, Florent; Houdelier, Cecilia; Le Bot, Oceane; Lumineau, Sophie] Univ Rennes 1, CNRS, Unite Mixte Rech Ethos 6552, Rennes, France; [Leterrier, Christine] INRA, Unite Mixte Rech Physiol Reprod & Comportements 8, F-37380 Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; INRAE	Lumineau, S (corresponding author), Univ Rennes 1, CNRS, Unite Mixte Rech Ethos 6552, Rennes, France.	sophie.lumineau@univ-rennes1.fr	Pittet, Florent/Q-2100-2015; Leterrier, Christine/AAY-7201-2020	Lumineau, Sophie/0000-0002-2076-9947				Ainsworth M., 1978, PATTERNS ATTACHMENT; AINSWORTH MDS, 1991, AM PSYCHOL, V46, P333, DOI 10.1037/0003-066X.46.4.333; Archer J, 1976, PERSPECTIVES ETHOLOG, P231; Bertin A, 2005, J EXP ZOOL PART A, V303A, P792, DOI 10.1002/jez.a.202; Boissy A, 1995, APPL ANIM BEHAV SCI, V46, P17, DOI 10.1016/0168-1591(95)00633-8; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Bredy TW, 2003, EUR J NEUROSCI, V18, P2903, DOI 10.1111/j.1460-9568.2003.02965.x; Calatayud F, 2001, PHYSIOL BEHAV, V74, P355, DOI 10.1016/S0031-9384(01)00566-2; Caldji C, 2004, NEUROPSYCHOPHARMACOL, V29, P1344, DOI 10.1038/sj.npp.1300436; Calkins SD, 1999, SOC DEV, V8, P310, DOI 10.1111/1467-9507.00098; Champagne F, 2001, Prog Brain Res, V133, P287; Cook CJ, 1999, PHYSIOL BEHAV, V67, P803, DOI 10.1016/S0031-9384(99)00107-9; COOK M, 1989, J ABNORM PSYCHOL, V98, P448, DOI 10.1037/0021-843X.98.4.448; DAVIS SR, 1979, J DAIRY RES, V46, P613, DOI 10.1017/S0022029900020677; de Margerie E, 2013, DEV PSYCHOBIOL, V55, P256, DOI 10.1002/dev.21019; Dwyer CM, 2008, SMALL RUMINANT RES, V76, P31, DOI 10.1016/j.smallrumres.2007.12.011; Feenders G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019074; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Gerull FC, 2002, BEHAV RES THER, V40, P279, DOI 10.1016/S0005-7967(01)00013-4; Grandinson K, 2005, LIVEST PROD SCI, V93, P43, DOI 10.1016/j.livprodsci.2004.11.005; Harlow H. F., 1969, DETERMINANTS INFANT, V4, P15; HARLOW HF, 1971, P NATL ACAD SCI USA, V68, P1534, DOI 10.1073/pnas.68.7.1534; Harris MJ, 2003, CAN J ANIM SCI, V83, P435, DOI 10.4141/A02-001; Hazard D, 2008, GEN COMP ENDOCR, V155, P288, DOI 10.1016/j.ygcen.2007.05.009; Hazard D, 2008, HORM BEHAV, V54, P645, DOI 10.1016/j.yhbeh.2008.07.002; Hinde K., 2013, BUILDING BABIES PRIM, P187; Houdelier C., 2013, NONGENETIC INHERITAN, V1, DOI [10.2478/ngi-2013-0007, DOI 10.2478/NGI-2013-0007]; Houdelier C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014604; JONES RB, 1991, J COMP PSYCHOL, V105, P15, DOI 10.1037/0735-7036.105.1.15; JONES RB, 1986, WORLD POULTRY SCI J, V42, P82, DOI 10.1079/WPS19860008; JONES RB, 1987, COGNITIVE ASPECTS SO, P40; Kikusui T, 2005, BEHAV BRAIN RES, V162, P200, DOI 10.1016/j.bbr.2005.03.013; LAUNAY F, 1993, BEHAV PROCESS, V29, P1, DOI 10.1016/0376-6357(93)90023-K; LICKLITER R, 1992, Developmental Psychobiology, V25, P17, DOI 10.1002/dev.420250103; Lindqvist C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000364; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; MAESTRIPIERI D, 1993, ETHOLOGY, V95, P32; Maestripieri D, 2007, DEV PSYCHOBIOL, V49, P165, DOI 10.1002/dev.20200; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Mills AD, 1997, NEUROSCI BIOBEHAV R, V21, P261, DOI 10.1016/S0149-7634(96)00028-0; MILLS AD, 1986, BIOL BEHAV, V11, P235; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; MILLS AD, 1993, PHYSIOL BEHAV, V53, P183, DOI 10.1016/0031-9384(93)90029-F; Mills AD, 2000, APPL ANIM BEHAV SCI, V69, P125, DOI 10.1016/S0168-1591(00)00126-X; MURPHY LB, 1978, ANIM BEHAV, V26, P422, DOI 10.1016/0003-3472(78)90059-3; Murphy P., 1998, P 32 C INT SOC APPL; Nowak R, 2011, J NEUROENDOCRINOL, V23, P1042, DOI 10.1111/j.1365-2826.2011.02205.x; Numan M, 2009, FRONT NEUROENDOCRIN, V30, P46, DOI 10.1016/j.yfrne.2008.10.002; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; ORCUTT FS, 1976, AUK, V93, P135; Pittet F, 2014, J EXP ZOOL PART A, V321, P265, DOI 10.1002/jez.1858; Pittet F, 2014, DEV PSYCHOBIOL, V56, P622, DOI 10.1002/dev.21129; Pittet F, 2014, ANIM BEHAV, V87, P31, DOI 10.1016/j.anbehav.2013.10.025; Pittet F, 2013, ANIM BEHAV, V85, P797, DOI 10.1016/j.anbehav.2013.01.026; Pittet F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036835; Plush KJ, 2011, APPL ANIM BEHAV SCI, V134, P130, DOI 10.1016/j.applanim.2011.07.009; PUGESEK BH, 1990, BEHAV ECOL SOCIOBIOL, V27, P211; Rehling A, 2008, ANIM BEHAV, V75, P1455, DOI 10.1016/j.anbehav.2007.09.019; Richard S, 2008, PROD ANIM, V21, P71; Richard S, 2010, BEHAV PROCESS, V85, P18, DOI 10.1016/j.beproc.2010.05.009; Richard-Yris M. A., 1994, COMPORTEMENT ADAPTAT, P61; Richard-Yris MA, 2005, DEV PSYCHOBIOL, V46, P1, DOI 10.1002/dev.20040; Saint-Dizier H, 2008, APPL ANIM BEHAV SCI, V112, P297, DOI 10.1016/j.applanim.2007.09.005; SEEGAL RF, 1974, PHYSIOL BEHAV, V13, P339, DOI 10.1016/0031-9384(74)90056-0; TENCATE C, 1989, ETHOLOGY, V82, P287; van der Staay FJ, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-50; Warren SL, 1997, J AM ACAD CHILD PSY, V36, P637, DOI 10.1097/00004583-199705000-00014; Zeanah CH, 2003, ANN NY ACAD SCI, V1008, P22, DOI 10.1196/annals.1301.003	68	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102800	10.1371/journal.pone.0102800	http://dx.doi.org/10.1371/journal.pone.0102800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033292	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300092
J	Teirila, L; Karvala, K; Ahonen, N; Riska, H; Pietinalho, A; Tuominen, P; Piirila, P; Puustinen, A; Wolff, H				Teirila, Laura; Karvala, Kirsi; Ahonen, Niina; Riska, Henrik; Pietinalho, Anne; Tuominen, Paivi; Piirila, Paivi; Puustinen, Anne; Wolff, Henrik			Proteomic Changes of Alveolar Lining Fluid in Illnesses Associated with Exposure to Inhaled Non-Infectious Microbial Particles	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; HUMAN SEMINAL PLASMA; IDIOPATHIC PULMONARY-FIBROSIS; INTERSTITIAL LUNG-DISEASES; HYPERSENSITIVITY PNEUMONITIS; ALPHA-1-ANTITRYPSIN DEFICIENCY; BRONCHIAL HYPERRESPONSIVENESS; AIRWAY INFLAMMATION; SYSTEMIC-SCLEROSIS; NLRP3 INFLAMMASOME	Background: Hyperresponsiveness to inhaled non-infectious microbial particles (NIMPs) has been associated with illnesses in the airways. Hypersensitivity pneumonitis (HP) is considered to be the prototype for these NIMPs-related diseases; however, there is no consensus on the definitions or diagnostic criteria for HP and the spectrum of related illnesses. Methods and Findings: In order to identify the possible diagnostic markers for illnesses associated with NIMPs in alveolar lining fluid, we performed a proteomic analysis using a two-dimensional difference gel electrophoresis on bronchoalveolar lavage (BAL) fluid from patients with exposure to NIMPs in the context of damp building-related illness (DBRI) or conditions on the borderline to acute HP, designated here as agricultural type of microbial exposure (AME). Samples from patients with HP and sarcoidosis (SARC) were included for reference. Results were compared to results of healthy subjects (CTR). Western blot was used for validation of potential marker proteins from BAL fluid and plasma. Protein expression patterns suggest a close similarity between AME and HP, while DBRI was similar to CTR. However, in DBRI the levels of the inflammation associated molecules galectin-3 and alpha-1-antitrypsin were increased. A novel finding emerging from this study was the increases of semenogelin levels in BAL fluid from patients with AME, HP and SARC. Histone 4 levels were increased in AME, HP and SARC. Elevated plasma levels of histone 2B were detected in HP and SARC, suggesting it to be a potential blood indicator for inflammatory diseases of the lungs. Conclusions: In this study, the proteomic changes in bronchoalveolar lavage of DBRI patients were distinct from other NIMP exposure associated lung diseases, while changes in AME overlapped those observed for HP patient samples. Some of the proteins identified in this study, semenogelin and histone 4, could function as diagnostic markers for differential diagnosis between DBRI and HP-like conditions.	[Teirila, Laura; Karvala, Kirsi; Ahonen, Niina; Tuominen, Paivi; Puustinen, Anne; Wolff, Henrik] Finnish Inst Occupat Hlth, Helsinki, Finland; [Riska, Henrik] Univ Helsinki, Cent Hosp, Dept Pulmonol, Helsinki, Finland; [Pietinalho, Anne] Raasepori Hlth Care Ctr, Raasepori, Finland; [Piirila, Paivi] Univ Helsinki, Cent Hosp, Med Imaging Ctr, Unit Clin Physiol,Dept Clin Physiol & Nucl Med, Helsinki, Finland	Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Wolff, H (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	henrik.wolff@ttl.fi	Piirilä, Päivi/H-2291-2018	Piirilä, Päivi/0000-0002-2535-4409; Puustinen, Anne/0000-0002-0262-9975	Nummela Foundation; Finnish Medical Society (Finska lakaresallskapet); Graduate School in Environmental Health 'SYTYKE'; Finnish Work Environment Fund (Tyosuojelurahasto)	Nummela Foundation; Finnish Medical Society (Finska lakaresallskapet); Graduate School in Environmental Health 'SYTYKE'; Finnish Work Environment Fund (Tyosuojelurahasto)	This work was supported by grants from the Nummela Foundation, the Finnish Medical Society (Finska lakaresallskapet), Graduate School in Environmental Health 'SYTYKE' and The Finnish Work Environment Fund (Tyosuojelurahasto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpinar-Elci M, 2008, INDOOR AIR, V18, P125, DOI 10.1111/j.1600-0668.2007.00514.x; [Anonymous], 1990, Eur Respir J, V3, P937; Bao SY, 2006, AM J PHYSIOL-LUNG C, V290, pL433, DOI 10.1152/ajplung.00341.2005; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Benson LM, 2009, J SEP SCI, V32, P44, DOI 10.1002/jssc.200800474; Bornehag CG, 2004, INDOOR AIR, V14, P243, DOI 10.1111/j.1600-0668.2004.00240.x; Bourgeon F, 2004, BIOL REPROD, V70, P768, DOI 10.1095/biolreprod.103.022533; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Canacci AM, 2011, PROSTATE, V71, P1108, DOI 10.1002/pros.21323; Canesin G, 2010, TUMOR BIOL, V31, P277, DOI 10.1007/s13277-010-0033-9; Carter JE, 2002, BIOCHEM BIOPH RES CO, V297, P1062, DOI 10.1016/S0006-291X(02)02292-1; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Congote LF, 2006, BIOCHEM BIOPH RES CO, V343, P617, DOI 10.1016/j.bbrc.2006.02.190; CORMIER Y, 1984, AM REV RESPIR DIS, V130, P1046; Costabel U, 2001, Curr Opin Pulm Med, V7, P255, DOI 10.1097/00063198-200109000-00002; de Boer RA, 2011, ANN MED, V43, P60, DOI 10.3109/07853890.2010.538080; Dhami R, 1999, J MOL MED-JMM, V77, P377, DOI 10.1007/s001090050364; Edstrom AML, 2008, J IMMUNOL, V181, P3413, DOI 10.4049/jimmunol.181.5.3413; Farnworth SL, 2008, AM J PATHOL, V172, P395, DOI 10.2353/ajpath.2008.070870; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Fisk WJ, 2007, INDOOR AIR, V17, P284, DOI 10.1111/j.1600-0668.2007.00475.x; FRIGERI LG, 1993, BIOCHEMISTRY-US, V32, P7644, DOI 10.1021/bi00081a007; Frol'ova L, 2009, INFLAMM RES, V58, P503, DOI 10.1007/s00011-009-0016-8; Ge XN, 2010, J IMMUNOL, V185, P1205, DOI 10.4049/jimmunol.1000039; Girard M, 2009, ALLERGY, V64, P322, DOI 10.1111/j.1398-9995.2009.01949.x; GOMZI M, 1989, Medicina del Lavoro, V80, P301; Greene CM, 2008, J INHERIT METAB DIS, V31, P21, DOI 10.1007/s10545-007-0748-y; Hacker S, 2009, J CLIN LAB ANAL, V23, P372, DOI 10.1002/jcla.20348; Health Canada, 2022, GUID GUID IND AIR CO; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hendrick DJ., 2002, OCCUPATIONAL DISORDE; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Holdenrieder S, 2009, CRIT REV CL LAB SCI, V46, P1, DOI [10.1080/10408360802485875 , 10.1080/10408360802485875]; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; Jacobs RL, 2005, ANN ALLERG ASTHMA IM, V95, P115, DOI 10.1016/S1081-1206(10)61200-8; Jonsson M, 2005, BIOCHEM J, V387, P447, DOI 10.1042/BJ20041424; Kankkunen P, 2014, HUM IMMUNOL, V75, P134, DOI 10.1016/j.humimm.2013.11.010; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Karvala K, 2012, INT ARCH OCC ENV HEA, V87, P1; Karvala K, 2013, SCAND J WORK ENV HEA, V39, P96, DOI 10.5271/sjweh.3289; Klech H, 1989, EUR RESPIR J, V2, P2; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kriegova E, 2006, AM J RESP CRIT CARE, V173, P1145, DOI 10.1164/rccm.200507-1126OC; Kumar V, 2008, MOL REPROD DEV, V75, P1767, DOI 10.1002/mrd.20910; Landi C, 2013, J PROTEOMICS, V83, P60, DOI 10.1016/j.jprot.2013.03.006; LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185; Lundwall A, 2002, MOL HUM REPROD, V8, P805, DOI 10.1093/molehr/8.9.805; Magi B, 2002, ELECTROPHORESIS, V23, P3434, DOI 10.1002/1522-2683(200210)23:19<3434::AID-ELPS3434>3.0.CO;2-R; Magi B, 2006, PROTEOMICS, V6, P6354, DOI 10.1002/pmic.200600303; Matsuda Y, 2008, HEPATOL RES, V38, P1098, DOI 10.1111/j.1872-034X.2008.00387.x; McSharry C, 2002, CLIN EXP IMMUNOL, V128, P3, DOI 10.1046/j.1365-2249.2002.01849.x; Mendell MJ, 2011, ENVIRON HEALTH PERSP, V119, P748, DOI 10.1289/ehp.1002410; Meyer KC, 2011, EUR RESPIR J, V38, P761, DOI 10.1183/09031936.00069509; Mitchell BL, 2005, CANCER INFORM, V1, P98; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; OConnell KL, 1997, ELECTROPHORESIS, V18, P349, DOI 10.1002/elps.1150180309; Okamoto T, 2012, ALLERGOL INT, V61, P83, DOI 10.2332/allergolint.11-OA-0315; Patel AM, 2001, J ALLERGY CLIN IMMUN, V108, P661; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Pietinalho A, 1993, 4 INT C BRONCH LAV U, p[P28, P76]; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Rodrigues RG, 2001, CLIN CANCER RES, V7, P854; Rottoli P, 2005, PROTEOMICS, V5, P1423, DOI 10.1002/pmic.200301007; Sallenave JM, 2002, BIOCHEM SOC T, V30, P111, DOI 10.1042/BST0300111; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Selman M, 2012, AM J RESP CRIT CARE, V186, P314, DOI 10.1164/rccm.201203-0513CI; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Sigsgaard T, 2000, EUR RESPIR J, V16, P50, DOI 10.1034/j.1399-3003.2000.16a09.x; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Straus DC, 2003, ARCH ENVIRON HEALTH, V58, P475, DOI 10.3200/AEOH.58.8.475-478; TASKINEN EI, 1994, PATHOL ANNU, V29, P121; TERHO EO, 1986, AM J IND MED, V10, P329, DOI 10.1002/ajim.4700100333; Truong-Tran AQ, 2002, AM J RESP CELL MOL, V27, P286, DOI 10.1165/rcmb.2001-0014OC; Wattiez R, 2000, ELECTROPHORESIS, V21, P2703, DOI 10.1002/1522-2683(20000701)21:13<2703::AID-ELPS2703>3.3.CO;2-N; Wolff CHJ, 2011, INT J BIOL SCI, V7, P261, DOI 10.7150/ijbs.7.261; Wolff H, 2003, SCAND J CLIN LAB INV, V63, P27, DOI 10.1080/00365510310000466; Wolff H, 2009, SCAND J CLIN LAB INV, V69, P537, DOI 10.1080/00365510902770061; Wu J, 2005, MOL CELL PROTEOMICS, V4, P1251, DOI 10.1074/mcp.M500041-MCP200; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; YAMAOKA A, 1995, J IMMUNOL, V154, P3479; Zhang YN, 2003, J IMMUNOTHER, V26, P461, DOI 10.1097/00002371-200311000-00001; Zuberi RI, 2004, AM J PATHOL, V165, P2045, DOI 10.1016/S0002-9440(10)63255-5	87	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102624	10.1371/journal.pone.0102624	http://dx.doi.org/10.1371/journal.pone.0102624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033447	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300070
J	Leonard, CE; Razzaghi, H; Freeman, CP; Roy, JA; Newcomb, CW; Hennessy, S				Leonard, Charles E.; Razzaghi, Hanieh; Freeman, Cristin P.; Roy, Jason A.; Newcomb, Craig W.; Hennessy, Sean			Empiric Potassium Supplementation and Increased Survival in Users of Loop Diuretics	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; SUDDEN CARDIAC DEATH; RENAL-INSUFFICIENCY; SERUM POTASSIUM; RISK; VALIDATION; ARRHYTHMIA; MORTALITY; THERAPY; TRIALS	Background: The effectiveness of the clinical strategy of empiric potassium supplementation in reducing the frequency of adverse clinical outcomes in patients receiving loop diuretics is unknown. We sought to examine the association between empiric potassium supplementation and 1) all-cause death and 2) outpatient-originating sudden cardiac death (SD) and ventricular arrhythmia (VA) among new starters of loop diuretics, stratified on initial loop diuretic dose. Methods: We conducted a one-to-one propensity score-matched cohort study using 1999-2007 US Medicaid claims from five states. Empiric potassium supplementation was defined as a potassium prescription on the day of or the day after the initial loop diuretic prescription. Death, the primary outcome, was ascertained from the Social Security Administration Death Master File; SD/VA, the secondary outcome, from incident, first-listed emergency department or principal inpatient SD/VA discharge diagnoses (positive predictive value = 85%). Results: We identified 654,060 persons who met eligibility criteria and initiated therapy with a loop diuretic, 27% of whom received empiric potassium supplementation (N = 179,436) and 73% of whom did not (N = 474,624). The matched hazard ratio for empiric potassium supplementation was 0.93 (95% confidence interval, 0.89-0.98, p = 0.003) for all-cause death. Stratifying on initial furosemide dose, hazard ratios for empiric potassium supplementation with furosemide <40 and >= 40 milligrams/day were 0.93 (0.86-1.00, p = 0.050) and 0.84 (0.79-0.89, p<0.0001). The matched hazard ratio for empiric potassium supplementation was 1.02 (0.83-1.24, p = 0.879) for SD/VA. Conclusions: Empiric potassium supplementation upon initiation of a loop diuretic appears to be associated with improved survival, with a greater apparent benefit seen with higher diuretic dose. If confirmed, these findings support the use of empiric potassium supplementation upon initiation of a loop diuretic.	[Leonard, Charles E.; Razzaghi, Hanieh; Freeman, Cristin P.; Roy, Jason A.; Newcomb, Craig W.; Hennessy, Sean] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Leonard, Charles E.; Razzaghi, Hanieh; Freeman, Cristin P.; Roy, Jason A.; Hennessy, Sean] Univ Penn, Perelman Sch Med, Ctr Pharmacoepidemiol Res & Training, Philadelphia, PA 19104 USA; [Hennessy, Sean] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Leonard, CE (corresponding author), Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.	celeonar@upenn.edu	Leonard, Charles/AAN-4463-2020		US Department of Health & Human Services (DHHS) National Institute on Aging [RC1AG035751, R01AG025152]; US DHHS National Institute of Diabetes and Kidney Diseases [R01DK102694]; US DHHS National Center for Advancing Translational Sciences [UL1TR000003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025152, RC1AG035751] Funding Source: NIH RePORTER	US Department of Health & Human Services (DHHS) National Institute on Aging; US DHHS National Institute of Diabetes and Kidney Diseases; US DHHS National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by RC1AG035751 and R01AG025152 from the US Department of Health & Human Services (DHHS) National Institute on Aging, R01DK102694 from the US DHHS National Institute of Diabetes and Kidney Diseases, and UL1TR000003 from the US DHHS National Center for Advancing Translational Sciences. The National Institutes of Health had no role in the design and conduct of the study; management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Abildstrom S. Z., 1999, CARDIAC ELECTROPHYSI, V3, P177, DOI DOI 10.1023/A:1009971104937; Ahmed MI, 2010, INT J CARDIOL, V144, P383, DOI 10.1016/j.ijcard.2009.04.041; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Cohn JN, 2000, ARCH INTERN MED, V160, P2429, DOI 10.1001/archinte.160.16.2429; Cooper HA, 1999, CIRCULATION, V100, P1311, DOI 10.1161/01.CIR.100.12.1311; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Ekundayo OJ, 2010, INT J CARDIOL, V141, P167, DOI 10.1016/j.ijcard.2008.11.195; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Grams ME, 2011, AM J KIDNEY DIS, V57, P44, DOI 10.1053/j.ajkd.2010.05.013; Green DM, 2002, NEUROLOGY, V59, P314, DOI 10.1212/WNL.59.3.314; Hennessy S, 2010, PHARMACOEPIDEM DR S, V19, P555, DOI 10.1002/pds.1869; Henz S, 2008, NEPHROL DIAL TRANSPL, V23, P3939, DOI 10.1093/ndt/gfn380; Holahan J, 2005, KAIS FAM FDN PUBL, V7346, P1; Holahan J, 2009, KAIS FAM FDN PUBL, V7846, P1; HOLLAND OB, 1981, AM J MED, V70, P762, DOI 10.1016/0002-9343(81)90530-1; Kaiser Family Foundation, 2011, KAIS FAM FDN PUBL; Leonard CE, 2010, PHARMACOEPIDEM DR S, V19, P576, DOI 10.1002/pds.1956; MACMAHON S, 1989, AM J CARDIOL, V63, P202, DOI 10.1016/0002-9149(89)90286-5; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Rose BD, 2012, DIURETIC INDUCED HYP; Rousseau D, 2010, KAIS FAM FDN PUBL, V7846-02, P1; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Sica Doemnic A, 2004, J Clin Hypertens (Greenwich), V6, P532, DOI 10.1111/j.1524-6175.2004.03789.x; Sica DA, 2011, J CLIN HYPERTENS, V13, P639, DOI 10.1111/j.1751-7176.2011.00512.x; SIEGEL D, 1992, JAMA-J AM MED ASSOC, V267, P1083, DOI 10.1001/jama.267.8.1083; SISCOVICK DS, 1994, NEW ENGL J MED, V330, P1852, DOI 10.1056/NEJM199406303302603; Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P1; van Kraaij DJW, 1998, EUR J CLIN PHARMACOL, V54, P323, DOI 10.1007/s002280050467; YUSUF S, 1990, AM J CARDIOL, V66, P315	30	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102279	10.1371/journal.pone.0102279	http://dx.doi.org/10.1371/journal.pone.0102279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029519	Green Submitted, Green Published, gold			2022-12-25	WOS:000341306600055
J	Pravetoni, M; Pentel, PR; Potter, DN; Chartoff, EH; Tally, L; LeSage, MG				Pravetoni, Marco; Pentel, Paul R.; Potter, David N.; Chartoff, Elena H.; Tally, Laura; LeSage, Mark G.			Effects of an Oxycodone Conjugate Vaccine on Oxycodone Self-Administration and Oxycodone-Induced Brain Gene Expression in Rats	PLOS ONE			English	Article							MORPHINE/HEROIN VACCINE; HEROIN; MICE; RELAPSE; HAPTEN; MAINTENANCE; ANTIBODIES; DEPENDENCE; ADDICTION; ABUSE	Prescription opioid abuse is an increasing public health concern in the USA. A vaccine comprising a hapten (OXY) conjugated to the carrier protein keyhole limpet hemocyanin (OXY-KLH) has been shown to attenuate the antinociceptive effects of oxycodone. Here, the vaccine's ability to prevent acquisition of intravenous (i.v.) oxycodone self-administration was studied in rats. Effects of vaccination on oxycodone-induced changes in the expression of several genes within the mesolimbic system, which are regulated by chronic opiate use, were also examined. Vaccination with OXY-KLH reduced the proportion of rats acquiring i.v. self-administration of oxycodone under a fixed ratio (FR) 3 schedule of reinforcement compared to control rats immunized with the unconjugated KLH carrier protein. Vaccination significantly reduced the mean number of infusions at FR3, total number of infusions, and total oxycodone intake during the entire protocol. Compared to oxycodone self-administering control rats immunized with the carrier alone, rats vaccinated with the OXY-KLH immunogen showed increased levels of adenylate cyclase 5 (Adcy5) and decreased levels of early growth response protein 2 (Egr2) and the early immediate gene c-Fos in the striatum. These data suggest that vaccination with OXY-KLH can attenuate the reinforcing effects of oxycodone at a clinically-relevant exposure level. Analysis of mRNA expression identified some addiction-relevant markers that may be of interest in understanding oxycodone effects or the protection provided by vaccination.	[Pravetoni, Marco; Pentel, Paul R.; Tally, Laura; LeSage, Mark G.] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55415 USA; [Pravetoni, Marco; Pentel, Paul R.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Pravetoni, Marco; Pentel, Paul R.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Potter, David N.; Chartoff, Elena H.] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA USA	Minneapolis Medical Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; McLean Hospital	Pravetoni, M (corresponding author), Minneapolis Med Res Fdn Inc, Minneapolis, MN 55415 USA.	prave001@umn.edu	LeSage, Mark G./AAS-8628-2020	Pravetoni, Marco/0000-0003-1036-0184	NIH [DA026300]; Minneapolis Medical Research Foundation Translational Research Program Award; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026300] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minneapolis Medical Research Foundation Translational Research Program Award; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by NIH DA026300 (Pentel) and Minneapolis Medical Research Foundation Translational Research Program Award (Pravetoni). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton B, 2006, VACCINE, V24, P3232, DOI 10.1016/j.vaccine.2006.01.047; Beardsley PM, 2004, EXP CLIN PSYCHOPHARM, V12, P163, DOI 10.1037/1064-1297.12.3.163; BERKOWITZ B, 1972, SCIENCE, V178, P1290, DOI 10.1126/science.178.4067.1290; BONESE KF, 1974, NATURE, V252, P708, DOI 10.1038/252708a0; Bremer PT, 2012, J MED CHEM, V55, P10776, DOI 10.1021/jm301262z; Cherrier MM, 2009, J PAIN, V10, P1038, DOI 10.1016/j.jpain.2009.03.017; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Dodrill CL, 2011, AM J PSYCHIAT, V168, P466, DOI 10.1176/appi.ajp.2010.10020260; Esterlis I, 2013, AM J PSYCHIAT, V170, P399, DOI 10.1176/appi.ajp.2012.12060793; Hassan HE, 2010, DRUG METAB DISPOS, V38, P157, DOI 10.1124/dmd.109.029199; Kantak KN, 2000, PSYCHOPHARMACOLOGY, V148, P251, DOI 10.1007/s002130050049; Kiraly KP, 2006, BRAIN RES BULL, V70, P233, DOI 10.1016/j.brainresbull.2006.05.005; Kreek MJ, 2002, J SUBST ABUSE TREAT, V23, P93, DOI 10.1016/S0740-5472(02)00259-3; Kuntz KL, 2008, PHARMACOL BIOCHEM BE, V90, P349, DOI 10.1016/j.pbb.2008.03.019; Leri F, 2005, PHARMACOL BIOCHEM BE, V82, P252, DOI 10.1016/j.pbb.2005.08.008; LeSage MG, 2006, PSYCHOPHARMACOLOGY, V184, P409, DOI 10.1007/s00213-005-0027-2; Li QQ, 2011, J NEUROCHEM, V119, P1271, DOI 10.1111/j.1471-4159.2011.07502.x; Mayer-Blackwell B, 2013, NEUROSCIENCE; McMillan DE, 2004, J PHARMACOL EXP THER, V309, P1248, DOI 10.1124/jpet.103.061762; Olesen AE, 2010, CLIN PHARMACOKINET, V49, P817, DOI 10.2165/11536610-000000000-00000; Pravetoni M, 2012, VACCINE, V30, P4617, DOI 10.1016/j.vaccine.2012.04.101; Pravetoni M, 2012, J PHARM EXP THER; Pravetoni M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096547; Pravetoni M, 2013, J MED CHEM, V56, P915, DOI 10.1021/jm3013745; Raleigh MD, 2013, J PHARMACOL EXP THER, V344, P397, DOI 10.1124/jpet.112.201194; Schlosburg JE, 2013, P NATL ACAD SCI USA, V110, P9036, DOI 10.1073/pnas.1219159110; Shen XY, 2012, CLIN PHARMACOL THER, V91, P60, DOI 10.1038/clpt.2011.281; Skolnick P, 2012, BIOL PSYCHIAT, V72, P890, DOI 10.1016/j.biopsych.2012.08.004; Spijker S, 2004, FASEB J, V18, P848, DOI 10.1096/fj.03-0612fje; Stowe GN, 2011, J MED CHEM, V54, P5195, DOI 10.1021/jm200461m; Taylor JJ, 2014, J IMMUNOL METHODS, V405, P74, DOI 10.1016/j.jim.2014.01.010; WAINER BH, 1972, SCIENCE, V176, P1143, DOI 10.1126/science.176.4039.1143; Xie KQ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002922; Zhang Y, 2013, PSYCHOPHARMACOLOGY B; Zhang Y, 2009, NEUROPSYCHOPHARMACOL, V34, P912, DOI 10.1038/npp.2008.134	35	37	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101807	10.1371/journal.pone.0101807	http://dx.doi.org/10.1371/journal.pone.0101807			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025380	Green Published, gold, Green Submitted			2022-12-25	WOS:000339992400022
J	Schafer, K; Bain, JM; Di Pietro, A; Gow, NAR; Erwig, LP				Schaefer, Katja; Bain, Judith M.; Di Pietro, Antonio; Gow, Neil A. R.; Erwig, Lars P.			Hyphal Growth of Phagocytosed Fusarium oxysporum Causes Cell Lysis and Death of Murine Macrophages	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS CONIDIA; BETA-GLUCAN RECEPTOR; CANDIDA-ALBICANS; MAMMALIAN HOSTS; VIRULENCE; RECOGNITION; INFECTIONS; PATHOGEN; DECTIN-1; ESCAPE	Fusarium oxysporum is an important plant pathogen and an opportunistic pathogen of humans. Here we investigated phagocytosis of F. oxysporum by J774.1 murine cell line macrophages using live cell video microscopy. Macrophages avidly migrated towards F. oxysporum germlings and were rapidly engulfed after cell-cell contact was established. F. oxysporum germlings continued hyphal growth after engulfment by macrophages, leading to associated macrophage lysis and escape. Macrophage killing depended on the multiplicity of infection. After engulfment, F. oxysporum inhibited macrophages from completing mitosis, resulting in large daughter cells fused together by means of a F. oxysporum hypha. These results shed new light on the initial stages of Fusarium infection and the innate immune response of the mammalian host.	[Schaefer, Katja; Di Pietro, Antonio] Univ Cordoba, Dept Genet, Cordoba, Spain; [Bain, Judith M.; Gow, Neil A. R.; Erwig, Lars P.] Univ Aberdeen, Aberdeen Fungal Grp, Inst Med Sci, Aberdeen, Scotland	Universidad de Cordoba; University of Aberdeen	Schafer, K (corresponding author), Univ Cordoba, Dept Genet, Cordoba, Spain.	k_scha11@hotmail.de	Di Pietro, Antonio/K-9220-2014; GOW, Neil/AAS-5323-2021; Schäfer, Katrin/P-4728-2015	Di Pietro, Antonio/0000-0001-5930-5763; GOW, Neil/0000-0002-2776-5850; bain, judith/0000-0002-1060-0419	Marie Curie Initial Training Network ARIADNE [FP7-PEOPLE-ITN-237936]; Spanish Ministerio de Economia y Competitividad (MINECO) [BIO2010-15505]; Wellcome Trust [080088, 086827, 075470, 099215]; Wellcome Trust Strategic Award [097377]; FP7 [HEALTH-F2- 2010-260338-ALLFUN]; Chief Scientist Senior Clinical Fellowship; Chief Scientist Office [SCD/03] Funding Source: researchfish	Marie Curie Initial Training Network ARIADNE; Spanish Ministerio de Economia y Competitividad (MINECO); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Strategic Award(Wellcome Trust); FP7; Chief Scientist Senior Clinical Fellowship; Chief Scientist Office	This work was supported by the following grants: Marie Curie Initial Training Network ARIADNE (FP7-PEOPLE-ITN-237936) to N.A.R.G. and A.D.P.; BIO2010-15505 from the Spanish Ministerio de Economia y Competitividad (MINECO) to A. D. P. Wellcome Trust (080088, 086827, 075470 and 099215) including a Wellcome Trust Strategic Award for Medical Mycology and Fungal Immunology 097377 and FP7-2007-2013 grant agreement HEALTH-F2- 2010-260338-ALLFUN to NARG and Chief Scientist Senior Clinical Fellowship to L.P.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Braedel S, 2004, BRIT J HAEMATOL, V125, P392, DOI 10.1111/j.1365-2141.2004.04922.x; Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91; Garcia-Rodas R, 2011, INFECT IMMUN, V79, P2136, DOI 10.1128/IAI.00044-11; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Ghosh S, 2009, INFECT IMMUN, V77, P1596, DOI 10.1128/IAI.01452-08; Gow NAR, 2012, NAT REV MICROBIOL; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Jahn B, 2002, CELL MICROBIOL, V4, P793, DOI 10.1046/j.1462-5822.2002.00228.x; Keppler-Ross S, 2010, EUKARYOT CELL, V9, P1776, DOI 10.1128/EC.00156-10; Klaas M, 2012, J IMMUNOL, V189, P2414, DOI 10.4049/jimmunol.1200776; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lewis LE, 2012, FUNGAL GENET BIOL, V49, P679, DOI 10.1016/j.fgb.2012.05.007; Lewis LE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002578; Lopez-Berges MS, 2013, MOL MICROBIOL, V87, P49, DOI 10.1111/mmi.12082; Lopez-Berges MS, 2012, PLANT CELL, V24, P3805, DOI 10.1105/tpc.112.098624; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Luo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003219; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Martinez-Rocha AL, 2008, CELL MICROBIOL, V10, P1339, DOI 10.1111/j.1462-5822.2008.01130.x; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; Mech F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019591; Nucci M, 2002, CLIN INFECT DIS, V35, P909, DOI 10.1086/342328; Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; Prados-Rosales RC, 2012, J BIOL CHEM, V287, P21970, DOI 10.1074/jbc.M112.364034; Rudkin FM, 2013, MBIO, V4, DOI 10.1128/mBio.00810-13; Schafer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089920; Sole A, 2005, CLIN MICROBIOL INFEC, V11, P359, DOI 10.1111/j.1469-0691.2005.01128.x; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; THAU N, 1994, INFECT IMMUN, V62, P4380, DOI 10.1128/IAI.62.10.4380-4388.1994; Uwamahoro N, 2014, MBIO, V5, DOI 10.1128/mBio.00003-14; Wald A, 1997, J INFECT DIS, V175, P1459, DOI 10.1086/516480	38	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101999	10.1371/journal.pone.0101999	http://dx.doi.org/10.1371/journal.pone.0101999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025395	gold, Green Published			2022-12-25	WOS:000339992400033
J	Erlendsson, S; Rathje, M; Heidarsson, PO; Poulsen, FM; Madsen, KL; Teilum, K; Gether, U				Erlendsson, Simon; Rathje, Mette; Heidarsson, Petur O.; Poulsen, Flemming M.; Madsen, Kenneth L.; Teilum, Kaare; Gether, Ulrik			Protein Interacting with C-kinase 1 (PICK1) Binding Promiscuity Relies on Unconventional PSD-95/Discs-Large/ZO-1 Homology (PDZ) Binding Modes for Nonclass II PDZ Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR SUBUNIT GLUR2; SURFACE EXPRESSION; NMR-SPECTROSCOPY; DOMAIN; RECOGNITION; COMPLEX; PHOSPHORYLATION; IDENTIFICATION; ORGANIZATION; ARCHITECTURE	PDZ domain proteins control multiple cellular functions by governing assembly of protein complexes. It remains unknown why individual PDZ domains can bind the extreme C terminus of very diverse binding partners and maintain selectivity. By employing NMR spectroscopy, together with molecular modeling, mutational analysis, and fluorescent polarization binding experiments, we identify here three structural mechanisms explaining why the PDZ domain of PICK1 selectively binds >30 receptors, transporters, and kinases. Class II ligands, including the dopamine transporter, adopt a canonical binding mode with promiscuity obtained via differential packing in the binding groove. Class I ligands, such as protein kinase C alpha, depend on residues upstream from the canonical binding sequence that are likely to interact with flexible loop residues of the PDZ domain. Finally, we obtain evidence that the unconventional ligand ASIC1a has a dual binding mode involving a canonical insertion and a noncanonical internal insertion with the two C-terminal residues forming interactions outside the groove. Together with an evolutionary analysis, the data show how unconventional binding modes might evolve for a protein recognition domain to expand the repertoire of functionally important interactions.	[Erlendsson, Simon; Rathje, Mette; Madsen, Kenneth L.; Gether, Ulrik] Univ Copenhagen, Mol Neuropharmacol Lab,Panum Inst 18 6, Lundbeck Fdn Ctr Biomembranes Nanomed, Dept Neurosci & Pharmacol,Fac Hlth & Med Sci, DK-2200 Copenhagen N, Denmark; [Erlendsson, Simon; Heidarsson, Petur O.; Poulsen, Flemming M.; Teilum, Kaare] Univ Copenhagen, Fac Sci, Dept Biol, Struct Biol & NMR Lab, DK-2200 Copenhagen N, Denmark	Lundbeckfonden; University of Copenhagen; University of Copenhagen	Teilum, K (corresponding author), Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	kaare.teilum@bio.ku.dk; gether@sund.ku.dk	Rathje, Mette/GZL-1300-2022; Teilum, Kaare/S-8410-2019; Teilum, Kaare/K-4340-2014; Madsen, Kenneth/C-7778-2012; Heidarsson, Petur/A-5299-2015	Teilum, Kaare/0000-0001-6919-1982; Madsen, Kenneth/0000-0001-9274-6691; Erlendsson, Simon/0000-0002-6378-870X; Heidarsson, Petur/0000-0003-2027-5434; Gether, Ulrik/0000-0002-0020-3807	National Institutes of Health [P01 DA 12408]; Danish Medical Research Council; University of Copenhagen BioScaRT Program of Excellence; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Novo Nordisk Foundation; Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF12OC0002181] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Copenhagen BioScaRT Program of Excellence; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DA 12408 (to U. G.). This work was also supported by the Danish Medical Research Council (to U. G., K. T., and K. L. M.), University of Copenhagen BioScaRT Program of Excellence (to U. G.), Lundbeck Foundation Center for Biomembranes in Nanomedicine (to U. G.), the Novo Nordisk Foundation (to U. G.), and Fabrikant Vilhelm Pedersen og Hustrus Mindelegat (to U. G.).	Bassan M, 2008, EUR J NEUROSCI, V27, P66, DOI 10.1111/j.1460-9568.2007.05986.x; Bezprozvanny I, 2001, FEBS LETT, V509, P457, DOI 10.1016/S0014-5793(01)03214-8; Bhattacharya S, 2013, J MOL BIOL, V425, P2509, DOI 10.1016/j.jmb.2013.04.001; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Bolia A, 2012, PROTEINS, V80, P1393, DOI 10.1002/prot.24034; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao M, 2007, J NEUROSCI, V27, P12945, DOI 10.1523/JNEUROSCI.2040-07.2007; Cao MA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001541; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Chi CN, 2012, BIOCHEMISTRY-US, V51, P8971, DOI 10.1021/bi300792h; Chung HJ, 2000, J NEUROSCI, V20, P7258; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dev KK, 2000, J NEUROSCI, V20, P7252; Dev KK, 2006, TRENDS PHARMACOL SCI, V27, P574, DOI 10.1016/j.tips.2006.09.007; Dhulesia A, 2008, J AM CHEM SOC, V130, P8931, DOI 10.1021/ja0752080; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Doucet MV, 2012, PHARMACOL THERAPEUT, V133, P218, DOI 10.1016/j.pharmthera.2011.11.005; Elkins JM, 2007, PROTEIN SCI, V16, P683, DOI 10.1110/ps.062657507; Escobar-Cabrera E, 2011, J BIOL CHEM, V286, P19816, DOI 10.1074/jbc.M111.231647; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Holst B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001542; Hruska-Hageman AM, 2002, BIOCHEM J, V361, P443, DOI 10.1042/0264-6021:3610443; Hultqvist G, 2013, STRUCTURE, V21, P1193, DOI 10.1016/j.str.2013.05.010; Jaravine VA, 2008, J AM CHEM SOC, V130, P3927, DOI 10.1021/ja077282o; Jaulin-Bastard F, 2001, J BIOL CHEM, V276, P15256, DOI 10.1074/jbc.M010032200; Kazimierczuk K, 2011, ANGEW CHEM INT EDIT, V50, P5556, DOI 10.1002/anie.201100370; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Madsen KL, 2005, J BIOL CHEM, V280, P20539, DOI 10.1074/jbc.M500577200; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Mostarda S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002429; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Terrien E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002941; Thorsen TS, 2010, P NATL ACAD SCI USA, V107, P413, DOI 10.1073/pnas.0902225107; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Tyler RC, 2010, BIOCHEMISTRY-US, V49, P951, DOI 10.1021/bi9017335; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; Williams ME, 2003, J NEUROSCI, V23, P11279; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Xu JY, 2006, NEUROSIGNALS, V15, P190, DOI 10.1159/000098482; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	60	31	32	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25327	25340		10.1074/jbc.M114.548743	http://dx.doi.org/10.1074/jbc.M114.548743			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25023278	Green Published, hybrid			2022-12-25	WOS:000341985300051
J	Redka, DS; Morizumi, T; Elmslie, G; Paranthaman, P; Shivnaraine, RV; Ellis, J; Ernst, OP; Wells, JW				Redka, Dar'ya S.; Morizumi, Takefumi; Elmslie, Gwendolynne; Paranthaman, Pranavan; Shivnaraine, Rabindra V.; Ellis, John; Ernst, Oliver P.; Wells, James W.			Coupling of G Proteins to Reconstituted Monomers and Tetramers of the M-2 Muscarinic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aggregation; Cooperativity; G Protein-coupled Receptor (GPCR); Membrane Reconstitution; Phospholipid Vesicle; G Protein Coupling; Monomers; Nanodiscs; Oligomers; Ternary Complex Model	BETA-ADRENERGIC-RECEPTOR; FLUORESCENCE CORRELATION SPECTROSCOPY; HIGHER-ORDER OLIGOMERS; TERNARY COMPLEX MODEL; ADENYLATE-CYCLASE; PHOSPHOLIPID-BILAYER; CHOLINERGIC-RECEPTOR; GUANINE-NUCLEOTIDES; ACETYLCHOLINE-RECEPTORS; CONSTITUTIVE ACTIVATION	Background: The allosteric interaction between agonists and guanylyl nucleotides reports on the interaction between G protein-coupled receptors and G proteins. Results: Such allostery differs in kind between reconstituted monomers and tetramers of the M-2 muscarinic receptor. Conclusion: Monomers and tetramers mediate allostery via different mechanisms. Significance: Only tetramers resemble muscarinic receptors in myocardial membranes in the nature of their sensitivity to guanylyl nucleotides. G protein-coupled receptors can be reconstituted as monomers in nanodiscs and as tetramers in liposomes. When reconstituted with G proteins, both forms enable an allosteric interaction between agonists and guanylyl nucleotides. Both forms, therefore, are candidates for the complex that controls signaling at the level of the receptor. To identify the biologically relevant form, reconstituted monomers and tetramers of the purified M-2 muscarinic receptor were compared with muscarinic receptors in sarcolemmal membranes for the effect of guanosine 5-[,-imido]triphosphate (GMP-PNP) on the inhibition of N-[H-3]methylscopolamine by the agonist oxotremorine-M. With monomers, a stepwise increase in the concentration of GMP-PNP effected a lateral, rightward shift in the semilogarithmic binding profile (i.e. a progressive decrease in the apparent affinity of oxotremorine-M). With tetramers and receptors in sarcolemmal membranes, GMP-PNP effected a vertical, upward shift (i.e. an apparent redistribution of sites from a state of high affinity to one of low affinity with no change in affinity per se). The data were analyzed in terms of a mechanistic scheme based on a ligand-regulated equilibrium between uncoupled and G protein-coupled receptors (the ternary complex model). The model predicts a rightward shift in the presence of GMP-PNP and could not account for the effects at tetramers in vesicles or receptors in sarcolemmal membranes. Monomers present a special case of the model in which agonists and guanylyl nucleotides interact within a complex that is both constitutive and stable. The results favor oligomers of the M-2 receptor over monomers as the biologically relevant state for coupling to G proteins.	[Redka, Dar'ya S.; Paranthaman, Pranavan; Shivnaraine, Rabindra V.; Wells, James W.] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada; [Morizumi, Takefumi; Ernst, Oliver P.] Univ Toronto, Dept Biochem, Fac Med, Toronto, ON M5S 1A8, Canada; [Elmslie, Gwendolynne; Ellis, John] Penn State Univ, Dept Psychiat, Coll Med, Hershey Med Ctr, Hershey, PA 17033 USA; [Elmslie, Gwendolynne; Ellis, John] Penn State Univ, Dept Pharmacol, Coll Med, Hershey Med Ctr, Hershey, PA 17033 USA; [Ernst, Oliver P.] Univ Toronto, Dept Mol Genet, Fac Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Toronto	Ellis, J (corresponding author), Penn State Univ, Dept Psychiat, Coll Med, 500 Univ Dr, Hershey, PA 17033 USA.	johnellis@psu.edu; oliver.ernst@utoronto.ca; jwells@phm.utoronto.ca	Morizumi, Takefumi/AAA-2063-2021	Morizumi, Takefumi/0000-0002-2785-209X	Canadian Institutes of Health Research [MOP97978]; Heart and Stroke Foundation of Ontario [T6280, NA7168]; National Institutes of Health [R01AG05214]; Canada Excellence Research Chair Program; Natural Sciences and Engineering Research Council of Canada; Ontario Graduate Scholarship; NATIONAL INSTITUTE ON AGING [R01AG005214] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Excellence Research Chair Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship(Ontario Graduate Scholarship); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Canadian Institutes of Health Research Grant MOP97978 (to J. W. W.), Heart and Stroke Foundation of Ontario Grants T6280 and NA7168 (to J. W. W.), National Institutes of Health Grant R01AG05214 (to J. E.), and the Canada Excellence Research Chair Program (to O. P. E.).; Recipient of a scholarship from the Natural Sciences and Engineering Research Council of Canada and an Ontario Graduate Scholarship.	Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 1998, J STRUCT BIOL, V123, P37, DOI 10.1006/jsbi.1998.4007; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BERRIE CP, 1979, BIOCHEM BIOPH RES CO, V87, P1000, DOI 10.1016/S0006-291X(79)80006-6; Bieri C, 1999, NAT BIOTECHNOL, V17, P1105, DOI 10.1038/15090; BIRDSALL NJM, 1977, ADV BEHAV BIOL, V24, P25; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BORNANCIN F, 1989, EUR J BIOCHEM, V184, P687, DOI 10.1111/j.1432-1033.1989.tb15068.x; Burstein ES, 1997, MOL PHARMACOL, V51, P312, DOI 10.1124/mol.51.2.312; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chidiac P, 1997, BIOCHEMISTRY-US, V36, P7361, DOI 10.1021/bi961939t; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; EHLERT FJ, 1990, MOL PHARMACOL, V38, P148; EHLERT FJ, 1985, MOL PHARMACOL, V28, P410; EHLERT FJ, 1980, J SUPRAMOL STR CELL, V14, P149, DOI 10.1002/jss.400140204; Ellis J, 2000, MOL PHARMACOL, V58, P1451, DOI 10.1124/mol.58.6.1451; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Golebiewska U, 2011, BIOCHEMISTRY-US, V50, P2829, DOI 10.1021/bi101701x; Green MA, 1997, BIOCHEMISTRY-US, V36, P7380, DOI 10.1021/bi961940s; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; HAGA K, 1986, J BIOL CHEM, V261, P133; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Herrick-Davis K, 2012, J BIOL CHEM, V287, P23604, DOI 10.1074/jbc.M112.350249; Heyse S, 1998, BIOCHEMISTRY-US, V37, P507, DOI 10.1021/bi971564r; HULME EC, 1981, EUR J PHARMACOL, V73, P137, DOI 10.1016/0014-2999(81)90085-6; Ianoul A, 2005, NAT CHEM BIOL, V1, P196, DOI 10.1038/nchembio726; Jakubik J, 1995, FEBS LETT, V377, P275, DOI 10.1016/0014-5793(95)01360-1; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; KENT RS, 1980, MOL PHARMACOL, V17, P14; Kuravi S, 2010, BIOPHYS J, V98, P2391, DOI 10.1016/j.bpj.2010.02.004; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; LEE TWT, 1986, BIOCHEMISTRY-US, V25, P7009, DOI 10.1021/bi00370a038; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; LIMBIRD LE, 1978, P NATL ACAD SCI USA, V75, P228, DOI 10.1073/pnas.75.1.228; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Ma AWS, 2008, BIOCHEM BIOPH RES CO, V374, P128, DOI 10.1016/j.bbrc.2008.06.105; Ma AWS, 2007, BIOCHEMISTRY-US, V46, P7907, DOI 10.1021/bi6026105; Mansoor SE, 2006, P NATL ACAD SCI USA, V103, P3060, DOI 10.1073/pnas.0511010103; MATESIC DF, 1991, MOL PHARMACOL, V40, P347; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; MINTON AP, 1990, BIOCHEMISTRY-US, V29, P1586, DOI 10.1021/bi00458a033; NEUBIG RR, 1985, MOL PHARMACOL, V28, P475; Palczewski K, 2010, TRENDS BIOCHEM SCI, V35, P595, DOI 10.1016/j.tibs.2010.05.002; Park PSH, 2003, BIOCHEMISTRY-US, V42, P12960, DOI 10.1021/bi034491m; Park PSH, 2002, BIOCHEMISTRY-US, V41, P5588, DOI 10.1021/bi011746s; Pisterzi LF, 2010, J BIOL CHEM, V285, P16723, DOI 10.1074/jbc.M109.069443; Rasband W., 2006, IMAGEJ; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Redka DS, 2008, MOL PHARMACOL, V74, P834, DOI 10.1124/mol.108.048074; Redka DS, 2013, BIOCHEMISTRY-US, V52, P7405, DOI 10.1021/bi4003869; REN Q, 1993, J BIOL CHEM, V268, P16483; ROSS EM, 1977, J BIOL CHEM, V252, P5761; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Spalding TA, 1997, BIOCHEMISTRY-US, V36, P10109, DOI 10.1021/bi970565g; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Vidi PA, 2008, FEBS LETT, V582, P3985, DOI 10.1016/j.febslet.2008.09.062; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; Wells J. W., 1992, RECEPTOR LIGAND INTE, P289; WELLS JW, 1990, EUR J PHARMACOL, V183, P1731, DOI 10.1016/0014-2999(90)92036-I; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WONG HMS, 1986, BIOCHEMISTRY-US, V25, P6995, DOI 10.1021/bi00370a037; WREGGETT KA, 1984, MOL PHARMACOL, V26, P214; WREGGETT KA, 1995, J BIOL CHEM, V270, P22488, DOI 10.1074/jbc.270.38.22488; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008; ZORICH NL, 1987, BIOCHIM BIOPHYS ACTA, V919, P181, DOI 10.1016/0005-2760(87)90206-2	73	31	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24347	24365		10.1074/jbc.M114.559294	http://dx.doi.org/10.1074/jbc.M114.559294			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023280	Green Published, hybrid			2022-12-25	WOS:000341505600030
J	Ogasawara, Y; Itakura, E; Kono, N; Mizushima, N; Arai, H; Nara, A; Mizukami, T; Yamamoto, A				Ogasawara, Yuta; Itakura, Eisuke; Kono, Nozomu; Mizushima, Noboru; Arai, Hiroyuki; Nara, Atsuki; Mizukami, Tamio; Yamamoto, Akitsugu			Stearoyl-CoA Desaturase 1 Activity Is Required for Autophagosome Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Endoplasmic Reticulum (ER); Fatty Acid; Lipid Metabolism; Membrane; SCD1	FRACTURE ELECTRON-MICROSCOPY; STARVATION-INDUCED AUTOPHAGY; ENDOPLASMIC-RETICULUM; FREEZE-FRACTURE; INDUCED AUTOPHAGOCYTOSIS; SIGNALING PATHWAY; FORMATION SITE; LIPID KINASE; HUMAN CANCER; FATTY-ACIDS	Background: Autophagosome membranes are believed to have a high content of unsaturated fatty acids, but the roles of unsaturated fatty acids in autophagy are not clear. Results: Stearoyl-CoA desaturase 1 inhibitor 28c suppressed autophagy at the earliest stage of autophagosome formation. Conclusion: Unsaturated fatty acids are required for autophagosome formation. Significance: This study clarifies the importance of fatty acid desaturation in the autophagosome formation. Autophagy is one of the major degradation pathways for cytoplasmic components. The autophagic isolation membrane is a unique membrane whose content of unsaturated fatty acids is very high. However, the molecular mechanisms underlying formation of this membrane, including the roles of unsaturated fatty acids, remain to be elucidated. From a chemical library consisting of structurally diverse compounds, we screened for novel inhibitors of starvation-induced autophagy by measuring LC3 puncta formation in mouse embryonic fibroblasts stably expressing GFP-LC3. One of the inhibitors we identified, 2,5-pyridinedicarboxamide, N2,N5-bis[5-[(dimethylamino)carbonyl]-4-methyl-2-thiazolyl], has a molecular structure similar to that of a known stearoyl-CoA desaturase (SCD) 1 inhibitor. To determine whether SCD1 inhibition influences autophagy, we examined the effects of the SCD1 inhibitor 28c. This compound strongly inhibited starvation-induced autophagy, as determined by LC3 puncta formation, immunoblot analyses of LC3, electron microscopic observations, and p62/SQSTM1 accumulation. Overexpression of SCD1 or supplementation with oleic acid, which is a catalytic product of SCD1 abolished the inhibition of autophagy by 28c. Furthermore, 28c suppressed starvation-induced autophagy without affecting mammalian target of rapamycin activity, and also inhibited rapamycin-induced autophagy. In addition to inhibiting formation of LC3 puncta, 28c also inhibited formation of ULK1, WIPI1, Atg16L, and p62/SQSTM1 puncta. These results suggest that SCD1 activity is required for the earliest step of autophagosome formation.	[Ogasawara, Yuta; Nara, Atsuki; Mizukami, Tamio; Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Nagahama, Shiga 5260829, Japan; [Itakura, Eisuke; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Kono, Nozomu; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Mizushima, Noboru] Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Tokyo 1130033, Japan; [Mizushima, Noboru] Univ Tokyo, Fac Med, Tokyo 1130033, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; University of Tokyo	Yamamoto, A (corresponding author), 1266 Tamura, Nagahama, Shiga 5260829, Japan.	a_yamamoto@nagahama-i-bio.ac.jp	Itakura, Eisuke/AAY-7977-2021; Mizushima, Noboru/C-3635-2009; Ogasawara, Yuta/C-4021-2016; Nara, Atsuki/ABD-4772-2021; KONO, nozomu/AAM-3178-2020	Itakura, Eisuke/0000-0001-7248-9333; Mizushima, Noboru/0000-0002-6258-6444; Nara, Atsuki/0000-0002-4115-3017; Ogasawara, Yuta/0000-0001-5345-6472	Japan Science Society	Japan Science Society	This work was supported by a Sasakawa Scientific Research Grant from the Japan Science Society.	Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fengsrud M, 2000, EUR J CELL BIOL, V79, P871, DOI 10.1078/0171-9335-00125; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; HIRSIMAKI Y, 1982, EUR J CELL BIOL, V27, P298; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jing K, 2011, AUTOPHAGY, V7, P1348, DOI 10.4161/auto.7.11.16658; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kohler K, 2009, AUTOPHAGY, V5, P980; lida T., 2008, [No title captured], Patent No. [WO 2008/123469 A1, 2008123469]; Liu G, 2007, J MED CHEM, V50, P3086, DOI 10.1021/jm070219p; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Miyazaki M, 2003, J BIOL CHEM, V278, P33904, DOI 10.1074/jbc.M304724200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nath S, 2014, NAT CELL BIOL, V16, P415, DOI 10.1038/ncb2940; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ohsumi Y, 1999, PHILOS T ROY SOC B, V354, P1577, DOI 10.1098/rstb.1999.0501; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Ragusa MJ, 2012, CELL, V151, P1501, DOI 10.1016/j.cell.2012.11.028; REUNANEN H, 1985, HISTOCHEMISTRY, V83, P513, DOI 10.1007/BF00492453; REZ G, 1980, LAB INVEST, V43, P269; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Tan SH, 2014, AUTOPHAGY, V10, P226, DOI 10.4161/auto.27003; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Young AJ, 2006, MED SCI SPORT EXER, V38, P1, DOI 10.1249/01.mss.0000196708.08925.8b	49	48	48	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23938	23950		10.1074/jbc.M114.591065	http://dx.doi.org/10.1074/jbc.M114.591065			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25023287	Green Published, hybrid			2022-12-25	WOS:000341505000059
J	Biffi, G; Tannahill, D; Miller, J; Howat, WJ; Balasubramanian, S				Biffi, Giulia; Tannahill, David; Miller, Jodi; Howat, William J.; Balasubramanian, Shankar			Elevated Levels of G-Quadruplex Formation in Human Stomach and Liver Cancer Tissues	PLOS ONE			English	Article							SMALL-MOLECULE; BREAKPOINT REGION; LIGAND RHPS4; IN-VITRO; DNA; INSTABILITY; MOTIFS; TRANSLOCATION; EXPRESSION; CONSISTENT	Four-stranded G-quadruplex DNA secondary structures have recently been visualized in the nuclei of human cultured cells. Here, we show that BG4, a G-quadruplex-specific antibody, can be used to stain DNA G-quadruplex structures in patient-derived tissues using immunohistochemistry. We observe a significantly elevated number of G-quadruplex-positive nuclei in human cancers of the liver and stomach as compared to background non-neoplastic tissue. Our results suggest that G-quadruplex formation can be detected and measured in patient-derived material and that elevated G-quadruplex formation may be a characteristic of some cancers.	[Biffi, Giulia; Tannahill, David; Miller, Jodi; Howat, William J.; Balasubramanian, Shankar] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge	Balasubramanian, S (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England.	sb10031@cam.ac.uk	Balasubramanian, Shankar/C-1671-2009	Tannahill, David/0000-0002-3811-6864; Miller, Jodi/0000-0001-6870-204X; Balasubramanian, Shankar/0000-0002-0281-5815; Biffi, Giulia/0000-0003-4592-0970	Cancer Research UK [C9681/A11961]; Cancer Research UK [22310, 12488] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The authors thank Cancer Research UK for programme grant (C9681/A11961) and core institutional funding to the Balasubramanian lab, and for a PhD studentship for GB (http://www.cancerresearchuk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor-Gueret M, 2006, CANCER LETT, V236, P1, DOI 10.1016/j.canlet.2005.04.023; Bejugam M, 2010, ACS MED CHEM LETT, V1, P306, DOI 10.1021/ml100062z; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Gomez D, 2006, CANCER RES, V66, P6908, DOI 10.1158/0008-5472.CAN-06-1581; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Katapadi VK, 2012, GENOMICS, V100, P72, DOI 10.1016/j.ygeno.2012.05.008; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Marinoni I, 2014, GASTROENTEROLOGY, V146, P453, DOI 10.1053/j.gastro.2013.10.020; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Nambiar M, 2013, MOL CELL BIOL, V33, P4266, DOI 10.1128/MCB.00540-13; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Phatak P, 2007, BRIT J CANCER, V96, P1223, DOI 10.1038/sj.bjc.6603691; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Rodriguez R, 2008, J AM CHEM SOC, V130, P15758, DOI 10.1021/ja805615w; Salvati E, 2007, J CLIN INVEST, V117, P3236, DOI 10.1172/JCI32461; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x	34	114	118	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102711	10.1371/journal.pone.0102711	http://dx.doi.org/10.1371/journal.pone.0102711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033211	Green Published, gold, Green Submitted			2022-12-25	WOS:000339418300083
J	Douglass, LL; Turner, J; Grantham, HS; Kaiser, S; Constable, A; Nicoll, R; Raymond, B; Post, A; Brandt, A; Beaver, D				Douglass, Lucinda L.; Turner, Joel; Grantham, Hedley S.; Kaiser, Stefanie; Constable, Andrew; Nicoll, Rob; Raymond, Ben; Post, Alexandra; Brandt, Angelika; Beaver, Daniel			A Hierarchical Classification of Benthic Biodiversity and Assessment of Protected Areas in the Southern Ocean	PLOS ONE			English	Article							ANTARCTIC POLAR FRONT; DEEP-WATER; PROMACHOCRINUS-KERGUELENSIS; CRYPTIC SPECIATION; LARVAL DISPERSAL; ATLANTIC SECTOR; MARINE; BIOGEOGRAPHY; SHELF; ICE	An international effort is underway to establish a representative system of marine protected areas (MPAs) in the Southern Ocean to help provide for the long-term conservation of marine biodiversity in the region. Important to this undertaking is knowledge of the distribution of benthic assemblages. Here, our aim is to identify the areas where benthic marine assemblages are likely to differ from each other in the Southern Ocean including near-shore Antarctica. We achieve this by using a hierarchical spatial classification of ecoregions, bathomes and environmental types. Ecoregions are defined according to available data on biogeographic patterns and environmental drivers on dispersal. Bathomes are identified according to depth strata defined by species distributions. Environmental types are uniquely classified according to the geomorphic features found within the bathomes in each ecoregion. We identified 23 ecoregions and nine bathomes. From a set of 28 types of geomorphic features of the seabed, 562 unique environmental types were classified for the Southern Ocean. We applied the environmental types as surrogates of different assemblages of biodiversity to assess the representativeness of existing MPAs. We found that 12 ecoregions are not represented in MPAs and that no ecoregion has their full range of environmental types represented in MPAs. Current MPA planning processes, if implemented, will substantially increase the representation of environmental types particularly within 8 ecoregions. To meet internationally agreed conservation goals, additional MPAs will be needed. To assist with this process, we identified 107 spatially restricted environmental types, which should be considered for inclusion in future MPAs. Detailed supplementary data including a spatial dataset are provided.	[Douglass, Lucinda L.; Grantham, Hedley S.; Beaver, Daniel] Univ Queensland, Sch Biol Sci, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia; [Douglass, Lucinda L.; Turner, Joel; Beaver, Daniel] Ctr Conservat Geog, Sydney, NSW, Australia; [Grantham, Hedley S.] Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA; [Kaiser, Stefanie; Brandt, Angelika] Univ Hamburg, Bioctr Grindel & Zool Museum, Hamburg, Germany; [Kaiser, Stefanie] German Ctr Marine Biodivers Res, Wilhelmshaven, Germany; [Constable, Andrew; Raymond, Ben] Australian Govt, Dept Environm, Australian Antarctic Div, Kingston, Tas, Australia; [Constable, Andrew; Raymond, Ben] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Nicoll, Rob] WWF Australia, Ultimo, NSW, Australia; [Post, Alexandra] Geosci Australia, Marine & Coastal Environm Grp, Canberra, ACT, Australia	University of Queensland; Conservation International; University of Hamburg; Australian Antarctic Division; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; World Wildlife Fund; Geoscience Australia	Douglass, LL (corresponding author), Univ Queensland, Sch Biol Sci, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia.	douglass.lucinda@gmail.com	Brandt, Angelika/C-1630-2018	Kaiser, Stefanie/0000-0003-2026-4663; Post, Alexandra/0000-0002-6287-3283	WWF	WWF	Research funding was provided by WWF (wwf.panda.org). The funders had no role in data collection and analysis or decision to publish the manuscript.	Agnew DJ, 1997, ANTARCT SCI, V9, P235, DOI 10.1017/S095410209700031X; Ainley DG, 2010, ROSS SEA BIOREGION 1; Aldea C, 2008, DEEP-SEA RES PT I, V55, P350, DOI 10.1016/j.dsr.2007.12.002; Allcock AL, 2011, DEEP-SEA RES PT II, V58, P242, DOI 10.1016/j.dsr2.2010.05.016; Allcock AL, 2005, ZOOL J LINN SOC-LOND, V143, P75, DOI 10.1111/j.1096-3642.2004.00146.x; Arango CP, 2011, DEEP-SEA RES PT II, V58, P212, DOI 10.1016/j.dsr2.2010.05.019; Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Arrigo KR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001739; Baines PG, 2007, ENCY ANTARCTIC, P1146; Barnes DKA, 2008, GLOBAL ECOL BIOGEOGR, V17, P84, DOI 10.1111/j.1466-8238.2007.00342.x; Barnes DKA, 2010, J BIOGEOGR, V37, P1648, DOI 10.1111/j.1365-2699.2010.02320.x; BARNES DKA, 1995, POLAR BIOL, V15, P335; Barry J.P., 1991, Ecological Studies, P270; Barry James P., 2003, Antarctic Research Series, V78, P327; BARRY JP, 1988, POLAR BIOL, V8, P367, DOI 10.1007/BF00442028; Beaman RJ, 2005, CONT SHELF RES, V25, P1657, DOI 10.1016/j.csr.2005.04.013; Bowden DA, 2011, DEEP-SEA RES PT II, V58, P119, DOI 10.1016/j.dsr2.2010.09.006; Bradbury IR, 2001, CAN J FISH AQUAT SCI, V58, P811, DOI 10.1139/cjfas-58-4-811; Brandao SN, 2010, MOL PHYLOGENET EVOL, V55, P1055, DOI 10.1016/j.ympev.2010.01.014; BRANDT A, 1992, MAR BIOL, V113, P415, DOI 10.1007/BF00349167; Brandt A, 2011, DEEP-SEA RES PT II, V58, P1962, DOI 10.1016/j.dsr2.2011.01.008; Brandt A, 2007, DEEP-SEA RES PT II, V54, P1760, DOI 10.1016/j.dsr2.2007.07.015; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Brandt A, 2009, DEEP-SEA RES PT I, V56, P2013, DOI 10.1016/j.dsr.2009.06.007; Brey T, 1996, ANTARCT SCI, V8, P3, DOI 10.1017/S0954102096000028; Brockington S, 2001, MAR BIOL, V139, P127; Cantero ALP, 2004, POLAR BIOL, V27, P767, DOI 10.1007/s00300-004-0654-9; CCAMLR, 2010, CONS MEAS 22 07 INT; CCAMLR, 2012, CONS MEAS 22 06 BOTT; CCAMLR, 2012, CONS MEAS 91 02 PROT; CCAMLR, 2009, CONS MEAS 91 03 2009; CCAMLR Secretariat, 2013, VULN MAR EC REG; Christiansen S, 2010, SID EV 12 UNEP GLOB; Clark MR, 2011, OCEAN COAST MANAGE, V54, P19, DOI 10.1016/j.ocecoaman.2010.10.006; Clarke A, 2004, ANTARCT SCI, V16, P559, DOI 10.1017/S0954102004002329; Clarke A, 2003, ECOSY WORLD, V28, P239; Clarke A, 2008, DEEP-SEA RES PT II, V55, P1988, DOI 10.1016/j.dsr2.2008.04.035; Clarke A, 2007, DIVERS DISTRIB, V13, P620, DOI 10.1111/j.1472-4642.2007.00380.x; Clarke A, 2006, DEEP-SEA RES PT II, V53, P803, DOI 10.1016/j.dsr2.2006.05.001; Clarke A, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000886; Constable AJ, 2000, ICES J MAR SCI, V57, P778, DOI 10.1006/jmsc.2000.0725; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Danis B, 2009, NATURE, V458, P830, DOI 10.1038/458830b; David B, 2003, ANTARCTIC ECHINOIDS; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; Delegations of Australia and France, 2011, PROP REPR SYST UNPUB; Diaz A, 2011, DEEP-SEA RES PT II, V58, P205, DOI 10.1016/j.dsr2.2010.10.012; Duhamel G, 2009, CCAMLR SCI, V16, P1; ERA, 2011, ANT PROT AR; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Feldman GC, 2010, SEAWIFS REPROCESSING; Fichefet T, 1999, GEOPHYS RES LETT, V26, P1015, DOI 10.1029/1999GL900159; France SC, 1996, MAR BIOL, V126, P633, DOI 10.1007/BF00351330; Fukamachi Y, 2010, NAT GEOSCI, V3, P327, DOI 10.1038/NGEO842; Gili JM, 2006, MAR ECOL PROG SER, V322, P43, DOI 10.3354/meps322043; Gjerde Kristina M., 2006, UNEP Regional Seas Reports and Studies, V178, P1; Gonzalez-Wevar CA, 2011, DEEP-SEA RES PT II, V58, P220, DOI 10.1016/j.dsr2.2010.05.026; Grant S, 2006, BIOR SO OC REP EXP W; Grantham HS, 2008, CONSERV LETT, V1, P190, DOI 10.1111/j.1755-263X.2008.00029.x; Grebmeier J.M., 1991, Journal of Marine Systems, V2, P495, DOI 10.1016/0924-7963(91)90049-Z; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; Griffiths HJ, 2009, J BIOGEOGR, V36, P162, DOI 10.1111/j.1365-2699.2008.01979.x; Gutt J, 2001, POLAR BIOL, V24, P553, DOI 10.1007/s003000100262; Gutt J, 2007, ANTARCT SCI, V19, P165, DOI 10.1017/S0954102007000247; Gutt J, 2013, NAT CONSERV-BULGARIA, P1, DOI 10.3897/natureconservation.4.4499; Hall S, 2011, POLAR BIOL, V34, P363, DOI 10.1007/s00300-010-0890-0; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2006, ECOL LETT, V9, P2, DOI 10.1111/j.1461-0248.2005.00827.x; Harris PT, 2011, MAR GEOL, V285, P69, DOI 10.1016/j.margeo.2011.05.008; Harris PT, 2009, OCEAN COAST MANAGE, V52, P22, DOI 10.1016/j.ocecoaman.2008.09.009; Harris PT, 2012, ELSEV INSIGHT, P1; Havermans C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074218; Held C, 2005, SCI MAR, V69, P175, DOI 10.3989/scimar.2005.69s2175; Held C, 2003, ANTARCTIC BIOLOGY IN A GLOBAL CONTEXT, PROCEEDINGS, P135; Hemery LG, 2012, MOL ECOL, V21, P2502, DOI 10.1111/j.1365-294X.2012.05512.x; Hoffman JI, 2011, J HERED, V102, P55, DOI 10.1093/jhered/esq094; Huang Z, 2011, CONT SHELF RES, V31, pS4, DOI 10.1016/j.csr.2010.03.012; Hunter RL, 2008, J HERED, V99, P137, DOI 10.1093/jhered/esm119; Kaiser S, 2013, MAR BIOL, V160, P2295, DOI 10.1007/s00227-013-2232-6; Kaiser S, 2011, DEEP-SEA RES PT II, V58, P91, DOI 10.1016/j.dsr2.2010.05.017; Kitchingman A., 2007, SEAMOUNTS ECOLOGY FI, V12, P26, DOI DOI 10.1002/9780470691953.CH2; Knox G. A., 2007, BIOL SO OCEAN; Kock KH, 2007, ANTARCT SCI, V19, P231, DOI 10.1017/S0954102007000302; Koubbi P, 2011, DEEP-SEA RES PT II, V58, P170, DOI 10.1016/j.dsr2.2010.09.007; Koubbi P, 2010, POLAR SCI, V4, P115, DOI 10.1016/j.polar.2010.04.012; Kruse S, 2009, POLAR BIOL, V32, P1359, DOI 10.1007/s00300-009-0632-3; Last PR, 2010, BIOL CONSERV, V143, P1675, DOI 10.1016/j.biocon.2010.04.008; Leese F, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-19; Leon TM, 2001, POLAR BIOL, V24, P941, DOI 10.1007/s003000100305; Linse K, 2006, DEEP-SEA RES PT II, V53, P985, DOI 10.1016/j.dsr2.2006.05.003; Locarnini R. A., 2006, WORLD OCEAN ATLAS 20, V1; Lombard AT, 2007, ANTARCT SCI, V19, P39, DOI 10.1017/S0954102007000077; Longhurst AR, 1998, ECOLOGICAL GEOGRAPHY; Martin S, 2001, ENCY OCEAN SCI, P2241, DOI DOI 10.1006/RWOS.2001.0007; Massom RA, 2010, POLAR SCI, V4, P149, DOI 10.1016/j.polar.2010.05.001; Matschiner M, 2009, MOL ECOL, V18, P2574, DOI 10.1111/j.1365-294X.2009.04220.x; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; McCartney MS, 2007, PROG OCEANOGR, V75, P675, DOI 10.1016/j.pocean.2007.02.008; McLeod DJ, 2010, POLAR SCI, V4, P353, DOI 10.1016/j.polar.2010.03.004; Meijers AJS, 2010, DEEP-SEA RES PT II, V57, P723, DOI 10.1016/j.dsr2.2009.04.019; Morley SA, 2012, MAR ECOL PROG SER, V450, P81, DOI 10.3354/meps09577; N.Z and U.S, 2012, REV 1 CONSERVATION M; Nicol S, 2000, NATURE, V406, P504, DOI 10.1038/35020053; Njaastad B, 2011, COMMUNICATION; O'Brien PE, 2009, SCI COMM COMM ANT MA; O'Brien PE, 1997, ANTARCT RES SER, V2, P109; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Penhale P, 2007, COMM CONS ANT MAR LI; Post AL, 2011, DEEP-SEA RES PT II, V58, P105, DOI 10.1016/j.dsr2.2010.05.020; Post AL, 2010, ANTARCT SCI, V22, P371, DOI 10.1017/S0954102010000180; Potthoff M, 2006, POLAR BIOL, V29, P543, DOI 10.1007/s00300-005-0086-1; Pressey RL, 2009, ORYX, V43, P464, DOI 10.1017/S0030605309990500; Robertson R, 2002, DEEP-SEA RES PT II, V49, P4791, DOI 10.1016/S0967-0645(02)00159-5; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; SC-CAMLR, 2010, PRER VERS REP 29 M S; SC-CAMLR, 2009, SCI COMM CONS ANT MA; SC-CAMLR, 2005, REP SCI COMM WORKSH; SC-CAMLR, 2009, REP JOINT SC CAMLR C; Schlacher TA, 2007, MAR ECOL PROG SER, V340, P73, DOI 10.3354/meps340073; Schnack-Schiel SB, 2005, SCI MARINA, V69; SCOTT J M, 1993, WILDLIFE MONOGR, V123, P3, DOI DOI 10.1016/0006-3207(94)90022-1; Shaw PW, 2004, MOL ECOL, V13, P3293, DOI 10.1111/j.1365-294X.2004.02327.x; Smith CR, 2006, DEEP-SEA RES PT II, V53, P875, DOI 10.1016/j.dsr2.2006.02.001; Smith W, 2010, MEASURED ESTIMATED S; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Sokolov S, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004072; Sokolov S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005108; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spreen G, 2008, J GEOPHYS RES, V113, P3481; Suhr SB, 2006, DEEP-SEA RES PT II, V53, P895, DOI 10.1016/j.dsr2.2006.02.002; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; Thornhill DJ, 2008, MOL ECOL, V17, P5104, DOI 10.1111/j.1365-294X.2008.03970.x; UQEC, 2009, SCI PRINC DES MAR PR; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Wiencke C, 2006, J ECOL, V94, P455, DOI 10.1111/j.1365-2745.2006.01102.x; Williams A, 2009, ICES J MAR SCI, V66, P214, DOI 10.1093/icesjms/fsn189; Williams R., 1995, CCAMLR Science, V2, P1; Wilson NG, 2007, MAR BIOL, V152, P895, DOI 10.1007/s00227-007-0742-9; Wilson PR, 2001, MAR ECOL PROG SER, V213, P301, DOI 10.3354/meps213301	139	42	43	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100551	10.1371/journal.pone.0100551	http://dx.doi.org/10.1371/journal.pone.0100551			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032993	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300009
J	Sadamura-Takenaka, Y; Ito, T; Noma, S; Oyama, Y; Yamada, S; Kawahara, K; Inoue, H; Maruyama, I				Sadamura-Takenaka, Yukari; Ito, Takashi; Noma, Satoshi; Oyama, Yoko; Yamada, Shingo; Kawahara, Ko-ichi; Inoue, Hiromasa; Maruyama, Ikuro			HMGB1 Promotes the Development of Pulmonary Arterial Hypertension in Rats	PLOS ONE			English	Article							CHROMATIN PROTEIN HMGB1; SMOOTH-MUSCLE-CELLS; GROUP BOX PROTEIN; ATHEROSCLEROTIC PLAQUES; INFLAMMATION; EXPRESSION; THERAPY; SIGNAL; HMG-1	Rationale: Pulmonary arterial hypertension (PAH) is characterized by increased pulmonary vascular resistance leading to right ventricular failure and death. Recent studies have suggested that chronic inflammatory processes are involved in the pathogenesis of PAH. However, the molecular and cellular mechanisms driving inflammation have not been fully elucidated. Objectives: To elucidate the roles of high mobility group box 1 protein (HMGB1), a ubiquitous DNA-binding protein with extracellular pro-inflammatory activity, in a rat model of PAH. Methods: Male Sprague-Dawley rats were administered monocrotaline (MCT). Concentrations of HMGB1 in bronchoalveolar lavage fluid (BALF) and serum, and localization of HMGB1 in the lung were examined over time. The protective effects of anti-HMGB1 neutralizing antibody against MCT-induced PAH were tested. Results: HMGB1 levels in BALF were elevated 1 week after MCT injection, and this elevation preceded increases of other pro-inflammatory cytokines, such as TNF-alpha, and the development of PAH. In contrast, serum HMGB1 levels were elevated 4 weeks after MCT injection, at which time the rats began to die. Immunohistochemical analyses indicated that HMGB1 was translocated to the extranuclear space in periarterial infiltrating cells, alveolar macrophages, and bronchial epithelial cells of MCT-injected rats. Anti-HMGB1 neutralizing antibody protected rats against MCT-induced lung inflammation, thickening of the pulmonary artery wall, and elevation of right ventricular systolic pressure, and significantly improved the survival of the MCT-induced PAH rats. Conclusions: Our results identify extracellular HMGB1 as a promoting factor for MCT-induced PAH. The blockade of HMGB1 activity improved survival of MCT-induced PAH rats, and thus might be a promising therapy for the treatment of PAH.	[Sadamura-Takenaka, Yukari; Noma, Satoshi; Inoue, Hiromasa] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima 890, Japan; [Sadamura-Takenaka, Yukari; Ito, Takashi; Noma, Satoshi; Maruyama, Ikuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Kagoshima 890, Japan; [Oyama, Yoko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Lab & Vasc Med, Kagoshima 890, Japan; [Yamada, Shingo] Shinotest Corp, Sagamihara, Kanagawa, Japan; [Kawahara, Ko-ichi] Osaka Inst Technol, Dept Biomed Engn, Osaka 535, Japan	Kagoshima University; Kagoshima University; Kagoshima University; Osaka Institute of Technology	Maruyama, I (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Kagoshima 890, Japan.	maruyama@m2.kufm.kagoshima-u.ac.jp			Japan Society for the Promotion of Science [25293192, 24390402, 23390412]; Grants-in-Aid for Scientific Research [25293192] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research grants from the Japan Society for the Promotion of Science (Grant-in-Aid 25293192, 24390402, and 23390412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Bauer EM, 2012, MOL MED, V18, P1509, DOI 10.2119/molmed.2012.00283; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Chaouat A, 2009, CHEST, V136, P678, DOI 10.1378/chest.08-2420; de Souza AWS, 2012, AUTOIMMUN REV, V11, P909, DOI 10.1016/j.autrev.2012.03.007; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Hatada T, 2005, THROMB HAEMOSTASIS, V94, P975, DOI 10.1160/TH05-05-0316; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Ikeda Y, 2002, AM J PHYSIOL-HEART C, V283, pH2021, DOI 10.1152/ajpheart.00919.2001; Ito T, 2007, NBER E A EC, V16, P1; Itoh T, 2006, RESPIROLOGY, V11, P158, DOI 10.1111/j.1440-1843.2006.00821.x; Itoh T, 2004, AM J RESP CRIT CARE, V170, P1204, DOI 10.1164/rccm.200404-455OC; Jaulmes A, 2006, FASEB J, V20, P1727, DOI 10.1096/fj.05-5514fje; Kuang TG, 2010, PULM PHARMACOL THER, V23, P456, DOI 10.1016/j.pupt.2010.02.003; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mathew R, 2010, CARDIOL REV, V18, P67, DOI 10.1097/CRD.0b013e3181cd612f; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Minamino T, 2001, P NATL ACAD SCI USA, V98, P8798, DOI 10.1073/pnas.161272598; Moreno JA, 2013, ARTERIOSCL THROM VAS, V33, P612, DOI 10.1161/ATVBAHA.112.300874; Oyama Y, 2010, LAB INVEST, V90, P853, DOI 10.1038/labinvest.2010.64; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033; Porto A, 2006, FASEB J, V20, P2565, DOI 10.1096/fj.06-5867fje; Pullamsetti SS, 2011, CLIN MICROBIOL INFEC, V17, P7, DOI 10.1111/j.1469-0691.2010.03285.x; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]; Tang D, ANTIOXID REDOX SIGNA, V14, P1315; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; Umar S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/702836; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang Q, 2013, VASC PHARMACOL, V58, P71, DOI 10.1016/j.vph.2012.07.006; Wang W, 2011, MOL BIOL REP, V38, P3277, DOI 10.1007/s11033-010-0390-x; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6	40	46	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102482	10.1371/journal.pone.0102482	http://dx.doi.org/10.1371/journal.pone.0102482			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032709	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300055
J	Toth, AE; Walter, FR; Bocsik, A; Santha, P; Veszelka, S; Nagy, L; Puskas, LG; Couraud, PO; Takata, F; Dohgu, S; Kataoka, Y; Deli, MA				Toth, Andrea E.; Walter, Fruzsina R.; Bocsik, Alexandra; Santha, Petra; Veszelka, Szilvia; Nagy, Lajos; Puskas, Laszlo G.; Couraud, Pierre-Olivier; Takata, Fuyuko; Dohgu, Shinya; Kataoka, Yasufumi; Deli, Maria A.			Edaravone Protects against Methylglyoxal-Induced Barrier Damage in Human Brain Endothelial Cells	PLOS ONE			English	Article							FREE-RADICAL GENERATION; GLYCATION END-PRODUCTS; OXIDATIVE STRESS; IN-VITRO; CARBONYL STRESS; DIABETIC COMPLICATIONS; ALZHEIMERS-DISEASE; ISCHEMIC-STROKE; GLYOXALASE-I; PERMEABILITY	Background: Elevated level of reactive carbonyl species, such as methylglyoxal, triggers carbonyl stress and activates a series of inflammatory responses leading to accelerated vascular damage. Edaravone is the active substance of a Japanese medicine, which aids neurological recovery following acute brain ischemia and subsequent cerebral infarction. Our aim was to test whether edaravone can exert a protective effect on the barrier properties of human brain endothelial cells (hCMEC/D3 cell line) treated with methylglyoxal. Methodology: Cell viability was monitored in real-time by impedance-based cell electronic sensing. The barrier function of the monolayer was characterized by measurement of resistance and flux of permeability markers, and visualized by immunohistochemistry for claudin-5 and beta-catenin. Cell morphology was also examined by holographic phase imaging. Principal Findings: Methylglyoxal exerted a time- and dose-dependent toxicity on cultured human brain endothelial cells: a concentration of 600 mu M resulted in about 50% toxicity, significantly reduced the integrity and increased the permeability of the barrier. The cell morphology also changed dramatically: the area of cells decreased, their optical height significantly increased. Edaravone (3 mM) provided a complete protection against the toxic effect of methylglyoxal. Co-administration of edaravone restored cell viability, barrier integrity and functions of brain endothelial cells. Similar protection was obtained by the well-known antiglycating molecule, aminoguanidine, our reference compound. Conclusion: These results indicate for the first time that edaravone is protective in carbonyl stress induced barrier damage. Our data may contribute to the development of compounds to treat brain endothelial dysfunction in carbonyl stress related diseases.	[Toth, Andrea E.; Walter, Fruzsina R.; Bocsik, Alexandra; Santha, Petra; Veszelka, Szilvia; Deli, Maria A.] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Nagy, Lajos; Puskas, Laszlo G.] Avidin Ltd, Szeged, Hungary; [Couraud, Pierre-Olivier] Inst Cochin, INSERM, U1016, Paris, France; [Couraud, Pierre-Olivier] CNRS, UMR8104, Paris, France; [Couraud, Pierre-Olivier] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Takata, Fuyuko; Dohgu, Shinya; Kataoka, Yasufumi] Fukuoka Univ, Dept Pharmaceut Care & Hlth Sci, Fukuoka 81401, Japan	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Fukuoka University	Deli, MA (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary.	deli.maria@brc.mta.hu	Toth, Andrea E. E/T-1226-2018; Dohgu, Shinya/AAK-9992-2020; Deli, Mária A./I-2885-2019	Toth, Andrea E. E/0000-0001-6122-919X; Deli, Mária A./0000-0001-6084-6524; Veszelka, Szilvia/0000-0001-8864-1184	European Union; State of Hungary - European Social Fund in the framework of "National Excellence Program'' [TAMOP-4.2.4. A/2-11-1-2012-0001, TAMOP-4.2.2.A-11/1/KONV-2012-0052]; Rollin D. Hotchkiss Foundation	European Union(European Commission); State of Hungary - European Social Fund in the framework of "National Excellence Program''; Rollin D. Hotchkiss Foundation	This research was supported by grants from the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP-4.2.4. A/2-11-1-2012-0001 "National Excellence Program'' and TAMOP-4.2.2.A-11/1/KONV-2012-0052, and the Dr. Rollin D. Hotchkiss Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Beard RS, 2011, BLOOD, V118, P2007, DOI 10.1182/blood-2011-02-338269; Beeri MS, 2011, MECH AGEING DEV, V132, P583, DOI 10.1016/j.mad.2011.10.007; Bruno A, 2010, CURR TREAT OPTION NE, V12, P492, DOI 10.1007/s11940-010-0093-6; Cardoso FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035919; Chang TJ, 2006, CAN J PHYSIOL PHARM, V84, P1229, DOI 10.1139/Y06-077; del Zoppo GJ, 2006, BIOCHEM SOC T, V34, P1261, DOI 10.1042/BST0341261; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Desai Kaushik, 2007, Recent Pat Cardiovasc Drug Discov, V2, P89; Desai Kaushik M., 2008, Drug Metabolism and Drug Interactions, V23, P151; Dobler D, 2006, DIABETES, V55, P1961, DOI 10.2337/db05-1634; Dukic-Stefanovic S, 2001, BIOGERONTOLOGY, V2, P19, DOI 10.1023/A:1010052800347; EDELSTEIN D, 1992, DIABETES, V41, P26, DOI 10.2337/diabetes.41.1.26; Kalapos MP, 2008, CHEM-BIOL INTERACT, V171, P251, DOI 10.1016/j.cbi.2007.11.009; Kalapos MP, 2013, DIABETES RES CLIN PR, V99, P260, DOI 10.1016/j.diabres.2012.11.003; Kaste M, 2013, CEREBROVASC DIS, V36, P196, DOI 10.1159/000353680; Kaur S, 2013, ARCH DERMATOL RES, V305, P489, DOI 10.1007/s00403-013-1362-5; Kiss L, 2013, J PHARM SCI-US, V102, P1173, DOI 10.1002/jps.23458; Kono S, 2013, J STROKE CEREBROVASC, V22, P1175, DOI 10.1016/j.jstrokecerebrovasdis.2013.02.010; Kurti L, 2013, EUR J PHARM SCI, V50, P86, DOI 10.1016/j.ejps.2013.03.012; Kurti L, 2013, CYTOTECHNOLOGY, V65, P395, DOI 10.1007/s10616-012-9493-7; Kuhla B, 2005, ANN NY ACAD SCI, V1043, P211, DOI 10.1196/annals.1333.026; Lapolla A, 2003, CLIN CHEM LAB MED, V41, P1166, DOI 10.1515/CCLM.2003.180; Lee C, 1998, J BIOL CHEM, V273, P25272, DOI 10.1074/jbc.273.39.25272; Li W, 2013, FREE RADICAL BIO MED, V54, P51, DOI 10.1016/j.freeradbiomed.2012.10.552; Li WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076025; Li WL, 2013, NEUROSCI LETT, V549, P146, DOI 10.1016/j.neulet.2013.06.007; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Liu JH, 2011, CARDIOVASC RES, V92, P494, DOI 10.1093/cvr/cvr239; LO TWC, 1994, J BIOL CHEM, V269, P32299; Lukic-Panin V, 2010, CURR NEUROVASC RES, V7, P319, DOI 10.2174/156720210793180747; Madacsi R, 2013, MED CHEM, V9, P911, DOI 10.2174/1573406411309070004; Mangalmurti NS, 2010, TRANSFUSION, V50, P2353, DOI 10.1111/j.1537-2995.2010.02689.x; Matafome P, 2013, ENDOCRINE, V43, P472, DOI 10.1007/s12020-012-9795-8; Moheimani F, 2010, BBA-MOL BASIS DIS, V1802, P561, DOI 10.1016/j.bbadis.2010.02.007; Munch G, 2012, AMINO ACIDS, V42, P1221, DOI 10.1007/s00726-010-0777-y; Mukohda M, 2012, J PHARMACOL SCI, V118, P303, DOI 10.1254/jphs.11R12CP; Munch G, 2003, BIOCHEM SOC T, V31, P1397; Murata-Kamiya N, 2001, NUCLEIC ACIDS RES, V29, P3433, DOI 10.1093/nar/29.16.3433; Nemet I, 2006, MOL NUTR FOOD RES, V50, P1105, DOI 10.1002/mnfr.200600065; Okouchi M, 2009, CURR NEUROVASC RES, V6, P267, DOI 10.2174/156720209789630348; Omori K, 2007, AM J PHYSIOL-CELL PH, V293, pC1523, DOI 10.1152/ajpcell.00524.2006; Onodera H, 2013, BRAIN RES, V1534, P87, DOI 10.1016/j.brainres.2013.08.019; Ozsvari B, 2010, INT J MOL MED, V25, P525, DOI 10.3892/ijmm_00000373; Paolinelli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070233; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Rabbani N, 2008, BIOCHEM SOC T, V36, P1045, DOI 10.1042/BST0361045; Rabbani N, 2011, DIABETES, V60, P1973, DOI 10.2337/db11-0085; Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0; Rouhiainen Ari, 2013, Methods Mol Biol, V963, P239, DOI 10.1007/978-1-62703-230-8_15; Sena CM, 2012, PHARMACOL RES, V65, P497, DOI 10.1016/j.phrs.2012.03.004; Srikanth V, 2013, J GERONTOL A-BIOL, V68, P68, DOI 10.1093/gerona/gls100; Stitt AW, 2002, EXPERT OPIN INV DRUG, V11, P1205, DOI 10.1517/13543784.11.9.1205; Thornalley PJ, 1996, BIOCHEM PHARMACOL, V51, P1365, DOI 10.1016/0006-2952(96)00059-7; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Turk Z, 2010, PHYSIOL RES, V59, P147, DOI 10.33549/physiolres.931585; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Vander Jagt DL, 2003, CHEM-BIOL INTERACT, V143, P341, DOI 10.1016/S0009-2797(02)00212-0; Wang CX, 2007, PROG NEUROBIOL, V83, P140, DOI 10.1016/j.pneurobio.2007.07.006; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Whitmer RA, 2007, CURR NEUROL NEUROSCI, V7, P373, DOI 10.1007/s11910-007-0058-7; Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164; Yamawaki H, 2008, AM J PHYSIOL-CELL PH, V295, pC1510, DOI 10.1152/ajpcell.00252.2008; Yao DC, 2006, CELL, V124, P275, DOI 10.1016/j.cell.2005.11.024; YIM HS, 1995, J BIOL CHEM, V270, P28228; Youdim KA, 2003, DRUG DISCOV TODAY, V8, P997, DOI 10.1016/S1359-6446(03)02873-3	68	38	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100152	10.1371/journal.pone.0100152	http://dx.doi.org/10.1371/journal.pone.0100152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033388	Green Published, Green Submitted, gold			2022-12-25	WOS:000339418300005
J	Wildhagen, KCAA; Schrijver, R; Beckers, L; ten Cate, H; Reutelingsperger, CPM; Lutgens, E; Nicolaes, GAF				Wildhagen, Karin C. A. A.; Schrijver, Roy; Beckers, Linda; ten Cate, Hugo; Reutelingsperger, Chris P. M.; Lutgens, Esther; Nicolaes, Gerry A. F.			Effects of Exogenous Recombinant APC in Mouse Models of Ischemia Reperfusion Injury and of Atherosclerosis	PLOS ONE			English	Article							ACTIVATED PROTEIN-C; REDUCED ANTICOAGULANT ACTIVITY; ENDOTHELIAL-CELLS; MYOCARDIAL-ISCHEMIA; FACTOR-V; LIPID-PEROXIDATION; THROMBOTIC DISEASE; DEFICIENT MICE; STROKE MODEL; INTERLEUKIN-6	Activated protein C (APC) is a serine protease that has both anticoagulant and cytoprotective properties. The cytoprotective effects are protease activated receptor 1 (PAR-1) and endothelial protein C receptor (EPCR) dependent and likely underlie protective effects of APC in animal models of sepsis, myocardial infarction and ischemic stroke. S360A-(A) PC, a variant (A) PC that has no catalytic activity, binds EPCR and shifts pro-inflammatory signaling of the thrombin-PAR-1 complex to anti-inflammatory signaling. In this study we investigated effects of human (h) wt-PC, hS360A-PC, hwt-APC and hS360A-APC in acute (mouse model of acute myocardial ischemia/reperfusion (I/R) injury) and chronic inflammation (apoE(-/-) mouse model of atherosclerosis). All h(A) PC variants significantly reduced myocardial infarct area (p<0.05) following I/R injury. IL-6 levels in heart homogenates did not differ significantly between sham, placebo and treatment groups in I/R injury. None of the h(A) PC variants decreased number and size of atherosclerotic plaques in apoE(-/-) mice. Only hS360A-APC slightly affected phenotype of plaques. IL-6 levels in plasma were significantly (p<0.001) decreased in hwt-APC and hS360A-PC treated mice. In the last group levels of monocyte chemotactic protein 1 (MCP-1) were significantly increased (p<0.05). In this study we show that both hwt and hS360A-(A)PC protect against acute myocardial I/R injury, which implies that protection from I/R injury is independent of the proteolytic activity of APC. However, in the chronic atherosclerosis model hwt and hS360-(A)PC had only minor effects. When the dose, species and mode of (A) PC administration will be adjusted, we believe that (A)PC will have potential to influence development of chronic inflammation as occurring during atherosclerosis as well.	[Wildhagen, Karin C. A. A.; Schrijver, Roy; ten Cate, Hugo; Reutelingsperger, Chris P. M.; Nicolaes, Gerry A. F.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [Beckers, Linda; Lutgens, Esther] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [ten Cate, Hugo] Maastricht Univ, Cardiovasc Res Inst Maastricht, Lab Clin Thrombosis & Haemostasis, Dept Internal Med, Maastricht, Netherlands	Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	Nicolaes, GAF (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands.	g.nicolaes@maastrichtuniversity.nl	Nicolaes, Gerry A.F./A-8421-2016; Cate, Hugo ten/AAM-4000-2021; Lutgens, Esther/E-2919-2010	Nicolaes, Gerry A.F./0000-0002-2482-0412; Lutgens, Esther/0000-0002-2609-5744	Netherlands Thrombosis Foundation [125/2008/OPI]; Cardiovascular Research Institute Maastricht	Netherlands Thrombosis Foundation; Cardiovascular Research Institute Maastricht	The authors would like to acknowledge the financial support by the Netherlands Thrombosis Foundation (project grant 125/2008/OPI, to HtC and GN) and grants from the Cardiovascular Research Institute Maastricht (to GN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2008, J THROMB HAEMOST, V6, P954, DOI 10.1111/j.1538-7836.2008.02924.x; Bae JS, 2008, THROMB HAEMOSTASIS, V100, P101, DOI 10.1160/TH08-02-0127; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Bae JS, 2007, P NATL ACAD SCI USA, V104, P2867, DOI 10.1073/pnas.0611493104; Bae JS, 2009, THROMB HAEMOSTASIS, V101, P513, DOI 10.1160/TH08-09-0568; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; Bock F, 2014, THROMB HAEMOSTASIS, V111, P610, DOI 10.1160/TH13-11-0967; BOISCLAIR MD, 1993, THROMB HAEMOSTASIS, V70, P253; Borissoff JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055784; BROEKMANS AW, 1983, NEW ENGL J MED, V309, P340, DOI 10.1056/NEJM198308113090604; Brueckner M, 2013, NEUROSCI LETT, V551, P28, DOI 10.1016/j.neulet.2013.06.055; Chen CM, 2006, CRIT CARE MED, V34, P1960, DOI 10.1097/01.CCM.0000224231.01533.B1; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Ding JW, 2010, J KOREAN MED SCI, V25, P1609, DOI 10.3346/jkms.2010.25.11.1609; Donners MMPC, 2008, BLOOD, V111, P4596, DOI 10.1182/blood-2007-05-088906; Elhage R, 2001, ATHEROSCLEROSIS, V156, P315, DOI 10.1016/S0021-9150(00)00682-1; Erlich JH, 2000, AM J PATHOL, V157, P1849, DOI 10.1016/S0002-9440(10)64824-9; FAY PJ, 1991, J BIOL CHEM, V266, P20139; Feistritzer C, 2006, J BIOL CHEM, V281, P20077, DOI 10.1074/jbc.M600506200; Fernandez JA, 2003, BLOOD CELL MOL DIS, V30, P271, DOI 10.1016/S1079-9796(03)00034-2; FRIEDRICH U, 1994, THROMB HAEMOSTASIS, V72, P567; Gale AJ, 1997, PROTEIN SCI, V6, P132; Galley HF, 2008, BRIT J ANAESTH, V100, P815, DOI 10.1093/bja/aen079; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; Guo H, 2004, NEURON, V41, P563, DOI 10.1016/S0896-6273(04)00019-4; Guo H, 2009, J NEUROCHEM, V109, P116, DOI 10.1111/j.1471-4159.2009.05921.x; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Hirose K, 2000, ANN SURG, V232, P272, DOI 10.1097/00000658-200008000-00018; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Iqbal K, 2002, AM J CARDIOL, V89, P334, DOI 10.1016/S0002-9149(01)02237-8; Jong WMC, 2003, COMPARATIVE MED, V53, P522; KALAFATIS M, 1994, J BIOL CHEM, V269, P31869; Keidar S, 2001, ARTERIOSCL THROM VAS, V21, P1464, DOI 10.1161/hq0901.095547; Krisinger MJ, 2009, FEBS J, V276, P6586, DOI 10.1111/j.1742-4658.2009.07371.x; Lay WN, 2012, INT J CARDIOL, V159, P246, DOI 10.1016/j.ijcard.2012.05.087; Libby P, 2010, ARTERIOSCLER THROMB, V32, P2045; Lin XJ, 2009, SHOCK, V32, P524, DOI 10.1097/SHK.0b013e3181a1a75d; Loubele S, 2009, THESIS MAASTRICHT U, P91; Loubele STBG, 2009, ARTERIOSCL THROM VAS, V29, P1087, DOI 10.1161/ATVBAHA.109.188656; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; Maehata Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038738; MARLAR RA, 1989, J PEDIATR-US, V114, P528, DOI 10.1016/S0022-3476(89)80688-2; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Murakami K, 1996, BLOOD, V87, P642, DOI 10.1182/blood.V87.2.642.bloodjournal872642; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nicolaes GAF, 2003, HEMATOL ONCOL CLIN N, V17, P37, DOI 10.1016/S0889-8588(02)00097-7; Nicolaes GAF, 2002, ARTERIOSCL THROM VAS, V22, P530, DOI 10.1161/01.ATV.0000012665.51263.B7; Nicolaes GAF, 2010, J BIOL CHEM, V285, P22888, DOI 10.1074/jbc.M110.131029; Park SW, 2009, KIDNEY INT, V76, P739, DOI 10.1038/ki.2009.255; Petaja J, 1999, J THORAC CARDIOV SUR, V118, P422, DOI 10.1016/S0022-5223(99)70178-9; Pirat B, 2007, CORONARY ARTERY DIS, V18, P61, DOI 10.1097/MCA.0b013e328010a44a; Preston RJS, 2005, FEBS J, V272, P97, DOI 10.1111/j.1432-1033.2004.04401.x; Raedschelders K, 2012, PHARMACOL THERAPEUT, V133, P230, DOI 10.1016/j.pharmthera.2011.11.004; SELIGSOHN U, 1984, NEW ENGL J MED, V310, P559, DOI 10.1056/NEJM198403013100904; Shibata M, 2001, CIRCULATION, V103, P1799, DOI 10.1161/01.CIR.103.13.1799; Song L, 2004, ATHEROSCLEROSIS, V177, P43, DOI 10.1016/j.atherosclerosis.2004.06.018; Sopel MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045663; Spagnoli LG, 2007, J NUCL MED, V48, P1800, DOI 10.2967/jnumed.107.038661; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Sun YH, 2003, BLOOD, V101, P2277, DOI 10.1182/blood-2002-06-1691; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; Teschendorf P, 2008, RESUSCITATION, V79, P316, DOI 10.1016/j.resuscitation.2008.05.005; Teschendorf P, 2009, RESUSCITATION, V80, P940, DOI 10.1016/j.resuscitation.2009.04.029; Thiyagarajan M, 2008, J NEUROSCI, V28, P12788, DOI 10.1523/JNEUROSCI.3485-08.2008; Van Lenten BJ, 2001, J BIOL CHEM, V276, P1923, DOI 10.1074/jbc.M004074200; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wang J, 2011, J THROMB HAEMOST, V9, P1308, DOI 10.1111/j.1538-7836.2011.04331.x; Wang YM, 2013, BLOOD CELL MOL DIS, V51, P104, DOI 10.1016/j.bcmd.2013.02.009; Wang YM, 2012, STROKE, V43, P2444, DOI 10.1161/STROKEAHA.112.658997; Yamaji K, 2005, THROMB RES, V115, P319, DOI 10.1016/j.thromres.2004.09.011; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zlokovic BV, 2005, ANN NEUROL, V58, P474, DOI 10.1002/ana.20602	74	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101446	10.1371/journal.pone.0101446	http://dx.doi.org/10.1371/journal.pone.0101446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032959	gold, Green Published, Green Submitted			2022-12-25	WOS:000339418300017
J	Zhao, J; Ozawa, K; Kyotani, Y; Nagayama, K; Ito, S; Komatsubara, AT; Tsuji, Y; Yoshizumi, M				Zhao, Jing; Ozawa, Kentaro; Kyotani, Yoji; Nagayama, Kosuke; Ito, Satoyasu; Komatsubara, Akira T.; Tsuji, Yuichi; Yoshizumi, Masanori			Azelnidipine Inhibits Cultured Rat Aortic Smooth Muscle Cell Death Induced by Cyclic Mechanical Stretch	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INDUCED APOPTOSIS; ANGIOTENSIN-II; CHANNEL BLOCKER; CALCIUM BLOCKER; P38; JNK; ATHEROSCLEROSIS; AMLODIPINE; PATHWAYS	Acute aortic dissection is the most common life-threatening vascular disease, with sudden onset of severe pain and a high fatality rate. Clarifying the detailed mechanism for aortic dissection is of great significance for establishing effective pharmacotherapy for this high mortality disease. In the present study, we evaluated the influence of biomechanical stretch, which mimics an acute rise in blood pressure using an experimental apparatus of stretching loads in vitro, on rat aortic smooth muscle cell (RASMC) death. Then, we examined the effects of azelnidipine and mitogen-activated protein kinase inhibitors on mechanical stretch-induced RASMC death. The major findings of the present study are as follows: (1) cyclic mechanical stretch on RASMC caused cell death in a time-dependent manner up to 4 h; (2) cyclic mechanical stretch on RASMC induced c-Jun N-terminal kinase (JNK) and p38 activation with peaks at 10 min; (3) azelnidipine inhibited RASMC death in a concentration-dependent manner as well as inhibited JNK and p38 activation by mechanical stretch; and (4) SP600125 (a JNK inhibitor) and SB203580 (a p38 inhibitor) protected against stretch-induced RASMC death; (5) Antioxidants, diphenylene iodonium and tempol failed to inhibit stretch-induced RASMC death. On the basis of the above findings, we propose a possible mechanism where an acute rise in blood pressure increases biomechanical stress on the arterial walls, which induces RASMC death, and thus, may lead to aortic dissection. Azelnidipine may be used as a pharmacotherapeutic agent for prevention of aortic dissection independent of its blood pressure lowering effect.	[Zhao, Jing; Ozawa, Kentaro; Kyotani, Yoji; Nagayama, Kosuke; Ito, Satoyasu; Komatsubara, Akira T.; Tsuji, Yuichi; Yoshizumi, Masanori] Nara Med Univ, Dept Pharmacol, Sch Med, Kashihara, Nara 634, Japan	Nara Medical University	Yoshizumi, M (corresponding author), Nara Med Univ, Dept Pharmacol, Sch Med, Kashihara, Nara 634, Japan.	yoshizu@naramed-u.ac.jp	Kyotani, Yoji/AAR-3830-2020	Kyotani, Yoji/0000-0002-7771-6889	JSPS KAKENHI [23590306, 26460345]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by JSPS KAKENHI Grants, number 23590306 and 26460345, to MY. (http://www.e-rad.go.jp/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chahine MN, 2012, CAN J PHYSIOL PHARM, V90, P1559, DOI 10.1139/y2012-141; Cheng WP, 2012, CARDIOVASC RES, V93, P181, DOI 10.1093/cvr/cvr280; Collins MJ, 2007, CLIN PATHOL, V61, P519; Cornelissen J, 2004, ARTERIOSCL THROM VAS, V24, P451, DOI 10.1161/01.ATV.0000116690.17017.8b; Costopouzos C, 2008, BIOCHEM PHARMACOL, V75, P1251, DOI 10.1016/j.bcp.2007.10.006; Eguchi K, 2007, J CARDIOVASC PHARM, V49, P394, DOI 10.1097/FJC.0b013e31804d1cf1; Fares Auda, 2013, N Am J Med Sci, V5, P266, DOI 10.4103/1947-2714.110430; Fujimoto S, 2009, NEPHROL DIAL TRANSPL, V24, P3651, DOI 10.1093/ndt/gfp407; GUILMET D, 1993, J CARDIOVASC SURG, V34, P23; Hamada K, 1998, J BIOL CHEM, V273, P6334, DOI 10.1074/jbc.273.11.6334; Hipper A, 2000, PFLUG ARCH EUR J PHY, V440, P19, DOI 10.1007/s004240000246; Huh JE, 2004, BIOCHEM PHARMACOL, V67, P1811, DOI 10.1016/j.bcp.2003.12.025; Iryo Y, 2000, BIOCHEM PHARMACOL, V60, P1875, DOI 10.1016/S0006-2952(00)00510-4; Kim BC, 2005, BIOCHEM PHARMACOL, V70, P1398, DOI 10.1016/j.bcp.2005.07.025; Kondo N, 2006, J PHARMACOL EXP THER, V316, P1047, DOI 10.1124/jpet.105.095331; Kurobe H, 2013, J THORAC CARDIOV SUR, V146, P1501, DOI 10.1016/j.jtcvs.2013.02.073; Kyaw M, 2001, HYPERTENS RES, V24, P251, DOI 10.1291/hypres.24.251; Nakayama H, 2009, CLIN EXP PHARMACOL P, V36, P1183, DOI 10.1111/j.1440-1681.2009.05224.x; Ohyama T, 2012, BRIT J PHARMACOL, V165, P1173, DOI 10.1111/j.1476-5381.2011.01599.x; OIZUMI K, 1990, JPN J PHARMACOL, V54, P1, DOI 10.1254/jjp.54.1; OIZUMI K, 1989, JPN J PHARMACOL, V51, P57, DOI 10.1254/jjp.51.57; Satoh K, 1998, JPN J PHARMACOL, V76, P369, DOI 10.1254/jjp.76.369; Song JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047657; Su BY, 2006, J VASC RES, V43, P229, DOI 10.1159/000091102; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Wernig F, 2003, HYPERTENSION, V41, P903, DOI 10.1161/01.HYP.0000062882.42265.88; Yoshimura K, 2006, ANN NY ACAD SCI, V1085, P74, DOI 10.1196/annals.1383.031; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Zhao XL, 2010, CLIN EXP HYPERTENS, V32, P372, DOI 10.3109/10641961003628510	29	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102813	10.1371/journal.pone.0102813	http://dx.doi.org/10.1371/journal.pone.0102813			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032824	Green Submitted, gold, Green Published			2022-12-25	WOS:000339418300096
J	Luff, JA; Yuan, H; Kennedy, D; Schlegel, R; Felsburg, P; Moore, PF				Luff, Jennifer A.; Yuan, Hang; Kennedy, Douglas; Schlegel, Richard; Felsburg, Peter; Moore, Peter F.			Keratinocyte Antiviral Response to Poly(dA:dT) Stimulation and Papillomavirus Infection in a Canine Model of X-Linked Severe Combined Immunodeficiency	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; IN-VIVO; GENE; IL-15; DIFFERENTIATION; INTERLEUKIN-15; EXPRESSION; CYTOKINES; DISEASE	X-linked severe combined immunodeficiency (XSCID) is caused by a genetic mutation within the common gamma chain (cc), an essential component of the cytokine receptors for interleukin (IL)-2, IL-4, IL-7, IL-9, IL-15, and IL-21. XSCID patients are most commonly treated with bone marrow transplants (BMT) to restore systemic immune function. However, BMT-XSCID humans and dogs remain at an increased risk for development of cutaneous papillomavirus (PV) infections and their associated neoplasms, most typically cutaneous papillomas. Since basal keratinocytes are the target cell for the initial PV infection, we wanted to determine if canine XSCID keratinocytes have a diminished antiviral cytokine response to poly(dA:dT) and canine papillomavirus-2 (CPV-2) upon initial infection. We performed quantitative RT-PCR for antiviral cytokines and downstream interferon stimulated genes (ISG) on poly(dA: dT) stimulated and CPV-2 infected monolayer keratinocyte cultures derived from XSCID and normal control dogs. We found that XSCID keratinocytes responded similarly to poly(dA: dT) as normal keratinocytes by upregulating antiviral cytokines and ISGs. CPV-2 infection of both XSCID and normal keratinocytes did not result in upregulation of antiviral cytokines or ISGs at 2, 4, or 6 days post infection. These data suggest that the antiviral response to initial PV infection of basal keratinocytes is similar between XSCID and normal patients, and is not the likely source for the remaining immunodeficiency in XSCID patients.	[Luff, Jennifer A.; Moore, Peter F.] Univ Calif Davis, Dept Vet Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; [Yuan, Hang; Schlegel, Richard] Georgetown Univ, Sch Med, Dept Pathol, Washington, DC USA; [Kennedy, Douglas; Felsburg, Peter] Univ Penn, Sch Vet Med, Dept Immunol, Philadelphia, PA 19104 USA	University of California System; University of California Davis; Georgetown University; University of Pennsylvania	Luff, JA (corresponding author), Univ Calif Davis, Dept Vet Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA.	jaluff@ucdavis.edu			Georgetown University [1R01RR032315-01]; National Center for Research Resources (NCRR) [R01AI043745, T32 RR07038]; Office of Research Infrastructure Programs (ORIP), a component of the National Institutes of Health (NIH); Center for Companion Animal Health, University of California, Davis [2011-14-F]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007038, R01RR032315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043745] Funding Source: NIH RePORTER	Georgetown University; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Companion Animal Health, University of California, Davis(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This publication was supported by grant number 1R01RR032315-01 (Georgetown University), R01AI043745 and T32 RR07038 from the National Center for Research Resources (NCRR) and the Office of Research Infrastructure Programs (ORIP), a component of the National Institutes of Health (NIH). This work was also made possible by the Center for Companion Animal Health, University of California, Davis through grant 2011-14-F. The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Bulfone-Paus S, 2006, BIOESSAYS, V28, P362, DOI 10.1002/bies.20380; Caruso R, 2009, NAT MED, V15, P1013, DOI 10.1038/nm.1995; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Fahey LM, 2009, J IMMUNOL, V183, P6151, DOI 10.4049/jimmunol.0902145; Felsburg PJ, 1997, BLOOD, V90, P3214, DOI 10.1182/blood.V90.8.3214; Felsburg PJ, 1999, VET IMMUNOL IMMUNOP, V69, P127, DOI 10.1016/S0165-2427(99)00049-5; Felsburg PJ, 1998, IMMUNOL RES, V17, P63, DOI 10.1007/BF02786431; Frazer IH, 2009, VIROLOGY, V384, P410, DOI 10.1016/j.virol.2008.10.004; Gaspar HB, 2004, BRIT J HAEMATOL, V127, P232, DOI 10.1111/j.1365-2141.2004.05176.x; Gill N, 2005, J VIROL, V79, P4470, DOI 10.1128/JVI.79.7.4470-4478.2005; Goldschmidt MH, 2006, J VIROL, V80, P6621, DOI 10.1128/JVI.02571-05; Hartnett BJ, 1999, VET IMMUNOL IMMUNOP, V69, P137, DOI 10.1016/S0165-2427(99)00050-1; HENTHORN PS, 1994, GENOMICS, V23, P69, DOI 10.1006/geno.1994.1460; Kennedy DR, 2011, VET IMMUNOL IMMUNOP, V142, P36, DOI 10.1016/j.vetimm.2011.04.003; Kolly C, 2005, J INVEST DERMATOL, V124, P1014, DOI 10.1111/j.0022-202X.2005.23655.x; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Laffort C, 2004, LANCET, V363, P2051, DOI 10.1016/S0140-6736(04)16457-X; Loser K, 2004, EUR J IMMUNOL, V34, P2022, DOI 10.1002/eji.200324785; Luff JA, 2013, VET IMMUNOL IMMUNOP, V153, P177, DOI 10.1016/j.vetimm.2013.02.001; McInnes IB, 2006, E SCHERING RES FDN W, V56, P29; Murata T, 1998, BLOOD, V91, P3884; Neven B, 2009, BLOOD, V113, P4114, DOI 10.1182/blood-2008-09-177923; Ozbun MA, 2002, J GEN VIROL, V83, P2753, DOI 10.1099/0022-1317-83-11-2753; Prens EP, 2008, J INVEST DERMATOL, V128, P932, DOI 10.1038/sj.jid.5701087; Rathinam VAK, 2011, VIROLOGY, V411, P153, DOI 10.1016/j.virol.2011.02.003; Ruckert R, 2000, J IMMUNOL, V165, P2240, DOI 10.4049/jimmunol.165.4.2240; Sapp M, 2009, FEBS J, V276, P7206, DOI 10.1111/j.1742-4658.2009.07400.x; Schluns KS, 2005, INT J BIOCHEM CELL B, V37, P1567, DOI 10.1016/j.biocel.2005.02.017; Stanley MA, 2012, CLIN MICROBIOL REV, V25, P215, DOI 10.1128/CMR.05028-11; SUTER MM, 1991, VET PATHOL, V28, P131, DOI 10.1177/030098589102800205; Terenzi F, 2008, EMBO J, V27, P3311, DOI 10.1038/emboj.2008.241; Thatte A, 2011, IMMUNOL CELL BIOL, V89, P663, DOI 10.1038/icb.2011.7; Ting-De Ravin SS, 2006, BLOOD, V107, P3091, DOI [10.1182/blood-2005-104057, 10.1182/blood-2005-10-4057]; Yuan H, 2007, VIROLOGY, V359, P28, DOI 10.1016/j.virol.2006.08.029; Zhang SQ, 2008, SCAND J IMMUNOL, V68, P397, DOI 10.1111/j.1365-3083.2008.02150.x	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102033	10.1371/journal.pone.0102033	http://dx.doi.org/10.1371/journal.pone.0102033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025687	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400035
J	Spassov, S; Pfeifer, D; Strosing, K; Ryter, S; Hummel, M; Faller, S; Hoetzel, A				Spassov, Sashko; Pfeifer, Dietmar; Strosing, Karl; Ryter, Stefan; Hummel, Matthias; Faller, Simone; Hoetzel, Alexander			Genetic Targets of Hydrogen Sulfide in Ventilator-Induced Lung Injury - A Microarray Study	PLOS ONE			English	Article							CARBON-MONOXIDE; MECHANICAL VENTILATION; TIDAL VOLUMES; EXPRESSION; PROTECTS; STRESS; MICE; METALLOPROTEINASES; PATHOGENESIS; APOPTOSIS	Recently, we have shown that inhalation of hydrogen sulfide (H2S) protects against ventilator-induced lung injury (VILI). In the present study, we aimed to determine the underlying molecular mechanisms of H2S-dependent lung protection by analyzing gene expression profiles in mice. C57BL/6 mice were subjected to spontaneous breathing or mechanical ventilation in the absence or presence of H2S (80 parts per million). Gene expression profiles were determined by microarray, sqRT-PCR and Western Blot analyses. The association of Atf3 in protection against VILI was confirmed with a Vivo-Morpholino knockout model. Mechanical ventilation caused a significant lung inflammation and damage that was prevented in the presence of H2S. Mechanical ventilation favoured the expression of genes involved in inflammation, leukocyte activation and chemotaxis. In contrast, ventilation with H2S activated genes involved in extracellular matrix remodelling, angiogenesis, inhibition of apoptosis, and inflammation. Amongst others, H2S administration induced Atf3, an anti-inflammatory and anti-apoptotic regulator. Morpholino mediated reduction of Atf3 resulted in elevated lung injury despite the presence of H2S. In conclusion, lung protection by H2S during mechanical ventilation is associated with down-regulation of genes related to oxidative stress and inflammation and up-regulation of anti-apoptotic and anti-inflammatory genes. Here we show that Atf3 is clearly involved in H2S mediated protection.	[Spassov, Sashko; Strosing, Karl; Hummel, Matthias; Faller, Simone; Hoetzel, Alexander] Univ Med Ctr Freiburg, Dept Anaesthesiol & Intens Care Med, Freiburg, Germany; [Pfeifer, Dietmar] Univ Med Ctr Freiburg, Dept Hematol Oncol & Stem Cell Transplantat, Genom Core Lab, Freiburg, Germany; [Ryter, Stefan] New York Presbyterian Hosp, Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, New York, NY USA	University of Freiburg; University of Freiburg; Cornell University; NewYork-Presbyterian Hospital	Spassov, S (corresponding author), Univ Med Ctr Freiburg, Dept Anaesthesiol & Intens Care Med, Freiburg, Germany.	sashko.spassov@uniklinik-freiburg.de	Spassov, Sashko/C-2105-2013	Spassov, Sashko/0000-0002-3585-3682; Faller, Simone/0000-0001-5345-8523	Deutsche Forschungsgemeinschaft [HO 2464/3-1]; Albert Ludwigs University Freiburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This work was supported by a grant from the "Deutsche Forschungsgemeinschaft'' (HO 2464/3-1 to Alexander Hoetzel). The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram A, 2010, AM J RESP CRIT CARE, V182, P489, DOI 10.1164/rccm.200906-0925OC; Altemeier WA, 2004, AM J PHYSIOL-LUNG C, V287, pL533, DOI 10.1152/ajplung.00004.2004; Armstrong DG, 2002, J AM PODIAT MED ASSN, V92, P12, DOI 10.7547/87507315-92-1-12; Aslami H, 2010, INTENS CARE MED, V36, P1946, DOI 10.1007/s00134-010-2022-2; Asuthkar S, 2011, NEURO-ONCOLOGY, V13, P1059, DOI 10.1093/neuonc/nor109; Baumgart K, 2009, CURR OPIN ANESTHESIO, V22, P168, DOI 10.1097/ACO.0b013e328328d22f; Belperio JA, 2006, SEMIN RESP CRIT CARE, V27, P350, DOI 10.1055/s-2006-948289; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Copland IB, 2003, AM J RESP CRIT CARE, V168, P1051, DOI 10.1164/rccm.200208-964OC; Dolinay T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001601; Dolinay T, 2006, PHYSIOL GENOMICS, V26, P68, DOI 10.1152/physiolgenomics.00110.2005; dos Santos CC, 2008, CRIT CARE MED, V36, P855, DOI 10.1097/CCM.0B013E3181659333; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Faller S, 2012, LAB INVEST, V92, P999, DOI 10.1038/labinvest.2012.55; Faller S, 2012, ANESTH ANALG, V114, P747, DOI 10.1213/ANE.0b013e31824762f0; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf; Grigoryev DN, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r34; Hoegl S, 2011, AM J RESP CELL MOL, V44, P369, DOI 10.1165/rcmb.2009-0440OC; Hoetzel A, 2008, AM J RESP CRIT CARE, V177, P1223, DOI 10.1164/rccm.200708-1265OC; Hoffmann DC, 2011, J BIOL CHEM, V286, P28889, DOI 10.1074/jbc.M111.249979; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Lionetti V, 2005, CURR OPIN CRIT CARE, V11, P82, DOI 10.1097/00075198-200502000-00013; Ma SF, 2005, AM J PHYSIOL-LUNG C, V289, pL468, DOI 10.1152/ajplung.00109.2005; Meyer NJ, 2009, FASEB J, V23, P1325, DOI 10.1096/fj.08-119073; Mitra S, 2011, AM J RESP CRIT CARE, V184, P1030, DOI 10.1164/rccm.201103-0447OC; Newby AC, 2007, TRENDS CARDIOVAS MED, V17, P253, DOI 10.1016/j.tcm.2007.09.001; Nishina K, 1998, ANESTHESIOLOGY, V88, P1300, DOI 10.1097/00000542-199805000-00022; Papaiahgari S, 2007, AM J RESP CRIT CARE, V176, P1222, DOI 10.1164/rccm.200701-060OC; Reddy SP, 2007, ANTIOXID REDOX SIGN, V9, P2003, DOI 10.1089/ars.2007.1770; Rizas KD, 2009, CARDIOL REV, V17, P201, DOI 10.1097/CRD.0b013e3181b04698; Roberts ES, 2008, TOXICOL PATHOL, V36, P560, DOI 10.1177/0192623308317422; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Vacek TP, 2010, AMINO ACIDS, V39, P1161, DOI 10.1007/s00726-010-0550-2; Van Lint P, 2006, CYTOKINE GROWTH F R, V17, P217, DOI 10.1016/j.cytogfr.2006.04.001; Wurfel Mark M, 2007, Proc Am Thorac Soc, V4, P77, DOI 10.1513/pats.200608-149JG; Yang Guang-Dong, 2007, Shengli Xuebao, V59, P133; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; 2000, N ENGL J MED, V342, P1301	41	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102401	10.1371/journal.pone.0102401	http://dx.doi.org/10.1371/journal.pone.0102401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025333	Green Submitted, gold, Green Published			2022-12-25	WOS:000339992400071
J	Tan, K; Chen, WW; Dong, SH; Liu, XW; Wang, YC; Nieh, JC				Tan, Ken; Chen, Weiwen; Dong, Shihao; Liu, Xiwen; Wang, Yuchong; Nieh, James C.			Imidacloprid Alters Foraging and Decreases Bee Avoidance of Predators	PLOS ONE			English	Article							APIS-MELLIFERA; LEARNING PERFORMANCES; HONEY-BEES; PESTICIDES; HYMENOPTERA; CERANA; DELTAMETHRIN; TOXICITY; DECLINES; EXPOSURE	Concern is growing over the effects of neonicotinoid pesticides, which can impair honey bee cognition. We provide the first demonstration that sublethal concentrations of imidacloprid can harm honey bee decision-making about danger by significantly increasing the probability of a bee visiting a dangerous food source. Apis cerana is a native bee that is an important pollinator of agricultural crops and native plants in Asia. When foraging on nectar containing 40 mu g/L (34 ppb) imidacloprid, honey bees (Apis cerana) showed no aversion to a feeder with a hornet predator, and 1.8 fold more bees chose the dangerous feeder as compared to control bees. Control bees exhibited significant predator avoidance. We also give the first evidence that foraging by A. cerana workers can be inhibited by sublethal concentrations of the pesticide, imidacloprid, which is widely used in Asia. Compared to bees collecting uncontaminated nectar, 23% fewer foragers returned to collect the nectar with 40 mu g/L imidacloprid. Bees that did return respectively collected 46% and 63% less nectar containing 20 mu g/L and 40 mu g/L imidacloprid. These results suggest that the effects of neonicotinoids on honey bee decision-making and other advanced cognitive functions should be explored. Moreover, research should extend beyond the classic model, the European honey bee (A. mellifera), to other important bee species.	[Tan, Ken] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming, Yunnan Province, Peoples R China; [Tan, Ken; Chen, Weiwen; Dong, Shihao; Liu, Xiwen; Wang, Yuchong] Yunnan Agr Univ, Eastern Bee Res Inst, Kunming, Yunnan Province, Peoples R China; [Nieh, James C.] Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Yunnan Agricultural University; University of California System; University of California San Diego	Tan, K (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming, Yunnan Province, Peoples R China.	kentan@xtbg.ac.cn	Nieh, James C/H-8705-2014; liu, xiwen/GSJ-3861-2022	Nieh, James C/0000-0001-6237-0726; 	Key Laboratory of Tropical Forest Ecology; CAS 135 program of Chinese Academy of Science [XTBGT01]; China National Research Fund [31260585]	Key Laboratory of Tropical Forest Ecology; CAS 135 program of Chinese Academy of Science; China National Research Fund	This work was supported by the Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, and the CAS 135 program (XTBGT01) of Chinese Academy of Science, China National Research Fund (31260585) to Ken Tan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrol Dharam Pal, 2006, Journal of Apicultural Science, V50, P39; Abrol DP, 2013, ASIATIC HONEYBEE API, P575, DOI [10.1007/978-94-007-6928-1_14, DOI 10.1007/978-94-007-6928-1_]; Arena M, 2014, ECOTOXICOLOGY, V23, P324, DOI 10.1007/s10646-014-1190-1; Barron AB, 2007, P NATL ACAD SCI USA, V104, P1703, DOI 10.1073/pnas.0610506104; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; Bray A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087459; Burgett M., 1982, Psyche (Cambridge), V89, P347, DOI 10.1155/1982/37970; Byrne FJ, 2014, PEST MANAG SCI, V70, P470, DOI 10.1002/ps.3596; Colin ME, 2004, ARCH ENVIRON CON TOX, V47, P387, DOI 10.1007/s00244-004-3052-y; Corlett RT, 2001, J TROP ECOL, V17, P155, DOI 10.1017/S0266467401001109; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dukas R, 2005, ECOSCIENCE, V12, P244, DOI 10.2980/i1195-6860-12-2-244.1; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goncalves-Souza T, 2008, ECOLOGY, V89, P2407, DOI 10.1890/07-1881.1; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gross M, 2013, CURR BIOL; Han P, 2010, ECOTOXICOLOGY, V19, P1612, DOI 10.1007/s10646-010-0546-4; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higo M., 1980, Honeybee Science, V1, P177; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Khan RB, 2005, ENVIRON TOXICOL, P59; Lambin M, 2001, ARCH INSECT BIOCHEM, V48, P129, DOI 10.1002/arch.1065; Landgraf T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021354; Lonsdorf E, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P168; Matsuura M, 1990, BIOL VESPINE WASPS; Mishra RC, 1982, INDIAN BEE J, V44, P475; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; Nauen R, 2001, PEST MANAG SCI, V57, P577, DOI 10.1002/ps.331; Pahl M, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P87, DOI 10.1007/978-3-642-02624-9_4; PENG YS, 1989, APIDOLOGIE, V20, P9, DOI 10.1051/apido:19890102; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Schmuck Richard, 2003, Bulletin of Insectology, V56, P27; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; SCHRICKER B, 1970, Journal of Apicultural Research, V9, P141; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Suh YT, 1988, KOREAN J ENV AGR, V8, P47; Sun Z., 1995, J PLANT PROTECT, V2, P44; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; Tan K, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14102; Tan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075841; Tome HVV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038406; Verma L.R., 1993, ASIAN HIVE BEE APIS; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williamson SM, 2013, INVERTEBR NEUROSCI, V13, P63, DOI 10.1007/s10158-012-0144-7; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; Yang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049472; Yang Guan-Huang, 2005, Acta Entomologica Sinica, V48, P401; Yu XL, 2011, ARCH INSECT BIOCHEM, V77, P163, DOI 10.1002/arch.20432; Yuchong W, 2014, J YUNNAN AG IN PRESS; Zar J. H., 2009, BIOSTATISTICAL ANAL	60	58	67	3	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102725	10.1371/journal.pone.0102725	http://dx.doi.org/10.1371/journal.pone.0102725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025334	gold, Green Published			2022-12-25	WOS:000339992400102
J	Shinko, A; Agari, T; Kameda, M; Yasuhara, T; Kondo, A; Tayra, JT; Sato, K; Sasaki, T; Sasada, S; Takeuchi, H; Wakamori, T; Borlongan, CV; Date, I				Shinko, Aiko; Agari, Takashi; Kameda, Masahiro; Yasuhara, Takao; Kondo, Akihiko; Tayra, Judith Thomas; Sato, Kenichiro; Sasaki, Tatsuya; Sasada, Susumu; Takeuchi, Hayato; Wakamori, Takaaki; Borlongan, Cesario V.; Date, Isao			Spinal Cord Stimulation Exerts Neuroprotective Effects against Experimental Parkinson's Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CEREBRAL-BLOOD-FLOW; SUBTHALAMIC NUCLEUS STIMULATION; DORSAL COLUMN STIMULATION; ELECTRICAL-STIMULATION; SUBARACHNOID HEMORRHAGE; DOPAMINERGIC-NEURONS; RAT MODEL; IN-VITRO; PAIN	In clinical practice, deep brain stimulation (DBS) is effective for treatment of motor symptoms in Parkinson's disease (PD). However, the mechanisms have not been understood completely. There are some reports that electrical stimulation exerts neuroprotective effects on the central nervous system diseases including cerebral ischemia, head trauma, epilepsy and PD, although there are a few reports on neuroprotective effects of spinal cord stimulation (SCS). We investigated the neuroprotective effects of high cervical SCS on PD model of rats. Adult female Sprague-Dawley rats received hour-long SCS (2, 50 or 200 Hz) with an epidural electrode at C1-2 level for 16 consecutive days. At 2 days after initial SCS, 6-hydroxydopamine (6-OHDA) was injected into the right striatum of rats. Behavioral evaluations of PD symptoms were employed, including cylinder test and amphetamine-induced rotation test performed at 1 and 2 weeks after 6-OHDA injection. Animals were subsequently euthanized for immunohistochemical investigations. In order to explore neurotrophic and growth factor upregulation induced by SCS, another cohort of rats that received 50 Hz SCS was euthanized at 1 and 2 weeks after lesion for protein assays. Behavioral tests revealed that the number of amphetamine-induced rotations decreased in SCS groups. Immunohistochemically, tyrosine hydroxylase (TH)-positive fibers in the striatum were significantly preserved in SCS groups. TH-positive neurons in the substantia nigra pars compacta were significantly preserved in 50 Hz SCS group. The level of vascular endothelial growth factor (VEGF) was upregulated by SCS at 1 week after the lesion. These results suggest that high cervical SCS exerts neuroprotection in PD model of rats, at least partially by upregulation of VEGF. SCS is supposed to suppress or delay PD progression and might become a less invasive option for PD patients, although further preclinical and clinical investigations are needed to confirm the effectiveness and safety.	[Shinko, Aiko; Agari, Takashi; Kameda, Masahiro; Yasuhara, Takao; Kondo, Akihiko; Tayra, Judith Thomas; Sato, Kenichiro; Sasaki, Tatsuya; Sasada, Susumu; Takeuchi, Hayato; Wakamori, Takaaki; Date, Isao] Okayama Univ, Grad Sch Med, Dept Neurol Surg, Okayama, Japan; [Borlongan, Cesario V.] Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL USA	Okayama University; State University System of Florida; University of South Florida	Agari, T (corresponding author), Okayama Univ, Grad Sch Med, Dept Neurol Surg, Okayama, Japan.	agarit@cc.okayama-u.ac.jp	Yasuhara, Takao/AEU-1075-2022; Borlongan, Cesar/I-5696-2012; Kondo, Akihiko/A-2130-2015; Sheshukova, Ekaterina/O-1365-2013	Borlongan, Cesar/0000-0002-2966-9782; Shindyapina, Anastasia/0000-0002-7336-3086; Sheshukova, Ekaterina/0000-0002-0934-3902				Baba T, 2009, STROKE, V40, pE598, DOI 10.1161/STROKEAHA.109.563627; CHANDLER MJ, 1993, EUR HEART J, V14, P96, DOI 10.1093/eurheartj/14.1.96; Cui JG, 1996, PAIN, V66, P287, DOI 10.1016/0304-3959(96)03069-2; Cui JG, 1997, PAIN, V73, P87, DOI 10.1016/S0304-3959(97)00077-8; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; EDVINSSON L, 1989, J CEREBR BLOOD F MET, V9, P212, DOI 10.1038/jcbfm.1989.31; Fuentes R, 2009, SCIENCE, V323, P1578, DOI 10.1126/science.1164901; Goksel HM, 2001, ACTA NEUROCHIR, V143, P383, DOI 10.1007/s007010170094; Gurelik M, 2005, NEUROSCIENCE, V134, P827, DOI 10.1016/j.neuroscience.2005.04.062; Harnack D, 2008, EXP NEUROL, V210, P257, DOI 10.1016/j.expneurol.2007.10.002; HOSOBUCHI Y, 1991, PACE, V14, P122, DOI 10.1111/j.1540-8159.1991.tb04056.x; HOSOBUCHI Y, 1985, APPL NEUROPHYSIOL, V48, P372, DOI 10.1159/000101161; Isono M, 1995, STEREOT FUNCT NEUROS, V64, P40, DOI 10.1159/000098732; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kadota T, 2009, BRAIN RES, V1254, P120, DOI 10.1016/j.brainres.2008.11.094; Kemler MA, 2000, NEW ENGL J MED, V343, P618, DOI 10.1056/NEJM200008313430904; Kumar K, 2007, PAIN, V132, P179, DOI 10.1016/j.pain.2007.07.028; Lee JY, 2008, J NEUROSURG, V109, P1148, DOI 10.3171/JNS.2008.109.12.1148; LEVIN BE, 1980, NEUROLOGY, V30, P65, DOI 10.1212/WNL.30.1.65; LINDEROTH B, 1995, NEUROSURGERY, V37, P266, DOI 10.1227/00006123-199508000-00011; LINDEROTH B, 1992, NEUROSURGERY, V31, P289, DOI 10.1227/00006123-199208000-00014; Maesawa S, 2004, J NEUROSURG, V100, P679, DOI 10.3171/jns.2004.100.4.0679; Maher J, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2008.01237.x; Maher J, 2009, NEUROGASTROENT MOTIL, V21, pe633; MEGLIO M, 1991, PACE, V14, P127, DOI 10.1111/j.1540-8159.1991.tb04057.x; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Morimoto T, 2011, CELL TRANSPLANT, V20, P1049, DOI 10.3727/096368910X544915; Patel S, 2004, NEUROSURGERY, V55, P201, DOI 10.1227/01.NEU.0000126949.28912.71; Patel S, 2003, J NEUROSURG, V99, P754, DOI 10.3171/jns.2003.99.4.0754; Paxions G, 1998, RAT BRAIN STEREOTAXI; Pitzer MR, 2003, EXP NEUROL, V182, P435, DOI 10.1016/S0014-4886(03)00100-6; Rajput AH, 2004, PARKINSONISM RELAT D, V10, P221, DOI 10.1016/j.parkreldis.2004.01.004; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Sagher O, 2003, J NEUROSURG, V99, P131, DOI 10.3171/jns.2003.99.1.0131; Sagher Oren, 2006, Neurosurg Focus, V21, pE2; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schechtmann G, 2008, PAIN, V139, P136, DOI 10.1016/j.pain.2008.03.023; SHEALY CN, 1967, ANESTH ANAL CURR RES, V46, P489; Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5; Song ZY, 2008, NEUROSCI LETT, V436, P7, DOI 10.1016/j.neulet.2008.02.044; Spieles-Engemann AL, 2011, J PARKINSON DIS, V1, P123, DOI 10.3233/JPD-2011-11008; Stiller CO, 1996, NEUROSURGERY, V39, P367, DOI 10.1097/00006123-199608000-00026; Temel Y, 2006, BRAIN RES, V1120, P100, DOI 10.1016/j.brainres.2006.08.082; Thevathasan W, 2010, NEUROLOGY, V74, P1325, DOI 10.1212/WNL.0b013e3181d9ed58; Vajkoczy P, 2005, J NEUROSURG, V103, P9, DOI 10.3171/jns.2005.103.1.0009; Visocchi M, 2001, STEREOT FUNCT NEUROS, V76, P262, DOI 10.1159/000066729; Visocchi M, 2001, STEREOT FUNCT NEUROS, V76, P269, DOI 10.1159/000066730; Visocchi M, 2001, ACTA NEUROCHIR, V143, P177; Yadav AP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03839; Yakhnitsa V, 1999, PAIN, V79, P223, DOI 10.1016/S0304-3959(98)00169-9; Yang X, 2008, NEUROSCIENCE, V152, P950, DOI 10.1016/j.neuroscience.2008.01.009; Yasuhara T, 2004, REV NEUROSCIENCE, V15, P293; Yuan WJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-75; Zhong J, 2004, ACTA NEUROCHIR, V146, P1227, DOI 10.1007/s00701-004-0364-7	55	24	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101468	10.1371/journal.pone.0101468	http://dx.doi.org/10.1371/journal.pone.0101468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009993	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800025
J	Chen, YY; Liu, JB; Huang, XB; Cai, SX; Su, ZM; Zhong, R; Zou, L; Miao, XP				Chen, Yan-Yan; Liu, Jian-Bing; Huang, Xi-Bao; Cai, Shun-Xiang; Su, Zheng-Ming; Zhong, Rong; Zou, Li; Miao, Xiao-Ping			New Integrated Strategy Emphasizing Infection Source Control to Curb Schistosomiasis japonica in a Marshland Area of Hubei Province, China: Findings from an Eight-Year Longitudinal Survey	PLOS ONE			English	Article							DONGTING LAKE REGION; REPUBLIC-OF-CHINA; ONCOMELANIA-HUPENSIS; CONTROL TRANSMISSION; GORGES DAM; IMPACT; PRAZIQUANTEL; METAANALYSIS; DOWNSTREAM; MORBIDITY	Background: Schistosomiasis remains a major public health problem in China. The major endemic foci are the lake and marshland regions of southern China, particularly the regions along the middle and lower reach of the Yangtze River in four provinces (Hubei, Hunan, Jiangxi, and Anhui). The purpose of our study is to assess the effect of a new integrated strategy emphasizing infection source control to curb schistosomiasis in marshland regions. Methods: In a longitudinal study, we implemented an integrated control strategy emphasizing infection source control in 16 villages from 2005 through 2012 in marshland regions of Hubei province. The interventions included removing cattle from snail-infested grasslands, providing farmers with mechanized farm equipment, improving sanitation by supplying tap water, building lavatories and latrines, praziquantel chemotherapy, controlling snails, and environmental modification. Results: Following the integrated control strategy designed to reduce the role of bovines and humans as sources of Schistosoma japonicum infection, the prevalence of human S. japonicum infection declined from 1.7% in 2005 to 0.4% in 2012 (P<0.001). Reductions were also observed in both sexes, across all age groups, and among high risk occupations. Moreover, the prevalence of bovine S. japonicum infection decreased from 11.7% in 2005 to 0.6% in 2012 (P<0.001). In addition, all the 16 villages achieved the national criteria of infection control in 2008. Conclusion: Our findings indicate that the integrated strategy was likely effective in controlling the transmission of S. japonicum in marshland regions in China.	[Chen, Yan-Yan; Zhong, Rong; Zou, Li; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth,Dept Epidemio, Wuhan 430074, Peoples R China; [Chen, Yan-Yan; Liu, Jian-Bing; Huang, Xi-Bao; Cai, Shun-Xiang; Su, Zheng-Ming] Hubei Ctr Dis Control & Prevent, Wuhan, Peoples R China	Huazhong University of Science & Technology	Miao, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth,Dept Epidemio, Wuhan 430074, Peoples R China.	hbcdcxf@126.com; miaoxp@gmail.com	Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Calu, Donna/0000-0003-2377-9494	National Science and Technology Support Program in China [2009BAI78B07]; Provincial Research of Schistosomiasis Prevention of Health Department of Hubei, China [XF2010-5, XF2010-30, XF2012-24, XF2012-26]	National Science and Technology Support Program in China; Provincial Research of Schistosomiasis Prevention of Health Department of Hubei, China	This study was funded by the National Science and Technology Support Program in China (2009BAI78B07), and the Provincial Research of Schistosomiasis Prevention of Health Department of Hubei, China (XF2010-5, XF2010-30, XF2012-24, XF2012-26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, EP STAT SCHIST CHIN; [Anonymous], 1992, WORLD BANK LOAN PROG; Balen J, 2007, B WORLD HEALTH ORGAN, V85, P519, DOI 10.2471/BLT.06.034033; Chen MG, 2005, ACTA TROP, V96, P168, DOI 10.1016/j.actatropica.2005.07.011; Chen XY, 2005, B WORLD HEALTH ORGAN, V83, P43; Chen YanYan, 2010, Chinese Journal of Schistosomiasis Control, V22, P411; Gray DJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001588; Gray DJ, 2010, LANCET INFECT DIS, V10, P733, DOI 10.1016/S1473-3099(10)70099-2; Gray DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005900; Guo JG, 2006, AM J TROP MED HYG, V74, P335, DOI 10.4269/ajtmh.2006.74.335; HALL SC, 1970, CALIF MED, V113, P75; He Hui, 2010, Redai Yixue Zazhi, V10, P1243; Hong XC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002122; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Jiang MingSen, 2010, Chinese Journal of Schistosomiasis Control, V22, P201; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Kumagai T, 2010, AM J TROP MED HYG, V83, P542, DOI 10.4269/ajtmh.2010.10-0016; Li SZ, 2009, CHINESE MED J-PEKING, V122, P1009, DOI 10.3760/cma.j.issn.0366-6999.2009.09.002; Li YS, 2007, EMERG INFECT DIS, V13, P973, DOI 10.3201/eid1307.060848; Liao SiQi, 2009, Journal of Tropical Medicine (Guangzhou), V9, P1288; Liu R, 2013, PARASITOL RES, V112, P1483, DOI 10.1007/s00436-013-3295-5; Liu R, 2012, PARASITOL RES, V110, P2081, DOI 10.1007/s00436-011-2721-9; Liu Wei, 2013, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V31, P206; MAO SB, 1986, CHINESE MED J-PEKING, V99, P439; McManus DP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001053; McManus DP, 2010, CLIN MICROBIOL REV, V23, P442, DOI 10.1128/CMR.00044-09; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Ross Allen G.P., 2001, Biologist (London), V48, P121; Seto EYW, 2008, ECOHEALTH, V5, P149, DOI 10.1007/s10393-008-0169-x; SHOUPAI M, 1982, AM J TROP MED HYG, V31, P92, DOI 10.4269/ajtmh.1982.31.92; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stone R, 2008, SCIENCE, V321, P628, DOI 10.1126/science.321.5889.628; Sun CS, 2002, ACTA TROP, V82, P169, DOI 10.1016/S0001-706X(02)00008-6; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; Wang LD, 2009, TROP MED INT HEALTH, V14, P1475, DOI 10.1111/j.1365-3156.2009.02403.x; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; WHO, 2006, WHO PREV CHEM HUM HE; X-hW Yang Hao, 2006, CHIN J SCHISTO CONTR, V18, P321; Zhao GM, 2005, ACTA TROP, V96, P288, DOI 10.1016/j.actatropica.2005.07.023; Zheng J, 2002, ACTA TROP, V82, P147, DOI 10.1016/S0001-706X(02)00046-3; Zhongdao Wu, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P163; Zhou D, 1994, World Health Forum, V15, P387; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005; Zhou YB, 2007, ANN TROP MED PARASIT, V101, P695, DOI 10.1179/136485907X241488; Zhou YB, 2011, AM J TROP MED HYG, V85, P83, DOI 10.4269/ajtmh.2011.10-0574; Zhu Hong, 2011, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V6, P908; Zhu Hong, 2010, Journal of Tropical Medicine (Guangzhou), V10, P982; Zhu HM, 2008, ECOHEALTH, V5, P137, DOI 10.1007/s10393-008-0168-y; Zhu HuiGuo, 2008, Chinese Journal of Schistosomiasis Control, V20, P251; Zhu YC, 2005, ACTA TROP, V96, P130, DOI 10.1016/j.actatropica.2005.07.007	53	30	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89779	10.1371/journal.pone.0089779	http://dx.doi.org/10.1371/journal.pone.0089779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	25025329	Green Published, gold, Green Submitted			2022-12-25	WOS:000332396200081
J	Zhang, QZ; Dijkstra, FA; Liu, XR; Wang, YD; Huang, J; Lu, N				Zhang, Qing-zhong; Dijkstra, Feike A.; Liu, Xing-ren; Wang, Yi-ding; Huang, Jian; Lu, Ning			Effects of Biochar on Soil Microbial Biomass after Four Years of Consecutive Application in the North China Plain	PLOS ONE			English	Article							FUMIGATION-EXTRACTION; MINERALIZATION; CARBON; DECOMPOSITION; CALIBRATION; COMMUNITY; NITROGEN; RELEASE; RESIDUE; IMPACT	The long term effect of biochar application on soil microbial biomass is not well understood. We measured soil microbial biomass carbon (MBC) and nitrogen (MBN) in a field experiment during a winter wheat growing season after four consecutive years of no (CK), 4.5 (B4.5) and 9.0 t biochar ha(-1) yr(-1) (B9.0) applied. For comparison, a treatment with wheat straw residue incorporation (SR) was also included. Results showed that biochar application increased soil MBC significantly compared to the CK treatment, and that the effect size increased with biochar application rate. The B9.0 treatment showed the same effect on MBC as the SR treatment. Treatments effects on soil MBN were less strong than for MBC. The microbial biomass C:N ratio was significantly increased by biochar. Biochar might decrease the fraction of biomass N mineralized (K-N), which would make the soil MBN for biochar treatments underestimated, and microbial biomass C: N ratios overestimated. Seasonal fluctuation in MBC was less for biochar amended soils than for CK and SR treatments, suggesting that biochar induced a less extreme environment for microorganisms throughout the season. There was a significant positive correlation between MBC and soil water content (SWC), but there was no significant correlation between MBC and soil temperature. Biochar amendments may therefore reduce temporal variability in environmental conditions for microbial growth in this system thereby reducing temporal fluctuations in C and N dynamics.	[Zhang, Qing-zhong; Liu, Xing-ren; Wang, Yi-ding; Huang, Jian; Lu, Ning] Chinese Acad Agr Sci, Key Lab Agr Environm, Sinoaustralian Joint Lab Sustainable Agroecosyst, Minist Agr,Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Dijkstra, Feike A.] Univ Sydney, Ctr Carbon Water & Food, Dept Environm Sci, Camden, NSW, Australia	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; University of Sydney	Zhang, QZ (corresponding author), Chinese Acad Agr Sci, Key Lab Agr Environm, Sinoaustralian Joint Lab Sustainable Agroecosyst, Minist Agr,Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	ecologyouth@126.com	Dijkstra, Feike A/H-2182-2012	Dijkstra, Feike A/0000-0002-6191-6018; Zhang, Yunchun/0000-0001-8259-5850	S & T Innovation Program of Chinese Academy of Agricultural Sciences	S & T Innovation Program of Chinese Academy of Agricultural Sciences	This work was supported by the S & T Innovation Program of Chinese Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Castaldi S, 2011, CHEMOSPHERE, V85, P1464, DOI 10.1016/j.chemosphere.2011.08.031; Chen Y, 2010, AUST J SOIL RES, V48, P526, DOI 10.1071/SR10011; Contin M, 2000, SOIL BIOL BIOCHEM, V32, P1219, DOI 10.1016/S0038-0717(00)00038-9; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; Dempster DN, 2012, PLANT SOIL, V354, P311, DOI 10.1007/s11104-011-1067-5; GREENFIELD LG, 1995, SOIL BIOL BIOCHEM, V27, P1235, DOI 10.1016/0038-0717(95)00023-8; [郭伟 GUO Wei], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P425; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P25, DOI 10.1016/0038-0717(95)00102-6; JOERGENSEN RG, 1990, SOIL BIOL BIOCHEM, V22, P1129, DOI 10.1016/0038-0717(90)90039-3; Kallenbach C, 2011, AGR ECOSYST ENVIRON, V144, P241, DOI 10.1016/j.agee.2011.08.020; Keith A, 2011, ENVIRON SCI TECHNOL, V45, P9611, DOI 10.1021/es202186j; Kolb SE, 2009, SOIL SCI SOC AM J, V73, P1173, DOI 10.2136/sssaj2008.0232; Kumar K, 2000, ADV AGRON, V68, P197; Kushwaha CP, 2000, SOIL TILL RES, V56, P153, DOI 10.1016/S0167-1987(00)00135-5; Lehmann J, 2009, EARTHSCAN, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Liang BQ, 2010, ORG GEOCHEM, V41, P206, DOI 10.1016/j.orggeochem.2009.09.007; Lou YS, 2004, SOIL BIOL BIOCHEM, V36, P1835, DOI 10.1016/j.soilbio.2004.05.006; Luo Y, 2013, SOIL BIOL BIOCHEM, V57, P513, DOI 10.1016/j.soilbio.2012.10.033; Luo Y, 2011, SOIL BIOL BIOCHEM, V43, P2304, DOI 10.1016/j.soilbio.2011.07.020; Nicolardot B, 2001, PLANT SOIL, V228, P83, DOI 10.1023/A:1004813801728; O'Neill B, 2009, MICROB ECOL, V58, P23, DOI 10.1007/s00248-009-9515-y; Piccolo A, 1996, SOIL USE MANAGE, V12, P209, DOI 10.1111/j.1475-2743.1996.tb00545.x; SPARLING G, 1993, SOIL BIOL BIOCHEM, V25, P1793, DOI 10.1016/0038-0717(93)90185-E; Steinbeiss S, 2009, SOIL BIOL BIOCHEM, V41, P1301, DOI 10.1016/j.soilbio.2009.03.016; Steiner C, 2008, PEDOBIOLOGIA, V51, P359, DOI 10.1016/j.pedobi.2007.08.002; Thiessen S, 2013, SOIL BIOL BIOCHEM, V57, P739, DOI 10.1016/j.soilbio.2012.10.029; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Zavalloni C, 2011, APPL SOIL ECOL, V50, P45, DOI 10.1016/j.apsoil.2011.07.012; Zhang QZ, 2013, SOIL RES, V51, P521, DOI 10.1071/SR13153; Zhang QZ, 2013, SOIL SCI SOC AM J, V77, P1478, DOI 10.2136/sssaj2012.0180; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	35	79	90	11	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102062	10.1371/journal.pone.0102062	http://dx.doi.org/10.1371/journal.pone.0102062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25184224	gold, Green Submitted, Green Published			2022-12-25	WOS:000339992400041
J	Zhang, BB; Shimada, Y; Kuroyanagi, J; Umemoto, N; Nishimura, Y; Tanaka, T				Zhang, Beibei; Shimada, Yasuhito; Kuroyanagi, Junya; Umemoto, Noriko; Nishimura, Yuhei; Tanaka, Toshio			Quantitative wPhenotyping-Based In Vivo Chemical Screening in a Zebrafish Model of Leukemia Stem Cell Xenotransplantation	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; KAPPA-B PATHWAY; APOPTOSIS; MECHANISMS; QUIESCENT; CML; PROLIFERATION; XENOGRAFTS; DISCOVERY; IMATINIB	Zebrafish-based chemical screening has recently emerged as a rapid and efficient method to identify important compounds that modulate specific biological processes and to test the therapeutic efficacy in disease models, including cancer. In leukemia, the ablation of leukemia stem cells (LSCs) is necessary to permanently eradicate the leukemia cell population. However, because of the very small number of LSCs in leukemia cell populations, their use in xenotransplantation studies (in vivo) and the difficulties in functionally and pathophysiologically replicating clinical conditions in cell culture experiments (in vitro), the progress of drug discovery for LSC inhibitors has been painfully slow. In this study, we developed a novel phenotype-based in vivo screening method using LSCs xenotransplanted into zebrafish. Aldehyde dehydrogenase-positive (ALDH+) cells were purified from chronic myelogenous leukemia K562 cells tagged with a fluorescent protein (Kusabira-orange) and then implanted in young zebrafish at 48 hours post-fertilization. Twenty-four hours after transplantation, the animals were treated with one of eight different therapeutic agents (imatinib, dasatinib, parthenolide, TDZD-8, arsenic trioxide, niclosamide, salinomycin, and thioridazine). Cancer cell proliferation, and cell migration were determined by high-content imaging. Of the eight compounds that were tested, all except imatinib and dasatinib selectively inhibited ALDH+ cell proliferation in zebrafish. In addition, these anti-LSC agents suppressed tumor cell migration in LSC-xenotransplants. Our approach offers a simple, rapid, and reliable in vivo screening system that facilitates the phenotype-driven discovery of drugs effective in suppressing LSCs.	[Zhang, Beibei; Shimada, Yasuhito; Kuroyanagi, Junya; Umemoto, Noriko; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Med Zebrafish Res Ctr, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Life Sci Res Ctr, Dept Bioinformat, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ Ind Technol Innovat, Dept Om Med, Tsu, Mie, Japan; [Shimada, Yasuhito; Umemoto, Noriko; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Syst Pharmacol, Tsu, Mie 514, Japan	Mie University; Mie University; Mie University; Mie University	Tanaka, T (corresponding author), Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan.	tanaka@doc.medic.mie-u.ac.jp	Shimada, Yasuhito/H-2916-2019	Shimada, Yasuhito/0000-0002-4111-8262; Zhang, Bin/0000-0002-7347-0367; Ichino, Noriko/0000-0002-7009-8299; Nishimura, Yuhei/0000-0003-1901-8799	Japan Science and Technology Agency; New Energy and Industrial Technology Development Organization	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the Japan Science and Technology Agency, KAKENHI of Grants-in-Aid for Scientific Research, and the New Energy and Industrial Technology Development Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2010, J EXP MED, V207, P677, DOI 10.1084/jem.20100523; Angstreich GR, 2005, BRIT J HAEMATOL, V130, P373, DOI 10.1111/j.1365-2141.2005.05606.x; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Corkery DP, 2011, BRIT J HAEMATOL, V153, P786, DOI 10.1111/j.1365-2141.2011.08661.x; Davison K, 2002, SEMIN HEMATOL, V39, P3, DOI 10.1053/shem.2002.33610; Delvecchio C, 2011, ASSAY DRUG DEV TECHN, V9, P354, DOI 10.1089/adt.2010.0346; Fleischman AG, 2012, BLOOD, V119, P3376, DOI 10.1182/blood-2012-02-406751; Fuchs Ota, 2010, Curr Mol Pharmacol, V3, P98; Gerber JM, 2011, AM J HEMATOL, V86, P31, DOI 10.1002/ajh.21915; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2007, BLOOD, V110, P4436, DOI 10.1182/blood-2007-05-088815; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; Heaney NCB, 2007, HEMATOL ONCOL, V25, P66, DOI 10.1002/hon.813; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Jing LL, 2011, DIS MODEL MECH, V4, P433, DOI 10.1242/dmm.006791; Jordan CT, 2007, BEST PRACT RES CL HA, V20, P13, DOI 10.1016/j.beha.2006.10.005; Ketola K, 2012, BRIT J CANCER, V106, P99, DOI 10.1038/bjc.2011.530; Konantz M, 2012, ANN NY ACAD SCI, V1266, P124, DOI 10.1111/j.1749-6632.2012.06575.x; Koyama-Nasu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053710; Liu L, 2011, MED ONCOL, V28, P835, DOI 10.1007/s12032-010-9529-9; Liu ZB, 2012, BIOCHEM BIOPH RES CO, V427, P223, DOI 10.1016/j.bbrc.2012.09.064; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Miller WH, 2002, CANCER RES, V62, P3893; Moreb JS, 2012, CHEM-BIOL INTERACT, V195, P52, DOI 10.1016/j.cbi.2011.10.007; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nakamura S, 2012, INT J CANCER, V130, P1046, DOI 10.1002/ijc.26065; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Peal DS, 2010, J CARDIOVASC TRANSL, V3, P454, DOI 10.1007/s12265-010-9212-8; Pei SS, 2012, BEST PRACT RES CL HA, V25, P415, DOI 10.1016/j.beha.2012.10.003; Pichler FB, 2003, NAT BIOTECHNOL, V21, P879, DOI 10.1038/nbt852; Pruvot B, 2011, HAEMATOL-HEMATOL J, V96, P612, DOI 10.3324/haematol.2010.031401; Rice KN, 2010, INT J HEMATOL, V91, P748, DOI 10.1007/s12185-010-0615-8; Rodrigues T, 2002, BRIT J PHARMACOL, V136, P136, DOI 10.1038/sj.bjp.0704672; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Savona M, 2008, NAT REV CANCER, V8, P341, DOI 10.1038/nrc2368; Smithen DA, 2013, ORG BIOMOL CHEM, V11, P62, DOI 10.1039/c2ob26535d; Snaar-Jagalska BE, 2009, ZEBRAFISH, V6, P441, DOI 10.1089/zeb.2009.0614; Stuart SA, 2009, CELL CYCLE, V8, P1338, DOI 10.4161/cc.8.9.8209; Szabo AZ, 2013, STEM CELLS, V31, P786, DOI 10.1002/stem.1329; Takeuchi Y, 2004, J NEUROCHEM, V88, P41, DOI 10.1046/j.1471-4159.2003.02129.x; Thomas Xavier, 2012, World J Stem Cells, V4, P44; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yang IH, 2008, IEEE ENG MED BIO, P1837, DOI 10.1109/IEMBS.2008.4649537; Yong ASM, 2008, LEUKEMIA, V22, P1721, DOI 10.1038/leu.2008.161; Yuan Lin-Bo, 2007, Zhejiang Da Xue Xue Bao Yi Xue Ban, V36, P191; Zhelev Z, 2004, CANCER CHEMOTH PHARM, V53, P267, DOI 10.1007/s00280-003-0738-1; Zhen XC, 2001, MOL PHARMACOL, V60, P857; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	54	71	73	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85439	10.1371/journal.pone.0085439	http://dx.doi.org/10.1371/journal.pone.0085439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	25036550	gold, Green Submitted, Green Published			2022-12-25	WOS:000330235100085
J	Chen, YW; Fiscella, KA; Bacharach, SZ; Calu, DJ				Chen, Yu-Wei; Fiscella, Kimberly A.; Bacharach, Samuel Z.; Calu, Donna J.			Effect of Cafeteria Diet History on Cue-, Pellet-Priming-, and Stress-Induced Reinstatement of Food Seeking in Female Rats	PLOS ONE			English	Article							SUCCESSIVE NEGATIVE CONTRAST; DOPAMINE D2 RECEPTORS; COCAINE-SEEKING; DRUG-SEEKING; HEROIN-SEEKING; WEIGHT-LOSS; DARK SIDE; RELAPSE; BEHAVIOR; REWARD	Background: Relapse to unhealthy eating habits is a major problem in human dietary treatment. The individuals most commonly seeking dietary treatment are overweight or obese women, yet the commonly used rat reinstatement model to study relapse to palatable food seeking during dieting primarily uses normal-weight male rats. To increase the clinical relevance of the relapse to palatable food seeking model, here we pre-expose female rats to a calorically-dense cafeteria diet in the home-cage to make them overweight prior to examining the effect of this diet history on cue-, pellet-priming-and footshock-induced reinstatement of food seeking. Methods: Post-natal day 32 female Long-Evans rats had seven weeks of home-cage access to either chow only or daily or intermittent cafeteria diet alongside chow. Next, they were trained to self-administer normally preferred 45 mg food pellets accompanied by a tone-light cue. After extinction, all rats were tested for reinstatement induced by discrete cue, pellet-priming, and intermittent footshock under extinction conditions. Results: Access to daily cafeteria diet and to a lesser degree access to intermittent cafeteria diet decreased food pellet self-administration compared to chow-only. Prior history of these cafeteria diets also reduced extinction responding, cue-and pellet-priming-induced reinstatement. In contrast, modest stress-induced reinstatement was only observed in rats with a history of daily cafeteria diet. Conclusion: A history of cafeteria diet does not increase the propensity for cue-and pellet-priming-induced relapse in the rat reinstatement model but does appear to make rats more susceptible to footshock stress-induced reinstatement.	[Chen, Yu-Wei; Fiscella, Kimberly A.; Bacharach, Samuel Z.; Calu, Donna J.] NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Calu, DJ (corresponding author), NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	donna.calu@nih.gov	Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Calu, Donna/0000-0003-2377-9494	Intramural Research Program of the National Institute on Drug Abuse	Intramural Research Program of the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	The work was supported by the Intramural Research Program of the National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 1997, PSYCHOPHARMACOLOGY, V132, P289, DOI 10.1007/s002130050347; Anker JJ, 2011, CURR TOP BEHAV NEURO, V8, P73, DOI 10.1007/7854_2010_93; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bossert JM, 2013, PSYCHOPHARMACOLOGY, V229, P453, DOI 10.1007/s00213-013-3120-y; Buczek Y, 1999, PSYCHOPHARMACOLOGY, V144, P183, DOI 10.1007/s002130050992; Calu DJ, 2014, NEUROPHARMACOLOGY, V76, P395, DOI 10.1016/j.neuropharm.2013.04.030; Cifani C, 2012, J NEUROSCI, V32, P8480, DOI 10.1523/JNEUROSCI.5895-11.2012; Cottone P, 2009, P NATL ACAD SCI USA, V106, P20016, DOI 10.1073/pnas.0908789106; Crespi LP, 1942, AM J PSYCHOL, V55, P467, DOI 10.2307/1417120; Davy SR, 2006, J AM DIET ASSOC, V106, P1673, DOI 10.1016/j.jada.2006.07.017; De Vries TJ, 2002, NEUROPSYCHOPHARMACOL, V26, P18, DOI 10.1016/S0893-133X(01)00293-7; Deroche V, 1999, EUR J NEUROSCI, V11, P2731, DOI 10.1046/j.1460-9568.1999.00696.x; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; Donahue RJ, 2014, BIOL PSYCHIAT, V76, P550, DOI 10.1016/j.biopsych.2013.12.014; Erb S, 1996, PSYCHOPHARMACOLOGY, V128, P408, DOI 10.1007/s002130050150; Feltenstein MW, 2011, PSYCHOPHARMACOLOGY, V216, P53, DOI 10.1007/s00213-011-2187-6; Flaherty C.F., 1996, INCENTIVE RELATIVITY; Fuchs RA, 2005, PSYCHOPHARMACOLOGY, V179, P662, DOI 10.1007/s00213-004-2080-7; Funk D, 2005, PSYCHOPHARMACOLOGY, V183, P341, DOI 10.1007/s00213-005-0194-1; Ghitza UE, 2007, J NEUROSCI, V27, P11522, DOI 10.1523/JNEUROSCI.5405-06.2007; Ghitza UE, 2006, NEUROPSYCHOPHARMACOL, V31, P2188, DOI 10.1038/sj.npp.1300964; GREENO CG, 1994, PSYCHOL BULL, V115, P444, DOI 10.1037/0033-2909.115.3.444; GRILO CM, 1989, J CONSULT CLIN PSYCH, V57, P488, DOI 10.1037/0022-006X.57.4.488; Grimm JW, 2000, NEUROPSYCHOPHARMACOL, V22, P473, DOI 10.1016/S0893-133X(99)00157-8; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P138, DOI 10.1037/0022-3514.60.1.138; Iemolo A, 2012, BEHAV PHARMACOL, V23, P593, DOI 10.1097/FBP.0b013e328357697f; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; KAYMAN S, 1990, AM J CLIN NUTR, V52, P800, DOI 10.1093/ajcn/52.5.800; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; KRAMER FM, 1989, INT J OBESITY, V13, P123; Lu L, 2004, PSYCHOPHARMACOLOGY, V176, P101, DOI 10.1007/s00213-004-1860-4; Martire SI, 2014, BEHAV BRAIN RES, V265, P132, DOI 10.1016/j.bbr.2014.02.027; McGuire MT, 1999, J CONSULT CLIN PSYCH, V67, P177, DOI 10.1037/0022-006X.67.2.177; Mitchell EN, 2012, BEHAV BRAIN RES, V234, P155, DOI 10.1016/j.bbr.2012.06.016; Nair SG, 2006, PHYSIOL BEHAV, V88, P559, DOI 10.1016/j.physbeh.2006.05.014; Nair SG, 2011, NEUROPSYCHOPHARMACOL, V36, P497, DOI 10.1038/npp.2010.181; Nair SG, 2009, PROG NEUROBIOL, V89, P18, DOI 10.1016/j.pneurobio.2009.05.003; Nair SG, 2009, PSYCHOPHARMACOLOGY, V205, P129, DOI 10.1007/s00213-009-1523-6; Pankevich DE, 2010, J NEUROSCI, V30, P16399, DOI 10.1523/JNEUROSCI.1955-10.2010; Parylak SL, 2011, PHYSIOL BEHAV, V104, P149, DOI 10.1016/j.physbeh.2011.04.063; Peterson CB, 1999, J CLIN PSYCHOL, V55, P685, DOI 10.1002/(SICI)1097-4679(199906)55:6<685::AID-JCLP3>3.0.CO;2-Y; Pickens CL, 2012, PSYCHOPHARMACOLOGY, V221, P341, DOI 10.1007/s00213-011-2585-9; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Pillitteri JL, 2008, OBESITY, V16, P790, DOI 10.1038/oby.2007.136; Polivy J, 1999, INT J EAT DISORDER, V26, P153, DOI 10.1002/(SICI)1098-108X(199909)26:2&lt;153::AID-EAT4&gt;3.0.CO;2-R; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; ROLLS BJ, 1980, J PHYSIOL-LONDON, V298, P415, DOI 10.1113/jphysiol.1980.sp013091; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Sastre A, 2006, BEHAV BRAIN RES, V170, P34, DOI 10.1016/j.bbr.2006.01.026; See RE, 1999, DRUG ALCOHOL DEPEN, V57, P41, DOI 10.1016/S0376-8716(99)00043-5; See RE, 2002, PHARMACOL BIOCHEM BE, V71, P517, DOI 10.1016/S0091-3057(01)00682-7; Self DW, 1998, DRUG ALCOHOL DEPEN, V51, P49, DOI 10.1016/S0376-8716(98)00065-9; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shaham Y, 1998, PSYCHOPHARMACOLOGY, V137, P184, DOI 10.1007/s002130050608; Shaham Y, 1996, J NEUROSCI, V16, P1957; SHAHAM Y, 1995, PSYCHOPHARMACOLOGY, V119, P334, DOI 10.1007/BF02246300; Shalev U, 2001, PSYCHOPHARMACOLOGY, V156, P98, DOI 10.1007/s002130100748; Sharma S, 2013, INT J OBESITY, V37, P382, DOI 10.1038/ijo.2012.48; Skender ML, 1996, J AM DIET ASSOC, V96, P342, DOI 10.1016/S0002-8223(96)00096-X; South T, 2012, PHYSIOL BEHAV, V105, P1052, DOI 10.1016/j.physbeh.2011.11.019; Spealman RD, 1999, PHARMACOL BIOCHEM BE, V64, P327, DOI 10.1016/S0091-3057(99)00049-0; STEWART J, 1992, PSYCHOPHARMACOLOGY, V108, P79, DOI 10.1007/BF02245289; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Swinburn BA, 2009, AM J CLIN NUTR, V89, P1723, DOI 10.3945/ajcn.2008.27061; Tannenbaum BM, 1997, AM J PHYSIOL-ENDOC M, V273, pE1168, DOI 10.1152/ajpendo.1997.273.6.E1168; Teegarden SL, 2007, BIOL PSYCHIAT, V61, P1021, DOI 10.1016/j.biopsych.2006.09.032; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; Vendruscolo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009296; Weiss F, 2001, NEUROPSYCHOPHARMACOL, V25, P361, DOI 10.1016/S0893-133X(01)00238-X; WEST TEG, 1988, BRAIN RES, V462, P126, DOI 10.1016/0006-8993(88)90594-X; Yamada N, 2011, ENDOCRINOLOGY, V152, P2634, DOI 10.1210/en.2011-0004	73	30	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102213	10.1371/journal.pone.0102213	http://dx.doi.org/10.1371/journal.pone.0102213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25025329	Green Submitted, Green Published, gold			2022-12-25	WOS:000339992400051
J	Chen, LH; Li, CX; Sargolzaei, M; Schenkel, F				Chen, Liuhong; Li, Changxi; Sargolzaei, Mehdi; Schenkel, Flavio			Impact of Genotype Imputation on the Performance of GBLUP and Bayesian Methods for Genomic Prediction	PLOS ONE			English	Article							RELATIONSHIP MATRIX; ACCURACY; SELECTION; VALUES; RELIABILITY; NUCLEOTIDE; STRATEGIES; CATTLE; CHIPS	The aim of this study was to evaluate the impact of genotype imputation on the performance of the GBLUP and Bayesian methods for genomic prediction. A total of 10,309 Holstein bulls were genotyped on the BovineSNP50 BeadChip (50 k). Five low density single nucleotide polymorphism (SNP) panels, containing 6,177, 2,480, 1,536, 768 and 384 SNPs, were simulated from the 50 k panel. A fraction of 0%, 33% and 66% of the animals were randomly selected from the training sets to have low density genotypes which were then imputed into 50 k genotypes. A GBLUP and a Bayesian method were used to predict direct genomic values (DGV) for validation animals using imputed or their actual 50 k genotypes. Traits studied included milk yield, fat percentage, protein percentage and somatic cell score (SCS). Results showed that performance of both GBLUP and Bayesian methods was influenced by imputation errors. For traits affected by a few large QTL, the Bayesian method resulted in greater reductions of accuracy due to imputation errors than GBLUP. Including SNPs with largest effects in the low density panel substantially improved the accuracy of genomic prediction for the Bayesian method. Including genotypes imputed from the 6 k panel achieved almost the same accuracy of genomic prediction as that of using the 50 k panel even when 66% of the training population was genotyped on the 6 k panel. These results justified the application of the 6 k panel for genomic prediction. Imputations from lower density panels were more prone to errors and resulted in lower accuracy of genomic prediction. But for animals that have close relationship to the reference set, genotype imputation may still achieve a relatively high accuracy.	[Chen, Liuhong; Li, Changxi] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Li, Changxi] Agr & Agri Food Canada, Lacombe Res Ctr, Lacombe, AB, Canada; [Sargolzaei, Mehdi] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Schenkel, Flavio] LAlliance Boviteq Inc, Quebec City, PQ, Canada	University of Alberta; Agriculture & Agri Food Canada; University of Guelph	Chen, LH (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	liuhong@ualberta.ca; schenkel@uoguelph.ca	Schenkel, Flavio/ABG-1842-2021	WU, KWAN-DUN/0000-0002-3339-1509; Schenkel, Flavio/0000-0001-8700-0633; CHEN, YUNG-MING/0000-0002-9241-1258	Natural Sciences and Engineering Research Council of Canada; L'Alliance Boviteq Inc., Quebec, Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); L'Alliance Boviteq Inc., Quebec, Canada	This work was supported by the Natural Sciences and Engineering Research Council of Canada, and L'Alliance Boviteq Inc., Quebec, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Calus M P L, 2008, Genetics, V178, P553, DOI 10.1534/genetics.107.080838; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Cleveland MA, 2013, J ANIM SCI, V91, P3583, DOI 10.2527/jas.2013-6270; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Dassonneville R, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-40; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Gilmour AR, 2009, ASREML USER GUIDE RE; Goddard ME, 2011, J ANIM BREED GENET, V128, P409, DOI 10.1111/j.1439-0388.2011.00964.x; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2009, GENETICS, V182, P343, DOI 10.1534/genetics.108.100289; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Huang YJ, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-25; Khatkar MS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-538; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Mulder HA, 2012, J DAIRY SCI, V95, P876, DOI 10.3168/jds.2011-4490; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; Sargolzaei M, 2011, GEBV SOFTWARE; Stachowicz K, 2011, J DAIRY SCI, V94, P5160, DOI 10.3168/jds.2010-3308; Van Doormaal B, 2012, GENOTYPING LOW DENSI; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Verbyla KL, 2009, GENET RES, V91, P307, DOI 10.1017/S0016672309990243; Weigel KA, 2010, J DAIRY SCI, V93, P5423, DOI 10.3168/jds.2010-3149; Wiggans GR, 2013, J DAIRY SCI, V96, P1258, DOI 10.3168/jds.2012-6192; Wiggans GR, 2011, J DAIRY SCI, V94, P6188, DOI 10.3168/jds.2011-4481; Zhang Z, 2011, J DAIRY SCI, V94, P3642, DOI 10.3168/jds.2010-3917; Zhang Z, 2010, J DAIRY SCI, V93, P5487, DOI 10.3168/jds.2010-3501; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648	34	80	86	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101544	10.1371/journal.pone.0101544	http://dx.doi.org/10.1371/journal.pone.0101544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	24551186	gold, Green Submitted, Green Published			2022-12-25	WOS:000339992400017
J	Liu, MX; Chen, X; Chen, G; Cui, QH; Yan, GY				Liu, Ming-Xi; Chen, Xing; Chen, Geng; Cui, Qing-Hua; Yan, Gui-Ying			A Computational Framework to Infer Human Disease-Associated Long Noncoding RNAs	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; DATABASE; GENOME; PROTEIN; INHIBITOR; MOUSE; OVEREXPRESSION; SUSCEPTIBILITY; IDENTIFICATION	As a major class of noncoding RNAs, long noncoding RNAs (lncRNAs) have been implicated in various critical biological processes. Accumulating researches have linked dysregulations and mutations of lncRNAs to a variety of human disorders and diseases. However, to date, only a few human lncRNAs have been associated with diseases. Therefore, it is very important to develop a computational method to globally predict potential associated diseases for human lncRNAs. In this paper, we developed a computational framework to accomplish this by combining human lncRNA expression profiles, gene expression profiles, and human disease-associated gene data. Applying this framework to available human long intergenic noncoding RNAs (lincRNAs) expression data, we showed that the framework has reliable accuracy. As a result, for non-tissue-specific lincRNAs, the AUC of our algorithm is 0.7645, and the prediction accuracy is about 89%. This study will be helpful for identifying novel lncRNAs for human diseases, which will help in understanding the roles of lncRNAs in human diseases and facilitate treatment. The corresponding codes for our method and the predicted results are all available at http://asdcd.amss.ac.cn/MingXiLiu/lncRNA-disease.html.	[Liu, Ming-Xi; Chen, Xing; Yan, Gui-Ying] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Liu, Ming-Xi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Xing; Yan, Gui-Ying] Chinese Acad Sci, Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Chen, Geng; Cui, Qing-Hua] Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Peking University	Cui, QH (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100871, Peoples R China.	cuiqinghua@hsc.pku.edu.cn; yangy@amss.ac.cn	Chen, Xing/G-6844-2016	Chen, Xing/0000-0001-9028-5342; Wang, Yunsheng/0000-0001-5003-4434	National Natural Science Foundation of China [10531070, 10721101, 11301517, 11371355, KJCX-YW-S7]; National Center for Mathematics and Interdisciplinary Sciences, CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for Mathematics and Interdisciplinary Sciences, CAS(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China under Grant Nos. 10531070, 10721101, 11301517, 11371355, KJCX-YW-S7 and National Center for Mathematics and Interdisciplinary Sciences, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bauer-Mehren A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020284; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Gatti DM, 2010, PHYSIOL GENOMICS, V42, P456, DOI 10.1152/physiolgenomics.00110.2009; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Haruta N, 2011, P JPN ACAD B-PHYS, V87, P641, DOI 10.2183/pjab.87.641; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Iwasaki M, 2012, J DENT RES, V91, P167, DOI 10.1177/0022034511431702; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li P, 2011, NAT PROD COMMUN, V6, P1801; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Masutani H, 2012, J CLIN BIOCHEM NUTR, V50, P23, DOI 10.3164/jcbn.11-36SR; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mattingly CJ, 2006, J EXP ZOOL PART A, V305A, P689, DOI 10.1002/jez.a.307; Mitsui Sachiko, 2011, Neural Syst Circuits, V1, P5, DOI 10.1186/2042-1001-1-5; Pibouin L, 2002, CANCER GENET CYTOGEN, V133, P55, DOI 10.1016/S0165-4608(01)00634-3; Sakuma Y, 2012, LAB INVEST, V92, P371, DOI 10.1038/labinvest.2011.187; Saviozzi S, 2009, CANCER RES, V69, P3390, DOI 10.1158/0008-5472.CAN-08-2981; Sawaki M, 2012, ONCOL LETT, V3, P61, DOI 10.3892/ol.2011.449; Sonkoly E, 2005, J BIOL CHEM, V280, P24159, DOI 10.1074/jbc.M501704200; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yoshihara C, 2012, ONCOL LETT, V3, P387, DOI 10.3892/ol.2011.467; Yoshihara C, 2012, GEN COMP ENDOCR, V175, P495, DOI 10.1016/j.ygcen.2011.12.009; Yoshihara Eiji, 2011, Japanese Journal of Alcohol Studies & Drug Dependence, V46, P570; Yoshihara K, 2011, GENE CHROMOSOME CANC, V50, P167, DOI 10.1002/gcc.20841; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164	51	195	205	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84408	10.1371/journal.pone.0084408	http://dx.doi.org/10.1371/journal.pone.0084408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	25244184	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100056
J	Chen, LX; Cai, Y; Zhou, GB; Shi, XJ; Su, JH; Chen, GW; Lin, K				Chen, Linxiang; Cai, Ying; Zhou, Guangbiao; Shi, Xiaojun; Su, Jianhui; Chen, Guanwu; Lin, Kun			Rapid Sanger Sequencing of the 16S rRNA Gene for Identification of Some Common Pathogens	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAINS; BACTERIAL IDENTIFICATION; DNA; PCR; AMPLIFICATION; SHIGELLA; SYSTEM; MYCOBACTERIA; DATABASE; SAMPLES	Conventional Sanger sequencing remains time-consuming and laborious. In this study, we developed a rapid improved sequencing protocol of 16S rRNA for pathogens identification by using a new combination of SYBR Green I real-time PCR and Sanger sequencing with FTA (R) cards. To compare the sequencing quality of this method with conventional Sanger sequencing, 12 strains, including three kinds of strains (1 reference strain and 3 clinical strains, which were previously identified by biochemical tests), which have 4 Pseudomonas aeruginosa, 4 Staphyloccocus aureus and 4 Escherichia coli, were targeted. Additionally, to validate the sequencing results and bacteria identification, expanded specimens with 90 clinical strains, also comprised of the three kinds of strains which included 30 samples respectively, were performed as just described. The results showed that although statistical differences (P<0.05) were found in sequencing quality between the two methods, their identification results were all correct and consistent. The workload, the time consumption and the cost per batch were respectively light versus heavy, 8 h versus 11 h and $420 versus $400. In the 90 clinical strains, all of the Pseudomonas aeruginosa and Staphyloccocus aureus strains were correctly identified, but only 26.7% of the Escherichia coli strains were recognized as Escherichia coli, while 33.3% as Shigella sonnei and 40% as Shigella dysenteriae. The protocol described here is a rapid, reliable, stable and convenient method for 16S rRNA sequencing, and can be used for Pseudomonas aeruginosa and Staphyloccocus aureus identification, yet it is not completely suitable for discriminating Escherichia coli and Shigella strains.	[Chen, Linxiang; Shi, Xiaojun; Lin, Kun] Shantou Univ Med Coll, Dept Prevent Med, Shantou, Guangdong, Peoples R China; [Chen, Linxiang; Cai, Ying; Zhou, Guangbiao; Su, Jianhui; Chen, Guanwu] Shantou Entry Exit Inspect & Quarantine Bur, Mol Biol Lab, Shantou, Guangdong, Peoples R China		Lin, K (corresponding author), Shantou Univ Med Coll, Dept Prevent Med, Shantou, Guangdong, Peoples R China.	klin@stu.edu.cn	Schenkel, Flavio/ABG-1842-2021	WU, KWAN-DUN/0000-0002-3339-1509; Schenkel, Flavio/0000-0001-8700-0633; CHEN, YUNG-MING/0000-0002-9241-1258	Shantou Bureau of Science and Technology [[2009]387-126]; Guangdong Entry-Exit Inspection and Quarantine Bureau [2012 GDK45]; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology	Shantou Bureau of Science and Technology; Guangdong Entry-Exit Inspection and Quarantine Bureau; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology	Shantou Bureau of Science and Technology (grant No. [2009]387-126), Guangdong Entry-Exit Inspection and Quarantine Bureau (grant No. 2012 GDK45) Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aye KS, 2011, JPN J INFECT DIS, V64, P246; Becker K, 2004, J CLIN MICROBIOL, V42, P4988, DOI 10.1128/JCM.42.11.4988-4995.2004; Bhattacharya D, 2003, APPL ENVIRON MICROB, V69, P1435, DOI 10.1128/AEM.69.3.1435-1441.2003; Cloud JL, 2004, J CLIN MICROBIOL, V42, P578, DOI 10.1128/JCM.42.2.578-584.2004; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Fukushima H, 2003, J CLIN MICROBIOL, V41, P5134, DOI 10.1128/JCM.41.11.5134-5146.2003; Fukushima M, 2002, J CLIN MICROBIOL, V40, P2779, DOI 10.1128/JCM.40.8.2779-2785.2002; Gustavsson I, 2009, J CLIN VIROL, V46, P112, DOI 10.1016/j.jcv.2009.06.021; Hall L, 2003, J CLIN MICROBIOL, V41, P1447, DOI 10.1128/JCM.41.4.1447-1453.2003; Han XY, 2002, AM J CLIN PATHOL, V118, P796, DOI 10.1309/HN44-XQYM-JMAQ-2EDL; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Lan R, 2001, TRENDS MICROBIOL, V9, P419, DOI 10.1016/S0966-842X(01)02133-3; Li YY, 2006, J CLIN MICROBIOL, V44, P4376, DOI 10.1128/JCM.01389-06; Menassa N, 2010, INVEST OPHTH VIS SCI, V51, P1905, DOI 10.1167/iovs.09-3737; Monnet C, 2006, APPL ENVIRON MICROB, V72, P6972, DOI 10.1128/AEM.01303-06; Mullen MP, 2009, IRISH J AGR FOOD RES, V48, P109; PEATTIE DA, 1979, P NATL ACAD SCI USA, V76, P1760, DOI 10.1073/pnas.76.4.1760; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Schuurman T, 2004, J CLIN MICROBIOL, V42, P734, DOI 10.1128/JCM.42.2.734-740.2004; Smith L. M., 2004, BMC Ecology, V4, P4, DOI 10.1186/1472-6785-4-4; Tewari D, 2011, J VET DIAGN INVEST, V23, P1104, DOI 10.1177/1040638711425583; Vliegen I, 2006, J MICROBIOL METH, V66, P156, DOI 10.1016/j.mimet.2005.11.005; Willi B, 2009, J CLIN MICROBIOL, V47, P4049, DOI 10.1128/JCM.01478-09; Woo PCY, 2001, DIAGN MICR INFEC DIS, V39, P85, DOI 10.1016/S0732-8893(01)00206-1; Woo PCY, 2003, J CLIN MICROBIOL, V41, P1996, DOI 10.1128/JCM.41.5.1996-2001.2003	27	80	86	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88886	10.1371/journal.pone.0088886	http://dx.doi.org/10.1371/journal.pone.0088886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551186	gold, Green Published, Green Submitted			2022-12-25	WOS:000331271500079
J	Fan, YT; Cheng, YW				Fan, Yang-Teng; Cheng, Yawei			Atypical Mismatch Negativity in Response to Emotional Voices in People with Autism Spectrum Conditions	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ASPERGER-SYNDROME; CHILDREN; SPEECH; BRAIN; PERCEPTION; ATTENTION; DISCRIMINATION; LANGUAGE; DISORDER	Autism Spectrum Conditions (ASC) are characterized by heterogeneous impairments of social reciprocity and sensory processing. Voices, similar to faces, convey socially relevant information. Whether voice processing is selectively impaired remains undetermined. This study involved recording mismatch negativity (MMN) while presenting emotionally spoken syllables dada and acoustically matched nonvocal sounds to 20 subjects with ASC and 20 healthy matched controls. The people with ASC exhibited no MMN response to emotional syllables and reduced MMN to nonvocal sounds, indicating general impairments of affective voice and acoustic discrimination. Weaker angry MMN amplitudes were associated with more autistic traits. Receiver operator characteristic analysis revealed that angry MMN amplitudes yielded a value of 0.88 (p<.001). The results suggest that people with ASC may process emotional voices in an atypical fashion already at the automatic stage. This processing abnormality can facilitate diagnosing ASC and enable social deficits in people with ASC to be predicted.	[Fan, Yang-Teng; Cheng, Yawei] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Fan, Yang-Teng; Cheng, Yawei] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Cheng, Yawei] Natl Yang Ming Univ Hosp, Dept Rehabil, Yilan, Taiwan; [Cheng, Yawei] Taipei City Hosp, Dept Res & Educ, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Cheng, YW (corresponding author), Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan.	ywcheng2@ym.edu.tw			Ministry of Science and Technology [MOST 103-2401-H-010-003-MY3]; National Yang-Ming University Hospital [RD2014-003]; Health Department of Taipei City Government [10301-62-009]; Ministry of Education (Aim for the Top University Plan)	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Yang-Ming University Hospital; Health Department of Taipei City Government; Ministry of Education (Aim for the Top University Plan)(Ministry of Education, Taiwan)	The study was funded by the Ministry of Science and Technology (MOST 103-2401-H-010-003-MY3), National Yang-Ming University Hospital (RD2014-003), Health Department of Taipei City Government (10301-62-009), and Ministry of Education (Aim for the Top University Plan). The funders had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Amenedo E, 2000, EUR J NEUROSCI, V12, P2570, DOI 10.1046/j.1460-9568.2000.00114.x; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2010, NEURON, V65, P733, DOI 10.1016/j.neuron.2010.03.018; Boersma P, 2001, GLOT INT, V5, P341; Ceponiene R, 2003, P NATL ACAD SCI USA, V100, P5567, DOI 10.1073/pnas.0835631100; Cheng YW, 2012, J COGNITIVE NEUROSCI, V24, P1411, DOI 10.1162/jocn_a_00214; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Dawson G., 1989, AUTISM NATURE DIAGNO; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Dunn MA, 2008, J AUTISM DEV DISORD, V38, P52, DOI 10.1007/s10803-007-0359-3; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Ethofer T, 2012, CEREB CORTEX, V22, P191, DOI 10.1093/cercor/bhr113; Fan YT, 2013, NEUROREPORT, V24, P457, DOI 10.1097/WNR.0b013e32836169b9; Ferri R, 2003, CLIN NEUROPHYSIOL, V114, P1671, DOI 10.1016/S1388-2457(03)00153-6; Flom R, 2007, DEV PSYCHOL, V43, P238, DOI 10.1037/0012-1649.43.1.238; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Golan O, 2007, J AUTISM DEV DISORD, V37, P1096, DOI 10.1007/s10803-006-0252-5; Gomot M, 2002, PSYCHOPHYSIOLOGY, V39, P577, DOI 10.1017/S0048577202394058; Griffin R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-61; Grossmann T, 2012, SOC NEUROSCI-UK, V7, P369, DOI 10.1080/17470919.2011.628758; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; HOBSON RP, 1989, BRIT J DEV PSYCHOL, V7, P237, DOI 10.1111/j.2044-835X.1989.tb00803.x; Hung AY, 2014, NEUROREPORT, V25, P464, DOI 10.1097/WNR.0000000000000115; Hung AY, 2013, J CHILD PSYCHOL PSYC, V54, P1016, DOI 10.1111/jcpp.12076; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Jansson-Verkasalo E, 2003, NEUROSCI LETT, V338, P197, DOI 10.1016/S0304-3940(02)01405-2; Jarvinen-Pasley A, 2008, DEVELOPMENTAL SCI, V11, P109, DOI 10.1111/j.1467-7687.2007.00644.x; KEMNER C, 1995, BIOL PSYCHIAT, V38, P150, DOI 10.1016/0006-3223(94)00247-Z; Khalfa S, 2004, HEARING RES, V198, P87, DOI 10.1016/j.heares.2004.07.006; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; Korpilahti P, 2007, J AUTISM DEV DISORD, V37, P1539, DOI 10.1007/s10803-006-0271-2; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Kujala T, 2001, CLIN NEUROPHYSIOL, V112, P1712, DOI 10.1016/S1388-2457(01)00625-3; Kujala T, 2005, NEUROSCI LETT, V383, P260, DOI 10.1016/j.neulet.2005.04.048; Lepisto T, 2008, BIOL PSYCHOL, V77, P25, DOI 10.1016/j.biopsycho.2007.08.010; Lepisto T, 2006, CLIN NEUROPHYSIOL, V117, P2161, DOI 10.1016/j.clinph.2006.06.709; Lepisto T, 2005, BRAIN RES, V1066, P147, DOI 10.1016/j.brainres.2005.10.052; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; LINCOLN AJ, 1993, J AUTISM DEV DISORD, V23, P37, DOI 10.1007/BF01066417; Locke J.L., 1993, CHILDS PATH SPOKEN L; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maestro S, 2002, J AM ACAD CHILD PSY, V41, P1239, DOI 10.1097/00004583-200210000-00014; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Mottron L, 2000, J CHILD PSYCHOL PSYC, V41, P1057, DOI 10.1111/1469-7610.00693; Mottron L, 2011, NATURE, V479, P33, DOI 10.1038/479033a; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NICHOLSON C, 1973, IEEE T BIO-MED ENG, VBM20, P278, DOI 10.1109/TBME.1973.324192; Novitski N, 2004, COGNITIVE BRAIN RES, V20, P26, DOI 10.1016/j.cogbrainres.2003.12.011; O'Connor K, 2012, NEUROSCI BIOBEHAV R, V36, P836, DOI 10.1016/j.neubiorev.2011.11.008; Paul R, 2005, J AUTISM DEV DISORD, V35, P205, DOI 10.1007/s10803-004-1999-1; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Roberts TPL, 2011, BIOL PSYCHIAT, V70, P263, DOI 10.1016/j.biopsych.2011.01.015; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Schirmer A, 2008, NEUROIMAGE, V40, P1402, DOI 10.1016/j.neuroimage.2008.01.018; Schirmer A, 2007, BRAIN RES, V1176, P103, DOI 10.1016/j.brainres.2007.08.008; Seri S, 1999, CLIN NEUROPHYSIOL, V110, P1825, DOI 10.1016/S1388-2457(99)00137-6; Stefanics G, 2012, NEUROIMAGE, V59, P3042, DOI 10.1016/j.neuroimage.2011.10.041; Sussman ES, 2013, BRAIN TOPOGR; Vouloumanos A, 2007, DEVELOPMENTAL SCI, V10, P159, DOI 10.1111/j.1467-7687.2007.00549.x; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wechsler D., 2012, WAIS 4 KASIKIRJA; Winer B.J., 1991, STAT PRINCIPLES EXPT	67	164	168	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102471	10.1371/journal.pone.0102471	http://dx.doi.org/10.1371/journal.pone.0102471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	24475058	Green Published, Green Submitted, gold			2022-12-25	WOS:000339615200061
J	Zhu, LL; Fan, Y; Zou, QH; Wang, J; Gao, JH; Niu, ZD				Zhu, Linlin; Fan, Yang; Zou, Qihong; Wang, Jue; Gao, Jia-Hong; Niu, Zhendong			Temporal Reliability and Lateralization of the Resting-State Language Network	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY MRI; TEST-RETEST RELIABILITY; HUMAN BRAIN; CORTICAL ORGANIZATION; ALZHEIMERS-DISEASE; COMPONENT ANALYSIS; CINGULATE CORTEX; FMRI; SCHIZOPHRENIA; ASYMMETRIES	The neural processing loop of language is complex but highly associated with Broca's and Wernicke's areas. The left dominance of these two areas was the earliest observation of brain asymmetry. It was demonstrated that the language network and its functional asymmetry during resting state were reproducible across institutions. However, the temporal reliability of resting-state language network and its functional asymmetry are still short of knowledge. In this study, we established a seed-based resting-state functional connectivity analysis of language network with seed regions located at Broca's and Wernicke's areas, and investigated temporal reliability of language network and its functional asymmetry. The language network was found to be temporally reliable in both short-and long-term. In the aspect of functional asymmetry, the Broca's area was found to be left lateralized, while the Wernicke's area is mainly right lateralized. Functional asymmetry of these two areas revealed high short-and long-term reliability as well. In addition, the impact of global signal regression (GSR) on reliability of the resting-state language network was investigated, and our results demonstrated that GSR had negligible effect on the temporal reliability of the resting-state language network. Our study provided methodology basis for future cross-culture and clinical researches of resting-state language network and suggested priority of adopting seed-based functional connectivity for its high reliability.	[Zhu, Linlin; Niu, Zhendong] Beijing Inst Technol, Sch Comp Sci & Technol, Beijing 100081, Peoples R China; [Fan, Yang; Zou, Qihong; Gao, Jia-Hong] Peking Univ, Sch Phys, Ctr MRI Res, Beijing 100871, Peoples R China; [Fan, Yang; Zou, Qihong; Gao, Jia-Hong] Peking Univ, Sch Phys, Beijing City Key Lab Med Phys & Engn, Beijing 100871, Peoples R China; [Wang, Jue] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou 310015, Zhejiang, Peoples R China; [Gao, Jia-Hong] Peking Univ, McGovern Inst Brain Res, Beijing 100871, Peoples R China	Beijing Institute of Technology; Peking University; Peking University; Hangzhou Normal University; Peking University	Zou, QH (corresponding author), Peking Univ, Sch Phys, Ctr MRI Res, Beijing 100871, Peoples R China.	zouqihong@pku.edu.cn; zniu@bit.edu.cn			China's National Strategic Basic Research Program (973) [2012CB720700]; National Key Technology R D Program [2011BAI12B01]; Natural Science Foundation of China [81201142, 81227003]	China's National Strategic Basic Research Program (973); National Key Technology R D Program(National Key Technology R&D Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by China's National Strategic Basic Research Program (973) (2012CB720700), the National Key Technology R& D Program (2011BAI12B01), and the Natural Science Foundation of China (81201142, 81227003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birn RM, 2013, NEUROIMAGE; Booth JR, 2006, BRAIN RES, V1071, P197, DOI 10.1016/j.brainres.2005.11.097; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Chen G, 2012, MAGN RESON MED, V68, P1828, DOI 10.1002/mrm.24201; Chou YH, 2012, AM J NEURORADIOL, V33, P833, DOI 10.3174/ajnr.A2894; Constable RT, 2013, NEUROIMAGE, V64, P371, DOI 10.1016/j.neuroimage.2012.09.008; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Crow TJ, 1997, TRENDS NEUROSCI, V20, P339; Dollfus S, 2005, BIOL PSYCHIAT, V57, P1020, DOI 10.1016/j.biopsych.2005.01.009; Dronkers NF, 2011, NEUROLOGY, V76, pA162; Egidi G, 2013, NEUROIMAGE, V71, P59, DOI 10.1016/j.neuroimage.2013.01.003; Fiecas M, 2013, NEUROIMAGE, V65, P231, DOI 10.1016/j.neuroimage.2012.09.052; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; HEILMAN KM, 1976, CORTEX, V12, P258, DOI 10.1016/S0010-9452(76)80007-X; Herbert MR, 2005, BRAIN, V128, P213, DOI 10.1093/brain/awh330; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hirnstein M, 2007, LATERALITY, V12, P87, DOI 10.1080/13576500600959247; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Jung WH, 2012, PLOS ONE, V7; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; KERTESZ A, 1986, CORTEX, V22, P117, DOI 10.1016/S0010-9452(86)80036-3; Kim JY, 2012, INT J AUDIOL, V51, P413, DOI 10.3109/14992027.2011.652677; Kollndorfer K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00095; Kristo G, 2014, HUM BRAIN MAPP, V35, P340, DOI 10.1002/hbm.22180; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Kuo WJ, 2004, NEUROIMAGE, V21, P1721, DOI 10.1016/j.neuroimage.2003.12.007; LARSEN JP, 1990, BRAIN LANG, V39, P289, DOI 10.1016/0093-934X(90)90015-9; LEMAY M, 1978, J COMPUT ASSIST TOMO, V2, P471; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liu HS, 2009, P NATL ACAD SCI USA, V106, P20499, DOI 10.1073/pnas.0908073106; Lohmann G, 2010, CEREB CORTEX, V20, P1286, DOI 10.1093/cercor/bhp190; Mannfolk P, 2011, J MAGN RESON IMAGING, V34, P511, DOI 10.1002/jmri.22654; Marcotte K, 2013, BRAIN LANG, V124, P45, DOI 10.1016/j.bandl.2012.11.004; MOHR JP, 1978, NEUROLOGY, V28, P311, DOI 10.1212/WNL.28.4.311; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Narr KL, 2001, AM J PSYCHIAT, V158, P244, DOI 10.1176/appi.ajp.158.2.244; OJEMANN GA, 1991, J NEUROSCI, V11, P2281; Petridou N, 2009, MAGN RESON IMAGING, V27, P1046, DOI 10.1016/j.mri.2009.02.006; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Pravata E, 2011, AM J NEURORADIOL, V32, P532, DOI 10.3174/ajnr.A2311; PREVIC FH, 1991, PSYCHOL REV, V98, P299, DOI 10.1037/0033-295X.98.3.299; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Proverbio AM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-116; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Thirion B, 2006, NEUROIMAGE, V29, P321, DOI 10.1016/j.neuroimage.2005.06.054; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tomasi D, 2012, MOL PSYCHIATR, V17, P841, DOI 10.1038/mp.2011.177; Tomasi D, 2005, NEUROIMAGE, V27, P377, DOI 10.1016/j.neuroimage.2005.04.010; Tomasi D, 2012, CEREB CORTEX, V22, P1455, DOI 10.1093/cercor/bhr230; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van den Heuvel M, 2008, PLOS ONE, P3; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wernicke C., 1874, APHASISCHE SYMPTOMEN; Worsley KJ, 2005, PHILOS T R SOC B, V360, P913, DOI 10.1098/rstb.2005.1637; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119; Xuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030570; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Zhang H, 2011, NEUROIMAGE, V55, P607, DOI 10.1016/j.neuroimage.2010.12.007; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029; Zuo X-N, 2012, NEUROIMAGE; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	90	164	168	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85880	10.1371/journal.pone.0085880	http://dx.doi.org/10.1371/journal.pone.0085880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475058	gold, Green Submitted, Green Published			2022-12-25	WOS:000330339800018
